PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Yu, X; Wang, H; Zhong, WL; Bai, JJ; Liu, PL; He, YK				Yu, Xiang; Wang, Han; Zhong, Weili; Bai, Jinjuan; Liu, Pinglin; He, Yuke			QTL Mapping of Leafy Heads by Genome Resequencing in the RIL Population of Brassica rapa	PLOS ONE			English	Article							WIDE ASSOCIATION; LINKAGE MAP; GENE; PETIOLE	Leaf heads of cabbage (Brassica oleracea), Chinese cabbage (B. rapa), and lettuce (Lactuca sativa) are important vegetables that supply mineral nutrients, crude fiber and vitamins in the human diet. Head size, head shape, head weight, and heading time contribute to yield and quality. In an attempt to investigate genetic basis of leafy head in Chinese cabbage (B. rapa), we took advantage of recent technical advances of genome resequencing to perform quantitative trait locus (QTL) mapping using 150 recombinant inbred lines (RILs) derived from the cross between heading and non-heading Chinese cabbage. The resequenced genomes of the parents uncovered more than 1 million SNPs. Genotyping of RILs using the high-quality SNPs assisted by Hidden Markov Model (HMM) generated a recombination map. The raw genetic map revealed some physical assembly error and missing fragments in the reference genome that reduced the quality of SNP genotyping. By deletion of the genetic markers in which recombination rates higher than 20%, we have obtained a high-quality genetic map with 2209 markers and detected 18 QTLs for 6 head traits, from which 3 candidate genes were selected. These QTLs provide the foundation for study of genetic basis of leafy heads and the other complex traits.	[Yu, Xiang; Wang, Han; Zhong, Weili; Bai, Jinjuan; Liu, Pinglin; He, Yuke] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	He, YK (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.	ykhe@sibs.ac.cn	Yu, Xiang/H-9666-2019	Yu, Xiang/0000-0002-5730-8802	National Basic Research Program of China [2012CB113903]	National Basic Research Program of China(National Basic Research Program of China)	This work is supported by National Basic Research Program of China (Grant No. 2012CB113903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Hatakeyama K, 2010, GENOME, V53, P257, DOI [10.1139/G10-001, 10.1139/g10-001]; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Kumar R, 2007, PLANT CELL, V19, P2719, DOI 10.1105/tpc.106.048769; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Marian AJ, 2012, TRANSL RES, V159, P64, DOI 10.1016/j.trsl.2011.08.001; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nagata T, 1999, PLANT PHYSIOL, V120, P113, DOI 10.1104/pp.120.1.113; Piao ZY, 2004, THEOR APPL GENET, V108, P1458, DOI 10.1007/s00122-003-1577-5; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; van der Graaff E, 2000, DEVELOPMENT, V127, P4971; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-289; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-239; Ward JM, 2006, PLANT CELL, V18, P29, DOI 10.1105/tpc.105.036707; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Xiao L, 2012, THEOR APPL GENET, V124, P903, DOI 10.1007/s00122-011-1754-x; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; ZENG ZB, 1994, GENETICS, V136, P1457	26	39	40	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76059	10.1371/journal.pone.0076059	http://dx.doi.org/10.1371/journal.pone.0076059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204591	Green Submitted, Green Published, gold			2022-12-27	WOS:000326241200009
J	Dong, RL; Xu, XZ; Li, G; Feng, WJ; Zhao, G; Zhao, JJ; Wang, DW; Tu, L				Dong, Ruolan; Xu, Xizhen; Li, Geng; Feng, Wenjing; Zhao, Gang; Zhao, Junjie; Wang, Dao Wen; Tu, Ling			Bradykinin Inhibits Oxidative Stress-Induced Cardiomyocytes Senescence via Regulating Redox State	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CELLULAR SENESCENCE; TISSUE KALLIKREIN; DNA-DAMAGE; CELLS; APOPTOSIS; RECEPTORS; PATHWAYS; MICE	Background: Cell senescence is central to a large body of age related pathology, and accordingly, cardiomyocytes senescence is involved in many age related cardiovascular diseases. In consideration of that, delaying cardiomyocytes senescence is of great importance to control clinical cardiovascular diseases. Previous study indicated that bradykinin (BK) protected endothelial cells from senescence induced by oxidative stress. However, the effects of bradykinin on cardiomyocytes senescence remain to be elucidated. In this study, we investigated the effect of bradykinin on H2O2-induced H9C2 cells senescence. Methods and Results: Bradykinin pretreatment decreased the senescence induced by H2O2 in cultured H9C2 cells in a dose dependent manner. Interestingly, 1 nmol/L of BK almost completely inhibited the increase in senescent cell number and p21 expression induced by H2O2. Since H2O2 induces senescence through superoxide-induced DNA damage, we also observed the DNA damage by comet assay, and BK markedly reduced DNA damage induced by H2O2, and moreover, BK treatment significantly prevented reactive oxygen species (ROS) production in H9C2 cells treated with H2O2. Importantly, when co-incubated with bradykinin B2 receptor antagonist HOE-140 or eNOS inhibitor N-methyl-L-arginine acetate salt (L-NAME), the protective effects of bradykinin on H9C2 senescence were totally blocked. Furthermore, BK administration significantly prevented the increase in nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity characterized by increased ROS generation and gp91 expression and increased translocation of p47 and p67 to the membrane and the decrease in superoxide dismutase (SOD) activity and expression induced by H2O2 in H9C2 cells, which was dependent on BK B2 receptor mediated nitric oxide (NO) release. Conclusions: Bradykinin, acting through BK B2 receptor induced NO release, upregulated antioxidant Cu/Zn-SOD and Mn-SOD activity and expression while downregulating NADPH oxidase activity and subsequently inhibited ROS production, and finally protected against cardiomyocytes senescence induced by oxidative stress.	[Dong, Ruolan; Li, Geng; Feng, Wenjing; Zhao, Junjie; Tu, Ling] Huazhong Univ Sci & Technol, Dept Geriatr Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Xu, Xizhen; Zhao, Gang; Wang, Dao Wen] Huazhong Univ Sci & Technol, Inst Hypertens, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Xu, Xizhen; Zhao, Gang; Wang, Dao Wen] Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tu, L (corresponding author), Huazhong Univ Sci & Technol, Dept Geriatr Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	proftu@tom.com			National Nature Science Foundation Committee of China [303061511, 30971247, 81100085]	National Nature Science Foundation Committee of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundation Committee of China (No. 303061511, No. 30971247 and No. 81100085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhard D, 2008, GERONTOLOGY, V54, P24, DOI 10.1159/000113503; Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009; Clarke R, 2009, J STEROID BIOCHEM, V114, P8, DOI 10.1016/j.jsbmb.2008.12.023; Cyr M, 2001, TRANSFUSION, V41, P136, DOI 10.1046/j.1537-2995.2001.41010136.x; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Feng J, 2010, ARTERIOSCL THROM VAS, V30, P1703, DOI 10.1161/ATVBAHA.110.209726; Frank A, 2012, SEMIN CARDIOTHORAC V, V16, P123, DOI 10.1177/1089253211436350; Frantz S, 2006, BASIC RES CARDIOL, V101, P127, DOI 10.1007/s00395-005-0568-x; Freedman DA, 2005, EXP CELL RES, V307, P118, DOI 10.1016/j.yexcr.2005.03.025; Gandarillas A, 2000, EXP GERONTOL, V35, P53, DOI 10.1016/S0531-5565(99)00088-1; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Iglesias-Ara A, 2010, ONCOGENE, V29, P5579, DOI 10.1038/onc.2010.296; Kakoki M, 2006, J CLIN INVEST, V116, P1302, DOI 10.1172/JCI26958; Kanai AJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1371, DOI 10.1152/ajpcell.1997.273.4.C1371; Kintsurashvili E, 2005, AM J PHYSIOL-HEART C, V289, pH202, DOI 10.1152/ajpheart.01287.2004; Linz W, 1999, CARDIOVASC RES, V43, P549, DOI 10.1016/S0008-6363(99)00091-7; Lou ZK, 2006, EXP CELL RES, V312, P2641, DOI 10.1016/j.yexcr.2006.06.009; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Oeseburg H, 2009, HYPERTENSION, V53, P417, DOI 10.1161/HYPERTENSIONAHA.108.123729; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Park SK, 2011, BMB REP, V44, P291, DOI 10.5483/BMBRep.2011.44.5.291; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Rahman K, 2007, CLIN INTERV AGING, V2, P219; Sayama K, 1999, J CELL PHYSIOL, V179, P40, DOI 10.1002/(SICI)1097-4652(199904)179:1<40::AID-JCP5>3.0.CO;2-Z; Tikellis C, 2011, CURR OPIN NEPHROL HY, V20, P62, DOI 10.1097/MNH.0b013e328341164a; Tu L, 2008, HUM GENE THER, V19, P318, DOI 10.1089/hum.2007.138; Unterluggauer H, 2003, EXP GERONTOL, V38, P1149, DOI 10.1016/j.exger.2003.08.007; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vasa M, 2000, CIRC RES, V87, P540, DOI 10.1161/01.RES.87.7.540; Vulliamy TJ, 2009, CELL MOL LIFE SCI, V66, P3091, DOI 10.1007/s00018-009-0091-6; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Westin ER, 2011, ANTIOXID REDOX SIGN, V14, P985, DOI 10.1089/ars.2010.3444; Xu XZ, 2012, INT J MOL MED, V29, P891, DOI 10.3892/ijmm.2012.922; Yang SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029652, 10.1371/journal.pone.0035836]; Yin H, 2008, LIFE SCI, V82, P156, DOI 10.1016/j.lfs.2007.10.021; Zhang MA, 2011, ARTERIOSCL THROM VAS, V31, P125, DOI 10.1161/ATVBAHA.110.207712; Zhang XL, 2005, J BIOL CHEM, V280, P19635, DOI 10.1074/jbc.M502262200; Zieman SJ, 2001, CIRC RES, V88, P97, DOI 10.1161/01.RES.88.1.97	39	34	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77034	10.1371/journal.pone.0077034	http://dx.doi.org/10.1371/journal.pone.0077034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204728	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400026
J	A'Bear, AD; Murray, W; Webb, R; Boddy, L; Jones, TH				A'Bear, A. Donald; Murray, William; Webb, Rachel; Boddy, Lynne; Jones, T. Hefin			Contrasting Effects of Elevated Temperature and Invertebrate Grazing Regulate Multispecies Interactions between Decomposer Fungi	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMUNITY STRUCTURE; WOODLAND SOIL; SITKA SPRUCE; BOTTOM-UP; TOP-DOWN; LITTER; BIODIVERSITY; IMPACTS; INOCULATION	Predicting the influence of biotic and abiotic factors on species interactions and ecosystem processes is among the primary aims of community ecologists. The composition of saprotrophic fungal communities is a consequence of competitive mycelial interactions, and a major determinant of woodland decomposition and nutrient cycling rates. Elevation of atmospheric temperature is predicted to drive changes in fungal community development. Top-down regulation of mycelial growth is an important determinant of, and moderator of temperature-driven changes to, two-species interaction outcomes. This study explores the interactive effects of a 4 degrees C temperature increase and soil invertebrate (collembola or woodlice) grazing on multispecies interactions between cord-forming basidiomycete fungi emerging from colonised beech (Fagus sylvatica) wood blocks. The fungal dominance hierarchy at ambient temperature (16 degrees C; Phanerochaete velutina > Resinicium bicolor > Hypholoma fasciculare) was altered by elevated temperature (20 degrees C; R. bicolor > P. velutina > H. fasciculare) in ungrazed systems. Warming promoted the competitive ability of the fungal species (R. bicolor) that was preferentially grazed by all invertebrate species. As a consequence, grazing prevented the effect of temperature on fungal community development and maintained a multispecies assemblage. Decomposition of fungal-colonised wood was stimulated by warming, with implications for increased CO2 efflux from woodland soil. Analogous to aboveground plant communities, increasing complexity of biotic and abiotic interactions appears to be important in buffering climate change effects on soil decomposers.	[A'Bear, A. Donald; Murray, William; Webb, Rachel; Boddy, Lynne; Jones, T. Hefin] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	A'Bear, AD (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.	BoddyL@Cardiff.ac.uk	Boddy, Lynne/A-7250-2010	Jones, T Hefin/0000-0002-7874-3627; Boddy, Lynne/0000-0003-1845-6738	Natural Environment Research Council [NERC/I527861]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Natural Environment Research Council provided a studentship to ADA (NERC/I527861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A'Bear AD, 2013, FUNGAL ECOL, V6, P137, DOI 10.1016/j.funeco.2013.01.001; A'Bear AD, 2012, GLOBAL CHANGE BIOL, V18, P1823, DOI 10.1111/j.1365-2486.2012.02637.x; A'Bear AD, 2013, FUNGAL ECOL, DOI [10.1016/j.funeco.2013.01.009, DOI 10.1016/J.FUNEC0.2013.01.009]; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Boddy L, 1999, MYCOLOGIA, V91, P13, DOI 10.2307/3761190; BODDY L, 1983, SOIL BIOL BIOCHEM, V15, P149, DOI 10.1016/0038-0717(83)90096-2; Boddy L, 2000, FEMS MICROBIOL ECOL, V31, P185, DOI 10.1111/j.1574-6941.2000.tb00683.x; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Crowther TW, 2012, ISME J, V6, P1992, DOI 10.1038/ismej.2012.53; Crowther TW, 2012, FEMS MICROBIOL ECOL, V81, P419, DOI 10.1111/j.1574-6941.2012.01364.x; Crowther TW, 2012, FUNGAL ECOL, V5, P277, DOI 10.1016/j.funeco.2011.07.006; Crowther TW, 2011, ECOL LETT, V14, P1134, DOI 10.1111/j.1461-0248.2011.01682.x; Crowther TW, 2011, SOIL BIOL BIOCHEM, V43, P2060, DOI 10.1016/j.soilbio.2011.06.003; Crowther TW, 2011, OECOLOGIA, V167, P535, DOI 10.1007/s00442-011-2005-1; Crowther TW, 2013, ECOLOGY IN PRESS; David JF, 2010, BIOL REV, V85, P881, DOI 10.1111/j.1469-185X.2010.00138.x; DOWSON CG, 1988, NEW PHYTOL, V109, P343, DOI 10.1111/j.1469-8137.1988.tb04204.x; DOWSON CG, 1988, NEW PHYTOL, V109, P335, DOI 10.1111/j.1469-8137.1988.tb04203.x; Eklof JS, 2012, ECOL LETT, V15, P864, DOI 10.1111/j.1461-0248.2012.01810.x; Fricker MD, 2008, BR MYCOL SY, V28, P3; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; HANLON RDG, 1979, OECOLOGIA, V38, P93, DOI 10.1007/BF00347827; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Jones TH, 1998, SCIENCE, V280, P441, DOI 10.1126/science.280.5362.441; Kaneko N, 1998, APPL SOIL ECOL, V9, P209, DOI 10.1016/S0929-1393(98)00077-8; Lawton JH, 1996, ECOLOGY, V77, P665, DOI 10.2307/2265488; LAWTON JH, 1995, SCIENCE, V269, P328, DOI 10.1126/science.269.5222.328; Leuzinger S, 2011, TRENDS ECOL EVOL, V26, P236, DOI 10.1016/j.tree.2011.02.011; Moore JC, 2003, ECOLOGY, V84, P846, DOI 10.1890/0012-9658(2003)084[0846:TIBDPI]2.0.CO;2; NEWELL K, 1984, SOIL BIOL BIOCHEM, V16, P235, DOI 10.1016/0038-0717(84)90007-5; NEWELL K, 1984, SOIL BIOL BIOCHEM, V16, P227, DOI 10.1016/0038-0717(84)90006-3; PETERSEN H, 1982, OIKOS, V39, P287, DOI 10.2307/3544689; Pollierer MM, 2009, SOIL BIOL BIOCH; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; R Core Team, 2021, R LANGUAGE ENV STAT; Ronn R, 2002, APPL ENVIRON MICROB, V68, P6094, DOI 10.1128/AEM.68.12.6094-6105.2002; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Topp W, 2006, SOIL BIOL BIOCHEM, V38, P43, DOI 10.1016/j.soilbio.2005.04.012; Tordoff GM, 2008, SOIL BIOL BIOCHEM, V40, P434, DOI 10.1016/j.soilbio.2007.09.006; Travleev AP, 1960, EURASIAN SOIL SCI, V10, P1108; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Veen GF, 2010, ECOLOGY, V91, P828, DOI 10.1890/09-0134.1; Voigt W, 2007, GLOBAL CHANGE BIOL, V13, P1710, DOI 10.1111/j.1365-2486.2007.01398.x; Walker M, 2001, OIKOS, V93, P177, DOI 10.1034/j.1600-0706.2001.930201.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Yuste JC, 2011, GLOBAL CHANGE BIOL, V17, P1475, DOI 10.1111/j.1365-2486.2010.02300.x	52	14	14	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77610	10.1371/journal.pone.0077610	http://dx.doi.org/10.1371/journal.pone.0077610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194892	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000071
J	Chiaverano, LM; Holland, BS; Crow, GL; Blair, L; Yanagihara, AA				Chiaverano, Luciano M.; Holland, Brenden S.; Crow, Gerald L.; Blair, Landy; Yanagihara, Angel A.			Long-Term Fluctuations in Circalunar Beach Aggregations of the Box Jellyfish Alatina moseri in Hawaii, with Links to Environmental Variability	PLOS ONE			English	Article							PACIFIC SUBTROPICAL GYRE; AURELIA-AURITA; GELATINOUS ZOOPLANKTON; TRIPEDALIA-CYSTOPHORA; PELAGIA-NOCTILUCA; CHIRONEX-FLECKERI; COMMON JELLYFISH; SOMATIC GROWTH; BLOOMS; CNIDARIA	The box jellyfish Alatina moseri forms monthly aggregations at Waikiki Beach 8-12 days after each full moon, posing a recurrent hazard to swimmers due to painful stings. We present an analysis of long-term (14 years: Jan 1998- Dec 2011) changes in box jellyfish abundance at Waikiki Beach. We tested the relationship of beach counts to climate and biogeochemical variables over time in the North Pacific Sub-tropical Gyre (NPSG). Generalized Additive Models (GAM), Change-Point Analysis (CPA), and General Regression Models (GRM) were used to characterize patterns in box jellyfish arrival at Waikiki Beach 8-12 days following 173 consecutive full moons. Variation in box jellyfish abundance lacked seasonality, but exhibited dramatic differences among months and among years, and followed an oscillating pattern with significant periods of increase (1998-2001; 2006-2011) and decrease (2001-2006). Of three climatic and 12 biogeochemical variables examined, box jellyfish showed a strong, positive relationship with primary production, >2 mm zooplankton biomass, and the North Pacific Gyre Oscillation (NPGO) index. It is clear that that the moon cycle plays a key role in synchronizing timing of the arrival of Alatina moseri medusae to shore. We propose that bottom-up processes, likely initiated by inter-annual regional climatic fluctuations influence primary production, secondary production, and ultimately regulate food availability, and are therefore important in controlling the inter-annual changes in box jellyfish abundance observed at Waikiki Beach.	[Chiaverano, Luciano M.] Univ Hawaii Manoa, Kewalo Marine Lab, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Holland, Brenden S.] Univ Hawaii Manoa, Ctr Conservat Res & Training, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Crow, Gerald L.] Univ Hawaii Manoa, Waikiki Aquarium, Honolulu, HI 96822 USA; [Blair, Landy] City & Cty Honolulu, Ocean Safety Serv, Honolulu, HI USA; [Blair, Landy] City & Cty Honolulu, Lifeguard Serv, Honolulu, HI USA; [Yanagihara, Angel A.] Univ Hawaii Manoa, Bekesy Lab, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Yanagihara, Angel A.] Univ Hawaii Manoa, Dept Trop Med, John A Burns Sch Med, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Chiaverano, LM (corresponding author), Univ Hawaii Manoa, Kewalo Marine Lab, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA.	lchiave@hawaii.edu	holland, brenden/J-5630-2019; Yanagihara, Angel/O-5664-2016	holland, brenden/0000-0002-7832-8589; Yanagihara, Angel/0000-0001-6908-8176; Chiaverano, Luciano/0000-0002-3730-9744	National Institutes of Health [U54 NS039406, P20 RR016453, G12 RR003061, R21 DA024444]; Victoria S and Bradley L Geist Foundation of Hawaii Community Foundation [HCF 958935, 991879, 20001741, 20011908, 20061497, 20071368, 47031]; Oahu Army Natural Resources Program; Directorate For Geosciences [1260164] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR016453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS039406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024444] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victoria S and Bradley L Geist Foundation of Hawaii Community Foundation; Oahu Army Natural Resources Program; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Field components of this project were partially supported by grants from the National Institutes of Health (U54 NS039406, P20 RR016453, G12 RR003061, P20 RR016453, R21 DA024444) and the Victoria S and Bradley L Geist Foundation of Hawaii Community Foundation (HCF 958935, 991879, 20001741, 20011908, 20061497, 20071368 and 47031) (AY). BSH and LMC were supported by the Oahu Army Natural Resources Program during preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M.N., 1997, FUNCTIONAL BIOL SCYP, P300; Arai MN, 2009, HYDROBIOLOGIA, V616, P241, DOI 10.1007/s10750-008-9588-5; Arneson AC, 1976, COELENTRATE ECOLOGY; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baker JD, 2012, MAR ECOL PROG SER, V469, P175, DOI 10.3354/meps09987; Bentlage B, 2010, P ROY SOC B-BIOL SCI, V277, P493, DOI 10.1098/rspb.2009.1707; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Boero F, 1996, TRENDS ECOL EVOL, V11, P177, DOI 10.1016/0169-5347(96)20007-2; Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7; Carrette T, 2002, TOXICON, V40, P1547, DOI 10.1016/S0041-0101(02)00168-X; Chiaverano L, 2004, HYDROBIOLOGIA, V530, P373, DOI 10.1007/s10750-004-2666-4; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; Courtney R, 2012, THESIS; Daryanabard R, 2008, J MAR BIOL ASSOC UK, V88, P477, DOI 10.1017/S0025315408000945; Dave AC, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006507; Dawson MN, 2009, HYDROBIOLOGIA, V616, P193, DOI 10.1007/s10750-008-9591-x; Delannoy CMJ, 2011, AQUACULTURE, V311, P255, DOI 10.1016/j.aquaculture.2010.11.033; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Dong ZJ, 2010, MAR POLLUT BULL, V60, P954, DOI 10.1016/j.marpolbul.2010.04.022; Dore JE, 2002, LIMNOL OCEANOGR, V47, P1595, DOI 10.4319/lo.2002.47.6.1595; Dore JE, 2008, PROG OCEANOGR, V76, P2, DOI 10.1016/j.pocean.2007.10.002; Doyle TK, 2008, J PLANKTON RES, V30, P963, DOI 10.1093/plankt/fbn052; Doyle TK, 2007, HYDROBIOLOGIA, V579, P29, DOI 10.1007/s10750-006-0362-2; Eberhardt LL, 1999, MAR MAMMAL SCI, V15, P766, DOI 10.1111/j.1748-7692.1999.tb00842.x; Fenner PJ, 2010, J TRAVEL MED, V17, P133, DOI 10.1111/j.1708-8305.2009.00390.x; Fenner PJ, 2002, MED J AUSTRALIA, V177, P362, DOI 10.5694/j.1326-5377.2002.tb04838.x; Fenner PJ, 1996, MED J AUSTRALIA, V165, P658, DOI 10.5694/j.1326-5377.1996.tb138679.x; Ferraris M, 2012, J PLANKTON RES, V34, P874, DOI 10.1093/plankt/fbs049; Fischer AB, 2004, HYDROBIOLOGIA, V530, P331, DOI 10.1007/s10750-004-2658-4; Garm A, 2012, BIOL BULL-US, V222, P35, DOI 10.1086/BBLv222n1p35; Gilhousen D. B., 1987, Journal of Atmospheric and Oceanic Technology, V4, P94, DOI 10.1175/1520-0426(1987)004<0094:AFEONM>2.0.CO;2; Gordon MR, 2009, HYDROBIOLOGIA, V616, P87, DOI 10.1007/s10750-008-9594-7; Graham WM, 2003, BIOL INVASIONS, V5, P53, DOI 10.1023/A:1024046707234; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Hamner WM, 2009, HYDROBIOLOGIA, V616, P161, DOI 10.1007/s10750-008-9620-9; HAMNER WM, 1982, LIMNOL OCEANOGR, V27, P896, DOI 10.4319/lo.1982.27.5.0896; HAMNER WM, 1974, AM ZOOL, V14, P833; Han Chang-Hoon, 2010, Plankton & Benthos Research, V5, P98; Hannides CCS, 2009, LIMNOL OCEANOGR, V54, P50, DOI 10.4319/lo.2009.54.1.0050; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hoover RA, 2009, HYDROBIOLOGIA, V616, P259, DOI 10.1007/s10750-008-9595-6; Houghton JDR, 2007, HYDROBIOLOGIA, V589, P1, DOI 10.1007/s10750-007-0572-2; Huynh TT, 2003, MED J AUSTRALIA, V178, P38, DOI 10.5694/j.1326-5377.2003.tb05041.x; Ishii H, 1998, J PLANKTON RES, V20, P805, DOI 10.1093/plankt/20.5.805; Kahn AS, 2012, DEEP-SEA RES PT I, V70, P36, DOI 10.1016/j.dsr.2012.08.001; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Karl DM, 1999, ECOSYSTEMS, V2, P181, DOI 10.1007/s100219900068; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; Lilley MKS, 2011, MAR BIOL, V158, P2429, DOI 10.1007/s00227-011-1744-1; Lucas CH, 1996, J PLANKTON RES, V18, P987, DOI 10.1093/plankt/18.6.987; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; Lucas CH, 1998, MAR BIOL, V131, P629, DOI 10.1007/s002270050355; Lynam CP, 2011, GLOBAL CHANGE BIOL, V17, P767, DOI 10.1111/j.1365-2486.2010.02352.x; Lynam CP, 2010, J MAR BIOL ASSOC UK, V90, P1153, DOI 10.1017/S0025315409990488; Ma XP, 2005, MAR BIOL, V147, P225, DOI 10.1007/s00227-004-1539-8; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Matsumoto George I., 2002, Bishop Museum Occasional Papers, V69, P44; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; Molinero JC, 2005, LIMNOL OCEANOGR, V50, P1213, DOI 10.4319/lo.2005.50.4.1213; Molinero Juan Carlos, 2009, Annales Series Historia Naturalis, V19, P11; Nagata Renato M., 2009, Pan-American Journal of Aquatic Sciences, V4, P312; Nogueira M, 2008, BRAZ J OCEANOGR, V56, P157, DOI 10.1590/S1679-87592008000300001; Palomares MLD, 2009, HYDROBIOLOGIA, V616, P11, DOI 10.1007/s10750-008-9582-y; Pauly D., 2009, UN ENV PROGRAMME REG, P23; Perea-Blazquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029569; Pierce J, 2009, ZOO BIOL, V28, P163, DOI 10.1002/zoo.20218; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2012, ANNU REV MAR SCI, V4, P209, DOI 10.1146/annurev-marine-120709-142751; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Robinson KL, 2013, LIMNOL OCEANOGR, V58, P235, DOI 10.4319/lo.2013.58.1.0235; Saba VS, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003655; Schroth W, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-1; Sheridan C, 2004, ICES J MAR SCI, V61, P57; Stewart SE, 1996, MAR FRESHW BEHAV PHY, V27, P175, DOI 10.1080/10236249609378963; Suchman CL, 2012, HYDROBIOLOGIA, V690, P113, DOI 10.1007/s10750-012-1055-7; Taylor WA, 2003, CHANGE POINT ANAL VE; Thomas C S, 2001, Hawaii Med J, V60, P100; Underwood AH, 2007, TOXICON, V49, P1073, DOI 10.1016/j.toxicon.2007.01.014; Valiela I, 1995, MARINE ECOLOGICAL PR; Webster CN, 2012, J EXP MAR BIOL ECOL, V436, P50, DOI 10.1016/j.jembe.2012.08.014; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Yoshimoto CM, 2002, T ROY SOC TROP MED H, V96, P300, DOI 10.1016/S0035-9203(02)90105-7	87	29	30	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77039	10.1371/journal.pone.0077039	http://dx.doi.org/10.1371/journal.pone.0077039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194856	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000035
J	Sanin, MJ; Anthelme, F; Pintaud, JC; Galeano, G; Bernal, R				Jose Sanin, Maria; Anthelme, Fabien; Pintaud, Jean-Christophe; Galeano, Gloria; Bernal, Rodrigo			Juvenile Resilience and Adult Longevity Explain Residual Populations of the Andean Wax Palm Ceroxylon quindiuense after Deforestation	PLOS ONE			English	Article							TREE; GROWTH; FOREST; PLANT; AVOIDANCE; DYNAMICS; PATTERNS; RISE	Wax palms are an important element of the cloud forests in the tropical Andes. Despite heavy deforestation, the density of adults seems to be similar in deforested pastures as in forests. We aimed to infer the mechanisms responsible for this apparent resilience in pastures and we tested two hypotheses to explain it: 1) adult palms survived in pastures because they were spared from logging, and 2) adults occurred in pastures through the resilience of large juvenile rosettes, which survived through subterranean meristems and later developed into adults. For this purpose, we characterized the demographic structure of C. quindiuense in a total of 122 plots of 400 m(2) in forests and pastures at two sites with contrasted land use histories in Colombia and Peru. Additionally, we implemented growth models that allowed us to estimate the age of individuals at four sites. These data were combined with information collected from local land managers in order to complete our knowledge on the land use history at each site. At two sites, the presence of old individuals up to 169 years and a wide age range evidenced that, at least, a portion of current adults in pastures were spared from logging at the time of deforestation. However, at the two other sites, the absence of older adults in pastures and the narrow age range of the populations indicated that individuals came exclusively from rosette resilience. These interpretations were consistent with the land use history of sites. In consequence, the combination of the two hypotheses (spared individuals and rosette resilience) explained patterns of C. quindiuense in pastures on a regional scale. Regeneration through subterranean meristems in palms is an important, yet overlooked mechanism of resilience, which occurs in a number of palm species and deserves being integrated in the conceptual framework of disturbance ecology.	[Jose Sanin, Maria; Galeano, Gloria; Bernal, Rodrigo] Univ Nacl Colombia, Inst Ciencias Nat, Bogota, Distrito Capita, Colombia; [Anthelme, Fabien; Pintaud, Jean-Christophe] Inst Rech Dev, Montpellier, Herault, France	Universidad Nacional de Colombia; Institut de Recherche pour le Developpement (IRD)	Sanin, MJ (corresponding author), Univ Nacl Colombia, Inst Ciencias Nat, Bogota, Distrito Capita, Colombia.	mjsaninp@unal.edu.co		Anthelme, Fabien/0000-0001-6249-995X; Sanin, Maria Jose/0000-0001-7211-5913	FP7-PALMS program [FP7-ENV-2007-I]; Direccion Nacional de Investigacion (DIB), Universidad Nacional de Colombia sede Bogota [15154]	FP7-PALMS program; Direccion Nacional de Investigacion (DIB), Universidad Nacional de Colombia sede Bogota	This study was funded by the FP7-PALMS program FP7-ENV-2007-I (www.fp7-palms.org), and by the Direccion Nacional de Investigacion (DIB), Universidad Nacional de Colombia sede Bogota (http://www.dib.unal.edu.co, Project Code 15154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo CA, 2001, PALMA CERA BOSQUES, P127; Andre E, 1879, TOUR MONDE NOUVEAU J; [Anonymous], 2001, PLANT STRATEGIES VEG; [Anonymous], ESTRATEGIA REGIONAL; Anthelme F, 2007, J VEG SCI, V18, P355, DOI 10.1111/j.1654-1103.2007.tb02547.x; Anthelme F, 2011, BIOL CONSERV, V144, P1059, DOI 10.1016/j.biocon.2010.12.025; Armenteras D., 2007, EVALUACION ESTADO BO, P72; Barot S, 2005, EVOL ECOL RES, V7, P1051; Bernal M, 2007, THESIS U ANDES BOGOT; Boussingault M, 1849, VIAJES CIENTIFICOS A, P322; Callaway R. M., 2007, POSITIVE INTERACTION; Cayuela L, 2006, J APPL ECOL, V43, P1172, DOI 10.1111/j.1365-2664.2006.01217.x; Chapman CA, 2010, BIOL CONSERV, V143, P366, DOI 10.1016/j.biocon.2009.10.023; Charles-Dominique P, 2001, DISS BOT, V346, P153; CHRISTIE KH, 1978, HISPANIC AM HIST REV, V58, P260, DOI 10.2307/2513088; Corner E. J. H., 1966, NATURAL HIST PALMS; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; ENRIGHT NJ, 1985, AUST J ECOL, V10, P461, DOI 10.1111/j.1442-9993.1985.tb00907.x; Fernandez JF, 2005, J HERED, V96, P635, DOI 10.1093/jhered/esi104; Galeano G, 2005, SERIE LIBROS ROJOS E, V2, P224; Galeano G., 2010, PALMAS COLOMBIA GUIA; Galeano Gloria, 2008, Rev. peru biol., V15, P65; Giordano CV, 2009, NEW PHYTOL, V181, P880, DOI 10.1111/j.1469-8137.2008.02708.x; Goerner A, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2784111; Gonzalez ME, 2002, PLANT ECOL, V161, P59, DOI 10.1023/A:1020378822847; Gross N, 2010, FUNCT ECOL, V24, P1122, DOI 10.1111/j.1365-2435.2010.01713.x; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Henderson A, 2002, ECOLOGY EVOLUTION PA; Holmgren M, 2012, OECOLOGIA, V169, P293, DOI 10.1007/s00442-011-2196-5; Sanin MJ, 2011, PHYTOTAXA, V34, P1; Kahn F, 2003, PEUPLEMENTS ANCIENS, P309; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Lara E, 2011, THESIS U NACL COLOMB; Laurance WF, 2000, TRENDS ECOL EVOL, V15, P433, DOI 10.1016/S0169-5347(00)01962-5; Lopez-Gallego C, 2010, POPUL ECOL, V52, P191, DOI 10.1007/s10144-009-0171-3; Lyell C., 1833, PRINCIPLES GEOLOGY; Mandle L, 2012, J ECOL, V100, P997, DOI 10.1111/j.1365-2745.2012.01982.x; McPherson K, 1996, AM J BOT, V83, P1566, DOI 10.2307/2445830; Milchunas DG, 2002, OIKOS, V99, P113, DOI 10.1034/j.1600-0706.2002.990112.x; Montufar R, 2011, BOT REV, V77, P426, DOI 10.1007/s12229-011-9085-9; Mora J, 2004, THESIS U NACL COLOMB, P135; Norden N, 2009, ECOL LETT, V12, P385, DOI 10.1111/j.1461-0248.2009.01292.x; Oleas NH, 2012, J HERED, V103, P557, DOI 10.1093/jhered/ess020; Orellana R., 1992, B I FR ETUDES ANDINE, V21, P651; PARSONS JJ, 1977, ANN ASSOC AM GEOGR, V67, P1, DOI 10.1111/j.1467-8306.1977.tb01116.x; Pintaud Jean-Christophe, 2008, Palms, V52, P96; Rasband W.S., 1997, IMAGE J; Svenning JC, 1998, BIODIVERS CONSERV, V7, P1529, DOI 10.1023/A:1008831600795; Tomlinson PB, 2012, AM J BOT, V99, P1891, DOI 10.3732/ajb.1200089; Tomlinson PB, 1990, STRUCTURAL BIOL PALM; Trenel P, 2008, MOL ECOL, V17, P3528, DOI 10.1111/j.1365-294X.2008.03853.x; Veldman JW, 2011, BIOL CONSERV, V144, P1419, DOI 10.1016/j.biocon.2011.01.011; Vergara-Chaparro L.K., 2002, THESIS U NACL COLOMB; Vesk PA, 2006, J ECOL, V94, P1027, DOI 10.1111/j.1365-2745.2006.01154.x; WATERHOUSE JT, 1978, BOT J LINN SOC, V77, P73, DOI 10.1111/j.1095-8339.1978.tb01374.x; Zelazowski P, 2011, PHILOS T R SOC A, V369, P137, DOI 10.1098/rsta.2010.0238	56	12	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e74139	10.1371/journal.pone.0074139	http://dx.doi.org/10.1371/journal.pone.0074139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194823	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000002
J	McGowan, C; Harris, M; Rhodes, T				McGowan, Catherine; Harris, Magdalena; Rhodes, Tim			Hepatitis C Avoidance in Injection Drug Users: A Typology of Possible Protective Practices	PLOS ONE			English	Article							VIRUS-INFECTION; HARM REDUCTION; RISK FACTOR; NEEDLE; PREVALENCE; EQUIPMENT; PROGRAMS	Introduction: Hepatitis C virus (HCV) represents a serious public health concern. People who inject drugs (PWID) are at particular risk and nearly half (45%) of PWID in England may be infected. HCV prevention interventions have only had moderate impact on the prevalence of HCV in this population. Using qualitative methods, we sought to detail the protective practices potentially linked to HCV avoidance among PWID, and explore the motivations for these. Methods: The study used a life history approach allowing participants to detail their lived experience both before and during the course of their injecting careers. Thirty-seven participants were recruited from drug services in London, and from referrals within local injecting networks. A baseline and follow-up in-depth qualitative interview was carried out with each participant, and for half, a third interview was also undertaken. All underwent testing for HCV antibody. Analyses focused on developing a descriptive typology of protective practices potentially linked to HCV avoidance. Results: Practices were deemed to be protective against HCV if they could be expected a priori to reduce the number of overall injections and/or the number of injections using shared injecting equipment. Participants reported engaging in various protective practices which fell into three categories identified through thematic analysis: principles about injecting, preparedness, and flexibility. Conclusions: All participants engaged in protective practices irrespective of serostatus. It is important to consider the relative importance of different motivations framing protective practices in order to formulate harm reduction interventions which appeal to the situated concerns of PWID, especially given that these protective practices may also help protect against HIV and other blood borne infections.	[McGowan, Catherine; Harris, Magdalena; Rhodes, Tim] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Harris, M (corresponding author), London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England.	Magdalena.Harris@lshtm.ac.uk	Rhodes, Tim/DNJ-9679-2022	Rhodes, Tim/0000-0003-2400-9838; McGowan, Catherine/0000-0001-6941-6539; Harris, Magdalena/0000-0001-8718-8226	Economic and Social Research Council (ESRC) [RES-062-23-1766]; Economic and Social Research Council [ES/G028753/1] Funding Source: researchfish; ESRC [ES/G028753/1] Funding Source: UKRI	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The Staying Safe project was funded by the Economic and Social Research Council (ESRC) [Grant Number: RES-062-23-1766] (http://www.esrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NEV 1 ML FIX NEEDL S; Backmund M, 2003, EUR J EPIDEMIOL, V18, P563, DOI 10.1023/A:1024603517136; Blane DB, 1996, SOC SCI MED, V42, P751, DOI 10.1016/0277-9536(95)00340-1; Bryant J, 2010, DRUG ALCOHOL DEPEN, V107, P182, DOI 10.1016/j.drugalcdep.2009.10.007; Cao W, 2006, DRUG ALCOHOL REV, V25, P439, DOI 10.1080/09595230600891282; Carruthers SJ, 2005, DRUG ALCOHOL REV, V24, P193, DOI 10.1080/09595230500102673; Copeland L, 2012, SCOT MED J, V57, P38, DOI 10.1258/smj.2011.011289; Craine N, 2009, EPIDEMIOL INFECT, V137, P1255, DOI 10.1017/S095026880900212X; Daniulaityte R, 2007, SUBST USE MISUSE, V42, P129, DOI 10.1080/10826080601174678; Darke S., 2011, LIFE HEROIN USER TYP; De Angelis D, 2009, STAT METHODS MED RES, V18, P361, DOI 10.1177/0962280208094691; Deacon R, 2010, HEPATITIS C SEROCONV; Diaz T, 2001, AM J PUBLIC HEALTH, V91, P23, DOI 10.2105/AJPH.91.1.23; Firestone M, 2007, CAN J PUBLIC HEALTH, V98, P130, DOI 10.1007/BF03404324; Hagan H, 2001, AM J PUBLIC HEALTH, V91, P42, DOI 10.2105/AJPH.91.1.42; Harris M, 2012, ADDICTION, V107, P1090, DOI 10.1111/j.1360-0443.2011.03749.x; Harris M, 2012, QUAL HEALTH RES, V22, P31, DOI 10.1177/1049732311420579; Health Protection Agency, 2007, SHOOT INF INJ DRUG U; Health Protection Agency, 2012, HEP C UK 2012 REP; Jost JJ, 2010, DRUG-EDUC PREV POLIC, V17, P821, DOI 10.3109/09687630902858948; Kondili LA, 2002, GUT, V50, P693, DOI 10.1136/gut.50.5.693; Mateu-Gelabert P, 2007, Trastor Adict, V9, P260; Miller CL, 2002, J URBAN HEALTH, V79, P257, DOI 10.1093/jurban/79.2.257; National Treatment Agency for Substance Misuse, 2004, RED DRUG REL DEATHS; Rhodes T, 2002, SOC SCI MED, V55, P211, DOI 10.1016/S0277-9536(01)00162-9; Rhodes T, 2008, ADDICTION, V103, P1593, DOI 10.1111/j.1360-0443.2008.02306.x; Rhodes T, 2008, HEALTH RISK SOC, V10, P221, DOI 10.1080/13698570802160921; Rondy M, 2013, EPIDEMIOL INFECT, V141, P563, DOI 10.1017/S0950268812000921; Roy E, 2007, INT J DRUG POLICY, V18, P397, DOI 10.1016/j.drugpo.2007.02.005; SLAVNEY PR, 1985, AM J PSYCHOTHER, V39, P57, DOI 10.1176/appi.psychotherapy.1985.39.1.57; Stark K, 1996, AIDS, V10, P311, DOI 10.1097/00002030-199603000-00010; Stein JA, 2004, DRUG ALCOHOL DEPEN, V75, P89, DOI 10.1016/j.drugalcdep.2004.02.002; Stein MD, 2009, J ADDICT DIS, V28, P389, DOI 10.1080/10550880903183034; Sutton AJ, 2012, EPIDEMIOL INFECT, V140, P2190, DOI 10.1017/S0950268812000489; Thein H. H., 2003, INT J DRUG POLICY, V14, P425; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; Thurairajah PH, 2008, J INFECT DIS, V198, P1749, DOI 10.1086/593337; Tilson H., 2006, PREVENTING HIV INFEC; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; Vickerman P, 2012, ADDICTION, V107, P1984, DOI 10.1111/j.1360-0443.2012.03932.x; Wilson S., 2007, QUALITATIVE RES, V7, P135, DOI [DOI 10.1177/1468794107071427, 10.1177/1468794107071427]; Wright Nat M J, 2006, Harm Reduct J, V3, P27, DOI 10.1186/1477-7517-3-27	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77038	10.1371/journal.pone.0077038	http://dx.doi.org/10.1371/journal.pone.0077038			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194855	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000034
J	Momigliano, P; Sparrow, L; Blair, D; Heimann, K				Momigliano, Paolo; Sparrow, Leanne; Blair, David; Heimann, Kirsten			The Diversity of Coolia spp. (Dinophyceae Ostreopsidaceae) in the Central Great Barrier Reef Region	PLOS ONE			English	Article							SP. NOV. DINOPHYCEAE; BENTHIC DINOFLAGELLATE; PHYLOGENETIC ANALYSIS; MONOTIS DINOPHYCEAE; SPECIES BOUNDARIES; GAMBIERDISCUS; MORPHOLOGY; DNA; PROROCENTRUM; STRAIN	Background: Dinoflagellates are important primary producers, crucial in marine food webs. Toxic strains, however, are the main causative agents of non-bacterial seafood poisoning, a major concern for public health worldwide. Despite their importance, taxonomic uncertainty within many genera of dinoflagellates is still high. The genus Coolia includes potentially harmful species and the diversity within the genus is just starting to become apparent. Methodology/Principal Findings: In the current study, cultures were established from strains of Coolia spp. isolated from the central Great Barrier Reef (GBR). Cultures were identified based on thecal plate morphology and analyses of sequences (18S, ITS and 28S) from the nuclear rRNA operon. We report that the central GBR harbors a high diversity of Coolia species, including two species known to be capable of toxin production (C. tropicalis and C. malayensis), as well as the non-toxic C. canariensis. The strain of C. canariensis isolated from the GBR may in fact be a cryptic species, closely related but nevertheless phylogenetically distinct from the strain on which the holotype of C. canariensis was based. We also found evidence of the occurrence of a cryptic species morphologically very similar to both C. malayensis and C. monotis. The consequences of taxonomic confusion within the genus are discussed. Conclusion/Significance: The central GBR region harbors a previously unreported high diversity of Coolia spp., including two species known to potentially produce toxins. The presence of a cryptic species of unknown toxicity highlights the importance of cryptic diversity within dinoflagellates.	[Momigliano, Paolo; Sparrow, Leanne; Blair, David; Heimann, Kirsten] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Sparrow, Leanne; Heimann, Kirsten] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Sparrow, Leanne; Heimann, Kirsten] James Cook Univ, North Queensland Algal Identificat Culturing Faci, Townsville, Qld 4811, Australia	James Cook University; James Cook University; James Cook University	Heimann, K (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	kirsten.heimann@jcu.edu.au	Momigliano, Paolo/H-7141-2019; Heimann, Kirsten/M-4814-2019; Heimann, Kirsten/N-1512-2013; Blair, David/O-2786-2019	Momigliano, Paolo/0000-0001-6390-6094; Heimann, Kirsten/0000-0003-2691-9659; Heimann, Kirsten/0000-0003-2691-9659; Blair, David/0000-0002-4658-3251	Marine and Tropical Science Research Facility	Marine and Tropical Science Research Facility	This work was funded by the Marine and Tropical Science Research Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI R, 1979, B JPN SOC SCI FISH, V45, P67; BAGNIS R, 1980, TOXICON, V18, P199, DOI 10.1016/0041-0101(80)90074-4; BESADA EG, 1982, B MAR SCI, V32, P723; Briggs JC, 2000, J BIOGEOGR, V27, P1183, DOI 10.1046/j.1365-2699.2000.00459.x; Chinain M, 1999, J PHYCOL, V35, P1282, DOI 10.1046/j.1529-8817.1999.3561282.x; Ciminiello P, 2006, ANAL CHEM, V78, P6153, DOI 10.1021/ac060250j; Connolly SR, 2003, ECOLOGY, V84, P2178, DOI 10.1890/02-0254; Dolapsakis NP, 2006, SCI MAR, V70, P67, DOI 10.3989/scimar.2006.70n167; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Faust MA, 1995, J PHYCOL, V31, P996, DOI 10.1111/j.0022-3646.1995.00996.x; FAUST MA, 1992, J PHYCOL, V28, P94; FAUST MA, 2011, ATOLL RES B, V569; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FENCHEL T, 1988, ANNU REV ECOL SYST, V19, P19, DOI 10.1146/annurev.es.19.110188.000315; Fraga S, 2008, J PHYCOL, V44, P1060, DOI 10.1111/j.1529-8817.2008.00555.x; FRITZ L, 1985, J PHYCOL, V21, P662, DOI 10.1111/j.0022-3646.1985.00662.x; Grzebyk D, 1998, J PHYCOL, V34, P1055, DOI 10.1046/j.1529-8817.1998.341055.x; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HANSEN PJ, 1991, MAR ECOL PROG SER, V73, P253, DOI 10.3354/meps073253; Haywood AJ, 2004, J PHYCOL, V40, P165, DOI 10.1111/j.0022-3646.2004.02-149.x; HEIMANN K, 2011, OCEAN SURFACE WARMIN; Holmes Michael J., 1995, Natural Toxins, V3, P355, DOI 10.1002/nt.2620030506; Holmes MJ, 1998, J PHYCOL, V34, P661, DOI 10.1046/j.1529-8817.1998.340661.x; HOLMES MJ, 1991, TOXICON, V29, P761, DOI 10.1016/0041-0101(91)90068-3; Howard MDA, 2009, APPL ENVIRON MICROB, V75, P54, DOI 10.1128/AEM.00818-08; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ki JS, 2011, J PHYCOL, V47, P426, DOI 10.1111/j.1529-8817.2010.00950.x; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Lajeunesse TC, 2012, J PHYCOL, V48, P1380, DOI 10.1111/j.1529-8817.2012.01217.x; Laza-Martinez A, 2011, EUR J PHYCOL, V46, P45, DOI 10.1080/09670262.2010.550387; Leaw CP, 2010, J PHYCOL, V46, P162, DOI 10.1111/j.1529-8817.2009.00778.x; LEWIS RJ, 1993, COMP BIOCHEM PHYS C, V106, P615, DOI 10.1016/0742-8413(93)90217-9; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; Litaker RW, 2009, PHYCOLOGIA, V48, P344, DOI 10.2216/07-15.1; MEUNIER A, 1919, MEMOIRES MUSEE ROYAL; Mohammad-Noor N, 2013, J PHYCOL, V49, P536, DOI 10.1111/jpy.12062; Murray S, 2005, PROTIST, V156, P269, DOI 10.1016/j.protis.2005.05.003; Murray S, 2004, J PHYCOL, V40, P366, DOI 10.1046/j.1529-8817.2004.03132.x; Murray S, 2007, PHYCOL RES, V55, P176, DOI 10.1111/j.1440-1835.2007.00460.x; MUSCATINE L, 1977, J BIOSCIENCE, V7, P454; Nagahama Y, 2011, J PHYCOL, V47, P178, DOI 10.1111/j.1529-8817.2010.00939.x; Rhodes LL, 2010, TOXICON, V56, P751, DOI 10.1016/j.toxicon.2009.05.017; Rhodes LL, 1997, NEW ZEAL J MAR FRESH, V31, P139, DOI 10.1080/00288330.1997.9516751; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Stern RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013991; SWIFT AEB, 1993, NAT TOXINS, V31, P1, DOI DOI 10.3109/15563659309000371; Takano Y, 2006, J PHYCOL, V42, P251, DOI 10.1111/j.1529-8817.2006.00177.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR DL, 1969, J CELL SCI, V4, P751; Ten-Hage L, 2000, PHYCOLOGIA, V39, P377, DOI 10.2216/i0031-8884-39-5-377.1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Zhang H, 2005, J PHYCOL, V41, P411, DOI 10.1111/j.1529-8817.2005.04168.x	56	26	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e79278	10.1371/journal.pone.0079278	http://dx.doi.org/10.1371/journal.pone.0079278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194962	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000326037000141
J	Zhou, Y; Xia, H; Li, XJ; Hu, R; Chen, Y; Li, XB				Zhou, Ying; Xia, Hui; Li, Xiao-Jie; Hu, Rong; Chen, Yun; Li, Xue-Bao			Overexpression of a Cotton Gene That Encodes a Putative Transcription Factor of AP2/EREBP Family in Arabidopsis Affects Growth and Development of Transgenic Plants	PLOS ONE			English	Article							RESPONSIVE ELEMENT; ECTOPIC EXPRESSION; AUXIN BIOSYNTHESIS; INDUCIBLE GENE; ROOT-FORMATION; CROSS-TALK; ERF GENE; ETHYLENE; ELONGATION; TRANSPORT	In the study, a gene encoding a putative ethylene response factor of AP2/EREBP family was isolated from cotton (Gossypium hirsutum) and designated as GhERF12. Sequence alignment showed that GhERF12 protein contains a central AP2/ERF domain (58 amino acids) with two functional conserved amino acid residues (ala14 and asp19). Transactivation assay indicated that GhERF12 displayed strong transcription activation activity in yeast cells, suggesting that this protein may be a transcriptional activator in cotton. Quantitative RT-PCR analysis showed that GhERF12 expression in cotton was induced by ACC and IAA. Overexpression of GhERF12 in Arabidopsis affected seedling growth and development. The GhERF12 transgenic plants grew slowly, and displayed a dwarf phenotype. The mean bolting time of the transgenic plants was delayed for about 10 days, compared with that of wild type. Further study revealed that some ethylene-related and auxin-related genes were dramatically up-regulated in the transgenic plants, compared with those of wild type. Collectively, we speculated that GhERF12, as a transcription factor, may be involved in regulation of plant growth and development by activating the constitutive ethylene response likely related to auxin biosynthesis and/or signaling.	[Zhou, Ying; Xia, Hui; Li, Xiao-Jie; Hu, Rong; Chen, Yun; Li, Xue-Bao] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China	Central China Normal University	Li, XB (corresponding author), Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	xbli@mail.ccnu.edu.cn			National Natural Sciences Foundation of China [31171174]; Ministry of Agriculture of China [2013ZX08009003-004]; Scientific Research Foundation of Hubei Province [2011CDA140, 2012FFA126]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Scientific Research Foundation of Hubei Province	This work was supported by National Natural Sciences Foundation of China (Grant No. 31171174), the project from the Ministry of Agriculture of China for transgenic research (Grant No. 2013ZX08009003-004), and the Scientific Research Foundation of Hubei Province (Grant No. 2011CDA140, 2012FFA126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banno H, 2001, PLANT CELL, V13, P2609, DOI 10.1105/tpc.13.12.2609; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Collett CE, 2000, PLANT PHYSIOL, V124, P553, DOI 10.1104/pp.124.2.553; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Fujita H, 1996, PLANT CELL PHYSIOL, V37, P1094, DOI 10.1093/oxfordjournals.pcp.a029059; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Hirota A, 2007, PLANT CELL, V19, P2156, DOI 10.1105/tpc.107.050674; Hu YB, 2008, J PLANT PHYSIOL, V165, P1717, DOI 10.1016/j.jplph.2007.12.006; Hu YB, 2011, ACTA PHYSIOL PLANT, V33, P667, DOI 10.1007/s11738-010-0587-6; Imin N, 2007, J EXP BOT, V58, P439, DOI 10.1093/jxb/erl224; Jin LG, 2008, PLANT PHYSIOL BIOCH, V46, P46, DOI 10.1016/j.plaphy.2007.10.004; Jin LG, 2010, J INTEGR PLANT BIOL, V52, P485, DOI 10.1111/j.1744-7909.2010.00914.x; Kieber JJ, 1997, ANNU REV PLANT PHYS, V48, P277, DOI 10.1146/annurev.arplant.48.1.277; Kirch T, 2003, PLANT CELL, V15, P694, DOI 10.1105/tpc.009480; Kitomi Y, 2011, PLANT J, V67, P472, DOI 10.1111/j.1365-313X.2011.04610.x; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Marsch-Martinez N, 2006, PLANT MOL BIOL, V62, P825, DOI 10.1007/s11103-006-9059-1; Menke FLH, 1999, EMBO J, V18, P4455, DOI 10.1093/emboj/18.16.4455; Nagpal P, 2000, PLANT PHYSIOL, V123, P563, DOI 10.1104/pp.123.2.563; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Ohta M, 2000, PLANT J, V22, P29, DOI 10.1046/j.1365-313x.2000.00709.x; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Rahman A, 2001, PLANT CELL PHYSIOL, V42, P301, DOI 10.1093/pcp/pce035; Rahman A, 2007, PLANT J, V50, P514, DOI 10.1111/j.1365-313X.2007.03068.x; Riechmann JL, 1998, BIOL CHEM, V379, P633; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sawa S, 2002, PLANT J, V32, P1011, DOI 10.1046/j.1365-313X.2002.01488.x; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Swarup R, 2002, PLANT MOL BIOL, V49, P411; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Thimann KV, 1977, HORMONE ACTION WHOLE, P448; Tian Q, 1999, DEVELOPMENT, V126, P711; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; van der Graaff E, 2000, DEVELOPMENT, V127, P4971; Vandenbussche F, 2003, PLANT PHYSIOL, V131, P1228, DOI 10.1104/pp.010850; Wilson K, 1996, PLANT CELL, V8, P659, DOI 10.1105/tpc.8.4.659; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5; Zhou JM, 1997, EMBO J, V16, P3207, DOI 10.1093/emboj/16.11.3207	46	6	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78635	10.1371/journal.pone.0078635	http://dx.doi.org/10.1371/journal.pone.0078635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194949	gold, Green Submitted, Green Published			2022-12-27	WOS:000326037000128
J	Cosin-Roger, J; Ortiz-Masia, D; Calatayud, S; Hernandez, C; Alvarez, A; Hinojosa, J; Esplugues, JV; Barrachina, MD				Cosin-Roger, Jesus; Ortiz-Masia, Dolores; Calatayud, Sara; Hernandez, Carlos; Alvarez, Angeles; Hinojosa, Joaquin; Esplugues, Juan V.; Barrachina, Maria D.			M2 Macrophages Activate WNT Signaling Pathway in Epithelial Cells: Relevance in Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BETA-CATENIN ACTIVATION; STEM-CELLS; GENE-EXPRESSION; SELF-RENEWAL; IN-VIVO; DIFFERENTIATION; POLARIZATION; HOMEOSTASIS; FATE	Macrophages, which exhibit great plasticity, are important components of the inflamed tissue and constitute an essential element of regenerative responses. Epithelial Wnt signalling is involved in mechanisms of proliferation and differentiation and expression of Wnt ligands by macrophages has been reported. We aim to determine whether the macrophage phenotype determines the expression of Wnt ligands, the influence of the macrophage phenotype in epithelial activation of Wnt signalling and the relevance of this pathway in ulcerative colitis. Human monocyte-derived macrophages and U937-derived macrophages were polarized towards M1 or M2 phenotypes and the expression of Wnt1 and Wnt3a was analyzed by qPCR. The effects of macrophages and the role of Wnt1 were analyzed on the expression of beta-catenin, Tcf-4, c-Myc and markers of cell differentiation in a co-culture system with Caco-2 cells. Immunohistochemical staining of CD68, CD206, CD86, Wnt1, beta-catenin and c-Myc were evaluated in the damaged and non-damaged mucosa of patients with UC. We also determined the mRNA expression of Lgr5 and c-Myc by qPCR and protein levels of beta-catenin by western blot. Results show that M2, and no M1, activated the Wnt signaling pathway in co-culture epithelial cells through Wnt1 which impaired enterocyte differentiation. A significant increase in the number of CD206+ macrophages was observed in the damaged mucosa of chronic vs newly diagnosed patients. CD206 immunostaining co-localized with Wnt1 in the mucosa and these cells were associated with activation of canonical Wnt signalling pathway in epithelial cells and diminution of alkaline phosphatase activity. Our results show that M2 macrophages, and not M1, activate Wnt signalling pathways and decrease enterocyte differentiation in co-cultured epithelial cells. In the mucosa of UC patients, M2 macrophages increase with chronicity and are associated with activation of epithelial Wnt signalling and diminution in enterocyte differentiation.	[Cosin-Roger, Jesus; Ortiz-Masia, Dolores; Calatayud, Sara; Alvarez, Angeles; Esplugues, Juan V.; Barrachina, Maria D.] Univ Valencia, Fac Med, Dept Farmacol, Valencia, Spain; [Cosin-Roger, Jesus; Ortiz-Masia, Dolores; Calatayud, Sara; Alvarez, Angeles; Esplugues, Juan V.; Barrachina, Maria D.] Univ Valencia, Fac Med, CIBERehd, Valencia, Spain; [Hernandez, Carlos; Esplugues, Juan V.] Hosp Dr Peset, FISABIO, Valencia, Spain; [Hinojosa, Joaquin] Hosp Manises, Valencia, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Valencia	Ortiz-Masia, D (corresponding author), Univ Valencia, Fac Med, Dept Farmacol, Valencia, Spain.	dolores.barrachina@uv.es	Alvarez, Angeles/ABF-4589-2020; Barrachina, Maria/ABB-9683-2021; ORTIZ-MASIA, MARIA DOLORES/M-1413-2017; SAEZ, CARLOS HERNANDEZ/M-3029-2014; Calatayud, Sara/ABB-9665-2021; Esplugues, Juan/ABC-1488-2021	ORTIZ-MASIA, MARIA DOLORES/0000-0002-7924-9962; SAEZ, CARLOS HERNANDEZ/0000-0001-8536-429X; Calatayud, Sara/0000-0001-9675-2423; Cosin roger, Jesus/0000-0002-2468-4908; Barrachina, Maria Dolores/0000-0002-4332-2929; Hinojosa del Val, Joaquin/0000-0002-2157-9328; Esplugues Mota, Juan Vicente/0000-0001-8205-021X; Alvarez, Angeles/0000-0002-2301-9746	Ministerio de Ciencia e Innovacion [SAF2010-20231, SAF2010-16030]; Ministerio de Sanidad y Consumo [PI11/00327]; CIBERehd [CB06/04/0071]; Generalitat Valenciana [PROMETEO/2010/060]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); CIBERehd; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by Ministerio de Ciencia e Innovacion [grants number SAF2010-20231 and SAF2010-16030], Ministerio de Sanidad y Consumo [grant number PI11/00327], CIBERehd [grant number CB06/04/0071] and Generalitat Valenciana [grant number PROMETEO/2010/060].	Allez M, 2002, GASTROENTEROLOGY, V123, P1516, DOI 10.1053/gast.2002.36588; Asonuma S, 2009, AM J PHYSIOL-GASTR L, V297, pG312, DOI 10.1152/ajpgi.00518.2007; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Brown JB, 2010, GASTROENTEROLOGY, V138, P595, DOI 10.1053/j.gastro.2009.10.038; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dahan S, 2008, GASTROENTEROLOGY, V134, P192, DOI 10.1053/j.gastro.2007.10.022; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fleet JC, 2003, PHYSIOL GENOMICS, V13, P57, DOI 10.1152/physiolgenomics.00152.2002; Henderson P, 2011, INFLAMM BOWEL DIS, V17, P382, DOI 10.1002/ibd.21379; Hernandez C, 2009, BRIT J PHARMACOL, V156, P262, DOI 10.1111/j.1476-5381.2008.00044.x; Hughes KR, 2011, INFLAMM BOWEL DIS, V17, P213, DOI 10.1002/ibd.21353; Hunter MM, 2010, GASTROENTEROLOGY, V138, P1395, DOI 10.1053/j.gastro.2009.12.041; Lee G, 2010, GASTROENTEROLOGY, V139, P869, DOI 10.1053/j.gastro.2010.05.037; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Liu SJ, 2013, J BIOL CHEM, V288, P8794, DOI 10.1074/jbc.M112.436204; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mariadason JM, 2001, CANCER RES, V61, P3465; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Neurath MF, 2012, GUT, V61, P1619, DOI 10.1136/gutjnl-2012-302830; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Ortiz-Masia D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048535; Ortiz-Masia D, 2010, FASEB J, V24, P136, DOI 10.1096/fj.09-137489; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Riano A, 2011, J GASTROENTEROL, V46, P565, DOI 10.1007/s00535-011-0374-1; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smith K, 1999, BRIT J CANCER, V81, P496, DOI 10.1038/sj.bjc.6690721; Tuin A, 2009, GUT, V58, P379, DOI 10.1136/gut.2007.128868; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Vos ACW, 2012, INFLAMM BOWEL DIS, V18, P401, DOI 10.1002/ibd.21818; Yeung TM, 2011, CELL MOL LIFE SCI, V68, P2513, DOI 10.1007/s00018-011-0687-5	35	87	90	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78128	10.1371/journal.pone.0078128	http://dx.doi.org/10.1371/journal.pone.0078128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167598	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500058
J	Donskow-Lysoniewska, K; Bien, J; Brodaczewska, K; Krawczak, K; Doligalska, M				Donskow-Lysoniewska, Katarzyna; Bien, Justyna; Brodaczewska, Klaudia; Krawczak, Katarzyna; Doligalska, Maria			Colitis Promotes Adaptation of an Intestinal Nematode: A Heligmosomoides Polygyrus Mouse Model System	PLOS ONE			English	Article							PARASITIC NEMATODE; NEMATOSPIROIDES-DUBIUS; DEXTRAN SULFATE; T-CELLS; EXPRESSION; PROTECTION; COMPONENTS; RESISTANCE	The precise mechanism of the very effective therapeutic effect of gastrointestinal nematodes on some autoimmune diseases is not clearly understood and is currently being intensively investigated. Treatment with living helminths has been initiated to reverse intestinal immune-mediated diseases in humans. However, little attention has been paid to the phenotype of nematodes in the IBD-affected gut and the consequences of nematode adaptation. In the present study, exposure of Heligmosomoides polygyrus larvae to the changed cytokine milieu of the intestine during colitis reduced inflammation in an experimental model of dextran sulphate sodium (DSS)-induced colitis, but increased nematode establishment in the moderate-responder BALB/c mouse strain. We used mass spectrometry in combination with two-dimensional Western blotting to determine changes in protein expression and changes in nematode antigens recognized by IgG1 in mice with colitis. We show that nematode larvae immunogenicity is changed by colitis as soon as 6 days post-infection; IgG1 did not recognize highly conserved proteins Lev-11 (isoform 1 of tropomyosin alpha 1 chain), actin-4 isoform or FTT-2 isoform a (14-3-3 family) protein. These results indicate that changes in the small intestine provoked by colitis directly influence the nematode proteome. The unrecognized proteins seem to be key antigenic epitopes able to induce protective immune responses. The proteome changes were associated with weak immune recognition and increased larval adaptation and worm growth, altered localization in the intestine and increased survival of males but reduced worm fecundity. In this report, the mechanisms influencing nematode survival and the consequences of changed immunogenicity that reflect the immune response at the site colonized by the parasite in mice with colitis are described. The results are relevant to the use of live parasites to ameliorate IBD.	[Donskow-Lysoniewska, Katarzyna; Brodaczewska, Klaudia; Krawczak, Katarzyna; Doligalska, Maria] Univ Warsaw, Dept Parasitol, Warsaw, Poland; [Bien, Justyna] Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland	University of Warsaw; Polish Academy of Sciences; Witold Stefanski Institute of Parasitology of the Polish Academy of Sciences	Donskow-Lysoniewska, K (corresponding author), Univ Warsaw, Dept Parasitol, Warsaw, Poland.	zuzia@biol.uw.edu.pl	Katarzyna, Donskow-Lysoniewska/AAF-8998-2021	Katarzyna, Donskow-Lysoniewska/0000-0003-4924-800X; Doligalska, Maria/0000-0002-3175-4564; Bien-Kalinowska, Justyna/0000-0002-7789-2751; Krawczak - Wojcik, Katarzyna/0000-0001-7557-8059; Brodaczewska, Klaudia K./0000-0003-2374-3600	Polish National Science Centre [N303 819140]	Polish National Science Centre	This work was supported by Polish National Science Centre Grant No. N303 819140. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1987, J PARASITOL, V73, P1164, DOI 10.2307/3282298; Andrade MA, 2004, NITRIC OXIDE-BIOL CH, V10, P150, DOI 10.1016/j.niox.2004.03.002; Baermann G., 1917, NEDERLANDS TIJDSCRIF, V57, P131; Balic A, 2000, ADV PARASIT, V45, P181, DOI 10.1016/S0065-308X(00)45005-0; BANSEMIR AD, 1994, J PARASITOL, V80, P24, DOI 10.2307/3283340; Barthlott T, 2003, J EXP MED, V197, P451, DOI 10.1084/jem.20021387; Bizimenyera ES, 2006, VET PARASITOL, V142, P336, DOI 10.1016/j.vetpar.2006.06.013; CRIADOFORNELIO A, 1995, PARASITOL RES, V81, P700, DOI 10.1007/BF00931850; Croese J, 2006, GUT, V55, P136, DOI 10.1136/gut.2005.079129; CYPESS RH, 1977, EXP PARASITOL, V42, P34, DOI 10.1016/0014-4894(77)90059-5; Donskow K, 2011, PARASITE IMMUNOL, V33, P158, DOI 10.1111/j.1365-3024.2010.01262.x; Donskow-Lysoniewska K, 2012, PARASITE IMMUNOL, V34, P536, DOI 10.1111/pim.12003; Donskow-Lysoniewska K, 2013, PRION, V7, P319, DOI 10.4161/pri.25008; Garrelds IM, 2002, DIGEST DIS SCI, V47, P2231, DOI 10.1023/A:1020183110468; Guinnee MA, 2003, PARASITOLOGY, V127, P507, DOI 10.1017/S0031182003003998; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; JENKINS DC, 1984, Z PARASITENKD, V70, P395, DOI 10.1007/BF00927827; Liu Q, 2010, J IMMUNOL, V184, P5213, DOI 10.4049/jimmunol.0902879; LIU SK, 1965, EXP PARASITOL, V17, P123, DOI 10.1016/0014-4894(65)90016-0; LORENTSEN KJ, 1989, ANN INTERN MED, V111, P561, DOI 10.7326/0003-4819-111-7-561; Mccoy KD, 2008, CELL HOST MICROBE, V4, P362, DOI 10.1016/j.chom.2008.08.014; McGonigle S, 2001, FEBS LETT, V490, P65, DOI 10.1016/S0014-5793(01)02133-0; MONROY FG, 1992, PARASITOL TODAY, V8, P49, DOI 10.1016/0169-4758(92)90084-F; Morgan C, 2006, PROTEOMICS, V6, P4633, DOI 10.1002/pmic.200600068; Morimoto M, 2004, J IMMUNOL, V172, P2424, DOI 10.4049/jimmunol.172.4.2424; Ruyssers NE, 2009, INFLAMM BOWEL DIS, V15, P491, DOI 10.1002/ibd.20787; Schechtman D, 2001, PARASITOLOGY, V123, P573, DOI 10.1017/S0031182001008769; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Stear MJ, 1997, NATURE, V389, P27, DOI 10.1038/37895; Stear MJ, 1996, PARASITOL TODAY, V12, P438, DOI 10.1016/0169-4758(96)10069-7; Sukhdeo MVK, 1996, INT J PARASITOL, V26, P483, DOI 10.1016/0020-7519(96)89378-7; Viney ME, 2006, PARASITOLOGY, V133, P477, DOI 10.1017/S003118200600062X; WAHID FN, 1992, INT J PARASITOL, V22, P699, DOI 10.1016/0020-7519(92)90118-5; Wollerton MC, 2001, RNA, V7, P819, DOI 10.1017/S1355838201010214; Yan FB, 2010, VET J, V185, P174, DOI 10.1016/j.tvjl.2009.05.021; Yazdanbakhsh M, 2001, TRENDS IMMUNOL, V22, P372, DOI 10.1016/S1471-4906(01)01958-5	36	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78034	10.1371/journal.pone.0078034	http://dx.doi.org/10.1371/journal.pone.0078034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167594	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500054
J	Elgendi, M; Norton, I; Brearley, M; Abbott, D; Schuurmans, D				Elgendi, Mohamed; Norton, Ian; Brearley, Matt; Abbott, Derek; Schuurmans, Dale			Systolic Peak Detection in Acceleration Photoplethysmograms Measured from Emergency Responders in Tropical Conditions	PLOS ONE			English	Article							BLOOD-PRESSURE; ARTERIAL; ATHEROSCLEROSIS; DISEASE; RISK	Photoplethysmogram (PPG) monitoring is not only essential for critically ill patients in hospitals or at home, but also for those undergoing exercise testing. However, processing PPG signals measured after exercise is challenging, especially if the environment is hot and humid. In this paper, we propose a novel algorithm that can detect systolic peaks under challenging conditions, as in the case of emergency responders in tropical conditions. Accurate systolic-peak detection is an important first step for the analysis of heart rate variability. Algorithms based on local maxima-minima, first-derivative, and slope sum are evaluated, and a new algorithm is introduced to improve the detection rate. With 40 healthy subjects, the new algorithm demonstrates the highest overall detection accuracy (99.84% sensitivity, 99.89% positive predictivity). Existing algorithms, such as Billauer's, Li's and Zong's, have comparable although lower accuracy. However, the proposed algorithm presents an advantage for real-time applications by avoiding human intervention in threshold determination. For best performance, we show that a combination of two event-related moving averages with an offset threshold has an advantage in detecting systolic peaks, even in heat-stressed PPG signals.	[Elgendi, Mohamed; Schuurmans, Dale] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Norton, Ian; Brearley, Matt] Natl Crit Care & Trauma Response Ctr, Darwin, NT, Australia; [Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	University of Alberta; University of Adelaide	Elgendi, M (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada.	moe.elgendi@gmail.com	Khandker, Raska U/O-1082-2015; Elgendi, Mohamed/I-8596-2016; Abbott, Derek/E-8352-2011	Elgendi, Mohamed/0000-0003-1831-0202; Abbott, Derek/0000-0002-0945-2674; Brearley, Matt/0000-0002-6655-3914	Australian government; Charles Darwin University	Australian government(Australian GovernmentCGIAR); Charles Darwin University	Mohamed Elgendi would like to gratefully acknowledges the Australian government and Charles Darwin University whose generous scholarships facilitated this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrienko G, 2010, IEEE INT CONF INF VI, P48, DOI 10.1109/IV.2010.17; Barenbrock M, 1995, J HYPERTENS, V13, P1712; Billauer E., 2012, PEAKDET PEAK DETECTI; Bonow R, 2004, BRAUNWALDS HEART DIS; Bortolotto LA, 2000, AM J HYPERTENS, V13, P165, DOI 10.1016/S0895-7061(99)00192-2; Brearley MB, 2013, PREHOSP DISASTER MED, V28, P139, DOI 10.1017/S1049023X12001847; CHIRIFE R, 1971, AM HEART J, V82, P222, DOI 10.1016/0002-8703(71)90269-9; Clifford G, 2006, ADV METHODS TOOLS EC; DARNE B, 1989, HYPERTENSION, V13, P392, DOI 10.1161/01.HYP.13.4.392; Domingues A, 2009, DEV STAND ALONE PULS; Elgendi M, 2009, P IEEE C BIOEL BIOIN, P76; Elgendi M, 2013, A B WAVES DETECTION; Elgendi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073557; Elgendi M, 2012, CURR CARDIOL REV, V8, P215, DOI 10.2174/157340312803217184; Elgendi M, 2012, CURR CARDIOL REV, V8, P14, DOI 10.2174/157340312801215782; Elgendi M, 2010, BIOSIGNALS 2010: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON BIO-INSPIRED SYSTEMS AND SIGNAL PROCESSING, P82; Elgendi M, 2010, BIOSIGNALS 2010: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON BIO-INSPIRED SYSTEMS AND SIGNAL PROCESSING, P428; Elgendi M, 2011, COMM COM INF SC, V127, P266; Elgendi M, 2009, 2009 35TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P78; FITCHETT DH, 1984, CARDIOVASC RES, V18, P651, DOI 10.1093/cvr/18.11.651; Imanaga I, 1998, JPN HEART J, V39, P775; Kelley DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001751; KELLY R, 1989, CIRCULATION, V80, P1652, DOI 10.1161/01.CIR.80.6.1652; Kimm SYS, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.5.e50; Leeson CPM, 2000, CIRCULATION, V101, P1533, DOI 10.1161/01.CIR.101.13.1533; Lerddararadsamee T., 2012, P 9 INT C EL ENG EL, P1; Li BN, 2010, BIOMED SIGNAL PROCES, V5, P76, DOI 10.1016/j.bspc.2009.06.002; Matsuyama A, 2009, THESIS C DARWIN U DA; ORourke MF, 1992, J INTENSIVE CARE MED, DOI [10.1177/088506669200700609, DOI 10.1177/088506669200700609]; Otsuka T, 2006, CIRC J, V70, P304, DOI 10.1253/circj.70.304; Roggo Y, 2010, TALANTA, V81, P988, DOI 10.1016/j.talanta.2010.01.046; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; Takazawa K, 1998, HYPERTENSION, V32, P365, DOI 10.1161/01.HYP.32.2.365; Zeng W, 2008, 2008 INTERNATIONAL CONFERENCE ON INFORMATION AND AUTOMATION, VOLS 1-4, P1667, DOI 10.1109/ICINFA.2008.4608272; Zong W, 2003, COMPUT CARDIOL, V30, P259, DOI 10.1109/CIC.2003.1291140	35	92	96	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76585	10.1371/journal.pone.0076585	http://dx.doi.org/10.1371/journal.pone.0076585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167546	Green Submitted, Green Published, gold			2022-12-27	WOS:000326034500005
J	Oreshkova, N; van Keulen, L; Kant, J; Moormann, RJM; Kortekaas, J				Oreshkova, Nadia; van Keulen, Lucien; Kant, Jet; Moormann, Rob J. M.; Kortekaas, Jeroen			A Single Vaccination with an Improved Nonspreading Rift Valley Fever Virus Vaccine Provides Sterile Immunity in Lambs	PLOS ONE			English	Article							NSS PROTEIN; SAFETY; EFFICACY; IMMUNOGENICITY; PROTECTION; VECTORS; CATTLE; PATHOGENESIS; PHLEBOVIRUS; PATHOLOGY	Rift Valley fever virus (RVFV) is an important pathogen that affects ruminants and humans. Recently we developed a vaccine based on nonspreading RVFV (NSR) and showed that a single vaccination with this vaccine protects lambs from viremia and clinical signs. However, low levels of viral RNA were detected in the blood of vaccinated lambs shortly after challenge infection. These low levels of virus, when present in a pregnant ewe, could potentially infect the highly susceptible fetus. We therefore aimed to further improve the efficacy of the NSR vaccine. Here we report the expression of Gn, the major immunogenic protein of the virus, from the NSR genome. The resulting NSR-Gn vaccine was shown to elicit superior CD8 and CD4-restricted memory responses and improved virus neutralization titers in mice. A dose titration study in lambs revealed that the highest vaccination dose of 10(6.3) TCID50/ml protected all lambs from clinical signs and viremia. The lambs developed neutralizing antibodies within three weeks after vaccination and no anamnestic responses were observed following challenge. The combined results suggest that sterile immunity was achieved by a single vaccination with the NSR-Gn vaccine.	[Oreshkova, Nadia; van Keulen, Lucien; Kant, Jet; Moormann, Rob J. M.; Kortekaas, Jeroen] Cent Vet Inst, Dept Virol, Lelystad, Netherlands; [Oreshkova, Nadia; Moormann, Rob J. M.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, Utrecht, Netherlands	Wageningen University & Research; Utrecht University	Kortekaas, J (corresponding author), Cent Vet Inst, Dept Virol, Lelystad, Netherlands.	jeroen.kortekaas@wur.nl	amsalu, ribka/G-8780-2019	Oreshkova, Nadia/0000-0001-8830-7055	Dutch Ministry of Economic Affairs [KB-12-004.02-003]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was supported by the Dutch Ministry of Economic Affairs, project code KB-12-004.02-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonis AFG, 2013, VECTOR BORNE ZOONOTI; BARNARD BJH, 1979, J S AFR VET ASSOC, V50, P155; BARNARD BJH, 1977, J S AFR VET ASSOC, V48, P45; Beer M, 2013, EPIDEMIOL INFECT, V141, P1, DOI 10.1017/S0950268812002245; Bhardwaj N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000725; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2011, J VIROL, V85, P12901, DOI 10.1128/JVI.06046-11; Boshra H, 2011, J VIROL, V85, P6098, DOI 10.1128/JVI.02641-10; Botros B, 2006, J MED VIROL, V78, P787, DOI 10.1002/jmv.20624; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Bouloy M, 2009, ANTIVIR RES, V84, P101, DOI 10.1016/j.antiviral.2009.08.002; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P1065; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P905; Chevalier V, 2010, EUROSURVEILLANCE, V15, P18; COETZER JAW, 1977, ONDERSTEPOORT J VET, V44, P205; COETZER JAW, 1982, ONDERSTEPOORT J VET, V49, P11; Cole Geoffrey A, 2005, Methods Mol Biol, V302, P191; de Boer SM, 2010, VACCINE, V28, P2330, DOI 10.1016/j.vaccine.2009.12.062; Dodd KA, 2012, J VIROL, V86, P4204, DOI 10.1128/JVI.07104-11; Dufour B, 2008, REV SCI TECH OIE, V27, P529, DOI 10.20506/rst.27.2.1817; Dungu B, 2010, VACCINE, V28, P4581, DOI 10.1016/j.vaccine.2010.04.085; Easterday B C, 1965, Adv Vet Sci, V10, P65; Elliott R.M., 1996, BUNYAVIRIDAE; Gale P, 2010, EPIDEMIOL INFECT, V138, P214, DOI 10.1017/S0950268809990367; Gambotto A, 2000, GENE THER, V7, P2036, DOI 10.1038/sj.gt.3301335; Gerdes GH, 2004, REV SCI TECH OIE, V23, P613, DOI 10.20506/rst.23.2.1500; Gerrard SR, 2002, J VIROL, V76, P12200, DOI 10.1128/JVI.76.23.12200-12210.2002; Gorchakov R, 2007, VIROLOGY, V366, P212, DOI 10.1016/j.virol.2007.04.014; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Hunter P, 2002, ONDERSTEPOORT J VET, V69, P95; Ikegami T, 2009, VACCINE, V27, pD69, DOI 10.1016/j.vaccine.2009.07.046; Ikegami T, 2009, ANN NY ACAD SCI, V1171, pE75, DOI 10.1111/j.1749-6632.2009.05054.x; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Indran SV, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00131; KAKACH LT, 1988, J VIROL, V62, P826, DOI 10.1128/JVI.62.3.826-833.1988; Kamal SA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-94; Kasari TR, 2008, JAVMA-J AM VET MED A, V232, P514, DOI 10.2460/javma.232.4.514; KEEGAN K, 1986, J VIROL, V58, P263, DOI 10.1128/JVI.58.2.263-270.1986; Kortekaas J, 2012, VACCINE, V30, P3423, DOI 10.1016/j.vaccine.2012.03.027; Kortekaas J, 2010, VACCINE, V28, P2271, DOI 10.1016/j.vaccine.2010.01.001; Kortekaas J, 2011, J VIROL, V85, P12622, DOI 10.1128/JVI.00841-11; LAUGHLIN LW, 1979, T ROY SOC TROP MED H, V73, P630, DOI 10.1016/0035-9203(79)90006-3; Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007; Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747; Morrill JC, 1997, AM J VET RES, V58, P1110; MORRILL JC, 1987, AM J VET RES, V48, P1042; MORRILL JC, 1991, VACCINE, V9, P35, DOI 10.1016/0264-410X(91)90314-V; Morrill JC, 1997, AM J VET RES, V58, P1104; Morrill JC, 2013, VACCINE, V31, P559, DOI 10.1016/j.vaccine.2012.10.118; Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Peters CJ, 2008, VACCINE; Roger M, 2011, EMERG INFECT DIS, V17, P1319, DOI 10.3201/eid1707.102031; SALUZZO JF, 1990, VACCINE, V8, P369, DOI 10.1016/0264-410X(90)90096-5; Sissoko D, 2009, EMERG INFECT DIS, V15, P568, DOI 10.3201/eid1504.081045; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Tao P, 2009, ANTIVIR RES, V81, P253, DOI 10.1016/j.antiviral.2008.12.009; Villadangos JA, 2001, MOL IMMUNOL, V38, P329, DOI 10.1016/S0161-5890(01)00069-4; von Teichman B, 2011, VACCINE, V29, P5771, DOI 10.1016/j.vaccine.2011.05.055; Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07	64	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77461	10.1371/journal.pone.0077461	http://dx.doi.org/10.1371/journal.pone.0077461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167574	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500033
J	Sato, S; Zhao, YS; Imai, M; Simister, PC; Feller, SM; Trackman, PC; Kirsch, KH; Sonenshein, GE				Sato, Seiichi; Zhao, Yingshe; Imai, Misa; Simister, Philip C.; Feller, Stephan M.; Trackman, Philip C.; Kirsch, Kathrin H.; Sonenshein, Gail E.			Inhibition of CIN85-Mediated Invasion by a Novel SH3 Domain Binding Motif in the Lysyl Oxidase Propeptide	PLOS ONE			English	Article							BREAST-CANCER CELLS; GROWTH-FACTOR RECEPTORS; INTRACELLULAR TRAFFICKING; G473A POLYMORPHISM; COMPLEX-FORMATION; STRUCTURAL BASIS; ADAPTER PROTEIN; C-CBL; CIN85; GENE	The lysyl oxidase gene inhibits Ras signaling in transformed fibroblasts and breast cancer cells. Its activity was mapped to the 162 amino acid propeptide domain (LOX-PP) of the lysyl oxidase precursor protein. LOX-PP inhibited the Her-2/Ras signaling axis in breast cancer cells, and reduced the Her-2-driven breast tumor burden in a xenograft model. Since its mechanism of action is largely unknown, co-affinity-purification/mass spectrometry was performed and the "Cbl-interacting protein of 85-kDa" (CIN85) identified as an associating protein. CIN85 is an SH3-containing adapter protein that is overexpressed in invasive breast cancers. The CIN85 SH3 domains interact with c-Cbl, an E3 ubiquitin ligase, via an unconventional PxxxPR ligand sequence, with the highest affinity displayed by the SH3-B domain. Interaction with CIN85 recruits c-Cbl to the AMAP1 complex where its ubiquitination activity is necessary for cancer cells to develop an invasive phenotype and to degrade the matrix. Direct interaction of LOX-PP with CIN85 was confirmed using co-immunoprecipitation analysis of lysates from breast cancer cells and of purified expressed proteins. CIN85 interaction with c-Cbl was reduced by LOX-PP. Domain specific CIN85 regions and deletion mutants of LOX-PP were prepared and used to map the sites of interaction to the SH3-B domain of CIN85 and to an epitope encompassing amino acids 111 to 116 of LOX-PP. Specific LOX-PP point mutant proteins P111A and R116A failed to interact with CIN85 or to compete for CIN85 binding with c-Cbl. Structural modeling identified a new atypical PxpxxRh SH3-binding motif in this region of LOX-PP. The LOX-PP interaction with CIN85 was shown to reduce the invasive phenotype of breast cancer cells, including their ability to degrade the surrounding extracellular matrix and for Matrigel outgrowth. Thus, LOX-PP interacts with CIN85 via a novel SH3-binding motif and this association reduces CIN85-promoted invasion by breast cancer cells.	[Sato, Seiichi; Imai, Misa; Sonenshein, Gail E.] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Zhao, Yingshe; Kirsch, Kathrin H.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Simister, Philip C.; Feller, Stephan M.] Univ Oxford, Weatherall Inst Mol Med, Dept Oncol, Oxford, England; [Feller, Stephan M.] Univ Halle Wittenberg, Inst Mol Med, Sect Tumor Biol, D-06108 Halle, Saale, Germany; [Trackman, Philip C.] Boston Univ, Henry M Goldman Sch Dent Med, Div Oral Biol, Boston, MA 02215 USA	Tufts University; Boston University; University of Oxford; Martin Luther University Halle Wittenberg; Boston University	Sonenshein, GE (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	gail.sonenshein@tufts.edu	Trackman, Philip C/AAX-9280-2021	Trackman, Philip C/0000-0001-5064-614X; Kirsch, Kathrin/0000-0003-1532-1715	National Institutes of Health (NIH) [R01 CA143108, PO1 ES011624]; Breast Cancer Campaign (UK); EU FP7 program (Targetbinder consortium); Rosetrees Trust; Cancer Research UK (CR-UK) through the Oxford Cancer Research Centre Development Fund [C38302/A12278]; NATIONAL CANCER INSTITUTE [R01CA143108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011624] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Campaign (UK); EU FP7 program (Targetbinder consortium); Rosetrees Trust(Rosetrees Trust); Cancer Research UK (CR-UK) through the Oxford Cancer Research Centre Development Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	These studies were supported by National Institutes of Health (NIH) grants R01 CA143108 and PO1 ES011624. SF is indebted for funding from the Breast Cancer Campaign (UK) and the EU FP7 program (Targetbinder consortium). SF and PS acknowledge funding from the Rosetrees Trust support by Cancer Research UK (CR-UK) grant number C38302/A12278, through the Oxford Cancer Research Centre Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ceregido MA, 2013, FEBS J, V280, P3399, DOI 10.1111/febs.12333; Bais MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031188; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Belguise K, 2007, CANCER RES, V67, P5763, DOI 10.1158/0008-5472.CAN-06-4327; Chandra V, 2010, J VIROL, V84, P3857, DOI 10.1128/JVI.01994-09; CONTENTE S, 1990, SCIENCE, V249, P796, DOI 10.1126/science.1697103; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Eddy SF, 2007, CANCER RES, V67, P9018, DOI 10.1158/0008-5472.CAN-07-1691; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Feng LF, 2011, CELL BIOCHEM FUNCT, V29, P589, DOI 10.1002/cbf.1792; Finniss S, 2004, BIOCHEM BIOPH RES CO, V325, P174, DOI 10.1016/j.bbrc.2004.10.007; Gaidos G, 2007, J CELL SCI, V120, P2366, DOI 10.1242/jcs.004333; Havrylov S, 2010, TRAFFIC, V11, P721, DOI 10.1111/j.1600-0854.2010.01061.x; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; Jozic D, 2005, NAT STRUCT MOL BIOL, V12, P972, DOI 10.1038/nsmb1000; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Kowanetz K, 2004, MOL BIOL CELL, V15, P3155, DOI 10.1091/mbc.E03-09-0683; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Maller O, 2013, J CELL SCI; Mayer BJ, 2001, J CELL SCI, V114, P1253; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; McNiven MA, 2013, TRENDS CELL BIOL, V23, P16, DOI 10.1016/j.tcb.2012.08.009; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Min CY, 2010, J CELL BIOCHEM, V111, P1160, DOI 10.1002/jcb.22828; Min CY, 2009, CANCER RES, V69, P6685, DOI 10.1158/0008-5472.CAN-08-4818; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moncalian G, 2006, J BIOL CHEM, V281, P38845, DOI 10.1074/jbc.M606411200; Nam JM, 2007, EMBO J, V26, P647, DOI 10.1038/sj.emboj.7601534; Roldan JLO, 2011, J BIOMOL NMR, V50, P103, DOI 10.1007/s10858-011-9505-5; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Ren JH, 2011, DNA CELL BIOL, V30, P111, DOI 10.1089/dna.2010.1098; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; Sato S, 2011, MOL CELL BIOL, V31, P2683, DOI 10.1128/MCB.01148-10; Schmidt MHH, 2003, J CELL SCI, V116, P2845, DOI 10.1242/jcs.00522; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Simister PC, 2012, MOL BIOSYST, V8, P33, DOI 10.1039/c1mb05272a; SOMMER P, 1993, LAB INVEST, V69, P460; Take H, 2000, BIOCHEM BIOPH RES CO, V268, P321, DOI 10.1006/bbrc.2000.2147; Tibaldi EV, 2003, INT IMMUNOL, V15, P313, DOI 10.1093/intimm/dxg032; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Vora SR, 2010, BIOCHEMISTRY-US, V49, P2962, DOI 10.1021/bi902218p; Wu J, 2012, GENET TEST MOL BIOMA, V16, P915, DOI 10.1089/gtmb.2011.0374; Yoon JH, 2011, APMIS, V119, P762, DOI 10.1111/j.1600-0463.2011.02802.x; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zhang J, 2009, CELL RES, V19, P733, DOI 10.1038/cr.2009.51; Zhao YS, 2009, J BIOL CHEM, V284, P1385, DOI 10.1074/jbc.M802612200	55	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77288	10.1371/journal.pone.0077288	http://dx.doi.org/10.1371/journal.pone.0077288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167568	Green Published, gold, Green Submitted			2022-12-27	WOS:000326034500027
J	Yan, J; Sun, JF; Guo, XL; Jin, Z; Li, Y; Li, ZJ; Tong, SB				Yan, Jing; Sun, Junfeng; Guo, Xiaoli; Jin, Zheng; Li, Yao; Li, Zhijun; Tong, Shanbao			Motor Imagery Cognitive Network after Left Ischemic Stroke: Study of the Patients during Mental Rotation Task	PLOS ONE			English	Article							CONTRALESIONAL HEMISPHERE; CORTICAL ACTIVATION; BETA-RHYTHMS; MOVEMENT; BRAIN; EEG; REORGANIZATION; SYNCHRONIZATION; PERFORMANCE; DYNAMICS	Although motor imagery could improve motor rehabilitation, the detailed neural mechanisms of motor imagery cognitive process of stroke patients, particularly from functional network perspective, remain unclear. This study investigated functional brain network properties in each cognitive sub-stage of motor imagery of stroke patients with ischemic lesion in left hemisphere to reveal the impact of stroke on the cognition of motor imagery. Both stroke patients and control subjects participated in mental rotation task, which includes three cognitive sub-stages: visual stimulus perception, mental rotation and response cognitive process. Event-related electroencephalograph was recorded and interdependence between two different cortical areas was assessed by phase synchronization. Both global and nodal properties of functional networks in three sub-stages were statistically analyzed. Phase synchronization of stroke patients significantly reduced in mental rotation sub-stage. Longer characteristic path length and smaller global clustering coefficient of functional network were observed in patients in mental rotation sub-stage which implied the impaired segregation and integration. Larger nodal clustering coefficient and betweenness in contralesional occipitoparietal and frontal area respectively were observed in patients in all sub-stages. In addition, patients also showed smaller betweenness in ipsilesional central-parietal area in response sub-stage. The compensatory effects on local connectedness and centrality indicated the neuroplasticity in contralesional hemisphere. The functional brain networks of stroke patients demonstrated significant alterations and compensatory effects during motor imagery.	[Yan, Jing; Sun, Junfeng; Guo, Xiaoli; Li, Yao; Tong, Shanbao] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Sun, Junfeng; Li, Yao; Tong, Shanbao] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China; [Jin, Zheng] Fifth Peoples Hosp Shanghai, Dept Neurol, Shanghai, Peoples R China; [Li, Zhijun] Shanghai Jiao Tong Univ, Sch Elect Informat & Elect Engn, Dept Automat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Tong, SB (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	stong@sjtu.edu.cn	Li, Yao/AAE-3550-2019; Sun, Junfeng/D-1590-2010	Sun, Junfeng/0000-0002-7614-7127; Jin, Zheng/0000-0002-9499-934X	National Basic Research Program of China (973 Program) [2011CB013304]; National Natural Science Foundation of China [60901025, 61001015]; International Science & Technology Cooperation Program of China [2011DFA10950]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	This work was supported by National Basic Research Program of China (973 Program) (No. 2011CB013304), National Natural Science Foundation of China (No. 60901025, 61001015), and International Science & Technology Cooperation Program of China (No. 2011DFA10950). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; Benjamini Y, 2001, ANN STAT, V29, P1165; Calautti C, 2001, STROKE, V32, P2534, DOI 10.1161/hs1101.097401; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Crofts JJ, 2011, NEUROIMAGE, V54, P161, DOI 10.1016/j.neuroimage.2010.08.032; Crosbie JH, 2004, CLIN REHABIL, V18, P60, DOI 10.1191/0269215504cr702oa; David O, 2004, NEUROIMAGE, V21, P659, DOI 10.1016/j.neuroimage.2003.10.006; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eder CF, 2006, EUR J NEUROL, V13, P1312, DOI 10.1111/j.1468-1331.2006.01550.x; Fallani FD, 2009, ANAT REC, V292, P2023, DOI 10.1002/ar.20965; Ganis G, 2000, CEREB CORTEX, V10, P175, DOI 10.1093/cercor/10.2.175; Gerloff C, 2006, BRAIN, V129, P791, DOI 10.1093/brain/awh713; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P535, DOI 10.1017/S0048577202020449; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lee MY, 2009, NEUROREHABILITATION, V25, P255, DOI 10.3233/NRE-2009-0523; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Meehan SK, 2011, HUM BRAIN MAPP, V32, P290, DOI 10.1002/hbm.21019; Micheloyannis S, 2009, HUM BRAIN MAPP, V30, P200, DOI 10.1002/hbm.20492; Neuper C, 1996, NEUROSCI LETT, V216, P17; Nomura EM, 2010, P NATL ACAD SCI USA, V107, P12017, DOI 10.1073/pnas.1002431107; Page SJ, 2001, CLIN REHABIL, V15, P233, DOI 10.1191/026921501672063235; Parkes LM, 2006, NEUROIMAGE, V29, P685, DOI 10.1016/j.neuroimage.2005.08.018; Petit LS, 2003, BRAIN COGNITION, V51, P95, DOI 10.1016/S0278-2626(02)00526-2; PFURTSCHELLER G, 1994, NEUROSCI LETT, V181, P43, DOI 10.1016/0304-3940(94)90556-8; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schaechter JD, 2008, CEREB CORTEX, V18, P638, DOI 10.1093/cercor/bhm096; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Sun JF, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046219; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Wu WQ, 2011, CLIN NEUROPHYSIOL, V122, P21, DOI 10.1016/j.clinph.2010.06.003; Yan J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042922	38	16	17	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77325	10.1371/journal.pone.0077325	http://dx.doi.org/10.1371/journal.pone.0077325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167569	Green Submitted, Green Published, gold			2022-12-27	WOS:000326034500028
J	Dong, ZX; Ran, JH; Zhou, H; Chen, JH; Lei, TL; Wang, WL; Sun, Y; Lin, GT; Bankir, L; Yang, BX				Dong, Zixun; Ran, Jianhua; Zhou, Hong; Chen, Jihui; Lei, Tianluo; Wang, Weiling; Sun, Yi; Lin, Guiting; Bankir, Lise; Yang, Baoxue			Urea Transporter UT-B Deletion Induces DNA Damage and Apoptosis in Mouse Bladder Urothelium	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GENOME-WIDE ASSOCIATION; ORNITHINE-DECARBOXYLASE; TERMINAL HYDROLASE-L1; CONCENTRATING ABILITY; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; SINGLET OXYGEN; IN-VIVO; ARGINASE	Background: Previous studies found that urea transporter UT-B is abundantly expressed in bladder urothelium. However, the dynamic role of UT-B in bladder urothelial cells remains unclear. The objective of this study is to evaluate the physiological roles of UT-B in bladder urothelium using UT-B knockout mouse model and T24 cell line. Methodology/Principal Findings: Urea and NO measurement, mRNA expression micro-array analysis, light and transmission electron microscopy, apoptosis assays, DNA damage and repair determination, and intracellular signaling examination were performed in UT-B null bladders vs wild-type bladders and in vitro T24 epithelial cells. UT-B was highly expressed in mouse bladder urothelium. The genes, Dcaf11, MCM2-4, Uch-L1, Bnip3 and 45 S pre rRNA, related to DNA damage and apoptosis were significantly regulated in UT-B null urothelium. DNA damage and apoptosis highly occurred in UT-B null urothelium. Urea and NO levels were significantly higher in UT-B null urothelium than that in wild-type, which may affect L-arginine metabolism and the intracellular signals related to DNA damage and apoptosis. These findings were consistent with the in vitro study in T24 cells that, after urea loading, exhibited cell cycle delay and apoptosis. Conclusions/Significance: UT-B may play an important role in protecting bladder urothelium by balancing intracellular urea concentration. Disruption of UT-B function induces DNA damage and apoptosis in bladder, which can result in bladder disorders.	[Dong, Zixun; Zhou, Hong; Chen, Jihui; Lei, Tianluo; Wang, Weiling; Sun, Yi; Yang, Baoxue] Peking Univ, State Key Lab Nat & Biomimet Drugs, Key Lab Mol Cardiovasc Sci, Minist Educ, Beijing 100871, Peoples R China; [Dong, Zixun; Zhou, Hong; Chen, Jihui; Lei, Tianluo; Wang, Weiling; Sun, Yi; Yang, Baoxue] Peking Univ, Dept Pharmacol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Ran, Jianhua] Chongqing Med Univ, Basic Med Coll, Neurosci Res Ctr, Dept Anat, Chongqing, Peoples R China; [Lin, Guiting] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Bankir, Lise] Ctr Rech Cordeliers, INSERM, U872, Paris, France	Peking University; Peking University; Chongqing Medical University; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Yang, BX (corresponding author), Peking Univ, State Key Lab Nat & Biomimet Drugs, Key Lab Mol Cardiovasc Sci, Minist Educ, Beijing 100871, Peoples R China.	baoxue@bjmu.edu.cn	BANKIR, Lise/AAK-2733-2020	BANKIR, Lise/0000-0002-3321-0819; Chen, Jihui/0000-0002-9819-9921	National Natural Science Foundation of China [30500171, 30870921, 31200869, 81261160507, 81170632]; Drug Discovery Program [2009ZX09301-010-30]; Research Fund for the Doctoral Program of Higher Education [20100001110047]; 111 project,; Beijing Natural Science Foundation [7102105]; International Science and Technology Cooperation Program of China;  [2012DFA11070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Drug Discovery Program; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); 111 project,(Ministry of Education, China - 111 Project); Beijing Natural Science Foundation(Beijing Natural Science Foundation); International Science and Technology Cooperation Program of China; 	This work was supported by National Natural Science Foundation of China grants 30500171, 30870921, 31200869, 81261160507, and 81170632, Drug Discovery Program grant 2009ZX09301-010-30, the Research Fund for the Doctoral Program of Higher Education 20100001110047, the 111 project, International Science and Technology Cooperation Program of China 2012DFA11070, and Beijing Natural Science Foundation grant 7102105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankir L, 2004, AM J PHYSIOL-RENAL, V286, pF144, DOI 10.1152/ajprenal.00205.2003; Bauer PM, 2001, J BIOL CHEM, V276, P34458, DOI 10.1074/jbc.M105219200; Bheda A, 2010, CELL CYCLE, V9, P980, DOI 10.4161/cc.9.5.10934; Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006764; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Dmitrieva N, 2000, J BIOL CHEM, V275, P18243, DOI 10.1074/jbc.M000522200; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; El-Bassossy HM, 2012, VASC PHARMACOL, V57, P194, DOI 10.1016/j.vph.2012.01.001; Feng ZH, 2012, P NATL ACAD SCI USA, V109, P7013, DOI 10.1073/pnas.1203930109; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Garcia-Closas M, 2011, HUM MOL GENET, V20, P4282, DOI 10.1093/hmg/ddr342; Giaginis C, 2009, DIGEST DIS SCI, V54, P282, DOI 10.1007/s10620-008-0305-z; Gonzalez MA, 2003, J CLIN ONCOL, V21, P4306, DOI 10.1200/JCO.2003.04.121; Guo LR, 2007, AM J PHYSIOL-CELL PH, V293, pC305, DOI 10.1152/ajpcell.00608.2006; Hussain S, 2010, LEUKEMIA, V24, P1641, DOI 10.1038/leu.2010.138; Ignarro LJ, 2001, P NATL ACAD SCI USA, V98, P4202, DOI 10.1073/pnas.071054698; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kawano K, 2006, J UROLOGY, V176, P387, DOI 10.1016/S0022-5347(06)00515-5; KHAN AU, 1992, P NATL ACAD SCI USA, V89, P11426, DOI 10.1073/pnas.89.23.11426; KHAN AU, 1992, P NATL ACAD SCI USA, V89, P11428, DOI 10.1073/pnas.89.23.11428; Kim HJ, 2009, ONCOGENE, V28, P117, DOI 10.1038/onc.2008.364; Kraus LM, 2001, KIDNEY INT, V59, pS102, DOI 10.1046/j.1523-1755.2001.59780102.x; Kunnev D, 2010, ONCOGENE, V29, P3630, DOI 10.1038/onc.2010.125; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; Li X, 2012, J MOL NEUROSCI, V46, P362, DOI 10.1007/s12031-011-9594-3; Luperchio S, 1996, FREE RADICAL BIO MED, V21, P513, DOI 10.1016/0891-5849(96)00219-5; Lygerou Z, 2000, SCIENCE, V290, P2271; Meng Y, 2009, SCI CHINA SER C, V52, P474, DOI 10.1007/s11427-009-0047-y; Michea L, 2000, AM J PHYSIOL-RENAL, V278, pF209, DOI 10.1152/ajprenal.2000.278.2.F209; Nikolaeva S D, 2008, Zh Evol Biokhim Fiziol, V44, P234; Pahan K, 1999, J BIOL CHEM, V274, P7528, DOI 10.1074/jbc.274.11.7528; PRABHAKAR SS, 1997, AM J PHYSIOL-CELL PH, V273, pC1882; Rafnar T, 2011, HUM MOL GENET, V20, P4268, DOI 10.1093/hmg/ddr303; Shen H, 2006, APOPTOSIS, V11, P1049, DOI 10.1007/s10495-006-6303-8; Singh R, 2008, BIOPHYS CHEM, V133, P81, DOI 10.1016/j.bpc.2007.12.006; Smith CP, 2006, J MEMBRANE BIOL, V212, P109, DOI 10.1007/s00232-006-0870-z; SNYDER RD, 1989, BIOCHEM J, V260, P697, DOI 10.1042/bj2600697; Spector DA, 2004, AM J PHYSIOL-RENAL, V287, pF102, DOI 10.1152/ajprenal.00442.2003; Spector DA, 2007, AM J PHYSIOL-RENAL, V292, pF467, DOI 10.1152/ajprenal.00181.2006; Stanley KP, 2006, AM J PHYSIOL-LUNG C, V290, pL298, DOI 10.1152/ajplung.00140.2005; Tan YY, 2008, MOL CELL BIOCHEM, V318, P109, DOI 10.1007/s11010-008-9862-x; Timmer RT, 2001, AM J PHYSIOL-CELL PH, V281, pC1318, DOI 10.1152/ajpcell.2001.281.4.C1318; Tratsiakovich Y, 2013, EUR J PHARM; Tsikas D, 2000, FEBS LETT, V478, P1, DOI 10.1016/S0014-5793(00)01686-0; Yang B, 2002, J BIOL CHEM, V277, P10633, DOI 10.1074/jbc.M200207200; Yang BX, 2005, AM J PHYSIOL-RENAL, V288, pF881, DOI 10.1152/ajprenal.00367.2004; Zhang Z, 2004, P NATL ACAD SCI USA, V101, P9491, DOI 10.1073/pnas.0402961101; Zhao D, 2007, BBA-BIOMEMBRANES, V1768, P1815, DOI 10.1016/j.bbamem.2007.04.010; Zou Q, 1998, PROTEINS, V31, P107, DOI 10.1002/(SICI)1097-0134(19980501)31:2<107::AID-PROT1>3.0.CO;2-J	50	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76952	10.1371/journal.pone.0076952	http://dx.doi.org/10.1371/journal.pone.0076952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204711	Green Published, gold			2022-12-27	WOS:000326032600017
J	Rajaram, N; Frees, AE; Fontanella, AN; Zhong, J; Hansen, K; Dewhirst, MW; Ramanujam, N				Rajaram, Narasimhan; Frees, Amy E.; Fontanella, Andrew N.; Zhong, Jim; Hansen, Katherine; Dewhirst, Mark W.; Ramanujam, Nirmala			Delivery Rate Affects Uptake of a Fluorescent Glucose Analog in Murine Metastatic Breast Cancer	PLOS ONE			English	Article							BLOOD-FLOW; NECK CANCER; TUMOR; METABOLISM; RADIOSENSITIVITY; THERAPY; GASES; HIF-1; PET	We demonstrate an optical strategy using intravital microscopy of dorsal skin flap window chamber models to image glucose uptake and vascular oxygenation in vivo. Glucose uptake was imaged using a fluorescent glucose analog, 2-[N-(7-nitrobenz-2-oxa-1,3-diaxol-4-yl)amino]-2-deoxyglucose (2-NBDG). SO2 was imaged using the differential absorption properties of oxygenated [HbO(2)] and deoxygenated hemoglobin [dHb]. This study was carried out on two sibling murine mammary adenocarcinoma lines, 4T1 and 4T07. 2-NBDG uptake in the 4T1 tumors was lowest when rates of delivery and clearance were lowest, indicating perfusion-limited uptake in poorly oxygenated tumor regions. For increasing rates of delivery that were still lower than the glucose consumption rate (as measured in vitro), both 2-NBDG uptake and the clearance rate from the tumor increased. When the rate of delivery of 2-NBDG exceeded the glucose consumption rate, 2-NBDG uptake decreased with any further increase in rate of delivery, but the clearance rate continued to increase. This inflection point was not observed in the 4T07 tumors due to an absence of low delivery rates close to the glucose consumption rate. In the 4T07 tumors, 2-NBDG uptake increased with increasing rates of delivery at low rates of clearance. Our results demonstrate that 2-NBDG uptake in tumors is influenced by the rates of delivery and clearance of the tracer. The rates of delivery and clearance are, in turn, dependent on vascular oxygenation of the tumors. Knowledge of the kinetics of tracer uptake as well as vascular oxygenation is essential to make an informed assessment of glucose demand of a tumor.	[Rajaram, Narasimhan; Frees, Amy E.; Fontanella, Andrew N.; Dewhirst, Mark W.; Ramanujam, Nirmala] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Zhong, Jim] Duke Univ, Sch Med, Durham, NC USA; [Hansen, Katherine; Dewhirst, Mark W.] Duke Univ, Dept Radiat Oncol, Durham, NC USA	Duke University; Duke University; Duke University	Rajaram, N (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	n.rajaram@duke.edu	Rajaram, Narasimhan/A-2249-2010; Dewhirst, Mark/Q-1302-2019; Ramanujam, Nimmi/AAA-7575-2021	Rajaram, Narasimhan/0000-0003-1224-8567; Dewhirst, Mark/0000-0003-3459-6546; Ramanujam, Nimmi/0000-0001-7319-8415; Martinez, Amy/0000-0002-8088-7398	Department of Defense Era of Hope Scholar Award [W81XWH-09-1-0410]	Department of Defense Era of Hope Scholar Award(United States Department of Defense)	Funding was provided by a Department of Defense Era of Hope Scholar Award (W81XWH-09-1-0410; PI: N. Ramanujam). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dunn TJ, 1999, BRIT J CANCER, V80, P117, DOI 10.1038/sj.bjc.6690330; Fokas E, 2012, CANCER RES, V72, P239, DOI 10.1158/0008-5472.CAN-11-2263; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Hermans R, 2003, INT J RADIAT ONCOL, V57, P1351, DOI 10.1016/S0360-3016(03)00764-8; KALLINOWSKI F, 1989, INT J CANCER, V44, P266, DOI 10.1002/ijc.2910440214; King LM, 1998, CARDIOVASC RES, V39, P381, DOI 10.1016/S0008-6363(98)00100-X; Komar G, 2009, CLIN CANCER RES, V15, P5511, DOI 10.1158/1078-0432.CCR-09-0414; KRUUV JA, 1967, CANCER, V20, P51, DOI 10.1002/1097-0142(1967)20:1<51::AID-CNCR2820200108>3.0.CO;2-D; Kunkel M, 2006, ORAL ONCOL, V42, P297, DOI 10.1016/j.oraloncology.2005.08.004; Kunkel M, 2003, ORAL ONCOL, V39, P170, DOI 10.1016/S1368-8375(02)00087-8; Lu X, 2010, J BIOL CHEM, V285, P9317, DOI 10.1074/jbc.C110.104448; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Mankoff DA, 2003, J NUCL MED, V44, P1806; Mankoff DA, 2002, J NUCL MED, V43, P500; Miller S, 2010, BOOK MIDWIVES CARE P, V2nd, P1; Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Nitin N, 2009, INT J CANCER, V124, P2634, DOI 10.1002/ijc.24222; O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6; Palmer GM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3523363; Semple SIK, 2004, EUR RADIOL, V14, P2038, DOI 10.1007/s00330-004-2454-6; Shankar LK, 2006, J NUCL MED, V47, P1059; Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Thorwarth D, 2006, RADIOTHER ONCOL, V80, P151, DOI 10.1016/j.radonc.2006.07.033; Tseng JC, 2012, MOL IMAGING BIOL, P1; Van den Abbeele AD, 2008, PET CLIN, V3, P77, DOI 10.1016/j.cpet.2008.08.001; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Yoshioka K, 1996, APPL MICROBIOL BIOT, V46, P400; Zasadny KR, 2003, EUR J NUCL MED MOL I, V30, P274, DOI 10.1007/s00259-002-1022-z; Zhong J, 2013, RADIOTHER ONCOL, V106, P390, DOI 10.1016/j.radonc.2013.02.013	33	25	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76524	10.1371/journal.pone.0076524	http://dx.doi.org/10.1371/journal.pone.0076524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204635	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300033
J	Tanabe, AS; Toju, H				Tanabe, Akifumi S.; Toju, Hirokazu			Two New Computational Methods for Universal DNA Barcoding: A Benchmark Using Barcode Sequences of Bacteria, Archaea, Animals, Fungi, and Land Plants	PLOS ONE			English	Article							TAXONOMIC CLASSIFICATION; MAXIMUM-LIKELIHOOD; IDENTIFICATION; ASSIGNMENT; PLACEMENT; DIVERSITY; BLAST	Taxonomic identification of biological specimens based on DNA sequence information (a.k.a. DNA barcoding) is becoming increasingly common in biodiversity science. Although several methods have been proposed, many of them are not universally applicable due to the need for prerequisite phylogenetic/machine-learning analyses, the need for huge computational resources, or the lack of a firm theoretical background. Here, we propose two new computational methods of DNA barcoding and show a benchmark for bacterial/archeal 16S, animal COX1, fungal internal transcribed spacer, and three plant chloroplast (rbcL, matK, and trnH-psbA) barcode loci that can be used to compare the performance of existing and new methods. The benchmark was performed under two alternative situations: query sequences were available in the corresponding reference sequence databases in one, but were not available in the other. In the former situation, the commonly used "1-nearest-neighbor" (1-NN) method, which assigns the taxonomic information of the most similar sequences in a reference database (i.e., BLAST-top-hit reference sequence) to a query, displays the highest rate and highest precision of successful taxonomic identification. However, in the latter situation, the 1-NN method produced extremely high rates of misidentification for all the barcode loci examined. In contrast, one of our new methods, the query-centric auto-k-nearest-neighbor (QCauto) method, consistently produced low rates of misidentification for all the loci examined in both situations. These results indicate that the 1-NN method is most suitable if the reference sequences of all potentially observable species are available in databases; otherwise, the QCauto method returns the most reliable identification results. The benchmark results also indicated that the taxon coverage of reference sequences is far from complete for genus or species level identification in all the barcode loci examined. Therefore, we need to accelerate the registration of reference barcode sequences to apply high-throughput DNA barcoding to genus or species level identification in biodiversity research.	[Tanabe, Akifumi S.; Toju, Hirokazu] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan; [Tanabe, Akifumi S.] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Res Ctr Aquat Genom, Yokohama, Kanagawa, Japan; [Toju, Hirokazu] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan	Kyoto University; Japan Fisheries Research & Education Agency (FRA); Kyoto University	Tanabe, AS (corresponding author), Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan.	akifumi.tanabe@gmail.com	Toju, Hirokazu/S-7307-2017; Toju, Hirokazu/T-7355-2019; Tanabe, Akifumi/P-9381-2015	Toju, Hirokazu/0000-0002-3362-3285; Tanabe, Akifumi/0000-0003-1017-6504	Funding Program for Next Generation World-Leading Researchers by the Japan Society for the Promotion of Science [GS014]	Funding Program for Next Generation World-Leading Researchers by the Japan Society for the Promotion of Science	This work was supported by grant-in-aid by Funding Program for Next Generation World-Leading Researchers (GS014) by the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Bachy C, 2013, ISME J, V7, P244, DOI 10.1038/ismej.2012.106; Brady A, 2011, NAT METHODS, V8, P367, DOI 10.1038/nmeth0511-367; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; Gerlach W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr225; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kemp PF, 2004, FEMS MICROBIOL ECOL, V47, P161, DOI 10.1016/S0168-6496(03)00257-5; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Little DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020552; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Primack R.B., 1993, ESSENTIALS CONSERVAT; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Stark M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-461; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Toju H, 2013, ECOL EVOL, V3, P1281, DOI 10.1002/ece3.546; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Zhang AB, 2012, MOL ECOL, V21, P1848, DOI 10.1111/j.1365-294X.2011.05235.x	47	133	144	5	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76910	10.1371/journal.pone.0076910	http://dx.doi.org/10.1371/journal.pone.0076910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204702	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300065
J	Wang, S; Cha, SW; Zorn, AM; Wylie, C				Wang, Sha; Cha, Sang-Wook; Zorn, Aaron M.; Wylie, Christopher			Par6b Regulates the Dynamics of Apicobasal Polarity during Development of the Stratified Xenopus Epidermis	PLOS ONE			English	Article							EPITHELIAL-CELL POLARITY; PROTEIN PAR6; JUNCTION FORMATION; GIANT-LARVAE; APKC; MORPHOGENESIS; LOCALIZATION; ECTODERM; CRUMBS; GENES	During early vertebrate development, epithelial cells establish and maintain apicobasal polarity, failure of which can cause developmental defects or cancer metastasis. This process has been mostly studied in simple epithelia that have only one layer of cells, but is poorly understood in stratified epithelia. In this paper we address the role of the polarity protein Partitioning defective-6 homolog beta (Par6b) in the developing stratified epidermis of Xenopus laevis. At the blastula stage, animal blastomeres divide perpendicularly to the apicobasal axis to generate partially polarized superficial cells and non-polarized deep cells. Both cell populations modify their apicobasal polarity during the gastrula stage, before differentiating into the superficial and deep layers of epidermis. Early differentiation of the epidermis is normal in Par6b-depleted embryos; however, epidermal cells dissociate and detach from embryos at the tailbud stage. Par6b-depleted epidermal cells exhibit a significant reduction in basolaterally localized E-cadherin. Examination of the apical marker Crumbs homolog 3 (Crb3) and the basolateral marker Lethal giant larvae 2 (Lgl2) after Par6b depletion reveals that Par6b cell-autonomously regulates the dynamics of apicobasal polarity in both superficial and deep epidermal layers. Par6b is required to maintain the "basolateral" state in both epidermal layers, which explains the reduction of basolateral adhesion complexes and epidermal cells shedding.	[Wang, Sha; Cha, Sang-Wook; Zorn, Aaron M.; Wylie, Christopher] Cincinnati Childrens Res Fdn, Div Dev Biol, Cincinnati, OH USA; [Wang, Sha] Cincinnati Childrens Res Fdn, Mol & Dev Biol Grad Program, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Wylie, C (corresponding author), Cincinnati Childrens Res Fdn, Div Dev Biol, Cincinnati, OH USA.	christopher.wylie@cchmc.org	Cha, Sang-Wook/D-3523-2016; Wang, Sha/J-7501-2019		National Institutes of Health [R01HD044764]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by National Institutes of Health grant R01HD044764. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILLETT FS, 1971, J ANAT, V108, P465; Bowerman B, 1997, DEVELOPMENT, V124, P3815; Cha SW, 2008, DEVELOPMENT, V135, P3719, DOI 10.1242/dev.029025; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Chalmers AD, 2003, DEVELOPMENT, V130, P2657, DOI 10.1242/dev.00490; Chalmers AD, 2002, DEV CELL, V2, P171, DOI 10.1016/S1534-5807(02)00113-2; Cline EG, 2007, MOL CELL BIOL, V27, P4431, DOI 10.1128/MCB.02235-06; Cunliffe HE, 2012, AM J CANCER RES, V2, P478; Gao L, 2004, J BIOL CHEM, V279, P41557, DOI 10.1074/jbc.M403723200; Guo S, 1996, CURR OPIN GENET DEV, V6, P408, DOI 10.1016/S0959-437X(96)80061-X; Hayase J, 2013, J CELL BIOL, V200, P635, DOI 10.1083/jcb.201208150; Helfrich I, 2007, J INVEST DERMATOL, V127, P782, DOI 10.1038/sj.jid.5700621; Hung TJ, 1999, DEVELOPMENT, V126, P127; Huynh JR, 2001, CURR BIOL, V11, P901, DOI 10.1016/S0960-9822(01)00244-5; JAMRICH M, 1987, GENE DEV, V1, P124, DOI 10.1101/gad.1.2.124; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; KELLER RE, 1980, J EMBRYOL EXP MORPH, V60, P201; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kishi M, 2000, DEVELOPMENT, V127, P791; Lee HS, 2008, NAT CELL BIOL, V10, P979, DOI 10.1038/ncb1758; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; LEVI G, 1991, DEVELOPMENT, V113, P1335; LEVI G, 1991, DEVELOPMENT, V111, P159; Longo D, 2004, DEV BIOL, V271, P210, DOI 10.1016/j.ydbio.2004.03.021; Margolis B, 2005, J CELL SCI, V118, P5157, DOI 10.1242/jcs.02597; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Mir A, 2007, DEVELOPMENT, V134, P779, DOI 10.1242/dev.02768; Mir Adnan, 2008, V469, P417, DOI 10.1007/978-1-60327-469-2_26; Muller HAJ, 2003, MECH DEVELOP, V120, P1231, DOI 10.1016/j.mod.2003.06.001; Munson C, 2008, DEV BIOL, V324, P41, DOI 10.1016/j.ydbio.2008.08.033; Muroyama A, 2012, SEMIN CELL DEV BIOL, V23, P890, DOI 10.1016/j.semcdb.2012.08.008; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Muthuswamy SK, 2012, ANNU REV CELL DEV BI, V28, P599, DOI 10.1146/annurev-cellbio-092910-154244; Nandadasa S, 2009, DEVELOPMENT, V136, P1327, DOI 10.1242/dev.031203; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Pieczynski J, 2011, AM J PHYSIOL-RENAL, V300, pF589, DOI 10.1152/ajprenal.00615.2010; Reischauer S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000720; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; St Johnston D, 2011, CURR OPIN CELL BIOL, V23, P540, DOI 10.1016/j.ceb.2011.07.005; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tadjuidje E, 2011, DEV DYNAM, V240, P1727, DOI 10.1002/dvdy.22671; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; TORPEY NP, 1992, J CELL SCI, V101, P151; Totong R, 2007, DEVELOPMENT, V134, P1259, DOI 10.1242/dev.02833; Wang Q, 2004, J BIOL CHEM, V279, P30715, DOI 10.1074/jbc.M401930200; Watts JL, 1996, DEVELOPMENT, V122, P3133; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6	50	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76854	10.1371/journal.pone.0076854	http://dx.doi.org/10.1371/journal.pone.0076854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204686	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300055
J	Li, CW; Zhang, W; Zhou, FY; Chen, CY; Zhou, L; Li, YF; Liu, L; Pei, F; Luo, H; Hu, ZX; Cai, J; Zeng, CY				Li, Chuanwei; Zhang, Wen; Zhou, Faying; Chen, Caiyu; Zhou, Liang; Li, Yafei; Liu, Ling; Pei, Fang; Luo, Hao; Hu, Zhangxue; Cai, Jing; Zeng, Chunyu			Cholesteryl Ester Transfer Protein Inhibitors in the Treatment of Dyslipidemia: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; LDL CHOLESTEROL; HDL CHOLESTEROL; STATIN THERAPY; TORCETRAPIB; EFFICACY; SAFETY; CETP	Cholesteryl ester transfer protein (CETP) inhibitors are gaining substantial research interest for raising high density lipoprotein cholesterol levels. The aim of the research was to estimate the efficacy and safety of cholesteryl ester transfer protein inhibitors as novel lipid modifying drugs. Systematic searches of English literature for randomized controlled trials (RCT) were collected from MEDLINE, EBASE, CENTRAL and references listed in eligible studies. Two independent authors assessed the search results and only included the double-blind RCTs by using cholesteryl ester transfer protein inhibitors as exclusively or co-administrated with statin therapy irrespective of gender in enrolled adult subjects. Two independent authors extracted the data by using predefined data fields. Of 503 studies identified, 14 studies met the inclusion criteria, and 12 studies were included into the final meta-analysis. Our meta-analysis revealed that CETP inhibitors increased the HDL-c levels (n = 2826, p<0.00001, mean difference (MD) = 20.47, 95% CI [19.80 to 21.15]) and total cholesterol (n = 3423, p = 0.0002, MD= 3.57, 95% CI [1.69 to 5.44] to some extent combined with a reduction in triglyceride (n = 3739, p<0.00001, MD = -10.47, 95% CI [-11.91 to -9.03]) and LDL-c (n = 3159, p<0.00001, MD= -17.12, 95% CI [-18.87 to -15.36]) irrespective of mono-therapy or co-administration with statins. Subgroup analysis suggested that the lipid modifying effects varied according to the four currently available CETP inhibitors. CETP inhibitor therapy did not increase the adverse events when compared with control. However, we observed a slight increase in blood pressure (SBP, n = 2384, p<0.00001, MD = 2.73, 95% CI [2.14 to 3.31], DBP, n = 2384, p<0.00001, MD = 1.16, 95% CI [0.73 to 1.60]) after CETP inhibitor treatment, which were mainly ascribed to the torcetrapib treatment subgroup. CETP inhibitors therapy is associated with significant increase in HDL-c and decrease in triglyceride and LDL-c with satisfactory safety and tolerability in patients with dyslipidemia. However, the side-effect on blood pressure deserves more consideration in future studies.	[Li, Chuanwei; Zhou, Faying; Chen, Caiyu; Pei, Fang; Luo, Hao; Hu, Zhangxue; Cai, Jing; Zeng, Chunyu] Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China; [Li, Chuanwei; Zhou, Faying; Chen, Caiyu; Pei, Fang; Luo, Hao; Hu, Zhangxue; Cai, Jing; Zeng, Chunyu] Chongqing Inst Cardiol, Chongqing, Peoples R China; [Zhang, Wen] Third Mil Med Univ, Xinqiao Hosp, Dept Resp, Chongqing, Peoples R China; [Zhou, Liang; Liu, Ling] Third Mil Med Univ, Dept Hlth Stat, Coll Prevent Med, Chongqing, Peoples R China; [Li, Yafei] Third Mil Med Univ, Dept Social Med & Hlth Serv Management, Key Lab Med Protect Electromagnet Radiat, Coll Prevent Med,Minist Educ China, Chongqing, Peoples R China	Army Medical University; Chinese Academy of Sciences; Army Medical University; Army Medical University; Army Medical University; Ministry of Education, China	Zeng, CY (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China.	chunyuzeng007@163.com			National Natural Science Foundation of China [30925018, 31130029, 81070559, 81100190]; National Basic Research Program of China (973 Program) [2008CB517308, 2012CB517801]; Natural Science Foundation Project of CQ CSTC (CSTC) [2009BA5044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation Project of CQ CSTC (CSTC)(Natural Science Foundation Project of CQ CSTC)	Dr. Zeng's laboratory is supported by grants from the National Natural Science Foundation of China (30925018, 31130029, 81070559, 81100190); National Basic Research Program of China (973 Program, 2008CB517308, 2012CB517801), and Natural Science Foundation Project of CQ CSTC (CSTC, 2009BA5044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Ballantyne CM, 2012, AM HEART J, V163, P515, DOI 10.1016/j.ahj.2011.11.017; Birjmohun RS, 2005, J AM COLL CARDIOL, V45, P185, DOI 10.1016/j.jacc.2004.10.031; Bisoendial RJ, 2005, ARTERIOSCL THROM VAS, V25, pE133, DOI 10.1161/01.ATV.0000179009.60612.28; Bloomfield D, 2009, AM HEART J, V157, P352, DOI 10.1016/j.ahj.2008.09.022; Briel M, 2012, INT J CARDIOL, V158, P93, DOI 10.1016/j.ijcard.2011.01.033; Briel Matthias, 2009, BMJ, V338, pb92, DOI 10.1136/bmj.b92; Cao GQ, 2011, J LIPID RES, V52, P2169, DOI 10.1194/jlr.M018069; Connelly MA, 2010, J CARDIOVASC PHARM, V55, P459, DOI 10.1097/FJC.0b013e3181cf03cb; Davidson MH, 2006, J AM COLL CARDIOL, V48, P1774, DOI 10.1016/j.jacc.2006.06.067; de Grooth GJ, 2002, CIRCULATION, V105, P2159, DOI 10.1161/01.CIR.0000015857.31889.7B; de Vries R, 2005, DIABETES, V54, P3554, DOI 10.2337/diabetes.54.12.3554; FOGER B, 1995, J MOL MED, V73, P369; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Guerin M, 2008, ARTERIOSCL THROM VAS, V28, P148, DOI 10.1161/ATVBAHA.107.151688; Hermann F, 2009, THROMB RES, V123, P460, DOI 10.1016/j.thromres.2008.06.022; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Hu X, 2009, ENDOCRINOLOGY, V150, P2211, DOI 10.1210/en.2008-1512; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Jafri H, 2010, ANN INTERN MED, V153, P800, DOI 10.7326/0003-4819-153-12-201012210-00006; Krishna R, 2007, LANCET, V370, P1907, DOI 10.1016/S0140-6736(07)61813-3; Kuivenhoven JA, 2005, AM J CARDIOL, V95, P1085, DOI 10.1016/j.amjcard.2004.12.064; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu T, 2007, J AM COLL CARDIOL, V49, P1642, DOI 10.1016/j.jacc.2006.12.042; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; McKenney JM, 2006, J AM COLL CARDIOL, V48, P1782, DOI 10.1016/j.jacc.2006.06.066; Nicholls SJ, 2011, JAMA-J AM MED ASSOC, V306, P2099, DOI 10.1001/jama.2011.1649; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Okamoto H, 2000, NATURE, V406, P203, DOI 10.1038/35018119; Otvos JD, 2006, CIRCULATION, V113, P1556, DOI 10.1161/CIRCULATIONAHA.105.565135; Plump AS, 1999, ARTERIOSCL THROM VAS, V19, P1105, DOI 10.1161/01.ATV.19.4.1105; Ray K, 2012, HEART, V98, P780, DOI 10.1136/heartjnl-2011-301405; Ritsch A, 2010, CIRCULATION, V121, P366, DOI 10.1161/CIRCULATIONAHA.109.875013; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Sahoo D, 2004, J LIPID RES, V45, P1122, DOI 10.1194/jlr.M300529-JLR200; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Simic B, 2012, EUR HEART J, V33, P1615, DOI 10.1093/eurheartj/ehr348; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; Vekic J, 2007, CLIN BIOCHEM, V40, P310, DOI 10.1016/j.clinbiochem.2006.11.013; Vergeer M, 2009, AM J CARDIOL, V104, p32E, DOI 10.1016/j.amjcard.2009.09.017; Vergeer M, 2008, CIRCULATION, V118, P2515, DOI 10.1161/CIRCULATIONAHA.108.772665; Vuorio A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006401.pub2	42	27	27	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77049	10.1371/journal.pone.0077049	http://dx.doi.org/10.1371/journal.pone.0077049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204732	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200017
J	Mugisha, JO; Baisley, K; Asiki, G; Seeley, J; Kuper, H				Mugisha, Joseph O.; Baisley, Kathy; Asiki, Gershim; Seeley, Janet; Kuper, Hannah			Prevalence, Types, Risk Factors and Clinical Correlates of Anaemia in Older People in a Rural Ugandan Population	PLOS ONE			English	Article							IRON-DEFICIENCY; BLOOD HEMOGLOBIN; AGE 70; HEMATOPOIESIS; MORTALITY; AMERICANS; FOLATE; COHORT; ACID	Background: Studies conducted in high income countries have shown that anaemia is a common medical condition among older people, but such data are scarce in Africa. The objectives of this study were to estimate the prevalence, types, risk factors and clinical correlates of anaemia in older people. Methods: Participants were aged (>= 50) years recruited from a general population cohort from January 2012 to January 2013. Blood samples were collected for assessing hemoglobin, serum ferritin, serum vitamin B12, serum folate, C-reactive protein, malaria infection and stool samples for assessment of hookworm infection. HIV status was assessed using an algorithm for HIV rapid testing. Questionnaires were used to collect data on sociodemographic characteristics and other risk factors for anaemia. Results: In total, 1449 people participated (response rate 72.3%). The overall prevalence of anaemia was 20.3 % (95% CI 18.2-22.3%), and this was higher for males (24.1%, 95% CI=20.7-27.7%) than females (17.5%, 95% CI=15.0-20.1%). In males, the prevalence of anaemia increased rapidly with age almost doubling between 50 and 65 years (p-trend<0.001). Unexplained anaemia was responsible for more than half of all cases (59.7%). Anaemia was independently associated with infections including malaria (OR 3.49, 95% CI 1.78-6.82), HIV (OR 2.17, 1.32-3.57) heavy hookworm infection (OR 3.45, 1.73-6.91), low fruit consumption (OR 1.55, 1.05-2.29) and being unmarried (OR 1.37, 95% CI 1.01-1.89). However, the odds of anaemia were lower among older people with elevated blood pressure (OR 0.47, 95% CI 0.29-0.77). Conclusion: Anaemia control programmes in Uganda should target older people and should include interventions to treat and control hookworms and educational programs on diets that enhance iron absorption. Clinicians should consider screening older people with HIV or malaria for anaemia. Further studies should be done on unexplained anaemia and serum ferritin levels that predict iron deficiency anaemia in older people.	[Mugisha, Joseph O.; Asiki, Gershim; Seeley, Janet] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Mugisha, Joseph O.; Baisley, Kathy; Seeley, Janet; Kuper, Hannah] London Sch Hyg & Trop Med, London WC1, England; [Seeley, Janet] Univ E Anglia, Sch Int Dev, Norwich NR4 7TJ, Norfolk, England	University of London; London School of Hygiene & Tropical Medicine; University of East Anglia	Mugisha, JO (corresponding author), MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda.	Joseph.MugishaOkello@lshtm.ac.uk		Asiki, Gershim/0000-0002-9966-1153; Seeley, Janet/0000-0002-0583-5272	MRC UK (Medical Research Council); MRC; DFID (Department For International Development) [G0700837]; Medical Research Council [MC_U950097148, G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	MRC UK (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DFID (Department For International Development); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by MRC UK (Medical Research Council). Kathy Baisley receives support from the MRC and DFID (Department For International Development) (grant number G0700837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain T. J., 1997, Central African Journal of Medicine, V43, P325; [Anonymous], 1968, NUTR AN; Artz AS, 2004, J AM GERIATR SOC, V52, P423, DOI 10.1111/j.1532-5415.2004.52116.x; Asiki G, 2013, INT J EPIDEMIOL, V42, P129, DOI 10.1093/ije/dys234; Asobayire FS, 2001, AM J CLIN NUTR, V74, P776; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Balducci L, 2005, CANC TREAT, P109; Balducci L, 2003, J AM GERIATR SOC, V51, pS2; Beutler E, 2005, BLOOD, V106, P740, DOI 10.1182/blood-2005-02-0713; Bjorkegren K, 2001, J INTERN MED, V249, P423, DOI 10.1046/j.1365-2796.2001.00819.x; CHATTA GS, 1993, J GERONTOL, V48, pM207, DOI 10.1093/geronj/48.5.M207; De Benoist B, 2008, ORLDWIDE PREVALENCE; den Elzen WPJ, 2009, CAN MED ASSOC J, V181, P151, DOI 10.1503/cmaj.090040; Gaskell Helen, 2008, BMC Geriatr, V8, P1, DOI 10.1186/1471-2318-8-1; Gomez JML, 2002, KIDNEY INT, V61, pS39, DOI 10.1046/j.1523-1755.61.s80.8.x; Gross Rainer, 1997, Food and Nutrition Bulletin, V18, P267; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; HIROTA Y, 1988, EUR J HAEMATOL, V40, P83; Hurrell R, 2002, NUTR REV, V60, pS7, DOI 10.1301/002966402320285137; INELMEN EM, 1994, AGING-CLIN EXP RES, V6, P81, DOI 10.1007/BF03324220; JOHNSON MA, 1990, J NUTR, V120, P1486, DOI 10.1093/jn/120.suppl_11.1486; KATZ N, 1970, J PARASITOL, V56, P1032, DOI 10.2307/3277532; Kikafunda JK, 2009, PUBLIC HEALTH NUTR, V12, P2302, DOI 10.1017/S1368980009005333; KIRKEBY O J, 1991, Scandinavian Journal of Primary Health Care, V9, P167, DOI 10.3109/02813439109018513; Kowal P, 2010, GLOBAL HEALTH ACTION, V3, P11, DOI 10.3402/gha.v3i0.5302; LETCHER RL, 1983, HYPERTENSION, V5, P757, DOI 10.1161/01.HYP.5.5.757; LIPSCHITZ DA, 1984, BLOOD, V63, P502; Mugisha JO, 2008, TROP MED INT HEALTH, V13, P788, DOI 10.1111/j.1365-3156.2008.02069.x; Mukhopadhyay D, 2002, AGE AGEING, V31, P87, DOI 10.1093/ageing/31.2.87; Nilsson-Ehle H, 2000, EUR J HAEMATOL, V65, P297, DOI 10.1034/j.1600-0609.2000.065005297.x; NILSSONEHLE H, 1989, BRIT J HAEMATOL, V71, P437; OLDEWAGETHERON W, 2009, J FAMILY ECOLOGY CON, V36; Patel KV, 2008, SEMIN HEMATOL, V45, P210, DOI 10.1053/j.seminhematol.2008.06.006; Patel KV, 2007, BLOOD, V109, P4663, DOI 10.1182/blood-2006-10-055384; PEARSON HA, 2008, ANAEMIAS OTHER RED C, P374; Sahadevan S., 1995, Singapore Medical Journal, V36, P375; Sasu BJ, 2010, BLOOD CELL MOL DIS, V45, P238, DOI 10.1016/j.bcmd.2010.07.013; Morris MS, 2007, AM J CLIN NUTR, V85, P193, DOI 10.1093/ajcn/85.1.193; United Nations Population Division, 2011, WORLD POP PROSP 2010; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; WHO, 2004, ASS IR STAT POP	41	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78394	10.1371/journal.pone.0078394	http://dx.doi.org/10.1371/journal.pone.0078394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194926	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000105
J	Prieto, ML; Oralkan, O; Khuri-Yakub, BT; Maduke, MC				Prieto, Martin Loynaz; Oralkan, Oemer; Khuri-Yakub, Butrus T.; Maduke, Merritt C.			Dynamic Response of Model Lipid Membranes to Ultrasonic Radiation Force	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; VIVO HUMAN SKULLS; LIGHT-SCATTERING; PROTEIN FUNCTION; CAPACITANCE; BILAYERS; CELLS; MONOLAYERS; SYSTEM; FLUCTUATIONS	Low-intensity ultrasound can modulate action potential firing in neurons in vitro and in vivo. It has been suggested that this effect is mediated by mechanical interactions of ultrasound with neural cell membranes. We investigated whether these proposed interactions could be reproduced for further study in a synthetic lipid bilayer system. We measured the response of protein-free model membranes to low-intensity ultrasound using electrophysiology and laser Doppler vibrometry. We find that ultrasonic radiation force causes oscillation and displacement of lipid membranes, resulting in small (<1%) changes in membrane area and capacitance. Under voltage-clamp, the changes in capacitance manifest as capacitive currents with an exponentially decaying sinusoidal time course. The membrane oscillation can be modeled as a fluid dynamic response to a step change in pressure caused by ultrasonic radiation force, which disrupts the balance of forces between bilayer tension and hydrostatic pressure. We also investigated the origin of the radiation force acting on the bilayer. Part of the radiation force results from the reflection of the ultrasound from the solution/air interface above the bilayer (an effect that is specific to our experimental configuration) but part appears to reflect a direct interaction of ultrasound with the bilayer, related to either acoustic streaming or scattering of sound by the bilayer. Based on these results, we conclude that synthetic lipid bilayers can be used to study the effects of ultrasound on cell membranes and membrane proteins.	[Prieto, Martin Loynaz; Maduke, Merritt C.] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Oralkan, Oemer; Khuri-Yakub, Butrus T.] Stanford Univ, Edward L Ginzton Lab, Stanford, CA 94305 USA	Stanford University; Stanford University	Maduke, MC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA.	maduke@stanford.edu		Khuri-Yakub, Butrus/0000-0003-3940-7898; Oralkan, Omer/0000-0001-8616-6877; Maduke, Merritt/0000-0001-7787-306X; PRIETO, MARTIN/0000-0002-8069-6719	Goldwasser Family Fund; National Institutes of Health [R21 NS076948]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076948] Funding Source: NIH RePORTER	Goldwasser Family Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Goldwasser Family Fund and National Institutes of Health grant R21 NS076948. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ O, 1978, BIOPHYS J, V21, P1, DOI 10.1016/S0006-3495(78)85505-2; Bystritsky A, 2011, BRAIN STIMUL, V4, P125, DOI 10.1016/j.brs.2011.03.007; Clement GT, 2005, J ULTRAS MED, V24, P1117, DOI 10.7863/jum.2005.24.8.1117; CRAWFORD GE, 1986, BIOPHYS J, V49, P869, DOI 10.1016/S0006-3495(86)83716-X; CRILLY JF, 1983, BIOPHYS J, V41, P197, DOI 10.1016/S0006-3495(83)84420-8; Duck F.A., 1998, ULTRASOUND MED; FETTIPLACE R, 1971, J MEMBRANE BIOL, V5, P277, DOI 10.1007/BF01870555; FRY FJ, 1958, SCIENCE, V127, P83, DOI 10.1126/science.127.3289.83; Gavrilov LR, 1996, ULTRASOUND MED BIOL, V22, P179, DOI 10.1016/0301-5629(96)83782-3; Grabitz P, 2002, BIOPHYS J, V82, P299, DOI 10.1016/S0006-3495(02)75395-2; GRABOWSKI EF, 1977, BIOPHYS J, V18, P23, DOI 10.1016/S0006-3495(77)85593-8; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Harvey EN, 1929, AM J PHYSIOL, V91, P294; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; Hildenbrand MF, 2005, BIOPHYS J, V88, P3360, DOI 10.1529/biophysj.104.050112; Hynynen K, 2004, MAGN RESON MED, V52, P100, DOI 10.1002/mrm.20118; Ismailov II, 1997, BIOPHYS J, V72, P1182, DOI 10.1016/S0006-3495(97)78766-6; King RL, 2013, ULTRASOUND MED BIOL, V39, P312, DOI 10.1016/j.ultrasmedbio.2012.09.009; KRAMER L, 1971, J CHEM PHYS, V55, P2097, DOI 10.1063/1.1676380; Leighton TG, 1998, MED SCI SER, P199; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; Martin E, 2009, ANN NEUROL, V66, P858, DOI 10.1002/ana.21801; McDannold N, 2010, IEEE T ULTRASON FERR, V57, P1967, DOI 10.1109/TUFFC.2010.1644; Menz MD, 2013, J NEUROSCI, V33, P4550, DOI 10.1523/JNEUROSCI.3521-12.2013; Min BK, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-23; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Naor O, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026006; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; POHL P, 1993, BIOCHIM BIOPHYS ACTA, V1145, P279, DOI 10.1016/0005-2736(93)90300-O; POHL P, 1993, BIOCHIM BIOPHYS ACTA, V1152, P155, DOI 10.1016/0005-2736(93)90242-R; REQUENA J, 1975, BIOPHYS J, V15, P77, DOI 10.1016/S0006-3495(75)85793-6; ROHR KR, 1978, BIOPHYS J, V23, P33, DOI 10.1016/S0006-3495(78)85430-7; Sachs F, 1998, REV PHYSIOL BIOCH P, V132, P1, DOI 10.1007/BFb0004985; Sarvazyan AP, 2010, ULTRASOUND MED BIOL, V36, P1379, DOI 10.1016/j.ultrasmedbio.2010.05.015; Shapiro MG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1742; Steppich D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061123; Suchyna TM, 2007, J PHYSIOL-LONDON, V581, P369, DOI 10.1113/jphysiol.2006.125021; SZEKELY JG, 1980, BIOCHIM BIOPHYS ACTA, V599, P73, DOI 10.1016/0005-2736(80)90057-7; TORR GR, 1984, AM J PHYS, V52, P402, DOI 10.1119/1.13625; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Tyler WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003511; WESTERVELT PJ, 1951, J ACOUST SOC AM, V23, P312, DOI 10.1121/1.1906764; WHITE SH, 1973, BIOCHIM BIOPHYS ACTA, V323, P7, DOI 10.1016/0005-2736(73)90428-8; WHITE SH, 1978, BIOPHYS J, V23, P337, DOI 10.1016/S0006-3495(78)85453-8; WOBSCHALL D, 1971, J COLLOID INTERF SCI, V36, P385, DOI 10.1016/0021-9797(71)90010-5; WOBSCHALL D, 1972, J COLLOID INTERF SCI, V40, P417, DOI 10.1016/0021-9797(72)90351-7; Wu J, 2008, ADV DRUG DELIVER REV, V60, P1103, DOI 10.1016/j.addr.2008.03.009; Wunderlich B, 2009, BIOPHYS J, V96, P4592, DOI 10.1016/j.bpj.2009.02.053; Yoo SS, 2011, NEUROIMAGE, V56, P1267, DOI 10.1016/j.neuroimage.2011.02.058	49	58	60	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77115	10.1371/journal.pone.0077115	http://dx.doi.org/10.1371/journal.pone.0077115			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194863	Green Submitted, gold, Green Published			2022-12-27	WOS:000326037000042
J	Thomassen, HA; Freedman, AH; Brown, DM; Buermann, W; Jacobs, DK				Thomassen, Henri A.; Freedman, Adam H.; Brown, David M.; Buermann, Wolfgang; Jacobs, David K.			Regional Differences in Seasonal Timing of Rainfall Discriminate between Genetically Distinct East African Giraffe Taxa	PLOS ONE			English	Article							GENE FLOW; POPULATION-STRUCTURE; VARIABLE IMPORTANCE; NATIONAL-PARK; SPECIATION; PHENOLOGY; CLIMATE; PHYLOGEOGRAPHY; CAMELOPARDALIS; SERENGETI	Masai (Giraffa tippelskirchi), Reticulated (G. reticulata) and Rothschild's (G. camelopardalis) giraffe lineages in East Africa are morphologically and genetically distinct, yet in Kenya their ranges abut. This raises the question of how divergence is maintained among populations of a large mammal capable of long-distance travel, and which readily hybridize in zoos. Here we test four hypotheses concerning the maintenance of the phylogeographic boundaries among the three taxa: 1) isolation-by-distance; 2) physical barriers to dispersal; 3) general habitat differences resulting in habitat segregation; or 4) regional differences in the seasonal timing of rainfall, and resultant timing of browse availability. We used satellite remotely sensed and climate data to characterize the environment at the locations of genotyped giraffes. Canonical variate analysis, random forest algorithms, and generalized dissimilarity modelling were employed in a landscape genetics framework to identify the predictor variables that best explained giraffes' genetic divergence. We found that regional differences in the timing of precipitation, and resulting green-up associated with the abundance of browse, effectively discriminate between taxa. Local habitat conditions, topographic and human-induced barriers, and geographic distance did not aid in discriminating among lineages. Our results suggest that selection associated with regional timing of events in the annual climatic cycle may help maintain genetic and phenotypic divergence in giraffes. We discuss potential mechanisms of maintaining divergence, and suggest that synchronization of reproduction with seasonal rainfall cycles that are geographically distinct may contribute to reproductive isolation. Coordination of weaning with green-up cycles could minimize the costs of lactation and predation on the young. Our findings are consistent with theory and empirical results demonstrating the efficacy of seasonal or phenologically dictated selection pressures in contributing to the reproductive isolation of parapatric populations.	[Thomassen, Henri A.; Freedman, Adam H.; Buermann, Wolfgang] Univ Calif Los Angeles, Ctr Trop Res, Los Angeles, CA 90095 USA; [Brown, David M.; Jacobs, David K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Buermann, Wolfgang] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Thomassen, HA (corresponding author), Univ Calif Los Angeles, Ctr Trop Res, Los Angeles, CA 90095 USA.	hathomassen@ucla.edu		Freedman, Adam/0000-0003-4714-3925				Alpers DL, 2004, MOL ECOL, V13, P1771, DOI 10.1111/j.1365-294X.2004.02204.x; Ansell W. F. H., 1971, P1; Antunes A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000251; Arctander P, 1999, MOL BIOL EVOL, V16, P1724, DOI 10.1093/oxfordjournals.molbev.a026085; Barnett R, 2006, P ROY SOC B-BIOL SCI, V273, P2119, DOI 10.1098/rspb.2006.3555; Bercovitch FB, 2004, J MAMMAL, V85, P428, DOI 10.1644/1545-1542(2004)085<0428:MIICG>2.0.CO;2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Brynard AM, 1960, KOEDOE, V3, P1; Caister LE, 2003, AFR J ECOL, V41, P201, DOI 10.1046/j.1365-2028.2003.00422.x; Chen C., 2004, USING RANDOM FOREST, V110, P24; Coyne J.A., 2004, SPECIATION; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; DAGG A I, 1971, Mammalian Species, V5, P1; Dagg A.I., 1976, GIRAFFE ITS BIOL BEH; Dagg AI, 1982, GIRAFFE ITS BIOL BEH; Dasmann R. F., 1962, Journal of Mammalogy, V43, P533, DOI 10.2307/1376916; del Castillo SM, 2005, GEN COMP ENDOCR, V141, P271, DOI 10.1016/j.ygcen.2005.01.011; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Doebeli M, 2005, EVOLUTION, V59, P691; Evans JS, 2009, LANDSCAPE ECOL, V24, P673, DOI 10.1007/s10980-009-9341-0; FAIRALL N, 1968, Zoologica Africana, V3, P189; FEDER JL, 1993, ENTOMOL EXP APPL, V69, P117, DOI 10.1007/BF02380639; de Leon LF, 2010, PHILOS T R SOC B, V365, P1041, DOI 10.1098/rstb.2009.0314; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Field C.R., 1973, Journal Reprod Fert, V19, P287; Flagstad O, 2001, P ROY SOC B-BIOL SCI, V268, P667, DOI 10.1098/rspb.2000.1416; Foster J.B., 1972, East African Wildlife Journal, V10, P1; Frolking S, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006588; Gavrilets S, 2000, EVOLUTION, V54, P1126; Gavrilets S, 2000, P ROY SOC B-BIOL SCI, V267, P2483, DOI 10.1098/rspb.2000.1309; Gavrilets S, 2007, MOL ECOL, V16, P2910, DOI 10.1111/j.1365-294X.2007.03304.x; Ginnett TF, 1999, AFR J ECOL, V37, P93, DOI 10.1046/j.1365-2028.1999.00163.x; Griffiths J.F., 1972, WORLD SURVEY CLIMATO, V10, P313; Groen TA, 2011, J ARID ENVIRON, V75, P724, DOI 10.1016/j.jaridenv.2011.03.010; Groves C, 2011, UNGULATE TAXONOMY; Hall-Martin AJ, 1975, E AFR WILDL J, V13, P237; HAMILTON AC, 1991, CLIMATIC CHANGE, V19, P65, DOI 10.1007/BF00142215; Hamilton AC, 1982, ENV HIST E AFRICAN S; Hansen MC, 2002, REMOTE SENS ENVIRON, V83, P303, DOI 10.1016/S0034-4257(02)00079-2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoelzer GA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000126; Homewood K, 2001, P NATL ACAD SCI USA, V98, P12544, DOI 10.1073/pnas.221053998; JACOBS DK, 1993, NATURE, V361, P710, DOI 10.1038/361710a0; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; KINGDON J, 1979, E AFRICAN MAMMALS B, V3; Le Pendu Y, 1999, J TROP ECOL, V15, P341, DOI 10.1017/S0266467499000863; Leps J, 2003, MULTIVARIATE ANAL EC; Liu Z, 2004, CLIM DYNAM, V22, P157, DOI 10.1007/s00382-003-0372-y; LONG D. G., 2001, EOS T AM GEOPHYS UN, V82, P503, DOI DOI 10.1029/01EO00303; Lorenzen ED, 2008, CONSERV GENET, V9, P593, DOI 10.1007/s10592-007-9375-2; Lorenzen ED, 2006, MOL ECOL, V15, P3787, DOI 10.1111/j.1365-294X.2006.03059.x; Malpaux B, 2001, J BIOL RHYTHM, V16, P336, DOI 10.1177/074873001129002051; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Murphy MA, 2010, ECOLOGY, V91, P252, DOI 10.1890/08-0879.1; Muwanika VB, 2003, HEREDITY, V91, P361, DOI 10.1038/sj.hdy.6800341; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Nix H., 1986, ATLAS ELAPID SNAKES; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Owen-Smith N, 2008, OIKOS, V117, P602, DOI 10.1111/j.0030-1299.2008.16309.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pease KM, 2009, MOL ECOL, V18, P1848, DOI 10.1111/j.1365-294X.2009.04112.x; PELLEW RA, 1984, J ZOOL, V202, P57, DOI 10.1111/j.1469-7998.1984.tb04288.x; PELLEW RA, 1983, AFR J ECOL, V21, P269, DOI 10.1111/j.1365-2028.1983.tb00326.x; PELLEW RA, 1984, J APPL ECOL, V21, P141, DOI 10.2307/2403043; PRATT DM, 1979, Z TIERPSYCHOL, V51, P233; Prienaar U. de V., 1963, Koedoe, VNo. 6, P1; Pritchard JK, 2000, GENETICS, V155, P945; R East, 1998, ASG COCHAIR AFRICAN; Ray N, 2005, MOL ECOL NOTES, V5, P177, DOI 10.1111/j.1471-8286.2004.00843.x; Reason Roger, 2000, Animal Keepers' Forum, V27, P120; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Ripley B. D., 1996, PATTERN RECOGNITION; Rossignol-Strick M, 1999, MAR GEOL, V153, P221, DOI 10.1016/S0025-3227(98)00080-2; Ryan SJ, 2007, BEHAV ECOL, V18, P635, DOI 10.1093/beheco/arm028; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Shirk AJ, 2010, MOL ECOL, V19, P3603, DOI 10.1111/j.1365-294X.2010.04745.x; Sinclair ARE, 2000, ECOLOGY, V81, P2100, DOI 10.1890/0012-9658(2000)081[2100:WDPASO]2.0.CO;2; Stamps JA, 2009, AM NAT, V174, P623, DOI 10.1086/644526; Stevenson-Hamilton J., 1947, WILD LIFE S AFRICA; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Templeton Alan R., 1996, P398; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Tuenter E, 2003, GLOBAL PLANET CHANGE, V36, P219, DOI 10.1016/S0921-8181(02)00196-0; van der Jeugd HP, 2000, J ZOOL, V251, P15, DOI 10.1017/S0952836900005033; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; White F., 1983, VEGETATION AFRICA DE, P356; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Yamamoto S, 2009, P R SOC B, V276, P2711, DOI 10.1098/rspb.2009.0349; Zhang XY, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005263; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83	97	19	19	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77191	10.1371/journal.pone.0077191	http://dx.doi.org/10.1371/journal.pone.0077191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194870	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000049
J	Adhi, M; Cashman, SM; Kumar-Singh, R				Adhi, Mehreen; Cashman, Siobhan M.; Kumar-Singh, Rajendra			Adeno-Associated Virus Mediated Delivery of a Non-Membrane Targeted Human Soluble CD59 Attenuates Some Aspects of Diabetic Retinopathy in Mice	PLOS ONE			English	Article							COMPLEMENT REGULATORY PROTEIN; RETINAL VASCULAR LEAKAGE; MOUSE MODEL; SYSTEM; CELLS; PATHOGENESIS; IMMUNOLOGY; BREAKDOWN; VECTORS; DRUSEN	Diabetic retinopathy is the leading cause of visual dysfunction in working adults and is attributed to retinal vascular and neural cell damage. Recent studies have described elevated levels of membrane attack complex (MAC) and reduced levels of membrane associated complement regulators including CD55 and CD59 in the retina of diabetic retinopathy patients as well as in animal models of this disease. We have previously described the development of a soluble membrane-independent form of CD59 (sCD59) that when delivered via a gene therapy approach using an adeno-associated virus vector (AAV2/8-sCD59) to the eyes of mice, can block MAC deposition and choroidal neovascularization. Here, we examine AAV2/8-sCD59 mediated attenuation of MAC deposition and ensuing complement mediated damage to the retina of mice following streptozotocin (STZ) induced diabetes. We observed a 60% reduction in leakage of retinal blood vessels in diabetic eyes pre-injected with AAV2/8-sCD59 relative to negative control virus injected diabetic eyes. AAV2/8-sCD59 injected eyes also exhibited protection from non-perfusion of retinal blood vessels. In addition, a 200% reduction in retinal ganglion cell apoptosis and a 40% reduction in MAC deposition were documented in diabetic eyes pre-injected with AAV2/8-sCD59 relative to diabetic eyes pre-injected with the control virus. This is the first study characterizing a viral gene therapy intervention that targets MAC in a model of diabetic retinopathy. Use of AAV2/8-sCD59 warrants further exploration as a potential therapy for advanced stages of diabetic retinopathy.	[Adhi, Mehreen; Cashman, Siobhan M.; Kumar-Singh, Rajendra] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Tufts University	Kumar-Singh, R (corresponding author), Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA.	rajendra.kumar-singh@tufts.edu	Adhi, Mehreen/AAS-9733-2021	Kumar-Singh, Rajendra/0000-0002-7754-0713	Ellison Foundation; Virginia B Smith Trust; National Institute of Health/NEI [EY021805, EY013887]; Lions Eye Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY021805] Funding Source: NIH RePORTER	Ellison Foundation(Lawrence Ellison Foundation); Virginia B Smith Trust; National Institute of Health/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Lions Eye Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants to RKS from The Ellison Foundation, The Virginia B Smith Trust, The National Institute of Health/NEI (EY021805 and EY013887), and grants to the Department of Ophthalmology at Tufts University from the Lions Eye Foundation and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2008, BRIT J PHARMACOL, V154, P136, DOI 10.1038/bjp.2008.48; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Barber AJ, 2003, PROG NEURO-PSYCHOPH, V27, P283, DOI 10.1016/S0278-5846(03)00023-X; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; Bhagat N, 2009, SURV OPHTHALMOL, V54, P1, DOI 10.1016/j.survophthal.2008.10.001; Bora NS, 2007, J IMMUNOL, V178, P1783, DOI 10.4049/jimmunol.178.3.1783; Bossi F, 2004, J IMMUNOL, V173, P6921, DOI 10.4049/jimmunol.173.11.6921; Bossi F, 2011, IMMUNOL LETT, V140, P7, DOI 10.1016/j.imlet.2011.06.006; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Cashman SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019078; Cashman SM, 2011, INVEST OPHTH VIS SCI, V52, P3436, DOI 10.1167/iovs.10-6002; Clermont A, 2011, DIABETES, V60, P1590, DOI 10.2337/db10-1260; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Fletcher EL, 2008, CLIN EXP OPTOM, V91, P67, DOI 10.1111/j.1444-0938.2007.00204.x; Gandhi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021621; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gerl VB, 2002, INVEST OPHTH VIS SCI, V43, P1104; Grant S, 2010, EUR J PHARMACOL, V627, P16, DOI 10.1016/j.ejphar.2009.10.029; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; Kowluru RA, 2008, CONTEMP DIABETES, P265, DOI 10.1007/978-1-59745-563-3_11; Lieth E, 1998, DIABETES, V47, P815, DOI 10.2337/diabetes.47.5.815; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; Maharjan S, 2011, EUR J PHARMACOL, V657, P35, DOI 10.1016/j.ejphar.2011.01.040; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Mullins RF, 2011, EXP EYE RES, V93, P565, DOI 10.1016/j.exer.2011.06.015; Nishikiori N, 2007, DIABETES, V56, P1333, DOI 10.2337/db06-1431; Osanai M, 2010, CURR DIABETES REV, V6, P35, DOI 10.2174/157339910790442619; Qin XB, 2004, DIABETES, V53, P2653, DOI 10.2337/diabetes.53.10.2653; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Satofuka S, 2009, DIABETES, V58, P1625, DOI 10.2337/db08-0254; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P4195; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wu KK, 2008, CURR PROTOC PHARM UN, DOI DOI 10.1002/0471141755.PH0547S40.HTTP://; Yanai R, 2012, ADV EXP MED BIOL, V946, P161, DOI 10.1007/978-1-4614-0106-3_10; Zhang A, 2002, DIABETES, V51, P3499; Zhang JF, 2008, INVEST OPHTH VIS SCI, V49, P732, DOI 10.1167/iovs.07-0721; Zhang SX, 2005, AM J PATHOL, V166, P313, DOI 10.1016/S0002-9440(10)62255-9; Zolotukhin S, 2005, HUM GENE THER, V16, P551, DOI 10.1089/hum.2005.16.551; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	47	21	23	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e79661	10.1371/journal.pone.0079661	http://dx.doi.org/10.1371/journal.pone.0079661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167638	Green Published, gold, Green Submitted			2022-12-27	WOS:000326034500099
J	Bellone, RR; Holl, H; Setaluri, V; Devi, S; Maddodi, N; Archer, S; Sandmeyer, L; Ludwig, A; Foerster, D; Pruvost, M; Reissmann, M; Bortfeldt, R; Adelson, DL; Lim, SL; Nelson, J; Haase, B; Engensteiner, M; Leeb, T; Forsyth, G; Mienaltowski, MJ; Mahadevan, P; Hofreiter, M; Paijmans, JLA; Gonzalez Fortes, G; Grahn, B; Brooks, SA				Bellone, Rebecca R.; Holl, Heather; Setaluri, Vijayasaradhi; Devi, Sulochana; Maddodi, Nityanand; Archer, Sheila; Sandmeyer, Lynne; Ludwig, Arne; Foerster, Daniel; Pruvost, Melanie; Reissmann, Monika; Bortfeldt, Ralf; Adelson, David L.; Lim, Sim Lin; Nelson, Janelle; Haase, Bianca; Engensteiner, Martina; Leeb, Tosso; Forsyth, George; Mienaltowski, Michael J.; Mahadevan, Padmanabhan; Hofreiter, Michael; Paijmans, Johanna L. A.; Gonzalez Fortes, Gloria; Grahn, Bruce; Brooks, Samantha A.			Evidence for a Retroviral Insertion in TRPM1 as the Cause of Congenital Stationary Night Blindness and Leopard Complex Spotting in the Horse	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MELANIN CONTENT; HUMAN GENES; CHANNEL; PROTEIN; APPALOOSA; ELEMENTS; LP; NYCTALOPIN; MUTATIONS	Leopard complex spotting is a group of white spotting patterns in horses caused by an incompletely dominant gene (LP) where homozygotes (LP/LP) are also affected with congenital stationary night blindness. Previous studies implicated Transient Receptor Potential Cation Channel, Subfamily M, Member 1 (TRPM1) as the best candidate gene for both CSNB and LP. RNA-Seq data pinpointed a 1378 bp insertion in intron 1 of TRPM1 as the potential cause. This insertion, a long terminal repeat (LTR) of an endogenous retrovirus, was completely associated with LP, testing 511 horses (chi(2)=1022.00, p<<0.0005), and CSNB, testing 43 horses (chi(2)=43, p<<0.0005). The LTR was shown to disrupt TRPM1 transcription by premature poly-adenylation. Furthermore, while deleterious transposable element insertions should be quickly selected against the identification of this insertion in three ancient DNA samples suggests it has been maintained in the horse gene pool for at least 17,000 years. This study represents the first description of an LTR insertion being associated with both a pigmentation phenotype and an eye disorder.	[Bellone, Rebecca R.; Nelson, Janelle; Mahadevan, Padmanabhan] Univ Tampa, Dept Biol, Tampa, FL 33606 USA; [Holl, Heather; Brooks, Samantha A.] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Setaluri, Vijayasaradhi; Devi, Sulochana; Maddodi, Nityanand] Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI USA; [Sandmeyer, Lynne; Grahn, Bruce] Univ Saskatchewan, Western Coll Vet Med, Dept Small Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada; [Ludwig, Arne; Foerster, Daniel; Pruvost, Melanie] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Genet, Berlin, Germany; [Pruvost, Melanie] Inst Jacques Monod, Epigen & Palaeogen Grp, F-75251 Paris, France; [Reissmann, Monika; Bortfeldt, Ralf] Humboldt Univ, Dept Breeding Biol & Mol Genet, D-10099 Berlin, Germany; [Adelson, David L.; Lim, Sim Lin] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Haase, Bianca] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Engensteiner, Martina; Leeb, Tosso] Univ Bern, Inst Genet, Bern, Switzerland; [Forsyth, George] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Biomed Sci, Saskatoon, SK S7N 0W0, Canada; [Mienaltowski, Michael J.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Hofreiter, Michael; Paijmans, Johanna L. A.; Gonzalez Fortes, Gloria] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of Tampa; Cornell University; University of Wisconsin System; University of Wisconsin Madison; University of Saskatchewan; Leibniz Institut fur Zoo und Wildtierforschung; UDICE-French Research Universities; Universite Paris Cite; Humboldt University of Berlin; University of Adelaide; University of Sydney; University of Bern; University of Saskatchewan; State University System of Florida; University of South Florida; University of York - UK	Bellone, RR (corresponding author), Univ Tampa, Dept Biol, Tampa, FL 33606 USA.	rbellone@ut.edu	Brooks, Samantha/ABD-5279-2020; Leeb, Tosso/G-3187-2014; Adelson, David/E-5506-2011; Gonzalez Fortes, Gloria/L-9213-2014; Hofreiter, Michael/A-3996-2017	Brooks, Samantha/0000-0002-4500-2689; Leeb, Tosso/0000-0003-0553-4880; Bellone, Rebecca/0000-0001-8838-7227; Adelson, David/0000-0003-2404-5636; Forster, Daniel/0000-0002-6934-0404; Gonzalez Fortes, Gloria/0000-0002-3700-7674; Waud, Bianca/0000-0001-6493-9808; Hofreiter, Michael/0000-0003-0441-4705; Paijmans, Johanna L.A./0000-0002-1938-7052	L. David Dube and Heather Ryan Veterinary Health Research Fund from the University of Saskatchewan; Dana Faculty Development Grant from the University of Tampa; Swiss National Science Foundation [31003A-133034]; NIH [AR AR056087]; DFG [LU 852/7-4]; NSF [1132229]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056087] Funding Source: NIH RePORTER	L. David Dube and Heather Ryan Veterinary Health Research Fund from the University of Saskatchewan; Dana Faculty Development Grant from the University of Tampa; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the L. David Dube and Heather Ryan Veterinary Health Research Fund from the University of Saskatchewan and a Dana Faculty Development Grant from the University of Tampa. This study was also supported by grant no. 31003A-133034 from the Swiss National Science Foundation to TL. Melanocyte culture work was supported by NIH Grant AR AR056087 to VS. Ancient DNA work was supported by the DFG grant LU 852/7-4 and the NSF grant 1132229. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; BARSH GS, 1995, AM J HUM GENET, V57, P743; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Bellone RR, 2010, ANIM GENET, V41, P207, DOI 10.1111/j.1365-2052.2010.02119.x; Bellone RR, 2010, ANIM GENET, V41, P100, DOI 10.1111/j.1365-2052.2010.02116.x; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Bellone RR, 2010, BRIEF FUNCT GENOMICS, V9, P193, DOI 10.1093/bfgp/elq002; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Cao Y, 2011, J NEUROSCI, V31, P11521, DOI 10.1523/JNEUROSCI.1682-11.2011; Chitale M, 2009, BIOINFORMATICS, V25, P1739, DOI 10.1093/bioinformatics/btp309; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chuong EB, 2013, NAT GENET, V45, P325, DOI 10.1038/ng.2553; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Conley AB, 2008, BIOINFORMATICS, V24, P1563, DOI 10.1093/bioinformatics/btn243; Devi S, 2013, PIGM CELL MELANOMA R, V26, P348, DOI 10.1111/pcmr.12083; Devi S, 2009, AM J PHYSIOL-CELL PH, V297, pC679, DOI 10.1152/ajpcell.00092.2009; DUHL DMJ, 1994, DEVELOPMENT, V120, P1695; Duncan LM, 1998, CANCER RES, V58, P1515; Dunn CA, 2006, GENE, V366, P335, DOI 10.1016/j.gene.2005.09.003; Dunn CA, 2003, P NATL ACAD SCI USA, V100, P12841, DOI 10.1073/pnas.2134464100; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GUNTAKA RV, 1993, MICROBIOL REV, V57, P511, DOI 10.1128/MMBR.57.3.511-521.1993; HARRIS R, LASTZ; Hawkins T, 2009, PROTEINS, V74, P566, DOI 10.1002/prot.22172; Horn S, 2012, METHODS MOL BIOL, V840, P177, DOI 10.1007/978-1-61779-516-9_21; Hughes S, 2012, EUR J NEUROSCI, V35, P34, DOI 10.1111/j.1460-9568.2011.07944.x; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Klooster J, 2011, INVEST OPHTH VIS SCI, V52, P8356, DOI 10.1167/iovs.11-7575; Koike C, 2010, CELL CALCIUM, V48, P95, DOI 10.1016/j.ceca.2010.08.004; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Locke MM, 2002, ANIM GENET, V33, P329, DOI 10.1046/j.1365-2052.2002.00885.x; MacLeod JN, 1996, J BIOL CHEM, V271, P18954, DOI 10.1074/jbc.271.31.18954; Mager DL, 1999, GENOMICS, V59, P255, DOI 10.1006/geno.1999.5877; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Martin M, 2011, CUTADAPT REMOVES ADA; Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779; Meyer M, 2010, COLD SPRING HARB PRO, DOI [DOI 10.1101/PDB.PR0T5448, 10.1101/pdb.prot5448]; Morgans CW, 2010, BIOESSAYS, V32, P609, DOI 10.1002/bies.200900198; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Nakamura M, 2010, MOL VIS, V16, P425; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Nunnery C, 2005, VET OPHTHALMOL, V8, P415, DOI 10.1111/j.1463-5224.2005.00416.x; Oancea E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000146; Pearring JN, 2011, J NEUROSCI, V31, P10060, DOI 10.1523/JNEUROSCI.1014-11.2011; Piriyapongsa J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-291; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruvost M, 2011, P NATL ACAD SCI USA, V108, P18626, DOI 10.1073/pnas.1108982108; Reissmann M, 2013, SEMIN CELL DEV BIOL, V24, P576, DOI 10.1016/j.semcdb.2013.03.014; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Sandmeyer LS, 2007, VET OPHTHALMOL, V10, P368, DOI 10.1111/j.1463-5224.2007.00572.x; Sandmeyer LS, 2012, VET OPHTHALMOL, V15, P18, DOI 10.1111/j.1463-5224.2011.00903.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; Smit A, 1996, REPEATMASKER OPEN 30; SPONENBERG DP, 1990, J HERED, V81, P323, DOI 10.1093/oxfordjournals.jhered.a110997; SPONENBERG DP, 2009, EQUINE COLOR GENETIC, V8; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Terai G, 2010, NUCLEIC ACIDS RES, V38, P1163, DOI 10.1093/nar/gkp1098; Terry RB, 2004, ANIM GENET, V35, P134, DOI 10.1111/j.1365-2052.2004.01113.x; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; WITZEL DA, 1978, INVEST OPHTH VIS SCI, V17, P788; WITZEL DA, 1977, J EQUINE MED SURG, V1, P226	71	73	75	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78280	10.1371/journal.pone.0078280	http://dx.doi.org/10.1371/journal.pone.0078280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167615	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500076
J	Ferreira, CD; Abreu, RM; da Silva, MC; Ferreira, AS; Nasser, PD; Carrilho, FJ; Ono, SK				Ferreira, Camila da Silva; Abreu, Rodrigo Martins; da Silva, Marlone Cunha; Ferreira, Aline Siqueira; Nasser, Paulo Dominguez; Carrilho, Flair Jose; Ono, Suzane Kioko			A Fast and Cost-Effective Method for Identifying a Polymorphism of Interleukin 28B Related to Hepatitis C	PLOS ONE			English	Article							GENETIC-VARIATION; VIRUS-INFECTION; IL28B; VARIANTS	Approximately 170 million people are chronic carriers of hepatitis C virus (HCV). Patients with chronic hepatitis C are currently treated with pegylated interferon and ribavirin (PEG-IFN/RBV). A genome-wide association with PEG-IFN/RBV treatment response and a single nucleotide polymorphism (rs12979860) has been identified near the interleukin 28B gene that encodes interferon-lambda-3. In this paper, we describe an innovative, fast, and low-cost multiplex polymerase chain reaction with confronting two-pair primers that detects the rs12979860 polymorphism. The assay is internally controlled and does not require the use of restriction endonucleases or special equipment. Moreover, the assay decreases costs, being about 40% cheaper than direct sequencing methods.	[Ferreira, Camila da Silva; Abreu, Rodrigo Martins; da Silva, Marlone Cunha; Nasser, Paulo Dominguez; Carrilho, Flair Jose; Ono, Suzane Kioko] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil; [Ferreira, Aline Siqueira] Univ Fed Juiz de Fora, Dept Parasitol Microbiol & Immunol, Inst Biol Sci, Juiz De Fora, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Juiz de Fora	Ono, SK (corresponding author), Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil.	skon@usp.br	Carrilho, Flair J/I-3046-2012; Ono, Suzane K/I-3107-2012	Cunha-Silva, Marlone/0000-0002-4424-6606	Alves de Queiroz Family Foundation	Alves de Queiroz Family Foundation	The work was supported by the Alves de Queiroz Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Montes-Cano MA, 2010, HEPATOLOGY, V52, P33, DOI 10.1002/hep.23624; Bacon BR, 2007, AM J MANAG CARE, V13, pS319; Chevaliez S, 2011, GASTROENTEROLOGY, V141, P119, DOI 10.1053/j.gastro.2011.03.039; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Cyr DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021854; Doehring A, 2010, ANTIVIR THER, V15, P1099, DOI 10.3851/IMP1689; Eurich D, 2011, LIVER TRANSPLANT, V17, P289, DOI 10.1002/lt.22235; Galmozzi E, 2011, J VIRAL HEPATITIS, V18, P628, DOI 10.1111/j.1365-2893.2010.01349.x; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; da Costa MZG, 2009, PANCREATOLOGY, V9, P173, DOI 10.1159/000178889; Hamajima N, 2000, JPN J CANCER RES, V91, P865, DOI 10.1111/j.1349-7006.2000.tb01026.x; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Ministerio da Saude, 2011, PROT CLIN DIR TER HE; Nakatani SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010150; Ono-Nita Suzane Kioko, 2006, Arq. Gastroenterol., V43, P71, DOI 10.1590/S0004-28032006000200001; Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease, 1998, CTR DIS CONTROL PREV, V47, P1; Reynolds JM, 2012, PLOS ONE, V7, P271, DOI 10.1371/journal.pone.0029983; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Urban T, 2012, HEPATOLOGY, V56, P361, DOI 10.1002/hep.25794	20	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78142	10.1371/journal.pone.0078142	http://dx.doi.org/10.1371/journal.pone.0078142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167602	Green Submitted, gold, Green Published			2022-12-27	WOS:000326034500062
J	Kisiel, M; Klar, AS; Ventura, M; Buijs, J; Mafina, MK; Cool, SM; Hilborn, J				Kisiel, Marta; Klar, Agnieszka S.; Ventura, Manuela; Buijs, Jos; Mafina, Marc-Krystelle; Cool, Simon M.; Hilborn, Joens			Complexation and Sequestration of BMP-2 from an ECM Mimetic Hyaluronan Gel for Improved Bone Formation	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-2; IN-VIVO; OSTEOGENIC ACTIVITY; CONTROLLED-RELEASE; HEPARIN; OSTEOINDUCTION; DIFFERENTIATION; PROTEOGLYCANS; ENHANCEMENT; METABOLISM	Bone morphogenetic protein-2 (BMP-2) is considered a promising adjuvant for the treatment of skeletal non-union and spinal fusion. However, BMP-2 delivery in a conventional collagen scaffold necessitates a high dose to achieve an efficacious outcome. To lower its effective dose, we precomplexed BMP-2 with the glycosaminoglycans (GAGs) dermatan sulfate (DS) or heparin (HP), prior to loading it into a hyaluronic acid (HA) hydrogel. In vitro release studies showed that BMP-2 precomplexed with DS or HP had a prolonged delivery compared to without GAG. BMP-2-DS complexes achieved a slightly faster release in the first 24 h than HP; however, both delivered BMP-2 for an equal duration. Analysis of the kinetic interaction between BMP-2 and DS or HP showed that HP had approximately 10 times higher affinity for BMP-2 than DS, yet it equally stabilized the protein, as determined by alkaline phosphatase activity. Ectopic bone formation assays at subcutaneous sites in rats demonstrated that HA hydrogel-delivered BMP-2 precomplexed with GAG induced twice the volume of bone compared with BMP-2 delivered uncomplexed to GAG.	[Kisiel, Marta; Hilborn, Joens] Uppsala Univ, Sci Life Lab, Dept Chem Angstrom, Div Polymers Chem, Uppsala, Sweden; [Klar, Agnieszka S.] Univ Childrens Hosp, Dept Surg, Tissue Biol Res Unit, Zurich, Switzerland; [Ventura, Manuela] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Buijs, Jos] GE Healthcare, Sci Life Lab, Stockholm, Sweden; [Mafina, Marc-Krystelle] Queen Mary Univ London, Sch Engn & Mat Sci, London, England; [Cool, Simon M.] ASTAR, Inst Med Biol, Glycotherapeut Grp, Singapore, Singapore	Uppsala University; University Children's Hospital Zurich; Radboud University Nijmegen; General Electric; University of London; Queen Mary University London; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Hilborn, J (corresponding author), Uppsala Univ, Sci Life Lab, Dept Chem Angstrom, Div Polymers Chem, Uppsala, Sweden.	hilborn@kemi.uu.se	Cool, Simon McKenzie/AAG-4346-2021; Kisiel, Marta/AAB-1312-2022; Cool, Simon/W-1257-2018; Mafina, Krystelle/E-5953-2014; Hilborn, Jons/W-2864-2018	Cool, Simon/0000-0001-8543-3056; Klar, Agnes S./0000-0003-3521-8010; Hilborn, Jons/0000-0001-6947-9601; Buijs, Jos/0000-0003-3955-1320	European Community's Seventh Framework Programme (MultiTERM) [238551]; European Community's Seventh Framework Programme (BIODESIGN) [262948]	European Community's Seventh Framework Programme (MultiTERM); European Community's Seventh Framework Programme (BIODESIGN)	This work was supported by the European Community's Seventh Framework Programme (MultiTERM, grant agreement No. 238551 and BIODESIGN, grant agreement No. 262948). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso L, 2011, J CLIN HYPERTENS, V13, P551, DOI 10.1111/j.1751-7176.2011.00476.x; Barger-Lux M Janet, 2002, Top Magn Reson Imaging, V13, P297; Bergman K, 2009, J BIOMED MATER RES A, V91A, P1111, DOI 10.1002/jbm.a.32289; Berner A, 2012, CELL TISSUE RES, V347, P501, DOI 10.1007/s00441-011-1184-8; Bhakta G, 2012, BIOMATERIALS, V33, P6113, DOI 10.1016/j.biomaterials.2012.05.030; Bramono DS, 2012, BONE, V50, P954, DOI 10.1016/j.bone.2011.12.013; Caetano-Lopes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016947; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Chao EYS, 1998, CLIN ORTHOP RELAT R, pS163; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X; Fu YC, 2008, BIOTECHNOL BIOENG, V99, P996, DOI 10.1002/bit.21648; Govender S, 2002, TRANSPORT POROUS MED, V49, P247, DOI 10.1023/A:1016241225343; HEIPLE KG, 1963, J BONE JOINT SURG AM, V45, P1593, DOI 10.2106/00004623-196345080-00003; Jeon O, 2008, BIOCHEM BIOPH RES CO, V369, P774, DOI 10.1016/j.bbrc.2008.02.099; Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023; Jha AK, 2009, BIOMATERIALS, V30, P6964, DOI 10.1016/j.biomaterials.2009.09.009; Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200; Johnson MR, 2011, CLIN ORTHOP RELAT R, V469, P3111, DOI 10.1007/s11999-011-2012-x; JONES G, 1994, DRUG SAFETY, V10, P480, DOI 10.2165/00002018-199410060-00006; Kisiel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071683; Kisiel M, 2013, BIOMATERIALS, V34, P704, DOI 10.1016/j.biomaterials.2012.10.015; Kisiel M, 2012, J CONTROL RELEASE, V162, P646, DOI 10.1016/j.jconrel.2012.08.004; Kozma EM, 2009, BIOCHIMIE, V91, P1394, DOI 10.1016/j.biochi.2009.07.010; Kusumoto K, 1998, BRIT J PLAST SURG, V51, P275, DOI 10.1054/bjps.1998.0008; Laub M, 2001, MATERIALWISS WERKST, V32, P926, DOI 10.1002/1521-4052(200112)32:12<926::AID-MAWE926>3.0.CO;2-1; Lepperdinger G, 2001, MATRIX BIOL, V20, P509, DOI 10.1016/S0945-053X(01)00170-6; Liu HW, 2007, TISSUE ENG, V13, P1113, DOI 10.1089/ten.2006.0209; Lyon M, 1998, J BIOL CHEM, V273, P271, DOI 10.1074/jbc.273.1.271; Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065; Martinez-Sanz E, 2012, J TISSUE ENG REGEN M, V6, ps15, DOI 10.1002/term.1593; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Nageeb M, 2012, MOL CRYST LIQ CRYST, V555, P177, DOI 10.1080/15421406.2012.635530; Neovius E, 2013, J PLAST RECONSTR AES, V66, P37, DOI 10.1016/j.bjps.2012.08.015; Okubo Y, 2000, BIOCHEM BIOPH RES CO, V267, P382, DOI 10.1006/bbrc.1999.1975; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; Osses N, 2006, BIOCHEM BIOPH RES CO, V344, P1207, DOI 10.1016/j.bbrc.2006.04.029; Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047; Peacock M, 2010, CLIN J AM SOC NEPHRO, V5, pS23, DOI 10.2215/CJN.05910809; PISKOUNOVA S, 2012, J TISSUE ENG REGEN M, P27307; Radek KA, 2009, WOUND REPAIR REGEN, V17, P118, DOI 10.1111/j.1524-475X.2008.00449.x; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107; Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055; Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72; Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Trowbridge JM, 2002, J BIOL CHEM, V277, P42815, DOI 10.1074/jbc.M204959200; Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2; WOLINSKYFRIEDLAND M, 1995, ENDOCRIN METAB CLIN, V24, P395, DOI 10.1016/S0889-8529(18)30046-X; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xu X, 2011, ACTA BIOMATER, V7, P3050, DOI 10.1016/j.actbio.2011.04.018; Yang HS, 2010, TISSUE ENG PT A, V16, P1225, DOI [10.1089/ten.tea.2009.0390, 10.1089/ten.TEA.2009.0390]; Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002; Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200	58	43	45	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78551	10.1371/journal.pone.0078551	http://dx.doi.org/10.1371/journal.pone.0078551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167632	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000326034500093
J	Speier, W; Arnold, C; Pouratian, N				Speier, William; Arnold, Corey; Pouratian, Nader			Evaluating True BCI Communication Rate through Mutual Information and Language Models	PLOS ONE			English	Article							COMPUTER INTERFACE BCI; DATA SET IIB; COMPETITION 2003; BRAIN	Brain-computer interface (BCI) systems are a promising means for restoring communication to patients suffering from "locked-in" syndrome. Research to improve system performance primarily focuses on means to overcome the low signal to noise ratio of electroencephalogric (EEG) recordings. However, the literature and methods are difficult to compare due to the array of evaluation metrics and assumptions underlying them, including that: 1) all characters are equally probable, 2) character selection is memoryless, and 3) errors occur completely at random. The standardization of evaluation metrics that more accurately reflect the amount of information contained in BCI language output is critical to make progress. We present a mutual information-based metric that incorporates prior information and a model of systematic errors. The parameters of a system used in one study were re-optimized, showing that the metric used in optimization significantly affects the parameter values chosen and the resulting system performance. The results of 11 BCI communication studies were then evaluated using different metrics, including those previously used in BCI literature and the newly advocated metric. Six studies' results varied based on the metric used for evaluation and the proposed metric produced results that differed from those originally published in two of the studies. Standardizing metrics to accurately reflect the rate of information transmission is critical to properly evaluate and compare BCI communication systems and advance the field in an unbiased manner.	[Speier, William; Pouratian, Nader] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Pouratian, Nader] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Pouratian, Nader] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA USA; [Pouratian, Nader] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Speier, William; Arnold, Corey] Univ Calif Los Angeles, Med Imaging Informat Grp, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Pouratian, N (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	npouratian@mednet.ucla.edu	Speier, William/H-9974-2019	Speier, William/0000-0002-0890-8684; Pouratian, Nader/0000-0002-0426-3241	NLM Training Grand [T15-LM007356]; National Institute Of Biomedical Imaging and Bioengineering [K23EB014326]; UCLA Scholars in Translational Medicine Program; UCLA Department of Neurosurgery Visionary Ball Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K23EB014326] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007356] Funding Source: NIH RePORTER	NLM Training Grand; National Institute Of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); UCLA Scholars in Translational Medicine Program; UCLA Department of Neurosurgery Visionary Ball Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the NLM Training Grand T15-LM007356 (WS), the National Institute Of Biomedical Imaging and Bioengineering Award Number K23EB014326 (NP), the UCLA Scholars in Translational Medicine Program (NP), and the UCLA Department of Neurosurgery Visionary Ball Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankertz B., 2006, P 3 INT BRAIN COMP I; Cecotti H, 2010, IEEE T NEUR SYS REH, V18, P127, DOI 10.1109/TNSRE.2009.2039594; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Francis W. N., 1979, DEP LINGUISTICS; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Jin J, 2011, MED BIOL ENG COMPUT, V49, P181, DOI 10.1007/s11517-010-0689-8; Kaper M, 2004, IEEE T BIO-MED ENG, V51, P1073, DOI 10.1109/TBME.2004.826698; Kaper M, 2004, C P IEEE ENG MED BIO, V6, P1073; Lu J, 2013, CLIN NEUROPHYSIOL, V124, P306, DOI 10.1016/j.clinph.2012.08.002; McFarland DJ, 2011, CLIN NEUROPHYSIOL, V122, P731, DOI 10.1016/j.clinph.2010.10.029; McFarland DJ, 2003, BIOL PSYCHOL, V63, P237, DOI 10.1016/S0301-0511(03)00073-5; Pierce J.R., 1980, INTRO INFORM THEORY; Ryan DB, 2011, INT J HUM-COMPUT INT, V27, P69, DOI 10.1080/10447318.2011.535754; Schreuder M., 2011, FRONT NEUROSCI, V5; Sellers EW, 2006, BIOL PSYCHOL, V73, P242, DOI 10.1016/j.biopsycho.2006.04.007; Serby H, 2005, IEEE T NEUR SYS REH, V13, P89, DOI 10.1109/TNSRE.2004.841878; Speier W, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/1/016004; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Wang P, 2012, ARXIV12120469CSHC CO; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu N, 2004, IEEE T BIO-MED ENG, V51, P1067, DOI 10.1109/TBME.2004.826699; Yin EW, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026012	22	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78432	10.1371/journal.pone.0078432	http://dx.doi.org/10.1371/journal.pone.0078432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239OF	24167623	Green Published, gold, Green Submitted			2022-12-27	WOS:000326034500084
J	Cho, YB; Jones, SI; Vodkin, L				Cho, Young B.; Jones, Sarah I.; Vodkin, Lila			The Transition from Primary siRNAs to Amplified Secondary siRNAs That Regulate Chalcone Synthase During Development of Glycine max Seed Coats	PLOS ONE			English	Article							GENE FAMILY; RNA; SUPPRESSION; PETUNIA; MIRNAS; BIOGENESIS; EXPRESSION; CLUSTER	The / locus is a 27-kb inverted repeat cluster of chalcone synthase genes CHS1-3-4 that mediates siRNA down-regulation of CHS7 and CHS8 target mRNAs during seed development leading to yellow seed coats lacking anthocyanin pigments. Here, we report small RNA sequencing of ten stages of seed development from a few days post fertilization through maturity, revealing the amplification from primary to secondary short interfering RNAs (siRNAs) occurring during development. The young seed populations had a higher proportion of siRNAs representing the CHS1-3-4 gene family members, consistent with this region as the origin of the primary siRNAs. More intriguingly, the very young seed had a higher proportion of 22-nt CHS siRNAs than did the mid-maturation seed. We infer that the primary CHS siRNAs increase during development to levels sufficient to trigger amplification of secondary CHS siRNAs from the CHS7/8 target mRNAs, enabling the total levels of 21-nt CHS siRNAs to rise dramatically. Further, we demonstrate that the soybean system exhibits tissue-specific CHS siRNA production because primary CHS siRNA levels are not sufficient to trigger secondary amplification in tissues other than the seed coat.	[Cho, Young B.; Jones, Sarah I.; Vodkin, Lila] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Vodkin, L (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	l-vodkin@illinois.edu			United Soybean Board; Illinois Soybean Association; USDA-CSREES	United Soybean Board; Illinois Soybean Association; USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This research was supported by grants from the United Soybean Board, the Illinois Soybean Association, and the USDA-CSREES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Clough SJ, 2004, GENOME, V47, P819, DOI 10.1139/G04-049; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; Dhaubhadel S, 2007, PLANT PHYSIOL, V143, P326, DOI 10.1104/pp.106.086306; Eckardt NA, 2009, PLANT CELL, V21, P1029, DOI 10.1105/tpc.109.210412; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Jones SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059270; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Kurauchi T, 2011, J PLANT PHYSIOL, V168, P1264, DOI 10.1016/j.jplph.2011.01.003; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Pak J, 2012, CELL, V151, P885, DOI 10.1016/j.cell.2012.10.022; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Senda M, 2004, PLANT CELL, V16, P807, DOI 10.1105/tpc.019885; Todd JJ, 1996, PLANT CELL, V8, P687, DOI 10.1105/tpc.8.4.687; Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352; Tuteja JH, 2008, CROP SCI, V48, pS49, DOI 10.2135/cropsci2007.10.0542tpg; Tuteja JH, 2009, PLANT CELL, V21, P3063, DOI 10.1105/tpc.109.069856; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Wang C. S., 1994, Plant Molecular Biology Reporter, V12, P132, DOI 10.1007/BF02668374; WANG CS, 1994, PLANT PHYSIOL, V105, P739, DOI 10.1104/pp.105.2.739; Yoshikawa M, 2013, P NATL ACAD SCI USA, V110, P4117, DOI 10.1073/pnas.1217050110; Zabala G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-26; Zabala G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-177; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111	29	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76954	10.1371/journal.pone.0076954	http://dx.doi.org/10.1371/journal.pone.0076954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204712	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600018
J	Dobson, AJ; Purves, J; Kamysz, W; Rolff, J				Dobson, Adam J.; Purves, Joanne; Kamysz, Wojciech; Rolff, Jens			Comparing Selection on S. aureus between Antimicrobial Peptides and Common Antibiotics	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM LT2; GRAM-NEGATIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; RESISTANCE; EVOLUTION; MECHANISM; INFECTION; MELITTIN	With a diminishing number of effective antibiotics, there has been interest in developing antimicrobial peptides (AMPs) as drugs. However, any new drug faces potential bacterial resistance evolution. Here, we experimentally compare resistance evolution in Staphylococcus aureus selected by three AMPs (from mammals, amphibians and insects), a combination of two AMPs, and two antibiotics: the powerful last-resort vancomycin and the classic streptomycin. We find that resistance evolves readily against single AMPs and against streptomycin, with no detectable fitness cost. However the response to selection from our combination of AMPs led to extinction, in a fashion qualitatively similar to vancomycin. This is consistent with the hypothesis that simultaneous release of multiple AMPs during immune responses is a factor which constrains evolution of AMP resistant pathogens.	[Dobson, Adam J.; Purves, Joanne; Rolff, Jens] Univ Sheffield, Sheffield, S Yorkshire, England; [Dobson, Adam J.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Purves, Joanne] Univ Nottingham, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Kamysz, Wojciech] Gdansk Univ Med, Fac Pharm, Gdansk, Poland; [Rolff, Jens] Free Univ Berlin, Inst Biol, Berlin, Germany	University of Sheffield; Cornell University; University of Nottingham; Fahrenheit Universities; Medical University Gdansk; Free University of Berlin	Rolff, J (corresponding author), Univ Sheffield, Western Bank, Sheffield, S Yorkshire, England.	jens.rolff@fu-berlin.de	Gutman, Gloria Margaret/H-8167-2014	Gutman, Gloria Margaret/0000-0001-8810-2287; Dobson, Adam/0000-0003-1541-927X; Kamysz, Wojciech/0000-0001-5335-3043; Rolff, Jens/0000-0002-1529-5409	ERCgrant Evoresin [260986]; Biotechnology and Biological Sciences Research Council studentship	ERCgrant Evoresin; Biotechnology and Biological Sciences Research Council studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding provided by ERCgrant Evoresin (grant number: 260986). AD was supported by a Biotechnology and Biological Sciences Research Council studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres E, 2012, EUR J CLIN MICROBIOL, V31, P881, DOI 10.1007/s10096-011-1430-8; Bell G, 2003, MICROBIOL-SGM, V149, P1367, DOI 10.1099/mic.0.26265-0; Bolintineanu D, 2010, PEPTIDES, V31, P1, DOI 10.1016/j.peptides.2009.11.010; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chait R, 2007, NATURE; Chen J, 2000, BIOPOLYMERS, V55, P88, DOI 10.1002/1097-0282(2000)55:1<88::AID-BIP80>3.3.CO;2-B; Fischbach MA, 2011, CURR OPIN MICROBIOL; Giacometti A, 2003, GUT, V52, P874, DOI 10.1136/gut.52.6.874; Gottler LM, 2009, BBA-BIOMEMBRANES, V1788, P1680, DOI 10.1016/j.bbamem.2008.10.009; Gruenheid S, 2012, FEMS MICROBIOL LETT, V330, P81, DOI 10.1111/j.1574-6968.2012.02528.x; Habets MGJL, 2012, P ROY SOC B-BIOL SCI, V279, P3803, DOI 10.1098/rspb.2012.1118; Habets MGJL, 2012, BIOL LETTERS, V8, P416, DOI 10.1098/rsbl.2011.1203; Kahm M, 2010, J STAT SOFTW, V33, P1; Login FH, 2011, SCIENCE, V334, P362, DOI 10.1126/science.1209728; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Prajsnar TK, 2012, CELL MICROBIOL, V14, P1600, DOI 10.1111/j.1462-5822.2012.01826.x; Pranting M, 2008, ANTIMICROB AGENTS CH, V52, P2734, DOI 10.1128/AAC.00205-08; Pranting M, 2010, J ANTIMICROB CHEMOTH, V65, P876, DOI 10.1093/jac/dkq059; Shaw LN, 2006, J BACTERIOL, V188, P6070, DOI 10.1128/JB.00551-06; Steinem C, 2000, PHYS CHEM CHEM PHYS, V2, P4580, DOI 10.1039/b003865m; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Wiedman G, 2013, BBA-BIOMEMBRANES, V1828, P1357, DOI 10.1016/j.bbamem.2013.01.021; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zdybicka-Barabas A, 2012, BBA-BIOMEMBRANES, V1818, P2623, DOI 10.1016/j.bbamem.2012.06.008	28	43	46	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76521	10.1371/journal.pone.0076521	http://dx.doi.org/10.1371/journal.pone.0076521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204634	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000326029300032
J	Skibinski, DAG; Hanson, BJ; Lin, YF; von Messling, V; Jegerlehner, A; Tee, JBS; Chye, D; Wong, SKK; Ng, AAP; Lee, HY; Au, BJ; Lee, BTK; Santoso, L; Poidinger, M; Fairhurst, AM; Matter, A; Bachmann, MF; Saudan, P; Connolly, JE				Skibinski, David A. G.; Hanson, Brendon J.; Lin, Yufang; von Messling, Veronika; Jegerlehner, Andrea; Tee, Jason Boon Sern; Chye, De Hoe; Wong, Steven K. K.; Ng, Amanda A. P.; Lee, Hui Yin; Au, Bijin; Lee, Bernett T. K.; Santoso, Lucia; Poidinger, Michael; Fairhurst, Anna-Marie; Matter, Alex; Bachmann, Martin F.; Saudan, Philippe; Connolly, John E.			Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; PHASE-I SAFETY; T-CELLS; AUTOIMMUNE ARTHRITIS; PRECLINICAL EFFICACY; ACTIVE IMMUNIZATION; PROTECTIVE IMMUNITY; DENDRITIC CELLS; DOUBLE-BLIND; A VIRUS	Influenza pandemics can spread quickly and cost millions of lives; the 2009 H1N1 pandemic highlighted the shortfall in the current vaccine strategy and the need for an improved global response in terms of shortening the time required to manufacture the vaccine and increasing production capacity. Here we describe the pre-clinical assessment of a novel 2009 H1N1 pandemic influenza vaccine based on the E. coli-produced HA globular head domain covalently linked to virus-like particles derived from the bacteriophage Q beta. When formulated with alum adjuvant and used to immunize mice, dose finding studies found that a 10 mu g dose of this vaccine (3.7 mu g globular HA content) induced antibody titers comparable to a 1.5 mu g dose (0.7 mu g globular HA content) of the licensed 2009 H1N1 pandemic vaccine Panvax, and significantly reduced viral titers in the lung following challenge with 2009 H1N1 pandemic influenza A/California/07/2009 virus. While Panvax failed to induce marked T cell responses, the novel vaccine stimulated substantial antigen-specific interferon-gamma production in splenocytes from immunized mice, alongside enhanced IgG2a antibody production. In ferrets the vaccine elicited neutralizing antibodies, and following challenge with influenza A/California/07/2009 virus reduced morbidity and lowered viral titers in nasal lavages.	[Skibinski, David A. G.; Ng, Amanda A. P.; Connolly, John E.] Agcy Sci Technol & Res, A STAR Program Translat Res Infect Dis, Singapore, Singapore; [Skibinski, David A. G.; Lin, Yufang; Ng, Amanda A. P.; Lee, Hui Yin; Au, Bijin; Lee, Bernett T. K.; Poidinger, Michael; Fairhurst, Anna-Marie; Connolly, John E.] Agcy Sci Technol & Res, Singapore Immunol Network SIgN, Singapore, Singapore; [Hanson, Brendon J.; Tee, Jason Boon Sern; Chye, De Hoe; Wong, Steven K. K.] Def Sci Org DSO Natl Labs, Singapore, Singapore; [von Messling, Veronika] Univ Quebec, Inst Armand Frappier, INRS, Quebec City, PQ, Canada; [Jegerlehner, Andrea; Bachmann, Martin F.; Saudan, Philippe] Cytos Biotechnol AG, Zurich, Switzerland; [Santoso, Lucia; Matter, Alex] Agcy Sci Technol & Res, ETC, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Quebec; Institut national de la recherche scientifique (INRS); Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre	Connolly, JE (corresponding author), ASTAR, IMCB, Singapore, Singapore.	jeconnolly@imcb.a-star.edu.sg		Fairhurst, Anna-Marie/0000-0002-8950-6192; Poidinger, Michael/0000-0002-1047-2277	A*Star Program in Translational Research on Infectious Disease Bio Medical Research Council [BMRC/EDB IAF311003]	A*Star Program in Translational Research on Infectious Disease Bio Medical Research Council	The study was supported by the A*Star Program in Translational Research on Infectious Disease Bio Medical Research Council (BMRC/EDB IAF311003; Connolly, J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambuhl PM, 2007, J HYPERTENS, V25, P63, DOI 10.1097/HJH.0b013e32800ff5d6; Arulanandam BP, 2000, J IMMUNOL, V164, P3698, DOI 10.4049/jimmunol.164.7.3698; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Baras B, 2011, VACCINE, V29, P2120, DOI 10.1016/j.vaccine.2010.12.125; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Chackerian B, 2001, J CLIN INVEST, V108, P415, DOI 10.1172/JCI11849; Chujo D, 2012, CELL TRANSPLANT, V21, P2783, DOI 10.3727/096368912X654993; Cornuz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002547; DAVENPORT FM, 1968, J IMMUNOL, V100, P1139; Gordon DL, 2012, VACCINE, V30, P5407, DOI 10.1016/j.vaccine.2012.06.009; Govorkova EA, 2006, J INFECT DIS, V194, P159, DOI 10.1086/505225; Guarnaccia T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003354; HOCART MJ, 1989, J GEN VIROL, V70, P2439, DOI 10.1099/0022-1317-70-9-2439; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Iyer V, 2012, HUM VACCIN IMMUNOTHE, V8; Jegerlehner A, 2002, EUR J IMMUNOL, V32, P3305, DOI 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; Keller SA, 2010, EUR J IMMUNOL, V40, P103, DOI 10.1002/eji.200939559; Kundig TM, 2006, J ALLERGY CLIN IMMUN, V117, P1470, DOI 10.1016/j.jaci.2006.01.040; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Link A, 2012, J IMMUNOL, V188, P3724, DOI 10.4049/jimmunol.1103312; Liu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020928; Maurer P, 2005, EUR J IMMUNOL, V35, P2031, DOI 10.1002/eji.200526285; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; McElhaney JE, 2005, VACCINE, V23, pS10, DOI 10.1016/j.vaccine.2005.04.019; McKinstry KK, 2012, J CLIN INVEST, V122, P2847, DOI 10.1172/JCI63689; Mozdzanowska K, 1997, J VIROL, V71, P4347, DOI 10.1128/JVI.71.6.4347-4355.1997; MURPHY BR, 1989, CURR TOP MICROBIOL, V146, P107; Palucka AK, 2006, J IMMUNOTHER, V29, P545, DOI 10.1097/01.cji.0000211309.90621.8b; Perrone LA, 2009, J VIROL, V83, P5726, DOI 10.1128/JVI.00207-09; Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436; Pushko P, 2010, VACCINE, V28, P4771, DOI 10.1016/j.vaccine.2010.04.093; Rappuoli R, 2012, SCIENCE, V336, P1531, DOI 10.1126/science.1221466; Reed LJ, 1938, AM J EPIDEMIOLOGY; Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658; Schmitz N, 2012, EUR J IMMUNOL, V42, P863, DOI 10.1002/eji.201041225; Seo SH, 2002, J VIROL, V76, P1071, DOI 10.1128/JVI.76.3.1071-1076.2002; Shaw A, 2012, VACCINE, V30, P4927, DOI 10.1016/j.vaccine.2012.04.095; Spohn G, 2005, J IMMUNOL, V175, P6211, DOI 10.4049/jimmunol.175.9.6211; Spohn G, 2008, EUR J IMMUNOL, V38, P877, DOI 10.1002/eji.200737989; Spohn G, 2007, J IMMUNOL, V178, P7450, DOI 10.4049/jimmunol.178.11.7450; Spohn G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-146; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; Tissot AC, 2008, LANCET, V371, P821, DOI 10.1016/S0140-6736(08)60381-5; Treanor J, 2009, NEW GENERATION VACCI; Vela EM, 2012, INFLUENZA OTHER RESP, V6, P328, DOI 10.1111/j.1750-2659.2011.00321.x; Vence L, 2007, P NATL ACAD SCI USA, V104, P20884, DOI 10.1073/pnas.0710557105; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; WHO, 2012, REC COMP INFL VIR VA; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Winblad B, 2012, LANCET NEUROL, V11, P597, DOI 10.1016/S1474-4422(12)70140-0	55	19	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76571	10.1371/journal.pone.0076571	http://dx.doi.org/10.1371/journal.pone.0076571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204639	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326029300037
J	Feige, B; Biscaldi, M; Saville, CWN; Kluckert, C; Bender, S; Ebner-Priemer, U; Hennighausen, K; Rauh, R; Fleischhaker, C; Klein, C				Feige, Bernd; Biscaldi, Monica; Saville, Christopher W. N.; Kluckert, Christian; Bender, Stephan; Ebner-Priemer, Ulrich; Hennighausen, Klaus; Rauh, Reinhold; Fleischhaker, Christian; Klein, Christoph			On the Temporal Characteristics of Performance Variability in Attention Deficit Hyperactivity Disorder (ADHD)	PLOS ONE			English	Article							INTRA-SUBJECT VARIABILITY; DEFICIT/HYPERACTIVITY DISORDER; RESPONSE VARIABILITY; CHILDREN; FLUCTUATIONS; DISTRIBUTIONS; DISSOCIATION; IMPAIRMENTS; ADOLESCENTS; INSTABILITY	Increased intra-subject variability of reaction times (ISV-RT) is one of the most consistent findings in attention-deficit/hyperactivity disorder (ADHD). Although the nature of this phenomenon is still unclear, it has been hypothesised to reflect interference from the Default Mode Network (DMN). So far, ISV-RT has been operationally defined either as a frequency spectrum of the underlying RT time series, or as a measure of dispersion of the RT scores distribution. Here, we use a novel RT analysis framework to link these hitherto unconnected facets of ISV-RT by determining the sensitivity of different measures of RT dispersion to the frequency content of the underlying RT time series. N=27 patients with ADHD and N=26 healthy controls performed several visual N-back tasks. Different measures of RT dispersion were repeatedly modelled after individual frequency bands of the underlying RT time series had been either extracted or suppressed using frequency-domain filtering. We found that the intra-subject standard deviation of RT preserves the "1/f noise" characteristic typical of human RT data. Furthermore and most importantly, we found that the ex-Gaussian parameter T is rather exclusively sensitive to frequencies below 0.025 Hz in the underlying RT time series and that the particularly slow RTs, which nourish T, occur regularly as part of an quasi-periodic, ultra-slow RT fluctuation. Overall, our results are compatible with the idea that ISV-RT is modulated by an endogenous, slowly fluctuating process that may reflect DMN interference.	[Feige, Bernd] Univ Freiburg, Dept Psychiat & Psychotherapy, D-79106 Freiburg, Germany; [Biscaldi, Monica; Saville, Christopher W. N.; Kluckert, Christian; Hennighausen, Klaus; Rauh, Reinhold; Fleischhaker, Christian; Klein, Christoph] Univ Freiburg, Dept Child & Adolescent Psychiat & Psychotherapy, D-79106 Freiburg, Germany; [Saville, Christopher W. N.; Klein, Christoph] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Bender, Stephan] Univ Dresden, Dept Child & Adolescent Psychiat, Dresden, Germany; [Ebner-Priemer, Ulrich] Karlsruhe Inst Technol, Dept Appl Psychol, D-76021 Karlsruhe, Germany	University of Freiburg; University of Freiburg; Bangor University; Technische Universitat Dresden; Helmholtz Association; Karlsruhe Institute of Technology	Klein, C (corresponding author), Univ Freiburg, Dept Child & Adolescent Psychiat & Psychotherapy, Hugstetter Str 55, D-79106 Freiburg, Germany.	christoph.klein.kjp@uniklinik-freiburg.de	Rauh, Reinhold/S-6361-2019; Bender, Stephan/AAT-1266-2021; Feige, Bernd/C-6690-2012	Rauh, Reinhold/0000-0003-3053-1163; Feige, Bernd/0000-0002-9436-1258; Saville, Christopher W N/0000-0003-4870-7630				Bellgrove MA, 2005, NEUROPSYCHOLOGIA, V43, P1847, DOI 10.1016/j.neuropsychologia.2005.03.011; Buzy WM, 2009, CHILD NEUROPSYCHOL, V15, P441, DOI 10.1080/09297040802646991; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Di Martino A, 2008, BIOL PSYCHIAT, V64, P607, DOI 10.1016/j.biopsych.2008.03.008; DOPFNER M, 2008, CBCL 4 18 ELTERNFRAG; Douglas V.I., 1999, HDB DISRUPTIVE BEHAV, P105, DOI [10.1007/978-1-4615-4881-2_5, DOI 10.1007/978-1-4615-4881-2_5]; Ebner-Priemer UW, 2007, PSYCHOL MED, V37, P961, DOI 10.1017/S0033291706009706; Ebner-Priemer UW, 2009, J ABNORM PSYCHOL, V118, P195, DOI 10.1037/a0014868; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; FISKE DW, 1955, PSYCHOL BULL, V52, P217, DOI 10.1037/h0045276; Flehmig H. C., 2007, PSYCHOL SCI, V49, P132; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Gilden DL, 2001, PSYCHOL REV, V108, P33, DOI 10.1037/0033-295X.108.1.33; Halperin JM, 2008, J CHILD PSYCHOL PSYC, V49, P958, DOI 10.1111/j.1469-7610.2008.01926.x; Heathcote A, 2004, BEHAV RES METH INS C, V36, P277, DOI 10.3758/BF03195574; Heathcote A, 1996, BEHAV RES METH INSTR, V28, P427, DOI 10.3758/BF03200523; HELLER KA, 1998, STANDARD PROGR MATRI, V1; Helps SK, 2011, NEUROPSYCHOLOGY, V25, P711, DOI 10.1037/a0024479; HENDRICKSON A, 1982, MODEL INTELLIGENCE; Hervey AS, 2006, CHILD NEUROPSYCHOL, V12, P125, DOI 10.1080/09297040500499081; Johnson KA, 2008, NEUROPSYCHOLOGIA, V46, P1532, DOI 10.1016/j.neuropsychologia.2008.01.002; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P2234, DOI 10.1016/j.neuropsychologia.2007.02.019; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P630, DOI 10.1016/j.neuropsychologia.2006.03.034; Kaufman J., 2001, KIDDIE SADS PRESENT; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Klein C., 2002, PERSON BIOL SOZIALEN, P29; Klein C, 2006, BIOL PSYCHIAT, V60, P1088, DOI 10.1016/j.biopsych.2006.04.003; Ko AL, 2011, J NEUROSCI, V31, P11728, DOI 10.1523/JNEUROSCI.5730-10.2011; Kollins SH, 2009, DRUG ALCOHOL DEPEN, V100, P169, DOI 10.1016/j.drugalcdep.2008.09.019; Kuntsi J, 2001, J CHILD PSYCHOL PSYC, V42, P211, DOI 10.1111/1469-7610.00712; KUNTSI J, 2012, CURRENT TOPICS BEHAV; Kuntsi J, 2010, ARCH GEN PSYCHIAT, V67, P1159, DOI 10.1001/archgenpsychiatry.2010.139; Leth-Steensen C, 2000, ACTA PSYCHOL, V104, P167, DOI 10.1016/S0001-6918(00)00019-6; Marsh R, 2006, HUM BRAIN MAPP, V27, P848, DOI 10.1002/hbm.20225; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Ram N, 2005, PSYCHOL AGING, V20, P623, DOI 10.1037/0882-7974.20.4.623; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; Rommelse NNJ, 2008, BEHAV GENET, V38, P121, DOI 10.1007/s10519-007-9186-8; Rubia K, 2007, BIOL PSYCHIAT, V62, P999, DOI 10.1016/j.biopsych.2007.02.024; Rucklidge JJ, 2002, J CHILD PSYCHOL PSYC, V43, P988, DOI 10.1111/1469-7610.00227; Russell Vivienne A, 2006, Behav Brain Funct, V2, P30, DOI 10.1186/1744-9081-2-30; Saville CWN, 2012, BIOL PSYCHOL, V91, P275, DOI 10.1016/j.biopsycho.2012.07.006; Saville CWN, 2011, PERS INDIV DIFFER, V51, P148, DOI 10.1016/j.paid.2011.03.034; Sergeant J, 2000, NEUROSCI BIOBEHAV R, V24, P7, DOI 10.1016/S0149-7634(99)00060-3; Sergeant J.A., 1999, HDB DISRUPTIVE BEHAV, P75, DOI DOI 10.1007/978-1-4615-4881-2_4; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Stasinopoulos DM, 2007, J STAT SOFTW, V23; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Toplak ME, 2006, J NEUROSCI METH, V151, P15, DOI 10.1016/j.jneumeth.2005.09.018; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Uebel H, 2010, J CHILD PSYCHOL PSYC, V51, P210, DOI 10.1111/j.1469-7610.2009.02139.x; Van Orden GC, 2003, J EXP PSYCHOL GEN, V132, P331, DOI 10.1037/0096-3445.132.3.331; Vaurio RG, 2009, NEUROPSYCHOLOGIA, V47, P2389, DOI 10.1016/j.neuropsychologia.2009.01.022; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P579, DOI 10.3758/BF03196615; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wood AC, 2010, PSYCHOL MED, V40, P1027, DOI 10.1017/S003329170999119X	58	34	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e69674	10.1371/journal.pone.0069674	http://dx.doi.org/10.1371/journal.pone.0069674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24204553	gold, Green Published			2022-12-27	WOS:000325434500001
J	Tsang, KM; Croen, LA; Torres, AR; Kharrazi, M; Delorenze, GN; Windham, GC; Yoshida, CK; Zerbo, O; Weiss, LA				Tsang, Kathryn M.; Croen, Lisa A.; Torres, Anthony R.; Kharrazi, Martin; Delorenze, Gerald N.; Windham, Gayle C.; Yoshida, Cathleen K.; Zerbo, Ousseny; Weiss, Lauren A.			A Genome-Wide Survey of Transgenerational Genetic Effects in Autism	PLOS ONE			English	Article							SPECTRUM DISORDERS; FETAL MICROCHIMERISM; EARLY MARKERS; RISK-FACTORS; TWIN PAIRS; BRAIN; ASSOCIATION; VARIANTS; PROGENITOR; PREGNANCY	Effects of parental genotype or parent-offspring genetic interaction are well established in model organisms for a variety of traits. However, these transgenerational genetic models are rarely studied in humans. We have utilized an autism case-control study with 735 mother-child pairs to perform genome-wide screening for maternal genetic effects and maternal-offspring genetic interaction. We used simple models of single locus parent-child interaction and identified suggestive results (P<10(-4)) that cannot be explained by main effects, but no genome-wide significant signals. Some of these maternal and maternal-child associations were in or adjacent to autism candidate genes including: PCDH9, FOXP1, GABRB3, NRXN1, RELN, MACROD2, FHIT, RORA, CNTN4, CNTNAP2, FAM135B, LAMA1, NFIA, NLGN4X, RAPGEF4, and SDK1. We attempted validation of potential autism association under maternal-specific models using maternal-paternal comparison in family-based GWAS datasets. Our results suggest that further study of parental genetic effects and parent-child interaction in autism is warranted.	[Tsang, Kathryn M.; Weiss, Lauren A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Tsang, Kathryn M.; Weiss, Lauren A.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Croen, Lisa A.; Delorenze, Gerald N.; Yoshida, Cathleen K.; Zerbo, Ousseny] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Torres, Anthony R.] Utah State Univ, Ctr Persons Disabil, Logan, UT 84322 USA; [Kharrazi, Martin] Calif Dept Hlth Serv, Genet Dis Screening Program, Richmond, CA USA; [Windham, Gayle C.] Calif Dept Hlth Serv, Div Environm & Occupat Dis Control, Richmond, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Utah System of Higher Education; Utah State University; California Department of Health Care Services; California Department of Health Care Services	Weiss, LA (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	Lauren.Weiss@ucsf.edu		Croen, Lisa/0000-0001-7849-9428; Weiss, Lauren/0000-0002-5700-135X	National Institute of environmental Health Sciences [R01-ES016669]; National Institute of Health [MH52708, MH39437, MH00219, MH00980, MH64547]; National Health Medical Research Council [0034328]; Scottish Rite; Spunk Fund, Inc.; Rebecca and Solomon Baker Fund; APEX Foundation; National Alliance for Research in Schizophrenia and Affective Disorders; Nancy Pritzker Laboratory (Stanford); Cure Autism Now Foundation; National Institute of Mental Health [1U24MH081810]; Medical Research Council [G0601030]; Wellcome Trust [075491/Z/04]; MRC [G0601030] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547, U24MH081810, K05MH000219, P01MH039437, R01MH052708] Funding Source: NIH RePORTER	National Institute of environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Scottish Rite; Spunk Fund, Inc.; Rebecca and Solomon Baker Fund; APEX Foundation; National Alliance for Research in Schizophrenia and Affective Disorders(NARSAD); Nancy Pritzker Laboratory (Stanford); Cure Autism Now Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Institute of environmental Health Sciences (http://www.niehs.nih.gov/- R01-ES016669). The collection of data and biomaterials that participated in the National Institute of Mental Health Autism Genetics Initiative has been supported by National Institute of Health grants MH52708, MH39437, MH00219 and MH00980; National Health Medical Research Council grant 0034328; and by grants from the Scottish Rite, the Spunk Fund, Inc., the Rebecca and Solomon Baker Fund, the APEX Foundation, the National Alliance for Research in Schizophrenia and Affective Disorders, the endowment fund of the Nancy Pritzker Laboratory (Stanford), by gifts from the Autism Society of America, the Janet M. Grace Pervasive Developmental Disorders Fund, and families and friends of individuals with autism. The collection data and biomaterials also come from the Autism Genetic Resource Exchange (AGRE) collection supported by a National Institute of Health grant MH64547 and the Cure Autism Now Foundation. AGRE is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to Clara M. Lajonchere (PI). Collection and submission of the data to dbGaP were supported by a grant from the Medical Research Council (G0601030) and the Wellcome Trust (075491/Z/04), Anthony P. Monaco, P. I., University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth HE, 2011, GENET EPIDEMIOL, V35, P19, DOI 10.1002/gepi.20547; Anney R, 2012, HUM MOL GENET, V21, P4781, DOI 10.1093/hmg/dds301; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Bacchelli E, 2003, MOL PSYCHIATR, V8, P916, DOI 10.1038/sj.mp.4001340; Becker JAJ, 2008, NEUROSCIENCE, V156, P950, DOI 10.1016/j.neuroscience.2008.07.070; Braunschweig D, 2008, NEUROTOXICOLOGY, V29, P226, DOI 10.1016/j.neuro.2007.10.010; Bristow JM, 2009, J CELL SCI, V122, P4535, DOI 10.1242/jcs.053728; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chao CCK, 2005, J NEUROSCI RES, V81, P153, DOI 10.1002/jnr.20552; Connolly JJ, 2013, CHILD DEV, V84, P17, DOI 10.1111/j.1467-8624.2012.01838.x; Croen LA, 2008, BIOL PSYCHIAT, V64, P583, DOI 10.1016/j.biopsych.2008.05.006; Croen LA, 2008, AUTISM RES, V1, P130, DOI 10.1002/aur.14; Delahanty RJ, 2011, MOL PSYCHIATR, V16, P86, DOI 10.1038/mp.2009.118; Dunster K, 2005, CLIN EXP IMMUNOL, V140, P556, DOI 10.1111/j.1365-2249.2005.02774.x; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Glezer I, 2009, J COMP NEUROL, V517, P906, DOI 10.1002/cne.22185; Godbole K, 2011, BIRTH DEFECTS RES A, V91, P848, DOI 10.1002/bdra.20841; Groer MW, 2011, BIOL RES NURS, V13, P346, DOI 10.1177/1099800410385840; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Howey R, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-149; Hsieh CL, 2011, NUCLEIC ACIDS RES, V39, P4048, DOI 10.1093/nar/gkq1338; Ichinose H, 2008, CHEM REC, V8, P378, DOI 10.1002/tcr.20166; Izaki T, 2006, BIOCHEM BIOPH RES CO, V341, P1001, DOI 10.1016/j.bbrc.2006.01.050; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Koch M, 2004, J BIOL CHEM, V279, P22514, DOI 10.1074/jbc.M400536200; Kohannim O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00115; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Kutzleb G, 2006, CELL BIOL, V127, P13; Lin SE, 2002, J BIOL CHEM, V277, P50612, DOI 10.1074/jbc.M209529200; Maloney S, 1999, J CLIN INVEST, V104, P41, DOI 10.1172/JCI6611; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin LA, 2008, BRAIN BEHAV IMMUN, V22, P806, DOI 10.1016/j.bbi.2007.12.007; MASONBROTHERS A, 1990, PEDIATRICS, V86, P514; Miles JH, 2011, GENET MED, V13, P278, DOI 10.1097/GIM.0b013e3181ff67ba; Mulatinho MV, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-30; Nadeau JH, 2009, HUM MOL GENET, V18, pR202, DOI 10.1093/hmg/ddp366; Narayanan G, 2012, STEM CELLS DEV, V21, P3351, DOI 10.1089/scd.2012.0232; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Ozgen HM, 2009, CLIN GENET, V76, P348, DOI 10.1111/j.1399-0004.2009.01254.x; Palmer CGS, 2002, AM J HUM GENET, V71, P1312, DOI 10.1086/344659; PARKHURST SM, 1991, GENE DEV, V5, P341, DOI 10.1101/gad.5.3.341; Passemard S, 2009, GENE REV; Persico AM, 2001, MOL PSYCHIATR, V6, P150, DOI 10.1038/sj.mp.4000850; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; Rogenhofer N, 2012, FERTIL STERIL, V98, P383, DOI 10.1016/j.fertnstert.2012.04.026; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sinsheimer JS, 2003, GENET EPIDEMIOL, V24, P1, DOI 10.1002/gepi.10211; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Tan XW, 2005, STEM CELLS, V23, P1443, DOI 10.1634/stemcells.2004-0169; Volcik KA, 2000, AM J MED GENET, V95, P21, DOI 10.1002/1096-8628(20001106)95:1<21::AID-AJMG6>3.0.CO;2-M; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wilcox CB, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-223; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49	65	41	42	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76978	10.1371/journal.pone.0076978	http://dx.doi.org/10.1371/journal.pone.0076978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204716	Green Submitted, gold, Green Published			2022-12-27	WOS:000326152300012
J	Chen, Y; Zhang, YC; Tang, Y; Huang, XH; Xie, YQ				Chen, Yu; Zhang, Yachen; Tang, Yong; Huang, Xiaohong; Xie, Yuquan			High-Maintenance-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RESIDUAL PLATELET REACTIVITY; MYOCARDIAL-INFARCTION; RESPONSE VARIABILITY; ANTIPLATELET THERAPY; CLINICAL-OUTCOMES; STANDARD; ASPIRIN; MG; RESPONSIVENESS; MANAGEMENT	Background: Despite routine use of clopidogrel, adverse cardiovascular events recur among some patients undergoing percutaneous coronary intervention (PCI). To optimize antiplatelet therapies, we performed a meta-analysis to quantify the efficacy of high versus standard-maintenance-dose clopidogrel in these patients. Methods: Randomized controlled trials (RCTs) comparing high (>75 mg) and standard maintenance doses of clopidogrel in patients undergoing PCI were included. The primary efficacy and safety end-points were major adverse cardiovascular/cerebrovascular events (MACE/MACCE) and major bleeding. The secondary end-points were other ischemic and bleeding adverse effects. The pooled odds ratio (OR) for each outcome was estimated. Results: 14 RCTs with 4424 patients were included. Compared with standard-maintenance-dose clopidogrel, high-maintenance-dose clopidogrel significantly reduced the incidence of MACE/MACCE (OR 0.60; 95% CI 0.43 to 0.83), stent thrombosis (OR 0.56; 95% CI 0.32 to 0.99) and target vessel revascularization (OR 0.38; 95% CI 0.20 to 0.74), without significant decrease of the risk of cardiovascular death (OR 0.92; 95% CI 0.74 to 1.13) and myocardial infarction (OR 0.83; 95% CI 0.51 to 1.33). For safety outcomes, it did not significantly increase the risk of major bleeding (OR 0.73; 95% CI 0.41 to 1.32), minor bleeding (OR 1.29; 95% CI 1.00 to 1.66) and any bleeding (OR 1.14; 95% CI 0.91 to 1.43). Conclusion: High-maintenance-dose clopidogrel reduces the recurrence of most ischemic events in patients post-PCI without increasing the risk of bleeding complications.	[Chen, Yu; Zhang, Yachen; Tang, Yong; Huang, Xiaohong; Xie, Yuquan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Div Cardiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhang, YC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Div Cardiol, Shanghai 200030, Peoples R China.	zhangyachen1965@163.com			National Natural Science Foundation of China [8117012, 81270209]; Shanghai Committee of Science and Technology of China [12JC1406400, 10ZR1420400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology of China	This work was supported by National Natural Science Foundation of China (numbers 8117012, 81270209) and the Shanghai Committee of Science and Technology of China (numbers 12JC1406400, 10ZR1420400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleil B, 2008, JACC-CARDIOVASC INTE, V1, P631, DOI 10.1016/j.jcin.2008.09.004; Angiolillo DJ, 2004, EUR HEART J, V25, P1903, DOI 10.1016/j.ehj.2004.07.036; Angiolillo DJ, 2008, THROMB HAEMOSTASIS, V99, P161, DOI 10.1160/TH07-09-0562; Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Aradi D, 2012, EUR J CLIN INVEST, V42, P384, DOI 10.1111/j.1365-2362.2011.02594.x; Ari H, 2012, INT J CARDIOL, V157, P374, DOI 10.1016/j.ijcard.2010.12.083; Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Cuisset T, 2006, J AM COLL CARDIOL, V48, P1339, DOI 10.1016/j.jacc.2006.06.049; Davis EM, 2011, PHARMACOTHERAPY, V31, P975, DOI 10.1592/phco.31.10.975; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferguson AD, 2008, TEX HEART I J, V35, P313; Gremmel T, 2012, INT J CARDIOL, V160, P109, DOI 10.1016/j.ijcard.2011.04.001; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Han YL, 2009, CHINESE MED J-PEKING, V122, P793, DOI 10.3760/cma.j.issn.0366-6999.2009.07.006; Heitzer T, 2006, ARTERIOSCL THROM VAS, V26, P1648, DOI 10.1161/01.ATV.0000225288.74170.dc; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jneid H, 2012, J AM COLL CARDIOL, V60, P645, DOI 10.1016/j.jacc.2012.06.004; Lassar TA, 2011, REV CARDIOVASC MED, V12, pS23, DOI 10.3909/ricm12S1S0003; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Muller I, 2003, THROMB HAEMOSTASIS, V89, P783, DOI 10.1055/s-0037-1613462; Palmerini T, 2010, THROMB RES, V125, P309, DOI 10.1016/j.thromres.2009.06.016; Patti G, 2011, J AM COLL CARDIOL, V57, P771, DOI 10.1016/j.jacc.2010.09.050; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Ren HS, 2010, J CARDIOVASC PHARM, V55, P617, DOI 10.1097/FJC.0b013e3181dc98dc; Ren Li-hui, 2012, Zhonghua Yi Xue Za Zhi, V92, P408; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Roghani F, 2011, ARYA ATHEROSCLER, V7, P18; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Siller-Matula JM, 2011, HEART, V97, P98, DOI 10.1136/hrt.2010.195438; Snoep JD, 2007, AM HEART J, V154, P221, DOI 10.1016/j.ahj.2007.04.014; Sofi F, 2008, INT J CARDIOL, V128, P166, DOI 10.1016/j.ijcard.2007.12.010; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Steiner S, 2012, THROMB HAEMOSTASIS, V108, P318, DOI 10.1160/TH11-08-0586; Tousek P, 2011, INT J CARDIOL, V150, P231, DOI 10.1016/j.ijcard.2011.05.021; Von Beckerath N, 2007, EUR HEART J, V28, P1814, DOI 10.1093/eurheartj/ehl489; Waksman R, 2008, J INTERV CARDIOL, V21, P122, DOI 10.1111/j.1540-8183.2008.00347.x; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wang XD, 2011, CLIN CARDIOL, V34, P332, DOI 10.1002/clc.20884; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wolfram RM, 2006, AM J CARDIOL, V97, P984, DOI 10.1016/j.amjcard.2005.10.064; Yusuf S, 2001, NEW ENGL J MED, V345, P494	45	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78549	10.1371/journal.pone.0078549	http://dx.doi.org/10.1371/journal.pone.0078549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194947	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000126
J	Hu, J; Ng, PC				Hu, Jing; Ng, Pauline C.			SIFT Indel: Predictions for the Functional Effects of Amino Acid Insertions/Deletions in Proteins	PLOS ONE			English	Article							MECHANISMS; DELETIONS; IMPACT	Indels in the coding regions of a gene can either cause frameshifts or amino acid insertions/deletions. Frameshifting indels are indels that have a length that is not divisible by 3 and subsequently cause frameshifts. Indels that have a length divisible by 3 cause amino acid insertions/deletions or block substitutions; we call these 3n indels. The new amino acid changes resulting from 3n indels could potentially affect protein function. Therefore, we construct a SIFT Indel prediction algorithm for 3n indels which achieves 82% accuracy, 81% sensitivity, 82% specificity, 82% precision, 0.63 MCC, and 0.87 AUC by 10-fold cross-validation. We have previously published a prediction algorithm for frameshifting indels. The rules for the prediction of 3n indels are different from the rules for the prediction of frameshifting indels and reflect the biological differences of these two different types of variations. SIFT Indel was applied to human 3n indels from the 1000 Genomes Project and the Exome Sequencing Project. We found that common variants are less likely to be deleterious than rare variants. The SIFT indel prediction algorithm for 3n indels is available at http://sift-dna.org/	[Hu, Jing] Franklin & Marshall Coll, Dept Math & Comp Sci, Lancaster, PA 17604 USA; [Ng, Pauline C.] Genome Inst Singapore, Dept Computat & Math Biol, Singapore, Singapore	Franklin & Marshall College; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Hu, J (corresponding author), Franklin & Marshall Coll, Dept Math & Comp Sci, Lancaster, PA 17604 USA.	jing.hu@fandm.edu; ngpc4@gis.a-star.edu.sg			A*STAR; Genome Institute of Singapore; Howard Hughes Medical Institute's Undergraduate Science Education Program	A*STAR(Agency for Science Technology & Research (A*STAR)); Genome Institute of Singapore; Howard Hughes Medical Institute's Undergraduate Science Education Program	PCN is supported by A*STAR and Genome Institute of Singapore. JH is supported by an award to Franklin and Marshall College from the Howard Hughes Medical Institute's Undergraduate Science Education Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Brown C, 2002, EMBED SYST PROGRAM, V15, P55; Capriotti E, 2012, BRIEF BIOINFORM, V13, P495, DOI 10.1093/bib/bbr070; Castellana S, 2013, BRIEF BIOINFORM, V14, P448, DOI 10.1093/bib/bbt013; Chang MSS, 2004, J MOL BIOL, V341, P617, DOI 10.1016/j.jmb.2004.05.045; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Hu J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r9; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; LIXPLI XM, 2001, CHINESEJ CLIN PHARM, V3, P21502; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Taylor MS, 2004, GENOME RES, V14, P555, DOI 10.1101/gr.1977804; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Wang MJ, 2013, CURR BIOINFORM, V8, P161, DOI 10.2174/1574893611308020004; Witten I.H., 2005, DATA MINING PRACTICA; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhao HY, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r23; 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534.PUBMED:20981092	28	71	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77940	10.1371/journal.pone.0077940	http://dx.doi.org/10.1371/journal.pone.0077940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194902	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000081
J	Kim, SK; Kim, H; Lee, DH; Kim, TS; Kim, T; Chung, C; Koh, GY; Kim, H; Lim, DS				Kim, Sang Kyum; Kim, Honsoul; Lee, Da-hye; Kim, Tae-shin; Kim, Tackhoon; Chung, Chaeuk; Koh, Gou Young; Kim, Hoguen; Lim, Dae-Sik			Reversing the Intractable Nature of Pancreatic Cancer by Selectively Targeting ALDH-High, Therapy-Resistant Cancer Cells	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 1; TWICE-WEEKLY GEMCITABINE; PHASE-II TRIAL; STEM-CELLS; KAPPA-B; DISULFIRAM; CHEMOTHERAPY; MARKER; CARCINOMA; RADIATION	Human pancreatic ductal adenocarcinoma (PDAC) is a cancer with a dismal prognosis. The efficacy of PDAC anticancer therapies is often short-lived; however, there is little information on how this disease entity so frequently gains resistance to treatment. We adopted the concept of cancer stem cells (CSCs) to explain the mechanism of resistance and evaluated the efficacy of a candidate anticancer drug to target these therapy-resistant CSCs. We identified a subpopulation of cells in PDAC with CSC features that were enriched for aldehyde dehydrogenase (ALDH), a marker expressed in certain stem/progenitor cells. These cells were also highly resistant to, and were further enriched by, treatment with gemcitabine. Similarly, surgical specimens from PDAC patients showed that those who had undergone preoperative chemo-radiation therapy more frequently displayed cancers with ALDH strongly positive subpopulations compared with untreated patients. Importantly, these ALDH-high cancer cells were sensitive to disulfiram, an ALDH inhibitor, when tested in vitro. Furthermore, in vivo xenograft studies showed that the effect of disulfiram was additive to that of low-dose gemcitabine when applied in combination. In conclusion, human PDAC-derived cells that express high levels of ALDH show CSC features and have a key role in the development of resistance to anticancer therapies. Disulfiram can be used to suppress this therapy-resistant subpopulation.	[Kim, Sang Kyum; Chung, Chaeuk; Koh, Gou Young] South Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Taejon, South Korea; [Kim, Honsoul] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Lee, Da-hye; Kim, Tae-shin; Kim, Tackhoon; Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kim, Hoguen] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Yonsei University Health System; Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Yonsei University Health System	Kim, SK (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea.	nicekyumi@kaist.ac.kr; daesiklim@kaist.ac.kr	Lim, Dae-Sik/C-1599-2011	Lim, Dae-Sik/0000-0003-2356-7555; Chung, Chaeuk/0000-0002-3978-0484; Kim, Tae-Shin/0000-0003-4736-0727; Kim, Sang Kyum/0000-0003-0768-9923	National Creative Research Initiatives Program [2010-001827]	National Creative Research Initiatives Program(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the National Creative Research Initiatives Program (2010-001827, http://www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKEVOLD KE, 1993, EUR J CANCER, V29A, P698, DOI 10.1016/S0959-8049(05)80349-1; Balber AE, 2011, STEM CELLS, V29, P570, DOI 10.1002/stem.613; Blackstock AW, 1999, J CLIN ONCOL, V17, P2208, DOI 10.1200/JCO.1999.17.7.2208; Brar SS, 2004, MOL CANCER THER, V3, P1049; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Cho HJ, 2007, J BIOCHEM MOL BIOL, V40, P1069; Cvek B, 2007, CURR PHARM DESIGN, V13, P3155, DOI 10.2174/138161207782110390; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dorado J, 2011, STEM CELLS BIOL REG, P79, DOI 10.1007/978-1-61779-246-5_5; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Edge SB, 2010, AJCC CANC STAGING MA; ENEANYA DI, 1981, ANNU REV PHARMACOL, V21, P575, DOI 10.1146/annurev.pa.21.040181.003043; Fuller RK, 2004, ADDICTION, V99, P21, DOI 10.1111/j.1360-0443.2004.00597.x; GASSLANDER T, 1992, SCAND J GASTROENTERO, V27, P564, DOI 10.3109/00365529209000120; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Girard N, 2010, INT J RADIAT ONCOL, V77, P1426, DOI 10.1016/j.ijrobp.2009.06.053; GORDON MY, 1985, LEUKEMIA RES, V9, P1017, DOI 10.1016/0145-2126(85)90072-4; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; JOHANSSON B, 1992, ACTA PSYCHIAT SCAND, V86, P15, DOI 10.1111/j.1600-0447.1992.tb03310.x; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Klinkenbijl JH, 1999, ANN SURG, V230, P776, DOI 10.1097/00000658-199912000-00006; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Maeda S, 2007, BRIT J CANCER, V97, P405, DOI 10.1038/sj.bjc.6603879; Magnino A, 2005, ONCOLOGY-BASEL, V68, P493, DOI 10.1159/000086993; Mishra G, 2005, AM J CLIN ONCOL-CANC, V28, P345, DOI 10.1097/01.coc.0000159559.42311.c5; Moreb JS, 1995, LEUKEMIA LYMPHOMA, V20, P77, DOI 10.3109/10428199509054756; Nagasao J, 2003, ANN ANAT, V185, P211, DOI 10.1016/S0940-9602(03)80025-0; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Pozza ED, 2011, FREE RADICAL BIO MED, V50, P926, DOI 10.1016/j.freeradbiomed.2011.01.001; RAINEY JM, 1977, AM J PSYCHIAT, V134, P371; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; SAHOVIC EA, 1988, CANCER RES, V48, P1223; SAIF MW, 2011, JOP, V20, P12; Sauna ZE, 2004, MOL PHARMACOL, V65, P675, DOI 10.1124/mol.65.3.675; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Singh B, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-82; Smeenk HG, 2007, ANN SURG, V246, P734, DOI 10.1097/SLA.0b013e318156eef3; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Takada T, 2002, CANCER, V95, P1685, DOI 10.1002/cncr.10831; Wang F, 2011, CANCER LETT, V300, P87, DOI 10.1016/j.canlet.2010.09.010; Wang WG, 2003, INT J CANCER, V104, P504, DOI 10.1002/ijc.10972; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yao J, 2010, ONCOL REP, V23, P1375, DOI 10.3892/or_00000774	49	38	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78130	10.1371/journal.pone.0078130	http://dx.doi.org/10.1371/journal.pone.0078130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194908	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000087
J	Shen, JJ; Xing, TJ; Yuan, HH; Liu, ZQ; Jin, ZP; Zhang, LP; Pei, YX				Shen, Jiejie; Xing, Tongji; Yuan, Huihong; Liu, Zhiqiang; Jin, Zhuping; Zhang, Liping; Pei, Yanxi			Hydrogen Sulfide Improves Drought Tolerance in Arabidopsis thaliana by MicroRNA Expressions	PLOS ONE			English	Article							NITRIC-OXIDE; ABSCISIC-ACID; STRESS; PROTEIN; GERMINATION; RESISTANCE; ALFALFA; ENZYMES; GROWTH	Hydrogen sulfide (H2S) is a gasotransmitter and plays an important role in many physiological processes in mammals. Studies of its functions in plants are attracting ever growing interest, for example, its ability to enhance drought resistance in Arabidopsis. A general role of microRNAs (miRNAs) in plant adaptive responses to drought stress has thereby increased our interest to delve into the possible interplay between H2S and miRNAs. Our results showed that treating wild type (WT) Arabidopsis seedlings with polyethylene glycol 8000 (PEG8000) to simulate drought stress caused an increase in production rate of endogenous H2S; and a significant transcriptional reformation of relevant miRNAs, which were also triggered by exogenous H2S in WT. When lcd mutants (with lower H2S production rate than WT) were treated with PEG8000, they showed lower levels of miRNA expression changes than WT. In addition, we detected significant changes in target gene expression of those miRNAs and the corresponding phenotypes in lcd, including less roots, retardation of leaf growth and development and greater superoxide dismutase (SOD) activity under drought stress. We thereby conclude that H2S can improve drought resistance through regulating drought associated miRNAs in Arabidopsis.	[Shen, Jiejie; Yuan, Huihong; Liu, Zhiqiang; Jin, Zhuping; Zhang, Liping; Pei, Yanxi] Shanxi Univ, Sch Life Sci, Taiyuan, Shanxi, Peoples R China; [Shen, Jiejie] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xing, Tongji] Appalachian State Univ, Dept Biol, Boone, NC 28608 USA; [Jin, Zhuping] North Univ China, Sch Chem Engn & Environm, Taiyuan, Shanxi, Peoples R China	Shanxi University; Zhejiang University; University of North Carolina; Appalachian State University; North University of China	Pei, YX (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan, Shanxi, Peoples R China.	peiyanxi@sxu.edu.cn	Pei, Yanxi/H-1501-2016; Zhang, Li/GWM-7501-2022	Pei, Yanxi/0000-0002-8428-3399; 	Natural Science Foundation of China [31372085]; National Natural Science Foundation of China [31300236]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (31372085 to Yanxi Pei) and the National Natural Science Foundation of China (31300236 to Zhiqiang Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Alvarez C, 2010, PLANT PHYSIOL, V152, P656, DOI 10.1104/pp.109.147975; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen ZH, 2011, PLANT MOL BIOL, V77, P619, DOI 10.1007/s11103-011-9838-1; Du JF, 2009, SCI CHINA SER C, V52, P771, DOI 10.1007/s11427-009-0099-z; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; Frazier TP, 2011, MOL BIOTECHNOL, V49, P159, DOI 10.1007/s12033-011-9387-5; Goetz M, 2007, PLANT PHYSIOL, V145, P351, DOI 10.1104/pp.107.104174; Jay F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002035; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Jin ZP, 2013, PLANT PHYSIOL BIOCH, V62, P41, DOI 10.1016/j.plaphy.2012.10.017; Jin ZP, 2011, BIOCHEM BIOPH RES CO, V414, P481, DOI 10.1016/j.bbrc.2011.09.090; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Li L, 2012, BIOMETALS, V25, P617, DOI 10.1007/s10534-012-9551-9; Li ZG, 2012, PLANT SCI, V185, P185, DOI 10.1016/j.plantsci.2011.10.006; Lin RC, 2008, MOL PLANT, V1, P42, DOI 10.1093/mp/ssm004; Liu DM, 2009, PHYSIOL PLANTARUM, V136, P223, DOI 10.1111/j.1399-3054.2009.01229.x; Liu ZQ, 2012, J EXP BOT, V63, P6371, DOI 10.1093/jxb/ers293; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Papenbrock J, 2007, PLANT BIOLOGY, V9, P582, DOI 10.1055/s-2007-965424; Pei YX, 2007, PLANT PHYSIOL, V144, P1913, DOI 10.1104/pp.107.099531; Riemenschneider A, 2005, FEBS J, V272, P1291, DOI 10.1111/j.1742-4658.2005.04567.x; Scaramagli S, 1999, J PLANT PHYSIOL, V155, P122, DOI 10.1016/S0176-1617(99)80151-5; Shen JJ, 2012, J APPL MICROBIOL, V113, P1130, DOI 10.1111/j.1365-2672.2012.05408.x; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Wang BL, 2010, PLANTA, V231, P1301, DOI 10.1007/s00425-010-1134-9; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang YQ, 2012, PLANT SOIL, V351, P107, DOI 10.1007/s11104-011-0936-2; Xu J, 2010, PLANT PHYSIOL, V154, P1319, DOI 10.1104/pp.110.162982; Xu MJ, 2008, SCI CHINA SER C, V51, P676, DOI 10.1007/s11427-008-0095-8; Zeid IM, 2006, BIOL PLANTARUM, V50, P635, DOI 10.1007/s10535-006-0099-9; Zhang H, 2011, POSTHARVEST BIOL TEC, V60, P251, DOI 10.1016/j.postharvbio.2011.01.006; Zhang H, 2010, ACTA PHYSIOL PLANT, V32, P849, DOI 10.1007/s11738-010-0469-y; Zhu JJ, 2006, J FOREST RES-JPN, V11, P319, DOI 10.1007/s10310-006-0214-y	37	96	110	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77047	10.1371/journal.pone.0077047	http://dx.doi.org/10.1371/journal.pone.0077047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194857	Green Submitted, gold, Green Published			2022-12-27	WOS:000326037000036
J	Sirinukunwattana, K; Savage, RS; Bari, MF; Snead, DRJ; Rajpoot, NM				Sirinukunwattana, Korsuk; Savage, Richard S.; Bari, Muhammad F.; Snead, David R. J.; Rajpoot, Nasir M.			Bayesian Hierarchical Clustering for Studying Cancer Gene Expression Data with Unknown Statistics	PLOS ONE			English	Article							MOLECULAR CLASSIFICATION; PREDICTION; RECURRENCE; SURVIVAL	Clustering analysis is an important tool in studying gene expression data. The Bayesian hierarchical clustering (BHC) algorithm can automatically infer the number of clusters and uses Bayesian model selection to improve clustering quality. In this paper, we present an extension of the BHC algorithm. Our Gaussian BHC (GBHC) algorithm represents data as a mixture of Gaussian distributions. It uses normal-gamma distribution as a conjugate prior on the mean and precision of each of the Gaussian components. We tested GBHC over 11 cancer and 3 synthetic datasets. The results on cancer datasets show that in sample clustering, GBHC on average produces a clustering partition that is more concordant with the ground truth than those obtained from other commonly used algorithms. Furthermore, GBHC frequently infers the number of clusters that is often close to the ground truth. In gene clustering, GBHC also produces a clustering partition that is more biologically plausible than several other state-of-the-art methods. This suggests GBHC as an alternative tool for studying gene expression data. The implementation of GBHC is available at https://sites.google.com/site/gaussianbhc/	[Sirinukunwattana, Korsuk; Rajpoot, Nasir M.] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Savage, Richard S.] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Bari, Muhammad F.; Snead, David R. J.] Univ Hosp Coventry & Warwickshire, Dept Pathol, Coventry, W Midlands, England; [Bari, Muhammad F.; Snead, David R. J.] Warwick Med Sch, Div Reprod, Coventry, W Midlands, England; [Bari, Muhammad F.; Snead, David R. J.] Warwick Med Sch, Div Metab & Vasc Hlth, Coventry, W Midlands, England; [Rajpoot, Nasir M.] Qatar Univ, Dept Comp Sci & Engn, Doha, Qatar	University of Warwick; University of Warwick; University of Warwick; University of Warwick; University of Warwick; Qatar University	Rajpoot, NM (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	N.M.Rajpoot@warwick.ac.uk		Rajpoot, Nasir/0000-0002-4706-1308; SNEAD, DAVID/0000-0002-0766-9650; Sirinukunwattana, Korsuk/0000-0002-3603-4435	Qatar National Research Fund [NPRP5-1345-1-228]; Department of Computer Science, University of Warwick; Medical Research Council [G0902104]; Higher Education Commission; Dow University of Health Science, Pakistan; West Midlands Lung Tissue Consortium; MRC [G0902104] Funding Source: UKRI	Qatar National Research Fund(Qatar National Research Fund (QNRF)); Department of Computer Science, University of Warwick; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Higher Education Commission(Ministry of Higher Education & Scientific Research (MHESR)); Dow University of Health Science, Pakistan; West Midlands Lung Tissue Consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Korsuk Sirinukunwattana is partly funded by Qatar National Research Fund grant no. NPRP5-1345-1-228 and partly by the Department of Computer Science, University of Warwick. RSS acknowledges the support of an Medical Research Council Biostatistics Fellowship (G0902104). MFB acknowledges the support of Higher Education Commission and Dow University of Health Science, Pakistan. Funding for the collection of lung tissue was from the West Midlands Lung Tissue Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango D, 2005, GASTROENTEROLOGY, V129, P874, DOI 10.1053/j.gastro.2005.06.066; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Cooke EJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-399; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Datta S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-397; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; FERGUSON TS, 1973, ANN STAT, V1, P209, DOI 10.1214/aos/1176342360; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Ghahramani Z., 2005, P 22 INT C MACH LEAR, P297, DOI DOI 10.1145/1102351.1102389; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370, DOI 10.1109/TKDE.2004.68; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Laiho P, 2007, ONCOGENE, V26, P312, DOI 10.1038/sj.onc.1209778; Macnaughton-Smith PNM, 1965, SOME STAT OTHER NUME, V6; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Matsui S, 2008, STAT MED, V27, P1106, DOI 10.1002/sim.2997; McLachlan G, 2000, FINITE MIXTURE MODEL, V299; MCQUITTY LL, 1960, EDUC PSYCHOL MEAS, V20, P55, DOI 10.1177/001316446002000106; Neal RM, 2000, J COMPUT GRAPH STAT, V9, P249, DOI 10.2307/1390653; Nutt CL, 2003, CANCER RES, V63, P1602; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rasmussen C, 2000, ADV NEURAL INFORM PR, V12, P2; Rasmussen CE, 2009, IEEE ACM T COMPUT BI, V6, P615, DOI 10.1109/TCBB.2007.70269; Salvador S, 2004, PROC INT C TOOLS ART, P576; Savage RS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-242; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Sokal RR, 1963, PRINCIPLES NUMERICAL; Su AI, 2001, CANCER RES, V61, P7388; Van Der Maaten Laurens, 2009, ARTIF INTELL, P384; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wang YX, 2004, J CLIN ONCOL, V22, P1564, DOI 10.1200/JCO.2004.08.186; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Yao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045894; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977	43	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e75748	10.1371/journal.pone.0075748	http://dx.doi.org/10.1371/journal.pone.0075748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194826	gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000005
J	Snapp-Childs, W; Casserly, E; Mon-Williams, M; Bingham, GP				Snapp-Childs, Winona; Casserly, Elizabeth; Mon-Williams, Mark; Bingham, Geoffrey P.			Active Prospective Control Is Required for Effective Sensorimotor Learning	PLOS ONE			English	Article							ROBOT-ASSISTED THERAPY; MOTOR CONTROL; INTERCEPTIVE ACTIONS; VISUAL ANTICIPATION; MOVEMENT; CHILDREN; SYSTEM; MODEL; COORDINATION; STRATEGIES	Passive modeling of movements is often used in movement therapy to overcome disabilities caused by stroke or other disorders (e.g. Developmental Coordination Disorder or Cerebral Palsy). Either a therapist or, recently, a specially designed robot moves or guides the limb passively through the movement to be trained. In contrast, action theory has long suggested that effective skill acquisition requires movements to be actively generated. Is this true? In view of the former, we explicitly tested the latter. Previously, a method was developed that allows children with Developmental Coordination Disorder to produce effective movements actively, so as to improve manual performance to match that of typically developing children. In the current study, we tested practice using such active movements as compared to practice using passive movement. The passive movement employed, namely haptic tracking, provided a strong test of the comparison, one that showed that the mere inaction of the muscles is not the problem. Instead, lack of prospective control was. The result was no effective learning with passive movement while active practice with prospective control yielded significant improvements in performance.	[Snapp-Childs, Winona; Casserly, Elizabeth; Bingham, Geoffrey P.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Mon-Williams, Mark] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England	Indiana University System; Indiana University Bloomington; University of Leeds	Snapp-Childs, W (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	wsnappch@indiana.edu		Mon-Williams, Mark/0000-0001-7595-8545; Snapp-Childs, Winona/0000-0003-4354-7092	NIH NIDCD Training Grant [T32DC00012]; NIH NICHD [R01HD070832]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000012] Funding Source: NIH RePORTER	NIH NIDCD Training Grant; NIH NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH NIDCD Training Grant T32DC00012 and NIH NICHD R01HD070832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy B., 1987, PHYSICAL ED REV, V10, P5; Abernethy B, 1990, J SPORT SCI, V8, P17, DOI 10.1080/02640419008732128; Bastin J, 2006, HUM MOVEMENT SCI, V25, P718, DOI 10.1016/j.humov.2006.04.001; Beets IAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037687; BINGHAM GP, 1988, HUM MOVEMENT SCI, V7, P225, DOI 10.1016/0167-9457(88)90013-9; Bingham GP, 2011, J VIS, V11, P960; Clark F. J. a. H.. K. W., 1986, HDB PERCEPTION HUMAN, V1; Clark JE, 2005, J PHYS EDUC RECREAT, V76, P49, DOI 10.1080/07303084.2005.10608237; Cole J., 1995, PRIDE DAILY MARATHON; Culmer PR, 2011, J NEUROSCI METH, V197, P259, DOI 10.1016/j.jneumeth.2011.03.004; Dessing JC, 2002, NEURAL NETWORKS, V15, P163, DOI 10.1016/S0893-6080(01)00136-8; Farrow D, 2005, MOTOR CONTROL, V9, P332; Farrow D, 2003, PERCEPTION, V32, P1127, DOI 10.1068/p3323; FELDMAN AG, 1966, BIOPHYS-USSR, V11, P565; FELDMAN AG, 1986, J MOTOR BEHAV, V18, P17; FELDMAN AG, 1990, MULTIPLE MUSCLE SYST, P195, DOI DOI 10.1007/978-1-4613-9030-5_12; Feldman AG, 2009, EXP BRAIN RES, V194, P39, DOI 10.1007/s00221-008-1667-3; Goodwin G M, 1976, Exerc Sport Sci Rev, V4, P87; Hildreth EC, 2000, J EXP PSYCHOL HUMAN, V26, P1106, DOI 10.1037//0096-1523.26.3.1106; HOGAN N, 1987, EXERCISE SPORT SCI R, V15, P153; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; Hogan N., 1990, MULTIPLE MUSCLE SYST, P149, DOI [10.1007/978-1-4613-9030-5_9, DOI 10.1007/978-1-4613-9030-5_9]; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; LAND M, 1995, NATURE, V377, P339, DOI 10.1038/377339a0; Latash M., 1993, CONTROL HUMAN MOVEME; Latash ML, 2012, FUNDAMENTALS OF MOTOR CONTROL, P1; Latash ML, 1996, PROGR MOTOR CONTROL, P289; Lee DN, 1993, ECOLOGICAL INTERPERS, P68; Liu J, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-20; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Marchal-Crespo L, 2010, EXP BRAIN RES, V201, P209, DOI 10.1007/s00221-009-2026-8; Marchal-Crespo L, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-20; MCCLOSKEY DI, 1978, PHYSIOL REV, V58, P763, DOI 10.1152/physrev.1978.58.4.763; McCloskey DI, 1980, SPINAL SUPRASPINAL M; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Milot MH, 2010, EXP BRAIN RES, V201, P119, DOI 10.1007/s00221-009-2014-z; Montagne G, 2005, INT J SPORT PSYCHOL, V36, P127; Montagne G, 2008, INT J SPORT PSYCHOL, V39, P149; NEWELL KM, 1991, ANNU REV PSYCHOL, V42, P213, DOI 10.1146/annurev.ps.42.020191.001241; Pedhazur E. J., 1982, MULTIPLE REGRESSION; POULTON EC, 1957, PSYCHOL BULL, V54, P467, DOI 10.1037/h0045515; Reinkensmeyer DJ, 2009, EXERC SPORT SCI REV, V37, P43, DOI 10.1097/JES.0b013e3181912108; Salvucci DD, 2004, PERCEPTION, V33, P1233, DOI 10.1068/p5343; Smits-Engelsman BCM, 2001, HUM MOVEMENT SCI, V20, P161, DOI 10.1016/S0167-9457(01)00033-1; Snapp-Childs W, 2013, J CHILD NEUROL, V28, P204, DOI 10.1177/0883073812461945; Studenka BE, 2013, J EXP PSYCHOL HUMAN, V39, P1557, DOI 10.1037/a0031744; Swinnen S., 1996, ADV MOTOR LEARNING C; Turvey M. T., 1992, ECOL PSYCHOL, V4, P173, DOI [10.1207/s15326969eco0403_3, DOI 10.1207/S15326969EC00403_]; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; Van der Kamp J, 2008, INT J SPORT PSYCHOL, V39, P100; VONHOFSTEN C, 1993, HUM DEV, V36, P253, DOI 10.1159/000278212; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; Weightman A, 2011, J REHABIL MED, V43, P359, DOI 10.2340/16501977-0679; Wilkie RM, 2010, EXP BRAIN RES, V204, P539, DOI 10.1007/s00221-010-2321-4; Wolpert DM, 2010, CURR BIOL, V20, pR467, DOI 10.1016/j.cub.2010.04.035; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wong JD, 2012, J NEUROPHYSIOL, V108, P3313, DOI 10.1152/jn.00122.2012	58	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77609	10.1371/journal.pone.0077609	http://dx.doi.org/10.1371/journal.pone.0077609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194891	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000070
J	Wang, HQ; Tsai, CJ				Wang, Hong-Qiang; Tsai, Chung-Jui			CorSig: A General Framework for Estimating Statistical Significance of Correlation and Its Application to Gene Co-Expression Analysis	PLOS ONE			English	Article							FALSE DISCOVERY RATE; REGULATORY NETWORKS; POPULUS-TRICHOCARPA; EXPRESSION; CONSERVATION; REGRESSION	With the rapid increase of omics data, correlation analysis has become an indispensable tool for inferring meaningful associations from a large number of observations. Pearson correlation coefficient (PCC) and its variants are widely used for such purposes. However, it remains challenging to test whether an observed association is reliable both statistically and biologically. We present here a new method, CorSig, for statistical inference of correlation significance. CorSig is based on a biology-informed null hypothesis, i.e., testing whether the true PCC (rho) between two variables is statistically larger than a user-specified PCC cutoff (t), as opposed to the simple null hypothesis of rho = 0 in existing methods, i.e., testing whether an association can be declared without a threshold. CorSig incorporates Fisher's Z transformation of the observed PCC (r), which facilitates use of standard techniques for p-value computation and multiple testing corrections. We compared CorSig against two methods: one uses a minimum PCC cutoff while the other (Zhu's procedure) controls correlation strength and statistical significance in two discrete steps. CorSig consistently outperformed these methods in various simulation data scenarios by balancing between false positives and false negatives. When tested on real-world Populus microarray data, CorSig effectively identified co-expressed genes in the flavonoid pathway, and discriminated between closely related gene family members for their differential association with flavonoid and lignin pathways. The rho-values obtained by CorSig can be used as a stand-alone parameter for stratification of co-expressed genes according to their correlation strength in lieu of an arbitrary cutoff. CorSig requires one single tunable parameter, and can be readily extended to other correlation measures. Thus, CorSig should be useful for a wide range of applications, particularly for network analysis of high-dimensional genomic data.	[Wang, Hong-Qiang] Chinese Acad Sci, Intelligent Comp Lab, Hefei Inst Phys Sci, Hefei, Peoples R China; [Tsai, Chung-Jui] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Tsai, Chung-Jui] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Wang, HQ (corresponding author), Chinese Acad Sci, Intelligent Comp Lab, Hefei Inst Phys Sci, Hefei, Peoples R China.	hqwang126@126.com; cjtsai@uga.edu	Tsai, CJ/C-2450-2009	Tsai, CJ/0000-0002-9282-7704	National Science Foundation of China [61133010, 61374181, 31271412, 61272339, 30900321]; K. C. Wong Education Foundation; Anhui Provincial Natural Science Foundation [1208085MF96]; U.S. National Science Foundation Plant Genome grant [DBI-0836433]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); K. C. Wong Education Foundation; Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); U.S. National Science Foundation Plant Genome grant	This work was supported by the National Science Foundation of China grant 61133010, 61374181, 31271412, 61272339 and 30900321, by K. C. Wong Education Foundation, by Anhui Provincial Natural Science Foundation grant 1208085MF96, and by the U.S. National Science Foundation Plant Genome grant DBI-0836433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Almaas E, 2007, J EXP BIOL, V210, P1548, DOI 10.1242/jeb.003731; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; [Anonymous], 2006, NAT BIOTECHNOL, V24, P1039, DOI 10.1038/nbt0906-1039; Barndorff-Nielson OE, 1989, ASYMPTOTIC TECHNIQUE; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bevington P. R., 2003, DATA REDUCTION ERROR, DOI 10.2307/2284752; Brazhnik P, 2002, TRENDS BIOTECHNOL, V20, P467, DOI 10.1016/S0167-7799(02)02053-X; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Cox DR, 1974, THEORETICAL STAT; Croxton FE, 1968, APPL GEN STAT; Davidson EH, 2006, REG GEN GEN REG; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Efron B, 2008, STAT SCI, V23, P1, DOI 10.1214/07-STS236; Emmert-Streib Frank, 2012, Frontiers in Genetics, V3, P8, DOI [10.3389/fgene.2012.00313, 10.3389/fgene.2012.00008]; Fisher R, 1921, METRON, V1, P1, DOI DOI 10.1093/BIOMET/9.1-2.22; Fisher RA, 1914, BIOMETRIKA, V10, P507; GAYEN AK, 1951, BIOMETRIKA, V38, P219, DOI 10.1093/biomet/38.1-2.219; Hamberger B, 2007, CAN J BOT, V85, P1182, DOI 10.1139/B07-098; Hardin J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-220; Harding SA, 2002, PLANT PHYSIOL, V128, P428, DOI 10.1104/pp.010603; HAWKINS DL, 1989, AM STAT, V43, P235, DOI 10.2307/2685369; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Hu WJ, 1998, P NATL ACAD SCI USA, V95, P5407, DOI 10.1073/pnas.95.9.5407; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Loscalzo Joseph, 2011, Proc Am Thorac Soc, V8, P196, DOI 10.1513/pats.201006-041MS; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Morrison JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-233; Nagarajan R, 2006, IEEE ACM T COMPUT BI, V3, P232, DOI 10.1109/TCBB.2006.30; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Pan KH, 2005, P NATL ACAD SCI USA, V102, P8961, DOI 10.1073/pnas.0502674102; Rahman N.A., 1968, COURSE THEORETICAL S; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Rogers S, 2005, BIOINFORMATICS, V21, P3131, DOI 10.1093/bioinformatics/bti487; Ryan T., 1997, MODERN REGRESSION ME; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; Stoughton RB, 2005, ANN REV BIOCH, P74; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Wang Y, 2005, COMPUT BIOL CHEM, V29, P37, DOI 10.1016/j.compbiolchem.2004.11.001; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Werhli AV, 2006, BIOINFORMATICS, V22, P2523, DOI 10.1093/bioinformatics/btl391; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yuan YA, 2009, P NATL ACAD SCI USA, V106, P22020, DOI 10.1073/pnas.0906869106; Zampieri M, 2008, BIOINFORMATICS, V24, P1510, DOI 10.1093/bioinformatics/btn220; Zhu DX, 2007, BIOINFORMATICS, V23, P2298, DOI 10.1093/bioinformatics/btm328; Zhu DX, 2005, J COMPUT BIOL, V12, P1029, DOI 10.1089/cmb.2005.12.1029	52	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77429	10.1371/journal.pone.0077429	http://dx.doi.org/10.1371/journal.pone.0077429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194884	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000063
J	Cranz-Mileva, S; Pamula, MC; Barua, B; Desai, B; Hong, YH; Russell, J; Trent, R; Wang, JQ; Walworth, NC; Hitchcock-DeGregori, SE				Cranz-Mileva, Susanne; Pamula, Melissa C.; Barua, Bipasha; Desai, Brinda; Hong, Yaejee Hannah; Russell, Jacquelyn; Trent, Richard; Wang, Jianqiu; Walworth, Nancy C.; Hitchcock-DeGregori, Sarah E.			A Molecular Evolution Approach to Study the Roles of Tropomyosin in Fission Yeast	PLOS ONE			English	Article							F-ACTIN CABLES; CONTRACTILE-RING; SCHIZOSACCHAROMYCES-POMBE; MYOSIN-II; SPATIAL REGULATION; BINDING-SITES; DIVISION SITE; CYTOKINESIS; PROTEIN; FORMIN	Tropomyosin, a coiled-coil protein that binds along the length of the actin filament, is a universal regulator of the actin cytoskeleton. We have taken a bioinformatics/proteomic approach to studying structure-function relationships in this protein. The presence of a single, essential tropomyosin gene, cdc8, in fission yeast, Schizosaccharomyces pombe, enables a systems-based approach to define the residues that are important for cellular functions. Using molecular evolution methodologies we identified the most conserved residues and related them to the coiled coil structure. Mutants in which one or more of 21 of the most conserved surface residues was mutated to Ala were tested for the ability to rescue growth of a temperature-sensitive cdc8 mutant when overexpressed at the restrictive temperature. Based on altered morphology of the septum and actin cytoskeleton, we selected three sets of mutations for construction of mutant cdc8 strains using marker reconstitution mutagenesis and analysis of recombinant protein in vitro: D16A.K30A, V114S.E117A.H118A and R121A.D131A.E138A. The mutations have sequence-specific effects on cellular morphology including cell length, organization of cytoskeletal structures (actin patches, actin cables and contractile rings), and in vitro actin affinity, lending credence to the proteomic approach introduced here. We propose that bioinformatics is a valid analysis tool for defining structure-function relationships in conserved proteins in this model organism.	[Cranz-Mileva, Susanne; Pamula, Melissa C.; Barua, Bipasha; Desai, Brinda; Hong, Yaejee Hannah; Russell, Jacquelyn; Trent, Richard; Wang, Jianqiu; Hitchcock-DeGregori, Sarah E.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA; [Walworth, Nancy C.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Hitchcock-DeGregori, SE (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA.	hitchcoc@rwjms.rutgers.edu		Russell, Jacquelyn/0000-0001-9928-2869; Walworth, Nancy/0000-0001-5940-8236; Pamula, Melissa/0000-0002-8010-9975	NIH [RO1 GM093065, GM53194]; Aresty Center for Undergraduate Research at Rutgers University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093065] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aresty Center for Undergraduate Research at Rutgers University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH RO1 GM093065 to SEHD and GM53194 to NCW. MCP, YHH, JR and RT received support from the Aresty Center for Undergraduate Research at Rutgers University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; [Anonymous], 2006, THESIS U TEXAS AUSTI; Arai R, 2002, J CELL SCI, V115, P887; Arai R, 1998, EUR J CELL BIOL, V76, P288, DOI 10.1016/S0171-9335(98)80007-1; Aylett CHS, 2011, INT REV CEL MOL BIO, V292, P1, DOI 10.1016/B978-0-12-386033-0.00001-3; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Balasubramanian MK, 1998, GENETICS, V149, P1265; Barua B, 2013, J BIOL CHEM, V288, P9602, DOI 10.1074/jbc.M113.451161; Barua B, 2012, P NATL ACAD SCI USA, V109, P18425, DOI 10.1073/pnas.1212754109; Barua B, 2011, P NATL ACAD SCI USA, V108, P10150, DOI 10.1073/pnas.1101221108; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97, DOI 10.1038/newbio238097a0; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 1996, PROTEINS, V26, P134; Chang F, 1996, J CELL SCI, V109, P131; Clayton JE, 2010, CURR BIOL, V20, P1423, DOI 10.1016/j.cub.2010.07.026; Coulton AT, 2010, J CELL SCI, V123, P3235, DOI 10.1242/jcs.069971; DesMarais V, 2002, J CELL SCI, V115, P4649, DOI 10.1242/jcs.00147; East DA, 2011, BIOCHEM J, V438, P265, DOI 10.1042/BJ20101316; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FANNING AS, 1994, CELL MOTIL CYTOSKEL, V29, P29, DOI 10.1002/cm.970290104; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Forsburg Susan L, 2003, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1317s64; Greenfield NJ, 1995, BIOCHEMISTRY-US, V34, P16797, DOI 10.1021/bi00051a030; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Hammell RL, 1996, J BIOL CHEM, V271, P4236; HEALD RW, 1988, J BIOL CHEM, V263, P5254; Hitchcock-De Gregori SE, 1982, J BIOL CHEM, V257, P8; HITCHCOCKDEGREGORI SE, 1987, J BIOL CHEM, V262, P9730; Hodges AR, 2012, CURR BIOL, V22, P1410, DOI 10.1016/j.cub.2012.05.035; Huang JQ, 2012, J CELL BIOL, V199, P831, DOI 10.1083/jcb.201209044; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jockusch BM, 2011, REV PHYSIOL BIOCH P, V161, P67, DOI 10.1007/112_2011_1; KANTERSMOLER G, 1994, BIOTECHNIQUES, V16, P798; Kovar DR, 2011, TRENDS CELL BIOL, V21, P177, DOI 10.1016/j.tcb.2010.11.001; Kurahashi H, 2002, GENES CELLS, V7, P375, DOI 10.1046/j.1365-2443.2002.00526.x; Laporte D, 2011, J CELL BIOL, V192, P1005, DOI 10.1083/jcb.201008171; Lee IJ, 2012, CYTOSKELETON, V69, P751, DOI 10.1002/cm.21052; Lees JG, 2011, CELL ADHES MIGR, V5, P181, DOI 10.4161/cam.5.2.14438; LEHRER SS, 1982, J BIOL CHEM, V257, P8073; LI XE, BIOPHYS J, V100, P1005; Ma B, 2013, TOP CURR CHEM; Maytum R, 2000, BIOCHEMISTRY-US, V39, P11913, DOI 10.1021/bi000977g; Mishra M, 2013, NAT CELL BIOL, V15, P853, DOI 10.1038/ncb2781; MITCHISON JM, 1985, J CELL SCI, V75, P357; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Motegi F, 2000, J CELL SCI, V113, P1813; Motegi F, 2004, J CELL BIOL, V165, P685, DOI 10.1083/jcb.200402097; Nakano K, 2006, GENES CELLS, V11, P893, DOI 10.1111/j.1365-2443.2006.00987.x; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; Padmanabhan A, 2011, CURR BIOL, V21, P467, DOI 10.1016/j.cub.2011.01.059; Paoletti A, 2000, MOL BIOL CELL, V11, P2757, DOI 10.1091/mbc.11.8.2757; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rasband W., 2006, IMAGEJ; Rincon SA, 2012, CYTOSKELETON, V69, P764, DOI 10.1002/cm.21056; Sambrook J., 2001, MOL CLONING LAB MANU; Skau CT, 2009, MOL BIOL CELL, V20, P2160, DOI 10.1091/mbc.E08-12-1201; Skoumpla K, 2007, J CELL SCI, V120, P1635, DOI 10.1242/jcs.001115; Stark BC, 2010, MOL BIOL CELL, V21, P989, DOI 10.1091/mbc.E09-10-0852; Strand J, 2001, J BIOL CHEM, V276, P34832, DOI 10.1074/jbc.M104750200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Subramanian D, 2013, GENETICS; Sveiczer A, 1996, J CELL SCI, V109, P2947; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tang X, 2006, J CELL BIOL, V173, P845, DOI 10.1083/jcb.200602152; Tang X, 2011, YEAST, V28, P205, DOI 10.1002/yea.1831; Ujfalusi Z, 2012, J BIOL CHEM, V287, P31894, DOI 10.1074/jbc.M112.341230; Ujfalusi Z, 2009, BIOPHYS J, V96, P162, DOI 10.1529/biophysj.108.138420; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2; Wawro B, 2007, BIOCHEMISTRY-US, V46, P8146, DOI 10.1021/bi700686p; Win TZ, 2001, J CELL SCI, V114, P69; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yonetani A, 2008, MOL BIOL CELL, V19, P2208, DOI 10.1091/mbc.E07-07-0731; Yonetani A, 2010, CURR BIOL, V20, P561, DOI 10.1016/j.cub.2010.01.061	81	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76726	10.1371/journal.pone.0076726	http://dx.doi.org/10.1371/journal.pone.0076726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167549	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500008
J	Tamburlini, G; Yadgarova, K; Kamilov, A; Bacci, A				Tamburlini, Giorgio; Yadgarova, Klara; Kamilov, Asamidin; Bacci, Alberta		Maternal Neonatal Care Quality	Improving the Quality of Maternal and Neonatal Care: the Role of Standard Based Participatory Assessments	PLOS ONE			English	Article							HOSPITAL-CARE; CHILDREN; MORTALITY; REVIEWS; HEALTH	Background: Gaps in quality of care are seriously affecting maternal and neonatal health globally but reports of successful quality improvement cycles implemented at large scale are scanty. We report the results of a nation-wide program to improve quality of maternal and neonatal hospital care in a lower-middle income country focusing on the role played by standard-based participatory assessments. Methods: Improvements in the quality of maternal and neonatal care following an action-oriented participatory assessment of 19 areas covering the whole continuum from admission to discharge were measured after an average period of 10 months in four busy referral maternity hospitals in Uzbekistan. Information was collected by a multidisciplinary national team with international supervision through visit to hospital services, examination of medical records, direct observation of cases and interviews with staff and mothers. Scores (range 0 to 3) attributed to over 400 items and combined in average scores for each area were compared with the baseline assessment. Results: Between the first and the second assessment, all four hospitals improved their overall score by an average 0.7 points out of 3 (range 0.4 to 1), i.e. by 22%. The improvements occurred in all main areas of care and were greater in the care of normal labor and delivery (+0.9), monitoring, infection control and mother and baby friendly care (+0.8) the role of the participatory action-oriented approach in determining the observed changes was estimated crucial in 6 out of 19 areas and contributory in other 8. Ongoing implementation of referral system and new classification of neonatal deaths impede the improved process of care to be reflected in current statistics. Conclusions: Important improvements in the quality of hospital care provided to mothers and newborn babies can be achieved through a standard-based action-oriented and participatory assessment and reassessment process.	[Tamburlini, Giorgio; Bacci, Alberta] European Sch Maternal Neonatal Child & Adolescent, Trieste, Italy; [Yadgarova, Klara] Tashkent Inst Postgrad Med Educ, Tashkent, Uzbekistan; [Kamilov, Asamidin] Minist Publ Hlth Republ Uzbekistan, Tashkent, Uzbekistan		Tamburlini, G (corresponding author), European Sch Maternal Neonatal Child & Adolescent, Trieste, Italy.	tamburlini@csbonlus.org			World Health Organization, Regional Office for Europe; UNITED Nations Children's Fund, Regional Office for Central and Eastern Europe; European Commission	World Health Organization, Regional Office for Europe; UNITED Nations Children's Fund, Regional Office for Central and Eastern Europe; European Commission(European CommissionEuropean Commission Joint Research Centre)	Funding was provided by: World Health Organization, Regional Office for Europe; UNITED Nations Children's Fund, Regional Office for Central and Eastern Europe; the European Commission. One of the authors ( AB) was regional coordinator for Making Pregnancy Safer at the WHO Regional Office for Europe until June 2011. The funding sources played no role in study design, collection and analysis of data and preparation of the manuscript.	[Anonymous], 2005, WHAT ARE ADV LIMITAT; Bacci A, 2007, REPROD HEALTH MATTER, V15, P145, DOI 10.1016/S0968-8080(07)30334-0; Boschi-Pinto C, 2010, INT J EPIDEMIOL, V39, P3, DOI 10.1093/ije/dyq018; Campbell H, 2008, PEDIATRICS, V121, pE984, DOI 10.1542/peds.2007-1395; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cattaneo A, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-5; Duke T, 2006, LANCET, V367, P919, DOI 10.1016/S0140-6736(06)68382-7; Gabrysch S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001340; Graham WJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001368; Lawn J, 2013, HLTH NEWBORN; Legido-Quigley H, 2008, ASSURING QUALITY HLT; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Save the Children, 2012, M REP; Soto EJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001282; Srofenyoh E, 2012, INT J GYNECOL OBSTET, V116, P17, DOI 10.1016/j.ijgo.2011.08.010; Tamburlini G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028763; United Nations Secretary General, 2010, GLOB STRAT WOM CHILD; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; WHO, 2013, EUR STRAT APPR MAK P; WHO, 2010, HLTH ALL DAT BAS; WHO, 2010, TRENDS MAT MORT, P1990; WHO, 2006, IMPAC PREGN CHILDB P; WHO Regional Office for Europe, 2013, MAK PREGN SAF ASS TO; WHO United Nations Population Fund Unicef World Bank, 2003, MAN COMPL PREGN CHIL; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2003, MAN NEWB PROBL GUID; World Health Organization, 2013, LONDON SCH HYGIENE T	27	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78282	10.1371/journal.pone.0078282	http://dx.doi.org/10.1371/journal.pone.0078282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167616	Green Published, gold, Green Submitted			2022-12-27	WOS:000326034500077
J	Trevaskis, JL; Mack, CM; Sun, CZ; Soares, CJ; D'Souza, LJ; Levy, OE; Lewis, DY; Jodka, CM; Tatarkiewicz, K; Gedulin, B; Gupta, S; Wittmer, C; Hanley, M; Forood, B; Parkes, DG; Ghosh, SS				Trevaskis, James L.; Mack, Christine M.; Sun, Chengzao; Soares, Christopher J.; D'Souza, Lawrence J.; Levy, Odile E.; Lewis, Diane Y.; Jodka, Carolyn M.; Tatarkiewicz, Krystyna; Gedulin, Bronislava; Gupta, Swati; Wittmer, Carrie; Hanley, Michael; Forood, Bruce; Parkes, David G.; Ghosh, Soumitra S.			Improved Glucose Control and Reduced Body Weight in Rodents with Dual Mechanism of Action Peptide Hybrids	PLOS ONE			English	Article							NATIVE CHEMICAL LIGATION; DIET-INDUCED OBESITY; FOOD-INTAKE; EXENATIDE EXENDIN-4; GLYCEMIC CONTROL; LEPTIN RESPONSIVENESS; REPERFUSION INJURY; TREATED PATIENTS; AMYLIN AGONISM; TYPE-2	Combination therapy is being increasingly used as a treatment paradigm for metabolic diseases such as diabetes and obesity. In the peptide therapeutics realm, recent work has highlighted the therapeutic potential of chimeric peptides that act on two distinct receptors, thereby harnessing parallel complementary mechanisms to induce additive or synergistic benefit compared to monotherapy. Here, we extend this hypothesis by linking a known antidiabetic peptide with an anti-obesity peptide into a novel peptide hybrid, which we termed a phybrid. We report on the synthesis and biological activity of two such phybrids (AC164204 and AC164209), comprised of a glucagon-like peptide-1 receptor (GLP1-R) agonist, and exenatide analog, AC3082, covalently linked to a second generation amylin analog, davalintide. Both molecules acted as full agonists at their cognate receptors in vitro, albeit with reduced potency at the calcitonin receptor indicating slightly perturbed amylin agonism. In obese diabetic Lep(ob)/Lep(ob) mice sustained infusion of AC164204 and AC164209 reduced glucose and glycated haemoglobin (Hb(A1c)) equivalently but induced greater weight loss relative to exenatide administration alone. Weight loss was similar to that induced by combined administration of exenatide and davalintide. In diet-induced obese rats, both phybrids dose-dependently reduced food intake and body weight to a greater extent than exenatide or davalintide alone, and equal to co-infusion of exenatide and davalintide. Phybrid-mediated and exenatide + davalintide-mediated weight loss was associated with reduced adiposity and preservation of lean mass. These data are the first to provide in vivo proof-of-concept for multi-pathway targeting in metabolic disease via a peptide hybrid, demonstrating that this approach is as effective as co-administration of individual peptides.	[Trevaskis, James L.; Mack, Christine M.; Sun, Chengzao; Soares, Christopher J.; D'Souza, Lawrence J.; Levy, Odile E.; Lewis, Diane Y.; Jodka, Carolyn M.; Tatarkiewicz, Krystyna; Gedulin, Bronislava; Gupta, Swati; Wittmer, Carrie; Hanley, Michael; Forood, Bruce; Parkes, David G.; Ghosh, Soumitra S.] Amylin Pharmaceut LLC, San Diego, CA USA		Ghosh, SS (corresponding author), Amylin Pharmaceut LLC, San Diego, CA USA.	Soumitra.Ghosh@bms.com	Soares, Carlos José/D-2126-2013	Soares, Carlos José/0000-0002-8830-605X; Trevaskis, James/0000-0002-5356-6118	Amylin Pharmaceuticals, LLC	Amylin Pharmaceuticals, LLC(Bristol-Myers Squibb)	This research was entirely funded by Amylin Pharmaceuticals, LLC. All authors were employed by and were shareholders in Amylin Pharmaceuticals during the study period. Patents filed or issued: United States Patent No 8,076,288, (Hybrid polypeptides having glucose lowering activity). There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Astrup A, 2013, INT J OBESITY, V37, P322, DOI 10.1038/ijo.2012.192; Bello NT, 2010, AM J PHYSIOL-REG I, V299, pR945, DOI 10.1152/ajpregu.00275.2010; Bhavsar S, 1998, PHYSIOL BEHAV, V64, P557, DOI 10.1016/S0031-9384(98)00110-3; Bunck MC, 2009, DIABETES CARE, V32, P762, DOI 10.2337/dc08-1797; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Claus TH, 2007, J ENDOCRINOL, V192, P371, DOI 10.1677/JOE-06-0018; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; Day JW, 2012, BIOPOLYMERS, V98, P443, DOI 10.1002/bip.22072; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Drucker DJ, 2005, NAT CLIN PRACT ENDOC, V1, P22, DOI 10.1038/ncpendmet0017; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Hackeng TM, 1999, P NATL ACAD SCI USA, V96, P10068, DOI 10.1073/pnas.96.18.10068; Heal DJ, 2013, INT J OBESITY, V37, P107, DOI 10.1038/ijo.2012.26; Howes LG, 2000, DIABETES OBES METAB, V2, P67, DOI 10.1046/j.1463-1326.2000.00047.x; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Klonoff DC, 2008, CURR MED RES OPIN, V24, P275, DOI 10.1185/030079908X253870; Laugero KD, 2009, METAB SYNDR RELAT DI; Mack CM, 2010, INT J OBESITY, V34, P385, DOI 10.1038/ijo.2009.238; Parkes DG, 2001, METABOLISM, V50, P583, DOI 10.1053/meta.2001.22519; Pocai A, 2009, DIABETES, V58, P2258, DOI 10.2337/db09-0278; Ravussin E, 2009, OBESITY, V17, P1736, DOI 10.1038/oby.2009.184; Resnick HE, 2006, DIABETES CARE, V29, P531, DOI 10.2337/diacare.29.03.06.dc05-1254; Roth JD, 2012, DIABETES OBES METAB, V14, P608, DOI 10.1111/j.1463-1326.2012.01570.x; Roth JD, 2008, INT J OBES LOND; Roth JD, 2008, P NATL ACAD SCI USA, V105, P7257, DOI 10.1073/pnas.0706473105; Roth JD, 2007, ENDOCRINOLOGY, V148, P6054, DOI 10.1210/en.2007-0898; Roth JD, 2012, BRIT J PHARMACOL, V166, P121, DOI 10.1111/j.1476-5381.2011.01537.x; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Smith SR, 2008, DIABETES CARE, V31, P1816, DOI 10.2337/dc08-0029; Sonne DP, 2008, REGUL PEPTIDES, V146, P243, DOI 10.1016/j.regpep.2007.10.001; Timmers L, 2009, J AM COLL CARDIOL, V53, P501, DOI 10.1016/j.jacc.2008.10.033; Trevaskis JL, 2008, ENDOCRINOLOGY, V149, P5679, DOI 10.1210/en.2008-0770; Trevaskis JL, 2010, PHYSIOL BEHAV, V100, P187, DOI 10.1016/j.physbeh.2010.02.023; Turner R, 1999, LANCET, V354, P600, DOI 10.1016/S0140-6736(05)77957-5; Weyer C, 2001, CURR PHARM DESIGN, V7, P1353, DOI 10.2174/1381612013397357; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Young A., 2005, AMYLIN PHYSL PHARM	42	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78154	10.1371/journal.pone.0078154	http://dx.doi.org/10.1371/journal.pone.0078154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167604	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500064
J	Unlu, I; Farajollahi, A; Strickman, D; Fonseca, DM				Unlu, Isik; Farajollahi, Ary; Strickman, Daniel; Fonseca, Dina M.			Crouching Tiger, Hidden Trouble: Urban Sources of Aedes albopictus (Diptera: Culicidae) Refractory to Source-Reduction	PLOS ONE			English	Article							TIRE-BREEDING MOSQUITOS; CULEX-PIPIENS DIPTERA; GEOGRAPHIC-DISTRIBUTION; SPATIAL-DISTRIBUTION; MANAGEMENT PROGRAM; PUPAL SURVEY; AEGYPTI; DENGUE; VECTOR; SITES	Our ultimate objective is to design cost-effective control strategies for Aedes albopictus, the Asian tiger mosquito, an important urban nuisance and disease vector that expanded worldwide during the last 40 years. We conducted mosquito larval surveys from May through October 2009 in the City of Trenton, New Jersey, USA, while performing intensive monthly source-reduction campaigns that involved removing, emptying, or treating all accessible containers with larvicides and pupicides. We examined patterns of occurrence of Ae. albopictus and Culex pipiens, another urban mosquito, among different container types by comparing observed and expected number of positive containers of each type. Expected use was based on the relative frequency of each container type in the environment. Aedes albopictus larvae and pupae were found significantly more often than expected in medium volumes of water in buckets and plant saucers but were rarely collected in small volumes of water found in trash items such as discarded cups and cans. They were also absent from large volumes of water such as in abandoned swimming pools and catch basins, although we consistently collected Cx. pipiens from those habitats. The frequency of Ae. albopictus in tires indicated rapid and extensive use of these ubiquitous urban containers. Standard larval-based indices did not correlate with adult catches in BG-Sentinel traps, but when based only on Ae. albopictus key containers (buckets, plant saucers, equipment with pockets of water, and tires) they did. Although we found that only 1.2% of the 20,039 water-holding containers examined contained immature Ae. albopictus (5.3% if only key containers were counted), adult populations were still above nuisance action thresholds six times during the 2009 mosquito season. We conclude that in urban New Jersey, effective source reduction for Ae. albopictus control will require scrupulous and repeated cleaning or treatment of everyday use containers and extensive homeowner collaboration.	[Unlu, Isik; Farajollahi, Ary; Fonseca, Dina M.] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA; [Unlu, Isik; Farajollahi, Ary] Mercer Cty Mosquito Control, West Trenton, NJ USA; [Strickman, Daniel] ARS, USDA, Off Natl Programs, Beltsville, MD USA	Rutgers State University New Brunswick; United States Department of Agriculture (USDA)	Fonseca, DM (corresponding author), Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA.	dinafons@rci.rutgers.edu	Fonseca, Dina Madeira/B-9951-2011; Fonseca, Dina/HHS-1320-2022	Fonseca, Dina Madeira/0000-0003-4726-7100; 	USDA; Rutgers University [USDA-ARS-58-6615-8-105]	USDA(United States Department of Agriculture (USDA)); Rutgers University	This work was funded by a cooperative Agreement between USDA and Rutgers University (USDA-ARS-58-6615-8-105) entitled "Area-wide Pest Management Program for the Asian Tiger Mosquito in New Jersey." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMERASINGHE FP, 1984, INSECT SCI APPL, V5, P493, DOI 10.1017/S1742758400004926; Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031; Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358; Bartlett-Healy K, 2011, J MED ENTOMOL, V48, P712, DOI 10.1603/ME10168; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Carrieri M, 2003, ENVIRON ENTOMOL, V32, P1313, DOI 10.1603/0046-225X-32.6.1313; Carrieri M, 2011, J MED ENTOMOL, V48, P1214, DOI 10.1603/ME10230; Costanzo KS, 2005, J MED ENTOMOL, V42, P559, DOI 10.1603/0022-2585(2005)042[0559:ACAPOA]2.0.CO;2; Crans WJ, 1996, J AM MOSQUITO CONTR, V12, P307; Crepeau TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060524; Darsie RFJ, 2005, IDENTIFICATION GEOGR; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Edillo FE, 2012, SE ASIAN J TROP MED, V43, P1365; ESTRADAFRANCO JG, 1995, BIOL DIS RELATIONSHI, V42, P1; FARAJOLLAHI A, 2013, J AM MOSQ C IN PRESS; Farajollahi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049181; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Farajollahi A, 2009, J MED ENTOMOL, V46, P1220, DOI 10.1603/033.046.0533; Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Halasa YA, 2012, J AM MOSQUITO CONTR, V28, P225, DOI 10.2987/12-6243R.1; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Kaplan L, 2010, BIOL INVASIONS, V12, P3277, DOI 10.1007/s10530-010-9721-z; Kawada H, 2010, JPN J INFECT DIS, V63, P19; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Maciel-de-Freitas R, 2011, TROP MED INT HEALTH, V16, P965, DOI 10.1111/j.1365-3156.2011.02797.x; MADDER DJ, 1980, CAN ENTOMOL, V112, P173, DOI 10.4039/Ent112173-2; Manrique-Saide P, 2008, J AM MOSQUITO CONTR, V24, P289, DOI 10.2987/5578.1; Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309; Nelder M, 2010, AM J TROP MED HYG, V82, P831, DOI 10.4269/ajtmh.2010.09-0546; Obenauer PJ, 2009, J MED ENTOMOL, V46, P900, DOI 10.1603/033.046.0424; Preechaporn W., 2006, Dengue Bulletin, V30, P204; Qualls WA, 2006, J AM MOSQUITO CONTR, V22, P601, DOI 10.2987/8756-971X(2006)22[601:LSOTMI]2.0.CO;2; Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521; Richards SL, 2008, J MED ENTOMOL, V45, P617, DOI 10.1603/0022-2585(2008)45[617:IOSROT]2.0.CO;2; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Rubio A, 2011, MEM I OSWALDO CRUZ, V106, P678, DOI 10.1590/S0074-02762011000600006; Sanchez L, 2010, TROP MED INT HEALTH, V15, P173, DOI 10.1111/j.1365-3156.2009.02437.x; SCHOOLEY DA, 1975, J AGR FOOD CHEM, V23, P293, DOI 10.1021/jf60198a059; Schwarz C. R., 1990, Bulletin Geodesique, V64, P28, DOI 10.1007/BF02530614; Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2; Sokal RR, 1995, BIOMETRY, P578; Strickman D, 2003, AM J TROP MED HYG, V68, P209, DOI 10.4269/ajtmh.2003.68.209; Su TY, 2003, J VECTOR ECOL, V28, P79; Sunahara T, 1997, RES POPUL ECOL, V39, P173, DOI 10.1007/BF02765263; Thammapalo S, 2008, EPIDEMIOL INFECT, V136, P135, DOI 10.1017/S0950268807008126; Tun-Lin W, 2009, TROP MED INT HEALTH, V14, P1143, DOI 10.1111/j.1365-3156.2009.02341.x; Unlu I, 2012, J AM MOSQUITO CONTR, V28, P334, DOI 10.2987/12-6262R.1; Unlu Isik, 2012, HACETTEPE JOURNAL OF BIOLOGY AND CHEMISTRY, V40, P23; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140; Wheeler AS, 2009, J AM MOSQUITO CONTR, V25, P251, DOI 10.2987/08-5794.1; *WHO, 1972, WKLY EPIDEMIOL REC, V25, P73; Wong J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001632; WONGKOON S, 2005, P WORLD ACAD SCI ENG, V32, P216; Worobey J, 2013, J AM MOSQUITO CONTR, V29, P78, DOI 10.2987/12-6296R.1	57	67	67	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77999	10.1371/journal.pone.0077999	http://dx.doi.org/10.1371/journal.pone.0077999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167593	Green Published, gold, Green Submitted			2022-12-27	WOS:000326034500053
J	Li, GL; Li, DW; Fang, YX; Song, YJ; Deng, ZJ; Gao, J; Xie, Y; Yin, TS; Ying, L; Tang, KF				Li, Guiling; Li, De-Wei; Fang, Yu-Xiao; Song, Yi-Jiang; Deng, Zhu-Jun; Gao, Jian; Xie, Yan; Yin, Tian-Sheng; Ying, Li; Tang, Kai-Fu			Performance of Shear Wave Elastography for Differentiation of Benign and Malignant Solid Breast Masses	PLOS ONE			English	Article							ACOUSTIC RADIATION FORCE; ULTRASONOGRAPHIC TISSUE QUANTIFICATION; ULTRASOUND ELASTOGRAPHY; CLINICAL-APPLICATION; SYSTEMATIC REVIEWS; LESIONS; TECHNOLOGY; EXPERIENCE; DIAGNOSIS; US	Objectives: To perform a meta-analysis assessing the ability of shear wave elastography (SWE) to identify malignant breast masses. Methods: PubMed, the Cochrane Library, and the ISI Web of Knowledge were searched for studies evaluating the accuracy of SWE for identifying malignant breast masses. The diagnostic accuracy of SWE was evaluated according to sensitivity, specificity, and hierarchical summary receiver operating characteristic (HSROC) curves. An analysis was also performed according to the SWE mode used: supersonic shear imaging (SSI) and the acoustic radiation force impulse (ARFI) technique. The clinical utility of SWE for identifying malignant breast masses was evaluated using analysis of Fagan plot. Results: A total of 9 studies, including 1888 women and 2000 breast masses, were analyzed. Summary sensitivities and specificities were 0.91 (95% confidence interval [CI], 0.88-0.94) and 0.82 (95% CI, 0.75-0.87) by SSI and 0.89 (95% CI, 0.81-0.94) and 0.91 (95% CI, 0.84-0.95) by ARFI, respectively. The HSROCs for SSI and ARFI were 0.92 (95% CI, 0.90-0.94) and 0.96 (95% CI, 0.93-0.97), respectively. SSI and ARFI were both very informative, with probabilities of 83% and 91%, respectively, for correctly differentiating between benign and malignant breast masses following a "positive'' measurement (over the threshold value) and probabilities of disease as low as 10% and 11%, respectively, following a "negative'' measurement (below the threshold value) when the pre-test probability was 50%. Conclusions: SWE could be used as a good identification tool for the classification of breast masses.	[Li, Guiling; Fang, Yu-Xiao; Song, Yi-Jiang; Deng, Zhu-Jun; Tang, Kai-Fu] Wenzhou Med Univ, Inst Genom Med, Wenzhou, Peoples R China; [Li, De-Wei; Xie, Yan; Yin, Tian-Sheng] Chongqing Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Chongqing, Peoples R China; [Gao, Jian] Second Affiliated Hosp, Dept Gastroenterol, Chongqing, Peoples R China; [Ying, Li] Wenzhou Med Univ, Affiliated Hosp 1, Dept Ultrasonog, Wenzhou 325000, Peoples R China	Wenzhou Medical University; Chongqing Medical University; Wenzhou Medical University	Ying, L (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Ultrasonog, Wenzhou 325000, Peoples R China.	yingli198312@yahoo.com.cn; tangkaifu@hotmail.com			Chongqing Medical Science Foundation [2011-1-055]; National Major Special Science and Technology project [2013ZX10002002]; Zhejiang Provincial Natural Science Foundation [R2110503]	Chongqing Medical Science Foundation; National Major Special Science and Technology project; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by the key project of Chongqing Medical Science Foundation (2011-1-055 to Jian Gao), National Major Special Science and Technology project (2013ZX10002002), and Zhejiang Provincial Natural Science Foundation (grant Nos. R2110503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou A, 2010, RADIOLOGY, V256, P297, DOI 10.1148/radiol.10090385; Bai M, 2012, J ULTRAS MED, V31, P289, DOI 10.7863/jum.2012.31.2.289; Barr RG, 2012, J ULTRAS MED, V31, P895, DOI 10.7863/jum.2012.31.6.895; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Chang JM, 2011, BREAST CANCER RES TR, V129, P89, DOI 10.1007/s10549-011-1627-7; Cheng Y, 2012, ULTRASOUND MED BIOL, V38, P1637, DOI 10.1016/j.ultrasmedbio.2012.04.022; Cosgrove DO, 2012, EUR RADIOL, V22, P1023, DOI 10.1007/s00330-011-2340-y; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Evans A, 2012, BRIT J CANCER, V107, P224, DOI 10.1038/bjc.2012.253; Evans A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2787; Gweon HM, 2013, EUR RADIOL, V23, P658, DOI 10.1007/s00330-012-2647-3; Hellmich M, 2005, METHOD INFORM MED, V44, P124; Hiltawsky KM, 2001, ULTRASOUND MED BIOL, V27, P1461, DOI 10.1016/S0301-5629(01)00434-3; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; Jin ZQ, 2012, CLIN BREAST CANCER, V12, P420, DOI 10.1016/j.clbc.2012.07.007; Lee SH, 2013, EUR RADIOL, V23, P1015, DOI 10.1007/s00330-012-2686-9; Meng W, 2011, ULTRASOUND MED BIOL, V37, P1436, DOI 10.1016/j.ultrasmedbio.2011.05.022; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Regner DM, 2006, RADIOLOGY, V238, P425, DOI 10.1148/radiol.2381041336; Sadigh G, 2012, BREAST CANCER RES TR, V134, P923, DOI 10.1007/s10549-012-2020-x; Schaefer FKW, 2011, EUR J RADIOL, V77, P450, DOI 10.1016/j.ejrad.2009.08.026; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Tozaki M, 2012, JPN J RADIOL, V30, P659, DOI 10.1007/s11604-012-0106-3; Tozaki M, 2011, ACTA RADIOL, V52, P1069, DOI 10.1258/ar.2011.110276; Tozaki M, 2011, EUR J RADIOL, V80, pE182, DOI 10.1016/j.ejrad.2011.05.020; Tozaki M, 2011, JPN J RADIOL, V29, P598, DOI 10.1007/s11604-011-0591-9; Tozaki M, 2011, JPN J RADIOL, V29, P452, DOI 10.1007/s11604-011-0561-2; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Ying L, 2013, J GASTROEN HEPATOL, V28, P1434, DOI 10.1111/jgh.12292; Ying L, 2012, EUR RADIOL, V22, P2798, DOI 10.1007/s00330-012-2540-0; Ying L, 2012, EUR J RADIOL, V81, P2576, DOI 10.1016/j.ejrad.2011.10.026; Zhao H, 2012, ULTRASOUND MED BIOL, V38, P1646, DOI 10.1016/j.ultrasmedbio.2012.05.015	32	38	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76322	10.1371/journal.pone.0076322	http://dx.doi.org/10.1371/journal.pone.0076322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204613	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300021
J	Liu, GY; Jiang, YS; Chen, XG; Zhang, RJ; Ma, GD; Feng, RN; Zhang, LC; Liao, MZ; Miao, YB; Chen, ZG; Zeng, R; Li, KS				Liu, Guiyou; Jiang, Yongshuai; Chen, Xiaoguang; Zhang, Ruijie; Ma, Guoda; Feng, Rennan; Zhang, Liangcai; Liao, Mingzhi; Miao, Yingbo; Chen, Zugen; Zeng, Rong; Li, Keshen			Measles Contributes to Rheumatoid Arthritis: Evidence from Pathway and Network Analyses of Genome-Wide Association Studies	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; ENRICHMENT ANALYSIS; RISK LOCUS; GENE; SUSCEPTIBILITY; CONFIRMATION; DESTRUCTION; DEFICIENCY; EXPRESSION; ANTIBODIES	Growing evidence from epidemiological studies indicates the association between rheumatoid arthritis (RA) and measles. However, the exact mechanism for this association is still unclear now. We consider that the strong association between both diseases may be caused by shared genetic pathways. We performed a pathway analysis of large-scale RA genome-wide association studies (GWAS) dataset with 5,539 cases and 20,169 controls of European descent. Meanwhile, we evaluated our findings using previously identified RA loci, protein-protein interaction network and previous results from pathway analysis of RA and other autoimmune diseases GWAS. We confirmed four pathways including Cytokine-cytokine receptor interaction, Jak-STAT signaling, T cell receptor signaling and Cell adhesion molecules. Meanwhile, we highlighted for the first time the involvement of Measles and Intestinal immune network for IgA production pathways in RA. Our results may explain the strong association between RA and measles, which may be caused by the shared genetic pathway. We believe that our results will be helpful for future genetic studies in RA pathogenesis and may significantly assist in the development of therapeutic strategies.	[Liu, Guiyou; Ma, Guoda; Li, Keshen] Guangdong Med Coll, Inst Neurol, Zhanjiang, Peoples R China; [Liu, Guiyou] Chinese Acad Sci, Genome Anal Lab, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Jiang, Yongshuai; Zhang, Ruijie; Liao, Mingzhi; Miao, Yingbo] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Chen, Xiaoguang] Chinese Acad Agr Sci, Sweetpotato Res Inst, Key Lab Sweetpotato Biol & Genet Breeding, Xuzhou, Jiangsu, Peoples R China; [Feng, Rennan] Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China; [Zhang, Liangcai] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Div Quantitat Sci, Houston, TX 77030 USA; [Chen, Zugen] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Zeng, Rong] Guangdong Med Coll, Affiliated Hosp, Dept Orthoped Surg, Zhanjiang, Peoples R China	Guangdong Medical University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Harbin Medical University; Chinese Academy of Agricultural Sciences; Jiangsu Academy of Agricultural Sciences; Harbin Medical University; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles; Guangdong Medical University	Zeng, R (corresponding author), Guangdong Med Coll, Affiliated Hosp, Dept Orthoped Surg, Zhanjiang, Peoples R China.	zr19641225@tom.com; keshenli2012@163.com	Zhang, Liangcai/AAD-4415-2020; Zhang, Liang/GWM-6088-2022	Liu, Guiyou/0000-0002-1126-2888	National Nature Science Foundation of China [81300945, 31200934, 31171219, 81271213, 81070878, 81271214, 81261120404]; Natural Science Foundation of Guangdong Province, China [S2012010008222]; Science and Technology Innovation Fund of Guangdong Medical College [STIF 201101]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Innovation Fund of Guangdong Medical College	This work was supported by funding from the National Nature Science Foundation of China (grant numbers 81300945, 31200934, 31171219, 81271213, 81070878, 81271214, and 81261120404), the Natural Science Foundation of Guangdong Province, China (No S2012010008222), and the Science and Technology Innovation Fund of Guangdong Medical College (No. STIF 201101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JRF, 2010, ARTHRITIS RHEUM-US, V62, P3289, DOI 10.1002/art.27656; Bakir-Gungor B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026277; Ballard David H, 2009, BMC Proc, V3 Suppl 7, pS91; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Beyene Joseph, 2009, BMC Proc, V3 Suppl 7, pS128; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Bryl E, 2005, ARTHRITIS RHEUM-US, V52, P2996, DOI 10.1002/art.21353; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cerhan JR, 2003, AM J EPIDEMIOL, V157, P345, DOI 10.1093/aje/kwf205; Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033; Corr M, 2009, ANN RHEUM DIS, V68, P257, DOI 10.1136/ard.2008.095356; Daha NA, 2009, ARTHRITIS RHEUM-US, V60, P1255, DOI 10.1002/art.24503; de Vries R, 2011, CURR OPIN RHEUMATOL, V23, P227, DOI 10.1097/BOR.0b013e3283457524; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Eleftherohorinou H, 2011, HUM MOL GENET, V20, P3494, DOI 10.1093/hmg/ddr248; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Eyre S, 2010, ANN RHEUM DIS, V69, P1407, DOI 10.1136/ard.2009.120428; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Freudenberg J, 2011, ARTHRITIS RHEUM-US, V63, P884, DOI 10.1002/art.30235; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Gui Hongsheng, 2011, BMC Res Notes, V4, P386, DOI 10.1186/1756-0500-4-386; Heijstek MW, 2013, JAMA-J AM MED ASSOC, V309, P2449, DOI 10.1001/jama.2013.6768; Heijstek MW, 2012, ANN RHEUM DIS, V71, P948, DOI 10.1136/annrheumdis-2011-200637; Hollis-Moffatt JE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3053; Hunt KA, 2013, NATURE; Ishizaki M, 2011, INT IMMUNOL, V23, P575, DOI 10.1093/intimm/dxr057; Jia PL, 2011, INT J NEUROPSYCHOPH, V14, P567, DOI 10.1017/S1461145710001446; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; KALLIOMAKI JL, 1975, ANN RHEUM DIS, V34, P43, DOI 10.1136/ard.34.1.43; Kasperkovitz PV, 2004, ANN RHEUM DIS, V63, P233, DOI 10.1136/ard.2003.013276; Klimiuk P, 2007, SCAND J RHEUMATOL, V36, P345, DOI 10.1080/03009740701406460; Knevel R, 2013, ARTHRITIS RHEUM-US, V65, P1684, DOI 10.1002/art.37938; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; LaBranche T P, 2012, ARTHRITIS RHEUM; Lee YC, 2009, ARTHRITIS RHEUM, V60, P1250, DOI 10.1002/art.24468; Lin TH, 2010, ARTHRITIS RHEUM-US, V62, P2283, DOI 10.1002/art.27536; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Luo L, 2010, EUR J HUM GENET, V18, P1045, DOI 10.1038/ejhg.2010.62; Maeshima Keisuke, 2012, ARTHRITIS RHEUM, V64; Malemud CJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/580295; Martin JE, 2010, ARTHRITIS RHEUM-US, V62, P3183, DOI 10.1002/art.27648; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Maxwell JR, 2012, RHEUMATOLOGY, V51, P1514, DOI 10.1093/rheumatology/kes134; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Olasz K, 2012, CLIN EXP IMMUNOL, V167, P346, DOI 10.1111/j.1365-2249.2011.04506.x; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Rosenau BJ, 2009, J RHEUMATOL, V36, P893, DOI 10.3899/jrheum.080856; Sakaguchi S, 2012, IMMUNOL CELL BIOL, V90, P277, DOI 10.1038/icb.2012.4; Seidel HM, 2000, ONCOGENE, V19, P2645, DOI 10.1038/sj.onc.1203550; Smith MD, 2001, RHEUMATOLOGY, V40, P965, DOI 10.1093/rheumatology/40.9.965; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Suzuki A, 2008, NAT GENET, V40, P1224, DOI 10.1038/ng.205; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Trynka G, 2010, TRENDS MOL MED, V16, P537, DOI 10.1016/j.molmed.2010.09.003; Wang JH, 2011, GENOME MED, V3, DOI 10.1186/gm217; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	64	27	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e75951	10.1371/journal.pone.0075951	http://dx.doi.org/10.1371/journal.pone.0075951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204584	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300005
J	Walther, BD; Kingsford, MJ; McCulloch, MT				Walther, Benjamin D.; Kingsford, Michael J.; McCulloch, Malcolm T.			Environmental Records from Great Barrier Reef Corals: Inshore versus Offshore Drivers	PLOS ONE			English	Article							UPWELLING ACTIVITY; BURDEKIN RIVER; IN-SITU; PACIFIC; WATER; SEA; VARIABILITY; DYNAMICS; PROXIES; BARIUM	The biogenic structures of stationary organisms can be effective recorders of environmental fluctuations. These proxy records of environmental change are preserved as geochemical signals in the carbonate skeletons of scleractinian corals and are useful for reconstructions of temporal and spatial fluctuations in the physical and chemical environments of coral reef ecosystems, including The Great Barrier Reef (GBR). We compared multi-year monitoring of water temperature and dissolved elements with analyses of chemical proxies recorded in Porites coral skeletons to identify the divergent mechanisms driving environmental variation at inshore versus offshore reefs. At inshore reefs, water Ba/Ca increased with the onset of monsoonal rains each year, indicating a dominant control of flooding on inshore ambient chemistry. Inshore multi-decadal records of coral Ba/Ca were also highly periodic in response to flood-driven pulses of terrigenous material. In contrast, an offshore reef at the edge of the continental shelf was subject to annual upwelling of waters that were presumed to be richer in Ba during summer months. Regular pulses of deep cold water were delivered to the reef as indicated by in situ temperature loggers and coral Ba/Ca. Our results indicate that although much of the GBR is subject to periodic environmental fluctuations, the mechanisms driving variation depend on proximity to the coast. Inshore reefs are primarily influenced by variable freshwater delivery and terrigenous erosion of catchments, while offshore reefs are dominated by seasonal and inter-annual variations in oceanographic conditions that influence the propensity for upwelling. The careful choice of sites can help distinguish between the various factors that promote Ba uptake in corals and therefore increase the utility of corals as monitors of spatial and temporal variation in environmental conditions.	[Walther, Benjamin D.] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA; [Walther, Benjamin D.; McCulloch, Malcolm T.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Kingsford, Michael J.] James Cook Univ, Sch Marine & Trop Biol, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [McCulloch, Malcolm T.] Univ Western Australia, Sch Earth & Environm, Australian Res Council, Ctr Excellence Coral Reef Studies, Crawley, WA, Australia	University of Texas System; University of Texas Austin; Australian National University; James Cook University; University of Western Australia	Walther, BD (corresponding author), Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA.	bwalther@utexas.edu	Walther, Benjamin/W-2681-2019; Kingsford, Michael J/C-2015-2008; Walther, Benjamin D/A-7284-2009; McCulloch, Malcolm Thomas/C-3651-2009	Kingsford, Michael J/0000-0003-1704-6198; Walther, Benjamin D/0000-0002-2902-4001; McCulloch, Malcolm Thomas/0000-0003-1538-1558	ARC Centre of Excellence for Coral Reef Studies; Australian Research Council	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian Research Council(Australian Research Council)	BDW was supported by the ARC Centre of Excellence for Coral Reef Studies (http://www.coralcoe.org.au/) and Australian Research Council (http://www.arc.gov.au/) funds awarded to MJK and MTM, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibert C, 2003, GEOCHIM COSMOCHIM AC, V67, P231, DOI 10.1016/S0016-7037(02)01055-4; Alibert C, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003979; Alibert C, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004263; ANDREWS JC, 1986, CONT SHELF RES, V6, P491, DOI 10.1016/0278-4343(86)90020-8; ANDREWS JC, 1982, MAR ECOL PROG SER, V8, P257, DOI 10.3354/meps008257; Asami R, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002555; Ayliffe LK, 2004, CONT SHELF RES, V24, P2343, DOI 10.1016/j.csr.2004.07.013; Berkelmans R, 2010, LIMNOL OCEANOGR, V55, P2634, DOI 10.4319/lo.2010.55.6.2634; Brinkman R, 2002, ESTUAR COAST SHELF S, V54, P655, DOI 10.1006/ecss.2001.0850; Bruland K.W., 2004, TREATISE GEOM, V6, P23; Carricart-Ganivet JP, 2007, J EXP MAR BIOL ECOL, V344, P67, DOI 10.1016/j.jembe.2006.12.018; CHAN LH, 1976, EARTH PLANET SC LETT, V32, P258, DOI 10.1016/0012-821X(76)90066-2; Cherubin LM, 2008, CORAL REEFS, V27, P503, DOI 10.1007/s00338-007-0348-1; Darwin C., 1842, STRUCTURE DISTRIBUTI; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Fallon SJ, 1999, EARTH PLANET SC LETT, V172, P221, DOI 10.1016/S0012-821X(99)00200-9; Furnas M, 2011, CONT SHELF RES, V31, P1967, DOI 10.1016/j.csr.2011.09.007; Gaetani GA, 2006, GEOCHIM COSMOCHIM AC, V70, P4617, DOI 10.1016/j.gca.2006.07.008; Hanson CE, 2005, CONT SHELF RES, V25, P1561, DOI 10.1016/j.csr.2005.04.003; Hatcher BG, 1997, CORAL REEFS, V16, pS77, DOI 10.1007/s003380050244; Inoue M, 2010, MAR GEOL, V271, P303, DOI 10.1016/j.margeo.2010.02.016; Isdale PJ, 1998, HOLOCENE, V8, P1, DOI 10.1191/095968398670905088; Jupiter S, 2008, CORAL REEFS, V27, P887, DOI 10.1007/s00338-008-0422-3; KING B, 2002, 44 CRC REEF RES CTR; Lambrechts J, 2008, ESTUAR COAST SHELF S, V79, P143, DOI 10.1016/j.ecss.2008.03.016; LEA DW, 1989, NATURE, V340, P373, DOI 10.1038/340373a0; Llewellyn LE, 2012, GEOCHIM COSMOCHIM AC, V83, P263, DOI 10.1016/j.gca.2011.12.028; Luick JL, 2007, CONT SHELF RES, V27, P757, DOI 10.1016/j.csr.2006.11.020; Marshall JF, 2002, GEOCHIM COSMOCHIM AC, V66, P3263, DOI 10.1016/S0016-7037(02)00926-2; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Montaggioni LF, 2006, PALAEOGEOGR PALAEOCL, V237, P436, DOI 10.1016/j.palaeo.2005.12.018; ODUM HT, 1955, ECOL MONOGR, V25, P291, DOI 10.2307/1943285; Orr JP, 1933, PHYS CHEM CONDITIONS, VII, P37; Ourbak T, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001064; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Pfeiffer M, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000964; Reuer MK, 2003, EARTH PLANET SC LETT, V210, P437, DOI [10.1016/S0012-821X(03)00162-6, 10.1016/S0012-821X(03)-00162-6]; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Shen GT, 1992, PALEOCEANOGRAPHY, V7, P563, DOI 10.1029/92PA01825; Sinclair DJ, 2011, GEOCHIM COSMOCHIM AC, V75, P5101, DOI 10.1016/j.gca.2011.05.012; Sinclair DJ, 2004, PALAEOGEOGR PALAEOCL, V214, P155, DOI 10.1016/j.palaeo.2004.07.028; Sinclair DJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1889, DOI 10.1016/S0016-7037(98)00112-4; SINCLAIR DJ, 1999, THESIS AUSTR NATL U; Steinberg C., 2007, CLIMATE CHANGE GREAT, P51; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tudhope AW, 1996, PALAIOS, V11, P347, DOI 10.2307/3515245; Walther BD, 2012, J FISH BIOL, V81, P796, DOI 10.1111/j.1095-8649.2012.03371.x; WOLANSKI E, 1983, AUST J MAR FRESH RES, V34, P49; WOLANSKI E, 1983, AUST J MAR FRESH RES, V34, P65; Wolanski E., 2001, OCEANOGRAPHIC PROCES; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; Wyatt ASJ, 2010, MAR ECOL PROG SER, V405, P113, DOI 10.3354/meps08508; Wyndham T, 2004, GEOCHIM COSMOCHIM AC, V68, P2067, DOI 10.1016/j.gca.2003.11.004; Zhang ZL, 2011, ECOL MODEL, V222, P1456, DOI 10.1016/j.ecolmodel.2011.01.014	58	28	28	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77091	10.1371/journal.pone.0077091	http://dx.doi.org/10.1371/journal.pone.0077091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204743	Green Accepted, Green Published, gold			2022-12-27	WOS:000326029300082
J	Stein, KWH; Werner, J				Stein, Koen W. H.; Werner, Jan			Preliminary Analysis of Osteocyte Lacunar Density in Long Bones of Tetrapods: All Measures Are Bigger in Sauropod Dinosaurs	PLOS ONE			English	Article							GROWTH-PATTERNS; EARLY EVOLUTION; CORTICAL BONE; BODY-SIZE; HISTOLOGY; RATES; OSTEOBLASTS; PARAMETERS; AMPHIBIANS; STRATEGIES	Osteocytes harbour much potential for paleobiological studies. Synchrotron radiation and spectroscopic analyses are providing fascinating data on osteocyte density, size and orientation in fossil taxa. However, such studies may be costly and time consuming. Here we describe an uncomplicated and inexpensive method to measure osteocyte lacunar densities in bone thin sections. We report on cell lacunar densities in the long bones of various extant and extinct tetrapods, with a focus on sauropodomorph dinosaurs, and how lacunar densities can help us understand bone formation rates in the iconic sauropod dinosaurs. Ordinary least square and phylogenetic generalized least square regressions suggest that sauropodomorphs have lacunar densities higher than scaled up or comparably sized mammals. We also found normal mammalian-like osteocyte densities for the extinct bovid Myotragus, questioning its crocodilian-like physiology. When accounting for body mass effects and phylogeny, growth rates are a main factor determining the density of the lacunocanalicular network. However, functional aspects most likely play an important role as well. Observed differences in cell strategies between mammals and dinosaurs likely illustrate the convergent nature of fast growing bone tissues in these groups.	[Stein, Koen W. H.] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Werner, Jan] Johannes Gutenberg Univ Mainz, Inst Zool, Abt Okol, Mainz, Germany	University of Bonn; Johannes Gutenberg University of Mainz	Stein, KWH (corresponding author), Leibniz Inst Res Evolut & Biodivers Berlin, Museum Nat Kunde, Berlin, Germany.	koen_stein@yahoo.co.uk	Stein, Koen HW/G-5731-2015	Stein, Koen/0000-0003-4246-3225	German Research Foundation (DFG) as part of the Research Unit FOR 533 "Biology of the Sauropod Dinosaurs''	German Research Foundation (DFG) as part of the Research Unit FOR 533 "Biology of the Sauropod Dinosaurs''	This work was supported by the German Research Foundation (DFG) as part of the third funding period of the Research Unit FOR 533 "Biology of the Sauropod Dinosaurs''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2008, GEODIVERSITAS, V30, P345; Amer SAM, 2008, GENES GENET SYST, V83, P275, DOI 10.1266/ggs.83.275; Beck RMD, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-93; Bennett SC, 2013, HIST BIOL, V25, P545, DOI 10.1080/08912963.2012.725727; Benton Michael J., 2009, P35; Berman DS, 2003, J PALEONTOL, V77, P172, DOI 10.1666/0022-3360(2003)077<0172:HOTAAS>2.0.CO;2; Bromage TG, 2009, CALCIFIED TISSUE INT, V84, P388, DOI 10.1007/s00223-009-9221-2; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; CANE V, 1982, CALCIFIED TISSUE INT, V34, P558, DOI 10.1007/BF02411304; Cao L, 2011, J BONE MINER METAB, V29, P662, DOI 10.1007/s00774-011-0268-6; Carter Y, 2013, BONE, V52, P126, DOI 10.1016/j.bone.2012.09.010; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Castanet J, 2004, J ZOOL, V263, P31, DOI 10.1017/S0952836904004844; CASTANET J, 1990, ANN SCI NAT ZOOL, V11, P191; Chinsamy A, 2001, NATURE, V412, P402, DOI 10.1038/35086650; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Chinsamy-Turan A., 2012, FORERUNNERS MAMMALS; Clack, 2012, GAINING GROUND ORIGI; Cubo J, 2012, PALEOBIOLOGY, V38, P335, DOI 10.1666/08093.1; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; De Buffrenil V, 2000, J HERPETOL, V34, P414, DOI 10.2307/1565365; de Ricqles A, 2008, ANN PALEONTOL, V94, P57, DOI 10.1016/j.annpal.2008.03.002; de Ricqles Armand J., 2003, Annales de Paleontologie, V89, P67, DOI 10.1016/S0753-3969(03)00005-3; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2006, SCIENCE, V313, P213, DOI 10.1126/science.1125721; FITZHUGH HA, 1976, J ANIM SCI, V42, P1036, DOI 10.2527/jas1976.4241036x; Francillon-Vieillot H., 1990, P471; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Ganse Bergita, 2011, P105; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hernandez CJ, 2004, BONE, V35, P1095, DOI 10.1016/j.bone.2004.07.002; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Ishimoto T, 2013, J BONE MINER RES, V28, P1170, DOI 10.1002/jbmr.1825; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klein N, 2007, SP PALAEONT, P169; Klein N, 2009, FOSS REC, V12, P121, DOI 10.1002/mmng.200900002; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Kohler M, 2009, P NATL ACAD SCI USA, V106, P20354, DOI 10.1073/pnas.0813385106; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; Lindgren J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019445; Ma YL, 2008, J BIOMECH, V41, P1324, DOI 10.1016/j.jbiomech.2008.01.017; Maddison WP, 2011, MESQUITE MODULAR SYS; Maddison WP., 2006, PAIRWISE COMP PACKAG; Marjanovic D, 2013, GEODIVERSITAS, V35, P207, DOI 10.5252/g2013n1a8; Marotti G., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P133; Marotti G, 1990, ITAL J MIN ELECTROL, V4, P93; Matsugaki A, 2012, BIOMATERIALS, V33, P7327, DOI 10.1016/j.biomaterials.2012.06.022; Mulcahy DG, 2010, MOL PHYLOGENET EVOL, V65, P974; Mullender MG, 1996, BONE, V18, P109, DOI 10.1016/8756-3282(95)00444-0; Mullender MG, 1996, J ORTHOPAED RES, V14, P972, DOI 10.1002/jor.1100140618; Muller J, 2005, BIOESSAYS, V27, P1069, DOI 10.1002/bies.20286; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Niven JE, 2007, TRENDS ECOL EVOL, V22, P57, DOI 10.1016/j.tree.2006.11.009; Noble BS, 2008, ARCH BIOCHEM BIOPHYS, V473, P106, DOI 10.1016/j.abb.2008.04.009; Padian K, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P1; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Parfitt A. M., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P499; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Petermann H, 2013, J ANAT, V222, P419, DOI 10.1111/joa.12028; Pisani D, 2002, P ROY SOC B-BIOL SCI, V269, P915, DOI 10.1098/rspb.2001.1942; Prondvai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031392; Qiu S, 2002, BONE, V31, P709, DOI 10.1016/S8756-3282(02)00907-9; R Development Core Team, 2012, R LANG ENV STAT COMP; Ray S, 2004, J VERTEBR PALEONTOL, V24, P634, DOI 10.1671/0272-4634(2004)024[0634:BHAGPO]2.0.CO;2; Remaggi Francesca, 1998, Italian Journal of Anatomy and Embryology, V103, P145; Remes K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006924; Rensberger JM, 2000, NATURE, V406, P619, DOI 10.1038/35020550; Sanchez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056992; Sander P. M., 2011, BIOL SAUROPOD DINOSA; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Schweitzer MH, 2013, BONE, V52, P414, DOI 10.1016/j.bone.2012.10.010; Sereno PC, 2007, SPEC PAP PALAEONTOL, P261; Shelton CD, T ROYAL SOC EDINBURG; Skedros JG, 2005, CELLS TISSUES ORGANS, V180, P215, DOI 10.1159/000088938; Skedros JG, 2003, ANAT REC PART A, V273A, P609, DOI 10.1002/ar.a.10073; Skutschas P, 2011, ZOOL J LINN SOC-LOND, V161, P816, DOI 10.1111/j.1096-3642.2010.00663.x; Stein K, 2013, BIOL REV, V89, P24, DOI [DOI 10.1111/BRV.12041, 10.1111/brv.12041]; Stein K., 2009, METHODS FOSSIL PREPA, P69; Stein K, 2010, P NATL ACAD SCI USA, V107, P9258, DOI 10.1073/pnas.1000781107; Stoinski Stefan, 2011, P94; Teti A, 2009, BONE, V44, P11, DOI 10.1016/j.bone.2008.09.017; Van der Geer A., 2010, EVOLUTION ISLAND MAM; Vashishth D, 2000, BONE, V26, P375, DOI 10.1016/S8756-3282(00)00236-2; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Werning S, 2011, J VERTEBR PALEONTOL, V31, P213; Werning S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033539; Woodward HN, 2011, J HERPETOL, V45, P339; Woodward HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023339; Yates Adam M., 2007, Historical Biology, V19, P93, DOI 10.1080/08912960600866953; Yates AM, 2007, SPEC PAP PALAEONTOL, P9	99	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77109	10.1371/journal.pone.0077109	http://dx.doi.org/10.1371/journal.pone.0077109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204748	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500016
J	Garziera, M; Canzonieri, V; Cannizzaro, R; Geremia, S; Caggiari, L; De Zorzi, M; Maiero, S; Orzes, E; Perin, T; Zanussi, S; De Paoli, P; De Re, V				Garziera, Marica; Canzonieri, Vincenzo; Cannizzaro, Renato; Geremia, Silvano; Caggiari, Laura; De Zorzi, Mariangela; Maiero, Stefania; Orzes, Enrico; Perin, Tiziana; Zanussi, Stefania; De Paoli, Paolo; De Re, Valli			Identification and Characterization of CDH1 Germline Variants in Sporadic Gastric Cancer Patients and in Individuals at Risk of Gastric Cancer	PLOS ONE			English	Article							E-CADHERIN GENE; CELL-CELL ADHESION; EARLY-ONSET; CRYSTAL-STRUCTURES; MOLECULAR-BIOLOGY; MUTATIONS; PROTEIN; POLYMORPHISMS; EXPRESSION; FREQUENCY	Objective: To screen and characterize germline variants for E-cadherin (CDH1) in non-hereditary gastric cancer (GC) patients and in subjects at risk of GC. Methods: 59 GCs, 59 first degree relatives (FDRs) of GC, 20 autoimmune metaplastic atrophic gastritis (AMAGs) and 52 blood donors (BDs) were analyzed for CDH1 by direct sequencing, structural modelling and bioinformatics. Functional impact on splicing was assessed for intronic mutations. E-cadherin/beta-catenin immunohistochemical staining and E-cadherin mRNA quantification using RT-PCR were performed. Results: In GCs, 4 missense variants (p.G274S; p.A298T; p.T470I; p.A592T), 1 mutation in the 59UTR (-71C>G) and 1 mutation in the intronic IVS12 (c.1937-13T>C) region were found. First pathogenic effect of p.A298T mutation was predicted by protein 3D modelling. The novel p.G274S mutation showed a no clear functional significance. Moreover, first, intronic IVS12 (c.1937-13T>C) mutation was demonstrated to lead to an aberrant CDH1 transcript with exon 11 deletion. This mutation was found in 2 GCs and in 1 BD. In FDRs, we identified 4 variants: the polymorphic (p.A592T) and 3 mutations in untranslated regions with unidentified functional role except for the 59UTR (-54G>C) that had been found to decrease CDH1 transcription. In AMAGs, we detected 2 alterations: 1 missense (p.A592T) and 1 novel variant (IVS1 (c.48+7C>T)) without effect on CDH1 splicing. Several silent and polymorphic substitutions were found in all the groups studied. Conclusions: Overall our study improves upon the current characterization of CDH1 mutations and their functional role in GC and in individuals at risk of GC. Mutations found in untranslated regions and data on splicing effects deserve a particular attention like associated with a reduced E-cadherin amount. The utility of CDH1 screening, in addition to the identification of other risk factors, could be useful for the early detection of GC in subjects at risk (i.e. FDRs and AMAGs), and warrants further study.	[Garziera, Marica; Caggiari, Laura; De Zorzi, Mariangela; De Re, Valli] Natl Canc Inst, Dept Translat Res, CRO, Aviano, Pordenone, Italy; [Canzonieri, Vincenzo; Perin, Tiziana] Natl Canc Inst, Pathol Unit, CRO, Aviano, Pordenone, Italy; [Cannizzaro, Renato; Maiero, Stefania; Orzes, Enrico] Natl Canc Inst, Gastroenterol Unit, CRO, Aviano, Pordenone, Italy; [Geremia, Silvano] Univ Trieste, Dept Chem Sci, CEB, Trieste, Italy; [Zanussi, Stefania] Natl Canc Inst, Microbiol Immunol & Virol Unit, CRO, Aviano, Pordenone, Italy; [De Paoli, Paolo] Natl Canc Inst, CRO, Aviano, Pordenone, Italy	IRCCS Aviano (CRO); IRCCS Aviano (CRO); IRCCS Aviano (CRO); University of Trieste; IRCCS Aviano (CRO); IRCCS Aviano (CRO)	De Re, V (corresponding author), Natl Canc Inst, Dept Translat Res, CRO, Aviano, Pordenone, Italy.	vdere@cro.it	De Paoli, Paolo/AAG-2586-2021; Cannizzaro, Renato/V-3804-2018; CAGGIARI, LAURA/Q-6125-2019; De Zorzi, Mariangela/AAA-8832-2019; Maiero, Stefania/ABD-6092-2020; Geremia, Silvano/E-7324-2011; De Re, Valli/K-4121-2016; DE RE, VALLI/AAA-1374-2019; Perin, Tiziana/AAC-2403-2020; Canzonieri, Vincenzo/AAA-7951-2019; Canzonieri, Vincenzo/Z-5933-2019; Zanussi, Stefania/I-2558-2018; Garziera, Marica/S-8383-2019	Cannizzaro, Renato/0000-0002-2020-222X; CAGGIARI, LAURA/0000-0003-1651-6653; De Zorzi, Mariangela/0000-0002-3794-270X; Maiero, Stefania/0000-0001-5085-1549; Geremia, Silvano/0000-0002-0711-5113; De Re, Valli/0000-0001-6100-9373; DE RE, VALLI/0000-0001-6100-9373; Perin, Tiziana/0000-0002-9823-0167; Canzonieri, Vincenzo/0000-0001-6010-0976; Zanussi, Stefania/0000-0003-0608-9766; Garziera, Marica/0000-0001-6902-210X; De Paoli, Paolo/0000-0002-9502-1781	Associazione Italiana per la Ricerca sul Cancro (AIRC) [10266]; AIRC Cannizzaro Special Program Molecular Clinical Oncology [12214]; Direzione Centrale del Lavoro, Formazione, Universita e Ricerca Della Regione Autonoma Friuli Venezia Giulia, Codice Progetto [200502027001]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC Cannizzaro Special Program Molecular Clinical Oncology(Fondazione AIRC per la ricerca sul cancro); Direzione Centrale del Lavoro, Formazione, Universita e Ricerca Della Regione Autonoma Friuli Venezia Giulia, Codice Progetto	Associazione Italiana per la Ricerca sul Cancro (AIRC De Re N. 10266 and AIRC Cannizzaro Special Program Molecular Clinical Oncology 5x1000 N. 12214), and Direzione Centrale del Lavoro, Formazione, Universita e Ricerca Della Regione Autonoma Friuli Venezia Giulia, Codice Progetto 200502027001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avizienyte E, 2001, J MED GENET, V38, P49, DOI 10.1136/jmg.38.1.49; Bacani JT, 2006, J MED GENET, V43, P867, DOI 10.1136/jmg.2006.043133; Barber M, 2006, BEST PRACT RES CL GA, V20, P721, DOI 10.1016/j.bpg.2006.03.014; Becker K F, 1999, Hum Mutat, V13, P171, DOI 10.1002/(SICI)1098-1004(1999)13:2<171::AID-HUMU14>3.0.CO;2-Z; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Carneiro F, 2010, INT J SURG PATHOL, V18, p33S, DOI 10.1177/1066896910366463; Chen QH, 2013, WORLD J GASTROENTERO, V19, P909, DOI 10.3748/wjg.v19.i6.909; Correia JS, 2012, PLOS ONE, V7; Corso G, 2013, J CLIN ONCOL, V31, P868, DOI 10.1200/JCO.2012.44.4612; Corso G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-8; Corso G, 2011, EUR J CANCER, V47, P631, DOI 10.1016/j.ejca.2010.10.011; De Re V, 2010, TUMOR BIOL, V31, P23, DOI 10.1007/s13277-009-0004-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzgerald RC, 2010, J MED GENET, V47, P436, DOI 10.1136/jmg.2009.074237; Garziera M, CLIN EXPT M IN PRESS; Graziano F, 2004, ANN ONCOL, V15, P489, DOI 10.1093/annonc/mdh108; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Guilford P, 2007, HERED CANCER CLIN PR, V5, P183, DOI 10.1186/1897-4287-5-4-183; Guilford P, 2010, GASTRIC CANCER, V13, P1, DOI 10.1007/s10120-009-0531-x; Hamilton SR, 2000, PATHOLOGY GENETICS T, P43; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Harrison OJ, 2010, NAT STRUCT MOL BIOL, V17, P348, DOI 10.1038/nsmb.1784; Ikonen T, 2001, CLIN CANCER RES, V7, P3465; Inghelmann R, 2007, TUMORI J, V93, P367; Jin XS, 2012, P NATL ACAD SCI USA, V109, pE127, DOI 10.1073/pnas.1117538108; Jordaan G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-88; Keller G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.015594; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LAUREN P, 1991, SCAND J GASTROENTERO, V26, P160; Lee YT, 2005, GUT, V54, P1541, DOI 10.1136/gut.2004.055772; Lim L, 2005, J CLIN ONCOL, V23, P6220, DOI 10.1200/JCO.2005.11.593; Livingston RJ, 2005, ES15478 NIEHS DEP GE; Martorelli D, 2012, CLIN CANCER RES, V18, P4080, DOI 10.1158/1078-0432.CCR-12-0763; Masciari S, 2007, J MED GENET, V44, P726, DOI 10.1136/jmg.2007.051268; Mateus AR, 2009, EXP CELL RES, V315, P1393, DOI 10.1016/j.yexcr.2009.02.020; Milne AN, 2010, WORLD J GASTRO ONCOL, V2, P59, DOI 10.4251/wjgo.v2.i2.59; More H, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9473; Murakami M, 2013, J PHARMACOL SCI, V121, P305, DOI 10.1254/jphs.12191FP; Nagini S, 2012, WORLD J GASTRO ONCOL, V4, P156, DOI 10.4251/wjgo.v4.i7.156; Nakamura A, 2002, MUTAT RES-FUND MOL M, V502, P19, DOI 10.1016/S0027-5107(02)00024-6; Oliveira C, 2002, HUM MUTAT, V19, P510, DOI 10.1002/humu.10068; Oliveira C, 2009, BEST PRACT RES CL GA, V23, P147, DOI 10.1016/j.bpg.2009.02.003; Oliveira C, 2009, GASTROENTEROLOGY, V136, P2137, DOI 10.1053/j.gastro.2009.02.065; Paredes J, 2012, BBA-REV CANCER, V1826, P297, DOI 10.1016/j.bbcan.2012.05.002; Pecina-Slaus N, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-17; Pedrazzani C, 2007, SURGERY, V142, P645, DOI 10.1016/j.surg.2007.06.006; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Perri F, 2007, AM J GASTROENTEROL, V102, P1361, DOI 10.1111/j.1572-0241.2007.01284.x; RISINGER JI, 1994, NAT GENET, V7, P98, DOI 10.1038/ng0594-98; Roviello F, 2007, EJSO-EUR J SURG ONC, V33, P448, DOI 10.1016/j.ejso.2006.10.028; Salahshor S, 2001, BREAST CANCER RES, V3, P199, DOI 10.1186/bcr295; Scartozzi M, 2004, CANCER TREAT REV, V30, P451, DOI 10.1016/j.ctrv.2004.01.001; Schrader KA, 2011, J MED GENET, V48, P64, DOI 10.1136/jmg.2010.079814; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sharma S, 2011, MOL CANCER THER, V10, P1751, DOI 10.1158/1535-7163.MCT-11-0248; Sharma S, 2009, BLOOD, V114, P4179, DOI 10.1182/blood-2009-03-206482; Shinmura K, 2005, CLIN GENET, V67, P81, DOI 10.1111/j.1399-0004.2005.00380.x; Strumane K, 2004, HANDB EXP PHARM, V165, P69, DOI 10.1007/978-3-540-68170-0_4; Suriano G, 2003, ONCOGENE, V22, P5716, DOI 10.1038/sj.onc.1206672; Suriano G, 2003, HUM MOL GENET, V12, P575, DOI 10.1093/hmg/ddg048; Suriano G, 2006, J MOL MED-JMM, V84, P1023, DOI 10.1007/s00109-006-0091-z; Tepes B, 2009, J PHYSIOL PHARMACOL, V60, P71; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Vauhkonen M, 2006, BEST PRACT RES CL GA, V20, P651, DOI 10.1016/j.bpg.2006.03.016; Windham TC, 2002, J SURG ONCOL, V81, P118, DOI 10.1002/jso.10157	66	29	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77035	10.1371/journal.pone.0077035	http://dx.doi.org/10.1371/journal.pone.0077035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204729	gold, Green Published, Green Submitted			2022-12-27	WOS:000326270700015
J	Mruwat, R; Yedgar, S; Lavon, I; Ariel, A; Krimsky, M; Shoseyov, D				Mruwat, Rufayda; Yedgar, Saul; Lavon, Iris; Ariel, Amiram; Krimsky, Miron; Shoseyov, David			Phospholipase A(2) in Experimental Allergic Bronchitis: A Lesson from Mouse and Rat Models	PLOS ONE			English	Article							ARACHIDONIC-ACID METABOLITES; INFLAMMATION; MEDIATORS; ASTHMA; RESOLUTION; INHIBITION; CHITINASES; MEMBRANE; DISEASES; ARGININE	Background: Phospholipases A(2) (PLA(2)) hydrolyzes phospholipids, initiating the production of inflammatory lipid mediators. We have previously shown that in rats, sPLA(2) and cPLA(2) play opposing roles in the pathophysiology of ovalbumin (OVA)induced experimental allergic bronchitis (OVA-EAB), an asthma model: Upon disease induction sPLA(2) expression and production of the broncho-constricting CysLTs are elevated, whereas cPLA(2) expression and the broncho-dilating PGE(2) production are suppressed. These were reversed upon disease amelioration by treatment with an sPLA(2) inhibitor. However, studies in mice reported the involvement of both sPLA(2) and cPLA(2) in EAB induction. Objectives: To examine the relevance of mouse and rat models to understanding asthma pathophysiology. Methods: OVA-EAB was induced in mice using the same methodology applied in rats. Disease and biochemical markers in mice were compared with those in rats. Results: As in rats, EAB in mice was associated with increased mRNA of sPLA(2), specifically sPLA(2)gX, in the lungs, and production of the broncho-constricting eicosanoids CysLTs, PGD(2) and TBX2 in bronchoalveolar lavage (BAL). In contrast, EAB in mice was associated also with elevated cPLA(2) mRNA and PGE(2) production. Yet, treatment with an sPLA(2) inhibitor ameliorated the EAB concomitantly with reverting the expression of both cPLA(2) and sPLA2, and eicosanoid production. Conclusions: In both mice and rats sPLA(2) is pivotal in OVA-induced EAB. Yet, amelioration of asthma markers in mouse models, and human tissues, was observed also upon cPLA(2) inhibition. It is plausible that airway conditions, involving multiple cell types and organs, require the combined action of more than one, essential, PLA(2)s.	[Mruwat, Rufayda; Yedgar, Saul] Hebrew Univ Jerusalem, Sch Med, Dept Biochem, IL-91010 Jerusalem, Israel; [Lavon, Iris; Krimsky, Miron] Hadassah Univ Hosp, Dept Neurol, IL-91120 Jerusalem, Israel; [Ariel, Amiram] Univ Haifa, Fac Nat Sci, Dept Biol, IL-31999 Haifa, Israel; [Krimsky, Miron; Shoseyov, David] Hadassah Univ Hosp, Dept Pediat, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Haifa; Hebrew University of Jerusalem	Yedgar, S (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Biochem, IL-91010 Jerusalem, Israel.	yedgar@md.huji.ac.il	Lavon, Iris/ABE-6651-2021		Flight Attendants Medical Research Institute (FAMRI), Miami, Florida; Hebrew University Research and Development authority	Flight Attendants Medical Research Institute (FAMRI), Miami, Florida; Hebrew University Research and Development authority	This study was supported by grants from the Flight Attendants Medical Research Institute (FAMRI), Miami, Florida, and the Hebrew University Research and Development authority. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Beck GC, 2003, CRIT CARE MED, V31, P2015, DOI 10.1097/01.CCM.0000074717.46748.64; Bickford JS, BIOCH J, V442, P127; Calabrese C, 2000, ALLERGY, V55, P27, DOI 10.1034/j.1398-9995.2000.00504.x; Capper EA, 2001, PROG LIPID RES, V40, P167, DOI 10.1016/S0163-7827(01)00002-9; Diaz BL, 2003, PROSTAG LEUKOTR ESS, V69, P87, DOI 10.1016/S0952-3278(03)00069-3; Donnelly LE, 2004, TRENDS PHARMACOL SCI, V25, P509, DOI 10.1016/j.tips.2004.08.002; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; Giannattasio G, 2010, J IMMUNOL, V185, P4430, DOI 10.4049/jimmunol.1001384; Giannattasio G, 2009, BBA-MOL CELL BIOL L, V1791, P92, DOI 10.1016/j.bbalip.2008.12.002; Granata F, 2003, INT ARCH ALLERGY IMM, V131, P153, DOI 10.1159/000071481; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Henderson WR, 2011, J BIOL CHEM, V286, P28049, DOI 10.1074/jbc.M111.235812; Horwitz RJ, 1998, AM J RESP CRIT CARE, V157, P1363, DOI 10.1164/ajrccm.157.5.9706059; Ingber A, 2007, INT J IMMUNOPATH PH, V20, P191, DOI 10.1177/039463200702000123; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; King NE, 2004, J NUTR, V134, p2830S, DOI 10.1093/jn/134.10.2830S; Kramer RM, 1997, FEBS LETT, V410, P49, DOI 10.1016/S0014-5793(97)00322-0; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Levy BD, PROSTAGLANDINS LEUKO, V82, P327; Miyahara T, 2008, J APPL PHYSIOL, V104, P354, DOI 10.1152/japplphysiol.00959.2006; Munoz NM, 2007, J IMMUNOL, V179, P4800, DOI 10.4049/jimmunol.179.7.4800; Murakami M, J BIOCH, V150, P233; Nelson CA, 2011, AM J PATHOL, V178, P2611, DOI 10.1016/j.ajpath.2011.02.024; Offer S, 2005, AM J PHYSIOL-LUNG C, V288, pL523, DOI 10.1152/ajplung.00199.2004; Patel S, J PHARM EXP THER, V340, P656; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shoseyov D, 2005, THORAX, V60, P747, DOI 10.1136/thx.2005.043695; Triggiani M, 2005, J ALLERGY CLIN IMMUN, V116, P1000, DOI 10.1016/j.jaci.2005.08.011; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Wenzel SE, 1997, PHARMACOTHERAPY, V17, pS3; Wijewickrama GT, 2006, J BIOL CHEM, V281, P10935, DOI 10.1074/jbc.M512657200; Yedgar S, 2003, ADV EXP MED BIOL, V525, P97; Yedgar S, 2000, BBA-MOL CELL BIOL L, V1488, P182, DOI 10.1016/S1388-1981(00)00120-7; Yedgar S, 2007, TRENDS PHARMACOL SCI, V28, P459, DOI 10.1016/j.tips.2007.07.005; Zimmermann N, 2006, EUR J PHARMACOL, V533, P253, DOI 10.1016/j.ejphar.2005.12.047	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76641	10.1371/journal.pone.0076641	http://dx.doi.org/10.1371/journal.pone.0076641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204651	Green Submitted, gold, Green Published			2022-12-27	WOS:000326270700010
J	Pawa, D; Firestone, R; Ratchasi, S; Dowling, O; Jittakoat, Y; Duke, A; Mundy, G				Pawa, Duangta; Firestone, Rebecca; Ratchasi, Sindh; Dowling, Olivia; Jittakoat, Yaowalak; Duke, Alex; Mundy, Gary			Reducing HIV Risk among Transgender Women in Thailand: A Quasi-Experimental Evaluation of the Sisters Program	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; PREVALENCE; PREVENTION; HEALTH; MEN; INFECTION; BANGKOK; WORKERS; FOCUS	Transgender women are particularly at risk of HIV infection, but little evidence exists on effective HIV prevention strategies with this population. We evaluated whether Sisters, a peer-led program for transgender women, could reduce HIV risks in Pattaya, Thailand. The study used time-location sampling to recruit 308 transgender women in Pattaya into a behavioral survey in 2011. Coarsened exact matching was used to create statistically equivalent groups of program participants and non-participants, based on factors influencing likelihood of program participation. Using multivariable logistic regression, we estimated effects of any program participation and participation by delivery channel on: condom use at last sex; consistent condom and condom/water-based lubricant use in the past 3 months with commercial, casual, and regular partners; and receipt of HIV testing in the past 6 months. Program coverage reached 75% of the population. In a matched sub-sample (n = 238), participation in outreach was associated with consistent condom/water-based lubricant use with commercial partners (AOR 3.22, 95% CI 1.64-6.31). Attendance at the Sisters drop-in center was associated with receiving an HIV test (AOR 2.58, 95% CI 1.47-4.52). Dedicated transgender-friendly programs are effective at reducing HIV risks and require expansion to better serve this key population and improve HIV prevention strategies.	[Pawa, Duangta; Ratchasi, Sindh; Jittakoat, Yaowalak] Populat Serv Int Thailand, Strateg Informat Dept, Bangkok, Thailand; [Firestone, Rebecca] Populat Serv Int, Res & Metr Dept, Washington, DC USA; [Dowling, Olivia; Mundy, Gary] Populat Serv Int, Res & Metr Dept, Bangkok, Thailand; [Duke, Alex] Populat Serv Int Thailand, Program Dept, Bangkok, Thailand		Pawa, D (corresponding author), Populat Serv Int Thailand, Strateg Informat Dept, Bangkok, Thailand.	duangta@psithailand.org			United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study is funded by United States Agency for International Development (USAID) http://www.usaid.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah MA, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-32; Amon J., 2000, BEHAV SURVEILLANCE S; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Berry S., 2012, AIDSTAR ONE CASE STU; Blackwell M, 2009, STATA J, V9, P524, DOI 10.1177/1536867X0900900402; Bockting W, 2005, INT J TRANSGENDERISM, V8, P123, DOI 10.1300/J485v08n02_11; Bockting WO, 2005, AIDS CARE, V17, P289, DOI 10.1080/09540120412331299825; Bockting WO, 1998, AIDS CARE, V10, P505, DOI 10.1080/09540129850124028; Clements-Nolle K, 2001, AM J PUBLIC HEALTH, V91, P915, DOI 10.2105/AJPH.91.6.915; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Craft EM, 2001, AM J PUBLIC HEALTH, V91, P889, DOI 10.2105/AJPH.91.6.889; De Santis JP, 2009, J ASSOC NURSE AIDS C, V20, P362, DOI 10.1016/j.jana.2009.06.005; Earth B., 2006, Gender and Development, V14, P259, DOI 10.1080/13552070600747297; Guadamuz TE, 2011, AIDS BEHAV, V15, P650, DOI 10.1007/s10461-010-9850-5; Haider AH, 2013, ANN SURG; Henkel R., 2006, Asia Pacific Journal of Tourism Research, V11, P269, DOI 10.1080/10941660600753299; Jackson PA, 1997, J HIST SEXUALITY, V8, P52; Jackson PA, 1999, TOLERANT UNACCEPTING; King G., 2011, COMP EFFECTIVE UNPUB; Longfield K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-872; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Mansergh G, 2006, AIDS BEHAV, V10, P743, DOI 10.1007/s10461-006-9108-4; Mayer K. H., 2007, HLTH SEXUAL MINORITI, P693; National AIDS Committee, 2012, THAIL AIDS RESP PROG; National AIDS Prevention and Alleviation Committee, 2010, UNGASS COUNTR PROGR; Nemoto T, 2005, AM J PUBLIC HEALTH, V95, P382, DOI 10.2105/AJPH.2004.040501; Nemoto T, 2004, AM J PUBLIC HEALTH, V94, P1193, DOI 10.2105/AJPH.94.7.1193; Nemoto T, 2012, AIDS CARE, V24, P210, DOI 10.1080/09540121.2011.597709; Ocha W, 2012, CULT HEALTH SEX, V14, P563, DOI 10.1080/13691058.2012.672653; Operario D, 2011, ARCH SEX BEHAV, V40, P1255, DOI 10.1007/s10508-011-9781-x; Pawa D, 2011, FACTORS ASS SEXUAL R; Peletz MG, 2006, CURR ANTHROPOL, V47, P309, DOI 10.1086/498947; Pisani E, 2004, SEX TRANSM INFECT, V80, P536, DOI 10.1136/sti.2003.007500; Population Service International, 2009, THAIL 2009 HIV AIDS; Prabawanti C, 2011, AIDS BEHAV, V15, P663, DOI 10.1007/s10461-010-9790-0; Sheridan S, 2009, AIDS, V23, P409, DOI 10.1097/QAD.0b013e32831ef510; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; ten Brummelhuis H., 1999, J GAY LESBIAN SOCIAL, V9, P121, DOI [https://doi.org/10.1300/J041v09n02_06, DOI 10.1300/J041V09N02_06]; Toole MJ, 2006, SEX TRANSM INFECT, V82, P135, DOI 10.1136/sti.2005.016923; UNAIDS, 2011, AIDSINFO DAT THAIL C; UNDP, 2011, UN ACC EX MUN HIV PR; van Griensven F, 2013, LANCET INFECT DIS, V13, P185, DOI 10.1016/S1473-3099(12)70326-2; Wells AR, 2013, POPUL HEALTH MANAG, V16, P35, DOI 10.1089/pop.2011.0104; Winter S, 2006, INT J TRANSGENDERISM, V9, P47, DOI 10.1300/J485v09n02_06; Winter S, 2006, INT J TRANSGENDERISM, V9, P15, DOI 10.1300/J485v09n01_03	45	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77113	10.1371/journal.pone.0077113	http://dx.doi.org/10.1371/journal.pone.0077113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242VF	24204750	gold, Green Published, Green Submitted			2022-12-27	WOS:000326270700018
J	Andersen, V; Holst, R; Kopp, TI; Tjonneland, A; Vogel, U				Andersen, Vibeke; Holst, Rene; Kopp, Tine Iskov; Tjonneland, Anne; Vogel, Ulla			Interactions between Diet, Lifestyle and IL10, IL1B, and PTGS2/COX-2 Gene Polymorphisms in Relation to Risk of Colorectal Cancer in a Prospective Danish Case-Cohort Study	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; RESISTANCE 1 MDR1; NSAID USE; INFLAMMATORY RESPONSE; ULCERATIVE-COLITIS; COLON-CANCER; CYCLOOXYGENASE-2; ALCOHOL; COX-2; ASSOCIATION	Background & Aims: Diet contributes to colorectal cancer development and may be potentially modified. We wanted to identify the biological mechanisms underlying colorectal carcinogenesis by assessment of diet-gene interactions. Methods: The polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons. Results: IL1b C-3737T, G-1464C and PTGS2 T8473C variant genotypes were associated with risk of CRC compared to the homozygous wildtype genotype (IRR=0.81, 95% CI: 0.68-0.97, p=0.02, and IRR=1.22, 95% CI: 1.04-1.44, p=0.02, IRR=0.75, 95% CI: 0.57-0.99, p=0.04, respectively). Interactions were found between diet and IL10 rs3024505 (P-value for interaction (P-int); meat=0.04, fish=0.007, fibre=0.0008, vegetables=0.0005), C-592A (P-int; fibre=0.025), IL1b C-3737T (P-int; vegetables=0.030, NSAID use=0.040) and PTGS2 genotypes G-765C (P-int; meat=0.006, fibre=0.0003, fruit 0.004), and T8473C (P-int; meat 0.049, fruit=0.03) and A-1195G (P-int; meat 0.038, fibre 0.040, fruit=0.059, vegetables=0.025, and current smoking=0.046). Conclusions: Genetically determined low COX-2 and high IL-1 beta activity were associated with increased risk of CRC in this northern Caucasian cohort. Furthermore, interactions were found between IL10, IL1b, and PTGS2 and diet and lifestyle factors in relation to CRC. The present study demonstrates that gene-environment interactions may identify genes and environmental factors involved in colorectal carcinogenesis.	[Andersen, Vibeke] Hosp Southern Jutland, Organ Ctr, Aabenraa, Denmark; [Andersen, Vibeke; Holst, Rene] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Andersen, Vibeke] Reg Hosp, Dept Med, Viborg, Viborg, Denmark; [Kopp, Tine Iskov] Natl Food Inst, Soborg, Denmark; [Kopp, Tine Iskov; Tjonneland, Anne] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark	University of Southern Denmark; Technical University of Denmark; Danish Cancer Society; National Research Centre for the Working Environment	Andersen, V (corresponding author), Hosp Southern Jutland, Organ Ctr, Aabenraa, Denmark.	vandersen@health.sdu.dk	Vogel, Ulla B/I-5048-2012; Andersen, Vibeke/I-7932-2012; Vogel, Ulla/ABC-2212-2020	Vogel, Ulla B/0000-0001-6807-1524; Andersen, Vibeke/0000-0002-0127-2863; Vogel, Ulla/0000-0001-6807-1524; Tjonneland, Anne/0000-0003-4385-2097; Kopp, Tine/0000-0003-3729-4420	Hospital of Southern Jutland	Hospital of Southern Jutland	This work was funded by the Hospital of Southern Jutland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo A, 2002, PUBLIC HEALTH NUTR, V5, P1179, DOI 10.1079/PHN2002398; Al-Ashy R, 2006, CYTOKINE, V36, P1, DOI 10.1016/j.cyto.2006.10.003; Al-Salihi MA, 2009, CANCER LETT, V273, P225, DOI 10.1016/j.canlet.2008.08.012; Andersen V, 2013, ALIMENT PHARM THER, V37, P383, DOI 10.1111/apt.12180; Andersen V, 2010, EUR J GASTROENTEROL; Andersen V, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-183; Andersen V, 2012, SCAND J GASTROENTERO, V47, P572, DOI 10.3109/00365521.2012.668933; Andersen V, 2011, INFLAMM BOWEL DIS, V17, P937, DOI 10.1002/ibd.21440; Andersen V, 2011, EUR J GASTROEN HEPAT, V23, P282, DOI 10.1097/MEG.0b013e3283417f76; Andersen V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-484; Andersen V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-407; Andersen V, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-18; [Anonymous], 2004, LANGUAGE A ENV STAT; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Chen HM, 2006, HUM MOL GENET, V15, P519, DOI 10.1093/hmg/ddi469; Erridge C, 2011, J FOOD SCI, V76, pH72, DOI 10.1111/j.1750-3841.2010.02018.x; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Friis S, 2009, CANCER CAUSE CONTROL, V20, P731, DOI 10.1007/s10552-008-9286-7; Garcia Rodriguez Luis A, 2013, Recent Results Cancer Res, V191, P67, DOI 10.1007/978-3-642-30331-9_4; Hansen RD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-54; Hansen RD, 2007, MUTAT RES-FUND MOL M, V619, P68, DOI 10.1016/j.mrfmmm.2007.02.002; Hansen RD, 2009, MUTAT RES-FUND MOL M, V664, P13, DOI 10.1016/j.mrfmmm.2009.01.009; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Joensen AM, 2010, BRIT J NUTR, V103, P602, DOI 10.1017/S0007114509992170; Koh WP, 2004, BRIT J CANCER, V90, P1760, DOI 10.1038/sj.bjc.6601797; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moore AE, 2012, ONCOGENE, V31, P1592, DOI 10.1038/onc.2011.349; Paul G, 2012, EUR J CLIN INVEST, V42, P95, DOI 10.1111/j.1365-2362.2011.02552.x; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; PROSKY L, 1985, J ASSOC OFF ANA CHEM, V68, P677; Ravn-Haren G, 2006, CARCINOGENESIS, V27, P820, DOI 10.1093/carcin/bgi267; Sanak M, 2005, J ALLERGY CLIN IMMUN, V116, P221, DOI 10.1016/j.jaci.2005.03.010; Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Stegger JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036829; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; TJONNELAND A, 1992, INT J EPIDEMIOL, V21, P770, DOI 10.1093/ije/21.4.770; Tjonneland A, 2009, GUT, V58, P1606, DOI 10.1136/gut.2008.169078; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Vangsted AJ, 2012, BRIT J HAEMATOL, V158, P515, DOI 10.1111/j.1365-2141.2012.09141.x; Vangsted AJ, 2011, ANN HEMATOL, V90, P1173, DOI 10.1007/s00277-011-1194-3; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Vogel U, 2008, MUTAT RES-FUND MOL M, V639, P89, DOI 10.1016/j.mrfmmm.2007.11.004; Vogel U, 2007, MUTAT RES-FUND MOL M, V624, P88, DOI 10.1016/j.mrfmmm.2007.04.006; Vogel U, 2007, MUTAT RES-FUND MOL M, V617, P138, DOI 10.1016/j.mrfmmm.2007.01.005; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003	51	47	47	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78366	10.1371/journal.pone.0078366	http://dx.doi.org/10.1371/journal.pone.0078366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194923	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000102
J	Blaser, N; Guskov, SI; Meskenaite, V; Kanevskyi, VA; Lipp, HP				Blaser, Nicole; Guskov, Sergei I.; Meskenaite, Virginia; Kanevskyi, Valerii A.; Lipp, Hans-Peter			Altered Orientation and Flight Paths of Pigeons Reared on Gravity Anomalies: A GPS Tracking Study	PLOS ONE			English	Article							FAMILIAR AREA MAP; HOMING PIGEONS; CELESTIAL ROTATION; MAGNETIC COMPASS; NAVIGATION; CUES; LOFT; CALIBRATION; DIRECTION; RELEASE	The mechanisms of pigeon homing are still not understood, in particular how they determine their position at unfamiliar locations. The "gravity vector" theory holds that pigeons memorize the gravity vector at their home loft and deduct home direction and distance from the angular difference between memorized and actual gravity vector. However, the gravity vector is tilted by different densities in the earth crust leading to gravity anomalies. We predicted that pigeons reared on different gravity anomalies would show different initial orientation and also show changes in their flight path when crossing a gravity anomaly. We reared one group of pigeons in a strong gravity anomaly with a north-to-south gravity gradient, and the other group of pigeons in a normal area but on a spot with a strong local anomaly with a west-to-east gravity gradient. After training over shorter distances, pigeons were released from a gravitationally and geomagnetically normal site 50 km north in the same direction for both home lofts. As expected by the theory, the two groups of pigeons showed divergent initial orientation. In addition, some of the GPS-tracked pigeons also showed changes in their flight paths when crossing gravity anomalies. We conclude that even small local gravity anomalies at the birth place of pigeons may have the potential to bias the map sense of pigeons, while reactivity to gravity gradients during flight was variable and appeared to depend on individual navigational strategies and frequency of position updates.	[Blaser, Nicole; Meskenaite, Virginia; Lipp, Hans-Peter] Univ Zurich, Inst Anat, Zurich, Switzerland; [Kanevskyi, Valerii A.] High Technol Inst, Kiev, Ukraine; [Guskov, Sergei I.] Ukrainian Geol Inst, Kiev, Ukraine	University of Zurich; Ukrainian State Geological Research Institute (UKRSGRI)	Blaser, N (corresponding author), Univ Zurich, Inst Anat, Zurich, Switzerland.	nicole.blaser@anatom.uzh.ch			Swiss National Science Foundation [SNF 31-122589]; SCOPES [IZ73Z0_128166]; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SCOPES; University of Zurich	This research was supported by grants from the Swiss National Science Foundation (SNF 31-122589) and SCOPES IZ73Z0_128166 (Swiss-Ukrainian Research Cooperation), and from intramural funds of the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLE KP, 1990, NATURE, V347, P378, DOI 10.1038/347378a0; ABLE KP, 1994, PROG NEUROBIOL, V42, P449, DOI 10.1016/0301-0082(94)90047-7; Able KP, 1982, SKYLIGHT POLARIZATIO; Batschelet E, 1981, CIRCULAR STAT BIOL; Benvenuti S, 1996, J EXP BIOL, V199, P2531; Bingman VP, 2002, CURR OPIN NEUROBIOL, V12, P745, DOI 10.1016/S0959-4388(02)00375-6; Bostrom JE, 2012, ECOGRAPHY, V35, P1039, DOI 10.1111/j.1600-0587.2012.07507.x; Burt T, 1997, ANIM BEHAV, V53, P1203, DOI 10.1006/anbe.1996.0389; CHENG K, 1994, ANIM LEARN BEHAV, V22, P291, DOI 10.3758/BF03209837; Dell'Ariccia G, 2009, J EXP BIOL, V212, P178, DOI 10.1242/jeb.024554; Dennis TE, 2007, P ROY SOC B-BIOL SCI, V274, P1153, DOI 10.1098/rspb.2007.3768; DORNFELDT K, 1991, BEHAV ECOL SOCIOBIOL, V28, P107; EMLEN ST, 1970, SCIENCE, V170, P1198, DOI 10.1126/science.170.3963.1198; Gagliardo A, 2001, P ROY SOC B-BIOL SCI, V268, P2065, DOI 10.1098/rspb.2001.1746; Gagliardo A, 2007, J EXP BIOL, V210, P1132, DOI 10.1242/jeb.003244; Gagliardo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022385; Gagliardo A, 2009, EUR J NEUROSCI, V29, P2389, DOI 10.1111/j.1460-9568.2009.06793.x; Guilford T, 1998, J EXP BIOL, V201, P895; Hagstrum JT, 2013, J EXP BIOL, V216, P687, DOI 10.1242/jeb.072934; Holland RA, 2003, J EXP BIOL, V206, P1773, DOI 10.1242/jeb.00365; Jorge P, 2008, NATURWISSENSCHAFTEN, V95, P223, DOI 10.1007/s00114-007-0321-4; Jorge PE, 2009, CURR BIOL, V19, P650, DOI 10.1016/j.cub.2009.02.066; Kanevskyi VA, 1984, REPORT ACAD SCI USSR, V282, P291; KEETON WT, 1971, P NATL ACAD SCI USA, V68, P102, DOI 10.1073/pnas.68.1.102; Kohler K.-H., 1975, Journal fur Ornithologie, V116, P357, DOI 10.1007/BF01649278; Kramer G., 1953, Journal fuer Ornithologie, V94, P201, DOI 10.1007/BF01922508; Larkin T., 1978, ANIMAL MIGRATION NAV, DOI [10.1007/978-3-662-11147-5_8, DOI 10.1007/978-3-662-11147-5_8]; LEDNOR AJ, 1984, J EXP BIOL, V111, P259; Lipp HP, 2004, CURR BIOL, V14, P1239, DOI 10.1016/j.cub.2004.07.024; Mora CV, 2009, P R SOC B, V276, P3295, DOI 10.1098/rspb.2009.0872; Muheim R, 2006, SCIENCE, V313, P837, DOI 10.1126/science.1129709; PAPI F, 1980, J COMP PHYSIOL, V135, P227, DOI 10.1007/BF00657250; PAPI F, 1971, Monitore Zoologico Italiano, V5, P265; Phillips JB, 2006, ANIMAL SPATIAL COGNI; Schiffner I, 2009, NATURWISSENSCHAFTEN, V96, P251, DOI 10.1007/s00114-008-0476-7; SCHMIDTKOENIG K, 1960, SCIENCE, V131, P826, DOI 10.1126/science.131.3403.826; SCHMIDTKOENIG K, 1963, BIOL BULL-US, V125, P154, DOI 10.2307/1539298; Skiles D.D., 1985, MAGNETITE BIOMINERAL, P43; WAGNER G, 1983, COMP BIOCHEM PHYS A, V76, P691, DOI 10.1016/0300-9629(83)90130-5; Walcott C, 2005, INTEGR COMP BIOL, V45, P574, DOI 10.1093/icb/45.3.574; WALCOTT C, 1974, SCIENCE, V184, P180, DOI 10.1126/science.184.4133.180; WALCOTT C, 1992, J EXP BIOL, V170, P127; Wallraff HG, 2004, ANIM BEHAV, V67, P189, DOI 10.1016/j.anbehav.2003.06.007; WALLRAFF HG, 1988, COMP BIOCHEM PHYS A, V89, P621, DOI 10.1016/0300-9629(88)90844-4; Wallraff HG., 1974, NAVIGATIONSSYSTEM V; Wallraff HG., 2005, AVIAN NAVIGATION PIG; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R, 2003, ANIM BEHAV, V65, P257, DOI 10.1006/anbe.2003.2054; WILTSCHKO R, 1989, BEHAV ECOL SOCIOBIOL, V24, P163, DOI 10.1007/BF00292099; Wiltschko R, 2009, J EXP BIOL, V212, P2983, DOI 10.1242/jeb.032722; Wolfer DP, 2001, PHYSIOL BEHAV, V73, P745, DOI 10.1016/S0031-9384(01)00531-5	51	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77102	10.1371/journal.pone.0077102	http://dx.doi.org/10.1371/journal.pone.0077102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194860	Green Submitted, gold, Green Published			2022-12-27	WOS:000326037000039
J	Garcia, PL; Council, LN; Christein, JD; Arnoletti, JP; Heslin, MJ; Gamblin, TL; Richardson, JH; Bjornsti, MA; Yoon, KJ				Garcia, Patrick L.; Council, Leona N.; Christein, John D.; Arnoletti, J. Pablo; Heslin, Marty J.; Gamblin, Tracy L.; Richardson, Joseph H.; Bjornsti, Mary-Ann; Yoon, Karina J.			Development and Histopathological Characterization of Tumorgraft Models of Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							CANCER STEM-CELLS; XENOGRAFT MODELS; NUDE-MICE; KRAS; GEMCITABINE; INSTABILITY; RESISTANCE; SIGNATURES; COOPERATE; CARCINOMA	Pancreatic cancer is the one of the deadliest of all malignancies. The five year survival rate for patients with this disease is 3-5%. Thus, there is a compelling need for novel therapeutic strategies to improve the clinical outcome for patients with pancreatic cancer. Several groups have demonstrated for other types of solid tumors that early passage human tumor xenograft models can be used to define some genetic and molecular characteristics of specific human tumors. Published studies also suggest that murine tumorgraft models (early passage xenografts derived from direct implantation of primary tumor specimens) may be useful in identifying compounds with efficacy against specific tumor types. Because pancreatic cancer is a fatal disease and few well-characterized model systems are available for translational research, we developed and characterized a panel of pancreatic tumorgraft models for biological evaluation and therapeutic drug testing. Of the 41 primary tumor specimens implanted subcutaneously into mice, 35 produced viable tumorgraft models. We document the fidelity of histological and morphological characteristics and of KRAS mutation status among primary (F0), F1, and F2 tumors for the twenty models that have progressed to the F3 generation. Importantly, our procedures produced a take rate of 85%, higher than any reported in the literature. Primary tumor specimens that failed to produce tumorgrafts were those that either contained <10% tumor cells or that were obtained from significantly smaller primary tumors. In view of the fidelity of characteristics of primary tumor specimens through at least the F2 generation in mice, we propose that these tumorgraft models represent a useful tool for identifying critical characteristics of pancreatic tumors and for evaluating potential therapies.	[Garcia, Patrick L.; Gamblin, Tracy L.; Bjornsti, Mary-Ann; Yoon, Karina J.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; [Council, Leona N.] Univ Alabama Birmingham, Dept Pathol, Div Anat Pathol, Birmingham, AL 35294 USA; [Christein, John D.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Arnoletti, J. Pablo; Heslin, Marty J.; Richardson, Joseph H.] Univ Alabama Birmingham, Dept Surg, Div Gen Surg, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Yoon, KJ (corresponding author), Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA.	kyoon@uab.edu			UAB/UMN SPORE in pancreatic cancer [P50 CA101955]; UAB-Comprehensive Cancer Center; Department of Pharmacology and Toxicology, University of Alabama at Birmingham; NATIONAL CANCER INSTITUTE [P50CA101955, P30CA013148] Funding Source: NIH RePORTER	UAB/UMN SPORE in pancreatic cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB-Comprehensive Cancer Center; Department of Pharmacology and Toxicology, University of Alabama at Birmingham; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by UAB/UMN SPORE in pancreatic cancer (P50 CA101955), UAB-Comprehensive Cancer Center, and Department of Pharmacology and Toxicology, University of Alabama at Birmingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, BIOCHEM PHARMACOL, V78, P1083, DOI 10.1016/j.bcp.2009.05.027; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Baumgarten Axel J., 2007, Cancer Genomics & Proteomics, V4, P223; BOVEN E, 1992, CANCER RES, V52, P5940; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Feldmann G, 2008, J MOL DIAGN, V10, P111, DOI 10.2353/jmoldx.2008.070115; Fiebig Heinz-Herbert, 2007, Cancer Genomics & Proteomics, V4, P197; Fiebig HH, 2004, EUR J CANCER, V40, P802, DOI 10.1016/j.ejca.2004.01.009; Garrido-Laguna I, 2010, BRIT J CANCER, V103, P649, DOI 10.1038/sj.bjc.6605819; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; GIOVANELLA BC, 1973, JNCI-J NATL CANCER I, V50, P1051, DOI 10.1093/jnci/50.4.1051; HAHN SA, 1995, CANCER RES, V55, P4670; Hausser HJ, 2005, BIOCHEM BIOPH RES CO, V333, P216, DOI 10.1016/j.bbrc.2005.05.097; Hidalgo M, 2011, MOL CANCER THER, V10, P1311, DOI 10.1158/1535-7163.MCT-11-0233; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hong SM, 2011, ARCH PATHOL LAB MED, V135, P716, DOI 10.1043/2010-0566-RA.1; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Hruban RH, 2007, GASTROENTEROL CLIN N, V36, P831, DOI 10.1016/j.gtc.2007.08.012; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Huynh H, 2006, CLIN CANCER RES, V12, P4306, DOI 10.1158/1078-0432.CCR-05-2568; Hylander BL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-22; Iacobuzio-Donahue CA, 2002, AM J PATHOL, V160, P91, DOI 10.1016/S0002-9440(10)64353-2; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Monsma DJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-125; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Quesnelle KM, 2012, CANCER BIOL THER, V13, P935, DOI 10.4161/cbt.20846; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Rajeshkumar NV, 2011, CLIN CANCER RES, V17, P2799, DOI 10.1158/1078-0432.CCR-10-2580; Rubio-Viqueira B, 2009, CLIN PHARMACOL THER, V85, P217, DOI 10.1038/clpt.2008.200; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; RYGAARD J, 1969, Acta Pathologica et Microbiologica Scandinavica, V77, P758; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SMIT VTHBM, 1988, NUCLEIC ACIDS RES, V16, P7773, DOI 10.1093/nar/16.16.7773; Troiani T, 2008, CRIT REV ONCOL HEMAT, V65, P200, DOI 10.1016/j.critrevonc.2007.10.003; Uronis JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038422; Venkatesha VA, 2012, NEOPLASIA, V14, P519, DOI 10.1593/neo.12538; Villarroel MC, 2011, MOL CANCER THER, V10, P3, DOI 10.1158/1535-7163.MCT-10-0893; Wong HH, 2009, NAT REV GASTRO HEPAT, V6, P412, DOI 10.1038/nrgastro.2009.89	49	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78183	10.1371/journal.pone.0078183	http://dx.doi.org/10.1371/journal.pone.0078183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194913	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000092
J	Hong, SH; Minai-Tehrani, A; Chang, SH; Jiang, HL; Lee, S; Lee, AY; Seo, HW; Chae, C; Beck, GR; Cho, MH				Hong, Seong-Ho; Minai-Tehrani, Arash; Chang, Seung-Hee; Jiang, Hu-Lin; Lee, Somin; Lee, Ah-Young; Seo, Hwi Won; Chae, Chanhee; Beck, George R., Jr.; Cho, Myung-Haing			Knockdown of the Sodium-Dependent Phosphate Co-Transporter 2b (NPT2b) Suppresses Lung Tumorigenesis	PLOS ONE			English	Article							SMALL INTERFERING RNA; TUMOR-GROWTH; TARGETING OSTEOPONTIN; GENE DELIVERY; CANCER; ANGIOGENESIS; LOCALIZATION; EXPRESSION; INHIBITION; THERAPY	The sodium-dependent phosphate co-transporter 2b (NPT2b) plays an important role in maintaining phosphate homeostasis. In previous studies, we have shown that high dietary inorganic phosphate (Pi) consumption in mice stimulated lung tumorigenesis and increased NPT2b expression. NPT2b has also been found to be highly expressed in human lung cancer tissues. The association of high expression of NPT2b in the lung with poor prognosis in oncogenic lung diseases prompted us to test whether knockdown of NPT2b may regulate lung cancer growth. To address this issue, aerosols that contained small interfering RNA (siRNA) directed against NPT2b (siNPT2b) were delivered into the lungs of K-ras(LA1) mice, which constitute a murine model reflecting human lung cancer. Our results clearly showed that repeated aerosol delivery of siNPT2b successfully suppressed lung cancer growth and decreased cancer cell proliferation and angiogenesis, while facilitating apoptosis. These results strongly suggest that NPT2b plays a role lung tumorigenesis and represents a novel target for lung cancer therapy.	[Hong, Seong-Ho; Minai-Tehrani, Arash; Chang, Seung-Hee; Lee, Somin; Lee, Ah-Young; Cho, Myung-Haing] Seoul Natl Univ, Coll Vet Med, Toxicol Lab, Seoul, South Korea; [Jiang, Hu-Lin] China Pharmaceut Univ, Sch Pharm, Nanjing, Jiangsu, Peoples R China; [Seo, Hwi Won; Chae, Chanhee] Seoul Natl Univ, Laboratrory Pathol, Coll Vet Med, Seoul, South Korea; [Beck, George R., Jr.] Emory Univ, Sch Med, Div Endocrinol Metab & Lipids, Atlanta, GA USA; [Cho, Myung-Haing] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Suwon, South Korea; [Lee, Somin; Cho, Myung-Haing] Seoul Natl Univ, Grad Grp Tumor Biol, Seoul, South Korea; [Cho, Myung-Haing] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon, South Korea	Seoul National University (SNU); China Pharmaceutical University; Seoul National University (SNU); Emory University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Cho, MH (corresponding author), Seoul Natl Univ, Coll Vet Med, Toxicol Lab, Seoul, South Korea.	mchotox@snu.ac.kr	Beck, George/AAO-2117-2020; Cho, Myung-Haing/B-7362-2014	Cho, Myung-Haing/0000-0002-3993-2011; Chae, Chanhee/0000-0002-0190-1957	National Research Foundation [NRF-2012-0000102]; Ministry of Education, Science, and Technology (MEST) of Korea; Veterinary Research Institute of Seoul National University in Korea; NATIONAL CANCER INSTITUTE [R01CA136716, R03CA136059] Funding Source: NIH RePORTER	National Research Foundation; Ministry of Education, Science, and Technology (MEST) of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Veterinary Research Institute of Seoul National University in Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Research Foundation (NRF-2012-0000102) and the Ministry of Education, Science, and Technology (MEST) of Korea. MHC also acknowledges the support of the Veterinary Research Institute of Seoul National University in Korea. The authors further thank the Korea Lung Tissue Bank (KLTB) of the Infrastructure Project for Basic Science of MEST for providing the human lung tissues. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Chang SH, 2006, AM J RESP CELL MOL, V35, P528, DOI 10.1165/rcmb.2005-0477OC; Chen DR, 2010, ANTICANCER RES, V30, P4135; Densmore CL, 2003, CURR CANCER DRUG TAR, V3, P275, DOI 10.2174/1568009033481886; Feild JA, 1999, BIOCHEM BIOPH RES CO, V258, P578, DOI 10.1006/bbrc.1999.0666; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Forster IC, 2006, KIDNEY INT, V70, P1548, DOI 10.1038/sj.ki.5001813; Gong MC, 2008, CANCER LETT, V272, P148, DOI 10.1016/j.canlet.2008.07.004; Gupta A, 2001, BONE, V29, P467, DOI 10.1016/S8756-3282(01)00601-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hashimoto M, 2000, AM J PATHOL, V157, P21, DOI 10.1016/S0002-9440(10)64512-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jin H, 2006, TOXICOL SCI, V90, P221, DOI 10.1093/toxsci/kfj066; Jin H, 2009, AM J RESP CRIT CARE, V179, P59, DOI 10.1164/rccm.200802-306OC; Jin H, 2007, TOXICOL SCI, V100, P215, DOI 10.1093/toxsci/kfm202; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Juliano R, 2008, NUCLEIC ACIDS RES, V36, P4158, DOI 10.1093/nar/gkn342; Khuri FR, 2001, ANN ONCOL, V12, P739, DOI 10.1023/A:1011197500223; Kim Hyun Sook, 2010, Korean Journal of Internal Medicine, V25, P399, DOI 10.3904/kjim.2010.25.4.399; Kiyamova R., 2011, Experimental Oncology, V33, P157; Lederer E, 2012, CLIN J AM SOC NEPHRO, V7, P1179, DOI 10.2215/CJN.09090911; Lee HY, 2004, CLIN CANCER RES, V10, P1074, DOI 10.1158/1078-0432.CCR-0833-3; Lee HY, 2002, CLIN CANCER RES, V8, P2970; Liu H, 2010, CANCER LETT, V295, P27, DOI 10.1016/j.canlet.2010.02.012; Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7; Minai-Tehrani A, 2012, INT J PHARMACEUT, V431, P197, DOI 10.1016/j.ijpharm.2012.04.028; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Oishi M, 2005, J AM CHEM SOC, V127, P1624, DOI 10.1021/ja044941d; Pirollo KF, 2008, CANCER RES, V68, P1247, DOI 10.1158/0008-5472.CAN-07-5810; Shyian M., 2011, Experimental Oncology, V33, P94; Takeda E, 2004, J CELL MOL MED, V8, P191, DOI 10.1111/j.1582-4934.2004.tb00274.x; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; Walter A, 2010, FASEB J, V24, P3360, DOI 10.1096/fj.09-149419; Xu H, 1999, GENOMICS, V62, P281, DOI 10.1006/geno.1999.6009	34	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77121	10.1371/journal.pone.0077121	http://dx.doi.org/10.1371/journal.pone.0077121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194864	Green Submitted, gold, Green Published			2022-12-27	WOS:000326037000043
J	Johansson, I; Ringner, M; Hedenfalk, I				Johansson, Ida; Ringner, Markus; Hedenfalk, Ingrid			The Landscape of Candidate Driver Genes Differs between Male and Female Breast Cancer	PLOS ONE			English	Article							COPY NUMBER; CLAUDIN-LOW; PATHWAYS; THY-1; IDENTIFICATION; ABERRATIONS; NETWORKS; ADHESION; CENSUS; CELL	The rapidly growing collection of diverse genome-scale data from multiple tumor types sheds light on various aspects of the underlying tumor biology. With the objective to identify genes of importance for breast tumorigenesis in men and to enable comparisons with genes important for breast cancer development in women, we applied the computational framework COpy Number and EXpression In Cancer (CONEXIC) to detect candidate driver genes among all altered passenger genes. Unique to this approach is that each driver gene is associated with several gene modules that are believed to be altered by the driver. Thirty candidate drivers were found in the male breast cancers and 67 in the female breast cancers. We identified many known drivers of breast cancer and other types of cancer, in the female dataset (e. g. GATA3, CCNE1, GRB7, CDK4). In contrast, only three known cancer genes were found among male breast cancers; MAP2K4, LHP, and ZNF217. Many of the candidate drivers identified are known to be involved in processes associated with tumorigenesis, including proliferation, invasion and differentiation. One of the modules identified in male breast cancer was regulated by THY1, a gene involved in invasion and related to epithelial-mesenchymal transition. Furthermore, men with THY1 positive breast cancers had significantly inferior survival. THY1 may thus be a promising novel prognostic marker for male breast cancer. Another module identified among male breast cancers, regulated by SPAG5, was closely associated with proliferation. Our data indicate that male and female breast cancers display highly different landscapes of candidate driver genes, as only a few genes were found in common between the two. Consequently, the pathobiology of male breast cancer may differ from that of female breast cancer and can be associated with differences in prognosis; men diagnosed with breast cancer may consequently require different management and treatment strategies than women.	[Johansson, Ida] Dept Clin Sci, Div Oncol, Lund, Sweden; Lund Univ, CREATE Hlth Strateg Ctr Translat Canc Res, Lund, Sweden	Lund University	Johansson, I (corresponding author), Dept Clin Sci, Div Oncol, Lund, Sweden.	Ida.Johansson@med.lu.se	Ringnér, Markus/G-3641-2011	Ringnér, Markus/0000-0001-5469-8940; Hedenfalk, Ingrid/0000-0002-6840-3397	Swedish Cancer Society; G Nilsson Cancer Foundation; Mrs. B Kamprad Foundation; King Gustaf V's Jubilee Foundation; Lund University Hospital Research Foundation; governmental funding of clinical research within the national health services (ALF)	Swedish Cancer Society(Swedish Cancer Society); G Nilsson Cancer Foundation; Mrs. B Kamprad Foundation; King Gustaf V's Jubilee Foundation; Lund University Hospital Research Foundation; governmental funding of clinical research within the national health services (ALF)	This study was supported by grants from the Swedish Cancer Society, the G Nilsson Cancer Foundation, the Mrs. B Kamprad Foundation, the King Gustaf V's Jubilee Foundation, the Lund University Hospital Research Foundation and governmental funding of clinical research within the national health services (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysinghe HR, 2004, CANCER GENET CYTOGEN, V149, P1, DOI 10.1016/S0165-4608(03)00234-6; Agrawal A, 2007, BREAST CANCER RES TR, V103, P11, DOI 10.1007/s10549-006-9356-z; Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Callari M, 2011, BREAST CANCER RES TR, V127, P601, DOI 10.1007/s10549-010-1015-8; Cheng BQ, 2012, ASIAN PAC J CANCER P, V13, P1349, DOI 10.7314/APJCP.2012.13.4.1349; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dutta B, 2012, BRIT J CANCER, V106, P1107, DOI 10.1038/bjc.2011.584; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fassan M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2348; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Fredlund E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3236; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Giordano SH, 2005, ONCOLOGIST, V10, P471, DOI 10.1634/theoncologist.10-7-471; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Johansson I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3116; Johansson I, 2011, BREAST CANCER RES TR, V129, P747, DOI 10.1007/s10549-010-1262-8; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Kersten Ferry Fj, 2012, Cilia, V1, P2, DOI 10.1186/2046-2530-1-2; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korde LA, 2010, J CLIN ONCOL, V28, P2114, DOI 10.1200/JCO.2009.25.5729; Lehmann U, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-109; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Lung HL, 2010, INT J CANCER, V127, P304, DOI 10.1002/ijc.25047; Nilsson C, 2013, MODERN PATHOL, V26, P87, DOI 10.1038/modpathol.2012.145; Nilsson C, 2013, ACTA ONCOL, V52, P102, DOI 10.3109/0284186X.2012.711952; Nilsson C, 2011, ACTA ONCOL, V50, P1083, DOI 10.3109/0284186X.2011.602114; Orr N, 2012, NAT GENET, V44, P1182, DOI 10.1038/ng.2417; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Saalbach A, 2005, ONCOGENE, V24, P4710, DOI 10.1038/sj.onc.1208559; Salari K, 2010, BIOINFORMATICS, V26, P414, DOI 10.1093/bioinformatics/btp702; Sanchez-Garcia F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-189; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Solvang HK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-197; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tommasi S, 2010, ANAL CELL PATHOL, V33, P113, DOI [10.1155/2010/468280, 10.3233/ACP-CLO-2010-0544]; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; [No title captured]; [No title captured], DOI DOI 10.1038/NATURE11017.PUBMED:22722201	50	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78299	10.1371/journal.pone.0078299	http://dx.doi.org/10.1371/journal.pone.0078299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194916	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000095
J	Koch, CT; Bruggmann, R; Tetens, J; Drogemuller, C				Koch, Caroline Tina; Bruggmann, Remy; Tetens, Jens; Droegemueller, Cord			A Non-Coding Genomic Duplication at the HMX1 Locus Is Associated with Crop Ears in Highland Cattle	PLOS ONE			English	Article							INHERITANCE	Highland cattle with congenital crop ears have notches of variable size on the tips of both ears. In some cases, cartilage deformation can be seen and occasionally the external ears are shortened. We collected 40 cases and 80 controls across Switzerland. Pedigree data analysis confirmed a monogenic autosomal dominant mode of inheritance with variable expressivity. All affected animals could be traced back to a single common ancestor. A genome-wide association study was performed and the causative mutation was mapped to a 4 Mb interval on bovine chromosome 6. The H6 family homeobox 1 (HMX1) gene was selected as a positional and functional candidate gene. By whole genome re-sequencing of an affected Highland cattle, we detected 6 non-synonymous coding sequence variants and two variants in an ultra-conserved element at the HMX1 locus with respect to the reference genome. Of these 8 variants, only a non-coding 76 bp genomic duplication (g.106720058_106720133dup) located in the conserved region was perfectly associated with crop ears. The identified copy number variation probably results in HMX1 misregulation and possible gain-of-function. Our findings confirm the role of HMX1 during the development of the external ear. As it is sometimes difficult to phenotypically diagnose Highland cattle with slight ear notches, genetic testing can now be used to improve selection against this undesired trait.	[Koch, Caroline Tina; Droegemueller, Cord] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Bruggmann, Remy] Univ Bern, Interfac Bioinformat Unit, Bern, Switzerland; [Tetens, Jens] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	University of Bern; University of Bern; University of Kiel	Drogemuller, C (corresponding author), Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland.	cord.droegemueller@vetsuisse.unibe.ch		Bruggmann, Remy/0000-0001-5629-6363; Drogemuller, Cord/0000-0001-9773-522X; Tetens, Jens/0000-0001-5352-464X				Alasti F, 2009, J MED GENET, V46, P361, DOI 10.1136/jmg.2008.062158; [Anonymous], 2013, DAIRY GOAT J; [Anonymous], 2013, WHO INT CLASS DIS; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Lacombe D, 1997, Rev Laryngol Otol Rhinol (Bord), V118, P5; Liu GE, 2012, FUNCT INTEGR GENOMIC, V12, P609, DOI 10.1007/s10142-012-0289-9; Lush JL, 1922, J HERED, V13, P8, DOI 10.1093/oxfordjournals.jhered.a102155; MacDONALD M. A., 1957, JOUR HEREDITY, V48, P244; Munroe RJ, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-27; Quina LA, 2012, DIS MODEL MECH, V5, P812, DOI 10.1242/dmm.009910; SCHEIDER A, 1994, BERL MUNCH TIERARZTL, V107, P348; Schorderet DF, 2008, AM J HUM GENET, V82, P1178, DOI 10.1016/j.ajhg.2008.03.007; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; Thomson RG, 2001, THOMSONS SPECIAL VET; Wriedt C, 1925, Z TIERZ ZUCHTUNGSBIO, V3, P235; Yamane J, 1915, J COL AGR TOHOKU IMP, V6, P166	17	16	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77841	10.1371/journal.pone.0077841	http://dx.doi.org/10.1371/journal.pone.0077841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194898	Green Submitted, gold, Green Published			2022-12-27	WOS:000326037000077
J	Becker, F; Junker, K; Parr, M; Hartmann, A; Fussel, S; Toma, M; Grobholz, R; Pflugmann, T; Wullich, B; Strauss, A; Behnes, CL; Otto, W; Stockle, M; Jung, V				Becker, Frank; Junker, Kerstin; Parr, Martin; Hartmann, Arndt; Fuessel, Susanne; Toma, Marieta; Grobholz, Rainer; Pflugmann, Thomas; Wullich, Bernd; Strauss, Arne; Behnes, Carl Ludwig; Otto, Wolfgang; Stoeckle, Michael; Jung, Volker			Collecting Duct Carcinomas Represent a Unique Tumor Entity Based on Genetic Alterations	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; CYTOGENETIC ANALYSIS; DIFFERENTIAL-DIAGNOSIS; BELLINI; HYBRIDIZATION; KIDNEY; CANCER; PAX8; CDC	Collecting duct carcinoma (CDC) is a rare renal neoplasm that is associated with poor prognosis due to its highly aggressive course and limited response to immuno-or chemotherapy. Histologically, CDC is defined as a subtype of renal cell carcinomas, but in some cases, it is difficult to differentiate from urothelial carcinomas (UC). Therefore the aim of this study was to determine genetic alterations of CDC in comparison to that of urothelial carcinomas of the upper urinary tract (UUT-UC) to clarify the histological origin of this rare tumor entity. Twenty-nine CDC samples were obtained from seven different German centers and compared with twenty-six urothelial carcinomas of the upper urinary tract. Comparative genomic hybridization (CGH) was used to investigate the genetic composition of patients' tumors and allowed the detection of losses and gains of DNA copy numbers throughout the entire genome. The clinical data were correlated with CGH results. CGH analysis of CDC revealed DNA aberrations in many chromosomes. DNA losses were more frequently observed than gains, while high-level amplifications were not detected. The mean frequency of CDC chromosomal aberrations (4.9/case) was slightly lower than that in UUT-UC (5.4/case). Recurrent CDC DNA losses occurred at 8p (n=9/29), 16p (9/29), 1p (n=7/29) and 9p (n=7/29), and gains occurred in 13q (n= 9/29). In contrast to CDC, the most frequently detected UUT-UC DNA aberration was a loss at 9q (n=13/26). DNA losses at 9q, 13q and 8q as well as gains at 8p showed significant variations in UUT-UC compared to CDC. There was no correlation between the patients' clinical course and the presence or absence of these recurrent genetic alterations. CDCs are characterized by a different genetic pattern compared to UUT-UC. Regarding the published data on renal cell carcinoma, we conclude that CDC appears to be a unique entity among kidney carcinomas.	[Becker, Frank; Junker, Kerstin; Parr, Martin; Stoeckle, Michael; Jung, Volker] Univ Saarland, Dept Urol, Homburg, Germany; [Hartmann, Arndt] Univ Hosp Erlangen, Dept Pathol, Erlangen, Germany; [Fuessel, Susanne] Tech Univ Dresden, Dept Urol, D-01062 Dresden, Germany; [Toma, Marieta] Tech Univ Dresden, Dept Pathol, D-01062 Dresden, Germany; [Grobholz, Rainer] Kantonsspital Aarau, Dept Pathol, Aarau, Switzerland; [Pflugmann, Thomas] St Franziskus Clin, Dept Urol, Monchengladbach, Germany; [Wullich, Bernd] Univ Hosp Erlangen, Dept Urol, Erlangen, Germany; [Strauss, Arne] Univ Gottingen, Dept Urol, D-37073 Gottingen, Germany; [Behnes, Carl Ludwig] Univ Gottingen, Dept Pathol, Gottingen, Germany; [Otto, Wolfgang] Univ Regensburg, Caritas Clin St Joseph, Dept Urol, D-93053 Regensburg, Germany; [Becker, Frank] Boxberg Ctr, Urol Grp Practice, Neunkirchen, Germany; [Becker, Frank] Boxberg Ctr, Clin Derouet Ponicke Becker, Neunkirchen, Germany; [Junker, Kerstin] Jena Univ Hosp, Dept Urol, Jena, Germany; [Junker, Kerstin; Parr, Martin; Hartmann, Arndt; Fuessel, Susanne; Toma, Marieta; Wullich, Bernd; Strauss, Arne; Behnes, Carl Ludwig; Otto, Wolfgang; Stoeckle, Michael; Jung, Volker] German Network Renal Cell Tumors, Jena, Germany	Saarland University; University of Erlangen Nuremberg; Technische Universitat Dresden; Technische Universitat Dresden; Kantonsspital Aarau AG (KSA); University of Erlangen Nuremberg; University of Gottingen; University of Gottingen; University of Regensburg; Friedrich Schiller University of Jena	Jung, V (corresponding author), Univ Saarland, Dept Urol, Homburg, Germany.	volker.jung@uks.eu	Toma, Marieta/AAI-8022-2021; Strauß, Arne/AAJ-7852-2021	Grobholz, Rainer/0000-0002-1901-7967; Otto, Wolfgang/0000-0003-0523-5442				Abern MR, 2012, UROLOGY, V80, P140, DOI 10.1016/j.urology.2012.03.034; Albadine R, 2010, AM J SURG PATHOL, V34, P965, DOI 10.1097/PAS.0b013e3181dc5e8a; CARTER MD, 1992, J UROLOGY, V147, P1096, DOI 10.1016/S0022-5347(17)37485-2; Carvalho JC, 2012, HISTOPATHOLOGY, V60, P597, DOI 10.1111/j.1365-2559.2011.04093.x; Cavazzana AO, 1996, EUR UROL, V30, P340; DIMOPOULOS MA, 1993, BRIT J UROL, V71, P388, DOI 10.1111/j.1464-410X.1993.tb15978.x; Dondeti VR, 2012, CANCER RES, V72, P112, DOI 10.1158/0008-5472.CAN-11-1698; Fadl-Elmula I, 1999, CANCER GENET CYTOGEN, V115, P123, DOI 10.1016/S0165-4608(99)00075-8; FLEMING S, 1986, HISTOPATHOLOGY, V10, P1131, DOI 10.1111/j.1365-2559.1986.tb02553.x; FUZESI L, 1992, HISTOPATHOLOGY, V21, P155, DOI 10.1111/j.1365-2559.1992.tb00364.x; Girgis AH, 2012, CANCER RES, V72, P5273, DOI 10.1158/0008-5472.CAN-12-0656; GregoriRomero MA, 1996, GENE CHROMOSOME CANC, V15, P170, DOI 10.1002/(SICI)1098-2264(199603)15:3<170::AID-GCC4>3.0.CO;2-#; Jung V, 2007, TOXICOL IN VITRO, V21, P183, DOI 10.1016/j.tiv.2006.09.021; Jung V, 1999, J NEUROPATH EXP NEUR, V58, P993, DOI 10.1097/00005072-199909000-00009; Junker K, 2003, RECENT RES CANCER, V162, P169; Kafe H, 2004, VIRCHOWS ARCH, V445, P637, DOI 10.1007/s00428-004-1124-z; Karakiewicz PI, 2007, EUR UROL, V52, P1140, DOI 10.1016/j.eururo.2007.01.070; KENNEDY SM, 1990, HUM PATHOL, V21, P449, DOI 10.1016/0046-8177(90)90209-N; Marin-Aguilera M, 2007, EUR UROL, V51, P409, DOI 10.1016/j.eururo.2006.08.045; May M, 2013, J UROL; Mejean A, 2003, J UROLOGY, V169, P1287, DOI 10.1097/01.ju.0000050221.51509.f5; Meloni-Ehrig AM, 2002, AM J MED GENET, V115, P164, DOI 10.1002/ajmg.10697; Misumi T, 2012, CANCER GENET-NY, V205, P313, DOI 10.1016/j.cancergen.2012.04.008; Orsola A, 2005, UROLOGY, V65, P49, DOI 10.1016/j.urology.2004.08.012; Oudard S, 2007, J UROLOGY, V177, P1698, DOI 10.1016/j.juro.2007.01.063; Parker R, 2005, UROLOGY, V66, P11109, DOI 10.1016/j.urology.2005.06.074; Pei JM, 2010, GENE CHROMOSOME CANC, V49, P610, DOI 10.1002/gcc.20771; SCHOENBERG M, 1995, GENE CHROMOSOME CANC, V12, P76, DOI 10.1002/gcc.2870120115; Singh Iqbal, 2002, International Urology and Nephrology, V34, P91, DOI 10.1023/A:1021315130481; Staehler M, 2009, CLIN GENITOURIN CANC, V7, P58, DOI 10.3816/CGC.2009.n.010; Tokuda N, 2006, J UROLOGY, V176, P40, DOI 10.1016/S0022-5347(06)00502-7; Verdorfer I, 1998, INT J ONCOL, V13, P461; Wilhelm M, 2002, CANCER RES, V62, P957; Wright JL, 2009, J UROLOGY, V182, P2595, DOI 10.1016/j.juro.2009.08.049	34	28	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78137	10.1371/journal.pone.0078137	http://dx.doi.org/10.1371/journal.pone.0078137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167600	Green Published, gold			2022-12-27	WOS:000326034500060
J	Zeng, ZP; Zhou, JQ; Hou, YX; Liang, XJ; Zhang, ZG; Xu, XJ; Xie, Q; Li, WH; Huang, ZR				Zeng, Zhipeng; Zhou, Jieqiong; Hou, Yuxi; Liang, Xiaojing; Zhang, Ziguan; Xu, Xuejing; Xie, Qiang; Li, Weihua; Huang, Zhengrong			Electrophysiological Characteristics of a SCN5A Voltage Sensors Mutation R1629Q Associated With Brugada Syndrome	PLOS ONE			English	Article							LONG QT SYNDROME; SODIUM-CHANNEL; DILATED CARDIOMYOPATHY; MOTION ABNORMALITIES; SLOW INACTIVATION; DOMAIN IV; CHANNELOPATHIES; FIBRILLATION; ACTIVATION; MECHANISMS	Brugada syndrome (BrS) is an inherited arrhythmogenic syndrome leading to sudden cardiac death, partially associated with autosomal dominant mutations in SCN5A, which encodes the cardiac sodium channel alpha-subunit (Na(v)1.5). To date some SCN5A mutations related with BrS have been identified in voltage sensor of Na(v)1.5. Here, we describe a dominant missense mutation (R1629Q) localized in the fourth segment of domain IV region (DIV-S4) in a Chinese Han family. The mutation was identified by direct sequencing of SCN5A from the proband's DNA. Co-expression of Wild-type (WT) or R1629Q Na(v)1.5 channel and h beta 1 subunit were achieved in human embryonic kidney cells by transient transfection. Sodium currents were recorded using whole cell patch-clamp protocols. No significant changes between WT and R1629Q currents were observed in current density or steady-state activation. However, hyperpolarized shift of steady-state inactivation curve was identified in cells expressing R1629Q channel (WT: V-1/2 = -81.1 +/- 1.3 mV, n = 13; R1629Q: V-1/2 = -101.7 +/- 1.2 mV, n = 18). Moreover, R1629Q channel showed enhanced intermediate inactivation and prolonged recovery time from inactivation. In summary, this study reveals that R1629Q mutation causes a distinct loss-of-function of the channel due to alter its electrophysiological characteristics, and facilitates our understanding of biophysical mechanisms of BrS.	[Zeng, Zhipeng; Zhou, Jieqiong; Hou, Yuxi; Liang, Xiaojing; Zhang, Ziguan; Xu, Xuejing; Xie, Qiang; Li, Weihua; Huang, Zhengrong] Xiamen Univ, Dept Cardiol, Affiliated Hosp 1, Xiamen, Peoples R China	Xiamen University	Li, WH (corresponding author), Xiamen Univ, Dept Cardiol, Affiliated Hosp 1, Xiamen, Peoples R China.	liweihuaxm@hotmail.com; huangzhengrong1@gmail.com	zeng, zhipeng/I-8456-2014		Chinese National Science Foundation [81170090, 81270277]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese National Science Foundation (No. 81170090 and No 81270277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Antzelevitch Charles, 2008, Curr Cardiol Rep, V10, P376, DOI 10.1007/s11886-008-0060-y; Bai R, 2009, CIRC-ARRHYTHMIA ELEC, V2, P6, DOI 10.1161/CIRCEP.108.782888; Berne P, 2012, CIRC J, V76, P1563, DOI 10.1253/circj.CJ-12-0717; Calloe K, 2013, CIRC-ARRHYTHMIA ELEC, V6, P177, DOI 10.1161/CIRCEP.112.974220; Capes DL, 2013, J GEN PHYSIOL, V142, P101, DOI 10.1085/jgp.201310998; Casini S, 2007, CARDIOVASC RES, V76, P418, DOI 10.1016/j.cardiores.2007.08.005; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Chen PS, 2008, J AM COLL CARDIOL, V51, P1176, DOI 10.1016/j.jacc.2007.12.006; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Goldschen-Ohm MP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2356; Hanck DA, 2007, TOXICON, V49, P181, DOI 10.1016/j.toxicon.2006.09.017; Huang ZR, 2007, CHINESE MED J-PEKING, V120, P1898, DOI 10.1097/00029330-200711010-00009; Ishikawa T, 2013, CIRC J, V77, P959, DOI 10.1253/circj.CJ-12-0995; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Mann SA, 2012, J AM COLL CARDIOL, V60, P1566, DOI 10.1016/j.jacc.2012.05.050; McNair WP, 2011, J AM COLL CARDIOL, V57, P2160, DOI 10.1016/j.jacc.2010.09.084; Mitrovic N, 2000, J GEN PHYSIOL, V115, P707, DOI 10.1085/jgp.115.6.707; Nair K, 2012, HEART RHYTHM, V9, P1681, DOI 10.1016/j.hrthm.2012.06.029; Olesen MS, 2012, CIRC-CARDIOVASC GENE, V5, P450, DOI 10.1161/CIRCGENETICS.111.962597; Schwartz PJ, 2013, J AM COLL CARDIOL, V62, P169, DOI 10.1016/j.jacc.2013.04.044; Sheets MF, 1999, BIOPHYS J, V77, P747, DOI 10.1016/S0006-3495(99)76929-8; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Takagi M, 2003, HEART, V89, P169, DOI 10.1136/heart.89.2.169; Tarradas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053220; Tukkie R, 2004, CIRCULATION, V109, P1272, DOI 10.1161/01.CIR.0000118467.53182.D1; Veltmann C, 2006, EUR HEART J, V27, P2544, DOI 10.1093/eurheartj/ehl205; Wang DW, 2000, CIRC RES, V87, pE37, DOI 10.1161/01.RES.87.8.e37; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wu L, 2008, J BIOL CHEM, V283, P6968, DOI 10.1074/jbc.M709721200; Yan GX, 1999, CIRCULATION, V100, P1660, DOI 10.1161/01.CIR.100.15.1660; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Zimmer T, 2008, PROG BIOPHYS MOL BIO, V98, P120, DOI 10.1016/j.pbiomolbio.2008.10.005	34	18	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78382	10.1371/journal.pone.0078382	http://dx.doi.org/10.1371/journal.pone.0078382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167619	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500080
J	Zhao, GY; Krishnamurthy, S; Cai, ZQ; Popov, VL; da Rosa, APT; Guzman, H; Cao, S; Virgin, HW; Tesh, RB; Wang, D				Zhao, Guoyan; Krishnamurthy, Siddharth; Cai, Zhengqiu; Popov, Vsevolod L.; da Rosa, Amelia P. Travassos; Guzman, Hilda; Cao, Song; Virgin, Herbert W.; Tesh, Robert B.; Wang, David			Identification of Novel Viruses Using VirusHunter - an Automated Data Analysis Pipeline	PLOS ONE			English	Article							HUMAN PARVOVIRUS; PROTEIN; ALIGNMENT	Quick and accurate identification of microbial pathogens is essential for both diagnosis and response to emerging infectious diseases. The advent of next-generation sequencing technology offers an unprecedented platform for rapid sequencing-based identification of novel viruses. We have developed a customized bioinformatics data analysis pipeline, VirusHunter, for the analysis of Roche/454 and other long read Next generation sequencing platform data. To illustrate the utility of VirusHunter, we performed Roche/454 GS FLX titanium sequencing on two unclassified virus isolates from the World Reference Center for Emerging Viruses and Arboviruses (WRCEVA). VirusHunter identified sequences derived from a novel bunyavirus and a novel reovirus in the two samples respectively. Further sequence analysis demonstrated that the viruses were novel members of the Phlebovirus and Orbivirus genera. Both Phlebovirus and Orbivirus genera include many economic important viruses or serious human pathogens.	[Zhao, Guoyan; Cai, Zhengqiu; Cao, Song; Virgin, Herbert W.; Wang, David] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Zhao, Guoyan; Cai, Zhengqiu; Cao, Song; Virgin, Herbert W.; Wang, David] Washington Univ, Sch Med, Dept Immunol, St Louis, MO USA; [Zhao, Guoyan; Krishnamurthy, Siddharth; Cai, Zhengqiu; Cao, Song; Virgin, Herbert W.; Wang, David] Midwest Reg Ctr Excellence Biodef & Emerging Dis, St Louis, MO USA; [Krishnamurthy, Siddharth; Wang, David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Popov, Vsevolod L.; da Rosa, Amelia P. Travassos; Guzman, Hilda; Tesh, Robert B.] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Medical Branch Galveston	Wang, D (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	davewang@wustl.edu		Virgin, Herbert/0000-0001-8580-7628; Krishnamurthy, Siddharth/0000-0003-1777-8292; Zhao, Guoyan/0000-0001-5615-6774	National Institutes of Health Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research [U54 AI057160]; NIAID [HHSN27220100004OI/HHSN27200004]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160] Funding Source: NIH RePORTER	National Institutes of Health Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research [U54 AI057160] and by NIAID contract HHSN27220100004OI/HHSN27200004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797; Benjamin LA, 2011, EMERG INFECT DIS, V17, P1484, DOI 10.3201/eid1708.110165; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Cheng LL, 1999, AM J TROP MED HYG, V60, P430, DOI 10.4269/ajtmh.1999.60.430; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Dilcher M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-166; ELMEKKI AA, 1981, T ROY SOC TROP MED H, V75, P799; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Holtz LR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-86; Karabatsos N, 1985, INT CATALOGUE ARBOVI, P885; King A.M.Q., 2011, VIRUS TAXONOMY, P1338; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loh J, 2011, J VIROL, V85, P2642, DOI 10.1128/JVI.01661-10; Loh J, 2009, J VIROL, V83, P13019, DOI 10.1128/JVI.00638-09; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; MIURA T, 1977, ARCH VIROL, V53, P281, DOI 10.1007/BF01315626; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palacios G, 2013, J GEN VIROL, V94, P837, DOI 10.1099/vir.0.048850-0; Palacios G, 2011, J GEN VIROL, V92, P1445, DOI 10.1099/vir.0.029389-0; Presti RM, 2009, J VIROL, V83, P11599, DOI 10.1128/JVI.00677-09; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Shi XH, 2006, J VIROL, V80, P8089, DOI 10.1128/JVI.00579-06; SHOPE RE, 1981, AM J TROP MED HYG, V30, P509, DOI 10.4269/ajtmh.1981.30.509; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Yokoyama CC, 2012, J VIROL, V86, P12262, DOI 10.1128/JVI.02018-12	36	59	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78470	10.1371/journal.pone.0078470	http://dx.doi.org/10.1371/journal.pone.0078470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167629	gold, Green Published			2022-12-27	WOS:000326034500090
J	Das, R				Das, Rhiju			Atomic-Accuracy Prediction of Protein Loop Structures through an RNA-Inspired Ansatz	PLOS ONE			English	Article							MOLECULAR-STRUCTURE; CRYSTAL; REFINEMENT; DOCKING; DESIGN; MODEL; CRYSTALLOGRAPHY; CONFORMATIONS; OPTIMIZATION; CASP9	Consistently predicting biopolymer structure at atomic resolution from sequence alone remains a difficult problem, even for small sub-segments of large proteins. Such loop prediction challenges, which arise frequently in comparative modeling and protein design, can become intractable as loop lengths exceed 10 residues and if surrounding side-chain conformations are erased. Current approaches, such as the protein local optimization protocol or kinematic inversion closure (KIC) Monte Carlo, involve stages that coarse-grain proteins, simplifying modeling but precluding a systematic search of all-atom configurations. This article introduces an alternative modeling strategy based on a 'stepwise ansatz', recently developed for RNA modeling, which posits that any realistic all-atom molecular conformation can be built up by residue-by-residue stepwise enumeration. When harnessed to a dynamic-programming-like recursion in the Rosetta framework, the resulting stepwise assembly (SWA) protocol enables enumerative sampling of a 12 residue loop at a significant but achievable cost of thousands of CPU-hours. In a previously established benchmark, SWA recovers crystallographic conformations with sub-Angstrom accuracy for 19 of 20 loops, compared to 14 of 20 by KIC modeling with a comparable expenditure of computational power. Furthermore, SWA gives high accuracy results on an additional set of 15 loops highlighted in the biological literature for their irregularity or unusual length. Successes include cis-Pro touch turns, loops that pass through tunnels of other side-chains, and loops of lengths up to 24 residues. Remaining problem cases are traced to inaccuracies in the Rosetta all-atom energy function. In five additional blind tests, SWA achieves sub-Angstrom accuracy models, including the first such success in a protein/RNA binding interface, the YbxF/kink-turn interaction in the fourth 'RNA-puzzle' competition. These results establish all-atom enumeration as an unusually systematic approach to ab initio protein structure modeling that can leverage high performance computing and physically realistic energy functions to more consistently achieve atomic accuracy.	[Das, Rhiju] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Das, Rhiju] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University; Stanford University	Das, R (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	rhiju@stanford.edu		Das, Rhiju/0000-0001-7497-0972	Burroughs Wellcome Career Award at the Scientific Interface; NIH [R21 GM102716]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM102716] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support came from a Burroughs Wellcome Career Award at the Scientific Interface and NIH R21 GM102716. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2013, ANNU REV BIOPHYS, V42, P265, DOI 10.1146/annurev-biophys-083012-130253; Baird NJ, 2012, RNA, V18, P759, DOI 10.1261/rna.031518.111; BUCKLE AM, 1993, J MOL BIOL, V234, P847, DOI 10.1006/jmbi.1993.1630; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Chen SJ, 2000, P NATL ACAD SCI USA, V97, P646, DOI 10.1073/pnas.97.2.646; Chou FC, 2013, NAT METHODS, V10, P74, DOI [10.1038/NMETH.2262, 10.1038/nmeth.2262]; Chu MH, 2011, PLANTA, V234, P243, DOI 10.1007/s00425-011-1398-8; Cruz JA, 2012, RNA, V18, P610, DOI 10.1261/rna.031054.111; Das R, 2011, PLOS ONE, V6; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Eddy SR, 2004, NAT BIOTECHNOL, V22, P909, DOI 10.1038/nbt0704-909; Eswar N, 2003, PROTEIN ENG, V16, P331, DOI 10.1093/protein/gzg046; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fleishman SJ, 2012, CELL, V149, P262, DOI 10.1016/j.cell.2012.03.016; GIBSON KD, 1987, J COMPUT CHEM, V8, P826, DOI 10.1002/jcc.540080611; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Grigg JC, 2013, P NATL ACAD SCI USA, V110, P7240, DOI 10.1073/pnas.1222214110; Hammond NB, 2010, BIOCHEMISTRY-US, V49, P5817, DOI 10.1021/bi100332r; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HARRIS GW, 1992, ACTA CRYSTALLOGR B, V48, P67, DOI 10.1107/S0108768191006663; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hockenmaier J, 2007, PROTEINS, V66, P1, DOI 10.1002/prot.21195; Kim DE, 2009, J MOL BIOL, V393, P249, DOI 10.1016/j.jmb.2009.07.063; Kinch L, 2011, PROTEINS, V79, P59, DOI 10.1002/prot.23181; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Kratzner R, 2005, ACTA CRYSTALLOGR D, V61, P1255, DOI 10.1107/S0907444905021207; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Lyskov S, 2013, PLOS ONE IN PRESS; Mandell DJ, 2009, CURR OPIN BIOTECH, V20, P420, DOI 10.1016/j.copbio.2009.07.006; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Martin ACR, 1995, PROTEIN ENG, V8, P1093; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MCPHALEN CA, 1985, P NATL ACAD SCI USA, V82, P7242, DOI 10.1073/pnas.82.21.7242; MCPHALEN CA, 1987, BIOCHEMISTRY-US, V26, P261, DOI 10.1021/bi00375a036; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Ollikainen N, 2013, METHOD ENZYMOL, V523, P61, DOI 10.1016/B978-0-12-394292-0.00004-7; Ozkan SB, 2007, P NATL ACAD SCI USA, V104, P11987, DOI 10.1073/pnas.0703700104; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Raval A, 2012, PROTEINS; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014; Sellers BD, 2008, PROTEINS, V72, P959, DOI 10.1002/prot.21990; Sontag D, 2008, TIGHTENING LP RELAXA, P503; Sripakdeevong P, 2011, P NATL ACAD IN PRESS; Sripakdeevong P, 2013, NAT METHODS IN PRESS; Sripakdeevong P, 2011, P NATL ACAD SCI USA, V108, P20573, DOI 10.1073/pnas.1106516108; Urakubo Y, 2008, PROTEIN SCI, V17, P1055, DOI 10.1110/ps.073322508; VAJDA S, 1990, BIOPOLYMERS, V29, P1755, DOI 10.1002/bip.360291408; Vallurupalli P, 2012, J AM CHEM SOC, V134, P8148, DOI 10.1021/ja3001419; Vernon R, 2010, STRUCTURE PREDICTION; Videau LL, 2004, PROTEINS, V56, P298, DOI 10.1002/prot.20101; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Xu D, 2011, PROTEINS, V79, P147, DOI 10.1002/prot.23111; Zhu K, 2006, PROTEINS, V65, P438, DOI 10.1002/prot.21040	65	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e74830	10.1371/journal.pone.0074830	http://dx.doi.org/10.1371/journal.pone.0074830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204571	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600003
J	Jonas, JB; Nangia, V; Matin, A; Bhojwani, K; Sinha, A; Khare, A; Agarwal, S; Bhate, K				Jonas, Jost B.; Nangia, Vinay; Matin, Arshia; Bhojwani, Krishna; Sinha, Ajit; Khare, Anshu; Agarwal, Shubhra; Bhate, Karishma			Pseudoexfoliation: Normative Data and Associations. The Central India Eye and Medical Study	PLOS ONE			English	Article							POPULATION-BASED SURVEY; ANGLE-CLOSURE GLAUCOMA; EXFOLIATION SYNDROME; INTRAOCULAR-PRESSURE; OCCLUDABLE ANGLES; THESSALONIKI EYE; CHINESE PEOPLE; SOUTHERN INDIA; PREVALENCE; CHAMBER	Purpose: To assess the prevalence of pseudoexfoliation (PEX) and its associations in a population-based setting. Design: Population-based, cross-sectional study. Methods: The Central India Eye and Medical Study included 4711 individuals. All study participants underwent a detailed ophthalmological examination. After medical pupil dilation, PEX was assessed by an experienced ophthalmologist using slit-lamp based biomicroscopy. Results: Slit lamp examination results were available for 4646 (98.6%) study participants with a mean age of 49.3 +/- 13.3 years (range: 30-100 years). PEX was detected in 87 eyes (prevalence: 0.95 +/- 0.10% (95% CI: 0.75, 1.15) of 69 subjects (prevalence: 1.49 +/- 0.18% (95% CI: 1.14, 1.83). PEX prevalence increased significantly (P<0.001) from 0% in the age group of 30-39 years, to 2.85 +/- 0.56% in the age group of 60-69 years, to 6.60 +/- 1.21% in the age group of 70-79 years, and to 12.3 +/- 4.11% in the age group of 80+ years. In multivariate analysis, PEX prevalence was associated with higher age (P<0.001; regression coefficient B:0.11; odds ratio (OR): 1.11 (95% CI: 1.09, 1.13)), lower body mass index (P = 0.001; B:-0.12; OR: 0.88 (95CI: 0.82, 0.95)) and higher diastolic blood pressure (P = 0.002; B: 0.02; OR: 1.03 (95% CI: 1.01, 1.04)). In the multivariate analysis, PEX was not associated with retinal nerve fiber layer cross section area (P = 0.76) and presence of open-angle glaucoma (P = 0.15). Conclusions: In a rural Central Indian population aged 30+ years, PEX prevalence (mean: 1.49 +/- 0.18%) was significantly associated with older age, lower body mass index and higher diastolic blood pressure. It was not significantly associated with optic nerve head measurements, refractive error, any ocular biometric parameter, nuclear cataract, early age-related macular degeneration and retinal vein occlusion, diabetes mellitus, smoking, and dyslipidemia.	[Jonas, Jost B.; Nangia, Vinay; Matin, Arshia; Bhojwani, Krishna; Sinha, Ajit; Khare, Anshu; Agarwal, Shubhra; Bhate, Karishma] Suraj Eye Inst, Nagpur, Maharashtra, India; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Suraj Eye Institute; Ruprecht Karls University Heidelberg	Jonas, JB (corresponding author), Suraj Eye Inst, Nagpur, Maharashtra, India.	Jost.Jonas@medma.uni-heidelberg.de; nagpursuraj@gmail.com	Bhate, Karishma/AAD-8609-2019		Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	Supported by an unrestricted grant from Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; and Carl Zeiss Meditec Co., Jena, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman AM, 2008, BRIT J OPHTHALMOL, V92, P1325, DOI 10.1136/bjo.2008.141523; Anastasopoulos E, 2011, J GLAUCOMA, V20, P160, DOI 10.1097/IJG.0b013e3181d9d8bd; Arnarsson A, 2007, ACTA OPHTHALMOL SCAN, V85, P822, DOI 10.1111/j.1600-0420.2007.01051.x; Arvind H, 2003, BRIT J OPHTHALMOL, V87, P1321, DOI 10.1136/bjo.87.11.1321; Astrom S, 2007, ACTA OPHTHALMOL SCAN, V85, P828, DOI 10.1111/j.1600-0420.2007.00992.x; Belovay GW, 2010, CURR OPIN OPHTHALMOL, V21, P25, DOI 10.1097/ICU.0b013e328332f814; Forsman E, 2007, ACTA OPHTHALMOL SCAN, V85, P500, DOI 10.1111/j.1600-0420.2007.00978.x; Foster PJ, 2005, BRIT J OPHTHALMOL, V89, P239, DOI 10.1136/bjo.2004.047605; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Foster PJ, 2000, BRIT J OPHTHALMOL, V84, P186, DOI 10.1136/bjo.84.2.186; GROSS FJ, 1994, AM J OPHTHALMOL, V117, P333, DOI 10.1016/S0002-9394(14)73141-1; HILLER R, 1982, ARCH OPHTHALMOL-CHIC, V100, P1080; Kang JH, 2012, OPHTHALMOLOGY, V119, P27, DOI 10.1016/j.ophtha.2011.06.018; Kassoff A, 2001, AM J OPHTHALMOL, V131, P167; Krishnadas R, 2003, AM J OPHTHALMOL, V135, P830, DOI 10.1016/S0002-9394(02)02271-7; Landers J, 2012, CLIN EXP OPHTHALMOL, V40, P454, DOI 10.1111/j.1442-9071.2011.02696.x; McCarty CA, 2000, AM J OPHTHALMOL, V129, P629, DOI 10.1016/S0002-9394(99)00466-3; Miyazaki M, 2005, J GLAUCOMA, V14, P482, DOI 10.1097/01.ijg.0000185436.15675.b3; Nangia V, 2010, OPHTHALMOLOGY, V117, P1360, DOI 10.1016/j.ophtha.2009.11.040; Naumann GOH, 1998, OPHTHALMOLOGY, V105, P951, DOI 10.1016/S0161-6420(98)96020-1; Nouri-Mahdavi K, 1999, ACTA OPHTHALMOL SCAN, V77, P581, DOI 10.1034/j.1600-0420.1999.770521.x; Ritch R, 1994, J Glaucoma, V3, P176; Ritch R, SURV OPHTHALMOL, V45, P265; Rotchford AP, 2003, ARCH OPHTHALMOL-CHIC, V121, P863, DOI 10.1001/archopht.121.6.863; Rudkin AK, 2008, BRIT J OPHTHALMOL, V92, P1595, DOI 10.1136/bjo.2008.146407; SCHLOTZERSCHREHARDT UM, 1992, ARCH OPHTHALMOL-CHIC, V110, P1752, DOI 10.1001/archopht.1992.01080240092038; Stein JD, 2011, ARCH OPHTHALMOL-CHIC, V129, P1053, DOI 10.1001/archophthalmol.2011.191; STREETEN BW, 1992, ARCH OPHTHALMOL-CHIC, V110, P1757, DOI 10.1001/archopht.1992.01080240097039; Thomas R, 2005, INVEST OPHTH VIS SCI, V46, P1170, DOI 10.1167/iovs.04-1062; Thomas R, 2012, INDIAN J OPHTHALMOL, V60, P446, DOI 10.4103/0301-4738.100546; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Topouzis F, 2011, AM J OPHTHALMOL, V152, P219, DOI 10.1016/j.ajo.2011.01.032; Topouzis F, 2009, AM J OPHTHALMOL, V148, P606, DOI 10.1016/j.ajo.2009.03.024; VANHERICK W, 1969, AM J OPHTHALMOL, V68, P626, DOI 10.1016/0002-9394(69)91241-0; Viso E, 2010, OPHTHAL EPIDEMIOL, V17, P118, DOI 10.3109/09286581003624970; You QS, 2013, OPHTHALMOLOGY, V2013; Young AL, 2004, BRIT J OPHTHALMOL, V88, P193, DOI 10.1136/bjo.2003.021816	37	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76770	10.1371/journal.pone.0076770	http://dx.doi.org/10.1371/journal.pone.0076770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204672	gold, Green Published, Green Submitted			2022-12-27	WOS:000326032600010
J	Sakai, R; Wang, W; Yamaguchi, N; Tamura, H; Goto, R; Kawachi, I				Sakai, Rie; Wang, Wei; Yamaguchi, Norihiro; Tamura, Hiroshi; Goto, Rei; Kawachi, Ichiro			The Impact of Japan's 2004 Postgraduate Training Program on Intra-prefectural Distribution of Pediatricians in Japan	PLOS ONE			English	Article							GEOGRAPHIC-DISTRIBUTION; MEDICAL-SCHOOL; PHYSICIANS; MALDISTRIBUTION; UNIVERSITY; EDUCATION; CHOICE	Objective: Inequity in physician distribution poses a challenge to many health systems. In Japan, a new postgraduate training program for all new medical graduates was introduced in 2004, and researchers have argued that this program has increased inequalities in physician distribution. We examined the trends in the geographic distribution of pediatricians as well as all physicians from 1996 to 2010 to identify the impact of the launch of the new training program. Methods: The Gini coefficient was calculated using municipalities as the study unit within each prefecture to assess whether there were significant changes in the intra-prefectural distribution of all physicians and pediatricians before and after the launch of the new training program. The effect of the new program was quantified by estimating the difference in the slope in the time trend of the Gini coefficients before and after 2004 using a linear change-point regression design. We categorized 47 prefectures in Japan into two groups: 1) predominantly urban and 2) others by the definition from OECD to conduct stratified analyses by urban-rural status. Results: The trends in physician distribution worsened after 2004 for all physicians (p value<.0001) and pediatricians (p value = 0.0057). For all physicians, the trends worsened after 2004 both in predominantly urban prefectures (p value = 0.0012) and others (p value<0.0001), whereas, for pediatricians, the distribution worsened in others (p value = 0.0343), but not in predominantly urban prefectures (p value = 0.0584). Conclusion: The intra-prefectural distribution of physicians worsened after the launch of the new training program, which may reflect the impact of the new postgraduate program. In pediatrics, changes in the Gini trend differed significantly before and after the launch of the new training program in others, but not in predominantly urban prefectures. Further observation is needed to explore how this difference in trends affects the health status of the child population.	[Wang, Wei] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Sakai, Rie] Juntendo Univ, Sch Med, Dept Med Educ, Tokyo 113, Japan; [Sakai, Rie] Juntendo Univ, Sch Med, Dept Pediat & Adolescent Med, Tokyo 113, Japan; [Wang, Wei] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Wang, Wei] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Yamaguchi, Norihiro] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA; [Tamura, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Tamura, Hiroshi] Kyoto Univ Hosp, Solut Ctr Hlth Insurance Claims, Kyoto 606, Japan; [Tamura, Hiroshi] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Goto, Rei] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto, Japan; [Goto, Rei] Kyoto Univ, Grad Sch Econ, Sakyo Ku, Kyoto, Japan; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Juntendo University; Juntendo University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Kyoto University; Kyoto University; Harvard University; Harvard T.H. Chan School of Public Health; Kyoto University; Kyoto University; Harvard University; Harvard T.H. Chan School of Public Health	Sakai, R (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	rsakai@hsph.harvard.edu	TAMURA, Hiroshi/H-1855-2011; Sakai-Bizmark, Rie/AAK-4146-2020	TAMURA, Hiroshi/0000-0002-7740-2732; Sakai-Bizmark, Rie/0000-0003-2452-5832	Japan Medical Association	Japan Medical Association	Rie Sakai was Supported by the fellowship program by the Japan Medical Association during the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 1998, Aust J Rural Health, V6, P136, DOI 10.1111/j.1440-1584.1998.tb00299.x; Association to support the certification of dease due to overwork of Dr.Nakahara, INC DEATH DUE OV DR; Australian Medical Workforce Advisory Committee (AMWAC), 2000, Aust Health Rev, V23, P8; Bureau of Statistics Ministry of Internal Affairs and Communications, 2005, MAJ METR AR METR AR; Dejardin O, 2005, BRIT J CANCER, V92, P1842, DOI 10.1038/sj.bjc.6602571; Deltas G, 2003, REV ECON STAT, V85, P226, DOI 10.1162/rest.2003.85.1.226; Ehara A, 2007, NIHON ISHIKAI ZASSHI, V136, P1804; Ehara A, 2008, J JAPANESE PEDIAT SO, V112, P879; Gorman D, 2007, INTERN MED J, V37, P669, DOI 10.1111/j.1445-5994.2007.01461.x; Gravelle H, 2001, J Health Serv Res Policy, V6, P6, DOI 10.1258/1355819011927143; Hann M, 2004, BRIT J GEN PRACT, V54, P894; Japan Pediatric Society & Investigative Committee for Pediatric Care Structure, REF PED CAR STRUCT; KOBAYASHI Y, 1992, LANCET, V340, P1391, DOI 10.1016/0140-6736(92)92569-2; Lagarde M, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-62; LAUNOY G, 1992, J EPIDEMIOL COMMUN H, V46, P365, DOI 10.1136/jech.46.4.365; Matsumoto M, 2012, RURAL REMOTE HEALTH, V12; Matsumoto M, 2010, HEALTH POLICY, V96, P255, DOI 10.1016/j.healthpol.2010.02.012; Matsumoto M, 2010, HEALTH POLICY, V96, P239, DOI 10.1016/j.healthpol.2010.02.008; Matsumoto M, 2010, J RURAL HEALTH, V26, P234, DOI 10.1111/j.1748-0361.2010.00286.x; Matsumoto M, 2010, HEALTH PLACE, V16, P164, DOI 10.1016/j.healthplace.2009.07.005; Matsumoto M, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-12; McEldowney R P, 1995, J Manag Med, V9, P68, DOI 10.1108/02689239510096839; McMurray JE, 2005, AM J MED, V118, P87, DOI 10.1016/j.amjmed.2004.11.005; Ministry of Health, SURV SUMM, P1; Ministry of Health, SURV SUMM; Ministry of Health, SURV PHYS DENT PHARM; Ministry of Health Labor and Welfare, REV POSTGR TRAIN PRO; Ministry of Health Labour and Welfare Outline of postgraduate clinical training, C WORK GROUP POSTGR; Ministry of Internal Affairs and Communications, BAS RES REG; Niel X, 2001, Cah Sociol Demogr Med, V41, P141; Nomura K, 2008, J GEN INTERN MED, V23, P1105, DOI 10.1007/s11606-008-0644-7; Odisho AY, 2009, J UROLOGY, V181, P760, DOI 10.1016/j.juro.2008.10.034; OECD, OECD REG TYP; Ogawa A, NEW POSTGRADUATE TRA; Ono K, 2010, OPHTHAL EPIDEMIOL, V17, P125, DOI 10.3109/09286581003624988; Rabinowitz HK, 2000, J RURAL HEALTH, V16, P249, DOI 10.1111/j.1748-0361.2000.tb00468.x; Rabinowitz HK, 2008, ACAD MED, V83, P235, DOI 10.1097/ACM.0b013e318163789b; Rabinowitz HK, 2012, ACAD MED, V87, P488, DOI 10.1097/ACM.0b013e3182488b19; Ricketts TC, 2000, ANNU REV PUBL HEALTH, V21, P639, DOI 10.1146/annurev.publhealth.21.1.639; Rosenthal MB, 2005, HEALTH SERV RES, V40, P1931, DOI 10.1111/j.1475-6773.2005.00440.x; Sakai R, 2011, ASIA PAC J PUBLIC HL; SCHWARTZ WB, 1980, NEW ENGL J MED, V303, P1032, DOI 10.1056/NEJM198010303031803; Science Counsel of Japan, THOS UND MALD PHYS; Shimada N, 2004, JPN J PUBL HLTH, V51, P117; Smith KB, 2008, AUST J RURAL HEALTH, V16, P56, DOI 10.1111/j.1440-1584.2008.00953.x; Stordeur S, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-28; Tanihara S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-260; Taylor HA, 2002, AM J PUBLIC HEALTH, V92, P548, DOI 10.2105/AJPH.92.4.548; The Kochi Shimbun, SHORT PHYS STILL EXS; Toyabe S, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-5; Wainer J, 2000, Aust J Rural Health, V8, P141, DOI 10.1046/j.1440-1584.2000.00304.x; Yang B M, 1989, Asia Pac J Public Health, V3, P68, DOI 10.1177/101053958900300110; Yang BM, 1989, ASIA-PAC J PUBLIC HE, V3, P85	53	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77045	10.1371/journal.pone.0077045	http://dx.doi.org/10.1371/journal.pone.0077045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24204731	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500013
J	Feehery, GR; Yigit, E; Oyola, SO; Langhorst, BW; Schmidt, VT; Stewart, FJ; Dimalanta, ET; Amaral-Zettler, LA; Davis, T; Quail, MA; Pradhan, S				Feehery, George R.; Yigit, Erbay; Oyola, Samuel O.; Langhorst, Bradley W.; Schmidt, Victor T.; Stewart, Fiona J.; Dimalanta, Eileen T.; Amaral-Zettler, Linda A.; Davis, Theodore; Quail, Michael A.; Pradhan, Sriharsa			A Method for Selectively Enriching Microbial DNA from Contaminating Vertebrate Host DNA	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; MITOCHONDRIAL-DNA; CPG METHYLATION; ORNAMENTAL FISH; GUT; BIODIVERSITY; BACTERIA; SEQUENCE; ABSENCE	DNA samples derived from vertebrate skin, bodily cavities and body fluids contain both host and microbial DNA; the latter often present as a minor component. Consequently, DNA sequencing of a microbiome sample frequently yields reads originating from the microbe(s) of interest, but with a vast excess of host genome-derived reads. In this study, we used a methyl-CpG binding domain (MBD) to separate methylated host DNA from microbial DNA based on differences in CpG methylation density. MBD fused to the Fc region of a human antibody (MBD-Fc) binds strongly to protein A paramagnetic beads, forming an effective one-step enrichment complex that was used to remove human or fish host DNA from bacterial and protistan DNA for subsequent sequencing and analysis. We report enrichment of DNA samples from human saliva, human blood, a mock malaria-infected blood sample and a black molly fish. When reads were mapped to reference genomes, sequence reads aligning to host genomes decreased 50-fold, while bacterial and Plasmodium DNA sequences reads increased 8-11.5-fold. The Shannon-Wiener diversity index was calculated for 149 bacterial species in saliva before and after enrichment. Unenriched saliva had an index of 4.72, while the enriched sample had an index of 4.80. The similarity of these indices demonstrates that bacterial species diversity and relative phylotype abundance remain conserved in enriched samples. Enrichment using the MBD-Fc method holds promise for targeted microbiome sequence analysis across a broad range of sample types.	[Feehery, George R.; Yigit, Erbay; Langhorst, Bradley W.; Stewart, Fiona J.; Dimalanta, Eileen T.; Davis, Theodore; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA USA; [Oyola, Samuel O.; Quail, Michael A.] Wellcome Trust Sanger Inst, Cambridge, England; [Schmidt, Victor T.; Amaral-Zettler, Linda A.] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Amaral-Zettler, Linda A.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Schmidt, Victor T.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	New England Biolabs; Wellcome Trust Sanger Institute; Marine Biological Laboratory - Woods Hole; Brown University; Brown University	Pradhan, S (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	Pradhan@neb.com	Quail, michael/ABE-6131-2020; Langhorst, Bradley/AAJ-5602-2020	Langhorst, Bradley/0000-0001-7390-1094; Oyola, Samuel O./0000-0002-6425-7345	Brown University Office of the Vice President of Research; Wellcome Trust Sanger Institute [098051, 079355/Z/06/Z]	Brown University Office of the Vice President of Research; Wellcome Trust Sanger Institute(Wellcome Trust)	LAZ and VS were funded by a Brown University Office of the Vice President of Research SEED grant (LAZ) entitled "Tracking disease spread through the wildlife trade: New techniques to identify infectious microbes in aquarium fishes." SOO and MQ were funded by Wellcome Trust Sanger Institute grant numbers 098051 and 079355/Z/06/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auburn S, 2011, PLOS ONE, V6; Austin B., 2012, BACTERIAL FISH PATHO, DOI DOI 10.1007/978-94-007-4884-2; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BOUDRAA M, 1987, NUCLEIC ACIDS RES, V15, P5729; Bright AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-262; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; CHAVES AL, 1995, PLANT MOL BIOL REP, V13, P18, DOI 10.1007/BF02668389; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; DAWID IB, 1974, SCIENCE, V184, P80, DOI 10.1126/science.184.4132.80; Diaz PI, 2012, MOL ORAL MICROBIOL, V27, P182, DOI 10.1111/j.2041-1014.2012.00642.x; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Gebhard C, 2006, CANCER RES, V66, P6118, DOI 10.1158/0008-5472.CAN-06-0376; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Goecks J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-397; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hong EE, 2013, MOL CELL BIOL, V33, P2683, DOI 10.1128/MCB.00220-13; Horz HP, 2010, ANAEROBE, V16, P47, DOI 10.1016/j.anaerobe.2009.04.009; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lazarevic Vladimir, 2012, J Clin Bioinforma, V2, P4, DOI 10.1186/2043-9113-2-4; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037919; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morgan XC, 2013, TRENDS GENET, V29, P51, DOI 10.1016/j.tig.2012.09.005; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; NIKOLSKA.II, 1968, BIOCHIM BIOPHYS ACTA, V155, P626, DOI 10.1016/0005-2787(68)90211-6; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Oyola SO, 2013, J CLIN MICROBIOL, V51, P745, DOI 10.1128/JCM.02507-12; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; REIS RJS, 1983, J BIOL CHEM, V258, P9078; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; RITCHOT N, 1990, GENE, V86, P103, DOI 10.1016/0378-1119(90)90120-G; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Shah N, 2011, BIOCOMPUT-PAC SYM, P165; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Verner-Jeffreys DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008388; Weir M, 2012, EPIDEMIOL INFECT, V140, P192, DOI 10.1017/S0950268811001798	46	101	115	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76096	10.1371/journal.pone.0076096	http://dx.doi.org/10.1371/journal.pone.0076096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204593	Green Published, gold			2022-12-27	WOS:000326241200010
J	Chen, XJ; Ghazanfar, B; Khan, AR; Hayat, S; Cheng, ZH				Chen, Xuejin; Ghazanfar, Bushra; Khan, Abdul Rehman; Hayat, Sikandar; Cheng, Zhihui			Comparative Analysis of Putative Orthologues of Mitochondrial Import Motor Subunit: Pam18 and Pam16 in Plants	PLOS ONE			English	Article							PROTEIN IMPORT; TRANSLOCATION; COMPONENTS	Pam18/Tim14 and Pam16/Tim16, highly conserved proteins among eukaryotes, are two essential subunits of protein import motors localized in the inner mitochondrial membrane. The heterodimer formed by Pam18 and Pam16 via their J-type domains serves a regulatory function in protein translocation. Here, we report that thirty-one Pam18 and twenty-six Pam16 putative orthologues in twelve plant species were identified and analyzed through bioinformatics strategy. Results data revealed that Pam18 and Pam16 were also highly conserved among plants including their J-type domains within the hydrophilic region. Key amino acid residues and an HPD motif of Pam18 were identical among the orthologues except OsPam18L5. N-myristoylation sites of Pam18 and casein kinase II phosphorylation sites of Pam 16 were more abundant, which might be important functional sites. Some Pam18 and Pam16 proteins contained a transmembrane region at the N-terminal region. Sub-cellular prediction results indicated that many orthologues localized at mitochondria. Gene expression analyses revealed that Pam18 and Pam16 in Arabidopsis might play roles in senescence and abiotic stress responses. Our detailed study provides a better understanding of Pam18 and Pam16 in plant kingdom.	[Chen, Xuejin; Ghazanfar, Bushra; Khan, Abdul Rehman; Hayat, Sikandar; Cheng, Zhihui] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Cheng, ZH (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	chengzh@nwsuaf.edu.cn			China National Key Technology Support Program [2006BAD07B02]	China National Key Technology Support Program	This work was supported by the Grants from China National Key Technology Support Program[2006BAD07B02]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andolfo G, 2013, NEW PHYTOL, V197, P223, DOI 10.1111/j.1469-8137.2012.04380.x; Bies C, 2004, BIOL CHEM, V385, P389, DOI 10.1515/BC.2004.043; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; Elsner S, 2009, INT J MOL SCI, V10, P2041, DOI 10.3390/ijms10052041; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; Endo T, 2011, BBA-BIOMEMBRANES, V1808, P955, DOI 10.1016/j.bbamem.2010.07.018; ERNSTER L, 1981, J CELL BIOL, V91, pS227, DOI 10.1083/jcb.91.3.227s; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; GLICK BS, 1995, CELL, V80, P11, DOI 10.1016/0092-8674(95)90444-1; Guiboileau A, 2010, CR BIOL, V333, P382, DOI 10.1016/j.crvi.2010.01.016; Hamilton JP, 2012, PLANT J, V70, P177, DOI 10.1111/j.1365-313X.2012.04894.x; Ho LHM, 2008, PLANT PHYSIOL, V147, P1858, DOI 10.1104/pp.108.121384; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huber SC, 2007, BIOCHEM SOC T, V35, P28, DOI 10.1042/BST0350028; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Marom M, 2011, BBA-BIOMEMBRANES, V1808, P990, DOI 10.1016/j.bbamem.2010.07.011; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Maxwell DP, 2002, PLANT J, V29, P269, DOI 10.1046/j.1365-313X.2002.01216.x; MCBRIDE MH, 2006, CURR BIOL, V16, P551, DOI DOI 10.1016/J.SBI.2006.06.011.PUBMED:16860735; Mokranjac D, 2006, EMBO J, V25, P4675, DOI 10.1038/sj.emboj.7601334; Mokranjac D, 2010, BBA-BIOENERGETICS, V1797, P1045, DOI 10.1016/j.bbabio.2010.01.026; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Pais JE, 2011, MOL BIOL CELL, V22, P4740, DOI 10.1091/mbc.E11-08-0715; Paul P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-189; Pilon M, 1999, CELL, V97, P679, DOI 10.1016/S0092-8674(00)80780-1; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Rayon C, 1998, J EXP BOT, V49, P1463, DOI 10.1093/jexbot/49.326.1463; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Scheible WR, 2003, PLANT CELL, V15, P1781, DOI 10.1105/tpc.013342; Schilke BA, 2012, GENETICS, V190, P1341, DOI 10.1534/genetics.112.138743; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Truscott KN, 2003, CURR BIOL, V13, pR326, DOI 10.1016/S0960-9822(03)00239-2; van der Laan M, 2005, MOL CELL BIOL, V25, P7449, DOI 10.1128/MCB.25.17.7449-7458.2005; van der Laan M, 2010, BBA-MOL CELL RES, V1803, P732, DOI 10.1016/j.bbamcr.2010.01.013; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoshida S, 2003, CURR OPIN PLANT BIOL, V6, P79, DOI 10.1016/S1369526602000092; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411	49	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78400	10.1371/journal.pone.0078400	http://dx.doi.org/10.1371/journal.pone.0078400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194927	gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000106
J	Demir, YK; Akan, Z; Kerimoglu, O				Demir, Yusuf K.; Akan, Zafer; Kerimoglu, Oya			Characterization of Polymeric Microneedle Arrays for Transdermal Drug Delivery	PLOS ONE			English	Article							DISSOLVING MICRONEEDLES; FABRICATION; GEOMETRY; NEEDLES	Microfabrication of dissolvable, swellable, and biodegradable polymeric microneedle arrays (MNs) were extensively investigated based in a nano sensitive fabrication style known as micromilling that is then combined with conventional micromolding technique. The aim of this study was to describe the polymer selection, and optimize formulation compounding parameters for various polymeric MNs. Inverse replication of micromilled master MNs reproduced with polydimethylsiloxane (PDMS), where solid out of plane polymeric MNs were subsequently assembled, and physicochemically characterized. Dissolvable, swellable, and biodegradable MNs were constructed to depth of less than 1 mm with an aspect ratio of 3.6, and 1/2 mm of both inter needle tip and base spacing. Micromolding step also enabled to replicate the MNs very precisely and accurate. Polymeric microneedles (MN) precision was ranging from +/- 0.18 to +/- 1.82% for microneedle height, +/- 0.45 to +/- 1.42% for base diameter, and +/- 0.22 to +/- 0.95% for interbase spacing. Although dissolvable sodium alginate MN showed less physical robustness than biodegradable polylactic-co-glycolic acid MN, their thermogravimetric analysis is of promise for constructing these polymeric types of matrix devices.	[Demir, Yusuf K.; Kerimoglu, Oya] Marmara Univ, Fac Pharm, Dept Pharmaceut Technol, Istanbul, Turkey; [Akan, Zafer] Celal Bayar Univ, Sch Med, Dept Biophys, Manisa, Turkey	Marmara University; Celal Bayar University	Demir, YK (corresponding author), Marmara Univ, Fac Pharm, Dept Pharmaceut Technol, Istanbul, Turkey.	ykdemir@marmara.edu.tr	Sipahigil, Oya/AAA-2809-2019; Demir, Yusuf Kemal/H-4375-2019	akan, zafer/0000-0002-4150-1720; Demir, Yusuf Kemal/0000-0001-7754-7192				Armani D, 1999, PROC IEEE MICR ELECT, P222, DOI 10.1109/MEMSYS.1999.746817; Attia UM, 2009, MICROFLUID NANOFLUID, V7, P1, DOI 10.1007/s10404-009-0421-x; Bediz B, 2014, PHARM RES-DORDR, V31, P117, DOI 10.1007/s11095-013-1137-x; Birchall J, 2005, J DRUG TARGET, V13, P415, DOI 10.1080/10611860500383705; Boehm RD, 2011, AIP ADV, V1, DOI 10.1063/1.3602461; Demir YK, 2012, THESIS MARMARA U; Demir YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063819; Donnelly R.F., 2012, MICRONEEDLE MEDIATED; Donnelly RF, 2012, ADV FUNCT MATER, V22, P4879, DOI 10.1002/adfm.201200864; Donnelly RF, 2011, PHARM RES-DORDR, V28, P41, DOI 10.1007/s11095-010-0169-8; El-Zaim H. S., 2001, POLYM BIOMATERIALS, P79; Falo LD, 2011, USA, Patent No. [US 2011/0098651 Al, 20110098651]; Filiz S, 2007, INT J MACH TOOL MANU, V47, P1088, DOI 10.1016/j.ijmachtools.2006.09.024; Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017; Gittard SD, 2013, J ADHES SCI TECHNOL, V27, P227, DOI 10.1080/01694243.2012.705101; Gittard Shaun D, 2009, J Diabetes Sci Technol, V3, P304; Griss P, 2002, IEEE T BIO-MED ENG, V49, P597, DOI 10.1109/TBME.2002.1001974; Hao Yu, 2010, Proceedings of the 2010 5th IEEE International Conference on Nano/Micro Engineered and Molecular Systems (NEMS 2010), P676, DOI 10.1109/NEMS.2010.5592495; Henry S, 1998, J PHARM SCI, V87, P922, DOI 10.1021/js980042+; Hughes GA, 2005, NANOMED-NANOTECHNOL, V1, P22, DOI 10.1016/j.nano.2004.11.009; Ito Y, 2006, J DRUG TARGET, V14, P255, DOI 10.1080/10611860600785080; Kaushik D, 2010, HANDBOOK OF NON-INVASIVE DRUG DELIVERY SYSTEMS: NON-INVASIVE AND MINIMALLY-INVASIVE DRUG DELIVERY SYSTEMS FOR PHARMACEUTICAL AND PERSONAL CARE PRODUCTS, P135, DOI 10.1016/B978-0-8155-2025-2.10006-X; Kim YC, 2010, AAPS PHARMSCITECH, V11, P1193, DOI 10.1208/s12249-010-9471-3; Kolli CS, 2008, PHARM RES-DORDR, V25, P104, DOI 10.1007/s11095-007-9350-0; Korkmaz E, 2011, THESIS BILKENT U; Kurisawa M, 2005, CHEM COMMUN, P4312, DOI 10.1039/b506989k; Lee JW, 2008, BIOMATERIALS, V29, P2113, DOI 10.1016/j.biomaterials.2007.12.048; Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+; Madou M., 2002, FUNDAMENTALS MICROFA; Martanto W, 2004, PHARM RES-DORDR, V21, P947, DOI 10.1023/B:PHAM.0000029282.44140.2e; Matsuo K, 2012, J CONTROL RELEASE, V161, P10, DOI 10.1016/j.jconrel.2012.01.033; McAllister DV, 2003, P NATL ACAD SCI USA, V100, P13755, DOI 10.1073/pnas.2331316100; Michniak B., 2002, POLYM BIOMATERIALS, P1007; Migalska K, 2011, PHARM RES-DORDR, V28, P1919, DOI 10.1007/s11095-011-0419-4; Miyano T, 2005, BIOMED MICRODEVICES, V7, P185, DOI 10.1007/s10544-005-3024-7; Oh JH, 2008, EUR J PHARM BIOPHARM, V69, P1040, DOI 10.1016/j.ejpb.2008.02.009; Park JH, 2005, J CONTROL RELEASE, V104, P51, DOI 10.1016/j.jconrel.2005.02.002; Park JH, 2006, PHARM RES-DORDR, V23, P1008, DOI 10.1007/s11095-006-0028-9; Parker ER, 2007, J MICROELECTROMECH S, V16, P289, DOI 10.1109/JMEMS.2007.892909; Prausnitz MR, 2004, ADV DRUG DELIVER REV, V56, P581, DOI 10.1016/j.addr.2003.10.023; Raphael AP, 2010, SMALL, V6, P1785, DOI 10.1002/smll.201000326; Reed ML, 2004, P IEEE, V92, P56, DOI 10.1109/JPROC.2003.820542; Sammoura F, 2007, MICROSYST TECHNOL, V13, P517, DOI [10.1007/s00542-006-0204-1, 10.1007/s00542-006-0204-l]; Schneider F, 2009, SENSOR ACTUAT A-PHYS, V151, P95, DOI 10.1016/j.sna.2009.01.026; Stoeber B, 2005, J MICROELECTROMECH S, V14, P472, DOI 10.1109/JMEMS.2005.844843; Sullivan SP, 2008, ADV MATER, V20, P933, DOI 10.1002/adma.200701205; System 3R UK, 2012, COMMERCIAL MICROMANU, V4, P11; Tuo J, 2011, Patent, Patent No. [US 2011/0195124 Al, 20110195124]; Wang PM, 2002, P ANN INT IEEE EMBS, P506, DOI 10.1109/IEMBS.2002.1136918; Wilke N, 2005, SENSOR ACTUAT A-PHYS, V123-24, P319, DOI 10.1016/j.sna.2005.05.017	50	80	82	2	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77289	10.1371/journal.pone.0077289	http://dx.doi.org/10.1371/journal.pone.0077289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194879	Green Published, gold			2022-12-27	WOS:000326037000058
J	Elshoff, L; Muthuraman, M; Anwar, AR; Deuschl, G; Stephani, U; Raethjen, J; Siniatchkin, M				Elshoff, Lydia; Muthuraman, Muthuraman; Anwar, Abdul Rauf; Deuschl, Guenther; Stephani, Ulrich; Raethjen, Jan; Siniatchkin, Michael			Dynamic Imaging of Coherent Sources Reveals Different Network Connectivity Underlying the Generation and Perpetuation of Epileptic Seizures	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; SOURCE LOCALIZATION; EEG-FMRI; NEURONAL NETWORKS; FUNCTIONAL MRI; CLASSIFICATION; SEGMENTATION; CHILDREN; SPIKES; STATE	The concept of focal epilepsies includes a seizure origin in brain regions with hyper synchronous activity (epileptogenic zone and seizure onset zone) and a complex epileptic network of different brain areas involved in the generation, propagation, and modulation of seizures. The purpose of this work was to study functional and effective connectivity between regions involved in networks of epileptic seizures. The beginning and middle part of focal seizures from ictal surface EEG data were analyzed using dynamic imaging of coherent sources (DICS), an inverse solution in the frequency domain which describes neuronal networks and coherences of oscillatory brain activities. The information flow (effective connectivity) between coherent sources was investigated using the renormalized partial directed coherence (RPDC) method. In 8/11 patients, the first and second source of epileptic activity as found by DICS were concordant with the operative resection site; these patients became seizure free after epilepsy surgery. In the remaining 3 patients, the results of DICS/RPDC calculations and the resection site were discordant; these patients had a poorer post-operative outcome. The first sources as found by DICS were located predominantly in cortical structures; subsequent sources included some subcortical structures: thalamus, Nucl. Subthalamicus and cerebellum. DICS seems to be a powerful tool to define the seizure onset zone and the epileptic networks involved. Seizure generation seems to be related to the propagation of epileptic activity from the primary source in the seizure onset zone, and maintenance of seizures is attributed to the perpetuation of epileptic activity between nodes in the epileptic network. Despite of these promising results, this proof of principle study needs further confirmation prior to the use of the described methods in the clinical praxis.	[Elshoff, Lydia; Stephani, Ulrich; Siniatchkin, Michael] Univ Kiel, Dept Neuropediat, Kiel, Germany; [Muthuraman, Muthuraman; Anwar, Abdul Rauf; Deuschl, Guenther; Raethjen, Jan] Univ Kiel, Dept Neurol, Kiel, Germany; [Anwar, Abdul Rauf] Univ Kiel, Tech Fac, Kiel, Germany; [Siniatchkin, Michael] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-60054 Frankfurt, Germany	University of Kiel; University of Kiel; University of Kiel; Goethe University Frankfurt	Muthuraman, M (corresponding author), Univ Kiel, Dept Neurol, Kiel, Germany.	m.muthuraman@neurologie.uni-kiel.de	Muthuraman, Muthuraman/ABD-2021-2020; Stephani, Ulrich/D-1004-2010; Deuschl, Gunther/A-7986-2010	Muthuraman, Muthuraman/0000-0001-6158-2663; Deuschl, Gunther/0000-0002-4176-9196	Deutsche Forschungsgemeinschaft [SI1419/2-1, SFB 855]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was financially supported by the Deutsche Forschungsgemeinschaft SI1419/2-1 as well as SFB 855, D2 and D3 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arnold N, 2001, ESTIMATION PARAMETER, P27; Arthuis M, 2009, BRAIN, V132, P2091, DOI 10.1093/brain/awp086; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Ben-Ari Y, 2010, EPILEPSY CURR, V10, P118, DOI 10.1111/j.1535-7511.2010.01376.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Blanke O, 2000, CLIN NEUROPHYSIOL, V111, P763, DOI 10.1016/S1388-2457(00)00251-0; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Boon P, 2002, J CLIN NEUROPHYSIOL, V19, P461, DOI 10.1097/00004691-200210000-00009; Bouet R, 2012, NEUROIMAGE, V59, P3955, DOI 10.1016/j.neuroimage.2011.10.052; Brodbeck V, 2011, BRAIN, V134, P2887, DOI 10.1093/brain/awr243; De Tiege X, 2007, EPILEPSIA, V48, P385, DOI 10.1111/j.1528-1167.2006.00951.x; Elshoff L, 2012, EPILEPSIA, V53, P1597, DOI 10.1111/j.1528-1167.2012.03587.x; Engel J, 1993, SURG TREATMENT EPILE, P609; Federico P, 2005, BRAIN, V128, P1811, DOI 10.1093/brain/awh533; Franaszczuk PJ, 1998, ELECTROEN CLIN NEURO, V106, P513, DOI 10.1016/S0013-4694(98)00024-8; GATH I, 1992, IEEE T BIO-MED ENG, V39, P952, DOI 10.1109/10.256429; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Gotman J, 2006, J MAGN RESON IMAGING, V23, P906, DOI 10.1002/jmri.20577; Gross J, 2002, P NATL ACAD SCI USA, V99, P2299, DOI 10.1073/pnas.032682099; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Japaridze N, 2013, BRAIN TOPOGR, V26, P157, DOI 10.1007/s10548-012-0245-y; Kahane P, 2010, CURR OPIN NEUROL, V23, P177, DOI 10.1097/WCO.0b013e3283374a39; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kobayashi E, 2006, NEUROLOGY, V66, P1049, DOI 10.1212/01.wnl.0000204232.37720.a4; Kujala J, 2008, NEUROIMAGE, V39, P1706, DOI 10.1016/j.neuroimage.2007.10.042; Kuzniecky R., 1995, MAGNETIC RESONANCE E; Lantz G, 2003, CLIN NEUROPHYSIOL, V114, P63, DOI 10.1016/S1388-2457(02)00337-1; Lantz G, 1999, CLIN NEUROPHYSIOL, V110, P176, DOI 10.1016/S0013-4694(98)00117-5; Lantz G, 2001, CLIN NEUROPHYSIOL, V112, P688, DOI 10.1016/S1388-2457(01)00479-5; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Laufs H, 2012, CURR OPIN NEUROL, V25, P194, DOI 10.1097/WCO.0b013e3283515db9; Levan P, 2010, NEUROIMAGE, V49, P366, DOI 10.1016/j.neuroimage.2009.07.064; Michels L, 2013, NEUROIMAGE, V81, P231, DOI 10.1016/j.neuroimage.2013.04.030; Moeller F, 2011, REPRESENTATION PROPA; Moeller F, 2013, HUM BRAIN MAPP, V34, P1896, DOI 10.1002/hbm.22026; Muthuraman M, 2012, NEUROIMAGE, V60, P1331, DOI 10.1016/j.neuroimage.2012.01.088; Muthuraman M, 2010, IEEE ENG MED BIO, P154, DOI 10.1109/IEMBS.2010.5627211; Muthuraman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033928; Norden AD, 2002, EPILEPSY BEHAV, V3, P219, DOI 10.1016/S1525-5050(02)00029-X; Oostenveld R., 2011, COMPUTATIONAL INTELL; Paz JT, 2005, J NEUROSCI, V25, P2092, DOI 10.1523/JNEUROSCI.4689-04.2005; Rosenberg DS, 2006, EPILEPSIA, V47, P98, DOI 10.1111/j.1528-1167.2006.00375.x; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Schelter B, 2009, J NEUROSCI METH, V179, P121, DOI 10.1016/j.jneumeth.2009.01.006; Siniatchkin M, 2010, BRAIN, V133, P2798, DOI 10.1093/brain/awq183; SO N, 1989, ANN NEUROL, V25, P423, DOI 10.1002/ana.410250502; SO N, 1989, ANN NEUROL, V25, P432, DOI 10.1002/ana.410250503; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; Sudmeyer M, 2006, MOVEMENT DISORD, V21, P2134, DOI 10.1002/mds.21136; Tae WS, 2005, NEUROIMAGE, V24, P101, DOI 10.1016/j.neuroimage.2004.08.005; Tapio S, 2001, ALGORITHM 808 ARFIT, P58; Thornton R, 2010, J NEUROL NEUROSUR PS, V81, P922, DOI 10.1136/jnnp.2009.196253; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Timmermann L, 2003, NEUROLOGY, V61, P689, DOI 10.1212/01.WNL.0000078816.05164.B1; Tyvaert L, 2008, BRAIN, V131, P2042, DOI 10.1093/brain/awn145; Tyvaert L, 2009, HUM BRAIN MAPP, V30, P3993, DOI 10.1002/hbm.20824; Van Uitert R, 2004, IEEE T BIO-MED ENG, V51, P2129, DOI 10.1109/TBME.2004.836490; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vulliemoz S, 2010, NEUROIMAGE, V49, P3219, DOI 10.1016/j.neuroimage.2009.11.055; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wendling F, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00154; Wu L, 1998, ELECTROEN CLIN NEURO, V106, P344, DOI 10.1016/S0013-4694(97)00156-9; Zijlmans M, 2007, BRAIN, V130, P2343, DOI 10.1093/brain/awm141	64	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78422	10.1371/journal.pone.0078422	http://dx.doi.org/10.1371/journal.pone.0078422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194931	gold, Green Published			2022-12-27	WOS:000326037000110
J	Liu, HG; Ma, Y; Meng, DW; Yang, AC; Zhang, JG				Liu, Huan-Guang; Ma, Yu; Meng, Da-Wei; Yang, An-Chao; Zhang, Jian-guo			A Rat Model of Hemidystonia Induced by 3-Nitropropionic Acid	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; GLOBUS-PALLIDUS INTERNUS; TERM-FOLLOW-UP; BASAL GANGLIA; NEURONAL-ACTIVITY; POSTTRAUMATIC HEMIDYSTONIA; GENERALIZED DYSTONIA; EXCITOTOXIC LESIONS; PAROXYSMAL DYSTONIA; PARKINSONS-DISEASE	Objective: Secondary dystonia commonly presents as hemidystonia and is often refractory to current treatments. We aimed to establish an inducible rat model of hemidystonia utilizing 3-nitropropionic acid (3-NP) and to determine the pathophysiology of this model. Methods: Two different doses of 3-NP were stereotactically administered into the ipsilateral caudate putamen (CPu) of Wistar rats. Behavioral changes and alterations in the neurotransmitter levels in the basal ganglia were analyzed. We also performed an electromyogram, 7.0-T magnetic resonance imaging and transmission electron microscopy examination to determine the pathophysiology of the model. Results: In the CPu region, 3-NP produced mitochondrial cristae rupture, axonal degeneration, increased excitatory synaptic vesicles and necrosis. The extracellular concentrations of excitatory amino acids increased, whereas the inhibitory amino acids decreased in the CPu. Furthermore, an imbalance of neurotransmitters was found in other regions of the basal ganglia with the exception of the external globus pallidus. This study demonstrated that 3-NP administration results in CPu damage, and combined with a neurotransmitter imbalance in the basal ganglia, it produces specific neurobehavioral changes in rats. Right limb (contralateral side of CPu lesion) and trunk dystonic postures, shortened step length and ipsiversive dystonic posturing were observed in these rats. Furthermore, EMG recordings confirmed that co-contraction of the agonist and antagonist muscles could be seen for several seconds in right limbs. Conclusions: Stereotactic injection of 3-NP into the ipsilateral CPu of rats established an inducible model for hemidystonia. This effect might result from an imbalance of neurotransmitter levels, which induce dysfunctional activity of the basal ganglia mainly via the cortico-striato-GPi direct pathway. Symptoms in this model were present for 1 week. Activation of the cortico-striato-GPe indirect pathway and rebalance of neurotransmitters may lead to recovery. This rat model may be a suitable tool used to understand and further investigate the pathophysiology of dystonia.	[Liu, Huan-Guang; Meng, Da-Wei; Yang, An-Chao; Zhang, Jian-guo] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Ma, Yu; Zhang, Jian-guo] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China	Capital Medical University; Beijing Neurosurgical Institute; Capital Medical University	Zhang, JG (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.	zjguo73@126.com		Meng, Dawei/0000-0002-3529-3873	National Natural Science Foundation of China [81171217]; Beijing Municipal Science and Technology New Star Program [2008-B-43]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology New Star Program	This work was supported by a Research Grant #81171217 from the National Natural Science Foundation of China and Research Grant #2008-B-43 from the Beijing Municipal Science and Technology New Star Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Alkhani A, 2006, MOVEMENT DISORD, V21, P852, DOI 10.1002/mds.20838; Asanuma Kotaro, 2005, J Med Invest, V52 Suppl, P272, DOI 10.2152/jmi.52.272; BEAL MF, 1993, J NEUROSCI, V13, P4181; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105; BURNS LH, 1995, NEUROSCIENCE, V64, P1007, DOI 10.1016/0306-4522(94)00431-4; Calderon DP, 2011, NAT NEUROSCI, V14, P357, DOI 10.1038/nn.2753; Cirillo G, 2010, NEUROCHEM INT, V56, P152, DOI 10.1016/j.neuint.2009.09.013; Cuny E, 2008, NEUROBIOL DIS, V30, P151, DOI 10.1016/j.nbd.2007.12.011; de Yebenes J G, 1988, Adv Neurol, V50, P167; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Drew KL, 2004, J NEUROSCI METH, V140, P127, DOI 10.1016/j.jneumeth.2004.04.039; Fernagut PO, 2002, NEUROSCIENCE, V114, P1005, DOI 10.1016/S0306-4522(02)00205-1; FU YT, 1995, NEUROTOXICOL TERATOL, V17, P413, DOI 10.1016/0892-0362(94)00078-R; Ghorayeb I, 2002, NEUROSCI LETT, V335, P34, DOI 10.1016/S0304-3940(02)01137-0; Gittis AH, 2012, TRENDS NEUROSCI, V35, P557, DOI 10.1016/j.tins.2012.06.008; Hallett M, 2011, NEUROBIOL DIS, V42, P177, DOI 10.1016/j.nbd.2010.08.025; Hamann M, 2007, BRAIN RES, V1150, P190, DOI 10.1016/j.brainres.2007.02.074; Hamasaki T, 2008, MOVEMENT DISORD, V23, P1762, DOI 10.1002/mds.22183; He FS, 1995, NEUROLOGY, V45, P2178, DOI 10.1212/WNL.45.12.2178; Horie C, 2009, ACTA NEUROL SCAND, V119, P49, DOI 10.1111/j.1600-0404.2008.01053.x; Jankovic J, 2006, LANCET NEUROL, V5, P864, DOI 10.1016/S1474-4422(06)70574-9; Jinnah HA, 2005, MOVEMENT DISORD, V20, P283, DOI 10.1002/mds.20364; Kang DW, 2010, NEUROMODULATION, V13, P261, DOI 10.1111/j.1525-1403.2010.00306.x; Kim JP, 2012, ACTA NEUROCHIR, V154, P823, DOI 10.1007/s00701-012-1306-4; Kohling R, 2004, NEUROBIOL DIS, V16, P236, DOI 10.1016/j.nbd.2004.01.012; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kupsch A, 2006, NEW ENGL J MED, V355, P1978, DOI 10.1056/NEJMoa063618; Lee WT, 2000, NEUROSCIENCE, V95, P89; Levy LM, 2002, ANN NEUROL, V51, P93, DOI 10.1002/ana.10073; Liu HG, 2012, BRAIN RES, V1477, P37, DOI 10.1016/j.brainres.2012.08.007; Liu Y, 2000, CHINESE MED J-PEKING, V113, P948; Loher TJ, 2000, J NEUROSURG, V92, P457, DOI 10.3171/jns.2000.92.3.0457; MARSDEN CD, 1985, BRAIN, V108, P463, DOI 10.1093/brain/108.2.463; Marti M, 2003, EUR J NEUROSCI, V18, P759, DOI 10.1046/j.1460-9568.2003.02806.x; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Meunier S, 2003, NEUROSCIENTIST, V9, P76, DOI 10.1177/1073858402239593; MING L, 1995, J TOXICOL-CLIN TOXIC, V33, P363, DOI 10.3109/15563659509028924; Montilla P, 2004, EUR J PHARMACOL, V488, P19, DOI 10.1016/j.ejphar.2004.02.004; Muller U, 2009, BRAIN, V132, P2005, DOI 10.1093/brain/awp172; Nadjar A, 2006, J NEUROSCI, V26, P8653, DOI 10.1523/JNEUROSCI.2582-06.2006; Nobrega JN, 2002, EXP NEUROL, V176, P371, DOI 10.1006/exnr.2002.7932; Obeso J A, 1988, Adv Neurol, V50, P113; Ouary S, 2000, NEUROSCIENCE, V97, P521, DOI 10.1016/S0306-4522(00)00020-8; Palfi S, 2000, MOVEMENT DISORD, V15, P524, DOI 10.1002/1531-8257(200005)15:3<524::AID-MDS1016>3.0.CO;2-F; Parrot S, 2003, J NEUROSCI RES, V71, P445, DOI 10.1002/jnr.10489; Paxinos G, 2006, RAT BRAIN STEREOTAXI, P24; PERSCHAK H, 1990, NEUROSCIENCE, V35, P283, DOI 10.1016/0306-4522(90)90082-F; PETTIGREW LC, 1985, J NEUROL NEUROSUR PS, V48, P650, DOI 10.1136/jnnp.48.7.650; Presti MF, 2004, PHARMACOL BIOCHEM BE, V77, P501, DOI 10.1016/j.pbb.2003.12.004; Raike Robert S, 2005, NeuroRx, V2, P504; Richter A, 1998, PROG NEUROBIOL, V54, P633, DOI 10.1016/S0301-0082(97)00089-0; Richter Angelika, 2005, P459, DOI 10.1016/B978-012088382-0/50042-6; Starr PA, 2005, J NEUROPHYSIOL, V93, P3165, DOI 10.1152/jn.00971.2004; Storgaard J, 2000, EXP NEUROL, V164, P227, DOI 10.1006/exnr.2000.7428; Tang JKH, 2007, J NEUROPHYSIOL, V98, P720, DOI 10.1152/jn.01107.2006; Vidailhet M, 2005, NEW ENGL J MED, V352, P459, DOI 10.1056/NEJMoa042187; Vidailhet M, 2012, J NEUROL NEUROSURG P, DOI 10.1136/jnnp-2011-301714; Vitek JL, 1999, ANN NEUROL, V46, P22, DOI 10.1002/1531-8249(199907)46:1<22::AID-ANA6>3.0.CO;2-Z; Volkmann J, 2012, LANCET NEUROL, V11, P1029, DOI 10.1016/S1474-4422(12)70257-0; Webb TI, 2007, CURR PHARM DESIGN, V13, P2350; Wilson CJ, 2007, PROG BRAIN RES, V160, P91, DOI 10.1016/S0079-6123(06)60006-X; Zhuang P, 2004, CLIN NEUROPHYSIOL, V115, P2542, DOI 10.1016/j.clinph.2004.06.006	65	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e79199	10.1371/journal.pone.0079199	http://dx.doi.org/10.1371/journal.pone.0079199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194961	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000140
J	Ma, X; Kelley, JL; Eilertson, K; Musharoff, S; Degenhardt, JD; Martins, AL; Vinar, T; Kosiol, C; Siepel, A; Gutenkunst, RN; Bustamante, CD				Ma, Xin; Kelley, Joanna L.; Eilertson, Kirsten; Musharoff, Shaila; Degenhardt, Jeremiah D.; Martins, Andre L.; Vinar, Tomas; Kosiol, Carolin; Siepel, Adam; Gutenkunst, Ryan N.; Bustamante, Carlos D.			Population Genomic Analysis Reveals a Rich Speciation and Demographic History of Orang-utans (Pongo pygmaeus and Pongo abelii)	PLOS ONE			English	Article							SOUTHEAST-ASIA; SUMATRAN ORANGUTANS; BORNEAN ORANGUTANS; NATURAL-SELECTION; DIVERGENCE DATES; ENZYME APOBEC3G; EVOLUTION; DNA; GLYCOPHORIN; PHYLOGENIES	To gain insights into evolutionary forces that have shaped the history of Bornean and Sumatran populations of orang-utans, we compare patterns of variation across more than 11 million single nucleotide polymorphisms found by previous mitochondrial and autosomal genome sequencing of 10 wild-caught orang-utans. Our analysis of the mitochondrial data yields a far more ancient split time between the two populations (similar to 3.4 million years ago) than estimates based on autosomal data (0.4 million years ago), suggesting a complex speciation process with moderate levels of primarily male migration. We find that the distribution of selection coefficients consistent with the observed frequency spectrum of autosomal non-synonymous polymorphisms in orang-utans is similar to the distribution in humans. Our analysis indicates that 35% of genes have evolved under detectable negative selection. Overall, our findings suggest that purifying natural selection, genetic drift, and a complex demographic history are the dominant drivers of genome evolution for the two orang-utan populations.	[Ma, Xin] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Kelley, Joanna L.; Musharoff, Shaila; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Eilertson, Kirsten] Gladstone Inst, Bioinformat Core, San Francisco, CA USA; [Degenhardt, Jeremiah D.; Martins, Andre L.; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Gutenkunst, Ryan N.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Vinar, Tomas] Comenius Univ, Dept Appl Informat, Bratislava, Slovakia; [Kosiol, Carolin] Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria	Stanford University; Stanford University; University of California System; University of California San Francisco; The J David Gladstone Institutes; Cornell University; University of Arizona; Comenius University Bratislava; University of Veterinary Medicine Vienna	Bustamante, CD (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	cdbustam@stanford.edu	Kelley, Joanna L/H-1693-2012; Vinar, Tomas/I-3695-2014	Kelley, Joanna L/0000-0002-7731-605X; Vinar, Tomas/0000-0003-3898-3447; Bustamante, Carlos D./0000-0002-4187-7920; Siepel, Adam/0000-0002-3557-7219	NSF [0606461, DEB-1146074, DBI-0644111]; NIH [P30-GM092391]; European Community [IRG-224885]; VEGA [VEGA 1/1085/12.]; NIH NRSA fellowship [GM087069]; Stanford Genome Training Grant Program (NIH/NHGRI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087069, P30GM092391] Funding Source: NIH RePORTER; Division Of Environmental Biology [1146074] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); NIH NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Genome Training Grant Program (NIH/NHGRI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	X.M., K. E., J.D.D. and C. D. B. were supported by NSF 0606461 and R.N.G. was supported by NIH grant P30-GM092391 and NSF grant DEB-1146074. A. S. and A. L. M were supported by NSF grant DBI-0644111. T. V. was supported by European Community FP7 IRG-224885 from VEGA funding agency VEGA 1/1085/12. J.L.K. was supported by NIH NRSA fellowship GM087069. S. A. M. was supported by the Stanford Genome Training Grant Program (NIH/NHGRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arora N, 2010, P NATL ACAD SCI USA, V107, P21376, DOI 10.1073/pnas.1010169107; BARKER G, 2002, P PREHIST SOC, V68, P147, DOI [10.1017/s0079497x00001481, DOI 10.1017/S0079497X00001481]; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Booth JW, 2003, J BIOL CHEM, V278, P14037, DOI 10.1074/jbc.M211879200; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bradley BJ, 2008, J ANAT, V212, P337, DOI 10.1111/j.1469-7580.2007.00840.x; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Bustamante CD, 2001, GENETICS, V159, P1779; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eilertson KE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002806; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; GALDIKAS BMF, 1985, AM J PRIMATOL, V8, P87, DOI 10.1002/ajp.1350080202; GALDIKAS BMF, 1988, INT J PRIMATOL, V9, P1, DOI 10.1007/BF02740195; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Higham CFW, 2011, ANTIQUITY, V85, P529, DOI 10.1017/S0003598X00067922; Keightley PD, 2007, GENETICS, V177, P2251, DOI 10.1534/genetics.107.080663; Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Maher DM, 2011, MOL CANCER RES, V9, P531, DOI 10.1158/1541-7786.MCR-10-0443; Mailund T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001319; Medway L, 1972, ASIAN PERSPECT, V20, P51; Nater A, 2013, J HERED, V104, P2, DOI 10.1093/jhered/ess065; Nater A, 2011, MOL BIOL EVOL, V28, P2275, DOI 10.1093/molbev/msr042; Nielsen R, 1998, GENETICS, V148, P929; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; OHYAMA K, 1993, BIOCHIM BIOPHYS ACTA, V1148, P133, DOI 10.1016/0005-2736(93)90170-5; Ortiz M, 2009, MOL BIOL EVOL, V26, P2865, DOI 10.1093/molbev/msp197; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; PAUL RW, 1987, VIROLOGY, V159, P94, DOI 10.1016/0042-6822(87)90351-5; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Sanchez g, 2004, J VIROL, V78, P9807, DOI 10.1128/JVI.78.18.9807-9813.2004; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Singleton I, 2002, FOLIA PRIMATOL, V73, P1, DOI 10.1159/000060415; Steiper ME, 2006, MOL PHYLOGENET EVOL, V41, P384, DOI 10.1016/j.ympev.2006.05.021; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; Utami SS, 2002, BEHAV ECOL, V13, P643, DOI 10.1093/beheco/13.5.643; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; van Schaik CP, 1999, PRIMATES, V40, P69, DOI 10.1007/BF02557703; Verstappen HT, 1997, J QUATERNARY SCI, V12, P413, DOI 10.1002/(SICI)1099-1417(199709/10)12:5<413::AID-JQS324>3.0.CO;2-P; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Warren KS, 2001, MOL BIOL EVOL, V18, P472, DOI 10.1093/oxfordjournals.molbev.a003826; Williams Larissa M, 2010, BMC Genet, V11, P32, DOI 10.1186/1471-2156-11-32; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; Wood B, 2011, NATURE, V470, P347, DOI 10.1038/nature09709; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Zhang JZ, 2004, HUM MOL GENET, V13, P1785, DOI 10.1093/hmg/ddh183; Zhi L, 1996, CURR BIOL, V6, P1326, DOI 10.1016/S0960-9822(02)70719-7	63	8	8	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77175	10.1371/journal.pone.0077175	http://dx.doi.org/10.1371/journal.pone.0077175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194868	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000326037000047
J	Marini, MA; Frontoni, S; Succurro, E; Arturi, F; Fiorentino, TV; Sciacqua, A; Hribal, ML; Perticone, F; Sesti, G				Marini, Maria Adelaide; Frontoni, Simona; Succurro, Elena; Arturi, Franco; Fiorentino, Teresa Vanessa; Sciacqua, Angela; Hribal, Marta Letizia; Perticone, Francesco; Sesti, Giorgio			Decreased Insulin Clearance in Individuals with Elevated 1-h Post-Load Plasma Glucose Levels	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BETA-CELL FUNCTION; AFRICAN-AMERICANS; LIFE-STYLE; PREVENTION; RESISTANCE; TOLERANCE; RISK; SENSITIVITY; EXTRACTION	Reduced insulin clearance has been shown to predict the development of type 2 diabetes. Recently, it has been suggested that plasma glucose concentrations >8.6 mmol/l (155 mg/dl) at 1 h during an oral glucose tolerance test (OGTT) can identify individuals at high risk for type 2 diabetes among those who have normal glucose tolerance (NGT 1 h-high). The aim of this study was to examine whether NGT 1 h-high have a decrease in insulin clearance, as compared with NGT individuals with 1-h post-load glucose <8.6 mmol/l (l (155 mg/dl, NGT 1 h-low). To this end, 438 non-diabetic White individuals were subjected to OGTT and euglycemic-hyperinsulinemic clamp to evaluate insulin clearance and insulin sensitivity. As compared with NGT 1 h-low individuals, NGT 1 h-high had significantly higher 1-h and 2-h post-load plasma glucose and 2-h insulin levels as well as higher fasting glucose and insulin levels. NGT 1 h-high exhibited also a significant decrease in both insulin sensitivity (P<0.0001) and insulin clearance (P = 0.006) after adjusting for age, gender, adiposity measures, and insulin sensitivity. The differences in insulin clearance remained significant after adjustment for fasting glucose (P = 0.02) in addition to gender, age, and BMI. In univariate analyses adjusted for gender and age, insulin clearance was inversely correlated with body weight, body mass index, waist, fat mass, 1-h and 2-h post-load glucose levels, fasting, 1-h and 2-h post-load insulin levels, and insulin-stimulated glucose disposal. In conclusion, our data show that NGT 1 h-high have a reduction in insulin clearance as compared with NGT 1 h-low individuals; this suggests that impaired insulin clearance may contribute to sustained fasting and post-meal hyperinsulinemia.	[Marini, Maria Adelaide; Frontoni, Simona] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Succurro, Elena; Arturi, Franco; Fiorentino, Teresa Vanessa; Sciacqua, Angela; Hribal, Marta Letizia; Perticone, Francesco; Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy	University of Rome Tor Vergata; Magna Graecia University of Catanzaro	Sesti, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.	sesti@unicz.it	Perticone, Francesco/I-4260-2017; FRONTONI, SIMONA/J-4893-2012; Sesti, Giorgio/B-1509-2012; Succurro, Elena/K-4138-2016; Fiorentino, Teresa Vanessa/AAP-1855-2020	FRONTONI, SIMONA/0000-0001-8241-7552; Succurro, Elena/0000-0003-2578-692X; ARTURI, Franco/0000-0002-1660-1228; Sesti, Giorgio/0000-0002-1618-7688	Italian Ministry of University [FIRB/MERIT RBNE08NKH7_002]	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	This work was supported by Italian Ministry of University grant FIRB/MERIT RBNE08NKH7_002 to G. Sesti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2008, DIABETES CARE, V31, P1650, DOI 10.2337/dc08-0225; Abdul-Ghani MA, 2009, DIABETES CARE, V32, P281, DOI 10.2337/dc08-1264; Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; Bardini G, 2010, DIABETES CARE, V33, P411, DOI 10.2337/dc09-1342; BONORA E, 1983, METABOLISM, V32, P438, DOI 10.1016/0026-0495(83)90004-5; BONORA E, 1984, J CLIN ENDOCR METAB, V59, P1121, DOI 10.1210/jcem-59-6-1121; Castaldo E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028312; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Duckworth WC, 1997, J INVEST MED, V45, P20; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fawcett J, 2010, BIOCHEM BIOPH RES CO, V402, P762, DOI 10.1016/j.bbrc.2010.10.104; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Hribal ML, 2001, MOL PHARMACOL, V59, P322, DOI 10.1124/mol.59.2.322; Jones CNO, 2000, AM J PHYSIOL-ENDOC M, V278, pE501, DOI 10.1152/ajpendo.2000.278.3.E501; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Lee CC, 2013, DIABETES CARE, V36, P901, DOI 10.2337/dc12-1316; Marini MA, 2003, J CLIN ENDOCR METAB, V88, P3368, DOI 10.1210/jc.2002-021716; Marini MA, 2012, DIABETES CARE, V35, P868, DOI 10.2337/dc11-2181; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mittelman SD, 2000, DIABETES, V49, P2116, DOI 10.2337/diabetes.49.12.2116; Osei K, 2007, METABOLISM, V56, P24, DOI 10.1016/j.metabol.2006.08.018; Perticone F, 2012, EUR J CLIN INVEST, V42, P1325, DOI 10.1111/eci.12005; Perticone F, 2012, DIABETES CARE, V35, P153, DOI 10.2337/dc11-1727; Sciacqua A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044470; Sciacqua A, 2011, DIABETES CARE, V34, P2291, DOI 10.2337/dc11-0879; Sciacqua A, 2011, DIABETES CARE, V34, P1406, DOI 10.2337/dc11-0155; Sesti G, 1996, DIABETOLOGIA, V39, P289; Succurro E, 2011, NUTR METAB CARDIOVAS, V21, P713, DOI 10.1016/j.numecd.2011.02.002; Succurro E, 2009, ATHEROSCLEROSIS, V207, P245, DOI 10.1016/j.atherosclerosis.2009.04.006; Succurro E, 2010, CLIN J AM SOC NEPHRO, V5, P1922, DOI 10.2215/CJN.03240410; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x	36	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77440	10.1371/journal.pone.0077440	http://dx.doi.org/10.1371/journal.pone.0077440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194886	gold, Green Submitted, Green Published			2022-12-27	WOS:000326037000065
J	Pietrzyk, JJ; Kwinta, P; Wollen, EJ; Bik-Multanowski, M; Madetko-Talowska, A; Gunther, CC; Jagla, M; Tomasik, T; Saugstad, OD				Pietrzyk, Jacek J.; Kwinta, Przemko; Wollen, Embjorg J.; Bik-Multanowski, Miroslaw; Madetko-Talowska, Anna; Gunther, Clara-Cecilie; Jagla, Mateusz; Tomasik, Tomasz; Saugstad, Ola D.			Gene Expression Profiling in Preterm Infants: New Aspects of Bronchopulmonary Dysplasia Development	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CHRONIC LUNG-DISEASE; OXYGEN; BIOINFORMATICS; INJURY; INFLAMMATION; MECHANISMS; CELLS; BIRTH; DNA	Rationale: Bronchopulmonary dysplasia is one of the most serious complications observed in premature infants. Thanks to microarray technique, expression of nearly all human genes can be reliably evaluated. Objective: To compare whole genome expression in the first month of life in groups of infants with and without bronchopulmonary dysplasia. Methods: 111 newborns were included in the study. The mean birth weight was 1029g (SD: 290), and the mean gestational age was 27.8 weeks (SD: 2.5). Blood samples were drawn from the study participants on the 5th, 14th and 28th day of life. The mRNA samples were evaluated for gene expression with the use of GeneChip (R) Human Gene 1.0 ST microarrays. The infants were divided into two groups: bronchopulmonary dysplasia (n=68) and control (n=43). Results: Overall 2086 genes were differentially expressed on the day 5, only 324 on the day 14 and 3498 on the day 28. Based on pathway enrichment analysis we found that the cell cycle pathway was up-regulated in the bronchopulmonary dysplasia group. The activation of this pathway does not seem to be related with the maturity of the infant. Four pathways related to inflammatory response were continuously on the 5th, 14th and 28th day of life down-regulated in the bronchopulmonary dysplasia group. However, the expression of genes depended on both factors: immaturity and disease severity. The most significantly down-regulated pathway was the T cell receptor signaling pathway. Conclusion: The results of the whole genome expression study revealed alteration of the expression of nearly 10% of the genome in bronchopulmonary dysplasia patients.	[Pietrzyk, Jacek J.; Kwinta, Przemko; Jagla, Mateusz; Tomasik, Tomasz] Jagiellonian Univ, Dept Pediat, Krakow, Poland; [Wollen, Embjorg J.; Saugstad, Ola D.] Univ Oslo, Dept Pediat Res, Oslo, Norway; [Bik-Multanowski, Miroslaw; Madetko-Talowska, Anna] Jagiellonian Univ, Dept Med Genet, Krakow, Poland; [Gunther, Clara-Cecilie] Norwegian Comp Ctr, Oslo, Norway	Jagiellonian University; University of Oslo; Jagiellonian University	Kwinta, P (corresponding author), Jagiellonian Univ, Dept Pediat, Krakow, Poland.	kwintap@mp.pl	Kwinta, Przemko/C-6056-2008; Saugstad, Ola/AAS-9041-2021; Jagla, Mateusz/Y-5152-2019; Bik-Multanowski, Miroslaw/GLQ-5864-2022	Kwinta, Przemko/0000-0002-3017-0348; Saugstad, Ola/0000-0002-3166-5254; Jagla, Mateusz/0000-0002-7030-3934; Bik-Multanowski, Miroslaw/0000-0003-1542-7050	Financial Mechanism of European Economic Area [PL0226]; Polish Ministry of Science [E023/P01/2008/02/85]	Financial Mechanism of European Economic Area; Polish Ministry of Science(Ministry of Science and Higher Education, Poland)	This study was supported by unrestricted grants of Financial Mechanism of European Economic Area (PL0226) and Polish Ministry of Science (E023/P01/2008/02/85). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asikainen TM, 2005, PEDIATR PULM, V40, P538, DOI 10.1002/ppul.20321; Askie LM, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001077.PUB2; Bengtsson H., 2008, 745 U CAL DEP STAT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beyer T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002121; Bhandari A, 2009, PEDIATRICS, V123, P1562, DOI 10.1542/peds.2008-1962; Bhandari V, 2006, PEDIATRICS, V117, P1901, DOI 10.1542/peds.2005-1414; Bhering CA, 2007, J PEDIAT-BRAZIL, V83, P163, DOI [10.2223/JPED.1599, 10.1590/S0021-75572007000200011]; Bourbon J, 2005, PEDIATR RES, V57, p38R, DOI 10.1203/01.PDR.0000159630.35883.BE; Bry K, 2006, SEMIN PERINATOL, V30, P121, DOI 10.1053/j.semperi.2006.04.009; Cheng J, 2011, IMMUNOL RES, V50, P113, DOI 10.1007/s12026-011-8216-z; Colaizy TT, 2007, PEDIATR RES, V61, P578, DOI 10.1203/pdr.0b013e318045be03; Cools F, 2009, COCHRANE DB SYST REV, V3; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Henderson-Smart DJ, 2006, ARCH DIS CHILD-FETAL, V91, pF40, DOI 10.1136/adc.2005.072264; Hollander M., 1973, NONPARAMETRIC STAT M, P185; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; James JR, 2011, J BIOL CHEM, V286, P31993, DOI 10.1074/jbc.M111.219212; Janer J, 2006, AM J RESP CRIT CARE, V174, P326, DOI 10.1164/rccm.200508-1291OC; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Kamlin C, 2004, COCHRANE DATABASE SY, V4; Kim K, 2010, J CLIN EPIDEMIOL, V63, P950, DOI 10.1016/j.jclinepi.2010.02.018; Kriebitzsch C, 2009, ANTICANCER RES, V29, P3471; Lapillonne A, 2004, CURR OPIN CLIN NUTR, V7, P151, DOI 10.1097/00075197-200403000-00008; Lassus P, 2001, AM J RESP CRIT CARE, V164, P1981, DOI 10.1164/ajrccm.164.10.2012036; Lee M. T., 2004, ANAL MICROARRAY EXPR, P191; Lepock JR, 2005, INT J HYPERTHER, V21, P681, DOI 10.1080/02656730500307298; Nedrelow JH, 2004, PEDIATR RES, V55, p496A; O'Reilly MA, 2001, AM J PHYSIOL-LUNG C, V281, pL291, DOI 10.1152/ajplung.2001.281.2.L291; Rudkowska I, 2011, OMICS, V15, P1, DOI 10.1089/omi.2010.0073; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Saugstad OD, 2011, NEONATOLOGY, V100, P1, DOI 10.1159/000322001; Saugstad OD, 2010, J PERINAT MED, V38, P571, DOI [10.1515/JPM.2010.108, 10.1515/jpm.2010.108]; Schelonka RL, 2007, SEMIN PERINATOL, V31, P2, DOI 10.1053/j.semperi.2007.01.001; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Speer CP, 2006, SEMIN FETAL NEONAT M, V11, P354, DOI 10.1016/j.siny.2006.03.004; Stevens TP, 2010, PEDIATR PULM, V45, P371, DOI 10.1002/ppul.21199; Stevens TP, 2007, COCHRANE DB SYST REV, V4; Thebaud B, 2007, NEONATOLOGY, V91, P291, DOI 10.1159/000101344; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Vento G, 2006, INTENS CARE MED, V32, P723, DOI 10.1007/s00134-006-0138-1; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED	48	32	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78585	10.1371/journal.pone.0078585	http://dx.doi.org/10.1371/journal.pone.0078585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194948	Green Published, gold			2022-12-27	WOS:000326037000127
J	Steinbauer, MJ				Steinbauer, Martin J.			Shoot Feeding as a Nutrient Acquisition Strategy in Free-Living Psylloids	PLOS ONE			English	Article							JUMPING PLANT-LICE; PHLOEM-SAP; HOST-PLANT; AMINO-ACID; NUTRITIONAL QUALITY; LIFE-HISTORY; CTENARYTAINA-EUCALYPTI; INSECT VECTOR; ADULT LEAVES; HEMIPTERA	Shoot feeding by sucking insects is accepted as an adaptation to feeding where plant nutrients are most concentrated and/or of higher quality. Psylloids are an important hemipteran taxon, most of which are free-living and comprise many shoot feeding species, whose nutritional ecology has been largely ignored. I conducted a longitudinal study of Ctenarytaina eucalypti (Maskell) and C. bipartita Burckhardt et al. (Aphalaridae) feeding on eucalypts to document how within-plant (ontogenic) variation in nutritional quality, in particular of free amino acids, determines host suitability and hence the distribution and abundance of nymphs. Nymphs were most abundant within developing apical buds but were not more abundant on branchlets of greater vigour (indicated by rate of extension). Nymphs could be found up to two (C. bipartita) to three (C. eucalypti) alternate leaf pairs distant from apical buds but infrequently and in low numbers; they were never found on older, fully expanded leaves. The position of a leaf on a branchlet (indicative of age) determined its nutritional quality. Younger leaves had higher water contents, lower chlorophyll contents and differed in amino acid (essential and non-essential) composition compared to older leaves. The abundance of C. eucalypti nymphs on expanding leaves and in buds was positively correlated with the concentrations of methionine, valine and threonine in E. globulus leaves at the same or comparable position on a branchlet. The abundance of C. bipartita nymphs was positively correlated with foliar leucine concentrations. Shoot feeding by these two psyllids facilitates access to more concentrated, better quality plant nutrients but may not entirely explain the adaptive significance of their behaviour. The humid microclimate created by the architecture of the hosts' apical buds protects eggs and nymphs from desiccation and is suggested to have had a significant influence on the evolution of host utilisation strategies of psyllids within this genus.	La Trobe Univ, Dept Zool, Melbourne, Vic, Australia	La Trobe University	Steinbauer, MJ (corresponding author), La Trobe Univ, Dept Zool, Melbourne, Vic, Australia.	M.Steinbauer@latrobe.edu.au	Steinbauer, Martin James/A-8612-2011	Steinbauer, Martin James/0000-0002-0345-2905	Australian Research Council [FT100100199]; Australia and Pacific Science Foundation [APSF 11-2]	Australian Research Council(Australian Research Council); Australia and Pacific Science Foundation	This work was funded by the Australian Research Council through a Future Fellowships award (FT100100199) granted to the author with additional financial support for research assistance provided by the Australia and Pacific Science Foundation (APSF 11-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTON DH, 1975, AUST J BOT, V23, P239, DOI 10.1071/BT9750239; Ball MC, 1997, PLANT CELL ENVIRON, V20, P155, DOI 10.1046/j.1365-3040.1997.d01-61.x; Behmer ST, 2011, FUNCT ECOL, V25, P484, DOI 10.1111/j.1365-2435.2010.01810.x; Blackmer JL, 1999, ENTOMOL EXP APPL, V93, P29, DOI 10.1023/A:1003886107024; Boughton BA, 2011, ANAL CHEM, V83, P7523, DOI 10.1021/ac201610x; Brennan EB, 2001, ENVIRON ENTOMOL, V30, P1144, DOI 10.1603/0046-225X-30.6.1144; Brennan EB, 2001, ENTOMOL EXP APPL, V100, P179, DOI 10.1023/A:1019295104902; Brennan EB, 2001, ENTOMOL EXP APPL, V100, P355, DOI 10.1023/A:1019201412579; Burckhardt D, 2013, ZOOTAXA, V3613, P589, DOI 10.11646/zootaxa.3613.6.5; Chiyaka C, 2012, P NATL ACAD SCI USA, V109, P12213, DOI 10.1073/pnas.1208326109; Day KR, 2004, ECOL ENTOMOL, V29, P555, DOI 10.1111/j.0307-6946.2004.00631.x; DOUGLAS AE, 1993, ECOL ENTOMOL, V18, P31, DOI 10.1111/j.1365-2311.1993.tb01076.x; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Hodkinson I, 2009, J NAT HIST, V43, P65, DOI 10.1080/00222930802354167; Hollis D, 2004, AUSTR PSYLLOIDEA JUM; JOURNET ARP, 1980, ECOL ENTOMOL, V5, P249, DOI 10.1111/j.1365-2311.1980.tb01148.x; Karley AJ, 2003, B ENTOMOL RES, V93, P425, DOI 10.1079/BER2003252; Karley AJ, 2002, J EXP BIOL, V205, P3009; KIDD NAC, 1985, OIKOS, V44, P114, DOI 10.2307/3544051; Koyama Y, 2004, ENTOMOL EXP APPL, V113, P35, DOI 10.1111/j.0013-8703.2004.00207.x; Levy J, 2013, J ECON ENTOMOL, V106, P1440, DOI 10.1603/EC12419; Luft PA, 1997, ENTOMOL EXP APPL, V84, P293, DOI 10.1023/A:1003037029782; Luft PA, 2001, ECOL ENTOMOL, V26, P263, DOI 10.1046/j.1365-2311.2001.00322.x; MAELZER DA, 1977, AUST J ZOOL, V25, P269, DOI 10.1071/ZO9770269; Mayer CJ, 2008, J CHEM ECOL, V34, P1045, DOI 10.1007/s10886-008-9516-1; MENSAH RK, 1992, ENTOMOL EXP APPL, V62, P261, DOI 10.1007/BF00353445; Merchant A, 2006, PLANT CELL ENVIRON, V29, P2017, DOI 10.1111/j.1365-3040.2006.01577.x; Merchant A, 2010, J EXP BOT, V61, P1785, DOI 10.1093/jxb/erq045; Morgan F. D., 1984, Psylloidea of South Australia.; Oppong CK, 2010, AFR INVERTEBR, V51, P201, DOI 10.5733/afin.051.0105; Ouvrard D, 2010, SYST ENTOMOL, V35, P172, DOI 10.1111/j.1365-3113.2009.00499.x; Paine TD, 2011, ANNU REV ENTOMOL, V56, P181, DOI 10.1146/annurev-ento-120709-144817; PFEIFFER DG, 1984, ENVIRON ENTOMOL, V13, P1487, DOI 10.1093/ee/13.6.1487; Pinkard EA, 2006, FOREST ECOL MANAG, V223, P211, DOI 10.1016/j.foreco.2005.11.003; Price P.W., 2003, MACROEVOLUTIONARY TH; Purvis G, 2002, ANN APPL BIOL, V141, P283, DOI 10.1111/j.1744-7348.2002.tb00220.x; RIENS B, 1991, PLANT PHYSIOL, V97, P227, DOI 10.1104/pp.97.1.227; Salt DT, 1998, GLOB CHANGE BIOL, V4, P91, DOI 10.1046/j.1365-2486.1998.00108.x; Sandstrom J, 2000, CHEMOECOLOGY, V10, P17, DOI 10.1007/s000490050003; SCURFIELD G., 1961, AUSTRALIAN JOUR BOT, V9, P37, DOI 10.1071/BT9610037; Sequeira R, 1996, EUR J ENTOMOL, V93, P53; SHARMA A, 2013, ARTH STRUCT IN PRESS; Sloan DB, 2012, MOL BIOL EVOL, V29, P3781, DOI 10.1093/molbev/mss180; Spaulding AW, 2001, INSECT MOL BIOL, V10, P57, DOI 10.1046/j.1365-2583.2001.00231.x; Steinbauer MJ, 1998, B ENTOMOL RES, V88, P641, DOI 10.1017/S0007485300054316; Steinbauer MJ, 1999, ENTOMOL EXP APPL, V91, P175, DOI 10.1023/A:1003614516588; Stone C, 2010, AUST FORESTRY, V73, P98, DOI 10.1080/00049158.2010.10676315; SUTTON RD, 1984, J ANIM ECOL, V53, P37, DOI 10.2307/4340; Suzuki DK, 2009, ARTHROPOD-PLANT INTE, V3, P241, DOI 10.1007/s11829-009-9064-9; Taylor Gary S., 1997, P37; Turgeon R, 2009, ANNU REV PLANT BIOL, V60, P207, DOI 10.1146/annurev.arplant.043008.092045; ULLMAN DE, 1988, ENTOMOL EXP APPL, V47, P115, DOI 10.1007/BF00367477; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; WATMOUGH RH, 1968, J ANIM ECOL, V37, P283, DOI 10.2307/2949; WHITE T C R, 1969, Ecology (Washington D C), V50, P905, DOI 10.2307/1933707; White TCR, 2009, OIKOS, V118, P807, DOI 10.1111/j.1600-0706.2009.17495.x; WHITE T C R, 1970, Australian Journal of Zoology, V18, P105, DOI 10.1071/ZO9700105; WOODBURN T L, 1973, Journal of the Australian Entomological Society, V12, P134	58	18	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77990	10.1371/journal.pone.0077990	http://dx.doi.org/10.1371/journal.pone.0077990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194907	gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000086
J	Vargas-Salinas, F; Amezquita, A				Vargas-Salinas, Fernando; Amezquita, Adolfo			Stream Noise, Hybridization, and Uncoupled Evolution of Call Traits in Two Lineages of Poison Frogs: Oophaga histrionica and Oophaga lehmanni	PLOS ONE			English	Article							ADVERTISEMENT CALL; PHYSALAEMUS-PUSTULOSUS; SEXUAL SELECTION; VISUAL-DISPLAYS; ACRIS-CREPITANS; SENSORY DRIVE; SPECIATION; ENVIRONMENT; PATTERNS; BIRD	According to the acoustic adaptation hypothesis, communication signals are evolutionary shaped in a way that minimizes its degradation and maximizes its contrast against the background noise. To compare the importance for call divergence of acoustic adaptation and hybridization, an evolutionary force allegedly promoting phenotypic variation, we compared the mate recognition signal of two species of poison frogs (Oophaga histrionica and O. lehmanni) at five localities: two (one per species) alongside noisy streams, two away from streams, and one interspecific hybrid. We recorded the calls of 47 males and characterized the microgeographic variation in their spectral and temporal features, measuring ambient noise level, body size, and body temperature as covariates. As predicted, frogs living in noisy habitats uttered high frequency calls and, in one species, were much smaller in size. These results support a previously unconsidered role of noise on streams as a selective force promoting an increase in call frequency and pleiotropic effects in body size. Regarding hybrid frogs, their calls overlapped in the signal space with the calls of one of the parental lineages. Our data support acoustic adaptation following two evolutionary routes but do not support the presumed role of hybridization in promoting phenotypic diversity.	[Vargas-Salinas, Fernando; Amezquita, Adolfo] Univ Los Andes, Dept Biol Sci, Bogota, Colombia	Universidad de los Andes (Colombia)	Vargas-Salinas, F (corresponding author), Univ Quindi, Fac Ciencias Basicas & Tecnol, Programa Biol, Armenia, Colombia.	vargassalinasf@yahoo.com		Amezquita, Adolfo/0000-0001-7320-1143	COLCIENCIAS [1204-452-21096 CT 266-2008]; Faculty of Sciences at the Universidad de los Andes-Colombia (Proyecto Semilla a FVS convocatoria) [2009-2]; Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas''COLCIENCIAS	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Faculty of Sciences at the Universidad de los Andes-Colombia (Proyecto Semilla a FVS convocatoria); Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas''COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This research was supported by COLCIENCIAS (Project code 1204-452-21096 CT 266-2008) and the Faculty of Sciences at the Universidad de los Andes-Colombia (Proyecto Semilla a FVS convocatoria 2009-2). The Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas''COLCIENCIAS provided economic support during the doctoral studies of FVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezquita A, 2009, BIOL J LINN SOC, V98, P826, DOI 10.1111/j.1095-8312.2009.01324.x; Anderson E., 1949, INTROGRESSIVE HYBRID; [Anonymous], 1972, EVOLUTION GENUS BUFO; Bosch J, 2004, CAN J ZOOL, V82, P880, DOI 10.1139/Z04-060; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; CASTROHERRERA F, 2004, SERIE LIBROS ROJOS E, P162; Center for Conservation Bioacoustics, 2011, RAV PROINT SOUND AN; CHAPUIS C, 1971, Terre et la Vie, V118, P183; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Coyne J.A., 2004, SPECIATION; Coyne JA, 1997, EVOLUTION, V51, P295, DOI [10.1111/j.1558-5646.1997.tb02412.x, 10.2307/2410984]; de Luna AG, 2010, ANIM BEHAV, V79, P739, DOI 10.1016/j.anbehav.2009.12.031; DUBOIS A, 1984, J ORNITHOL, V125, P455, DOI 10.1007/BF01640137; Duellman WE, 2001, HYLID FROGS MIDDLE A; Duellman WE, 1986, BIOL AMPHIBIANS, P1; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; Fleishman Leo J., 2000, P209; FLEISHMAN LJ, 1992, AM NAT, V139, pS36, DOI 10.1086/285304; GERHARDT HC, 1980, COPEIA, P577; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gomez D, 2004, ECOL LETT, V7, P279, DOI 10.1111/j.1461-0248.2004.00584.x; Grafe TU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037965; Haven Wiley R., 1982, P131; Hoedl Walter, 2001, P121; Irwin DE, 2000, EVOLUTION, V54, P998; Kime NM, 2000, BEHAV ECOL, V11, P71, DOI 10.1093/beheco/11.1.71; Larsen PA, 2010, P NATL ACAD SCI USA, V107, P11447, DOI 10.1073/pnas.1000133107; Lotters S., 2007, POISON FROGS BIOL SP; Lougheed SC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-23; Maan ME, 2008, EVOLUTION, V62, P2334, DOI 10.1111/j.1558-5646.2008.00454.x; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; MARCHETTI K, 1993, NATURE, V362, P149, DOI 10.1038/362149a0; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; McClelland BE, 1996, J EXP BIOL, V199, P1907; Medina I, 2013, ECOL EVOL, V3, P4388, DOI 10.1002/ece3.794; Meenderink SWF, 2010, BIOL LETTERS, V6, P278, DOI 10.1098/rsbl.2009.0763; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Narins PM, 2004, J ACOUST SOC AM, V115, P910, DOI 10.1121/1.1636851; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; Nemeth E, 2010, AM NAT, V176, P465, DOI 10.1086/656275; Ord TJ, 2007, P R SOC B, V274, P1057, DOI 10.1098/rspb.2006.0263; Penna M, 1998, BEHAV ECOL SOCIOBIOL, V42, P371, DOI 10.1007/s002650050452; Price T, 2007, SPECIATION BIRDS; Roberts JL, 2007, J BIOGEOGR, V34, P417, DOI 10.1111/j.1365-2699.2006.01621.x; Rundle Howard D., 2010, P471; Ryan M. J., 1987, EVOLUTION AMPHIBIAN, P637; RYAN MJ, 1991, BIOL J LINN SOC, V44, P249, DOI 10.1111/j.1095-8312.1991.tb00619.x; Ryan MJ, 1996, EVOLUTION, V50, P2435, DOI 10.1111/j.1558-5646.1996.tb03630.x; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; RYAN MJ, 1990, BIOL J LINN SOC, V40, P37, DOI 10.1111/j.1095-8312.1990.tb00533.x; Saetre GP, 1997, NATURE, V387, P589; Schneider Hans, 2007, Amphibian Biology, V7, P2893; Seddon N, 2005, EVOLUTION, V59, P200; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; SILVERSTONE P A, 1973, Herpetologica, V29, P295; Silverstone PA., 1975, NAT HIST, V21, P1; Summers K, 2004, J HERPETOL, V38, P1, DOI 10.1670/51-03A; Summers K, 1999, P ROY SOC B-BIOL SCI, V266, P2141, DOI 10.1098/rspb.1999.0900; Velazquez EBE, 2009, EVALUACION ESTADO CO; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Wiens JJ, 2004, AM NAT, V163, P914, DOI 10.1086/386552; Wilczynski W, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P234; Wollenberg KC, 2008, BIOL J LINN SOC, V93, P433, DOI 10.1111/j.1095-8312.2007.00906.x; Ziegler L, 2011, BEHAV ECOL, V22, P520, DOI 10.1093/beheco/arr011; ZIMMERMAN BL, 1983, HERPETOLOGICA, V39, P235	71	26	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77545	10.1371/journal.pone.0077545	http://dx.doi.org/10.1371/journal.pone.0077545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194888	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000067
J	Vijgen, GHEJ; Bouvy, ND; Leenen, L; Rijkers, K; Cornips, E; Majoie, M; Brans, B; Lichtenbelt, WDV				Vijgen, Guy H. E. J.; Bouvy, Nicole D.; Leenen, Loes; Rijkers, Kim; Cornips, Erwin; Majoie, Marian; Brans, Boudewijn; Lichtenbelt, Wouter D. van Marken			Vagus Nerve Stimulation Increases Energy Expenditure: Relation to Brown Adipose Tissue Activity	PLOS ONE			English	Article							WEIGHT-LOSS; VENTROMEDIAL HYPOTHALAMUS; FEEDING-BEHAVIOR; RATS; OBESITY; ADULTS; THERMOGENESIS; ENTEROSTATIN; VAGOTOMY; GALANIN	Background: Human brown adipose tissue (BAT) activity is inversely related to obesity and positively related to energy expenditure. BAT is highly innervated and it is suggested the vagus nerve mediates peripheral signals to the central nervous system, there connecting to sympathetic nerves that innervate BAT. Vagus nerve stimulation (VNS) is used for refractory epilepsy, but is also reported to generate weight loss. We hypothesize VNS increases energy expenditure by activating BAT. Methods and Findings: Fifteen patients with stable VNS therapy (age: 45 +/- 10yrs; body mass index; 25.2 +/- 3.5 kg/m(2)) were included between January 2011 and June 2012. Ten subjects were measured twice, once with active and once with inactivated VNS. Five other subjects were measured twice, once with active VNS at room temperature and once with active VNS under cold exposure in order to determine maximal cold-induced BAT activity. BAT activity was assessed by 18-Fluoro-Deoxy-Glucose-Positron-Emission-Tomography-and-Computed-Tomography. Basal metabolic rate (BMR) was significantly higher when VNS was turned on (mean change; +2.2%). Mean BAT activity was not significantly different between active VNS and inactive VNS (BAT SUVMean; 0.55 +/- 0.25 versus 0.67 +/- 0.46, P = 0.619). However, the change in energy expenditure upon VNS intervention (On-Off) was significantly correlated to the change in BAT activity (r = 0.935, P < 0.001). Conclusions: VNS significantly increases energy expenditure. The observed change in energy expenditure was significantly related to the change in BAT activity. This suggests a role for BAT in the VNS increase in energy expenditure. Chronic VNS may have a beneficial effect on the human energy balance that has potential application for weight management therapy.	[Vijgen, Guy H. E. J.; Lichtenbelt, Wouter D. van Marken] Maastricht Univ, Med Ctr, Sch Nutr Toxicol & Metab NUTRIM, Dept Human Biol, Maastricht, Netherlands; [Vijgen, Guy H. E. J.; Bouvy, Nicole D.] Maastricht Univ, Med Ctr, Dept Gen Surg, Maastricht, Netherlands; [Rijkers, Kim; Cornips, Erwin] Maastricht Univ, Med Ctr, Dept Neurosurg, Maastricht, Netherlands; [Brans, Boudewijn] Maastricht Univ, Med Ctr, Dept Nucl Med, Maastricht, Netherlands; [Leenen, Loes; Majoie, Marian] Epilepsy Ctr Kempenhaeghe, Heeze, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University	Vijgen, GHEJ (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr Toxicol & Metab NUTRIM, Dept Human Biol, Maastricht, Netherlands.	guy.vijgen@gmail.com	Bouvy, Nicole/AAD-2844-2021	Majoie, Marian/0000-0003-0579-8122; Vijgen, Guy/0000-0002-6011-753X; Leenen, Loes/0000-0002-7117-8768	Netherlands Science Foundation ZonMw [TOP 91209037]; Netherlands Organization for Scientific Research (NWO); Maastricht University Medical Centre	Netherlands Science Foundation ZonMw; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Maastricht University Medical Centre	This work is part of the research program TOP-subsidies (Netherlands Science Foundation ZonMw, TOP 91209037 to W. D. van Marken Lichtenbelt), which is (partly) financed by the Netherlands Organization for Scientific Research (NWO). Guy H. Vijgen received a Kootstra Talent Fellowship from the Maastricht University Medical Centre that allowed him to perform this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2009, BRIT J RADIOL, V82, P625, DOI 10.1259/bjr/24661539; ARCH JRS, 1984, NATURE, V309, P163, DOI 10.1038/309163a0; Balbo SL, 2007, ENDOCRINE, V31, P142, DOI 10.1007/s12020-007-0021-z; BLIGH J, 1973, Journal of Applied Physiology, V35, P941; Bodenlos JS, 2007, APPETITE, V48, P145, DOI 10.1016/j.appet.2006.07.080; Bodenlos Jamie S, 2007, J Diabetes Sci Technol, V1, P771; Burneo JG, 2002, NEUROLOGY, V59, P463, DOI 10.1212/WNL.59.3.463; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Dedeurwaerdere S, 2006, NEUROSCIENCE, V140, P1443, DOI 10.1016/j.neuroscience.2006.03.014; Fruhbeck G, 2009, TRENDS PHARMACOL SCI, V30, P387, DOI 10.1016/j.tips.2009.05.003; Kingma Boris, 2012, Front Biosci (Elite Ed), V4, P1975; Kosel M, 2003, CNS SPECTRUMS, V8, P515, DOI 10.1017/S1092852900018988; Laskiewicz J, 2003, J PHYSIOL PHARMACOL, V54, P603; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Mano-Otagiri A, REGUL PEPT, V160, P81; Mano-Otagiri A, 2009, J ENDOCRINOL, V201, P341, DOI 10.1677/JOE-08-0374; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Nagase H, 2002, J GASTROENTEROL, V37, P118, DOI 10.1007/BF03326430; Nagase H, 1996, BRAIN RES, V709, P44, DOI 10.1016/0006-8993(95)01292-3; Pardo JV, 2007, INT J OBESITY, V31, P1756, DOI 10.1038/sj.ijo.0803666; PERKINS MN, 1981, NATURE, V289, P401, DOI 10.1038/289401a0; PRECHTL JC, 1990, ANAT EMBRYOL, V181, P101; Privitera MD, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002896; RANDLE PJ, 1963, LANCET, V1, P785; Ruffin MP, 1999, BRAIN RES, V846, P23, DOI 10.1016/S0006-8993(99)01922-8; Saindon CS, 2001, AUTON NEUROSCI-BASIC, V87, P243, DOI 10.1016/S1566-0702(00)00280-0; SAITO M, 1989, BRAIN RES, V481, P298, DOI 10.1016/0006-8993(89)90806-8; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Simpson SA, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d8042; Sobocki J, 2006, SURGERY, V139, P209, DOI 10.1016/j.surg.2005.06.025; Val-Laillet D, 2010, APPETITE, V55, P245, DOI 10.1016/j.appet.2010.06.008; Lichtenbelt WDV, 2006, PHYSIOL BEHAV, V88, P489, DOI 10.1016/j.physbeh.2006.04.026; Vijgen GH, 2012, J CLIN ENDOCRINOL ME; Vijgen GH, 2012, FRONT BIOSC IN PRESS; Vijgen GHEJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017247; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vosselman MJ, 2013, AM J CLIN NUTR; Wu CX, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/159834; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	40	52	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77221	10.1371/journal.pone.0077221	http://dx.doi.org/10.1371/journal.pone.0077221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194874	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000053
J	Wansink, B; Hanks, AS				Wansink, Brian; Hanks, Andrew S.			Slim by Design: Serving Healthy Foods First in Buffet Lines Improves Overall Meal Selection	PLOS ONE			English	Article							BODY-MASS INDEX; US ADULTS; PREVALENCE; OBESITY; TRENDS; INCREASE; CHILDREN; CHOICES	Objective: Each day, tens of millions of restaurant goers, conference attendees, college students, military personnel, and school children serve themselves at buffets - many being all-you-can-eat buffets. Knowing how the food order at a buffet triggers what a person selects could be useful in guiding diners to make healthier selections. Method: The breakfast food selections of 124 health conference attendees were tallied at two separate seven-item buffet lines (which included cheesy eggs, potatoes, bacon, cinnamon rolls, low-fat granola, low-fat yogurt, and fruit). The food order between the two lines was reversed (least healthy to most healthy, and vise-versa). Participants were randomly assigned to choose their meal from one line or the other, and researchers recorded what participants selected. Results: With buffet foods, the first ones seen are the ones most selected. Over 75% of diners selected the first food they saw, and the first three foods a person encountered in the buffet comprised 66% of all the foods they took. Serving the less healthy foods first led diners to take 31% more total food items (p<0.001). Indeed, diners in this line more frequently chose less healthy foods in combinations, such as cheesy eggs and bacon (r = 0.47; p<0.001) or cheesy eggs and fried potatoes (r = 0.37; p<0.001). This co-selection of healthier foods was less common. Conclusions: Three words summarize these results: First foods most. What ends up on a buffet diner's plate is dramatically determined by the presentation order of food. Rearranging food order from healthiest to least healthy can nudge unknowing or even resistant diners toward a healthier meal, helping make them slim by design. Health-conscious diners, can proactively start at the healthier end of the line, and this same basic principle of "first foods most" may be relevant in other contexts - such as when serving or passing food at family dinners.	[Wansink, Brian] Cornell Univ, Charles S Dyson Sch Appl Econ & Management, Ithaca, NY USA; [Hanks, Andrew S.] Cornell Univ, Dept Appl Econ & Management, Ithaca, NY USA	Cornell University; Cornell University	Wansink, B (corresponding author), Cornell Univ, Charles S Dyson Sch Appl Econ & Management, Ithaca, NY USA.	foodandbrandlab@cornell.edu	Hanks, Andrew/B-7807-2015	Hanks, Andrew/0000-0003-0687-4772				Boon B, 1998, BRIT J HEALTH PSYCH, V3, P27, DOI 10.1111/j.2044-8287.1998.tb00553.x; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Hanks A. S., 2012, Agricultural and Resource Economics Review, V41, P114; Hanks AS, 2013, J PEDIATR-US, V162, P867, DOI 10.1016/j.jpeds.2012.12.031; Hanks AS, 2012, J PUBLIC HEALTH-UK, V34, P370, DOI 10.1093/pubmed/fds003; HANKS AS, 2013, J ACAD NUTR IN PRESS; Novemsky N, 2003, J CONSUM RES, V29, P507, DOI 10.1086/346246; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Parducci A., 1995, HAPPINESS PLEASURE J; Rolls ET, 1997, PHYSIOL BEHAV, V61, P461, DOI 10.1016/S0031-9384(96)00464-7; Sunstein CR, 2013, SIMPLER FUTURE GOVT; Wansink, 2006, MINDLESS EATING WHY; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; WANSINK B, SLIM DESIGN MINDLESS; Wansink B, 2013, CHILD OBES, V9, P277, DOI 10.1089/chi.2013.9405; Wansink B, 2012, PREV MED, V55, P330, DOI 10.1016/j.ypmed.2012.07.012; Wansink B, 2012, PSYCHOL REP, V111, P228, DOI 10.2466/01.PR0.111.4.228-232; Wansink B, 2010, PHYSIOL BEHAV, V100, P454, DOI 10.1016/j.physbeh.2010.05.003; Wisdom J, 2010, AM ECON J-APPL ECON, V2, P164, DOI 10.1257/app.2.2.164	21	58	58	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77055	10.1371/journal.pone.0077055	http://dx.doi.org/10.1371/journal.pone.0077055			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194859	gold, Green Published			2022-12-27	WOS:000326037000038
J	Yang, XB; Zhao, JJ; Huang, CY; Wang, QJ; Pan, K; Wang, DD; Pan, QZ; Jiang, SS; Lv, L; Gao, X; Chen, HW; Yao, JY; Zhi, M; Xia, JC				Yang, Xiao-bo; Zhao, Jing-jing; Huang, Chun-yu; Wang, Qi-jing; Pan, Ke; Wang, Dan-dan; Pan, Qiu-zhong; Jiang, Shan-shan; Lv, Lin; Gao, Xiang; Chen, Huang-wei; Yao, Jia-yin; Zhi, Min; Xia, Jian-chuan			Decreased Expression of the FOXO3a Gene Is Associated with Poor Prognosis in Primary Gastric Adenocarcinoma Patients	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; PROMOTES TUMORIGENESIS; CANCER; SURVIVAL; IDENTIFICATION; CARCINOMA; PROFILE; CELLS	Background: FOXO3a, a member of the forkhead class 'O' (FOXO) transcription factor family, controls a wide spectrum of biological processes, such as DNA damage repair, apoptosis, and cell cycle regulation. FOXO3a has been shown to be a tumor suppressor in various cancers. This study investigated the expression of FOXO3a in primary gastric adenocarcinomas and its prognostic value for primary gastric adenocarcinoma patients. Methods: Real-time quantitative RT-PCR (qRT-PCR), western blotting, and immunohistochemical staining were used to detect FOXO3a expression in primary gastric cancerous surgical specimens and adjacent non-tumorous tissues. Results: Our data showed that the expression of FOXO3a mRNA (p = 0.03) and protein (p = 0.019) was lower in cancerous tissues compared with their adjacent non-tumorous tissues. In addition, the chi-square test revealed that low FOXO3a expression was significantly correlated with larger tumor size (p = 0.007), poor histopathological classification (p = 0.029), depth of invasion (p = 0.049), local lymph node metastasis (p = 0.013), distant metastasis (p = 0.013) and AJCC staging (p<0.001). Kaplan-Meier survival analysis demonstrated that low expression of FOXO3a was significantly correlated with a poor prognosis for gastric cancer patients (p<0.001). The multivariate analysis showed that FOXO3a expression was an independent prognostic factor of the overall survival rate of patients with primary gastric adenocarcinoma. Conclusion: Our study suggested that decreased FOXO3a expression may play an important role in the progression of gastric cancer. FOXO3a could be a valuable prognostic marker as well as a potential molecular therapy target for gastric cancer patients.	[Yang, Xiao-bo; Zhao, Jing-jing; Wang, Qi-jing; Pan, Ke; Wang, Dan-dan; Pan, Qiu-zhong; Jiang, Shan-shan; Lv, Lin; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Xiao-bo; Zhao, Jing-jing; Wang, Qi-jing; Pan, Ke; Wang, Dan-dan; Pan, Qiu-zhong; Jiang, Shan-shan; Lv, Lin; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Xiao-bo; Gao, Xiang; Chen, Huang-wei; Yao, Jia-yin; Zhi, Min] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Jing-jing; Wang, Qi-jing; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, Dept Biotherapy Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Chun-yu] Sun Yat Sen Univ, Ctr Canc, Dept Endoscopy, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhi, M (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China.	merryzhi@163.com; xiajch@mail.sysu.edu.cn			National Natural Science Foundation of China [u0772002, 30700985, 30973398]; Guangdong Natural Science Foundation [925100890]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (u0772002, 30700985, 30973398) and Guangdong Natural Science Foundation (925100890). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Arden KC, 2006, EXP GERONTOL, V41, P709, DOI 10.1016/j.exger.2006.05.015; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Caruso RA, 2002, MODERN PATHOL, V15, P831, DOI 10.1097/01.MP.0000020391.98998.6B; Chen CN, 2005, J CLIN ONCOL, V23, P7286, DOI 10.1200/JCO.2004.00.2253; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Habashy HO, 2011, BREAST CANCER RES TR, V129, P11, DOI 10.1007/s10549-010-1161-z; Hippo Y, 2002, CANCER RES, V62, P233; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang Haojie, 2006, Future Oncol, V2, P83, DOI 10.2217/14796694.2.1.83; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karger S, 2009, ENDOCR-RELAT CANCER, V16, P189, DOI 10.1677/ERC-07-0283; Lee HS, 2007, CLIN CANCER RES, V13, P4154, DOI 10.1158/1078-0432.CCR-07-0173; Ma HQ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-190; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Partridge L, 2008, ONCOGENE, V27, P2351, DOI 10.1038/onc.2008.28; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Shukla S, 2009, INT J ONCOL, V34, P1613, DOI 10.3892/ijo_00000291; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024897; Yang JY, 2008, NAT CELL BIOL, V10, P370; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yasui Wataru, 2005, Gastric Cancer, V8, P86, DOI 10.1007/s10120-005-0320-0; Yasui W, 2009, PATHOL INT, V59, P121, DOI 10.1111/j.1440-1827.2009.02329.x; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033655; Zigrino P, 2005, BIOCHIMIE, V87, P321, DOI 10.1016/j.biochi.2004.10.025; Zou YY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1872	33	28	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78158	10.1371/journal.pone.0078158	http://dx.doi.org/10.1371/journal.pone.0078158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194912	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000091
J	Mahmoud, AM; Zhu, T; Parray, A; Siddique, HR; Yang, WC; Saleem, M; Bosland, MC				Mahmoud, Abeer M.; Zhu, Tian; Parray, Aijaz; Siddique, Hifzur R.; Yang, Wancai; Saleem, Mohammad; Bosland, Maarten C.			Differential Effects of Genistein on Prostate Cancer Cells Depend on Mutational Status of the Androgen Receptor	PLOS ONE			English	Article							LIGAND-BINDING DOMAIN; KAPPA-B ACTIVATION; LNCAP CELLS; GENE-EXPRESSION; DOWN-REGULATION; WILD-TYPE; IN-VITRO; SOY FOOD; INHIBITION; PROGRESSION	Blocking the androgen receptor (AR) activity is the main goal of therapies for advanced prostate cancer (PCa). However, relapse with a more aggressive, hormone refractory PCa arises, which harbors restored AR activity. One mechanism of such reactivation occurs through acquisition of AR mutations that enable its activation by various steroidal and non-steroidal structures. Thus, natural and chemical compounds that contribute to inappropriate (androgen-independent) activation of the AR become an area of intensive research. Here, we demonstrate that genistein, a soy phytoestrogen binds to both the wild and the Thr877Ala (T877A) mutant types of AR competitively with androgen, nevertheless, it exerts a pleiotropic effect on PCa cell proliferation and AR activity depending on the mutational status of the AR. Genistein inhibited, in a dose-dependent way, cell proliferation and AR nuclear localization and expression in LAPC-4 cells that have wild AR. However, in LNCaP cells that express the T877A mutant AR, genistein induced a biphasic effect where physiological doses (0.5-5 mu mol/L) stimulated cell growth and increased AR expression and transcriptional activity, and higher doses induced inhibitory effects. Similar biphasic results were achieved in PC-3 cells transfected with AR mutants; T877A, W741C and H874Y. These findings suggest that genistein, at physiological concentrations, potentially act as an agonist and activate the mutant AR that can be present in advanced PCa after androgen ablation therapy.	[Mahmoud, Abeer M.; Yang, Wancai; Bosland, Maarten C.] Univ Illinois, Dept Pathol, Chicago, IL 60607 USA; [Zhu, Tian] Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL USA; [Parray, Aijaz; Siddique, Hifzur R.; Saleem, Mohammad] Univ Minnesota, Hormel Inst, Sect Mol Chemoprevent & Therapeut, Austin, TX USA; [Yang, Wancai] Xinxiang Med Univ, Dept Pathol, Xinxiang, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Minnesota System; Xinxiang Medical University	Mahmoud, AM (corresponding author), Univ Illinois, Dept Pathol, Chicago, IL 60607 USA.	amahmo4@uic.edu; boslandm@uic.edu	Saleem, Mohammad/GVS-9221-2022; Siddique, Hifzur R/H-4049-2019; Yang, Wancai/O-7655-2019	Saleem, Mohammad/0000-0002-7422-7967; Siddique, Hifzur R/0000-0001-8736-0487; Yang, Wancai/0000-0001-7437-9197	Egyptian Ministry of Higher Education [GM 842]; NIH [CA 116195]; NATIONAL CANCER INSTITUTE [R01CA116195] Funding Source: NIH RePORTER	Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	1. Grant No. GM 842 from the Egyptian Ministry of Higher Education. 2. NIH Grant No. CA 116195. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERCREUTZ H, 1993, LANCET, V342, P1209, DOI 10.1016/0140-6736(93)92188-Y; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; [Anonymous], 2011, LIGPREP VERS 2 5; Balk SP, 2008, NUCL RECEPT SIGNAL, V6, pe001, DOI DOI 10.1621/NRS.06001; Basak S, 2008, MOL CANCER THER, V7, P3195, DOI 10.1158/1535-7163.MCT-08-0617; Bektic J, 2004, EUR UROL, V45, P245, DOI 10.1016/j.eururo.2003.09.001; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Case DA., 2010, AMBER 11; Chang KL, 2009, CANCER LETT, V276, P14, DOI 10.1016/j.canlet.2008.10.033; CULIG Z, 1993, MOL ENDOCRINOL, V7, P1541, DOI 10.1210/me.7.12.1541; Davis JN, 2000, INT J ONCOL, V16, P1091; Davis JN, 1999, NUTR CANCER, V35, P167, DOI 10.1207/S15327914NC352_11; Davis JN, 2002, MOL CARCINOGEN, V34, P91, DOI 10.1002/mc.10053; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Duff J, 2005, MOL ENDOCRINOL, V19, P2943, DOI 10.1210/me.2005-0231; Ewald P.P, 1921, ANN PHYS-NEW YORK, V64, P253, DOI [10.1002/andp.19213690304, DOI 10.1002/ANDP.19213690304]; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; FOTSIS T, 1995, J NUTR, V125, pS790, DOI 10.1093/jn/125.suppl_3.790S; Gao S, 2004, PROSTATE, V59, P214, DOI 10.1002/pros.10375; Gardner CD, 2009, PROSTATE, V69, P719, DOI 10.1002/pros.20922; Georget V, 2002, BIOCHEMISTRY-US, V41, P11824, DOI 10.1021/bi0259150; Gregory CW, 2001, CANCER RES, V61, P4315; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hwang YW, 2009, NUTR CANCER, V61, P598, DOI 10.1080/01635580902825639; IARC, 2008, CANC INCIDENCE 5 CON, VIX, P1; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jian L, 2009, MOL NUTR FOOD RES, V53, P217, DOI 10.1002/mnfr.200800167; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jones JO, 2009, P NATL ACAD SCI USA, V106, P7233, DOI 10.1073/pnas.0807282106; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Lakshman M, 2008, CANCER RES, V68, P2024, DOI 10.1158/0008-5472.CAN-07-1246; Lazarevic B, 2008, ONCOL REP, V19, P1231; Lee J, 2012, NUTR CANCER, V64, P153, DOI 10.1080/01635581.2012.630161; Lee WY, 2007, NUTR CANCER, V58, P239, DOI 10.1080/01635580701328636; Li P, 2002, AM J PATHOL, V161, P1467, DOI 10.1016/S0002-9440(10)64422-7; Li YW, 1999, INT J ONCOL, V15, P525; Li YW, 2004, NEOPLASIA, V6, P354, DOI 10.1593/neo.03478; Li YW, 2002, CLIN CANCER RES, V8, P2369; Linja MJ, 2004, CLIN CANCER RES, V10, P1032, DOI 10.1158/1078-0432.CCR-0990-3; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Maggiolini M, 2002, MOL PHARMACOL, V62, P1027, DOI 10.1124/mol.62.5.1027; Messina MJ, 2003, NUTR REV, V61, P117, DOI [10.1301/nr.2003.apr.117&ndash;131, 10.1301/nr.2003.apr.117-131]; Nakamura Y, 2000, J AOAC INT, V83, P635; Oh HY, 2010, BIOCHEM BIOPH RES CO, V393, P319, DOI 10.1016/j.bbrc.2010.01.133; Ozers MS, 2007, BIOCHEMISTRY-US, V46, P683, DOI 10.1021/bi061321b; RuizLarrea MB, 1997, FREE RADICAL RES, V26, P63, DOI 10.3109/10715769709097785; Schiliro T, 2011, J STEROID BIOCHEM, V127, P139, DOI 10.1016/j.jsbmb.2011.03.002; Seo YJ, 2011, J KOREAN MED SCI, V26, P1489, DOI 10.3346/jkms.2011.26.11.1489; Setchell KDR, 2001, J NUTR, V131, p1362S, DOI 10.1093/jn/131.4.1362S; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Shi XB, 2002, CANCER RES, V62, P1496; Siddique HR, 2011, CLIN CANCER RES, V17, P5379, DOI 10.1158/1078-0432.CCR-11-0916; Suzuki H, 1996, PROSTATE, V29, P153, DOI 10.1002/1097-0045(199609)29:3<153::AID-PROS2990290303>3.0.CO;2-5; Takahashi Y, 2006, MOL CARCINOGEN, V45, P18, DOI 10.1002/mc.20153; Takahashi Y, 2004, MOL CARCINOGEN, V41, P108, DOI 10.1002/mc.20045; Tanner MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016027; Taplin ME, 1999, CANCER RES, V59, P2511; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Tilley WD, 1996, CLIN CANCER RES, V2, P277; Uehara M, 2000, BIOFACTORS, V12, P217, DOI 10.1002/biof.5520120134; Urushibara M, 2007, PROSTATE, V67, P799, DOI 10.1002/pros.20542; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Wiren KM, 1997, ENDOCRINOLOGY, V138, P2291, DOI 10.1210/en.138.6.2291; Wong S, 2009, J CHEM THEORY COMPUT, V5, P422, DOI 10.1021/ct8003707; Xu L, 2006, MOL PHARMACOL, V70, P869, DOI 10.1124/mol.106.023861; Yan L, 2005, INT J CANCER, V117, P667, DOI 10.1002/ijc.21266; Yan L, 2009, AM J CLIN NUTR, V89, P1155, DOI 10.3945/ajcn.2008.27029; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhang LQ, 2003, CANCER RES, V63, P4552; Zhou JM, 2010, PROTEINS, V78, P623, DOI 10.1002/prot.22592; Zhou JR, 2002, PROSTATE, V53, P143, DOI 10.1002/pros.10141	77	40	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78479	10.1371/journal.pone.0078479	http://dx.doi.org/10.1371/journal.pone.0078479			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167630	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500091
J	Spyrakis, F; Singh, R; Cozzini, P; Campanini, B; Salsi, E; Felici, P; Raboni, S; Benedetti, P; Cruciani, G; Kellogg, GE; Cook, PF; Mozzarelli, A				Spyrakis, Francesca; Singh, Ratna; Cozzini, Pietro; Campanini, Barbara; Salsi, Enea; Felici, Paolo; Raboni, Samanta; Benedetti, Paolo; Cruciani, Gabriele; Kellogg, Glen E.; Cook, Paul F.; Mozzarelli, Andrea			Isozyme-Specific Ligands for O-acetylserine sulfhydrylase, a Novel Antibiotic Target	PLOS ONE			English	Article							SALMONELLA-TYPHIMURIUM LT-2; TIME-RESOLVED FLUORESCENCE; BIENZYME COMPLEX-FORMATION; CYSTEINE SYNTHASE COMPLEX; MYCOBACTERIUM-TUBERCULOSIS; SERINE ACETYLTRANSFERASE; ESCHERICHIA-COLI; ACTIVE-SITE; PHOSPHOSERINE SULFHYDRYLASE; PYRIDOXAL 5'-PHOSPHATE	The last step of cysteine biosynthesis in bacteria and plants is catalyzed by O-acetylserine sulfhydrylase. In bacteria, two isozymes, O-acetylserine sulfhydrylase-A and O-acetylserine sulfhydrylase-B, have been identified that share similar binding sites, although the respective specific functions are still debated. O-acetylserine sulfhydrylase plays a key role in the adaptation of bacteria to the host environment, in the defense mechanisms to oxidative stress and in antibiotic resistance. Because mammals synthesize cysteine from methionine and lack O-acetylserine sulfhydrylase, the enzyme is a potential target for antimicrobials. With this aim, we first identified potential inhibitors of the two isozymes via a ligand-and structure-based in silico screening of a subset of the ZINC library using FLAP. The binding affinities of the most promising candidates were measured in vitro on purified O-acetylserine sulfhydrylase-A and O-acetylserine sulfhydrylase-B from Salmonella typhimurium by a direct method that exploits the change in the cofactor fluorescence. Two molecules were identified with dissociation constants of 3.7 and 33 mu M for O-acetylserine sulfhydrylase-A and O-acetylserine sulfhydrylase-B, respectively. Because GRID analysis of the two isoenzymes indicates the presence of a few common pharmacophoric features, cross binding titrations were carried out. It was found that the best binder for O-acetylserine sulfhydrylase-B exhibits a dissociation constant of 29 mu M for O-acetylserine sulfhydrylase-A, thus displaying a limited selectivity, whereas the best binder for O-acetylserine sulfhydrylase-A exhibits a dissociation constant of 50 mu M for O-acetylserine sulfhydrylase-B and is thus 8-fold selective towards the former isozyme. Therefore, isoform-specific and isoform-independent ligands allow to either selectively target the isozyme that predominantly supports bacteria during infection and long-term survival or to completely block bacterial cysteine biosynthesis.	[Spyrakis, Francesca; Cozzini, Pietro] Univ Parma, Dept Food Sci, I-43100 Parma, Italy; [Singh, Ratna; Campanini, Barbara; Salsi, Enea; Felici, Paolo; Raboni, Samanta; Mozzarelli, Andrea] Univ Parma, Dept Pharm, I-43100 Parma, Italy; [Cozzini, Pietro; Mozzarelli, Andrea] Natl Inst Biostruct & Biosyst, Rome, Italy; [Benedetti, Paolo] Mol Discovery Ltd, London, England; [Cruciani, Gabriele] Univ Perugia, Dept Chem, I-06100 Perugia, Italy; [Kellogg, Glen E.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Kellogg, Glen E.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA USA; [Cook, Paul F.] Univ Oklahoma, Dept Biochem, Norman, OK 73019 USA	University of Parma; University of Parma; University of Perugia; Virginia Commonwealth University; Virginia Commonwealth University; University of Oklahoma System; University of Oklahoma - Norman	Campanini, B (corresponding author), Univ Parma, Dept Pharm, I-43100 Parma, Italy.	barbara.campanini@unipr.it; andrea.mozzarelli@unipr.it	Benedetti, Paolo/R-2649-2017; Cruciani, Gabriele/E-5927-2014; CRUCIANI, Gabriele/AAH-4627-2019; Campanini, Barbara/L-9723-2017; Mozzarelli, Andrea/C-3615-2014; Singh, Ratna/AAM-7340-2021; RABONI, Samanta/P-7823-2018	Benedetti, Paolo/0000-0001-7985-1753; Cruciani, Gabriele/0000-0002-4162-8692; CRUCIANI, Gabriele/0000-0002-4162-8692; Campanini, Barbara/0000-0003-0359-0627; Mozzarelli, Andrea/0000-0003-3762-0062; Singh, Ratna/0000-0003-0487-2861; RABONI, Samanta/0000-0003-3068-3714; spyrakis, francesca/0000-0002-4016-227X; Kellogg, Glen/0000-0002-6282-6794	University of Parma	University of Parma	University of Parma grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SM, 2008, INT J PARASITOL, V38, P137, DOI 10.1016/j.ijpara.2007.09.009; Agren D, 2008, J BIOL CHEM, V283, P31567, DOI 10.1074/jbc.M804877200; Agren D, 2009, FEBS LETT, V583, P330, DOI 10.1016/j.febslet.2008.12.019; Ali V, 2007, CLIN MICROBIOL REV, V20, P164, DOI 10.1128/CMR.00019-06; Amadasi A, 2006, J MOL BIOL, V358, P289, DOI 10.1016/j.jmb.2006.01.053; Amadasi A, 2007, CURR MED CHEM, V14, P1291, DOI 10.2174/092986707780597899; Amori L, 2012, MEDCHEMCOMM, V3, P1111, DOI 10.1039/c2md20100c; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Baroni M, 2007, J CHEM INF MODEL, V47, P279, DOI 10.1021/ci600253e; BECKER MA, 1969, J BIOL CHEM, V244, P2418; BECKER MA, 1969, J BIOL CHEM, V244, P6023; Beinert H, 2000, EUR J BIOCHEM, V267, P5657, DOI 10.1046/j.1432-1327.2000.01637.x; Benci S, 1999, BBA-PROTEIN STRUCT M, V1429, P317, DOI 10.1016/S0167-4838(98)00229-5; Benci S, 1997, BIOCHEMISTRY-US, V36, P15419, DOI 10.1021/bi970464i; Benci S, 1999, J PHOTOCH PHOTOBIO B, V48, P17, DOI 10.1016/S1011-1344(99)00003-2; Bender A, 2004, ORG BIOMOL CHEM, V2, P3204, DOI 10.1039/b409813g; Bettati S, 2002, BBA-PROTEIN STRUCT M, V1596, P47, DOI 10.1016/S0167-4838(01)00316-8; Bettati S, 2000, J BIOL CHEM, V275, P40244, DOI 10.1074/jbc.M007015200; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Bielska Ewa, 2011, Biotechnologia (Poznan), V92, P249; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Brincat JP, 2011, J MED CHEM, V54, P354, DOI 10.1021/jm1011963; Broccatelli F, 2011, J MED CHEM, V54, P1740, DOI 10.1021/jm101421d; Burkhard P, 2000, J MOL BIOL, V303, P279, DOI 10.1006/jmbi.2000.4109; Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Campanini B, 2005, PROTEIN SCI, V14, P2115, DOI 10.1110/ps.051492805; Campanini B, 2003, J BIOL CHEM, V278, P37511, DOI 10.1074/jbc.M305138200; Carosati E, 2008, J MED CHEM, V51, P5552, DOI 10.1021/jm800151n; Carosati E, 2007, J MED CHEM, V50, P2117, DOI 10.1021/jm061440p; Carosati E, 2012, J MED CHEM, V55, P10272, DOI 10.1021/jm300850v; Carosati E, 2010, BIOORGAN MED CHEM, V18, P7773, DOI 10.1016/j.bmc.2010.09.065; Chartron J, 2006, J MOL BIOL, V364, P152, DOI 10.1016/j.jmb.2006.08.080; Chattopadhyay A, 2007, BIOCHEMISTRY-US, V46, P8315, DOI 10.1021/bi602603c; Chinthalapudi K, 2008, PROTEINS, V72, P1222, DOI 10.1002/prot.22013; Claus MT, 2005, BIOCHEMISTRY-US, V44, P8620, DOI 10.1021/bi050485+; COOK PF, 1978, J BIOL CHEM, V253, P7874; COOK PF, 1977, ARCH BIOCHEM BIOPHYS, V178, P293, DOI 10.1016/0003-9861(77)90194-1; Copland RA, 2005, EVALUATION ENZYME IN; Cosconati S, 2008, J MED CHEM, V51, P6627, DOI 10.1021/jm800571m; Cozzini P, 2002, J MED CHEM, V45, P2469, DOI 10.1021/jm0200299; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Cross S, 2012, J CHEM INF MODEL, V52, P2587, DOI 10.1021/ci300153d; Cross S, 2012, J CHEM INF MODEL, V52, P2599, DOI [10.1021/ci300154n, 10.1021/ci300154]; Cross S, 2010, J CHEM INF MODEL, V50, P1442, DOI 10.1021/ci100221g; Cross S, 2010, DRUG DISCOV TODAY, V15, P23, DOI 10.1016/j.drudis.2008.12.006; Diner EJ, 2012, GENE DEV, V26, P515, DOI 10.1101/gad.182345.111; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Fornabaio M, 2004, J MED CHEM, V47, P4507, DOI 10.1021/jm030596b; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fyfe PK, 2012, ACTA CRYSTALLOGR F, V68, P738, DOI 10.1107/S1744309112019124; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hatzios SK, 2008, BIOCHEMISTRY-US, V47, P5823, DOI 10.1021/bi702453s; Hatzios SK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002036; Heine A, 2004, PROTEINS, V56, P387, DOI 10.1002/prot.20003; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; HULANICKA MD, 1986, J BACTERIOL, V168, P322, DOI 10.1128/jb.168.1.322-327.1986; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jurgenson CT, 2008, BIOCHEMISTRY-US, V47, P10354, DOI 10.1021/bi800915j; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; Kellogg GE, 2001, J COMPUT AID MOL DES, V15, P381, DOI 10.1023/A:1011136228678; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Koparde VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015920; Kredich N.M., 1996, ESCHERICHIA COLI SAL, P514; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; Kumar VUJ, 2013, BIOORG MED CHEM LETT, V23, P1182, DOI 10.1016/j.bmcl.2013.01.031; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Ma DL, 2013, CHEM SOC REV, V42, P2130, DOI 10.1039/c2cs35357a; MCCLURE GD, 1994, BIOCHEMISTRY-US, V33, P1674, DOI 10.1021/bi00173a009; MILES EW, 1991, ADV ENZYMOL RAMB, V64, P93; Milletti F, 2007, J CHEM INF MODEL, V47, P2172, DOI 10.1021/ci700018y; Milletti F, 2010, EUR J MED CHEM, V45, P4270, DOI 10.1016/j.ejmech.2010.06.026; Milletti F, 2009, J CHEM INF MODEL, V49, P68, DOI 10.1021/ci800340j; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1628, DOI 10.1271/bbb.64.1628; Mino K, 1999, BIOSCI BIOTECH BIOCH, V63, P168, DOI 10.1271/bbb.63.168; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1874, DOI 10.1271/bbb.64.1874; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mozzarelli A, 2011, BBA-PROTEINS PROTEOM, V1814, P1497, DOI 10.1016/j.bbapap.2011.04.011; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Nagpal I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030305; NAKAMURA T, 1983, J BACTERIOL, V156, P656, DOI 10.1128/JB.156.2.656-662.1983; Nakamura T, 2012, J MOL BIOL, V422, P33, DOI 10.1016/j.jmb.2012.05.009; Nakatani T, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-62; Oda Y, 2005, J MOL BIOL, V351, P334, DOI 10.1016/j.jmb.2005.05.064; Osterberg F, 2002, PROTEINS, V46, P34, DOI 10.1002/prot.10028; Poyraz O, 2013, J MED CHEM, V56, P6457, DOI 10.1021/jm400710k; Raboni S, 2009, CELL MOL LIFE SCI, V66, P2391, DOI 10.1007/s00018-009-0028-0; Raj I, 2012, ACTA CRYSTALLOGR D, V68, P909, DOI 10.1107/S0907444912016459; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Salsi E, 2010, J BIOL CHEM, V285, P12813, DOI 10.1074/jbc.M109.075762; Salsi E, 2010, J MED CHEM, V53, P345, DOI 10.1021/jm901325e; Santi-Rocca J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031777; Schelle MW, 2006, CHEMBIOCHEM, V7, P1516, DOI 10.1002/cbic.200600224; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; Schnell R, 2010, BIOCHEM BIOPH RES CO, V396, P33, DOI 10.1016/j.bbrc.2010.02.118; Sekowska A, 2000, J MOL MICROB BIOTECH, V2, P145; Senaratne RH, 2006, MOL MICROBIOL, V59, P1744, DOI 10.1111/j.1365-2958.2006.05075.x; Singh R, 2013, J ENZYM INHIB MED CH, V28, P183, DOI 10.3109/14756366.2011.643305; Sirci F, 2012, J CHEM INF MODEL, V52, P3308, DOI 10.1021/ci3004094; Sirci F, 2012, J COMPUT AID MOL DES, V26, P1247, DOI 10.1007/s10822-012-9612-8; Spyrakis F, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-4; Spyrakis F, 2013, CURR PHARM DESIGN, V19, P4291, DOI 10.2174/1381612811319230011; Spyrakis F, 2013, BBA-PROTEINS PROTEOM, V1834, P169, DOI 10.1016/j.bbapap.2012.09.009; TAI CH, 1993, BIOCHEMISTRY-US, V32, P6433, DOI 10.1021/bi00076a017; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Turnbull AL, 2010, RES MICROBIOL, V161, P643, DOI [10.1016/J.resmic.2010.06.004, 10.1016/j.resmic.2010.06.004]; Turnbull AL, 2008, MICROBIOL-SGM, V154, P3410, DOI 10.1099/mic.0.2008/020347-0; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wade R C, 1989, Prog Clin Biol Res, V289, P433; Wang T, 2012, J BIOL CHEM, V287, P4360, DOI 10.1074/jbc.M111.288423; Westrop GD, 2006, J BIOL CHEM, V281, P25062, DOI 10.1074/jbc.M600688200; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zhao CH, 2006, BIOCHEM BIOPH RES CO, V341, P911, DOI 10.1016/j.bbrc.2006.01.054	124	42	42	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77558	10.1371/journal.pone.0077558	http://dx.doi.org/10.1371/journal.pone.0077558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167577	Green Published, gold			2022-12-27	WOS:000326034500036
J	Rastogi, A; Kumari, Y; Rani, S; Kumar, V				Rastogi, Ashutosh; Kumari, Yatinesh; Rani, Sangeeta; Kumar, Vinod			Neural Correlates of Migration: Activation of Hypothalamic Clock(s) in and out of Migratory State in the Blackheaded Bunting (Emberiza melanocephala)	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; NEUROPEPTIDE-Y; SUPRACHIASMATIC NUCLEUS; JAPANESE-QUAIL; C-FOS; MEDIOBASAL HYPOTHALAMUS; PHOTOPERIODIC RESPONSE; SEASONAL REPRODUCTION; LUTEINIZING-HORMONE; GONADAL DEVELOPMENT	Background: Many vertebrates distinguish between short and long day lengths using suprachiasmatic nuclei (SCN). In birds particular, the mediobasal hypothalamus (MBH) is suggested to be involved in the timing of seasonal reproduction. This study investigated the response of SCN and MBH to a single long day, and the role of MBH in induction of the migratory phenotype in night-migratory blackheaded buntings. Methodology/Principal Findings: Experiment 1 immunocytochemically measured c-fos in the SCN, and c-fos, vasoactive intestinal peptide (VIP) and neuropeptide Y (NPY) in the MBH of buntings exposed to a 20 h light period. Long light period induced significantly stronger c-fos expression, measured as number of c-fos-like immunoreactive (c-fos-lir) cells, in MBH, but not in the SCN. Within the MBH, c-fos-lir cells were significantly denser in the inferior hypothalamic nucleus (IH) and infundibular nucleus (IN), but not in the dorsomedial hypothalamus (DMH). IH and IN also had significantly increased number of VIP and NPY labeled cells. DMH had significantly increased number of VIP labeled cells only. Experiment 2 assayed c-fos, VIP and NPY immunoreactivities in the middle of day and night in the MBH of buntings, after seven long days (day active, non-migratory state) and after seven days of Zugunruhe (night active, migratory state) in long days. In the migratory state, the number of c-fos-lir cells was significantly greater only in DMH; VIP-lir cells were denser in all three MBH regions suggesting enhanced light sensitivity at night. The denser NPY-lir cells only in IN in the non-migratory state were probably due to premigratory hyperphagia. Conclusions/Significance: In buntings, SCN may not be involved in the photoperiod-induced seasonal responses. MBH contains the seasonal clock sensitive to day length. VIP and NPY are parts of the neuroendocrine mechanism(s) involved, respectively, in sensing and translating the photoperiodic message in a seasonal response.	[Rastogi, Ashutosh; Kumari, Yatinesh; Rani, Sangeeta] Univ Lucknow, Dept Zool, Lucknow 226007, Uttar Pradesh, India; [Kumar, Vinod] Univ Delhi, Dept Zool, Delhi 110007, India	Lucknow University; University of Delhi	Kumar, V (corresponding author), Univ Delhi, Dept Zool, Delhi 110007, India.	drvkumar11@yahoo.com	Kumari, Yatinesh/F-9755-2018	Kumari, Yatinesh/0000-0001-6544-1243	Department of Science and Technology, New Delhi, India through Intensification of Research in High Priority Areas research funding [IR/SO/LU-02/2005]	Department of Science and Technology, New Delhi, India through Intensification of Research in High Priority Areas research funding	The study was funded by a generous research grant from the Department of Science and Technology, New Delhi, India, through Intensification of Research in High Priority Areas research funding (IR/SO/LU-02/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S., 1974, HDB BIRDS INDIA PAKI; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Bartell PA, 2005, J BIOL RHYTHM, V20, P538, DOI 10.1177/0748730405281826; Bernardis LL, 1998, P SOC EXP BIOL MED, V218, P284; Boswell Tim, 2005, Journal of Poultry Science, V42, P161, DOI 10.2141/jpsa.42.161; Brandstatter R, 2003, CHRONOBIOL INT, V20, P637, DOI 10.1081/CBI-120023343; Budki P, 2012, J EXP BIOL, V215, P3774, DOI 10.1242/jeb.065581; Cantwell EL, 2006, J COMP NEUROL, V496, P97, DOI 10.1002/cne.20935; Chou TC, 2003, J NEUROSCI, V23, P10691; CONTIJOCH AM, 1993, NEUROENDOCRINOLOGY, V57, P135, DOI 10.1159/000126353; D'Hondt E, 1999, J NEUROSCI METH, V91, P31, DOI 10.1016/S0165-0270(99)00067-9; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; ELHALAWANI ME, 1997, PERSPECTIVES AVIAN E, P403; FRALEY GS, 1993, LIFE SCI, V52, P1649, DOI 10.1016/0024-3205(93)90047-7; Gentner TQ, 2001, J NEUROBIOL, V46, P48, DOI 10.1002/1097-4695(200101)46:1<48::AID-NEU5>3.0.CO;2-3; Gupta NJ, 2013, ANIM BIOL IN PRESS; Gwinner E, 1996, J EXP BIOL, V199, P39; Heyers D, 2010, P NATL ACAD SCI USA, V107, P9394, DOI 10.1073/pnas.0907068107; Kawaguchi M, 2005, AM J PHYSIOL-REG I, V288, pR1800, DOI 10.1152/ajpregu.00805.2004; King VM, 1997, J COMP PHYSIOL A, V180, P541, DOI 10.1007/s003590050071; KLUVER H, 1953, J NEUROPATH EXP NEUR, V12, P400; Kuenzel WJ, 2000, POULTRY SCI, V79, P1679, DOI 10.1093/ps/79.11.1679; KUENZEL WJ, 1987, PEPTIDES, V8, P823, DOI 10.1016/0196-9781(87)90066-0; KUMAR V, 1993, REPROD NUTR DEV, V33, P143, DOI 10.1051/rnd:19930207; Kumar V, 2004, BIOL RHYTHM RES, V35, P121, DOI 10.1080/09291010412331313287; Kumar V, 1997, MOL BRAIN RES, V52, P242, DOI 10.1016/S0169-328X(97)00260-X; KUMAR V, 1988, J ZOOL, V216, P253, DOI 10.1111/j.1469-7998.1988.tb02429.x; Kumar V, 2010, PHYSIOL BIOCHEM ZOOL, V83, P827, DOI 10.1086/652243; Li HY, 2008, BRAIN RES BULL, V76, P586, DOI 10.1016/j.brainresbull.2008.04.007; MACNAMEE MC, 1986, GEN COMP ENDOCR, V62, P470, DOI 10.1016/0016-6480(86)90057-2; Malik S, 2004, CHRONOBIOL INT, V21, P367, DOI 10.1081/CBI-120038742; Meddle SL, 1997, J NEUROSCI, V17, P8909; MOLINERO P, 1993, NEUROSCI LETT, V151, P130, DOI 10.1016/0304-3940(93)90003-4; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; OHTA M, 1984, J COMP PHYSIOL, V154, P583, DOI 10.1007/BF00610171; OPEL H, 1988, P SOC EXP BIOL MED, V187, P455; Perfito N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034997; PROUDMAN J, 1983, POULTRY SCI, V62, P1484; Ramakrishnan S, 2007, J NEUROENDOCRINOL, V19, P163, DOI 10.1111/j.1365-2826.2006.01520.x; Rani S, 2006, CURR SCI INDIA, V91, P1093; Rastogi A, 2011, EUR J NEUROSCI, V34, P99, DOI 10.1111/j.1460-9568.2011.07737.x; Rathinam T, 2005, BRAIN RES BULL, V64, P455, DOI 10.1016/j.brainresbull.2004.10.003; RICHARDSON RD, 1995, AM J PHYSIOL-REG I, V268, pR1418, DOI 10.1152/ajpregu.1995.268.6.R1418; Saab SS, 2010, J NEUROENDOCRINOL, V22, P196, DOI 10.1111/j.1365-2826.2010.01954.x; Sakharkar AJ, 2005, J COMP NEUROL, V489, P148, DOI 10.1002/cne.20614; Saldanha CJ, 2001, J BIOL RHYTHM, V16, P39, DOI 10.1177/074873040101600105; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Sharp PJ, 2005, ANN NY ACAD SCI, V1040, P189, DOI 10.1196/annals.1327.024; SHARP PJ, 1989, J ENDOCRINOL, V122, P5, DOI 10.1677/joe.0.1220005; SHARP PJ, 1969, NEUROENDOCRINOLOGY, V5, P205, DOI 10.1159/000121861; SILVER R, 1988, CELL TISSUE RES, V253, P189; Small TW, 2008, BRAIN BEHAV EVOLUT, V71, P127, DOI 10.1159/000111459; Stevenson TJ, 2012, EUR J NEUROSCI, V36, P2859, DOI 10.1111/j.1460-9568.2012.08209.x; Sumova A, 2002, PHYSL RES, V51; Teruyama R, 2001, CELL TISSUE RES, V303, P403, DOI 10.1007/s004410000313; TEWARY PD, 1984, CURR SCI INDIA, V53, P1307; TEWARY PD, 1981, INDIAN J EXP BIOL, V19, P469; Thayananuphat A, 2007, J NEUROENDOCRINOL, V19, P407, DOI 10.1111/j.1365-2826.2007.01544.x; WALLMAN J, 1994, J COMP PHYSIOL A, V174, P297; Wang G, 2011, GEN COMP ENDOCR, V170, P589, DOI 10.1016/j.ygcen.2010.11.014; WILSON FE, 1991, J EXP ZOOL, V259, P117, DOI 10.1002/jez.1402590114; Yasuo S, 2003, ENDOCRINOLOGY, V144, P3742, DOI 10.1210/en.2003-0435; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	65	45	46	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e70065	10.1371/journal.pone.0070065	http://dx.doi.org/10.1371/journal.pone.0070065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204554	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600001
J	Dong, DY; Wang, B; Yin, W; Ding, XQ; Yu, JJ; Kang, YJ				Dong, Daoyin; Wang, Biao; Yin, Wen; Ding, Xueqing; Yu, Jingjing; Kang, Y. James			Disturbance of Copper Homeostasis Is a Mechanism for Homocysteine-Induced Vascular Endothelial Cell Injury	PLOS ONE			English	Article							PENICILLAMINE ADMINISTRATION REVERSES; PLASMA TOTAL HOMOCYSTEINE; DEPENDENT RELAXATION; HYPERHOMOCYSTEINAEMIA; BINDING	Elevation of serum homocysteine (Hcy) levels is a risk factor for cardiovascular diseases. Previous studies suggested that Hcy interferes with copper (Cu) metabolism in vascular endothelial cells. The present study was undertaken to test the hypothesis that Hcy-induced disturbance of Cu homeostasis leads to endothelial cell injury. Exposure of human umbilical vein endothelial cells (HUVECs) to concentrations of Hcy at 0.01, 0.1 or 1 mM resulted in a concentration-dependent decrease in cell viability and an increase in necrotic cell death. Pretreatment of the cells with a final concentration of 5 mu M Cu in cultures prevented the effects of Hcy. Hcy decreased intracellular Cu concentrations. HPLC-ICP-MS analysis revealed that Hcy caused alterations in the distribution of intracellular Cu; more Cu was redistributed to low molecular weight fractions. ESI-Q-TOF detected the formation of Cu-Hcy complexes. Hcy also decreased the protein levels of Cu chaperone COX17, which was accompanied by a decrease in the activity of cytochrome c oxidase (CCO) and a collapse of mitochondrial membrane potential. These effects of Hcy were all preventable by Cu pretreatment. The study thus demonstrated that Hcy disturbs Cu homeostasis and limits the availability of Cu to critical molecules such as COX17 and CCO, leading to mitochondrial dysfunction and endothelial cell injury.	[Dong, Daoyin; Wang, Biao; Yin, Wen; Ding, Xueqing; Kang, Y. James] Sichuan Univ, Regenerat Med Res Ctr, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Yu, Jingjing] Agilent Technol China Co Ltd, Beijing, Peoples R China	Sichuan University; Agilent Technologies	Kang, YJ (corresponding author), Sichuan Univ, Regenerat Med Res Ctr, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	yjkang01@louisville.edu	Dong, Daoyin/D-6014-2016; WANG, BIAO/AAN-7583-2020	Dong, Daoyin/0000-0003-0544-8341; WANG, BIAO/0000-0003-1049-8546	National Science Foundation of China [81230004]; Sichuan University West China Hospital	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan University West China Hospital	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the National Science Foundation of China (grant number:81230004 to Y. J. Kang) and Sichuan University West China Hospital.	Apostolova MD, 2003, J INORG BIOCHEM, V95, P321, DOI 10.1016/S0162-0134(03)00133-8; BABSON AL, 1973, CLIN CHEM, V19, P766; Carrasco-Pozo C, 2006, EXP BIOL MED, V231, P1569, DOI 10.1177/153537020623100918; Emsley AM, 1999, BRIT J PHARMACOL, V126, P1034, DOI 10.1038/sj.bjp.0702374; Exner M, 2002, FEBS LETT, V531, P402, DOI 10.1016/S0014-5793(02)03571-8; Garcia AJ, 2002, J CHROMATOGR B, V779, P359, DOI 10.1016/S1570-0232(02)00401-4; Getz J, 2011, BIOL TRACE ELEM RES, V143, P368, DOI 10.1007/s12011-010-8858-z; Jeremy JY, 2002, ANN THORAC SURG, V74, P1553, DOI 10.1016/S0003-4975(02)03807-9; Kang YJ, 2011, PHARMACOL THERAPEUT, V129, P321, DOI 10.1016/j.pharmthera.2010.11.004; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; KLAASSEN CD, 1994, ENVIRON HEALTH PERSP, V102, P141, DOI 10.2307/3431778; Koupparis AJ, 2006, BJU INT, V98, P440, DOI 10.1111/j.1464-410X.2006.06212.x; Linnebank M, 2006, NEUROBIOL DIS, V23, P725, DOI 10.1016/j.nbd.2006.06.010; Malinow MR, 1999, CIRCULATION, V99, P178, DOI 10.1161/01.CIR.99.1.178; Mansoor MA, 2000, CLIN CHEM, V46, P385; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Palumaa P, 2004, BIOCHEM J, V382, P307, DOI 10.1042/BJ20040360; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Selhub J, 2006, J NUTR, V136, p1726S, DOI 10.1093/jn/136.6.1726S; Shukla N, 2006, EUR J PHARMACOL, V531, P201, DOI 10.1016/j.ejphar.2005.12.003; Shukla N, 2007, ANN THORAC SURG, V84, P43, DOI 10.1016/j.athoracsur.2007.03.087	21	20	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76209	10.1371/journal.pone.0076209	http://dx.doi.org/10.1371/journal.pone.0076209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204604	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300014
J	Goli, S; Arokiasamy, P				Goli, Srinivas; Arokiasamy, Perianayagam			Demographic Transition in India: An Evolutionary Interpretation of Population and Health Trends Using 'Change-Point Analysis'	PLOS ONE			English	Article							FERTILITY TRANSITION; CONVERGENCE; PATTERNS; DECLINE; MORTALITY	Background and Rationale: Lack of a robust analytical tool for trend analysis of population and health indicators is the basic rationale of this study. In an effort to fill this gap, this study advances 'Change-Point analyzer' as a new analytical tool for assessment of the progress and its pattern in population and health indicators. Methodology/Principal Findings: The defining feature of 'change-point analyzer' is that, it detects subtle changes that are often missed in simple trend line plots and also quantified the volume of change that is not possible in simple trend line plots. A long-term assessment of 'change-point analyses' of trends in population and health indicators such as IMR, Population size, TFR, and LEB in India show multiple points of critical changes. Measured change points of demographic and health trends helps in understanding the demographic transitional shifts connecting it to contextual policy shifts. Critical change-points in population and health indicators in India are associated with the evolution of structural changes in population and health policy framework. Conclusions: This study, therefore, adds significantly to the evolutionary interpretation of critical change-points in long-term trajectories of population and health indicators vis-a-vis population and health policy shifts in India. The results have not only helped in reassessing the historical past and the current demographic transition trajectory but also advanced a new method of assessing the population and health trends which are necessary for robust monitoring of the progress in population and health policies.	[Goli, Srinivas] Giri Inst Dev Studies GIDS, Dept Dev Studies, Lucknow, Uttar Pradesh, India; [Arokiasamy, Perianayagam] Int Inst Populat Sci IIPS, Dept Dev Studies, Bombay, Maharashtra, India	International Institute for Population Sciences	Goli, S (corresponding author), Giri Inst Dev Studies GIDS, Dept Dev Studies, Lucknow, Uttar Pradesh, India.	sirispeaks2u@gmail.com	Perianayagam, Arokiasamy/AAT-4147-2020; Goli, Srinivas/J-7238-2012	Perianayagam, Arokiasamy/0000-0001-8698-217X; Goli, Srinivas/0000-0002-8481-484X				Angeles L, 2010, J POPUL ECON, V23, P99, DOI 10.1007/s00148-009-0255-6; [Anonymous], 2000, CHANGE POINT ANAL 2; Bhat P.N.M., 1984, 24 COMM POP DEM; BHAT PNM, 1989, INDIAS HIST DEMOGRAP; BHAT PNM, 1997, KERALAS DEMOGRAPHIC, P33; Bloom DE, 1998, WORLD BANK ECON REV, V12, P419, DOI 10.1093/wber/12.3.419; Bongaarts J, 2003, WORKING PAPER; Box G.E.P., 1997, STAT CONTROL MONITOR; Caldwell JC, 2004, POPUL DEV REV, V30, P297, DOI 10.1111/j.1728-4457.2004.014_1.x; Casterline JB, 2011, POPUL DEV REV, V37, P395, DOI 10.1111/j.1728-4457.2011.00417.x; Casterline JB, 2001, POPUL DEV REV, V27, P17; Census of India, 1871, FIN POP TOT; Census of India, 2011, PROV POP TOT; CHANDRASEKHAR S, 1972, INFANT MORTALITY POP; DASGUPTA M, 2005, ECON POLIT WEEKLY, V40, P5159; DAVIS K, 1963, POPUL INDEX, V29, P345; Davis K., 1951, POPULATION INDIA PAK; Doepke M, 2005, J POPUL ECON, V18, P337, DOI 10.1007/s00148-004-0208-z; Dorius SF, 2008, POPUL DEV REV, V34, P519, DOI 10.1111/j.1728-4457.2008.00235.x; Dorius SF, 2010, SOC FORCES, V88, P1941, DOI 10.1353/sof.2010.0040; Dyson, 2004, 21 CENTURY INDIA POP, P57; DYSON T, 1989, INDIAN ECON SOC HIST, V26, P167, DOI 10.1177/001946468902600202; Dyson T, 2010, POPULATION DEV DEMOG; Dyson Tim, 2004, 21 CENTURY INDIA POP; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fogelson Raymond, 2001, ANTHR INDIANS NEW S, pix; Fujisaki I, 2008, POPUL ECOL, V50, P275, DOI 10.1007/s10144-008-0083-7; GHOSH A, 1956, POP STUD-J DEMOG, V9, P217, DOI 10.2307/2172141; Guilmoto CZ, 2001, POPUL DEV REV, V27, P713, DOI 10.1111/j.1728-4457.2001.00713.x; HINKLEY D, 1987, BIOMETRIKA, V74, P85, DOI 10.1093/biomet/74.1.85; HINKLEY DV, 1971, BIOMETRIKA, V58, P509, DOI 10.1093/biomet/58.3.509; James K. S., 2005, Economic and Political Weekly, V40, P375; James KS, 1995, ECON POLIT WEEKLY, V30, P3274; KARKAL M, 1985, ECON POLIT WEEKLY, V20, P1835; Kulkarni P. M., 2005, Economic and Political Weekly, V40, P403; Kulkarni PM, 2011, G SIMM MEM LECT 33 A; Mahalanobis P. C., 1976, ARTHA VIJNANA, V18, P1; McNay K, 2003, POP STUD-J DEMOG, V57, P21, DOI 10.1080/0032472032000061703; Moser K, 2005, B WORLD HEALTH ORGAN, V83, P202; Mukherjee Moni, 1969, NATL INCOME INDIA TR; Notestien FW, 1945, FOOD WORLD; Office of Registrar General of India, 2009, COMP SAMPL REG SYST; PAGE ES, 1955, BIOMETRIKA, V42, P243, DOI 10.1093/biomet/42.1-2.243; PAGE ES, 1957, BIOMETRIKA, V44, P248, DOI 10.2307/2333258; PETTITT AN, 1980, BIOMETRIKA, V67, P79; Preston SH, 1980, POPULATION EC CHANGE, P289; RBI, 1955, HDB STAT; RELE JR, 1987, POPUL DEV REV, V13, P513, DOI 10.2307/1973137; Rele JR, 1982, COUNTRY MONOGRAPH SE, V10, P91; Sibanda T, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-46; Srinivasan K., 2007, Economic and Political Weekly, V42, P2931; Taylor W, 2011, CHANGE POINT ANAL PO; United Nations Development Programmeme, 2011, HUM DEV IND REP 2011; VANDEWALLE E, 1980, POPUL BULL, V34, P3; Visaria L, 2011, DEMOGRAPHIC TRANSITI; VISARIA P, 1994, ECON POLIT WEEKLY, V29, P3281; Visaria P, 2003, ECON POLIT WEEKLY, V38, P4763; Weeks JR, 2004, ANN ASSOC AM GEOGR, V94, P74, DOI 10.1111/j.1467-8306.2004.09401005.x; Wilson C, 2001, POPUL DEV REV, V27, P155, DOI 10.1111/j.1728-4457.2001.00155.x; Wilson C, 1999, POP STUD-J DEMOG, V53, P117; Wilson C, 2011, POPUL DEV REV, V37, P375, DOI 10.1111/j.1728-4457.2011.00415.x	61	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76404	10.1371/journal.pone.0076404	http://dx.doi.org/10.1371/journal.pone.0076404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239MM	24204621	gold, Green Published			2022-12-27	WOS:000326029300025
J	Salgado-Salazar, C; Rossman, AY; Chaverri, P				Salgado-Salazar, Catalina; Rossman, Amy Y.; Chaverri, Priscila			Not as Ubiquitous as We Thought: Taxonomic Crypsis, Hidden Diversity and Cryptic Speciation in the Cosmopolitan Fungus Thelonectria discophora (Nectriaceae, Hypocreales, Ascomycota)	PLOS ONE			English	Article							PHYLOGENETIC SPECIES RECOGNITION; BAYESIAN-INFERENCE; GENETIC-VARIATION; TREES; CONCORDANCE; BIOGEOGRAPHY; DISPERSAL; ALIGNMENT; PATTERNS; COMPLEX	The distribution of microbial species, including fungi, has long been considered cosmopolitan. Recently, this perception has been challenged by molecular studies in historical biogeography, phylogeny and population genetics. Here we explore this issue using the fungal morphological species Thelonectria discophora, one of the most common species of fungi in the family Nectriaceae, encountered in almost all geographic regions and considered as a cosmopolitan taxon. In order to determine if T. discophora is a single cosmopolitan species or an assemblage of sibling species, we conducted various phylogenetic analyses, including standard gene concatenation, Bayesian concordance methods, and coalescent-based species tree reconstruction on isolates collected from a wide geographic range. Results show that diversity among isolates referred as T. discophora is greatly underestimated and that it represents a species complex. Within this complex, sixteen distinct highly supported lineages were recovered, each of which has a restricted geographic distribution and ecology. The taxonomic status of isolates regarded as T. discophora is reconsidered, and the assumed cosmopolitan distribution of this species is rejected. We discuss how assumptions about geographically widespread species have implications regarding their taxonomy, true diversity, biological diversity conservation, and ecological functions.	[Salgado-Salazar, Catalina; Chaverri, Priscila] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; [Rossman, Amy Y.] ARS, Systemat Mycol & Microbiol Lab, USDA, Beltsville, MD USA	University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA)	Salgado-Salazar, C (corresponding author), Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA.	salgadoc@umd.edu		Salgado Salazar, Catalina/0000-0002-4156-692X; Chaverri, Priscila/0000-0002-8486-6033	United States National Science Foundation (PEET) [DEB-0925696]	United States National Science Foundation (PEET)	This study was funded by a grant from United States National Science Foundation (PEET program, grant number DEB-0925696: "Monographic Studies in the Nectriaceae, Hypocreales: Nectria, Cosmospora, and Neonectria" http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ane C, 2007, MOL BIOL EVOL, V24, P412; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Baum DA, 2007, TAXON, V56, P417, DOI 10.1002/tax.562013; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Bleidorn C, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-47; Booth C, 1966, MYCOL PAP; Brayford D, 2004, MYCOLOGIA, V96, P572, DOI 10.2307/3762176; Brayford D, 1991, COMPENDIUM RASPBERRY; Carriconde F, 2008, MICROB ECOL, V56, P513, DOI 10.1007/s00248-008-9370-2; Chaverri P, 2011, STUD MYCOL, P57, DOI 10.3114/sim.2011.68.03; Chaverri P, 2006, BIOTROPICA, V38, P531, DOI 10.1111/j.1744-7429.2006.00176.x; Cothran RD, 2013, OIKOS, V122, P1429, DOI 10.1111/j.1600-0706.2013.00294.x; Cranston KA, 2009, SYST BIOL, V58, P489, DOI 10.1093/sysbio/syp054; Dahlberg A, 2011, FUNGAL ECOL, V4, P147, DOI 10.1016/j.funeco.2010.11.001; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Finlay BJ, 1996, NATURE, V383, P132, DOI 10.1038/383132a0; Finlay BJ, 2004, PROTIST, V155, P237, DOI 10.1078/143446104774199619; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Guu HR, 2007, BOT STUD, V48, P187; Hawksworth DL, 1997, PHYTOPATHOLOGY, V87, P888, DOI 10.1094/PHYTO.1997.87.9.888; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hirooka Y, 2012, STUD MYCOL, P1, DOI 10.3114/sim0001; Hirooka Y, 2011, STUD MYCOL, P35, DOI [10.3114/sim.2011.68.02, 10.3114/sim.2011.68.03]; Hirooka Yuuri, 2007, Mycoscience, V48, P53, DOI 10.1007/s10267-006-0330-8; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; James TY, 1999, EVOLUTION, V53, P1665, DOI [10.1111/j.1558-5646.1999.tb04552.x, 10.2307/2640430]; Kalla SE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-31; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Klautau M, 1999, EVOLUTION, V53, P1414, DOI 10.1111/j.1558-5646.1999.tb05406.x; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Leache AD, 2011, SYST BIOL, V60, P126, DOI 10.1093/sysbio/syq073; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V59, P587, DOI 10.1016/j.ympev.2011.03.020; Lee JY, 2012, SYST BIOL, V61, P253, DOI 10.1093/sysbio/syr101; Leigh JW, 2008, SYST BIOL, V57, P104, DOI 10.1080/10635150801910436; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lombard L, 2010, STUD MYCOL, P15, DOI 10.3114/sim.2010.66.02; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; McDonald MC, 2012, FUNGAL GENET BIOL, V49, P882, DOI 10.1016/j.fgb.2012.08.001; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nei M., 1987, MOL EVOLUTIONARY GEN; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Peay KG, 2010, NEW PHYTOL, V185, P878, DOI 10.1111/j.1469-8137.2009.03158.x; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Qu YH, 2012, MOL ECOL, V21, P6117, DOI 10.1111/mec.12080; Queloz V, 2011, GLOBAL ECOL BIOGEOGR, V20, P160, DOI 10.1111/j.1466-8238.2010.00589.x; Rambaut A, 2007, TRACER V 1 5; Rambaut A, 2005, FIGTREE V1 3 1; Roe AD, 2010, MOL ECOL RESOUR, V10, P946, DOI 10.1111/j.1755-0998.2010.02844.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roper M, 2010, P NATL ACAD SCI USA, V107, P17474, DOI 10.1073/pnas.1003577107; Roper M, 2008, P NATL ACAD SCI USA, V105, P20583, DOI 10.1073/pnas.0805017105; Rydholm C, 2006, EUKARYOT CELL, V5, P650, DOI 10.1128/EC.5.4.650-657.2006; Salgado-Salazar C, 2012, MYCOLOGIA, V104, P1325, DOI 10.3852/12-055; Samuels G.J., 1990, MEM N Y BOT GARD, V59, P6; Sato H, 2012, MOL ECOL, V21, P5599, DOI 10.1111/mec.12053; Seifert KA, 2010, IMA FUNGUS, V1, P109, DOI 10.5598/imafungus.2010.01.02.02; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stielow B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015614; Suatoni E, 2006, MOL PHYLOGENET EVOL, V41, P86, DOI 10.1016/j.ympev.2006.04.025; Tamames J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-85; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Vanormelingen P, 2008, BIODIVERS CONSERV, V17, P393, DOI 10.1007/s10531-007-9257-4; Wedin M, 2009, CLADISTICS, V25, P161, DOI 10.1111/j.1096-0031.2009.00240.x; Weisrock DW, 2012, MOL BIOL EVOL, V29, P1615, DOI 10.1093/molbev/mss008; Zufall RA, 2013, MOL ECOL, V22, P1081, DOI 10.1111/mec.12066	78	22	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76737	10.1371/journal.pone.0076737	http://dx.doi.org/10.1371/journal.pone.0076737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204665	Green Published, gold			2022-12-27	WOS:000326029300049
J	Zhang, SP; Suo, ML; Liu, SL; Liang, W				Zhang, Shuping; Suo, Mingli; Liu, Shenglin; Liang, Wei			Do Major Roads Reduce Gene Flow in Urban Bird Populations?	PLOS ONE			English	Article							LANDSCAPE; WILDLIFE; HABITAT; EXTINCTION; PROXIMITY; DIVERSITY; ABUNDANCE; WOODLAND; IMPACT	Background: Although the negative effects of roads on the genetics of animal populations have been extensively reported, the question of whether roads reduce gene flow in volant, urban bird populations has so far not been addressed. In this study, we assess whether highways decreased gene flow and genetic variation in a small passerine bird, the tree sparrow (Passer montanus). Methodology: We assessed genetic differences among tree sparrows (Passer montanus) sampled at 19 sites within Beijing Municipality, China, using 7 DNA microsatellites as genetic markers. Results: AMOVA showed that genetic variation between sites, between urban and rural populations, and between opposite sides of the same highway, were very weak. Mantel tests on all samples, and on urban samples only, indicated that the age and number of highways, and the number of ordinary roads, were uncorrelated with genetic differences (FST) among tree sparrows from different urban sites. Birds sampled at urban sites had similar levels of genetic diversity to those at rural sites. There was, however, evidence of some weak genetic structure between urban sites. Firstly, there were significant genetic differences (FST) between birds from opposite sides of the same highway, but no significant FST values between those from sites that were not separated by highways. Secondly, birds from eleven urban sites had loci that significantly deviated from the Hardy-Weinberg equilibrium but no such deviation was found in birds from rural sites. Conclusion: We cannot, therefore, conclusively reject the hypothesis that highways have no effect on the gene flow of tree sparrow populations. Furthermore, since the significance of these results may increase with time, we suggested that research on the influence of highways on gene flow in urban bird populations needs to be conducted over several decades.	[Zhang, Shuping; Suo, Mingli; Liu, Shenglin] Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China; [Liang, Wei] Hainan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Trop Anim & Plant Ecol, Haikou, Peoples R China	Minzu University of China; Hainan Normal University	Liang, W (corresponding author), Hainan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Trop Anim & Plant Ecol, Haikou, Peoples R China.	liangwei@hainnu.edu.cn			National Natural Science Foundation of China [30900181, 31071938, 31272328, 31372225]; Program for New Century Excellent Talents in University [NCET-10-0111]; 985 Program in Minzu University of China [MUC98504-14, MUC98507- 08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 985 Program in Minzu University of China	This study was supported by the National Natural Science Foundation of China (Nos. 30900181, 31071938, 31272328 and 31372225), Program for New Century Excellent Talents in University (NCET-10-0111), and 985 Program in Minzu University of China (MUC98504-14, MUC98507- 08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS A, 1990, Australian Zoologist, V26, P130; Balkenhol N, 2009, MOL ECOL, V18, P4151, DOI 10.1111/j.1365-294X.2009.04322.x; BARTON NH, 1995, PHILOS T ROY SOC B, V349, P49, DOI 10.1098/rstb.1995.0090; Brotons L, 2001, LANDSCAPE URBAN PLAN, V57, P77, DOI 10.1016/S0169-2046(01)00191-8; Clevenger AP, 2000, CONSERV BIOL, V14, P47, DOI 10.1046/j.1523-1739.2000.00099-085.x; Corlatti L, 2009, CONSERV BIOL, V23, P548, DOI 10.1111/j.1523-1739.2008.01162.x; Dyer SJ, 2001, J WILDLIFE MANAGE, V65, P531, DOI 10.2307/3803106; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Field RH, 2004, IBIS, V146, P60, DOI 10.1111/j.1474-919X.2004.00356.x; Forman R. T. T., 2003, ROAD ECOLOGY; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gagnon JW, 2007, J WILDLIFE MANAGE, V71, P2318, DOI 10.2193/2006-224; Gauffre B, 2008, MOL ECOL, V17, P4619, DOI 10.1111/j.1365-294X.2008.03950.x; Griffith SC, 1999, BIOL J LINN SOC, V68, P303, DOI 10.1111/j.1095-8312.1999.tb01171.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Holderegger R, 2010, BASIC APPL ECOL, V11, P522, DOI 10.1016/j.baae.2010.06.006; Jaarsma CF, 2006, TRANSPORT RES D-TR E, V11, P264, DOI 10.1016/j.trd.2006.05.001; Johansson M, 2005, GLOBAL CHANGE BIOL, V11, P1664, DOI 10.1111/j.1365-2486.2005.1005.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Keller I, 2003, P ROY SOC B-BIOL SCI, V270, P417, DOI 10.1098/rspb.2002.2247; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Murphy MA, 2008, ECOGRAPHY, V31, P685, DOI 10.1111/j.1600-0587.2008.05428.x; Pan Chao, 2003, Journal of Beijing Normal University (Natural Science), V39, P537; Partecke J, 2006, ECOLOGY, V87, P1945, DOI 10.1890/0012-9658(2006)87[1945:SATCUA]2.0.CO;2; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; Rheindt FE, 2003, J ORNITHOL, V144, P295, DOI 10.1046/j.1439-0361.2003.03004.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roedenbeck IA, 2008, EUR J WILDLIFE RES, V54, P425, DOI 10.1007/s10344-007-0166-3; Ruan X., 1991, P99; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Spellerberg IF, 1998, GLOBAL ECOL BIOGEOGR, V7, P317, DOI 10.1046/j.1466-822x.1998.00308.x; Summers-Smith JD, 1995, TREE SPARROW; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; VANDERZANDE AN, 1980, BIOL CONSERV, V18, P299, DOI 10.1016/0006-3207(80)90006-3; Yang CC, 2013, J AVIAN BIOL, V44, P216, DOI 10.1111/j.1600-048X.2013.00123.x; Zhang S, 2008, FRONT BIOL CHINA, V3, P122; Zhang SN, 2010, SCI CHINA PHYS CHEM, V53, P1, DOI 10.1007/s11433-010-0065-6	41	7	7	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77026	10.1371/journal.pone.0077026	http://dx.doi.org/10.1371/journal.pone.0077026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204724	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300075
J	Schluck, T; Nienhaus, U; Aegerter-Wilmsen, T; Aegerter, CM				Schluck, Thomas; Nienhaus, Ulrike; Aegerter-Wilmsen, Tinri; Aegerter, Christof M.			Mechanical Control of Organ Size in the Development of the Drosophila Wing Disc	PLOS ONE			English	Article							IMAGINAL DISC; GRADIENT FORMATION; GROWTH; CELLS; PROLIFERATION; CULTURE; PATTERN; MODEL; DPP	Control of cessation of growth in developing organs has recently been proposed to be influenced by mechanical forces acting on the tissue due to its growth. In particular, it was proposed that stretching of the tissue leads to an increase in cell proliferation. Using the model system of the Drosophila wing imaginal disc, we directly stretch the tissue finding a significant increase in cell proliferation, thus confirming this hypothesis. In addition, we characterize the growth over the entire growth period of the wing disc finding a correlation between the apical cell area and cell proliferation rate.	[Schluck, Thomas; Nienhaus, Ulrike; Aegerter, Christof M.] Univ Zurich, Inst Phys, Zurich, Switzerland; [Aegerter-Wilmsen, Tinri] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich; University of Zurich	Aegerter, CM (corresponding author), Univ Zurich, Inst Phys, Zurich, Switzerland.	aegerter@physik.uzh.ch		Aegerter, Christof/0000-0002-7200-7987	Swiss National Science Foundation; Forschungskredit of UZH; SystemsX.ch	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Forschungskredit of UZH; SystemsX.ch	This work was supported by the Swiss National Science Foundation, the Forschungskredit of UZH as well as SystemsX.ch in the framework of the WingX RTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Aegerter-Wilmsen T, 2012, DEVELOPMENT, V139, P3221, DOI 10.1242/dev.082800; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Bittig T, 2009, EUR PHYS J E, V30, P93, DOI 10.1140/epje/i2009-10507-6; BRUNETTE DM, 1984, J CELL SCI, V69, P35; BRYANT PJ, 1985, DEV BIOL, V107, P355, DOI 10.1016/0012-1606(85)90317-3; DAMBLYCHAUDIERE C, 1986, DEV BIOL, V113, P288, DOI 10.1016/0012-1606(86)90164-8; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Ishihara S, 2012, J THEOR BIOL, V313, P201, DOI 10.1016/j.jtbi.2012.08.017; Lander AD, 2011, CELL, V144, P955, DOI 10.1016/j.cell.2011.03.009; LEUNG DYM, 1976, SCIENCE, V191, P475; Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640; Montel F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188102; Nienhaus U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047594; Nienhaus U, 2009, MECH DEVELOP, V126, P942, DOI 10.1016/j.mod.2009.09.002; Oda H, 2001, J CELL SCI, V114, P493; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Rees JS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002386; Schluck T, 2010, EUR PHYS J E, V33, P111, DOI 10.1140/epje/i2010-10580-8; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Wolpert L, 2007, PRINCIPLES DEV, P350; Zartman J, 2013, DEVELOPMENT, V140, P667, DOI 10.1242/dev.088872; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	29	42	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76171	10.1371/journal.pone.0076171	http://dx.doi.org/10.1371/journal.pone.0076171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204600	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000326155400012
J	Klepeisz, P; Sagmeister, S; Haudek-Prinz, V; Pichlbauer, M; Grasl-Kraupp, B; Gerner, C				Klepeisz, Philip; Sagmeister, Sandra; Haudek-Prinz, Verena; Pichlbauer, Melanie; Grasl-Kraupp, Bettina; Gerner, Christopher			Phenobarbital Induces Alterations in the Proteome of Hepatocytes and Mesenchymal Cells of Rat Livers	PLOS ONE			English	Article							CONSTITUTIVE ACTIVE/ANDROSTANE RECEPTOR; DISCRIMINATE RODENT CARCINOGENS; VITRO GENOTOXICITY TESTS; IN-VITRO; OXIDATIVE STRESS; CHEMICAL CARCINOGENS; KUPFFER CELLS; FOLLOW-UP; EXPRESSION; INDUCTION	Preceding studies on the mode of action of non-genotoxic hepatocarcinogens (NGCs) have concentrated on alterations induced in hepatocytes (HCs). A potential role of non-parenchymal liver cells (NPCs) in NGC-driven hepatocarcinogenesis has been largely neglected so far. The aim of this study is to characterize NGC-induced alterations in the proteome profiles of HCs as well as NPCs. We chose the prototypic NGC phenobarbital (PB) which was applied to male rats for a period of 14 days. The livers of PB-treated rats were perfused by collagenase and the cell suspensions obtained were subjected to density gradient centrifugation to separate HCs from NPCs. In addition, HCs and NPC isolated from untreated animals were treated with PB in vitro. Proteome profiling was done by CHIP-HPLC and ion trap mass spectrometry. Proteome analyses of the in vivo experiments showed many of the PB effects previously described in HCs by other methods, e. g. induction of phase I and phase II drug metabolising enzymes. In NPCs proteins related to inflammation and immune regulation such as PAI-1 and S100-A10, ADP-ribosyl cyclase 1 and to cell migration such as kinesin-1 heavy chain, myosin regulatory light chain RLC-A and dihydropyrimidinase-related protein 1 were found to be induced, indicating major PB effects on these cells. Remarkably, in vitro treatment of HCs and NPCs with PB hardly reproduced the proteome alterations observed in vivo, indicating differences of NGC induced responses of cells at culture conditions compared to the intact organism. To conclude, the present study clearly demonstrated that PB induces proteome alterations not only in HCs but also in NPCs. Thus, any profound molecular understanding on the mode of action of NGCs has to consider effects on cells of the hepatic mesenchyme.	[Klepeisz, Philip; Sagmeister, Sandra; Haudek-Prinz, Verena; Pichlbauer, Melanie; Grasl-Kraupp, Bettina; Gerner, Christopher] Med Univ Vienna, Inst Canc Res, Ctr Comprehens Canc, Dept Inner Med 1, Vienna, Austria; [Haudek-Prinz, Verena; Gerner, Christopher] Univ Vienna, Inst Analyt Chem, Fac Chem, A-1090 Vienna, Austria	Medical University of Vienna; University of Vienna	Gerner, C (corresponding author), Med Univ Vienna, Inst Canc Res, Ctr Comprehens Canc, Dept Inner Med 1, Vienna, Austria.	christopher.gerner@univie.ac.at		Gerner, Christopher/0000-0003-4964-0642	Innovative Medicine Initiative Joint Undertaking (IMI JU) [115001]	Innovative Medicine Initiative Joint Undertaking (IMI JU)	The research leading to these results has received funding from the Innovative Medicine Initiative Joint Undertaking (IMI JU) under grant agreement number 115001 (MARCAR project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; Cohen SM, 2004, TOXICOL SCI, V78, P181, DOI 10.1093/toxsci/kfh073; DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Dudgeon C, 2012, ONCOGENE, V31, P4848, DOI 10.1038/onc.2011.644; Elrick MM, 2005, TOXICOL PATHOL, V33, P118, DOI 10.1080/01926230590888298; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fox EM, 2009, STEROIDS, V74, P622, DOI 10.1016/j.steroids.2008.10.014; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Griss J, 2011, PROTEOMICS, V11, P1000, DOI 10.1002/pmic.201000507; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; Haudek VJ, 2009, J PROTEOME RES, V8, P3834, DOI 10.1021/pr801085g; Haudek-Prinz VJ, 2012, J PROTEOMICS, V76, P150, DOI 10.1016/j.jprot.2012.07.012; Hernandez LG, 2009, MUTAT RES-REV MUTAT, V682, P94, DOI 10.1016/j.mrrev.2009.07.002; HEWETT JA, 1993, PHARMACOL REV, V45, P381; Hoek JB, 2002, ALCOHOL, V27, P63, DOI 10.1016/S0741-8329(02)00215-X; Holsapple MP, 2006, TOXICOL SCI, V89, P51, DOI 10.1093/toxsci/kfj001; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JENKE HS, 1994, XENOBIOTICA, V24, P569, DOI 10.3109/00498259409043260; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Kirkland D, 2005, MUTAT RES-GEN TOX EN, V584, P1, DOI 10.1016/j.mrgentox.2005.02.004; Kirkland D, 2008, MUTAT RES-GEN TOX EN, V654, P114, DOI 10.1016/j.mrgentox.2008.05.002; Kirkland D, 2008, MUTAT RES-GEN TOX EN, V653, P99, DOI 10.1016/j.mrgentox.2008.03.008; Kirkland D, 2006, MUTAT RES-GEN TOX EN, V608, P29, DOI 10.1016/j.mrgentox.2006.04.017; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; Koj A, 1996, BBA-MOL BASIS DIS, V1317, P84, DOI 10.1016/S0925-4439(96)00048-8; Kopydlowski KM, 1999, J IMMUNOL, V163, P1537; Kudlicki A, 2012, PLOS ONE, V6.5, DOI [10.1371/journal.pone.0032339, DOI 10.1371/J0URNAL.P0NE.0032339]; LASKIN DL, 1988, HEPATOLOGY, V8, P1051, DOI 10.1002/hep.1840080512; Lorenz O, 2009, PROTEOM CLIN APPL, V3, P947, DOI 10.1002/prca.200800173; Low-Baselli A, 2000, CARCINOGENESIS, V21, P79, DOI 10.1093/carcin/21.1.79; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Matsuda Y, 2011, MED MOL MORPHOL, V44, P183, DOI 10.1007/s00795-011-0558-z; MATTSON RH, 1985, NEW ENGL J MED, V313, P145, DOI 10.1056/NEJM198507183130303; Mori K, 2004, CANCER RES, V64, P7464, DOI 10.1158/0008-5472.CAN-04-1725; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Partida-Sanchez S, 2004, IMMUNITY, V20, P279, DOI 10.1016/S1074-7613(04)00048-2; PARZEFALL W, 1989, ARCH TOXICOL, V63, P456, DOI 10.1007/BF00316448; Paulitschke V, 2009, J PROTEOME RES, V8, P2501, DOI 10.1021/pr8010827; Perks A, 2012, BRIT J ANAESTH, V108, P562, DOI 10.1093/bja/aes027; Phillips JM, 2009, TOXICOL SCI, V110, P319, DOI 10.1093/toxsci/kfp108; Phillips JM, 2009, TOXICOL SCI, V108, P273, DOI 10.1093/toxsci/kfp031; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Roberts RA, 2007, TOXICOL SCI, V96, P2, DOI 10.1093/toxsci/kfl173; Sagmeister S, 2008, J HEPATOL, V49, P955, DOI 10.1016/j.jhep.2008.06.031; Schaefer O, 2012, DRUG METAB DISPOS, V40, P93, DOI 10.1124/dmd.111.042275; SCHWARZ M, 1987, CARCINOGENESIS, V8, P1355, DOI 10.1093/carcin/8.9.1355; Slany A, 2009, ELECTROPHORESIS, V30, P1306, DOI 10.1002/elps.200800440; SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TANELIAN DL, 1993, ANESTHESIOLOGY, V78, P757, DOI 10.1097/00000542-199304000-00020; Teeguarden JG, 2000, J APPL TOXICOL, V20, P113, DOI 10.1002/(SICI)1099-1263(200003/04)20:2<113::AID-JAT641>3.0.CO;2-9; Teufelhofer O, 2005, CARCINOGENESIS, V26, P319, DOI 10.1093/carcin/bgh320; Teufelhofer O, 2006, ELECTROPHORESIS, V27, P4112, DOI 10.1002/elps.200600017; Toyokuni S, ANTIOXID REDOX S AUG, P1373, DOI [10.1089/ars.2006.8.1373, DOI 10.1089/ARS.2006.8.1373.PUBMED:16910784]; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; Vasseur P, 2012, MUTAT RES-GEN TOX EN, V744, P8, DOI 10.1016/j.mrgentox.2011.11.007; Vegeto E, 2008, FRONT NEUROENDOCRIN, V29, P507, DOI 10.1016/j.yfrne.2008.04.001; WAXMAN DJ, 1992, BIOCHEM J, V281, P577, DOI 10.1042/bj2810577; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yano Y, 2004, CANCER LETT, V207, P139, DOI 10.1016/j.canlet.2003.11.002	69	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76137	10.1371/journal.pone.0076137	http://dx.doi.org/10.1371/journal.pone.0076137			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204595	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300002
J	Nording, ML; Yang, J; Georgi, K; Karbowski, CH; German, JB; Weiss, RH; Hogg, RJ; Trygg, J; Hammock, BD; Zivkovic, AM				Nording, Malin L.; Yang, Jun; Georgi, Katrin; Karbowski, Christine Hegedus; German, J. Bruce; Weiss, Robert H.; Hogg, Ronald J.; Trygg, Johan; Hammock, Bruce D.; Zivkovic, Angela M.			Individual Variation in Lipidomic Profiles of Healthy Subjects in Response to Omega-3 Fatty Acids	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; FISH-OIL SUPPLEMENTATION; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; DIETARY SUPPLEMENTATION; CARDIOVASCULAR-DISEASE; INFLAMMATORY MEDIATORS; PROSTAGLANDIN E-2; GENETIC-VARIANTS; N-3	Introduction: Conflicting findings in both interventional and observational studies have resulted in a lack of consensus on the benefits of omega 3 fatty acids in reducing disease risk. This may be due to individual variability in response. We used a multi-platform lipidomic approach to investigate both the consistent and inconsistent responses of individuals comprehensively to a defined omega 3 intervention. Methods: The lipidomic profile including fatty acids, lipid classes, lipoprotein distribution, and oxylipins was examined multi- and uni-variately in 12 healthy subjects pre vs. post six weeks of omega 3 fatty acids (1.9 g/d eicosapentaenoic acid [EPA] and 1.5 g/d docosahexaenoic acid [DHA]). Results: Total lipidomic and oxylipin profiles were significantly different pre vs. post treatment across all subjects (p=0.00007 and p=0.00002 respectively). There was a strong correlation between oxylipin profiles and EPA and DHA incorporated into different lipid classes (r(2)=0.93). However, strikingly divergent responses among individuals were also observed. Both omega 3 and omega 6 fatty acid metabolites displayed a large degree of variation among the subjects. For example, in half of the subjects, two arachidonic acid cyclooxygenase products, prostaglandin E-2 (PGE(2)) and thromboxane B2 (TXB2), and a lipoxygenase product, 12-hydroxyeicosatetraenoic acid (12-HETE) significantly decreased post intervention, whereas in the other half they either did not change or increased. The EPA lipoxygenase metabolite 12-hydroxyeicosapentaenoic acid (12-HEPE) varied among subjects from an 82% decrease to a 5,000% increase. Conclusions: Our results show that certain defined responses to omega 3 fatty acid intervention were consistent across all subjects. However, there was also a high degree of inter-individual variability in certain aspects of lipid metabolism. This lipidomic based phenotyping approach demonstrated that individual responsiveness to omega 3 fatty acids is highly variable and measurable, and could be used as a means to assess the effectiveness of omega 3 interventions in modifying disease risk and determining metabolic phenotype.	[Nording, Malin L.; Trygg, Johan] Umea Univ, Dept Chem, Computat Life Sci Cluster CLiC, Umea, Sweden; [Nording, Malin L.; Yang, Jun; Georgi, Katrin; Karbowski, Christine Hegedus; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Yang, Jun; Hammock, Bruce D.] Univ Calif Davis, Ctr Comprehens Canc, Davis, CA 95616 USA; [German, J. Bruce] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [German, J. Bruce; Zivkovic, Angela M.] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA; [Weiss, Robert H.] Univ Calif Davis, Dept Med, Div Nephrol, Davis, CA 95616 USA; [Weiss, Robert H.] Sacramento VA Med Ctr, Med Serv, Sacramento, CA USA; [Hogg, Ronald J.] Scott & White Mem Hosp & Clin, Temple, TX USA; [Zivkovic, Angela M.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	Umea University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Scott & White Medical Center; University of California System; University of California Davis	Zivkovic, AM (corresponding author), Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA.	amzivkovic@ucdavis.edu	Yang, Jun/B-2262-2010	Yang, Jun/0000-0001-8126-1728; Nording, Malin/0000-0002-1732-8147; Zivkovic, Angela/0000-0002-2828-7862	Center for Health and Nutrition Research (CHNR); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK49368]; University of California [05GEB01NHB]; National Institute of Environmental Health Sciences (NIEHS) [P42ES004699]; NIEHS [R01 ES002710, ES011269]; California Dairy Research Foundation; American Asthma Association [09-0269]; Cystic Fibrosis Research Inc.; Swedish Research Councils VR [2011-6044]; Formas [2010-303]; Vinnova [2010-02070]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049368, U24DK097154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011269, R01ES002710, P42ES004699] Funding Source: NIH RePORTER	Center for Health and Nutrition Research (CHNR); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of California(University of California System); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); California Dairy Research Foundation; American Asthma Association; Cystic Fibrosis Research Inc.; Swedish Research Councils VR(Swedish Research Council); Formas(Swedish Research Council Formas); Vinnova(Vinnova); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided in part by The Center for Health and Nutrition Research (CHNR) Pilot Grant Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01 DK49368; The University of California Discovery Program (05GEB01NHB); the National Institute of Environmental Health Sciences (NIEHS) P42ES004699, NIEHS R01 ES002710, and NIEHS Superfund Research Program P42 ES011269; the California Dairy Research Foundation; the American Asthma Association #09-0269; JY was supported by the Elizabeth Nash Memorial fellowship from the Cystic Fibrosis Research Inc.; BDH is a George and Judy Marcus Senior Fellow of the American Asthma Foundation; the Swedish Research Councils VR (#2011-6044), Formas (#2010-303), and Vinnova (#2010-02070); West Coast Comprehensive Metabolomics Center National Institutes of Health/NIDDK U24 DK097154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong P, 2012, J NUTR, V142, P1417, DOI 10.3945/jn.112.159814; BANG HO, 1971, LANCET, V1, P1143, DOI 10.1016/S0140-6736(71)91658-8; Baum SJ, 2012, J CLIN LIPIDOL, V6, P216, DOI 10.1016/j.jacl.2012.04.077; Bernstein AM, 2012, J NUTR, V142, P99, DOI 10.3945/jn.111.148973; BLONK MC, 1990, AM J CLIN NUTR, V52, P120, DOI 10.1093/ajcn/52.1.120; Bryan DL, 2006, LIPIDS, V41, P1101, DOI 10.1007/s11745-006-5059-9; Burillo E, 2012, CURR VASC PHARMACOL, V10, P432, DOI 10.2174/157016112800812845; Burr ML, 2007, P NUTR SOC, V66, P9, DOI 10.1017/S0029665107005241; Burr ML, 2003, EUR J CLIN NUTR, V57, P193, DOI 10.1038/sj.ejcn.1601539; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Cansell MS, 2007, INT J PHARMACEUT, V343, P277, DOI 10.1016/j.ijpharm.2007.04.014; Cottin SC, 2011, P NUTR SOC, V70, P215, DOI 10.1017/S0029665111000061; de Roos B, 2009, BRIT J PHARMACOL, V158, P413, DOI 10.1111/j.1476-5381.2009.00189.x; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gillingham LG, 2013, AM J CLIN NUTR, V97, P195, DOI 10.3945/ajcn.112.043117; Harris WS, 2009, J NUTR, V139, p804S, DOI 10.3945/jn.108.101329; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; Harslof LBS, 2013, AM J CLIN NUTR, V97, P1403, DOI 10.3945/ajcn.113.058685; Hartweg J, 2007, DIABETOLOGIA, V50, P1593, DOI 10.1007/s00125-007-0695-z; Jacobson TA, 2012, J CLIN LIPIDOL, V6, P5, DOI 10.1016/j.jacl.2011.10.018; Johnson JL, 2004, ATHEROSCLEROSIS, V176, P371, DOI 10.1016/j.atherosclerosis.2004.05.018; Keenan AH, 2012, J LIPID RES, V53, P1662, DOI 10.1194/jlr.P025577; Kelley DS, 2012, P NUTR SOC, V71, P322, DOI 10.1017/S0029665112000080; Kelley DS, 2012, METAB SYNDR RELAT D, V10, P32, DOI 10.1089/met.2011.0081; Kelley DS, 1999, LIPIDS, V34, P317, DOI 10.1007/s11745-999-0369-5; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; KROKAN HE, 1993, BIOCHIM BIOPHYS ACTA, V1168, P59, DOI 10.1016/0005-2760(93)90266-C; Langerhuus SN, 2012, BRIT J NUTR, V107, P735, DOI 10.1017/S0007114511003503; Lattka E, 2010, CLIN NUTR, V29, P277, DOI 10.1016/j.clnu.2009.11.005; LeBlanc CJ, 2008, AM J VET RES, V69, P486, DOI 10.2460/ajvr.69.4.486; LEE TH, 1984, J CLIN INVEST, V74, P1922, DOI 10.1172/JCI111612; LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903; LEE TH, 1984, J BIOL CHEM, V259, P2383; Lopez-Huertas E, 2012, BRIT J NUTR, V107, pS185, DOI 10.1017/S0007114512001572; Lundstrom SL, 2013, MOL NUTR FOOD RES, V57, P1378, DOI 10.1002/mnfr.201200827; Minihane AM, 2000, ARTERIOSCL THROM VAS, V20, P1990, DOI 10.1161/01.ATV.20.8.1990; Molto-Puigmarti C, 2010, AM J CLIN NUTR, V91, P1368, DOI 10.3945/ajcn.2009.28789; Mozaffarian D, 2012, J NUTR, V142, p614S, DOI 10.3945/jn.111.149633; MUELLER BA, 1989, CLIN PHARMACY, V8, P328; Ottestad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042550; Pei J, 2012, J RENAL NUTR, V22, P525, DOI 10.1053/j.jrn.2012.04.005; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Shearer GC, 2010, J LIPID RES, V51, P2074, DOI 10.1194/M900193-JLR200; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Thifault E, 2013, J NUTRIGENET NUTRIGE, V6, P73, DOI 10.1159/000350744; Trygg J, 2002, J CHEMOMETR, V16, P283, DOI 10.1002/cem.724; VONSCHACKY C, 1993, BIOCHIM BIOPHYS ACTA, V1166, P20, DOI 10.1016/0005-2760(93)90278-H; Watkins SM, 2002, J LIPID RES, V43, P1809, DOI 10.1194/jlr.M200169-JLR200; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Zivkovic AM, 2012, METABOLOMICS, V8, P1102, DOI 10.1007/s11306-012-0417-5; Zivkovic AM, 2009, METABOLOMICS, V5, P507, DOI 10.1007/s11306-009-0174-2; Zulyniak MA, 2013, METABOLISM, V62, P1107, DOI 10.1016/j.metabol.2013.02.004	57	73	74	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76575	10.1371/journal.pone.0076575	http://dx.doi.org/10.1371/journal.pone.0076575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204640	gold, Green Published, Green Submitted			2022-12-27	WOS:000326152300007
J	Garcia-Pravia, C; Galvan, JA; Gutierrez-Corral, N; Solar-Garcia, L; Garcia-Perez, E; Garcia-Ocana, M; Del Amo-Iribarren, J; Menendez-Rodriguez, P; Garcia-Garcia, J; de los Toyos, JR; Simon-Buela, L; Barneo, L				Garcia-Pravia, Carmen; Galvan, Jose A.; Gutierrez-Corral, Natalia; Solar-Garcia, Lorena; Garcia-Perez, Eva; Garcia-Ocana, Marcos; Del Amo-Iribarren, Jokin; Menendez-Rodriguez, Primitiva; Garcia-Garcia, Juan; de los Toyos, Juan R.; Simon-Buela, Laureano; Barneo, Luis			Overexpression of COL11A1 by Cancer-Associated Fibroblasts: Clinical Relevance of a Stromal Marker in Pancreatic Cancer	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; TUMOR-CELLS; ADENOCARCINOMA; IDENTIFICATION; CARCINOMA; COLLAGEN; DISCOVERY; MODEL; RISK	Background: The collagen11A1 (COL11A1) gene is overexpressed in pancreatic cancer. The expression of COL11A1 protein could be involved in desmoplastic events in pancreatic cancer, but an antibody that specifically stains the COL11A1 protein is not currently available. Methods and findings: A total of 54 pancreatic ductal adenocarcinomas (PDAC), 23 chronic pancreatitis (CP) samples, and cultured peritumoral stromal cells of PDAC (passages 3-6) were studied. Normal human pancreas tissue samples were obtained through a cadaveric organ donation program. 1) Validation of COL11A1 gene overexpression by q-RT-PCR. the expression of COL11A1 gene is significantly increased in PDAC samples vs. normal and CP samples. 2) Analysis of COL11A1 by immunohistochemistry using highly specific anti-proCOL11A1 antibodies. anti-proCOL11A1 stains stromal cells/cancer-associated fibroblasts (CAFs) of PDAC but it does not stain chronic benign condition (chronic pancreatitis) stromal cells, epithelial cells, or normal fibroblasts. 3) Evaluation of the discrimination ability of the antibody. anti-proCOL11A1 immunostaining accurately discriminates between PDAC and CP (AUC 0.936, 95% CI 0.851, 0.981). 4) Phenotypic characterization of proCOL11A1+ stromal cells co-staining with mesenchymal, epithelial and stellate cell markers on pancreatic tissue samples and cultured peritumoral pancreatic cancer stromal cells. ProCOL11A1+ cells present co-staining with mesenchymal, stellate and epithelial markers (EMT phenotype) in different proportions. Conclusions/Significance: Detection of proCOL11A1 through immunostaining with this newly-developed antibody allows for a highly accurate distinction between PDAC and CP. Unlike other available antibodies commonly used to detect CAFs, anti-proCOL11A1 is negative in stromal cells of the normal pancreas and almost absent in benign inflammation. These results strongly suggest that proCOL11A1 is a specific marker for CAFs, and thus, anti-proCOL11A1 is a powerful new tool for cancer research and clinical diagnostics.	[Garcia-Pravia, Carmen; Menendez-Rodriguez, Primitiva; Garcia-Garcia, Juan] HUCA, Serv Anat Pathol, Oviedo, Spain; [Garcia-Pravia, Carmen; Galvan, Jose A.; Garcia-Ocana, Marcos; de los Toyos, Juan R.; Barneo, Luis] IUOPA, Oviedo, Spain; [Galvan, Jose A.; Garcia-Perez, Eva; Barneo, Luis] Univ Oviedo, Dept Surg, Sch Med & Hlth Sci, Oviedo, Spain; [Gutierrez-Corral, Natalia; Solar-Garcia, Lorena; Barneo, Luis] HUCA, Gen Surg Serv, Oviedo, Spain; [Garcia-Ocana, Marcos] Tech Sci Serv, Biotechnol & Biomed Assays Unit, Oviedo, Spain; [Del Amo-Iribarren, Jokin] Progenika Biopharma SA, Derio, Spain; [de los Toyos, Juan R.] Univ Oviedo, Sch Med & Hlth Sci, Immunol Area, Oviedo, Spain; [Simon-Buela, Laureano] Oncomatrix SL, Derio, Spain	Central University Hospital Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oviedo; Central University Hospital Asturias; Grifols; University of Oviedo	Barneo, L (corresponding author), IUOPA, Oviedo, Spain.	lbarneo@uniovi.es	barneo, Luis/AAE-1634-2022; de los Toyos, Juan R./M-1681-2014; Galván, Jose A./C-7753-2013; Barneo, Luis/M-2712-2017	de los Toyos, Juan R./0000-0002-3880-6339; Galván, Jose A./0000-0003-3138-7642; Barneo, Luis/0000-0001-9410-4262	ERDF Funds from the EuropeanUnion; INNPACTO-ONCOPAN [IPT-010000-2010-31]; Ministry of Science and Innovation, Spain [FISS-09-PS09/01911]; FICYT [FC-11-PC10-23]; ERDF Operational Framework Programme of the Principality of Asturias, Spain; Progenika Biopharma, S. A.; Oncomatrix, S. L. Derio, Spain	ERDF Funds from the EuropeanUnion; INNPACTO-ONCOPAN; Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FICYT; ERDF Operational Framework Programme of the Principality of Asturias, Spain; Progenika Biopharma, S. A.; Oncomatrix, S. L. Derio, Spain	This research has been co-financed by ERDF Funds from the EuropeanUnion; by INNPACTO-ONCOPAN IPT-010000-2010-31 Project; by FISS-09-PS09/01911 Project, Ministry of Science and Innovation, Spain; by FC-11-PC10-23 Project, FICYT, Axe 1 of the 2007-2013 ERDF Operational Framework Programme of the Principality of Asturias, Spain; and by Progenika Biopharma, S. A. and Oncomatrix, S. L. Derio, Spain. The proCOL11A1 mAb has been patented by Oncomatrix, S. L. (PCT/ES2012/070616; WO 2013/021088 A2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barneo L, 2006, PROCEEDINGS OF THE XLI CONGRESS OF THE EUROPEAN SOCIETY FOR SURGICAL RESEARCH, P27; Binkley CE, 2004, PANCREAS, V29, P254, DOI 10.1097/00006676-200411000-00003; Bowen KB, 2008, J HISTOCHEM CYTOCHEM, V56, P275, DOI 10.1369/jhc.7A7310.2007; Buchholz M, 2001, PANCREATOLOGY, V1, P581, DOI 10.1159/000055867; Chong IW, 2006, ONCOL REP, V16, P981; Crnogorac-Jurcevic T, 2003, J PATHOL, V201, P63, DOI 10.1002/path.1418; Crnogorac-Jurcevic T, 2001, ONCOGENE, V20, P7437, DOI 10.1038/sj.onc.1204935; del Amo J, 2005, EJC SUPPL, V3, P54; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Erkan M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-88; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Fischer H, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-17; Friess H, 2003, CELL MOL LIFE SCI, V60, P1180, DOI 10.1007/s00018-003-3036-5; Fuentes N, 2010, VIRCHOWS ARCH, V457, P230; Garcia Pravia C, 2009, BRIT J SURG, V96, P11; Garcia-Ocana M, 2012, INT J ONCOL, V40, P1447, DOI 10.3892/ijo.2012.1360; Garcia-Perez E, 2013, BRIT J SURG, V100, P6; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Han HY, 2002, CANCER RES, V62, P2890; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Howes N, 2002, GUT, V51, P765, DOI 10.1136/gut.51.6.765; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Iacobuzio-Donahue CA, 2002, AM J PATHOL, V160, P1239, DOI 10.1016/S0002-9440(10)62551-5; IMAMURA T, 1995, PANCREAS, V11, P357, DOI 10.1097/00006676-199511000-00007; Jin G, 2005, WORLD J GASTROENTERO, V11, P6543, DOI 10.3748/wjg.v11.i41.6543; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kim HJ, 2010, J CERAM PROCESS RES, V11, P11; Kollmannsberger C, 1998, CANCER TREAT REV, V24, P133, DOI 10.1016/S0305-7372(98)90079-2; Kore M, 1997, AM J SURG, V194, pS84; Lim JE, 2003, ANN SURG, V237, P74, DOI 10.1097/00000658-200301000-00011; Linder S, 2001, HEPATO-GASTROENTEROL, V48, P1321; Logsdon CD, 2003, CANCER RES, V63, P2649; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Luciani MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020016; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Marjolin J-N, 1828, DICT MED, V21; Missiaglia E, 2004, INT J CANCER, V112, P100, DOI 10.1002/ijc.20376; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Nelson Fuentes Martinez, 2009, THESIS U OVIEDO SPAI; Olumi AF, 1999, CANCER RES, V59, P5002; Otsuki M, 2003, J GASTROENTEROL, V38, P315, DOI 10.1007/s005350300058; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilarsky C, 2008, J CELL MOL MED, V12, P2823, DOI 10.1111/j.1582-4934.2008.00289.x; Porrero-Guerrero B, 2013, BRIT J SURG, V100, P7; Raviraj V, 2012, CLIN EXP METASTAS, V29, P273, DOI 10.1007/s10585-011-9450-4; Sadlonova A, 2009, CANCER MICROENVIRON, V2, P9, DOI 10.1007/s12307-008-0017-0; Sato N, 2004, CANCER RES, V64, P6950, DOI 10.1158/0008-5472.CAN-04-0677; Schmalbach CE, 2004, ARCH OTOLARYNGOL, V130, P295, DOI 10.1001/archotol.130.3.295; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sok JC, 2003, ARCH OTOLARYNGOL, V129, P760, DOI 10.1001/archotol.129.7.760; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Tan ZJ, 2003, WORLD J GASTROENTERO, V9, P818, DOI 10.3748/wjg.v9.i4.818	56	50	51	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78327	10.1371/journal.pone.0078327	http://dx.doi.org/10.1371/journal.pone.0078327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194920	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000099
J	Hunt, CP; Fabb, SA; Pouton, CW; Haynes, JM				Hunt, Cameron P.; Fabb, Stewart A.; Pouton, Colin W.; Haynes, John M.			DNA-Dependent Protein Kinase Is a Context Dependent Regulator of Lmx1a and Midbrain Specification	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DOPAMINE NEURONS; NEURAL INDUCTION; GENE-EXPRESSION; SMALL MOLECULES; STEM-CELLS; DIFFERENTIATION; NOTCH; PHOSPHORYLATION; IDENTIFICATION	The identification of small molecules capable of directing pluripotent cell differentiation towards specific lineages is highly desirable to both reduce cost, and increase efficiency. Within neural progenitors, LIM homeobox transcription factor 1 alpha (Lmx1a) is required for proper development of roof plate and cortical hem structures of the forebrain, as well as the development of floor plate and midbrain dopaminergic neurons. In this study we generated homologous recombinant cell lines expressing either luciferase or beta-lactamase under the control of the Lmx1a promoter, and used these cell lines to investigate kinase-mediated regulation of Lmx1a activity during neuronal differentiation. A screen of 143 small molecule tyrosine kinase inhibitors yielded 16 compounds that positively or negatively modulated Lmx1a activity. Inhibition of EGF, VEGF and DNA-dependent protein kinase (DNA-PK) signaling significantly upregulated Lmx1a activity whereas MEK inhibition strongly downregulated its activity. Quantitative FACS analysis revealed that the DNA-PK inhibitor significantly increased the number of Lmx1a+ progenitors while subsequent qPCR showed an upregulation of Notch effectors, the basic helix-loop-helix genes, Hes5 and Hey1. FACS further revealed that DNA-PK-mediated regulation of Lmx1a+ cells is dependent on the rapamycin-sensitive complex, mTORC1. Interestingly, this DNA-PK inhibitor effect was preserved in a co-culture differentiation protocol. Terminal differentiation assays showed that DNA-PK inhibition shifted development of neurons from forebrain toward midbrain character as assessed by Pitx3/TH immunolabeling and corresponding upregulation of midbrain (En1), but not forebrain (FoxG1) transcripts. These studies show that Lmx1a signaling in mouse embryonic stem cells contributes to a molecular cascade establishing neuronal specification. The data presented here identifies a novel regulatory pathway where signaling from DNA-PK appears to suppress midbrain-specific Lmx1a expression.	[Hunt, Cameron P.; Fabb, Stewart A.; Pouton, Colin W.; Haynes, John M.] Monash Univ Parkville, Monash Inst Pharmaceut Sci, Melbourne, Vic, Australia	Monash University	Pouton, CW (corresponding author), Monash Univ Parkville, Monash Inst Pharmaceut Sci, Melbourne, Vic, Australia.	colin.pouton@monash.edu; john.haynes@monash.edu	Pouton, Colin W/M-2049-2016	Pouton, Colin W/0000-0003-0224-3308; , john/0000-0003-3075-1553; Fabb, Stewart/0000-0002-8887-7661; Hunt, Cameron/0000-0002-2295-5866	Monash University; Pfizer	Monash University(Monash University); Pfizer(Pfizer)	CPH was a recipient of a faculty scholarship from Monash University. Additional funding for was gratefully received from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KA, 2000, DEVELOPMENT, V127, P1857; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Allsopp TE, 2010, MEDCHEMCOMM, V1, P16, DOI 10.1039/c0md00055h; An J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-18; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bailis W, 2012, BLOOD, V120, P1349, DOI 10.1182/blood-2012-06-435099; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Bartkova J, 2005, CELL CYCLE, V4, P838, DOI 10.4161/cc.4.6.1742; Bergmans BA, 2008, STEM CELLS, V3, P183; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Briscoe J, 2009, EMBO J, V28, P457, DOI 10.1038/emboj.2009.12; Burbach JPH, 2006, TRENDS NEUROSCI, V29, P601, DOI 10.1016/j.tins.2006.09.003; Cajanek L, 2009, STEM CELLS, V27, P2917, DOI 10.1002/stem.210; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; Chanoux RA, 2009, J BIOL CHEM, V284, P5994, DOI 10.1074/jbc.M806739200; Chen CW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-33; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chizhikov VV, 2004, DEVELOPMENT, V131, P2693, DOI 10.1242/dev.01139; Chung S, 2009, CELL STEM CELL, V5, P646, DOI 10.1016/j.stem.2009.09.015; Deng QL, 2011, DEVELOPMENT, V138, P3399, DOI 10.1242/dev.065482; Ding S, 2005, CURR TOP MED CHEM, V5, P383, DOI 10.2174/1568026053828402; Endo M, 2009, J BIOL CHEM, V284, P5107, DOI 10.1074/jbc.M807745200; Failli V, 2002, MECH DEVELOP, V118, P225, DOI 10.1016/S0925-4773(02)00254-X; Finlay MRV, 2012, BIOORG MED CHEM LETT, V22, P5352, DOI 10.1016/j.bmcl.2012.06.053; Friedmann BJ, 2006, MOL CANCER THER, V5, P209, DOI 10.1158/1535-7163.MCT-05-0239; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Hwang DY, 2009, J NEUROCHEM, V111, P1202, DOI 10.1111/j.1471-4159.2009.06404.x; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Jonsson ME, 2009, EXP NEUROL, V219, P341, DOI 10.1016/j.expneurol.2009.06.006; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Mak SK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/140427; Matsunaga E, 2000, DEVELOPMENT, V127, P2357; Maxwell SL, 2005, DEV BIOL, V282, P467, DOI 10.1016/j.ydbio.2005.03.028; Morizane A, 2011, J NEUROSCI RES, V89, P117, DOI 10.1002/jnr.22547; Nefzger CM, 2012, STEM CELLS, V30, P1349, DOI 10.1002/stem.1105; Panman L, 2011, CELL STEM CELL, V8, P663, DOI 10.1016/j.stem.2011.04.001; Schmole AC, 2010, BIOORGAN MED CHEM, V18, P6785, DOI 10.1016/j.bmc.2010.07.045; Schugar RC, 2008, GENE THER, V15, P126, DOI 10.1038/sj.gt.3303062; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Smidt MP, 2012, PLOS ONE, V7, pe42641, DOI [10.1371/journal.pone.0042641, DOI 10.1371/J0URNAL.P0NE.0042641.PUBMED:22870339]; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Stavridis MP, 2010, DEVELOPMENT, V137, P881, DOI 10.1242/dev.043117; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Watmuff B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031999; Xiong N, 2011, GENE THER, V18, P394, DOI 10.1038/gt.2010.152; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yoon S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.188078; Zeng WR, 2011, NEUROCHEM INT, V59, P394, DOI 10.1016/j.neuint.2011.04.002; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x	60	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78759	10.1371/journal.pone.0078759	http://dx.doi.org/10.1371/journal.pone.0078759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194952	gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000131
J	Kershenbaum, A; Sayigh, LS; Janik, VM				Kershenbaum, Arik; Sayigh, Laela S.; Janik, Vincent M.			The Encoding of Individual Identity in Dolphin Signature Whistles: How Much Information Is Needed?	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; TURSIOPS-TRUNCATUS; CATEGORIZATION; RECOGNITION; DISCRIMINATION; CLASSIFICATION; REPERTOIRES; EVOLUTION; PITFALLS; BEHAVIOR	Bottlenose dolphins (Tursiops truncatus) produce many vocalisations, including whistles that are unique to the individual producing them. Such "signature whistles" play a role in individual recognition and maintaining group integrity. Previous work has shown that humans can successfully group the spectrographic representations of signature whistles according to the individual dolphins that produced them. However, attempts at using mathematical algorithms to perform a similar task have been less successful. A greater understanding of the encoding of identity information in signature whistles is important for assessing similarity of whistles and thus social influences on the development of these learned calls. We re-examined 400 signature whistles from 20 individual dolphins used in a previous study, and tested the performance of new mathematical algorithms. We compared the measure used in the original study (correlation matrix of evenly sampled frequency measurements) to one used in several previous studies (similarity matrix of time-warped whistles), and to a new algorithm based on the Parsons code, used in music retrieval databases. The Parsons code records the direction of frequency change at each time step, and is effective at capturing human perception of music. We analysed similarity matrices from each of these three techniques, as well as a random control, by unsupervised clustering using three separate techniques: k-means clustering, hierarchical clustering, and an adaptive resonance theory neural network. For each of the three clustering techniques, a seven-level Parsons algorithm provided better clustering than the correlation and dynamic time warping algorithms, and was closer to the near-perfect visual categorisations of human judges. Thus, the Parsons code captures much of the individual identity information present in signature whistles, and may prove useful in studies requiring quantification of whistle similarity.	[Kershenbaum, Arik] Natl Inst Math & Biol Synth, Knoxville, TN USA; [Kershenbaum, Arik] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Sayigh, Laela S.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Janik, Vincent M.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	University of Tennessee System; University of Tennessee Knoxville; University of Haifa; Woods Hole Oceanographic Institution; University of St Andrews	Kershenbaum, A (corresponding author), Natl Inst Math & Biol Synth, Knoxville, TN USA.	arik@nimbios.org	Kershenbaum, Arik/C-3552-2012	Kershenbaum, Arik/0000-0003-0464-0243; Janik, Vincent/0000-0001-7894-0121	National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF [EF-0832858]; University of Tennessee, Knoxville; University of Haifa; Dolphin Quest; Chicago Zoological Society; Natural Environment Research Council [smru10001] Funding Source: researchfish; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF(National Science Foundation (NSF)); University of Tennessee, Knoxville; University of Haifa; Dolphin Quest; Chicago Zoological Society; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Arik Kershenbaum is a Postdoctoral Fellow at the National Institute for Mathematical and Biological Synthesis, an Institute sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF Award #EF-0832858, with additional support from The University of Tennessee, Knoxville. Part of this work was conducted while Arik Kershenbaum was provided with a doctoral scholarship by the University of Haifa. Funding for access to the dolphins for recordings was provided by Dolphin Quest and the Chicago Zoological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer K, 1999, LECT NOTES COMPUT SC, V1540, P217; Boughman JW, 2003, SPR HDB AUD, V16, P138; BUCK JR, 1993, J ACOUST SOC AM, V94, P2497, DOI 10.1121/1.407385; Caldwell M.C., 1990, P199; CARPENTER GA, 1987, APPL OPTICS, V26, P4919, DOI 10.1364/AO.26.004919; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; Cook MLH, 2004, P ROY SOC B-BIOL SCI, V271, P1043, DOI 10.1098/rspb.2003.2610; Cox T. F., 2000, MULTIDIMENSIONAL SCA; D'Errico J, 2012, SLM SHAPE LANGUAGE M; Datta S, 2002, SIGNAL PROCESS, V82, P251, DOI 10.1016/S0165-1684(01)00184-0; Deecke VB, 2006, J ACOUST SOC AM, V119, P645, DOI 10.1121/1.2139067; Deecke VB, 2011, AQUAT BIOL, V13, P79, DOI 10.3354/ab00353; Downie JS, 2003, ANNU REV INFORM SCI, V37, P295, DOI 10.1002/aris.1440370108; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Fripp D, 2005, ANIM COGN, V8, P17, DOI 10.1007/s10071-004-0225-z; Garrett A., 2003, FUZZY ART FUZZY ARTM; Harley HE, 2008, BEHAV PROCESS, V77, P243, DOI 10.1016/j.beproc.2007.11.002; Henry KS, 2011, J COMP PHYSIOL A, V197, P351, DOI 10.1007/s00359-010-0619-0; Janik VM, 2006, P NATL ACAD SCI USA, V103, P8293, DOI 10.1073/pnas.0509918103; Janik VM, 1999, ANIM BEHAV, V57, P133, DOI 10.1006/anbe.1998.0923; Janik VM, 1998, ANIM BEHAV, V56, P829, DOI 10.1006/anbe.1998.0881; Ji A, 2013, J ACOUST SOC AM, V133, P1762, DOI 10.1121/1.4789936; Kershenbaum A, 2012, P ROY SOC B-BIOL SCI, V279, P2974, DOI 10.1098/rspb.2012.0322; Koren L, 2011, BEHAV ECOL SOCIOBIOL, V65, P675, DOI 10.1007/s00265-010-1069-y; Krull CR, 2012, J ACOUST SOC AM, V132, P1189, DOI 10.1121/1.4734237; Lemstrom K., 2009, P 10 INT SOC MUSIC I, P591; Likic V, 2008, 7 MELB BIOINF COURS; MCCOWAN B, 1995, ETHOLOGY, V100, P194, DOI 10.1111/j.1439-0310.1995.tb00325.x; Mico P., 2008, CONTINUOUS DYNAMIC T; Mullensiefen D., 2003, COMPUTING MUSICOLOGY, V13, P147; Mullensiefen D, 2007, MUSIC SCI, P183; Nanayakkara S. C., 2007, OCEANS 2007 EUR, P1; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Parsons D., 1975, DIRECTORY TUNES MUSI; Pauws S., 2002, P 3 INT C MUS INF RE, P187; Quick NJ, 2012, P ROY SOC B-BIOL SCI, V279, P2539, DOI 10.1098/rspb.2011.2537; RALSTON JV, 1995, J COMP PSYCHOL, V109, P268, DOI 10.1037/0735-7036.109.3.268; Sayigh LS, 2007, ANIM BEHAV, V74, P1631, DOI 10.1016/j.anbehav.2007.02.018; Sayigh LS, 1999, ANIM BEHAV, V57, P41, DOI 10.1006/anbe.1998.0961; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Thornton A, 2012, PHILOS T R SOC B, V367, P2670, DOI 10.1098/rstb.2012.0270; TYACK P, 1986, BEHAV ECOL SOCIOBIOL, V18, P251, DOI 10.1007/BF00300001; UKKONEN E, 1985, INFORM CONTROL, V64, P100, DOI 10.1016/S0019-9958(85)80046-2; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Zeng FG, 2005, P NATL ACAD SCI USA, V102, P2293, DOI 10.1073/pnas.0406460102; Zhong S, 2005, KNOWL INF SYST, V8, P374, DOI 10.1007/s10115-004-0194-1	47	36	36	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77671	10.1371/journal.pone.0077671	http://dx.doi.org/10.1371/journal.pone.0077671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194893	gold, Green Published			2022-12-27	WOS:000326037000072
J	Vanura, K; Rieder, F; Kastner, MT; Biebl, J; Sandhofer, M; Le, T; Strassl, R; Puchhammer-Stockl, E; Perkmann, T; Steininger, CF; Stamatopoulos, K; Graninger, W; Jager, U; Steininger, C				Vanura, Katrina; Rieder, Franz; Kastner, Marie-Theres; Biebl, Julia; Sandhofer, Michael; Trang Le; Strassl, Robert; Puchhammer-Stoeckl, Elisabeth; Perkmann, Thomas; Steininger, Christoph F.; Stamatopoulos, Kostas; Graninger, Wolfgang; Jaeger, Ulrich; Steininger, Christoph			Chronic Lymphocytic Leukemia Patients Have a Preserved Cytomegalovirus-Specific Antibody Response despite Progressive Hypogammaglobulinemia	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; INFECTIOUS COMPLICATIONS; T-CELLS; B-CELLS; PROTEINS; BLOOD; PHOSPHOPROTEIN; PERSISTENCE; EXPRESSION; TEGUMENT	Chronic lymphocytic leukemia (CLL) is characterized by progressive hypogammaglobulinemia predisposing affected patients to a variety of infectious diseases but paradoxically not to cytomegalovirus (CMV) disease. Moreover, we found reactivity of a panel of CLL recombinant antibodies (CLL-rAbs) encoded by a germ-line allele with a single CMV protein, pUL32, despite differing antibody binding motifs. To put these findings into perspective, we studied prospectively relative frequency of viremia, kinetics of total and virus-specific IgG over time, and UL32 genetic variation in a cohort of therapy-naive patients (n=200). CMV-DNA was detected in 3% (6/200) of patients. The decay of total IgG was uniform (mean, 0.03; SD, 0.03) and correlated with that of IgG subclasses 1-4 in the paired samples available (n=64; p<0.001). Total CMV-specific IgG kinetics were more variable (mean, 0,02; SD, 0,06) and mean decay values differed significantly from those of total IgG (p=0.034). Boosts of CMV-specific antibody levels were observed in 49% (22/45) of CMV-seropositive patients. In contrast, VZV- and EBV-specific IgG levels decayed in parallel with total IgG levels (p=0.003 and p=0.001, respectively). VZV-specific IgG even became undetectable in 18% (9/50) of patients whereas CMV-specific ones remained detectable in all seropositive patients. The observed CMV-specific IgG kinetics were predicated upon the highly divergent kinetics of IgG specific for individual antigens - glycoprotein B-specific IgG were boosted in 51% and pUL32-specific IgG in 32% of patients. In conclusion, CLL patients have a preserved CMV-specific antibody response despite progressive decay of total IgG and IgG subclasses. CMV-specific IgG levels are frequently boosted in contrast to that of other herpesviruses indicative of a higher rate of CMV reactivation and antigen-presentation. In contrast to the reactivity of multiple different CLL-rAbs with pUL32, boosts of humoral immunity are triggered apparently by other CMV antigens than pUL32, like glycoprotein B.	[Vanura, Katrina; Trang Le; Jaeger, Ulrich] Med Univ Vienna, Dept Med 1, Div Hematol & Hemostaseol, CCC, Vienna, Austria; [Rieder, Franz; Kastner, Marie-Theres; Biebl, Julia; Sandhofer, Michael; Steininger, Christoph F.; Graninger, Wolfgang; Steininger, Christoph] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria; [Strassl, Robert; Puchhammer-Stoeckl, Elisabeth] Med Univ Vienna, Dept Virol, Vienna, Austria; [Perkmann, Thomas] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Stamatopoulos, Kostas] G Papanicolaou Hosp, Dept Hematol, Thessaloniki, Greece; [Stamatopoulos, Kostas] G Papanicolaou Hosp, HCT Unit, Thessaloniki, Greece	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; George Papanikolaou General Hospital of Thessaloniki; George Papanikolaou General Hospital of Thessaloniki	Steininger, C (corresponding author), Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria.	christoph.steininger@meduniwien.ac.at	Vanura, Katrina/AAG-1236-2021; Perkmann, Thomas/F-3074-2012; Steininger, Christoph/U-8815-2019	Vanura, Katrina/0000-0002-2217-4998; Steininger, Christoph/0000-0003-3500-7205; Stamatopoulos, Kostas/0000-0001-8529-640X; Rieder, Franz/0000-0002-4839-9845; Perkmann, Thomas/0000-0002-7976-0285	European Society of Clinical Microbiology and Infectious Diseases; independent Karl-Landsteiner Society, Austria; Initiative Krebsforschung of the Medical University of Vienna, Austria	European Society of Clinical Microbiology and Infectious Diseases; independent Karl-Landsteiner Society, Austria; Initiative Krebsforschung of the Medical University of Vienna, Austria	This study was supported in part by a grant from the European Society of Clinical Microbiology and Infectious Diseases, the independent Karl-Landsteiner Society, Austria, and the Initiative Krebsforschung of the Medical University of Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JM, 2010, LEUKEMIA, V24, P877, DOI 10.1038/leu.2009.298; Baxter MK, 2001, J VIROL, V75, P6865, DOI 10.1128/JVI.75.15.6865-6873.2001; Beghetto E, 2008, J VIROL METHODS, V151, P7, DOI 10.1016/j.jviromet.2008.04.005; Brinkhof MWG, 2013, VACCINE, V31, P1490, DOI 10.1016/j.vaccine.2013.01.011; Buhl AM, 2006, EUR J HAEMATOL, V76, P455, DOI 10.1111/j.0902-4441.2005.t01-1-EJH2530.x; CHOU SW, 1991, J INFECT DIS, V163, P1229, DOI 10.1093/infdis/163.6.1229; CRNKOVIC I, 1994, J EXP MED, V179, P1713, DOI DOI 10.1084/JEM.179.5.1713.PUBMED:8163949; Daniels JA, 2007, AM J SURG PATHOL, V31, P1800, DOI 10.1097/PAS.0b013e3180cab60c; Dati F, 2001, CLIN CHEM LAB MED, V39, P1134, DOI 10.1515/CCLM.2001.179; Engelmann I, 2008, J MED VIROL, V80, P467, DOI 10.1002/jmv.21095; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Goodyear CS, 2005, SPRINGER SEMIN IMMUN, V26, P463, DOI 10.1007/s00281-004-0190-2; Greijer AE, 1999, J CLIN MICROBIOL, V37, P179, DOI 10.1128/JCM.37.1.179-188.1999; Hillmen P, 2007, J CLIN ONCOL, V25, P5616, DOI 10.1200/JCO.2007.12.9098; Kainulainen L, 1999, AM J RESP CRIT CARE, V159, P1199, DOI 10.1164/ajrccm.159.4.9807067; Kater AP, 2004, BRIT J HAEMATOL, V127, P404, DOI 10.1111/j.1365-2141.2004.05225.x; Keating MJ, 2002, BLOOD, V99, P3554, DOI 10.1182/blood.V99.10.3554; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Kostareli E, 2009, LEUKEMIA, V23, P919, DOI 10.1038/leu.2008.379; La Rosa C, 2005, HUM IMMUNOL, V66, P116, DOI 10.1016/j.humimm.2004.10.008; Lazzarotto T, 1997, J CLIN MICROBIOL, V35, P393, DOI 10.1128/JCM.35.2.393-397.1997; Leuridan E, 2012, EUR J PEDIATR, V171, P1167, DOI 10.1007/s00431-012-1691-y; Mackus WJM, 2003, BLOOD, V102, P1057, DOI 10.1182/blood-2003-01-0182; Malphettes M, 2009, CLIN INFECT DIS, V49, P1329, DOI 10.1086/606059; Martin SI, 2006, CLIN INFECT DIS, V43, P16, DOI 10.1086/504811; MOLICA S, 1993, HAEMATOLOGICA, V78, P374; Morrison VA, 2009, CLIN LYMPHOMA MYELOM, V9, P365, DOI 10.3816/CLM.2009.n.071; NOVAK J, 1991, J GEN VIROL, V72, P1409, DOI 10.1099/0022-1317-72-6-1409; Pourgheysari B, 2007, J VIROL, V81, P7759, DOI 10.1128/JVI.01262-06; Pourgheysari B, 2010, BLOOD, V116, P2968, DOI 10.1182/blood-2009-12-257147; Puchhammer-Stockl E, 2006, J CLIN VIROL, V36, P239, DOI 10.1016/j.jcv.2006.03.004; Riches JC, 2013, BLOOD, V121, P1612, DOI 10.1182/blood-2012-09-457531; Sampaio KL, 2005, J VIROL, V79, P2754, DOI 10.1128/JVI.79.5.2754-2767.2005; Sanchez V, 2000, J VIROL, V74, P975, DOI 10.1128/JVI.74.2.975-986.2000; Schafer P, 1998, J CLIN MICROBIOL, V36, P1008; Silva MC, 2003, J VIROL, V77, P10594, DOI 10.1128/JVI.77.19.10594-10605.2003; Silverman GJ, 2006, NAT REV IMMUNOL, V6, P465, DOI 10.1038/nri1853; Steininger C, 2005, AIDS, V19, P273; Steininger C, 2004, J INFECT DIS, V190, P1908, DOI 10.1086/424677; Steininger C, 2012, BLOOD, V119, P2293, DOI 10.1182/blood-2011-08-374058; Stowe RP, 2007, EXP GERONTOL, V42, P563, DOI 10.1016/j.exger.2007.01.005; Takahashi I, 2002, BIOSCI BIOTECH BIOCH, V66, P2402, DOI 10.1271/bbb.66.2402; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLORWIEDEMAN J, 1991, J GEN VIROL, V72, P2059, DOI 10.1099/0022-1317-72-9-2059; Tsiodras S, 2000, MAYO CLIN PROC, V75, P1039, DOI 10.4065/75.10.1039; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Wadhwa PD, 2006, SEMIN ONCOL, V33, P240, DOI 10.1053/j.seminoncol.2005.12.013; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Widhopf GF, 2004, BLOOD, V104, P2499, DOI 10.1182/blood-2004-03-0818	49	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78925	10.1371/journal.pone.0078925	http://dx.doi.org/10.1371/journal.pone.0078925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194956	gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000135
J	Aravindraja, C; Viszwapriya, D; Pandian, SK				Aravindraja, Chairmandurai; Viszwapriya, Dharmaprakash; Pandian, Shunmugiah Karutha			Ultradeep 16S rRNA Sequencing Analysis of Geographically Similar but Diverse Unexplored Marine Samples Reveal Varied Bacterial Community Composition	PLOS ONE			English	Article							CORAL ACROPORA-DIGITIFERA; PHYLOGENETIC CHARACTERIZATION; MICROBIAL DIVERSITY; BACILLUS-PUMILUS; GENERATION; LIBRARIES; MUCUS; GULF	Background: Bacterial community composition in the marine environment differs from one geographical location to another. Reports that delineate the bacterial diversity of different marine samples from geographically similar location are limited. The present study aims to understand whether the bacterial community compositions from different marine samples harbour similar bacterial diversity since these are geographically related to each other. Methods and Principal Findings: In the present study, 16S rRNA deep sequencing analysis targeting V3 region was performed using Illumina bar coded sequencing. A total of 22.44 million paired end reads were obtained from the metagenomic DNA of Marine sediment, Rhizosphere sediment, Seawater and the epibacterial DNA of Seaweed and Seagrass. Diversity index analysis revealed that Marine sediment has the highest bacterial diversity and the least bacterial diversity was observed in Rhizosphere sediment. Proteobacteria, Actinobacteria and Bacteroidetes were the dominant taxa present in all the marine samples. Nearly 62-71% of rare species were identified in all the samples and most of these rare species were unique to a particular sample. Further taxonomic assignment at the phylum and genus level revealed that the bacterial community compositions differ among the samples. Conclusion: This is the first report that supports the fact that, bacterial community composition is specific for specific samples irrespective of its similar geographical location. Existence of specific bacterial community for each sample may drive overall difference in bacterial structural composition of each sample. Further studies like whole metagenomic sequencing will throw more insights to the key stone players and its interconnecting metabolic pathways. In addition, this is one of the very few reports that depicts the unexplored bacterial diversity of marine samples (Marine sediment, Rhizosphere sediment, Seawater) and the host associated marine samples (Seaweed and Seagrass) at higher depths from uncharacterised coastal region of Palk Bay, India using next generation sequencing technology.	[Aravindraja, Chairmandurai; Viszwapriya, Dharmaprakash; Pandian, Shunmugiah Karutha] Alagappa Univ, Dept Biotechnol, Karaikkudi, Tamil Nadu, India	Alagappa University	Pandian, SK (corresponding author), Alagappa Univ, Dept Biotechnol, Karaikkudi, Tamil Nadu, India.	sk_pandian@rediffmail.com	Pandian, Shunmugiah Karutha/AAV-2803-2020; Shunmugiah, Karutha Pandian/B-6765-2018; Aravindraja, Chairmandurai/GLS-1403-2022	Pandian, Shunmugiah Karutha/0000-0003-2925-0575; Shunmugiah, Karutha Pandian/0000-0003-2925-0575; 	Department of Biotechnology (DBT), the Government of India (GOI) [BT/PR11994/NDB/52/134/2009]; Department of Biotechnology (DBT), the Government of India (GOI); Council of Scientific and Industrial Research (CSIR), India [09/688(0017)/2011-EMR-I]; DBT, GOI [BT/BI/25/001/2006]	Department of Biotechnology (DBT), the Government of India (GOI)(Department of Biotechnology (DBT) India); Department of Biotechnology (DBT), the Government of India (GOI)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); DBT, GOI(Department of Biotechnology (DBT) India)	This study was supported by a Research grant from Department of Biotechnology (DBT), the Government of India (GOI) (Grant number BT/PR11994/NDB/52/134/2009). Financial support provided to CA and DV in the form of Junior Research Fellowship from Department of Biotechnology (DBT), the Government of India (GOI) and Council of Scientific and Industrial Research (CSIR) (09/688(0017)/2011-EMR-I, India, respectively is gratefully acknowledged. The authors sincerely acknowledge the computational and bioinformatics facility provided by the Alagappa University Bioinformatics Infrastructure Facility (funded by DBT, GOI; Grant No, BT/BI/25/001/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen MC, 2002, BIODIVERS CONSERV, V11, P113, DOI 10.1023/A:1014098917535; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Burke C, 2009, APPL ENVIRON MICROB, V75, P252, DOI 10.1128/AEM.01630-08; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Glass EM, 2011, METAGENOMICS COMPLEM, V8, P325, DOI [10.1002/9781118010518.CH37, DOI 10.1002/9781118010518.CH37, 10.1002/9781118010518.ch37]; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jiang YX, 2011, J BIOSCI BIOENG, V111, P153, DOI 10.1016/j.jbiosc.2010.10.006; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Madrid VM, 2001, APPL ENVIRON MICROB, V67, P1663, DOI 10.1128/AEM.67.4.1663-1674.2001; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nithya C, 2012, APPL BIOCHEM BIOTECH, V167, P1763, DOI 10.1007/s12010-012-9578-y; Nithya C, 2011, BIOFOULING, V27, P519, DOI 10.1080/08927014.2011.586127; Nithya C, 2010, RES MICROBIOL, V161, P293, DOI 10.1016/j.resmic.2010.03.002; Nithyanand P, 2011, FEMS MICROBIOL LETT, V314, P112, DOI 10.1111/j.1574-6968.2010.02149.x; Nithyanand P, 2009, FEMS MICROBIOL ECOL, V69, P384, DOI 10.1111/j.1574-6941.2009.00723.x; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Pandey S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-35; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Wu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011285; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	37	51	52	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76724	10.1371/journal.pone.0076724	http://dx.doi.org/10.1371/journal.pone.0076724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167548	Green Published, gold, Green Submitted			2022-12-27	WOS:000326034500007
J	Hilderink, J; Otto, C; Slump, C; Lenferink, A; Engelse, M; van Blitterswijk, C; de Koning, E; Karperien, M; van Apeldoorn, A				Hilderink, Janneke; Otto, Cees; Slump, Cees; Lenferink, Aufried; Engelse, Marten; van Blitterswijk, Clemens; de Koning, Eelco; Karperien, Marcel; van Apeldoorn, Aart			Label-Free Detection of Insulin and Glucagon within Human Islets of Langerhans Using Raman Spectroscopy	PLOS ONE			English	Article							DIABETES-MELLITUS; CELL FUNCTION; LIVING CELLS; STEM-CELLS; IN-VIVO; TRANSPLANTATION; MICROSCOPY; DISEASE; MICROSPECTROSCOPY; EPIDEMIOLOGY	Intrahepatic transplantation of donor islets of Langerhans is a promising therapy for patients with type 1 diabetes. It is of critical importance to accurately monitor islet quality before transplantation, which is currently done by standard histological methods that are performed off-line and require extensive sample preparation. As an alternative, we propose Raman spectroscopy which is a non-destructive and label-free technique that allows continuous real-time monitoring of the tissue to study biological changes as they occur. By performing Raman spectroscopic measurements on purified insulin and glucagon, we showed that the 520 cm(-1) band assigned to disulfide bridges in insulin, and the 1552 cm(-1) band assigned to tryptophan in glucagon are mutually exclusive and could therefore be used as indirect markers for the label-free distinction between both hormones. High-resolution hyperspectral Raman imaging for these bands showed the distribution of disulfide bridges and tryptophan at sub-micrometer scale, which correlated with the location of insulin and glucagon as revealed by conventional immunohistochemistry. As a measure for this correlation, quantitative analysis was performed comparing the Raman images with the fluorescence images, resulting in Dice coefficients (ranging between 0 and 1) of 0.36 for insulin and 0.19 for glucagon. Although the use of separate microscope systems with different spatial resolution and the use of indirect Raman markers cause some image mismatch, our findings indicate that Raman bands for disulfide bridges and tryptophan can be used as distinctive markers for the label-free detection of insulin and glucagon in human islets of Langerhans.	[Hilderink, Janneke; Karperien, Marcel; van Apeldoorn, Aart] Univ Twente, Dept Dev BioEngn, NL-7500 AE Enschede, Netherlands; [Otto, Cees; Lenferink, Aufried] Univ Twente, Dept Med Cell Biophys, NL-7500 AE Enschede, Netherlands; [Slump, Cees] Univ Twente, Dept Syst & Signals, NL-7500 AE Enschede, Netherlands; [Engelse, Marten; de Koning, Eelco] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [van Blitterswijk, Clemens] Univ Twente, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands	University of Twente; University of Twente; University of Twente; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Twente	van Apeldoorn, A (corresponding author), Univ Twente, Dept Dev BioEngn, POB 217, NL-7500 AE Enschede, Netherlands.	A.A.vanApeldoorn@utwente.nl	Otto, Cees/H-8421-2019; de Koning, Eelco JP/H-6030-2011; van Apeldoorn, Aart/AAP-5433-2021; Karperien, Marcel/R-3270-2018	de Koning, Eelco JP/0000-0002-1232-7022; van Apeldoorn, Aart/0000-0002-2940-5699; Lenferink, Aufried/0000-0002-8210-5898; van Blitterswijk, Clemens/0000-0003-2371-4615; Karperien, Marcel/0000-0003-0751-0604	Dutch Program for Tissue Engineering (DPTE); Dutch Fund for Economic Structure Reinforcement (FES); Dutch Diabetes Research Foundation as part of the Diabetes Cell Therapy Initiative (DCTI)	Dutch Program for Tissue Engineering (DPTE); Dutch Fund for Economic Structure Reinforcement (FES); Dutch Diabetes Research Foundation as part of the Diabetes Cell Therapy Initiative (DCTI)	The authors gratefully acknowledge the financial support of the Dutch Program for Tissue Engineering (DPTE), the Dutch Fund for Economic Structure Reinforcement (FES) and the Dutch Diabetes Research Foundation as part of the Diabetes Cell Therapy Initiative (DCTI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM T, 1992, DIABETES, V41, P508, DOI 10.2337/diabetes.41.4.508; Antkowiak PF, 2009, AM J PHYSIOL-ENDOC M, V296, pE573, DOI 10.1152/ajpendo.90336.2008; Bertuzzi F, 2007, DIABETES CARE, V30, P410, DOI 10.2337/dc06-1233; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Bruno G, 2011, TRANSPL P, V43, P327, DOI 10.1016/j.transproceed.2010.09.098; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Chan JW, 2009, J BIOPHOTONICS, V2, P656, DOI 10.1002/jbio.200910041; Chan JW, 2009, ANAL CHEM, V81, P1324, DOI 10.1021/ac801665m; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Ellis DI, 2006, ANALYST, V131, P875, DOI 10.1039/b602376m; Ellis DI, 2013, ANALYST, V138, P3871, DOI 10.1039/c3an00698k; Hervada-Sala C, 2004, COMPUT GEOSCI-UK, V30, P881, DOI 10.1016/j.cageo.2004.07.003; Jue T, 2010, BIOMEDICAL APPL BIOP; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Langer RM, 2010, TRANSPL P, V42, P1421, DOI 10.1016/j.transproceed.2010.04.021; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Mariani MM, 2010, INTEGR BIOL-UK, V2, P94, DOI 10.1039/b920572a; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Moore A, 2001, DIABETES, V50, P2231, DOI 10.2337/diabetes.50.10.2231; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Notingher I, 2003, BIOPOLYMERS, V72, P230, DOI 10.1002/bip.10378; Notingher I, 2006, EXPERT REV MED DEVIC, V3, P215, DOI 10.1586/17434440.3.2.215; Ortiz C, 2004, ANAL BIOCHEM, V332, P245, DOI 10.1016/j.ab.2004.06.013; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Petrich W, 2000, APPL OPTICS, V39, P3372, DOI 10.1364/AO.39.003372; Pully VV, 2009, J RAMAN SPECTROSC, V40, P473, DOI 10.1002/jrs.2269; Raman CV, 1998, CURR SCI INDIA, V74, P381; RICORDI C, 1991, PANCREAS, V6, P242, DOI 10.1097/00006676-199103000-00018; Rong X, 2010, BIOPOLYMERS; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Rutter GA, 2006, PHYSIOLOGY, V21, P189, DOI 10.1152/physiol.00002.2006; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Shapiro A M, 2000, Diabetes Technol Ther, V2, P449, DOI 10.1089/15209150050194314; Soltesz G, 2007, PEDIATR DIABETES, V8, P6, DOI 10.1111/j.1399-5448.2007.00280.x; Street CN, 2004, DIABETES, V53, P3107, DOI 10.2337/diabetes.53.12.3107; Swain RJ, 2007, BIOCHEM SOC T, V35, P544, DOI 10.1042/BST0350544; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; Uzunbajakava N, 2003, BIOPHYS J, V84, P3968, DOI 10.1016/S0006-3495(03)75124-8; van Manen HJ, 2008, ANAL CHEM, V80, P9576, DOI 10.1021/ac801841y; van Manen HJ, 2005, P NATL ACAD SCI USA, V102, P10159, DOI 10.1073/pnas.0502746102; Virostko J, 2010, MOL IMAGING BIOL, V12, P42, DOI 10.1007/s11307-009-0240-1; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yamamoto T, 2009, J HEPATO-BILIARY-PAN, V16, P131, DOI 10.1007/s00534-009-0064-z; YU NT, 1972, J MOL BIOL, V70, P117, DOI 10.1016/0022-2836(72)90167-2; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	46	18	18	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78148	10.1371/journal.pone.0078148	http://dx.doi.org/10.1371/journal.pone.0078148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167603	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500063
J	La Monica, S; Caffarra, C; Saccani, F; Galvani, E; Galetti, M; Fumarola, C; Bonelli, M; Cavazzoni, A; Cretella, D; Sirangelo, R; Gatti, R; Tiseo, M; Ardizzoni, A; Giovannetti, E; Petronini, PG; Alfieri, RR				La Monica, Silvia; Caffarra, Cristina; Saccani, Francesca; Galvani, Elena; Galetti, Maricla; Fumarola, Claudia; Bonelli, Mara; Cavazzoni, Andrea; Cretella, Daniele; Sirangelo, Rita; Gatti, Rita; Tiseo, Marcello; Ardizzoni, Andrea; Giovannetti, Elisa; Petronini, Pier Giorgio; Alfieri, Roberta R.			Gefitinib Inhibits Invasive Phenotype and Epithelial-Mesenchymal Transition in Drug-Resistant NSCLC Cells with MET Amplification	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; MUTANT LUNG-CANCER; FACTOR-RECEPTOR; ACQUIRED-RESISTANCE; IRREVERSIBLE INHIBITORS; EGFR MUTATION; E-CADHERIN; IN-VITRO; ERLOTINIB	Despite the initial response, all patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) eventually develop acquired resistance to EGFR tyrosine kinase inhibitors (TKIs). The EGFR-T790M secondary mutation is responsible for half of acquired resistance cases, while MET amplification has been associated with acquired resistance in about 5-15% of NSCLCs. Clinical findings indicate the retained addiction of resistant tumors on EGFR signaling. Therefore, we evaluated the molecular mechanisms supporting the therapeutic potential of gefitinib maintenance in the HCC827 GR5 NSCLC cell line harbouring MET amplification as acquired resistance mechanism. We demonstrated that resistant cells can proliferate and survive regardless of the presence of gefitinib, whereas the absence of the drug significantly enhanced cell migration and invasion. Moreover, the continuous exposure to gefitinib prevented the epithelial-mesenchymal transition (EMT) with increased E-cadherin expression and down-regulation of vimentin and N-cadherin. Importantly, the inhibition of cellular migration was correlated with the suppression of EGFR-dependent Src, STAT5 and p38 signaling as assessed by a specific kinase array, western blot analysis and silencing functional studies. On the contrary, the lack of effect of gefitinib on EGFR phosphorylation in the H1975 cells (EGFR-T790M) correlated with the absence of effects on cell migration and invasion. In conclusion, our findings suggest that certain EGFR-mutated patients may still benefit from a second-line therapy including gefitinib based on the specific mechanism underlying tumor cell resistance.	[La Monica, Silvia; Caffarra, Cristina; Saccani, Francesca; Galvani, Elena; Galetti, Maricla; Fumarola, Claudia; Bonelli, Mara; Cavazzoni, Andrea; Cretella, Daniele; Sirangelo, Rita; Petronini, Pier Giorgio; Alfieri, Roberta R.] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Galvani, Elena; Giovannetti, Elisa] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Galetti, Maricla] Univ Parma, Res Ctr, Italian Workers Compensat Author INAIL, I-43100 Parma, Italy; [Gatti, Rita] Univ Parma, Dept Biotechnol Biomed & Translat Sci, I-43100 Parma, Italy; [Tiseo, Marcello; Ardizzoni, Andrea] Univ Hosp Parma, Div Med Oncol, Parma, Italy	University of Parma; University Hospital of Parma; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Parma; University of Parma; University of Parma; University Hospital of Parma	Giovannetti, E (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands.	e.giovannetti@vumc.nl; roberta.alfieri@unipr.it	Tiseo, Marcello/K-6119-2016; Galvani, Elena/L-3133-2016; caffarra, cristina/I-2361-2018; Galetti, Maricla/CAG-4178-2022; ardizzoni, andrea/AAC-4337-2021; giovannetti, elisa/F-4261-2011; Galetti, Maricla/AAJ-8927-2020; Cretella, Daniele/AAB-2482-2019; Alfieri, Roberta R/G-6350-2012; Cavazzoni, Andrea/J-8079-2019	Tiseo, Marcello/0000-0002-9553-8465; caffarra, cristina/0000-0003-4582-353X; Galetti, Maricla/0000-0002-8061-8649; ardizzoni, andrea/0000-0003-2678-0714; giovannetti, elisa/0000-0002-7565-7504; Galetti, Maricla/0000-0002-8061-8649; Cavazzoni, Andrea/0000-0002-3752-1868; La Monica, Silvia/0000-0003-3578-3917	AstraZeneca, Milan Italy	AstraZeneca, Milan Italy(AstraZeneca)	This work was supported by AstraZeneca, Milan Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami K, 2013, LUNG CANCER, V79, P276, DOI 10.1016/j.lungcan.2012.11.022; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Cavazzoni A, 2008, MOL CANCER THER, V7, P361, DOI 10.1158/1535-7163.MCT-07-0477; Chaft JE, 2011, CLIN CANCER RES, V17, P6298, DOI 10.1158/1078-0432.CCR-11-1468; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Das S, 2007, PROSTATE, V67, P1550, DOI 10.1002/pros.20640; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Faehling M, 2013, LUNG CANCER, V80, P306, DOI 10.1016/j.lungcan.2013.02.010; Fumarola C, 2005, CELL DEATH DIFFER, V12, P1344, DOI 10.1038/sj.cdd.4401660; Galvani E, 2013, CURR PHARM DESIGN, V19, P818, DOI 10.2174/138161213804547222; Galvani E, 2013, NEOPLASIA, V15, P61, DOI 10.1593/neo.121434; Gu L, 2010, ENDOCR-RELAT CANCER, V17, P481, DOI 10.1677/ERC-09-0328; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hata A, 2013, J THORAC ONCOL, V8, pE27, DOI 10.1097/JTO.0b013e318282e047; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwon CH, 2013, MOL CELLS, V35, P226, DOI 10.1007/s10059-013-2269-x; La Monica S, 2009, BIOCHEM PHARMACOL, V78, P460, DOI 10.1016/j.bcp.2009.04.033; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Merk BC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-184; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nishie K, 2012, J THORAC ONCOL, V7, P1722, DOI 10.1097/JTO.0b013e31826913f7; Nishino M, 2013, LUNG CANCER, V79, P283, DOI 10.1016/j.lungcan.2012.11.007; Nurwidya F, 2012, CANCER RES TREAT, V44, P151, DOI 10.4143/crt.2012.44.3.151; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Peghini PL, 2002, CLIN CANCER RES, V8, P2273; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Riely GJ, 2007, CLIN CANCER RES, V13, P5150, DOI 10.1158/1078-0432.CCR-07-0560; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Suh Y, 2012, ONCOGENE; Thomson S, 2008, CLIN EXP METASTAS, V25, P843, DOI 10.1007/s10585-008-9200-4; Wang XF, 2013, ANTI-CANCER AGENT ME, V13, P923, DOI 10.2174/18715206113139990143; Watanabe S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-1; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yoshida T, 2010, CANCER SCI, V101, P167, DOI 10.1111/j.1349-7006.2009.01368.x; Yu H., 2013, CLIN CANC RES; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017	50	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78656	10.1371/journal.pone.0078656	http://dx.doi.org/10.1371/journal.pone.0078656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167634	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500095
J	Caramalho, R; Gusmao, L; Lackner, M; Amorim, A; Araujo, R				Caramalho, Rita; Gusmao, Leonor; Lackner, Michaela; Amorim, Antonio; Araujo, Ricardo			SNaPAfu: A Novel Single Nucleotide Polymorphism Multiplex Assay for Aspergillus fumigatus Direct Detection, Identification and Genotyping in Clinical Specimens	PLOS ONE			English	Article							INVASIVE PULMONARY ASPERGILLOSIS; SECTION FUMIGATI; MOLECULAR-DETECTION; GENETIC DIVERSITY; FUNGAL DISEASE; DIAGNOSIS; PCR; RESISTANCE; EPIDEMIOLOGY; FREQUENCY	Objective: Early diagnosis of invasive aspergillosis is essential for positive patient outcome. Likewise genotyping of fungal isolates is desirable for outbreak control in clinical setting. We designed a molecular assay that combines detection, identification, and genotyping of Aspergillus fumigatus in a single reaction. Methods: To this aim we combined 20 markers in a multiplex reaction and the results were seen following mini-sequencing readings. Pure culture extracts were firstly tested. Thereafter, Aspergillus-DNA samples obtained from clinical specimens of patients with possible, probable, or proven aspergillosis according to European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria. Results: A new set of designed primers allowed multilocus sequence typing (MLST) gene amplification in a single multiplex reaction. The newly proposed SNaPAfu assay had a specificity of 100%, a sensitivity of 89% and detection limit of 1 ITS copy/mL (similar to 0.5 fg genomic Aspergillus-DNA/mL). The marker A49_F was detected in 89% of clinical samples. The SNaPAfu assay was accurately performed on clinical specimens using only 1% of DNA extract (total volume 50 mu L) from 1 mL of used bronchoalveolar lavage. Conclusions: The first highly sensitive and specific, time-and cost-economic multiplex assay was implemented that allows detection, identification, and genotyping of A. fumigatus strains in a single amplification followed by mini-sequencing reaction. The new test is suitable to clinical routine and will improve patient management.	[Caramalho, Rita; Gusmao, Leonor; Amorim, Antonio; Araujo, Ricardo] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Caramalho, Rita; Amorim, Antonio; Araujo, Ricardo] Univ Porto, Fac Sci, P-4100 Oporto, Portugal; [Gusmao, Leonor] Univ Estado Rio De Janeiro, DNA Diagnost Lab, Rio De Janeiro, Brazil; [Lackner, Michaela] Med Univ Innsbruck, Div Hyg & Med Microbiol, A-6020 Innsbruck, Austria	Universidade do Porto; Universidade do Porto; Universidade do Estado do Rio de Janeiro; Medical University of Innsbruck	Araujo, R (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ricjparaujo@yahoo.com	Gusmao, Leonor/B-3122-2013; Amorim, Antonio/A-7938-2008; Gusmão, Leonor/L-8931-2019; Lackner, Michaela/Q-9471-2018; Araujo, Ricardo/H-2297-2018	Gusmao, Leonor/0000-0003-0432-6481; Amorim, Antonio/0000-0002-7518-6247; Gusmão, Leonor/0000-0003-0432-6481; Araujo, Ricardo/0000-0001-7382-4834	Fundacao Calouste Gulbenkian grant [35-9924-S/2009]; Pfizer Inc. [WS1948668]; Fundacao para a Ciencia e a Tecnologia (FCT) Ciencia; European Social Fund; FCT; Austrian Science Fund (FWF) [I 656] Funding Source: researchfish	Fundacao Calouste Gulbenkian grant; Pfizer Inc.(Pfizer); Fundacao para a Ciencia e a Tecnologia (FCT) Ciencia; European Social Fund(European Social Fund (ESF)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Fundacao Calouste Gulbenkian grant no. 35-9924-S/2009 and partially resulted in the Master Thesis on Forensic Genetics of RC. The work was also partially supported by Pfizer Inc. (grant n. IIR#WS1948668). RA is supported by Fundacao para a Ciencia e a Tecnologia (FCT) Ciencia 2007 and by the European Social Fund. Institute of Molecular Pathology and Immunology of the University of Porto is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar-Fuoli L, 2008, ANTIMICROB AGENTS CH, V52, P1244, DOI 10.1128/AAC.00942-07; Almeida LA, 2013, INFECT GENET EVOL, V13, P67, DOI 10.1016/j.meegid.2012.08.011; Amorim A, 2010, INT J ANTIMICROB AG, V35, P396, DOI 10.1016/j.ijantimicag.2009.12.007; Araujo R, 2009, CLIN MICROBIOL INFEC, V15, P260, DOI 10.1111/j.1469-0691.2008.02661.x; Araujo R, 2010, MED MYCOL, V48, P832, DOI 10.3109/13693780903575360; Badiee P, 2008, INFECTION, V36, P580, DOI 10.1007/s15010-008-7385-8; Bain JM, 2007, J CLIN MICROBIOL, V45, P1469, DOI 10.1128/JCM.00064-07; Balajee SA, 2007, EUKARYOT CELL, V6, P1392, DOI 10.1128/EC.00164-07; Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06; Balajee SA, 2005, EUKARYOT CELL, V4, P625, DOI 10.1128/EC.4.3.625-632.2005; Ben-Darif E, 2010, J CLIN MICROBIOL, V48, P1055, DOI 10.1128/JCM.01566-09; Caillot D, 2001, CLIN MICROBIOL INFEC, V7, P54, DOI 10.1111/j.1469-0691.2001.tb00010.x; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Debeaupuis JP, 1997, INFECT IMMUN, V65, P3080, DOI 10.1128/IAI.65.8.3080-3085.1997; Denning DW, 2011, CLIN INFECT DIS, V52, P1123, DOI 10.1093/cid/cir179; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Eusebio N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066083; Ferri L, 2010, J MICROBIOL METH, V80, P251, DOI 10.1016/j.mimet.2010.01.008; Geiser DM, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.59.01; Guinea J, 2011, J CLIN MICROBIOL, V49, P3498, DOI 10.1128/JCM.01159-11; Herrera ML, 2009, J CLIN MICROBIOL, V47, P1325, DOI 10.1128/JCM.02073-08; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Klaassen CHW, 2009, J MICROBIOL METH, V77, P292, DOI 10.1016/j.mimet.2009.03.004; Kousha M, 2011, EUR RESPIR REV, V20, P156, DOI 10.1183/09059180.00001011; Lass-Florl C, 2013, J CLIN MICROBIOL, V51, P863, DOI 10.1128/JCM.02965-12; Luong ML, 2011, CLIN INFECT DIS, V52, P1218, DOI 10.1093/cid/cir185; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Martens M, 2008, INT J SYST EVOL MICR, V58, P200, DOI 10.1099/ijs.0.65392-0; Mayr A, 2011, EUR J MED RES, V16, P153, DOI 10.1186/2047-783X-16-4-153; Ostrosky-Zeichner L, 2012, AM J MED, V125, pS14, DOI 10.1016/j.amjmed.2011.10.008; Pelaez T, 2012, CLIN INFECT DIS, V54, pE24, DOI 10.1093/cid/cir771; Samson RA, 2007, STUD MYCOL, P147, DOI 10.3114/sim.2007.59.14; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Segal BH, 2006, AM J RESP CRIT CARE, V173, P707, DOI 10.1164/rccm.200505-727SO; Serrano R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-82; Stephens AJ, 2006, J MED MICROBIOL, V55, P43, DOI 10.1099/jmm.0.46157-0; Walsh TJ, 2011, J CLIN MICROBIOL, V49, P4150, DOI 10.1128/JCM.00570-11; White PL, 2010, J CLIN MICROBIOL, V48, P1231, DOI 10.1128/JCM.01767-09	38	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e75968	10.1371/journal.pone.0075968	http://dx.doi.org/10.1371/journal.pone.0075968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204585	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300006
J	van Vonderen, JJ; Narayen, NE; Walther, FJ; Siew, ML; Davis, PG; Hooper, SB; te Pas, AB				van Vonderen, Jeroen J.; Narayen, Nadia E.; Walther, Frans J.; Siew, Melissa L.; Davis, Peter G.; Hooper, Stuart B.; te Pas, Arjan B.			The Administration of 100% Oxygen and Respiratory Drive in Very Preterm Infants at Birth	PLOS ONE			English	Article							ROOM-AIR; BREATHING PATTERNS; NEWBORN-INFANTS; RESUSCITATION; VENTILATION; VOLUME	Aim: To retrospectively investigate the changes of SpO(2) and respiratory drive in preterm infants at birth after administration of 100% oxygen. Methods: Respiratory parameters, FiO(2) and oximetry of infants <32 weeks gestation before and after receiving FiO(2) 1.0 were reviewed during continuous positive airway pressure (CPAP) or positive pressure ventilation (PPV). Results: Results are given as median (IQR) or percentages where appropriate. Suitable recordings were made in 50 infants (GA 27 (26-29) weeks), 17 received CPAP and 33 PPV. SpO(2) increased rapidly in the first minute after FiO(2) 1.0 and remained stable. The duration of FiO(2) 1.0 tended to be shorter in the CPAP group than in the PPV group (CPAP vs. PPV: 65 (33-105) vs. 100 (40-280) s; p = 0.05), SpO(2) >95% occurred more often in PPV group (53% vs. 69%) and lasted longer (70(40-95) vs. 120(50-202) s). In CPAP group, minute volume increased from 134 (76-265) mL/kg/min 1 minute before to 240 (157-370) mL/kg/min (p<0.01) 1 minute after start FiO(2) 1.0 and remained stable at 2 minutes (252 (135-376) mL/kg/min; ns). The rate of rise to maximum tidal volume increased (from 13.8 (8.0-22.4) mL/kg/s to 18.2 (11.0-27.5) mL/kg/s; p<0.0001) to 18.8 (11.8-27.8) mL/kg/s; ns). In the PPV group respiratory rate increased from 0(0-4) to 9(0-20) at 1 minute (p<0.001) to 23 (0-34) breaths per minute at 2 minutes (p<0.01). Conclusion: In preterm infants at birth, a rapid increase in oxygenation, resulting from a transient increase to 100% oxygen might improve respiratory drive, but increases the risk for hyperoxia.	[van Vonderen, Jeroen J.; Narayen, Nadia E.; Walther, Frans J.; Siew, Melissa L.; te Pas, Arjan B.] Leiden Univ, Dept Pediat, Div Neonatol, Med Ctr, Leiden, Netherlands; [Siew, Melissa L.; Hooper, Stuart B.; te Pas, Arjan B.] Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Davis, Peter G.] Royal Womens Hosp, Dept Newborn Res, Melbourne, Vic, Australia	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Monash University	van Vonderen, JJ (corresponding author), Leiden Univ, Dept Pediat, Div Neonatol, Med Ctr, Leiden, Netherlands.	J.J.van_Vonderen@lumc.nl	pas, arjan te/AAA-9019-2020; van Vonderen, Jeroen J./L-4067-2019	pas, arjan te/0000-0001-7831-8797; van Vonderen, Jeroen J./0000-0002-1258-5224; Hooper, Stuart/0000-0003-1676-4825; Walther, Frans/0000-0003-1931-159X	Veni-grant, The Netherlands Organisation for Health Research and Development (ZonMw), part of the Innovational Research Incentives Scheme Veni-Vidi-Vici [91612027]; Willem-Alexander Children's Foundation scholarship	Veni-grant, The Netherlands Organisation for Health Research and Development (ZonMw), part of the Innovational Research Incentives Scheme Veni-Vidi-Vici; Willem-Alexander Children's Foundation scholarship	A.B. te Pas is the recipient of a Veni-grant, The Netherlands Organisation for Health Research and Development (ZonMw), part of the Innovational Research Incentives Scheme Veni-Vidi-Vici, project number 91612027. J.J. van Vonderen is the recipient of a Willem-Alexander Children's Foundation scholarship www.willem-alexanderkinderfonds.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bookatz GB, 2007, PEDIATR RES, V61, P698, DOI 10.1203/pdr.0b013e3180534171; Davey MG, 1996, RESP PHYSIOL, V105, P57, DOI 10.1016/0034-5687(96)00038-2; Dawson JA, 2010, PEDIATRICS, V125, pE1340, DOI 10.1542/peds.2009-1510; Escrig R, 2008, PEDIATRICS, V121, P875, DOI 10.1542/peds.2007-1984; Finer NN, 2009, PEDIATRICS, V123, P865, DOI 10.1542/peds.2008-0560; Fischer HS, 2008, PHYSIOL MEAS, V29, P95, DOI 10.1088/0967-3334/29/1/007; FOITZIK B, 1994, BIOMED TECH, V39, P85, DOI 10.1515/bmte.1994.39.4.85; Givan Deborah C, 2003, Semin Pediatr Neurol, V10, P271, DOI 10.1016/S1071-9091(03)00073-1; GLUCKMAN PD, 1987, J PHYSIOL-LONDON, V382, P373, DOI 10.1113/jphysiol.1987.sp016372; Hellstrom-Westas L, 2006, PEDIATRICS, V118, pE1798, DOI 10.1542/peds.2006-0102; Higgins RD, 2007, PEDIATRICS, V119, P790, DOI 10.1542/peds.2006-2200; Lakshminrusimha S, 2011, J APPL PHYSIOL, V111, P1441, DOI 10.1152/japplphysiol.00711.2011; O'Donnell CPF, 2010, J PEDIATR-US, V156, P846, DOI 10.1016/j.jpeds.2010.01.007; Pas ABT, 2008, PEDIATR RES, V64, P281, DOI 10.1203/PDR.0b013e31817d9c35; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Rabi Y, 2007, RESUSCITATION, V72, P353, DOI 10.1016/j.resuscitation.2006.06.134; Rabi Y, 2011, PEDIATRICS, V128, pE374, DOI 10.1542/peds.2010-3130; Roske K, 1998, J CLIN MONIT COMPUT, V14, P413, DOI 10.1023/A:1009993916980; Saugstad OD, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e1; Saugstad OD, 2008, NEONATOLOGY, V94, P176, DOI 10.1159/000143397; Schilleman K, 2012, RESUSCITATION, V83, P1135, DOI 10.1016/j.resuscitation.2012.01.036; Schmolzer GM, 2011, ARCH DIS CHILD-FETAL, V96, pF254, DOI 10.1136/adc.2010.191171; Sobotka KS, 2011, PEDIATR RES, V70, P56, DOI 10.1203/PDR.0b013e31821d06a1; Tan A, 2005, COCHRANE DB SYST REV, V2; te Pas AB, 2009, J PEDIATR-US, V154, P369, DOI 10.1016/j.jpeds.2008.09.029; te Pas AB, 2009, PEDIATR RES, V65, P352, DOI 10.1203/PDR.0b013e318193f117; TEITEL DF, 1990, PEDIATR RES, V27, P372, DOI 10.1203/00006450-199004000-00010; Vento M, 2011, J PEDIAT S, V158, P5; Vento M, 2009, PEDIATRICS, V124, pE439, DOI 10.1542/peds.2009-0434; Wang CL, 2008, PEDIATRICS, V121, P1083, DOI 10.1542/peds.2007-1460; Wyllie J, 2010, RESUSCITATION, V81, pE260, DOI 10.1016/j.resuscitation.2010.08.029	31	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76898	10.1371/journal.pone.0076898	http://dx.doi.org/10.1371/journal.pone.0076898			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204698	Green Published, gold			2022-12-27	WOS:000326029300063
J	Yu, K; Wang, Y; Shen, KQ; Li, XP				Yu, Ke; Wang, Yue; Shen, Kaiquan; Li, Xiaoping			The Synergy between Complex Channel-Specific FIR Filter and Spatial Filter for Single-Trial EEG Classification	PLOS ONE			English	Article							MOTOR IMAGERY; PATTERNS	The common spatial pattern analysis (CSP), a frequently utilized feature extraction method in brain-computer-interface applications, is believed to be time-invariant and sensitive to noises, mainly due to an inherent shortcoming of purely relying on spatial filtering. Therefore, temporal/spectral filtering which can be very effective to counteract the unfavorable influence of noises is usually used as a supplement. This work integrates the CSP spatial filters with complex channel-specific finite impulse response (FIR) filters in a natural and intuitive manner. Each hybrid spatial-FIR filter is of high-order, data-driven and is unique to its corresponding channel. They are derived by introducing multiple time delays and regularization into conventional CSP. The general framework of the method follows that of CSP but performs better, as proven in single-trial classification tasks like event-related potential detection and motor imagery.	[Yu, Ke; Wang, Yue; Li, Xiaoping] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore; [Shen, Kaiquan] Natl Univ Singapore, Inst Neurotechnol, Ctr Life Sci, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Li, XP (corresponding author), Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.	mpelixp@nus.edu.sg						Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; Dornhege G, 2006, IEEE T BIO-MED ENG, V53, P2274, DOI 10.1109/TBME.2006.883649; Falzon O, 2012, IEEE T BIO-MED ENG, V59, P2486, DOI 10.1109/TBME.2012.2205246; Falzon O, 2010, IEEE ENG MED BIO, P4707, DOI 10.1109/IEMBS.2010.5626381; Gerson AD, 2006, IEEE T NEUR SYS REH, V14, P174, DOI 10.1109/TNSRE.2006.875550; Grosse-Wentrup M, 2009, IEEE T BIO-MED ENG, V56, P1209, DOI 10.1109/TBME.2008.2009768; Lemm S, 2005, IEEE T BIO-MED ENG, V52, P1541, DOI 10.1109/TBME.2005.851521; Lotte F, 2011, IEEE T BIO-MED ENG, V58, P355, DOI 10.1109/TBME.2010.2082539; Naeem M, 2006, J NEURAL ENG, V3, P208, DOI 10.1088/1741-2560/3/3/003; Osuna BE, 1997, SUPPORT VECTOR MACHI; Parra LC, 2005, NEUROIMAGE, V28, P326, DOI 10.1016/j.neuroimage.2005.05.032; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Sajda P, 2010, P IEEE, V98, P462, DOI 10.1109/JPROC.2009.2038406; Samek W, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026013; Schlogl A, 2005, J NEURAL ENG, V2, pL14, DOI 10.1088/1741-2560/2/4/L02; Shao SY, 2009, IEEE T BIO-MED ENG, V56, P336, DOI 10.1109/TBME.2008.2005969; Tomioka R, 2006, SPECTRALLY WEIGHTED; Wang HX, 2012, IEEE T BIO-MED ENG, V59, P2496, DOI 10.1109/TBME.2012.2205383; Wu W, 2008, IEEE T BIO-MED ENG, V55, P1733, DOI 10.1109/TBME.2008.919125; Yu K, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046013; Yu K, 2012, J NEUROSCI METH, V204, P288, DOI 10.1016/j.jneumeth.2011.11.023; Yu K, 2011, IEEE T BIO-MED ENG, V58, P2513, DOI 10.1109/TBME.2011.2158542; Yu Zhang, 2012, 2012 9th International Conference on Fuzzy Systems and Knowledge Discovery, P891, DOI 10.1109/FSKD.2012.6234268	29	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76923	10.1371/journal.pone.0076923	http://dx.doi.org/10.1371/journal.pone.0076923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204705	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300067
J	Lu, LN; Lei, YL				Lu, Linna; Lei, Yalin			Scale Determinants of Fiscal Investment in Geological Exploration: Evidence from China	PLOS ONE			English	Article							OPTIMAL GOVERNMENT SIZE; PRODUCTIVITY; POLICY; ECONOMY; MODEL	With the continued growth in demand for mineral resources and China's efforts in increasing investment in geological prospecting, fiscal investment in geological exploration becomes a research hotspot. This paper examines the yearly relationship among fiscal investment in geological exploration of the current term, that of the last term and prices of mining rights over the period 1999-2009. Hines and Catephores' investment acceleration model is applied to describe the scale determinants of fiscal investment in geological exploration which are value-added of mining rights, value of mining rights and fiscal investment in the last term. The results indicate that when value-added of mining rights, value of mining rights or fiscal investment in the last term moves at 1 unit, fiscal investment in the current term will move 0.381, 1.094 or 0.907 units respectively. In order to determine the scale of fiscal investment in geological exploration for the current year, the Chinese government should take fiscal investment in geological exploration for the last year and the capital stock of the previous investments into account. In practice, combination of government fiscal investment in geological exploration with its performance evaluation can create a virtuous circle of capital management mechanism.	[Lu, Linna] China Univ Geosci, Sch Human & Econ Management, Beijing, Peoples R China; [Lu, Linna; Lei, Yalin] Chinese Acad Land & Resource Econ, Beijing, Peoples R China	China University of Geosciences	Lei, YL (corresponding author), Chinese Acad Land & Resource Econ, Beijing, Peoples R China.	leiyalin@cugb.edu.cn			National Natural Science Foundation of China [71173200]; Fundamental Research Funds for the Central Universities [2011YXS057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (number 71173200) and the Fundamental Research Funds for the Central Universities (number 2011YXS057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any errors and all views expressed remain the authors'.	Allen F, 2012, CHINAS FINANCIAL SYS, P3; ANDERSON GJ, 1981, ECON J, V91, P88, DOI 10.2307/2231698; [Anonymous], 2010, J RELATIONSHIP MARKE, DOI DOI 10.1080/15332660903551883; Arrow Kenneth J., 1970, PUBLIC INVESTMENT RA; ASCHAUER DA, 1989, J MONETARY ECON, V23, P177, DOI 10.1016/0304-3932(89)90047-0; BARRO RJ, 1990, J POLIT ECON, V98, pS103, DOI 10.1086/261726; BEAN CR, 1981, ECON J, V91, P106, DOI 10.2307/2231700; Besley T, 2003, J PUBLIC ECON, V87, P2611, DOI 10.1016/S0047-2727(02)00141-X; Boarnet MG, 1997, NATL TAX J, V50, P39; Cassou SP, 1998, J ECON DYN CONTROL, V22, P911, DOI 10.1016/S0165-1889(97)00083-3; Chandra A, 2000, REG SCI URBAN ECON, V30, P457, DOI 10.1016/S0166-0462(00)00040-5; Changge YU, 2006, J FINANCE EC, V32, P30; Chen yuanxu, 2006, CHINA MINING MAGAZIN, V15, P37; Chinese National People's Congress, 2011, CHIN NAT PE IN PRESS; Collingham Lizzie, 2011, THESIS U N CAROLINA, p[4, 16, 22, 50, 76, 83, 181, 220, 325, 380, 501]; Derlega VJ, 2011, PARTN ABUSE, V2, P300, DOI 10.1891/1946-6560.2.3.300; Dincer Oguzhan, 2005, OPTIMAL GOVT SIZE TR; Dong XY, 2000, J DEV STUD, V36, P100, DOI 10.1080/00220380008422630; Fang M., 2000, GEOL TECHNOL EC MANA, V1, P26; Feng B, 2011, 2011 INTERNATIONAL CONFERENCE ON ELECTRONICS, COMMUNICATIONS AND CONTROL (ICECC), P1138, DOI 10.1109/ICECC.2011.6066511; Fischer S, 2012, J INT ECON, V2, P211; Gugler P, 2009, ROUTLEDGE CONT ASIA, P101; Guo Q, 2010, EC RES J, V11, P8; Guo QW, 2012, SOC SCI CHINA, V33, P104, DOI 10.1080/02529203.2012.650412; Hanousek J, 2011, FISC STUD, V32, P43, DOI 10.1111/j.1475-5890.2011.00127.x; Hines AG, 1970, INVESTMENT UK MANUFA, P202; Huang H, 2011, J GUANGXI U FINANCE, V1, P12; Karras G, 1996, ECON INQ, V34, P193, DOI 10.1111/j.1465-7295.1996.tb01372.x; Karras G, 1997, MANCH SCH ECON SOC, V65, P280, DOI 10.1111/1467-9957.00057; Keynes JM, 1936, GEN THEORY EMPLOYMEN, P23; Li XM, 1996, ECON PLANN, V29, P117, DOI 10.1007/BF00361418; Li XU, 2010, TECHNOECONOMICS MANA, V4, P27; Lin Y.F., 1994, PROPERTY RIGHTS I CH; Liu HJ, 2009, J CENTRAL U FINANCE, V2, P6; [刘洋 LIU Yang], 2009, [管理学报, Chinese Journal of Management], V6, P1653; Liu Yunzhong, 2008, NATURAL RESOURCE EC, V6, P24; Lu LN, 2012, RESOUR POLICY, V37, P375, DOI 10.1016/j.resourpol.2012.05.001; Ma S, 2005, STAT RES, V1, P15; Ministry of Land and Resources of the People's Republic of China, 2000, CHINA WATER RESOURCE, P19; Ministry of Land and Resources of the People's Republic of China, 2010, MLRS PROP EST NEW ME; Pevcin P., 2004, EC BUSINESS REV, V6, P213; Remmer KL, 2000, COMP POLIT STUD, V33, P419, DOI 10.1177/0010414000033004001; Su X, 2008, RESOUR POLICY, V33, P23, DOI 10.1016/j.resourpol.2007.12.001; Tanaka J, 2003, J ECON, V79, P19, DOI 10.1007/s00712-002-0575-4; Wang LY, 2011, CHINA WORLD ECON, V19, P60, DOI 10.1111/j.1749-124X.2011.01235.x; Wang W, 2011, GEOLOGICAL WORK MANA, P6; Wei YH, 1996, GEOFORUM, V27, P329, DOI 10.1016/S0016-7185(96)00017-6; Wen J, 2009, 2 SESS 11 NAT PEOPL, P24; Wong Christine, 2008, CHINAS GREAT EC TRAN, P429, DOI DOI 10.1017/CBO9780511754234.013; Yao HJ, 2005, NATURAL RESOURCE EC, V9, P29; Yao HJ, 2005, NATURAL RESOURCE EC, V9, P34; Yu YH, 2011, SOC SCI J, V48, P458, DOI 10.1016/j.soscij.2011.05.006; Zhan JV, 2009, J CONTEMP CHINA, V18, P445, DOI 10.1080/10670560902770628; Zhang J, 1996, SCAND J ECON, V98, P387, DOI 10.2307/3440733; ZHANG R, 2008, 15 ANN C P INT C IEE, P1197; Zhang X, 2011, ENERGY PROCEDIA, V13, P1039; Zhang XB, 2006, J COMP ECON, V34, P713, DOI 10.1016/j.jce.2006.08.006; Zhang Z, 2007, STAT DECISION, V22, P42; Zhong Z, 2006, FINANCE TRADE RES, V6, P44; Ziran Z, 2002, RESOUR POLICY, V28, P117, DOI 10.1016/j.resourpol.2003.09.001	60	0	0	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76656	10.1371/journal.pone.0076656	http://dx.doi.org/10.1371/journal.pone.0076656			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242VF	24204652	Green Submitted, gold, Green Published			2022-12-27	WOS:000326270700011
J	Li, B; Li, Q; Chen, C; Guan, Y; Liu, SY				Li, Bin; Li, Qiong; Chen, Cong; Guan, Yu; Liu, Shiyuan			Diagnostic Accuracy of Computer Tomography Angiography and Magnetic Resonance Angiography in the Stenosis Detection of Autologuous Hemodialysis Access: A Meta-Analysis	PLOS ONE			English	Article							NEPHROGENIC SYSTEMIC FIBROSIS; COLOR DOPPLER ULTRASONOGRAPHY; ARTERIOVENOUS-FISTULAS; MDCT ANGIOGRAPHY; MR-ANGIOGRAPHY; CONTRAST AGENTS; VASCULAR ACCESS; UPPER EXTREMITY; CT ANGIOGRAPHY; SUBTRACTION	Purpose: To compare the diagnostic performances of computer tomography angiography (CTA) and magnetic resonance angiography (MRA) for detection and assessment of stenosis in patients with autologuous hemodialysis access. Materials and Methods: Search of PubMed, MEDLINE, EMBASE and Cochrane Library database from January 1984 to May 2013 for studies comparing CTA or MRA with DSA or surgery for autologuous hemodialysis access. Eligible studies were in English language, aimed to detect more than 50% stenosis or occlusion of autologuous vascular access in hemodialysis patients with CTA and MRA technology and provided sufficient data about diagnosis performance. Methodological quality was assessed by the Quality Assessment of Diagnostic Studies (QUADAS) instrument. Sensitivities (SEN), specificities (SPE), positive likelihood ratio (PLR), negative likelihood values (NLR), diagnostic odds ratio (DOR) and areas under the receiver operator characteristic curve (AUC) were pooled statistically. Potential threshold effect, heterogeneity and publication bias was evaluated. The clinical utility of CTA and MRA in detection of stenosis was also investigated. Result: Sixteen eligible studies were included, with a total of 500 patients. Both CTA and MRA were accurate modality (sensitivity, 96.2% and 95.4%, respectively; specificity, 97.1 and 96.1%, respectively; DOR [diagnostic odds ratio], 393.69 and 211.47, respectively) for hemodialysis vascular access. No significant difference was detected between the diagnostic performance of CTA (AUC, 0.988) and MRA (AUC, 0.982). Meta-regression analyses and subgroup analyses revealed no statistical difference. The Deek's funnel plots suggested a publication bias. Conclusion: Diagnostic performance of CTA and MRA for detecting stenosis of hemodialysis vascular access had no statistical difference. Both techniques may function as an alternative or an important complement to conventional digital subtraction angiography (DSA) and may be able to help guide medical management.	[Li, Bin; Li, Qiong; Guan, Yu; Liu, Shiyuan] Second Mil Med Univ, Dept Radiol, Shanghai Changzheng Hosp, Shanghai, Peoples R China; [Chen, Cong] 100 Hosp PLA, Radiat Treatment Ctr, Suzhou, Jiangsu, Peoples R China	Naval Medical University	Liu, SY (corresponding author), Second Mil Med Univ, Dept Radiol, Shanghai Changzheng Hosp, Shanghai, Peoples R China.	lsy20112077@163.com			Natioanl Natural Science Foundation of China [81171333, 81230030]	Natioanl Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grant no. 81171333 and no. 81230030 from the Natioanl Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besarab A, 2007, J NEPHROL, V20, P656; Bode AS, 2012, EUR J VASC ENDOVASC, V43, P88, DOI 10.1016/j.ejvs.2011.09.012; Bongartz G, 2008, EUR J RADIOL, V66, P213, DOI 10.1016/j.ejrad.2008.01.031; Brown PWG, 2006, EUR J VASC ENDOVASC, V31, P64, DOI 10.1016/j.ejvs.2005.10.002; Cansu A, 2013, EUR J RADIOL, V82, P1436, DOI 10.1016/j.ejrad.2013.03.015; Cavagna E, 2000, CARDIOVASC INTER RAD, V23, P262, DOI 10.1007/s002700010066; Chen MC, 2010, AM J ROENTGENOL, V194, P838, DOI 10.2214/AJR.09.3357; Coentrao L, 2013, J VASC ACCESS, V14, P209, DOI 10.5301/jva.5000141; Dimopoulou A, 2011, ACTA RADIOL, V52, P935, DOI 10.1258/ar.2011.110255; Doelman C, 2005, J VASC SURG, V42, P739, DOI 10.1016/j.jvs.2005.06.006; Duijm LEM, 2006, AM J KIDNEY DIS, V48, P98, DOI 10.1053/j.ajkd.2006.03.076; Edenberg Jan, 2009, Tidsskr Nor Laegeforen, V129, P1635, DOI 10.4045/tidsskr.09.34272; Froger CL, 2005, RADIOLOGY, V234, P284, DOI 10.1148/radiol.2341031859; GREGOIRE G, 1995, J CLIN EPIDEMIOL, V48, P159, DOI 10.1016/0895-4356(94)00098-B; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; Heye S, 2009, AM J ROENTGENOL, V192, P1079, DOI 10.2214/AJR.08.1620; Jennings WC, 2011, SEMIN VASC SURG, V24, P72, DOI 10.1053/j.semvascsurg.2011.05.009; Karadeli E, 2009, EUR J RADIOL, V69, P184, DOI 10.1016/j.ejrad.2007.09.014; Kathrein H, 1993, Fortschr Med, V111, P313; Ko SF, 2005, AM J ROENTGENOL, V185, P1268, DOI 10.2214/AJR.04.1553; Laissy JP, 1999, INVEST RADIOL, V34, P218, DOI 10.1097/00004424-199903000-00011; Lin YP, 1998, AM J NEPHROL, V18, P117, DOI 10.1159/000013319; Nael K, 2011, EUR J RADIOL, V80, P2, DOI 10.1016/j.ejrad.2011.01.092; Nesrallah GE, 2013, AM J KIDNEY DIS, V62, P187, DOI 10.1053/j.ajkd.2013.02.351; Pinto C, 2006, J VASC INTERV RADIOL, V17, P1003, DOI 10.1097/01.RVI.0000220395.05050.77; Planken RN, 2003, J MAGN RESON IMAGING, V17, P54, DOI 10.1002/jmri.10225; Prince MR, 2008, RADIOLOGY, V248, P807, DOI 10.1148/radiol.2483071863; Ravani P, 2013, J AM SOC NEPHROL, V24, P465, DOI 10.1681/ASN.2012070643; Rooijens PPGM, 2008, J VASC ACCESS, V9, P278, DOI 10.1177/112972980800900409; Sadowski EA, 2007, RADIOLOGY, V243, P148, DOI 10.1148/radiol.2431062144; Satoh S, 2008, AM J ROENTGENOL, V191, P464, DOI 10.2214/AJR.07.3133; Sigovan M, 2012, RADIOLOGY, V265, P584, DOI 10.1148/radiol.12112694; Takahashi N, 2004, ACTA RADIOL, V45, P608, DOI 10.1080/02841850410001141; Visser K, 2003, RADIOLOGY, V227, P647, DOI 10.1148/radiol.2273020441; Waldman GJ, 1996, MAGN RESON IMAGING, V14, P197, DOI 10.1016/0730-725X(95)02054-W; Wasinrat J, 2011, VASC ENDOVASC SURG, V45, P69, DOI 10.1177/1538574410379922; Wertman R, 2008, RADIOLOGY, V248, P799, DOI 10.1148/radiol.2483072093; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Yang L, 2012, RADIOLOGY, V265, P248, DOI 10.1148/radiol.12112783; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	40	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78409	10.1371/journal.pone.0078409	http://dx.doi.org/10.1371/journal.pone.0078409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194928	gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000107
J	Ruby, FJM; Smallwood, J; Engen, H; Singer, T				Ruby, Florence J. M.; Smallwood, Jonathan; Engen, Haakon; Singer, Tania			How Self-Generated Thought Shapes Mood-The Relation between Mind-Wandering and Mood Depends on the Socio-Temporal Content of Thoughts	PLOS ONE			English	Article							MEMORY; FUTURE; RUMINATION; ATTENTION; THINKING; BRAIN; FOCUS; LEAD	Recent work has highlighted that the generation of thoughts unrelated to the current environment may be both a cause and a consequence of unhappiness. The current study used lag analysis to examine whether the relationship between self-generated thought and negative affect depends on the content of the thoughts themselves. We found that the emotional content could strongly predict subsequent mood (e.g. negative thoughts were associated with subsequent negative mood). However, this direct relationship was modulated by the socio-temporal content of the thoughts: thoughts that were past- and other-related were associated with subsequent negative mood, even if current thought content was positive. By contrast, future-and self-related thoughts preceded improvements of mood, even when current thought content was negative. These results highlight the important link between self-generated thought and mood and suggest that the socio-temporal content plays an important role in determining whether an individual's future affective state will be happy or sad.	[Ruby, Florence J. M.; Smallwood, Jonathan; Engen, Haakon; Singer, Tania] Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany; [Ruby, Florence J. M.; Smallwood, Jonathan] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	Max Planck Society; University of York - UK	Ruby, FJM (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany.	florence.j.m.ruby@gmail.com	Smallwood, Jonathan/ABE-8365-2020; Engen, Haakon/L-6612-2019	Smallwood, Jonathan/0000-0002-7298-2459	US Office of Education [R305A110277]	US Office of Education	The study was partly supported by Grant R305A110277 from the US Office of Education awarded to J.W. Schooler and J. Smallwood. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Baayen RH, 2011, LANGUAGER DATA SETS; Baird B, 2012, PSYCHOL SCI, V23, P1117, DOI 10.1177/0956797612446024; Baird B, 2011, CONSCIOUS COGN, V20, P1604, DOI 10.1016/j.concog.2011.08.007; Bates D, 2012, LME4 LINEAR MIXED EF; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Berntsen D, 2010, MEM COGNITION, V38, P265, DOI 10.3758/MC.38.3.265; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Iijima Yudai, 2012, Shinrigaku Kenkyu, V83, P232; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; KLINGER E, 1978, J ALTER ST CONSCIOUS, V4, P97; Klinger E, 1999, AT PLAY IN THE FIELDS OF CONSCIOUSNESS, P29; Lagarde E, 2012, INJURY PREV, V18, pA200, DOI 10.1136/injuryprev-2012-040590t.6; LimeSurvey Project Team, 2012, LIMESURVEY OPEN SOUR; McVay JC, 2012, J EXP PSYCHOL GEN, V141, P302, DOI 10.1037/a0025250; McVay JC, 2009, PSYCHON B REV, V16, P857, DOI 10.3758/PBR.16.5.857; Mrazek MD, 2012, J EXP PSYCHOL GEN, V141, P788, DOI 10.1037/a0027968; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Core Team, 2012, R LANG ENV STAT COMP; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Schneider W., 2002, E PRIME VERSION 20 C; Schneider W., 2002, E PRIME USERS GUIDE; Smallwood J, 2008, MEM COGNITION, V36, P1144, DOI 10.3758/MC.36.6.1144; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2013, PSYCHOL BULL, V139, P519, DOI 10.1037/a0030010; Smallwood J, 2013, CONSCIOUS COGN, V22, P1, DOI 10.1016/j.concog.2012.10.007; Smallwood J, 2011, COGNITION EMOTION, V25, P1481, DOI 10.1080/02699931.2010.545263; Smallwood J, 2011, CONSCIOUS COGN, V20, P1120, DOI 10.1016/j.concog.2010.12.017; Smallwood J, 2009, CONSCIOUS COGN, V18, P118, DOI 10.1016/j.concog.2008.11.004; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; Stawarczyk D, CONSCIOUS C IN PRESS; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Watkins E, 2001, J ABNORM PSYCHOL, V110, P353, DOI 10.1037/0021-843X.110.2.333; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	36	144	144	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77554	10.1371/journal.pone.0077554	http://dx.doi.org/10.1371/journal.pone.0077554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194889	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000068
J	Wejnert, C; Le, B; Rose, CE; Oster, AM; Smith, AJ; Zhu, JL; The, GPBF				Wejnert, Cyprian; Le, Binh; Rose, Charles E.; Oster, Alexandra M.; Smith, Amanda J.; Zhu, Julia; The, Gabriela Paz-Bailey For		NHBS Study Grp	HIV Infection and Awareness among Men Who Have Sex with Men-20 Cities, United States, 2008 and 2011	PLOS ONE			English	Article							BEHAVIORAL SURVEILLANCE SYSTEM; PERSONS AWARE; STIGMA; RISK; PREVENTION; PREVALENCE; UNAWARE; PEOPLE; US	Over half of HIV infections in the United States occur among men who have sex with men (MSM). Awareness of infection is a necessary precursor to antiretroviral treatment and risk reduction among HIV-infected persons. We report data on prevalence and awareness of HIV infection among MSM in 2008 and 2011, using data from 20 cities participating in the 2008 and 2011 National HIV Behavioral Surveillance System (NHBS) among MSM. Venue-based, time-space sampling was used to recruit men for interview and HIV testing. We analyzed data for men who reported >= 1 male sex partner in the past 12 months. Participants who tested positive were considered to be aware of their infection if they reported a prior positive HIV test. We used multivariable analysis to examine differences between results from 2011 vs. 2008. HIV prevalence was 19% in 2008 and 18% in 2011 (p = 0.14). In both years, HIV prevalence was highest among older age groups, blacks, and men with lower education and income. In multivariable analysis, HIV prevalence did not change significantly from 2008 to 2011 overall (p = 0.51) or in any age or racial/ethnic category (p>0.15 in each category). Among those testing positive, a greater proportion was aware of their infection in 2011 (66%) than in 2008 (56%) (p<0.001). In both years, HIV awareness was higher for older age groups, whites, and men with higher education and income. In multivariable analysis, HIV awareness increased from 2008 to 2011 overall (p<0.001) and for all age and racial/ethnic categories (p<0.01 in each category). In both years, black MSM had the highest HIV prevalence and the lowest awareness among racial/ethnic groups. These findings suggest that HIV-positive MSM are increasingly aware of their infections.	[Wejnert, Cyprian; Le, Binh; Rose, Charles E.; Oster, Alexandra M.; Smith, Amanda J.; Zhu, Julia; The, Gabriela Paz-Bailey For; NHBS Study Grp] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Wejnert, C (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA 30329 USA.	CWejnert@cdc.gov			Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The National HIV Behavioral Surveillance System is funded by the Centers for Disease Control and Prevention (CDC). Study design and data collection are conducted by funded sites in accordance with a standardized protocol developed by CDC. Data analysis and preparation of the manuscript were conducted by CDC staff.	Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; [Anonymous], 2010, NAT HIV AIDS STRAT U; [Anonymous], 2004, MMWR MORB MORTAL WKL; Babalola S, 2007, AIDS BEHAV, V11, P759, DOI 10.1007/s10461-006-9189-0; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Berendes S, 2011, J ASSOC NURSE AIDS C, V22, P215, DOI 10.1016/j.jana.2010.08.005; CDC, 2013, HIV SURV REP; CDC, 1999, GUID DEF PUBL HLTH R; CDC, 2013, EST HIV INC US 200 S; CDC, 2013, ENH COMPR HIV PREV P; Center for Disease Control and Prevention (CDC), 2011, HIGHL CDC ACT ADDR H; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P211; Centers for Disease Control and Prevention (CDC), 2013, HIV TEST TRENDS US 2; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; Cooley LA, 2013, EP INT SERV C ATL CA; Darrow WW, 2009, AIDS BEHAV, V13, P1178, DOI 10.1007/s10461-009-9601-7; Emlet CA, 2006, AIDS PATIENT CARE ST, V20, P350, DOI 10.1089/apc.2006.20.350; Finlayson Teresa J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fortenberry JD, 2002, AM J PUBLIC HEALTH, V92, P378, DOI 10.2105/AJPH.92.3.378; Gallagher KM, 2007, PUBLIC HEALTH REP, V122, P32, DOI 10.1177/00333549071220S106; Glick SN, 2010, JAIDS-J ACQ IMM DEF, V55, P516, DOI 10.1097/QAI.0b013e3181f275e0; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Karon JM, 2012, J URBAN HEALTH, V89, P565, DOI 10.1007/s11524-012-9676-8; Machkum P, 2011, POPULATION DISTRIBUT; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Rintamaki LS, 2006, AIDS PATIENT CARE ST, V20, P359, DOI 10.1089/apc.2006.20.359; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Viall Abigail H., 2011, Morbidity and Mortality Weekly Report, V60, P805	31	99	99	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76878	10.1371/journal.pone.0076878	http://dx.doi.org/10.1371/journal.pone.0076878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194848	gold, Green Published			2022-12-27	WOS:000326037000027
J	Roede, JR; Uppal, K; Park, Y; Lee, K; Tran, V; Walker, D; Strobel, FH; Rhodes, SL; Ritz, B; Jones, DP				Roede, James R.; Uppal, Karan; Park, Youngja; Lee, Kichun; Tran, Vilinh; Walker, Douglas; Strobel, Frederick H.; Rhodes, Shannon L.; Ritz, Beate; Jones, Dean P.			Serum Metabolomics of Slow vs. Rapid Motor Progression Parkinson's Disease: a Pilot Study	PLOS ONE			English	Article							POLYAMINES; CATABOLISM	Progression of Parkinson's disease (PD) is highly variable, indicating that differences between slow and rapid progression forms could provide valuable information for improved early detection and management. Unfortunately, this represents a complex problem due to the heterogeneous nature of humans in regards to demographic characteristics, genetics, diet, environmental exposures and health behaviors. In this pilot study, we employed high resolution mass spectrometry-based metabolic profiling to investigate the metabolic signatures of slow versus rapidly progressing PD present in human serum. Archival serum samples from PD patients obtained within 3 years of disease onset were analyzed via dual chromatography-high resolution mass spectrometry, with data extraction by xMSanalyzer and used to predict rapid or slow motor progression of these patients during follow-up. Statistical analyses, such as false discovery rate analysis and partial least squares discriminant analysis, yielded a list of statistically significant metabolic features and further investigation revealed potential biomarkers. In particular, N8-acetyl spermidine was found to be significantly elevated in the rapid progressors compared to both control subjects and slow progressors. Our exploratory data indicate that a fast motor progression disease phenotype can be distinguished early in disease using high resolution mass spectrometry-based metabolic profiling and that altered polyamine metabolism may be a predictive marker of rapidly progressing PD.	[Uppal, Karan; Park, Youngja; Lee, Kichun; Tran, Vilinh; Walker, Douglas; Jones, Dean P.] Emory Univ, Clin Biomarkers Lab, Atlanta, GA 30322 USA; [Roede, James R.; Uppal, Karan; Park, Youngja; Lee, Kichun; Walker, Douglas; Jones, Dean P.] Emory Univ, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; [Strobel, Frederick H.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Walker, Douglas] Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA; [Rhodes, Shannon L.; Ritz, Beate] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Uppal, Karan] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Park, Youngja] Korea Univ, Coll Pharm, Sejong City, South Korea	Emory University; Emory University; Emory University; Tufts University; University of California System; University of California Los Angeles; University System of Georgia; Georgia Institute of Technology; Korea University	Jones, DP (corresponding author), Emory Univ, Clin Biomarkers Lab, Atlanta, GA 30322 USA.	dpjones@emory.edu	Ritz, Beate R/E-3043-2015	Uppal, Karan/0000-0001-5985-1668; Park, Youngja/0000-0002-1310-148X	National Institutes of Health [K99ES022266, P01ES016731, R01ES010544, P01ES016732, R01NS038367, U54ES012078]; American Parkinson's Disease Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016732, R01ES010544, K99ES022266, P01ES016731, U54ES012078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Parkinson's Disease Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The following research was supported by the grants from the National Institutes of Health and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript: K99ES022266, P01ES016731, R01ES010544, P01ES016732, R01NS038367, U54ES012078. This work was also supported by a pilot grant from the American Parkinson's Disease Association.	Barnum CJ, 2012, CURR NEUROL NEUROSCI, V12, P350, DOI 10.1007/s11910-012-0283-6; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; CASERO RA, 1993, FASEB J, V7, P653, DOI 10.1096/fasebj.7.8.8500690; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Fahn S, 1987, RECENT DEV PARKINSON; Gasparoli E, 2002, NEUROL SCI, V23, pS77, DOI 10.1007/s100720200078; Hatano T, 2009, J NEUROCHEM, V111, P1075, DOI 10.1111/j.1471-4159.2009.06403.x; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Jacob EL, 2010, PARKINSONISM RELAT D, V16, P576, DOI 10.1016/j.parkreldis.2010.06.014; Johansen KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007551; Jones DP, 2012, ANNU REV NUTR, V32, P183, DOI 10.1146/annurev-nutr-072610-145159; Krasnoslobodtsev AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038099; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Markley JL, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P157; Michell AW, 2008, METABOLOMICS, V4, P191, DOI 10.1007/s11306-008-0111-9; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; Moinard C, 2005, CLIN NUTR, V24, P184, DOI 10.1016/j.clnu.2004.11.001; Mudumba S, 2002, BIOCHEM PHARMACOL, V63, P2011, DOI 10.1016/S0006-2952(02)00991-7; Osborn MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072737; Paik MJ, 2010, CLIN CHIM ACTA, V411, P1532, DOI 10.1016/j.cca.2010.05.034; Poewe W, 2006, NEUROLOGY, V66, pS2, DOI 10.1212/WNL.66.10_suppl_4.S2; POYHONEN MJ, 1990, AM J CLIN NUTR, V52, P746; Rao AM, 2000, J NEUROCHEM, V74, P1106; Ritz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036199; Roede JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033020; Rommelfanger KS, 2007, BIOCHEM PHARMACOL, V74, P177, DOI 10.1016/j.bcp.2007.01.036; Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z; Sharon D, 2010, DIS MARKERS, V28, P209, DOI [10.1155/2010/152759, 10.3233/DMA-2010-0707]; Shulman LM, 2010, ARCH NEUROL-CHICAGO, V67, P64, DOI 10.1001/archneurol.2009.295; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Soltow QA, 2011, METABOLOMICS; Uppal K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-15; Wang J, 2012, DRUG DISCOV TODAY; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097	37	83	87	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77629	10.1371/journal.pone.0077629	http://dx.doi.org/10.1371/journal.pone.0077629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167579	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500038
J	Tornroos, A; Nordstrom, MC; Bonsdorff, E				Tornroos, Anna; Nordstrom, Marie C.; Bonsdorff, Erik			Coastal Habitats as Surrogates for Taxonomic, Functional and Trophic Structures of Benthic Faunal Communities	PLOS ONE			English	Article							ESTUARINE HABITATS; BIOLOGICAL TRAITS; DIVERSITY; BIODIVERSITY; ECOLOGY; REEF; ASSEMBLAGES; INVERTEBRATES; ASSIMILATION; DISTURBANCE	Due to human impact, there is extensive degradation and loss of marine habitats, which calls for measures that incorporate taxonomic as well as functional and trophic aspects of biodiversity. Since such data is less easily quantifiable in nature, the use of habitats as surrogates or proxies for biodiversity is on the rise in marine conservation and management. However, there is a critical gap in knowledge of whether pre-defined habitat units adequately represent the functional and trophic structure of communities. We also lack comparisons of different measures of community structure in terms of both between-(beta) and within-habitat (alpha) variability when accounting for species densities. Thus, we evaluated a priori defined coastal habitats as surrogates for traditional taxonomic, functional and trophic zoobenthic community structure. We focused on four habitats (bare sand, canopy-forming algae, seagrass above-and belowground), all easily delineated in nature and defined through classification systems. We analyzed uni- and multivariate data on species and trait diversity as well as stable isotope ratios of benthic macrofauna. A good fit between habitat types and taxonomic and functional structure was found, although habitats were more similar functionally. This was attributed to within-habitat heterogeneity so when habitat divisions matched the taxonomic structure, only bare sand was functionally distinct. The pre-defined habitats did not meet the variability of trophic structure, which also proved to differentiate on a smaller spatial scale. The quantification of trophic structure using species density only identified an epi- and an infaunal unit. To summarize the results we present a conceptual model illustrating the match between pre-defined habitat types and the taxonomic, functional and trophic community structure. Our results show the importance of including functional and trophic aspects more comprehensively in marine management and spatial planning.	[Tornroos, Anna; Nordstrom, Marie C.; Bonsdorff, Erik] Abo Akad Univ, Dept Biosci Environm & Marine Biol, Turku, Finland	Abo Akademi University	Tornroos, A (corresponding author), Abo Akad Univ, Dept Biosci Environm & Marine Biol, Turku, Finland.	anna.m.tornroos@abo.fi	Nordström, Marie C./C-8956-2012	Nordström, Marie C./0000-0001-5763-1813; Bonsdorff, Erik/0000-0001-5070-4880; Tornroos, Anna/0000-0002-5790-2449	Maj and Tor Nessling Foundation [2010127, 2011079]; Norden Top-level Research Initiative sub-programme "Effect Studies and Adaptation to Climate Change"; Stiftelsen for Abo Akademi	Maj and Tor Nessling Foundation; Norden Top-level Research Initiative sub-programme "Effect Studies and Adaptation to Climate Change"; Stiftelsen for Abo Akademi	Financial support was received from Maj and Tor Nessling Foundation (Project no. 2010127 and 2011079) and Stiftelsen for Abo Akademi. Research presented in this paper contributes to the Nordic Centre for Research on Marine Ecosystems and Resources under Climate Change (NorMER), which is funded by the Norden Top-level Research Initiative sub-programme "Effect Studies and Adaptation to Climate Change." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2004, PERMDISP FORTRAN COM; Arias-Gonzalez JE, 2006, MAR ECOL PROG SER, V320, P29, DOI 10.3354/meps320029; Arkema KK, 2006, FRONT ECOL ENVIRON, V4, P525, DOI 10.1890/1540-9295(2006)4[525:MEMFCT]2.0.CO;2; Borja A, 2010, MAR POLLUT BULL, V60, P2175, DOI 10.1016/j.marpolbul.2010.09.026; Bostrom C, 2000, MAR ECOL PROG SER, V205, P123, DOI 10.3354/meps205123; Bostrom C, 1997, J SEA RES, V37, P153, DOI 10.1016/S1385-1101(96)00007-X; Bostrom C, 2006, ESTUAR COAST SHELF S, V68, P383, DOI 10.1016/j.ecss.2006.01.026; Bostrom C, 2010, J EXP MAR BIOL ECOL, V390, P106, DOI 10.1016/j.jembe.2010.05.008; Bremner J, 2003, MAR ECOL PROG SER, V254, P11, DOI 10.3354/meps254011; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Chevenet F, 1994, FRESHWATER BIOL, V43, P277; Clarke KR, 1994, CHANGE MARINE COMMUN; Connolly RM, 2005, OECOLOGIA, V144, P684, DOI 10.1007/s00442-005-0167-4; Costello MJ, 2009, MAR ECOL PROG SER, V397, P253, DOI 10.3354/meps08317; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; Davies CE, 2004, J EXP MAR BIOL ECOL, DOI DOI 10.1016/J.JEMBE.2008.07.015; de Juan S, 2007, MAR ECOL PROG SER, V334, P117; Dobson AJ, 2010, INTRO GEN LINEAR MOD, P48; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Frid CLJ, 2008, HYDROBIOLOGIA, V606, P69, DOI 10.1007/s10750-008-9343-y; Fry B., 2006, STABLE ISOTOPE ECOLO; Galparsoro I, 2012, MAR POLLUT BULL, V64, P2630, DOI 10.1016/j.marpolbul.2012.10.010; Guest MA, 2004, MAR ECOL PROG SER, V278, P27, DOI 10.3354/meps278027; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harborne AR, 2008, ECOL APPL, V18, P1689, DOI 10.1890/07-0454.1; HELCOM, 2009, HELS COMM BALT SEA B, V116B; Hewitt JE, 2008, J EXP MAR BIOL ECOL, V366, P116, DOI 10.1016/j.jembe.2008.07.016; Kosenius AK, 2011, EC VALUATION ECOSYST, V57; Kraufvelin P, 2004, ESTUAR COAST SHELF S, V61, P369, DOI 10.1016/j.ecss.2004.06.006; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Macdonald TA, 2012, MAR ECOL PROG SER, V445, P129, DOI 10.3354/meps09478; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mumby PJ, 2008, CONSERV BIOL, V22, P941, DOI 10.1111/j.1523-1739.2008.00933.x; Naeem S., 2009, BIODIVERSITY ECOSYST, P281; Nohren E, 2009, ESTUAR COAST SHELF S, V84, P1, DOI 10.1016/j.ecss.2009.05.012; Nordstrom MC, 2010, J EXP MAR BIOL ECOL, V391, P101, DOI 10.1016/j.jembe.2010.06.015; Nordstrom M, 2009, MAR ECOL PROG SER, V378, P13, DOI 10.3354/meps07872; Norkko A, 1996, MAR ECOL PROG SER, V131, P143, DOI 10.3354/meps131143; Norusis M, 2010, PASW STAT 18 ADV STA, P418; Olenin S, 2006, MAR POLLUT BULL, V53, P20, DOI 10.1016/j.marpolbul.2006.01.003; Olsen YS, 2013, MAR ENVIRON RES, V86, P12, DOI 10.1016/j.marenvres.2013.02.002; Olsgard F, 1998, MAR ECOL PROG SER, V172, P25, DOI 10.3354/meps172025; Paganelli D, 2012, ESTUAR COAST SHELF S, V96, P245, DOI 10.1016/j.ecss.2011.11.014; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Riera Pascal, 2009, Marine Biodiversity Records, V2, pe47, DOI 10.1017/S1755267209000529; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Ronnback P, 2007, AMBIO, V36, P534, DOI 10.1579/0044-7447(2007)36[534:EGASFS]2.0.CO;2; Sarkar S, 2005, CONSERV BIOL, V19, P815, DOI 10.1111/j.1523-1739.2005.00236.x; Schaal G, 2011, MAR BIOL, V158, P623, DOI 10.1007/s00227-010-1586-2; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Schmiing M, 2013, MAR ECOL PROG SER, V474, P201, DOI 10.3354/meps10099; Stevens T, 2004, BIOL CONSERV, V119, P351, DOI 10.1016/j.biocon.2003.12.001; Tornroos A, 2012, ECOL APPL, V22, P2221; Tyler EHM, 2012, GLOBAL ECOL BIOGEOGR, V21, P922, DOI 10.1111/j.1466-8238.2011.00726.x; Van Wynsberge S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040997; Villeger S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040679; Ward TJ, 1999, ECOL APPL, V9, P691; Wikstrom SA, 2007, ESTUAR COAST SHELF S, V72, P168, DOI 10.1016/j.ecss.2006.10.009	66	24	24	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78910	10.1371/journal.pone.0078910	http://dx.doi.org/10.1371/journal.pone.0078910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167635	Green Submitted, Green Published, gold			2022-12-27	WOS:000326034500096
J	Zheng, LZ; Liu, Z; Lei, M; Peng, J; He, YX; Xie, XH; Man, CW; Huang, L; Wang, XL; Fong, DTP; Xiao, DM; Wang, DP; Chen, Y; Feng, JQ; Liu, Y; Zhang, G; Qin, L				Zheng, Li-Zhen; Liu, Zhong; Lei, Ming; Peng, Jiang; He, Yi-Xin; Xie, Xin-Hui; Man, Chi-Wai; Huang, Le; Wang, Xin-Luan; Fong, Daniel Tik-Pui; Xiao, De-Ming; Wang, Da-Ping; Chen, Yang; Feng, Jian Q.; Liu, Ying; Zhang, Ge; Qin, Ling			Steroid-Associated Hip Joint Collapse in Bipedal Emus	PLOS ONE			English	Article							FEMORAL-HEAD OSTEONECROSIS; ACUTE-RESPIRATORY-SYNDROME; BONE-MARROW EDEMA; CORTICOSTEROID-INDUCED OSTEONECROSIS; NONTRAUMATIC OSTEONECROSIS; PHYTOMOLECULE ICARITIN; AVASCULAR NECROSIS; SUBCHONDRAL BONE; NATURAL-HISTORY; ANIMAL-MODEL	In this study we established a bipedal animal model of steroid-associated hip joint collapse in emus for testing potential treatment protocols to be developed for prevention of steroid-associated joint collapse in preclinical settings. Five adult male emus were treated with a steroid-associated osteonecrosis (SAON) induction protocol using combination of pulsed lipopolysaccharide (LPS) and methylprednisolone (MPS). Additional three emus were used as normal control. Post-induction, emu gait was observed, magnetic resonance imaging (MRI) was performed, and blood was collected for routine examination, including testing blood coagulation and lipid metabolism. Emus were sacrificed at week 24 post-induction, bilateral femora were collected for micro-computed tomography (micro-CT) and histological analysis. Asymmetric limping gait and abnormal MRI signals were found in steroid-treated emus. SAON was found in all emus with a joint collapse incidence of 70%. The percentage of neutrophils (Neut %) and parameters on lipid metabolism significantly increased after induction. Micro-CT revealed structure deterioration of subchondral trabecular bone. Histomorphometry showed larger fat cell fraction and size, thinning of subchondral plate and cartilage layer, smaller osteoblast perimeter percentage and less blood vessels distributed at collapsed region in SAON group as compared with the normal controls. Scanning electron microscope (SEM) showed poor mineral matrix and more osteo-lacunae outline in the collapsed region in SAON group. The combination of pulsed LPS and MPS developed in the current study was safe and effective to induce SAON and deterioration of subchondral bone in bipedal emus with subsequent femoral head collapse, a typical clinical feature observed in patients under pulsed steroid treatment. In conclusion, bipedal emus could be used as an effective preclinical experimental model to evaluate potential treatment protocols to be developed for prevention of ON-induced hip joint collapse in patients.	[Zheng, Li-Zhen; Liu, Zhong; Peng, Jiang; He, Yi-Xin; Xie, Xin-Hui; Man, Chi-Wai; Huang, Le; Wang, Xin-Luan; Fong, Daniel Tik-Pui; Zhang, Ge; Qin, Ling] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Lei, Ming; Xiao, De-Ming; Wang, Da-Ping; Chen, Yang] Shenzhen Second Peoples Hosp, Dept Orthopaed & Traumatol, Shenzhen, Peoples R China; [Wang, Xin-Luan; Qin, Ling] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Translat Med R&D Ctr, Shenzhen, Peoples R China; [Peng, Jiang] Chinese Peoples Liberat Army, Gen Hosp, Orthoped Res Inst, Beijing, Peoples R China; [Feng, Jian Q.; Liu, Ying] Univ Missouri, Baylor Coll Dent, Kansas City, MO 64110 USA; [Lei, Ming; Xiao, De-Ming] Beijing Univ, Shenzhen Hosp, Dept Orthopead, Shenzhen, Peoples R China; [Xie, Xin-Hui] Southeast Univ, Zhongda Hosp, Dept Orthopaed, Nanjing, Jiangsu, Peoples R China; [Zhang, Ge] Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Second People's Hospital of Shenzhen; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese People's Liberation Army General Hospital; University of Missouri System; University of Missouri Kansas City; Peking University; Southeast University - China; Hong Kong Baptist University	Zhang, G (corresponding author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.	zhangge@ort.cuhk.edu.hk; lingqin@cuhk.edu.hk	Zhang, Ge/K-9118-2019; Zhang, Ge/N-4150-2013; Fong, Daniel T.P./AAT-8659-2020; Zheng, Lizhen/C-6550-2014; Man, Gene Chi-Wai/AAH-4865-2019; Qin, Ling/J-9047-2018	Zhang, Ge/0000-0002-7807-7695; Zhang, Ge/0000-0002-7807-7695; Man, Gene Chi-Wai/0000-0002-8608-9688; Qin, Ling/0000-0001-6173-6167; Fong, Daniel Tik-Pui/0000-0001-7314-189X	Hong Kong ITC [GHP/001/08]; Hong Kong ITF [ITS/451/09FP]; Shenzhen Science & Technology Fund [SG200810200101A/02/A]; NIDCR/NIH [DE018486]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018486] Funding Source: NIH RePORTER	Hong Kong ITC; Hong Kong ITF; Shenzhen Science & Technology Fund; NIDCR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by Hong Kong ITC (GHP/001/08 and ITF Tier 2 ITS/451/09FP): https://www.itf.gov.hk/; Shenzhen Science & Technology Fund (SG200810200101A/02/A): http://www.szsti.gov.cn/; and DE018486 from NIDCR/NIH: http://www.nidcr.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada T, 2008, RHEUMATOLOGY, V47, P591, DOI 10.1093/rheumatology/ken037; Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; Bitto A, 2009, J ENDOCRINOL, V201, P321, DOI 10.1677/JOE-08-0552; Bradway J K, 1993, J Arthroplasty, V8, P383, DOI 10.1016/S0883-5403(06)80036-7; Chan MHM, 2006, PATHOLOGY, V38, P229, DOI 10.1080/00313020600696231; Chen SH, 2013, ACTA BIOMATER, V9, P6711, DOI 10.1016/j.actbio.2013.01.024; Chen SH, 2012, ACTA BIOMATER, V8, P3128, DOI 10.1016/j.actbio.2012.04.030; Conzemius MG, 2002, J ORTHOP RES, V20, P303, DOI 10.1016/S0736-0266(01)00108-5; Cui QJ, 2000, CONNECT TISSUE RES, V41, P45; Cui QJ, 1997, CLIN ORTHOP RELAT R, P8; Davis ET, 2006, J BONE JOINT SURG AM, V88A, P110, DOI 10.2106/JBJS.F.00771; Drescher W, 2004, J ORTHOPAED RES, V22, P501, DOI 10.1016/j.orthres.2003.10.002; Drescher W, 2001, J BONE JOINT SURG BR, V83B, P274, DOI 10.1302/0301-620X.83B2.10323; Drescher W, 2006, J BONE JOINT SURG AM, V88A, P162, DOI 10.2106/JBJS.F.00452; Fan M, 2011, J INT MED RES, V39, P187, DOI 10.1177/147323001103900120; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; FORDYCE MJF, 1993, J BONE JOINT SURG BR, V75, P365, DOI 10.1302/0301-620X.75B3.8496201; Fujioka M, 2001, MAGN RESON IMAGING, V19, P985, DOI 10.1016/S0730-725X(01)00424-6; Goetz JE, 2008, J BIOMECH, V41, P2197, DOI 10.1016/j.jbiomech.2008.04.032; Goetz JE, 2008, J BIOMECH, V41, P770, DOI 10.1016/j.jbiomech.2007.11.022; Griffith JF, 2005, RADIOLOGY, V235, P168, DOI 10.1148/radiol.2351040100; Hansen T, 2006, J ORAL PATHOL MED, V35, P155, DOI 10.1111/j.1600-0714.2006.00391.x; Hernigou P, 1999, J BONE JOINT SURG BR, V81B, P349, DOI 10.1302/0301-620X.81B2.8818; Irisa T, 2001, BONE, V28, P641, DOI 10.1016/S8756-3282(01)00460-4; Ito H, 2006, AM J ROENTGENOL, V186, P1761, DOI 10.2214/AJR.05.0086; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koo KH, 1999, RADIOLOGY, V213, P715, DOI 10.1148/radiology.213.3.r99dc06715; Kubo T, 1997, MAGN RESON IMAGING, V15, P1017, DOI 10.1016/S0730-725X(97)00159-8; LANE LB, 1977, J BONE JOINT SURG BR, V59, P272, DOI 10.1302/0301-620X.59B3.893504; Lau EMC, 2005, BONE, V37, P420, DOI 10.1016/j.bone.2005.04.018; Law RKY, 2008, WORK, V30, P17; Li Zi-rong, 2005, Zhonghua Wai Ke Za Zhi, V43, P1048; Lieberman Jay R, 2003, Instr Course Lect, V52, P337; Lv H, 2009, TROP MED INT HEALTH, V14, P79, DOI 10.1111/j.1365-3156.2008.02187.x; MARTIN DM, 1978, J MICROSC-OXFORD, V112, P345, DOI 10.1111/j.1365-2818.1978.tb00085.x; MILLER SC, 1985, J DENT RES, V64, P1062, DOI 10.1177/00220345850640080701; Mont MA, 2006, J BONE JOINT SURG AM, V88A, P1117, DOI 10.2106/JBJS.E.01041; Moskal J T, 1997, Am J Orthop (Belle Mead NJ), V26, P609; Nishii T, 2002, CLIN ORTHOP RELAT R, P149; Okazaki S, 2009, RHEUMATOLOGY, V48, P227, DOI 10.1093/rheumatology/ken462; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Plenk H, 2001, CLIN ORTHOP RELAT R, P42; Qin L, 2006, BONE, V39, P863, DOI 10.1016/j.bone.2006.04.018; Reed KL, 2003, J BIOMECH, V36, P1317, DOI 10.1016/S0021-9290(03)00154-4; Resources I. O. L. A., 1996, GUIDE CARE USED LAB; Shen Jun, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P189; Sheng H, 2009, J ORTHOP RES, V27, P742, DOI 10.1002/jor.20765; Solomon DH, 2006, ARTHRIT RHEUM-ARTHR, V55, P873, DOI 10.1002/art.22350; Sun W, 2006, INT ORTHOP, V30, P143, DOI 10.1007/s00264-005-0067-6; Sun Y, 2009, JOINT BONE SPINE, V76, P685, DOI 10.1016/j.jbspin.2009.04.002; Takano-Murakami R, 2009, TOHOKU J EXP MED, V217, P51, DOI 10.1620/tjem.217.51; Troy KL, 2009, J BIOMECH, V42, P2495, DOI 10.1016/j.jbiomech.2009.07.017; TURNER DA, 1989, RADIOLOGY, V171, P135, DOI 10.1148/radiology.171.1.2928517; Wang SX, 2007, ARTHRITIS RHEUM-US, V56, P1537, DOI 10.1002/art.22574; Wang XL, 2013, J ORTHOP RES, V31, P164, DOI 10.1002/jor.22188; Xie XH, 2011, J BONE JOINT SURG BR, V93B, P558, DOI 10.1302/0301-620X.93B4.25442; Xie XH, 2012, ARTHRITIS RHEUM-US, V64, P1562, DOI 10.1002/art.34525; Yamamoto T, 1997, ARTHRITIS RHEUM, V40, P2055, DOI 10.1002/art.1780401119; YAMAMOTO T, 1995, CLIN ORTHOP RELAT R, P235; Yamamoto T, 2006, J RHEUMATOL, V33, P1701; Yang L, 2009, J ORTHOP RES, V27, P169, DOI 10.1002/jor.20733; Zhang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006419; Zhang G, 2009, BONE, V44, P345, DOI 10.1016/j.bone.2008.10.035	63	13	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76797	10.1371/journal.pone.0076797	http://dx.doi.org/10.1371/journal.pone.0076797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204675	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600011
J	Mayer, M; Rabindranath, R; Borner, J; Horner, E; Bentz, A; Salgado, J; Han, H; Bose, H; Probst, J; Shamonin, M; Monkman, GJ; Schlunck, G				Mayer, Matthias; Rabindranath, Raman; Boerner, Juliane; Hoerner, Eva; Bentz, Alexander; Salgado, Josefina; Han, Hong; Boese, Holger; Probst, Joern; Shamonin, Mikhail; Monkman, Gareth J.; Schlunck, Guenther			Ultra-Soft PDMS-Based Magnetoactive Elastomers as Dynamic Cell Culture Substrata	PLOS ONE			English	Article							ELASTIC MAGNETIC-MATERIALS; SMOOTH MUSCLE ACTIN; MECHANOTRANSDUCTION; STIFFNESS; TENSION; HYDROGELS; BEHAVIOR; DAMPERS; SEALS	Mechanical cues such as extracellular matrix stiffness and movement have a major impact on cell differentiation and function. To replicate these biological features in vitro, soft substrata with tunable elasticity and the possibility for controlled surface translocation are desirable. Here we report on the use of ultra-soft (Young's modulus <100 kPa) PDMS-based magnetoactive elastomers (MAE) as suitable cell culture substrata. Soft non-viscous PDMS (<18 kPa) is produced using a modified extended crosslinker. MAEs are generated by embedding magnetic microparticles into a soft PDMS matrix. Both substrata yield an elasticity-dependent (14 vs. 100 kPa) modulation of alpha-smooth muscle actin expression in primary human fibroblasts. To allow for static or dynamic control of MAE material properties, we devise low magnetic field (approximate to 40 mT) stimulation systems compatible with cell-culture environments. Magnetic field-instigated stiffening (14 to 200 kPa) of soft MAE enhances the spreading of primary human fibroblasts and decreases PAX-7 transcription in human mesenchymal stem cells. Pulsatile MAE movements are generated using oscillating magnetic fields and are well tolerated by adherent human fibroblasts. This MAE system provides spatial and temporal control of substratum material characteristics and permits novel designs when used as dynamic cell culture substrata or cell culture-coated actuator in tissue engineering applications or biomedical devices.	[Mayer, Matthias; Hoerner, Eva; Bentz, Alexander; Shamonin, Mikhail; Monkman, Gareth J.] Regensburg Univ Appl Sci, Dept Elect Engn & Informat Technol, Regensburg, Germany; [Rabindranath, Raman; Boese, Holger; Probst, Joern] Fraunhofer Inst Silicatforsch, Ctr Smart Mat, Wurzburg, Germany; [Boerner, Juliane; Salgado, Josefina; Han, Hong; Schlunck, Guenther] Wurzburg Univ Hosp, Dept Ophthalmol, Wurzburg, Germany; [Schlunck, Guenther] Univ Freiburg, Med Ctr, Dept Ophthalmol, Freiburg, Germany	University of Regensburg; Fraunhofer Gesellschaft; University of Wurzburg; University of Freiburg	Mayer, M (corresponding author), Regensburg Univ Appl Sci, Dept Elect Engn & Informat Technol, Regensburg, Germany.	matthias.mayer@hs-regensburg.de; guenther.schlunck@uniklinik-freiburg.de	Monkman, Gareth/D-9731-2015	Monkman, Gareth/0000-0003-4891-8745; Shamonin, Mikhail/0000-0001-5637-7526	German Federal Ministry of Education and Research [13N10575, 17PNT021]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This material is based upon work supported by the German Federal Ministry of Education and Research (grants 13N10575, 17PNT021), http://foerderportal.bund.de/foekat/jsp/SucheAction.do?actionMode = view&fkz = 13N10574; http://foerderportal.bund.de/foekat/jsp/SucheAction.do?actionMode = view&fkz = 17PNT021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramchuk S, 2007, POLYM ADVAN TECHNOL, V18, P883, DOI 10.1002/pat.924; Abramchuk S, 2007, POLYM ADVAN TECHNOL, V18, P513, DOI 10.1002/pat.923; ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; Adrian RJ., 2010, PARTICLE IMAGE VELOC; [Anonymous], 2012, J ASTM INT; [Anonymous], 2003, 1457712002 DIN EN IS; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bartalena G, 2012, SOFT MATTER, V8, P673, DOI 10.1039/c1sm06250f; Bose H, 2007, INT J MOD PHYS B, V21, P4790, DOI 10.1142/S0217979207045670; Bose H, 2009, US Patent, Patent No. 7608197; Cesa CM, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2712870; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Fischer-Cripps AC, 2011, MECH ENG SER, P235, DOI 10.1007/978-1-4419-9872-9_13; Fuchs A, 2007, J APPL POLYM SCI, V105, P2497, DOI 10.1002/app.24348; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Gordaninejad F, 2012, J INTEL MAT SYST STR, V23, P1033, DOI 10.1177/1045389X12448286; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Kuhn H., 2000, FRACTURE TOUGHNESS F, V8, DOI [10.31399/asm.hb.v08.a0003305, DOI 10.31399/ASM.HB.V08.A0003305]; Li YH, 2013, ADV FUNCT MATER, V23, P660, DOI 10.1002/adfm.201201708; Lin IK, 2009, J MICROELECTROMECH S, V18, P1087, DOI 10.1109/JMEMS.2009.2029166; Mezger T G, 2010, RHEOLOGIE HDB ANWEND; Mitsumata T, 2012, J PHYS CHEM B, V116, P12341, DOI 10.1021/jp3049372; Nendza M, 2007, MAR POLLUT BULL, V54, P1190, DOI 10.1016/j.marpolbul.2007.04.009; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Palchesko RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051499; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Regehr KJ, 2009, LAB CHIP, V9, P2132, DOI 10.1039/b903043c; Schlunck G, 2008, INVEST OPHTH VIS SCI, V49, P262, DOI 10.1167/iovs.07-0956; Stepanov GV, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/20/204121; Stolbov OV, 2010, POLYM SCI SER A+, V52, P1344, DOI 10.1134/S0965545X10120138; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; Varga Z, 2006, POLYMER, V47, P227, DOI 10.1016/j.polymer.2005.10.139; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wipff PJ, 2009, BIOMATERIALS, V30, P1781, DOI 10.1016/j.biomaterials.2008.12.022; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	43	44	45	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76196	10.1371/journal.pone.0076196	http://dx.doi.org/10.1371/journal.pone.0076196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204603	Green Published, gold			2022-12-27	WOS:000326029300013
J	Walker, JA; Alfaro, ME; Noble, MM; Fulton, CJ				Walker, Jeffrey A.; Alfaro, Michael E.; Noble, Mae M.; Fulton, Christopher J.			Body Fineness Ratio as a Predictor of Maximum Prolonged-Swimming Speed in Coral Reef Fishes	PLOS ONE			English	Article							PERFORMANCE TRADE-OFFS; THREESPINE STICKLEBACK; GENETIC-DIVERGENCE; FIN MUSCLE; MORPHOLOGY; SHAPE; FLOW; HYDRODYNAMICS; ENERGETICS; SELECTION	The ability to sustain high swimming speeds is believed to be an important factor affecting resource acquisition in fishes. While we have gained insights into how fin morphology and motion influences swimming performance in coral reef fishes, the role of other traits, such as body shape, remains poorly understood. We explore the ability of two mechanistic models of the causal relationship between body fineness ratio and endurance swimming-performance to predict maximum prolonged-swimming speed (U-max) among 84 fish species from the Great Barrier Reef, Australia. A drag model, based on semi-empirical data on the drag of rigid, submerged bodies of revolution, was applied to species that employ pectoral-fin propulsion with a rigid body at U-max. An alternative model, based on the results of computer simulations of optimal shape in self-propelled undulating bodies, was applied to the species that swim by body-caudal-fin propulsion at U-max. For pectoral-fin swimmers, U-max increased with fineness, and the rate of increase decreased with fineness, as predicted by the drag model. While the mechanistic and statistical models of the relationship between fineness and U-max were very similar, the mechanistic (and statistical) model explained only a small fraction of the variance in U-max. For body-caudal-fin swimmers, we found a non-linear relationship between fineness and U-max, which was largely negative over most of the range of fineness. This pattern fails to support either predictions from the computational models or standard functional interpretations of body shape variation in fishes. Our results suggest that the widespread hypothesis that a more optimal fineness increases endurance-swimming performance via reduced drag should be limited to fishes that swim with rigid bodies.	[Walker, Jeffrey A.] Univ So Maine, Dept Biol Sci, Portland, ME 04103 USA; [Alfaro, Michael E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Noble, Mae M.; Fulton, Christopher J.] Australian Natl Univ, Res Sch Biol, ARC Ctr Excellence Coral Reef Studies, Canberra, ACT, Australia	University of Maine System; University of Southern Maine; University of California System; University of California Los Angeles; Australian National University	Walker, JA (corresponding author), Univ So Maine, Dept Biol Sci, Portland, ME 04103 USA.	walker@maine.edu	Fulton, Christopher/A-5971-2008; Alfaro, Michael/Q-2113-2017	Fulton, Christopher/0000-0002-1140-1999; Alfaro, Michael/0000-0002-8898-8230	National Science Foundation Division of Environmental Biology (NSF DEB) [0842397]; Australian Research Council	National Science Foundation Division of Environmental Biology (NSF DEB)(National Science Foundation (NSF)); Australian Research Council(Australian Research Council)	MEA was partially supported by National Science Foundation Division of Environmental Biology (NSF DEB) grant 0842397 (http://www.nsf.gov/div/index.jsp?div = DEB). CJF was partially supported by the Australian Research Council (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlborn BK, 2009, CAN J ZOOL, V87, P124, DOI 10.1139/Z08-144; Anderson EJ, 2001, J EXP BIOL, V204, P81; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Ashley-Ross MA, 2002, J EXP ZOOL, V293, P561, DOI 10.1002/jez.10183; BAINBRIDGE R, 1960, J EXP BIOL, V37, P129; Bellwood DR, 2002, FUNCT ECOL, V16, P557, DOI 10.1046/j.1365-2435.2002.00655.x; Biewener AA, 2012, J EXP BIOL, V215, P4051, DOI 10.1242/jeb.081794; Blake R.W., 1983, FISH LOCOMOTION; Blake RW, 2005, J FISH BIOL, V67, P834, DOI 10.1111/j.0022-1112.2005.00788.x; Blake RW, 2004, J FISH BIOL, V65, P1193, DOI 10.1111/j.0022-1112.2004.00568.x; Boily P, 2002, J EXP BIOL, V205, P1031; Borazjani I, 2010, J EXP BIOL, V213, P89, DOI 10.1242/jeb.030932; Borazjani I, 2008, J EXP BIOL, V211, P1541, DOI 10.1242/jeb.015644; Borazjani I, 2009, J EXP BIOL, V212, P576, DOI 10.1242/jeb.025007; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chung MH, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/3/036001; Collin H, 2011, MOL ECOL, V20, P4490, DOI 10.1111/j.1365-294X.2011.05284.x; Dalziel AC, 2012, J EXP BIOL, V215, P3587, DOI 10.1242/jeb.071951; Dalziel AC, 2012, EVOLUTION, V66, P1226, DOI 10.1111/j.1558-5646.2011.01498.x; Davison W., 1994, New Zealand Natural Sciences, V21, P11; Domenici P, 2003, EXPTL BIOL REV, P137; Ellerby DJ, 2011, EVOL BIOL, V38, P422, DOI 10.1007/s11692-011-9130-y; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fischer-Rousseau L, 2010, J EXP ZOOL PART B, V314B, P67, DOI 10.1002/jez.b.21311; Fisher R, 2007, J EXP BIOL, V210, P2436, DOI 10.1242/jeb.004275; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fulton CJ, 2007, CORAL REEFS, V26, P217, DOI 10.1007/s00338-007-0195-0; Fulton CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054033; Fulton CJ, 2005, P ROY SOC B-BIOL SCI, V272, P827, DOI 10.1098/rspb.2004.3029; Fulton CJ, 2004, MAR BIOL, V144, P429, DOI 10.1007/s00227-003-1216-3; Fulton CJ, 2001, MAR BIOL, V139, P25; GARLAND T, 1994, PHYSIOL ZOOL, V67, P797, DOI 10.1086/physzool.67.4.30163866; Gerstner CL, 1999, CAN J ZOOL, V77, P1102, DOI 10.1139/cjz-77-7-1102; Haas TC, 2010, BIOL LETTERS, V6, P803, DOI 10.1098/rsbl.2010.0401; HAMMER C, 1995, COMP BIOCHEM PHYS A, V112, P1, DOI 10.1016/0300-9629(95)00060-K; Heatwole SJ, 2013, MAR BIOL, V160, P677, DOI 10.1007/s00227-012-2123-2; Hendry AP, 2011, J EVOLUTION BIOL, V24, P23, DOI 10.1111/j.1420-9101.2010.02155.x; Hobson E. S., 1978, FISHERY B, V76; Hoerner S. F, 1965, FLUID DYNAMIC DRAG; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Jastrebski CJ, 2003, EVOL ECOL RES, V6, P1; Johansen JL, 2008, MAR ECOL PROG SER, V360, P219, DOI 10.3354/meps07482; Jones EA, 2007, J EXP BIOL, V210, P3422, DOI 10.1242/jeb.005744; Kingsolver JG, 2007, BIOSCIENCE, V57, P561, DOI 10.1641/B570706; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; Kunze S, 2011, EXP FLUIDS, V50, P747, DOI 10.1007/s00348-010-0981-2; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Langerhans RB, 2009, J EVOLUTION BIOL, V22, P1057, DOI 10.1111/j.1420-9101.2009.01716.x; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; Langerhans R. Brian, 2010, P200, DOI 10.1201/b10190-8; Langerhans RB, 2009, BIOL LETTERS, V5, P488, DOI 10.1098/rsbl.2009.0179; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Li D, 2009, J FISH BIOL, V74, P186, DOI 10.1111/j.1095-8649.2008.02128.x; Lighthill J., 1975, MATH BIOFLUIDDYNAMIC; LIGHTHILL MJ, 1971, PROC R SOC SER B-BIO, V179, P125, DOI 10.1098/rspb.1971.0085; LUIKER EA, 1993, CAN J ZOOL, V71, P2185, DOI 10.1139/z93-307; McGuigan K, 2003, EVOLUTION, V57, P104; MITCHELLOLDS T, 1987, EVOLUTION, V41, P1149, DOI [10.2307/2409084, 10.1111/j.1558-5646.1987.tb02457.x]; Nanami A, 2007, J EXP MAR BIOL ECOL, V348, P1, DOI 10.1016/j.jembe.2007.02.016; Ohlberger J, 2006, J COMP PHYSIOL B, V176, P17, DOI 10.1007/s00360-005-0024-0; Ojanguren AF, 2003, ECOL FRESHW FISH, V12, P241, DOI 10.1046/j.1600-0633.2003.00016.x; Orme D, 2012, CAPER COMP ANAL PHYL; Oufiero CE, 2011, ECOLOGY, V92, P170, DOI 10.1890/09-1912.1; Pakkasmaa S, 2000, EVOL ECOL, V14, P721, DOI 10.1023/A:1011691810801; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peres-Neto PR, 2004, OECOLOGIA, V140, P36, DOI 10.1007/s00442-004-1562-y; Pettersson LB, 2000, P ROY SOC B-BIOL SCI, V267, P759, DOI 10.1098/rspb.2000.1068; Plaut I, 2001, COMP BIOCHEM PHYS A, V131, P41, DOI 10.1016/S1095-6433(01)00462-7; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramamurti R, 2002, J EXP BIOL, V205, P2997; Reid DAP, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021901; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Rouleau S, 2010, FUNCT ECOL, V24, P310, DOI 10.1111/j.1365-2435.2009.01636.x; Sagnes P, 2009, AQUAT LIVING RESOUR, V22, P79, DOI 10.1051/alr/2009008; Sambilay V.C.J., 1990, FISHBYTE, V8, P16; Schaefer J, 2011, BIOL J LINN SOC, V103, P612, DOI 10.1111/j.1095-8312.2011.01660.x; Seiler SM, 2007, CAN J FISH AQUAT SCI, V64, P127, DOI 10.1139/F06-175; Shalizi C., 2013, ADV DATA ANAL ELEMEN; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Shen L, 2003, J FLUID MECH, V484, P197, DOI 10.1017/S0022112003004294; TANEDA S, 1974, J PHYS SOC JPN, V36, P1683, DOI 10.1143/JPSJ.36.1683; TAYLOR EB, 1986, CAN J ZOOL, V64, P416, DOI 10.1139/z86-064; Techet AH, 2003, FLOW TURBUL COMBUST, V71, P105, DOI 10.1023/B:APPL.0000014923.28324.87; Thorsen DH, 2004, J MORPHOL, V263, P133, DOI 10.1002/(ISSN)1097-4687.; Tokic G, 2012, P ROY SOC B-BIOL SCI, V279, P3065, DOI 10.1098/rspb.2012.0057; Triantafyllou MS, 2004, IEEE J OCEANIC ENG, V29, P585, DOI 10.1109/JOE.2004.833216; Tudorache C, 2007, J FISH BIOL, V71, P1448, DOI 10.1111/j.1095-8649.2007.01612.x; Tytell ED, 2010, INTEGR COMP BIOL, V50, P1140, DOI 10.1093/icb/icq057; Tytell ED, 2010, P NATL ACAD SCI USA, V107, P19832, DOI 10.1073/pnas.1011564107; Walker JA, 2000, P ROY SOC B-BIOL SCI, V267, P1875, DOI 10.1098/rspb.2000.1224; Walker JA, 2004, J EXP BIOL, V207, P1925, DOI 10.1242/jeb.00994; Walker JA, 2002, INTEGR COMP BIOL, V42, P232, DOI 10.1093/icb/42.2.232; Walker JA, 2002, J EXP BIOL, V205, P177; Walker JA, 2010, INTEGR COMP BIOL, V50, P1051, DOI 10.1093/icb/icq014; WARE DM, 1982, CAN J FISH AQUAT SCI, V39, P3, DOI 10.1139/f82-002; Webb PW, 2010, INTEGR COMP BIOL, V50, P1155, DOI 10.1093/icb/icq020	98	33	37	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e75422	10.1371/journal.pone.0075422	http://dx.doi.org/10.1371/journal.pone.0075422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204575	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300003
J	Yang, Y; Li, RK; Li, WJ; Wang, M; Cao, Y; Wu, ZL; Xu, Q				Yang, Yang; Li, Runkui; Li, Wenjing; Wang, Meng; Cao, Yang; Wu, Zhenglai; Xu, Qun			The Association between Ambient Air Pollution and Daily Mortality in Beijing after the 2008 Olympics: A Time Series Study	PLOS ONE			English	Article							EXPOSURE-RESPONSE FUNCTIONS; PARTICULATE MATTER; CARBON-MONOXIDE; HEALTH OUTCOMES; PUBLIC-HEALTH; CHINA; CITIES; AGE; MODIFIERS; PARTICLES	In recent decades, ambient air pollution has been an important public health issue in Beijing, but little is known about air pollution and health effects after the 2008 Beijing Olympics. We conduct a time-series analysis to evaluate associations between daily mortality (nonaccidental, cardiovascular and respiratory mortality) and the major air pollutants (carbon monoxide, nitrogen dioxide and particulate matter less than 10 mm in aerodynamic diameter) in Beijing during the two years (2009 similar to 2010) after the 2008 Beijing Olympics. We used generalized additive model to analyze relationship between daily mortality and air pollution. In single air pollutant model with two-day moving average concentrations of the air pollutants, increase in their interquartile range (IQR) associated with percent increase in nonaccidental mortality, 2.55 percent [95% confidence interval (CI): 1.99, 3.11] for CO, 2.54 percent (95% CI: 2.00, 3.08) for NO2 and 1.80 percent (95% CI: 1.21, 2.40) for PM10, respectively; increases in the IQR of air pollutant concentrations associated with percent increase in cardiovascular mortality, 2.88 percent (95% CI: 2.10,3.65) for CO, 2.63 percent (95% CI: 1.87, 3.39) for NO2 and 1.72 percent (95% CI: 0.88, 2.55) for PM10, respectively; and increase in IQR of air pollutant concentrations associated with respiratory mortality, 2.39 percent (95% CI: 0.68, 4.09) for CO, 1.79 percent (95% CI: 0.11, 3.47) for NO2 and 2.07 percent (95% CI: 0.21, 3.92) for PM10, respectively. We used the principal component analysis to avoid collinearity of varied air pollutants. In addition, the association stratified by sex and age was also examined. Ambient air pollution remained a significant contributor to nonaccidental and cardiopulmonary mortalities in Beijing during 2009,2010.	[Yang, Yang; Li, Wenjing; Wang, Meng; Wu, Zhenglai; Xu, Qun] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Biostat, Beijing 100730, Peoples R China; [Yang, Yang; Li, Wenjing; Wang, Meng; Wu, Zhenglai; Xu, Qun] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Li, Runkui] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China; [Cao, Yang] Karolinska Inst, Inst Environm Med, Unit Biostat, S-10401 Stockholm, Sweden	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Karolinska Institutet	Xu, Q (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Biostat, Beijing 100730, Peoples R China.	qunxu@ibms.pumc.edu.cn	Li, Runkui/AAH-1534-2021; Cao, Yang/C-6185-2008; Cao, Yang/HGD-6463-2022	Cao, Yang/0000-0002-3552-9153; xu, qun/0000-0003-0141-4427	Gong-Yi Program of China Ministry of Environmental Protection [200909016, 201209046, 201309045]	Gong-Yi Program of China Ministry of Environmental Protection	This study was funded by Gong-Yi Program of China Ministry of Environmental Protection (200909016, 201209046, 201309045). URL:http://kjs.mep.gov.cn/gyxhykyzx/The funders had no role in study design, data collection and analysis, decision to publish, or preperation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2007, BEIJ STAT YB; Aunan K, 2004, SCI TOTAL ENVIRON, V329, P3, DOI 10.1016/j.scitotenv.2004.03.008; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Braga ALF, 2001, J OCCUP ENVIRON MED, V43, P927; Chen BH, 2004, TOXICOLOGY, V198, P291, DOI 10.1016/j.tox.2004.02.005; Chen RJ, 2011, SCI TOTAL ENVIRON, V409, P4923, DOI 10.1016/j.scitotenv.2011.08.029; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Dong J W, 1996, Zhonghua Liu Xing Bing Xue Za Zhi, V17, P13; Gouveia N, 2000, J EPIDEMIOL COMMUN H, V54, P750, DOI 10.1136/jech.54.10.750; *HLTH EFF I, 2004, HLTH EFF OUTD AIR PO; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Kan Haidong, 2010, Res Rep Health Eff Inst, P17; Kan HD, 2005, BIOMED ENVIRON SCI, V18, P159; Katsouyanni K, 2001, EPIDEMIOLOGY, V12, P521, DOI 10.1097/00001648-200109000-00011; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; McGrath JJ, 2000, INHAL TOXICOL, V12, P91, DOI 10.1080/089583700750019521; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; O'Neill MS, 2003, ENVIRON HEALTH PERSP, V111, P1861, DOI 10.1289/ehp.6334; Puett RC, 2008, AM J EPIDEMIOL, V168, P1161, DOI 10.1093/aje/kwn232; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Samoli E, 2008, ENVIRON HEALTH PERSP, V116, P1480, DOI 10.1289/ehp.11345; Samoli E, 2007, ENVIRON HEALTH PERSP, V115, P1578, DOI 10.1289/ehp.10375; Stieb DM, 2002, J AIR WASTE MANAGE, V52, P470, DOI 10.1080/10473289.2002.10470794; Sun Ying, 2011, Huanjing Kexue, V32, P2732; Xu ZY, 2000, ARCH ENVIRON HEALTH, V55, P115, DOI 10.1080/00039890009603397; [杨敏娟 YANG Minjuan], 2008, [环境与健康杂志, Journal of Environment and Health], V25, P294; Zeger SL, 2006, ANNU REV PUBL HEALTH, V27, P57, DOI 10.1146/annurev.publhealth.26.021304.144517; Zeka A, 2006, AM J EPIDEMIOL, V163, P849, DOI 10.1093/aje/kwj116; Zhang FY, 2011, INT J ENV RES PUB HE, V8, P2109, DOI 10.3390/ijerph8062109; Zhao QG, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-2; [No title captured]; [No title captured]; [No title captured]	34	43	45	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76759	10.1371/journal.pone.0076759	http://dx.doi.org/10.1371/journal.pone.0076759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204670	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300051
J	Pussila, M; Sarantaus, L; Bebek, DD; Valo, S; Reyhani, N; Ollila, S; Paivarinta, E; Peltomaki, P; Mutanen, M; Nystrom, M				Pussila, Marjaana; Sarantaus, Laura; Bebek, Denis Dermadi; Valo, Satu; Reyhani, Nima; Ollila, Saara; Paivarinta, Essi; Peltomaki, Paivi; Mutanen, Marja; Nystrom, Minna			Cancer-Predicting Gene Expression Changes in Colonic Mucosa of Western Diet Fed Mlh1(+/-) Mice	PLOS ONE			English	Article							ANTAGONIST DICKKOPF-1 GENE; DNA METHYLATION; EPIGENETIC INACTIVATION; MOLECULAR-GENETICS; BETA-CATENIN/TCF; VITAMIN-D; HYPERMETHYLATION; TUMORIGENESIS; MICROARRAY; NUTRITION	Colorectal cancer (CRC) is the second most common cause of cancer-related deaths in the Western world and interactions between genetic and environmental factors, including diet, are suggested to play a critical role in its etiology. We conducted a long-term feeding experiment in the mouse to address gene expression and methylation changes arising in histologically normal colonic mucosa as putative cancer-predisposing events available for early detection. The expression of 94 growth-regulatory genes previously linked to human CRC was studied at two time points (5 weeks and 12 months of age) in the heterozygote Mlh1(+/-) mice, an animal model for human Lynch syndrome (LS), and wild type Mlh1(+/+) littermates, fed by either Western-style (WD) or AIN-93G control diet. In mice fed with WD, proximal colon mucosa, the predominant site of cancer formation in LS, exhibited a significant expression decrease in tumor suppressor genes, Dkk1, Hoxd1, Slc5a8, and Socs1, the latter two only in the Mlh1(+/-) mice. Reduced mRNA expression was accompanied by increased promoter methylation of the respective genes. The strongest expression decrease (7.3 fold) together with a significant increase in its promoter methylation was seen in Dkk1, an antagonist of the canonical Wnt signaling pathway. Furthermore, the inactivation of Dkk1 seems to predispose to neoplasias in the proximal colon. This and the fact that Mlh1 which showed only modest methylation was still expressed in both Mlh1(+/-) and Mlh1(+/+) mice indicate that the expression decreases and the inactivation of Dkk1 in particular is a prominent early marker for colon oncogenesis.	[Pussila, Marjaana; Sarantaus, Laura; Bebek, Denis Dermadi; Valo, Satu; Ollila, Saara; Nystrom, Minna] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Reyhani, Nima] Aalto Univ, Dept Informat & Comp Sci, Espoo, Finland; [Ollila, Saara] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Paivarinta, Essi; Mutanen, Marja] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Peltomaki, Paivi] Univ Helsinki, Dept Med Genet, Helsinki, Finland	University of Helsinki; Aalto University; University of Helsinki; University of Helsinki; University of Helsinki	Nystrom, M (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	minna.nystrom@helsinki.fi	Ollila, Saara/A-4336-2014	Ollila, Saara/0000-0002-8190-257X; Peltomaki, Paivi/0000-0001-8819-2980; Nystrom, Minna/0000-0003-0827-0243; Dermadi Bebek, Denis/0000-0001-6268-4178; Pussila, Marjaana/0000-0002-5494-0685; Paivarinta, Essi/0000-0002-0242-9682	European Research Council [2008-AdG-232635]; Sigrid Juselius Foundation; Finnish Cancer Organizations; Academy of Finland; Biocentrum Helsinki	European Research Council(European Research Council (ERC)European Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organizations; Academy of Finland(Academy of Finland); Biocentrum Helsinki	This work was financially supported by the grants from European Research Council (2008-AdG-232635), The Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation), Finnish Cancer Organizations (http://www.cancer.fi/en/), The Academy of Finland (http://www.aka.fi/eng), and Biocentrum Helsinki (http://www.helsinki.fi/biocentrum/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Aguilera O, 2007, CARCINOGENESIS, V28, P1877, DOI 10.1093/carcin/bgm094; Ahuja N, 1998, CANCER RES, V58, P5489; Ahuja N, 2000, HISTOL HISTOPATHOL, V15, P835, DOI 10.14670/HH-15.835; Akilesh S, 2003, GENOME RES, V13, P1719, DOI 10.1101/gr.533003; Arasaradnam RP, 2008, EPIGENETICS-US, V3, P193, DOI 10.4161/epi.3.4.6508; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Bingham S, 2004, NAT REV CANCER, V4, P206, DOI 10.1038/nrc1298; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Burgess AW, 2011, EXP CELL RES, V317, P2748, DOI 10.1016/j.yexcr.2011.08.010; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Edelmann W, 1999, CANCER RES, V59, P1301; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Erdelyi I, 2009, J NUTR, V139, P2072, DOI 10.3945/jn.108.104125; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hitchler MJ, 2009, FREE RADICAL BIO MED, V47, P115, DOI 10.1016/j.freeradbiomed.2009.04.010; Issa JPJ, 2001, CANCER RES, V61, P3573; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jacinto FV, 2007, CANCER RES, V67, P11481, DOI 10.1158/0008-5472.CAN-07-2687; Janssens S, 2010, INT J DEV BIOL, V54, P1435, DOI 10.1387/ijdb.092985sj; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kawakami K, 2006, BRIT J CANCER, V94, P593, DOI 10.1038/sj.bjc.6602940; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; Maehata T, 2008, WORLD J GASTROENTERO, V14, P2702, DOI 10.3748/wjg.14.2702; Newmark HL, 2009, CARCINOGENESIS, V30, P88, DOI 10.1093/carcin/bgn229; Newmark HL, 2001, CARCINOGENESIS, V22, P1871, DOI 10.1093/carcin/22.11.1871; Oyama T, 2008, CARCINOGENESIS, V29, P666, DOI 10.1093/carcin/bgn001; Pendas-Franco N, 2008, ANTICANCER RES, V28, P2613; Rawson JB, 2012, NUTR CANCER, V64, P919, DOI 10.1080/01635581.2012.711418; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Schneider MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014325; Shiraishi M, 2002, ONCOGENE, V21, P3659, DOI 10.1038/sj.onc.1205453; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Tammariello AE, 2010, J NUTR BIOCHEM, V21, P77, DOI 10.1016/j.jnutbio.2009.09.014; Taniguchi K, 2006, ONCOLOGY-BASEL, V71, P124, DOI 10.1159/000100522; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verma M, 2012, ANTIOXID REDOX SIGN, V17, P355, DOI 10.1089/ars.2011.4388; Worthley DL, 2010, ONCOGENE, V29, P1653, DOI 10.1038/onc.2009.449; Yang K, 2005, J NUTR, V135, P2710, DOI 10.1093/jn/135.11.2710; Yang K, 2008, CANCER RES, V68, P7803, DOI 10.1158/0008-5472.CAN-08-1209	49	6	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76865	10.1371/journal.pone.0076865	http://dx.doi.org/10.1371/journal.pone.0076865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24204690	Green Published, Green Submitted, gold			2022-12-27	WOS:000325552200080
J	Luo, R; Li, XP; Wang, YQ; Li, YQ; Deng, Y; Wan, YQ; Jiang, ZG; Hua, W; Wu, XS				Luo, Rong; Li, Xiaoping; Wang, Yuequn; Li, Yongqing; Deng, Yun; Wan, Yongqi; Jiang, Zhigang; Hua, Wei; Wu, Xiushan			The Influence of Angiotensin Converting Enzyme and Angiotensinogen Gene Polymorphisms on Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; BINDING-PROTEIN-C; DILATED CARDIOMYOPATHY; ALDOSTERONE SYSTEM; JAPANESE PATIENTS; ESSENTIAL-HYPERTENSION; MACULAR DEGENERATION; I/D POLYMORPHISM; INDIAN PATIENTS; HEART-FAILURE	Some studies have reported that angiotensin converting enzyme (ACE) and angiotensinogen (AGT) genes have been associated with hypertrophic cardiomyopathy (HCM). However, there have been inconsonant results among different studies. To clarify the influence of ACE and AGT on HCM, a systemic review and meta-analysis of case-control studies were performed. The following databases were searched to indentify related studies: PubMed database, the Embase database, the Cochrane Central Register of Controlled Trials database, China National Knowledge Information database, and Chinese Scientific and Technological Journal database. Search terms included "hypertrophic cardiomyopathy", "angiotensin converting enzyme" (ACE) or "ACE" and "polymorphism or mutation". For the association of AGT M235T polymorphism and HCM, "angiotensin converting enzyme" or "ACE" was replaced with "angiotensinogen". A total of seventeen studies were included in our review. For the association of ACE I/D polymorphism and HCM, eleven literatures were included in the meta-analysis on association of penetrance and genotype. Similarly, six case-control studies were included in the meta-analysis for AGT M235T. For ACE I/D polymorphism, the comparison of DI/II genotype vs DD genotype was performed in the present meta-analysis. The OR was 0.73 (95% CI: 0.527, 0.998, P = 0.049, power = 94%, alpha = 0.05) after the study which deviated from Hardy-Weinberg Equilibrium was excluded, indicating that the ACE I/D gene polymorphism might be associated with HCM. The AGT M235T polymorphism did not significantly affect the risk of HCM. In addition, ACE I/D gene polymorphism did not significantly influence the interventricular septal thickness in HCM patients. In conclusion, the ACE I/D polymorphism might be associated with the risk of HCM.	[Luo, Rong; Wang, Yuequn; Li, Yongqing; Deng, Yun; Wan, Yongqi; Jiang, Zhigang; Wu, Xiushan] Hunan Normal Univ, Coll Life Sci, Ctr Heart Dev, Key Lab MOE Dev Biol & Prot Chem, Changsha, Hunan, Peoples R China; [Luo, Rong] Guangxi Med Univ, Med Sci Res Ctr, Nanning, Guangxi, Peoples R China; [Li, Xiaoping; Hua, Wei] Chinese Acad Med Sci, Peking Union Med Coll, Cardiac Arrhythmia Ctr, Cardiovasc Inst, Beijing 100730, Peoples R China; [Li, Xiaoping; Hua, Wei] Chinese Acad Med Sci, Peking Union Med Coll, Fuwai Hosp, Beijing 100730, Peoples R China	Hunan Normal University; Guangxi Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Wu, XS (corresponding author), Hunan Normal Univ, Coll Life Sci, Ctr Heart Dev, Key Lab MOE Dev Biol & Prot Chem, Changsha, Hunan, Peoples R China.	xiushanwu@yahoo.com			National Natural Science Foundation of China [81000104, 81160141, 30930054, 31171402, 81170088, 31071999, 30970425, 31272396, 81270291]; Natural Science Foundation of Guangxi Zhuang Autonomous Region in China [2012GXNSFBA053116]; Postdoctoral Science Foundation of China [2013M542120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi Zhuang Autonomous Region in China; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	The project was supported by the National Natural Science Foundation of China (no. 81000104, 81160141, 30930054, 31171402, 81170088, 31071999, 30970425, 31272396, 81270291), the Natural Science Foundation of Guangxi Zhuang Autonomous Region in China (no. 2012GXNSFBA053116) and the Postdoctoral Science Foundation of China (no. 2013M542120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleumink GS, 2004, GENET MED, V6, P465, DOI 10.1097/01.GIM.0000144061.70494.95; Brito D, 2010, EUROPEAN J HEART FAI, V12, pS250; Buck PC, 2009, BRAZ J MED BIOL RES, V42, P717, DOI 10.1590/S0100-879X2009005000001; Cai Si-yu, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P280; Coto E, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-64; DAHLOF B, 1992, AM J HYPERTENS, V5, P95, DOI 10.1093/ajh/5.2.95; DANSER AHJ, 1995, CIRCULATION, V92, P1387, DOI 10.1161/01.CIR.92.6.1387; Doolan G, 2004, INT J CARDIOL, V96, P157, DOI 10.1016/j.ijcard.2004.05.003; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; GRIENDLING KK, 1993, CIRCULATION, V87, P1816, DOI 10.1161/01.CIR.87.6.1816; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ho CY, 2006, CIRCULATION, V113, pE858, DOI 10.1161/CIRCULATIONAHA.105.591982; Ishanov A, 1997, AM HEART J, V133, P184, DOI 10.1016/S0002-8703(97)70207-2; Jeunemaitre X, 1997, AM J HUM GENET, V60, P1448, DOI 10.1086/515452; Kawaguchi Hideaki, 2003, Exp Clin Cardiol, V8, P155; Kaya CT, 2010, J RENIN-ANGIO-ALDO S, V11, P192, DOI 10.1177/1470320310368190; Keren A, 2008, NAT CLIN PRACT CARD, V5, P158, DOI 10.1038/ncpcardio1110; Kolder IC, EUR J HUM GENET, V20, P1071; LECHIN M, 1995, CIRCULATION, V92, P1808, DOI 10.1161/01.CIR.92.7.1808; Lopez-Haldon J, 1999, MED CLIN-BARCELONA, V113, P161; Luo R, 2013, DNA CELL BIOL, V32, P130, DOI 10.1089/dna.2012.1911; Malik FS, 1997, AM HEART J, V134, P514, DOI 10.1016/S0002-8703(97)70089-9; MARIAN AJ, 1993, LANCET, V342, P1085, DOI 10.1016/0140-6736(93)92064-Z; Marian AJ, 2000, LANCET, V355, P58, DOI 10.1016/S0140-6736(99)06187-5; MARIAN AJ, 1995, CIRCULATION, V92, P1336, DOI 10.1161/01.CIR.92.5.1336; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Moiseev VS, 1997, TERAPEVT ARKH, V69, P18; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Ogimoto A, 2002, J HUM GENET, V47, P184, DOI 10.1007/s100380200021; Ommen SR, 2004, CURR PROB CARDIOLOGY, V29, P239, DOI 10.1016/j.cpcardiol.2004.01.001; Orenes-Pinero E, 2011, J RENIN-ANGIO-ALDO S, V12, P521, DOI 10.1177/1470320311405247; Ortlepp JR, 2002, HEART, V87, P270, DOI 10.1136/heart.87.3.270; Osterop APRM, 1998, HYPERTENSION, V32, P825, DOI 10.1161/01.HYP.32.5.825; Perkins MJ, 2005, EUR HEART J, V26, P2457, DOI 10.1093/eurheartj/ehi438; Petitti DB, 1994, METAANALYSIS DECISIO, P90; Pfeufer A, 1996, AM J CARDIOL, V78, P362, DOI 10.1016/S0002-9149(96)00296-2; Rai TS, 2008, MOL CELL BIOCHEM, V311, P67, DOI 10.1007/s11010-007-9695-z; Rao PPKM, 2011, J RENIN-ANGIO-ALDO S, V12, P238, DOI 10.1177/1470320310387955; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Schut AFC, 2004, EUR HEART J, V25, P2143, DOI 10.1016/j.ehj.2004.08.026; Sethi AA, 2003, ARTERIOSCL THROM VAS, V23, P1269, DOI 10.1161/01.ATV.0000079007.40884.5C; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Tesson F, 1997, J MOL CELL CARDIOL, V29, P831, DOI 10.1006/jmcc.1996.0332; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thakkinstian A, 2012, AM J EPIDEMIOL, V176, P361, DOI 10.1093/aje/kws031; Thakkinstian A, 2011, AM J EPIDEMIOL, V173, P1365, DOI 10.1093/aje/kwr025; TIMMERMANS PBMWM, 1995, J HUM HYPERTENS, V9, pS3; Wang JG, 2000, EUR J PHARMACOL, V410, P289, DOI 10.1016/S0014-2999(00)00822-0; Xue H, 2010, CHINESE MED J-PEKING, V123, P188, DOI 10.3760/cma.j.issn.0366-6999.2010.02.012; Yamada Y, 1997, AM J HYPERTENS, V10, P921, DOI 10.1016/S0895-7061(97)00112-X; YONEYA K, 1995, AM HEART J, V130, P1089, DOI 10.1016/0002-8703(95)90213-9	52	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77030	10.1371/journal.pone.0077030	http://dx.doi.org/10.1371/journal.pone.0077030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204726	gold, Green Published			2022-12-27	WOS:000326155400024
J	Xiao, J; Gao, GJ; Li, YM; Zhang, W; Tian, YF; Huang, YX; Su, WJ; Han, N; Yang, D; Zhao, HX				Xiao, Jiang; Gao, Guiju; Li, Yanmei; Zhang, Wen; Tian, Yunfei; Huang, Yinxiu; Su, Wenjing; Han, Ning; Yang, Di; Zhao, Hongxin			Spectrums of Opportunistic Infections and Malignancies in HIV-Infected Patients in Tertiary Care Hospital, China	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; AIDS; INDIA; PNEUMONIA; DIAGNOSIS; PROGRAM; TRENDS	Background: HIV-related opportunistic infections (OIs) and malignancies continued to cause morbidity and mortality in Chinese HIV-infected individuals. The objective for this study is to elucidate the prevalence and spectrums of OIs and malignancies in HIV-infected patients in the Beijing Ditan Hospital. Methods: The evaluation of the prevalence and spectrums of OIs and malignancies was conducted by using the clinical data of 834 HIV-infected patients admitted in the Beijing Ditan hospital from January 1, 2009, to November 30, 2012. Results: The prevalence and spectrums of OIs and malignancies varied contingent on geographic region, transmission routes, and CD4 levels. We found that tuberculosis was most common OI and prevalence was 32.5%, followed by candidiasis(29.3%), Pneumocystis pneumonia(PCP)(22.4%), cytomegalovirus(CMV) infection(21.7%), other fungal infections(16.2%), mycobacterium avium complex(MAC)(11.3%), cryptococcosis(8.0%), progressive multifocal leukoencephalopathy(PML)(4.4%), Cerebral Toxoplasmosis(3.5%) and Penicillium marneffei infection(1.4%); while Lymphoma(2.9%), Kaposi's sarcoma(0.8%) and cervix carcinoma(0.3%) were emerged as common AIDS-defining malignancies. Pulmonary OI infections were the most prevalent morbidity and mortality in patients in the AIDS stage including pulmonary tuberculosis (26.6%) and PCP (22.4%). CMV infection(21.7%) was most common viral infection; Fungal OIs were one of most prevalent morbidity in patients in the AIDS stage, including oral candidiasis (29.3%), other fungal infection (16.2%), Cryptococcosis (8.0%) and Penicillium marneffei infection (1.4%). We found the low prevalence of AIDS-defining illnesses in central neural system in this study, including progressive multifocal leukoencephalopathy (4.4%), cerebral toxoplasmosis (3.5%), tuberculosis meningitis (3.2%), cryptococcal meningitis (2.4%) and CMV encephalitis (1.1%). In-hospital mortality rate was 4.3 per 100 person-years due to severe OIs, malignancies, and medical cost constraints. Conclusions: The prevalence and spectrums of OIs, malignancies and co-infections were discussed in this study. It would help increase the awareness for physicians to make a diagnosis and empirical treatment sooner and plan good management strategies, especially in resource limited regions.	[Xiao, Jiang; Gao, Guiju; Li, Yanmei; Zhang, Wen; Tian, Yunfei; Huang, Yinxiu; Su, Wenjing; Han, Ning; Yang, Di; Zhao, Hongxin] Capital Med Univ, Ditan Hosp, Ctr Infect Dis, Beijing, Peoples R China	Capital Medical University	Zhao, HX (corresponding author), Capital Med Univ, Ditan Hosp, Ctr Infect Dis, Beijing, Peoples R China.	13911022130@163.com			Twelve-fifth Key Project The Study of Construction of Representative areas for Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis in Chaoyang District, Beijing [2012ZX10004-904]; Beijing Natural Science Fund [7112065]	Twelve-fifth Key Project The Study of Construction of Representative areas for Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis in Chaoyang District, Beijing; Beijing Natural Science Fund(Beijing Natural Science Foundation)	Support for this work was provided by: (1) The Twelve-fifth Key Project The Study of Construction of Representative areas for Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis in Chaoyang District, Beijing (2012ZX10004-904); (2) Beijing Natural Science Fund The evaluation of association between polymorphism of leptin or adiponectin and NAFLD complicated with AIDS(7112065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AG, 2012, J ACQ IMMUN DEF SYND; Armstrong AW, 2013, EPIDEMIOL INFECT, V141, P200, DOI 10.1017/S0950268812000325; Chaiwarith R, 2011, CURR HIV RES, V9, P334, DOI 10.2174/157016211797635991; Chaiwun B, 2011, INT J INFECT DIS, V15, pE236, DOI 10.1016/j.ijid.2010.12.001; Chakraborty N, 2008, JPN J INFECT DIS, V61, P49; Chou IH, 2004, NAT MED, V10, P4, DOI 10.1038/nm0104-4a; Dou ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013737; Jabs DA, 2002, AM J OPHTHALMOL, V133, P48, DOI 10.1016/S0002-9394(01)01322-8; Jones JL, 1998, J INFECT DIS, V178, P114, DOI 10.1086/515593; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Mocroft A, 2000, LANCET, V356, P291, DOI 10.1016/S0140-6736(00)02504-6; Naba Mazen R, 2010, J Infect Public Health, V3, P130, DOI 10.1016/j.jiph.2010.07.005; Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents, 2013, UID PREV TREATM OPP; Pisculli ML, 2008, CLIN INFECT DIS, V46, P1928, DOI 10.1086/588564; Saha K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-116; Sax PE, 2011, CLIN INFECT DIS, V53, P197, DOI 10.1093/cid/cir335; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Sharma SK, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-52; Srirangaraj S, 2011, INDIAN J MED MICROBI, V29, P395, DOI 10.4103/0255-0857.90175; UNAIDS/WHO Working Group on HIV Global/AIDS and STI Surveillance, 2012, CHIN EP RESP 2012 UP; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b	22	55	69	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e75915	10.1371/journal.pone.0075915	http://dx.doi.org/10.1371/journal.pone.0075915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204583	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400009
J	Field, KJ; George, R; Fearn, B; Quick, WP; Davey, MP				Field, Katie J.; George, Rachel; Fearn, Brian; Quick, W. Paul; Davey, Matthew P.			Best of Both Worlds: Simultaneous High-Light and Shade-Tolerance Adaptations within Individual Leaves of the Living Stone Lithops aucampiae	PLOS ONE			English	Article							CALCIUM-OXALATE CRYSTALS; LEAF WINDOWS; PHOTOPROTECTION; DIFFERENTIATION; ANTHOCYANINS; IDIOBLASTS; AIZOACEAE; RESPONSES; TISSUES; STRESS	"Living stones" (Lithops spp.) display some of the most extreme morphological and physiological adaptations in the plant kingdom to tolerate the xeric environments in which they grow. The physiological mechanisms that optimise the photosynthetic processes of Lithops spp. while minimising transpirational water loss in both above- and below-ground tissues remain unclear. Our experiments have shown unique simultaneous high-light and shade-tolerant adaptations within individual leaves of Lithops aucampiae. Leaf windows on the upper surfaces of the plant allow sunlight to penetrate to photosynthetic tissues within while sunlight-blocking flavonoid accumulation limits incoming solar radiation and aids screening of harmful UV radiation. Increased concentration of chlorophyll a and greater chlorophyll a:b in above- ground regions of leaves enable maximum photosynthetic use of incoming light, while inverted conical epidermal cells, increased chlorophyll b, and reduced chlorophyll a:b ensure maximum absorption and use of low light levels within the below-ground region of the leaf. High NPQ capacity affords physiological flexibility under variable natural light conditions. Our findings demonstrate unprecedented physiological flexibility in a xerophyte and further our understanding of plant responses and adaptations to extreme environments.	[Field, Katie J.; George, Rachel; Quick, W. Paul] Univ Sheffield, Western Bank, Sheffield, S Yorkshire, England; [Fearn, Brian] Abbey Brook Cactus Nursery, Matlock, Derbyshire, England; [Davey, Matthew P.] Univ Cambridge, Dept Plant Sci, Cambridge, England	University of Sheffield; University of Cambridge	Davey, MP (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge, England.	mpd39@cam.ac.uk		Davey, Matthew/0000-0002-5220-4174; Field, Katie/0000-0002-5196-2360	Natural Environment Research Council [NE/C507837/1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by the Natural Environment Research Council - Post-Genomics and Proteomics programme (NE/C507837/1) who financed MPD and the chlorophyll fluorescence imager equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Cote GG, 2009, AM J BOT, V96, P1245, DOI 10.3732/ajb.0800276; Davey MP, 2008, NEW PHYTOL, V177, P380, DOI 10.1111/j.1469-8137.2007.02282.x; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Egbert KJ, 2002, PHOTOSYNTHETICA, V40, P35, DOI 10.1023/A:1020129820295; Ellis AG, 2006, J ECOL, V94, P322, DOI 10.1111/j.1365-2745.2005.01074.x; Fearn B., 1977, Cactus and Succulent Journal of Great Britain, V39, P68; FOSTER AS, 1956, PROTOPLASMA, V46, P184, DOI 10.1007/BF01248877; Gal A, 2012, ADV MATER, V24, pOP77, DOI 10.1002/adma.201104548; Gibson AC, 1998, BIOSCIENCE, V48, P911, DOI 10.2307/1313295; IHLENFELDT H-D, 1982, Mitteilungen aus dem Institut fuer Allgemeine Botanik Hamburg, V18, P103; Kellner A, 2011, PLANT BIOLOGY, V13, P368, DOI 10.1111/j.1438-8677.2010.00354.x; Kuo-Huang LL, 2007, BOT STUD, V48, P155; Martin CE, 2013, PLANT BIOLOGY, V15, P243, DOI 10.1111/j.1438-8677.2012.00672.x; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Nesse W.D., 2000, INTRO MINERALOGY; Opel MR, 2005, HASELTONIA, P27; Raven P. H., 1999, BIOL PLANTS, V6th; Steyn WJ, 2002, NEW PHYTOL, V155, P349, DOI 10.1046/j.1469-8137.2002.00482.x; TANNER V, 1986, J PLANT PHYSIOL, V125, P285, DOI 10.1016/S0176-1617(86)80151-1; Vogt T, 1999, PHYTOCHEMISTRY, V52, P583, DOI 10.1016/S0031-9422(99)00151-X; von Willert D.J., 1992, LIFE STRATEGIES SUCC; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Weryszko-Chmielewska Elzbieta, 2011, Acta Agrobotanica, V64, P11; Whitney HM, ANN BOT	25	9	9	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e75671	10.1371/journal.pone.0075671	http://dx.doi.org/10.1371/journal.pone.0075671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194825	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000004
J	Valletti, A; Gigante, M; Palumbo, O; Carella, M; Divella, C; Sbisa, E; Tullo, A; Picardi, E; D'Erchia, AM; Battaglia, M; Gesualdo, L; Pesole, G; Ranieri, E				Valletti, Alessio; Gigante, Margherita; Palumbo, Orazio; Carella, Massimo; Divella, Chiara; Sbisa, Elisabetta; Tullo, Apollonia; Picardi, Ernesto; D'Erchia, Anna Maria; Battaglia, Michele; Gesualdo, Loreto; Pesole, Graziano; Ranieri, Elena			Genome-Wide Analysis of Differentially Expressed Genes and Splicing Isoforms in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; CANCER; HYPERMETHYLATION; TRANSCRIPT; BIOMARKERS; DATABASE; ASPICDB; TCF21; DAB2; EXON	Clear cell renal cell carcinoma (ccRCC) is the most common malignant renal epithelial tumor and also the most deadly. To identify molecular changes occurring in ccRCC, in the present study we performed a genome wide analysis of its entire complement of mRNAs. Gene and exon-level analyses were carried out by means of the Affymetrix Exon Array platform. To achieve a reliable detection of differentially expressed cassette exons we implemented a novel methodology that considered contiguous combinations of exon triplets and candidate differentially expressed cassette exons were identified when the expression level was significantly different only in the central exon of the triplet. More detailed analyses were performed for selected genes using quantitative RT-PCR and confocal laser scanning microscopy. Our analysis detected over 2,000 differentially expressed genes, and about 250 genes alternatively spliced and showed differential inclusion of specific cassette exons comparing tumor and non-tumoral tissues. We demonstrated the presence in ccRCC of an altered expression of the PTP4A3, LAMA4, KCNJ1 and TCF21 genes (at both transcript and protein level). Furthermore, we confirmed, at the mRNA level, the involvement of CAV2 and SFRP genes that have previously been identified. At exon level, among potential candidates we validated a differentially included cassette exon in DAB2 gene with a significant increase of DAB2 p96 splice variant as compared to the p67 isoform. Based on the results obtained, and their robustness according to both statistical analysis and literature surveys, we believe that a combination of gene/isoform expression signature may remarkably contribute, after suitable validation, to a more effective and reliable definition of molecular biomarkers for ccRCC early diagnosis, prognosis and prediction of therapeutic response.	[Valletti, Alessio; Picardi, Ernesto; D'Erchia, Anna Maria; Pesole, Graziano] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy; [Gigante, Margherita; Ranieri, Elena] Univ Foggia, Dept Surg & Med Sci, Foggia, Italy; [Palumbo, Orazio; Carella, Massimo] IRCCS Casa Sollievo Sofferenza, Med Genet Unit, San Giovanni Rotondo, Italy; [Divella, Chiara; Battaglia, Michele; Gesualdo, Loreto] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Bari, Italy; [Sbisa, Elisabetta; Tullo, Apollonia] CNR, Inst Biomed Technol UOS Bari, I-70126 Bari, Italy; [Picardi, Ernesto; D'Erchia, Anna Maria] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Foggia; IRCCS Casa Sollievo Della Sofferenza; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Universita degli Studi di Bari Aldo Moro	Pesole, G (corresponding author), CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy.	g.pesole@ibbe.cnr.it	Pesole, Graziano/K-5283-2019; Sbisa', Elisabetta/AAW-9727-2020; Pesole, Graziano/E-9051-2014; Gesualdo, Loreto/K-7751-2016; Valletti, Alessio/P-1842-2018; Carella, Massimo/A-2804-2014; Tullo, Apollonia/AAX-1079-2020; Ranieri, Elena/AAD-8449-2019; PALUMBO, ORAZIO/C-1133-2014; Picardi, Ernesto/A-5863-2015; D'Erchia, Anna maria/K-9001-2016; Divella, Chiara/K-2783-2016	Pesole, Graziano/0000-0003-3663-0859; Gesualdo, Loreto/0000-0002-4861-0911; Valletti, Alessio/0000-0002-6772-1211; Carella, Massimo/0000-0002-6830-6829; Tullo, Apollonia/0000-0002-5081-4745; PALUMBO, ORAZIO/0000-0001-6583-3482; Picardi, Ernesto/0000-0002-6549-0114; Divella, Chiara/0000-0003-2717-3158; BATTAGLIA, Michele/0000-0002-2453-2349; D'ERCHIA, Anna Maria/0000-0002-4627-0626	MIUR [PON01_01297 - VIRTUALAB - RC]; Ministero dell'Istruzione, Universita e Ricerca, Italy; Consiglio Nazionale delle Ricerche, Italy; Apulia Region, Italy [PS_012]	MIUR(Ministry of Education, Universities and Research (MIUR)); Ministero dell'Istruzione, Universita e Ricerca, Italy(Ministry of Education, Universities and Research (MIUR)); Consiglio Nazionale delle Ricerche, Italy(Consiglio Nazionale delle Ricerche (CNR)); Apulia Region, Italy(Regione Puglia)	This work was supported by MIUR (PON01_01297 - VIRTUALAB - R&C 2007-2013); PRIN projects 2009 and 2010 by Ministero dell'Istruzione, Universita e Ricerca, Italy; Progetto "Medicina Personalizzata" by Consiglio Nazionale delle Ricerche, Italy; Progetto Strategico PS_012 by Apulia Region, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdueva D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000913; Allory Y, 2011, PATHOBIOLOGY, V78, P90, DOI 10.1159/000315543; Ares GR, 2011, AM J PHYSIOL-RENAL, V301, pF1143, DOI 10.1152/ajprenal.00396.2011; Arsanious A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-20; Bonizzoni P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-244; Brannon AR, 2012, EUR UROL, V61, P258, DOI 10.1016/j.eururo.2011.10.007; Bratslavsky G, 2011, J CANCER, V2, P271, DOI 10.7150/jca.2.271; Castrignano T, 2008, BIOINFORMATICS, V24, P1300, DOI 10.1093/bioinformatics/btn113; Cattaneo E, 2011, EMBO MOL MED, V3, P334, DOI 10.1002/emmm.201100141; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Costa VL, 2011, EPIGENETICS-US, V6, P1120, DOI 10.4161/epi.6.9.16376; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dubosq F, 2011, UROL ONCOL, V30, P833; Elsheikh SE, 2008, BRIT J CANCER, V99, P327, DOI 10.1038/sj.bjc.6604463; Epstein, 2004, PATHOLOGY GENETICS T, V7; Fisher R, 2013, SEMIN CANCER BIOL, V23, P38, DOI 10.1016/j.semcancer.2012.06.004; Gaidatzis D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp508; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Hong SK, 2011, BJU INT, V107, P409, DOI 10.1111/j.1464-410X.2010.09561.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang XH, 2008, J CANCER RES CLIN, V134, P705, DOI 10.1007/s00432-007-0342-6; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kenne E, 2010, J LEUKOCYTE BIOL, V88, P523, DOI 10.1189/jlb.0110043; Kinoshita T, 2011, HEPATO-GASTROENTEROL, V58, P1051; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lugassy C, 2009, J CUTAN PATHOL, V36, P1237, DOI 10.1111/j.1600-0560.2009.01273.x; Martelli PL, 2011, NUCLEIC ACIDS RES, V39, pD80, DOI 10.1093/nar/gkq1073; Maurer ME, 2005, J CELL SCI, V118, P5345, DOI 10.1242/jcs.02650; Osanto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038298; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Marin AP, 2012, UROL ONCOL-SEMIN ORI, V30, P356, DOI 10.1016/j.urolonc.2009.11.008; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanjmyatav J, 2011, J UROLOGY, V186, P289, DOI 10.1016/j.juro.2011.03.033; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; Sobin L, 2009, TNM CLASSIFICATION M; Tang XR, 2010, J INNATE IMMUN, V2, P43, DOI 10.1159/000235685; Tong JH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-253; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasudev NS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-112; Yu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042377; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013; Zhao Q, 2013, CLIN CANCER RES, V19, P2460, DOI 10.1158/1078-0432.CCR-12-3708; Zimmerman MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058300	45	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78452	10.1371/journal.pone.0078452	http://dx.doi.org/10.1371/journal.pone.0078452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194935	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000114
J	Woitek, R; Kasprian, G; Lindner, C; Stuhr, F; Weber, M; Schopf, V; Brugger, PC; Asenbaum, U; Furtner, J; Bettelheim, D; Seidl, R; Prayer, D				Woitek, Ramona; Kasprian, Gregor; Lindner, Christian; Stuhr, Fritz; Weber, Michael; Schoepf, Veronika; Brugger, Peter C.; Asenbaum, Ulrika; Furtner, Julia; Bettelheim, Dieter; Seidl, Rainer; Prayer, Daniela			Fetal Eye Movements on Magnetic Resonance Imaging	PLOS ONE			English	Article							BEHAVIORAL STATES; SMOOTH-PURSUIT; MRI; MATURATION; SACCADES; FETUSES; INFANTS; SLEEP; TIME	Objectives: Eye movements are the physical expression of upper fetal brainstem function. Our aim was to identify and differentiate specific types of fetal eye movement patterns using dynamic MRI sequences. Their occurrence as well as the presence of conjugated eyeball motion and consistently parallel eyeball position was systematically analyzed. Methods: Dynamic SSFP sequences were acquired in 72 singleton fetuses (17-40 GW, three age groups [17-23 GW, 24-32 GW, 33-40 GW]). Fetal eye movements were evaluated according to a modified classification originally published by Birnholz (1981): Type 0: no eye movements; Type I: single transient deviations; Type Ia: fast deviation, slower reposition; Type Ib: fast deviation, fast reposition; Type II: single prolonged eye movements; Type III: complex sequences; and Type IV: nystagmoid. Results: In 95.8% of fetuses, the evaluation of eye movements was possible using MRI, with a mean acquisition time of 70 seconds. Due to head motion, 4.2% of the fetuses and 20.1% of all dynamic SSFP sequences were excluded. Eye movements were observed in 45 fetuses (65.2%). Significant differences between the age groups were found for Type I (p = 0.03), Type Ia (p = 0.031), and Type IV eye movements (p = 0.033). Consistently parallel bulbs were found in 27.3-45%. Conclusions: In human fetuses, different eye movement patterns can be identified and described by MRI in utero. In addition to the originally classified eye movement patterns, a novel subtype has been observed, which apparently characterizes an important step in fetal brainstem development. We evaluated, for the first time, eyeball position in fetuses. Ultimately, the assessment of fetal eye movements by MRI yields the potential to identify early signs of brainstem dysfunction, as encountered in brain malformations such as Chiari II or molar tooth malformations.	[Woitek, Ramona; Kasprian, Gregor; Lindner, Christian; Stuhr, Fritz; Weber, Michael; Schoepf, Veronika; Asenbaum, Ulrika; Furtner, Julia; Prayer, Daniela] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Brugger, Peter C.] Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria; [Bettelheim, Dieter] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Seidl, Rainer] Med Univ Vienna, Dept Paediat & Adolescent Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Woitek, R (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	ramona.woitek@meduniwien.ac.at	Kasprian, Gregor/AAJ-5052-2020; Weber, Michael/L-9836-2016	Kasprian, Gregor/0000-0003-3858-3347; Weber, Michael/0000-0002-8507-2219; Woitek, Ramona/0000-0002-9146-9159; Schopf, Veronika/0000-0003-1937-4216; Furtner, Julia/0000-0001-8258-3681				BIRNHOLZ JC, 1981, SCIENCE, V213, P679, DOI 10.1126/science.7256272; BRIDGEMAN B, 1983, INVEST OPHTH VIS SCI, V24, P658; Brugger PC, 2006, EUR J RADIOL, V57, P172, DOI 10.1016/j.ejrad.2005.11.017; Brugger PC, 2012, EUR J RADIOL, V81, pE194, DOI 10.1016/j.ejrad.2011.01.115; Dan B, 2006, DEV MED CHILD NEUROL, V48, P773, DOI 10.1017/S0012162206001654; Garbutt S, 2006, DEV MED CHILD NEUROL, V48, P662, DOI 10.1017/S0012162206001393; HAINLINE L, 1984, VISION RES, V24, P1771, DOI 10.1016/0042-6989(84)90008-7; INOUE M, 1986, AM J OBSTET GYNECOL, V155, P170, DOI 10.1016/0002-9378(86)90105-5; Joseph R, 2000, DEV REV, V20, P81, DOI 10.1006/drev.1999.0486; KREMENITZER JP, 1979, CHILD DEV, V50, P442, DOI 10.1111/j.1467-8624.1979.tb04127.x; Li XB, 2010, PRENATAL DIAG, V30, P1064, DOI 10.1002/pd.2612; Mirmiran M, 2003, SLEEP MED REV, V7, P321, DOI 10.1053/smrv.2002.0243; Nijhuis JG, 1998, EARLY HUM DEV, V52, P125, DOI 10.1016/S0378-3782(98)00016-4; NIJHUIS JG, 1982, EARLY HUM DEV, V6, P177, DOI 10.1016/0378-3782(82)90106-2; Pieh C, 2012, BRIT J OPHTHALMOL, V96, P73, DOI 10.1136/bjo.2010.191726; PILLAI M, 1990, ARCH DIS CHILD-FETAL, V65, P39, DOI 10.1136/adc.65.1_Spec_No.39; Prayer D, 2004, PEDIATR RADIOL, V34, P685, DOI 10.1007/s00247-004-1246-0; Qu J, 2006, EXP EYE RES, V82, P300, DOI 10.1016/j.exer.2005.07.002; Romanini C, 1995, EARLY HUM DEV, V43, P117, DOI 10.1016/0378-3782(95)01667-8; Stark RI, 1998, SLEEP, V21, P167; Thomke F, 2008, AUGENBEWEGUNGSSTORUN	21	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77439	10.1371/journal.pone.0077439	http://dx.doi.org/10.1371/journal.pone.0077439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194885	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000064
J	Kumar, R; Ramaswamy, R; Mallick, BN				Kumar, Rupesh; Ramaswamy, Ram; Mallick, Birendra Nath			Local Properties of Vigilance States: EMD Analysis of EEG Signals during Sleep-Waking States of Freely Moving Rats	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; LOCUS-COERULEUS; ELECTROENCEPHALOGRAM; OSCILLATIONS; BEHAVIOR	Understanding the inherent dynamics of the EEG associated to sleep-waking can provide insights into its basic neural regulation. By characterizing the local properties of the EEG using power spectrum, empirical mode decomposition (EMD) and Hilbert-spectral analysis, we can examine the dynamics over a range of time-scales. We analyzed rat EEG during wake, NREMS and REMS using these methods. The average instantaneous phase, power spectral density (PSD) of intrinsic mode functions (IMFs) and the energy content in various frequency bands show characteristic changes in each of the vigilance states. The 2nd and 7th IMFs show changes in PSD for wake and REMS, suggesting that those modes may carry wake-and REMS-associated cognitive, conscious and behavior-specific information of an individual even though the EEG may appear similar. The energy content in theta(2) (6Hz-9Hz) band of the 1st IMF for REMS is larger than that of wake. The decrease in the phase function of IMFs from wake to REMS to NREMS indicates decrease of the mean frequency in these states, respectively. The rate of information processing in waking state is more in the time scale described by the first three IMFs than in REMS state. However, for IMF5-IMF7, the rate is more for REMS than that for wake. We obtained Hilbert-Huang spectral entropy, which is a suitable measure of information processing in each of these state-specific EEG. It is possible to evaluate the complex dynamics of the EEG in each of the vigilance states by applying measures based on EMD and Hilbert-transform. Our results suggest that the EMD based nonlinear measures of the EEG can provide useful estimates of the information possessed by various oscillations associated with the vigilance states. Further, the EMD-based spectral measures may have implications in understanding anatamo-physiological correlates of sleep-waking behavior and clinical diagnosis of sleep-pathology.	[Kumar, Rupesh; Ramaswamy, Ram] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Kumar, Rupesh; Mallick, Birendra Nath] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Ramaswamy, Ram] Univ Hyderabad, Hyderabad 500134, Andhra Pradesh, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; University of Hyderabad	Ramaswamy, R (corresponding author), Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India.	r.ramaswamy@gmail.com; remsbnm@yahoo.com	Chillale, Rupesh/GYU-9179-2022; Nath, Mallick Birendra/AAF-1781-2020; Ramaswamy, Ramakrishna/L-5306-2019	Ramaswamy, Ramakrishna/0000-0002-9085-8224; Kumar, Rupesh/0000-0002-0858-9660	Department of Biotechnology, India; J. C. Bose Fellowship	Department of Biotechnology, India(Department of Biotechnology (DBT) India); J. C. Bose Fellowship(Department of Science & Technology (India))	Department of Biotechnology, India; J. C. Bose Fellowship to BNM and RR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya R, 2005, COMPUT METH PROG BIO, V80, P37, DOI 10.1016/j.cmpb.2005.06.011; Beersma D G, 1998, Sleep Med Rev, V2, P31, DOI 10.1016/S1087-0792(98)90052-1; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Bjorvatn B, 1998, PHYSIOL BEHAV, V63, P413, DOI 10.1016/S0031-9384(97)00460-5; Borbely A A, 1982, Hum Neurobiol, V1, P195; BORBELY AA, 1984, BEHAV BRAIN RES, V14, P171, DOI 10.1016/0166-4328(84)90186-4; Borbely AA, 2001, ARCH ITAL BIOL, V139, P53; COLLERTON D, 1986, NEUROSCIENCE, V19, P1, DOI 10.1016/0306-4522(86)90002-3; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; DIJK DJ, 1990, SLEEP, V13, P430, DOI 10.1093/sleep/13.5.430; Dringenberg HC, 2000, BEHAV BRAIN RES, V115, P235, DOI 10.1016/S0166-4328(00)00261-8; Dringenberg HC, 2000, NEUROBIOL AGING, V21, P135, DOI 10.1016/S0197-4580(00)00108-1; Fang GZ, 2010, PHYSIOL MEAS, V31, P795, DOI 10.1088/0967-3334/31/6/005; Fell J, 1996, ELECTROEN CLIN NEURO, V98, P401, DOI 10.1016/0013-4694(96)95636-9; Ferri R, 1996, ELECTROEN CLIN NEURO, V99, P539; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Gottesmann C, 1976, Rev Electroencephalogr Neurophysiol Clin, V6, P37, DOI 10.1016/S0370-4475(76)80058-5; Gupta K, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046220; Hsu D, 2010, J NEUROSCI METH, V194, P179, DOI 10.1016/j.jneumeth.2010.09.019; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; INOUYE T, 1991, ELECTROEN CLIN NEURO, V79, P204, DOI 10.1016/0013-4694(91)90138-T; Kobayashi T, 1999, PSYCHIAT CLIN NEUROS, V53, P159, DOI 10.1046/j.1440-1819.1999.00540.x; Kolmogorov A. N., 1968, International Journal of Computer Mathematics, V2, P157, DOI 10.1080/00207166808803030; Lee CK, 2010, HEALTHC INFORM RES, V16, P46, DOI 10.4258/hir.2010.16.1.46; Li XL, 2006, PHYS LETT A, V356, P237, DOI 10.1016/j.physleta.2006.03.045; Li XL, 2008, CLIN NEUROPHYSIOL, V119, P2465, DOI 10.1016/j.clinph.2008.08.006; Louis RP, 2004, J NEUROSCI METH, V133, P71, DOI 10.1016/j.jneumeth.2003.09.025; Mallick B. N., 2011, RAPID EYE MOVEMENT S, P21; Mallick BN, 2005, BEHAV BRAIN RES, V158, P9, DOI 10.1016/j.bbr.2004.08.004; Mallick BN, 2001, NEUROSCIENCE, V104, P467, DOI 10.1016/S0306-4522(01)00062-8; MARKS GA, 1993, BRAIN RES, V623, P241, DOI 10.1016/0006-8993(93)91434-T; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; Ning TK, 2009, IEEE ENG MED BIO, P3437, DOI 10.1109/IEMBS.2009.5334635; NING TK, 1990, IEEE ENG MED BIOL, V9, P47, DOI 10.1109/51.62905; PENTTILA M, 1985, ELECTROEN CLIN NEURO, V60, P1, DOI 10.1016/0013-4694(85)90942-3; Pereda E, 1998, NEUROSCI LETT, V250, P91, DOI 10.1016/S0304-3940(98)00435-2; RIEKKINEN P, 1990, NEUROSCI RES, V8, P12, DOI 10.1016/0168-0102(90)90052-G; RIEKKINEN P, 1990, PHARMACOL BIOCHEM BE, V37, P405, DOI 10.1016/0091-3057(90)90004-2; Rilling G., 2003, IEEE EURASIP WORKSH, V3, P8; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sitnikova E, 2009, J NEUROSCI METH, V180, P304, DOI 10.1016/j.jneumeth.2009.04.006; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Suleyman Baykut PG, 2009, P INT C BIOINSP SYST, P14; Sweeney-Reed CM, 2007, J COMPUT NEUROSCI, V23, P79, DOI 10.1007/s10827-007-0020-3; VANDERWOLF CH, 1988, INT REV NEUROBIOL, V30, P225; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008	48	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78174	10.1371/journal.pone.0078174	http://dx.doi.org/10.1371/journal.pone.0078174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167606	Green Submitted, Green Published, gold			2022-12-27	WOS:000326034500066
J	Han, LZ; Liu, YZ; Zhang, DD; Jin, Y; Luo, YJ				Han, Longzhu; Liu, Yunzhe; Zhang, Dandan; Jin, Yi; Luo, Yuejia			Low-Arousal Speech Noise Improves Performance in N-Back Task: An ERP Study	PLOS ONE			English	Article							WORKING-MEMORY; BACKGROUND-NOISE; ELECTROPHYSIOLOGICAL EVIDENCE; STIMULI; ATTENTION; P300; TIME; PARADIGM; CAPACITY; ADULTS	The relationship between noise and human performance is a crucial topic in ergonomic research. However, the brain dynamics of the emotional arousal effects of background noises are still unclear. The current study employed meaningless speech noises in the n-back working memory task to explore the changes of event-related potentials (ERPs) elicited by the noises with low arousal level vs. high arousal level. We found that the memory performance in low arousal condition were improved compared with the silent and the high arousal conditions; participants responded more quickly and had larger P2 and P3 amplitudes in low arousal condition while the performance and ERP components showed no significant difference between high arousal and silent conditions. These findings suggested that the emotional arousal dimension of background noises had a significant influence on human working memory performance, and that this effect was independent of the acoustic characteristics of noises (e. g., intensity) and the meaning of speech materials. The current findings improve our understanding of background noise effects on human performance and lay the ground for the investigation of patients with attention deficits.	[Han, Longzhu] Beihang Univ, Sch Biol Sci & Med Engn, Beijing, Peoples R China; [Liu, Yunzhe; Jin, Yi] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Dandan; Luo, Yuejia] Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China	Beihang University; Beijing Normal University; Shenzhen University	Zhang, DD (corresponding author), Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China.	zhangdd05@gmail.com			National Natural Science Foundation of China [31300867]; National Key Basic Research Program of China (973 Program) [2014CB744602]; Open project of Key Laboratory of Cryogenics, TIPC, Chinese Academy of Sciences [CYRO201224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Open project of Key Laboratory of Cryogenics, TIPC, Chinese Academy of Sciences	This study was funded by the National Natural Science Foundation of China (31300867), National Key Basic Research Program of China (973 Program, 2014CB744602), and the Open project of Key Laboratory of Cryogenics, TIPC, Chinese Academy of Sciences (CYRO201224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2012, HEARING RES, V283, P126, DOI 10.1016/j.heares.2011.10.007; Alain C, 2009, EUR J NEUROSCI, V30, P132, DOI 10.1111/j.1460-9568.2009.06792.x; Amemiya S, 2010, PHYSIOL BEHAV, V99, P521, DOI 10.1016/j.physbeh.2010.01.001; Baddeley A, 1974, PSYCHOL LEARN MOTIV, P531; Botteldooren D, 2011, P 10 INT C NOIS PUBL, P341; BRITTON LA, 1989, PERCEPT MOTOR SKILL, V68, P875, DOI 10.2466/pms.1989.68.3.875; BROADBENT DE, 1978, PSYCHOL BULL, V85, P1052, DOI 10.1037/0033-2909.85.5.1052; Cabani Fernando Tolosa, 2005, Rev Enferm, V28, P26; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Conway ARA, 2001, PSYCHON B REV, V8, P331, DOI 10.3758/BF03196169; Cote KA, 2008, PHYSIOL BEHAV, V95, P353, DOI 10.1016/j.physbeh.2008.06.016; DELAY ER, 1985, PERCEPT MOTOR SKILL, V61, P415, DOI 10.2466/pms.1985.61.2.415; Frtusova JB, 2013, PSYCHOL AGING, V28, P481, DOI 10.1037/a0031243; Gevins A, 1996, ELECTROEN CLIN NEURO, V98, P327, DOI 10.1016/0013-4694(96)00288-X; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; HOUSTON K, 1967, J EXP PSYCHOL, V74, P54, DOI 10.1037/h0024492; Jones DM, 1993, AAOS INSTR COURSE LE, P219; JONES DM, 1992, HDB HUMAN PERFORMANC, V1, P29; Keeser D, 2011, NEUROIMAGE, V55, P644, DOI 10.1016/j.neuroimage.2010.12.004; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KRAMER AF, 1991, PSYCHOPHYSIOLOGY, V28, P425, DOI 10.1111/j.1469-8986.1991.tb00726.x; Kryter KD, 1970, EFFECTS NOISE MAN, P129; Liu P, 2012, BEHAV RES METHODS, V44, P1042, DOI 10.3758/s13428-012-0203-3; McEvoy LK, 1998, CEREB CORTEX, V8, P563, DOI 10.1093/cercor/8.7.563; OLTMAN PK, 1964, PERCEPT MOTOR SKILL, V19, P441, DOI 10.2466/pms.1964.19.2.441; OMALLEY JJ, 1971, PERCEPT MOTOR SKILL, V33, P887, DOI 10.2466/pms.1971.33.3.887; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; POLICH J, 1985, BIOL PSYCHOL, V21, P309, DOI 10.1016/0301-0511(85)90185-1; SALAME P, 1982, J VERB LEARN VERB BE, V21, P150, DOI 10.1016/S0022-5371(82)90521-7; Salisbury DF, 2002, PSYCHOPHYSIOLOGY, V39, P111, DOI 10.1017/S0048577201020030; SanMiguel I, 2008, J COGNITIVE NEUROSCI, V20, P1131, DOI 10.1162/jocn.2008.20078; Savini N, 2012, INT J PSYCHOPHYSIOL, V86, P220, DOI 10.1016/j.ijpsycho.2012.09.007; Smith A, 2012, PSYCHOL BULL, V138, P1262, DOI 10.1037/a0028867; Smith A, 2010, NOISE HEALTH, V12, P235, DOI 10.4103/1463-1741.70502; SMITH AP, 1983, BRIT J PSYCHOL, V74, P83, DOI 10.1111/j.2044-8295.1983.tb01845.x; Soderlund G, 2007, J CHILD PSYCHOL PSYC, V48, P840, DOI 10.1111/j.1469-7610.2007.01749.x; Soderlund GBW, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-55; Sorqvist P, 2010, APPL COGNITIVE PSYCH, V24, P67, DOI 10.1002/acp.1543; Spronk M, 2012, INT J PSYCHOPHYSIOL, V83, P24, DOI 10.1016/j.ijpsycho.2011.09.019; STRAYER DL, 1990, J EXP PSYCHOL LEARN, V16, P67, DOI 10.1037/0278-7393.16.1.67; Szalma JL, 2011, PSYCHOL BULL, V137, P682, DOI 10.1037/a0023987; Trimmel M, 2006, ERGONOMICS, V49, P202, DOI 10.1080/00140130500434986; Watter S, 2001, PSYCHOPHYSIOLOGY, V38, P998, DOI 10.1111/1469-8986.3860998; Xu JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014552	44	18	21	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76261	10.1371/journal.pone.0076261	http://dx.doi.org/10.1371/journal.pone.0076261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239MM	24204607	gold, Green Submitted, Green Published			2022-12-27	WOS:000326029300016
J	Nanayakkara, M; Lania, G; Maglio, M; Kosova, R; Sarno, M; Gaito, A; Discepolo, V; Troncone, R; Auricchio, S; Auricchio, R; Barone, MV				Nanayakkara, Merlin; Lania, Giuliana; Maglio, Mariantonia; Kosova, Roberta; Sarno, Marco; Gaito, Alessandra; Discepolo, Valentina; Troncone, Riccardo; Auricchio, Salvatore; Auricchio, Renata; Barone, Maria Vittoria			Enterocyte Proliferation and Signaling Are Constitutively Altered in Celiac Disease	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN; ACTIVATION; RESPONSES; GLIADIN; SYSTEM; GENES; CELLS; ERK	Celiac disease (CD) occurs frequently, and is caused by ingestion of prolamins from cereals in subjects with a genetic predisposition. The small intestinal damage depends on an intestinal stress/innate immune response to certain gliadin peptides (e. g., A-gliadin P31-43) in association with an adaptive immune response to other gliadin peptides (e. g., A-gliadin P57-68). Gliadin and peptide P31-43 affect epithelial growth factor receptor (EGFR) signaling and CD enterocyte proliferation. The reason why the stress/innate immune and proliferative responses to certain gliadin peptides are present in CD and not in control intestine is so far unknown. The aim of this work is to investigate if, in CD, a constitutive alteration of enterocyte proliferation and signaling exists that may represent a predisposing condition to the damaging effects of gliadin. Immunofluorescence and immunohistochemistry were used to study signaling in CD fibroblasts and intestinal biopsies. Western blot (WB) analysis, immunoprecipitation, and quantitative PCR were also used. We found in CD enterocytes enhancement of both proliferation and Epidermal Growth Factor Receptor (EGFR)/ligand system. In CD enterocytes and fibroblasts we found increase of the phosphorylated downstream signaling molecule Extracellular Signal Regulated Kinase (ERK); block of the ERK activation normalizes enterocytes proliferation in CD mucosa. In conclusion the same pathway, which gliadin and gliadin peptide P31-43 can interfere with, is constitutively altered in CD cells. This observation potentially explains the specificity of the damaging effects of certain gliadin peptides on CD intestine.	[Nanayakkara, Merlin; Lania, Giuliana; Maglio, Mariantonia; Kosova, Roberta; Sarno, Marco; Gaito, Alessandra; Discepolo, Valentina; Troncone, Riccardo; Auricchio, Salvatore; Auricchio, Renata; Barone, Maria Vittoria] Univ Naples Federico II, Dept Traslat Med, Sect Pediat, Naples, Italy; [Nanayakkara, Merlin; Lania, Giuliana; Maglio, Mariantonia; Kosova, Roberta; Sarno, Marco; Gaito, Alessandra; Discepolo, Valentina; Troncone, Riccardo; Auricchio, Salvatore; Auricchio, Renata; Barone, Maria Vittoria] Univ Naples Federico II, ELFID European Lab Invest Food Induced Dis, Naples, Italy; [Discepolo, Valentina] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Naples Federico II; University of Naples Federico II; University of Chicago	Barone, MV (corresponding author), Univ Naples Federico II, Dept Traslat Med, Sect Pediat, Naples, Italy.	mv.barone@unina.it	AURICCHIO, RENATA/AAC-7718-2022; Discepolo, Valentina/AAC-7665-2022	NANAYAKKARA, MERLIN/0000-0002-2569-4606; Discepolo, Valentina/0000-0001-6158-0545; BARONE, Maria Vittoria/0000-0001-6190-4917	PRIN (Research Programs of National Interest) [CUP E61J11000300001]	PRIN (Research Programs of National Interest)(Ministry of Education, Universities and Research (MIUR))	PRIN 2009 (Research Programs of National Interest), code CUP E61J11000300001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Barone MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017039; Barone MV, 2007, GASTROENTEROLOGY, V132, P1245, DOI 10.1053/j.gastro.2007.01.030; Barone MV, 2007, GUT, V56, P480, DOI 10.1136/gut.2005.086637; Barone MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012246; Barone MV, 2001, ONCOGENE, V20, P6973, DOI 10.1038/sj.onc.1204886; Boughan PK, 2006, J BIOL CHEM, V281, P11637, DOI 10.1074/jbc.M510275200; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Castoria G, 2003, J CELL BIOL, V161, P547, DOI 10.1083/jcb.200211099; DeWitt AE, 2001, J CELL SCI, V114, P2301; Diosdado B, 2004, GUT, V53, P944, DOI 10.1136/gut.2003.018374; FALCONE G, 1987, EXP CELL RES, V168, P273, DOI 10.1016/0014-4827(87)90435-6; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Jabri B, 2006, NAT CLIN PRACT GASTR, V3, P516, DOI 10.1038/ncpgasthep0582; Juuti-Uusitalo K, 2007, CLIN EXP IMMUNOL, V150, P294, DOI 10.1111/j.1365-2249.2007.03500.x; Kopp R, 2003, RECENT RESULTS CANC, V162, P115; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Lewkowicz P, 2005, IMMUNOL LETT, V96, P203, DOI 10.1016/j.imlet.2004.08.012; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; MARSH MN, 1992, EUR J GASTROEN HEPAT, V4, P667; MARSH MN, 1995, BAILLIERE CLIN GASTR, V9, P273, DOI 10.1016/0950-3528(95)90032-2; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; MULDER CJJ, 1993, GUT, V34, P1740, DOI 10.1136/gut.34.12.1740; Nanayakkara M, 2013, AM J CLIN N IN PRESS; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53	30	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76006	10.1371/journal.pone.0076006	http://dx.doi.org/10.1371/journal.pone.0076006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204586	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300007
J	Serafini, A; Pisu, D; Palu, G; Rodriguez, GM; Manganelli, R				Serafini, Agnese; Pisu, Davide; Palu, Giorgio; Rodriguez, G. Marcela; Manganelli, Riccardo			The ESX-3 Secretion System Is Necessary for Iron and Zinc Homeostasis in Mycobacterium tuberculosis	PLOS ONE			English	Article							GENE-EXPRESSION; PATHOGENIC MYCOBACTERIA; EXTRACELLULAR SIDEROPHORE; BACILLUS-SUBTILIS; ABC TRANSPORTER; PROTEIN EXPORT; BOVIS BCG; VIRULENCE; SMEGMATIS; IDENTIFICATION	ESX-3 is one of the five type VII secretion systems encoded by the Mycobacterium tuberculosis genome. We recently showed the essentiality of ESX-3 for M. tuberculosis viability and proposed its involvement in iron and zinc metabolism. In this study we confirmed the role of ESX-3 in iron uptake and its involvement in the adaptation to low zinc environment in M. tuberculosis. Moreover, we unveiled functional differences between the ESX-3 roles in M. tuberculosis and M. smegmatis showing that in the latter ESX-3 is only involved in the adaptation to iron and not to zinc restriction. Finally, we also showed that in M. tuberculosis this secretion system is essential for iron and zinc homeostasis not only in conditions in which the concentrations of these metals are limiting but also in metal sufficient conditions.	[Serafini, Agnese; Pisu, Davide; Palu, Giorgio; Manganelli, Riccardo] Univ Padua, Dept Mol Med, Padua, Italy; [Rodriguez, G. Marcela] Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ 07102 USA	University of Padua; Rutgers State University Newark; Rutgers State University New Brunswick	Manganelli, R (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	riccardo.manganelli@unipd.it	Pisu, Davide/AAK-1095-2021; Manganelli, Riccardo/A-7361-2009; Serafini, Agnese/AAN-6952-2020	Manganelli, Riccardo/0000-0003-0940-7336; Serafini, Agnese/0000-0002-1904-6012; Pisu, Davide/0000-0001-5641-8877	European Community [201762]; National Institutes of Health [AI044856]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI044856, R01AI044856] Funding Source: NIH RePORTER	European Community(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research received funding from the European Community Seventh Framework Program (FP7/2007-2013) under grant agreement 201762 (RM) and from National Institutes of Health grant AI044856 (GMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Agarwal N, 2007, INFECT IMMUN, V75, P452, DOI 10.1128/IAI.01395-06; Arnvig KB, 2012, RNA BIOL, V9, P427, DOI 10.4161/rna.20105; Bhat KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052601; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; Botella H, 2012, TRENDS MICROBIOL, V20, P106, DOI 10.1016/j.tim.2012.01.005; Botella H, 2011, CELL HOST MICROBE, V10, P248, DOI 10.1016/j.chom.2011.08.006; Bottai D, 2012, MOL MICROBIOL, V83, P1195, DOI 10.1111/j.1365-2958.2012.08001.x; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Cascioferro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027713; Cascioferro A, 2010, APPL ENVIRON MICROB, V76, P5312, DOI 10.1128/AEM.00382-10; Casonato S, 2012, INFECT IMMUN, V80, P3132, DOI 10.1128/IAI.06328-11; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Di Luca M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052059; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feltcher ME, 2010, FUTURE MICROBIOL, V5, P1581, DOI [10.2217/fmb.10.112, 10.2217/FMB.10.112]; FISS EH, 1994, MOL MICROBIOL, V14, P557, DOI 10.1111/j.1365-2958.1994.tb02189.x; Gaballa A, 1998, J BACTERIOL, V180, P5815, DOI 10.1128/JB.180.22.5815-5821.1998; Garces A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000957; Gey van Pittius NC, 2001, GENOME BIOL, V2; GOBIN J, 1995, P NATL ACAD SCI USA, V92, P5189, DOI 10.1073/pnas.92.11.5189; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Huet G, 2005, J BACTERIOL, V187, P6137, DOI 10.1128/JB.187.17.6137-6146.2005; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Ilghari D, 2011, J BIOL CHEM, V286, P29993, DOI 10.1074/jbc.M111.248732; Jones CM, 2011, J BACTERIOL, V193, P1767, DOI 10.1128/JB.01312-10; Jones CM, 2010, J BACTERIOL, V192, P6411, DOI 10.1128/JB.00986-10; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Ligon LS, 2012, TUBERCULOSIS, V92, P121, DOI 10.1016/j.tube.2011.11.005; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Maciag A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-48; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Moore CM, 2005, CURR OPIN MICROBIOL, V8, P188, DOI 10.1016/j.mib.2005.02.007; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Provvedi R, 2008, J BACTERIOL, V190, P7859, DOI 10.1128/JB.00714-08; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Ratledge C, 1996, MICROBIOL-UK, V142, P2207, DOI 10.1099/13500872-142-8-2207; Reddy PV, 2013, J INFECT DIS; Rodriguez GM, 2006, J BACTERIOL, V188, P424, DOI 10.1128/JB.188.2.424-430.2006; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Ryndak MB, 2010, J BACTERIOL, V192, P861, DOI 10.1128/JB.00223-09; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; SHARMAN GJ, 1995, BIOCHEM J, V305, P187, DOI 10.1042/bj3050187; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; SNOW GA, 1965, BIOCHEM J, V94, P160, DOI 10.1042/bj0940160; Soldati T, 2012, TRAFFIC, V13, P1042, DOI 10.1111/j.1600-0854.2012.01358.x; Stoop EJM, 2012, TRENDS MICROBIOL, V20, P477, DOI 10.1016/j.tim.2012.07.001; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Tullius MV, 2008, INFECT IMMUN, V76, P5200, DOI 10.1128/IAI.00434-08; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van der Woude AD, 2012, CURR TOP MICROBIOL I; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Vaquerizas JM, 2005, NUCLEIC ACIDS RES, V33, pW616, DOI 10.1093/nar/gki500; Wagner D, 2005, MICROBIOL-SGM, V151, P323, DOI 10.1099/mic.0.27213-0	69	78	83	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78351	10.1371/journal.pone.0078351	http://dx.doi.org/10.1371/journal.pone.0078351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155985	Green Published, gold			2022-12-27	WOS:000325887300120
J	Lin, CY; Huo, C; Kuo, LK; Hiipakka, RA; Jones, RB; Lin, HP; Hung, YW; Su, LC; Tseng, JC; Kuo, YY; Wang, YL; Fukui, Y; Kao, YH; Kokontis, JM; Yeh, CC; Chen, LY; Yang, SD; Fu, HH; Chen, YW; Tsai, KKC; Chang, JY; Chuu, CP				Lin, Ching-Yu; Huo, Chieh; Kuo, Li-Kuo; Hiipakka, Richard A.; Jones, Richard Baker; Lin, Hui-Ping; Hung, Yuwen; Su, Liang-Cheng; Tseng, Jen-Chih; Kuo, Ying-Yu; Wang, Yu-Ling; Fukui, Yasuhisa; Kao, Yung-Hsi; Kokontis, John M.; Yeh, Chien-Chih; Chen, Linyi; Yang, Shiaw-Der; Fu, Hsiao-Hui; Chen, Ya-Wen; Tsai, Kelvin K. C.; Chang, Jang-Yang; Chuu, Chih-Pin			Cholestane-3 beta, 5 alpha, 6 beta-triol Suppresses Proliferation, Migration, and Invasion of Human Prostate Cancer Cells	PLOS ONE			English	Article							ACID PHENETHYL ESTER; TO-MESENCHYMAL TRANSITION; 73/73 ENDOTHELIAL-CELLS; BOVINE ADRENAL-CORTEX; RICTOR-MTOR COMPLEX; X-RECEPTOR AGONIST; ANDROGEN RECEPTOR; CHOLESTEROL OXIDES; ATHYMIC MICE; C-MYC	Oxysterols are oxidation products of cholesterol. Cholestane-3 beta, 5 alpha, 6 beta-triol (abbreviated as triol) is one of the most abundant and active oxysterols. Here, we report that triol exhibits anti-cancer activity against human prostate cancer cells. Treatment of cells with triol dose-dependently suppressed proliferation of LNCaP CDXR-3, DU-145, and PC-3 human prostate cancer cells and reduced colony formation in soft agar. Oral administration of triol at 20 mg/kg daily for three weeks significantly retarded the growth of PC-3 xenografts in nude mice. Flow cytometric analysis revealed that triol treatment at 10-40 mu M caused G1 cell cycle arrest while the TUNEL assay indicated that triol treatment at 20-40 mu M induced apoptosis in all three cell lines. Micro-Western Arrays and traditional Western blotting methods indicated that triol treatment resulted in reduced expression of Akt1, phospho-Akt Ser473, phospho-Akt Thr308, PDK1, c-Myc, and Skp2 protein levels as well as accumulation of the cell cycle inhibitor p27(Kip). Triol treatment also resulted in reduced Akt1 protein expression in PC-3 xenografts. Overexpression of Skp2 in PC-3 cells partially rescued the growth inhibition caused by triol. Triol treatment suppressed migration and invasion of DU-145, PC-3, and CDXR-3 cells. The expression levels of proteins associated with epithelial-mesenchymal transition as well as focal adhesion kinase were affected by triol treatment in these cells. Triol treatment caused increased expression of E-cadherin protein levels but decreased expression of N-cadherin, vimentin, Slug, FAK, phospho-FAK Ser722, and phospho-FAK Tyr861 protein levels. Confocal laser microscopy revealed redistribution of beta-actin and alpha-tubulin at the periphery of the CDXR-3 and DU-145 cells. Our observations suggest that triol may represent a promising therapeutic agent for advanced metastatic prostate cancer.	[Lin, Ching-Yu; Huo, Chieh; Lin, Hui-Ping; Hung, Yuwen; Su, Liang-Cheng; Tseng, Jen-Chih; Kuo, Ying-Yu; Wang, Yu-Ling; Fukui, Yasuhisa; Chuu, Chih-Pin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan; [Lin, Ching-Yu; Huo, Chieh; Lin, Hui-Ping; Su, Liang-Cheng; Kuo, Ying-Yu; Chen, Ya-Wen; Tsai, Kelvin K. C.; Chang, Jang-Yang; Chuu, Chih-Pin] Natl Hlth Res Inst, Translat Ctr Glandular Malignancies, Miaoli, Taiwan; [Lin, Ching-Yu; Chen, Ya-Wen; Tsai, Kelvin K. C.; Chang, Jang-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Huo, Chieh; Kao, Yung-Hsi] Natl Cent Univ, Dept Life Sci, Tao Yuan, Taiwan; [Kuo, Li-Kuo] Mackay Mem Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taipei, Taiwan; [Hiipakka, Richard A.; Jones, Richard Baker; Kokontis, John M.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Jones, Richard Baker] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Hung, Yuwen; Tseng, Jen-Chih; Yang, Shiaw-Der; Fu, Hsiao-Hui] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Wang, Yu-Ling; Chen, Linyi] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Yeh, Chien-Chih] Taoyuan Armed Forces Gen Hosp, Div Colon & Rectal Surg, Tao Yuan, Taiwan; [Yeh, Chien-Chih] Taoyuan Armed Forces Gen Hosp, Dept Surg, Tao Yuan, Taiwan; [Chuu, Chih-Pin] China Med Univ, Grad Program Aging, Taichung, Taiwan; [Chuu, Chih-Pin] Natl Chung Hsing Univ, PhD Program Tissue Engn & Regenerat Med, Taichung 40227, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Central University; Mackay Memorial Hospital; University of Chicago; University of Chicago; National Tsing Hua University; National Tsing Hua University; China Medical University Taiwan; National Chung Hsing University	Chuu, CP (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan.	cpchuu@nhri.org.tw	Chuu, Chih-Pin/B-1086-2010; Tseng, Jen-Chih/AAK-3386-2020; Chen, Ya-Wen/AAG-7549-2019; Katanaev, Vladimir/F-9480-2014; Chuu, Chih-Pin/N-6697-2019; Fukui, Yasuhisa/E-8806-2010; Chen, Linyi/AAV-2632-2020; Lin, Ching Yu/AAN-9581-2020; Chen, Ya-Wen/B-1100-2010; Chang, Jang-Yang/D-2099-2010; Tsai, Kun-Chih/C-1371-2010	Chen, Ya-Wen/0000-0002-6080-8859; Katanaev, Vladimir/0000-0002-7909-5617; Chen, Linyi/0000-0001-7258-8817; Lin, Ching Yu/0000-0001-9041-5653; 	National Health Research Institutes [CS-101-PP-14]; (National Science Council) in Taiwan [NSC 99-2320-B-400-015-MY3, NSC 101-2325-B-400-014]; (Department of Health) in Taiwan [DOH101-TD-C-111-004]	National Health Research Institutes(National Health Research Institutes, Japan); (National Science Council) in Taiwan(Ministry of Science and Technology, Taiwan); (Department of Health) in Taiwan	This work was supported by CS-101-PP-14 (National Health Research Institutes), NSC 99-2320-B-400-015-MY3 and NSC 101-2325-B-400-014 (National Science Council) in Taiwan for CPC; DOH101-TD-C-111-004 (Department of Health) in Taiwan for JYC and CPC. CYL is supported by DOH101-TD-C-111-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ao MF, 2006, CANCER RES, V66, P8007, DOI 10.1158/0008-5472.CAN-05-4451; Ayala-Torres S, 1999, EXP CELL RES, V246, P193, DOI 10.1006/excr.1998.4308; Beach S, 2008, ONCOGENE, V27, P2243, DOI 10.1038/sj.onc.1210860; Biasi F, 2013, BIOCHIMIE, V95, P632, DOI 10.1016/j.biochi.2012.10.011; BOSISIO E, 1976, EUR J BIOCHEM, V63, P491, DOI 10.1111/j.1432-1033.1976.tb10252.x; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Cantwell H, 1998, CELL BIOL TOXICOL, V14, P401, DOI 10.1023/A:1007595527176; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Chuu CP, 2007, J BIOMED SCI, V14, P543, DOI 10.1007/s11373-007-9160-8; Chuu CP, 2007, BIOCHEM BIOPH RES CO, V357, P341, DOI 10.1016/j.bbrc.2007.03.116; Chuu CP, 2006, CANCER RES, V66, P6482, DOI 10.1158/0008-5472.CAN-06-0632; Chuu CP, 2012, CANCER PREV RES, V5, P788, DOI 10.1158/1940-6207.CAPR-12-0004-T; Chuu CP, 2011, CANCER SCI, V102, P2022, DOI 10.1111/j.1349-7006.2011.02043.x; Chuu CP, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-63; Chuu CP, 2011, MED HYPOTHESES, V76, P697, DOI 10.1016/j.mehy.2011.01.037; Chuu CP, 2010, ANTICANCER RES, V30, P3643; Chuu CP, 2009, CANCER LETT, V275, P86, DOI 10.1016/j.canlet.2008.10.001; Chuu CP, 2005, CANCER RES, V65, P2082, DOI 10.1158/0008-5472.CAN-04-3992; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Coffer PJ, 1998, BIOCHEM J, V335, P1; Dufour J, 2012, CURR OPIN PHARM; Edwards J, 2003, CLIN CANCER RES, V9, P5271; ELLEDGE SJ, 1994, CURR OPIN CELL BIOL, V6, P847, DOI 10.1016/0955-0674(94)90055-8; Franzen CA, 2009, CANCER PREV RES, V2, P830, DOI 10.1158/1940-6207.CAPR-09-0066; Fukuchi J, 2004, CANCER RES, V64, P7686, DOI 10.1158/0008-5472.CAN-04-2332; Gilligan T, 2002, UROLOGY, V60, P94, DOI 10.1016/S0090-4295(02)01583-2; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Grad JM, 1999, MOL ENDOCRINOL, V13, P1896, DOI 10.1210/me.13.11.1896; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Hause RJ, 2011, EXPERT REV PROTEOMIC, V8, P565, DOI [10.1586/EPR.11.49, 10.1586/epr.11.49]; Hellerstedt BA, 2002, CA-CANCER J CLIN, V52, P154, DOI 10.3322/canjclin.52.3.154; Ibrahim T, 2010, CANCER-AM CANCER SOC, V116, P1406, DOI 10.1002/cncr.24896; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jusakul A, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-44; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kang KA, 2005, BIOL PHARM BULL, V28, P1377, DOI 10.1248/bpb.28.1377; Keller ET, 2001, CANCER METAST REV, V20, P333, DOI 10.1023/A:1015599831232; KOKONTIS J, 1994, CANCER RES, V54, P1566; Kokontis JM, 2005, PROSTATE, V65, P287, DOI 10.1002/pros.20285; Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Lin HP, 2013, INT J MOL SCI, V14, P5264, DOI 10.3390/ijms14035264; Lin HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031286, 10.1371/journal.pone.0035240]; Lin HP, 2012, PHYTOTHER RES, V26, P122, DOI 10.1002/ptr.3523; Liu CC, 2013, MED HYPOTHESES, V80, P617, DOI 10.1016/j.mehy.2013.02.003; Liu J, 2011, HEAD NECK-J SCI SPEC, V33, P1774, DOI 10.1002/hed.21701; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Moriel P, 2002, BRAZ J MED BIOL RES, V35, P1301, DOI 10.1590/S0100-879X2002001100007; Nolasco S, 2005, FEBS LETT, V579, P3515, DOI 10.1016/j.febslet.2005.05.022; Palladini G, 1996, EXP CELL RES, V223, P83, DOI 10.1006/excr.1996.0060; Palladini G, 1996, EXP CELL RES, V223, P72, DOI 10.1006/excr.1996.0059; Panagiotou S, 1999, J CELL BIOCHEM, V73, P204, DOI 10.1002/(SICI)1097-4644(19990501)73:2<204::AID-JCB6>3.0.CO;2-V; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Senapati S, 2010, ONCOGENE, V29, P1293, DOI 10.1038/onc.2009.420; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Umekita Y, 1996, P NATL ACAD SCI USA, V93, P11802, DOI 10.1073/pnas.93.21.11802; Vellaichamy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010936; WATABE T, 1979, J BIOL CHEM, V254, P3854; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Zheng DQ, 1999, CANCER RES, V59, P1655	66	4	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65734	10.1371/journal.pone.0065734	http://dx.doi.org/10.1371/journal.pone.0065734			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	24204696	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800076
J	Malkin, E; Yogev, R; Abughali, N; Sliman, J; Wang, CK; Zuo, FR; Yang, CF; Eickhoff, M; Esser, MT; Tang, RS; Dubovsky, F				Malkin, Elissa; Yogev, Ram; Abughali, Nazha; Sliman, Joseph; Wang, C. Kathy; Zuo, Fengrong; Yang, Chin-Fen; Eickhoff, Mark; Esser, Mark T.; Tang, Roderick S.; Dubovsky, Filip			Safety and Immunogenicity of a Live Attenuated RSV Vaccine in Healthy RSV-Seronegative Children 5 to 24 Months of Age	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; YOUNG-CHILDREN; CANDIDATE; INFANTS; INFECTION; PHASE-1	Despite substantial morbidity associated with respiratory syncytial virus (RSV) infection, there is no licensed vaccine. MEDI-559 is a live attenuated intranasal vaccine candidate being developed for prevention of lower respiratory illness due to RSV in young children. This randomized, placebo-controlled study evaluated safety of MEDI-559 in healthy, RSV-seronegative children. MEDI-559 or placebo was administered on 3 occasions, 2 months apart. Primary safety was based on solicited symptoms (SSs) and adverse events (AEs) collected for 28 days after each dose. Nasal wash samples were collected 3 times after each dose (days 7-10, 12-18, 28-34) and at sick visits. Serum was collected for measuring antibody immune responses to RSV prior to first vaccination and 28 days post final dose. Long-term safety was monitored for 365 days from first dose. SSs were mild and frequent (MEDI-559 84%; placebo 91%); most common SSs were runny/stuffy nose, cough, and irritability/fussiness. AEs occurred in 67% MEDI-559 and 57% placebo recipients: most common AE was upper respiratory tract infection (MEDI-559 35%; placebo 23%). Higher incidence of medically attended lower respiratory illness within 28 days after dosing occurred in the MEDI-559 arm compared to placebo (none associated with vaccine virus shedding). There was no evidence of enhanced RSV disease. Vaccine virus was detected only in MEDI-559 recipients; shedding occurred in 56% subjects, primarily post dose 1. A functional immune response was observed in 59% and 9% MEDI-559 and placebo recipients, respectively, by an RSV microneutralization assay. Vaccine take, assessed by proportion that shed vaccine-type virus or had a seroresponse against RSV, was seen in 95% MEDI-559 subjects. MEDI-559 is therefore biologically active and immunogenic in this seronegative pediatric population. Although the frequency of SSs and AEs was not considered clinically significant, the increase in medically attended lower respiratory illnesses in the vaccine group warrants expanded safety studies.	[Malkin, Elissa; Sliman, Joseph; Dubovsky, Filip] MedImmune, Clin Dev, Gaithersburg, MD USA; [Yogev, Ram] Ann & Robert Lurie Childrens Mem Hosp, Chicago, IL USA; [Abughali, Nazha] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Wang, C. Kathy] MedImmune, Appl Immunol & Microbiol, Mountain View, CA USA; [Zuo, Fengrong; Yang, Chin-Fen; Esser, Mark T.; Tang, Roderick S.] MedImmune, Res & Dev, Gaithersburg, MD USA; [Eickhoff, Mark] MedImmune, Clin Operat, Gaithersburg, MD USA	AstraZeneca; Medimmune; Ann & Robert H. Lurie Children's Hospital of Chicago; Case Western Reserve University; AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune	Dubovsky, F (corresponding author), MedImmune, Clin Dev, Gaithersburg, MD USA.	dubovskyf@medimmune.com		Tang, Roderick/0000-0003-0018-4869	MedImmune	MedImmune(AstraZenecaMedimmune)	Elissa Malkin, Joseph Sliman, Roderick Tang, and Chin-Fen Yang were employees of MedImmune during the conduct of the study. Mark Eickhoff, Mark Esser, Kathy Wang, Fengrong Zuo, and Filip Dubovsky are employees of MedImmune and receive stock/stock options from AstraZeneca. Ram Yogev received research funding from MedImmune for the conduct of the study and has been paid for lectures, including service on the Speakers Bureau for MedImmune. Nazha Abughali received research funding from MedImmune for the conduct of the study. All authors confirm that this does not alter their adherence to all PLOS ONE policies on sharing data and materials. MedImmune funded the study and was involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Bernstein DI, 2012, PEDIATR INFECT DIS J, V31, P109, DOI 10.1097/INF.0b013e31823386f1; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Durbin AP, 2003, CLIN INFECT DIS, V37, P1668, DOI 10.1086/379775; Firestone CY, 1996, VIROLOGY, V225, P419, DOI 10.1006/viro.1996.0618; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Karron RA, 1997, J INFECT DIS, V176, P1428, DOI 10.1086/514138; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; Liang C, 1998, J VIROL, V72, P6629, DOI 10.1128/JVI.72.8.6629-6636.1998; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schickli JH, 2012, VIRUS RES, V169, P38, DOI 10.1016/j.virusres.2012.06.027; Stockman LJ, 2012, PEDIATR INFECT DIS J, V31, P5, DOI 10.1097/INF.0b013e31822e68e6; Tang RS, 2004, J VIROL, V78, P11198, DOI 10.1128/JVI.78.20.11198-11207.2004; Whitehead SS, 1999, J VIROL, V73, P871, DOI 10.1128/JVI.73.2.871-877.1999; Wright PF, 2000, J INFECT DIS, V182, P1331, DOI 10.1086/315859; Yang DP, 2007, BIOLOGICALS, V35, P183, DOI 10.1016/j.biologicals.2006.09.004	17	54	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77104	10.1371/journal.pone.0077104	http://dx.doi.org/10.1371/journal.pone.0077104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204744	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700017
J	Pennesi, C; Totti, C; Beolchini, F				Pennesi, Chiara; Totti, Cecilia; Beolchini, Francesca			Removal of Vanadium(III) and Molybdenum(V) from Wastewater Using Posidonia oceanica (Tracheophyta) Biomass	PLOS ONE			English	Article							METAL CONTAMINATION; L. DELILE; BIOSORPTION; SEAGRASS; EQUILIBRIUM; RECOVERY; CHROMIUM; ADSORPTION; EXPRESSION; SEQUENCES	The use of dried and re-hydrated biomass of the seagrass Posidonia oceanica was investigated as an alternative and -low-cost biomaterial for removal of vanadium(III) and molybdenum(V) from wastewaters. Initial characterisation of this biomaterial identified carboxylic groups on the cuticle as potentially responsible for cation sorption, and confirmed the toxic-metal bioaccumulation. The combined effects on biosorption performance of equilibrium pH and metal concentrations were investigated in an ideal single-metal system and in more real-life multicomponent systems. There were either with one metal (vanadium or molybdenum) and sodium nitrate, as representative of high ionic strength systems, or with the two metals (vanadium and molybdenum). For the single-metal solutions, the optimum was at pH 3, where a significant proportion of vanadium was removed (ca. 70%) while there was ca. 40% adsorption of molybdenum. The data obtained from the more real-life multicomponent systems showed that biosorption of one metal was improved both by the presence of the other metal and by high ionic strength, suggesting a synergistic effect on biosorption rather than competition. There data ware used for the development of a simple multi-metal equilibrium model based on the noncompetitive Langmuir approach, which was successfully fitted to experimental data and represents a useful support tool for the prediction of biosorption performance in such real-life systems. Overall, the results suggest that biomass of P. oceanica can be used as an efficient biosorbent for removal of vanadium(III) and molybdenum(V) from aqueous solutions. This process thus offers an eco-compatible solution for the reuse of the waste material of leaves that accumulate on the beach due to both human activities and to storms at sea.	[Pennesi, Chiara; Totti, Cecilia; Beolchini, Francesca] Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy	Marche Polytechnic University	Pennesi, C (corresponding author), Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy.	c.pennesi@univpm.it	Totti, Cecilia Maria/A-9178-2016; Beolchini, Francesca/L-6205-2014; Pennesi, Chiara/B-7786-2013	Totti, Cecilia Maria/0000-0002-1532-6009; Beolchini, Francesca/0000-0002-6211-6354; Pennesi, Chiara/0000-0002-5774-2190	Polytechnic University of the Marche	Polytechnic University of the Marche	This study was funded by research funds of the Polytechnic University of the Marche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche FN, 2011, CHEM ENG J, V168, P1174, DOI 10.1016/j.cej.2011.02.005; [Anonymous], [No title captured]; Aydin M, 2012, J RADIOANAL NUCL CH, V293, P489, DOI 10.1007/s10967-012-1782-2; Benavente J, 1998, COLLOID SURFACE A, V140, P333, DOI 10.1016/S0927-7757(97)00290-2; Benedetto G, 2012, DOSSIER COSTE PROFIL; Beolchini F, 2006, ENVIRON SCI TECHNOL, V40, P2746, DOI 10.1021/es052114m; Beolchini F, 2005, HYDROMETALLURGY, V76, P73, DOI 10.1016/j.hydromet.2004.09.003; Beolchini F, 2010, J HAZARD MATER, V178, P529, DOI 10.1016/j.jhazmat.2010.01.114; Boudouresque C.F., 1982, CAH PARC NATION PORT, V4, P1; Boudouresque C.F., 2006, PRESERVATION CONSERV; Bulgariu D, 2012, BIORESOURCE TECHNOL, V103, P489, DOI 10.1016/j.biortech.2011.10.016; Cengiz S, 2012, CHEM ENG J, V189, P32, DOI 10.1016/j.cej.2012.02.015; Cozza R, 2006, AQUAT BOT, V85, P317, DOI 10.1016/j.aquabot.2006.06.010; Davis TA, 2000, WATER RES, V34, P4270, DOI 10.1016/S0043-1354(00)00177-9; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; Demirak A, 2011, MICROCHEM J, V99, P97, DOI 10.1016/j.microc.2011.04.002; Ferrat L, 2003, AQUAT TOXICOL, V65, P187, DOI 10.1016/S0166-445X(03)00133-4; Ferrat L, 2003, COMP BIOCHEM PHYS C, V134, P147, DOI 10.1016/S1532-0456(02)00220-X; Fourest E., 1996, TOXICOL ENVIRON CHEM, V54, P1, DOI DOI 10.1080/02772249609358291; Fourqurean JW, 2007, MAR BIOL, V151, P219, DOI 10.1007/s00227-006-0473-3; Francour P, 2006, MANAGEMENT GUIDE MAR; Gacia E, 2007, ESTUAR COAST SHELF S, V72, P579, DOI 10.1016/j.ecss.2006.11.021; GARDEATORRESDEY JL, 1990, ENVIRON SCI TECHNOL, V24, P1372, DOI 10.1021/es00079a011; Gerke TL, 2010, SCI TOTAL ENVIRON, V408, P5845, DOI 10.1016/j.scitotenv.2010.08.036; Giordani T, 2000, PLANT PHYSIOL, V123, P1571, DOI 10.1104/pp.123.4.1571; Gonzalez-Correa JM, 2005, J EXP MAR BIOL ECOL, V320, P65, DOI 10.1016/j.jembe.2004.12.032; Hoffman R.V., 2004, ORGANIC CHEM INTERME, Vsecond, DOI [10.1002/0471648736, DOI 10.1002/0471648736]; Izquierdo M, 2010, BIORESOURCE TECHNOL, V101, P510, DOI 10.1016/j.biortech.2009.08.018; Izqulerdo M, 2012, CLEAN-SOIL AIR WATER, V40, P428, DOI 10.1002/clen.201100303; Khiari R, 2010, BIORESOURCE TECHNOL, V101, P775, DOI 10.1016/j.biortech.2009.08.079; Krika F, 2012, INT J ENVIRON RES, V6, P719; Lafabrie C, 2008, MAR POLLUT BULL, V57, P155, DOI 10.1016/j.marpolbul.2007.10.007; Lafabrie C, 2008, ENVIRON POLLUT, V151, P262, DOI 10.1016/j.envpol.2007.01.047; Lafabrie C, 2007, CHEMOSPHERE, V68, P2033, DOI 10.1016/j.chemosphere.2007.02.039; Lafabrie C, 2007, ENVIRON POLLUT, V148, P688, DOI 10.1016/j.envpol.2006.11.015; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Liber K, 2011, ECOTOX ENVIRON SAFE, V74, P1171, DOI 10.1016/j.ecoenv.2011.02.014; Maserti BE, 2005, AQUAT TOXICOL, V75, P288, DOI 10.1016/j.aquatox.2005.08.008; Michalowski T, 2005, TALANTA, V65, P1241, DOI 10.1016/j.talanta.2004.08.053; Michalowski T, 2008, ANAL CHIM ACTA, V606, P172, DOI 10.1016/j.aca.2007.11.020; Montazer-Rahmati MM, 2011, J HAZARD MATER, V185, P401, DOI 10.1016/j.jhazmat.2010.09.047; Murphy V, 2008, CHEMOSPHERE, V70, P1128, DOI 10.1016/j.chemosphere.2007.08.015; Ncibi MC, 2009, DESALINATION, V243, P109, DOI 10.1016/j.desal.2008.04.018; Ncibi MC, 2007, J HAZARD MATER, V139, P280, DOI 10.1016/j.jhazmat.2006.06.029; Pennesi C, 2012, J APPL PHYCOL, V24, P1495, DOI 10.1007/s10811-012-9808-2; Pennesi C, 2012, WATER ENVIRON RES, V84, P9, DOI 10.2175/106143011X12989211841296; Piazzi L, 1999, AQUAT BOT, V63, P103, DOI 10.1016/S0304-3770(98)00115-6; Puigdomenech I, 2009, PROGRAM MEDUSA MAKE; Rocchetti L, 2013, WASTE MANAGE RES, V31, P568, DOI 10.1177/0734242X13476364; Sari A, 2008, J HAZARD MATER, V160, P349, DOI 10.1016/j.jhazmat.2008.03.005; Sheng PX, 2004, J COLLOID INTERF SCI, V275, P131, DOI 10.1016/j.jcis.2004.01.036; Shriver DF., 2010, INORG CHEM, V5, P851; Stasko R, 2006, MATER CHARACT, V56, P340, DOI 10.1016/j.matchar.2005.09.012; Tang ZH, 2008, MATER CHARACT, V59, P717, DOI 10.1016/j.matchar.2007.06.001; Veglio F, 1997, HYDROMETALLURGY, V44, P301, DOI 10.1016/S0304-386X(96)00059-X; Volesky B, 1990, BIOSORPTION HEAVY ME, P7; Wahab MA, 2011, J HAZARD MATER, V191, P333, DOI 10.1016/j.jhazmat.2011.04.085; Whittaker G, 2000, BIOS INSTANT NOTES P	58	28	29	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76870	10.1371/journal.pone.0076870	http://dx.doi.org/10.1371/journal.pone.0076870			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204692	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400019
J	Rossignol, L; Pelat, C; Lambert, B; Flahault, A; Chartier-Kastler, E; Hanslik, T				Rossignol, Louise; Pelat, Camille; Lambert, Bruno; Flahault, Antoine; Chartier-Kastler, Emmanuel; Hanslik, Thomas			A Method to Assess Seasonality of Urinary Tract Infections Based on Medication Sales and Google Trends	PLOS ONE			English	Article							PUBLIC-HEALTH; PEAKS	Background: Despite the fact that urinary tract infection (UTI) is a very frequent disease, little is known about its seasonality in the community. Methods and Findings: To estimate seasonality of UTI using multiple time series constructed with available proxies of UTI. Eight time series based on two databases were used: sales of urinary antibacterial medications reported by a panel of pharmacy stores in France between 2000 and 2012, and search trends on the Google search engine for UTI-related terms between 2004 and 2012 in France, Germany, Italy, the USA, China, Australia and Brazil. Differences between summers and winters were statistically assessed with the Mann-Whitney test. We evaluated seasonality by applying the Harmonics Product Spectrum on Fast Fourier Transform. Seven time series out of eight displayed a significant increase in medication sales or web searches in the summer compared to the winter, ranging from 8% to 20%. The eight time series displayed a periodicity of one year. Annual increases were seen in the summer for UTI drug sales in France and Google searches in France, the USA, Germany, Italy, and China. Increases occurred in the austral summer for Google searches in Brazil and Australia. Conclusions: An annual seasonality of UTIs was evidenced in seven different countries, with peaks during the summer.	[Rossignol, Louise] Univ Paris 06, Dept Med Gen, Paris, France; [Rossignol, Louise] Univ Paris 06, UMRS 707, Paris, France; [Rossignol, Louise; Flahault, Antoine; Hanslik, Thomas] INSERM, U707, Paris, France; [Pelat, Camille] INSERM, U738, Paris, France; [Pelat, Camille] Univ Paris Diderot, UMRS 738, Paris, France; [Lambert, Bruno] IMS Hlth, La Defense, France; [Flahault, Antoine] Sorbonne Paris Cite, Descartes Sch Med, Paris, France; [Chartier-Kastler, Emmanuel] Urologist Hop Univ Pitie Salpetriere, AP HP, Fac Med Pierre & Marie Curie Paris 6, Paris, France; [Hanslik, Thomas] Univ Versailles St Quentin En Yvelines, Versailles, France	UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay	Rossignol, L (corresponding author), Univ Paris 06, Dept Med Gen, Paris, France.	rossignol@u707.jussieu.fr						Agence francaise de securite sanitaire des produits de sante, 2008, REC BONN PRAT DIAGN; Agence Nationale de Securite du Medicament, 2008, RES CAR PROD MON AD; Agence Nationale de Securite du Medicament, 2011, RES CAR PROD RUF; Al-Hasan MN, 2009, CLIN MICROBIOL INFEC, V15, P947, DOI 10.1111/j.1469-0691.2009.02877.x; Althouse BM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001258; ANDERSON JE, 1983, J EPIDEMIOL COMMUN H, V37, P286, DOI 10.1136/jech.37.4.286; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Chazan B, 2011, CLIN MICROBIOL INFEC, V17, P851, DOI 10.1111/j.1469-0691.2010.03327.x; Conseil de l'Ordre des pharmaciens, 2008, PHARM; Eber MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025298; EphMRA, 2012, AN CLASS; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; FoxNews.com, 2009, FOXNEWS; Freeman JT, 2009, CLIN MICROBIOL INFEC, V15, P951, DOI 10.1111/j.1469-0691.2009.02866.x; George DB, 2010, EPIDEMIOL INFECT, V138, P1679, DOI 10.1017/S0950268810001639; Google, 2012, UPD VERT TAX; Google, 2011, NOT IMPR OUR GEOGR A; Google, 2012, GOOGL INS SEARCH; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; Keating Karen N, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P457, DOI 10.1586/14737167.5.4.457; Pelat C, 2010, PHARMACOEPIDEM DR S, V19, P1009, DOI 10.1002/pds.1965; Pelat C, 2009, EMERG INFECT DIS, V15, P1327, DOI 10.3201/eid1508.090299; Perencevich EN, 2008, INFECT CONT HOSP EP, V29, P1124, DOI 10.1086/592698; Richet H, 2012, CLIN MICROBIOL INFEC, V18, P934, DOI 10.1111/j.1469-0691.2012.03954.x; SCHROEDER MR, 1968, J ACOUST SOC AM, V43, P829, DOI 10.1121/1.1910902; Singleton R. C., 1979, MIXED RADIX FAST FOU; STAMM WE, 1993, NEW ENGL J MED, V329, P1328, DOI 10.1056/NEJM199310283291808; STANSFELD JM, 1966, BMJ-BRIT MED J, V1, P631, DOI 10.1136/bmj.1.5488.631; Valdivia A, 2010, EURO SURVEILL, V15, P19621; Valdivia A, 2010, EMERG INFECT DIS, V16, P168, DOI 10.3201/eid1601.091308; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yang AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013728; Zeger SL, 2006, ANNU REV PUBL HEALTH, V27, P57, DOI 10.1146/annurev.publhealth.26.021304.144517	34	39	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76020	10.1371/journal.pone.0076020	http://dx.doi.org/10.1371/journal.pone.0076020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204587	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400010
J	Telford, RD; Cunningham, RB; Waring, P; Telford, RM; Olive, LS; Abhayaratna, WP				Telford, Richard D.; Cunningham, Ross B.; Waring, Paul; Telford, Rohan M.; Olive, Lisa S.; Abhayaratna, Walter P.			Physical Education and Blood Lipid Concentrations in Children: The LOOK Randomized Cluster Trial	PLOS ONE			English	Article							LIPOPROTEIN CHOLESTEROL LEVELS; CARDIOVASCULAR RISK; LIFE-STYLE; HEALTHY-CHILDREN; YOUNG FINNS; CHILDHOOD; ADOLESCENTS; ASSOCIATION; ADIPOSITY; ADULTHOOD	Background and Objectives: Elevated blood lipids during childhood are predictive of dyslipidemia in adults. Although obese and inactive children have elevated values, any potentially protective role of elementary school physical education is unknown. Our objective was to determine the effect of a modern elementary school physical education (PE) program on the blood lipid concentrations in community-based children. Methods: In this cluster-randomized controlled trial, 708 healthy children (8.1+/-0.3 years, 367 boys) in 29 schools were allocated to either a 4-year intervention program of specialist-taught PE (13 schools) or to a control group of the currently practiced PE conducted by generalist classroom teachers. Fasting blood lipids were measured at ages 8, 10, and 12 years and intervention and control class activities were recorded. Results: Intervention classes included more fitness work and more moderate and vigorous physical activity than control classes (both p<0.001). With no group differences at baseline, the percentage of 12 year-old boys and girls with elevated low density lipoprotein cholesterol (LDL-C, >3.36mmol.L-1,130 mg/dL) was lower in the intervention than control group (14% vs. 23%, p = 0.02). There was also an intervention effect on mean LDL-C across all boys (reduction of 9.6% for intervention v 2.8% control, p = 0.02), but not girls (p = 0.2). The intervention effect on total cholesterol mirrored LDL-C, but there were no detectable 4-year intervention effects on high-density lipoprotein cholesterol or triglycerides. Conclusions: The PE program delivered by specialist teachers over four years in elementary school reduced the incidence of elevated LDL-C in boys and girls, and provides a means by which early preventative practices can be offered to all children.	[Telford, Richard D.] Univ Canberra, Fac Hlth, Natl Inst Sports Studies, Canberra, ACT 2601, Australia; [Telford, Richard D.; Abhayaratna, Walter P.] Canberra Hosp, Acad Unit Internal Med, Clin Trials Unit, Garran, ACT, Australia; [Cunningham, Ross B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Waring, Paul] Australian Natl Univ, ANU Coll, Canberra, ACT, Australia; [Telford, Rohan M.] Univ Canberra, Fac Hlth, Ctr Res & Act Publ Hlth, Bruce, ACT, Australia; [Olive, Lisa S.] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia; [Abhayaratna, Walter P.] Australian Natl Univ, Sch Med, Coll Med Biol & Environm, Canberra, ACT, Australia	University of Canberra; Australian National University; Canberra Hospital; Australian National University; Australian National University; University of Canberra; Australian National University; Australian National University	Telford, RD (corresponding author), Univ Canberra, Fac Hlth, Natl Inst Sports Studies, Canberra, ACT 2601, Australia.	richard.telford@look.org.au		Olive, Lisa/0000-0003-4643-8561; Telford, Richard/0000-0003-4485-9362; Abhayaratna, Walter/0000-0002-4908-0641; Telford, Rohan/0000-0002-1723-2559	Commonwealth Education Trust (New Zealand House, London, UK); Canberra Hospital Salaried Staff Specialists Fund	Commonwealth Education Trust (New Zealand House, London, UK); Canberra Hospital Salaried Staff Specialists Fund	Sources of funding were The Commonwealth Education Trust (New Zealand House, London, UK) (http://www.commonwealth.org.uk/) and the Canberra Hospital Salaried Staff Specialists Fund (http://healthresearch.anu.edu.au/documents/PPFVACATION/ppf-major-info-2012.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LB, 2011, BRIT J SPORT MED, V45, P871, DOI 10.1136/bjsports-2011-090333; [Anonymous], AUSTR NAT CHILDR NUT; COHEN CJ, 1991, J SPORT MED PHYS FIT, V31, P183; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; Ducher G, 2009, AM J CLIN NUTR, V90, P1104, DOI 10.3945/ajcn.2009.28025; DUKE PM, 1980, PEDIATRICS, V66, P918; Eliakim A, 2000, INT J SPORTS MED, V21, P332, DOI 10.1055/s-2000-3779; Frontini MG, 2008, PEDIATRICS, V121, P924, DOI 10.1542/peds.2007-1472; Hands BP, 2004, PHYS ACTIVITY NUTR L; Juhola J, 2011, J PEDIATR-US, V159, P584, DOI 10.1016/j.jpeds.2011.03.021; Juonala M, 2010, CIRCULATION, V122, P2514, DOI 10.1161/CIRCULATIONAHA.110.966465; Kavey REW, 2003, J PEDIATR-US, V142, P368, DOI 10.1067/mpd.2003.205; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kriemler S, 2011, BRIT J SPORT MED, V45, P923, DOI 10.1136/bjsports-2011-090186; Lamb MM, 2011, AM J CLIN NUTR, V94, P877, DOI 10.3945/ajcn.111.015776; McKenzie T.L., 1991, J TEACH PHYS EDUC, V11, P195; Morgan PJ, 2008, RES Q EXERCISE SPORT, V79, P506, DOI 10.1080/02701367.2008.10599517; Nauck M, 2002, CLIN CHEM, V48, P236; Olive LS, 2012, MENTAL HLTH PHYS ACT, V5, P116, DOI DOI 10.1016/J.MHPA.2012.08.004; Resaland GK, 2011, SCAND J MED SCI SPOR, V21, pE122, DOI 10.1111/j.1600-0838.2010.01181.x; Sakuragi S, 2009, HYPERTENSION, V53, P611, DOI 10.1161/HYPERTENSIONAHA.108.123364; Southcott EK, 2010, CLIN CHIM ACTA, V411, P1421, DOI 10.1016/j.cca.2010.06.018; Srinivasan SR, 2006, PEDIATRICS, V118, P201, DOI 10.1542/peds.2005-1856; Stoedefalke K, 2000, ACTA PAEDIATR, V89, P1290, DOI 10.1080/080352500300002453; Tanner JM, 1962, GROWTH ADOLESCENCE, P1; Telford RD, 2009, ANN HUM BIOL, P1; Telford RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050014; Telford RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047438; Telford RD, 2012, AM J PUBLIC HEALTH, V102, P368, DOI 10.2105/AJPH.2011.300220; Telford RD, 2009, J SCI MED SPORT, V12, P156, DOI 10.1016/j.jsams.2007.03.009; Tomkinson GR, 2003, SPORTS MED, V33, P285, DOI 10.2165/00007256-200333040-00003; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e	32	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76124	10.1371/journal.pone.0076124	http://dx.doi.org/10.1371/journal.pone.0076124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204594	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400011
J	Lajus, J; Kraikovski, A; Lajus, D				Lajus, Julia; Kraikovski, Alexei; Lajus, Dmitry			Coastal Fisheries in the Eastern Baltic Sea (Gulf of Finland) and Its Basin from the 15 to the Early 20th Centuries	PLOS ONE			English	Article							WHITE; CATCH; POPULATIONS; DYNAMICS; EUROPE; FISH	The paper describes and analyzes original data, extracted from historical documents and scientific surveys, related to Russian fisheries in the southeastern part of the Gulf of Finland and its inflowing rivers during the 15- early 20th centuries. The data allow tracing key trends in fisheries development and in the abundance of major commercial species. In particular, results showed that, over time, the main fishing areas moved from the middle part of rivers downstream towards and onto the coastal sea. Changes in fishing patterns were closely interrelated with changes in the abundance of exploited fish. Anadromous species, such as Atlantic sturgeon, Atlantic salmon, brown trout, whitefish, vimba bream, smelt, lamprey, and catadromous eel were the most important commercial fish in the area because they were abundant, had high commercial value and were easily available for fishing in rivers. Due to intensive exploitation and other human-induced factors, populations of most of these species had declined notably by the early 20th century and have now lost commercial significance. The last sturgeon was caught in 1996, and today only smelt and lamprey support small commercial fisheries. According to historical sources, catches of freshwater species such as roach, ide, pike, perch, ruffe and burbot regularly occurred, in some areas exceeding half of the total catch, but they were not as important as migrating fish and no clear trends in abundance are apparent. Of documented marine catch, Baltic herring appeared in the 16th century, but did not become commercially significant until the 19th century. From then until now herring have been the dominant catch.	[Lajus, Julia] Natl Res Univ, Higher Sch Econ, St Petersburg, Russia; [Lajus, Julia; Kraikovski, Alexei] European Univ St Petersburg, St Petersburg, Russia; [Lajus, Dmitry] St Petersburg State Univ, St Petersburg 199034, Russia	HSE University (National Research University Higher School of Economics); European University at Saint Petersburg; Saint Petersburg State University	Lajus, D (corresponding author), St Petersburg State Univ, St Petersburg 199034, Russia.	dlajus@gmail.com	Kraikovski, Alexei/GVS-8917-2022; Lajus, Dmitry L/L-1326-2013; Kraikovski, Alexei/C-2960-2012	Lajus, Dmitry L/0000-0002-2264-5825; Kraikovski, Alexei/0000-0002-1355-7954	Alfred P. Sloan Foundation (United States of America); Census of Marine Life; History of Marine Animal Populations Programme; Russian Foundation for Basic Research [10-04-91005-ANF_a]	Alfred P. Sloan Foundation (United States of America); Census of Marine Life; History of Marine Animal Populations Programme; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This research was supported by Alfred P. Sloan Foundation (United States of America), Census of Marine Life, History of Marine Animal Populations Programme, which also provided publication fees, and a grant from Russian Foundation for Basic Research 10-04-91005-ANF_a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1882, MAT STAT NARODNOGO K, V17; [Anonymous], 1871, B ST PET POL, P141; [Anonymous], 1885, MAT STAT NARODNOGO K, V3; [Anonymous], 1851, VOENN STAT OB ROSS I, V3; Barrett JH, 2004, P ROY SOC B-BIOL SCI, V271, P2417, DOI 10.1098/rspb.2004.2885; Beliaev ID, 1851, VREMENNIK IMPERATORS, V11; Berg LS, 1940, IZVESTIIA VNIORKH, V23, P3; Berg LS, 1912, FAUNA ROSSII SSSR SO, VIII, P1; Bogoiavlensky SK, 1905, NOVGORODSKIE PISTSOV, V5; Borodin NA, 1909, VESTNIK RYBOPROMYSHL, V24, P368; Danilevsky NA, 1875, ISSLEDOVANIA SOSTOIA, VIX; Domrachev PF, 1926, MAT ISSLEDOVANIIU RE, V10; Eero M, 2007, ICES J MAR SCI, V64, P1257, DOI 10.1093/icesjms/fsm114; Frantsuzova EB, 2002, GORODA ROSSII 16 VEK; Grimm OA, 1905, VESTNIK RYBOPROMYSHL, V4, P211; Grimm OA, 1889, SELSKOYE KHOZIAISTVO, VCLXII, P121; Hoffmann RC, 1996, AM HIST REV, V101, P631, DOI 10.2307/2169418; Holm Poul, 2010, P3; Isachenko GA, 1998, OKNO EVROPU ISTORIA; Ivanova-Berg M.M., 1932, IZVESTIYA INSTITUTA, VXIV, P5; IYu Popov, 2003, K AQ 11 14 NOV 2003, P127; Jackson JBC, 2011, FUTURE OCEAN FISHERI; Karlsson Lars, 1994, Dana, V10, P61; Kazakov RV, 1990, ISKUSSTVENNOE FORMIR; KAZAKOV RV, 1998, ATLANTICHESKII LOSOS, P383; Kessler K, 1864, ESTESTVENNO ISTORICH, VI; Kuchina EC, 1939, IZVESTIYA VSESOYUZNO, V21, P157; Kudersky LA, 2005, MAT K AQ ST PET, P324; Kudersky LA, 1999, FINSKII ZALIV USLOVI, P257; Kuratov AA, 1991, METROLOGIA ROSSII RU; Laamanen M, 2005, 22005 HELCOM EUTRO; Lajus DL, 2005, ICES J MAR SCI, V62, P1426, DOI 10.1016/j.icesjms.2005.02.011; Lajus DL, 2007, FISH RES, V87, P255, DOI 10.1016/j.fishres.2007.06.018; Lajus DL, 2007, FISH RES, V87, P240, DOI 10.1016/j.fishres.2007.07.001; Lajus J., 2010, MORE NASHE POLE KOLI; LAJUS JA, 2001, EXPLOITED SEAS NEW D, P67; Lajus J, 2007, FISH RES, V87, P126, DOI 10.1016/j.fishres.2007.07.004; Lebedev V.D, 1960, PRESNOVODNAIA CHETVE; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Ludwig A, 2002, NATURE, V419, P447, DOI 10.1038/419447a; Luzanskaia DI, 1965, RYBOKHOZIASTVENNOE I; MacKenzie BR, 2002, CAN J FISH AQUAT SCI, V59, P173, DOI 10.1139/F01-201; MacKenzie BR, 2011, MAR POLICY, V35, P266, DOI 10.1016/j.marpol.2010.10.004; McKinnell SM, 1999, ICES J MAR SCI, V56, P433, DOI 10.1006/jmsc.1999.0456; Mikhin V, 1935, RYBNUIU IND SEVERA, V12, P24; Mikhin V. S., 1932, IZVESTIIA VNIORKH, V15, P3; Ojaveer H, 2007, FISH RES, V87, P137, DOI 10.1016/j.fishres.2007.07.010; Ojaveer H, 2007, FISH RES, V87, P102, DOI 10.1016/j.fishres.2007.08.011; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Ozeretskovsky NYa, 1812, PUTESHESTVIE AKAD N; Paaver T., 1996, STURGEON Q, V4, P3; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Persov P, 1935, ZA RYBNUIU IND SEVER, V10, P38; Podushka S.B, 1999, POIMKA ATLANTICHESKO, P5; Savvaitov P, 1868, NOVGORODSKIE PISCOVY, V3; Schultz AYa, 1863, ISSKEDOVANIA SOSTOIA, VVII; Sendek DS, 2010, VOPROSY RYBOLOVSTVA, V11, P514; Shaskolsky IP, 1994, RUSSKAIA MORSKAIA TO; Shimansky A, 1921, NEVA RYBAK SEVERA, V1, P9; Shustov Y., 2003, ATLANTIC SALMON BIOL, P51; Smirnov A.N., 1972, Inst ozern rechn rybn Khozyaist, V82, P3; Tikhiy MI, 1923, T PERVOGO VSEROSSIIS, P35; Van Neer W., 2010, ECOLOGIES EC MEDIEVA, P193, DOI DOI 10.1163/EJ.9789004180079.I-227.33; von Baer KE, 1860, ISSLEDOVANIA SOSTOIA, VI; Yergomyshev N, 1910, VESTNIK RYBOPROMYSHL, VXXV, P383; Zotov AI, 1899, VESTNIK RYBOPROMYSHL, VXIV, P259; Zotov AI, 1899, VESTNIK RYBOPROMYSHL, VXIV, P6; Zotov II, 1889, SEZD RUSSKIKH RYBOPR, P124	68	19	19	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77059	10.1371/journal.pone.0077059	http://dx.doi.org/10.1371/journal.pone.0077059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204735	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300014
J	Chiou, YW; Lin, HK; Tang, MJ; Lin, HH; Yeh, ML				Chiou, Yu-Wei; Lin, Hsiu-Kuan; Tang, Ming-Jer; Lin, Hsi-Hui; Yeh, Ming-Long			The Influence of Physical and Physiological Cues on Atomic Force Microscopy-Based Cell Stiffness Assessment	PLOS ONE			English	Article							LOW SUBSTRATUM RIGIDITY; STEM-CELLS; VISCOELASTIC PROPERTIES; MECHANICAL-PROPERTIES; ACTIN CYTOSKELETON; ACTOMYOSIN TENSION; EPITHELIAL-CELLS; ELASTICITY; FIBROBLASTS; PROTEINS	Atomic force microscopy provides a novel technique for differentiating the mechanical properties of various cell types. Cell elasticity is abundantly used to represent the structural strength of cells in different conditions. In this study, we are interested in whether physical or physiological cues affect cell elasticity in Atomic force microscopy (AFM)-based assessments. The physical cues include the geometry of the AFM tips, the indenting force and the operating temperature of the AFM. All of these cues show a significant influence on the cell elasticity assessment. Sharp AFM tips create a two-fold increase in the value of the effective Young's modulus (Eeff) relative to that of the blunt tips. Higher indenting force at the same loading rate generates higher estimated cell elasticity. Increasing the operation temperature of the AFM leads to decreases in the cell stiffness because the structure of actin filaments becomes disorganized. The physiological cues include the presence of fetal bovine serum or extracellular matrix-coated surfaces, the culture passage number, and the culture density. Both fetal bovine serum and the extracellular matrix are critical for cells to maintain the integrity of actin filaments and consequently exhibit higher elasticity. Unlike primary cells, mouse kidney progenitor cells can be passaged and maintain their morphology and elasticity for a very long period without a senescence phenotype. Finally, cell elasticity increases with increasing culture density only in MDCK epithelial cells. In summary, for researchers who use AFM to assess cell elasticity, our results provide basic and significant information about the suitable selection of physical and physiological cues.	[Chiou, Yu-Wei; Yeh, Ming-Long] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Lin, Hsiu-Kuan; Tang, Ming-Jer; Lin, Hsi-Hui] Natl Cheng Kung Univ, Dept Physiol, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University	Lin, HH (corresponding author), Natl Cheng Kung Univ, Dept Physiol, Tainan 70101, Taiwan.	sophialin0113@hotmail.com; mlyeh@mail.ncku.edu.tw		Lin, Hsi-Hui/0000-0002-4880-3481; Tang, Ming-Jer/0000-0002-0883-4363	National Science Council of Taiwan [100-2627-B006-009-, 100-2627-B006-018-]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan (100-2627-B006-009- and 100-2627-B006-018-) (http://web1.nsc.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JL, 2003, LIFE SCI, V72, P2553, DOI 10.1016/S0024-3205(03)00165-6; Battista PJ, 1991, IN VITRO CELL DEV BI, V27; Berdyyeva TK, 2005, PHYS MED BIOL, V50, P81, DOI 10.1088/0031-9155/50/1/007; BILODEAU GG, 1992, J APPL MECH-T ASME, V59, P519, DOI 10.1115/1.2893754; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; Califano JP, 2010, CELL MOL BIOENG, V3, P68, DOI 10.1007/s12195-010-0102-6; Chancellor TJ, 2010, BIOPHYS J, V99, P115, DOI 10.1016/j.bpj.2010.04.011; Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040; CHRZANOWSKAWODNICKA M, 1994, J CELL SCI, V107, P3643; Clark EA, 1996, J BIOL CHEM, V271, P14814, DOI 10.1074/jbc.271.25.14814; Costa KD, 2006, J BIOMECH ENG-T ASME, V128, P176, DOI 10.1115/1.2165690; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Cuerrier CM, 2007, BIOCHEM BIOPH RES CO, V355, P632, DOI 10.1016/j.bbrc.2007.01.190; Docheva D, 2008, J CELL MOL MED, V12, P537, DOI 10.1111/j.1582-4934.2007.00138.x; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; FERRI A, 1982, BIOCHEM J, V205, P281, DOI 10.1042/bj2050281; Goncalves RP, 2006, NAT METHODS, V3, P1007, DOI 10.1038/nmeth965; Guck J, 2010, INTEGR BIOL-UK, V2, P575, DOI 10.1039/c0ib00050g; Hategan A, 2003, BIOPHYS J, V85, P2746, DOI 10.1016/S0006-3495(03)74697-9; Ketene AN, 2012, INTEGR BIOL-UK, V4, P540, DOI 10.1039/c2ib00168c; Ketene AN, 2012, NANOMED-NANOTECHNOL, V8, P93, DOI 10.1016/j.nano.2011.05.012; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Kidoaki S, 2007, J BIOMED MATER RES A, V81A, P803, DOI 10.1002/jbm.a.31114; Kim DH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00555; Koch CM, 2013, GENOME RES, V23, P248, DOI 10.1101/gr.141945.112; Kuznetsova TG, 2007, MICRON, V38, P824, DOI 10.1016/j.micron.2007.06.011; Lee PT, 2010, STEM CELLS, V28, P573, DOI 10.1002/stem.310; Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Lim SM, 2010, EXP CELL RES, V316, P2833, DOI 10.1016/j.yexcr.2010.06.010; Lu L, 2008, BIOPHYS J, V95, P6060, DOI 10.1529/biophysj.108.133462; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Lulevich V, 2006, LANGMUIR, V22, P8151, DOI 10.1021/la060561p; Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9; Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; Muller DJ, 2008, NAT NANOTECHNOL, V3, P261, DOI 10.1038/nnano.2008.100; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Obataya I, 2005, NANO LETT, V5, P27, DOI 10.1021/nl0485399; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Pelling AE, 2007, NANOMED-NANOTECHNOL, V3, P43, DOI 10.1016/j.nano.2006.11.006; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Roduit C, 2009, BIOPHYS J, V97, P674, DOI 10.1016/j.bpj.2009.05.010; Rotsch C, 1997, CELL BIOL INT, V21, P685, DOI 10.1006/cbir.1997.0213; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; SHYY TT, 1989, J CELL BIOL, V108, P997, DOI 10.1083/jcb.108.3.997; Sirghi L, 2008, EUR BIOPHYS J BIOPHY, V37, P935, DOI 10.1007/s00249-008-0311-2; Sokolov I, 2007, CANCER NANOTECHNOL, P1; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Sunyer R, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025009; Takai E, 2005, ANN BIOMED ENG, V33, P963, DOI 10.1007/s10439-005-3555-3; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Trickey WR, 2006, J BIOMECH, V39, P78, DOI 10.1016/j.jbiomech.2004.11.006; Wang YH, 2007, J BIOL CHEM, V282, P752, DOI 10.1074/jbc.M604801200; Wang YK, 2001, AM J PHYSIOL-CELL PH, V280, pC1440, DOI 10.1152/ajpcell.2001.280.6.C1440; Wei WC, 2008, AM J PHYSIOL-CELL PH, V295, pC1579, DOI 10.1152/ajpcell.00223.2008; WELCH WJ, 1985, J CELL BIOL, V101, P1198, DOI 10.1083/jcb.101.4.1198; Zeng XM, 2007, STEM CELL REV, V3, P270, DOI 10.1007/s12015-007-9005-x; Zhang QP, 2002, GENOMICS, V80, P473, DOI 10.1006/geno.2002.6859	67	55	57	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77384	10.1371/journal.pone.0077384	http://dx.doi.org/10.1371/journal.pone.0077384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194882	gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000061
J	Mickenautsch, S; Yengopal, V				Mickenautsch, Steffen; Yengopal, Veerasamy			Validity of Sealant Retention as Surrogate for Caries Prevention - A Systematic Review	PLOS ONE			English	Review							GLASS-IONOMER CEMENT; END-POINTS; FISSURE SEALANTS; CLINICAL-TRIALS; RESIN; PIT; PROPORTION; CRITERIA; MARKER	Introduction/Aim: To appraise the clinical literature in determining whether loss of complete sealant retention as surrogate endpoint is directly associated with caries occurrence on sealed teeth as its clinical endpoint and to apply the appraised evidence in testing the null-hypothesis that the retention/caries ratio between different types of sealant materials (resin and glass-ionomer cement) is not statistically significant (= Prentice criterion for surrogate endpoint validity). Methods: Databases searched PubMed/Medline, Directory of Open Access Journals; IndMed, Scielo. Systematic reviews were checked for suitable trials. The search terms: "fiss* AND seal*" and "fissure AND sealant" were used. Article selection criteria were: clinical trial reporting on the retention and caries occurrence of resin and/or glass-ionomer cement (GIC) fissure sealed permanent molar teeth; minimum 24-month follow-up period; systematic review or meta-analysis. Datasets and information were extracted from accepted trials. The principle outcome measure was the ratio of Risk of loss of complete retention to the Risk of caries occurrence per sealant type (RCR). Risk of bias was assessed in trials and sensitivity analysis with regard to potential confounding factors conducted. The null-hypothesis was tested by graphical and statistical methods. Results: The risk of loss of complete retention of sealant materials was associated with the risk of caries occurrence for resin but not for GIC based sealants. The difference between RCR values of the two sealant types was statistically significant (p<0.05). The null-hypothesis was rejected. Conclusions: The current clinical evidence suggests that complete retention of pit and fissure sealants may not be a valid surrogate endpoint for caries prevention as its clinical endpoint. Further research is required to corroborate the current results.	[Mickenautsch, Steffen; Yengopal, Veerasamy] Univ Witwatersrand, Fac Hlth Sci, Dept Community Dent, Systemat Review Initiat Evidence Based Minimum In, Johannesburg, South Africa	University of Witwatersrand	Mickenautsch, S (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Community Dent, Systemat Review Initiat Evidence Based Minimum In, Johannesburg, South Africa.	neem@global.co.za	Mickenautsch, Steffen/D-1235-2013	Mickenautsch, Steffen/0000-0002-4994-2328				Abt E, 2004, J EVID BASED DENT PR, V4, P200; Ahovuo-Saloranta A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001830.pub3; Baker Stuart G, 2003, BMC Med Res Methodol, V3, P16, DOI 10.1186/1471-2288-3-16; Berger VW, 2005, STAT PRACT, P1, DOI 10.1002/0470863641; Buyse M, 1998, BIOMETRICS, V54, P1014, DOI 10.2307/2533853; Molina GF, 2009, J APPL ORAL SCI, V17, P89, DOI 10.1590/S1678-77572009000700016; Feigal Robert J, 2002, Pediatr Dent, V24, P415; Flandre P, 1999, STAT MED, V18, P107, DOI 10.1002/(SICI)1097-0258(19990115)18:1<107::AID-SIM965>3.0.CO;2-P; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Frencken JE, 1999, ATRAUMATIC RESTORATI; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; GOING RE, 1977, J AM DENT ASSOC, V95, P972, DOI 10.14219/jada.archive.1977.0163; Gupta K, 2010, J CLIN RES BEST PRAC, V8, P1; Holloway RG, 2002, NEUROLOGY, V58, P679, DOI 10.1212/WNL.58.5.679; HOROWITZ HS, 1977, J AM DENT ASSOC, V95, P1133, DOI 10.14219/jada.archive.1977.0201; Kitchens Dinah H, 2005, J Contemp Dent Pract, V6, P95; Kuhnisch J, 2012, DENT MATER, V28, P298, DOI 10.1016/j.dental.2011.11.002; MEJARE I, 1990, SCAND J DENT RES, V98, P345; Mickenautsch S, 2013, J MINIMUM INTERV DEN, V6, P30; Mickenautsch S, 2013, OPEN DENT J, V7, P102, DOI 10.2174/18742106201305130001; Mickenautsch Steffen, 2011, BMC Res Notes, V4, P22, DOI 10.1186/1756-0500-4-22; OVREBO RC, 1990, SCAND J DENT RES, V98, P66; Papacchini F, 2005, J DENT, V33, P459, DOI 10.1016/j.jdent.2004.11.007; PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407; Quinonez RB, 2005, J PUBLIC HEALTH DENT, V65, P82, DOI 10.1111/j.1752-7325.2005.tb02791.x; ROCK WP, 1982, J DENT, V10, P39, DOI 10.1016/0300-5712(82)90007-0; THYLSTRUP A, 1978, SCAND J DENT RES, V86, P21; Tucker GT, 1995, CLIN MEASUREMENT DRU; Wang Y, 2002, BIOMETRICS, V58, P803, DOI 10.1111/j.0006-341X.2002.00803.x; WILSON AD, 1985, BIOMATERIALS, V6, P431, DOI 10.1016/0142-9612(85)90107-3; Yengopal V, 2010, EUR ARCH PAEDIATR DE, V11, P18, DOI 10.1007/BF03262705	31	43	47	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77103	10.1371/journal.pone.0077103	http://dx.doi.org/10.1371/journal.pone.0077103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194861	Green Published, gold			2022-12-27	WOS:000326037000040
J	Mills, JD; Kavanagh, T; Kim, WS; Chen, BJ; Kawahara, Y; Halliday, GM; Janitz, M				Mills, James D.; Kavanagh, Tomas; Kim, Woojin S.; Chen, Bei Jun; Kawahara, Yoshihiro; Halliday, Glenda M.; Janitz, Michael			Unique Transcriptome Patterns of the White and Grey Matter Corroborate Structural and Functional Heterogeneity in the Human Frontal Lobe	PLOS ONE			English	Article							RNA-SEQ; GENE; ALZHEIMERS; NEURONS; DISEASE; COMPLEX; TOPHAT; CORTEX; GALAXY; VOLUME	The human frontal lobe has undergone accelerated evolution, leading to the development of unique human features such as language and self-reflection. Cortical grey matter and underlying white matter reflect distinct cellular compositions in the frontal lobe. Surprisingly little is known about the transcriptomal landscape of these distinct regions. Here, for the first time, we report a detailed transcriptomal profile of the frontal grey (GM) and white matter (WM) with resolution to alternatively spliced isoforms obtained using the RNA-Seq approach. We observed more vigorous transcriptome activity in GM compared to WM, presumably because of the presence of cellular bodies of neurons in the GM and RNA associated with the nucleus and perinuclear space. Among the top differentially expressed genes, we also identified a number of long intergenic non-coding RNAs (lincRNAs), specifically expressed in white matter, such as LINC00162. Furthermore, along with confirmation of expression of known markers for neurons and oligodendrocytes, we identified a number of genes and splicing isoforms that are exclusively expressed in GM or WM with examples of GABRB2 and PAK2 transcripts, respectively. Pathway analysis identified distinct physiological and biochemical processes specific to grey and white matter samples with a prevalence of synaptic processes in GM and myelination regulation and axonogenesis in the WM. Our study also revealed that expression of many genes, for example, the GPR123, is characterized by isoform switching, depending in which structure the gene is expressed. Our report clearly shows that GM and WM have perhaps surprisingly divergent transcriptome profiles, reflecting distinct roles in brain physiology. Further, this study provides the first reference data set for a normal human frontal lobe, which will be useful in comparative transcriptome studies of cerebral disorders, in particular, neurodegenerative diseases.	[Mills, James D.; Kavanagh, Tomas; Chen, Bei Jun; Janitz, Michael] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Kim, Woojin S.; Halliday, Glenda M.] Neurosci Res Australia, Sydney, NSW, Australia; [Kim, Woojin S.; Halliday, Glenda M.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Kawahara, Yoshihiro] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Bioinformat Res Unit, Tsukuba, Ibaraki, Japan	University of New South Wales Sydney; Neuroscience Research Australia; University of New South Wales Sydney; National Institute of Agrobiological Sciences - Japan	Janitz, M (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	m.janitz@unsw.edu.au	Halliday, Glenda M/E-8555-2011; Janitz, Michael/E-9823-2015	Halliday, Glenda M/0000-0003-0422-8398; Janitz, Michael/0000-0002-4878-0259; Kavanagh, Tomas/0000-0003-2184-3552; Chen, Bei Jun/0000-0002-1910-9079	National Health and Medical Research Council of Australia (NHMRC) [1022325]; National Health and Medical Research Council of Australia (NHMRC); University of New South Wales; Neuroscience Research Australia; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism [NIH (NIAAA) R24AA012725]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725, R24AA012725] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales; Neuroscience Research Australia; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a National Health and Medical Research Council of Australia (NHMRC) project grant (#1022325). GMH is a NHMRC Senior Principal Research Fellow (#630434). Tissues were received from the Sydney Brain Bank at Neuroscience Research Australia and the New South Wales Tissue Resource Centre at the University of Sydney which are supported by the National Health and Medical Research Council of Australia (NHMRC), University of New South Wales, Neuroscience Research Australia, Schizophrenia Research Institute and National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA) R24AA012725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Borgwardt S, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-138; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Costa V, 2013, EUR J HUM GENET, V21, P134, DOI 10.1038/ejhg.2012.129; Courtney E, 2010, J NEUROSCI METH, V193, P189, DOI 10.1016/j.jneumeth.2010.08.018; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Halliday GM, 2011, ACTA NEUROPATHOL, V122, P187, DOI 10.1007/s00401-011-0852-9; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Ho-Pun-Cheung A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-31; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johns TG, 1999, J NEUROCHEM, V72, P1, DOI 10.1046/j.1471-4159.1999.0720001.x; Khodosevich K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-18; Kim MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009003; KIMBERG DY, 1993, J EXP PSYCHOL GEN, V122, P411, DOI 10.1037/0096-3445.122.4.411; Lagerstrom MC, 2007, J NEUROCHEM, V100, P1129, DOI 10.1111/j.1471-4159.2006.04281.x; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; Mills JD, 2013, NEUROSCI LETT, V536, P90, DOI 10.1016/j.neulet.2012.12.042; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosell A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016750; Sachdev PS, 2013, CURR OPIN PSYCHIATR, V26, P244, DOI 10.1097/YCO.0b013e32835ed6e8; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394; Sibille E, 2008, J NEUROSCI METH, V167, P198, DOI 10.1016/j.jneumeth.2007.08.009; Smaers JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009123; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wakabayashi K, 1998, J NEUROL SCI, V156, P114, DOI 10.1016/S0022-510X(98)00018-5; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036351; ZILES K, 2011, HUMAN NERVOUS SYSTEM, P836	44	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78480	10.1371/journal.pone.0078480	http://dx.doi.org/10.1371/journal.pone.0078480			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194939	gold, Green Submitted, Green Published			2022-12-27	WOS:000326037000118
J	Nozaki, Y; Koyasu, M				Nozaki, Yuki; Koyasu, Masuo			The Relationship between Trait Emotional Intelligence and Interaction with Ostracized Others' Retaliation	PLOS ONE			English	Article							ULTIMATUM GAME; DARK SIDE; UNFAIRNESS; ANGER; INFORMATION; EXPLORATION; PERFORMANCE; VALIDATION; SEROTONIN; CRITERION	Background: Regulation of emotions in others is distinct from other activities related to trait emotional intelligence in that only such behavior can directly change other people's psychological states. Although emotional intelligence has generally been associated with prosociality, emotionally intelligent people may manipulate others' behaviors to suit their own interests using high-level capabilities to read and manage the emotions of others. This study investigated how trait emotional intelligence was related to interacting with ostracized others who attempt retaliation. Method: We experimentally manipulated whether two people were simultaneously ostracized or not by using an online ball-tossing game called Cyberball. Eighty university students participated in Cyberball for manipulating ostracism and a "recommendation game," a variation of the ultimatum game for assessing how to interact with others who attempt retaliation, with four participants. After the recommendation game, participants rated their intention to retaliate during the game. Results: People with higher interpersonal emotional intelligence were more likely to recommend that the ostracized other should inhibit retaliation and maximize additional rewards when they have a weaker intention to retaliate. However, they were more likely to recommend that the ostracized other should retaliate against the ostracizers when they have a stronger intention to retaliate. Conclusion: This is the first laboratory study that empirically reveals that people with high interpersonal emotional intelligence influence others' emotions based on their own goals contrary to the general view. Trait emotional intelligence itself is neither positive nor negative, but it can facilitate interpersonal behaviors for achieving goals. Our study offers valuable contributions for the refinement of the trait emotional intelligence concept in the respect of its social function.	[Nozaki, Yuki; Koyasu, Masuo] Kyoto Univ, Grad Sch Educ, Kyoto, Japan; [Nozaki, Yuki] Japan Soc Promot Sci, Tokyo, Japan	Kyoto University; Japan Society for the Promotion of Science	Nozaki, Y (corresponding author), Kyoto Univ, Grad Sch Educ, Kyoto, Japan.	yuki.nozaki.kt@gmail.com	Nozaki, Yuki/AAY-5041-2021	Nozaki, Yuki/0000-0001-6510-7827	 [23243071]		This research was supported by a Grants-in-Aid for Scientific Research-Scientific Research (A), Grant No. 23243071(http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Austin EJ, 2005, PERS INDIV DIFFER, V39, P403, DOI 10.1016/j.paid.2005.01.017; Austin EJ, 2004, PERS INDIV DIFFER, V36, P1855, DOI 10.1016/j.paid.2003.07.006; Austin EJ, 2007, PERS INDIV DIFFER, V43, P179, DOI 10.1016/j.paid.2006.11.019; Bates D, 2012, LME4 LINEAR MIXED EF; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Chow RM, 2008, J EXP SOC PSYCHOL, V44, P896, DOI 10.1016/j.jesp.2007.09.004; Cote S, 2011, PSYCHOL SCI, V22, P1073, DOI 10.1177/0956797611416251; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; Ford BQ, 2012, EMOTION, V12, P685, DOI 10.1037/a0027149; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Goleman D, 2020, EMOTIONAL INTELLIGEN, V25th; Gross JJ, 1999, COGNITION EMOTION, V13, P551, DOI 10.1080/026999399379186; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Harle KM, 2007, EMOTION, V7, P876, DOI 10.1037/1528-3542.7.4.876; Jaccard James., 2001, INTERACTION EFFECTS, DOI 10.4135/9781412984515; Kilduff M, 2010, RES ORGAN BEHAV, V30, P129, DOI 10.1016/j.riob.2010.10.002; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Laborde S, 2010, PERS INDIV DIFFER, V49, P784, DOI 10.1016/j.paid.2010.06.031; Law KS, 2004, J APPL PSYCHOL, V89, P483, DOI 10.1037/0021-9010.89.3.483; Leary MR, 2006, PERS SOC PSYCHOL REV, V10, P111, DOI 10.1207/s15327957pspr1002_2; Lelieveld GJ, 2013, SOC PSYCHOL PERS SCI, V4, P206, DOI 10.1177/1948550612446661; Levenson RW, 1999, COGNITION EMOTION, V13, P481, DOI 10.1080/026999399379159; Lopes PN, 2005, EMOTION, V5, P113, DOI 10.1037/1528-3542.5.1.113; Maslow A.H., 1968, PSYCHOL BEING, V(2nd); Mayer J. D., 1997, EMOTIONAL DEV EMOTIO, P3, DOI DOI 10.1177/1066480710387486; Mayer JD, 1999, INTELLIGENCE, V27, P267, DOI 10.1016/S0160-2896(99)00016-1; Mayer JD, 2008, ANNU REV PSYCHOL, V59, P507, DOI 10.1146/annurev.psych.59.103006.093646; McEnrue P, 2010, LEADERSH REV, V10, P3; Mikolajczak M, 2007, J RES PERS, V41, P1107, DOI 10.1016/j.jrp.2007.01.003; Mikolajczak M, 2008, PERS INDIV DIFFER, V44, P1445, DOI 10.1016/j.paid.2007.12.012; Mikolajczak M, 2009, BRIT J PSYCHOL, V100, P699, DOI 10.1348/000712608X395522; Niven K, 2009, EMOTION, V9, P498, DOI 10.1037/a0015962; Nozaki Y, 2012, JPN J PERS, V20, P179; Nozaki Y, 2013, PSYCHOLOGIA IN PRESS; Petrides KV, 2007, COGNITION EMOTION, V21, P26, DOI 10.1080/02699930601038912; Petrides KV, 2007, BRIT J PSYCHOL, V98, P273, DOI 10.1348/000712606X120618; Petrides KV, 2003, EUR J PERSONALITY, V17, P39, DOI 10.1002/per.466; Petrides KV, 2001, EUR J PERSONALITY, V15, P425, DOI 10.1002/per.416; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; R Development Core Team, 2012, R LANG ENV STAT COMP; Sakurai Y., 2007, B CTR ED RES DEV, V16, P13; Salovey P., 1990, IMAGINATION COGNITIO, V9, P185, DOI [https://doi.org/10.2190/DUGG-P24E-52WK-6CDG, 10.2190/DUGG-P24E-52WK-6CDG, DOI 10.2190/DUGG-P24E-52WK-6CDG]; Schroder-Abe M, 2011, EUR J PERSONALITY, V25, P155, DOI 10.1002/per.818; Schutte NS, 2001, J SOC PSYCHOL, V141, P523, DOI 10.1080/00224540109600569; Schwarz N, 2003, PSYCHOL INQ, V14, P296, DOI 10.1207/S15327965PLI1403&4_20; Takahashi H, 2012, P NATL ACAD SCI USA, V109, P4281, DOI 10.1073/pnas.1118687109; Telle NT, 2011, PERS INDIV DIFFER, V50, P523, DOI 10.1016/j.paid.2010.11.010; Tett RP, 2005, PERS SOC PSYCHOL B, V31, P859, DOI 10.1177/0146167204272860; Twenge JM, 2001, J PERS SOC PSYCHOL, V81, P1058, DOI 10.1037//0022-3514.81.6.1058; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Williams KD, 2009, ADV EXP SOC PSYCHOL, V41, P275, DOI 10.1016/S0065-2601(08)00406-1; Wong CS, 2002, LEADERSHIP QUART, V13, P243, DOI 10.1016/S1048-9843(02)00099-1; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006; Zeidner M, 2008, EUR PSYCHOL, V13, P64, DOI 10.1027/1016-9040.13.1.64	56	16	16	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77579	10.1371/journal.pone.0077579	http://dx.doi.org/10.1371/journal.pone.0077579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194890	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000069
J	Veloso, A; Biewen, B; Paulsen, MT; Berg, N; Lima, LCD; Prasad, J; Bedi, K; Magnuson, B; Wilson, TE; Ljungman, M				Veloso, Artur; Biewen, Benjamin; Paulsen, Michelle T.; Berg, Nathan; de Andrade Lima, Leonardo Carmo; Prasad, Jayendra; Bedi, Karan; Magnuson, Brian; Wilson, Thomas E.; Ljungman, Mats			Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin	PLOS ONE			English	Article							DNA TOPOISOMERASE-I; RNA-POLYMERASE-II; DOUBLE-STRAND BREAKS; DRUG CAMPTOTHECIN; CLEAVABLE COMPLEXES; CELLS; ELONGATION; REPAIR; DAMAGE; INITIATION	The anti-cancer drug camptothecin inhibits replication and transcription by trapping DNA topoisomerase I (Top1) covalently to DNA in a "cleavable complex". To examine the effects of camptothecin on RNA synthesis genome-wide we used Bru-Seq and show that camptothecin treatment primarily affected transcription elongation. We also observed that camptothecin increased RNA reads past transcription termination sites as well as at enhancer elements. Following removal of camptothecin, transcription spread as a wave from the 5'-end of genes with no recovery of transcription apparent from RNA polymerases stalled in the body of genes. As a result, camptothecin preferentially inhibited the expression of large genes such as proto-oncogenes, and anti-apoptotic genes while smaller ribosomal protein genes, pro-apoptotic genes and p53 target genes showed relative higher expression. Cockayne syndrome group B fibroblasts (CS-B), which are defective in transcription-coupled repair (TCR), showed an RNA synthesis recovery profile similar to normal fibroblasts suggesting that TCR is not involved in the repair of or RNA synthesis recovery from transcription-blocking Top1 lesions. These findings of the effects of camptothecin on transcription have important implications for its anti-cancer activities and may aid in the design of improved combinatorial treatments involving Top1 poisons.	[Veloso, Artur; Biewen, Benjamin; Paulsen, Michelle T.; Berg, Nathan; de Andrade Lima, Leonardo Carmo; Prasad, Jayendra; Bedi, Karan; Magnuson, Brian; Ljungman, Mats] Univ Michigan, Dept Radiat Oncol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Veloso, Artur; Biewen, Benjamin; Paulsen, Michelle T.; Berg, Nathan; de Andrade Lima, Leonardo Carmo; Prasad, Jayendra; Bedi, Karan; Magnuson, Brian; Ljungman, Mats] Univ Michigan, Translat Oncol Program, Ann Arbor, MI 48109 USA; [Veloso, Artur] Univ Michigan, Bioinformat Program, Ann Arbor, MI 48109 USA; [Veloso, Artur] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Biewen, Benjamin] Gustavus Adolphus Coll, St Peter, MN 56082 USA; [de Andrade Lima, Leonardo Carmo] Univ Sao Paulo, Sao Paulo, Brazil; [Bedi, Karan; Ljungman, Mats] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Wilson, Thomas E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Wilson, Thomas E.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Gustavus Adolphus College; Universidade de Sao Paulo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ljungman, M (corresponding author), Univ Michigan, Dept Radiat Oncol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	ljungman@umich.edu	Bedi, Karan/AAA-3331-2022	Bedi, Karan/0000-0002-7843-738X; Berg, Nathaniel/0000-0002-2568-2867; Veloso, Artur/0000-0003-1735-7711	National Institute of Environmental Sciences [1R21ES020946]; National Human Genome Research Institute [1R01HG006786]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES020946] Funding Source: NIH RePORTER	National Institute of Environmental Sciences; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by funds from National Institute of Environmental Sciences (1R21ES020946) and National Human Genome Research Institute (1R01HG006786). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman KJ, 2001, BRIT J CANCER, V84, P106, DOI 10.1054/bjoc.2000.1555; Chen AY, 1999, ONCOLOGY-NY, V13, P39; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Durand-Dubief M, 2011, TRANSCR-AUSTIN, V2, P66, DOI 10.4161/trns.2.2.14411; Horibata K, 2011, GENES CELLS, V16, P101, DOI 10.1111/j.1365-2443.2010.01467.x; HSIANG YH, 1988, CANCER RES, V48, P1722; HSIANG YH, 1989, CANCER RES, V49, P5077; Lin RK, 2013, J BIOL CHEM, V288, P7182, DOI 10.1074/jbc.M112.415471; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Ljungman M, 2001, ONCOGENE, V20, P5964, DOI 10.1038/sj.onc.1204734; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; Ljungman M, 1996, CARCINOGENESIS, V17, P31, DOI 10.1093/carcin/17.1.31; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; Paulsen MT, 2013, P NATL ACAD SCI USA, V110, P2240, DOI 10.1073/pnas.1219192110; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Sakai A, 2012, GENES GENET SYST, V87, P265, DOI 10.1266/ggs.87.265; Sakasai R, 2010, J BIOL CHEM, V285, P15201, DOI 10.1074/jbc.M110.101808; Solier S, 2013, CANCER RES, V73, P4830, DOI 10.1158/0008-5472.CAN-12-3504; Sordet O, 2009, EMBO REP, V10, P887, DOI 10.1038/embor.2009.97; SQUIRES S, 1993, CANCER RES, V53, P2012; Wu JX, 1997, NUCLEIC ACIDS RES, V25, P4181, DOI 10.1093/nar/25.21.4181; Zhang YW, 2011, NUCLEIC ACIDS RES, V39, P3607, DOI 10.1093/nar/gkq1304	28	35	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78190	10.1371/journal.pone.0078190	http://dx.doi.org/10.1371/journal.pone.0078190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194914	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000093
J	Yang, WC; Kuang, HO; Wang, SS; Wang, J; Liu, W; Wu, ZH; Tian, YY; Huang, ZY; Miao, XQ				Yang, Wenchao; Kuang, Haiou; Wang, Shanshan; Wang, Jie; Liu, Wei; Wu, Zhenhong; Tian, Yuanyuan; Huang, Zachary Y.; Miao, Xiaoqing			Comparative Sucrose Responsiveness in Apis mellifera and A. cerana Foragers	PLOS ONE			English	Article							RESPONSE THRESHOLDS; HONEYBEES APIS; L.; GENOTYPE	In the European honey bee, Apis mellifera, pollen foragers have a higher sucrose responsiveness than nectar foragers when tested using a proboscis extension response (PER) assay. In addition, Africanized honey bees have a higher sucrose responsiveness than European honey bees. Based on the biology of the Eastern honey bee, A. cerana, we hypothesized that A. cerana should also have a higher responsiveness to sucrose than A. mellifera. To test this hypothesis, we compared the sucrose thresholds of pollen foragers and nectar foragers in both A. cerana and A. mellifera in Fujian Province, China. Pollen foragers were more responsive to sucrose than nectar foragers in both species, consistent with previous studies. However, contrary to our hypothesis, A. mellifera was more responsive than A. cerana. We also demonstrated that this higher sucrose responsiveness in A. mellifera was not due to differences in the colony environment by co-fostering two species of bees in the same mixed-species colonies. Because A. mellifera foragers were more responsive to sucrose, we predicted that their nectar foragers should bring in less concentrated nectar compared to that of A. cerana. However, we found no differences between the two species. We conclude that A. cerana shows a different pattern in sucrose responsiveness from that of Africanized bees. There may be other mechanisms that enable A. cerana to perform well in areas with sparse nectar resources.	[Yang, Wenchao; Wang, Shanshan; Wang, Jie; Liu, Wei; Wu, Zhenhong; Tian, Yuanyuan; Huang, Zachary Y.; Miao, Xiaoqing] Fujian Agr & Forestry Univ, Coll Honey Bee Sci, Fuzhou, Fujian, Peoples R China; [Kuang, Haiou] Yunnan Agr Univ, Res Inst Eastern Honeybee, Kunming, Yunnan, Peoples R China; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	Fujian Agriculture & Forestry University; Yunnan Agricultural University; Michigan State University	Huang, ZY (corresponding author), Fujian Agr & Forestry Univ, Coll Honey Bee Sci, Fuzhou, Fujian, Peoples R China.	bees@msu.edu; mxqsf88@126.com	Huang, Zachary/D-5485-2011	Huang, Zachary/0000-0001-5354-5547	Fujian Provincial Department of Science and Technology [2011J05043]; Fujian Agriculture and Forestry University; Earmarked Fund for Modern Agro-Industry Technology Research System [CARS-45-KXJ19]	Fujian Provincial Department of Science and Technology; Fujian Agriculture and Forestry University; Earmarked Fund for Modern Agro-Industry Technology Research System	The authors are thankful for the support of Honey Bee Biology Observation Station (Fujian) of Agriculture Ministry of China. This work was funded by grants from Fujian Provincial Department of Science and Technology (2011J05043 to WY), Fujian Agriculture and Forestry University ( to XM) and the Earmarked Fund for Modern Agro-Industry Technology Research System (CARS-45-KXJ19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS WH, 1990, WEED SCI, V38, P452, DOI 10.1017/S0043174500056824; Cao YF, 2006, J BEE, V2, P5; DYER FC, 1987, J EXP BIOL, V127, P1; Li HL, 2007, API CHINA, V58, P8; Mc Cabe SI, 2007, J COMP PHYSIOL A, V193, P1089, DOI 10.1007/s00359-007-0260-8; Miao XiaoQing, 2001, Journal of Fujian Agricultural University, V30, P524; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Pankiw T, 2003, BEHAV ECOL SOCIOBIOL, V54, P458, DOI 10.1007/s00265-003-0640-1; Pankiw T, 2003, J COMP PHYSIOL A, V189, P675, DOI 10.1007/s00359-003-0442-y; Pankiw T, 2002, ANN ENTOMOL SOC AM, V95, P761, DOI 10.1603/0013-8746(2002)095[0761:PFRTBP]2.0.CO;2; Pankiw T, 2001, J COMP PHYSIOL A, V187, P293, DOI 10.1007/s003590100201; Pankiw T, 2005, HONEY BEE FORAGING B, P1, DOI [10.1109/SIS, DOI 10.1109/SIS.P.2005.1501595:1-6]; Qin QH, 2012, J COMP PHYSIOL A, V198, P777, DOI 10.1007/s00359-012-0747-9; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Scheiner R, 2012, ANIM BEHAV, V84, P305, DOI 10.1016/j.anbehav.2012.05.011; Su SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002365; Visscher PK, 1996, J INSECT PHYSIOL, V42, P1089, DOI 10.1016/S0022-1910(96)00058-3; Wang Feng-He, 2007, Chinese Bulletin of Entomology, V44, P923; WINSTON M L, 1980, Journal of the Kansas Entomological Society, V53, P157; WINSTON ML, 1982, BEHAV ECOL SOCIOBIOL, V10, P125, DOI 10.1007/BF00300172; Yang Guan-Huang, 2005, Acta Entomologica Sinica, V48, P401; Yang MX, 2010, J INSECT PHYSIOL, V56, P706, DOI 10.1016/j.jinsphys.2009.12.011; Yu YS, 2010, SPEC EC ANIM PLANTS, V2, P8; Zhou BF, 1991, APICULTURE CHINA, V4, P3	24	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e79026	10.1371/journal.pone.0079026	http://dx.doi.org/10.1371/journal.pone.0079026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194958	gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000137
J	Bogui, P; Balayssac-Siransy, E; Connes, P; Tuo, N; Ouattara, S; Pichon, A; Dah, CS				Bogui, Pascal; Balayssac-Siransy, Edwige; Connes, Philippe; Tuo, Nalourgo; Ouattara, Soualiho; Pichon, Aurelien; Dah, Cyrille Serges			The PhysioFlow Thoracic Impedancemeter Is Not Valid for the Measurements of Cardiac Hemodynamic Parameters in Chronic Anemic Patients	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; LEFT-VENTRICULAR FUNCTION; STROKE VOLUME; DIRECT FICK; OUTPUT; EXERCISE; DOPPLER; CARDIOGRAPHY; BIOIMPEDANCE; PERFORMANCE	The aim of the present study was to test the validity of the transthoracic electrical bioimpedance method PhysioFlow (R) to measure stroke volume in patients with chronic anemia. Stroke volume index (SVI), as well as cardiac index (CI) obtained by transthoracic electrical bioimpedance method and doppler echocardiography were compared in healthy subjects (n = 25) and patients with chronic anemia (i.e. mainly with sickle cell anemia; n = 32), at rest. While doppler echocardiography was able to detect difference in SVI between the two populations, the Physioflow (R) failed to detect any difference. Bland & Altman analyses have demonstrated no interchangeability between the two methods to assess CI and SVI in anemic patients and healthy subjects. While doppler echocardiography displayed a good concordance for SVI results with those obtained in the literature for anemic patients, the Physioflow (R) did not. Finally, in contrast to doppler echocardiography: 1) the CI obtained with the Physioflow (R) was not correlated with the hemoglobin level and 2) the stroke volume determined by the Physioflow (R) was highly influenced by body surface area. In conclusion, our findings indicate that the Physioflow (R) device is inaccurate for the measurement of SVI and CI in patients with chronic anemia and has a poor accuracy for the measurement of these parameters in African healthy subjects.	[Bogui, Pascal; Balayssac-Siransy, Edwige; Tuo, Nalourgo; Ouattara, Soualiho; Dah, Cyrille Serges] Univ Felix Houphouet Boigny, Unite Format & Rech Sci Med, Lab Physiol & Explorat Fonct, Abidjan, Cote Ivoire; [Bogui, Pascal; Balayssac-Siransy, Edwige; Tuo, Nalourgo; Ouattara, Soualiho] Ctr Hosp Univ Yopougon, Serv Explorat Fonct & Endoscop, Abidjan, Cote Ivoire; [Connes, Philippe] Univ Antilles Guyane, INSERM, UMR 665, Pointe A Pitre, Guadeloupe, France; [Connes, Philippe] Univ Antilles Guyane, Dept Physiol, Lab ACTES EA 3596, Pointe A Pitre, Guadeloupe, France; [Connes, Philippe; Pichon, Aurelien] PRES Sorbonne, Lab Excellence GR Ex Red Cell Genesis Death, Paris, France; [Pichon, Aurelien] Univ Paris 13, PRES Sorbonne Paris Cite, Lab Reponses Cellulaires & Fonct Hypoxie EA2363, Bobigny, France; [Dah, Cyrille Serges] Ctr Hosp Univ Cocody, Serv Explorat Fonct Resp, Abidjan, Cote Ivoire	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite des Antilles; Universite des Antilles; Universite Paris 13	Bogui, P (corresponding author), Univ Felix Houphouet Boigny, Unite Format & Rech Sci Med, Lab Physiol & Explorat Fonct, Abidjan, Cote Ivoire.	pasbogui@yahoo.fr	Pichon, Aurélien/AAD-3320-2021; Connes, Philippe/J-7835-2019	Connes, Philippe/0000-0002-9232-0268; Philippe, Connes/0000-0001-8449-7998				Anthi A, 2007, AM J RESP CRIT CARE, V175, P1272, DOI 10.1164/rccm.200610-1498OC; Balayssac-Siransy E, 2011, BRIT J HAEMATOL, V154, P398, DOI 10.1111/j.1365-2141.2011.08728.x; BHATIA ML, 1969, BRIT HEART J, V31, P365; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRANNON ES, 1945, J CLIN INVEST, V24, P332, DOI 10.1172/JCI101610; Cain Peter A, 2009, BMC Med Imaging, V9, P2, DOI 10.1186/1471-2342-9-2; Caldas MC, 2008, J AM SOC ECHOCARDIOG, V21, P1163, DOI 10.1016/j.echo.2007.06.001; Charloux A, 2000, EUR J APPL PHYSIOL, V82, P313, DOI 10.1007/s004210000226; CHUNG EE, 1987, J AM COLL CARDIOL, V9, P1038, DOI 10.1016/S0735-1097(87)80305-4; COVITZ W, 1995, CHEST, V108, P1214, DOI 10.1378/chest.108.5.1214; Critchley LAH, 1999, J CLIN MONIT COMPUT, V15, P85, DOI 10.1023/A:1009982611386; DENENBERG BS, 1983, AM J CARDIOL, V51, P1674, DOI 10.1016/0002-9149(83)90208-4; DUKE M, 1969, CIRCULATION, V39, P503, DOI 10.1161/01.CIR.39.4.503; EGGERS GWN, 1962, J APPL PHYSIOL, V17, P75, DOI 10.1152/jappl.1962.17.1.75; ESTRADE G, 1989, ARCH MAL COEUR VAISS, V82, P1975; GERRY JL, 1976, AM J MED, V60, P968, DOI 10.1016/0002-9343(76)90568-4; GRAETTINGER JS, 1963, ANN INTERN MED, V58, P617, DOI 10.7326/0003-4819-58-4-617; Haryadi DG, 2000, J CLIN MONIT COMPUT, V16, P361, DOI 10.1023/A:1011403717822; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEIGHT L, 1954, CIRCULATION, V10, P653, DOI 10.1161/01.CIR.10.5.653; LEWIS JF, 1984, CIRCULATION, V70, P425, DOI 10.1161/01.CIR.70.3.425; LINDSAY J, 1974, ARCH INTERN MED, V133, P643, DOI 10.1001/archinte.133.4.643; LONSDORFER J, 1983, B EUR PHYSIOPATH RES, V19, P339; Machado RF, 2007, BRIT J HAEMATOL, V136, P319, DOI 10.1111/j.1365-2141.2006.06417.x; MANNO BV, 1983, AM J CARDIOL, V52, P584, DOI 10.1016/0002-9149(83)90031-0; MARDELLE T, 1986, AM HEART J, V112, P1356, DOI 10.1016/0002-8703(86)90403-5; Martins W d, 1999, Arq Bras Cardiol, V73, P463; Richard R, 2001, EUR J APPL PHYSIOL, V85, P202, DOI 10.1007/s004210100458; Robach P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002996; ROY SB, 1963, CIRCULATION, V28, P346, DOI 10.1161/01.CIR.28.3.346; SHUBIN H, 1960, AM J CARDIOL, V6, P875, DOI 10.1016/0002-9149(60)90287-3; Spiering W, 1998, HEART, V79, P437, DOI 10.1136/hrt.79.5.437; SPROULE BJ, 1958, J CLIN INVEST, V37, P486, DOI 10.1172/JCI103629; Taylor K, 2012, ANESTH ANALG, V114, P771, DOI 10.1213/ANE.0b013e318246c32c; Taylor K, 2011, J CARDIOTHOR VASC AN, V25, P776, DOI 10.1053/j.jvca.2011.05.002; THADANI U, 1978, AM J CARDIOL, V41, P52, DOI 10.1016/0002-9149(78)90131-5; Tordi N, 2004, INT J SPORTS MED, V25, P145; Tripette J, 2009, HAEMATOL-HEMATOL J, V94, P1060, DOI 10.3324/haematol.2008.005371; VARAT MA, 1972, AM HEART J, V83, P415, DOI 10.1016/0002-8703(72)90445-0; WANG Y, 1960, J CLIN INVEST, V39, P1051, DOI 10.1172/JCI104120; Wierre F, 2010, EUR J ANAESTH, V27, P64, DOI 10.1097/00003643-201006121-00205	41	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e79086	10.1371/journal.pone.0079086	http://dx.doi.org/10.1371/journal.pone.0079086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167637	gold, Green Submitted, Green Published			2022-12-27	WOS:000326034500098
J	Richomme, C; Boadella, M; Courcoul, A; Durand, B; Drapeau, A; Corde, Y; Hars, J; Payne, A; Fediaevsky, A; Boschiroli, ML				Richomme, Celine; Boadella, Mariana; Courcoul, Aurelie; Durand, Benoit; Drapeau, Antoine; Corde, Yannick; Hars, Jean; Payne, Ariane; Fediaevsky, Alexandre; Boschiroli, Maria Laura			Exposure of Wild Boar to Mycobacterium tuberculosis Complex in France since 2000 Is Consistent with the Distribution of Bovine Tuberculosis Outbreaks in Cattle	PLOS ONE			English	Article							SUS-SCROFA; DISEASE RISKS; RED DEER; PREVALENCE; ANTIBODIES; LIVESTOCK; SWEDEN; TESTS; SPAIN	The Eurasian wild boar (Sus scrofa) is increasingly considered as a relevant actor in the epidemiology of animal tuberculosis (TB). Therefore, monitoring TB in wild boar becomes a key tool for establishing comprehensive control schemes for this disease. To estimate the exposure of free living wild boar to Mycobacterium tuberculosis complex (MTC) in France, a bovine-purified protein derivative based ELISA was used to test 2,080 archived serum samples of hunter-harvested animals in 58 French "departements". Two cut-off values were used for diagnostic interpretation: 0.2, recommended by the manufacturer (specificity: 96.43%; sensitivity: 72.6%), and 0.5 (specificity: 100%; sensitivity: 64%). During the same period, at the 0.2 cut-off, global true seroprevalence was 5.9% (IC95%: 4.3%-7.7%) and 76% of the sampled "departements" had seropositive wild boar, including seven cattle TB-free "departements. At the 0.5 cut-off, global true seroprevalence was 2.2% (IC95%: 1.5-3.2) and positive wild boar belonged to 21% of the "departements". All but one of these positive "departements" had reported at least one cattle TB outbreak since 2000. A good consistence between seropositive wild boar and TB outbreaks in cattle was found, especially at the 0.5 cut-off value (the mean distance to the nearest cattle TB outbreak was 13km and 27km for seropositive and seronegative wild boar, respectively; P<0.05). The use of an ELISA to detect MTC antibodies in wild boar has permitted the description of the geographic distribution of MTC contact in wild boar in France. Our results suggest that the ELISA could be used as a first screening tool to conduct TB surveillance in wild boar at a population level. High-risk wild boar populations (e. g. overabundant) could be tested and if identified positive by ELISA they should be surveyed in detail by combining pathology and culture.	[Richomme, Celine] Anses, Nancy Lab Rabies & Wildlife, Malzeville, France; [Boadella, Mariana] SaBio IREC CSIC UCLM JCCM, Ciudad Real, Spain; [Courcoul, Aurelie; Durand, Benoit] Univ Paris Est, Anses, Hlth Anim Lab, Epidemiol Unit, Maisons Alfort, France; [Drapeau, Antoine; Corde, Yannick; Boschiroli, Maria Laura] Univ Paris Est, Anses, Hlth Anim Lab, Bovine TB Natl Reference Lab, Maisons Alfort, France; [Hars, Jean; Payne, Ariane] Natl Hunting & Wildlife Agcy ONCFS, Res Dept, Gieres, France; [Payne, Ariane] Lyon Univ, UMR CNRS 5558, Villeurbanne, France; [Fediaevsky, Alexandre] Directorate Gen Food DGAI, Minist Food Agr & Fisheries, Paris, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technopole Agricole et Veterinaire; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup	Boschiroli, ML (corresponding author), Univ Paris Est, Anses, Hlth Anim Lab, Bovine TB Natl Reference Lab, Maisons Alfort, France.	maria-laura.boschiroli@anses.fr	Durand, Benoit/GSE-2511-2022; Boadella, Mariana/I-8029-2012; Boschiroli, Maria Laura/AAR-3319-2021	Boadella, Mariana/0000-0001-6402-9927; Durand, Benoit/0000-0003-0669-1394	Anses	Anses	This study was funded by our own institutional resources (Anses). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2006, ACTA THERIOL, V51, P327, DOI 10.1007/BF03192685; Acevedo P, 2011, LANDSCAPE ECOL, V26, P19, DOI 10.1007/s10980-010-9538-2; ANSES (French agency for food environmental and occupational health and safety), 2011, TUB BOV FAUN SAUV; Aurtenetxe O, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-43; Boadella M, 2011, ECOHEALTH, V8, P478, DOI 10.1007/s10393-011-0713-y; Boadella Mariana, 2011, BMC Res Notes, V4, P498, DOI 10.1186/1756-0500-4-498; Boadella M, 2011, EUR J WILDLIFE RES, V57, P697, DOI 10.1007/s10344-011-0550-x; Boadella M, 2011, J VET DIAGN INVEST, V23, P77, DOI 10.1177/104063871102300111; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; Gortazar C, 2006, EUR J WILDLIFE RES, V52, P81, DOI 10.1007/s10344-005-0022-2; Gortazar C, 2007, EUR J WILDLIFE RES, V53, P241, DOI 10.1007/s10344-007-0098-y; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Hars J, 2012, B EPIDEMIOLOGIQUE SA, V52, P7; Hartley M, 2010, VET REC, V166, P487, DOI 10.1136/vr.c2051; Lemel J, 2003, WILDLIFE BIOL, V9, P29, DOI 10.2981/wlb.2003.061; Lyashchenko KP, 2007, VET MICROBIOL, V125, P265, DOI 10.1016/j.vetmic.2007.05.026; Marreros N, 2012, TUBERCULOSIS WILD BO; Mentaberre G, 2010, VET REC, V166, P700, DOI 10.1136/vr.c2552; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Nugent G, 2002, J WILDLIFE DIS, V38, P665, DOI 10.7589/0090-3558-38.4.665; Payne A, 2012, EUR J WILDLIFE RES, P1; Payne A., 2011, B PID MIOLOGIQUE ST, V44, P2; Prevot C., 2013, EUR J WILDLIFE RES, V59, P1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reiczigel J, 2010, EPIDEMIOL INFECT, V138, P1674, DOI 10.1017/S0950268810000385; Rhodes SG, 2011, VET IMMUNOL IMMUNOP, V144, P129, DOI 10.1016/j.vetimm.2011.07.020; Richomme C, 2010, J WILDLIFE DIS, V46, P627, DOI 10.7589/0090-3558-46.2.627; Rossi S., 2008, B EPID SANT ANIM ALI, V29, P5; Truve J, 2003, WILDLIFE BIOL, V9, P51, DOI 10.2981/wlb.2003.056; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Zanella G, 2008, VET REC, V163, P43, DOI 10.1136/vr.163.2.43; Zanella G, 2008, J WILDLIFE DIS, V44, P99, DOI 10.7589/0090-3558-44.1.99	33	34	35	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77842	10.1371/journal.pone.0077842	http://dx.doi.org/10.1371/journal.pone.0077842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167584	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500043
J	Sana, TG; Soscia, C; Tonglet, CM; Garvis, S; Bleves, S				Sana, Thibault G.; Soscia, Chantal; Tonglet, Celine M.; Garvis, Steve; Bleves, Sophie			Divergent Control of Two Type VI Secretion Systems by RpoN in Pseudomonas aeruginosa	PLOS ONE			English	Article							STRAIN PAO1; PROTEIN; IDENTIFICATION; EXPRESSION; REGULON; LOCUS; ACTIVATORS; TARGETS; GENES; PHASE	Three Type VI Secretion System (T6SS) loci called H1- to H3-T6SS coexist in Pseudomonas aeruginosa. H1-T6SS targets prokaryotic cells whereas H2-T6SS mediates interactions with both eukaryotic and prokaryotic host cells. Little is known about the third system, except that it may be connected to H2-T6SS during the host infection. Here we show that H3-T6SS is required for P. aeruginosa PAO1 virulence in the worm model. We demonstrate that the two putative H3-T6SS operons, called "left" and "right", are coregulated with H2-T6SS by the Las and Rhl Quorum Sensing systems. Interestingly, the RpoN sigma 54 factor has divergent effects on the three operons. As for many T6SSs, RpoN activates the expression of H3-T6SS left. However, RpoN unexpectedly represses the expression of H3-T6SS right and also H2-T6SS. Sfa2 and Sfa3 are putative enhancer binding proteins encoded on H2-T6SS and H3-T6SS left. In other T6SSs EBPs can act as s54 activators to promote T6SS transcription. Strikingly, we found that the RpoN effects of H3-T6SS are Sfa-independent while the RpoN mediated repression of H2-T6SS is Sfa2-dependent. This is the first example of RpoN repression of a T6SS being mediated by a T6SS-encoded EBP.	[Bleves, Sophie] CNRS, UMR7255, Lab Ingn Syst Macromol, Marseille, France; Aix Marseille Univ, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Bleves, S (corresponding author), CNRS, UMR7255, Lab Ingn Syst Macromol, Marseille, France.	bleves@imm.cnrs.fr	Bleves, SOPHIE/HII-4948-2022; Sana, Thibault G/B-1599-2013	garvis, steve/0000-0002-0547-0672; Sana, Thibault/0000-0003-0723-6924	French Research Ministry; "Teaching & Research" fellowship (ATER) from AMU; "Pathomics" ERA-net PATHO [ANR-08-PATH-004-01]	French Research Ministry(Ministry of Research, France); "Teaching & Research" fellowship (ATER) from AMU; "Pathomics" ERA-net PATHO	TGS was financed with a PhD fellowship from the French Research Ministry and with a "Teaching & Research" fellowship (ATER) from AMU. This work was supported by "Pathomics" ERA-net PATHO (ANR-08-PATH-004-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bernard CS, 2011, J BACTERIOL, V193, P2158, DOI 10.1128/JB.00029-11; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; BORDI C, 2010, MOL MICROBIOL; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Caiazza NC, 2004, J BACTERIOL, V186, P4476, DOI 10.1128/JB.186.14.4476-4485.2004; Chugani S, 2007, MICROB PATHOGENESIS, V42, P29, DOI 10.1016/j.micpath.2006.10.004; Dong TG, 2012, NUCLEIC ACIDS RES, V40, P7766, DOI 10.1093/nar/gks567; EspinosaUrgel M, 1996, MOL MICROBIOL, V21, P657; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Hagins JM, 2010, MICROBIOL-SGM, V156, P1201, DOI 10.1099/mic.0.033381-0; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Heurlier K, 2003, J BACTERIOL, V185, P2227, DOI 10.1128/JB.185.7.2227-2235.2003; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Miller VL, 2002, CURR OPIN MICROBIOL, V5, P211, DOI 10.1016/S1369-5274(02)00303-X; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sana TG, 2012, J BIOL CHEM, V287, P27095, DOI 10.1074/jbc.M112.376368; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2004, MOL MICROBIOL, V51, P973, DOI 10.1046/j.1365-2958.2003.03886.x; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wilderman PJ, 2001, MOL MICROBIOL, V39, P291, DOI 10.1046/j.1365-2958.2001.02282.x; Zhang WP, 2011, ARCH MICROBIOL, V193, P351, DOI 10.1007/s00203-011-0680-2; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x	42	34	36	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76030	10.1371/journal.pone.0076030	http://dx.doi.org/10.1371/journal.pone.0076030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204589	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600004
J	Bennett, L; Kersaitis, C; Macaulay, SL; Munch, G; Niedermayer, G; Nigro, J; Payne, M; Sheean, P; Vallotton, P; Zabaras, D; Bird, M				Bennett, Louise; Kersaitis, Cindy; Macaulay, Stuart Lance; Muench, Gerald; Niedermayer, Garry; Nigro, Julie; Payne, Matthew; Sheean, Paul; Vallotton, Pascal; Zabaras, Dimitrios; Bird, Michael			Vitamin D-2-Enriched Button Mushroom (Agaricus bisporus) Improves Memory in Both Wild Type and APPswe/PS1dE9 Transgenic Mice	PLOS ONE			English	Article							PLASMA AMYLOID-BETA; MOUSE MODEL; D DEFICIENCY; COGNITIVE IMPAIRMENT; EXPLORATORY ACTIVITY; ELDERLY-WOMEN; DISEASE; ALZHEIMER; BRAIN; HEALTH	Vitamin D deficiency is widespread, affecting over 30% of adult Australians, and increasing up to 80% for at-risk groups including the elderly (age>65). The role for Vitamin D in development of the central nervous system is supported by the association between Vitamin D deficiency and incidence of neurological and psychiatric disorders including Alzheimer's disease (AD). A reported positive relationship between Vitamin D status and cognitive performance suggests that restoring Vitamin D status might provide a cognitive benefit to those with Vitamin D deficiency. Mushrooms are a rich source of ergosterol, which can be converted to Vitamin D-2 by treatment with UV light, presenting a new and convenient dietary source of Vitamin D-2. We hypothesised that Vitamin D-2-enriched mushrooms (VDM) could prevent the cognitive and pathological abnormalities associated with dementia. Two month old wild type (B6C3) and AD transgenic (APP(Swe)/PS1dE9) mice were fed a diet either deficient in Vitamin D-2 or a diet which was supplemented with VDM, containing 1 +/- 0.2 mu g/kg (similar to 54 IU/kg) vitamin D-2, for 7 months. Effects of the dietary intervention on memory were assessed pre- and post-feeding. Brain sections were evaluated for amyloid beta (A beta) plaque loads and inflammation biomarkers using immuno-histochemical methods. Plasma vitamin D metabolites, A beta 40, A beta 42, calcium, protein and cholesterol were measured using biochemical assays. Compared with mice on the control diet, VDM-fed wild type and AD transgenic mice displayed improved learning and memory, had significantly reduced amyloid plaque load and glial fibrillary acidic protein, and elevated interleukin-10 in the brain. The results suggest that VDM might provide a dietary source of Vitamin D-2 and other bioactives for preventing memory-impairment in dementia. This study supports the need for a randomised clinical trial to determine whether or not VDM consumption can benefit cognitive performance in the wider population.	[Bennett, Louise; Sheean, Paul] Commonwealth Sci & Ind Res Org Preventat Hlth Fla, Anim Food & Hlth Sci, Werribee, Vic, Australia; [Kersaitis, Cindy; Muench, Gerald; Niedermayer, Garry; Bird, Michael] Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia; [Macaulay, Stuart Lance; Nigro, Julie] Commonwealth Sci & Ind Res Org Preventat Hlth Fla, Mat Sci & Engn, Parkville, Vic, Australia; [Payne, Matthew; Vallotton, Pascal] Commonwealth Sci & Ind Res Org Math & Informat Sc, N Ryde, NSW, Australia; [Zabaras, Dimitrios] Commonwealth Sci & Ind Res Org, Anim Food & Hlth Sci, N Ryde, NSW, Australia; [Muench, Gerald] Univ Western Sydney, Mol Med Res Grp, Campbelltown, NSW, Australia; [Muench, Gerald] Univ Western Sydney, Ctr Complementary Med Res, Campbelltown, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Western Sydney University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Western Sydney University; Western Sydney University	Bennett, L (corresponding author), Commonwealth Sci & Ind Res Org Preventat Hlth Fla, Anim Food & Hlth Sci, Werribee, Vic, Australia.	louise.bennett@csiro.au	Vallotton, Pascal/A-3633-2009; Bennett, Louise/AAA-8266-2020; Macaulay, Stuart Lance/A-6086-2008; Zabaras, Dimitrios/B-8538-2011	Vallotton, Pascal/0000-0002-0795-8719; Bennett, Louise/0000-0001-9421-4410; Macaulay, Stuart Lance/0000-0001-5069-9516; Zabaras, Dimitrios/0000-0002-3022-7965	Horticulture Australia Limited; Australian Mushroom Growers Association; Australian Government; CSIRO Preventative Health National Research Flagship	Horticulture Australia Limited(Horticulture Australia Limited); Australian Mushroom Growers Association; Australian Government(Australian GovernmentCGIAR); CSIRO Preventative Health National Research Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was conducted with support from Horticulture Australia Limited, the Australian Mushroom Growers Association, the Australian Government and the CSIRO Preventative Health National Research Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annweiler C, 2010, NEUROLOGY, V75, P1810, DOI 10.1212/WNL.0b013e3181fd6352; Annweiler C, 2010, NEUROLOGY, V74, P27, DOI 10.1212/WNL.0b013e3181beecd3; Annweiler C, 2012, J GERONTOLOGY A; Annweiler C, 2011, J AM GERIATR SOC, V59, P169, DOI 10.1111/j.1532-5415.2010.03166.x; Annweiler C, 2010, NEUROPSYCHOBIOLOGY, V62, P139, DOI 10.1159/000318570; [Anonymous], 2006, FOOD AUST, V58, P298; AOAC, 2006, FAT MILK; Balion C, 2012, NEUROLOGY, V79, P1397, DOI 10.1212/WNL.0b013e31826c197f; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Beelman R, 2009, PENN STATE RES FOUND, V28; Bennett LE, INT J MED M IN PRESS; BINI F, 2009, N S ARCH PHARMACOL, V380, P361; Bischoff-Ferrari H, 2010, DERMATOL THER, V23, P23, DOI 10.1111/j.1529-8019.2009.01288.x; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Bogh MKB, 2010, J INVEST DERMATOL, V130, P546, DOI 10.1038/jid.2009.323; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Briones TL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-244; Buell JS, 2010, NEUROLOGY, V74, P18, DOI 10.1212/WNL.0b013e3181beecb7; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cohen MP, 2009, CLIN EXP PHARMACOL P, V36, P1099, DOI 10.1111/j.1440-1681.2009.05201.x; Daly RM, 2012, CLIN ENDOCRINOL, V77, P26, DOI 10.1111/j.1365-2265.2011.04320.x; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Du J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005530; Dubost NJ, 2007, FOOD CHEM, V105, P727, DOI 10.1016/j.foodchem.2007.01.030; Dursun E, 2011, J ALZHEIMERS DIS, V23, P207, DOI 10.3233/JAD-2010-101377; Durup D, 2012, J CLIN ENDOCRINOLOGY; Etgen T, 2012, DEMENT GERIATR COGN, V33, P297, DOI 10.1159/000339702; Eyles DW, VITAMIN D E IN PRESS; Eyles DW, 2012, FRONTIERS NEUROENDOC; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Garcion E, 1998, GLIA, V22, P282, DOI 10.1002/(SICI)1098-1136(199803)22:3<282::AID-GLIA7>3.0.CO;2-7; Gardener S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.91; Gezen-Ak D, 2012, NEUROLOGICAL SCI; Gezen-Ak D, 2007, TOHOKU J EXP MED, V212, P275, DOI 10.1620/tjem.212.275; Gezen-Ak D, 2012, TOHOKU J EXP MED, V228, P189, DOI 10.1620/tjem.228.189; GLOVER M, 1952, BIOCHEM J, V51, P1; Higashi T, 2001, BIOL PHARM BULL, V24, P738, DOI 10.1248/bpb.24.738; Holick MF, 2008, MOL ASPECTS MED, V29, P361, DOI 10.1016/j.mam.2008.08.008; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Ito S, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-20; Japelt RB, 2011, FOOD CHEM, V129, P217, DOI 10.1016/j.foodchem.2011.04.029; Jasinghe VJ, 2006, J TOXICOL ENV HEAL A, V69, P1979, DOI 10.1080/15287390600751413; Kalaras MD, 2012, FOOD CHEM, V135, P396, DOI 10.1016/j.foodchem.2012.04.132; Kalueff AV, 2007, CURR OPIN CLIN NUTR, V10, P12, DOI 10.1097/MCO.0b013e328010ca18; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kesby JP, 2011, MOL CELL ENDOCRINOL, V347, P121, DOI 10.1016/j.mce.2011.05.014; Kiraly SJ, 2006, THESCIENTIFICWORLDJO, V6, P125, DOI 10.1100/tsw.2006.25; Koyyalamudi SR, 2009, J AGR FOOD CHEM, V57, P3351, DOI 10.1021/jf803908q; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; Lalonde R, 2004, NEUROSCI LETT, V369, P156, DOI 10.1016/j.neulet.2004.07.069; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lee DM, 2009, J NEUROL NEUROSUR PS, V80, P722, DOI 10.1136/jnnp.2008.165720; Lee GS, 2009, EUR J NUTR, V48, P75, DOI 10.1007/s00394-008-0763-2; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Liu LH, 2009, FOOD CHEM, V115, P495, DOI 10.1016/j.foodchem.2008.12.042; Llewellyn DJ, 2011, J GERONTOL A-BIOL, V66, P59, DOI 10.1093/gerona/glq185; Llewellyn DJ, 2010, ARCH INTERN MED, V170, P1135, DOI 10.1001/archinternmed.2010.173; MALEFYT RD, 1991, J EXP MED, V174, P1209; Mattila P, 2002, J AGR FOOD CHEM, V50, P6419, DOI 10.1021/jf020608m; McPherson CS, 2010, CEREB CORTEX, V20, P941, DOI 10.1093/cercor/bhp159; Minkeviciene R, 2008, J NEUROCHEM, V105, P584, DOI 10.1111/j.1471-4159.2007.05147.x; Mizwicki MT, 2012, J ALZHEIMERS DIS, V29, P51, DOI 10.3233/JAD-2012-110560; Mori K, 2009, PHYTOTHER RES, V23, P367, DOI 10.1002/ptr.2634; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1990, COLD SPRING HARB SYM, V55, P161; Oh ES, 2008, NEUROMOL MED, V10, P195, DOI 10.1007/s12017-008-8035-0; Oudshoorn C, 2008, DEMENT GERIATR COGN, V25, P539, DOI 10.1159/000134382; Ozzard A, 2008, BRIT J GEN PRACT, V58, P644, DOI 10.3399/bjgp08X341959; Perez-Llamas F, 2008, NUTRITION, V24, P414, DOI 10.1016/j.nut.2008.01.006; Phan CW, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-102; Przybelski RJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P202, DOI 10.1016/j.abb.2006.12.018; Rapuri PB, 2004, CALCIFIED TISSUE INT, V74, P150, DOI 10.1007/s00223-003-0083-8; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Sato Y, 1998, BONE, V23, P555, DOI 10.1016/S8756-3282(98)00134-3; Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x; Scheltens P, 2012, J ALZHEIMERS DIS, V29, P37; Scheltens P, 2012, J ALZHEIMERS DIS, V31, P225, DOI 10.3233/JAD-2012-121189; Serra-Majem L, 2009, BRIT J NUTR, V101, pS21, DOI 10.1017/S0007114509990559; Sheean P, 2012, FEBS J, V279, P1291, DOI 10.1111/j.1742-4658.2012.08524.x; Short JL, 2006, NEUROPSYCHOPHARMACOL, V31, P525, DOI 10.1038/sj.npp.1300852; Slinin Y, 2012, J GERONTOLOGY A; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Souberbielle JC, 2010, AUTOIMMUN REV, V9, P709, DOI 10.1016/j.autrev.2010.06.009; Stephensen CB, 2012, J NUTR; Stover KR, 2012, BEHAV BRAIN RES, V231, P75, DOI 10.1016/j.bbr.2012.02.044; SUTHERLAND MK, 1992, MOL BRAIN RES, V13, P239; Szelenyi J, 2001, BRAIN RES BULL, V54, P329, DOI 10.1016/S0361-9230(01)00428-2; Tammer AH, 2002, CLIN EXP IMMUNOL, V129, P453, DOI 10.1046/j.1365-2249.2002.01905.x; Tripkovic L, 2012, AM J CLIN NUTR, V95, P1357, DOI 10.3945/ajcn.111.031070; Tukaj C, 2008, POSTEP HIG MED DOSW, V62, P502; Vehmas AK, 2001, DNA CELL BIOL, V20, P713, DOI 10.1089/10445490152717578; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wang L, 2012, NEUROBIOLOGY AGING; Wang SH, 2009, NUTR RES REV, V22, P188, DOI 10.1017/S0954422409990151; Wang YJ, 2009, NEUROTOX RES, V15, P3, DOI 10.1007/s12640-009-9000-x; Wimo A, 2010, WORLD ALZHEIMER REPO; Xiong HQ, 2011, NEUROSCI BULL, V27, P221, DOI 10.1007/s12264-011-1015-7; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yu J, 2011, J ALZHEIMERS DIS, V25, P295, DOI 10.3233/JAD-2011-101986	102	38	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76362	10.1371/journal.pone.0076362	http://dx.doi.org/10.1371/journal.pone.0076362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204618	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300024
J	Garrigan, E; Belkin, NS; Alexander, JJ; Han, Z; Seydel, F; Carter, J; Atkinson, M; Wasserfall, C; Clare-Salzler, MJ; Amick, MA; Litherland, SA				Garrigan, Erin; Belkin, Nicole S.; Alexander, John J.; Han, Zhao; Seydel, Federica; Carter, Jamal; Atkinson, Mark; Wasserfall, Clive; Clare-Salzler, Michael J.; Amick, Matthew A.; Litherland, Sally A.			Persistent STAT5 Phosphorylation and Epigenetic Dysregulation of GM-CSF and PGS2/COX2 Expression in Type 1 Diabetic Human Monocytes	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; MACROPHAGES; ACTIVATION; MELLITUS; SITES; SUSCEPTIBILITY; INTERLEUKIN-4; DYSFUNCTION; DEFECTS; DISPLAY	STAT5 proteins are adaptor proteins for histone acetylation enzymes. Histone acetylation at promoter and enhancer chromosomal regions opens the chromatin and allows access of transcription enzymes to specific genes in rapid response cell signals, such as in inflammation. Histone acetylation-mediated gene regulation is involved in expression of 2 key inflammatory response genes: CSF2, encoding granulocyte-macrophage colony stimulating factor (GM-CSF), and PTGS2, encoding prostaglandin synthase 2/cyclooxygenase 2 (PGS2/COX2). Prolonged CSF2 expression, high GM-CSF production, and GM-CSF activation of PTGS2 gene expression all are seen in type 1 diabetes (T1D) monocytes. Persistent phosphorylation activation of monocyte STAT5 (STAT5Ptyr) is also found in individuals with or at-risk for T1D. To examine whether elevated T1D monocyte STAT5Ptyr may be associated with aberrant inflammatory gene expression in T1D, blood monocytes from non-autoimmune controls and T1D patients were analyzed by flow cytometry for STAT5Ptyr activation, and by chromatin immuno-precipitation (ChIP) analyses for STAT5Ptyr's ability to bind at CSF2 and PTGS2 regulatory sites in association with histone acetylation. In unstimulated monocytes, STAT5Ptyr was elevated in 59.65% of T1D, but only 2.44% of control subjects (p<0.0001). Increased STAT5Ptyr correlated with T1D disease duration (p = 0.0030, r(2) = 0.0784). Unstimulated (p = 0.140) and GM-CSF-stimulated (p = 0.0485) T1D monocytes, had greater STAT5Ptyr binding to epigenetic regulatory sites upstream of CSF2 than control monocytes. Increased STAT5Ptyr binding in T1D monocytes was concurrent with binding at these sites of STAT6Ptyr (p = 0.0283), CBP/P300 histone acetylase, acetylated histones H3, SMRT/NCoR histone deacetylase (p = 0.0040), and RNA Polymerase II (p = 0.0040). Our study indicates that in T1D monocytes, STAT5Ptyr activation is significantly higher and that STAT5Ptyr is found bound to CSF2 promoter and PTGS2 enhancer regions coincident with histone acetylation and RNA polymerase II. These findings suggest that the persistent activation of STAT5 by GM-CSF may be involved in altering the epigenetic regulation of these inflammatory response genes in T1D monocytes.	[Garrigan, Erin; Belkin, Nicole S.; Alexander, John J.; Han, Zhao; Seydel, Federica; Carter, Jamal; Atkinson, Mark; Wasserfall, Clive; Clare-Salzler, Michael J.; Litherland, Sally A.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Amick, Matthew A.; Litherland, Sally A.] Sanford Burnham Med Res Inst Orlando, Orlando, FL USA	State University System of Florida; University of Florida; Sanford Burnham Prebys Medical Discovery Institute	Litherland, SA (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.	Sally.Litherland@flhosp.org	wasserfall, clive/J-9078-2012; Alexander, John/GVS-7271-2022; Wasserfall, Clive/ABF-9385-2020	wasserfall, clive/0000-0002-3522-8932; Wasserfall, Clive/0000-0002-3522-8932; carter, jamal/0000-0002-2436-0428	NIH/NIDDK [DK002947, DK08082]; JDRF [33-2008-407]; NIH/NIAID [PO1 AI42288]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI042288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK002947, R21DK068082] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JDRF(Juvenile Diabetes Research Foundation); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to SAL from the NIH/NIDDK (DK002947 & DK08082) and the JDRF (33-2008-407)and to MA/MJCS from the NIH/NIAID (PO1 AI42288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman MA, 1996, J IMMUNOL, V157, P4690; CHASE HP, 1979, J PEDIATR-US, V94, P185, DOI 10.1016/S0022-3476(79)80819-7; Chen XX, 2005, MOL CELL BIOL, V25, P3209, DOI 10.1128/MCB.25.8.3209-3219.2005; Clare-Salzler MJ, 1998, NOD MICE RELATED STR, P101; David M, 1996, J BIOL CHEM, V271, P9185, DOI 10.1074/jbc.271.16.9185; Dendrou CA, 2008, J CLIN IMMUNOL, V9; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Feili-Hariri M, 2001, CLIN IMMUNOL, V98, P133, DOI 10.1006/clim.2000.4959; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Hamilton TA, 1999, PATHOBIOLOGY, V67, P241, DOI 10.1159/000028101; Hashimoto S, 2001, J IMMUNOL, V167, P3619, DOI 10.4049/jimmunol.167.7.3619; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Litherland S A, 2003, Pediatr Diabetes, V4, P10, DOI 10.1034/j.1399-5448.2003.00042.x; Litherland SA, 1999, J CLIN INVEST, V104, P515, DOI 10.1172/JCI4852; Litherland SA, 2005, J IMMUNOL, V175, P4561, DOI 10.4049/jimmunol.175.7.4561; Litherland SA, 2005, J AUTOIMMUN, V24, P297, DOI 10.1016/j.jaut.2005.02.001; Litherland SA, 2004, J AUTOIMMUN, V22, P227, DOI 10.1016/j.jaut.2003.12.006; Litherland SA, 2008, DIABETES, V57, P3184, DOI 10.2337/db08-1275; Maio F, 2007, J BIOL CHEM, V282, P13854; Maio F, 2008, J IMMUNOL, V180, P2264; Mi QS, 2004, DIABETES, V53, P1303, DOI 10.2337/diabetes.53.5.1303; Miao F, 2008, DIABETES, V57, P3189, DOI 10.2337/db08-0645; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Ohmori Y, 1998, J BIOL CHEM, V273, P29202, DOI 10.1074/jbc.273.44.29202; Rumore-Maton B, 2009, CLIN DEV IMMUNOL, P769; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SERREZE DV, 1993, FASEB J, V7, P1092, DOI 10.1096/fasebj.7.11.8370480; SERREZE DV, 1993, J IMMUNOL, V150, P2534; Seydel F, 2008, J AUTOIMMUN, V31, P377, DOI 10.1016/j.jaut.2008.08.010; Yamaoka K, 1998, J IMMUNOL, V160, P838	31	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76919	10.1371/journal.pone.0076919	http://dx.doi.org/10.1371/journal.pone.0076919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204704	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300066
J	Pandey, RB; Farmer, BL				Pandey, Ras B.; Farmer, Barry L.			Conformational Response to Solvent Interaction and Temperature of a Protein (Histone h3.1) by a Multi-Grained Monte Carlo Simulation	PLOS ONE			English	Article							DYNAMICS; POTENTIALS	Interaction with the solvent plays a critical role in modulating the structure and dynamics of a protein. Because of the heterogeneity of the interaction strength, it is difficult to identify multi-scale structural response. Using a coarse-grained Monte Carlo approach, we study the structure and dynamics of a protein (H3.1) in effective solvent media. The structural response is examined as a function of the solvent-residue interaction strength (based on hydropathy index) in a range of temperatures (spanning low to high) involving a knowledge-based (Miyazawa-Jernigan(MJ)) residue-residue interaction. The protein relaxes rapidly from an initial random configuration into a quasi-static structure at low temperatures while it continues to diffuse at high temperatures with fluctuating conformation. The radius of gyration (R-g) of the protein responds non-monotonically to solvent interaction, i.e., on increasing the residue-solvent interaction strength (f(s)), the increase in R-g (f(s)<= f(sc)) is followed by decay (f(s)>= f(sc)) with a maximum at a characteristic value (f(sc)) of the interaction. Raising the temperature leads to wider spread of the distribution of the radius of gyration with higher magnitude of f(sc). The effect of solvent on the multi-scale (lambda residue to R-g) structures of the protein is examined by analyzing the structure factor (S(q), vertical bar q vertical bar = 2 pi/lambda is the wave vector of wavelength, lambda) in detail. Random-coil to globular transition with temperature of unsolvated protein (H3.1) is dramatically altered by the solvent at low temperature while a systematic change in structure and scale is observed on increasing the temperature. The interaction energy profile of the residues is not sufficient to predict its mobility in the solvent. Fine-grain representation of protein with two-node and three-node residue enhances the structural resolution; results of the fine-grained simulations are consistent with the finding described above of the coarse-grained description with one-node residue.	[Pandey, Ras B.] Univ So Mississippi, Dept Phys & Astron, Hattiesburg, MS 39406 USA; [Farmer, Barry L.] Air Force Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH USA	University of Southern Mississippi; United States Department of Defense; United States Air Force; US Air Force Research Laboratory	Pandey, RB (corresponding author), Univ So Mississippi, Dept Phys & Astron, Hattiesburg, MS 39406 USA.	ras.pandey@usm.edu			Air Force Research Laboratory	Air Force Research Laboratory	This work is supported by the Air Force Research Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betancourt MR, 1999, PROTEIN SCI, V8, P361; Binder K, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-642-03163-2; Binder K, 1995, MOL DYNAMICS SIMULAT; Doster W, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.098101; Fritsche M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064507; Godzik A, 1996, STRUCTURE, V4, P363, DOI 10.1016/S0969-2126(96)00041-X; Hinsen K, 2008, PROTEINS, V70, P1235, DOI 10.1002/prot.21655; Hissam RS, 2011, PHYS CHEM CHEM PHYS, V13, P21262, DOI 10.1039/c1cp22361e; Hong L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028104; Huang SY, 2011, PROTEINS, V79, P2648, DOI 10.1002/prot.23086; Kurkal V, 2005, CHEM PHYS, V317, P267, DOI 10.1016/j.chemphys.2005.05.019; Liwo A, 2008, CURR OPIN STRUC BIOL, V18, P134, DOI 10.1016/j.sbi.2007.12.001; Marcos E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000738; Materese CK, 2008, P NATL ACAD SCI USA, V105, P10659, DOI 10.1073/pnas.0801850105; Miao YL, 2012, J AM CHEM SOC, V134, P19576, DOI 10.1021/ja3097898; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Pandey RB, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3358340; Pandey RB, 2012, PLOS ONE, V7; Pandey RB, 2013, PLOS ONE, V8; Sakai VG, 2013, SOFT MATTER, V9, P5336, DOI 10.1039/c3sm50492a; Xu ZJ, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3698164	21	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76069	10.1371/journal.pone.0076069	http://dx.doi.org/10.1371/journal.pone.0076069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204592	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300009
J	Wang, YL; Li, TQ				Wang, Yanlu; Li, Tie-Qiang			Analysis of Whole-Brain Resting-State fMRI Data Using Hierarchical Clustering Approach	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; EFFICIENT ALGORITHM	Background: Previous studies using hierarchical clustering approach to analyze resting-state fMRI data were limited to a few slices or regions-of-interest (ROIs) after substantial data reduction. Purpose: To develop a framework that can perform voxel-wise hierarchical clustering of whole-brain resting-state fMRI data from a group of subjects. Materials and Methods: Resting-state fMRI measurements were conducted for 86 adult subjects using a single-shot echoplanar imaging (EPI) technique. After pre-processing and co-registration to a standard template, pair-wise cross-correlation coefficients (CC) were calculated for all voxels inside the brain and translated into absolute Pearson's distances after imposing a threshold CC >= 0.3. The group averages of the Pearson's distances were then used to perform hierarchical clustering with the developed framework, which entails gray matter masking and an iterative scheme to analyze the dendrogram. Results: With the hierarchical clustering framework, we identified most of the functional connectivity networks reported previously in the literature, such as the motor, sensory, visual, memory, and the default-mode functional networks (DMN). Furthermore, the DMN and visual system were split into their corresponding hierarchical sub-networks. Conclusion: It is feasible to use the proposed hierarchical clustering scheme for voxel-wise analysis of whole-brain resting-state fMRI data. The hierarchical clustering result not only confirmed generally the finding in functional connectivity networks identified previously using other data processing techniques, such as ICA, but also revealed directly the hierarchical structure within the functional connectivity networks.	[Wang, Yanlu; Li, Tie-Qiang] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Wang, Yanlu; Li, Tie-Qiang] Karolinska Univ Hosp, Dept Med Phys, Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Wang, YL (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	yanlu.wang@ki.se		Li, Tie-Qiang/0000-0002-4866-5904	Swedish Research Console	Swedish Research Console	The authors would like to acknowledge that this study is partly supported by a research grant from the Swedish Research Console. No additional external funding received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Benjaminsson S, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00034; Boly M, 2012, P NATL ACAD SCI USA, V109, P5856, DOI 10.1073/pnas.1111133109; Cordes D, 2002, MAGN RESON IMAGING, V20, P305, DOI 10.1016/S0730-725X(02)00503-9; DEFAYS D, 1977, COMPUT J, V20, P364, DOI 10.1093/comjnl/20.4.364; Gomez-Laberge C, 2011, BIOMEDICAL ENG IEEE, P1; Johanna Ooberg TJ, 2011, AGING RELATED CHANGE; Liu X, 2012, J NEUROSCI METH, V211, P94, DOI 10.1016/j.jneumeth.2012.08.016; Marrelec G, 2008, MED IMAGE ANAL, V12, P484, DOI 10.1016/j.media.2008.02.002; Marrelec G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014788; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Narasimhan M, 2005, AGING RELATED CHANGE; Pamilo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042000; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; SIBSON R, 1973, COMPUT J, V16, P30, DOI 10.1093/comjnl/16.1.30; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	17	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76315	10.1371/journal.pone.0076315	http://dx.doi.org/10.1371/journal.pone.0076315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204612	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300020
J	Kato, T; Zhou, X; Ma, Y				Kato, Toshiaki; Zhou, Xin; Ma, Yan			Possible Involvement of Nitric Oxide and Reactive Oxygen Species in Glucose Deprivation-Induced Activation of Transcription Factor Rst2	PLOS ONE			English	Article							REGULATES CELL INTEGRITY; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; PROTEIN-KINASE; S-NITROSYLATION; HYDROGEN-PEROXIDE; MAP KINASE; THIOREDOXIN; STRESS; GENE	Glucose is one of the most important sources of cellular nutrition and glucose deprivation induces various cellular responses. In Schizosaccharomyces pombe, zinc finger protein Rst2 is activated upon glucose deprivation, and regulates gene expression via the STREP (stress response element of Schizosaccharomyces pombe) motif. However, the activation mechanism of Rst2 is not fully understood. We monitored Rst2 transcriptional activity in living cells using a Renilla luciferase reporter system. Hydrogen peroxide (H2O2) enhanced Rst2 transcriptional activity upon glucose deprivation and free radical scavenger inhibited Rst2 transcriptional activity upon glucose deprivation. In addition, deletion of the trx2(+) gene encoding mitochondrial thioredoxin enhanced Rst2 transcriptional activity. Notably, nitric oxide (NO) generators enhanced Rst2 transcriptional activity upon glucose deprivation as well as under glucose-rich conditions. Furthermore, NO specific scavenger inhibited Rst2 transcriptional activity upon glucose deprivation. Altogether, our data suggest that NO and reactive oxygen species may be involved in the activation of transcription factor Rst2.	[Kato, Toshiaki; Zhou, Xin; Ma, Yan] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen, Kobe, Hyogo 657, Japan; [Zhou, Xin] Liaoning Med Univ, Affiliated Hosp 1, Jinzhou, Liaoning Provin, Peoples R China	Kobe University; Jinzhou Medical University	Ma, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen, Kobe, Hyogo 657, Japan.	mayan@med.kobe-u.ac.jp			Japan Society for the Promotion of Science [21790241]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Financial support for this study was provided by Grant-in-Aid for Young Scientists (B) to Yan Ma (No. 21790241), from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aon MA, 2012, J GEN PHYSIOL, V139, P479, DOI 10.1085/jgp.201210772; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Cao BJ, 2002, EUR J PHARMACOL, V448, P27, DOI 10.1016/S0014-2999(02)01908-8; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Ferretti AC, 2012, MOL GENET METAB, V105, P186, DOI 10.1016/j.ymgme.2011.11.007; Fourquet S, 2008, ANTIOXID REDOX SIGN, V10, P1565, DOI 10.1089/ars.2008.2049; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; HOFFMAN CS, 1990, GENETICS, V124, P807; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Jara M, 2007, MOL BIOL CELL, V18, P2288, DOI 10.1091/mbc.E06-11-1039; Kig C, 2009, PROTOPLASMA, V238, P59, DOI 10.1007/s00709-009-0074-3; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Koike A, 2012, J BIOL CHEM, V287, P19294, DOI 10.1074/jbc.M111.310615; Ma Y, 2007, CURR GENET, V52, P97, DOI 10.1007/s00294-007-0142-1; Madrid M, 2004, J BIOL CHEM, V279, P41594, DOI 10.1074/jbc.M405509200; MAEDA T, 1994, J BIOL CHEM, V269, P9632; McConell GK, 2012, AM J PHYSIOL-ENDOC M, V303, pE301, DOI 10.1152/ajpendo.00667.2011; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Reinartz M, 2008, J BIOL CHEM, V283, P17440, DOI 10.1074/jbc.M800126200; Ryuko S, 2012, MOL GENET GENOMICS, V287, P651, DOI 10.1007/s00438-012-0705-9; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Sengupta R, 2012, BBA-GEN SUBJECTS, V1820, P689, DOI 10.1016/j.bbagen.2011.08.012; Song JY, 2008, J MICROBIOL, V46, P408, DOI 10.1007/s12275-008-0076-4; Song JY, 2008, EUKARYOT CELL, V7, P2160, DOI 10.1128/EC.00106-08; Takada H, 2007, MOL BIOL CELL, V18, P4794, DOI 10.1091/mbc.E07-03-0282; Toda T, 1996, MOL CELL BIOL, V16, P6752; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Watson WH, 2004, TOXICOL SCI, V78, P3, DOI 10.1093/toxsci/kfh050; Yamawaki H, 2003, CIRC RES, V93, P1029, DOI 10.1161/01.RES.0000102869.39150.23; Zhou X, 2012, J BIOL CHEM, V287, P23434, DOI 10.1074/jbc.C111.338715; Zhou X, 2010, J BIOL CHEM, V285, P32818, DOI 10.1074/jbc.M110.135764	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78012	10.1371/journal.pone.0078012	http://dx.doi.org/10.1371/journal.pone.0078012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155978	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300112
J	Uthman, OA; Okwundu, CI; Wiysonge, CS; Young, T; Clarke, A				Uthman, Olalekan A.; Okwundu, Charles I.; Wiysonge, Charles S.; Young, Taryn; Clarke, Aileen			Citation Classics in Systematic Reviews and Meta-Analyses: Who Wrote the Top 100 Most Cited Articles?	PLOS ONE			English	Review							EVIDENCE-BASED MEDICINE; JOURNAL IMPACT FACTORS; PUBLICATIONS; COUNTRIES; HEALTH	Background: Systematic reviews of the literature occupy the highest position in currently proposed hierarchies of evidence. The aims of this study were to assess whether citation classics exist in published systematic review and meta-analysis (SRM), examine the characteristics of the most frequently cited SRM articles, and evaluate the contribution of different world regions. Methods: The 100 most cited SRM were identified in October 2012 using the Science Citation Index database of the Institute for Scientific Information. Data were extracted by one author. Spearman's correlation was used to assess the association between years since publication, numbers of authors, article length, journal impact factor, and average citations per year. Results: Among the 100 citation classics, published between 1977 and 2008, the most cited article received 7308 citations and the least-cited 675 citations. The average citations per year ranged from 27.8 to 401.6. First authors from the USA produced the highest number of citation classics (n=46), followed by the UK (n=28) and Canada (n=15). The 100 articles were published in 42 journals led by the Journal of the American Medical Association (n=18), followed by the British Medical Journal (n=14) and The Lancet (n=13). There was a statistically significant positive correlation between number of authors (Spearman's rho=0.320, p=0.001), journal impact factor (rho=0.240, p=0.016) and average citations per year. There was a statistically significant negative correlation between average citations per year and year since publication (rho = -0.636, p=0.0001). The most cited papers identified seminal contributions and originators of landmark methodological aspects of SRM and reflect major advances in the management of and predisposing factors for chronic diseases. Conclusions: Since the late 1970s, the USA, UK, and Canada have taken leadership in the production of citation classic papers. No first author from low or middle-income countries (LMIC) led one of the most cited 100 SRM.	[Uthman, Olalekan A.] Univ Warwick, WCAHRD, Div Hlth Sci, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Uthman, Olalekan A.] Univ Liverpool, Liverpool Sch Trop Med, Int Hlth Grp, Liverpool L3 5QA, Merseyside, England; [Uthman, Olalekan A.; Okwundu, Charles I.; Wiysonge, Charles S.; Young, Taryn] Univ Stellenbosch, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, ZA-7505 Tygerberg, South Africa; [Okwundu, Charles I.; Young, Taryn] South African Med Res Council, South African Cochrane Ctr, Tygerberg, South Africa; [Clarke, Aileen] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick; Liverpool School of Tropical Medicine; University of Liverpool; Stellenbosch University; South African Medical Research Council; University of Warwick	Uthman, OA (corresponding author), Univ Warwick, WCAHRD, Div Hlth Sci, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	olalekan.uthman@warwick.ac.uk	Uthman, Olalekan/N-5584-2019; Wiysonge, Charles Shey U/A-3843-2008; Clarke, Aileen/I-5679-2012	Uthman, Olalekan/0000-0002-8567-3081; Wiysonge, Charles Shey U/0000-0002-1273-4779; Clarke, Aileen/0000-0001-8299-3146; Young, Taryn/0000-0003-2406-081X				Baltussen A, 2004, INTENS CARE MED, V30, P902, DOI 10.1007/s00134-004-2195-7; Baltussen A, 2004, ANESTH ANALG, V98, P443, DOI 10.1213/01.ANE.0000096185.13474.0A; Chinnock P, 2005, EVID-BASED COMPL ALT, V2, P321, DOI 10.1093/ecam/neh114; DUMONT JE, 1989, TRENDS BIOCHEM SCI, V14, P327, DOI 10.1016/0968-0004(89)90164-3; Egghe L, 2000, J AM SOC INFORM SCI, V51, P145, DOI 10.1002/(SICI)1097-4571(2000)51:2<145::AID-ASI6>3.0.CO;2-9; Evans D, 2003, J CLIN NURS, V12, P77, DOI 10.1046/j.1365-2702.2003.00662.x; Fenton JE, 2002, J LARYNGOL OTOL, V116, P494, DOI 10.1258/002221502760132557; Gastner MT, 2004, P NATL ACAD SCI USA, V101, P7499, DOI 10.1073/pnas.0400280101; Gisvold SE, 1999, ACTA ANAESTH SCAND, V43, P971, DOI 10.1034/j.1399-6576.1999.431001.x; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Manchikanti L, 2008, PAIN PHYSICIAN, V11, P161; Montori VM, 2003, BMC MED, V1, DOI 10.1186/1741-7015-1-2; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Paladugu R, 2002, WORLD J SURG, V26, P1099, DOI 10.1007/s00268-002-6376-7; Perez-Iratxeta C, 2002, SCIENCE, V297, P519; Rahman M, 2003, INT J TECHNOL ASSESS, V19, P249, DOI 10.1017/S0266462303000229; Schein, 2000, Curr Surg, V57, P252, DOI 10.1016/S0149-7944(00)00177-X; Schein M, 2000, BRIT J SURG, V87, P261, DOI 10.1046/j.1365-2168.2000.01419.x; Seglen PO, 1998, ACTA ORTHOP SCAND, V69, P224, DOI 10.3109/17453679809000920; Swingler GH, 2003, BRIT MED J, V327, P1083, DOI 10.1136/bmj.327.7423.1083; The Cochrane Collaboration, 2013, OCHR REV; Tsai YL, 2006, AM J EMERG MED, V24, P647, DOI 10.1016/j.ajem.2006.01.001; Uthman OA, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-46; Waters E, 2004, BRIT MED J, V328, P585, DOI 10.1136/bmj.328.7439.585; Wright RW, 2007, CLIN ORTHOP RELAT R, P23, DOI 10.1097/BLO.0b013e31802c9098	25	56	58	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78517	10.1371/journal.pone.0078517	http://dx.doi.org/10.1371/journal.pone.0078517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155987	Green Published, Green Accepted, gold			2022-12-27	WOS:000325887300122
J	Lin, JR; Hu, JJ				Lin, Jhih-rong; Hu, Jianjun			SeqNLS: Nuclear Localization Signal Prediction Based on Frequent Pattern Mining and Linear Motif Scoring	PLOS ONE			English	Article							SEQUENCE; PROTEINS; BINDING; SERVER; IDENTIFICATION; RECOGNITION; DEFINITION; DISCOVERY; DATABASE; CONTEXT	Nuclear localization signals (NLSs) are stretches of residues in proteins mediating their importing into the nucleus. NLSs are known to have diverse patterns, of which only a limited number are covered by currently known NLS motifs. Here we propose a sequential pattern mining algorithm SeqNLS to effectively identify potential NLS patterns without being constrained by the limitation of current knowledge of NLSs. The extracted frequent sequential patterns are used to predict NLS candidates which are then filtered by a linear motif-scoring scheme based on predicted sequence disorder and by the relatively local conservation (IRLC) based masking. The experiment results on the newly curated Yeast and Hybrid datasets show that SeqNLS is effective in detecting potential NLSs. The performance comparison between SeqNLS with and without the linear motif scoring shows that linear motif features are highly complementary to sequence features in discerning NLSs. For the two independent datasets, our SeqNLS not only can consistently find over 50% of NLSs with prediction precision of at least 0.7, but also outperforms other state-of-the-art NLS prediction methods in terms of F1 score or prediction precision with similar or higher recall rates. The web server of the SeqNLS algorithm is available at http://mleg.cse.sc.edu/seqNLS.	[Lin, Jhih-rong; Hu, Jianjun] Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Hu, JJ (corresponding author), Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA.	jianjunh@cse.sc.edu			National Science Foundation [BIO-DBI-0845381]; Div Of Biological Infrastructure [0845381] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation Career Award (Grant BIO-DBI-0845381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2013, DOI 10.1093/nar/20.suppl.2013; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Davey NE, 2011, NUCLEIC ACIDS RES, V39, pW56, DOI 10.1093/nar/gkr402; Davey NE, 2009, BIOINFORMATICS, V25, P443, DOI 10.1093/bioinformatics/btn664; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fu SC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr493; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gutman R, 2005, NUCLEIC ACIDS RES, V33, pW255, DOI 10.1093/nar/gki496; Hahn S, 2008, J MOL BIOL, V379, P678, DOI 10.1016/j.jmb.2008.04.038; Haslam NJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-104; Hicks GR, 1995, ANNU REV CELL DEV BI, V11, P155, DOI 10.1146/annurev.cb.11.110195.001103; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Mehdi AM, 2011, BIOINFORMATICS, V27, P1239, DOI 10.1093/bioinformatics/btr121; Monastyrskyy B, 2011, PROTEINS, V79, P107, DOI 10.1002/prot.23161; Nair R, 2003, NUCLEIC ACIDS RES, V31, P397, DOI 10.1093/nar/gkg001; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Plewczynski D, 2005, BIOINFORMATICS, V21, P2525, DOI 10.1093/bioinformatics/bti333; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Ramu C, 2003, NUCLEIC ACIDS RES, V31, P3771, DOI 10.1093/nar/gkg546; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Tan PN, 2006, INTRO DATA MINING, Vxxi; Tan SH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-502; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Via A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-351	42	67	72	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76864	10.1371/journal.pone.0076864	http://dx.doi.org/10.1371/journal.pone.0076864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204689	gold, Green Published			2022-12-27	WOS:000326270700013
J	Wang, Y; Jiang, D; Zhuang, DF; Huang, YH; Wang, W; Yu, XF				Wang, Yong; Jiang, Dong; Zhuang, Dafang; Huang, Yaohuan; Wang, Wei; Yu, Xinfang			Effective Key Parameter Determination for an Automatic Approach to Land Cover Classification Based on Multispectral Remote Sensing Imagery	PLOS ONE			English	Article							SPATIAL-PATTERN; IDENTIFICATION; LANDSCAPE; AGREEMENT; ACCURACY; DATABASE; KAPPA; CHINA	The classification of land cover based on satellite data is important for many areas of scientific research. Unfortunately, some traditional land cover classification methods (e. g. known as supervised classification) are very labor-intensive and subjective because of the required human involvement. Jiang et al. proposed a simple but robust method for land cover classification using a prior classification map and a current multispectral remote sensing image. This new method has proven to be a suitable classification method; however, its drawback is that it is a semi-automatic method because the key parameters cannot be selected automatically. In this study, we propose an approach in which the two key parameters are chosen automatically. The proposed method consists primarily of the following three interdependent parts: the selection procedure for the pure-pixel training-sample dataset, the method to determine the key parameters, and the optimal combination model. In this study, the proposed approach employs both overall accuracy and their Kappa Coefficients (KC), and Time-Consumings (TC, unit: second) in order to select the two key parameters automatically instead of using a test-decision, which avoids subjective bias. A case study of Weichang District of Hebei Province, China, using Landsat-5/TM data of 2010 with 30 m spatial resolution and prior classification map of 2005 recognised as relatively precise data, was conducted to test the performance of this method. The experimental results show that the methodology determining the key parameters uses the portfolio optimisation model and increases the degree of automation of Jiang et al.'s classification method, which may have a wide scope of scientific application.	[Wang, Yong; Jiang, Dong; Zhuang, Dafang; Huang, Yaohuan; Yu, Xinfang] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Wang, Wei] Beijing Technol & Business Univ, Sch Comp & Informat Engn, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Beijing Technology & Business University	Jiang, D (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	jiangd@igsnrr.ac.cn		Wang, Yong/0000-0002-0821-6549	China Postdoctoral Science Foundation [20060400496]; Chinese Academy of Sciences [KZZD-EW-08]; National Natural Science Foundation of China [41001279]; National Scientific and Technological Support Projects of China [2011BAJ07B01]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Scientific and Technological Support Projects of China	This study was partially funded by the China Postdoctoral Science Foundation (20060400496), the Chinese Academy of Sciences (KZZD-EW-08), the National Natural Science Foundation of China (41001279), and the National Scientific and Technological Support Projects of China (2011BAJ07B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah SA, 2006, LANDSCAPE URBAN PLAN, V77, P263, DOI 10.1016/j.landurbplan.2005.03.003; Aitkenhead MJ, 2011, REMOTE SENS ENVIRON, V115, P1285, DOI 10.1016/j.rse.2011.01.012; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Baidu, INTR MONG WEICH MANC; Berberoglu S, 2010, INT J REMOTE SENS, V31, P2793, DOI 10.1080/01431160903111077; Blackman NJM, 2000, STAT MED, V19, P723, DOI 10.1002/(SICI)1097-0258(20000315)19:5<723::AID-SIM379>3.0.CO;2-A; Canty MJ, 2006, IMAGE ANAL CLASSIFIC, P77; Chen J, 2003, PHOTOGRAMM ENG REM S, V69, P369, DOI 10.14358/PERS.69.4.369; Chen J, 2011, IEEE GEOSCI REMOTE S, V8, P317, DOI 10.1109/LGRS.2010.2068537; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Congalton R.G., 2019, ASSESSING ACCURACY R, VThird, DOI 10.1201/9780429052729; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; De Santiago FF, 2013, INT J REMOTE SENS, V34, P563, DOI 10.1080/01431161.2012.715773; Denis R, 2011, INT J REMOTE SENS, V32, P1747; Foody GM, 2007, PROG PHYS GEOG, V31, P439, DOI 10.1177/0309133307081294; Foody GM, 1997, INT J REMOTE SENS, V18, P937, DOI 10.1080/014311697218845; Fortier J, 2011, PHOTOGRAMM ENG REM S, V77, P181, DOI 10.14358/PERS.77.2.181; Fraser R, 2012, POLAR REC, V48, P83, DOI 10.1017/S0032247411000477; Geneletti D, 2003, INT J REMOTE SENS, V24, P1273, DOI 10.1080/01431160210144499; Gong P, 2003, INT J REMOTE SENS, V24, P1303, DOI 10.1080/01431160110115870; Gupta M, 2010, WATER INT, V35, P233, DOI 10.1080/02508061003664419; Gutman G, 2004, LAND CHANGE SCI OBSE, P108; Hansen M, 1996, INT J REMOTE SENS, V17, P1075, DOI 10.1080/01431169608949069; Jensen JR, 2005, INTRO DIGITAL IMAGE, P495; Jiang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045889; Lambin EF, 2006, LAND USE LAND COVER, P38; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liu Jiyuan, 2002, Journal of Geographical Sciences, V12, P275; Liu JY, 2010, CHINESE SCI BULL, V55, P1354, DOI 10.1007/s11434-009-0733-y; Liu JY, 2003, SCI CHINA SER D, V46, P373; Liu JY, 2005, REMOTE SENS ENVIRON, V98, P442, DOI 10.1016/j.rse.2005.08.012; LOVELAND TR, 1991, PHOTOGRAMM ENG REM S, V57, P1453; Orenstein DE, 2011, INT J REMOTE SENS, V32, P2621, DOI 10.1080/01431161003713036; Paneque-Galvez J, 2013, INT J APPL EARTH OBS, V23, P372, DOI 10.1016/j.jag.2012.10.007; Pouteau R, 2013, REMOTE SENS LETT, V4, P686, DOI 10.1080/2150704X.2013.784848; Richards JA, 1999, REMOTE SENSING DIGIT, P102; Schneider A, 2010, REMOTE SENS ENVIRON, V114, P1733, DOI 10.1016/j.rse.2010.03.003; Veldkamp A, 2001, AGR ECOSYST ENVIRON, V85, P1, DOI 10.1016/S0167-8809(01)00199-2; Wang YC, 2011, INT J REMOTE SENS, V32, P3765, DOI 10.1080/01431161.2010.540590; Weng Q, 2011, T&F SER REMOTE SENS, P1, DOI 10.1201/b10599; Xian G, 2009, REMOTE SENS ENVIRON, V113, P1133, DOI 10.1016/j.rse.2009.02.004; Xie YC, 2010, ISPRS J PHOTOGRAMM, V65, P182, DOI 10.1016/j.isprsjprs.2009.10.007; Yvonne MMB, 1975, DISCRETE MULTIVARIAT, P58; Zhao Y, 2003, APPL PRINCIPLE METHO, P57	44	2	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e75852	10.1371/journal.pone.0075852	http://dx.doi.org/10.1371/journal.pone.0075852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204582	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200008
J	Alon, M; Malka, O; Eakteiman, G; Elbaz, M; Ben Zvi, MM; Vainstein, A; Morin, S				Alon, Michal; Malka, Osnat; Eakteiman, Galit; Elbaz, Moshe; Ben Zvi, Michal Moyal; Vainstein, Alexander; Morin, Shai			Activation of the Phenylpropanoid Pathway in Nicotiana tabacum Improves the Performance of the Whitefly Bemisia tabaci via Reduced Jasmonate Signaling	PLOS ONE			English	Article							PLANT DEFENSE; TRANSCRIPTION FACTOR; SALICYLIC-ACID; INDUCED RESISTANCE; CROSS-TALK; ARABIDOPSIS; RESPONSES; EXPRESSION; TOBACCO; APHIDS	Background: Phloem-feeding insects can manipulate plant-induced resistance and are able to suppress effective jasmonic acid/ethylene (JA/ET) defenses by the induction of inefficient salicylic acid (SA) based responses. As a result, activation of the phenylpropanoid biosynthesis pathway in transgenic plants is anticipated to cause complex interactions between phloem-feeding insects and their host plants due to predicted contradiction between two defense forces: the toxicity of various phenylpropanoids and the accumulation of SA via a branch of the activated pathway. Methodology/Principal Findings: Here, we investigated the effect of activating the phenylpropanoids pathway in Nicotiana tabacum, by over-expression of the PAP1 transcription factor, on the whitefly Bemisia tabaci, a phloem-feeding insect model. Our performance assays indicated that the over-expression made the transgenic plants a more suitable host for B. tabaci than wild-type (WT) plants, although these plants accumulated significantly higher levels of flavonoids. Transcription analyses of indicator genes in the SA (PR1a) and JA/ET (ERF1, COI1 and AOC) pathways followed by quantification of the SA and JA hormone levels, indicated that B. tabaci infestation periods longer than 8 hours, caused higher levels of activity of SA signaling in transgenic plants and higher levels of JA/ET signaling in WT plants. Conclusions/Significance: Taken together, these results emphasize the important role JA/ET-induced defenses play in protecting plants from successful infestation by B. tabaci and likely other phloem-feeding insects. It also indicates the necessity of phloem feeders to suppress these defenses for efficient utilization of plant hosts. Our data also indicate that the defensive chemistry produced by the phenylpropanoids pathway has only a minor effect on the insect fitness.	[Alon, Michal; Malka, Osnat; Eakteiman, Galit; Elbaz, Moshe; Morin, Shai] Hebrew Univ Jerusalem, Dept Entomol, IL-76100 Rehovot, Israel; [Ben Zvi, Michal Moyal; Vainstein, Alexander] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Morin, S (corresponding author), Hebrew Univ Jerusalem, Dept Entomol, IL-76100 Rehovot, Israel.	shai.morin@mail.huji.ac.il			Israel Science Foundation [971/04, 848/08]	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation (http://www.isf.org.il/) grants 971/04 and 848/08 to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon M, 2012, INSECT BIOCHEM MOLEC, V42, P251, DOI 10.1016/j.ibmb.2011.12.007; Antico Christopher J, 2012, [Frontiers in Biology, 生物学前沿], V7, P48; Baldwin IT, 1999, J CHEM ECOL, V25, P3, DOI 10.1023/A:1020880931488; Ben Zvi MM, 2008, PLANT BIOTECHNOL J, V6, P403, DOI 10.1111/j.1467-7652.2008.00329.x; Berner JM, 2010, CEREAL RES COMMUN, V38, P506, DOI 10.1556/CRC.38.2010.4.7; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; CALATAYUD PA, 1994, ENTOMOL EXP APPL, V72, P47, DOI 10.1007/BF02382414; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Cui H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-76; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; de Vos M, 2007, BIOESSAYS, V29, P871, DOI 10.1002/bies.20624; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Elsayed G., 2011, Archives of Phytopathology and Plant Protection, V44, P1534, DOI 10.1080/03235408.2010.507957; Felton GW, 1999, CURR BIOL, V9, P317, DOI 10.1016/S0960-9822(99)80140-7; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Glazebrook J, 1999, CURR OPIN PLANT BIOL, V2, P280, DOI 10.1016/S1369-5266(99)80050-8; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Heil M, 2002, CURR OPIN PLANT BIOL, V5, P345, DOI 10.1016/S1369-5266(02)00267-4; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Johnson ET, 2004, J AGR FOOD CHEM, V52, P5135, DOI 10.1021/jf0308049; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Kusnierczyk A, 2008, PLANT CELL ENVIRON, V31, P1097, DOI 10.1111/j.1365-3040.2008.01823.x; Lattanzio V, 2000, J AGR FOOD CHEM, V48, P5316, DOI 10.1021/jf000229y; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; MACLEOD NJ, 1966, PHYTOCHEMISTRY, V5, P777, DOI 10.1016/S0031-9422(00)83659-6; Malone LA, 2009, ENTOMOL EXP APPL, V133, P117, DOI 10.1111/j.1570-7458.2009.00910.x; Misra P, 2010, PLANT PHYSIOL, V152, P2258, DOI 10.1104/pp.109.150979; Niki T, 1998, PLANT CELL PHYSIOL, V39, P500, DOI 10.1093/oxfordjournals.pcp.a029397; O'Neill BF, 2010, J CHEM ECOL, V36, P35, DOI 10.1007/s10886-009-9727-0; Paschold A, 2008, PLANT CELL PHYSIOL, V49, P1165, DOI 10.1093/pcp/pcn091; Pieterse CMJ, 1999, TRENDS PLANT SCI, V4, P52, DOI 10.1016/S1360-1385(98)01364-8; Pyati P, 2011, J INSECT PHYSIOL, V57, P881, DOI 10.1016/j.jinsphys.2011.03.024; Rahbe Y, 2003, PLANT SCI, V164, P441, DOI 10.1016/S0168-9452(02)00402-8; Rojo E, 1999, PLANT J, V20, P135, DOI 10.1046/j.1365-313x.1999.00570.x; Salvucci ME, 1998, ARCH INSECT BIOCHEM, V39, P155, DOI 10.1002/(SICI)1520-6327(1998)39:4&lt;155::AID-ARCH3&gt;3.0.CO;2-#; Thaler JS, 1999, J CHEM ECOL, V25, P1597, DOI 10.1023/A:1020840900595; TODD GW, 1971, ANN ENTOMOL SOC AM, V64, P718, DOI 10.1093/aesa/64.3.718; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Van Cutsem E, 2011, PROTEOMICS, V11, P440, DOI 10.1002/pmic.201000356; van Dam NM, 2008, PLANT SIGNAL BEHAV, V3, P91, DOI 10.4161/psb.3.2.5220; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; WALKER GP, 1994, ANN ENTOMOL SOC AM, V87, P363, DOI 10.1093/aesa/87.3.363; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Wuyts N, 2006, J EXP BOT, V57, P2825, DOI 10.1093/jxb/erl044; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhu-Salzman K, 2004, PLANT PHYSIOL, V134, P420, DOI 10.1104/pp.103.028324	58	25	27	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76619	10.1371/journal.pone.0076619	http://dx.doi.org/10.1371/journal.pone.0076619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204646	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400015
J	Radhakrishnan, P; Mohr, AM; Grandgenett, PM; Steele, MM; Batra, SK; Hollingsworth, MA				Radhakrishnan, Prakash; Mohr, Ashley M.; Grandgenett, Paul M.; Steele, Maria M.; Batra, Surinder K.; Hollingsworth, Michael A.			MicroRNA-200c Modulates the Expression of MUC4 and MUC16 by Directly Targeting Their Coding Sequences in Human Pancreatic Cancer	PLOS ONE			English	Article							EPITHELIAL OVARIAN-CANCER; E-CADHERIN; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; REDUCED EXPRESSION; GENE-EXPRESSION; DOWN-REGULATION; UP-REGULATION; LET-7; METASTASIS	Transmembrane mucins, MUC4 and MUC16 are associated with tumor progression and metastatic potential in human pancreatic adenocarcinoma. We discovered that miR-200c interacts with specific sequences within the coding sequence of MUC4 and MUC16 mRNAs, and evaluated the regulatory nature of this association. Pancreatic cancer cell lines S2.028 and T3M-4 transfected with miR-200c showed a 4.18 and 8.50 fold down regulation of MUC4 mRNA, and 4.68 and 4.82 fold down regulation of MUC16 mRNA compared to mock-transfected cells, respectively. A significant reduction of glycoprotein expression was also observed. These results indicate that miR-200c overexpression regulates MUC4 and MUC16 mucins in pancreatic cancer cells by directly targeting the mRNA coding sequence of each, resulting in reduced levels of MUC4 and MUC16 mRNA and protein. These data suggest that, in addition to regulating proteins that modulate EMT, miR-200c influences expression of cell surface mucins in pancreatic cancer.	[Radhakrishnan, Prakash; Mohr, Ashley M.; Grandgenett, Paul M.; Steele, Maria M.; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Hollingsworth, MA (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	mahollin@unmc.edu		Steele, Maria/0000-0003-0186-2633	National Cancer Institute: SPORE [1P50CA127297]; National Cancer Institute: Early Detection Research Network [5U01CA111294]; National Cancer Institute: Alliance of Glycobiologist for Detection of Cancer and Cancer Risk [5U01CA128437]; National Cancer Institute: Tumor Microenvironment Network [U54 CA163120]; National Cancer Institute [R01CA57362]; NATIONAL CANCER INSTITUTE [P50CA127297, U54CA163120, U01CA128437, R01CA057362, U01CA111294] Funding Source: NIH RePORTER	National Cancer Institute: SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute: Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute: Alliance of Glycobiologist for Detection of Cancer and Cancer Risk; National Cancer Institute: Tumor Microenvironment Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following grants from the National Cancer Institute: SPORE (1P50CA127297), Early Detection Research Network (5U01CA111294), the Alliance of Glycobiologist for Detection of Cancer and Cancer Risk (5U01CA128437), Tumor Microenvironment Network (U54 CA163120), and R01CA57362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033; Argueso P, 2003, INVEST OPHTH VIS SCI, V44, P2487, DOI 10.1167/iovs.02-0862; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chaturvedi P, 2007, MOL CANCER RES, V5, P309, DOI 10.1158/1541-7786.MCR-06-0353; Cittelly DM, 2012, MOL CANCER THER, V11, P2556, DOI 10.1158/1535-7163.MCT-12-0463; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Gabriel M, 2005, CLIN ORAL INVEST, V9, P284, DOI 10.1007/s00784-005-0007-2; Haridas D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026839; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Huang SL, 2010, NUCLEIC ACIDS RES, V38, P7211, DOI 10.1093/nar/gkq564; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hurteau GJ, 2009, CELL CYCLE, V8, P2064, DOI 10.4161/cc.8.13.8883; IWAMURA T, 1992, J GASTROEN HEPATOL, V7, P512, DOI 10.1111/j.1440-1746.1992.tb01030.x; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liu SJ, 2012, AM J PATHOL, V181, P1823, DOI 10.1016/j.ajpath.2012.07.009; Mohr AM, 2013, PLOS ONE IN PRESS; OLIVER MH, 1989, J CELL SCI, V92, P513; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Remmers N, 2013, CLIN CANCER RES, V19, P1981, DOI 10.1158/1078-0432.CCR-12-2662; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Shimizu A, 2012, CANCER SCI, V103, P739, DOI 10.1111/j.1349-7006.2012.02214.x; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Theriault C, 2011, GYNECOL ONCOL, V121, P434, DOI 10.1016/j.ygyno.2011.02.020; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169	37	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e73356	10.1371/journal.pone.0073356	http://dx.doi.org/10.1371/journal.pone.0073356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204560	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400003
J	Hanefeld, J; Horsfall, D; Lunt, N; Smith, R				Hanefeld, Johanna; Horsfall, Daniel; Lunt, Neil; Smith, Richard			Medical Tourism: A Cost or Benefit to the NHS?	PLOS ONE			English	Article							SERVICES; HEALTH; IMPACT; CARE	'Medical Tourism' - the phenomenon of people travelling abroad to access medical treatment - has received increasing attention in academic and popular media. This paper reports findings from a study examining effect of inbound and outbound medical tourism on the UK NHS, by estimating volume of medical tourism and associated costs and benefits. A mixed methods study it includes analysis of the UK International Passenger Survey (IPS); interviews with 77 returning UK medical tourists, 63 policymakers, NHS managers and medical tourism industry actors policymakers, and a review of published literature. These informed costing of three types of treatments for which patients commonly travel abroad: fertility treatment, cosmetic and bariatric surgery. Costing of inbound tourism relied on data obtained through 28 Freedom-of-Information requests to NHS Foundation Trusts. Findings demonstrate that contrary to some popular media reports, far from being a net importer of patients, the UK is now a clear net exporter of medical travellers. In 2010, an estimated 63,000 UK residents travelled for treatment, while around 52,000 patients sought treatment in the UK. Inbound medical tourists treated as private patients within NHS facilities may be especially profitable when compared to UK private patients, yielding close to a quarter of revenue from only 7% of volume in the data examined. Costs arise where patients travel abroad and return with complications. Analysis also indicates possible savings especially in future health care and social costs averted. These are likely to be specific to procedures and conditions treated. UK medical tourism is a growing phenomenon that presents risks and opportunities to the NHS. To fully understand its implications and guide policy on issues such as NHS global activities and patient safety will require investment in further research and monitoring. Results point to likely impact of medical tourism in other universal public health systems.	[Hanefeld, Johanna] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London WC1, England; [Horsfall, Daniel; Lunt, Neil] Univ York, Dept Social Work & Social Policy, York YO10 5DD, N Yorkshire, England; [Smith, Richard] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of York - UK; University of London; London School of Hygiene & Tropical Medicine	Hanefeld, J (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London WC1, England.	Johanna.Hanefeld@lshtm.ac.uk		Smith, Richard/0000-0003-3837-6559	National Institute for Health Research Health Services and Delivery Research (HSDR) Programme [HSR 09/2001/21]	National Institute for Health Research Health Services and Delivery Research (HSDR) Programme	This project was funded by the National Institute for Health Research Health Services and Delivery Research (HS&DR) Programme (project number HSR 09/2001/21). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HS&DR Programme, National Institute for Health Research, National Health Service or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Culley L, 2011, HUM REPROD, V26, P2373, DOI 10.1093/humrep/der191; Hanefeld J, 2012, HLTH POLICY; Hawkins SC, 2007, OBES SURG, V17, P434, DOI 10.1007/s11695-007-9073-7; Johnson Robert, 2010, INT J EQUITY HEALTH, P9; Johnson TJ, 2010, HEALTH POLICY, V98, P171, DOI 10.1016/j.healthpol.2010.06.006; Kentikelenis A, 2011, LANCET, V378, P1457, DOI 10.1016/S0140-6736(11)61556-0; Legido-Quigley H, 2011, BMJ, V342; Lunt N, 2010, MATURITAS, V66, P27, DOI 10.1016/j.maturitas.2010.01.017; McKelvey A, 2009, BJOG-INT J OBSTET GY, V116, P1520, DOI 10.1111/j.1471-0528.2009.02294.x; Miyagi K, 2012, J PLAST RECONSTR AES, V65, P22, DOI 10.1016/j.bjps.2011.07.027; O'Neil P, 2010, SHEDDING POUNDS OBES; Pocock NS, 2011, GLOBALIZATION HLTH, P7; Pollock AM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8496; Pollock AM, 2012, LANCET, V379, P387, DOI 10.1016/S0140-6736(12)60119-6; Smith M, 2009, BRIT DENT J, V206, P185, DOI 10.1038/sj.bdj.2009.132; Smith R, 2012, LANCET, V379, P1180, DOI 10.1016/S0140-6736(12)60166-4; Smith R, 2011, HEALTH POLICY, V103, P276, DOI 10.1016/j.healthpol.2011.06.009; Vick L, 2012, CLIN RISK, V18, DOI DOI 10.1258/CR.2012.012017	18	68	72	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e70406	10.1371/journal.pone.0070406	http://dx.doi.org/10.1371/journal.pone.0070406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204556	gold, Green Accepted, Green Published			2022-12-27	WOS:000326152300001
J	Andersson, M; Karlsson, O; Bergstrom, U; Brittebo, EB; Brandt, I				Andersson, Marie; Karlsson, Oskar; Bergstrom, Ulrika; Brittebo, Eva B.; Brandt, Ingvar			Maternal Transfer of the Cyanobacterial Neurotoxin beta-N-Methylamino-L-Alanine (BMAA) via Milk to Suckling Offspring	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; AMINO-ACID TRANSPORTERS; BLOOD-BRAIN-BARRIER; RAT MAMMARY-GLAND; NEURODEGENERATIVE DISEASE; PROTEIN; EXPOSURE; CELLS; GUAM; INTESTINE	The cyanobacterial neurotoxin beta-N-methylamino-L-alanine (BMAA) has been implicated in the etiology of neurodegenerative disease and proposed to be biomagnified in terrestrial and aquatic food chains. We have previously shown that the neonatal period in rats, which in humans corresponds to the last trimester of pregnancy and the first few years of age, is a particularly sensitive period for exposure to BMAA. The present study aimed to examine the secretion of C-14-labeled L-and D-BMAA into milk in lactating mice and the subsequent transfer of BMAA into the developing brain. The results suggest that secretion into milk is an important elimination pathway of BMAA in lactating mothers and an efficient exposure route predominantly for L-BMAA but also for D-BMAA in suckling mice. Following secretion of [C-14] L-BMAA into milk, the levels of [C-14] L-BMAA in the brains of the suckling neonatal mice significantly exceeded the levels in the maternal brains. In vitro studies using the mouse mammary epithelial HC11 cell line confirmed a more efficient influx and efflux of L-BMAA than of D-BMAA in cells, suggesting enantiomer-selective transport. Competition experiments with other amino acids and a low sodium dependency of the influx suggests that the amino acid transporters LAT1 and LAT2 are involved in the transport of L-BMAA into milk. Given the persistent neurodevelopmental toxicity following injection of L-BMAA to neonatal rodent pups, the current results highlight the need to determine whether BMAA is enriched mother's and cow's milk.	[Andersson, Marie; Karlsson, Oskar; Bergstrom, Ulrika; Brandt, Ingvar] Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden; [Karlsson, Oskar; Brittebo, Eva B.] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden	Uppsala University; Uppsala University	Brandt, I (corresponding author), Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden.	Ingvar.Brandt@ebc.uu.se	Brittebo, Eva/F-5005-2016	Brittebo, Eva/0000-0002-7644-1967; Karlsson, Oskar/0000-0001-8009-0015; Brandt, Ingvar/0000-0002-5386-2400	Swedish Research Council Formas	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was funded by the Swedish Research Council Formas (http://www.formas.se/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman G, 2009, METABOLISM, V58, P594, DOI 10.1016/j.metabol.2008.12.003; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Banack SA, 2003, NEUROLOGY, V61, P387, DOI 10.1212/01.WNL.0000078320.18564.9F; Banack SA, 2007, MAR DRUGS, V5, P180, DOI 10.3390/md20070014; Bradley WG, 2013, AMYOTROPH LAT SCL FR, V14, P325, DOI 10.3109/21678421.2012.750364; Brand LE, 2010, HARMFUL ALGAE, V9, P620, DOI 10.1016/j.hal.2010.05.002; Cox PA, 2003, P NATL ACAD SCI USA, V100, P13380, DOI 10.1073/pnas.2235808100; Cox PA, 2005, P NATL ACAD SCI USA, V102, P5074, DOI 10.1073/pnas.0501526102; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DREJER J, 1983, NEUROCHEM RES, V8, P231, DOI 10.1007/BF00963923; DUNCAN MW, 1992, NEUROBIOL AGING, V13, P333, DOI 10.1016/0197-4580(92)90047-2; DUNCAN MW, 1991, J PHARMACOL EXP THER, V258, P27; Engskog MK, 2013, TOXICOLOGY; Eriksson P, 1997, NEUROTOXICOLOGY, V18, P719; Field NC, 2013, TOXICON, V70, P179, DOI 10.1016/j.toxicon.2013.04.010; Hasegawa H, 2004, AM J PHYSIOL-ENDOC M, V287, pE160, DOI 10.1152/ajpendo.00397.2003; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA110, DOI 10.1289/ehp.120-a110; Jager, 2008, BMC RES NOTES, V1; Jonasson S, 2010, P NATL ACAD SCI USA, V107, P9252, DOI 10.1073/pnas.0914417107; Karlsson O, 2013, J PROTEOME RES; Karlsson O, 2012, TOXICOL SCI, V130, P391, DOI 10.1093/toxsci/kfs241; Karlsson O, 2011, BEHAV BRAIN RES, V219, P310, DOI 10.1016/j.bbr.2011.01.056; Karlsson O, 2009, TOXICOL SCI, V112, P185, DOI 10.1093/toxsci/kfp196; Karlsson O, 2009, PIGM CELL MELANOMA R, V22, P120, DOI 10.1111/j.1755-148X.2008.00508.x; Karlsson O, 2009, TOXICOL SCI, V109, P286, DOI 10.1093/toxsci/kfp062; Kim DK, 2004, NEUROSCI RES, V50, P437, DOI 10.1016/j.neures.2004.08.003; MALATHI P, 1973, BIOCHIM BIOPHYS ACTA, V307, P613, DOI 10.1016/0005-2736(73)90306-4; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; Metcalf JS, 2013, CHEMOSPHERE, V90, P835, DOI 10.1016/j.chemosphere.2012.09.094; Metcalf JS, 2012, SCI TOTAL ENVIRON, V421, P118, DOI 10.1016/j.scitotenv.2012.01.053; Mondo K, 2012, MAR DRUGS, V10, P509, DOI 10.3390/md10020509; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Murch SJ, 2004, ACTA NEUROL SCAND, V110, P267, DOI 10.1111/j.1600-0404.2004.00320.x; MYERS TG, 1990, J BIOL CHEM, V265, P10193; NUNN PB, 1989, FEBS LETT, V251, P31, DOI 10.1016/0014-5793(89)81423-1; Okle O, 2013, TOXICOL SCI, V131, P217, DOI 10.1093/toxsci/kfs291; Pablo J, 2009, ACTA NEUROL SCAND, V120, P216, DOI 10.1111/j.1600-0404.2008.01150.x; PERRY TL, 1989, J NEUROL SCI, V94, P173, DOI 10.1016/0022-510X(89)90227-X; Pineda M, 1999, J BIOL CHEM, V274, P19738, DOI 10.1074/jbc.274.28.19738; Prasanna R, 2012, WORLD J MICROB BIOT, V28, P1223, DOI 10.1007/s11274-011-0926-9; Rajan DP, 2000, BBA-BIOMEMBRANES, V1463, P6, DOI 10.1016/S0005-2736(99)00224-2; ROSS SM, 1987, BRAIN RES, V425, P120, DOI 10.1016/0006-8993(87)90490-2; Rossier G, 1999, J BIOL CHEM, V274, P34948, DOI 10.1074/jbc.274.49.34948; Sarwar G, 1998, BRIT J NUTR, V79, P129, DOI 10.1079/BJN19980023; Shennan DB, 2002, BBA-BIOMEMBRANES, V1564, P133, DOI 10.1016/S0005-2736(02)00410-8; Shennan DB, 2000, PHYSIOL REV, V80, P925, DOI 10.1152/physrev.2000.80.3.925; SMITH QR, 1992, J NEUROCHEM, V58, P1330, DOI 10.1111/j.1471-4159.1992.tb11346.x; SPENCER PS, 1987, SCIENCE, V237, P517, DOI 10.1126/science.3603037; SPENCER PS, 1987, CIBA F SYMP, V126, P221; SVANBERG U, 1977, AM J CLIN NUTR, V30, P499, DOI 10.1093/ajcn/30.4.499; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Uchino H, 2002, MOL PHARMACOL, V61, P729, DOI 10.1124/mol.61.4.729; Ullberg S., 1977, SCI TOOLS LKB INSTRU, P2; VERMA N, 1993, INDIAN J MED RES-B, V98, P297; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Xie XB, 2013, NEUROREPORT, V24, P779, DOI 10.1097/WNR.0b013e328363fd89; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991	57	32	32	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78133	10.1371/journal.pone.0078133	http://dx.doi.org/10.1371/journal.pone.0078133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194910	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000089
J	Garcia-Alvarez, I; Garrido, L; Romero-Ramirez, L; Nieto-Sampedro, M; Fernandez-Mayoralas, A; Campos-Olivas, R				Garcia-Alvarez, Isabel; Garrido, Leoncio; Romero-Ramirez, Lorenzo; Nieto-Sampedro, Manuel; Fernandez-Mayoralas, Alfonso; Campos-Olivas, Ramon			The Effect of Antitumor Glycosides on Glioma Cells and Tissues as Studied by Proton HR-MAS NMR Spectroscopy	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; HUMAN BRAIN; IN-VITRO; SCYLLO-INOSITOL; METABOLISM; APOPTOSIS; HYPOXIA; VIVO; SPHINGOLIPIDS; INHIBITION	The effect of the treatment with glycolipid derivatives on the metabolic profile of intact glioma cells and tumor tissues, investigated using proton high resolution magic angle spinning (H-1 HR-MAS) nuclear magnetic resonance (NMR) spectroscopy, is reported here. Two compounds were used, a glycoside and its thioglycoside analogue, both showing anti-proliferative activity on glioma C6 cell cultures; however, only the thioglycoside exhibited antitumor activity in vivo. At the drug concentrations showing anti-proliferative activity in cell culture (20 and 40 mu M), significant increases in choline containing metabolites were observed in the H-1 NMR spectra of the same intact cells. In vivo experiments in nude mice bearing tumors derived from implanted C6 glioma cells, showed that reduction of tumor volume was associated with significant changes in the metabolic profile of the same intact tumor tissues; and were similar to those observed in cell culture. Specifically, the activity of the compounds is mainly associated with an increase in choline and phosphocholine, in both the cell cultures and tumoral tissues. Taurine, a metabolite that has been considered a biomarker of apoptosis, correlated with the reduction of tumor volume. Thus, the results indicate that the mode of action of the glycoside involves, at least in part, alteration of phospholipid metabolism, resulting in cell death.	[Garcia-Alvarez, Isabel; Romero-Ramirez, Lorenzo; Nieto-Sampedro, Manuel] Hosp Nacl Paraplej, Unidad Neurol Expt, Serv Salud Castilla La Mancha SESCAM, Toledo, Spain; [Garcia-Alvarez, Isabel; Fernandez-Mayoralas, Alfonso] CSIC, Inst Quim Organ Gen, Madrid, Spain; [Garrido, Leoncio] CSIC, Inst Ciencia & Tecnol Polimeros, Madrid, Spain; [Romero-Ramirez, Lorenzo; Nieto-Sampedro, Manuel] CSIC, Inst Cajal Neurobiol, Madrid, Spain; [Campos-Olivas, Ramon] Spanish Natl Canc Ctr CNIO, Spect & NMR Unit, Struct Biol & Biocomp Programme, Madrid, Spain	Hospital Nacional de Paraplejicos; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Organica General (IQOG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia & Tecnologia de Polimeros (ICTP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Centro Nacional de Investigaciones Oncologicas (CNIO)	Garcia-Alvarez, I (corresponding author), Hosp Nacl Paraplej, Unidad Neurol Expt, Serv Salud Castilla La Mancha SESCAM, Toledo, Spain.	garcia.alvarez@iqog.csic.es; rcampos@cnio.es	García-Álvarez, Isabel/J-8022-2014; Alvarez, Isabel Garcia/J-7347-2017; Alvarez, Isabel Garcia/ABH-2430-2020; Garrido, Leoncio -/K-3092-2014; Fernández-Mayoralas, Alfonso/K-2929-2014; Campos-Olivas, Ramón/L-9173-2014	García-Álvarez, Isabel/0000-0002-2273-5046; Alvarez, Isabel Garcia/0000-0002-2273-5046; Garrido, Leoncio -/0000-0002-7587-1260; Fernández-Mayoralas, Alfonso/0000-0002-1241-7538; Campos-Olivas, Ramón/0000-0002-5743-2221	Servicio de Salud de Castilla-La Mancha Community (SESCAM), Fundacion para la Investigacion Sanitaria de Castilla-La Mancha (FISCAM) [PI-2008/18, PI-2008/19, PI-2009/51]; Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) [PI11/00592, PI11/01436]; Comunidad de Madrid [S2009/PPQ-1752]	Servicio de Salud de Castilla-La Mancha Community (SESCAM), Fundacion para la Investigacion Sanitaria de Castilla-La Mancha (FISCAM); Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS); Comunidad de Madrid(Comunidad de Madrid)	The financial support was provided by the Servicio de Salud de Castilla-La Mancha Community (SESCAM), Fundacion para la Investigacion Sanitaria de Castilla-La Mancha (FISCAM) (PI-2008/18, PI-2008/19 and PI-2009/51); Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) (PI11/00592 and PI11/01436) and Comunidad de Madrid (Grant S2009/PPQ-1752). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye EO, 1999, CANCER RES, V59, P80; Andrieu-Abadie N, 2001, FREE RADICAL BIO MED, V31, P717, DOI 10.1016/S0891-5849(01)00655-4; Bello C, 2011, BIOORGAN MED CHEM, V19, P7720, DOI 10.1016/j.bmc.2011.07.053; Benedetti E, 2010, INT J IMMUNOPATH PH, V23, P235, DOI 10.1177/039463201002300121; Brindle KM, 2002, ADV ENZYME REGUL, V42, P101, DOI 10.1016/S0065-2571(01)00025-5; Brown B. W., 1977, STAT BIOMEDICAL INTR; Cao MD, 2012, NMR BIOMED, V25, P1033, DOI 10.1002/nbm.2766; Duarte IF, 2010, VIRCHOWS ARCH, V457, P715, DOI 10.1007/s00428-010-0993-6; Farooqui AA, 2007, J NEUROSCI RES, V85, P1834, DOI 10.1002/jnr.21268; Gallego-Ortega D, 2011, ADV ENZYME REGUL, V51, P183, DOI 10.1016/j.advenzreg.2010.09.010; Gallinger A, 2011, ANGEW CHEM INT EDIT, V50, P11672, DOI 10.1002/anie.201104836; Garcia-Alvarez I, 2007, J MED CHEM, V50, P364, DOI 10.1021/jm0611556; Garcia-Alvarez I, 2011, J MED CHEM, V54, P6949, DOI 10.1021/jm200961q; Garcia-Alvarez I, 2011, CURR TOP MED CHEM, V11, P27, DOI 10.2174/156802611793611841; Garcia-Alvarez I, 2011, MOL BIOSYST, V7, P129, DOI 10.1039/c0mb00125b; Garcia-Alvarez I, 2009, J MED CHEM, V52, P1263, DOI 10.1021/jm8012807; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Gomez-Munoz A, 2004, J LIPID RES, V45, P99, DOI 10.1194/jlr.M300158-JLR200; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Griffin JL, 2002, NMR BIOMED, V15, P375, DOI 10.1002/nbm.792; Griffin JL, 2001, MAGNET RESON MED, V46, P249, DOI 10.1002/mrm.1185; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Imperiale A, 2011, PEDIATR BLOOD CANCER, V56, P24, DOI 10.1002/pbc.22668; Kaiser LG, 2005, NMR BIOMED, V18, P51, DOI 10.1002/nbm.927; Kinoshita Y, 1997, NMR BIOMED, V10, P2, DOI 10.1002/(SICI)1099-1492(199701)10:1<2::AID-NBM442>3.0.CO;2-N; KUNZ M, 2003, MOL CANCER, V2, P1, DOI DOI 10.1186/1476-4598-2-1.PUBMED:12537587; Laurenti G, 2011, J CELL BIOCHEM, V112, P3891, DOI 10.1002/jcb.23323; Lindon JC, 2009, PROG NUCL MAG RES SP, V55, P79, DOI 10.1016/j.pnmrs.2008.11.004; Lutz NW, 2005, METABOLOMICS, V1, P251, DOI 10.1007/s11306-005-0005-z; Mazzio EA, 2010, CELL BIOL TOXICOL, V26, P177, DOI 10.1007/s10565-009-9138-6; MENDENHALL W, 1989, INTRO PROBABILITY ST; MICHAELIS T, 1993, NMR BIOMED, V6, P105, DOI 10.1002/nbm.1940060116; Milkevitch M, 2005, BBA-MOL CELL BIOL L, V1734, P1, DOI 10.1016/j.bbalip.2005.01.008; Mirbahai L, 2011, INT J BIOCHEM CELL B, V43, P990, DOI 10.1016/j.biocel.2010.07.002; Moestue S, 2011, CURR TOP MED CHEM, V11, P2, DOI 10.2174/156802611793611869; Moore D. S., 1989, INTRO PRACTICE STAT; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Morse DL, 2007, MAGN RESON MED, V58, P270, DOI 10.1002/mrm.21333; Ohanian J, 2001, CELL MOL LIFE SCI, V58, P2053, DOI 10.1007/PL00000836; Opstad KS, 2009, BRIT J CANCER, V100, P789, DOI 10.1038/sj.bjc.6604933; Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U; Quintero M, 2007, BBA-MOL CELL BIOL L, V1771, P31, DOI 10.1016/j.bbalip.2006.10.003; Rocha CM, 2010, J PROTEOME RES, V9, P319, DOI 10.1021/pr9006574; Rodriguez-Gonzalez A, 2004, ONCOGENE, V23, P8247, DOI 10.1038/sj.onc.1208045; Rodriguez-Gonzalez Agustin, 2003, Prog Cell Cycle Res, V5, P191; Sitter B, 2009, PROG NUCL MAG RES SP, V54, P239, DOI 10.1016/j.pnmrs.2008.10.001; Somashekar BS, 2011, J PROTEOME RES, V10, P5232, DOI 10.1021/pr200800w; VEECH RL, 1991, NMR BIOMED, V4, P53, DOI 10.1002/nbm.1940040204; Venugopal N, 2012, MAGN RESON IMAGING, V30, P195, DOI 10.1016/j.mri.2011.09.020; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x	51	10	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78391	10.1371/journal.pone.0078391	http://dx.doi.org/10.1371/journal.pone.0078391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194925	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000104
J	Bonnet, N; Gineyts, E; Ammann, P; Conway, SJ; Garnero, P; Ferrari, S				Bonnet, Nicolas; Gineyts, Evelyne; Ammann, Patrick; Conway, Simon J.; Garnero, Patrick; Ferrari, Serge			Periostin Deficiency Increases Bone Damage and Impairs Injury Response to Fatigue Loading in Adult Mice	PLOS ONE			English	Article							MICRODAMAGE ACCUMULATION; MECHANICAL-PROPERTIES; GENE-EXPRESSION; CORTICAL BONE; FEMORAL-NECK; MATRIX; RESORPTION; STRENGTH; REPAIR; MODEL	Bone damage removal and callus formation in response to fatigue loading are essential to prevent fractures. Periostin (Postn) is a matricellular protein that mediates adaptive response of cortical bone to loading. Whether and how periostin influences damage and the injury response to fatigue remains unknown. We investigated the skeletal response of Postn(-/-) and Postn(+/+) mice after fatigue stimulus by axial compression of their tibia. In Postn(+/+) mice, cracks number and surface (CsNb, CsS) increased 1h after fatigue, with a decrease in strength compared to non-fatigued tibia. At 15 days, CsNb had started to decline, while CtTV and CtBV increased in fatigued vs non-fatigued tibia, reflecting a woven bone response that was present in 75% of the fatigued bones. Cortical porosity and remodelling also prominently increased in the fatigued tibia of Postn(+/+) mice. At 30 days, paralleling a continuous removal of cortical damage, strength of the fatigued tibia was similar to the non-fatigue tibia. In Postn(-/-) mice, cracks were detectable even in the absence of fatigue, while the amount of collagen crosslinks and tissue hardness was decreased compared to Postn(+/+). Fatigue significantly increased CsNb and CsS in Postn(-/-), but was not associated with changes in CtTV and CtBV, as only 16% of the fatigued bones formed some woven bone. Cortical porosity and remodelling did not increase either after fatigue in Postn(-/-), and the level of damage remained high even after 30 days. As a result, strength remained compromised in Postn(-/-) mice. Contrary to Postn(+/+), which osteocytic lacunae showed a change in the degree of anisotropy (DA) after fatigue, Postn(-/-) showed no DA change. Hence periostin appears to influence bone materials properties, damage accumulation and repair, including local modeling/remodeling processes in response to fatigue. These observations suggest that the level of periostin expression could influence the propensity to fatigue fractures.	[Bonnet, Nicolas; Ammann, Patrick; Ferrari, Serge] Univ Hosp Geneva, Dept Internal Med Specialties, Div Bone Dis, Geneva, Switzerland; [Gineyts, Evelyne; Garnero, Patrick] Univ Lyon, Hop Edouard Herriot, INSERM, UMR 1033, Lyon, France; [Conway, Simon J.] Indiana Univ Sch Med, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	University of Geneva; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Indiana University System; Indiana University Bloomington	Bonnet, N (corresponding author), Univ Hosp Geneva, Dept Internal Med Specialties, Div Bone Dis, Geneva, Switzerland.	nicolas.bonnet@unige.ch	Ferrari, Serge/ABD-2730-2020	Ferrari, Serge/0000-0002-1372-4417; Bonnet, Nicolas/0000-0001-9832-5767; Gineyts, Evelyne/0000-0003-3868-5810	Swiss National Science Foundation [3100A0-116633/ 1]; EC [201099-TALOS]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EC(European CommissionEuropean Commission Joint Research Centre)	These studies were supported by a Swiss National Science Foundation grant no. 3100A0-116633/ 1 and EC 201099-TALOS (to S. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet N, 2012, P NATL ACAD SCI USA, V109, P15048, DOI 10.1073/pnas.1203085109; Bonnet N, 2009, J BIOL CHEM, V284, P35939, DOI 10.1074/jbc.M109.060335; Brennan-Speranza TC, 2011, BONE, V49, P1073, DOI 10.1016/j.bone.2011.07.039; Burr D. B., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P201; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; BURR DB, 1995, BONE, V17, P431, DOI 10.1016/S8756-3282(95)00241-3; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; BURR DB, 1985, J BIOMECH, V18, P189, DOI 10.1016/0021-9290(85)90204-0; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Conway SJ, 2011, THESCIENTIFICWORLDJO, V11, P1509, DOI 10.1100/tsw.2011.132; Currey JD, 1996, J BIOMECH, V29, P257, DOI 10.1016/0021-9290(95)00048-8; Danova NA, 2003, BONE, V33, P197, DOI 10.1016/S8756-3282(03)00155-8; Gillan L, 2002, CANCER RES, V62, P5358; Gineyts E, 2010, J CHROMATOGR B, V878, P1449, DOI 10.1016/j.jchromb.2010.03.039; Hazenberg JG, 2006, J BIOMECH, V39, P2096, DOI 10.1016/j.jbiomech.2005.06.006; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hsieh YF, 2002, J ORTHOP RES, V20, P764, DOI 10.1016/S0736-0266(01)00161-9; Kennedy OD, 2012, BONE, V50, P1115, DOI 10.1016/j.bone.2012.01.025; Kidd LJ, 2010, BONE, V46, P369, DOI 10.1016/j.bone.2009.10.009; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kozloff KM, 2004, J BONE MINER RES, V19, P614, DOI 10.1359/JBMR.040111; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Li CY, 2003, CALCIFIED TISSUE INT, V72, P42, DOI 10.1007/s00223-001-1086-y; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Litvin J, 2004, J CELL BIOCHEM, V92, P1044, DOI 10.1002/jcb.20115; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Ma DD, 2009, IN VITRO CELL DEV-AN, V45, P467, DOI 10.1007/s11626-009-9214-5; Martin RB, 2001, CRC SER EXERC PHSIOL, P183; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Mori S, 1997, BONE, V21, P521, DOI 10.1016/S8756-3282(97)00200-7; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nakazawa T, 2004, J ORTHOP RES, V22, P520, DOI 10.1016/j.orthres.2003.10.007; Norman TL, 2008, J BIOMECH, V41, P2868, DOI 10.1016/j.jbiomech.2008.06.032; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; Schneider P, 2007, J BONE MINER RES, V22, P1557, DOI 10.1359/JBMR.070703; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Sugiyama T, 2012, J BONE MINER RES, V27, P1784, DOI 10.1002/jbmr.1599; Tang SY, 2012, J BONE MINER RES, V27, P1936, DOI 10.1002/jbmr.1646; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Uthgenannt BA, 2007, J BONE MINER RES, V22, P1548, DOI 10.1359/JBMR.0070614; Vatsa A, 2008, BONE, V43, P452, DOI 10.1016/j.bone.2008.01.030; Waldorf EI, 2010, J BONE MINER RES, V25, P734, DOI 10.1359/jbmr.091016; Wohl GR, 2009, BONE, V44, P320, DOI 10.1016/j.bone.2008.09.010; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7; Zioupos P, 2001, J MICROSC-OXFORD, V201, P270, DOI 10.1046/j.1365-2818.2001.00783.x	52	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78347	10.1371/journal.pone.0078347	http://dx.doi.org/10.1371/journal.pone.0078347			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167618	gold, Green Submitted, Green Published			2022-12-27	WOS:000326034500079
J	Kong, PC; Zhu, Y; Wang, MS; Li, HP; Chen, XJ; Jiang, MX				Kong, Peng-Cheng; Zhu, Yan; Wang, Mei-Shan; Li, He-Ping; Chen, Xue-Jin; Jiang, Man-Xi			Reprogramming of Round Spermatids by the Germinal Vesicle Cytoplasm in Mice	PLOS ONE			English	Article							MAMMALIAN SOMATIC-CELLS; XENOPUS-LAEVIS OOCYTE; FULL-TERM DEVELOPMENT; MOUSE OOCYTES; INTRACYTOPLASMIC INJECTION; EMBRYOS; NUCLEUS; BIRTH; MICROINSEMINATION; FERTILIZATION	The birthrate following round spermatid injection (ROSI) remains low in current and evidence suggests that factors in the germinal vesicle (GV) cytoplasm and certain substances in the GV such as the nucleolus might be responsible for genomic reprogramming and embryonic development. However, little is known whether the reprogramming factors in GV oocyte cytoplasm and/or nucleolus in GV are beneficial to the reprogramming of round spermatids and development of ROSI embryos. Here, round spermatids were treated with GV cytolysates and injected this round spermatid alone or co-injected with GV oocyte nucleolus into mature metaphase II oocytes. Subsequent embryonic development was assessed morphologically and by Oct4 expression in blastocysts. There was no significant difference between experimental groups at the zygote to four-cell development stages. Blastocysts derived from oocytes which were injected with cytolysate treated-round spermatid alone or co-injected with nucleoli injection yielded 63.6% and 70.3% high quality embryos, respectively; comparable to blastocysts derived by intracytoplasmic sperm injection (ICSI), but higher than these oocytes which were co-injected with lysis buffer-treated round spermatids and nucleoli or injected with the lysis buffer-treated round spermatids alone. Furthermore, the proportion of live offspring resulting from oocytes which were co-injected with cytolysate treated-round spermatids and nucleoli or injected with cytolysate treated-round spermatids alone was higher than those were injected with lysis buffer treated-round spermaids, but comparable with the ICSI group. Our results demonstrate that factors from the GV cytoplasm improve round spermatid reprogramming, and while injection of the extra nucleolus does not obviously improve reprogramming its potential contribution, although which cannot be definitively excluded. Thus, some reprogramming factors are evidently present in GV oocyte cytoplasm and could significantly facilitate ROSI technology, while the nucleolus in GV seems also having a potential to improve reprogramming of round spermatids.	[Kong, Peng-Cheng; Wang, Mei-Shan; Chen, Xue-Jin; Jiang, Man-Xi] Shanghai Jiao Tong Univ, Sch Med, Dept Lab Anim Sci, Shanghai 200030, Peoples R China; [Zhu, Yan] Shanghai Inst Planned Parenthood Res, Key Lab Contracept Drugs & Devices, Natl Populat & Family Planning Comm, Shanghai, Peoples R China; [Li, He-Ping] Northeast Forestry Univ, Coll Wildlife Resource, Harbin, Peoples R China	Shanghai Jiao Tong University; Northeast Forestry University - China	Chen, XJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Lab Anim Sci, Shanghai 200030, Peoples R China.	chenxuejin@shsmu.edu.cn; manxijiang@yahoo.com	Wang, Meishan/O-2023-2019; Jiang, Man-Xi/A-1790-2016	Wang, Meishan/0000-0001-8085-2657; 				Alberio R, 2005, EXP CELL RES, V307, P131, DOI 10.1016/j.yexcr.2005.02.028; Bao SQ, 2000, BIOL REPROD, V62, P616, DOI 10.1095/biolreprod62.3.616; Bian YH, 2009, EPIGENETICS-US, V4, P194, DOI 10.4161/epi.4.3.8787; Bui HT, 2008, DEVELOPMENT, V135, P3935, DOI 10.1242/dev.023747; Bui HT, 2012, DEVELOPMENT, V139, P4330, DOI 10.1242/dev.086116; Byrne JA, 2003, CURR BIOL, V13, P1206, DOI 10.1016/S0960-9822(03)00462-7; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Fulka J, 2003, THERIOGENOLOGY, V59, P1879, DOI 10.1016/S0093-691X(02)01226-8; Fulka J, 2011, J ASSIST REPROD GEN, V28, P385, DOI 10.1007/s10815-011-9565-1; Gao SR, 2002, BIOL REPROD, V67, P928, DOI 10.1095/biolreprod.102.004606; Gasparrini B, 2003, BIOL REPROD, V68, P1259, DOI 10.1095/biolreprod.102.008730; Greda P, 2006, REPRODUCTION, V132, P741, DOI 10.1530/rep.1.01204; Haigo K, 2004, BIOL REPROD, V71, P194, DOI 10.1095/biolreprod.104.027706; Halley-Stott RP, 2010, METHODS, V51, P56, DOI 10.1016/j.ymeth.2010.01.035; Hayashi S, 2003, BIOL REPROD, V69, P1170, DOI 10.1095/biolreprod.103.016832; Hirabayashi M, 2002, MOL REPROD DEV, V62, P295, DOI 10.1002/mrd.10127; Jiang MX, 2005, ZYGOTE, V13, P249, DOI 10.1017/S0967199405003308; Jiang MX, 2005, MOL REPROD DEV, V72, P129, DOI 10.1002/mrd.20328; Jiang MX, 2005, MOL REPROD DEV, V71, P439, DOI 10.1002/mrd.20299; Jullien J, 2010, P NATL ACAD SCI USA, V107, P5483, DOI 10.1073/pnas.1000599107; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; Kishigami S, 2006, DEV BIOL, V289, P195, DOI 10.1016/j.ydbio.2005.10.026; Latham KE, 1999, INT REV CYTOL, V193, P71; Miyamoto K, 2007, MOL REPROD DEV, V74, P1268, DOI 10.1002/mrd.20691; MONESI V, 1965, EXP CELL RES, V39, P197, DOI 10.1016/0014-4827(65)90023-6; Obata Y, 2002, NATURE, V418, P497, DOI 10.1038/418497a; Ogonuki N, 2005, MOL REPROD DEV, V72, P411, DOI 10.1002/mrd.20363; Ogonuki N, 2003, BIOL REPROD, V68, P1821, DOI 10.1095/biolreprod.102.011726; OGURA A, 1994, P NATL ACAD SCI USA, V91, P7460, DOI 10.1073/pnas.91.16.7460; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; Polanski Z, 2005, DEV BIOL, V281, P184, DOI 10.1016/j.ydbio.2005.02.024; Polanski Z, 2008, INT J DEV BIOL, V52, P295, DOI 10.1387/ijdb.072347zp; Rathbone AJ, 2010, CELL REPROGRAM, V12, P609, DOI 10.1089/cell.2010.0015; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; SCHULTZ MC, 1990, AM J ANAT, V189, P1, DOI 10.1002/aja.1001890102; Shamanski FL, 1999, HUM REPROD, V14, P1050, DOI 10.1093/humrep/14.4.1050; SOFIKITIS NV, 1994, J ASSIST REPROD GEN, V11, P335, DOI 10.1007/BF02214138; TAKEUCHI IK, 1990, J STRUCT BIOL, V103, P104, DOI 10.1016/1047-8477(90)90014-4; TESARIK JN, 1995, NEW ENGL J MED, V333, P525, DOI 10.1056/NEJM199508243330819; Van Soom Ann, 2003, Reprod Biomed Online, V7, P664; Wakayama T, 1998, J REPROD FERTIL, V112, P11, DOI 10.1530/jrf.0.1120011; Wakayama T, 2001, REPRODUCTION, V122, P49, DOI 10.1530/rep.0.1220049; Zhu ZY, 2003, BIOL REPROD, V68, P943, DOI 10.1095/biolreprod.102.009910	44	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78437	10.1371/journal.pone.0078437	http://dx.doi.org/10.1371/journal.pone.0078437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167624	Green Submitted, gold, Green Published			2022-12-27	WOS:000326034500085
J	Navarro, A; Mendez, E; Diaz, C; del Valle, E; Martinez-Pinilla, E; Ordonez, C; Tolivia, J				Navarro, Ana; Mendez, Elena; Diaz, Celso; del Valle, Eva; Martinez-Pinilla, Eva; Ordonez, Cristina; Tolivia, Jorge			Lifelong Expression of Apolipoprotein D in the Human Brainstem: Correlation with Reduced Age-Related Neurodegeneration	PLOS ONE			English	Article							RNA TISSUE DISTRIBUTION; MESSENGER-RNA; AGING BRAIN; MOLECULAR CHARACTERIZATION; STRESS RESISTANCE; PERIPHERAL-NERVE; GENE; IDENTIFICATION; LOCALIZATION; INCREASES	The lipocalin apolipoprotein D (Apo D) is upregulated in peripheral nerves following injury and in regions of the central nervous system, such as the cerebral cortex, hippocampus, and cerebellum, during aging and progression of certain neurological diseases. In contrast, few studies have examined Apo D expression in the brainstem, a region necessary for survival and generally less prone to age-related degeneration. We measured Apo D expression in whole human brainstem lysates by slot-blot and at higher spatial resolution by quantitative immunohistochemistry in eleven brainstem nuclei (the 4 nuclei of the vestibular nuclear complex, inferior olive, hypoglossal nucleus, oculomotor nucleus, facial motor nucleus, nucleus of the solitary tract, dorsal motor nucleus of the vagus nerve, and Roller's nucleus). In contrast to cortex, hippocampus, and cerebellum, apolipoprotein D was highly expressed in brainstem tissue from subjects (N = 26, 32-96 years of age) with no history of neurological disease, and expression showed little variation with age. Expression was significantly stronger in somatomotor nuclei (hypoglossal, oculomotor, facial) than visceromotor or sensory nuclei. Both neurons and glia expressed Apo D, particularly neurons with larger somata and glia in the periphery of these brainstem centers. Immunostaining was strongest in the neuronal perinuclear region and absent in the nucleus. We propose that strong brainstem expression of Apo D throughout adult life contributes to resistance against neurodegenerative disease and age-related degeneration, possibly by preventing oxidative stress and ensuing lipid peroxidation.	[Navarro, Ana; Mendez, Elena; Diaz, Celso; del Valle, Eva; Martinez-Pinilla, Eva; Ordonez, Cristina; Tolivia, Jorge] Univ Oviedo, Fac Biol & Med, Dpto Morfol & Biol Celular, Inst Neurociencias Principado Asturias INEUROPA, Asturias, Spain	University of Oviedo	Navarro, A (corresponding author), Univ Oviedo, Fac Biol & Med, Dpto Morfol & Biol Celular, Inst Neurociencias Principado Asturias INEUROPA, Asturias, Spain.	anavarro@uniovi.es; jtolivia@uniovi.es	Martínez-Pinilla, Eva/C-7907-2013; del Valle, Eva/D-6820-2012; Tolivia, Jorge/D-2248-2010; Navarro, Ana/N-2092-2014	Martínez-Pinilla, Eva/0000-0002-0572-0926; del Valle, Eva/0000-0002-7959-4790; Tolivia, Jorge/0000-0001-8984-8849; Navarro, Ana/0000-0001-6206-6505	MEC (Ministerio de Educacion y Ciencia); FEDER (Fondo Europeo de Desarrollo Regional) [SAF2007-64076/]; Principado de Asturias [SV-PA-13-ECOEMP-80]	MEC (Ministerio de Educacion y Ciencia)(Spanish GovernmentEuropean Commission); FEDER (Fondo Europeo de Desarrollo Regional)(European Commission); Principado de Asturias(Principality of Asturias)	This work was supported by MEC (Ministerio de Educacion y Ciencia) and FEDER (Fondo Europeo de Desarrollo Regional)(SAF2007-64076/) grant and Principado de Asturias (SV-PA-13-ECOEMP-80). CO was a predoctoral fellow from "Gobierno del Principado de Asturias" Spain (BP05-064). EM was predoctoral fellows from "Ministerio de Educacion y Ciencia" Spain (AP-2005-3815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JC, 2000, MECH AGEING DEV, V114, P149, DOI 10.1016/S0047-6374(00)00098-1; Bajo-Graneras R, 2011, J NEUROCHEM, V117, P949, DOI 10.1111/j.1471-4159.2011.07266.x; BOYLES JK, 1990, J BIOL CHEM, V265, P17805; Chia WJ, 2011, NEUROCHEM INT, V59, P591, DOI 10.1016/j.neuint.2011.04.007; del Valle E, 2003, J HISTOCHEM CYTOCHEM, V51, P1285, DOI 10.1177/002215540305101005; Diaz C, 1996, ANAT RECORD, V246, P403, DOI 10.1002/(SICI)1097-0185(199611)246:3<403::AID-AR11>3.0.CO;2-S; Do Carmo S, 2007, BBA-MOL CELL RES, V1773, P954, DOI 10.1016/j.bbamcr.2007.03.007; Do Carmo S, 2009, AM J PHYSIOL-ENDOC M, V296, pE802, DOI 10.1152/ajpendo.90725.2008; DRAYNA D, 1986, J BIOL CHEM, V261, P6535; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Ganfornina MD, 2010, GLIA, V58, P1320, DOI 10.1002/glia.21010; Hardardottir I, 1997, BBA-LIPID LIPID MET, V1344, P210, DOI 10.1016/S0005-2760(96)00143-9; He X, 2009, NEUROSCI LETT, V455, P183, DOI 10.1016/j.neulet.2009.03.038; Kalman J, 2000, NEUROL RES, V22, P330; Kang MK, 2003, EXP CELL RES, V287, P272, DOI 10.1016/S0014-4827(03)00061-2; Kosacka J, 2009, NEUROSCIENCE, V162, P282, DOI 10.1016/j.neuroscience.2009.04.073; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; LAMBERT J, 1993, BIOCHIM BIOPHYS ACTA, V1172, P190, DOI 10.1016/0167-4781(93)90292-L; Lee B, 2003, MOL CELL ENDOCRINOL, V205, P33, DOI 10.1016/S0303-7207(03)00210-7; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; LOPEZBOADO YS, 1994, J BIOL CHEM, V269, P26871; Muffat J, 2008, P NATL ACAD SCI USA, V105, P7088, DOI 10.1073/pnas.0800896105; Muffat J, 2010, CELL CYCLE, V9, P269, DOI 10.4161/cc.9.2.10433; Navarro A, 1998, NEUROSCI LETT, V254, P17, DOI 10.1016/S0304-3940(98)00639-9; Navarro A, 2008, HISTOL HISTOPATHOL, V23, P995, DOI 10.14670/HH-23.995; Navarro A, 2010, AGE, V32, P85, DOI 10.1007/s11357-009-9117-0; Navarro-Incio AM, 2004, REV NEUROLOGIA, V38, P1166, DOI 10.33588/rn.3812.2004046; Ordonez C, 2006, HISTOL HISTOPATHOL, V21, P361, DOI 10.14670/HH-21.361; Ordonez C, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.01.010; Paxinos G., 1995, ATLAS HUMAN BRAINSTE; PROVOST PR, 1991, FEBS LETT, V290, P139, DOI 10.1016/0014-5793(91)81244-3; PROVOST PR, 1990, J LIPID RES, V31, P2057; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Reindl M, 2001, J NEUROIMMUNOL, V119, P327, DOI 10.1016/S0165-5728(01)00378-2; Sanchez D, 2006, CURR BIOL, V16, P680, DOI 10.1016/j.cub.2006.03.024; SCHAERENWIEMERS N, 1995, J NEUROCHEM, V65, P10; SEGUIN D, 1995, MOL BRAIN RES, V30, P242, DOI 10.1016/0169-328X(95)00008-G; SMITH KM, 1990, J LIPID RES, V31, P995; SPREYER P, 1990, EMBO J, V9, P2479, DOI 10.1002/j.1460-2075.1990.tb07426.x; Terrisse L, 1998, J NEUROCHEM, V71, P1643; Thomas EA, 2003, BIOL PSYCHIAT, V54, P136, DOI 10.1016/S0006-3223(02)01976-5; Thomas EA, 2001, P NATL ACAD SCI USA, V98, P4066, DOI 10.1073/pnas.071056198; Tolivia J, 2006, ANAL QUANT CYTOL, V28, P43; TOLIVIA J, 1988, ANAT REC, V222, P437, DOI 10.1002/ar.1092220416; TOLIVIA J, 1994, HISTOCHEMISTRY, V102, P101, DOI 10.1007/BF00269013	46	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77852	10.1371/journal.pone.0077852	http://dx.doi.org/10.1371/journal.pone.0077852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167586	gold, Green Published, Green Submitted			2022-12-27	WOS:000326034500045
J	Wang, J; Ge, Y; Zhang, CB; Bai, Y; Du, ZK				Wang, Jiang; Ge, Yuan; Zhang, Chong B.; Bai, Yi; Du, Zhao K.			Dominant Functional Group Effects on the Invasion Resistance at Different Resource Levels	PLOS ONE			English	Article							LIMITING SIMILARITY; SPECIES IDENTITY; BIOTIC RESISTANCE; PLANT COMMUNITY; LONG-TERM; DIVERSITY; INVASIBILITY; ESTABLISHMENT; INVASIVENESS; NUTRIENTS	Background: Functional group composition may affect invasion in two ways the effect of abundance, i.e. dominance of functional group; and the effect of traits, i.e. identity of functional groups. However, few studies have focused on the role of abundance of functional group on invasion resistance. Moreover, how resource availability influences the role of the dominant functional group in invasion resistance is even less understood. Methodology/Principal Findings: In this experiment, we established experimental pots using four different functional groups (annual grass, perennial grass, deciduous shrub or arbor and evergreen shrub or arbor), and the dominant functional group was manipulated. These experimental pots were respectively constructed at different soil nitrogen levels (control and fertilized). After one year of growth, we added seeds of 20 different species (five species per functional group) to the experimental pots. Fertilization significantly increased the overall invasion success, while dominant functional group had little effect on overall invasion success. When invaders were grouped into functional groups, invaders generally had lower success in pots dominated by the same functional group in the control pots. However, individual invaders of the same functional group exhibited different invasion patterns. Fertilization generally increased success of invaders in pots dominated by the same than by another functional group. However, fertilization led to great differences for individual invaders. Conclusions/Significance: The results showed that the dominant functional group, independent of functional group identity, had a significant effect on the composition of invaders. We suggest that the limiting similarity hypothesis may be applicable at the functional group level, and limiting similarity may have a limited role for individual invaders as shown by the inconsistent effects of dominant functional group and fertilization.	[Wang, Jiang; Zhang, Chong B.; Bai, Yi; Du, Zhao K.] Taizhou Univ, Sch Life Sci, Linhai, Peoples R China; [Ge, Yuan] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Earth Res Inst, Santa Barbara, CA 93106 USA	Taizhou University; University of California System; University of California Santa Barbara	Ge, Y (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Earth Res Inst, Santa Barbara, CA 93106 USA.	gyuan@bren.ucsb.edu	Ge, Yuan/D-2997-2009	Ge, Yuan/0000-0003-0234-5638	National Natural Science Foundation of China [31000256]; Natural Science Foundation of Zhejiang Province, China [LY13C030003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This research was financially supported by the National Natural Science Foundation of China (Project 31000256) and by the Natural Science Foundation of Zhejiang Province, China (Project LY13C030003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas SR, 2010, ECOLOGY, V91, P28, DOI 10.1890/08-0887.1; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Byun C, 2013, J ECOL, V101, P128, DOI 10.1111/1365-2745.12016; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Davis MA, 2001, ECOL LETT, V4, P421, DOI 10.1046/j.1461-0248.2001.00246.x; Drenovsky RE, 2012, AM J BOT, V99, P629, DOI 10.3732/ajb.1100417; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dukes JS, 2002, ECOL APPL, V12, P602, DOI 10.1890/1051-0761(2002)012[0602:SCADAG]2.0.CO;2; Dukes JS, 2001, OECOLOGIA, V126, P563, DOI 10.1007/s004420000549; Emery SM, 2007, J ECOL, V95, P1027, DOI 10.1111/j.1365-2745.2007.01274.x; Emery SM, 2007, ECOLOGY, V88, P954, DOI 10.1890/06-0568; Emery SM, 2006, OIKOS, V115, P549, DOI 10.1111/j.2006.0030-1299.15172.x; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; Foster BL, 2002, OIKOS, V99, P300, DOI 10.1034/j.1600-0706.2002.990210.x; Funk JL, 2008, TRENDS ECOL EVOL, V23, P695, DOI 10.1016/j.tree.2008.07.013; Garcia-Serrano H, 2004, CAN J BOT, V82, P1346, DOI [10.1139/B04-097, 10.1139/b04-097]; Gross KL, 2005, ECOLOGY, V86, P476, DOI 10.1890/04-0122; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Hooper DU, 2010, J ECOL, V98, P764, DOI 10.1111/j.1365-2745.2010.01673.x; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Incera M, 2009, MAR ECOL PROG SER, V377, P91, DOI 10.3354/meps07866; Leishman MR, 2005, J ECOL, V93, P38, DOI 10.1111/j.1365-2745.2004.00938.x; Li W, 2012, OIKOS, V121, P435, DOI 10.1111/j.1600-0706.2011.19762.x; Longo G, 2013, J ECOL IN PRESS; Maron J, 2007, ECOLOGY, V88, P2651, DOI 10.1890/06-1993.1; Maron JL, 2008, J ECOL, V96, P1187, DOI 10.1111/j.1365-2745.2008.01440.x; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McCune B., 2011, PC ORD MULTIVARIATE; McLaren JR, 2011, J VEG SCI, V22, P503, DOI 10.1111/j.1654-1103.2011.01263.x; Milbau A, 2004, WEED TECHNOL, V18, P1301, DOI 10.1614/0890-037X(2004)018[1301:TROSTI]2.0.CO;2; Parker IM, 2000, ECOL APPL, V10, P726, DOI 10.1890/1051-0761(2000)010[0726:IDOCSA]2.0.CO;2; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Price JN, 2013, OIKOS, V122, P649, DOI 10.1111/j.1600-0706.2012.00121.x; Prieur-Richard AH, 2002, OIKOS, V99, P338, DOI 10.1034/j.1600-0706.2002.990215.x; Prieur-Richard AH, 2002, OECOLOGIA, V130, P96, DOI 10.1007/s004420100774; Roscher C, 2009, J ECOL, V97, P32, DOI 10.1111/j.1365-2745.2008.01451.x; Shea K, 1998, ECOL APPL, V8, P824, DOI 10.1890/1051-0761(1998)008[0824:EBAIWM]2.0.CO;2; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; Smith MD, 2004, OIKOS, V106, P253, DOI 10.1111/j.0030-1299.2004.13057.x; Symstad AJ, 2000, ECOLOGY, V81, P99, DOI 10.1890/0012-9658(2000)081[0099:ATOTEO]2.0.CO;2; Tan WB, 2009, CHINESE SCI BULL, V54, P1759, DOI 10.1007/s11434-009-0046-1; Thompson K, 2010, J ECOL, V98, P480, DOI 10.1111/j.1365-2745.2009.01610.x; Von Holle B, 2005, J ECOL, V93, P16, DOI 10.1111/j.0022-0477.2004.00946.x; Yang R, 2010, SCI TOTAL ENVIRON, V408, P4624, DOI 10.1016/j.scitotenv.2010.06.006	45	8	8	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77220	10.1371/journal.pone.0077220	http://dx.doi.org/10.1371/journal.pone.0077220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167565	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500024
J	Deng, B; Liu, SG; Liu, S; Jansa, L; Li, ZW; Zhong, Y				Deng, Bin; Liu, Shugen; Liu, Sun; Jansa, Luba; Li, Zhiwu; Zhong, Yong			Progressive Indosinian N-S Deformation of the Jiaochang Structure in the Songpan-Ganzi Fold-Belt, Western China	PLOS ONE			English	Article							EASTERN TIBETAN PLATEAU; THRUST BELT; TECTONIC EVOLUTION; SICHUAN BASIN; OROGENIC BELT; SOUTH CHINA; STRAIN; CONSTRAINTS; GRANITE; SALIENT	Integrated field data, microstructural and three-dimensional strain analyses are used to document coaxial N-S shortening and southward increase in deformation intensity and metamorphism at the Jiaochang structure. Two episodes of deformation (D-1,D-2) with localized post-D-2 deformation have been identified in the area. The first deformation (D-1) episode is defined by a main axial-plane of parallel folds observable on a micro-to kilometer-scale, while the second episode of deformation (D-2) is defined by micro-scale metamorphic folds, associated with E-W oriented stretching lineation. These processes are the result of Indosinian tectonism (Late Triassic to Early Jurassic) characterized by nearly coaxial N-S compression and deformation. This is indicated by E-W trending, sub-parallel to parallel foliation (S-1, e. g. axial-plane of folds, and S-2, i.e. axial-plane of metamorphic folds, crenulation cleavage) and lineation (L-1, e. g. axis of folds, and L-2, i.e. stretching lineation, axis of metamorphic folds and B-axis of echelon lens). Most of the porphyroblasts and minerals (e. g. pyrite, biotite) show two growth phases with localized growth in the third phase (muscovite). The progressive D-1-D-2 structure is widespread in the south of the Jiaochang area, but only D-1 structure crops out at the north. The strain intensity (c), compression ratios (c%) and octahedral strain intensity (epsilon(s)) are similar across the Jiaochang structure (i.e., gamma approximate to 1.8, c approximate to 27%, epsilon(s) = 0.9), showing a broad range of Flinn values (K = 0.77 to 7.57). The long-axis orientations are roughly symmetric between two limbs of the structure. Therefore, we suggest that the architecture of the Jiaochang structure has been controlled by coaxial N-S shortening and deformation (D1-D2) during the Indosinian tectonic epoch, with insignificant post-D-2 deformation.	[Deng, Bin; Liu, Shugen; Liu, Sun; Li, Zhiwu] Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China; [Jansa, Luba] Dalhousie Univ, Halifax, NS, Canada; [Jansa, Luba] Geol Survey Canada Atlantic, Dartmouth, NS, Canada; [Zhong, Yong] CCDE Geophys Prospecting Co, Chengdu, Peoples R China	Chengdu University of Technology; Dalhousie University; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Liu, SG (corresponding author), Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China.	lsg@cdut.edu.cn		Li, Zhiwu/0000-0002-4312-6768	National Natural Science Foundation of China [41230313]; College of Energy Resources of CDUT	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); College of Energy Resources of CDUT	This study was supported by the National Natural Science Foundation of China (No. 41230313), and by a College of Energy Resources of CDUT graduate fellowship to B. Deng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruguier O, 1997, EARTH PLANET SC LETT, V152, P217, DOI 10.1016/S0012-821X(97)00138-6; Burchfiel B.C., 1995, INT GEOL REV, V37, P661, DOI DOI 10.1080/00206819509465424; CHEN SF, 1995, BASIN RES, V7, P235, DOI 10.1111/j.1365-2117.1995.tb00108.x; Deng B, 2012, J GEOL SOC INDIA, V80, P241, DOI 10.1007/s12594-012-0134-8; Deng B, 2012, J ASIAN EARTH SCI, V48, P43, DOI 10.1016/j.jseaes.2011.12.019; Dirks P H G M, 1994, J SE ASIAN EARTH SCI, V9, P181, DOI DOI 10.1016/0743-9547(94)90074-4; Flinn D., 1962, Q J GEOL SOC LOND, V118, P385, DOI DOI 10.1144/GSJGS.118.1.0385; FRY N, 1979, TECTONOPHYSICS, V60, P89, DOI 10.1016/0040-1951(79)90135-5; Harrowfield MJ, 2005, J STRUCT GEOL, V27, P101, DOI 10.1016/j.jsg.2004.06.010; HIRTH G, 1992, J STRUCT GEOL, V14, P145, DOI 10.1016/0191-8141(92)90053-Y; Huang M, 2003, J METAMORPH GEOL, V21, P223, DOI 10.1046/j.1525-1314.2003.00438.x; Kollmeier JM, 2000, EARTH PLANET SC LETT, V181, P203, DOI 10.1016/S0012-821X(00)00203-X; Li SZ, 2007, GONDWANA RES, V12, P121, DOI 10.1016/j.gr.2006.11.011; Lin SF, 2001, GEOLOGY, V29, P767, DOI 10.1130/0091-7613(2001)029<0767:UASVIS>2.0.CO;2; Liu SG, 2012, J ASIAN EARTH SCI, V47, P204, DOI 10.1016/j.jseaes.2011.10.012; Macedo J, 1999, GEOL SOC AM BULL, V111, P1808, DOI 10.1130/0016-7606(1999)111<1808:COTGOF>2.3.CO;2; Marshak S, 1996, J STRUCT GEOL, V18, P891, DOI 10.1016/0191-8141(96)00016-8; Marshak S., 2004, THRUST TECTONICS HYD, V82, P131, DOI DOI 10.1306/M82813C9; Passchier CW., 2005, MICROTECTONICS; Pullen A, 2008, GEOLOGY, V36, P351, DOI 10.1130/G24435A.1; Ramsay J. G., 1983, TECHNIQUES MODERN ST, V1; Reid AJ, 2005, J STRUCT GEOL, V27, P119, DOI 10.1016/j.jsg.2004.06.011; Reiter K, 2011, EARTH PLANET SC LETT, V302, P132, DOI 10.1016/j.epsl.2010.12.002; RIES AC, 1976, PHILOS T R SOC A, V283, P281, DOI 10.1098/rsta.1976.0085; Roger F, 2004, J ASIAN EARTH SCI, V22, P465, DOI 10.1016/S1367-9120(03)00089-0; Roger F, 2010, J ASIAN EARTH SCI, V39, P254, DOI 10.1016/j.jseaes.2010.03.008; Sussman A.J., 2004, 383 GEOL SOC AM; Tikoff B, 1997, J STRUCTURAL GEOLOGY, V19, P267; Wang Erqi, 2001, EARTH SCI FRONTIERS, V8, P375; Weil AB, 2010, GEOL SOC AM BULL, V122, P3, DOI 10.1130/B26483.1; Worley BA, 1996, J STRUCT GEOL, V18, P395, DOI 10.1016/0191-8141(95)00095-U; Xu Z. Q, 1992, OROGENIC PROCESSES S; Yan DP, 2003, J STRUCT GEOL, V25, P765, DOI 10.1016/S0191-8141(02)00059-7; Yuan C, 2010, EARTH PLANET SC LETT, V290, P481, DOI 10.1016/j.epsl.2010.01.005; Zhang HF, 2007, LITHOS, V97, P323, DOI 10.1016/j.lithos.2007.01.002; Zhang HF, 2006, J ASIAN EARTH SCI, V27, P751, DOI 10.1016/j.jseaes.2005.07.008	36	7	8	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76732	10.1371/journal.pone.0076732	http://dx.doi.org/10.1371/journal.pone.0076732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204663	gold, Green Submitted, Green Published			2022-12-27	WOS:000326029300048
J	Shah, N; Martin-Antonio, B; Yang, H; Ku, S; Lee, DA; Cooper, LJN; Decker, WK; Li, SF; Robinson, SN; Sekine, T; Parmar, S; Gribben, J; Wang, M; Rezvani, K; Yvon, E; Najjar, A; Burks, J; Kaur, I; Champlin, RE; Bollard, CM; Shpall, EJ				Shah, Nina; Martin-Antonio, Beatriz; Yang, Hong; Ku, Stephanie; Lee, Dean A.; Cooper, Laurence J. N.; Decker, William K.; Li, Sufang; Robinson, Simon N.; Sekine, Takuya; Parmar, Simrit; Gribben, John; Wang, Michael; Rezvani, Katy; Yvon, Eric; Najjar, Amer; Burks, Jared; Kaur, Indreshpal; Champlin, Richard E.; Bollard, Catherine M.; Shpall, Elizabeth J.			Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSE FORMATION; EX-VIVO EXPANSION; TERM-FOLLOW-UP; MULTIPLE-MYELOMA; BONE-MARROW; NK CELLS; UNRELATED DONOR; AUTOLOGOUS TRANSPLANTATION; ANTITUMOR-ACTIVITY; T-LYMPHOCYTES	Natural killer (NK) cells are important mediators of anti-tumor immunity and are active against several hematologic malignancies, including multiple myeloma (MM). Umbilical cord blood (CB) is a promising source of allogeneic NK cells but large scale ex vivo expansion is required for generation of clinically relevant CB-derived NK (CB-NK) cell doses. Here we describe a novel strategy for expanding NK cells from cryopreserved CB units using artificial antigen presenting feeder cells (aAPC) in a gas permeable culture system. After 14 days, mean fold expansion of CB-NK cells was 1848-fold from fresh and 2389-fold from cryopreserved CB with >95% purity for NK cells (CD56(+)/CD3(-)) and less than 1% CD3(+) cells. Though surface expression of some cytotoxicity receptors was decreased, aAPC-expanded CB-NK cells exhibited a phenotype similar to CB-NK cells expanded with IL-2 alone with respect to various inhibitory receptors, NKG2C and CD94 and maintained strong expression of transcription factors Eomesodermin and T-bet. Furthermore, CB-NK cells formed functional immune synapses with and demonstrated cytotoxicity against various MM targets. Finally, aAPC-expanded CB-NK cells showed significant in vivo activity against MM in a xenogenic mouse model. Our findings introduce a clinically applicable strategy for the generation of highly functional CB-NK cells which can be used to eradicate MM.	[Shah, Nina; Martin-Antonio, Beatriz; Yang, Hong; Li, Sufang; Robinson, Simon N.; Sekine, Takuya; Parmar, Simrit; Rezvani, Katy; Yvon, Eric; Kaur, Indreshpal; Champlin, Richard E.; Shpall, Elizabeth J.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Ku, Stephanie; Decker, William K.; Bollard, Catherine M.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Lee, Dean A.; Cooper, Laurence J. N.] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Decker, William K.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Gribben, John] Queen Mary Univ London, Inst Canc, Barts & London Sch Med, Ctr Med Oncol, London, England; [Wang, Michael] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma, Houston, TX 77030 USA; [Najjar, Amer] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; [Burks, Jared] Univ Texas MD Anderson Canc Ctr, Dept Leukemia Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of London; Queen Mary University London; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shah, N (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA.	nshah@mdanderson.org	Lee, Dean Anthony/AAK-8443-2021; Martín-Antonio, Beatriz/D-4963-2014	Lee, Dean Anthony/0000-0001-6693-5392; Martín-Antonio, Beatriz/0000-0003-0612-2693; Bollard, Catherine M./0000-0001-5140-9090	National Institutes of Health [K12 CA088084]; Cancer Prevention and Research Institute of Texas RP [100430]; NATIONAL CANCER INSTITUTE [P01CA049639, P30CA016672, K12CA088084, P01CA081534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas RP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health K12 CA088084 (Shah) and Cancer Prevention and Research Institute of Texas RP#100430 (Shpall). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alici E, 2007, EXP HEMATOL, V35, P1839, DOI 10.1016/j.exphem.2007.08.006; Alici E, 2008, BLOOD, V111, P3155, DOI 10.1182/blood-2007-09-110312; Anasetti C, 2012, BIOL BLOOD MARROW TR, V18, pS161, DOI 10.1016/j.bbmt.2011.11.004; Beck RC, 2009, BIOL BLOOD MARROW TR, V15, P1026, DOI 10.1016/j.bbmt.2009.06.002; Bjorkstrand B, 2011, J CLIN ONCOL, V29, P3016, DOI 10.1200/JCO.2010.32.7312; Brunstein CG, 2009, BLOOD, V113, P5628, DOI 10.1182/blood-2008-12-197467; Carbone E, 2005, BLOOD, V105, P251, DOI 10.1182/blood-2004-04-1422; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Denman CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030264; Fauriat C, 2006, LEUKEMIA, V20, P732, DOI 10.1038/sj.leu.2404096; Feinman R, 1999, BLOOD, V93, P3044; Garg TK, 2012, HAEMATOL-HEMATOL J, V97, P1348, DOI 10.3324/haematol.2011.056747; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Giaccone L, 2011, BLOOD, V117, P6721, DOI 10.1182/blood-2011-03-339945; Gill S, 2012, BLOOD, V119, P5758, DOI 10.1182/blood-2012-03-415364; Gluckman E, 2011, BRIT J HAEMATOL, V154, P441, DOI 10.1111/j.1365-2141.2011.08598.x; Godfrey J, 2012, LEUKEMIA LYMPHOMA, V53, P1666, DOI 10.3109/10428194.2012.676175; Harousseau JL, 2009, NEW ENGL J MED, V360, P2645, DOI 10.1056/NEJMct0805626; Hoyos V, 2010, LEUKEMIA, V24, P1160, DOI 10.1038/leu.2010.75; Hsu KC, 2006, BIOL BLOOD MARROW TR, V12, P828, DOI 10.1016/j.bbmt.2006.04.008; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jurisic V, 2007, MED ONCOL, V24, P312, DOI 10.1007/s12032-007-0007-y; Kanga U, 2012, TRANSPL P, V44, P919, DOI 10.1016/j.transproceed.2012.03.036; Katodritou E, 2011, AM J HEMATOL, V86, P967, DOI 10.1002/ajh.22163; Krishnan A, 2011, LANCET ONCOL, V12, P1195, DOI 10.1016/S1470-2045(11)70243-1; Kroger N, 2011, LEUKEMIA, V25, P1657, DOI 10.1038/leu.2011.138; Lapteva N, 2012, CYTOTHERAPY, V14, P1131, DOI 10.3109/14653249.2012.700767; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Lundqvist A, 2007, BLOOD, V109, P3603, DOI 10.1182/blood-2006-05-024315; Miller JS, 2007, BLOOD, V109, P5058, DOI 10.1182/blood-2007-01-065383; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Paley MA, 2012, J LEUKOC BIOL; Passweg JR, 2005, BONE MARROW TRANSPL, V35, P637, DOI 10.1038/sj.bmt.1704810; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Ramsay AG, 2008, J CLIN INVEST, V118, P2427, DOI 10.1172/JCI35017; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Roda-Navarro P, 2006, P NATL ACAD SCI USA, V103, P11258, DOI 10.1073/pnas.0600721103; Rosinol L, 2008, BLOOD, V112, P3591, DOI 10.1182/blood-2008-02-141598; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruggeri L, 2004, BLOOD CELL MOL DIS, V33, P216, DOI 10.1016/j.bcmd.2004.08.005; Savoldo B, 2007, BLOOD, V110, P2620, DOI 10.1182/blood-2006-11-059139; Sawanobori M, 1997, ACTA HAEMATOL-BASEL, V98, P150, DOI 10.1159/000203610; Shi J, 2008, BRIT J HAEMATOL, V143, P641, DOI 10.1111/j.1365-2141.2008.07340.x; Spanholtz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020740; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; TANNER J, 1991, J CLIN INVEST, V88, P239, DOI 10.1172/JCI115283; Tinhofer I, 2000, BLOOD, V95, P610, DOI 10.1182/blood.V95.2.610; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Willemze R, 2010, BEST PRACT RES CL HA, V23, P283, DOI 10.1016/j.beha.2010.05.005; Xing DX, 2010, J IMMUNOTHER, V33, P684, DOI 10.1097/CJI.0b013e3181e475e9; Yang J, 2009, CLIN CANCER RES, V15, P951, DOI 10.1158/1078-0432.CCR-08-1823	52	123	128	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76781	10.1371/journal.pone.0076781	http://dx.doi.org/10.1371/journal.pone.0076781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204673	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300052
J	Alvarado, S; Wyglinski, J; Suderman, M; Andrews, SA; Szyf, M				Alvarado, Sebastian; Wyglinski, Joanne; Suderman, Matthew; Andrews, Stephen A.; Szyf, Moshe			Methylated DNA Binding Domain Protein 2 (MBD2) Coordinately Silences Gene Expression through Activation of the MicroRNA hsa-mir-496 Promoter in Breast Cancer Cell Line	PLOS ONE			English	Article							IN-VITRO; DEMETHYLATION; GROWTH; METHYLTRANSFERASE; HYPOMETHYLATION; TUMORIGENESIS; TRANSITION; MECHANISM; FAMILY	Methylated DNA binding protein 2 (MBD2) binds methylated promoters and suppresses transcription in cis through recruitment of a chromatin modification repressor complex. We show here a new mechanism of action for MBD2: suppression of gene expression indirectly through activation of microRNA hsa-mir-496. Overexpression of MBD2 in breast epithelial cell line MCF-10A results in induced expression and demethylation of hsa-mir-496 while depletion of MBD2 in a human breast cancer cell lines MCF-7 and MDA-MB231 results in suppression of hsa-mir-496. Activation of hsa-mir-496 by MBD2 is associated with silencing of several of its target genes while depletion of MBD2 leads to induction of hsa-mir-496 target genes. Depletion of hsa-mir-496 by locked nucleic acid (LNA) antisense oligonucleotide leads to activation of these target genes in MBD2 overexpressing cells supporting that hsa-mir-496 is mediating in part the effects of MBD2 on gene expression. We demonstrate that MBD2 binds the promoter of hsa-mir-496 in MCF-10A, MCF-7 and MDA-MB-231 cells and that it activates an in vitro methylated hsa-mir-496 promoter driving a CG-less luciferase reporter in a transient transfection assay. The activation of hsa-mir-496 is associated with reduced methylation of the promoter. Taken together these results describe a novel cascade for gene regulation by DNA methylation whereby activation of a methylated microRNA by MBD2 that is associated with loss of methylation triggers repression of downstream targets.	[Alvarado, Sebastian; Wyglinski, Joanne; Suderman, Matthew; Andrews, Stephen A.; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Szyf, Moshe] McGill Univ, Sackler Program Epigenet & Dev Psychobiol, Montreal, PQ, Canada; [Suderman, Matthew] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Szyf, M (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	moshe.szyf@mcgill.ca	; Alvarado, Sebastian/S-7607-2018	Suderman, Matthew/0000-0002-2715-9930; Alvarado, Sebastian/0000-0001-5866-4043	National Cancer Institute of Canada; Canadian Institute of Health Research [MOP-42411]; Canadian Institute for Advanced Research; Sackler program in Epigenetics and psychobiology	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Sackler program in Epigenetics and psychobiology	This study was supported by a grant from the National Cancer Institute of Canada and the Canadian Institute of Health Research (MOP-42411) (http://cancer.ca/Research.aspx). MS is supported by the Canadian Institute for Advanced Research and the Sackler program in Epigenetics and psychobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrisano T, 2006, NUCLEIC ACIDS RES, V34, P364, DOI 10.1093/nar/gkj400; Aoki K, 2009, J IMMUNOL, V182, P7698, DOI 10.4049/jimmunol.0801643; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Billard LM, 2002, ONCOGENE, V21, P2704, DOI 10.1038/sj/onc/1205357; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Broday L, 1999, MOL CELL BIOL, V19, P3198; Buurman R, 2012, GASTROENTEROLOGY, V143, P811, DOI 10.1053/j.gastro.2012.05.033; Campbell PM, 2004, CARCINOGENESIS, V25, P499, DOI 10.1093/carcin/bgh045; Chen C. C., 2013, J BIOL CHEM; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Detich N, 2002, J BIOL CHEM, V277, P35791, DOI 10.1074/jbc.C200408200; Ego T, 2005, ONCOGENE, V24, P1914, DOI 10.1038/sj.onc.1208394; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Goel A, 2003, J BIOL CHEM, V278, P15333, DOI 10.1074/jbc.M300608200; Han L, 2007, CANCER BIOL THER, V6, P1284; HE L, 2004, NAT REV GENET, V5, P522; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Ishibashi O, 1999, Cancer Biochem Biophys, V17, P69; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kirschke H, 1997, ADV EXP MED BIOL, V421, P253; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Mohr F, 2011, EXP HEMATOL, V39, P272, DOI 10.1016/j.exphem.2010.12.004; Munnes M, 1998, ONCOGENE, V17, P2573, DOI 10.1038/sj.onc.1202165; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Omura N, 2010, MOL CANCER RES, V8, P821, DOI 10.1158/1541-7786.MCR-09-0336; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Pakneshan P, 2004, J BIOL CHEM, V279, P31735, DOI 10.1074/jbc.M401669200; Pakneshan P, 2004, CLIN CANCER RES, V10, P3035, DOI 10.1158/1078-0432.CCR-03-0545; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; ROULEAU J, 1992, J BIOL CHEM, V267, P7368; Saito Y, 2006, CELL CYCLE, V5, P2220, DOI 10.4161/cc.5.19.3340; Saito Yoshimasa, 2012, Frontiers in Genetics, V3, P186, DOI 10.3389/fgene.2012.00186; Sansom OJ, 2003, NAT GENET, V34, P145, DOI 10.1038/ng1155; Shukeir N, 2006, CANCER RES, V66, P9202, DOI 10.1158/0008-5472.CAN-06-1954; Slack A, 2002, J GENE MED, V4, P381, DOI 10.1002/jgm.288; Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823; Wang LL, 2009, HUM REPROD, V24, P562, DOI 10.1093/humrep/den439; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yu FY, 2012, J BIOL CHEM, V287, P465, DOI 10.1074/jbc.M111.280768; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Z, 2006, ONCOGENE, V25, P5436, DOI 10.1038/sj.onc.1209530; ZUCMAN J, 1992, GENOMICS, V13, P395, DOI 10.1016/0888-7543(92)90259-U	53	24	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e74009	10.1371/journal.pone.0074009	http://dx.doi.org/10.1371/journal.pone.0074009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204564	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700001
J	Jin, SB; Fu, HT; Zhou, Q; Sun, SM; Jiang, SF; Xiong, YW; Gong, YS; Qiao, H; Zhang, WY				Jin, Shubo; Fu, Hongtuo; Zhou, Qiao; Sun, Shengming; Jiang, Sufei; Xiong, Yiwei; Gong, Yongsheng; Qiao, Hui; Zhang, Wenyi			Transcriptome Analysis of Androgenic Gland for Discovery of Novel Genes from the Oriental River Prawn, Macrobrachium nipponense, Using Illumina Hiseq 2000	PLOS ONE			English	Article							SEQUENCE TAG ANALYSIS; FRESH-WATER PRAWNS; SEXUAL CHARACTERISTICS; EXPRESSION ANALYSIS; MOLECULAR-CLONING; RNA-SEQ; FTZ-F1; IDENTIFICATION; HOMOLOG; PROTEIN	Background: The oriental river prawn, Macrobrachium nipponense, is an important aquaculture species in China, even in whole of Asia. The androgenic gland produces hormones that play crucial roles in sexual differentiation to maleness. This study is the first de novo M. nipponense transcriptome analysis using cDNA prepared from mRNA isolated from the androgenic gland. Illumina/Solexa was used for sequencing. Methodology and Principal Finding: The total volume of RNA sample was more than 5 ug. We generated 70,853,361 high quality reads after eliminating adapter sequences and filtering out low-quality reads. A total of 78,408 isosequences were obtained by clustering and assembly of the clean reads, producing 57,619 non-redundant transcripts with an average length of 1244.19 bp. In total 70,702 isosequences were matched to the Nr database, additional analyses were performed by GO (33,203), KEGG (17,868), and COG analyses (13,817), identifying the potential genes and their functions. A total of 47 sex-determination related gene families were identified from the M. nipponense androgenic gland transcriptome based on the functional annotation of non-redundant transcripts and comparisons with the published literature. Furthermore, a total of 40 candidate novel genes were found, that may contribute to sex-determination based on their extremely high expression levels in the androgenic compared to other sex glands,. Further, 437 SSRs and 65,535 high-confidence SNPs were identified in this EST dataset from which 14 EST-SSR markers have been isolated. Conclusion: Our study provides new sequence information for M. nipponense, which will be the basis for further genetic studies on decapods crustaceans. More importantly, this study dramatically improves understanding of sex-determination mechanisms, and advances sex-determination research in all crustacean species. The huge number of potential SSR and SNP markers isolated from the transcriptome may shed the lights on research in many fields, including the evolution and molecular ecology of Macrobrachium species.	[Jin, Shubo; Fu, Hongtuo; Zhou, Qiao] Nanjing Agr Univ, Wuxi Fishery Coll, Wuxi, Peoples R China; [Jin, Shubo; Fu, Hongtuo; Sun, Shengming; Jiang, Sufei; Xiong, Yiwei; Gong, Yongsheng; Qiao, Hui; Zhang, Wenyi] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Wuxi, Peoples R China	Nanjing Agricultural University; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs	Fu, HT (corresponding author), Nanjing Agr Univ, Wuxi Fishery Coll, Wuxi, Peoples R China.	fuht@ffrc.cn		Jin, Shubo/0000-0002-6550-9268	National Natural Science Foundation of China [31272654]; National Science & Technology Supporting Program of the 12th Five-year Plan of China [2012BAD26B04]; Science & Technology Supporting Program of Jiangsu Province [BE2012334]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Supporting Program of the 12th Five-year Plan of China; Science & Technology Supporting Program of Jiangsu Province	The project was supported by the National Natural Science Foundation of China (Grant No.31272654) (http://www.nsfc.gov.cn/Portal0/InfoModule_544/29249.htm), the National Science & Technology Supporting Program of the 12th Five-year Plan of China (Grant No. 2012BAD26B04) (http://www.most.gov.cn/kjbgz/201208/t20120821_96332.htm) and the Science & Technology Supporting Program of Jiangsu Province (Grant No. BE2012334)(http://www.jiangsu.gov.cn/xxgk/bmhsxwj/bmwj/201206/t20120626_740122.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BOND U, 1985, MOL CELL BIOL, V5, P949, DOI 10.1128/MCB.5.5.949; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bureau of Fishery Ministry of Agriculture and P.R.C., 2009, CHIN FISH YB, P236; Cai YX, 2006, RAFFLES B ZOOL, V54, P245; CARLSON N, 1987, J CELL BIOL, V104, P547, DOI 10.1083/jcb.104.3.547; Casas E, 1999, ZYGOTE, V7, P21, DOI 10.1017/S0967199499000350; Chini V, 2008, GENE, V410, P207, DOI 10.1016/j.gene.2007.12.012; Chung JS, 2011, GEN COMP ENDOCR, V173, P4, DOI 10.1016/j.ygcen.2011.04.017; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; de Grave Sammy, 2006, Aquatic Invasions, V1, P204; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Feng Jian-bin, 2008, Shanghai Shuichan Daxue Xuebao, V17, P371; Galderisi U, 2003, ONCOGENE, V22, P5208, DOI 10.1038/sj.onc.1206558; Gaudet J, 1996, MOL BIOL CELL, V7, P1107, DOI 10.1091/mbc.7.7.1107; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Hake L, 2008, NATURE ED, V1; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; Ito M, 2000, PLANT MOL BIOL, V43, P677, DOI 10.1023/A:1006336005587; Jones DO, 2001, DNA SEQUENCE, V12, P147, DOI 10.3109/10425170109080769; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kawahara-Miki R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026043; Kwon J, 2004, BIOL REPROD, V71, P515, DOI 10.1095/biolreprod.104.027565; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; LAVORGNA G, 1991, SCIENCE, V252, P848, DOI 10.1126/science.1709303; LAVORGNA G, 1993, P NATL ACAD SCI USA, V90, P3004, DOI 10.1073/pnas.90.7.3004; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li H, 1997, ENDOCRINOLOGY, V138, P1289, DOI 10.1210/en.138.3.1289; Li SH, 2012, GEN COMP ENDOCR, V177, P246, DOI 10.1016/j.ygcen.2012.04.010; Li WW, 2011, PEPTIDES, V32, P518, DOI 10.1016/j.peptides.2010.08.027; Ma KY, 2013, GEN COMP ENDOCR, V185, P90, DOI 10.1016/j.ygcen.2013.01.018; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Ma KY, 2011, GENE, V487, P160, DOI 10.1016/j.gene.2011.07.017; MALECHA SR, 1992, AQUACULTURE, V105, P201, DOI 10.1016/0044-8486(92)90087-2; Manor R, 2004, INVERTEBR REPROD DEV, V45, P151, DOI 10.1080/07924259.2004.9652584; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mareddy VR, 2011, AQUACULTURE, V318, P364, DOI 10.1016/j.aquaculture.2011.05.027; MATSUMOTO M, 1993, BIOCHIM BIOPHYS ACTA, V1174, P274, DOI 10.1016/0167-4781(93)90196-K; Mirabdullaev IM, 2005, 2 INT S INVASION ALI, P113; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; NAGAMINE C, 1980, GEN COMP ENDOCR, V41, P423, DOI 10.1016/0016-6480(80)90048-9; Oba K, 1996, BIOCHEM BIOPH RES CO, V226, P261, DOI 10.1006/bbrc.1996.1343; Okuno A, 2002, PEPTIDES, V23, P567, DOI 10.1016/S0196-9781(01)00635-0; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Preechaphol R, 2007, J BIOCHEM MOL BIOL, V40, P501; Qiao H, 2012, COMP BIOCHEM PHYS D, V7, P268, DOI 10.1016/j.cbd.2012.04.003; QUELLER DC, 1993, TRENDS ECOL EVOL, V8, P285, DOI 10.1016/0169-5347(93)90256-O; RABOY B, 1991, ACTA BIOL HUNG, V42, P3; RETZEK H, 1992, DNA CELL BIOL, V11, P661, DOI 10.1089/dna.1992.11.661; SAGI A, 1990, GEN COMP ENDOCR, V77, P15, DOI 10.1016/0016-6480(90)90201-V; SAGI A, 1986, AQUACULTURE, V51, P265, DOI 10.1016/0044-8486(86)90318-2; Sagi A., 1990, World Aquaculture, V21, P87; Salman Salman D., 2006, Aquatic Invasions, V1, P109, DOI 10.3391/ai.2006.1.3.2; Sambrook J., 2011, MOL CLONING LAB MANU, V3rd; Schwartz AL, 1999, ANNU REV MED, V50, P57; Shen BL, 2009, MOL BIOL REP, V36, P1149, DOI 10.1007/s11033-008-9291-7; Sroyraya M, 2010, TISSUE CELL, V42, P293, DOI 10.1016/j.tice.2010.07.003; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; UEDA H, 1992, MOL CELL BIOL, V12, P5667, DOI 10.1128/MCB.12.12.5667; UEDA H, 1990, NUCLEIC ACIDS RES, V18, P7229, DOI 10.1093/nar/18.24.7229; UEDA H, 1990, GENE DEV, V4, P624, DOI 10.1101/gad.4.4.624; Uryu K, 2006, AM J PATHOL, V168, P947, DOI 10.2353/ajpath.2006.050770; Ventura T, 2012, BIOTECHNOL ADV, V30, P1543, DOI 10.1016/j.biotechadv.2012.04.008; Ventura Tomer, 2011, ISRN Endocrinol, V2011, P476283, DOI 10.5402/2011/476283; Ventura T, 2009, ENDOCRINOLOGY, V150, P1278, DOI 10.1210/en.2008-0906; von Hofsten J, 2001, GEN COMP ENDOCR, V121, P146, DOI 10.1006/gcen.2000.7582; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wu P, 2002, WATER CONSERVANCY RE, V123, P21; Wu P, 2009, COMP BIOCHEM PHYS D, V4, P111, DOI 10.1016/j.cbd.2008.12.004; Yamaguchi K, 1998, EXP CELL RES, V242, P303, DOI 10.1006/excr.1997.4082; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Yu H-P, 1972, OHMU, V3, P45; Zeng S, 2002, GENE, V294, P45, DOI 10.1016/S0378-1119(02)00791-6; Zhang FY, 2010, COMP BIOCHEM PHYS B, V155, P288, DOI 10.1016/j.cbpb.2009.11.013; Zhang WM, 2007, MOL REPROD DEV, V74, P665, DOI 10.1002/mrd.20642; Zhang YP, 2013, J WORLD AQUACULT SOC, V44, P338, DOI 10.1111/jwas.12039; Zhang YP, 2013, GENETIC MOL IN PRESS; Zhao WH, 2011, MOL BIOL REP, V38, P1399, DOI 10.1007/s11033-010-0243-7	88	53	57	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76840	10.1371/journal.pone.0076840	http://dx.doi.org/10.1371/journal.pone.0076840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204682	Green Published, Green Submitted, gold			2022-12-27	WOS:000326241200016
J	Silvestris, N; Pantano, F; Ibrahim, T; Gamucci, T; De Vita, F; Di Palma, T; Pedrazzoli, P; Barni, S; Bernardo, A; Febbraro, A; Satolli, MA; Bertocchi, P; Catalano, V; Giommoni, E; Comandone, A; Maiello, E; Riccardi, F; Ferrara, R; Trogu, A; Berardi, R; Leo, S; Bertolini, A; Angelini, F; Cinieri, S; Russo, A; Pisconti, S; Brunetti, AE; Azzariti, A; Santini, D				Silvestris, Nicola; Pantano, Francesco; Ibrahim, Toni; Gamucci, Teresa; De Vita, Fernando; Di Palma, Teresa; Pedrazzoli, Paolo; Barni, Sandro; Bernardo, Antonio; Febbraro, Antonio; Satolli, Maria Antonietta; Bertocchi, Paola; Catalano, Vincenzo; Giommoni, Elisa; Comandone, Alessandro; Maiello, Evaristo; Riccardi, Ferdinando; Ferrara, Raimondo; Trogu, Antonio; Berardi, Rossana; Leo, Silvana; Bertolini, Alessandro; Angelini, Francesco; Cinieri, Saverio; Russo, Antonio; Pisconti, Salvatore; Brunetti, Anna Elisabetta; Azzariti, Amalia; Santini, Daniele			Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey	PLOS ONE			English	Article							ZOLEDRONIC ACID; PAMIDRONATE; EFFICACY; EVENTS	Background: Bone metastasis represents an increasing clinical problem in advanced gastric cancer (GC) as disease-related survival improves. In literature, few data on the natural history of bone disease in GC are available. Patients and Methods: Data on clinicopathology, skeletal outcomes, skeletal-related events (SREs), and bone-directed therapies for 208 deceased GC patients with evidence of bone metastasis were statistically analyzed. Results: Median time to bone metastasis was 8 months (CI 95%, 6.125-9.875 months) considering all included patients. Median number of SREs/patient was one. Less than half of the patients (31%) experienced at least one and only 4 and 2% experienced at least two and three events, respectively. Median times to first and second SRE were 2 and 4 months, respectively. Median survival was 6 months after bone metastasis diagnosis and 3 months after first SRE. Median survival in patients who did not experience SREs was 5 months. Among patients who received zoledronic acid before the first SRE, the median time to appearance of first SRE was significantly prolonged compared to control (7 months vs 4 months for control; P: 0.0005). Conclusions: To our knowledge, this retrospective analysis is the largest multicenter study to demonstrate that bone metastases from GC are not so rare, are commonly aggressive and result in relatively early onset of SREs in the majority of patients. Indeed, our large study, which included 90 patients treated with ZOL, showed, for the first time in literature, a significant extension of time to first SRE and increase in the median survival time after diagnosis of bone metastasis. Taken together, these data may support the beneficial effects of ZOL in GC patients.	[Silvestris, Nicola; Brunetti, Anna Elisabetta] Natl Canc Res Ctr Ist Tumori Giovanni Paolo II, Med Oncol Unit, Bari, Italy; [Pantano, Francesco; Santini, Daniele] Univ Campus Biomed, Med Oncol Unit, Rome, Italy; [Ibrahim, Toni] IRCCS Romagnolo Sci Inst Study & Treatment Canc, Osteoncol & Rare Tumors Ctr, Meldola, Italy; [Gamucci, Teresa] Hosp Frosinone, Med Oncol Unit, Frosinone, Italy; [De Vita, Fernando] Univ Naples 2, Med Oncol Unit, Naples, Italy; [Di Palma, Teresa] Hosp Latina, Med Oncol Unit, Latina, Italy; [Pedrazzoli, Paolo] Hosp Pavia, Dept Hematol Oncol, Pavia, Italy; [Barni, Sandro] Treviglio Caravaggio Hosp, Div Med Oncol, Treviglio, Italy; [Bernardo, Antonio] IRCCS Fdn Maugeri, Operat Unit Oncol, Pavia, Italy; [Febbraro, Antonio] Hosp Benevento, Med Oncol Unit, Benevento, Italy; [Satolli, Maria Antonietta] San Giovanni Battista Hosp, Dept Med Oncol, Turin, Italy; [Bertocchi, Paola] Fdn Poliambulanza Brescia, Dept Med Oncol, Brescia, Italy; [Catalano, Vincenzo] Hosp Pesaro, Med Oncol Unit, Pesaro, Italy; [Giommoni, Elisa] Careggi Hosp, Med Oncol Unit, Florence, Italy; [Comandone, Alessandro] Gradenigo Hosp, Dept Oncol, Turin, Italy; [Comandone, Alessandro] Grp Piemontese Sarcomi, Turin, Italy; [Maiello, Evaristo] Hosp Casa Sollievo Sofferenza, Med Oncol Unit, San Giovanni Rotondo, Italy; [Riccardi, Ferdinando] Hosp Cardarelli, Med Oncol Unit, Naples, Italy; [Ferrara, Raimondo] Hosp Barletta, Med Oncol Unit, Barletta, Italy; [Trogu, Antonio] Hosp Aosta, Med Oncol Unit, Aosta, Italy; [Berardi, Rossana] Univ Ancona, Med Oncol Unit, Ancona, Italy; [Leo, Silvana] Hosp Lecce, Med Oncol Unit, Lecce, Italy; [Bertolini, Alessandro] Hosp Sondrio, Med Oncol Unit, Sondrio, Italy; [Angelini, Francesco] Hosp Regina Apostolorum, Med Oncol Unit, Albano Laziale, Italy; [Cinieri, Saverio] Hosp Brindisi, Dept Med Oncol, Milan, Italy; [Cinieri, Saverio] Hosp Brindisi, Breast Unit, Milan, Italy; [Cinieri, Saverio] European Inst Oncol, Dept Med Oncol, Milan, Italy; [Russo, Antonio] Univ Palermo, Med Oncol Unit, Palermo, Italy; [Pisconti, Salvatore] Hosp Taranto, Dept Med Oncol, Taranto, Italy; [Azzariti, Amalia] Natl Canc Res Ctr Ist Tumori Giovanni Paolo II, Clin & Preclin Pharmacol Lab, Bari, Italy	IRCCS Istituto Tumori Bari Giovanni Paolo II; University Campus Bio-Medico - Rome Italy; Universita della Campania Vanvitelli; Ospedale di Treviglio-Caravaggio; Istituti Clinici Scientifici Maugeri IRCCS; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Florence; Azienda Ospedaliero Universitaria Careggi; Humanitas Hospital Gradenigo; IRCCS Casa Sollievo Della Sofferenza; Antonio Cardarelli Hospital; Azienda USL della Valle d'Aosta; Marche Polytechnic University; IRCCS European Institute of Oncology (IEO); University of Palermo; IRCCS Istituto Tumori Bari Giovanni Paolo II	Silvestris, N (corresponding author), Natl Canc Res Ctr Ist Tumori Giovanni Paolo II, Med Oncol Unit, Bari, Italy.	n.silvestris@oncologico.bari.it	Catalano, Vincenzo/AAP-9561-2020; Berardi, Rossana/AAC-5758-2022; Azzariti, Amalia/K-4498-2016; Pedrazzoli, Paolo/AAB-8690-2019; Berardi, Rossana/AAC-5216-2022; bernardo, Antonio/AAB-9474-2020; SATOLLI, MARIA ANTONIETTA/AHE-0053-2022; Giommoni, Elisa/K-6950-2018; riccardi, ferdinando/K-7370-2016; Pantano, Francesco/D-8459-2012; Maiello, Evaristo/C-5224-2017	Azzariti, Amalia/0000-0002-6149-5049; Pedrazzoli, Paolo/0000-0002-9419-7160; Berardi, Rossana/0000-0002-9529-2960; bernardo, Antonio/0000-0002-2751-2626; Giommoni, Elisa/0000-0002-1715-8440; CINIERI, Saverio/0000-0002-5555-0814; riccardi, ferdinando/0000-0002-2852-2770; Ibrahim, Toni/0000-0003-0259-4167; Santini, Daniele/0000-0002-9118-3337; Pisconti, Salvatore/0000-0002-1658-523X; Pantano, Francesco/0000-0002-2894-9686; Maiello, Evaristo/0000-0003-3890-3435				ABRAMS HL, 1950, CANCER, V3, P74, DOI 10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7; Baiocchi GL, 2010, ANN SURG, V252, P70, DOI 10.1097/SLA.0b013e3181e4585e; Berenson JR, 1996, NEW ENGL J MED, V334, P488, DOI 10.1056/NEJM199602223340802; CRIVELLARI D, 1995, TUMORI, V81, P74, DOI 10.1177/030089169508100117; D'Angelica M, 2004, ANN SURG, V240, P808, DOI 10.1097/01.sla.0000143245.28656.15; Guggenheim DE, 2013, J SURG ONCOL, V107, P230, DOI 10.1002/jso.23262; Henry DH, 2011, J CLIN ONCOL, V29, P1125, DOI 10.1200/JCO.2010.31.3304; Hortobagyi GN, 1996, NEW ENGL J MED, V335, P1785, DOI 10.1056/NEJM199612123352401; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lipton A, 2013, CLIN ONCOL-UK, V25, P217, DOI 10.1016/j.clon.2012.11.004; Major P, 2001, J CLIN ONCOL, V19, P558, DOI 10.1200/JCO.2001.19.2.558; Major Pierre P, 2009, BMC Cancer, V9, P272, DOI 10.1186/1471-2407-9-272; Mortimer JE, 2010, SEMIN ONCOL, V37, pS66, DOI 10.1053/j.seminoncol.2010.06.006; Nakanishi H, 2004, CLIN ORTHOP RELAT R, P208, DOI 10.1097/01.blo.0000129159.65684.b3; Park HS, 2011, ONCOLOGY-BASEL, V80, P142, DOI 10.1159/000328507; Park JM, 2013, GASTRIC CANCER, V16, P362, DOI 10.1007/s10120-012-0193-y; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Rosen LS, 2003, J CLIN ONCOL, V21, P3150, DOI 10.1200/JCO.2003.04.105; Saito H, 2010, J SURG ONCOL, V101, P622, DOI 10.1002/jso.21562; Santini D, 2012, ANN ONCOL, V23, P2072, DOI 10.1093/annonc/mdr572; SETO M, 1983, Kaku Igaku, V20, P795; Xu DZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038681; YOSHIKAWA K, 1983, JPN J SURG, V13, P173, DOI 10.1007/BF02469472	24	43	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e74402	10.1371/journal.pone.0074402	http://dx.doi.org/10.1371/journal.pone.0074402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204569	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200002
J	Zhao, J; Zhao, L				Zhao, Jun; Zhao, Long			Cruciferous Vegetables Intake Is Associated with Lower Risk of Renal Cell Carcinoma: Evidence from a Meta-Analysis of Observational Studies	PLOS ONE			English	Article							COLORECTAL-CANCER; PROSTATE-CANCER; FRUIT; CONSUMPTION; CAROTENOIDS; INHIBITION; VITAMIN; FIBER; DIET	Background: Epidemiologic studies have evaluated the association between cruciferous vegetables(CV) intake and the risk of renal cell carcinoma(RCC); however, the existing results are controversial. The aim of this meta-analysis was to investigate the association between CV intake and RCC risk. Methods: A literature search was carried out using PUBMED and EMBASE database between January 1966 and March 2013. Fixed-effect and random-effect models were used to estimate summary relative risks (RR) and the corresponding 95% confidence intervals (CIs). Potential sources of heterogeneity were detected by meta-regression. Subgroup analyses, sensitivity analysis and cumulative meta-analysis were also performed. Results: A total of 12 studies (six cohorts, six case-control) contributed to the analysis, involving 1,228,518 participants and 5,773 RCC cases. When all studies were pooled, we observed a significantly inverse association between CV intake and RCC risk (RR = 0.81, 95% CI [0.72, 0.91]). This association was also significant when analyses were restricted to six high-quality studies (RR = 0.89, 95% CI [0.82, 0.98]). In subgroup analyses, CV intake was significantly associated with reduced RCC risk among studies conducted in America (RR = 0.77, 95% CI [0.70, 0.86]); however, CV intake had no significant association with RCC risk among studies conducted in Europe (RR = 0.87, 95% CI [0.71, 1.07]). Furthermore, sensitivity analysis confirmed the stability of results. Conclusions: The findings of this meta-analysis suggested that high intake of CV was inversely associated with RCC risk among Americans. More studies, especially high quality cohort studies with larger sample size, well controlled confounding factors are warranted to confirm this association.	[Zhao, Jun] Shandong Weifang Peoples Hosp, Dept Nephrol, Weifang, Peoples R China; [Zhao, Long] Shandong Univ, Dept Nephrol, Hosp 2, Jinan 250100, Peoples R China	Shandong University	Zhao, J (corresponding author), Shandong Weifang Peoples Hosp, Dept Nephrol, Weifang, Peoples R China.	junzhao63@126.com						Aune D, 2011, GASTROENTEROLOGY, V141, P106, DOI 10.1053/j.gastro.2011.04.013; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bertoia M, 2010, INT J CANCER, V126, P1504, DOI 10.1002/ijc.24829; Brock KE, 2012, BRIT J NUTR, V108, P1077, DOI 10.1017/S0007114511006489; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Conaway CC, 2002, CURR DRUG METAB, V3, P233, DOI 10.2174/1389200023337496; Daniel CR, 2013, AM J CLIN NUTR, V97, P1036, DOI 10.3945/ajcn.112.045351; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhote R, 2000, BJU INT, V86, P20, DOI 10.1046/j.1464-410x.2000.00708.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gerhauser C, 2013, CURR OPIN CLIN NUTR; Hecht SS, 2000, DRUG METAB REV, V32, P395, DOI 10.1081/DMR-100102342; Hecht SS, 2004, CANCER EPIDEM BIOMAR, V13, P997; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsu CC, 2007, AM J EPIDEMIOL, V166, P62, DOI 10.1093/aje/kwm043; Hu JF, 2003, CANCER CAUSE CONTROL, V14, P705, DOI 10.1023/A:1026310323882; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim SH, 2013, CANC PREV RES PHILA; Kurilich AC, 1999, J AGR FOOD CHEM, V47, P1576, DOI 10.1021/jf9810158; Lee JE, 2006, CANCER EPIDEM BIOMAR, V15, P2445, DOI 10.1158/1055-9965.EPI-06-0553; Lee JE, 2009, CANCER EPIDEM BIOMAR, V18, P1730, DOI 10.1158/1055-9965.EPI-09-0045; Lindblad P, 1997, CANCER EPIDEM BIOMAR, V6, P215; Liu B, 2013, WORLD J UROL, V31, P127, DOI 10.1007/s00345-012-0850-0; Liu B, 2012, INT J UROL, V19, P134, DOI 10.1111/j.1442-2042.2011.02906.x; Maclure M, 1990, Epidemiology, V1, P430, DOI 10.1097/00001648-199011000-00004; Melchini A, 2013, NUTR CANCER, V65, P132, DOI 10.1080/01635581.2013.741747; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Rashidkhani B, 2005, INT J CANCER, V113, P451, DOI 10.1002/ijc.20577; Saw CLL, 2011, BIOPHARM DRUG DISPOS, V32, P289, DOI 10.1002/bdd.759; van Dijk BAC, 2005, INT J CANCER, V117, P648, DOI 10.1002/ijc.21203; Weikert S, 2006, INT J CANCER, V118, P3133, DOI 10.1002/ijc.21765; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Wu QJ, 2013, ANN ONCOL, V24, P1079, DOI 10.1093/annonc/mds601; Wu QJ, 2013, CANC SCI; Wu QJ, 2013, ANN ONCOL; Yuan JM, 1998, INT J CANCER, V77, P211, DOI 10.1002/(SICI)1097-0215(19980717)77:2&lt;211::AID-IJC7&gt;3.0.CO;2-T; Zhou Y, 2011, GASTROENTEROLOGY, V141, P80, DOI 10.1053/j.gastro.2011.03.057	41	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e75732	10.1371/journal.pone.0075732	http://dx.doi.org/10.1371/journal.pone.0075732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204579	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200007
J	Martelli-Palomino, G; Pancotto, JA; Muniz, YC; Mendes, CT; Castelli, EC; Massaro, JD; Krawice-Radanne, I; Poras, I; Rebmann, V; Carosella, ED; Rouas-Freiss, N; Moreau, P; Donadi, EA				Martelli-Palomino, Gustavo; Pancotto, Joao A.; Muniz, Yara C.; Mendes-Junior, Celso T.; Castelli, Erick C.; Massaro, Juliana D.; Krawice-Radanne, Irene; Poras, Isabelle; Rebmann, Vera; Carosella, Edgardo D.; Rouas-Freiss, Nathalie; Moreau, Philippe; Donadi, Eduardo A.			Polymorphic Sites at the 3 ' Untranslated Region of the HLA-G Gene Are Associated with Differential hla-g Soluble Levels in the Brazilian and French Population	PLOS ONE			English	Article							LEUKOCYTE ANTIGEN-G; G MESSENGER-RNA; G 3'UTR POLYMORPHISMS; G GENOTYPE; HAPLOTYPE FREQUENCIES; SUSCEPTIBILITY; ALLELE; PREECLAMPSIA; RECEPTOR; CELLS	HLA-G molecule has well-recognized tolerogenic properties, and the encoding gene shows lower frequency of polymorphism at the coding region but higher variability at regulatory 5' and 3' untranslated (3' UTR) regions. At least three 3' UTR polymorphic sites have been associated with HLA-G mRNA regulation, including the 14 base pair (14bp) Insertion/Deletion, +3142C-G and +3187A-G. We studied the association of polymorphic sites at 3' UTR (sequencing analysis, encompassing the 14bp Ins-Del/+3003T-C/+3010C-G/+3027C-A/+3035C-T/+3142C-G/+3187A-G/+3196C-G polymorphic sites) with plasma soluble HLA-G levels (sHLA-G, detected by ELISA) in 187 French and 153 Brazilian healthy individuals. Allele and genotype frequencies were closely similar in both populations; however, Brazilians showed a higher HLA-G 3' UTR haplotype diversity. Considering sHLA-G levels in both populations altogether, individuals presenting 14bp Del/Del showed higher levels compared to 14bpIns/Ins genotype (P < 0.05); those presenting +3010C/G showed higher levels compared to the +3010C-C genotype (P<0.05); those presenting +3027C-C showed higher levels than the +3027A-A genotype (P<0.05); and those bearing +3035C-C showed higher levels compared to the +3035C-T (P < 0.01) and +3035T-T (P < 0.05) genotypes. The analyses of 3' UTR haplotypes showed that UTR-1 (DelTGCCCGC) was associated with higher expression of sHLA-G, whereas UTR-5 (InsTCCTGAC) and UTR-7 (InsTCATGAC) with lower expression and other UTRs (UTR-2/3/4/6) exhibited intermediate levels. Since the differential expression of HLA-G may be beneficial or harmful depending on the underlying condition, the identification of individuals genetically programmed to differentially express HLA-G may help on defining novel strategies to control the immune response against the underlying disorder.	[Martelli-Palomino, Gustavo; Donadi, Eduardo A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Program Basic & Appl Immunol, Sao Paulo, Brazil; [Martelli-Palomino, Gustavo; Pancotto, Joao A.; Muniz, Yara C.; Krawice-Radanne, Irene; Poras, Isabelle; Carosella, Edgardo D.; Rouas-Freiss, Nathalie; Moreau, Philippe] Hop St Louis, Commissariat Energie Atom & Energies Alternat, Inst Malad Emergentes & Therapies Innovantes, Serv Rech Hematoimmunol, Paris, France; [Martelli-Palomino, Gustavo; Pancotto, Joao A.; Krawice-Radanne, Irene; Poras, Isabelle; Carosella, Edgardo D.; Rouas-Freiss, Nathalie; Moreau, Philippe] Univ Paris Diderot, Hop St Louis, Sorbonne Paris Cite, Inst Univ Hematol,Umr E5, Paris, France; [Pancotto, Joao A.] Univ Fed Espirito Santo, Sao Mateus, ES, Brazil; [Muniz, Yara C.] Univ Fed Santa Catarina, Program Cellular & Dev Biol, BR-88040900 Florianopolis, SC, Brazil; [Mendes-Junior, Celso T.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, Ribeirao Preto, SP, Brazil; [Castelli, Erick C.] Univ State Sao Paulo UNESP, Sch Med Botucatu, Dept Pathol, Botucatu, SP, Brazil; [Massaro, Juliana D.; Donadi, Eduardo A.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Med, Div Clin Immunol, Sao Paulo, Brazil; [Rebmann, Vera] Univ Hosp Essen, Inst Transfus Med, Essen, Germany	Universidade de Sao Paulo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; CEA; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Universidade Federal do Espirito Santo; Universidade Federal de Santa Catarina (UFSC); Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; University of Duisburg Essen	Moreau, P (corresponding author), Hop St Louis, Commissariat Energie Atom & Energies Alternat, Inst Malad Emergentes & Therapies Innovantes, Serv Rech Hematoimmunol, Paris, France.	philippe.moreau@cea.fr	Massaro, Juliana/V-4894-2019; Mendes-Junior, Celso Teixeira/B-1994-2010; Castelli, Erick C./B-4250-2010; Pancoto, João Alexandre Trés/AAI-9743-2021; donadi, eduardo A/H-7080-2013	Mendes-Junior, Celso Teixeira/0000-0002-7337-1203; Castelli, Erick C./0000-0003-2142-7196; Pancoto, João Alexandre Trés/0000-0003-1986-1452; donadi, eduardo A/0000-0002-9457-9601; Moreau, Philippe/0000-0002-2868-7401; Muniz, Yara Costa Netto/0000-0001-9526-8306; Rebmann, Vera/0000-0003-4660-3870	Binational Research Cooperation Program (CAPES/Brazil-COFECUB/France) [653/09]; Commissariat a L'Energie Atomique (CEA), France; CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil); ANR Agence Nationale de la Recherche [2010 PRSP 012 003]; Deutsche Krebshilfe [109816]	Binational Research Cooperation Program (CAPES/Brazil-COFECUB/France); Commissariat a L'Energie Atomique (CEA), France(French Atomic Energy Commission); CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ANR Agence Nationale de la Recherche(French National Research Agency (ANR)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This research was supported by grants from: (1) The Binational Research Cooperation Program (CAPES/Brazil-COFECUB/France project no. 653/09), (2) Commissariat a L'Energie Atomique (CEA), France, (3) CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil), (4) ANR Agence Nationale de la Recherche (2010 PRSP 012 003) (5) Deutsche Krebshilfe 109816. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasood A, 2011, HUM IMMUNOL, V72, P1064, DOI 10.1016/j.humimm.2011.08.016; Alvarez M, 2009, INT J IMMUNOGENET, V36, P361, DOI 10.1111/j.1744-313X.2009.00875.x; Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331; Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005; Castelli EC, 2010, GENES IMMUN, V11, P134, DOI 10.1038/gene.2009.74; Castelli EC, 2011, MOL BIOL EVOL, V28, P3069, DOI 10.1093/molbev/msr138; Castelli EC, 2009, HUM IMMUNOL, V70, P1020, DOI 10.1016/j.humimm.2009.07.028; Castro MJ, 2000, HUM IMMUNOL, V61, P1157, DOI 10.1016/S0198-8859(00)00188-9; Alves DCC, 2012, HUM IMMUNOL, V73, P52, DOI 10.1016/j.humimm.2011.10.007; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Consiglio CR, 2011, TISSUE ANTIGENS, V77, P540, DOI 10.1111/j.1399-0039.2011.01635.x; Di Cristofaro J, 2012, HUM IMMUNOL, V2; Di Cristofaro J, 2013, HUM IMMUNOL, V74, P203, DOI 10.1016/j.humimm.2012.10.027; Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Garcia A, 2013, INFECT GENET EVOL, V16, P263, DOI 10.1016/j.meegid.2013.02.021; Glas J, 2007, INT IMMUNOL, V19, P621, DOI 10.1093/intimm/dxm027; Gonzalez A, 2012, CRIT REV CL LAB SCI, V49, P63, DOI 10.3109/10408363.2012.677947; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z; Hviid TVF, 2006, HUM REPROD UPDATE, V12, P209, DOI 10.1093/humupd/dmi048; Hviid TVF, 2004, IMMUNOGENETICS, V56, P135, DOI 10.1007/s00251-004-0673-2; Hviid TVF, 2004, TISSUE ANTIGENS, V64, P66, DOI 10.1111/j.1399-0039.2004.00239.x; Jiang YT, 2011, DNA CELL BIOL, V30, P1027, DOI 10.1089/dna.2011.1238; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Le Gal FA, 1999, INT IMMUNOL, V11, P1351, DOI 10.1093/intimm/11.8.1351; Lucena-Silva N, 2012, TISSUE ANTIGENS, V79, P272, DOI 10.1111/j.1399-0039.2012.01842.x; Lucena-Silva N, 2013, J RHEUMATOL; Manaster I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033395; Mendes CT, 2007, TISSUE ANTIGENS, V69, P255, DOI 10.1111/j.1399-0039.2006.00797.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moreau P, 2008, BIOL REPROD, V79, P459, DOI 10.1095/biolreprod.108.068874; Moreau P, 2010, J CELL MOL MED, V14, P2540, DOI 10.1111/j.1582-4934.2010.01198.x; Moreau P, 2009, J CELL MOL MED, V13, P2973, DOI 10.1111/j.1582-4934.2009.00800.x; Nuckel Holger, 2012, Methods Mol Biol, V882, P123, DOI 10.1007/978-1-61779-842-9_7; O'Brien M, 2001, CELL MOL LIFE SCI, V58, P1943, DOI 10.1007/PL00000828; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; Rebmann V, 2001, TISSUE ANTIGENS, V57, P15, DOI 10.1034/j.1399-0039.2001.057001015.x; Rebmann V, 2005, HUM IMMUNOL, V66, P853, DOI 10.1016/j.humimm.2005.05.003; Ristich V, 2005, EUR J IMMUNOL, V35, P1133, DOI 10.1002/eji.200425741; Rizzo R, 2008, TISSUE ANTIGENS, V71, P520, DOI 10.1111/j.1399-0039.2008.01037.x; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P5249, DOI 10.1073/pnas.94.10.5249; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Silva ID, 2013, HUM IMMUNOL, V74, P452, DOI 10.1016/j.humimm.2012.11.025; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187; Yie SM, 2008, MOL HUM REPROD, V14, P649, DOI 10.1093/molehr/gan059; Zhu XM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.002	53	102	105	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e71742	10.1371/journal.pone.0071742	http://dx.doi.org/10.1371/journal.pone.0071742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204558	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400002
J	Wang, W; Luo, J; Hou, PP; Yang, YM; Xiao, F; Ming, YC; Qu, AL; Wang, LY; Ding, JP				Wang, Wei; Luo, Jie; Hou, Panpan; Yang, Yimei; Xiao, Feng; Ming Yuchi; Qu, Anlian; Wang, Luyang; Ding, Jiuping			Native Gating Behavior of Ion Channels in Neurons with Null-Deviation Modeling	PLOS ONE			English	Article							KINETICS; CLAMP	Computational modeling has emerged as an indispensable approach to resolve and predict the intricate interplay among the many ion channels underlying neuronal excitability. However, simulation results using the classic formula-based Hodgkin-Huxley (H-H) model or the superior Markov kinetic model of ion channels often deviate significantly from native cellular signals despite using carefully measured parameters. Here we found that the filters of patch-clamp amplifier not only delayed the signals, but also introduced ringing, and that the residual series resistance in experiments altered the command voltages, which had never been fully eliminated by improving the amplifier itself. To remove all the above errors, a virtual device with the parameters exactly same to that of amplifier was introduced into Markov kinetic modeling so as to establish a null-deviation model. We demonstrate that our novel null-deviation approach fully restores the native gating-kinetics of ion-channels with the data recorded at any condition, and predicts spike waveform and firing patterns clearly distinctive from those without correction.	[Wang, Wei; Luo, Jie; Hou, Panpan; Qu, Anlian; Ding, Jiuping] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Luo, Jie] Sun Yat Sen Univ, Sch Engn, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Yimei; Wang, Luyang] Univ Toronto, Program Neurosci & Mental Hlth, SickKids Res Inst, Toronto, ON, Canada; [Yang, Yimei; Wang, Luyang] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Xiao, Feng; Ming Yuchi] Huazhong Univ Sci & Technol, Key Lab Image Proc & Intelligent Control, Coll Life Sci & Technol, Minist Educ,Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Sun Yat Sen University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Huazhong University of Science & Technology	Wang, LY (corresponding author), Univ Toronto, Program Neurosci & Mental Hlth, SickKids Res Inst, Toronto, ON, Canada.	luyang.wang@utoronto.ca; jpding@mail.hust.edu.cn	Yuchi, Ming/AHB-9595-2022; Hou, Panpan/Q-2941-2019	Yuchi, Ming/0000-0003-1506-0631; Yang, Yi-Mei/0000-0003-1491-8106; Hou, Panpan/0000-0001-7694-2262	National Basic Research Program of China [2010CB529804]; National Science Foundation of China [30971179, 31170814, 31028006]; Canadian Institutes of Health Research; China-Canada Joint Health Research Initiative Grant; Canada Research Chair	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); China-Canada Joint Health Research Initiative Grant; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by grants from the National Basic Research Program of China (2010CB529804), the National Science Foundation of China (30971179, 31170814, 31028006) (to JPD), and by individual Operating Grants from the Canadian Institutes of Health Research, China-Canada Joint Health Research Initiative Grant and Canada Research Chair (to LYW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brette R, 2008, NEURON, V59, P379, DOI 10.1016/j.neuron.2008.06.021; Gillis KD, 2000, PFLUG ARCH EUR J PHY, V439, P655, DOI 10.1007/s004240050990; Gurkiewicz M, 2007, PLOS COMPUT BIOL, V3, P1633, DOI 10.1371/journal.pcbi.0030169; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Milescu LS, 2005, BIOPHYS J, V88, P2494, DOI 10.1529/biophysj.104.053256; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Qin F, 2000, BIOPHYS J, V79, P1928, DOI 10.1016/S0006-3495(00)76442-3; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; Sun L, 2009, BIOPHYS J, V97, P1832, DOI 10.1016/j.bpj.2009.06.042; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035208	10	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77105	10.1371/journal.pone.0077105	http://dx.doi.org/10.1371/journal.pone.0077105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204745	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400028
J	Li, Z; Zhou, ZG; Huang, G; Hu, F; Xiang, YF; He, LN				Li, Zhen; Zhou, Zhiguang; Huang, Gan; Hu, Fang; Xiang, Yufei; He, Lining			Exendin-4 Protects Mitochondria from Reactive Oxygen Species Induced Apoptosis in Pancreatic Beta Cells	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; INDEPENDENT PHOSPHOLIPASE A(2); FREE FATTY-ACIDS; OXIDATIVE STRESS; EXENATIDE EXENDIN-4; GLYCEMIC CONTROL; CARDIOLIPIN; DEGRADATION; INHIBITION; METFORMIN	Objective: Mitochondrial oxidative stress is the basis for pancreatic beta-cell apoptosis and a common pathway for numerous types of damage, including glucotoxicity and lipotoxicity. We cultivated mice pancreatic beta-cell tumor Min6 cell lines in vitro and observed pancreatic beta-cell apoptosis and changes in mitochondrial function before and after the addition of Exendin-4. Based on these observations, we discuss the protective role of Exendin-4 against mitochondrial oxidative damage and its relationship with Ca2+-independent phospholipase A2. Methods: We established a pancreatic beta-cell oxidative stress damage model using Min6 cell lines cultured in vitro with tert-buty1 hydroperoxide and hydrogen peroxide. We then added Exendin-4 to observe changes in the rate of cell apoptosis (Annexin-V-FITC-PI staining flow cytometry and DNA ladder). We detected the activity of the caspase 3 and 8 apoptotic factors, measured the mitochondrial membrane potential losses and reactive oxygen species production levels, and detected the expression of cytochrome c and Smac/DLAMO in the cytosol and mitochondria, mitochondrial Ca-2-independent phospholipase A2 and Ca2+-independent phospholipase A2 mRNA. Results: The time-concentration curve showed that different percentages of apoptosis occurred at different time-concentrations in tert-buty1 hydroperoxide- and hydrogen peroxide-induced Min6 cells. Incubation with 100 mmol/l of Exendin-4 for 48 hours reduced the Min6 cell apoptosis rate (p<0.05). The mitochondrial membrane potential loss and total reactive oxygen species levels decreased (p<0.05), and the release of cytochrome c and Smac/DLAMO from the mitochondria was reduced. The study also showed that Ca2+-independent phospholipase A2 activity was positively related to Exendin-4 activity. Conclusion: Exendin-4 reduces Min6 cell oxidative damage and the cell apoptosis rate, which may be related to Ca-2-independent phospholipase A2.	[Zhou, Zhiguang] Cent S Univ, Ctr Diabet, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; Cent S Univ, Inst Metab & Endocrinol, Key Lab Diabet Immunol, Minist Educ, Changsha, Hunan, Peoples R China	Central South University; Central South University	Zhou, ZG (corresponding author), Cent S Univ, Ctr Diabet, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	zhouzg@hotmail.com		Zhou, Zhiguang/0000-0002-0374-1838	National Natural Science Foundation of China [81170725, 81070672, 81000316, 30831160518]; Science and Technology Department of Hunan Province of China [2010SK2007]; Hunan Provincial Natural Science Foundation of China [11JJ7005]; National Department Public Benefit (Health) Research Foundation of China [201002002]; Jiangsu Hengrui Pharmaceutical Joint Stock Co.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Hunan Province of China; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); National Department Public Benefit (Health) Research Foundation of China; Jiangsu Hengrui Pharmaceutical Joint Stock Co.	This study was financial supported by the National Natural Science Foundation of China (Grant No. 81170725, 81070672, 81000316). Web site: http://www.nsfc.gov.cn/; the International Cooperation and Exchange of the National Natural Science Foundation of China (Grant No. 30831160518). Web site: http://www.nsfc.gov.cn/; the Key Project of Science and Technology Department of Hunan Province of China (2010SK2007); Hunan Provincial Natural Science Foundation of China(11JJ7005); the National Department Public Benefit (Health) Research Foundation of China(Grant No. 201002002). Web site: http://www.hnst.gov.cn/. This work was also supported by Jiangsu Hengrui Pharmaceutical Joint Stock Co. grants the trial medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Department of Diabetes Center, 2nd Xiangya Hospital specifically disclaims responsibility for any analyses, interpretations, or conclusions.	Bulotta A, 2002, J MOL ENDOCRINOL, V29, P347, DOI 10.1677/jme.0.0290347; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen JQ, 2006, BIOCHEM BIOPH RES CO, V346, P1067, DOI 10.1016/j.bbrc.2006.06.027; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Copley K, 2006, CURR DRUG METAB, V7, P367, DOI 10.2174/138920006776873490; Creutzfeldt WOC, 1996, DIABETES CARE, V19, P580, DOI 10.2337/diacare.19.6.580; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003; Li YH, 2005, DIABETES, V54, P482, DOI 10.2337/diabetes.54.2.482; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Ma Z, 2001, J BIOL CHEM, V276; Mileykovskaya E, 2005, BIOCHEMISTRY-MOSCOW+, V70, P154, DOI 10.1007/s10541-005-0095-2; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Monami M, 2009, EUR J ENDOCRINOL, V160, P909, DOI 10.1530/EJE-09-0101; Orrenius S, 2004, TOXICOL LETT, V149, P19, DOI 10.1016/j.toxlet.2003.12.017; Piro S, 2002, METABOLISM, V51, P1340, DOI 10.1053/meta.2002.35200; Ritzel RA, 2006, DIABETES CARE, V29, P717, DOI 10.2337/diacare.29.03.06.dc05-1538; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; SCHLAME M, 1990, BIOCHEM J, V272, P589, DOI 10.1042/bj2720589; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Song K, 2005, MOL ENDOCRINOL, V19, P504, DOI 10.1210/me.2004-0169; WANG YH, 1995, ENDOCRINOLOGY, V136, P4910, DOI 10.1210/en.136.11.4910; Widlansky ME, 2010, TRANSL RES, V156, P15, DOI 10.1016/j.trsl.2010.04.001; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4; Wiswedel I, 2010, FREE RADICAL RES, V44, P135, DOI 10.3109/10715760903352841; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016	34	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76172	10.1371/journal.pone.0076172	http://dx.doi.org/10.1371/journal.pone.0076172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204601	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300003
J	Sprayberry, JDH; Ritter, KA; Riffell, JA				Sprayberry, Jordanna D. H.; Ritter, Kaitlin A.; Riffell, Jeffrey A.			The Effect of Olfactory Exposure to Non-Insecticidal Agrochemicals on Bumblebee Foraging Behavior	PLOS ONE			English	Article							HONEY-BEE; CONSERVATION; GROWTH; FUNGICIDES; MECHANISM; EVOLUTION; COLONIES; DECLINE	Declines in bumblebee populations have led to investigations into potential causes - including agrochemical effects on bumblebee physiology. The indirect effects of agrochemicals (i.e. behavior modulation) have been postulated, but rarely directly tested. Olfactory information is critical in mediating bumblebee-floral interactions. As agrochemicals emit volatiles, they may indirectly modify foraging behavior. We tested the effects of olfactory contamination of floral odor by agrochemical scent on foraging activity of Bombus impatiens using two behavioral paradigms: localization of food within a maze and forced-choice preference. The presence of a fungicide decreased bumblebees' ability to locate food within a maze. Additionally, bumblebees preferred to forage in non-contaminated feeding chambers when offered a choice between control and either fertilizer- or fungicide-scented chambers.	[Sprayberry, Jordanna D. H.; Ritter, Kaitlin A.] Muhlenberg Coll, Dept Biol, Allentown, PA 18104 USA; [Riffell, Jeffrey A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Sprayberry, JDH (corresponding author), Muhlenberg Coll, Dept Biol, Allentown, PA 18104 USA.	jsprayberry@muhlenberg.edu	Sprayberry, Jordanna/AAY-2501-2021	Sprayberry, Jordanna/0000-0002-6974-5735	Muhlenberg College; University of Washington; National Science Foundation [IOS 1120200]	Muhlenberg College; University of Washington(University of Washington); National Science Foundation(National Science Foundation (NSF))	Funding for this project came from Muhlenberg College start-up funds (to JDHS), University of Washington's Royalty Research Fund, and National Science Foundation grants IOS 1120200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani L, 2004, PESTIC BIOCHEM PHYS, V80, P163, DOI 10.1016/j.pestbp.2004.07.004; [Anonymous], 1971, INSECT SOC; Bhattacharya M, 2003, BIOL CONSERV, V109, P37, DOI 10.1016/S0006-3207(02)00130-1; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Farooqui T, 2013, NEUROCHEM INT, V62, P122, DOI 10.1016/j.neuint.2012.09.020; Fernandez PC, 2009, J NEUROSCI, V29, P10191, DOI 10.1523/JNEUROSCI.1874-09.2009; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goyret J, 2006, J EXP BIOL, V209, P1585, DOI 10.1242/jeb.02169; Hegland SJ, 2008, OIKOS, V117, P883, DOI [10.1111/j.0030-1299.2008.16561.x, 10.1111/j.2008.0030-1299.16561.x]; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johansen NS, 2007, COMP BIOCHEM PHYS C, V145, P473, DOI 10.1016/j.cbpc.2007.02.004; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kulahci IG, 2008, P R SOC B, V275, P797, DOI 10.1098/rspb.2007.1176; Leonard AS, 2011, J EXP BIOL, V214, P113, DOI 10.1242/jeb.047407; Lynn SK, 2005, EVOLUTION, V59, P1300, DOI 10.1111/j.0014-3820.2005.tb01780.x; McFrederick QS, 2008, ATMOS ENVIRON, V42, P2336, DOI 10.1016/j.atmosenv.2007.12.033; MULLER CB, 1992, ECOL ENTOMOL, V17, P343, DOI 10.1111/j.1365-2311.1992.tb01068.x; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; OWEN RE, 1980, BEHAV ECOL SOCIOBIOL, V7, P287, DOI 10.1007/BF00300669; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Shiotsuki T, 2004, J PESTIC SCI, V29, P121, DOI 10.1584/jpestics.29.121; SNYDER GK, 1995, J THEOR BIOL, V172, P199, DOI 10.1006/jtbi.1995.0016; Spaethe J, 2003, J EXP BIOL, V206, P3447, DOI 10.1242/jeb.00570; Spaethe J, 2006, VISUAL SEARCH DECISI; Spaethe J, 2007, NATURWISSENSCHAFTEN, V94, P733, DOI 10.1007/s00114-007-0251-1; Strube-Bloss MF, 2011, J NEUROSCI, V31, P3129, DOI 10.1523/JNEUROSCI.2583-10.2011; Suzuki K, 2007, PLANT SPEC BIOL, V22, P141, DOI 10.1111/j.1442-1984.2007.00187.x; Theis N, 2006, J CHEM ECOL, V32, P917, DOI 10.1007/s10886-006-9051-x; Vandame R, 1998, NEUROSCI LETT, V251, P57, DOI 10.1016/S0304-3940(98)00494-7; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Yuan JS, 2009, TRENDS ECOL EVOL, V24, P323, DOI 10.1016/j.tree.2009.01.012	37	11	13	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76273	10.1371/journal.pone.0076273	http://dx.doi.org/10.1371/journal.pone.0076273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204608	Green Submitted, gold, Green Published			2022-12-27	WOS:000326152300004
J	Akk, G; Eaton, M; Li, P; Zheng, S; Lo, J; Steinbach, JH				Akk, Gustav; Eaton, Megan; Li, Ping; Zheng, Steven; Lo, Joshua; Steinbach, Joe Henry			Energetic Contributions to Channel Gating of Residues in the Muscle Nicotinic Receptor beta 1 Subunit	PLOS ONE			English	Article							TRANSMEMBRANE DOMAIN INTERFACE; CYS-LOOP RECEPTORS; ACETYLCHOLINE-RECEPTOR; AGONIST BINDING; GABA(A) RECEPTORS; EXTRACELLULAR DOMAIN; PHARMACOLOGY; SUPERFAMILY; SENSITIVITY; ACTIVATION	In the pentameric ligand-gated ion channel family, transmitter binds in the extracellular domain and conformational changes result in channel opening in the transmembrane domain. In the muscle nicotinic receptor and other heteromeric members of the family one subunit does not contribute to the canonical agonist binding site for transmitter. A fundamental question is whether conformational changes occur in this subunit. We used records of single channel activity and rate-equilibrium free energy relationships to examine the beta 1 (non-ACh-binding) subunit of the muscle nicotinic receptor. Mutations to residues in the extracellular domain have minimal effects on the gating equilibrium constant. Positions in the channel lining (M2 transmembrane) domain contribute strongly and relatively late during gating. Positions thought to be important in other subunits in coupling the transmitter-binding to the channel domains have minimal effects on gating. We conclude that the conformational changes involved in channel gating propagate from the binding-site to the channel in the ACh-binding subunits and subsequently spread to the non-binding subunit.	[Steinbach, Joe Henry] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Steinbach, JH (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	jhs@morpheus.wustl.edu	Akk, Gustav/CAG-1703-2022		National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R21NS72770, R01NS22356]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022356, R21NS072770] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award numbers R21NS72770 and R01NS22356. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk G, 2005, J NEUROSCI, V25, P1992, DOI 10.1523/JNEUROSCI.4985-04.2005; Akk G, 2004, J PHYSIOL-LONDON, V556, P387, DOI 10.1113/jphysiol.2003.058230; Akk G, 2002, J PHYSIOL-LONDON, V544, P695, DOI 10.1113/jphysiol.2002.029413; Andersen N, 2011, J NEUROSCI, V31, P3662, DOI 10.1523/JNEUROSCI.5940-10.2011; Auerbach A, 2007, J GEN PHYSIOL, V130, P543, DOI 10.1085/jgp.200709898; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bondarenko V, 2012, BBA-BIOMEMBRANES, V1818, P1261, DOI 10.1016/j.bbamem.2012.02.008; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Bruhova I, 2010, J BIOL CHEM, V285, P38898, DOI 10.1074/jbc.M110.169110; Chang YC, 1999, BIOPHYS J, V77, P2542, DOI 10.1016/S0006-3495(99)77089-X; Colquhoun D, 2005, BIOPHYS J, V89, P3673, DOI 10.1529/biophysj.105.071563; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; Dent JA, 2006, J MOL EVOL, V62, P523, DOI 10.1007/s00239-005-0018-2; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hogg RC, 2003, J BIOL CHEM, V278, P26908, DOI 10.1074/jbc.M212628200; Jha A, 2012, J PHYSIOL-LONDON, V590, P119, DOI 10.1113/jphysiol.2011.213892; Jha A, 2009, BIOPHYS J, V96, P4075, DOI 10.1016/j.bpj.2009.02.030; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lape R, 2009, J PHYSIOL-LONDON, V587, P5045, DOI 10.1113/jphysiol.2009.176305; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Mitra A, 2005, P NATL ACAD SCI USA, V102, P15069, DOI 10.1073/pnas.0505090102; Mnatsakanyan N, 2013, J NEUROCHEM, DOI [10.1111/jnc.12260, DOI 10.1111/JNC.12260.PUBMED:23565737]; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mukhtasimova N, 2013, BIOPHYS J, V104, P355, DOI 10.1016/j.bpj.2012.12.013; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Purohit P, 2007, J GEN PHYSIOL, V130, P559, DOI 10.1085/jgp.200709857; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Shen XM, 2003, J CLIN INVEST, V111, P497, DOI 10.1172/JC1200316997; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; Sine SM, 2012, PHYSIOL REV, V92, P1189, DOI 10.1152/physrev.00015.2011; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215	45	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78539	10.1371/journal.pone.0078539	http://dx.doi.org/10.1371/journal.pone.0078539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194945	Green Published, gold			2022-12-27	WOS:000326037000124
J	Hedlund, G; Eriksson, H; Sundstedt, A; Forsberg, G; Jakobsen, BK; Pumphrey, N; Rodstrom, K; Lindkvist-Petersson, K; Bjork, P				Hedlund, Gunnar; Eriksson, Helena; Sundstedt, Anette; Forsberg, Goran; Jakobsen, Bent K.; Pumphrey, Nicholas; Rodstrom, Karin; Lindkvist-Petersson, Karin; Bjork, Per			The Tumor Targeted Superantigen ABR-217620 Selectively Engages TRBV7-9 and Exploits TCR-pMHC Affinity Mimicry in Mediating T Cell Cytotoxicity	PLOS ONE			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; RECEPTOR BETA-CHAIN; CLASS-II; NAPTUMOMAB ESTAFENATOX; MONOCLONAL-ANTIBODY; ANTIGEN RECEPTOR; METASTATIC MELANOMA; ESCHERICHIA-COLI; CANCER-THERAPY; IN-VIVO	The T lymphocytes are the most important effector cells in immunotherapy of cancer. The conceptual objective for developing the tumor targeted superantigen (TTS) ABR-217620 (naptumomab estafenatox, 5T4Fab-SEA/E-120), now in phase 3 studies for advanced renal cell cancer, was to selectively coat tumor cells with cytotoxic T lymphocytes (CTL) target structures functionally similar to natural CTL pMHC target molecules. Here we present data showing that the molecular basis for the anti-tumor activity by ABR-217620 resides in the distinct interaction between the T cell receptor beta variable (TRBV) 7-9 and the engineered superantigen (Sag) SEA/E-120 in the fusion protein bound to the 5T4 antigen on tumor cells. Multimeric but not monomeric ABR-217620 selectively stains TRBV7-9 expressing T lymphocytes from human peripheral blood similar to antigen specific staining of T cells with pMHC tetramers. SEA/E-120 selectively activates TRBV7-9 expressing T lymphocytes resulting in expansion of the subset. ABR-217620 selectively triggers TRBV7-9 expressing cytotoxic T lymphocytes to kill 5T4 positive tumor cells. Furthermore, ABR-217620 activates TRBV7-9 expressing T cell line cells in the presence of cell-and bead-bound 5T4 tumor antigen. Surface plasmon resonance analysis revealed that ABR-217620 binds to 5T4 with high affinity, to TRBV7-9 with low affinity and to MHC class II with very low affinity. The T lymphocyte engagement by ABR-217620 is constituted by displaying high affinity binding to the tumor cells (K-D approximately 1 nM) and with the mimicry of natural productive immune TCR-pMHC contact using affinities of around 1 mu M. This difference in kinetics between the two components of the ABR-217620 fusion protein will bias the binding towards the 5T4 target antigen, efficiently activating T-cells via SEA/E-120 only when presented by the tumor cells.	[Hedlund, Gunnar; Eriksson, Helena; Sundstedt, Anette; Forsberg, Goran; Bjork, Per] Act Biotech AB, Lund, Sweden; [Rodstrom, Karin; Lindkvist-Petersson, Karin] Lund Univ, Lund, Sweden	Lund University	Hedlund, G (corresponding author), Act Biotech AB, Lund, Sweden.	gunnar.hedlund@activebiotech.com		Rodstrom, Karin/0000-0002-2952-0400; Lindkvist, Karin/0000-0002-5209-3160				Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Andersen PS, 2001, J BIOL CHEM, V276, P33452, DOI 10.1074/jbc.M103750200; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI [10.1107/S0907444994003112., DOI 10.1107/S0907444994003112.PUBMED:15299374]; Antonsson P, 1997, J IMMUNOL, V158, P4245; Arad G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001149; Arden Bernhard, 1995, Immunogenetics, V42, P455; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; BJORK P, 1993, J BIOL CHEM, V268, P24232; Borghaei H, 2009, J CLIN ONCOL, V27, P4116, DOI 10.1200/JCO.2008.20.2515; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Cavallin A, 2000, J BIOL CHEM, V275, P1665, DOI 10.1074/jbc.275.3.1665; Cheng JD, 2004, J CLIN ONCOL, V22, P602, DOI 10.1200/JCO.2004.12.034; Cho HI, 2009, CANCER RES, V69, P9012, DOI 10.1158/0008-5472.CAN-09-2019; DOHLSTEN M, 1991, IMMUNOL TODAY, V12, P147, DOI 10.1016/0167-5699(91)90078-8; DOHLSTEN M, 1995, P NATL ACAD SCI USA, V92, P9791, DOI 10.1073/pnas.92.21.9791; DOHLSTEN M, 1991, P NATL ACAD SCI USA, V88, P9287, DOI 10.1073/pnas.88.20.9287; DOHLSTEN M, 1994, P NATL ACAD SCI USA, V91, P8945, DOI 10.1073/pnas.91.19.8945; DOHLSTEN M, 1990, IMMUNOLOGY, V71, P96; DOHLSTEN M, 1993, INT J CANCER, V54, P482, DOI 10.1002/ijc.2910540321; Dreier T, 2002, INT J CANCER, V100, P690, DOI 10.1002/ijc.10557; Dudley ME, 2010, CLIN CANCER RES, V16, P6122, DOI 10.1158/1078-0432.CCR-10-1297; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Erlandsson E, 2003, J MOL BIOL, V333, P893, DOI 10.1016/j.jmb.2003.09.009; Forsberg G, 1997, J BIOL CHEM, V272, P12430, DOI 10.1074/jbc.272.19.12430; Forsberg G, 2001, BRIT J CANCER, V85, P129, DOI 10.1054/bjoc.2001.1891; Forsberg G, 2010, J IMMUNOTHER, V33, P492, DOI 10.1097/CJI.0b013e3181d75820; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; Govern CC, 2010, P NATL ACAD SCI USA, V107, P8724, DOI 10.1073/pnas.1000966107; Guillet M, 2002, J IMMUNOL, V168, P5088, DOI 10.4049/jimmunol.168.10.5088; HEDLUND G, 1990, CELL IMMUNOL, V129, P426, DOI 10.1016/0008-8749(90)90218-G; IRWIN MJ, 1992, NATURE, V359, P841, DOI 10.1038/359841a0; JANEWAY CA, 1989, IMMUNOL REV, V107, P61, DOI 10.1111/j.1600-065X.1989.tb00003.x; Kammertoens T, 2009, EUR J IMMUNOL, V39, P2345, DOI 10.1002/eji.200939612; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; LANDO PA, 1995, INT J CANCER, V62, P466, DOI 10.1002/ijc.2910620418; Leder L, 1998, J EXP MED, V187, P823, DOI 10.1084/jem.187.6.823; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; Petersson K, 2002, STRUCTURE, V10, P1619, DOI 10.1016/S0969-2126(02)00895-X; Petersson K, 2004, SCAND J IMMUNOL, V59, P345, DOI 10.1111/j.0300-9475.2004.01404.x; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Robinson MK, 2010, EXPERT OPIN BIOL TH, V10, P273, DOI 10.1517/14712590903575620; Rosendahl A, 2000, METH MOL B, V145, P241; Saline M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1117; Sarikonda G, 2008, J IMMUNOL, V181, P7738, DOI 10.4049/jimmunol.181.11.7738; Shaw DM, 2007, BRIT J CANCER, V96, P567, DOI 10.1038/sj.bjc.6603567; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; Sykulev Y, 1995, P NATL ACAD SCI USA, V92, P11990, DOI 10.1073/pnas.92.26.11990; Thauland TJ, 2010, IMMUNOLOGY, V131, P466, DOI 10.1111/j.1365-2567.2010.03366.x; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; Wooldridge L, 2009, IMMUNOLOGY, V126, P147, DOI 10.1111/j.1365-2567.2008.02848.x; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099	57	16	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e79082	10.1371/journal.pone.0079082	http://dx.doi.org/10.1371/journal.pone.0079082			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194959	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000138
J	Liu, Y; He, XQ; Huang, X; Ding, L; Xu, L; Shen, YT; Zhang, F; Zhu, MB; Xu, BH; Qi, ZQ; Wang, HL				Liu, Yu; He, Xiao-Qin; Huang, Xin; Ding, Lu; Xu, Lin; Shen, Yu-Ting; Zhang, Fei; Zhu, Mao-Bi; Xu, Bai-Hui; Qi, Zhong-Quan; Wang, Hai-Long			Resveratrol Protects Mouse Oocytes from Methylglyoxal-Induced Oxidative Damage	PLOS ONE			English	Article							DNA-DAMAGE; PARTHENOGENETIC ACTIVATION; CHROMOSOME SEGREGATION; MAMMALIAN OOCYTES; INDUCED APOPTOSIS; CARBONYL STRESS; LDL OXIDATION; IN-VITRO; ANTIOXIDANT; CHECKPOINT	Methylglyoxal, a reactive dicarbonyl compound, is mainly formed from glycolysis. Methylglyoxal can lead to the dysfunction of mitochondria, the depletion of cellular anti-oxidation enzymes and the formation of advanced glycation ends. Previous studies showed that the accumulation of methylglyoxal and advanced glycation ends can impair the oocyte maturation and reduce the oocyte quality in aged and diabetic females. In this study, we showed that resveratrol, a kind of phytoalexin found in the skin of grapes, red wine and other botanical extracts, can alleviate the adverse effects caused by methylglyoxal, such as inhibition of oocyte maturation and disruption of spindle assembly. Besides, methylglyoxal-treated oocytes displayed more DNA double strands breaks and this can also be decreased by treatment of resveratrol. Further investigation of these processes revealed that methylglyoxal may affect the oocyte quality by resulting in excessive reactive oxygen species production, aberrant mitochondrial distribution and high level lipid peroxidation, and resveratrol can block these cytotoxic changes. Collectively, our results showed that resveratrol can protect the oocytes from methylglyoxal-induced cytotoxicity and this was mainly through the correction of the abnormity of cellular reactive oxygen species metabolism.	[Liu, Yu; Huang, Xin; Xu, Lin; Zhu, Mao-Bi; Xu, Bai-Hui; Qi, Zhong-Quan; Wang, Hai-Long] Xiamen Univ, Coll Med, Organ Transplantat Inst, Xiamen, Fujian Province, Peoples R China; [He, Xiao-Qin; Shen, Yu-Ting; Zhang, Fei] Xiamen Univ, Dept Obstet & Gynaecol, Zhongshan Hosp, Xiamen, Fujian Province, Peoples R China; [Ding, Lu] Xiamen Matern & Child Hlth Care Hosp, Ctr Reprod Med, Xiamen, Fujian Province, Peoples R China	Xiamen University; Xiamen University	Qi, ZQ (corresponding author), Xiamen Univ, Coll Med, Organ Transplantat Inst, Xiamen, Fujian Province, Peoples R China.	oti@xmu.edu.cn; hailongwang@xmu.edu.cn	Ding, Lu/ABF-8526-2020	Ding, Lu/0000-0001-8087-2738; Qi, Zhongquan/0000-0002-7210-4955	National Natural Science Foundation of China [31201695]; Major State Scientific Research Program of China [2012CBA01303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Scientific Research Program of China	This work was supported by grants from the National Natural Science Foundation of China (No. 31201695) and Major State Scientific Research Program of China (No. 2012CBA01303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2004, REPROD BIOMED ONLINE, V9, P338, DOI 10.1016/S1472-6483(10)62151-7; Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chang YJ, 2010, TOXICOL LETT, V193, P217, DOI 10.1016/j.toxlet.2010.01.007; Chun YJ, 1999, BIOCHEM BIOPH RES CO, V262, P20, DOI 10.1006/bbrc.1999.1152; De Salvia R, 2002, TOXICOL LETT, V135, P1, DOI 10.1016/S0378-4274(02)00151-0; Degen J, 2012, J AGR FOOD CHEM, V60, P7071, DOI 10.1021/jf301306g; Desai Kaushik, 2007, Recent Pat Cardiovasc Drug Discov, V2, P89; Ding L, 2012, THERIOGENOLOGY, V78, P784, DOI 10.1016/j.theriogenology.2012.03.026; Du J, 2001, FREE RADICAL BIO MED, V31, P469, DOI 10.1016/S0891-5849(01)00611-6; FRANKEL EN, 1993, LANCET, V341, P1103, DOI 10.1016/0140-6736(93)92472-6; Fremont L, 1999, LIFE SCI, V64, P2511, DOI 10.1016/S0024-3205(99)00209-X; Fujii EY, 2010, FERTIL STERIL, V94, P694, DOI 10.1016/j.fertnstert.2009.03.029; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang F. J., 2011, ENV TOXICOL, DOI 10.1002/tox.20734; Huang X, 2011, MICROSC MICROANAL, V17, P197, DOI 10.1017/S1431927610094456; Huang X, 2013, HISTOCHEM CELL BIOL, V139, P525, DOI 10.1007/s00418-012-1051-z; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Kang JH, 2003, TOXICOL LETT, V145, P181, DOI 10.1016/S0378-4274(03)00305-9; Kilhovd BK, 2003, METABOLISM, V52, P163, DOI 10.1053/meta.2003.50035; Kwak SS, 2012, THERIOGENOLOGY, V78, P86, DOI 10.1016/j.theriogenology.2012.01.024; Lankin V. Z., 2012, Biomeditsinskaya Khimiya, V58, P727; Lee K, 2010, J REPROD DEVELOP, V56, P330, DOI 10.1262/jrd.09-174K; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Liu MY, 2013, HUM REPROD, V28, P707, DOI 10.1093/humrep/des437; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; McKeegan PJ, 2012, REPROD FERT DEVELOP, V24, P59, DOI 10.1071/RD11907; MCLELLAN AC, 1994, CLIN SCI, V87, P21, DOI 10.1042/cs0870021; Nagai S, 2006, TOHOKU J EXP MED, V210, P137, DOI 10.1620/tjem.210.137; Nakayama K, 2009, J TOXICOL SCI, V34, P699, DOI 10.2131/jts.34.699; Okado A, 1996, BIOCHEM BIOPH RES CO, V225, P219, DOI 10.1006/bbrc.1996.1157; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Reynier P, 2001, MOL HUM REPROD, V7, P425, DOI 10.1093/molehr/7.5.425; Sareen D, 2007, MOL PHARMACOL, V72, P1466, DOI 10.1124/mol.107.039040; Schon E A, 2000, Hum Reprod, V15 Suppl 2, P160; Sobinoff AP, 2012, TOXICOL APPL PHARM, V260, P70, DOI 10.1016/j.taap.2012.01.028; Sobinoff AP, 2010, TOXICOL SCI, V118, P653, DOI 10.1093/toxsci/kfq272; Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005; Tarin JJ, 2002, THERIOGENOLOGY, V57, P869, DOI 10.1016/S0093-691X(01)00687-2; Tarin JJ, 1996, MOL HUM REPROD, V2, P717, DOI 10.1093/molehr/2.10.717; Tatone C, 2011, HUM REPROD, V26, P1843, DOI 10.1093/humrep/der140; THORNALLEY P, 1984, BIOCHIM BIOPHYS ACTA, V797, P276, DOI 10.1016/0304-4165(84)90131-4; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vogt E, 2008, MUTAT RES-GEN TOX EN, V651, P14, DOI 10.1016/j.mrgentox.2007.10.015; Wei L, 2010, CELL CYCLE, V9, P1112, DOI 10.4161/cc.9.6.10957; Wu HJ, 2007, TOXICOL IN VITRO, V21, P335, DOI 10.1016/j.tiv.2006.09.002	50	44	47	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77960	10.1371/journal.pone.0077960	http://dx.doi.org/10.1371/journal.pone.0077960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194906	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000085
J	Voura, EB; English, JL; Yu, HYE; Ho, AT; Subarsky, P; Hill, RP; Hojilla, CV; Khokha, R				Voura, Evelyn B.; English, Jane L.; Yu, Hoi-Ying E.; Ho, Andrew T.; Subarsky, Patrick; Hill, Richard P.; Hojilla, Carlo V.; Khokha, Rama			Proteolysis during Tumor Cell Extravasation In Vitro: Metalloproteinase Involvement across Tumor Cell Types	PLOS ONE			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; HUMAN GELATINASE-A; TRANSENDOTHELIAL MIGRATION; EXTRACELLULAR-MATRIX; TISSUE INHIBITOR; MELANOMA-CELLS; IV COLLAGENASE; ACTIVATION; MECHANISM; VESICLES	To test if proteolysis is involved in tumor cell extravasation, we developed an in vitro model where tumor cells cross an endothelial monolayer cultured on a basement membrane. Using this model we classified the ability of the cells to transmigrate through the endothelial cell barrier onto the underlying matrix, and scored this invasion according to the stage of passage through the endothelium. Metalloproteinase inhibitors reduced tumor cell extravasation by at least 35%. Visualization of protease and cell adhesion molecules by confocal microscopy demonstrated the cell surface localization of MMP-2, MMP-9, MT1-MMP, furin, CD44 and alpha(v)beta(3), during the process of transendothelial migration. By the addition of inhibitors and bio-modulators we assessed the functional requirement of the aforementioned molecules for efficient migration. Proteolytic digestion occurred at the cell-matrix interface and was most evident during the migratory stage. All of the inhibitors and biomodulators affected the transition of the tumor cells into the migratory stage, highlighting the most prevalent use of proteolysis at this particular step of tumor cell extravasation. These data suggest that a proteolytic interface operates at the tumor cell surface within the tumor-endothelial cell microenvironment.	[Voura, Evelyn B.; English, Jane L.; Yu, Hoi-Ying E.; Ho, Andrew T.; Subarsky, Patrick; Hill, Richard P.; Hojilla, Carlo V.; Khokha, Rama] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Voura, Evelyn B.] Dominican Coll Blauvelt, Dept Biol, Orangeburg, NY 10962 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Khokha, R (corresponding author), Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada.	rkhokha@uhnres.utoronto.ca	Ho, Andrew Tri Van/D-9681-2019	Ho, Andrew Tri Van/0000-0002-5501-6419; Khokha, Rama/0000-0002-6028-1524; Hill, Richard Peter/0000-0001-5331-8045	U.S. Army [DAMD17-01-1-0433]; NSERC	U.S. Army; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	U.S. Army: DAMD17-01-1-0433 (http://mrmc.amedd.army.mil/index.cfm) and NSERC Post Doctoral Fellowship: E.B. Voura (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1990, CANCER RES, V50, P6757; ANGLIKER H, 1993, BIOCHEM J, V293, P75, DOI 10.1042/bj2930075; Basbaum CB, 1996, CURR OPIN CELL BIOL, V8, P731, DOI 10.1016/S0955-0674(96)80116-5; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Casimiro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063153; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Desai B, 2009, J CELL BIOCHEM, V108, P272, DOI 10.1002/jcb.22248; Desch A, 2012, AM J PATHOL, V181, P693, DOI 10.1016/j.ajpath.2012.04.012; Dolo V, 1998, CANCER RES, V58, P4468; DOLO V, 1994, J SUBMICR CYTOL PATH, V26, P173; Dolo V, 1999, CLIN EXP METASTAS, V17, P131, DOI 10.1023/A:1006500406240; DOLO V, 1995, CLIN EXP METASTAS, V13, P277, DOI 10.1007/BF00133483; Dufour A, 2013, TRENDS PHARMACOL SCI, V34, P233, DOI 10.1016/j.tips.2013.02.004; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ellerbroek SM, 1999, BIOESSAYS, V21, P940, DOI 10.1002/(SICI)1521-1878(199911)21:11<940::AID-BIES6>3.3.CO;2-A; Fang XJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-290; Ginestra A, 1997, J BIOL CHEM, V272, P17216, DOI 10.1074/jbc.272.27.17216; Gioia M, 2009, J MOL BIOL, V386, P419, DOI 10.1016/j.jmb.2008.12.021; Golubkov VS, 2011, J BIOL CHEM, V286, P34215, DOI 10.1074/jbc.M111.264036; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hofmann UB, 2000, J INVEST DERMATOL, V115, P337, DOI 10.1046/j.1523-1747.2000.00068.x; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Ivaska J, 2000, CELL MOL LIFE SCI, V57, P16, DOI 10.1007/s000180050496; JIAO Y, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0041591; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kargozaran H, 2007, CLIN EXP METASTAS, V24, P495, DOI 10.1007/s10585-007-9086-6; Kasaoka T, 2008, CLIN EXP METASTAS, V25, P827, DOI 10.1007/s10585-008-9198-7; KOOP S, 1994, CANCER RES, V54, P4791; Kruger A, 1997, BLOOD, V90, P1993, DOI 10.1182/blood.V90.5.1993; Kruger A, 1998, ONCOGENE, V16, P2419, DOI 10.1038/sj.onc.1201774; Kurschat P, 1999, J BIOL CHEM, V274, P21056, DOI 10.1074/jbc.274.30.21056; Legrand C, 1999, J CELL BIOL, V146, P517, DOI 10.1083/jcb.146.2.517; Leroy-Dudal J, 2005, INT J CANCER, V114, P531, DOI 10.1002/ijc.20778; Maquoi E, 1998, FEBS LETT, V424, P262, DOI 10.1016/S0014-5793(98)00187-2; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Overall CM, 1999, J BIOL CHEM, V274, P4421, DOI 10.1074/jbc.274.7.4421; Overall CM, 2000, J BIOL CHEM, V275, P39497, DOI 10.1074/jbc.M005932200; PFAFF M, 1994, J BIOL CHEM, V269, P20233; POSTE G, 1980, P NATL ACAD SCI-BIOL, V77, P399, DOI 10.1073/pnas.77.1.399; RAMOSDESIMONE N, 1993, HYBRIDOMA, V12, P349, DOI 10.1089/hyb.1993.12.349; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Remacle AG, 2006, ONCOGENE, V25, P5648, DOI 10.1038/sj.onc.1209572; Rodrigues-Ferreira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035667; Rozanov DV, 2003, J BIOL CHEM, V278, P8257, DOI 10.1074/jbc.M213246200; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Rupp PA, 2008, MOL BIOL CELL, V19, P5529, DOI 10.1091/mbc.E07-05-0480; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sandig M, 1997, CELL MOTIL CYTOSKEL, V38, P351, DOI 10.1002/(SICI)1097-0169(1997)38:4<351::AID-CM5>3.3.CO;2-Z; Sato T, 1999, J BIOL CHEM, V274, P37280, DOI 10.1074/jbc.274.52.37280; Steffensen B, 1998, J BIOL CHEM, V273, P20622, DOI 10.1074/jbc.273.32.20622; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; THOMAS L, 1992, J CELL BIOL, V118, P971, DOI 10.1083/jcb.118.4.971; Voura EB, 1998, MICROSC RES TECHNIQ, V43, P265, DOI 10.1002/(SICI)1097-0029(19981101)43:3<265::AID-JEMT9>3.0.CO;2-Z; Voura EB, 2001, MOL BIOL CELL, V12, P2699, DOI 10.1091/mbc.12.9.2699; Voura EB, 2001, CLIN EXP METASTAS, V18, P527, DOI 10.1023/A:1011884807746; Voura EB, 1998, CELL TISSUE RES, V293, P375, DOI 10.1007/s004410051129; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu Q, 2000, GENE DEV, V14, P163	68	31	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78413	10.1371/journal.pone.0078413	http://dx.doi.org/10.1371/journal.pone.0078413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194929	gold, Green Submitted, Green Published			2022-12-27	WOS:000326037000108
J	Yamaguchi, M; Terao, Y; Mori-Yamaguchi, Y; Domon, H; Sakaue, Y; Yagi, T; Nishino, K; Yamaguchi, A; Nizet, V; Kawabata, S				Yamaguchi, Masaya; Terao, Yutaka; Mori-Yamaguchi, Yuka; Domon, Hisanori; Sakaue, Yuuki; Yagi, Tetsuya; Nishino, Kunihiko; Yamaguchi, Akihito; Nizet, Victor; Kawabata, Shigetada			Streptococcus pneumoniae Invades Erythrocytes and Utilizes Them to Evade Human Innate Immunity	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; HOST-PATHOGEN INTERACTIONS; STAPHYLOCOCCUS-AUREUS; CONJUGATE VACCINE; VIRULENCE FACTORS; OXIDATIVE STRESS; LIPID RAFTS; STRAIN R6; IRON; PNEUMOLYSIN	Streptococcus pneumoniae, a Gram-positive bacterium, is a major cause of invasive infection-related diseases such as pneumonia and sepsis. In blood, erythrocytes are considered to be an important factor for bacterial growth, as they contain abundant nutrients. However, the relationship between S. pneumoniae and erythrocytes remains unclear. We analyzed interactions between S. pneumoniae and erythrocytes, and found that iron ion present in human erythrocytes supported the growth of Staphylococcus aureus, another major Gram-positive sepsis pathogen, while it partially inhibited pneumococcal growth by generating free radicals. S. pneumoniae cells incubated with human erythrocytes or blood were subjected to scanning electron and confocal fluorescence microscopic analyses, which showed that the bacterial cells adhered to and invaded human erythrocytes. In addition, S. pneumoniae cells were found associated with human erythrocytes in cultures of blood from patients with an invasive pneumococcal infection. Erythrocyte invasion assays indicated that LPXTG motif-containing pneumococcal proteins, erythrocyte lipid rafts, and erythrocyte actin remodeling are all involved in the invasion mechanism. In a neutrophil killing assay, the viability of S. pneumoniae co-incubated with erythrocytes was higher than that without erythrocytes. Also, H2O2 killing of S. pneumoniae was nearly completely ineffective in the presence of erythrocytes. These results indicate that even when S. pneumoniae organisms are partially killed by iron ion-induced free radicals, they can still invade erythrocytes. Furthermore, in the presence of erythrocytes, S. pneumoniae can more effectively evade antibiotics, neutrophil phagocytosis, and H2O2 killing.	[Yamaguchi, Masaya; Nishino, Kunihiko; Yamaguchi, Akihito] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Osaka, Japan; [Yamaguchi, Masaya; Terao, Yutaka; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka, Japan; [Yamaguchi, Masaya; Mori-Yamaguchi, Yuka; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Terao, Yutaka; Domon, Hisanori; Sakaue, Yuuki] Niigata Univ, Grad Sch Med & Dent Sci, Div Microbiol & Infect Dis, Chuo Ku, Niigata, Japan; [Yagi, Tetsuya] Nagoya Univ Hosp, Ctr Natl Univ Hosp Infect Control, Nagoya, Aichi, Japan	Osaka University; Osaka University; University of California System; University of California San Diego; Niigata University; Nagoya University	Terao, Y (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka, Japan.	terao@dent.niigata-u.ac.jp	Yamaguchi, Masaya/I-8156-2019; Yagi, Tetsuya/J-3303-2012; Domon, Hisa/ADQ-4045-2022; Nizet, Victor/AAF-3190-2019	Yamaguchi, Masaya/0000-0001-6218-7112; Nizet, Victor/0000-0003-3847-0422; Terao, Yutaka/0000-0002-4450-5583	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS); JSPS; Grants-in-Aid for Scientific Research [24659812, 23592700] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, as well as Grants-in-Aid for Scientific Research (B), Young Scientists (A), and Challenging Exploratory Research from the Japan Society for the Promotion of Science (JSPS) and a Fellowship from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Doherty CP, 2007, J NUTR, V137, P1341, DOI 10.1093/jn/137.5.1341; EGGLETON P, 1989, J IMMUNOL METHODS, V121, P105, DOI 10.1016/0022-1759(89)90425-0; Fallarino F, 2004, J EXP MED, V200, P1051, DOI 10.1084/jem.20040942; Farrell DJ, 2007, PEDIATR INFECT DIS J, V26, P123, DOI 10.1097/01.inf.0000253059.84602.c3; GARVEY EP, 1994, J BIOL CHEM, V269, P26669; Gertz RE, 2010, J INFECT DIS, V201, P770, DOI 10.1086/650496; Groebel K, 2009, INFECT IMMUN, V77, P576, DOI 10.1128/IAI.00773-08; Hament JM, 2003, EUR J CLIN INVEST, V33, P169, DOI 10.1046/j.1365-2362.2002.01109.x; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Hirst RA, 2002, INFECT IMMUN, V70, P1017, DOI 10.1128/IAI.70.2.1017-1022.2002; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Iliev AI, 2007, P NATL ACAD SCI USA, V104, P2897, DOI 10.1073/pnas.0608213104; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Li J, 2010, INFECT IMMUN, V78, P3129, DOI 10.1128/IAI.01263-09; Lofling J, 2011, CELL MICROBIOL, V13, P186, DOI 10.1111/j.1462-5822.2010.01560.x; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marriott HM, 2008, CURR MOL MED, V8, P497, DOI 10.2174/156652408785747924; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Mori Y, 2012, J BIOL CHEM, V287, P10472, DOI 10.1074/jbc.M111.280321; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ong CLY, 2013, INFECT IMMUN, V81, P421, DOI 10.1128/IAI.00805-12; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Polizzotto MN, 2008, TRANSFUSION, V48, P1520, DOI 10.1111/j.1537-2995.2008.01764.x; Price KE, 2009, J BACTERIOL, V191, P2163, DOI 10.1128/JB.01489-08; Pucheu S, 1996, CARDIOVASC DRUG THER, V10, P331, DOI 10.1007/BF02627957; Regev-Yochay G, 2007, J BACTERIOL, V189, P6532, DOI 10.1128/JB.00813-07; Regev-Yochay G, 2006, J BACTERIOL, V188, P4996, DOI 10.1128/JB.00317-06; REITER RJ, 1995, J PINEAL RES, V18, P1, DOI 10.1111/j.1600-079X.1995.tb00133.x; Rohde M, 2003, CELL MICROBIOL, V5, P323, DOI 10.1046/j.1462-5822.2003.00279.x; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Tas SW, 1999, J IMMUNOL, V163, P5056; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; Urban CF, 2006, CELL MICROBIOL, V8, P1687, DOI 10.1111/j.1462-5822.2006.00792.x; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Vieira FS, 2010, BIOL CELL, V102, P391, DOI 10.1042/BC20090138; Vogl G, 2008, INFECT IMMUN, V76, P71, DOI 10.1128/IAI.00871-07; Yamaguchi M, 2013, CELL MICROBIOL, V15, P503, DOI 10.1111/cmi.12083; Yamaguchi M, 2009, BIOCHEM BIOPH RES CO, V390, P155, DOI 10.1016/j.bbrc.2009.09.099; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	51	22	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77282	10.1371/journal.pone.0077282	http://dx.doi.org/10.1371/journal.pone.0077282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194877	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000056
J	Jankowski, J; Paus, S; Scheef, L; Bewersdorff, M; Schild, HH; Klockgether, T; Boecker, H				Jankowski, Jakob; Paus, Sebastian; Scheef, Lukas; Bewersdorff, Malte; Schild, Hans H.; Klockgether, Thomas; Boecker, Henning			Abnormal Movement Preparation in Task-Specific Focal Hand Dystonia	PLOS ONE			English	Article							CONTINGENT NEGATIVE-VARIATION; PRIMARY SOMATOSENSORY CORTEX; SUPPLEMENTARY MOTOR AREA; CEREBRAL-BLOOD-FLOW; EVENT-RELATED FMRI; WRITERS CRAMP; BASAL GANGLIA; SENSORIMOTOR INTEGRATION; CERVICAL DYSTONIA; IMPAIRED INHIBITION	Electrophysiological and behavioral studies in primary dystonia suggest abnormalities during movement preparation, but this crucial phase preceding movement onset has not yet been studied specifically with functional magnetic resonance imaging (fMRI). To identify abnormalities in brain activation during movement preparation, we used event-related fMRI to analyze behaviorally unimpaired sequential finger movements in 18 patients with task-specific focal hand dystonia (FHD) and 18 healthy subjects. Patients and controls executed self-initiated or externally cued prelearnt four-digit sequential movements using either right or left hands. In FHD patients, motor performance of the sequential finger task was not associated with task-related dystonic posturing and their activation levels during motor execution were highly comparable with controls. On the other hand reduced activation was observed during movement preparation in the FHD patients in left premotor cortex / precentral gyrus for all conditions, and for self-initiation additionally in supplementary motor area, left mid-insula and anterior putamen, independent of effector side. Findings argue for abnormalities of early stages of motor control in FHD, manifesting during movement preparation. Since deficits map to regions involved in the coding of motor programs, we propose that task-specific dystonia is characterized by abnormalities during recruitment of motor programs: these do not manifest at the behavioral level during simple automated movements, however, errors in motor programs of complex movements established by extensive practice (a core feature of FHD), trigger the inappropriate movement patterns observed in task-specific dystonia.	[Jankowski, Jakob; Scheef, Lukas; Bewersdorff, Malte; Boecker, Henning] Univ Bonn, Radiol Univ Klin, FE Funkt Neurobildgebung, Bonn, Germany; [Paus, Sebastian; Klockgether, Thomas] Univ Bonn, Neurol Univ Klin, Bonn, Germany; [Schild, Hans H.] Univ Bonn, Radiol Univ Klin, Bonn, Germany; [Klockgether, Thomas] German Ctr Neurodegenerat Dis, Bonn, Germany	University of Bonn; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Boecker, H (corresponding author), Univ Bonn, Radiol Univ Klin, FE Funkt Neurobildgebung, Bonn, Germany.	henning.boecker@ukb.uni-bonn.de	Boecker, Henning/N-7172-2019	Boecker, Henning/0000-0003-2346-0598				Abbruzzese G, 2003, MOVEMENT DISORD, V18, P231, DOI 10.1002/mds.10327; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Beck S, 2008, J NEUROSCI, V28, P10363, DOI 10.1523/JNEUROSCI.3564-08.2008; Berardelli A, 1998, BRAIN, V121, P1195, DOI 10.1093/brain/121.7.1195; Blood AJ, 2004, ANN NEUROL, V55, P744, DOI 10.1002/ana.20108; Blood Anne J, 2008, Biosci Hypotheses, V1, P14, DOI 10.1016/j.bihy.2008.01.006; Boecker H, 2008, NEUROIMAGE, V39, P1356, DOI 10.1016/j.neuroimage.2007.09.069; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Byl NN, 1996, NEUROLOGY, V47, P508, DOI 10.1212/WNL.47.2.508; Castrop F, 2012, MOVEMENT DISORD, V27, P1432, DOI 10.1002/mds.24944; CeballosBaumann AO, 1997, BRAIN, V120, P571, DOI 10.1093/brain/120.4.571; Chen R, 1997, NEUROLOGY, V49, P1054, DOI 10.1212/WNL.49.4.1054; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P395, DOI 10.1007/s00429-010-0270-0; Cunnington R, 2005, HUM MOVEMENT SCI, V24, P644, DOI 10.1016/j.humov.2005.10.001; Cunnington R, 2003, NEUROIMAGE, V20, P404, DOI 10.1016/S1053-8119(03)00291-X; Cuny E, 2008, NEUROBIOL DIS, V30, P151, DOI 10.1016/j.nbd.2007.12.011; Curra A, 2000, MOVEMENT DISORD, V15, P103, DOI 10.1002/1531-8257(200001)15:1<103::AID-MDS1016>3.0.CO;2-3; de Vries PM, 2008, CLIN NEUROL NEUROSUR, V110, P120, DOI 10.1016/j.clineuro.2007.09.020; Delmaire C, 2005, NEUROLOGY, V64, P1391, DOI 10.1212/01.WNL.0000158424.01299.76; Delnooz CC, 2011, HUM BRAIN MAPP, P613; Deuschl G, 1995, ANN NEUROL, V38, P862, DOI 10.1002/ana.410380606; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ekstrom A, 2010, BRAIN RES REV, V62, P233, DOI 10.1016/j.brainresrev.2009.12.004; Elsinger CL, 2006, NEUROIMAGE, V31, P1177, DOI 10.1016/j.neuroimage.2006.01.041; Fahn S., 1989, QUANTIFICATION NEURO, P241; Filipovic Sasa R, 2004, Adv Neurol, V94, P191; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Guehl D, 2009, PROG NEUROBIOL, V87, P118, DOI 10.1016/j.pneurobio.2008.10.003; Hallett M, 2000, BRAIN, V123, P1765, DOI 10.1093/brain/123.9.1765; Hallett M, 2011, NEUROBIOL DIS, V42, P177, DOI 10.1016/j.nbd.2010.08.025; Hamano T, 1999, CLIN NEUROPHYSIOL, V110, P508, DOI 10.1016/S1388-2457(98)00045-5; Havrankova P, 2012, CLIN NEUROPHYSIOL, V123, P755, DOI 10.1016/j.clinph.2011.08.002; Horenstein C, 2009, HUM BRAIN MAPP, V30, P1397, DOI 10.1002/hbm.20610; Hu XY, 2006, CHINESE MED J-PEKING, V119, P1263, DOI 10.1097/00029330-200608010-00006; Hummel F, 2002, BRAIN, V125, P404, DOI 10.1093/brain/awf030; Ibanez V, 1999, NEUROLOGY, V53, P96, DOI 10.1212/WNL.53.1.96; Ikeda A, 1996, MOVEMENT DISORD, V11, P683, DOI 10.1002/mds.870110614; Islam T, 2009, NEUROL SCI, V30, P219, DOI 10.1007/s10072-009-0045-7; Jahanshahi M, 2001, EXP BRAIN RES, V140, P460, DOI 10.1007/s002210100847; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P177, DOI 10.1016/S0926-6410(00)00028-8; Jankowski J, 2009, NEUROIMAGE, V44, P1369, DOI 10.1016/j.neuroimage.2008.10.059; Kaji R, 1995, ANN NEUROL, V38, P837, DOI 10.1002/ana.410380603; KAJI R, 1995, BRAIN, V118, P511, DOI 10.1093/brain/118.2.511; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lerner A, 2004, NEUROIMAGE, V21, P904, DOI 10.1016/j.neuroimage.2003.10.019; Lim Vanessa K, 2004, Adv Neurol, V94, P267; Lin PT, 2009, J HAND THER, V22, P109, DOI 10.1016/j.jht.2008.10.008; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Manoach DS, 2000, BIOL PSYCHIAT, V48, P99, DOI 10.1016/S0006-3223(00)00227-4; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Meunier S, 2012, EUR J NEUROSCI, V35, P975, DOI 10.1111/j.1460-9568.2012.08034.x; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Monfils MH, 2005, NEUROSCIENTIST, V11, P471, DOI 10.1177/1073858405278015; Murase N, 2000, BRAIN, V123, P1813, DOI 10.1093/brain/123.9.1813; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nelson AJ, 2009, ANN NEUROL, V66, P146, DOI 10.1002/ana.21626; Neychev VK, 2011, NEUROBIOL DIS, V42, P185, DOI 10.1016/j.nbd.2011.01.026; Odergren T, 1998, MOVEMENT DISORD, V13, P497, DOI 10.1002/mds.870130321; Pantano P, 2011, AM J NEURORADIOL, V32, P81, DOI 10.3174/ajnr.A2242; Peller M, 2006, BRAIN, V129, P2697, DOI 10.1093/brain/awl181; Peterson DA, 2010, NEUROBIOL DIS, V37, P558, DOI 10.1016/j.nbd.2009.12.003; Pujol J, 2000, NEUROIMAGE, V12, P257, DOI 10.1006/nimg.2000.0615; Quartarone A, 2011, NEUROBIOL DIS, V42, P162, DOI 10.1016/j.nbd.2010.12.011; Quartarone A, 2009, BRAIN STIMUL, V2, P108, DOI 10.1016/j.brs.2008.09.010; Reiner A, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00142; Rijntjes M, 1999, J NEUROSCI, V19, P8043; Rosenkranz K, 2005, BRAIN, V128, P918, DOI 10.1093/brain/awh402; Rosenkranz K, 2007, J NEUROSCI, V27, P5200, DOI 10.1523/JNEUROSCI.0836-07.2007; Ruiz MH, 2009, HUM BRAIN MAPP, V30, P2689, DOI 10.1002/hbm.20700; SHEEHY MP, 1982, BRAIN, V105, P461, DOI 10.1093/brain/105.3.461; Shin HW, 2012, EXP BRAIN RES, V219, P403, DOI 10.1007/s00221-012-3102-z; Summers JJ, 2009, HUM MOVEMENT SCI, V28, P566, DOI 10.1016/j.humov.2009.01.002; Tanabe LM, 2009, NAT REV NEUROL, V5, P598, DOI 10.1038/nrneurol.2009.160; Tecchio F, 2008, NEUROSCIENCE, V154, P563, DOI 10.1016/j.neuroscience.2008.03.045; Theorin A, 2007, NEUROIMAGE, V36, pT2, DOI 10.1016/j.neuroimage.2007.03.042; Thomsen K, 2004, J PHYSIOL-LONDON, V560, P181, DOI 10.1113/jphysiol.2004.068072; Toma Keiichiro, 2002, Magn Reson Med Sci, V1, P109, DOI 10.2463/mrms.1.109; Toro C, 2000, ANN NEUROL, V47, P456, DOI 10.1002/1531-8249(200004)47:4<456::AID-ANA8>3.3.CO;2-H; Torres-Russotto D, 2008, ANN NY ACAD SCI, V1142, P179, DOI 10.1196/annals.1444.012; VANDERKAMP W, 1995, MOVEMENT DISORD, V10, P630, DOI 10.1002/mds.870100516; Vidailhet M, 2009, CURR OPIN NEUROL, V22, P406, DOI 10.1097/WCO.0b013e32832d9ef3; Wu CC, 2010, J NEUROL NEUROSUR PS, V81, P659, DOI 10.1136/jnnp.2009.185637; Yazawa S, 1999, BRAIN, V122, P1357, DOI 10.1093/brain/122.7.1357; Zoons E, 2011, NEUROIMAGE	88	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78234	10.1371/journal.pone.0078234	http://dx.doi.org/10.1371/journal.pone.0078234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167610	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500071
J	Jung, DY; Chalasani, U; Pan, N; Friedline, RH; Prosdocimo, DA; Nam, M; Azuma, Y; Maganti, R; Yu, K; Velagapudi, A; O'Sullivan-Murphy, B; Sartoretto, JL; Jain, MK; Cooper, MP; Urano, F; Kim, JK; Gray, S				Jung, Dae Young; Chalasani, UmaDevi; Pan, Ning; Friedline, Randall H.; Prosdocimo, Domenick A.; Nam, Minwoo; Azuma, Yoshihiro; Maganti, Rajanikanth; Yu, Kristine; Velagapudi, Ashish; O'Sullivan-Murphy, Bryan; Sartoretto, Juliano L.; Jain, Mukesh K.; Cooper, Marcus P.; Urano, Fumihiko; Kim, Jason K.; Gray, Susan			KLF15 Is a Molecular Link between Endoplasmic Reticulum Stress and Insulin Resistance	PLOS ONE			English	Article							ER STRESS; SKELETAL-MUSCLE; GENE-EXPRESSION; AUTOPHAGY; ACTIVATION; OBESITY; MTOR; KINASE; ATF6; CELL	Obesity places major demands on the protein folding capacity of the endoplasmic reticulum (ER), resulting in ER stress, a condition that promotes hepatic insulin resistance and steatosis. Here we identify the transcription factor, Kruppel-like factor 15 (KLF15), as an essential mediator of ER stress-induced insulin resistance in the liver. Mice with a targeted deletion of KLF15 exhibit increased hepatic ER stress, inflammation, and JNK activation compared to WT mice; however, KLF15(-/-) mice are protected against hepatic insulin resistance and fatty liver under high-fat feeding conditions and in response to pharmacological induction of ER stress. The mammalian target of rapamycin complex 1 (mTORC1), a key regulator of cellular energy homeostasis, has been shown to cooperate with ER stress signaling pathways to promote hepatic insulin resistance and lipid accumulation. We find that the uncoupling of ER stress and insulin resistance in KLF15(-/-) liver is associated with the maintenance of a low energy state characterized by decreased mTORC1 activity, increased AMPK phosphorylation and PGC-1 alpha expression and activation of autophagy, an intracellular degradation process that enhances hepatic insulin sensitivity. Furthermore, in primary hepatocytes, KLF15 deficiency markedly inhibits activation of mTORC1 by amino acids and insulin, suggesting a mechanism by which KLF15 controls mTORC1-mediated insulin resistance. This study establishes KLF15 as an important molecular link between ER stress and insulin action.	[Jung, Dae Young; Chalasani, UmaDevi; Friedline, Randall H.; Azuma, Yoshihiro; Maganti, Rajanikanth; Yu, Kristine; Velagapudi, Ashish; Sartoretto, Juliano L.; Kim, Jason K.; Gray, Susan] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Div Endocrinol Metab & Diabet, Worcester, MA USA; [Nam, Minwoo; Cooper, Marcus P.] Univ Massachusetts, Sch Med, Div Cardiovasc Med, Worcester, MA USA; [Pan, Ning; O'Sullivan-Murphy, Bryan; Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Urano, Fumihiko] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Prosdocimo, Domenick A.; Jain, Mukesh K.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Sartoretto, Juliano L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Washington University (WUSTL); Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gray, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	Susan.Gray@umassmed.edu	Urano, Fumihiko/AAF-4492-2020	O'Sullivan-Murphy, Bryan/0000-0002-1426-5013; Kim, Jason/0000-0002-7185-042X	National Institutes of Health [DK080742, DK080756, DK090963, DK067493, DK016746, P60 DK020579, RR024992, UL1 TR000448, DK089185, HL072952, HL084154, T32HL105338, F32HL110538]; JDRF [11-2011-40]; National Center for Research Resources [S10RR027897]; UMass Mouse Metabolic Phenotyping Center (NIH) [U24-DK093000]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027897, UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL110538, R01HL072952, T32HL105338, R01HL084154, R01HL112486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK093000, R24DK090963, R01DK080742, R01DK016746, R37DK016746, R01DK089185, R01DK080756, P30DK020579, P60DK020579, R01DK067493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UMass Mouse Metabolic Phenotyping Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK080742 to S. G., DK080756 and DK090963 to J.K.K., DK067493, DK016746, P60 DK020579, RR024992, and UL1 TR000448 to F. U., DK089185 to M. P. C., HL072952 and HL084154 to M.K.J., T32HL105338 and F32HL110538 to D. A. P. and by JDRF grant (11-2011-40) to F. U. Electron microscopy was performed at the Core Electron Microscopy Facility at UMass Medical School with support from the National Center for Research Resources (Award #S10RR027897). Part of this study was conducted by the UMass Mouse Metabolic Phenotyping Center (NIH Award #U24-DK093000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Brey CW, 2009, INT J BIOL SCI, V5, P622; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Flamment M, 2010, CURR OPIN LIPIDOL, V21, P239, DOI 10.1097/MOL.0b013e3283395e5c; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Haldar SM, 2012, P NATL ACAD SCI USA, V109, P6739, DOI 10.1073/pnas.1121060109; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Jeyaraj D, 2012, CELL METAB, V15, P311, DOI 10.1016/j.cmet.2012.01.020; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003; Takashima M, 2010, DIABETES, V59, P1608, DOI 10.2337/db09-1679; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	59	30	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77851	10.1371/journal.pone.0077851	http://dx.doi.org/10.1371/journal.pone.0077851			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167585	Green Published, gold			2022-12-27	WOS:000326034500044
J	Rellstab, C; Karvonen, A; Louhi, KR; Jokela, J				Rellstab, Christian; Karvonen, Anssi; Louhi, Katja-Riikka; Jokela, Jukka			Genotype-Specific vs. Cross-Reactive Host Immunity against a Macroparasite	PLOS ONE			English	Article							COMPLEX LIFE-CYCLE; DIPLOSTOMUM-SPATHACEUM; PROTECTIVE IMMUNITY; EYE FLUKES; ONCORHYNCHUS-MYKISS; GENETIC DIVERSITY; SPATIAL VARIATION; RAINBOW-TROUT; TRADE-OFFS; RED QUEEN	Vertebrate hosts often defend themselves against several co-infecting parasite genotypes simultaneously. This has important implications for the ecological dynamics and the evolution of host defence systems and parasite strategies. For example, it can drive the specificity of the adaptive immune system towards high genotype-specificity or cross-reactivity against several parasite genotypes depending on the sequence and probability of re-infections. However, to date, there is very little evidence on these interactions outside mammalian disease literature. In this study we asked whether genotype-specific or cross-reactive responses dominate in the adaptive immune system of a fish host towards a common macroparasite. In other words, we investigated if the infection success of a parasite genotype is influenced by the immunization genotype. We reciprocally immunized and re-exposed rainbow trout (Oncorhynchus mykiss) to a range of genotypes of the trematode eye fluke Diplostomum pseudospathaceum, and measured infection success of the parasite. We found that the infection success of the parasite genotypes in the re-exposure did not depend on the immunization genotype. While immunization reduced average infection success by 31%, the reduction was not larger against the initial immunization genotype. Our results suggest significant cross-reactivity, which may be advantageous for the host in genetically diverse re-exposures and have significant evolutionary implications for parasite strategies. Overall, our study is among the first to demonstrate cross-reactivity of adaptive immunity against genetically diverse macroparasites with complex life cycles.	[Rellstab, Christian; Karvonen, Anssi; Louhi, Katja-Riikka] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Rellstab, Christian] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Jokela, Jukka] Eawag Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland; [Jokela, Jukka] ETH, Inst Integrat Biol, Zurich, Switzerland	University of Jyvaskyla; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Jokela, J (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland.	jukka.jokela@eawag.ch	Rellstab, Christian/D-6460-2012	Rellstab, Christian/0000-0002-0221-5975; Jokela, Jukka/0000-0002-1731-727X; Karvonen, Anssi/0000-0002-2731-3344	Academy of Finland's Centre of Excellence in Evolutionary Research	Academy of Finland's Centre of Excellence in Evolutionary Research(Academy of Finland)	The study was funded by the Academy of Finland's Centre of Excellence in Evolutionary Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran S, 2011, J EVOLUTION BIOL, V24, P554, DOI 10.1111/j.1420-9101.2010.02190.x; Byers JE, 2008, ECOLOGY, V89, P439, DOI 10.1890/06-1036.1; Chappell L.H., 1994, P59; Criscione CD, 2004, EVOLUTION, V58, P198, DOI 10.1111/j.0014-3820.2004.tb01587.x; DUPASQUIER L, 1982, NATURE, V296, P311, DOI 10.1038/296311a0; Eisen DP, 2002, AM J TROP MED HYG, V67, P8, DOI 10.4269/ajtmh.2002.67.8; Faltynkova A, 2008, PARASITOLOGY, V135, P1691, DOI 10.1017/S0031182008005027; Faltynkova A, 2009, PARASITOLOGY, V136, P1375, DOI 10.1017/S0031182009990862; GOYAL PK, 1993, PARASITOLOGY, V107, P311, DOI 10.1017/S0031182000079282; Hamilton W.D., 1982, Life Sciences Research Report, P269; Haolla FA, 2009, VACCINE, V27, P5644, DOI 10.1016/j.vaccine.2009.07.013; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; Jokela J, 2000, OIKOS, V89, P267, DOI 10.1034/j.1600-0706.2000.890207.x; JOKELA J, 1995, OECOLOGIA, V103, P509, DOI 10.1007/BF00328690; Kalbe M, 2006, PARASITOLOGY, V132, P105, DOI 10.1017/S0031182005008681; Karvonen A, 2005, PARASITOL RES, V95, P55, DOI 10.1007/s00436-004-1246-x; Karvonen A, 2004, PARASITOLOGY, V129, P159, DOI 10.1017/S0031182004005505; Karvonen A, 2004, PARASITOLOGY, V129, P87, DOI 10.1017/S0031182004005281; Karvonen A, 2003, PARASITOLOGY, V127, P217, DOI 10.1017/S0031182003003561; Karvonen A, 2010, J FISH BIOL, V76, P1508, DOI 10.1111/j.1095-8649.2010.02597.x; Karvonen A, 2008, AQUACULTURE, V279, P6, DOI 10.1016/j.aquaculture.2008.04.013; Karvonen A, 2012, P ROY SOC B-BIOL SCI, V279, P171, DOI 10.1098/rspb.2011.0879; Karvonen Anssi, 2009, Journal of Animal Ecology, V78, P945, DOI 10.1111/j.1365-2656.2009.01562.x; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Kurtz J, 2004, MICROBES INFECT, V6, P1410, DOI 10.1016/j.micinf.2004.10.002; Lanford RE, 2004, J VIROL, V78, P1575, DOI 10.1128/JVI.78.3.1575-1581.2004; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Lively C. M., 1995, P421, DOI 10.1017/CBO9780511629396.017; LIVELY CM, 1990, NATURE, V344, P864, DOI 10.1038/344864a0; Louhi KR, 2013, J ANIM ECOL, V82, P191, DOI 10.1111/j.1365-2656.2012.02028.x; Louhi KR, 2010, INFECT GENET EVOL, V10, P1271, DOI 10.1016/j.meegid.2010.08.013; Magnadottir B, 2006, FISH SHELLFISH IMMUN, V20, P137, DOI 10.1016/j.fsi.2004.09.006; Magnadottir B, 2010, MAR BIOTECHNOL, V12, P361, DOI 10.1007/s10126-010-9279-x; Wegner KM, 2007, EVOL ECOL, V21, P473, DOI 10.1007/s10682-006-9129-5; Paterson S, 2005, INT J PARASITOL, V35, P1539, DOI 10.1016/j.ijpara.2005.08.007; Paterson S, 2003, P ROY SOC B-BIOL SCI, V270, P1023, DOI 10.1098/rspb.2003.2346; Porrozzi R, 2004, AM J TROP MED HYG, V71, P297, DOI 10.4269/ajtmh.2004.71.297; Raberg L, 2006, AM NAT, V168, P41, DOI 10.1086/505160; Rauch G, 2005, J EVOLUTION BIOL, V18, P1069, DOI 10.1111/j.1420-9101.2005.00895.x; Rauch G, 2006, BIOL LETT-UK, V2, P382, DOI 10.1098/rsbl.2006.0462; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Rellstab C, 2011, INFECT GENET EVOL, V11, P1276, DOI 10.1016/j.meegid.2011.04.018; Reusch TBH, 2004, MOL ECOL NOTES, V4, P577, DOI 10.1111/j.1471-8286.2004.00740.x; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Seppala O, 2005, ANIM BEHAV, V70, P889, DOI 10.1016/j.anbehav.2005.01.020; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; SWEETING RA, 1974, PARASITOLOGY, V69, P291, DOI 10.1017/S0031182000062995; Tamura SI, 2005, JPN J INFECT DIS, V58, P195; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Valtonen ET, 1997, ANN ZOOL FENN, V34, P47; WHYTE SK, 1990, J FISH DIS, V13, P281, DOI 10.1111/j.1365-2761.1990.tb00784.x; Wijayalath WAWK, 2008, PARASITE IMMUNOL, V30, P630, DOI 10.1111/j.1365-3024.2008.01065.x; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; WOOTTEN R, 1974, J HELMINTHOL, V48, P73, DOI 10.1017/S0022149X00022628	55	14	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78427	10.1371/journal.pone.0078427	http://dx.doi.org/10.1371/journal.pone.0078427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167622	gold, Green Published, Green Submitted			2022-12-27	WOS:000326034500083
J	Zhan, H; Gilmour, K; Chan, L; Farzaneh, F; McNicol, AM; Xu, JH; Adams, S; Fehse, B; Veys, P; Thrasher, A; Gaspar, H; Qasim, W				Zhan, Hong; Gilmour, Kimberly; Chan, Lucas; Farzaneh, Farzin; McNicol, Anne Marie; Xu, Jin-Hua; Adams, Stuart; Fehse, Boris; Veys, Paul; Thrasher, Adrian; Gaspar, Hubert; Qasim, Waseem			Production and First-in-Man Use of T Cells Engineered to Express a HSVTK-CD34 Sort-Suicide Gene	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; DONOR LYMPHOCYTES; TRANSDUCTION; DEPLETION; THERAPY	Suicide gene modified donor T cells can improve immune reconstitution after allogeneic haematopoietic stem cell transplantation (SCT), but can be eliminated in the event of graft versus host disease (GVHD) through the administration of prodrug. Here we report the production and first-in-man use of mismatched donor T cells modified with a gamma-retroviral vector expressing a herpes simplex thymidine kinase (HSVTK): truncated CD34 (tCD34) suicide gene/magnetic selection marker protein. A stable packaging cell line was established to produce clinical grade vector pseudotyped with the Gibbon Ape Leukaemia Virus (GALV). T cells were transduced in a closed bag system following activation with anti-CD3/CD28 beads, and enriched on the basis of CD34 expression. Engineered cells were administered in two escalating doses to three children receiving T-depleted, CD34 stem cell selected, mismatched allogeneic grafts. All patients had pre-existing viral infections and received chemotherapy conditioning without serotherapy. In all three subjects cell therapy was tolerated without acute toxicity or the development of acute GVHD. Circulating gene modified T cells were detectable by flow cytometry and by molecular tracking in all three subjects. There was resolution of virus infections, concordant with detectable antigen-specific T cell responses and gene modified cells persisted for over 12 months. These findings highlight the suitability of tCD34 as a GMP compliant selection marker and demonstrate the feasibility, safety and immunological potential of HSVTK-tCD34 suicide gene modified donor T cells.	[Zhan, Hong; Gilmour, Kimberly; McNicol, Anne Marie; Xu, Jin-Hua; Adams, Stuart; Veys, Paul; Thrasher, Adrian; Gaspar, Hubert; Qasim, Waseem] UCL, Inst Child Hlth, Mol Immunol Unit, London, England; [Chan, Lucas; Farzaneh, Farzin] Kings Coll London, Rayne Inst, Dept Haematol Med, London, England; [Fehse, Boris] Univ Hamburg, Bone Marrow Transplant Unit, Hamburg, Germany	University of London; University College London; University of London; King's College London; University of Hamburg	Qasim, W (corresponding author), UCL, Inst Child Hlth, Mol Immunol Unit, London, England.	W.Qasim@ucl.ac.uk	Fehse, Boris/A-8721-2012; Farzaneh, Farzin/B-4902-2009	Fehse, Boris/0000-0001-9780-7211; Farzaneh, Farzin/0000-0002-9275-2415; QASIM, WASEEM/0000-0001-8353-4494	Moulton Trust; Department of Health, UK; Leukaemia and Lymphoma Research; BBSRC [BB/E005896/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E005896/1] Funding Source: researchfish	Moulton Trust; Department of Health, UK; Leukaemia and Lymphoma Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funders: 1. Moulton Trust; trial costs. 2. Department of Health, UK; vector costs. 3. Leukaemia and Lymphoma Research supported WQ through lecturership award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Borchers S, 2011, HUM GENE THER, V22, P829, DOI 10.1089/hum.2010.162; Burt RK, 2003, EXP HEMATOL, V31, P903, DOI 10.1016/S0301-472X(03)00226-1; Ciceri F, 2005, CYTOTHERAPY, V7, P144, DOI 10.1080/14653240510018136; Ciceri F, 2009, LANCET ONCOL; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Fehse B, 2000, MOL THER, V1, P448, DOI 10.1006/mthe.2000.0068; Fehse B, 2004, BLOOD, V104, P3408, DOI 10.1182/blood-2004-07-2813; Fehse B, 2002, GENE THER, V9, P1633, DOI 10.1038/sj.gt.3301828; Hiwarkar P, 2013, BONE MARROW TRANSPL, V48, P803, DOI 10.1038/bmt.2012.221; Ho VT, 2001, BLOOD, V98, P3192, DOI 10.1182/blood.V98.12.3192; Miller AD, 1991, J VIROL, P65; Oevermann L, 2012, ANN NY ACAD SCI, V1266, P161, DOI 10.1111/j.1749-6632.2012.06606.x; Qasim W, 2003, BRIT J HAEMATOL, V123, P712, DOI 10.1046/j.1365-2141.2003.04672.x; Qasim W, 2002, GENE THER, V9, P824, DOI 10.1038/sj.gt.3301690; Qasim W, 2007, MOL THER, V15, P355, DOI 10.1038/sj.mt.6300042; Tiberghien P, 2001, BLOOD, V97, P63, DOI 10.1182/blood.V97.1.63; Traversari C, 2007, BLOOD, V109, P4708, DOI 10.1182/blood-2006-04-015230; Vago L, 2012, BLOOD, V120, P1820, DOI 10.1182/blood-2012-01-405670; Verzeletti S, 1998, HUM GENE THER, V9, P2243, DOI 10.1089/hum.1998.9.15-2243	20	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77106	10.1371/journal.pone.0077106	http://dx.doi.org/10.1371/journal.pone.0077106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204746	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600021
J	Tsai, PH; Lee, HS; Siow, TY; Chang, YC; Chou, MC; Lin, MH; Lin, CY; Chung, HW; Huang, GS				Tsai, Ping-Huei; Lee, Herng-Sheng; Siow, Tiing Yee; Chang, Yue-Cune; Chou, Ming-Chung; Lin, Ming-Huang; Lin, Chien-Yuan; Chung, Hsiao-Wen; Huang, Guo-Shu			Sequential Change in T2*Values of Cartilage, Meniscus, and Subchondral Bone Marrow in a Rat Model of Knee Osteoarthritis	PLOS ONE			English	Article							CRUCIATE LIGAMENT TRANSECTION; HUMAN ARTICULAR-CARTILAGE; 3 T; MENISCECTOMIZED MODELS; RELAXATION-TIMES; WATER-CONTENT; VIVO; T-2; MRI; ASSOCIATION	Background: There is an emerging interest in using magnetic resonance imaging (MRI) T2* measurement for the evaluation of degenerative cartilage in osteoarthritis (OA). However, relatively few studies have addressed OA-related changes in adjacent knee structures. This study used MRI T2* measurement to investigate sequential changes in knee cartilage, meniscus, and subchondral bone marrow in a rat OA model induced by anterior cruciate ligament transection (ACLX). Materials and Methods: Eighteen male Sprague Dawley rats were randomly separated into three groups (n = 6 each group). Group 1 was the normal control group. Groups 2 and 3 received ACLX and sham-ACLX, respectively, of the right knee. T2* values were measured in the knee cartilage, the meniscus, and femoral subchondral bone marrow of all rats at 0, 4, 13, and 18 weeks after surgery. Results: Cartilage T2* values were significantly higher at 4, 13, and 18 weeks postoperatively in rats of the ACLX group than in rats of the control and sham groups (p < 0.001). In the ACLX group (compared to the sham and control groups), T2* values increased significantly first in the posterior horn of the medial meniscus at 4 weeks (p = 0.001), then in the anterior horn of the medial meniscus at 13 weeks (p < 0.001), and began to increase significantly in the femoral subchondral bone marrow at 13 weeks (p = 0.043). Conclusion: Quantitative MR T2* measurements of OA-related tissues are feasible. Sequential change in T2* over time in cartilage, meniscus, and subchondral bone marrow were documented. This information could be potentially useful for in vivo monitoring of disease progression.	[Tsai, Ping-Huei] Taipei Med Univ, Imaging Res Ctr, Taipei, Taiwan; [Tsai, Ping-Huei] Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Lee, Herng-Sheng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Siow, Tiing Yee] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Med Imaging & Intervent, Tao Yuan, Taiwan; [Siow, Tiing Yee; Lin, Ming-Huang; Lin, Chien-Yuan] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chang, Yue-Cune] Tamkang Univ, Dept Math, Taipei, Taiwan; [Chou, Ming-Chung] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Chung, Hsiao-Wen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Huang, Guo-Shu] Triserv Gen Hosp, Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Defense Medical Center; Tri-Service General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Academia Sinica - Taiwan; Tamkang University; Kaohsiung Medical University; National Taiwan University; National Defense Medical Center; Tri-Service General Hospital	Huang, GS (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan.	gsh5@seed.net.tw		Chung, Hsiao-Wen/0000-0001-7127-1244	National Science Council, Taiwan [NSC96-2628-B-016-008-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council (NSC96-2628-B-016-008-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binks DA, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120163; Cha JG, 2012, KOREAN J RADIOL, V13, P332, DOI 10.3348/kjr.2012.13.3.332; Chou MC, 2009, OSTEOARTHR CARTILAGE, V17, P441, DOI 10.1016/j.joca.2008.09.009; Crema MD, 2010, OSTEOARTHR CARTILAGE, V18, P336, DOI 10.1016/j.joca.2009.11.003; Englund M, 2009, ARTHRITIS RHEUM-US, V60, P831, DOI 10.1002/art.24383; Felson DT, 2007, ARTHRITIS RHEUM-US, V56, P2986, DOI 10.1002/art.22851; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; Fragonas E, 1998, OSTEOARTHR CARTILAGE, V6, P24, DOI 10.1053/joca.1997.0089; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Grunder W, 1998, MAGN RESON MED, V39, P376, DOI 10.1002/mrm.1910390307; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Huang GS, 2010, OSTEOARTHR CARTILAGE, V18, P54, DOI 10.1016/j.joca.2009.08.014; Jean YH, 2006, J ORTHOP RES, V24, P1052, DOI 10.1002/jor.20123; Jimenez P. A., 1995, Inflammation Research, V44, pS129, DOI 10.1007/BF01778296; Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011; Libicher M, 2005, EUR RADIOL, V15, P390, DOI 10.1007/s00330-004-2486-y; Link TM, 2007, EUR RADIOL, V17, P1135, DOI 10.1007/s00330-006-0453-5; Lusse S, 2000, MAGN RESON IMAGING, V18, P423, DOI 10.1016/S0730-725X(99)00144-7; Mamisch TC, 2012, SKELETAL RADIOL, V41, P287, DOI 10.1007/s00256-011-1171-x; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; MILLER AJ, 1993, MAGN RESON IMAGING, V11, P1051, DOI 10.1016/0730-725X(93)90225-3; Mlynarik V, 2002, AM J ROENTGENOL, V178, P1287, DOI 10.2214/ajr.178.5.1781287; Mosher TJ, 2004, SEMIN MUSCULOSKEL R, V8, P355, DOI 10.1055/s-2004-861764; Mosher TJ, 2001, AM J ROENTGENOL, V177, P665, DOI 10.2214/ajr.177.3.1770665; Mosher TJ, 2000, RADIOLOGY, V214, P259, DOI 10.1148/radiology.214.1.r00ja15259; Naraoka T, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4181; Newbould RD, 2012, J MAGN RESON IMAGING, V35, P1422, DOI 10.1002/jmri.23598; Nieminen MT, 2001, MAGN RESON MED, V46, P487, DOI 10.1002/mrm.1218; Nieminen MT, 2000, MAGNET RESON MED, V43, P676, DOI 10.1002/(SICI)1522-2594(200005)43:5<676::AID-MRM9>3.0.CO;2-X; Nishioka H, 2012, J MAGN RESON IMAGING, V35, P147, DOI 10.1002/jmri.22811; Nissi MJ, 2004, J ORTHOP RES, V22, P557, DOI 10.1016/j.orthres.2003.09.008; Pelletier JP, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2272; Pickarski M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-197; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Qian YX, 2010, MAGN RESON MED, V64, P1427, DOI 10.1002/mrm.22450; RADIN EL, 1986, CLIN ORTHOP RELAT R, P34; Roemer FW, 2010, OSTEOARTHR CARTILAGE, V18, P47, DOI 10.1016/j.joca.2009.08.018; Shiomi T, 2010, MAGN RESON MED, V64, P707, DOI 10.1002/mrm.22469; Smith GN, 2002, OSTEOARTHR CARTILAGE, V10, P321, DOI 10.1053/joca.2002.0520; Wang YY, 2010, RHEUMATOLOGY, V49, P997, DOI 10.1093/rheumatology/keq034; Wiener E, 2011, ROFO-FORTSCHR RONTG, V183, P226, DOI 10.1055/s-0029-1245739; Williams A, 2012, OSTEOARTHR CARTILAGE, V20, P486, DOI 10.1016/j.joca.2012.01.009; Williams A, 2011, OSTEOARTHR CARTILAGE, V19, P84, DOI 10.1016/j.joca.2010.10.018; Zanetti M, 2000, RADIOLOGY, V215, P835, DOI 10.1148/radiology.215.3.r00jn05835; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	45	17	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76658	10.1371/journal.pone.0076658	http://dx.doi.org/10.1371/journal.pone.0076658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204653	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300041
J	Koskensalo, S; Louhimo, J; Hagstrom, J; Lundin, M; Stenman, UH; Haglund, C				Koskensalo, Selja; Louhimo, Johanna; Hagstrom, Jaana; Lundin, Mikael; Stenman, Ulf-Hakan; Haglund, Caj			Concomitant Tumor Expression of EGFR and TATI/SPINK1 Associates with Better Prognosis in Colorectal Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SECRETORY TRYPSIN-INHIBITOR; RECTAL-CANCER; 1ST-LINE TREATMENT; TISSUE MICROARRAY; PATIENT PROGNOSIS; COLON-CANCER; CETUXIMAB; SURVIVAL; KRAS	Background: Epidermal growth factor receptor (EGFR) activation plays a role in colorectal cancer (CRC) carcinogenesis, and anti-EGFR drugs are used in treatment of advanced CRC. One of the EGFR ligands is tumor-associated trypsinogen inhibitor TATI, also called serine protease inhibitor Kazal type1 (SPINK 1), which we recently showed to be an independent prognostic marker in CRC. Methods: We studied the prognostic value of immunohistochemical expression of EGFR and concomitant expression of EGFR and TATI/SPINK1 in a series of 619 colorectal cancer patients. Results: Of the samples, 92% were positive for EGFR. EGFR+/TATI+ was seen in 62.8%, EGFR+/TATI- in 29.5%, EGFR-/TATI+ in 4.9%, and EGFR-/TATI- in 2.7% of patients. EGFR expression correlated with WHO grade (p = 0.040). In univariate analysis, EGFR expression correlated with favourable survival (p = 0.006). EGFR+/TATI+ patients showed better survival than did those with other combinations (p<0.001). In multivariate analysis, EGFR+/TATI+ was an independent prognostic factor of favourable prognosis (p<0.001). Conclusion: Concomitant positivity of EGFR and TATI/SPINK1 predicts favourable prognosis in CRC.	[Koskensalo, Selja; Louhimo, Johanna; Haglund, Caj] Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland; [Hagstrom, Jaana; Haglund, Caj] Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki, Finland; [Lundin, Mikael] Univ Helsinki, Finnish Inst Mol Med Helsinki, Helsinki, Finland; [Stenman, Ulf-Hakan] Univ Helsinki, Cent Hosp, Dept Clin Chem, Helsinki, Finland; [Haglund, Caj] Univ Helsinki, Res Programs Unit, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Haglund, C (corresponding author), Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland.	caj.haglund@hus.fi	Haglund, Caj/N-1240-2019; Hagström, Jaana/G-1468-2018	Hagström, Jaana/0000-0001-6079-7881; Louhimo, Johanna Marika/0000-0002-6208-978X; Stenman, Ulf-Hakan/0000-0002-2695-3454	Finska Lakaresallskapet; Medicinska Understosforeningen Liv och Halsa; Sigrid Juselius Foundation	Finska Lakaresallskapet; Medicinska Understosforeningen Liv och Halsa; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by Finska Lakaresallskapet, Medicinska Understosforeningen Liv och Halsa and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2011, BRIT J CANCER, V105, P255, DOI 10.1038/bjc.2011.223; Bibeau F, 2006, VIRCHOWS ARCH, V449, P281, DOI 10.1007/s00428-006-0247-9; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Boyle P, 2008, WORLD CANC REPORT; Chang DZ, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-18; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cunningham MP, 2006, INT J ONCOL, V28, P329; DAVIS NC, 1984, DIS COLON RECTUM, V27, P707, DOI 10.1007/BF02554593; Debucquoy A, 2009, INT J COLORECTAL DIS, V24, P129, DOI 10.1007/s00384-008-0608-8; Deng YH, 2009, AM J CLIN ONCOL-CANC, V32, P245, DOI 10.1097/COC.0b013e3181891326; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Eklof V, 2013, BRIT J CANCER, V108, P2153, DOI 10.1038/bjc.2013.212; Febbo PG, 2011, J NATL COMPR CANC NE, V9, pS1, DOI 10.6004/jnccn.2011.0137; Ferlay J., 2004, IARC CANCERBASE; Fernebro E, 2004, INT J CANCER, V111, P921, DOI 10.1002/ijc.20229; Galizia G, 2006, ANN SURG ONCOL, V13, P823, DOI 10.1245/ASO.2006.05.052; Giralt J, 2005, RADIOTHER ONCOL, V74, P101, DOI 10.1016/j.radonc.2004.12.021; Howlader N, 2011, SEER CANC STAT REV 1; Imamura Y, 2012, CLIN CANCER RES, V18, P4753, DOI 10.1158/1078-0432.CCR-11-3210; Koskensalo S, 2012, ONCOLOGY-BASEL, V82, P234, DOI 10.1159/000336080; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; McKay JA, 2002, EUR J CANCER, V38, P2258, DOI 10.1016/S0959-8049(02)00234-4; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Molaei M, 2009, EUR J GASTROEN HEPAT, V21, P289, DOI 10.1097/MEG.0b013e32830b82ba; Ozaki N, 2009, MOL CANCER RES, V7, P1572, DOI 10.1158/1541-7786.MCR-08-0567; Paju A, 2006, CRIT REV CL LAB SCI, V43, P103, DOI 10.1080/10408360500523852; Rego RL, 2010, BRIT J CANCER, V102, P165, DOI 10.1038/sj.bjc.6605473; Resnick MB, 2004, CLIN CANCER RES, V10, P3069, DOI 10.1158/1078-0432.CCR-03-0462; Saif MW, 2010, EXPERT OPIN INV DRUG, V19, P357, DOI 10.1517/13543781003593962; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SCHEVING LA, 1983, ARCH BIOCHEM BIOPHYS, V226, P411, DOI 10.1016/0003-9861(83)90309-0; Spano JP, 2005, ANN ONCOL, V16, P102, DOI 10.1093/annonc/mdi006; Stephen BE BD, 2010, CANC STAGING HDB 3, P173; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Wiksten JP, 2005, HISTOPATHOLOGY, V46, P380, DOI 10.1111/j.1365-2559.2005.02073.x; Yasuda H, 2009, ONCOL REP, V22, P709, DOI 10.3892/or_00000491	37	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76906	10.1371/journal.pone.0076906	http://dx.doi.org/10.1371/journal.pone.0076906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204699	Green Submitted, gold, Green Published			2022-12-27	WOS:000326155400020
J	Li, Y; Shea, SM; Lorenz, CH; Jiang, HY; Chou, MC; Mori, S				Li, Yue; Shea, Steven M.; Lorenz, Christine H.; Jiang, Hangyi; Chou, Ming-Chung; Mori, Susumu			Image Corruption Detection in Diffusion Tensor Imaging for Post-Processing and Real-Time Monitoring	PLOS ONE			English	Article							LOG-EUCLIDEAN METRICS; SINGLE-SHOT EPI; ROBUST ESTIMATION; WEIGHTED EPI; BRAIN; ARTIFACTS; NOISE; TRACKING; RESTORE	Due to the high sensitivity of diffusion tensor imaging (DTI) to physiological motion, clinical DTI scans often suffer a significant amount of artifacts. Tensor-fitting-based, post-processing outlier rejection is often used to reduce the influence of motion artifacts. Although it is an effective approach, when there are multiple corrupted data, this method may no longer correctly identify and reject the corrupted data. In this paper, we introduce a new criterion called "corrected Inter-Slice Intensity Discontinuity" (cISID) to detect motion-induced artifacts. We compared the performance of algorithms using cISID and other existing methods with regard to artifact detection. The experimental results show that the integration of cISID into fitting-based methods significantly improves the retrospective detection performance at post-processing analysis. The performance of the cISID criterion, if used alone, was inferior to the fitting-based methods, but cISID could effectively identify severely corrupted images with a rapid calculation time. In the second part of this paper, an outlier rejection scheme was implemented on a scanner for real-time monitoring of image quality and reacquisition of the corrupted data. The real-time monitoring, based on cISID and followed by post-processing, fitting-based outlier rejection, could provide a robust environment for routine DTI studies.	[Li, Yue; Shea, Steven M.; Lorenz, Christine H.; Jiang, Hangyi; Mori, Susumu] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Li, Yue] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Shea, Steven M.; Lorenz, Christine H.] Siemens Corp Res & Technol, Ctr Appl Med Imaging, Baltimore, MD USA; [Chou, Ming-Chung] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan	Johns Hopkins University; Johns Hopkins University; Siemens AG; Kaohsiung Medical University	Mori, S (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	susumu@mri.jhu.edu	Chou, Mingchung/AAC-3628-2021	Shea, Steven/0000-0002-0360-4884	National Institutes of Health [P41EB015909, RO1AG20012]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants P41EB015909 and RO1AG20012. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON AW, 1994, MAGNET RESON MED, V32, P379, DOI 10.1002/mrm.1910320313; Arsigny V, 2006, MAGN RESON MED, V56, P411, DOI 10.1002/mrm.20965; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Brockstedt S, 1999, ACTA RADIOL, V40, P263, DOI 10.3109/02841859909175552; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chang LC, 2012, MAGN RESON MED, V68, P1654, DOI 10.1002/mrm.24173; Dougherty E, 1994, GRAY SCALE MORPHOLOG, P57; Fillard P, 2007, IEEE T MED IMAGING, V26, P1472, DOI 10.1109/TMI.2007.899173; Gui MZ, 2008, J MAGN RESON IMAGING, V27, P1164, DOI 10.1002/jmri.21335; Habib J, 2008, P 16 ANN M ISMRM TOR, P3133; Habib J, 2009, P 11 ANN M ISMRM HON, P3523; Habib J, 2010, MAGN RESON MED, V63, P1098, DOI 10.1002/mrm.22232; HENKELMAN RM, 1985, MED PHYS, V12, P232, DOI 10.1118/1.595711; Jeurissen B., 2012, HUMAN BRAIN MAPPING, DOI 10.1002/hbm.22099; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jiang HY, 2002, MAGN RESON MED, V47, P818, DOI 10.1002/mrm.10102; Jones DK, 2005, P 13 ANN M ISMRM MIA, P222; Li Y, 2010, IMPROVED REAL TIME A, P4039; Mangin JF, 2002, MED IMAGE ANAL, V6, P191, DOI 10.1016/S1361-8415(02)00079-8; Maximov II, 2011, J MAGN RESON, V213, P136, DOI 10.1016/j.jmr.2011.09.035; Nunes RG, 2005, J MAGN RESON, V177, P102, DOI 10.1016/j.jmr.2005.07.005; Pierpaoli C, 2003, ANAL CONTRIBUTION CA, P70; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Robson MD, 2005, MAGN RESON IMAGING, V23, P899, DOI 10.1016/j.mri.2005.09.005; Skare S, 2001, MAGN RESON IMAGING, V19, P1125, DOI 10.1016/S0730-725X(01)00415-5; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Wang JJ, 2005, MAGN RESON IMAGING, V23, P585, DOI 10.1016/j.mri.2005.02.005; Zhou ZY, 2011, MAGN RESON IMAGING, V29, P230, DOI 10.1016/j.mri.2010.06.022	29	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e49764	10.1371/journal.pone.0049764	http://dx.doi.org/10.1371/journal.pone.0049764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204551	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400001
J	Hongisto, V; Jernstrom, S; Fey, V; Mpindi, JP; Sahlberg, KK; Kallioniemi, O; Perala, M				Hongisto, Vesa; Jernstrom, Sandra; Fey, Vidal; Mpindi, John-Patrick; Sahlberg, Kristine Kleivi; Kallioniemi, Olli; Perala, Merja			High-Throughput 3D Screening Reveals Differences in Drug Sensitivities between Culture Models of JIMT1 Breast Cancer Cells	PLOS ONE			English	Article							CONFLUENCE-DEPENDENT RESISTANCE; COLLAGEN GEL CULTURES; IN-VITRO EVALUATION; GENE-EXPRESSION; 3-DIMENSIONAL CULTURE; EXTRACELLULAR-MATRIX; ILLUMINA MICROARRAY; BASEMENT-MEMBRANE; EPITHELIAL-CELLS; GROWTH	The traditional method for studying cancer in vitro is to grow immortalized cancer cells in two-dimensional monolayers on plastic. However, many cellular features are impaired in these artificial conditions, and large changes in gene expression compared to tumors have been reported. Three-dimensional cell culture models have become increasingly popular and are suggested to be better models than two-dimensional monolayers due to improved cell-to-cell contact and structures that resemble in vivo architecture. The aim of this study was to develop a simple high-throughput three-dimensional drug screening method and to compare drug responses in JIMT1 breast cancer cells when grown in two dimensions, in poly(2-hydroxyethyl methacrylate) induced anchorage-independent three-dimensional models, and in Matrigel three-dimensional cell culture models. We screened 102 compounds with multiple concentrations and biological replicates for their effects on cell proliferation. The cells were either treated immediately upon plating, or they were allowed to grow in three-dimensional cultures for 4 days before the drug treatment. Large variations in drug responses were observed between the models indicating that comparisons of culture model-influenced drug sensitivities cannot be made based on the effects of a single drug. However, we show with the 63 most prominent drugs that, in general, JIMT1 cells grown on Matrigel were significantly more sensitive to drugs than cells grown in two-dimensional cultures, while the responses of cells grown in poly(2-hydroxyethyl methacrylate) resembled those of the two-dimensional cultures. Furthermore, comparing the gene expression profiles of the cell culture models to xenograft tumors indicated that cells cultured in Matrigel and as xenografts most closely resembled each other. In this study, we also suggest that three-dimensional cultures can provide a platform for systematic experimentation of larger compound collections in a high-throughput mode and be used as alternatives to traditional two-dimensional screens for better comparability to the in vivo state.	[Hongisto, Vesa; Jernstrom, Sandra; Fey, Vidal; Kallioniemi, Olli; Perala, Merja] VTT Tech Res Ctr Finland, Turku, Finland; [Jernstrom, Sandra; Sahlberg, Kristine Kleivi] Radiumhospitalet, Oslo Univ Hosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Jernstrom, Sandra; Sahlberg, Kristine Kleivi] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, Oslo, Norway; [Mpindi, John-Patrick; Kallioniemi, Olli] Univ Helsinki, FIMM, Helsinki, Finland; [Sahlberg, Kristine Kleivi] Vestre Viken Hosp Trust, Dept Res, Drammen, Norway	VTT Technical Research Center Finland; University of Oslo; University of Oslo; University of Helsinki	Hongisto, V (corresponding author), VTT Tech Res Ctr Finland, Turku, Finland.	vesa.hongisto@vtt.fi	; Kallioniemi, Olli/H-4738-2012	Kleivi Sahlberg, Kristine/0000-0002-7281-2759; Kallioniemi, Olli/0000-0002-3231-0332; Fey, Vidal/0000-0003-1388-5904	Academy Finland postdoctoral grant [253108]; Academy of Finland Centre of Excellence in Translational Genome Scale Biology program [129620]; Sigrid Juselius Foundation	Academy Finland postdoctoral grant; Academy of Finland Centre of Excellence in Translational Genome Scale Biology program; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	Funding for this work has been provided by Academy Finland postdoctoral grant #253108, Academy of Finland Centre of Excellence in Translational Genome Scale Biology program #129620 and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto N, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3329; BADINER GJ, 1987, INVEST NEW DRUG, V5, P219; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Cheng WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034705; David L, 2008, ACTA BIOMATER, V4, P256, DOI 10.1016/j.actbio.2007.08.012; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; DIMANCHEBOITREL MT, 1992, INT J CANCER, V50, P677, DOI 10.1002/ijc.2910500502; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; ERLICHMAN C, 1984, CANCER RES, V44, P5369; Fernando A, 2006, ANTI-CANCER DRUG, V17, P913, DOI 10.1097/01.cad.0000224445.23953.d9; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; GARRIDO C, 1995, INT J CANCER, V61, P873, DOI 10.1002/ijc.2910610621; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh S, 2005, J CELL PHYSIOL, V204, P522, DOI 10.1002/jcp.20320; Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039556; KOBAYASHI H, 1993, P NATL ACAD SCI USA, V90, P3294, DOI 10.1073/pnas.90.8.3294; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; KUCZEK T, 1987, P NATL ACAD SCI USA, V84, P4490, DOI 10.1073/pnas.84.13.4490; Lan SF, 2010, TOXICOL IN VITRO, V24, P1314, DOI 10.1016/j.tiv.2010.02.015; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; LI ML, 1987, P NATL ACAD SCI USA, V84, P136, DOI 10.1073/pnas.84.1.136; Li QW, 2010, J PHARMACOL EXP THER, V332, P821, DOI 10.1124/jpet.109.160390; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lin Y, 2009, NEOPLASIA, V11, P864, DOI 10.1593/neo.09542; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Martin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036911; MILLER BE, 1985, CANCER RES, V45, P4200; MILLER FR, 1989, CANCER RES, V49, P6091; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; PELLETIER H, 1990, CANCER RES, V50, P6626; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Serebriiskii I, 2008, MATRIX BIOL, V27, P573, DOI 10.1016/j.matbio.2008.02.008; Shi Y, 2011, J BIOMOL SCREEN, V16, P525, DOI 10.1177/1087057111398486; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tanner M, 2004, MOL CANCER THER, V3, P1585; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; WERB Z, 1990, CELL DIFFER DEV, V32, P299, DOI 10.1016/0922-3371(90)90043-V	49	118	122	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77232	10.1371/journal.pone.0077232	http://dx.doi.org/10.1371/journal.pone.0077232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194875	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000054
J	Zang, K; Wang, JY; Dong, MF; Sun, RX; Wang, YX; Huang, YN; Liu, XX; Li, YM; Wang, FN; Yu, M				Zang, Kun; Wang, Jingyu; Dong, Miaofang; Sun, Ruixin; Wang, Yuxiong; Huang, Yinong; Liu, Xiaoxia; Li, Yimin; Wang, Fangnian; Yu, Min			Brd2 Inhibits Adipogenesis via the ERK1/2 Signaling Pathway in 3T3-L1 Adipocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PPAR-GAMMA; MEDIATED PHOSPHORYLATION; BIOLOGICAL FUNCTIONS; DIABETES EPIDEMIC; RECEPTOR-GAMMA; C-MYC; OBESITY; DIFFERENTIATION; RAF	Bromodomain-containing protein 2 (Brd2) is a nuclear serine/threonine kinase involved in transcriptional regulation. In 3T3-L1 adipocytes, Brd2 normally co-represses PPAR gamma (peroxisome proliferator-activated receptor gamma) and inhibits adipogenesis. Here, we show that Brd2 over-expression in preadipocytes inhibits their differentiation into adipocytes, while Brd2 knockdown promotes adipogenic differentiation in vitro and forces cells to undergo adipogenesis independent of the MDI (methyisobutylxanthane, dexamethasone and insulin) induction. In this study, the two key transcription factors for adipogenesis, PPAR gamma and C/EBPa (CCAAT/enhancer binding protein-alpha) were persistently expressed during the differentiation of preadipocytes to mature adipocytes in Brd2 knockdown 3T3-L1 cells, but their expression was inhibited in cells in which Brd2 was overexpressed. To investigate the role of Brd2 in signal transduction we examined the expression of several signaling molecules involved in the regulation of gene expression and cell differentiation by immunoblotting assay. Down-regulation of Brd2 expression in 3T3-L1 cells led to a decrease in extracellular signal-regulated kinase1/2 (ERK1/2) activity and, conversely, the up-regulation of Brd2 leads to increase in ERK1/2 phosphorylation. Nevertheless, changes in Brd2 expression do not affect the activities of JNK and p38 MAPK. In addition, the phosphorylation of Rafs is not affected by changes in Brd2 expression in 3T3-L1 cells. MEK inhibitor UO126 partly restores differentiation of 3T3-L1 cells that overexpress Brd2. In conclusion, these results indicate that Brd2 regulates ERK1/2 activity independently of Raf signaling in 3T3-L1 adipocytes.	[Zang, Kun; Wang, Jingyu; Dong, Miaofang; Sun, Ruixin; Wang, Yuxiong; Huang, Yinong; Wang, Fangnian; Yu, Min] Fudan Univ, Key Lab Mol Med, Minist Educ, Shanghai 200433, Peoples R China; [Zang, Kun; Wang, Jingyu; Dong, Miaofang; Sun, Ruixin; Wang, Yuxiong; Huang, Yinong; Wang, Fangnian; Yu, Min] Fudan Univ, Dept Biochem & Mol Biol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Liu, Xiaoxia; Li, Yimin] Fudan Univ, Dept Endocrinol, Hua Shan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, FN (corresponding author), Fudan Univ, Key Lab Mol Med, Minist Educ, Shanghai 200433, Peoples R China.	fangnianwang@hotmail.com; minyu@shmu.edu.cn	WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022		National Natural Science Foundation of China [30870565, 81171912, 81200561]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (numbers 30870565, 81171912 and 81200561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; Beck S, 1992, DNA Seq, V2, P203, DOI 10.3109/10425179209020804; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Dalla Vecchia CF, 2005, J PERIODONTOL, V76, P1721, DOI 10.1902/jop.2005.76.10.1721; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Denis GV, 2010, DISCOV MED, V10, P489; Denis GV, 2006, J PROTEOME RES, V5, P502, DOI 10.1021/pr050430u; Denis GV, 2000, CELL GROWTH DIFFER, V11, P417; Denis GV, 1996, GENE DEV, V10, P261, DOI 10.1101/gad.10.3.261; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; DiBenedetto AJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-39; Dorresteijn JAN, 2012, OBES REV, V13, P17, DOI 10.1111/j.1467-789X.2011.00914.x; Engelman JA, 1999, J BIOL CHEM, V274, P35630, DOI 10.1074/jbc.274.50.35630; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; Floyd ZE, 2002, J BIOL CHEM, V277, P4062, DOI 10.1074/jbc.M108473200; Franssen R, 2011, MED CLIN N AM, V95, P893, DOI 10.1016/j.mcna.2011.06.003; Graves JD, 1995, ANN NY ACAD SCI, V766, P320, DOI 10.1111/j.1749-6632.1995.tb26684.x; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Guo N, 2000, J CELL SCI, V113, P3085; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Lloyd CM, 2013, NAT MED, V19, P976, DOI 10.1038/nm.3296; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Pischon N, 2007, J DENT RES, V86, P400, DOI 10.1177/154405910708600503; Rauch J, 2011, CANCER RES, V71, P4664, DOI 10.1158/0008-5472.CAN-10-4447; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schlesinger Thomas K., 1998, Frontiers in Bioscience, V3, pD1181; Speliotes EK, 2009, GASTROENTEROLOGY, V136, P1492, DOI 10.1053/j.gastro.2009.03.020; Thompson D, 2001, Obes Rev, V2, P189, DOI 10.1046/j.1467-789x.2001.00037.x; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tzotzas T, 2011, OBES REV, V12, pe282, DOI 10.1111/j.1467-789X.2010.00807.x; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Wang FN, 2010, BIOCHEM J, V425, P71, DOI 10.1042/BJ20090928; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	52	26	28	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78536	10.1371/journal.pone.0078536	http://dx.doi.org/10.1371/journal.pone.0078536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194944	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000123
J	De Stefano, LM; Ferraz, ALB; Ferreira, ALD; Gut, AL; Cogni, AL; Farah, E; Matsubara, BB				De Stefano, Laercio Martins; Barbosa Ferraz, Alex Lombardi; dos Anjos Ferreira, Ana Lucia; Gut, Ana Lucia; Cogni, Ana Lucia; Farah, Elaine; Matsubara, Beatriz Bojikian			Predictors of Beta-Blocker Intolerance and Mortality in Patients After Acute Coronary Syndrome	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; MEDICAL THERAPY; RENAL DYSFUNCTION; AMERICAN-COLLEGE; GLOBAL REGISTRY; HEART-DISEASE; RISK; CARE; GUIDELINES	Purpose: To investigate the predictors of intolerance to beta-blockers treatment and the 6-month mortality in hospitalized patients with acute coronary syndrome (ACS). Methods: This was a single-center, prospective, and longitudinal study including 370 consecutive ACS patients in Killip class I or II. BBs were prescribed according to international guidelines and withdrawn if intolerance occurred. The study was approved by the institutional ethics committee of our university. Statistics: the clinical parameters evaluated at admission, and the related intolerance to BBs and death at 6 months were analyzed using logistic regression (p<0.05) in PATIENTS. Results: BB intolerance was observed in 84 patients and was associated with no prior use of statins (OR: 2.16, 95%CI: 1.26-3.69, p= 0.005) and Killip class II (OR: 2.5, 95%CI: 1.30-4.75, p=0.004) in the model adjusted for age, sex, blood pressure, and renal function. There was no association with ST-segment alteration or left anterior descending coronary artery plaque. Intolerance to BB was associated with the greatest risk of death (OR: 4.5, 95%CI: 2.15-9.40, p<0.001). Conclusions: After ACS, intolerance to BBs in the first 48 h of admission was associated to non previous use of statin and Killip class II and had a high risk of death within 6 months.	[De Stefano, Laercio Martins; Barbosa Ferraz, Alex Lombardi; dos Anjos Ferreira, Ana Lucia; Gut, Ana Lucia; Cogni, Ana Lucia; Farah, Elaine; Matsubara, Beatriz Bojikian] Univ Estadual Paulista, Dept Clin Med, Fac Med Botucatu, Sao Paulo, Brazil	Universidade Estadual Paulista	De Stefano, LM (corresponding author), Univ Estadual Paulista, Dept Clin Med, Fac Med Botucatu, Sao Paulo, Brazil.	laercio@fmb.unesp.br		Gut, Ana Lucia/0000-0001-5763-0829				*ACC INV, 2011, AM HEART J, V162; Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Alexander KP, 2005, J AM COLL CARDIOL, V46, P1479, DOI 10.1016/j.jacc.2005.05.084; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Awad HH, 2011, AM J CARDIOL, V108, P1252, DOI 10.1016/j.amjcard.2011.06.040; Edwards J, 2011, AM HEART J, V161, P291, DOI 10.1016/j.ahj.2010.10.034; Krim SR, 2011, AM HEART J, V162, P988, DOI 10.1016/j.ahj.2011.09.006; Lee JH, 2010, AM HEART J, V159, P1012, DOI 10.1016/j.ahj.2010.03.009; Lopez-Sendon J, 2004, EUR HEART J, V25, P1341, DOI 10.1016/j.ehj.2004.06.002; McCullough PA, 2002, AM HEART J, V144, P226, DOI 10.1067/mhj.2002.125513; McGirt MJ, 2005, J VASC SURG, V42, P829, DOI 10.1016/j.jvs.2005.08.039; MEMBERS WC, 2008, CIRCULATION, V118, P2596; MEMBERS WC, 2004, CIRCULATION, V110, pE82; Mukherjee D, 2004, CIRCULATION, V109, P745, DOI 10.1161/01.CIR.0000112577.69066.CB; *MYAB YIAD, 2011, EMERG MED CLIN N AM, V29, P699, DOI DOI 10.1016/J.EMC.2011.09.016.PUBMED:22040701; Nguyen HL, 2010, CORONARY ARTERY DIS, V21, P336, DOI 10.1097/MCA.0b013e32833ce07c; Patel MR, 2007, AM J MED, V120, P40, DOI 10.1016/j.amjmed.2006.10.008; PEDERSEN TR, 1994, LANCET, V344, P1383; Poldermans D, 2003, CIRCULATION, V107, P1848, DOI 10.1161/01.CIR.0000066286.15621.98; Roe MT, 2006, AM HEART J, V151, P1205, DOI 10.1016/j.ahj.2005.08.006; Rosengren A, 2006, EUR HEART J, V27, P789, DOI 10.1093/eurheartj/ehi774; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SHEPHERD J, 1998, NEW ENGL J MED, V339, P1349, DOI DOI 10.1056/NEJM199811053391902.PUBMED:9841303; Shroff GR, 2012, AM HEART J, V163, P399, DOI 10.1016/j.ahj.2011.12.002; Soiza RL, 2005, J AM GERIATR SOC, V53, P1961, DOI 10.1111/j.1532-5415.2005.53573.x; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; Wright RS, 2002, ANN INTERN MED, V137, P563, DOI 10.7326/0003-4819-137-7-200210010-00007; Yan AT, 2007, AM HEART J, V154, P1108, DOI 10.1016/j.ahj.2007.07.040	32	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77747	10.1371/journal.pone.0077747	http://dx.doi.org/10.1371/journal.pone.0077747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167581	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500040
J	Migheli, R; Del Giudice, MG; Spissu, Y; Sanna, G; Xiong, YL; Dawson, TM; Dawson, VL; Galioto, M; Rocchitta, G; Biosa, A; Serra, PA; Carri, MT; Crosio, C; Iaccarino, C				Migheli, Rossana; Del Giudice, Maria Grazia; Spissu, Ylenia; Sanna, Giovanna; Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.; Galioto, Manuela; Rocchitta, Gaia; Biosa, Alice; Serra, Pier Andrea; Carri, Maria Teresa; Crosio, Claudia; Iaccarino, Ciro			LRRK2 Affects Vesicle Trafficking, Neurotransmitter Extracellular Level and Membrane Receptor Localization	PLOS ONE			English	Article							OXIDE/CYCLIC GMP PATHWAY; MICRODIALYSIS IN-VITRO; PARKINSONS-DISEASE; PC12 CELLS; KINASE-ACTIVITY; PLEOMORPHIC PATHOLOGY; DOPAMINE SECRETION; MUTANT LRRK2; PHOSPHORYLATION; ENDOCYTOSIS	The leucine-rich repeat kinase 2 (LRRK2) gene was found to play a role in the pathogenesis of both familial and sporadic Parkinson's disease (PD). LRRK2 encodes a large multi-domain protein that is expressed in different tissues. To date, the physiological and pathological functions of LRRK2 are not clearly defined. In this study we have explored the role of LRRK2 in controlling vesicle trafficking in different cellular or animal models and using various readouts. In neuronal cells, the presence of LRRK2(G2019S) pathological mutant determines increased extracellular dopamine levels either under basal conditions or upon nicotine stimulation. Moreover, mutant LRRK2 affects the levels of dopamine receptor D1 on the membrane surface in neuronal cells or animal models. Ultrastructural analysis of PC12-derived cells expressing mutant LRRK2(G2019S) shows an altered intracellular vesicle distribution. Taken together, our results point to the key role of LRRK2 to control vesicle trafficking in neuronal cells.	[Migheli, Rossana; Spissu, Ylenia; Rocchitta, Gaia; Biosa, Alice; Serra, Pier Andrea] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Del Giudice, Maria Grazia; Sanna, Giovanna; Galioto, Manuela; Crosio, Claudia; Iaccarino, Ciro] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD USA; [Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Carri, Maria Teresa; Crosio, Claudia; Iaccarino, Ciro] IRCCS, Fdn Santa Lucia, Rome, Italy; [Carri, Maria Teresa] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	University of Sassari; University of Sassari; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; IRCCS Santa Lucia; University of Rome Tor Vergata	Iaccarino, C (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	ciaccarino@uniss.it	Spissu, Ylenia/AAY-3011-2020; Spissu, Ylenia/AGQ-3624-2022; Dawson, Valina/Y-9757-2019; Rocchitta, Gaia/HHM-8002-2022; Carri, Maria Teresa/K-5480-2016	Spissu, Ylenia/0000-0003-1551-8817; SERRA, Pier Andrea/0000-0003-2401-5146; Carri, Maria Teresa/0000-0002-1789-1546; MIGHELI, Rossana/0000-0001-5520-5511; CROSIO, Claudia/0000-0003-2452-1145; Dawson, Valina/0000-0002-2915-3970; ROCCHITTA, Gaia Giovanna Maria/0000-0002-4319-4197; IACCARINO, Ciro/0000-0003-1619-7146	Fondazione Banco di Sardegna, PRIN [20083R593R_002, 20083R593R_001]; Regione Sardegna [CRP-17171]; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [P50NS038377]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377] Funding Source: NIH RePORTER	Fondazione Banco di Sardegna, PRIN; Regione Sardegna(Regione Sardegna); National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Fondazione Banco di Sardegna, PRIN 2008 (grant no 20083R593R_002 and 20083R593R_001) and Regione Sardegna (grant noCRP-17171). Maria Grazia Dal Giudice is supported by a fellowship of Regione Sardegna. This work was supported in part by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) P50NS038377. Ted M. Dawson is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biskup S, 2008, J NEUROL, V255, P8, DOI 10.1007/s00415-008-5005-2; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Bonifati V, 2006, CURR NEUROL NEUROSCI, V6, P355, DOI 10.1007/s11910-996-0013-z; BRADBERRY CW, 1991, J NEUROSCI METH, V36, P85, DOI 10.1016/0165-0270(91)90141-L; Buckley KM, 2000, J PHYSIOL-LONDON, V525, P11, DOI 10.1111/j.1469-7793.2000.t01-2-00011.x; Esposito G, 2012, DEV NEUROBIOL, V72, P134, DOI 10.1002/dneu.20916; FINBERG JPM, 1983, NEUROPHARMACOLOGY, V22, P441, DOI 10.1016/0028-3908(83)90194-6; FUJITA K, 1989, ENVIRON HEALTH PERSP, V80, P127, DOI 10.2307/3430738; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Ghijsen WEJM, 2005, CELL MOL LIFE SCI, V62, P937, DOI 10.1007/s00018-004-4525-0; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Hatano T, 2007, HUM MOL GENET, V16, P678, DOI 10.1093/hmg/ddm013; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Heo Hye Young, 2010, Exp Neurobiol, V19, P97, DOI 10.5607/en.2010.19.2.97; Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080; Iaccarino C, 2011, NEUROBIOL DIS, V43, P642, DOI 10.1016/j.nbd.2011.05.013; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jiang Y, 2008, SYNAPSE, V62, P797, DOI 10.1002/syn.20554; Kawakami F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030834; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Lee HW, 2008, NEUROSCI LETT, V436, P245, DOI 10.1016/j.neulet.2008.03.038; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Marin I, 2008, FASEB J, V22, P3103, DOI 10.1096/fj.08-111310; MARKEY KA, 1980, MOL PHARMACOL, V17, P79; Martin TFJ, 2003, METHOD CELL BIOL, V71, P267, DOI 10.1016/S0091-679X(03)01012-4; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Migheli R, 1999, J NEUROCHEM, V73, P1155, DOI 10.1046/j.1471-4159.1999.0731155.x; Migheli R, 2008, ANAL BIOCHEM, V380, P323, DOI 10.1016/j.ab.2008.05.050; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; RODA LG, 1980, EXP CELL RES, V128, P103, DOI 10.1016/0014-4827(80)90392-4; Sanna G, 2012, BIOCHEM SOC T, V40, P1117, DOI 10.1042/BST20120117; Schapira AH, 2011, MOVEMENT DISORD, V26, P1049, DOI 10.1002/mds.23732; Serra PA, 2003, J NEUROCHEM, V86, P1403, DOI 10.1046/j.1471-4159.2003.01947.x; Serra PA, 2003, NEUROSCI LETT, V353, P5, DOI 10.1016/j.neulet.2003.07.022; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Stokes AH, 2000, BRAIN RES, V858, P1, DOI 10.1016/S0006-8993(99)02329-X; Tong YR, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-2; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; WICK PF, 1993, J BIOL CHEM, V268, P10983; Xiong YL, 2012, J NEUROSCI, V32, P3877, DOI 10.1523/JNEUROSCI.4566-11.2012; Zhou HX, 2011, INT J BIOL SCI, V7, P753, DOI 10.7150/ijbs.7.753; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	55	53	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77198	10.1371/journal.pone.0077198	http://dx.doi.org/10.1371/journal.pone.0077198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167564	gold, Green Submitted, Green Published			2022-12-27	WOS:000326034500023
J	Reddy, RM; Srivastava, A; Kumar, A				Reddy, Rachamalla Maheedhar; Srivastava, Akshay; Kumar, Ashok			Monosaccharide-Responsive Phenylboronate-Polyol Cell Scaffolds for Cell Sheet and Tissue Engineering Applications	PLOS ONE			English	Article							POLY(VINYL ALCOHOL); POLYMER; COPOLYMERS; COMPLEXES; CRYOGEL; GRAFTS; BORATE; GEL	Analyte-responsive smart polymeric materials are of great interest and have been actively investigated in the field of regenerative medicine. Phenylboronate containing copolymers form gels with polyols under alkaline conditions. Monosaccharides, by virtue of their higher affinity towards boronate, can displace polyols and solubilize such gels. In the present study, we investigate the possibility of utilizing phenylboronate-polyol interactions at physiological pH in order to develop monosaccharide-responsive degradable scaffold materials for systems dealing with cells and tissues. Amine assisted phenylboronate-polyol interactions were employed to develop novel hydrogel and cryogel scaffolds at neutral pH. The scaffolds displayed monosaccharide inducible gel-sol phase transformability. In vitro cell culture studies demonstrated the ability of scaffolds to support cell adhesion, viability and proliferation. Fructose induced gel degradation is used to recover cells cultured on the hydrogels. The cryogels displayed open macroporous structure and superior mechanical properties. These novel phase transformable phenylboronate-polyol based scaffolds displayed a great potential for various cell sheet and tissue engineering applications. Their monosaccharide responsiveness at physiological pH is very useful and can be utilized in the fields of cell immobilization, spheroid culture, saccharide recognition and analyte-responsive drug delivery.	[Reddy, Rachamalla Maheedhar; Srivastava, Akshay; Kumar, Ashok] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Kumar, A (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	ashokkum@iitk.ac.in	Kumar, Ashok/G-8515-2015; KUMAR, ASHOK/AAF-4055-2021	KUMAR, ASHOK/0000-0002-9244-0622; Kumar, Ashok/0000-0002-4910-9440; Srivastava, Akshay/0000-0001-5048-9420				Aoki T, 1996, POLYM J, V28, P371, DOI 10.1295/polymj.28.371; Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.0.CO;2-C; Dainiak MB, 2006, P NATL ACAD SCI USA, V103, P849, DOI 10.1073/pnas.0508432103; Hisamitsu I, 1997, PHARMACEUT RES, V14, P289, DOI 10.1023/A:1012033718302; Ivanov AE, 2004, POLYMER, V45, P2495, DOI 10.1016/j.polymer.2004.02.022; Ivanov AE, 2008, INT J PHARM, V358, P36, DOI 10.1016/j.ijpharm.2008.02.017; Ivanov AE, 2006, J MOL RECOGNIT, V19, P322, DOI 10.1002/jmr.792; Ivanov AE, 2009, J BIOMED MATER RES A, V88A, P213, DOI 10.1002/jbm.a.31880; Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009; KITANO S, 1991, MAKROMOL CHEM-RAPID, V12, P227; KITANO S, 1992, J CONTROL RELEASE, V19, P162; Kitano S, 1991, POLYM ADVAN TECHNOL, V2, P261, DOI 10.1002/pat.1991.220020508; Kuzimenkova MV, 2008, POLYMER, V49, P1444, DOI 10.1016/j.polymer.2008.02.009; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; LORAND JP, 1959, J ORG CHEM, V24, P769, DOI 10.1021/jo01088a011; Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269; Mikos Antonios G., 2000, EJB Electronic Journal of Biotechnology, V3, P1; Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30; Plieva FM, 2008, TRENDS MICROBIOL, V16, P543, DOI 10.1016/j.tim.2008.08.005; Shiino D, 1995, J CONTROL RELEASE, V37, P269, DOI 10.1016/0168-3659(95)00084-4; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Shiroyanagi Y, 2003, TISSUE ENG, V9, P1005, DOI 10.1089/107632703322495646; Srivastava A, 2007, MAT SCI ENG A-STRUCT, V464, P93, DOI 10.1016/j.msea.2007.03.057; VANDENBERG R, 1994, CARBOHYD RES, V253, P1, DOI 10.1016/0008-6215(94)80050-2; WISE ET, 1995, MACROMOLECULES, V28, P8321, DOI 10.1021/ma00128a048; Yamato M, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00234-2; Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645	28	12	13	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77861	10.1371/journal.pone.0077861	http://dx.doi.org/10.1371/journal.pone.0077861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167587	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500046
J	Wu, JX; Dong, FZ; Wang, RA; Wang, JF; Zhao, JP; Yang, MM; Gong, WB; Cui, RT; Dong, L				Wu, Jinxiang; Dong, Fangzheng; Wang, Rui-An; Wang, Junfei; Zhao, Jiping; Yang, Mengmeng; Gong, Wenbin; Cui, Rutao; Dong, Liang			Central Role of Cellular Senescence in TSLP-Induced Airway Remodeling in Asthma	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; BRONCHIAL EPITHELIAL-CELLS; ONCOGENE-INDUCED SENESCENCE; GENOME-WIDE ASSOCIATION; SIGNAL TRANSDUCERS; EXPRESSION; INFLAMMATION; CYTOKINE; SUSCEPTIBILITY; ACTIVATION	Background: Airway remodeling is a repair process that occurs after injury resulting in increased airway hyper-responsiveness in asthma. Thymic stromal lymphopoietin (TSLP), a vital cytokine, plays a critical role in orchestrating, perpetuating and amplifying the inflammatory response in asthma. TSLP is also a critical factor in airway remodeling in asthma. Objectives: To examine the role of TSLP-induced cellular senescence in airway remodeling of asthma in vitro and in vivo. Methods: Cellular senescence and airway remodeling were examined in lung specimens from patients with asthma using immunohischemical analysis. Both small molecule and shRNA approaches that target the senescent signaling pathways were used to explore the role of cellular senescence in TSLP-induced airway remodeling in vitro. Senescence-Associated beta-galactosidase (SA-beta-Gal) staining, and BrdU assays were used to detect cellular senescence. In addition, the Stat3-targeted inhibitor, WP1066, was evaluated in an asthma mouse model to determine if inhibiting cellular senescence influences airway remodeling in asthma. Results: Activation of cellular senescence as evidenced by checkpoint activation and cell cycle arrest was detected in airway epithelia samples from patients with asthma. Furthermore, TSLP-induced cellular senescence was required for airway remodeling in vitro. In addition, a mouse asthma model indicates that inhibiting cellular senescence blocks airway remodeling and relieves airway resistance. Conclusion: TSLP stimulation can induce cellular senescence during airway remodeling in asthma. Inhibiting the signaling pathways of cellular senescence overcomes TSLP-induced airway remodeling.	[Wu, Jinxiang; Wang, Junfei; Zhao, Jiping; Yang, Mengmeng; Gong, Wenbin; Dong, Liang] Shandong Univ, Qilu Hosp, Dept Resp, Jinan 250100, Shandong, Peoples R China; [Dong, Fangzheng] Univ Iowa, Coll Liberal Arts & Sci, Iowa City, IA USA; [Wang, Rui-An] Fourth Mil Med Univ, Dept Pathol, Xian 710032, Shanxi, Peoples R China; [Cui, Rutao] Shanghai Univ TCM, Longhua Hosp, Shanghai, Peoples R China; [Dong, Fangzheng; Cui, Rutao] Boston Univ, Sch Med, Dept Dermatol & Biochem, Boston, MA 02118 USA	Shandong University; University of Iowa; Air Force Military Medical University; Shanghai University of Traditional Chinese Medicine; Boston University	Cui, RT (corresponding author), Shanghai Univ TCM, Longhua Hosp, Shanghai, Peoples R China.	rutaocui@bu.edu; dl5506@aliyun.com	Wang, Brian/HGA-9535-2022	Dong, Liang/0000-0001-7707-9982; Yang, Hongxing/0000-0002-4528-7020	National Nature Science Foundation of China (NSFC) [81270072]; Natural Science Funding committee of Shandong province (SDNSF) [ZR2011HM020]; Longhua Medical Project	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Funding committee of Shandong province (SDNSF); Longhua Medical Project	This research is supported by National Nature Science Foundation of China (NSFC) (NSFC for LD, Grant No: 81270072), Natural Science Funding committee of Shandong province (SDNSF) (Grant No: ZR2011HM020) and Longhua Medical Project (RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Aoshiba Kazutetsu, 2009, Proc Am Thorac Soc, V6, P596, DOI 10.1513/pats.200904-017RM; Beckett PA, 2003, THORAX, V58, P163, DOI 10.1136/thorax.58.2.163; Bleck B, 2008, J CLIN IMMUNOL, V28, P147, DOI 10.1007/s10875-007-9149-0; Bleck B, 2010, J IMMUNOL, V185, P6636, DOI 10.4049/jimmunol.1000719; Boulet L P, 1998, Can Respir J, V5, P270; Burns TF, 2013, MOL CANCER RES, V11, P329, DOI 10.1158/1541-7786.MCR-12-0456; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Camp RL, 1999, CANCER, V86, P2259, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; CAO J, 2013, MOL CELL, P73372; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051268; Chuang CY, 2009, INHAL TOXICOL, V21, P153, DOI [10.1080/08958370802368730, 10.1080/08958370802368730 ]; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Damera G, 2009, BRIT J PHARMACOL, V158, P1429, DOI 10.1111/j.1476-5381.2009.00428.x; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fabbri LM, 2003, AM J RESP CRIT CARE, V167, P418, DOI 10.1164/rccm.200203-183OC; Fedorov IA, 2005, THORAX, V60, P389, DOI 10.1136/thx.2004.030262; Ferrajoli A, 2007, CANCER RES, V67, P11291, DOI 10.1158/0008-5472.CAN-07-0593; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Halwani R, 2010, CURR OPIN PHARMACOL, V10, P236, DOI 10.1016/j.coph.2010.06.004; Harada M, 2009, AM J RESP CELL MOL, V40, P368, DOI 10.1165/rcmb.2008-0041OC; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Hussain SF, 2007, CANCER RES, V67, P9630, DOI 10.1158/0008-5472.CAN-07-1243; James AL, 2007, EUR RESPIR J, V30, P134, DOI 10.1183/09031936.00146905; Kashyap M, 2011, J IMMUNOL, V187, P1207, DOI 10.4049/jimmunol.1100355; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kim SJ, 2013, AM J RHINOL ALLERGY, V27, pE11, DOI 10.2500/ajra.2013.27.3853; Kong LY, 2008, CLIN CANCER RES, V14, P5759, DOI 10.1158/1078-0432.CCR-08-0377; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lanigan F, 2011, ONCOGENE, V30, P2901, DOI 10.1038/onc.2011.34; Leonard WJ, 2002, NAT IMMUNOL, V3, P605, DOI 10.1038/ni0702-605; Levy DE, 2006, P NATL ACAD SCI USA, V103, P10151, DOI 10.1073/pnas.0604042103; Liu W, 2012, EXP LUNG RES, V38, P375, DOI 10.3109/01902148.2012.714840; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Liu YJ, 2009, ADV IMMUNOL, V101, P1, DOI 10.1016/S0065-2776(08)01001-8; Mauad T, 2007, J ALLERGY CLIN IMMUN, V120, P997, DOI 10.1016/j.jaci.2007.06.031; McDonald ER, 2001, ANN MED, V33, P113, DOI 10.3109/07853890109002066; Nakamura Y, 2008, J ALLERGY CLIN IMMUN, V122, P1208, DOI 10.1016/j.jaci.2008.09.022; Nguyen Khoa D, 2010, Allergy Asthma Clin Immunol, V6, P4, DOI 10.1186/1710-1492-6-4; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Ota K, 2011, ANTIOXID REDOX SIGN, V14, P2441, DOI 10.1089/ars.2010.3574; Pelaia G, 2012, NAT REV DRUG DISCOV, V11, P958, DOI 10.1038/nrd3792; Ramakrishna G, 2012, EUR J CELL BIOL, V91, P739, DOI 10.1016/j.ejcb.2012.08.002; Ramos-Barbon D, 2011, ARCH BRONCONEUMOL, V47, P113, DOI 10.1016/j.arbres.2010.12.001; Reddel R R, 1988, Oncogene Res, V3, P401; Rochman Y, 2008, CURR OPIN PHARMACOL, V8, P249, DOI 10.1016/j.coph.2008.03.002; Semlali A, 2010, ALLERGY, V65, P1438, DOI 10.1111/j.1398-9995.2010.02376.x; Semlali A, 2010, J ALLERGY CLIN IMMUN, V125, P844, DOI 10.1016/j.jaci.2010.01.044; Shikotra A, 2012, J ALLERGY CLIN IMMUN, V129, P104, DOI 10.1016/j.jaci.2011.08.031; Shivshankar P, 2012, AM J RESP CELL MOL, V47, P28, DOI 10.1165/rcmb.2011-0349OC; Soumelis V, 2012, EUR J IMMUNOL, V42, P293, DOI 10.1002/eji.201142337; Tagaya Etsuko, 2007, Allergol Int, V56, P331; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Tsuji T, 2004, AM J RESP CELL MOL, V31, P643, DOI 10.1165/rcmb.2003-0290OC; Tuder Rubin M, 2012, Proc Am Thorac Soc, V9, P62, DOI 10.1513/pats.201201-012MS; Tuder Rubin M, 2011, Proc Am Thorac Soc, V8, P485, DOI 10.1513/pats.201103-029MW; Wu JX, 2013, CELL BIOCHEM FUNCT, V31, P496, DOI 10.1002/cbf.2926; Yang G, 2008, MOL CELL, V32, P554, DOI 10.1016/j.molcel.2008.11.002; Yao WG, 2013, IMMUNITY, V38, P360, DOI 10.1016/j.immuni.2013.01.007; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Ying S, 2008, J IMMUNOL, V181, P2790, DOI 10.4049/jimmunol.181.4.2790; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006	63	38	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77795	10.1371/journal.pone.0077795	http://dx.doi.org/10.1371/journal.pone.0077795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167583	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500042
J	Kubitz, N; Mehra, M; Potluri, RC; Garg, N; Cossrow, N				Kubitz, Nicole; Mehra, Maneesha; Potluri, Ravi C.; Garg, Nitesh; Cossrow, Nicole			Characterization of Treatment Resistant Depression Episodes in a Cohort of Patients from a US Commercial Claims Database	PLOS ONE			English	Article							EPIDEMIOLOGY; EMPLOYEES; DISORDER; BURDEN; COSTS	Context: Treatment Resistant Depression (TRD) is a significant and burdensome health concern. Objective: To characterize, compare and understand the difference between TRD and non-TRD patients and episodes in respect of their episode duration, treatment patterns and healthcare resource utilization. Design and Setting: Patients between 18 and 64 years with a new diagnosis of major depressive disorder (MDD) and without a previous or comorbid diagnosis of schizophrenia or bipolar disease were included from PharMetrics Integrated Database, a claims database of commercial insurers in the US. Episodes of these patients in which there were at least two distinct failed regimens involving antidepressants and antipsychotics were classified as TRD. Patients: 82,742 MDD patients were included in the analysis; of these patients, 125,172 episodes were identified (47,654 of these were drug-treated episodes). Main Outcome Measures: Comparison between TRD and non-TRD episodes in terms of their duration, number and duration of lines of treatment, comorbidities, and medical resource utilization. Results: Of the treated episodes, 6.6% (N = 3,134) met the criteria for TRD. The median time to an episode becoming TRD was approximately one year. The mean duration of a TRD episode was 1,004 days (vs. 452 days for a non-TRD episode). More than 75% of TRD episodes had at least four lines of therapy; half of the treatment regimens included a combination of drugs. Average hospitalization costs were higher for TRD than non-TRD episodes: $6,464 vs. $1,734, as were all other health care utilization costs. Conclusions: While this study was limited to relatively young and commercially covered patients, used a rigorous definition of TRD and did not analyze for cause or consequence, the results highlight high unmet medical need and burden of TRD on patients and health care resources.	[Kubitz, Nicole] Janssen Cilag GmbH, Neurosci, Global Commercial Strategy Org, Market Access, Neuss, Germany; [Mehra, Maneesha; Cossrow, Nicole] Janssen Global Serv LLC, Market Access Analyt, Global Market Access & Commercial Strategy Org, Raritan, NJ USA; [Potluri, Ravi C.; Garg, Nitesh] SmartAnalyst Inc, New York, NY USA	Johnson & Johnson; Johnson & Johnson; Janssen Pharmaceuticals	Kubitz, N (corresponding author), Janssen Cilag GmbH, Neurosci, Global Commercial Strategy Org, Market Access, Neuss, Germany.	nkubitz@its.jnj.com			Janssen	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	SmartAnalyst Inc was commissioned by Janssen Global Services to carry out the data analysis required for this project, for which it received a fee. The authors affiliated to the funders, Janssen Global Services and Janssen-Cilag GmbH, were involved in study design, the decision to publish, and preparation of the manuscript, but not in data analysis. Mr. Potluri and Mr. Garg are employees of SmartAnalyst Inc, which was contracted by Janssen to carry out the data analysis as well as contribute to manuscript development. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2010, OECD EXP M MENT HLTH; [Anonymous], 2007, ANTIPRESSANT MEDICAT; [Anonymous], 2010, PRACTICE GUIDELINE T; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Corey-Lisle PK, 2002, J CLIN PSYCHIAT, V63, P717, DOI 10.4088/JCP.v63n0810; Crown WH, 2002, J CLIN PSYCHIAT, V63, P963, DOI 10.4088/JCP.v63n1102; EMEA-CHMP, 2009, CONC PAP NEED REV NO; French L, TREATMENT COMORBID A; Gaynes BN, 2009, PSYCHIAT SERV, V60, P1439, DOI 10.1176/ps.2009.60.11.1439; Gibson TB, 2010, AM J MANAG CARE, V16, P370; Greenberg P, 2004, PHARMACOECONOMICS, V22, P363, DOI 10.2165/00019053-200422060-00003; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Hirschfeld RMA, 2002, NEUROPSYCHOPHARMACOL; Ivanova JI, 2010, CURR MED RES OPIN, V26, P2475, DOI 10.1185/03007995.2010.517716; Keller MB, 2005, J CLIN PSYCHIAT, V66, P5; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Nemeroff CB, 2007, J CLIN PSYCHIAT, V68, P17; Philip NS, 2010, EXPERT OPIN PHARMACO, V11, P709, DOI 10.1517/14656561003614781; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Souery D, 1999, EUR NEUROPSYCHOPHARM, V9, P83, DOI 10.1016/S0924-977X(98)00004-2; The Global Burden of Disease, 2004, GLOB BURD DIS; Vieta E, 2011, ANN MED, V43, P512, DOI 10.3109/07853890.2011.583675	24	95	95	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76882	10.1371/journal.pone.0076882	http://dx.doi.org/10.1371/journal.pone.0076882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204694	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300060
J	Zhang, H; Taxipalati, M; Yu, LY; Que, F; Feng, FQ				Zhang, Hui; Taxipalati, Maierhaba; Yu, Liyi; Que, Fei; Feng, Fengqin			Structure-Activity Relationship of a U-Type Antimicrobial Microemulsion System	PLOS ONE			English	Article								The structure-activity relationship of a U-type antimicrobial microemulsion system containing glycerol monolaurate and ethanol at a 1: 1 mass ratio as oil phase and Tween 20 as surfactant were investigated along a water dilution line at a ratio of 80: 20 mass% surfactant/oil phase, based on a pseudo-ternary phase diagram. The differential scanning calorimetry results showed that in the region of up to 33% water, all water molecules are confined to the hydrophilic core of the reverse micelles, leading to the formation of w/o microemulsion. As the water content increases, the water gains mobility, and transforms into bicontinuous in the region of 33-39% water, and finally the microemulsion become o/w in the region of above 39% water. The microstructure characterization was confirmed by the dynamic light scattering measurements and freeze-fracture transmission electron microscope observation. The antimicrobial activity assay using kinetics of killing analysis demonstrated that the microemulsions in w/o regions exhibited relatively high antimicrobial activity against Escherichia coli and Staphylococcus aureus due to the antimicrobial oil phase as the continuous phase, while the antimicrobial activity started to decrease when the microemulsions entered the bicontinuous region, and decreased rapidly as the water content increased in the o/w region, as a result of the dilution of antimicrobial oil droplets in the aqueous continuous phase.	[Zhang, Hui; Taxipalati, Maierhaba; Yu, Liyi; Feng, Fengqin] Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Hui; Taxipalati, Maierhaba; Yu, Liyi; Feng, Fengqin] Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Que, Fei] Zhejiang Econ & Trade Polytech, Dept Appl Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Feng, FQ (corresponding author), Zhejiang Univ, Dept Food Sci & Nutr, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	fengfq@zju.edu.cn			National Natural Science Foundation of China [31000818]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (Grant No. 31000818). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Adham ISI, 2000, J APPL MICROBIOL, V89, P32, DOI 10.1046/j.1365-2672.2000.01078.x; Al-Adham ISI, 2003, LETT APPL MICROBIOL, V36, P97, DOI 10.1046/j.1472-765X.2003.01266.x; Schlievert PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040350; SENATRA D, 1991, PROG COLL POL SCI S, V84, P122; Spernath A, 2006, J COLLOID INTERF SCI, V299, P900, DOI 10.1016/j.jcis.2006.02.024; Teixeira PC, 2007, INT J FOOD MICROBIOL, V118, P15, DOI 10.1016/j.ijfoodmicro.2007.05.008; Thevenin MA, 1996, INT J PHARM, V137, P177, DOI 10.1016/0378-5173(96)04518-8; Weast R. C., 1982, HDB CHEM PHYS C; Zhang H, 2010, INT J PHARMACEUT, V395, P154, DOI 10.1016/j.ijpharm.2010.05.022	9	5	7	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76245	10.1371/journal.pone.0076245	http://dx.doi.org/10.1371/journal.pone.0076245			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204605	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300015
J	Weiss, GJ; Liang, WS; Demeure, MJ; Kiefer, JA; Hostetter, G; Izatt, T; Sinari, S; Christoforides, A; Aldrich, J; Kurdoglu, A; Phillips, L; Benson, H; Reiman, R; Baker, A; Marsh, V; Von Hoff, DD; Carpten, JD; Craig, DW				Weiss, Glen J.; Liang, Winnie S.; Demeure, Michael J.; Kiefer, Jeff A.; Hostetter, Galen; Izatt, Tyler; Sinari, Shripad; Christoforides, Alexis; Aldrich, Jessica; Kurdoglu, Ahmet; Phillips, Lori; Benson, Hollie; Reiman, Rebecca; Baker, Angela; Marsh, Vickie; Von Hoff, Daniel D.; Carpten, John D.; Craig, David W.			A Pilot Study Using Next-Generation Sequencing in Advanced Cancers: Feasibility and Challenges	PLOS ONE			English	Article							TRIALS; GENOME	Purpose: New anticancer agents that target a single cell surface receptor, up-regulated or amplified gene product, or mutated gene, have met with some success in treating advanced cancers. However, patients' tumors still eventually progress on these therapies. If it were possible to identify a larger number of targetable vulnerabilities in an individual's tumor, multiple targets could be exploited with the use of specific therapeutic agents, thus possibly giving the patient viable therapeutic alternatives. Experimental Design: In this exploratory study, we used next-generation sequencing technologies (NGS) including whole genome sequencing (WGS), and where feasible, whole transcriptome sequencing (WTS) to identify genomic events and associated expression changes in advanced cancer patients. Results: WGS on paired tumor and normal samples from nine advanced cancer patients and WTS on six of these patients' tumors was completed. One patient's treatment was based on targets and pathways identified by NGS and the patient had a short-lived PET/CT response with a significant reduction in his tumor-related pain. To design treatment plans based on information garnered from NGS, several challenges were encountered: NGS reporting delays, communication of results to out-of-state participants and their treating oncologists, and chain of custody handling for fresh biopsy samples for Clinical Laboratory Improvement Amendments (CLIA) target validation. Conclusion: While the initial effort was a slower process than anticipated due to a variety of issues, we demonstrate the feasibility of using NGS in advanced cancer patients so that treatments for patients with progressing tumors may be improved.	[Weiss, Glen J.; Demeure, Michael J.; Marsh, Vickie; Von Hoff, Daniel D.] Virginia G Piper Canc Ctr Clin Trials Scottsdale, Scottsdale, AZ USA; [Weiss, Glen J.; Liang, Winnie S.; Demeure, Michael J.; Kiefer, Jeff A.; Hostetter, Galen; Izatt, Tyler; Sinari, Shripad; Christoforides, Alexis; Aldrich, Jessica; Kurdoglu, Ahmet; Phillips, Lori; Benson, Hollie; Reiman, Rebecca; Baker, Angela; Von Hoff, Daniel D.; Carpten, John D.; Craig, David W.] Translat Genom Res Inst, Phoenix, AZ USA; [Hostetter, Galen] Van Andel Res Inst, Grand Rapids, MI USA	Translational Genomics Research Institute; Van Andel Institute	Weiss, GJ (corresponding author), Virginia G Piper Canc Ctr Clin Trials Scottsdale, Scottsdale, AZ USA.	glen.weiss@ctca-hope.com	Craig, David Wesley/K-6961-2019; Jeff/ABB-2636-2021	Craig, David Wesley/0000-0003-2040-1955; Jeff/0000-0002-1238-3120	National Foundation of Cancer Research; Lee T. Hanley Fund for Pancreatic Cancer Research	National Foundation of Cancer Research; Lee T. Hanley Fund for Pancreatic Cancer Research	Funding was provided by the National Foundation of Cancer Research (www.nfcr.org) and the Lee T. Hanley Fund for Pancreatic Cancer Research (http://www.tgenfoundation.org/netcommunity/page.aspx?pid = 1196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzeid WM, 2009, J CLIN INVEST, V119, P1974, DOI 10.1172/JCI33816; Arora S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045614; Cherni I, 2012, CANC RES, V72; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; Dopeso H, 2010, CLIN CANCER RES, V16, P2375, DOI 10.1158/1078-0432.CCR-09-3275; ESTEY E, 1986, CANCER TREAT REP, V70, P1105; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Horstmann E, 2005, NEW ENGL J MED, V352, P895, DOI 10.1056/NEJMsa042220; Liang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043192; Smith TL, 1996, J CLIN ONCOL, V14, P287, DOI 10.1200/JCO.1996.14.1.287; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; Von Hoff DD, 2010, J CLIN ONCOL, V28, P4877, DOI 10.1200/JCO.2009.26.5983; Weiss GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037029; Weiss GJ, 2011, J THORAC ONCOL, V6, pS1302; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10	15	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e76438	10.1371/journal.pone.0076438	http://dx.doi.org/10.1371/journal.pone.0076438			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204627	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500007
J	Liu, SR; Li, WY; Long, D; Hu, CG; Zhang, JZ				Liu, Sheng-Rui; Li, Wen-Yang; Long, Dang; Hu, Chun-Gen; Zhang, Jin-Zhi			Development and Characterization of Genomic and Expressed SSRs in Citrus by Genome-Wide Analysis	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; MICROSATELLITE MARKERS; IDENTIFICATION; GENES; TAGS; SELECTION; NUMBER; BARLEY; MAIZE; RICE	Microsatellites or simple sequence repeats (SSRs) are one of the most popular sources of genetic markers and play a significant role in plant genetics and breeding. In this study, we identified citrus SSRs in the genome of Clementine mandarin and analyzed their frequency and distribution in different genomic regions. A total of 80,708 SSRs were detected in the genome with an overall density of 268 SSRs/Mb. While di-nucleotide repeats were the most frequent microsatellites in genomic DNA sequence, tetra-nucleotides, which had more repeat units than any other SSR types, had the highest cumulative sequence length. We identified 6,834 transcripts as containing 8,989 SSRs in 33,929 Clementine mandarin transcripts, among which, tri-nucleotide motifs (36.0%) were the most common, followed by di-nucleotide (26.9%) and hexa-nucleotide motifs (15.1%). The motif AG (16.7%) was most abundant among these SSRs, while motifs AAG (6.6%), AAT (5.0%), and TAG (2.2%) were most common among tri-nucleotides. Functional categorization of transcripts containing SSRs revealed that 5,879 (86.0%) of such transcripts had homology with known proteins, GO and KEGG annotation revealed that transcripts containing SSRs were those implicated in diverse biological processes in plants, including binding, development, transcription, and protein degradation. When 27 genomic and 78 randomly selected SSRs were tested on Clementine mandarin, 95 SSRs revealed polymorphism. These 95 SSRs were further deployed on 18 genotypes of the three generas of Rutaceae for the genetic diversity assessment, genomic SSRs generally show low transferability in comparison to SSRs developed from expressed sequences. These transcript-markers identified in our study may provide a valuable genetic and genomic tool for further genetic research and varietal development in citrus, such as diversity study, QTL mapping, molecular breeding, comparative mapping and other genetic analyses.	[Liu, Sheng-Rui; Li, Wen-Yang; Long, Dang; Hu, Chun-Gen; Zhang, Jin-Zhi] Huazhong Agr Univ, Coll Hort & Forestry Sci, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China	Huazhong Agricultural University	Zhang, JZ (corresponding author), Huazhong Agr Univ, Coll Hort & Forestry Sci, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China.	jinzhizhang@mail.hzau.edu.cn		Zhang, Jin-Zhi/0000-0002-3820-889X	Fundamental Research Funds for the Central Universities [2013PY083]; National Natural Science Foundation of China [31071777, 31130046, 31101528]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported financially by the Fundamental Research Funds for the Central Universities (2013PY083) and the National Natural Science Foundation of China (grant nos. 31071777, 31130046, and 31101528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar MH, 2011, SCI HORTIC-AMSTERDAM, V128, P220, DOI 10.1016/j.scienta.2011.01.021; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; [Anonymous], 1999, POPGENE VERSION 1 3; Bao JS, 2002, THEOR APPL GENET, V105, P898, DOI 10.1007/s00122-002-1049-3; Cardle L, 2000, GENETICS, V156, P847; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chen CX, 2008, TREE GENET GENOMES, V4, P1, DOI 10.1007/s11295-007-0083-3; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Cheng YunJiang, 2003, Plant Molecular Biology Reporter, V21, p177a, DOI 10.1007/BF02774246; Collard B, 2013, DEV NEW FLOOD TOLERA, P42; Coulibaly I, 2005, ANIM GENET, V36, P309, DOI 10.1111/j.1365-2052.2005.01305.x; Deng XiuXin, 2005, Acta Horticulturae Sinica, V32, P1140; Dresselhaus T, 1999, MOL GEN GENET, V261, P416, DOI 10.1007/s004380050983; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Geuna F, 2003, PLANT BREEDING, V122, P526, DOI 10.1111/j.1439-0523.2003.00897.x; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; Gupta HS, 2009, CURR SCI INDIA, V96, P230; Gupta PK, 2000, EUPHYTICA, V113, P163, DOI 10.1023/A:1003910819967; Holton TA, 2002, MOL BREEDING, V9, P63, DOI 10.1023/A:1026785207878; Johnson R., 2004, Plant Breeding Reviews, V24, P293; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; KIMURA M, 1964, GENETICS, V49, P725; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; Lewontin R.C., 1972, NATURE, V236, P181, DOI DOI 10.1038/236181A0; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Metzgar D, 2000, GENOME RES, V10, P72; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mun JH, 2006, GENETICS, V172, P2541, DOI 10.1534/genetics.105.054791; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1983, GENETICS, V105, P207; Newcomb RD, 2006, PLANT PHYSIOL, V141, P147, DOI 10.1104/pp.105.076208; Palmieri DA, 2007, GENET MOL BIOL, V30, P1009, DOI 10.1590/S1415-47572007000500029; Pashley CH, 2006, J HERED, V97, P381, DOI 10.1093/jhered/esl013; Qureshi S. N., 2004, Journal of Cotton Science, V8, P112; Schmid R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-180; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Trifonov EN, 2004, EVOLUTIONARY THEORY AND PROCESSES: MODERN HORIZONS, P115; Ueno S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-136; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhao SF, 2011, INT J ONCOL, V38, P1319, DOI 10.3892/ijo.2011.965; Zhao YL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-237	47	53	59	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e75149	10.1371/journal.pone.0075149	http://dx.doi.org/10.1371/journal.pone.0075149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204572	Green Submitted, Green Published, gold			2022-12-27	WOS:000326241200003
J	Wang, HJ; Ye, F; Wang, Y; Huntington, D				Wang, Haijun; Ye, Fang; Wang, Yan; Huntington, Dale		Study Grp Econ Impact Maternal	Economic Impact of Maternal Death on Households in Rural China: A Prospective Cohort Study	PLOS ONE			English	Article							EMERGENCY OBSTETRIC CARE; HEALTH-CARE; MORTALITY; INCOME	Objective: To assess the economic impact of maternal death on rural Chinese households during the year after maternal death. Methods: A prospective cohort study matched 183 households who had suffered a maternal death to 346 households that experienced childbirth without maternal death in rural areas of three provinces in China. Surveys were conducted at baseline (1-3 months after maternal death or childbirth) and one year after baseline using the quantitative questionnaire. We investigated household income, expenditure, accumulated debts, and self-reported household economic status. Difference-in-Difference (DID), linear regression, and logistic regression analyses were used to compare the economic status between households with and without maternal death. Findings: The households with maternal death had a higher risk of self-reported "household economy became worse'' during the follow-up period (adjusted OR = 6.04, p<0.001). During the follow-up period, at the household level, DID estimator of income and expenditure showed that households with maternal death had a significant relative reduction of US$ 869 and US$ 650, compared to those households that experienced childbirth with no adverse event (p<0.001). Converted to proportions of change, an average of 32.0% reduction of annual income and 24.9% reduction of annual expenditure were observed in households with a maternal death. The mean increase of accumulated debts in households with a maternal death was 3.2 times as high as that in households without maternal death (p=0.024). Expenditure pattern of households with maternal death changed, with lower consumption on food (p=0.037), clothes and commodity (p=0.003), traffic and communication (p=0.022) and higher consumption on cigarette or alcohol (p=0.014). Conclusion: Compared with childbirth, maternal death had adverse impact on household economy, including higher risk of self-reported "household economy became worse'', decreased income and expenditure, increased debts and changed expenditure pattern.	[Wang, Haijun; Ye, Fang; Wang, Yan] Peking Univ, Sch Publ Hlth, Div Maternal & Child Hlth, Beijing 100871, Peoples R China; [Huntington, Dale] World Hlth Org Western Pacific Reg Off, Asia Pacific Observ Hlth Syst & Policies, Manila, Philippines	Peking University; World Health Organization	Wang, Y (corresponding author), Peking Univ, Sch Publ Hlth, Div Maternal & Child Hlth, Beijing 100871, Peoples R China.	wangyan@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021	Wang, Haijun/0000-0003-0849-2903	United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland;  [A65403]	United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland; 	The study was supported by a grant from the United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland (http://www.who.int/reproductivehealth/en/). The Grant number is A65403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth M, 1998, IMPACT ADULT DEATHS; Arsenault C, 2013, B WORLD HEALTH ORGAN, V91, P207, DOI 10.2471/BLT.12.108969; Bachmann MO, 2004, AIDS CARE, V16, P817, DOI 10.1080/09540120412331290220; Basu A, 1998, WORKSH CONS PREGN MA; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Feng XL, 2010, HEALTH ECON, V19, P69, DOI 10.1002/hec.1593; GERTLER P, 2003, LOSING PRESENCE PRES; Greene M.E., 2005, POVERTY REDUCTION DO; Islam MK, 2006, COSTS MATERNAL NEWBO; Justine H, 2012, LANCET, V380, P1157, DOI [10.1016/S0140-6736(12)61415-9, DOI 10.1016/S0140-6736(12)61415-9]; Liu XN, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-566; Long QA, 2010, TROP MED INT HEALTH, V15, P1210, DOI 10.1111/j.1365-3156.2010.02602.x; Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381; Over M, 1997, IMPACT ADULT MORTALI; Prescott N, 1999, INT DEV BANK C SOC P; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; State Statistical Bureau, 2010, CHIN STAT YB; State Statistical Bureau, 2012, CHIN STAT YB; Storeng KT, 2008, SOC SCI MED, V66, P545, DOI 10.1016/j.socscimed.2007.10.001; Wagstaff A, 2009, J HEALTH ECON, V28, P1, DOI 10.1016/j.jhealeco.2008.10.007; Wooldridge JM, 2002, INTRO ECONOMETRICS M; WOOLLEY FR, 1994, REV INCOME WEALTH, P415; Ye F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038467	25	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76624	10.1371/journal.pone.0076624	http://dx.doi.org/10.1371/journal.pone.0076624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241FR	24204648	Green Published, gold			2022-12-27	WOS:000326152300008
J	Yang, W; Wu, JM; Bi, AD; Ou-Yang, YC; Shen, HH; Chirn, GW; Zhou, JH; Weiss, E; Holman, EP; Liao, DJ				Yang, Wei; Wu, Jian-min; Bi, An-ding; Ou-yang, Yong-chang; Shen, Hai-hong; Chirn, Gung-wei; Zhou, Jian-hua; Weiss, Emily; Holman, Emily Pauline; Liao, D. Joshua			Possible Formation of Mitochondrial-RNA Containing Chimeric or Trimeric RNA Implies a Post-Transcriptional and Post-Splicing Mechanism for RNA Fusion	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; COPY NUMBER; EXPRESSION; TRANSCRIPTOME; GENOME; CANCER; GENES; DISEASE; BREAST; TUMORS	Human cells are known to express many chimeric RNAs, i.e. RNAs containing two genes' sequences. Wondering whether there also is trimeric RNA, i.e. an RNA containing three genes' sequences, we wrote simple computer code to screen human expression sequence tags (ESTs) deposited in different public databases, and obtained hundreds of putative trimeric ESTs. We then used NCBI Blast and UCSC Blat browsers to further analyze their sequences, and identified 61 trimeric and two tetrameric ESTs (one EST containing four different sequences). We also identified 57 chimeric, trimeric or teterameric ESTs that contained both mitochondrial (mt) RNA and nuclear RNA (nRNA), i.e. were mtRNA-nRNA fusions. In some trimeric ESTs, the downstream partner was fused to the poly-A tail of the upstream partner, which, together with the mtRNA-nRNA fusions, suggests a possible new mechanism for RNA fusion that occurs after both transcription and splicing have been terminated, and possibly outside the nucleus, in contrast to the two current hypothetical mechanisms, trans-splicing and transcriptional-slippage, that occur in the nucleus. The mt-sequences in the mtRNA-nRNA fusions had pseudogenes in the nucleus but, surprisingly, localized mainly in chromosomes 1 and 5. In some mtRNA-nRNA fusions, as well as in some ESTs that were derived only from mtRNA, the mt-sequences might be cis- or trans-spliced. Actually, we cloned a new cis-spliced mtRNA, coined as 16SrRNA-s. Hence, mtDNA may not always be intron-less. Fusion of three or more RNAs to one, fusion of nRNA to mtRNA, and cis- or trans-splicing of mtRNA should all enlarge the cellular RNA repertoire, in turn enlarging the cellular functions. Therefore, future experimental verification of the existence of these novel classes of fusion RNAs and spliced mtRNAs in human cells should significantly advance our understanding of biology and medicine.	[Yang, Wei; Wu, Jian-min] Guangxi Vet Res Inst, Nanning, Guangxi, Peoples R China; [Bi, An-ding; Ou-yang, Yong-chang; Weiss, Emily; Holman, Emily Pauline; Liao, D. Joshua] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Shen, Hai-hong] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Chirn, Gung-wei] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Zhou, Jian-hua] Nantong Univ, Nantong, Jiangsu, Peoples R China	Guangxi Veterinary Research Institute; University of Minnesota System; Gwangju Institute of Science & Technology (GIST); Boston University; Nantong University	Yang, W (corresponding author), Guangxi Vet Res Inst, Nanning, Guangxi, Peoples R China.	gxyangwei@163.com; djliao@hi.umn.edu			Department of Defense of United States [W81XWH-11-1-0119]	Department of Defense of United States	This work was supported by a grant from the Department of Defense of United States (DOD Award W81XWH-11-1-0119) to DJL. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641; Aral C, 2010, GENET MOL BIOL, V33, P1, DOI 10.1590/S1415-47572009005000102; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Burzio VA, 2009, P NATL ACAD SCI USA, V106, P9430, DOI 10.1073/pnas.0903086106; Celestino R, 2012, GENE CHROMOSOME CANC, V51, P1154, DOI 10.1002/gcc.22003; Charlesworth A, 2013, WIRES RNA, V4, P437, DOI 10.1002/wrna.1171; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; Farre JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052644; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Grewe F, 2011, NUCLEIC ACIDS RES, V39, P2890, DOI 10.1093/nar/gkq1227; Jackson CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056777; Landerer E, 2011, CELL ONCOL, V34, P297, DOI 10.1007/s13402-011-0018-8; Lasda EL, 2011, WIRES RNA, V2, P417, DOI 10.1002/wrna.71; Lebedeva MA, 2007, CELL CYCLE, V6, P2048, DOI 10.4161/cc.6.16.4572; Li X, 2009, J MOL EVOL, V68, P56, DOI 10.1007/s00239-008-9187-0; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Nicholls TJ, 2013, INT J BIOCHEM CELL B, V45, P845, DOI 10.1016/j.biocel.2013.01.005; Pink JJ, 1997, BRIT J CANCER, V75, P17, DOI 10.1038/bjc.1997.4; Pink JJ, 1996, NUCLEIC ACIDS RES, V24, P962, DOI 10.1093/nar/24.5.962; Rackham O, 2012, WIRES RNA, V3, P675, DOI 10.1002/wrna.1128; Ramos A, 2011, MITOCHONDRION, V11, P946, DOI 10.1016/j.mito.2011.08.009; Rorbach J, 2012, BIOCHEM J, V444, P357, DOI 10.1042/BJ20112208; Seligmann H, 2013, J THEOR BIOL, V324, P1, DOI 10.1016/j.jtbi.2013.01.024; Seligmann H, 2012, J THEOR BIOL, V315, P38, DOI 10.1016/j.jtbi.2012.08.044; Sun Y, 2013, ONCOGENE, V32, P1794, DOI 10.1038/onc.2012.200; Sun Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.-pone.0041659, DOI 10.1371/J0URNAL.-P0NE.0041659]; Sun Y, 2012, J CANCER, V3, P93, DOI 10.7150/jca.4163; Szczesny RJ, 2013, BBA-GENE REGUL MECH, V1829, P842, DOI 10.1016/j.bbagrm.2013.02.009; Tonska K, 2012, GENE, V506, P161, DOI 10.1016/j.gene.2012.06.081; Tsuji J, 2012, NUCLEIC ACIDS RES, V40, P9073, DOI 10.1093/nar/gks424; VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122; Villegas J, 2000, DNA CELL BIOL, V19, P579, DOI 10.1089/104454900439809; Villegas J, 2007, NUCLEIC ACIDS RES, V35, P7336, DOI 10.1093/nar/gkm863; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Woischnik M, 2002, GENOME RES, V12, P885, DOI 10.1101/gr.227202; Yang M, 2012, MOL BIOL REP, V39, P9247, DOI 10.1007/s11033-012-1798-2; Yang M, 2011, J CANCER, V2, P386, DOI 10.7150/jca.2.386; Yuan CF, 2013, RNA BIOL, V10, P958, DOI 10.4161/rna.24570	39	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77016	10.1371/journal.pone.0077016	http://dx.doi.org/10.1371/journal.pone.0077016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204722	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300013
J	Andries, A; Isaakidis, P; Das, M; Khan, S; Paryani, R; Desai, C; Dalal, A; Mansoor, H; Verma, R; Fernandes, D; Sotgiu, G; Migliori, GB; Saranchuk, P				Andries, Aristomo; Isaakidis, Petros; Das, Mrinalini; Khan, Samsuddin; Paryani, Roma; Desai, Chitranjan; Dalal, Alpa; Mansoor, Homa; Verma, Reena; Fernandes, Dolorosa; Sotgiu, Giovanni; Migliori, Giovanni B.; Saranchuk, Peter			High Rate of Hypothyroidism in Multidrug-Resistant Tuberculosis Patients Co-Infected with HIV in Mumbai, India	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; MDR-TB; ANTIRETROVIRAL THERAPY; INCREASED PREVALENCE; ETHIONAMIDE; METAANALYSIS; GUIDELINES; ENDOCRINE; REGIMENS; EFFICACY	Background: Adverse events (AEs) among HIV-infected patients with multidrug-resistant tuberculosis (MDR-TB) receiving anti-TB and antiretroviral treatments (ART) are under-researched and underreported. Hypothyroidism is a common AE associated with ethionamide, p-aminosalicylic acid (PAS), and stavudine. The aim of this study was to determine the frequency of and risk factors associated with hypothyroidism in HIV/MDR-TB co-infected patients. Methods: This was a prospective, observational cohort study, using routine laboratory data in a Medecins Sans Frontieres (MSF) clinic in collaboration with Sewri TB Hospital, Mumbai, India. Hypothyroidism was defined as a thyroid stimulating hormone (TSH) result >10 mIU/L at least once during treatment. Patients having a baseline result and one additional result after 3 months were eligible for enrolment. Results: Between October 2006 and March 2013, 116 patients were enrolled, 69 of whom were included. The median (IQR) age was 38 years (34-43) and 61% were male. By March 2013, 37/69 (54%) had hypothyroidism after at least 90 days of treatment. Age, gender, CD4 counts and stavudine-based ART were not associated with the occurrence of hypothyroidism in multivariate models. The co-administration of PAS and ethionamide was found to double the risk of hypothyroidism (RR: 1.93, 95% CI: 1.06-3.54). Discussion: High rate of hypothyroidism was recorded in a Mumbai cohort of MDR-TB/HIV co-infected patients on treatment. This is a treatable and reversible AE, however, it may go undiagnosed in the absence of regular monitoring. Care providers should not wait for clinical symptoms, as this risks compromising treatment adherence. Simple, affordable and reliable point-of-care tools for measuring TSH are needed, especially in high MDR-TB burden countries. Our findings suggest the need for TSH screening at baseline, three months, six months, and every six months thereafter for HIV-infected patients on MDR-TB treatment regimens containing PAS and/or ethionamide, until newer, safer and more efficacious MDR-TB regimens become available.	[Andries, Aristomo; Isaakidis, Petros; Das, Mrinalini; Khan, Samsuddin; Paryani, Roma; Mansoor, Homa; Verma, Reena; Fernandes, Dolorosa] Med Sans Frontieres, Mumbai, Maharashtra, India; [Desai, Chitranjan; Dalal, Alpa] Sewri GTB Hosp, Chest Dept, Mumbai, Maharashtra, India; [Sotgiu, Giovanni] Univ Sassari, Epidemiol & Med Stat Unit, Dept Biomed Sci, Res Med Educ & Profess Dev Unit,AOU, I-07100 Sassari, Italy; [Migliori, Giovanni B.] World Hlth Org Collaborating Ctr TB & Lung Dis, S Maugeri Fdn, Tradate, Italy; [Saranchuk, Peter] Med Sans Frontieres, SAMU, Cape Town, South Africa	University of Sassari; Istituti Clinici Scientifici Maugeri IRCCS; World Health Organization	Isaakidis, P (corresponding author), Med Sans Frontieres, Mumbai, Maharashtra, India.	msfocb-asia-epidemio@brussels.msf.org	Migliori, Giovanni Battista/AAB-8589-2020; Sotgiu, Giovanni/N-1032-2017	Migliori, Giovanni Battista/0000-0002-2597-574X; Sotgiu, Giovanni/0000-0002-1600-4474; Isaakidis, Petros/0000-0002-7881-1554				Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Alsaad N, 2013, EUR RESPIR J, V42, P504, DOI 10.1183/09031936.00114812; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Beltran S, 2003, CLIN INFECT DIS, V37, P579, DOI 10.1086/376626; Brust JCM, 2013, JAIDS-J ACQ IMM DEF, V62, P436, DOI 10.1097/QAI.0b013e31828175ed; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Central TBDivision, 2012, REV NAT TUB CONTR PR; CURRY FJ, 2008, DRUG RESISTANT TUBER; De Benoist B., 2004, IODINE STATUS WORLDW; De Lorenzo S, 2013, EUR RESPIR J, V41, P1386, DOI 10.1183/09031936.00124312; Do HM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-154; DRUCKER D, 1984, ANN INTERN MED, V100, P837, DOI 10.7326/0003-4819-100-6-837; Dutta BS, 2012, INT J TUBERC LUNG D, V16, P141, DOI 10.5588/ijtld.11.0388; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Falzon D, 2013, EUR RESPIR J, V42, P156, DOI 10.1183/09031936.00134712; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Grappin M, 2000, AIDS, V14, P1070, DOI 10.1097/00002030-200005260-00026; Gupta J, 2012, INT J TUBERC LUNG D, V16, P1278, DOI 10.5588/ijtld.12.0305; Heufelder AE, 1996, EUR J ENDOCRINOL, V134, P669, DOI 10.1530/eje.0.1340685; Isaakidis P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040781; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115; Kosack CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033704; LOPRESTI JS, 1989, ANN INTERN MED, V110, P970, DOI 10.7326/0003-4819-110-12-970; MACGREGOR AG, 1954, LANCET, V2, P931; McDonnell ME, 2005, NEW ENGL J MED, V352, P2757, DOI 10.1056/NEJM200506303522621; Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312; Modongo C, 2012, INT J TUBERC LUNG D, V16, P1561, DOI 10.5588/ijtld.12.0403; RAFFI F, 1991, AIDS, V5, P729, DOI 10.1097/00002030-199106000-00013; Satti H, 2012, INT J TUBERC LUNG D, V16, P468, DOI 10.5588/ijtld.11.0615; Sellmeyer DE, 1996, ENDOCR REV, V17, P518, DOI 10.1210/er.17.5.518; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Shin SS, 2007, INT J TUBERC LUNG D, V11, P1314; Sotgiu G, 2012, EUR RESPIR J, V40, P1430, DOI 10.1183/09031936.00022912; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2008, WHOHTMTB2008402; Yaqoob A., 2012, J PUBLIC HLTH BIOL S, V1, P53	38	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78313	10.1371/journal.pone.0078313	http://dx.doi.org/10.1371/journal.pone.0078313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194919	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000098
J	Braima, KA; Sum, JS; Ghazali, ARM; Muslimin, M; Jeffery, J; Lee, WC; Shaker, MR; Elamin, AEM; Jamaiah, I; Lau, YL; Rohela, M; Kamarulzaman, A; Sitam, F; Mohd-Noh, R; Abdul-Aziz, NM				Braima, Kamil A.; Sum, Jia-Siang; Ghazali, Amir-Ridhwan M.; Muslimin, Mustakiza; Jeffery, John; Lee, Wenn-Chyau; Shaker, Mohammed R.; Elamin, Alaa-Eldeen M.; Jamaiah, Ibrahim; Lau, Yee-Ling; Rohela, Mahmud; Kamarulzaman, Adeeba; Sitam, Frankie; Mohd-Noh, Rosnida; Abdul-Aziz, Noraishah M.			Is There a Risk of Suburban Transmission of Malaria in Selangor, Malaysia?	PLOS ONE			English	Article							PLASMODIUM-KNOWLESI; INFECTIONS	Background: The suburban transmission of malaria in Selangor, Malaysia's most developed and populous state still remains a concern for public health in this region. Despite much successful control efforts directed at its reduction, sporadic cases, mostly brought in by foreigners have continued to occur. In addition, cases of simian malaria caused by Plasmodium knowlesi, some with fatal outcome have caused grave concern to health workers. The aim of this study was to investigate the possibility of local malaria transmission in suburban regions of Selangor, which are adjacent to secondary rainforests. Findings: A malaria survey spanning 7 years (2006 - 2012) was conducted in Selangor. A total of 1623 laboratory confirmed malaria cases were reported from Selangor's nine districts. While 72.6% of these cases (1178/1623) were attributed to imported malaria (cases originating from other countries), 25.5% (414/1623) were local cases and 1.9% (31/1623) were considered as relapse and unclassified cases combined. In this study, the most prevalent infection was P. vivax (1239 cases, prevalence 76.3%) followed by P. falciparum (211, 13.0%), P. knowlesi (75, 4.6%), P. malariae (71, 4.4%) and P. ovale (1, 0.06%). Mixed infections comprising of P. vivax and P. falciparum were confirmed (26, 1.6%). Entomological surveys targeting the residences of malaria patients' showed that the most commonly trapped Anopheles species was An. maculatus. No oocysts or sporozoites were found in the An. maculatus collected. Nevertheless, the possibility of An. maculatus being the malaria vector in the investigated locations was high due to its persistent occurrence in these areas. Conclusions: Malaria cases reported in this study were mostly imported cases. However the co-existence of local cases and potential Plasmodium spp. vectors should be cause for concern. The results of this survey reflect the need of maintaining closely monitored malaria control programs and continuous extensive malaria surveillance in Peninsula Malaysia.	[Braima, Kamil A.; Sum, Jia-Siang; Ghazali, Amir-Ridhwan M.; Muslimin, Mustakiza; Jeffery, John; Lee, Wenn-Chyau; Shaker, Mohammed R.; Jamaiah, Ibrahim; Lau, Yee-Ling; Rohela, Mahmud; Abdul-Aziz, Noraishah M.] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Elamin, Alaa-Eldeen M.] Univ Malaya, Dept Civil Engn, Fac Engn, Kuala Lumpur, Malaysia; [Kamarulzaman, Adeeba] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Sitam, Frankie] Dept Wildlife & Natl Pk Peninsular Malaysia, Kuala Lumpur, Malaysia; [Mohd-Noh, Rosnida] Univ Teknol MARA UiTM, Fac Med, Sungai Buloh, Selangor, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Abdul-Aziz, NM (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	noisha@ummc.edu.my	ABDUL-AZIZ, NORAISHAH MYDIN/B-9337-2010; Shaker, Mohammed/AAI-9852-2021; Sitam, Frankie Thomas/AAF-6279-2021; KAMARULZAMAN, ADEEBA/B-5216-2010; Sum, Jia Siang/ABA-1036-2020; Lau, Yee Ling/C-6996-2009; LEE, Wenn-Chyau/AAR-4072-2020	ABDUL-AZIZ, NORAISHAH MYDIN/0000-0002-2447-3211; Shaker, Mohammed/0000-0002-3675-4598; Sitam, Frankie Thomas/0000-0001-7160-6243; Sum, Jia Siang/0000-0003-3621-1021; Lau, Yee Ling/0000-0002-2037-2165; LEE, Wenn-Chyau/0000-0002-7324-5792; Mohd Ghazali, Amir Ridhwan/0000-0001-6885-3606; Braima, Kamil A./0000-0003-2529-2313	University Malaya Postgraduate Research Fund [PV052/2012A]; University Malaya High-Impact Research [UM.C/HIR/MOHE/MED/18]; University of Malaya FRGS [FP036/2010A, FP022/2010B]; Peruntukan Penyelidikan Jangka Pendek (PJP); Universiti Malaya [FS344/2008C]	University Malaya Postgraduate Research Fund; University Malaya High-Impact Research; University of Malaya FRGS(Universiti Malaya); Peruntukan Penyelidikan Jangka Pendek (PJP); Universiti Malaya(Universiti Malaya)	This work was supported by grants from the University Malaya Postgraduate Research Fund (PV052/2012A); and University Malaya High-Impact Research (UM.C/HIR/MOHE/MED/18); University of Malaya FRGS 2010 (FP036/2010A); University of Malaya FRGS 2010 (FP022/2010B); Peruntukan Penyelidikan Jangka Pendek 2008 (PJP); Universiti Malaya (FS344/2008C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2011, MALARIA J, V10, P1, DOI [10.1186/1475-2875-10-1, DOI 10.1186/1475-2875-10-1.PUBMED:21214892]; Census Malaysia, 2010, POP DISTR BAS DEM CH; CHIN W, 1965, SCIENCE, V149, P865, DOI 10.1126/science.149.3686.865; CHIN W, 1968, AM J TROP MED HYG, V17, P355, DOI 10.4269/ajtmh.1968.17.355; Cox-Singh J, 2012, CURR OPIN INFECT DIS, V25, P530, DOI 10.1097/QCO.0b013e3283558780; ESRI, 2006, ARCGIS 9 2; Garske T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056487; Hafiz H, 2012, HLTH ENV, V3, P46; Hodgkin Ernest P, 1956, TRANSMISSION MALARIA; Jamaiah I, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P60; Jamaiah I, 2007, SE ASIAN J TROP MED, V38, P1; Jamaiah I, 2006, SE ASIAN J TROP MED; Jeffery J., 2012, ILLUSTRATED KEYS SOM; Jiang N, 2010, EMERG INFECT DIS, V16, P1476, DOI 10.3201/eid1609.100339; Jongwutiwes S, 2004, EMERG INFECT DIS, V10, P2211, DOI 10.3201/eid1012.040293; Kantele A, 2008, EMERG INFECT DIS, V14, P1434, DOI 10.3201/eid1409.080170; Kaur G, 2009, TROP BIOMED, V26, P57; Lee C E, 2010, Med J Malaysia, V65, P63; Lloyd O. L., 1994, Journal of the Hong Kong Medical Association, V46, P3; Luchavez J, 2008, EMERG INFECT DIS, V14, P811, DOI 10.3201/eid1405.071407; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; Masitah M., 2008, J HLTH TRANSLATIONAL, V11, P53; Ng OT, 2008, EMERG INFECT DIS, V14, P814, DOI 10.3201/eid1405.070863; Norhayati M, 2001, Med J Malaysia, V56, P271; Pinedo-Cancino V, 2006, AM J TROP MED HYG, V75, P238, DOI 10.4269/ajtmh.2006.75.238; Rahman Wahab A., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P599; REID JA, 1968, STUDIES I MED RES MA, V31; Sandosham AA., 1983, MALARIOLOGY SPECIAL; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh J., 1988, World Health Organization, WHO/VBC, V88, P1; Singh J., 1988, CASE HIST MALARIA VE; Sinton J, 1932, REC MAL SURV IND, P381; Van den Eede P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-249; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vythilingam I, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-26; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Zhu Huai-min, 2006, Chinese Journal of Parasitology and Parasitic Diseases, V24, P70	37	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77924	10.1371/journal.pone.0077924	http://dx.doi.org/10.1371/journal.pone.0077924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194901	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000080
J	Stoppelenburg, AJ; Salimi, V; Hennus, M; Plantinga, M; in 't Veld, RH; Walk, J; Meerding, J; Coenjaerts, F; Bont, L; Boes, M				Stoppelenburg, Arie Jan; Salimi, Vahid; Hennus, Marije; Plantinga, Maud; in 't Veld, Ron Huis; Walk, Jona; Meerding, Jenny; Coenjaerts, Frank; Bont, Louis; Boes, Marianne			Local IL-17A Potentiates Early Neutrophil Recruitment to the Respiratory Tract during Severe RSV Infection	PLOS ONE			English	Article							SYNCYTIAL VIRUS BRONCHIOLITIS; COLONY-STIMULATING FACTOR; T-CELLS; VIRAL-INFECTION; GENE-EXPRESSION; MESSENGER-RNA; LUNG; INFLAMMATION; CHEMOKINE; INFANTS	Respiratory syncytial virus (RSV) bronchiolitis triggers a strong innate immune response characterized by excessive neutrophil infiltration which contributes to RSV induced pathology. The cytokine IL-17A enhances neutrophil infiltration into virus infected lungs. IL-17A is however best known as an effector of adaptive immune responses. The role of IL-17A in early immune modulation in RSV infection is unknown. We aimed to elucidate whether local IL-17A facilitates the innate neutrophil infiltration into RSV infected lungs prior to adaptive immunity. To this end, we studied IL-17A production in newborns that were hospitalized for severe RSV bronchiolitis. In tracheal aspirates we measured IL-17A concentration and neutrophil counts. We utilized cultured human epithelial cells to test if IL-17A regulates RSV infection-induced IL-8 release as mediator of neutrophil recruitment. In mice we investigated the cell types that are responsible for early innate IL-17A production during RSV infection. Using IL-17A neutralizing antibodies we tested if IL-17A is responsible for innate neutrophil infiltration in mice. Our data show that increased IL-17A production in newborn RSV patient lungs correlates with subsequent neutrophil counts recruited to the lungs. IL-17A potentiates RSV-induced production of the neutrophil-attracting chemokine IL-8 by airway epithelial cells in vitro. Various lung-resident lymphocytes produced IL-17A during early RSV infection in Balb/c mice, of which a local population of CD4 T cells stood out as the predominant RSV-induced cell type. By removing IL-17A during early RSV infection in mice we showed that IL-17A is responsible for enhanced innate neutrophil infiltration in vivo. Using patient material, in vitro studies, and an animal model of RSV infection, we thus show that early local IL-17A production in the airways during RSV bronchiolitis facilitates neutrophil recruitment with pathologic consequences to infant lungs.	[Stoppelenburg, Arie Jan; Salimi, Vahid; Plantinga, Maud; in 't Veld, Ron Huis; Walk, Jona; Meerding, Jenny; Boes, Marianne] Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Salimi, Vahid] Univ Tehran Med Sci, Dept Virol, Tehran, Iran; [Hennus, Marije] Univ Med Ctr Utrecht, Dept Pediat Intens Care, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Coenjaerts, Frank] Univ Med Ctr Utrecht, Dept Virol, Utrecht, Netherlands; [Bont, Louis] Univ Med Ctr Utrecht, Dept Pediat, Utrecht, Netherlands; [Bont, Louis] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Tehran University of Medical Sciences; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Boes, M (corresponding author), Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, Wilhelmina Childrens Hosp, Utrecht, Netherlands.	M.L.Boes@umcutrecht.nl	Stoppelenburg, Arie/AAR-4381-2020; Walk, Jona/G-2793-2016; Hennus, Marije/D-1643-2014	Stoppelenburg, Arie/0000-0002-1969-6146; Walk, Jona/0000-0002-9420-4578; Salimi, Vahid/0000-0002-8541-7846; Boes, Marianne/0000-0003-2590-1692; Hennus, Marije/0000-0003-1508-0456	WKZ [R1812]	WKZ	This study was funded by the WKZ research fund (grant number R1812). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bera MM, 2011, J IMMUNOL, V187, P4245, DOI 10.4049/jimmunol.1101789; Cheng P, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-38; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; de Jager W, 2005, J IMMUNOL METHODS, V300, P124, DOI 10.1016/j.jim.2005.03.009; de Pol ACV, 2010, J CLIN MICROBIOL, V48, P3569, DOI 10.1128/JCM.00097-10; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Faber TE, 2012, J MED VIROL, V84, P1084, DOI 10.1002/jmv.23291; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fiedler MA, 1995, AM J PHYSIOL-LUNG C, V269, pL865, DOI 10.1152/ajplung.1995.269.6.L865; Franz A, 2010, J CLIN VIROL, V48, P239, DOI 10.1016/j.jcv.2010.05.007; Halfhide CP, 2011, J INFECT DIS, V204, P451, DOI 10.1093/infdis/jir280; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hashimoto K, 2005, J ALLERGY CLIN IMMUN, V116, P550, DOI 10.1016/j.jaci.2005.03.051; Hashimoto K, 2004, AM J RESP CRIT CARE, V170, P306, DOI 10.1164/rccm.200301-030OC; Heidema J, 2007, J IMMUNOL, V179, P8410, DOI 10.4049/jimmunol.179.12.8410; Houben ML, 2010, J MED VIROL, V82, P1266, DOI 10.1002/jmv.21771; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Kallal LE, 2010, J IMMUNOL, V185, P4137, DOI 10.4049/jimmunol.1000677; Kim JS, 2011, J EXP MED, V208, P2201, DOI 10.1084/jem.20110680; Laan M, 1999, J IMMUNOL, V162, P2347; Larranaga CL, 2009, PEDIATR INFECT DIS J, V28, P867, DOI 10.1097/INF.0b013e3181a3ea71; Lukens MV, 2010, J VIROL, V84, P2374, DOI 10.1128/JVI.01807-09; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; Mukherjee S, 2012, SHOCK, V38, P515, DOI 10.1097/SHK.0b013e31826f862c; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; Newcomb DC, 2013, THORAX, V68, P717, DOI 10.1136/thoraxjnl-2012-202404; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Ryzhakov G, 2011, J IMMUNOL, V187, P5357, DOI 10.4049/jimmunol.1100917; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Tanaka S, 2009, J IMMUNOL, V183, P7523, DOI 10.4049/jimmunol.0803828; van Schaik SM, 1998, J INFECT DIS, V177, P269, DOI 10.1086/514208; Vanden Eijnden S, 2006, EUR J IMMUNOL, V36, P21, DOI 10.1002/eji.200535467; Yasui K, 2005, PEDIATR INT, V47, P190, DOI 10.1111/j.1442-200x.2005.02039.x; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	41	59	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78461	10.1371/journal.pone.0078461	http://dx.doi.org/10.1371/journal.pone.0078461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194936	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000115
J	van 't Klooster, R; Patterson, AJ; Young, VE; Gillard, JH; Reiber, JHC; van der Geest, RJ				van 't Klooster, Ronald; Patterson, Andrew J.; Young, Victoria E.; Gillard, Jonathan H.; Reiber, Johan H. C.; van der Geest, Rob J.			An Objective Method to Optimize the MR Sequence Set for Plaque Classification in Carotid Vessel Wall Images Using Automated Image Segmentation	PLOS ONE			English	Article							IN-VIVO; COMPONENTS	A typical MR imaging protocol to study the status of atherosclerosis in the carotid artery consists of the application of multiple MR sequences. Since scanner time is limited, a balance has to be reached between the duration of the applied MR protocol and the quantity and quality of the resulting images which are needed to assess the disease. In this study an objective method to optimize the MR sequence set for classification of soft plaque in vessel wall images of the carotid artery using automated image segmentation was developed. The automated method employs statistical pattern recognition techniques and was developed based on an extensive set of MR contrast weightings and corresponding manual segmentations of the vessel wall and soft plaque components, which were validated by histological sections. Evaluation of the results from nine contrast weightings showed the tradeoff between scan duration and automated image segmentation performance. For our dataset the best segmentation performance was achieved by selecting five contrast weightings. Similar performance was achieved with a set of three contrast weightings, which resulted in a reduction of scan time by more than 60%. The presented approach can help others to optimize MR imaging protocols by investigating the tradeoff between scan duration and automated image segmentation performance possibly leading to shorter scanning times and better image interpretation. This approach can potentially also be applied to other research fields focusing on different diseases and anatomical regions.	[van 't Klooster, Ronald; Reiber, Johan H. C.; van der Geest, Rob J.] Leiden Univ, Div Image Proc, Dept Radiol, Med Ctr, Leiden, Netherlands; [Patterson, Andrew J.; Young, Victoria E.; Gillard, Jonathan H.] Cambridge Univ Hosp NHS Fdn Trust, Univ Dept Radiol, Cambridge, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cambridge	van der Geest, RJ (corresponding author), Leiden Univ, Div Image Proc, Dept Radiol, Med Ctr, Leiden, Netherlands.	rvdgeest@lumc.nl	van der Geest, Rob J/J-8193-2015	van der Geest, Rob J/0000-0002-9084-5597; Patterson, Andrew/0000-0001-8338-5652	Dutch Technology Foundation STW, which is the applied science division of NWO; Technology Programme of the Ministry of Economic Affairs [LGT.6454]	Dutch Technology Foundation STW, which is the applied science division of NWO(Technologiestichting STW); Technology Programme of the Ministry of Economic Affairs	This study was funded by the Dutch Technology Foundation STW, which is the applied science division of NWO, and the Technology Programme of the Ministry of Economic Affairs. Project number LGT.6454. http://www.stw.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame IM, 2004, MAGN RESON MATER PHY, V16, P227, DOI 10.1007/s10334-003-0030-8; Balu N, 2011, MAGN RESON MED, V65, P627, DOI 10.1002/mrm.22642; Cappendijk VC, 2005, RADIOLOGY, V234, P487, DOI 10.1148/radiol.2342032101; Duin R, 2007, PRTOOLS4 1 MATLAB TO; Hofman JMA, 2006, MAGN RESON MED, V55, P790, DOI 10.1002/mrm.20828; Karmonik C, 2009, IEEE T BIO-MED ENG, V56, P352, DOI 10.1109/TBME.2008.2003100; Liu F, 2006, MAGN RESON MED, V55, P659, DOI 10.1002/mrm.20814; Moody AR, 2003, CIRCULATION, V107, P3047, DOI 10.1161/01.CIR.0000074222.61572.44; PasterkampC FalkE, 2000, J CLIN BASIC CARDIOL, V3, P81; Takaya N, 2006, STROKE, V37, P818, DOI 10.1161/01.STR.0000204638.91099.91; Young VE, 2010, NEURORADIOLOGY, V52, P929, DOI 10.1007/s00234-010-0680-y; Yuan C, 2001, CIRCULATION, V104, P2051, DOI 10.1161/hc4201.097839; Yuan C, 2008, J NUCL CARDIOL, V15, P266, DOI 10.1016/j.nuclcard.2008.02.001; Zhao XH, 2010, INVEST RADIOL, V45, P36, DOI 10.1097/RLI.0b013e3181beada7	14	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78492	10.1371/journal.pone.0078492	http://dx.doi.org/10.1371/journal.pone.0078492			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194941	gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000120
J	Yan, YL; Gong, ZC; Zhang, L; Li, YP; Li, X; Zhu, L; Sun, LQ				Yan, Yuanliang; Gong, Zhicheng; Zhang, Lu; Li, Yanping; Li, Xiong; Zhu, Lin; Sun, Lunquan			Association of Follicle-Stimulating Hormone Receptor Polymorphisms with Ovarian Response in Chinese Women: A Prospective Clinical Study	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SER680ASN POLYMORPHISM; MOLECULAR-BIOLOGY; FSHR GENE; HYPERSTIMULATION; MUTATIONS; PATHOPHYSIOLOGY; PHYSIOLOGY; IVF	Background: Follicular stimulating hormone (FSH) is a glycoprotein and widely used for the treatment of infertility; FSH action is mediated by FSH receptor (FSHR), SNPs of which determine the ovarian response. Two polymorphisms of the FSHR gene were identified, which caused a change of threonine (T) to alanine (A) at position 307 and asparagine (N) to serine(S) at position 680. Both polymorphic sites give rise to three discrete variants of the FSHR: TT, TA, and AA for position 307; NN, NS, and SS for position 680. Methodology/Principal Findings: 450 Chinese women were recruited in an assisted reproductive technology program from October 2011 to March 2012. FSHR polymorphisms at the positions 307 and 680 were examined by PCR-RFLP. Serum FSH and estradiol level, FSH amount, ovarian response and pregnancy rate were recorded during treatment. The basal FSH levels were higher in AA [7.38 +/- 2.07 vs 6.34 +/- 1.75, 6.63 +/- 1.94, P< 0.05, 95% CI (6.75, 8.01)] and SS [7.51 +/- 2.01 vs 6.31 +/- 1.75, 6.66 +/- 1.96, P< 0.05, 95% CI (6.88, 8.15)] compared to other genotypes respectively; the days for ovulation induction was slightly longer in AA and SS. Women with AA and SS have higher rates of poor response compared to carriers of other genotypes (P< 0.05). Furthermore, there is a nearly complete linkage between these two polymorphisms in Chinese women (D'=0.95, r(2)=0.84). Conclusions/Significance: In Chinese women receiving ART, the subjects with AA and SS genotypes have higher basal FSH levels, and these genotypes are associated with an increased risk of poor response. Our data suggested that the personalized FSH therapy may be applied according to patient's genetic background in clinical settings. The linkage suggested that the polymorphisms of Thr307Ala and Asn680Ser may be used as TAG-SNP markers for analysis of potential genotyping in ART.	[Yan, Yuanliang; Gong, Zhicheng] Cent S Univ, Xiangya Hosp, Dept Pharm, Changsha, Hunan, Peoples R China; [Yan, Yuanliang] Cent S Univ, Sch Pharmaceut Sci, Changsha, Hunan, Peoples R China; [Zhang, Lu; Li, Xiong; Sun, Lunquan] Cent S Univ, Xiangya Hosp, Ctr Mol Med, Changsha, Hunan, Peoples R China; [Li, Yanping; Zhu, Lin] Cent S Univ, Xiangya Hosp, Dept Reprod Med, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Gong, ZC (corresponding author), Cent S Univ, Xiangya Hosp, Dept Pharm, Changsha, Hunan, Peoples R China.	gongzhicheng2012@126.com	Yan, Yuanliang/K-7149-2019		Fundamental Research Funds for the Central Universities of Central South University [2012zzts112]; Hunan Provincial Department of Finance [[2012]30]; Planned Science and Technology Project of Hunan Province of China [2012FJ3140]; Hunan Provincial Natural Science Foundation of China [12JJ5050]	Fundamental Research Funds for the Central Universities of Central South University; Hunan Provincial Department of Finance; Planned Science and Technology Project of Hunan Province of China; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	The study was supported by the Fundamental Research Funds for the Central Universities of Central South University (2012zzts112), Hunan Provincial Department of Finance ([2012]30), Planned Science and Technology Project of Hunan Province of China (2012FJ3140) and Hunan Provincial Natural Science Foundation of China (12JJ5050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achrekar SK, 2009, FERTIL STERIL, V91, P432, DOI 10.1016/j.fertnstert.2007.11.093; Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Altmae S, 2011, HUM REPROD UPDATE, V17, P813, DOI 10.1093/humupd/dmr034; Behre HM, 2005, PHARMACOGENET GENOM, V15, P451, DOI 10.1097/01.fpc.0000167330.92786.5e; Boudjenah R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038700; Casarini L, 2011, REV ENDOCR METAB DIS, V12, P303, DOI 10.1007/s11154-011-9192-2; Coccia ME, 2008, ANN NY ACAD SCI, V1127, P27, DOI 10.1196/annals.1434.011; Daelemans C, 2004, J CLIN ENDOCR METAB, V89, P6310, DOI 10.1210/jc.2004-1044; de Castro F, 2003, FERTIL STERIL, V80, P571, DOI 10.1016/S0015-0282(03)00795-7; George JW, 2011, BIOL REPROD, V84, P7, DOI 10.1095/biolreprod.110.085043; Gromoll J, 1996, GENOMICS, V35, P308, DOI 10.1006/geno.1996.0361; Huang QO, 2010, ACTA PHARMACOL SIN, V31, P709, DOI 10.1038/aps.2010.47; Humaidan P, 2010, FERTIL STERIL, V94, P389, DOI 10.1016/j.fertnstert.2010.03.028; Jun JK, 2006, J HUM GENET, V51, P665, DOI 10.1007/s10038-006-0005-5; Kene PS, 2004, J ENDOCRINOL, V182, P501, DOI 10.1677/joe.0.1820501; Kuijper EAM, 2011, REPROD BIOMED ONLINE, V22, pS60, DOI 10.1016/S1472-6483(11)60010-2; Levallet J, 1999, ARCH MED RES, V30, P486, DOI 10.1016/S0188-0128(99)00058-5; Loutradis D, 2008, ANN NY ACAD SCI, V1127, P10, DOI 10.1196/annals.1434.001; Lussiana C, 2008, OBSTET GYNECOL SURV, V63, P785, DOI 10.1097/OGX.0b013e31818957eb; Mayorga MP, 2000, J CLIN ENDOCR METAB, V85, P3365, DOI 10.1210/jc.85.9.3365; Mohiyiddeen L, 2010, HUM FERTIL, V13, P72, DOI 10.3109/14647271003632322; Polyzos NP, 2011, FERTIL STERIL, V96, P1058, DOI 10.1016/j.fertnstert.2011.09.048; Popovic-Todorovic B, 2003, HUM REPROD, V18, P781, DOI 10.1093/humrep/deg181; Rodini GP, 2011, J ASSIST REPROD GEN, V28, P221, DOI 10.1007/s10815-010-9503-7; Simoni M, 2008, HUM REPROD UPDATE, V14, P459, DOI 10.1093/humupd/dmn024; Simoni M, 2002, HUM REPROD UPDATE, V8, P413, DOI 10.1093/humupd/8.5.413; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Sudo S, 2002, MOL HUM REPROD, V8, P893, DOI 10.1093/molehr/8.10.893; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Ukkola O, 2002, J CLIN ENDOCR METAB, V87, P3708, DOI 10.1210/jc.87.8.3708; Ulloa-Aguirre A, 2007, ENDOCRINE, V32, P251, DOI 10.1007/s12020-008-9041-6; Vilodre LC, 2008, J ENDOCRINOL INVEST, V31, P552, DOI 10.1007/BF03346407; Wunsch A, 2007, ANN ENDOCRINOL-PARIS, V68, P160, DOI 10.1016/j.ando.2007.04.006; Yao Y, 2011, MOL GENET METAB, V103, P388, DOI 10.1016/j.ymgme.2011.04.005	34	31	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78138	10.1371/journal.pone.0078138	http://dx.doi.org/10.1371/journal.pone.0078138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167601	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500061
J	Seeliger, D				Seeliger, Daniel			Development of Scoring Functions for Antibody Sequence Assessment and Optimization	PLOS ONE			English	Article							BIOPHYSICAL PROPERTIES; AFFINITY MATURATION; MONOCLONAL-ANTIBODY; PROTEIN AGGREGATION; VARIABLE DOMAINS; PREDICTION; STABILITY; CHALLENGES; MUTATIONS; LIBRARIES	Antibody development is still associated with substantial risks and difficulties as single mutations can radically change molecule properties like thermodynamic stability, solubility or viscosity. Since antibody generation methodologies cannot select and optimize for molecule properties which are important for biotechnological applications, careful sequence analysis and optimization is necessary to develop antibodies that fulfil the ambitious requirements of future drugs. While efforts to grab the physical principles of undesired molecule properties from the very bottom are becoming increasingly powerful, the wealth of publically available antibody sequences provides an alternative way to develop early assessment strategies for antibodies using a statistical approach which is the objective of this paper. Here, publically available sequences were used to develop heuristic potentials for the framework regions of heavy and light chains of antibodies of human and murine origin. The potentials take into account position dependent probabilities of individual amino acids but also conditional probabilities which are inevitable for sequence assessment and optimization. It is shown that the potentials derived from human sequences clearly distinguish between human sequences and sequences from mice and, hence, can be used as a measure of humaness which compares a given sequence with the phenotypic pool of human sequences instead of comparing sequence identities to germline genes. Following this line, it is demonstrated that, using the developed potentials, humanization of an antibody can be described as a simple mathematical optimization problem and that the in-silico generated framework variants closely resemble native sequences in terms of predicted immunogenicity.	Boehringer Ingelheim Pharma GmbH & Co KG, Dept Lead Identificat & Optimizat Support, Biberach, Germany	Boehringer Ingelheim	Seeliger, D (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Dept Lead Identificat & Optimizat Support, Biberach, Germany.	daniel.seeliger@boehringer-ingelheim.com						Abhinandan KR, 2007, J MOL BIOL, V369, P852, DOI 10.1016/j.jmb.2007.02.100; Almagro JC, 2008, FRONT BIOSCI-LANDMRK, V13, P1619, DOI 10.2741/2786; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Chaudhri A, 2012, J PHYS CHEM B, V116, P8045, DOI 10.1021/jp301140u; Choulier L, 2000, PROTEINS, V41, P475, DOI 10.1002/1097-0134(20001201)41:4<475::AID-PROT50>3.0.CO;2-G; De Groot AS, 2009, CLIN IMMUNOL, V131, P189, DOI 10.1016/j.clim.2009.01.009; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; Dudgeon K, 2012, P NATL ACAD SCI USA, V109, P10879, DOI 10.1073/pnas.1202866109; Ewert S, 2004, METHODS, V34, P184, DOI 10.1016/j.ymeth.2004.04.007; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Fuchs A, 2007, BIOINFORMATICS, V23, P3312, DOI 10.1093/bioinformatics/btm515; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Hugo N, 2002, PROTEIN SCI, V11, P2697, DOI 10.1110/ps.0209302; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kabat EA, 1992, SEQUENCES PROTEINS I; Koren E, 2007, CLIN IMMUNOL, V124, P26, DOI 10.1016/j.clim.2007.03.544; Larson SM, 2000, J MOL BIOL, V303, P433, DOI 10.1006/jmbi.2000.4146; Lauer TM, 2012, J PHARM SCI-US, V101, P102, DOI 10.1002/jps.22758; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; McConnell AD, 2013, PROTEIN ENG DES SEL, V26, P151, DOI 10.1093/protein/gzs090; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Perchiacca JM, 2012, PROTEIN ENG DES SEL, V25, P591, DOI 10.1093/protein/gzs042; Perchiacca JM, 2012, ANNU REV CHEM BIOMOL, V3, P263, DOI 10.1146/annurev-chembioeng-062011-081052; Philo JS, 2009, CURR PHARM BIOTECHNO, V10, P348, DOI 10.2174/138920109788488932; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Schaefer JV, 2012, PROTEIN ENG DES SEL, V25, P485, DOI 10.1093/protein/gzs039; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shire SJ, 2004, J PHARM SCI-US, V93, P1390, DOI 10.1002/jps.20079; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tiller T, 2013, MABS-AUSTIN, V5, P445, DOI 10.4161/mabs.24218; Weiss WF, 2009, J PHARM SCI-US, V98, P1246, DOI 10.1002/jps.21521; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Wu SJ, 2010, PROTEIN ENG DES SEL, V23, P643, DOI 10.1093/protein/gzq037	41	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76909	10.1371/journal.pone.0076909	http://dx.doi.org/10.1371/journal.pone.0076909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204701	Green Submitted, gold, Green Published			2022-12-27	WOS:000326032600014
J	Vilhena, DA; Smith, AB				Vilhena, Daril A.; Smith, Andrew B.			Spatial Bias in the Marine Fossil Record	PLOS ONE			English	Article							LARGE-SCALE; ROCK RECORD; DIVERSITY; BIODIVERSITY; TRENDS; SHELF; AREA; DISSOLUTION; BIVALVES; MOLLUSKS	Inference of past and present global biodiversity requires enough global data to distinguish biological pattern from sampling artifact. Pertinently, many studies have exposed correlated relationships between richness and sampling in the fossil record, and methods to circumvent these biases have been proposed. Yet, these studies often ignore paleobiogeography, which is undeniably a critical component of ancient global diversity. Alarmingly, our global analysis of 481,613 marine fossils spread throughout the Phanerozoic reveals that where localities are and how intensively they have been sampled almost completely determines empirical spatial patterns of richness, suggesting no separation of biological pattern from sampling pattern. To overcome this, we analyze diversity using occurrence records drawn from two discrete paleolatitudinal bands which cover the bulk of the fossil data. After correcting the data for sampling bias, we find that these two bands have similar patterns of richness despite markedly different spatial coverage. Our findings suggest that i) long-term diversity trends result from large-scale tectonic evolution of the planet, ii) short-term diversity trends are region-specific, and iii) paleodiversity studies must constrain their analyses to well-sampled regions to uncover patterns not driven by sampling.	[Vilhena, Daril A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Smith, Andrew B.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	University of Washington; University of Washington Seattle; Natural History Museum London	Vilhena, DA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	daril@uw.edu	Smith, Andrew B/B-9849-2009					ALLISON PA, 1993, GEOLOGY, V21, P65, DOI 10.1130/0091-7613(1993)021<0065:PSBPSD>2.3.CO;2; Alroy J, 2010, SCIENCE, V329, P1191, DOI 10.1126/science.1189910; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Ausich WI, 2005, PALEOBIOLOGY, V31, P538, DOI 10.1666/0094-8373(2005)031[0538:ARMHFO]2.0.CO;2; Belanger CL, 2012, P NATL ACAD SCI USA, V109, P14046, DOI 10.1073/pnas.1212381109; Benson RBJ, 2013, GEOLOGY, V41, P43, DOI 10.1130/G33543.1; BROWN JH, 1989, SCIENCE, V243, P1145, DOI 10.1126/science.243.4895.1145; Cherns L, 2000, GEOLOGY, V28, P791, DOI 10.1130/0091-7613(2000)28<791:MMAEOL>2.0.CO;2; Cherns L, 2011, TOP GEOBIOL, V32, P79, DOI 10.1007/978-90-481-8643-3_3; Crampton JS, 2006, PALAIOS, V21, P86, DOI 10.2110/palo.2004.p04-90; Hannisdal B, 2011, SCIENCE, V334, P1121, DOI 10.1126/science.1210695; Harnik PG, 2010, P ROY SOC B-BIOL SCI, V277, P3427, DOI 10.1098/rspb.2010.0628; Holland SM, 2012, PALEOBIOLOGY, V38, P205, DOI 10.1666/11030.1; Jackson JBC, 2001, SCIENCE, V293, P2401, DOI 10.1126/science.1063789; Johnson KG, 2003, PALEOBIOLOGY, V29, P19, DOI 10.1666/0094-8373(2003)029<0019:NDFOQ>2.0.CO;2; Kidwell SM, 2002, ANNU REV ECOL SYST, V33, P561, DOI 10.1146/annurev.ecolsys.33.030602.152151; Lagomarcino AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040472; Lloyd GT, 2012, BIOL LETTERS, V8, P123, DOI 10.1098/rsbl.2011.0210; McGowan AJ, 2008, PALEOBIOLOGY, V34, P80, DOI 10.1666/07019.1; Melott AL, 2011, PALEOBIOLOGY, V37, P383, DOI 10.1666/09055.1; Meyers SR, 2011, EARTH PLANET SC LETT, V303, P174, DOI 10.1016/j.epsl.2010.12.044; Miller AI, 1996, PALEOBIOLOGY, V31, P533; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Schmachtenberg WF, 2011, PALEOBIOLOGY, V37, P438, DOI 10.1666/09015.1; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Smith AB, 2007, PALAEONTOLOGY, V50, P765, DOI 10.1111/j.1475-4983.2007.00693.x; Smith AB, 2013, GEOLOGY, V41, P171, DOI 10.1130/G33773.1; Smith AB, 2012, P ROY SOC B-BIOL SCI, V279, P4489, DOI 10.1098/rspb.2012.1793; Valentine JW, 2006, P NATL ACAD SCI USA, V103, P6599, DOI 10.1073/pnas.0601264103; Walker LJ, 2002, J GEOL, V110, P75, DOI 10.1086/324318	32	42	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e74470	10.1371/journal.pone.0074470	http://dx.doi.org/10.1371/journal.pone.0074470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204570	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500005
J	Gritti, N; Caccia, M; Sironi, L; Collini, M; D'Alfonso, L; Granucci, F; Zanoni, I; Chirico, G				Gritti, Nicola; Caccia, Michele; Sironi, Laura; Collini, Maddalena; D'Alfonso, Laura; Granucci, Francesca; Zanoni, Ivan; Chirico, Giuseppe			Modeling Leukocyte-Leukocyte Non-Contact Interactions in a Lymph Node	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DENDRITIC CELLS; T-CELLS; BROWNIAN DYNAMICS; IN-VIVO; DEPENDENT ACTIVATION; IMMUNE-RESPONSES; NK CELLS; CHEMOTAXIS; TRAFFICKING	The interaction among leukocytes is at the basis of the innate and adaptive immune-response and it is largely ascribed to direct cell-cell contacts. However, the exchange of a number of chemical stimuli (chemokines) allows also non-contact interaction during the immunological response. We want here to evaluate the extent of the effect of the non-contact interactions on the observed leukocyte-leukocyte kinematics and their interaction duration. To this aim we adopt a simplified mean field description inspired by the Keller-Segel chemotaxis model, of which we report an analytical solution suited for slowly varying sources of chemokines. Since our focus is on the non-contact interactions, leukocyte-leukocyte contact interactions are simulated only by means of a space dependent friction coefficient of the cells. The analytical solution of the Keller-Segel model is then taken as the basis of numerical simulations of interactions between leukocytes and their duration. The mean field interaction force that we derive has a time-space separable form and depends on the chemotaxis sensitivity parameter as well as on the chemokines diffusion coefficient and their degradation rate. All these parameters affect the distribution of the interaction durations. We draw a successful qualitative comparison between simulated data and sets of experimental data for DC-NK cells interaction duration and other kinematic parameters. Remarkably, the predicted percentage of the leukocyte-leukocyte interactions falls in the experimental range and depends (congruent to 25% increase) upon the chemotactic parameter indicating a non-negligible direct effect of the non-contact interaction on the leukocyte interactions.	[Gritti, Nicola; Caccia, Michele; Sironi, Laura; Collini, Maddalena; D'Alfonso, Laura; Chirico, Giuseppe] Univ Milano Bicocca, Dipartimento Fis, Milan, Italy; [Granucci, Francesca; Zanoni, Ivan] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Sironi, Laura] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy	University of Milano-Bicocca; University of Milano-Bicocca; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Chirico, G (corresponding author), Univ Milano Bicocca, Dipartimento Fis, Milan, Italy.	giuseppe.chirico@mib.infn.it	Caccia, Michele/Q-5623-2018; Gritti, Nicola/AAA-6604-2019; Sironi, Laura/AAA-5384-2022; Caccia, Michele/AAW-2808-2021; D'Alfonso, Laura/J-4193-2012; GRANUCCI, Francesca/K-6150-2019	Gritti, Nicola/0000-0002-7637-4258; Caccia, Michele/0000-0002-2968-5635; D'Alfonso, Laura/0000-0002-7378-4462; granucci, francesca/0000-0002-7046-4914; CHIRICO, Giuseppe/0000-0001-6578-6460; Zanoni, Ivan/0000-0002-3423-7474; SIRONI, LAURA/0000-0002-6638-7709	FP7 program ENCITE [201842]; Regional Project of Regione Lombardia, "Accordo Quadro"	FP7 program ENCITE; Regional Project of Regione Lombardia, "Accordo Quadro"	This work has been partially funded by the FP7 program ENCITE (grant agreement number 201842; http://www.encite.org) to FG and GC and by the Regional Project of Regione Lombardia, "Accordo Quadro" 2009, to GC (http://www.formalavoro.regione.lombardia.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Baldazzi V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-387; Beltman JB, 2007, IMMUNOL CELL BIOL, V85, P306, DOI 10.1038/sj.icb.7100054; Beuneu H, 2009, BLOOD, V114, P3227, DOI 10.1182/blood-2009-06-228759; Biron CA, 1997, CURR OPIN IMMUNOL, V9, P24, DOI 10.1016/S0952-7915(97)80155-0; Bousso P, 2004, IMMUNITY, V21, P349, DOI 10.1016/j.immuni.2004.08.005; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Byrne HM, 1998, IMA J MATH APPL MED, V15, P235; Caccia M, 2008, EUR BIOPHYS J BIOPHY, V37, P979, DOI 10.1007/s00249-008-0323-y; Caccia M, 2010, PROC SPIE, V7565, DOI 10.1117/12.842214; Cahalan MD, 2003, CURR OPIN IMMUNOL, V15, P372, DOI 10.1016/S0952-7915(03)00079-7; Chavanis PH, 2010, COMMUN NONLINEAR SCI, V15, P60, DOI 10.1016/j.cnsns.2008.09.002; CHIRICO G, 1992, MACROMOLECULES, V25, P769, DOI 10.1021/ma00028a041; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Doi M, 1986, THEORY POLYM DYNAMIC, P52; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; ERMAK DL, 1978, J CHEM PHYS, V69, P1352, DOI 10.1063/1.436761; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Keller EF, 2006, B MATH BIOL, V68, P1033, DOI 10.1007/s11538-006-9097-5; Frank T, 1996, FOKKER PLANCK EQUATI; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Harizi H, 2013, CELL MOL IMMUNOL, V10, P213, DOI 10.1038/cmi.2013.1; Janeway CA, 2007, IMMUNOBIOLOGY IMMUNE, P13; Jinquan Tan, 1995, Journal of Immunology, V154, P3742; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Klenin K, 1998, BIOPHYS J, V74, P780, DOI 10.1016/S0006-3495(98)74003-2; Kloeden PE, 1994, APPL MATH, V23, P305; Matzavinos A, 2004, MATH MED BIOL, V21, P1; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Millington OR, 2007, INFLAMM RES, V56, P391, DOI 10.1007/s00011-007-7017-2; Narang V, 2012, IMMUNOL RES, V53, P251, DOI 10.1007/s12026-012-8305-7; Newman KC, 2007, NAT REV IMMUNOL, V7, P279, DOI 10.1038/nri2057; Pearce IG, 2007, J MATH BIOL, V55, P365, DOI 10.1007/s00285-007-0088-4; Press WH, 2007, NUMERICAL RECIPES AR, P287; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rapin N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009862; SHERRATT JA, 1994, B MATH BIOL, V56, P129, DOI 10.1016/S0092-8240(05)80208-3; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Textor J, 2011, P NATL ACAD SCI USA, V108, P12401, DOI 10.1073/pnas.1102288108; Thakar J, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-35; Tindall MJ, 2008, B MATH BIOL, V70, P1570, DOI 10.1007/s11538-008-9322-5; TRANQUILLO RT, 1988, CELL MOTIL CYTOSKEL, V11, P1, DOI 10.1002/cm.970110102; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Villa CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012216; Walzer T, 2005, EXPERT OPIN BIOL TH, V5, pS49, DOI 10.1517/14712598.5.1.S49; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Wei SH, 2003, IMMUNOL REV, V195, P136, DOI 10.1034/j.1600-065X.2003.00076.x; Zanoni I, 2005, J IMMUNOL, V175, P286, DOI 10.4049/jimmunol.175.1.286	53	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76756	10.1371/journal.pone.0076756	http://dx.doi.org/10.1371/journal.pone.0076756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204669	Green Submitted, gold, Green Published			2022-12-27	WOS:000326241200013
J	Shinozaki, S; Chiba, T; Kokame, K; Miyata, T; Kaneko, E; Shimokado, K				Shinozaki, Shohei; Chiba, Tsuyoshi; Kokame, Koichi; Miyata, Toshiyuki; Kaneko, Eiji; Shimokado, Kentaro			A Deficiency of Herp, an Endoplasmic Reticulum Stress Protein, Suppresses Atherosclerosis in ApoE Knockout Mice by Attenuating Inflammatory Responses	PLOS ONE			English	Article							C/EBP HOMOLOGOUS PROTEIN; ACCELERATED ATHEROSCLEROSIS; MACROPHAGE APOPTOSIS; CELL-LINE; EXPRESSION; RECEPTOR; PATHWAYS; DISEASE; ER; DEGRADATION	Herp was originally identified as an endoplasmic reticulum (ER) stress protein in vascular endothelial cells. ER stress is induced in atherosclerotic lesions, but it is not known whether Herp plays any role in the development of atherosclerosis. To address this question, we generated Herp-and apolipoprotein E (apoE)-deficient mice (Herp(-/-); apoE(-/-) mice) by crossbreeding Herp(-/-) mice and apoE(-/-) mice. Herp was expressed in the endothelial cells and medial smooth muscle cells of the aorta, as well as in a subset of macrophages in the atherosclerotic lesions in apoE(-/-) mice, while there was no expression of Herp in the Herp(-/-); apoE(-/-) mice. The doubly deficient mice developed significantly fewer atherosclerotic lesions than the apoE(-/-) mice at 36 and 72 weeks of age, whereas the plasma levels of cholesterol and triglycerides were not significantly different between the strains. The plasma levels of non-esterified fatty acids were significantly lower in the Herp(-/-); apoE(-/-) mice when they were eight and 16 weeks old. The gene expression levels of ER stress response proteins (GRP78 and CHOP) and inflammatory cytokines (IL-1 beta, IL-6, TNF-alpha and MCP-1) in the aorta were significantly lower in Herp(-/-); apoE(-/-) mice than in apoE(-/-) mice, suggesting that Herp mediated ER stress-induced inflammation. In fact, peritoneal macrophages isolated from Herp-deficient mice and RAW264.7 macrophages in which Herp was eliminated with a siRNA expressed lower levels of mRNA for inflammatory cytokines when they were treated with tunicamycin. Herp deficiency affected the major mediators of the unfolded protein response, including IRE1 and PERK, but not ATF6. These findings suggest that a deficiency of Herp suppressed the development of atherosclerosis by attenuating the ER stress-induced inflammatory reactions.	[Shinozaki, Shohei; Chiba, Tsuyoshi; Kaneko, Eiji; Shimokado, Kentaro] Tokyo Med & Dent Univ, Grad Sch, Tokyo, Japan; [Chiba, Tsuyoshi] Natl Inst Hlth & Nutr, Informat Ctr, Tokyo 162, Japan; [Kokame, Koichi; Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Osaka, Japan	Tokyo Medical & Dental University (TMDU); National Institute of Health & Nutrition - Japan; National Cerebral & Cardiovascular Center - Japan	Shimokado, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Tokyo, Japan.	k.shimoka.vasc@tmd.ac.jp	Shinozaki, Shohei/AAT-3018-2021	Kokame, Koichi/0000-0002-9654-6299	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a grant to KS from Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EK, 2012, ARTERIOSCL THROM VAS, V32, P1687, DOI 10.1161/ATVBAHA.112.250142; Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Chiba T, 2007, ATHEROSCLEROSIS; Chiba T, 2006, J ATHEROSCLER THROMB, V13, P308, DOI 10.5551/jat.13.308; Chigurupati S, 2009, J BIOL CHEM; Deng JN, 2012, J BIOL CHEM, V287, P6240, DOI 10.1074/jbc.M111.299115; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; Eura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034298; Gao JH, 2011, CIRCULATION, V124, P830, DOI 10.1161/CIRCULATIONAHA.110.014050; Hartley JW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-1; Hartley T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-59; Higaki M, 1999, ARTERIOSCL THROM VAS, V19, P2127, DOI 10.1161/01.ATV.19.9.2127; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu J, 2005, ARTERIOSCL THROM VAS, V25, P174, DOI 10.1161/01.ATV.0000148548.47755.22; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Nogalska A, 2006, J NEUROCHEM, V96, P1491, DOI 10.1111/j.1471-4159.2006.03668.x; Parker RA, 2005, MOL PHARMACOL, V67, P1909, DOI 10.1124/mol.104.010165; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Sai XR, 2003, FEBS LETT, V553, P151, DOI 10.1016/S0014-5793(03)01009-3; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Scull CM, 2011, ARTERIOSCL THROM VAS, V31, P2792, DOI 10.1161/ATVBAHA.111.224881; Shinozaki S, 2007, HORM METAB RES, V39, P192, DOI 10.1055/s-2007-970417; Slodzinski H, 2009, CLIN NEUROPATHOL, V28, P333, DOI 10.2379/NPX08162; Suyama K, 2008, BIOCHEM BIOPH RES CO, V367, P176, DOI 10.1016/j.bbrc.2007.12.132; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Tuvia S, 2007, J CELL BIOL, V177, P51, DOI 10.1083/jcb.200611036; Wong KS, 1999, ONCOGENE, V18, P5525, DOI 10.1038/sj.onc.1202938; Yamazaki H, 2009, J IMMUNOL, V183, P1480, DOI 10.4049/jimmunol.0900017; Yan S, 2012, EXP DIABETES RES, DOI 10.1155/2012/743780; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhou AX, 2013, SEMIN IMMUNOPATHOL, V35, P321, DOI 10.1007/s00281-013-0372-x; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1; Zhou J, 2004, CIRCULATION, V110, P207, DOI 10.1161/01.CIR.0000134487.51510.97	41	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e75249	10.1371/journal.pone.0075249	http://dx.doi.org/10.1371/journal.pone.0075249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204574	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200004
J	Kung, WM; Chen, ST; Lin, CH; Lu, YM; Chen, TH; Lin, MS				Kung, Woon-Man; Chen, Shuo-Tsung; Lin, Chung-Hsiang; Lu, Yu-Mei; Chen, Tzu-Hsuan; Lin, Muh-Shi			Verifying Three-Dimensional Skull Model Reconstruction Using Cranial Index of Symmetry	PLOS ONE			English	Article							DECOMPRESSIVE CRANIECTOMY; TITANIUM MESH; CRANIOPLASTY; TECHNOLOGIES; IMPLANTS; DEFECT	Background: Difficulty exists in scalp adaptation for cranioplasty with customized computer-assisted design/manufacturing (CAD/CAM) implant in situations of excessive wound tension and sub-cranioplasty dead space. To solve this clinical problem, the CAD/CAM technique should include algorithms to reconstruct a depressed contour to cover the skull defect. Satisfactory CAM-derived alloplastic implants are based on highly accurate three-dimensional (3-D) CAD modeling. Thus, it is quite important to establish a symmetrically regular CAD/CAM reconstruction prior to depressing the contour. The purpose of this study is to verify the aesthetic outcomes of CAD models with regular contours using cranial index of symmetry (CIS). Materials and methods: From January 2011 to June 2012, decompressive craniectomy (DC) was performed for 15 consecutive patients in our institute. 3-D CAD models of skull defects were reconstructed using commercial software. These models were checked in terms of symmetry by CIS scores. Results: CIS scores of CAD reconstructions were 99.24+/-0.004% (range 98.47-99.84). CIS scores of these CAD models were statistically significantly greater than 95%, identical to 99.5%, but lower than 99.6% (p<0.001, p = 0.064, p = 0.021 respectively, Wilcoxon matched pairs signed rank test). These data evidenced the highly accurate symmetry of these CAD models with regular contours. Conclusions: CIS calculation is beneficial to assess aesthetic outcomes of CAD-reconstructed skulls in terms of cranial symmetry. This enables further accurate CAD models and CAM cranial implants with depressed contours, which are essential in patients with difficult scalp adaptation.	[Kung, Woon-Man] Chinese Culture Univ, Coll Educ, Dept Exercise & Hlth Promot, Taipei, Taiwan; [Kung, Woon-Man] Lotung Poh Ai Hosp, Lo Hsu Fdn, Dept Neurosurg, Luodong, Yilan, Taiwan; [Chen, Shuo-Tsung] Tunghai Univ, Dept Appl Math, Taichung 40704, Taiwan; [Lin, Chung-Hsiang] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Coll Elect Engn & Comp Sci, Taipei 10764, Taiwan; [Lu, Yu-Mei] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan; [Chen, Tzu-Hsuan] Mackay Mem Hosp, Dept Phys Med & Rehabil, Hsinchu, Taiwan; [Lin, Muh-Shi] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Surg, Taipei 112, Taiwan; [Lin, Muh-Shi] Taipei City Hosp, Dept Neurosurg, Zhong Xiao Branch, Taipei, Taiwan; [Kung, Woon-Man] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan; [Kung, Woon-Man] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan	Chinese Culture University; Tunghai University; National Taiwan University; National Taiwan Normal University; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Taipei City Hospital; National Taiwan University; National Taiwan University	Lin, MS (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Dept Surg, Taipei 112, Taiwan.	neurosurgery2005@yahoo.com.tw	Kung, Woon-Man/Q-3012-2019; Lin, 林牧熹 醫學博士 法學碩士 Muh-Shi/U-7004-2019	Kung, Woon-Man/0000-0001-8311-2902; Lin, 林牧熹 醫學博士 法學碩士 Muh-Shi/0000-0002-9798-8160				Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Durham SR, 2003, NEUROSURGERY, V52, P842, DOI 10.1227/01.NEU.0000054220.01290.8E; Galantucci L. M., 2006, Journal of Medical Engineering & Technology, V30, P102, DOI 10.1080/03091900500131714; Janecka IP, 2000, ARCH OTOLARYNGOL, V126, P396, DOI 10.1001/archotol.126.3.396; Joseph V, 2009, J NEUROSURG, V111, P650, DOI 10.3171/2009.3.JNS0984; Kasper EM, 2012, NEUROSURGERY, V71, P15, DOI 10.1227/NEU.0b013e318242cea2; Klammert U, 2010, J CRANIO MAXILL SURG, V38, P565, DOI 10.1016/j.jcms.2010.01.009; Kung WM, 2012, BRAIN INJURY, V26, P1737, DOI 10.3109/02699052.2012.698361; Kung WM, 2012, J NEUROTRAUM, V29, P2030, DOI 10.1089/neu.2011.2220; Lin MS, 2013, J NEUROPSYCH CLIN N, V25, pE52, DOI 10.1176/appi.neuropsych.12080189; Lin Samuel J, 2008, Semin Plast Surg, V22, P281, DOI 10.1055/s-0028-1095887; MALIS LI, 1989, NEUROSURGERY, V25, P351, DOI 10.1227/00006123-198909000-00005; Miyazawa T, 2007, SURG NEUROL, V67, P291, DOI 10.1016/j.surneu.2006.04.019; Patel A, 2011, FACIAL PLAST SURG CL, V19, P683, DOI 10.1016/j.fsc.2011.07.010; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Scholz M, 2007, J CRANIO MAXILL SURG, V35, P388, DOI 10.1016/j.jcms.2007.06.006; Vanezis P, 2000, FORENSIC SCI INT, V108, P81, DOI 10.1016/S0379-0738(99)00026-2; Winder RJ, 2006, ST HEAL T, V119, P574; Zonenshayn M, 2004, J NEUROSURG, V100, P537, DOI 10.3171/ped.2004.100.5.0537	20	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e74267	10.1371/journal.pone.0074267	http://dx.doi.org/10.1371/journal.pone.0074267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204566	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400005
J	Auer, MK; Hohne, N; Bazarra-Castro, MA; Pfister, H; Fuss, J; Stalla, GK; Sievers, C; Ising, M				Auer, Matthias K.; Hoehne, Nina; Bazarra-Castro, Maria Angeles; Pfister, Hildegard; Fuss, Johannes; Stalla, Guenter K.; Sievers, Caroline; Ising, Marcus			Psychopathological Profiles in Transsexuals and the Challenge of Their Special Status among the Sexes	PLOS ONE			English	Article							MALE-TO-FEMALE; ANXIETY DISORDERS; REASSIGNMENT; PREVALENCE; THERAPY; SURGERY; HEALTH; CARE	Objective: Investigating psychopathological profiles of transsexuals raises a very basic methodological question: are control groups, which represent the biological or the phenotypic sex, most suited for an optimal evaluation of psychopathology of transsexuals? Method: Male-to-female (MtF) (n=52) and female-to-male transsexuals (FtM) (n=32), receiving cross-sex hormone treatment, were compared with age matched healthy subjects of the same genetic sex (n=178) and with the same phenotypic sex (n=178) by means of the Symptom Check List-90-Revisited instrument (SCL-90-R). We performed analyses of covariance (ANCOVA) to test for group and sex effects. Furthermore, we used a profile analysis to determine if psychopathological symptom profiles of transsexuals more closely resemble genotypic sex or phenotypic sex controls. Results: Transsexual patients reported more symptoms of psychopathological distress than did healthy control subjects in all subscales of the SCL-90-R (all p<0.001), regardless of whether they were compared with phenotype or genotype matched controls. Depressive symptoms were more pronounced in MtF than in FtM (SCL-90-R score 0.85 vs. 0.45, p = 0.001). We could demonstrate that FtM primarily reflect the psychopathological profile of biological males rather than that of biological females (r = 0.945), while MtF showed a slightly higher profile similarity with biological females than with biological males (r = 0.698 vs. r = 0.685). Conclusion: Our findings suggest that phenotypic sex matched controls are potentially more appropriate for comparison with the psychopathology of transsexual patients than are genetic sex matched controls.	[Auer, Matthias K.; Bazarra-Castro, Maria Angeles; Stalla, Guenter K.; Sievers, Caroline] Max Planck Inst Psychiat, Dept Internal Med Endocrinol & Clin Chem, Munich, Germany; [Hoehne, Nina; Pfister, Hildegard; Ising, Marcus] Max Planck Inst Psychiat, Dept Mol Psychol, D-80804 Munich, Germany; [Fuss, Johannes] Heidelberg Univ, Dept Psychiat & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany	Max Planck Society; Max Planck Society; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Auer, MK (corresponding author), Max Planck Inst Psychiat, Dept Internal Med Endocrinol & Clin Chem, Munich, Germany.	mauer@mpipsykl.mpg.de	Fuss, Johannes/AAI-6580-2021; Auer, Matthias/AAI-5449-2021					Altemus M, 2006, HORM BEHAV, V50, P534, DOI 10.1016/j.yhbeh.2006.06.031; Asscheman H, 2011, EUR J ENDOCRINOL, V164, P635, DOI 10.1530/EJE-10-1038; Association A.P., 2000, DIAGNOSTIC STAT MANU; AUER MK, 2013, FERTIL STERIL, P9495; Bazarra-Castro MA, 2009, EXP CLIN ENDOCR DIAB, V117, P660; DECUYPERE G, 1995, ACTA PSYCHIAT SCAND, V91, P180; Derogatis LR., 1977, SCL 90 ADM SCORING P; Devor A. H., 2004, J GAY LESBIAN PSYCHO, V8, P41, DOI [10.1300/J236v08n01_05, DOI 10.1300/J236V08N01_05]; Dhejne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016885; Franke G.H., 2002, SCL 90 R SYMPTOM CHE; FUSS J, 2013, J PSYCHIAT RES, V7; Gater R, 1998, ARCH GEN PSYCHIAT, V55, P405, DOI 10.1001/archpsyc.55.5.405; Gomez-Gil E, 2012, PSYCHONEUROENDOCRINO, V37, P662, DOI 10.1016/j.psyneuen.2011.08.010; Gomez-Gil E, 2009, ARCH SEX BEHAV, V38, P378, DOI 10.1007/s10508-007-9307-8; Gooren LJ, 2011, NEW ENGL J MED, V364, P1251, DOI 10.1056/NEJMcp1008161; Haraldsen IR, 2000, ACTA PSYCHIAT SCAND, V102, P276, DOI 10.1034/j.1600-0447.2000.102004276.x; Hembree WC, 2009, J CLIN ENDOCR METAB, V94, P3132, DOI 10.1210/jc.2009-0345; Hepp U, 2004, EUR PSYCHIAT, V19, p130S; HEYLENS G, 2013, BRIT J PSYCHIAT, P69030; Inoubli A, 2011, J SEX MED, V8, P475, DOI 10.1111/j.1743-6109.2010.02130.x; Joffe H, 1998, BIOL PSYCHIAT, V44, P798, DOI 10.1016/S0006-3223(98)00169-3; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Klein C, 2009, J SEX MED, V6, P2922, DOI 10.1111/j.1743-6109.2009.01370.x; KOCKOTT G, 1988, ARCH SEX BEHAV, V17, P539, DOI 10.1007/BF01542341; Kohli MA, 2011, NEURON, V70, P252, DOI 10.1016/j.neuron.2011.04.005; Kraemer B, 2008, PSYCHOPATHOLOGY, V41, P96, DOI 10.1159/000111554; KUIPER B, 1988, ARCH SEX BEHAV, V17, P439, DOI 10.1007/BF01542484; Landen M, 1998, ACTA PSYCHIAT SCAND, V97, P189, DOI 10.1111/j.1600-0447.1998.tb09986.x; LEITENBERG H, 1983, ARCH SEX BEHAV, V12, P337, DOI 10.1007/BF01542194; Murad MH, 2010, CLIN ENDOCRINOL, V72, P214, DOI 10.1111/j.1365-2265.2009.03625.x; Olsen LR, 2004, ACTA PSYCHIAT SCAND, V110, P225, DOI 10.1111/j.1600-0447.2004.00399.x; ORGANIZATION WH, 1993, ICD 10 CLASS MENT BE; Schmidt PJ, 1998, NEW ENGL J MED, V338, P209, DOI 10.1056/NEJM199801223380401; Schneider HJ, 2006, PSYCHONEUROENDOCRINO, V31, P265, DOI 10.1016/j.psyneuen.2005.07.005; Shores MM, 2004, ARCH GEN PSYCHIAT, V61, P162, DOI 10.1001/archpsyc.61.2.162; Weyers S, 2009, J SEX MED, V6, P752, DOI 10.1111/j.1743-6109.2008.01082.x	36	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78469	10.1371/journal.pone.0078469	http://dx.doi.org/10.1371/journal.pone.0078469			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194937	Green Published, gold			2022-12-27	WOS:000326037000116
J	Lu, XZ; Ke, JT; Luo, X; Zhu, YW; Zou, L; Li, HJ; Zhu, BB; Xiong, ZG; Chen, W; Deng, LY; Lou, J; Wang, XX; Zhang, Y; Wang, ZL; Miao, XP; Cheng, LM				Lu, Xuzai; Ke, Juntao; Luo, Xia; Zhu, Yaowu; Zou, Li; Li, Huijun; Zhu, Beibei; Xiong, Zhigang; Chen, Wei; Deng, Lingyan; Lou, Jiao; Wang, Xianxiu; Zhang, Yu; Wang, Zhenling; Miao, Xiaoping; Cheng, Liming			The SNP rs402710 in 5p15.33 Is Associated with Lung Cancer Risk: A Replication Study in Chinese Population and a Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; GENETIC-VARIANTS; POLYMORPHISMS; BIAS; TERT	Background: Lung cancer is the most commonly diagnosed cancer and leading cause of cancer mortality in the world. A single nucleotide polymorphism (SNP), rs402710, located in 5p15.33, was firstly identified to be associated with the lung cancer risk in a genome-wide association study. However, some following replication studies yielded inconsistent results. Methodology and Findings: A case-control study of 611 cases and 1062 controls in a Chinese population was conducted, and then a meta-analysis integrating the current and previously published studies with a total 31811 cases and 36333 controls was performed to explore the real effect of rs402710 on lung cancer susceptibility. Significant associations between the SNP rs402710 and lung cancer risk were observed in both case-control study and meta-analysis, with ORs equal to 0.77 (95% CI = 0.63-0.95) and 0.83 (95% CI = 0.81-0.86) in dominant model, respectively. By stratified analysis of our case-control study, the associations were also observed in never smoker group and non-small cell lung cancer(NSCLC) group with ORs equal to 0.71 (95% CI = 0.53-0.95) and 0.69 (95% CI = 0.55-0.87), which was remarkable that larger effect of the minor allele T was seen in the two groups than that in overall lung cancer. Besides, the sensitive and cumulative analysis indicated the robust stability of the current results of meta-analysis. Conclusion: The results from our replication study and the meta-analysis provided firm evidence that rs402710 T allele significantly contributed to decreased lung cancer risk, and the case-control study implied that the variant may yield stronger effect on NSCLC and never smokers. However, the mechanism underlying the polymorphism conferring susceptibility to lung cancer is warranted to clarify in the follow-up studies.	[Lu, Xuzai; Ke, Juntao; Zou, Li; Zhu, Beibei; Chen, Wei; Lou, Jiao; Zhang, Yu; Wang, Zhenling; Miao, Xiaoping] Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat, Key Lab Environm & Hlth,Minist Environm Protect, MOE Minist Educ,Key Lab Environm & Hlth Wuhan, Wuhan 430074, Peoples R China; [Lu, Xuzai; Ke, Juntao; Zou, Li; Zhu, Beibei; Chen, Wei; Lou, Jiao; Zhang, Yu; Wang, Zhenling; Miao, Xiaoping] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Luo, Xia; Zhu, Yaowu; Li, Huijun; Xiong, Zhigang; Deng, Lingyan; Wang, Xianxiu; Cheng, Liming] Huazhong Univ Sci & Technol, Dept Lab Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Lu, Xuzai] Guangdong Maternal & Child Hlth Care Hosp, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Miao, XP (corresponding author), Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat, Key Lab Environm & Hlth,Minist Environm Protect, MOE Minist Educ,Key Lab Environm & Hlth Wuhan, Wuhan 430074, Peoples R China.	miaoxp@mail.hust.edu.cn; chengliming@tjh.tjmu.edu.cn	Xiao, Hu/GMX-0258-2022; miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722				Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Bae EY, 2012, RESPIROLOGY, V17, P699, DOI 10.1111/j.1440-1843.2012.02165.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brennan P, 2011, LANCET ONCOL, V12, P399, DOI 10.1016/S1470-2045(10)70126-1; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Chen XF, 2012, GENET MOL RES, V11, P370, DOI 10.4238/2012.February.16.2; Chung CC, 2010, CARCINOGENESIS, V31, P111, DOI 10.1093/carcin/bgp273; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garcia-Barcelo MM, 2010, HUM MOL GENET, V19, P2917, DOI 10.1093/hmg/ddq196; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Ito H, 2012, J THORAC ONCOL, V7, P790, DOI 10.1097/JTO.0b013e3182475028; James MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036116; Jaworowska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025057; Jin GF, 2009, CARCINOGENESIS, V30, P987, DOI 10.1093/carcin/bgp090; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Knobloch K, 2011, J CRANIO MAXILL SURG, V39, P91, DOI 10.1016/j.jcms.2010.11.001; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Liu L, 2011, CANCER-AM CANCER SOC, V117, P5172, DOI 10.1002/cncr.26154; MANTEL N, 1959, J NATL CANCER I, V22, P719; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; Mullen B, 2001, PERS SOC PSYCHOL B, V27, P1450, DOI 10.1177/01461672012711006; Pabalan NA, 2010, ASIAN PAC J CANCER P, V11, P33; Pande M, 2011, CARCINOGENESIS, V32, P1493, DOI 10.1093/carcin/bgr136; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020; Xun WW, 2011, MUTAGENESIS, V26, P657, DOI 10.1093/mutage/ger030; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Yang P, 2010, CANCER EPIDEM BIOMAR, V19, P240, DOI 10.1158/1055-9965.EPI-09-0710; Yoon KA, 2010, HUM MOL GENET, V19, P4948, DOI 10.1093/hmg/ddq421; Young RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016476; Zhong H, 2009, GENETIC EPIDEMIOLOGY, pn/a; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	43	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76252	10.1371/journal.pone.0076252	http://dx.doi.org/10.1371/journal.pone.0076252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194831	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000010
J	Rehan, SM; Leys, R; Schwarz, MP				Rehan, Sandra M.; Leys, Remko; Schwarz, Michael P.			First Evidence for a Massive Extinction Event Affecting Bees Close to the K-T Boundary	PLOS ONE			English	Article							CRETACEOUS TERTIARY BOUNDARY; EXONEURINE ALLODAPINE BEES; HISTORICAL BIOGEOGRAPHY; DIVERGENCE TIMES; SOUTH-AMERICA; NORTH-DAKOTA; EVOLUTION; DIVERSIFICATION; HYMENOPTERA; PHYLOGENY	Bees and eudicot plants both arose in the mid-late Cretaceous, and their co-evolutionary relationships have often been assumed as an important element in the rise of flowering plants. Given the near-complete dependence of bees on eudicots we would expect that major extinction events affecting the latter would have also impacted bees. However, given the very patchy distribution of bees in the fossil record, identifying any such extinctions using fossils is very problematic. Here we use molecular phylogenetic analyses to show that one bee group, the Xylocopinae, originated in the mid-Cretaceous, coinciding with the early radiation of the eudicots. Lineage through time analyses for this bee subfamily show very early diversification, followed by a long period of seemingly no radiation and then followed by rapid diversification in each of the four constituent tribes. These patterns are consistent with both a long-fuse model of radiation and a massive extinction event close to the K-T boundary. We argue that massive extinction is much more plausible than a long fuse, given the historical biogeography of these bees and the diversity of ecological niches that they occupy. Our results suggest that events near the K-T boundary would have disrupted many plant-bee relationships, with major consequences for the subsequent evolution of eudicots and their pollinators.	[Rehan, Sandra M.] Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA; [Leys, Remko; Schwarz, Michael P.] Flinders Univ South Australia, Sch Biol Sci, Adelaide, SA, Australia; [Leys, Remko] South Australia Museum, Evolutionary Biol Unit, Adelaide, SA, Australia; [Leys, Remko] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia	University System Of New Hampshire; University of New Hampshire; Flinders University South Australia; South Australian Museum; University of Adelaide	Rehan, SM (corresponding author), Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA.	sandra.rehan@gmail.com		Leijs, Remko/0000-0001-6909-5659	Australian Endeavour fellowships; Australian Research Council	Australian Endeavour fellowships(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Research Council(Australian Research Council)	This research was supported by Australian Endeavour fellowships to SMR and an Australian Research Council grant to MPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara S, 2010, AM J BOT, V97, P782, DOI 10.3732/ajb.0900182; Almeida EAB, 2012, J BIOGEOGR, V39, P526, DOI 10.1111/j.1365-2699.2011.02624.x; Antonelli A, 2011, SYST BIOL, V60, P596, DOI 10.1093/sysbio/syr062; Barrera E, 1999, GEOL S AM S, P245; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cardinal S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2686; Cardinal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021086; Cardinal S, 2010, P NATL ACAD SCI USA, V107, P16207, DOI 10.1073/pnas.1006299107; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Chenoweth LB, 2011, J BIOGEOGR, V38, P1471, DOI 10.1111/j.1365-2699.2011.02488.x; Crepet WL, 1998, AM J BOT, V85, P1122, DOI 10.2307/2446345; Crisp MD, 2009, EVOLUTION, V63, P2257, DOI 10.1111/j.1558-5646.2009.00728.x; Danforth BN, 2006, P NATL ACAD SCI USA, V103, P15118, DOI 10.1073/pnas.0604033103; Danforth BN, 2013, ANNU REV ENTOMOL, V58, P57, DOI 10.1146/annurev-ento-120811-153633; Dingle RV, 1998, PALAEOGEOGR PALAEOCL, V141, P215, DOI 10.1016/S0031-0182(98)00056-X; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Engel M.S., 2013, STINGLESS BEES PROCE, P1; Engel MS, 2001, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2001)259<0001:AMOTBA>2.0.CO;2; Engel MS, 2001, P NATL ACAD SCI USA, V98, P1661, DOI 10.1073/pnas.98.4.1661; Flores-Prado L, 2012, REV CHIL HIST NAT, V85, P245, DOI 10.4067/S0716-078X2012000300001; Gibbs J, 2012, MOL PHYLOGENET EVOL, V65, P926, DOI 10.1016/j.ympev.2012.08.013; Groom SVC, 2013, MOL PHYLOGENET EVOL, V68, P582, DOI 10.1016/j.ympev.2013.04.015; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hu SS, 2008, P NATL ACAD SCI USA, V105, P240, DOI 10.1073/pnas.0707989105; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iglesias A, 2011, BIOL J LINN SOC, V103, P409, DOI 10.1111/j.1095-8312.2011.01657.x; JOHNSON KR, 1992, CRETACEOUS RES, V13, P91, DOI 10.1016/0195-6671(92)90029-P; Judd WS, 2004, AM J BOT, V91, P1627, DOI 10.3732/ajb.91.10.1627; Kayaalp P, 2013, MOL PHYLOGENET EVOL, V66, P668, DOI 10.1016/j.ympev.2012.10.018; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; Labandeira CC, 2002, P NATL ACAD SCI USA, V99, P2061, DOI 10.1073/pnas.042492999; Leys R, 2002, BIOL J LINN SOC, V77, P249, DOI 10.1046/j.1095-8312.2002.00108.x; Litman JR, 2011, P ROY SOC B-BIOL SCI, V278, P3593, DOI 10.1098/rspb.2011.0365; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Ortiz-Jaureguizar E, 2006, J ARID ENVIRON, V66, P498, DOI 10.1016/j.jaridenv.2006.01.007; Packer L, 2005, CONSERV BIOL, V19, P195, DOI 10.1111/j.1523-1739.2005.00601.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pike EM, 1995, AMBER TAPHONOMY GRAS; Pole M, 2009, CRETACEOUS RES, V30, P917, DOI 10.1016/j.cretres.2009.02.007; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rambaut A., 2007, TRACER V1 5; Rehan SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034690; Rehan SM, 2010, MOL PHYLOGENET EVOL, V55, P1042, DOI 10.1016/j.ympev.2010.01.011; Ricklefs RE, 2007, AM NAT, V170, pS56, DOI 10.1086/519402; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Schwarz MP, 2011, BIOL LETTERS, V7, P277, DOI 10.1098/rsbl.2010.0757; Schwarz MP, 2006, SYST BIOL, V55, P31, DOI 10.1080/10635150500431148; Smith JA, 2013, BIOL J LINN SOC, V109, P320, DOI 10.1111/bij.12043; Smith SD, 2010, NEW PHYTOL, V188, P354, DOI 10.1111/j.1469-8137.2010.03292.x; Soltis PS, 2004, AM J BOT, V91, P1614, DOI 10.3732/ajb.91.10.1614; Stadler T., 2010, TREESIM R SIMULATING; Stadler T, 2011, SYST BIOL, V60, P676, DOI 10.1093/sysbio/syr029; TSCHUDY RH, 1986, GEOLOGY, V14, P667, DOI 10.1130/0091-7613(1986)14<667:EASOPL>2.0.CO;2; Wilf P, 2003, SCIENCE, V300, P122, DOI 10.1126/science.1080475; Wilf P, 2004, PALEOBIOLOGY, V30, P347, DOI 10.1666/0094-8373(2004)030<0347:LPEATE>2.0.CO;2; Wing SL., 2004, EXTINCTIONS HIST LIF, P61; Zayed A, 2005, CONSERV GENET, V6, P1017, DOI 10.1007/s10592-005-9094-5	64	22	22	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76683	10.1371/journal.pone.0076683	http://dx.doi.org/10.1371/journal.pone.0076683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194843	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000022
J	de Ruyter, JC; Katan, MB; Kuijper, LDJ; Liem, DG; Olthof, MR				de Ruyter, Janne C.; Katan, Martijn B.; Kuijper, Lothar D. J.; Liem, Djin G.; Olthof, Margreet R.			The Effect of Sugar-Free Versus Sugar-Sweetened Beverages on Satiety, Liking and Wanting: An 18 Month Randomized Double-Blind Trial in Children	PLOS ONE			English	Article							SENSORY-SPECIFIC SATIETY; FOOD-INTAKE; ENERGY-INTAKE; BODY-WEIGHT; CONSUMPTION; APPETITE; ASPARTAME; SUCROSE; HUNGER; DRINKS	Background: Substituting sugar-free for sugar-sweetened beverages reduces weight gain. A possible explanation is that sugar-containing and sugar-free beverages cause the same degree of satiety. However, this has not been tested in long-term trials. Methods: We randomized 203 children aged 7-11 years to receive 250 mL per day of an artificially sweetened sugar-free beverage or a similarly looking and tasting sugar-sweetened beverage. We measured satiety on a 5-point scale by questionnaire at 0, 6, 12 and 18 months. We calculated the change in satiety from before intake to 1 minute after intake and 15 minutes after intake. We then calculated the odds ratio that satiety increased by 1 point in the sugar-group versus the sugar-free group. We also investigated how much the children liked and wanted the beverages. Results: 146 children or 72% completed the study. We found no statistically significant difference in satiety between the sugar-free and sugar-sweetened group; the adjusted odds ratio for a 1 point increase in satiety in the sugar group versus the sugar-free group was 0.77 at 1 minute (95% confidence interval, 0.46 to 1.29), and 1.44 at 15 minutes after intake (95% CI, 0.86 to 2.40). The sugar-group liked and wanted their beverage slightly more than the sugar-free group, adjusted odds ratio 1.63 (95% CI 1.05 to 2.54) and 1.65 (95% CI 1.07 to 2.55), respectively. Conclusions: Sugar-sweetened and sugar-free beverages produced similar satiety. Therefore when children are given sugar-free instead of sugar-containing drinks they might not make up the missing calories from other sources. This may explain our previous observation that children in the sugar-free group accumulated less body fat than those in the sugar group.	[de Ruyter, Janne C.; Katan, Martijn B.; Kuijper, Lothar D. J.; Olthof, Margreet R.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands; [de Ruyter, Janne C.; Katan, Martijn B.; Kuijper, Lothar D. J.; Olthof, Margreet R.] Vrije Univ Amsterdam, Fac Earth & Life Sci, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Liem, Djin G.] Deakin Univ, Ctr Phys Act & Nutr Res, Sch Exercise & Nutr Sci, Burwood, Vic, Australia	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Deakin University	de Ruyter, JC (corresponding author), Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands.	J.C.de.ruyter@vu.nl	Katan, Martijn/ABB-6613-2021	, Margreet/0000-0002-1982-9244	ZonMW [120520010]; Dutch Heart Foundation [2008B96]; Royal Netherlands Academy of Arts and Sciences [ISK/741/PAH]	ZonMW(Netherlands Organization for Health Research and Development); Dutch Heart Foundation(Netherlands Heart Foundation); Royal Netherlands Academy of Arts and Sciences	Funding provided by ZonMW: grantnumber: 120520010 http://www.zonmw.nl/nl/, Dutch Heart Foundation: grantnumber: 2008B96 http://www.hartstichting.nl/ and Royal Netherlands Academy of Arts and Sciences: grantnumber: ISK/741/PAH http://www.knaw.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton SD, 2010, APPETITE, V55, P37, DOI 10.1016/j.appet.2010.03.009; Bellisle F, 2012, J NUTR, V142, p1149S, DOI 10.3945/jn.111.149583; Beridot-Therond ME, 1998, APPETITE, V31, P67, DOI 10.1006/appe.1997.0153; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; BIRCH LL, 1985, LEARN MOTIV, V16, P341, DOI 10.1016/0023-9690(85)90020-7; Blundell J, 2010, OBES REV, V11, P251, DOI 10.1111/j.1467-789X.2010.00714.x; CANTY DJ, 1991, AM J CLIN NUTR, V53, P1159, DOI 10.1093/ajcn/53.5.1159; Cassady BA, 2012, AM J CLIN NUTR, V95, P587, DOI 10.3945/ajcn.111.025437; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; de Ruyter JC, 2012, CONTEMP CLIN TRIALS, V33, P247, DOI 10.1016/j.cct.2011.10.007; Donders-Engelen M.R, 2003, MATEN GEWICHTEN CODE; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Erlanson-Albertsson C, 2005, ACTA PAEDIATR, V94, P40, DOI 10.1080/08035320510035249; Faith MS, 2002, PHYSIOL BEHAV, V76, P173, DOI 10.1016/S0031-9384(02)00702-3; Hetherington M. M., 2000, British Food Journal, V102, P507, DOI 10.1108/00070700010336517; Holt SHA, 2000, INT J FOOD SCI NUTR, V51, P59, DOI 10.1080/096374800100912; Leon F, 1999, FOOD QUAL PREFER, V10, P93, DOI 10.1016/S0950-3293(98)00046-9; Liem DG, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-38; Mattes RD, 2009, J AM DIET ASSOC, V109, P430, DOI 10.1016/j.jada.2008.11.031; Mela DJ, 2006, APPETITE, V47, P10, DOI 10.1016/j.appet.2006.02.006; PORIKOS KP, 1977, AM J CLIN NUTR, V30, P1638, DOI 10.1093/ajcn/30.10.1638; RIVM, 2011, NEVO ONL VERS; ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3; ROLLS BJ, 1990, PHYSIOL BEHAV, V48, P19, DOI 10.1016/0031-9384(90)90254-2; ROLLS BJ, 1988, APPETITE, V11, P62, DOI 10.1016/S0195-6663(88)80048-5; ROLLS BJ, 1989, APPETITE, V13, P115, DOI 10.1016/0195-6663(89)90109-8; ROLLS ET, 1985, PHYSIOL BEHAV, V34, P1017, DOI 10.1016/0031-9384(85)90032-0; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963; TOURNIER A, 1991, APPETITE, V16, P17, DOI 10.1016/0195-6663(91)90107-4; Van Wymelbeke V, 2004, EUR J CLIN NUTR, V58, P154, DOI 10.1038/sj.ejcn.1601762; Zandstra EH, 2000, APPETITE, V35, P113, DOI 10.1006/appe.2000.0342	34	37	37	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78039	10.1371/journal.pone.0078039	http://dx.doi.org/10.1371/journal.pone.0078039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167595	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500055
J	Juanola-Falgarona, M; Candido-Fernandez, J; Salas-Salvado, J; Martinez-Gonzalez, MA; Estruch, R; Fiol, M; Arija-Val, V; Bullo, M				Juanola-Falgarona, Marti; Candido-Fernandez, Jose; Salas-Salvado, Jordi; Martinez-Gonzalez, Miguel A.; Estruch, Ramon; Fiol, Miquel; Arija-Val, Victoria; Bullo, Monica		PREDIMED Study Investigators	Association between Serum Ferritin and Osteocalcin as a Potential Mechanism Explaining the Iron-Induced Insulin Resistance	PLOS ONE			English	Article							BETA-CELL FUNCTION; METABOLIC SYNDROME; GENERAL-POPULATION; NATIONAL-HEALTH; STORES; RISK; TRANSFERRIN; MEN; GLUCOSE; WOMEN	Background: Increased iron stores are associated with increased risk of type 2 diabetes, however, the mechanisms underlying these associations are poorly understood. Because a reduction of circulating osteocalcin levels after iron overload have been demonstrated in cell cultures, and osteocalcin is related to glucose and insulin metabolism, the iron-induced osteocalcin reductions could contribute to explain the role of iron metabolism in the development of type 2 diabetes mellitus. Objective: To analyzed the associations between serum total and uncarboxylated osteocalcin and adiponectin concentrations with serum ferritin and soluble transferrin receptor (sTfR) in elderly subjects. Design: We evaluated a total of 423 subjects from the PREDIMED cohort in a population-based cross-sectional analysis. Extensive clinical, nutritional and laboratory measurements, including total and uncarboxylated osteocalcin, adiponectin, ferritin and sTfR were recorded. Results: Serum ferritin was positively correlated with increased glucose and insulin circulating levels but also with HOMA-IR, and was inversely associated with total osteocalcin and adiponectin. A regression analysis revealed that serum ferritin and transferrin receptor levels were significantly associated with a decrease in total and uncarboxylated osteocalcin. Serum sTfR levels were associated with lower uncarboxylated osteocalcin levels in the whole-study subjects and remained significant only in the IFG (impaired fasting glucose) individuals. Conclusions: We described, for the first time, an inverse association between serum ferritin and sTfR with osteocalcin and extend previous results on adiponectin, thus supporting that factors related to iron metabolism could contribute to the insulin resistance and the development of type 2 diabetes mellitus.	[Juanola-Falgarona, Marti; Candido-Fernandez, Jose; Salas-Salvado, Jordi; Arija-Val, Victoria; Bullo, Monica] Univ Rovira & Virgili, IISPV, Fac Med & Hlth Sci, Human Nutr Unit, E-43201 Reus, Spain; [Juanola-Falgarona, Marti; Candido-Fernandez, Jose; Salas-Salvado, Jordi; Arija-Val, Victoria; Bullo, Monica] Univ Rovira & Virgili, IISPV, Fac Med & Hlth Sci, Prevent Med Unit, E-43201 Reus, Spain; [Juanola-Falgarona, Marti; Salas-Salvado, Jordi; Martinez-Gonzalez, Miguel A.; Estruch, Ramon; Fiol, Miquel; Bullo, Monica] Inst Hlth Carlos III ISCIII, CIBERobn Physiopathol Obes & Nutr, Madrid, Spain; [Martinez-Gonzalez, Miguel A.] Univ Navarra, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Estruch, Ramon] Inst Invest Biomed August Pi Sunyer, Dept Internal Med, Barcelona, Spain; [Fiol, Miquel] Univ Inst Hlth Sci Invest, Palma De Mallorca, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Navarra; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Salas-Salvado, J (corresponding author), Univ Rovira & Virgili, IISPV, Fac Med & Hlth Sci, Human Nutr Unit, C St Llorenc 21, E-43201 Reus, Spain.	jordi.salas@urv.cat; monica.bullo@urv.cat	Estruch, Ramon/AAZ-3723-2020; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Juanola-Falgarona, Martí/AFN-4252-2022; Fiol, Miguel/F-6793-2016; Casas, Rosa/ABD-1915-2020; Salas-Salvado, Jordi/C-7229-2017; Bulló, Mònica/F-2925-2016; Fernández-Cao, José Cándido/N-1509-2018	Fiol, Miguel/0000-0002-5370-1391; Casas, Rosa/0000-0002-0211-9166; Salas-Salvado, Jordi/0000-0003-2700-7459; Bulló, Mònica/0000-0002-0218-7046; Fernández-Cao, José Cándido/0000-0002-1697-3443; Juanola-Falgarona, Marti/0000-0002-4566-7154; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808	FEDER (Fondo Europeo de Desarrollo Regional) [PI041828, PI10/01407, PI051839, G03/140, RD06/0045]; Public Health Division of the Department of Health of the Autonomous Government of Catalonia	FEDER (Fondo Europeo de Desarrollo Regional)(European Commission); Public Health Division of the Department of Health of the Autonomous Government of Catalonia	CIBERobn and RTIC RD 06/0045 are initiatives of ISCIII, Spain. Fondo de Investigacion Sanitaria projects PI041828, PI10/01407, PI051839, G03/140, RD06/0045, FEDER (Fondo Europeo de Desarrollo Regional), the Public Health Division of the Department of Health of the Autonomous Government of Catalonia in collaboration to Merck Sharp & Dohme laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkhami-Ardekani M, 2009, J DIABETES COMPLICAT, V23, P194, DOI 10.1016/j.jdiacomp.2007.11.006; Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Angelopoulos NG, 2006, OSTEOPOROSIS INT, V17, P150, DOI 10.1007/s00198-005-1920-6; Bao W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-119; Bullo M, 2012, AM J CLIN NUTR, V95, P249, DOI 10.3945/ajcn.111.016642; Cooksey RC, 2010, AM J PHYSIOL-ENDOC M, V298, pE1236, DOI 10.1152/ajpendo.00022.2010; Doyard M, 2012, OSTEOPOROSIS INT, V23, P2435, DOI 10.1007/s00198-011-1871-z; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Fernandez-Real JM, 2007, DIABETES CARE, V30, P604, DOI 10.2337/dc06-1138; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Fumeron F, 2006, DIABETES CARE, V29, P2090, DOI 10.2337/dc06-0093; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Gillum RF, 2001, INT J OBESITY, V25, P639, DOI 10.1038/sj.ijo.0801561; Haap M, 2003, ANN INTERN MED, V139, P869, DOI 10.7326/0003-4819-139-10-200311180-00029; Iwasaki T, 2005, DIABETES CARE, V28, P2486, DOI 10.2337/diacare.28.10.2486; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Kim BJ, 2012, J BONE MINER RES, V27, P2279, DOI 10.1002/jbmr.1692; Ku BJ, 2009, DIS MARKERS, V27, P303, DOI [10.1155/2009/931082, 10.3233/DMA-2009-0676]; Lee BK, 2011, METABOLISM, V60, P1416, DOI 10.1016/j.metabol.2011.02.008; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MERKEL PA, 1988, NEW ENGL J MED, V318, P809, DOI 10.1056/NEJM198803313181303; Messer JG, 2009, BONE, V45, P972, DOI 10.1016/j.bone.2009.07.073; Moreiras O, 2005, TABLAS COMPOSICION A; Neve A, 2013, J CELL PHYSIOL, V228, P1149, DOI 10.1002/jcp.24278; Nigg CR, 1999, GERONTOLOGIST, V39, P473, DOI 10.1093/geront/39.4.473; Rajpathak SN, 2009, DIABETES OBES METAB, V11, P472, DOI 10.1111/j.1463-1326.2008.00985.x; Rumberger JM, 2004, DIABETES, V53, P2535, DOI 10.2337/diabetes.53.10.2535; Salonen JT, 1998, BRIT MED J, V317, P727, DOI 10.1136/bmj.317.7160.727; Sharifi F, 2008, DIABETES VASC DIS RE, V5, P15, DOI 10.3132/dvdr.2008.003; Syrovatka P, 2009, ANN NUTR METAB, V54, P268, DOI 10.1159/000229507; Vari IS, 2007, DIABETES CARE, V30, P1795, DOI 10.2337/dc06-2312; Weinberg ED, 2006, BIOMETALS, V19, P633, DOI 10.1007/s10534-006-9000-8; Wilson JG, 2003, AM J MED SCI, V325, P332, DOI 10.1097/00000441-200306000-00004; Witte DL, 1996, CLIN CHIM ACTA, V245, P139, DOI 10.1016/0009-8981(95)06212-2; Wlazlo N, 2013, DIABETES CARE, V36, P309, DOI 10.2337/dc12-0505; Yang Q, 2011, J BONE MINER RES, V26, P1188, DOI 10.1002/jbmr.337; Zarjou A, 2010, J BONE MINER RES, V25, P164, DOI 10.1359/jbmr.091002	39	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76433	10.1371/journal.pone.0076433	http://dx.doi.org/10.1371/journal.pone.0076433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167545	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500004
J	Mao, X; Li, Y; Zhao, SS; Zhang, J; Lei, Q; Meng, DD; Ma, FY; Hu, W; Chen, MJ; Chang, JL; Wang, YS; Yang, GX; He, GY				Mao, Xiang; Li, Yin; Zhao, Shasha; Zhang, Jian; Lei, Qian; Meng, Dandan; Ma, Fengyun; Hu, Wei; Chen, Mingjie; Chang, Junli; Wang, Yuesheng; Yang, Guangxiao; He, Guangyuan			The Interactive Effects of Transgenically Overexpressed 1Ax1 with Various HMW-GS Combinations on Dough Quality by Introgression of Exogenous Subunits into an Elite Chinese Wheat Variety	PLOS ONE			English	Article							BREAD-MAKING QUALITY; WEIGHT GLUTENIN SUBUNITS; FUNCTIONAL-PROPERTIES; ALLELIC VARIATION; MIXING PROPERTIES; TECHNOLOGICAL QUALITY; AGRONOMIC PERFORMANCE; BAKING PROPERTIES; LINES; FIELD	Seed storage proteins in wheat endosperm, particularly high-molecular-weight glutenin subunits (HMW-GS), are primary determinants of dough properties, and affect both end-use quality and grain utilization of wheat (Triticum aestivum L). In order to investigate the interactive effects between the transgenically overexpressed 1Ax1 subunit with different HMW-GS on dough quality traits, we developed a set of 8 introgression lines (ILs) overexpressing the transgenic HMW-glutenin subunit 1Ax1 by introgression of this transgene from transgenic line B102-1-2/1 into an elite Chinese wheat variety Chuanmai107 (C107), using conventional crossing and backcrossing breeding technique. The donor C107 strain lacks 1Ax1 but contains the HMW-GS pairs 1Dx2+1Dy12 and 1Bx7+1By9. The resultant ILs showed robust and stable expression of 1Ax1 even after five generations of self-pollination, and crossing/backcrossing three times. In addition, overexpression of 1Ax1 was compensated by the endogenous gluten proteins. All ILs exhibited superior agronomic performance when compared to the transgenic parent line, B102-1-2/1. Mixograph results demonstrated that overexpressed 1Ax1 significantly improved dough strength, resistance to extension and over-mixing tolerance, in the targeted wheat cultivar C107. Further, comparisons among the ILs showed the interactive effects of endogenous subunits on dough properties when 1Ax1 was overexpressed: subunit pair 17+18 contributed to increased over-mixing tolerance of the dough; expression of the Glu-D1 allele maintained an appropriate balance between x-type and y-type subunits and thereby improved dough quality. It is consistent with ILs C4 (HMW-GS are 1, 17+18, 2+12) had the highest gluten index and Zeleny sedimentation value. This study demonstrates that wheat quality could be improved by using transgenic wheat overexpressing HMW-GS and the feasibility of using such transgenic lines in wheat quality breeding programs.	[Wang, Yuesheng] HUST, Genet Engn Int Cooperat Base, Chinese Minist Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Wuhan, Peoples R China; HUST, Coll Life Sci & Technol, Key Lab Mol Biophys, Chinese Minist Educ, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, YS (corresponding author), HUST, Genet Engn Int Cooperat Base, Chinese Minist Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Wuhan, Peoples R China.	wysh@hust.edu.cn; ygx@hust.edu.cn; hegy@hust.edu.cn	Ma, Fengyun/I-8408-2019		National Science and Technology Major Project of China [2013ZX08002-004, 2013ZX08010-004]; National Natural Science Foundation of China [30871524, 31071403]; National Natural Science Foundation of Hubei, China [2011CDB370]; Fundamental Research Funds for the Central Universities, HUST [2011TS150]	National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Hubei, China; Fundamental Research Funds for the Central Universities, HUST(Fundamental Research Funds for the Central Universities)	Funding: This work was supported by 1. the National Science and Technology Major Project of China (2013ZX08002-004; 2013ZX08010-004) (http://www.nmp.gov.cn/), 2. the National Natural Science Foundation of China (No. 30871524 and No. 31071403) (http://www.nsfc.gov.cn/Portal0/default152.htm), 3. the National Natural Science Foundation of Hubei, China (2011CDB370) (http://www.hbstd.gov.cn/), 4. the Fundamental Research Funds for the Central Universities, HUST (2011TS150), (http://kfy.hust.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altpeter F, 1996, NAT BIOTECHNOL, V14, P1155, DOI 10.1038/nbt0996-1155; Alvarez ML, 2000, THEOR APPL GENET, V100, P319, DOI 10.1007/s001220050042; Alvarez ML, 2001, MOL BREEDING, V8, P103, DOI 10.1023/A:1011995625202; American Association of Cereal Chemists, 2000, APPR METH AACC; Barro F, 2003, MOL BREEDING, V12, P223, DOI 10.1023/A:1026367214120; Barro F, 2003, J CEREAL SCI, V37, P65, DOI 10.1006/jcrs.2002.0479; Barro F, 2002, THEOR APPL GENET, V105, P980, DOI 10.1007/s00122-002-0996-z; Barro F, 1997, NAT BIOTECHNOL, V15, P1295, DOI 10.1038/nbt1197-1295; Blechl AE, 1996, NAT BIOTECHNOL, V14, P875, DOI 10.1038/nbt0796-875; Blechl A, 2007, J CEREAL SCI, V45, P172, DOI 10.1016/j.jcs.2006.07.009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bregitzer P, 1998, THEOR APPL GENET, V96, P421, DOI 10.1007/s001220050758; CARRILLO JM, 1990, THEOR APPL GENET, V79, P321, DOI 10.1007/BF01186074; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; Darlington H, 2003, J CEREAL SCI, V38, P301, DOI 10.1016/S0733-5210(03)00034-1; Deng ZY, 2005, PLANT BREEDING, V124, P428, DOI 10.1111/j.1439-0523.2005.01158.x; Eagles HA, 2002, AUST J AGR RES, V53, P367, DOI 10.1071/AR01074; Fido RJ, 1997, J CEREAL SCI, V26, P271, DOI 10.1006/jcrs.1997.0138; Field JM, 2008, J CEREAL SCI, V48, P457, DOI 10.1016/j.jcs.2007.10.010; GUPTA RB, 1989, THEOR APPL GENET, V77, P57, DOI 10.1007/BF00292316; GUPTA RB, 1994, J CEREAL SCI, V19, P9, DOI 10.1006/jcrs.1994.1003; He GY, 1999, MOL BREEDING, V5, P377, DOI 10.1023/A:1009681321708; Hernandez P, 2000, J PLANT PHYSIOL, V156, P223, DOI 10.1016/S0176-1617(00)80310-7; Jin H, 2013, J CEREAL SCI, V57, P146, DOI [10.1016/j.jcs.2012.10.011, 10.1016/j.jcs.2012.10.01]; Juhasz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029501; LAWRENCE GJ, 1987, J CEREAL SCI, V6, P99, DOI 10.1016/S0733-5210(87)80045-0; Leon E, 2009, J CEREAL SCI, V49, P148, DOI 10.1016/j.jcs.2008.08.002; Leon E, 2010, J CEREAL SCI, V51, P13, DOI 10.1016/j.jcs.2009.09.001; Li SH, 2007, ACTA BIOCH BIOPH SIN, V39, P377, DOI 10.1111/j.1745-7270.2007.00284.x; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Li YL, 2010, J CEREAL SCI, V51, P127, DOI 10.1016/j.jcs.2009.10.008; Liu Y, 2007, GENET RESOUR CROP EV, V54, P865, DOI 10.1007/s10722-006-9154-9; Martinant JP, 1998, J CEREAL SCI, V27, P179, DOI 10.1006/jcrs.1997.0156; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1981, J SCI FOOD AGR, V32, P51, DOI 10.1002/jsfa.2740320109; PAYNE PI, 1987, J SCI FOOD AGR, V40, P51, DOI 10.1002/jsfa.2740400108; Piston F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024754; Popineau Y, 2001, J AGR FOOD CHEM, V49, P395, DOI 10.1021/jf001015j; Rakszegi M, 2008, J CEREAL SCI, V47, P310, DOI 10.1016/j.jcs.2007.04.010; Rakszegi M, 2005, J CEREAL SCI, V42, P15, DOI 10.1016/j.jcs.2005.02.006; Rooke L, 1999, THEOR APPL GENET, V99, P851, DOI 10.1007/s001220051305; Rooke L, 1999, J CEREAL SCI, V30, P115, DOI 10.1006/jcrs.1999.0265; She MY, 2011, FUNCT INTEGR GENOMIC, V11, P23, DOI 10.1007/s10142-010-0196-x; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shewry P R, 1995, Methods Mol Biol, V49, P399; Shewry Peter R, 2003, Adv Food Nutr Res, V45, P219; Shewry PR, 2006, THEOR APPL GENET, V113, P128, DOI 10.1007/s00122-006-0279-1; Shewry PR, 2005, ANN APPL BIOL, V147, P1, DOI 10.1111/j.1744-7348.2005.00009.x; SHEWRY PR, 1995, BIO-TECHNOL, V13, P1185, DOI 10.1038/nbt1195-1185; Uthayakumaran S, 2001, CEREAL CHEM, V78, P138, DOI 10.1094/CCHEM.2001.78.2.138; Vasil IK, 2001, J PLANT PHYSIOL, V158, P521, DOI 10.1078/0176-1617-00365; Wang YS, 2010, J SCI FOOD AGR, V90, P106, DOI 10.1002/jsfa.3790; Wu YR, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-77; Wu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032850; Yao Q, 2006, J EXP BOT, V57, P3737, DOI 10.1093/jxb/erl145; Zhang YanBin, 2003, Acta Agronomica Sinica, V29, P93	56	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78451	10.1371/journal.pone.0078451	http://dx.doi.org/10.1371/journal.pone.0078451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167625	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500086
J	Yip, YL; Pang, PS; Deng, W; Tsang, CM; Zeng, MS; Hau, PM; Man, C; Jin, YS; Yuen, APW; Tsao, SW				Yip, Yim Ling; Pang, Pei Shin; Deng, Wen; Tsang, Chi Man; Zeng, Musheng; Hau, Pok Man; Man, Cornelia; Jin, Yuesheng; Yuen, Anthony Po Wing; Tsao, Sai Wah			Efficient Immortalization of Primary Nasopharyngeal Epithelial Cells for EBV Infection Study	PLOS ONE			English	Article							VIRUS-ENCODED LMP1; LIFE-SPAN; HUMAN FIBROBLASTS; SELF-RENEWAL; STEM-CELLS; BMI-1; SENESCENCE; EXPRESSION; CARCINOMA; CANCER	Nasopharyngeal carcinoma (NPC) is common among southern Chinese including the ethnic Cantonese population living in Hong Kong. Epstein-Barr virus (EBV) infection is detected in all undifferentiated type of NPC in this endemic region. Establishment of stable and latent EBV infection in premalignant nasopharyngeal epithelial cells is an early event in NPC development and may contribute to its pathogenesis. Immortalized primary nasopharyngeal epithelial cells represent an important tool for investigation of EBV infection and its tumorigenic potential in this special type of epithelial cells. However, the limited availability and small sizes of nasopharyngeal biopsies have seriously restricted the establishment of primary nasopharyngeal epithelial cells for immortalization. A reliable and effective method to immortalize primary nasopharyngeal epithelial cells will provide unrestricted materials for EBV infection studies. An earlier study has reported that Bmi-1 expression could immortalize primary nasopharyngeal epithelial cells. However, its efficiency and actions in immortalization have not been fully characterized. Our studies showed that Bmi-1 expression alone has limited ability to immortalize primary nasopharyngeal epithelial cells and additional events are often required for its immortalization action. We have identified some of the key events associated with the immortalization of primary nasopharyngeal epithelial cells. Efficient immortalization of nasopharyngeal epithelial cells could be reproducibly and efficiently achieved by the combined actions of Bmi-1 expression, activation of telomerase and silencing of p16 gene. Activation of MAPK signaling and gene expression downstream of Bmi-1 were detected in the immortalized nasopharyngeal epithelial cells and may play a role in immortalization. Furthermore, these newly immortalized nasopharyngeal epithelial cells are susceptible to EBV infection and supported a type II latent EBV infection program characteristic of EBV-infected nasopharyngeal carcinoma. The establishment of an efficient method to immortalize primary nasopharyngeal epithelial cells will facilitate the investigation into the role of EBV infection in pathogenesis of nasopharyngeal carcinoma.	[Yip, Yim Ling; Pang, Pei Shin; Deng, Wen; Tsang, Chi Man; Hau, Pok Man; Man, Cornelia; Tsao, Sai Wah] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Canc Biol Lab, Pokfulam, Hong Kong, Peoples R China; [Deng, Wen] Univ Hong Kong, Li Ka Shing Fac Med, Sch Nursing, Pokfulam, Hong Kong, Peoples R China; [Zeng, Musheng] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Man, Cornelia] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Jin, Yuesheng] Lund Univ, Dept Clin Genet, Lund, Sweden; [Yuen, Anthony Po Wing] Hong Kong Head & Neck Ear Nose Throat Surg Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; State Key Lab Oncology South China; Sun Yat Sen University; Hong Kong Polytechnic University; Lund University	Tsao, SW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Canc Biol Lab, Pokfulam, Hong Kong, Peoples R China.	gswtsao@hkucc.hku.hk	Deng, Wen/M-5208-2019		Hong Kong General Research Fund [HKU 777809M]; AoE NPC grant [AoE/M-06/08]; Health and Medical Research Fund of Hong Kong grant [12110782]; CRCG from the University of Hong Kong	Hong Kong General Research Fund; AoE NPC grant; Health and Medical Research Fund of Hong Kong grant; CRCG from the University of Hong Kong	This work was supported by the Hong Kong General Research Fund (HKU 777809M), the AoE NPC grant (AoE/M-06/08), Health and Medical Research Fund of Hong Kong grant (12110782) and CRCG funding support from the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya J, 2012, CANCER SCI, V103, P34, DOI 10.1111/j.1349-7006.2011.02121.x; Brooke S, 2004, EXP CELL RES, V298, P549, DOI 10.1016/j.yexcr.2004.04.035; Deng W, 2004, ONCOGENE, V23, P9090, DOI 10.1038/sj.onc.1208119; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Dimri GP, 2002, CANCER RES, V62, P4736; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Goessel G, 2005, P NATL ACAD SCI USA, V102, P15599, DOI 10.1073/pnas.0409730102; Haga K, 2007, CANCER SCI, V98, P147, DOI 10.1111/j.1349-7006.2006.00373.x; HUANG DP, 1994, CANCER RES, V54, P4003; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kim RH, 2007, EXP CELL RES, V313, P462, DOI 10.1016/j.yexcr.2006.10.025; Kim RH, 2010, EXP CELL RES, V316, P2600, DOI 10.1016/j.yexcr.2010.04.013; Li HM, 2006, INT J CANCER, V119, P1567, DOI 10.1002/ijc.22032; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Lo AKF, 2004, INT J CANCER, V109, P919, DOI 10.1002/ijc.20051; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Shakhova O, 2005, J MOL MED, V83, P596, DOI 10.1007/s00109-005-0682-0; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Tsang CM, 2012, P NATL ACAD SCI USA, V109, pE3473, DOI 10.1073/pnas.1202637109; Tsang CM, 2010, INT J CANCER, V127, P1570, DOI 10.1002/ijc.25173; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Yip YL, 2008, INT J ONCOL, V33, P713, DOI 10.3892/ijo_00000057; Yip YL, 2010, J MED VIROL, V82, P1711, DOI 10.1002/jmv.21875	27	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78395	10.1371/journal.pone.0078395	http://dx.doi.org/10.1371/journal.pone.0078395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167620	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500081
J	Solinas, M; Massi, P; Cinquina, V; Valenti, M; Bolognini, D; Gariboldi, M; Monti, E; Rubino, T; Parolaro, D				Solinas, Marta; Massi, Paola; Cinquina, Valentina; Valenti, Marta; Bolognini, Daniele; Gariboldi, Marzia; Monti, Elena; Rubino, Tiziana; Parolaro, Daniela			Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect	PLOS ONE			English	Article							STEM-LIKE CELLS; MATRIX METALLOPROTEINASES; CANCER; GLIOBLASTOMA; EXPRESSION; PATHWAY; GROWTH; ANGIOGENESIS; ACTIVATION; THERAPY	In the present study, we found that CBD inhibited U87-MG and T98G cell proliferation and invasiveness in vitro and caused a decrease in the expression of a set of proteins specifically involved in growth, invasion and angiogenesis. In addition, CBD treatment caused a dose-related down-regulation of ERK and Akt prosurvival signaling pathways in U87-MG and T98G cells and decreased hypoxia inducible factor HIF-1 alpha expression in U87-MG cells. Taken together, these results provide new insights into the antitumor action of CBD, showing that this cannabinoid affects multiple tumoral features and molecular pathways. As CBD is a non-psychoactive phytocannabinoid that appears to be devoid of side effects, our results support its exploitation as an effective anti-cancer drug in the management of gliomas.	[Solinas, Marta; Cinquina, Valentina; Valenti, Marta; Gariboldi, Marzia; Monti, Elena; Rubino, Tiziana; Parolaro, Daniela] Univ Insubria, Ctr Neurosci, Biomed Res Div, Dept Theoret & Appl Sci, Busto Arsizio, Varese, Italy; [Massi, Paola] Univ Milan, Dept Pharmacol Chemotherapy & Toxicol, Milan, Italy; [Bolognini, Daniele] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Insubria; University of Milan; University of Toronto	Parolaro, D (corresponding author), Univ Insubria, Ctr Neurosci, Biomed Res Div, Dept Theoret & Appl Sci, Busto Arsizio, Varese, Italy.	daniela.parolaro@uninsubria.it	Gariboldi, Marzia Bruna/U-1331-2019; Bolognini, Daniele/AAF-7892-2020; Rubino, Tiziana/AAC-8210-2020	Gariboldi, Marzia Bruna/0000-0002-5683-0885; RUBINO, Tiziana/0000-0002-3128-6377; Cinquina, Valentina/0000-0002-7365-1395	University of Milan-F.I.R.S.T; GW Pharmaceuticals	University of Milan-F.I.R.S.T; GW Pharmaceuticals	This work was supported by a grant from University of Milan-F.I.R.S.T 2008. GW Pharmaceuticals funded part of the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andradas C, 2011, ONCOGENE, V30, P245, DOI 10.1038/onc.2010.402; Bisogno T, 2001, BRIT J PHARMACOL, V134, P845, DOI 10.1038/sj.bjp.0704327; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Di Cosimo S, 2008, EUR J CANCER, V44, P2781, DOI 10.1016/j.ejca.2008.09.026; Eberle K, 2000, ANTICANCER RES, V20, P1679; El-Alfy AT, 2010, PHARMACOL BIOCHEM BE, V95, P434, DOI 10.1016/j.pbb.2010.03.004; Fillmore HL, 2001, J NEURO-ONCOL, V53, P187, DOI 10.1023/A:1012213604731; Franceschi E, 2009, EXPERT REV ANTICANC, V9, P613, DOI [10.1586/era.09.23, 10.1586/ERA.09.23]; Gallia GL, 2009, MOL CANCER THER, V8, P386, DOI 10.1158/1535-7163.MCT-08-0680; Groft LL, 2001, BRIT J CANCER, V85, P55, DOI 10.1054/bjoc.2001.1854; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Jones NA, 2012, SEIZURE-EUR J EPILEP, V21, P344, DOI 10.1016/j.seizure.2012.03.001; Kaur B, 2004, J NEURO-ONCOL, V70, P229, DOI 10.1007/s11060-004-2752-5; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Liang KC, 2007, J CELL PHYSIOL, V211, P759, DOI 10.1002/jcp.20992; Lu KV, 2004, LAB INVEST, V84, P8, DOI 10.1038/labinvest.3700003; Ludwig A, 2005, J NEUROCHEM, V93, P1293, DOI 10.1111/j.1471-4159.2005.03123.x; Marcu JP, 2010, MOL CANCER THER, V9, P180, DOI 10.1158/1535-7163.MCT-09-0407; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massi P, 2008, J NEUROCHEM, V104, P1091, DOI 10.1111/j.1471-4159.2007.05073.x; Massi P, 2006, CELL MOL LIFE SCI, V63, P2057, DOI 10.1007/s00018-006-6156-x; Massi P, 2004, J PHARMACOL EXP THER, V308, P838, DOI 10.1124/jpet.103.061002; Massi P, 2013, BRIT J CLIN PHARMACO, V75, P303, DOI 10.1111/j.1365-2125.2012.04298.x; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; McPartland JM, 2007, BRIT J PHARMACOL, V152, P583, DOI 10.1038/sj.bjp.0707399; Mizutani K, 2009, NEOPLASIA, V11, P1235, DOI 10.1593/neo.09988; Ramer R, 2012, FASEB J, V26, P1535, DOI 10.1096/fj.11-198184; Ramer R, 2010, BIOCHEM PHARMACOL, V79, P955, DOI 10.1016/j.bcp.2009.11.007; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Sarfaraz S, 2008, CANCER RES, V68, P339, DOI 10.1158/0008-5472.CAN-07-2785; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Solinas M, 2012, BRIT J PHARMACOL, V167, P1218, DOI 10.1111/j.1476-5381.2012.02050.x; Soroceanu L, 2013, CANCER RES, V73, P1559, DOI 10.1158/0008-5472.CAN-12-1943; Takeuchi H, 2004, BRIT J CANCER, V90, P1069, DOI 10.1038/sj.bjc.6601605; Torres S, 2011, MOL CANCER THER, V10, P90, DOI 10.1158/1535-7163.MCT-10-0688; Ulisse S, 2009, CURR CANCER DRUG TAR, V9, P32, DOI 10.2174/156800909787314002; Vaccani A, 2005, BRIT J PHARMACOL, V144, P1032, DOI 10.1038/sj.bjp.0706134; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248	45	85	87	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76918	10.1371/journal.pone.0076918	http://dx.doi.org/10.1371/journal.pone.0076918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204703	gold, Green Published			2022-12-27	WOS:000326032600015
J	Di Cristofaro, J; Pennarun, E; Mazieres, S; Myres, NM; Lin, AA; Temori, SA; Metspalu, M; Metspalu, E; Witzel, M; King, RJ; Underhill, PA; Villems, R; Chiaroni, J				Di Cristofaro, Julie; Pennarun, Erwan; Mazieres, Stephane; Myres, Natalie M.; Lin, Alice A.; Temori, Shah Aga; Metspalu, Mait; Metspalu, Ene; Witzel, Michael; King, Roy J.; Underhill, Peter A.; Villems, Richard; Chiaroni, Jacques			Afghan Hindu Kush: Where Eurasian Sub-Continent Gene Flows Converge	PLOS ONE			English	Article							CHROMOSOME HAPLOGROUP C; MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; CONTRASTING PATTERNS; POSITIVE SELECTION; NATIVE-AMERICANS; MODERN HUMANS; ETHNIC-GROUPS; SILK ROAD; LANDSCAPE	Despite being located at the crossroads of Asia, genetics of the Afghanistan populations have been largely overlooked. It is currently inhabited by five major ethnic populations: Pashtun, Tajik, Hazara, Uzbek and Turkmen. Here we present autosomal from a subset of our samples, mitochondrial and Y- chromosome data from over 500 Afghan samples among these 5 ethnic groups. This Afghan data was supplemented with the same Y-chromosome analyses of samples from Iran, Kyrgyzstan, Mongolia and updated Pakistani samples (HGDP-CEPH). The data presented here was integrated into existing knowledge of pan-Eurasian genetic diversity. The pattern of genetic variation, revealed by structure-like and Principal Component analyses and Analysis of Molecular Variance indicates that the people of Afghanistan are made up of a mosaic of components representing various geographic regions of Eurasian ancestry. The absence of a major Central Asian-specific component indicates that the Hindu Kush, like the gene pool of Central Asian populations in general, is a confluence of gene flows rather than a source of distinctly autochthonous populations that have arisen in situ: a conclusion that is reinforced by the phylogeography of both haploid loci.	[Di Cristofaro, Julie; Mazieres, Stephane; Chiaroni, Jacques] Aix Marseille Univ, CNRS, ADES UMR7268, EFS AM, Marseille, France; [Pennarun, Erwan; Metspalu, Mait; Metspalu, Ene; Villems, Richard] Univ Tartu, Estonian Bioctr, EE-50090 Tartu, Estonia; [Pennarun, Erwan; Metspalu, Mait; Metspalu, Ene; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; [Myres, Natalie M.] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA; [Lin, Alice A.; King, Roy J.] Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA; [Temori, Shah Aga] Kabul Med Univ, Dept Biochem, Kabul, Afghanistan; [Witzel, Michael] Harvard Univ, Dept South Asian Studies, Cambridge, MA 02138 USA; [Underhill, Peter A.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Villems, Richard] Estonian Acad Sci, EE-200103 Tallinn, Estonia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Estonian Biocentre; University of Tartu; University of Tartu; Stanford University; Harvard University; Stanford University; Estonian Academy of Sciences	Chiaroni, J (corresponding author), Aix Marseille Univ, CNRS, ADES UMR7268, EFS AM, Marseille, France.	jacques.chiaroni@efs.sante.fr	Mazières, Stéphane/R-2061-2019; Mazieres, Stephane/G-1702-2010; Pennarun, Erwan/AAW-7041-2020; Metspalu, Mait/G-8671-2015; Chiaroni, Jacques/ABA-2944-2021	Mazieres, Stephane/0000-0003-1266-4659; Pennarun, Erwan/0000-0002-8267-883X; Metspalu, Mait/0000-0003-3099-9161; Chiaroni, Jacques/0000-0002-3133-8990; Di Cristofaro, Julie/0000-0001-7867-6455	Agence National de la Recherche [BLAN07-3_222301, CSD 9 - Sciences humaines et sociales]	Agence National de la Recherche(French National Research Agency (ANR))	Research was granted by the Agence National de la Recherche (Grant #BLAN07-3_222301, CSD 9 - Sciences humaines et sociales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KM, 2012, BEIGNNINGS ANCIENT K; Alexander D.H., 2010, ADMIXTURE 1 04 SOFTW; Ali Ihsan, 2005, FRONTIER ARCHAEOLOGY, V3, P109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anthony DW, 2007, HORSE, THE WHEEL, AND LANGUAGE: HOW BRONZE-AGE RIDERS FROM THE EURASIAN STEPPES SHAPED THE MODERN WORLD, P1; Bailey H. W., 2002, INDOIRANIAN LANGUAGE; Bashir E, 1998, TOPICS KALASHA SYNTA; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Behar DM, 2004, HUM GENET, V114, P354, DOI 10.1007/s00439-003-1073-7; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bengtson J, 2003, MOTHER TONGUE, V8, P131; Bengtson John D., 1997, GEORGICA, V20, P88; Bryk J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002209; Busby GBJ, 2012, P ROY SOC B-BIOL SCI, V279, P884, DOI 10.1098/rspb.2011.1044; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Cann HM, 2002, SCIENCE, V296, P261; Carpelan CP, 2001, URALIC INDOEUROPEAN; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; Chiaroni J, 2009, P NATL ACAD SCI USA, V106, P20174, DOI 10.1073/pnas.0910803106; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Comas D, 2000, AM J PHYS ANTHROPOL, V112, P5, DOI 10.1002/(SICI)1096-8644(200005)112:1<5::AID-AJPA2>3.0.CO;2-Z; Di Cristofaro J, 2012, FORENSIC SCI INT-GEN, V6, pE44, DOI 10.1016/j.fsigen.2011.03.004; Dulik MC, 2012, AM J HUM GENET, V90, P229, DOI 10.1016/j.ajhg.2011.12.014; Dulik MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017548; Elfenbein JH, 1987, PERIPLOUS BRAHUI PRO, V16, P215; Elisseeff V, 2001, SILK ROADS HIGHWAYS; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Findley C., 2005, TURKS WORLD HIST; Frachetti MD, 2012, CURR ANTHROPOL, V53, P2, DOI 10.1086/663692; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Fuller DQ, 2009, ETHNOGENESIS S CENTR, P3; Genealogy ISoG, 2012, Y DNA HAPL TREE 2012; Geppert M, 2011, FORENSIC SCI INT-GEN, V5, P100, DOI 10.1016/j.fsigen.2010.08.016; Golden PB, 2011, CENTRAL ASIA WORLD H, P192; Haber M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034288; Hegedus I, 2010, POSITION NURISTANI I; Hiebert F.T., 1994, ORIGINS BRONZE AGE O; Hintze A, 1996, INNSBRUCK, V22, P139; Hodoglugil U, 2012, ANN HUM GENET, V76, P128, DOI 10.1111/j.1469-1809.2011.00701.x; Holster CW, 1993, TURKS CENTRAL ASIA; Holt Frank L., 2006, LAND BONES ALEXANDER; Irwin JA, 2010, INT J LEGAL MED, V124, P195, DOI 10.1007/s00414-009-0406-z; Jackson P, 2005, MONGOLS W 1221 1410, P448; Katoh T, 2005, GENE, V346, P63, DOI 10.1016/j.gene.2004.10.023; Keyser-Tracqui C, 2003, AM J HUM GENET, V73, P247, DOI 10.1086/377005; Keyser-Tracqui C, 2006, AM J PHYS ANTHROPOL, V131, P272, DOI 10.1002/ajpa.20429; Kuz'mina EE, 2012, HELSINKI MEMOIRES SO, V242, P289; Kuzmina EE, 2008, ENCOUNTERS ASIA, P1; Lacau H, 2012, EUR J HUM GENET; Lacau H, 2011, LEGAL MED-TOKYO, V13, P103, DOI 10.1016/j.legalmed.2010.11.004; Lamberg-Karlovsky CC, 2002, CURR ANTHROPOL, V43, P63, DOI 10.1086/324130; Li H, 2007, AM J HUM GENET, V81, P842, DOI 10.1086/521201; Li H, 2009, AM J HUM GENET, V85, P934, DOI 10.1016/j.ajhg.2009.10.024; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lubotsky A, 2001, SUOMALAIS UGRILAISEN; Malyarchuk B, 2011, J HUM GENET, V56, P583, DOI 10.1038/jhg.2011.64; Malyarchuk B, 2010, ANN HUM GENET, V74, P539, DOI 10.1111/j.1469-1809.2010.00601.x; Martinez-Cruz B, 2011, EUR J HUM GENET, V19, P216, DOI 10.1038/ejhg.2010.153; Mazieres S, 2013, TRANSFUS MED; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Morgenstierne G., 1973, INDOIRANIAN FRONTIER, VIV; Oranskij IosifM., 1977, LANGUES IRANIENNES; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pinault G-J, 2003, HIST SPRACHFORSCHUNG, V116, P175; Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Redei K, SITZUNGSBERICHTE STE, Vvol 468; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Witzel M, 2003, PHILADELPHIA SINO PL, P129; Witzel M, 1999, MOTHER TONGUE; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yunusbayev B., 2011, MOL BIOL EVOL; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247; Zhong H, 2010, J HUM GENET, V55, P428, DOI 10.1038/jhg.2010.40	93	75	78	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76748	10.1371/journal.pone.0076748	http://dx.doi.org/10.1371/journal.pone.0076748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204668	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300050
J	Walters, DM; Stokes, JB; Adair, SJ; Stelow, EB; Borgman, CA; Lowrey, BT; Xin, WJ; Blais, EM; Lee, JK; Papin, JA; Parsons, JT; Bauer, TW				Walters, Dustin M.; Stokes, Jayme B.; Adair, Sara J.; Stelow, Edward B.; Borgman, Cheryl A.; Lowrey, Bryce T.; Xin, Wenjun; Blais, Edik M.; Lee, Jae K.; Papin, Jason A.; Parsons, J. Thomas; Bauer, Todd W.			Clinical, Molecular and Genetic Validation of a Murine Orthotopic Xenograft Model of Pancreatic Adenocarcinoma Using Fresh Human Specimens	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; CELL-LINES; CURATIVE RESECTION; CANCER XENOGRAFTS; BRCA2 MUTATIONS; PROBE LEVEL; K-RAS; GROWTH; MICE; CARCINOMA	Background: Relevant preclinical models that recapitulate the key features of human pancreatic ductal adenocarcinoma (PDAC) are needed in order to provide biologically tractable models to probe disease progression and therapeutic responses and ultimately improve patient outcomes for this disease. Here, we describe the establishment and clinical, pathological, molecular and genetic validation of a murine, orthotopic xenograft model of PDAC. Methods: Human PDACs were resected and orthotopically implanted and propagated in immunocompromised mice. Patient survival was correlated with xenograft growth and metastatic rate in mice. Human and mouse tumor pathology were compared. Tumors were analyzed for genetic mutations, gene expression, receptor tyrosine kinase activation, and cytokine expression. Results: Fifteen human PDACs were propagated orthotopically in mice. Xenograft-bearing mice developed peritoneal and liver metastases. Time to tumor growth and metastatic efficiency in mice each correlated with patient survival. Tumor architecture, nuclear grade and stromal content were similar in patient and xenografted tumors. Propagated tumors closely exhibited the genetic and molecular features known to characterize pancreatic cancer (e.g. high rate of KRAS, P53, SMAD4 mutation and EGFR activation). The correlation coefficient of gene expression between patient tumors and xenografts propagated through multiple generations was 93 to 99%. Analysis of gene expression demonstrated distinct differences between xenografts from fresh patient tumors versus commercially available PDAC cell lines. Conclusions: The orthotopic xenograft model derived from fresh human PDACs closely recapitulates the clinical, pathologic, genetic and molecular aspects of human disease. This model has resulted in the identification of rational therapeutic strategies to be tested in clinical trials and will permit additional therapeutic approaches and identification of biomarkers of response to therapy.	[Walters, Dustin M.; Stokes, Jayme B.; Adair, Sara J.; Lowrey, Bryce T.; Bauer, Todd W.] Univ Virginia, Dept Surg, Charlottesville, VA 22903 USA; [Stelow, Edward B.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Xin, Wenjun; Lee, Jae K.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Blais, Edik M.; Papin, Jason A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Borgman, Cheryl A.; Parsons, J. Thomas] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Bauer, TW (corresponding author), Univ Virginia, Dept Surg, Charlottesville, VA 22903 USA.	twb7f@virginia.edu	Adair, Sara J./AAD-5589-2019	Lowrey, Bryce/0000-0002-0656-8604; Papin, Jason/0000-0002-2769-5805	NIH [T32 HL007849, R03CA141245-01, T32 CA009109]; American Cancer Society [MRSG-0700201CCE]; University of Virginia Cancer Center; James and Rebecca Craig Research Scholars Award; NCI Cancer Center Support Grant [P30 CA44579]; NATIONAL CANCER INSTITUTE [P30CA044579, R03CA141245, T32CA009109] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007849] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); University of Virginia Cancer Center; James and Rebecca Craig Research Scholars Award; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sources of funding that have supported the work: 1. NIH T32 HL007849 (JBS; http://www.nih.gov/), 2. American Cancer Society MRSG-0700201CCE (TWB; http://www.cancer.org/), 3. NIH R03CA141245-01 (TWB, JTP; http://www.nih.gov/), 4. NIH T32 CA009109 (EB; http://www.nih.gov/), and the 5. University of Virginia Cancer Center (http://www.medicine.virginia.edu/research/research-centers/cancer-center/home.html) through the Farrow Fellowship Fund, the James and Rebecca Craig Research Scholars Award, and the NCI Cancer Center Support Grant, P30 CA44579.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Arshad A., 2011, AM J CLIN ONCOL; Bauer TW, 2005, CANCER RES, V65, P7775, DOI 10.1158/0008-5472.CAN-05-0946; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; CALDAS C, 1995, INT J PANCREATOL, V18, P1; Conlon KC, 1996, ANN SURG, V223, P273, DOI 10.1097/00000658-199603000-00007; Couch FJ, 2007, CANCER EPIDEM BIOMAR, V16, P342, DOI 10.1158/1055-9965.EPI-06-0783; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Eltawil KM, 2012, HPB, V14, P260, DOI 10.1111/j.1477-2574.2012.00441.x; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Herreros-Villanueva M, 2012, WORLD J GASTROENTERO, V18, P1286, DOI 10.3748/wjg.v18.i12.1286; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hughes P, 2007, BIOTECHNIQUES, V43, P575, DOI 10.2144/000112598; Huynh AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020330; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; John T, 2011, CLIN CANCER RES, V17, P134, DOI 10.1158/1078-0432.CCR-10-2224; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Kimura K, 2006, CLIN CANCER RES, V12, P4925, DOI 10.1158/1078-0432.CCR-06-0544; Kojima K, 2007, CANCER RES, V67, P8121, DOI 10.1158/0008-5472.CAN-06-4167; Komoto M, 2009, CANCER SCI, V100, P1243, DOI 10.1111/j.1349-7006.2009.01176.x; Larbouret C, 2012, NEOPLASIA, V14, P121, DOI 10.1593/neo.111602; Loukopoulos P, 2004, PANCREAS, V29, P193, DOI 10.1097/00006676-200410000-00004; Merk J, 2009, EUR J CARDIO-THORAC, V36, P454, DOI 10.1016/j.ejcts.2009.03.054; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, Vxxv; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; REDSTON MS, 1994, CANCER RES, V54, P3025; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Shi CJ, 2009, MOL CANCER RES, V7, P230, DOI 10.1158/1541-7786.MCR-08-0206; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Sun CL, 2001, ONCOL REP, V8, P89; Tseng WW, 2010, CLIN CANCER RES, V16, P3684, DOI 10.1158/1078-0432.CCR-09-2384; Tuveson DA, 2006, CANCER RES, V66, P242, DOI 10.1158/0008-5472.CAN-05-2305; Wagner T, 1999, GENOMICS, V62, P369, DOI 10.1006/geno.1999.6026; Walters DM, 2013, NEOPLASIA, V15, P143, DOI 10.1593/neo.121712; Wang H, 2005, ARCH DERMATOL, V141, P177, DOI 10.1001/archderm.141.2.177	42	60	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77065	10.1371/journal.pone.0077065	http://dx.doi.org/10.1371/journal.pone.0077065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204737	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300078
J	Widhalm, G; Kiesel, B; Woehrer, A; Traub-Weidinger, T; Preusser, M; Marosi, C; Prayer, D; Hainfellner, JA; Knosp, E; Wolfsberger, S				Widhalm, Georg; Kiesel, Barbara; Woehrer, Adelheid; Traub-Weidinger, Tatjana; Preusser, Matthias; Marosi, Christine; Prayer, Daniela; Hainfellner, Johannes A.; Knosp, Engelbert; Wolfsberger, Stefan			5-Aminolevulinic Acid Induced Fluorescence Is a Powerful Intraoperative Marker for Precise Histopathological Grading of Gliomas with Non-Significant Contrast-Enhancement	PLOS ONE			English	Article							INDUCED PROTOPORPHYRIN-IX; DIFFUSELY INFILTRATING GLIOMAS; GUIDED RESECTION; BRAIN-TUMORS; QUANTITATIVE FLUORESCENCE; MALIGNANT GLIOMA; ANAPLASTIC FOCI; IMAGE FUSION; SURGERY; MANAGEMENT	Background: Intraoperative identification of anaplastic foci in diffusely infiltrating gliomas (DIG) with non-significant contrast-enhancement on MRI is indispensible to avoid histopathological undergrading and subsequent treatment failure. Recently, we found that 5-aminolevulinic acid (5-ALA) induced protoporphyrin IX (PpIX) fluorescence can visualize areas with increased proliferative and metabolic activity in such gliomas intraoperatively. As treatment of DIG is predominantely based on histopathological World Health Organisation (WHO) parameters, we analyzed whether PpIX fluorescence can detect anaplastic foci according to these criteria. Methods: We prospectively included DIG patients with non-significant contrast-enhancement that received 5-ALA prior to resection. Intraoperatively, multiple samples from PpIX positive and negative intratumoral areas were collected using a modified neurosurgical microscope. In all samples, histopathological WHO criteria and proliferation rate were assessed and correlated to the PpIX fluorescence status. Results: A total of 215 tumor specimens were collected in 59 patients. Of 26 WHO grade III gliomas, 23 cases (85%) showed focal PpIX fluorescence, whereas 29 (91%) of 33 WHO grade II gliomas were PpIX negative. In intratumoral areas with focal PpIX fluorescence, mitotic rate, cell density, nuclear pleomorphism, and proliferation rate were significantly higher than in non-fluorescing areas. The positive predictive value of focal PpIX fluorescence for WHO grade III histology was 85%. Conclusions: Our study indicates that 5-ALA induced PpIX fluorescence is a powerful marker for intraoperative identification of anaplastic foci according to the histopathological WHO criteria in DIG with non-significant contrast-enhancement. Therefore, application of 5-ALA optimizes tissue sampling for precise histopathological diagnosis independent of brain-shift.	[Widhalm, Georg; Kiesel, Barbara; Knosp, Engelbert; Wolfsberger, Stefan] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Widhalm, Georg; Woehrer, Adelheid; Hainfellner, Johannes A.] Med Univ Vienna, Inst Neurol, Vienna, Austria; [Traub-Weidinger, Tatjana] Med Univ Vienna, Dept Nucl Med, Vienna, Austria; [Preusser, Matthias; Marosi, Christine] Med Univ Vienna, Dept Internal Med 1, Vienna, Austria; [Prayer, Daniela] Med Univ Vienna, Dept Radiol, Vienna, Austria; [Widhalm, Georg; Kiesel, Barbara; Woehrer, Adelheid; Traub-Weidinger, Tatjana; Preusser, Matthias; Marosi, Christine; Prayer, Daniela; Hainfellner, Johannes A.; Knosp, Engelbert; Wolfsberger, Stefan] Med Univ Vienna, Ctr Comprehens Canc, Cent Nervous Syst Tumours Unit CCC CNS, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Widhalm, G (corresponding author), Med Univ Vienna, Dept Neurosurg, Vienna, Austria.	georg.widhalm@meduniwien.ac.at	Preusser, Matthias/C-8530-2011; Widhalm, Georg/AFK-1669-2022	Preusser, Matthias/0000-0003-3541-2315; Widhalm, Georg/0000-0001-6014-0273; Kiesel, Barbara/0000-0003-0939-9831; Woehrer, Adelheid/0000-0001-8435-8189; Traub-Weidinger, Tatjana/0000-0003-1118-926X				Arita H, 2012, CANCER-AM CANCER SOC, V118, P1619, DOI 10.1002/cncr.26445; Bekelis K, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS1112; Coluccia D, 2010, ACTA NEUROCHIR, V152, P1711, DOI 10.1007/s00701-010-0708-4; Duffau H, 2009, CURR OPIN ONCOL, V21, P543, DOI 10.1097/CCO.0b013e3283305996; Eljamel M Sam, 2009, Clin Neurosurg, V56, P93; Ewelt C, 2011, CLIN NEUROL NEUROSUR, V113, P541, DOI 10.1016/j.clineuro.2011.03.008; Floeth FW, 2011, EUR J NUCL MED MOL I, V38, P731, DOI 10.1007/s00259-010-1690-z; Hefti M, 2008, SWISS MED WKLY, V138, P180, DOI 2008/11/smw-12077; Ishihara R, 2007, NEUROL MED-CHIR, V47, P53, DOI 10.2176/nmc.47.53; Kamp MA, 2012, ACTA NEUROCHIR, V154, P223, DOI 10.1007/s00701-011-1200-5; Kuhnt Daniela, 2012, Critical Reviews in Biomedical Engineering, V40, P175, DOI 10.1615/CritRevBiomedEng.v40.i3.20; Kunz M, 2011, NEURO-ONCOLOGY, V13, P307, DOI 10.1093/neuonc/noq196; Li Y, 2013, INTRAOPERATIVE FLUOR; Moriuchi S, 2011, J NEUROSURG, V115, P278, DOI 10.3171/2011.4.JNS102137; Murahari MS, 2013, CURR PHARM DESIGN, V19, P4622, DOI 10.2174/1381612811319250009; Nguyen QT, 2013, NAT REV CANC; Nimsky C, 2000, NEUROSURGERY, V47, P1070, DOI 10.1097/00006123-200011000-00008; Nimsky Christopher, 2009, Top Magn Reson Imaging, V19, P197, DOI 10.1097/RMR.0b013e31819574ad; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; PAULUS W, 1989, CANCER, V64, P442, DOI 10.1002/1097-0142(19890715)64:2<442::AID-CNCR2820640217>3.0.CO;2-S; Potzi C, 2007, J NEURO-ONCOL, V84, P305, DOI 10.1007/s11060-007-9375-6; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Roberts DW, 2011, J NEUROSURG, V114, P595, DOI 10.3171/2010.2.JNS091322; Roessler K, 2007, MINIM INVAS NEUROSUR, V50, P273, DOI 10.1055/s-2007-991143; Sanai N, 2011, J NEUROSURG, V115, P740, DOI 10.3171/2011.6.JNS11252; Scherer H., 1940, AM J CANC, VXL, P1; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 1998, J PHOTOCH PHOTOBIO B, V45, P160, DOI 10.1016/S1011-1344(98)00176-6; Stummer W, 1998, ACTA NEUROCHIR, V140, P995, DOI 10.1007/s007010050206; Stupp R, 2003, SEMIN ONCOL, V30, P23, DOI 10.1053/j.seminoncol.2003.11.029; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; Su XH, 2013, WIRES NANOMED NANOBI, V5, P219, DOI 10.1002/wnan.1212; The WHO, 2020, CLASSIFICATION TUMOU; Tsugu A, 2011, WORLD NEUROSURG, V76, P120, DOI 10.1016/j.wneu.2011.02.005; Utsuki S, 2006, J NEUROSURG, V104, P618, DOI 10.3171/jns.2006.104.4.618; Utsuki S, 2007, BRAIN TUMOR PATHOL, V24, P53, DOI 10.1007/s10014-007-0223-3; Valdes PA, 2011, J NEUROSURG, V115, P11, DOI 10.3171/2011.2.JNS101451; Valdes PA, 2011, NEURO-ONCOLOGY, V13, P846, DOI 10.1093/neuonc/nor086; von Campe G, 2012, ACTA NEUROCHIR, V154, P585, DOI 10.1007/s00701-012-1290-8; Wester HJ, 1999, J NUCL MED, V40, P205; Widhalm G, 2012, NEUROSURG REV, V35, P381, DOI 10.1007/s10143-012-0374-5; Widhalm G, 2011, J NEUROL NEUROSUR PS, V82, P512, DOI 10.1136/jnnp.2010.205229; Widhalm G, 2010, CANCER-AM CANCER SOC, V116, P1545, DOI 10.1002/cncr.24903; Zhao SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063682	47	109	111	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76988	10.1371/journal.pone.0076988	http://dx.doi.org/10.1371/journal.pone.0076988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204718	gold, Green Submitted, Green Published			2022-12-27	WOS:000326029300072
J	Smid, HGOM; Martens, S; de Witte, MR; Bruggeman, R				Smid, Henderikus G. O. M.; Martens, Sander; de Witte, Marc R.; Bruggeman, Richard			Inflexible Minds: Impaired Attention Switching in Recent-Onset Schizophrenia	PLOS ONE			English	Article							CONTINUOUS PERFORMANCE-TEST; VISUAL SELECTIVE ATTENTION; CONTINGENT NEGATIVE-VARIATION; EVENT-RELATED POTENTIALS; PERCEPTUAL ORGANIZATION; WORKING-MEMORY; TRANSIENT ATTENTION; FEATURE CONJUNCTION; OBJECT RECOGNITION; SPATIAL-FREQUENCY	Impairment of sustained attention is assumed to be a core cognitive abnormality in schizophrenia. However, this seems inconsistent with a recent hypothesis that in schizophrenia the implementation of selection (i.e., sustained attention) is intact but the control of selection (i.e., switching the focus of attention) is impaired. Mounting evidence supports this hypothesis, indicating that switching of attention is a bigger problem in schizophrenia than maintaining the focus of attention. To shed more light on this hypothesis, we tested whether schizophrenia patients are impaired relative to controls in sustaining attention, switching attention, or both. Fifteen patients with recent-onset schizophrenia and fifteen healthy volunteers, matched on age and intelligence, performed sustained attention and attention switching tasks, while performance and brain potential measures of selective attention were recorded. In the sustained attention task, patients did not differ from the controls on these measures. In the attention switching task, however, patients showed worse performance than the controls, and early selective attention related brain potentials were absent in the patients while clearly present in the controls. These findings support the hypothesis that schizophrenia is associated with an impairment of the mechanisms that control the direction of attention (attention switching), while the mechanisms that implement a direction of attention (sustained attention) are intact.	[Smid, Henderikus G. O. M.; de Witte, Marc R.; Bruggeman, Richard] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Groningen, Netherlands; [Martens, Sander] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands; [Martens, Sander] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Smid, HGOM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Groningen, Netherlands.	h.g.o.m.smid@psy.umcg.nl		Martens, Sander/0000-0001-8237-7984; Bruggeman, Richard/0000-0002-3238-8471	University Medical Center Groningen	University Medical Center Groningen	This study was supported by the University Medical Center Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2002, SCHIZOPHR RES, V57, P69, DOI 10.1016/S0920-9964(01)00303-6; Alain C, 2001, SCHIZOPHR RES, V49, P179, DOI 10.1016/S0920-9964(00)00138-9; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Baas JMP, 2002, CLIN NEUROPHYSIOL, V113, P1840, DOI 10.1016/S1388-2457(02)00269-9; Chen EYH, 2001, SCHIZOPHR RES, V48, P29, DOI 10.1016/S0920-9964(00)00107-9; CORNBLATT BA, 1988, PSYCHIAT RES, V26, P223, DOI 10.1016/0165-1781(88)90076-5; Doniger GM, 2002, ARCH GEN PSYCHIAT, V59, P1011, DOI 10.1001/archpsyc.59.11.1011; EARLY TS, 1989, PSYCHIAT DEV, V7, P85; Eimer M, 1996, PSYCHOPHYSIOLOGY, V33, P13, DOI 10.1111/j.1469-8986.1996.tb02104.x; Eimer M, 1997, BIOL PSYCHOL, V44, P143, DOI 10.1016/S0301-0511(96)05217-9; Elvevag B, 2000, AM J PSYCHIAT, V157, P772, DOI 10.1176/appi.ajp.157.5.772; FEINBERG TE, 1986, ARCH GEN PSYCHIAT, V43, P276; Fuller RL, 2006, J ABNORM PSYCHOL, V115, P266, DOI 10.1037/0021-843X.115.2.266; Gold JM, 2006, J ABNORM PSYCHOL, V115, P658, DOI 10.1037/0021-843X.115.4.658; Gold JM, 2002, J NERV MENT DIS, V190, P638, DOI 10.1097/00005053-200209000-00010; GORDON M, 1986, INSTRUCTION MANUAL G; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; HACKLEY SA, 1990, ACTA PSYCHOL, V74, P15, DOI 10.1016/0001-6918(90)90032-B; Harter M. R., 1984, VARIETIES ATTENTION, P293; Heinrichs RW, 2001, SEARCH MADNESS SCHIZ; HEINZE HJ, 1995, NEUROPSYCHOLOGIA, V33, P889, DOI 10.1016/0028-3932(95)00023-V; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Henik Avishai, 2004, Behav Cogn Neurosci Rev, V3, P42, DOI 10.1177/1534582304263252; Hillyard S.A., 1987, HDB PHYSL 1, V5, P519; HILLYARD SA, 1984, PERCEPT PSYCHOPHYS, V36, P185, DOI 10.3758/BF03202679; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; KENEMANS JL, 1993, ELECTROEN CLIN NEURO, V88, P51, DOI 10.1016/0168-5597(93)90028-N; Kosmidis MH, 2006, NEUROSCI LETT, V409, P234, DOI 10.1016/j.neulet.2006.09.049; Kurtz MM, 2001, SCHIZOPHR RES, V48, P307, DOI 10.1016/S0920-9964(00)00060-8; Leuthold H, 1996, J EXP PSYCHOL GEN, V125, P307, DOI 10.1037/0096-3445.125.3.307; Luck SJ, 2008, BIOL PSYCHIAT, V64, P34, DOI 10.1016/j.biopsych.2008.02.014; Luck SJ, 2006, SCHIZOPHR RES, V85, P174, DOI 10.1016/j.schres.2006.03.040; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; MANGUN GR, 1995, OX PSYCH S, P40; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; MARUFF P, 1995, NEUROPSYCHOLOGIA, V33, P1205, DOI 10.1016/0028-3932(95)00037-4; Mass R, 2000, SCHIZOPHRENIA BULL, V26, P167, DOI 10.1093/oxfordjournals.schbul.a033437; Molholm S, 2004, CEREB CORTEX, V14, P452, DOI 10.1093/cercor/bhh007; Naatanen R., 2018, ATTENTION BRAIN FUNC; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; PLACE EJS, 1980, J ABNORM PSYCHOL, V89, P409; POSNER MI, 1988, ARCH GEN PSYCHIAT, V45, P814; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Potts GF, 2002, ARCH GEN PSYCHIAT, V59, P418, DOI 10.1001/archpsyc.59.5.418; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Rotte M, 1997, BIOL PSYCHOL, V46, P199, DOI 10.1016/S0301-0511(97)00018-5; Sehatpour P, 2010, ARCH GEN PSYCHIAT, V67, P772, DOI 10.1001/archgenpsychiatry.2010.85; ServanSchreiber D, 1996, ARCH GEN PSYCHIAT, V53, P1105; Silverstein SM, 2011, SCHIZOPHRENIA BULL, V37, P690, DOI 10.1093/schbul/sbr052; Smid HGOM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059983; Smid HGOM, 2009, PSYCHIAT RES, V170, P75, DOI 10.1016/j.psychres.2008.06.007; Smid HGOM, 1997, BRAIN, V120, P1041, DOI 10.1093/brain/120.6.1041; Smid HGOM, 1999, PSYCHOPHYSIOLOGY, V36, P264, DOI 10.1017/S0048577299971135; Smid HGOM, 2006, J CLIN EXP NEUROPSYC, V28, P859, DOI 10.1080/13803390591001025; SMID HGOM, 1991, J EXP PSYCHOL HUMAN, V17, P696, DOI 10.1037/0096-1523.17.3.696; Smid HGOM, 1996, J EXP PSYCHOL HUMAN, V22, P3, DOI 10.1037/0096-1523.22.1.3; Smid HGOM, 2000, J EXP PSYCHOL HUMAN, V26, P1053, DOI 10.1037//0096-1523.26.3.1053; Smith GL, 1998, J ABNORM PSYCHOL, V107, P390, DOI 10.1037/0021-843X.107.3.390; Strandburg RJ, 1999, BIOL PSYCHIAT, V45, P1356, DOI 10.1016/S0006-3223(98)00349-7; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Uhlhaas PJ, 2007, SCHIZOPHRENIA BULL, V33, P142, DOI 10.1093/schbul/sbl047; Uhlhaas PJ, 2005, PSYCHOL BULL, V131, P618, DOI 10.1037/0033-2909.131.4.618; van Laar MW, 2002, PSYCHOPHARMACOLOGY, V162, P351, DOI 10.1007/s00213-002-1116-0; Verleger R, 1999, CLIN NEUROPHYSIOL, V110, P1175, DOI 10.1016/S1388-2457(99)00023-1; Verleger R, 2013, CLIN NEUROPHYSIOL, V124, P881, DOI 10.1016/j.clinph.2012.11.003; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Wang K, 2005, SCHIZOPHR RES, V78, P235, DOI 10.1016/j.schres.2005.01.019; WIJERS AA, 1989, PSYCHOPHYSIOLOGY, V26, P89, DOI 10.1111/j.1469-8986.1989.tb03137.x; Wills AJ, 2007, J COGNITIVE NEUROSCI, V19, P843, DOI 10.1162/jocn.2007.19.5.843; Wood SM, 2007, PSYCHIAT RES-NEUROIM, V156, P105, DOI 10.1016/j.pscychresns.2007.04.014	72	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78062	10.1371/journal.pone.0078062	http://dx.doi.org/10.1371/journal.pone.0078062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237RD	24155980	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300114
J	Peres, S; Felicori, L; Molina, F				Peres, Sabine; Felicori, Liza; Molina, Franck			Elementary Flux Modes Analysis of Functional Domain Networks Allows a Better Metabolic Pathway Interpretation	PLOS ONE			English	Article							DEHYDROGENASE; COMPLEX; BRICKS; TOOL	Metabolic network analysis is an important step for the functional understanding of biological systems. In these networks, enzymes are made of one or more functional domains often involved in different catalytic activities. Elementary flux mode (EFM) analysis is a method of choice for the topological studies of these enzymatic networks. In this article, we propose to use an EFM approach on networks that encompass available knowledge on structure-function. We introduce a new method that allows to represent the metabolic networks as functional domain networks and provides an application of the algorithm for computing elementary flux modes to analyse them. Any EFM that can be represented using the classical representation can be represented using our functional domain network representation but the fine-grained feature of functional domain networks allows to highlight new connections in EFMs. This methodology is applied to the tricarboxylic acid cycle (TCA cycle) of Bacillus subtilis, and compared to the classical analyses. This new method of analysis of the functional domain network reveals that a specific inhibition on the second domain of the lipoamide dehydrogenase (pdhD) component of pyruvate dehydrogenase complex leads to the loss of all fluxes. Such conclusion was not predictable in the classical approach.	[Peres, Sabine] Univ Paris 11, CNRS, Lab Rech Informat, UMR 8623, F-91405 Orsay, France; [Peres, Sabine] INRIA Saclay, Orsay, France; [Felicori, Liza] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Peres, Sabine; Felicori, Liza; Molina, Franck] SysDiag UMR3145 CNRS Biorad Parc Euromed, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universidade Federal de Minas Gerais; Centre National de la Recherche Scientifique (CNRS)	Peres, S (corresponding author), Univ Paris 11, CNRS, Lab Rech Informat, UMR 8623, F-91405 Orsay, France.	speres@lri.fr; franck.molina@sysdiag.cnrs.fr	Felicori, Liza F/I-6683-2013	Peres, Sabine/0000-0002-4467-9989	BaSysBio FP6 EU project [LSHG-CT-2006-037469]	BaSysBio FP6 EU project	The work has been supported by BaSysBio FP6 EU project (LSHG-CT-2006-037469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; ASALI TBA, 1993, J MOL BIOL, V234, P779; Betts MJ, 2009, NAT STRUCT MOL BIOL, V16, P1125, DOI 10.1038/nsmb1109-1125; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Cuff AL, 2011, NUCLEIC ACIDS RES, V39, pD420, DOI 10.1093/nar/gkq1001; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; HOCH JA, 1978, J BACTERIOL, V133, P265, DOI 10.1128/JB.133.1.265-269.1978; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Maziere P, 2004, J MOL BIOL, V339, P77, DOI 10.1016/j.jmb.2004.03.029; Pei XY, 2008, STRUCTURE, V16, P1860, DOI 10.1016/j.str.2008.10.009; Peres S, 2010, BIOINFORMATICS, V26, P1542, DOI 10.1093/bioinformatics/btq169; Pfeiffer T, 1999, BIOINFORMATICS, V15, P251, DOI 10.1093/bioinformatics/15.3.251; Rialle S, 2010, BIOINFORMATICS, V26, P2298, DOI 10.1093/bioinformatics/btq409; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Ruppin E, 2010, CURR OPIN BIOTECH, V21, P502, DOI 10.1016/j.copbio.2010.07.002; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; SCHUSTER STEFAN, 1994, J BIOL SYST, V2, P165, DOI [DOI 10.1142/S0218339094000131, 10.1142/S0218339094000131]; SONENSHEIN AL, 2002, KREBS CRITIC ACID CY, P151; Tung CH, 2007, NUCLEIC ACIDS RES, V35, pW438, DOI 10.1093/nar/gkm288; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; von Kamp A, 2006, BIOINFORMATICS, V22, P1930, DOI 10.1093/bioinformatics/btl267; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yellaboina S, 2011, NUCLEIC ACIDS RES, V39, pD730, DOI 10.1093/nar/gkq1229; Zhang Y, 2009, SCIENCE, V325, P1544, DOI 10.1126/science.1174671	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76143	10.1371/journal.pone.0076143	http://dx.doi.org/10.1371/journal.pone.0076143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204596	Green Published, gold			2022-12-27	WOS:000326270700003
J	Ng, CA; Ke, Y; Perry, MD; Tan, PS; Hill, AP; Vandenberg, JI				Ng, Chai Ann; Ke, Ying; Perry, Matthew D.; Tan, Peter S.; Hill, Adam P.; Vandenberg, Jamie I.			C-Terminal beta 9-Strand of the Cyclic Nucleotide-Binding Homology Domain Stabilizes Activated States of Kv11.1 Channels	PLOS ONE			English	Article							LONG-QT SYNDROME; PROTEIN-STRUCTURE PREDICTION; SWISS-MODEL WORKSPACE; MOLECULAR-DYNAMICS; K+ CHANNEL; POTASSIUM CHANNEL; FUNCTIONAL-CHARACTERIZATION; CARDIAC-ARRHYTHMIA; PITUITARY-CELLS; HERG MUTATIONS	Kv11.1 potassium channels are important for regulation of the normal rhythm of the heartbeat. Reduced activity of Kv11.1 channels causes long QT syndrome type 2, a disorder that increases the risk of cardiac arrhythmias and sudden cardiac arrest. Kv11.1 channels are members of the KCNH subfamily of voltage-gated K+ channels. However, they also share many similarities with the cyclic nucleotide gated ion channel family, including having a cyclic nucleotide-binding homology (cNBH) domain. Kv11.1 channels, however, are not directly regulated by cyclic nucleotides. Recently, crystal structures of the cNBH domain from mEAG and zELK channels, both members of the KCNH family of voltage-gated potassium channels, revealed that a C-terminal beta 9-strand in the cNBH domain occupied the putative cyclic nucleotide-binding site thereby precluding binding of cyclic nucleotides. Here we show that mutations to residues in the beta 9-strand affect the stability of the open state relative to the closed state of Kv11.1 channels. We also show that disrupting the structure of the beta 9-strand reduces the stability of the inactivated state relative to the open state. Clinical mutations located in this beta 9-strand result in reduced trafficking efficiency, which suggests that binding of the C-terminal beta 9-strand to the putative cyclic nucleotide-binding pocket is also important for assembly and trafficking of Kv11.1 channels.	[Ng, Chai Ann; Ke, Ying; Perry, Matthew D.; Tan, Peter S.; Hill, Adam P.; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia; [Ng, Chai Ann; Ke, Ying; Perry, Matthew D.; Hill, Adam P.; Vandenberg, Jamie I.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2052, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Vandenberg, JI (corresponding author), Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia.	j.vandenberg@victorchang.edu.au	Vandenberg, Jamie I/B-6608-2013	Vandenberg, Jamie I/0000-0002-3859-3716; Ng, Chai Ann/0000-0002-3120-5450	National Health and Medical Research Council of Australia [573715]; National Heart Foundation of Australia [G11S5829]; NHMRC Senior Research Fellowship [1019693]; Australian Research Council Future Fellowship [FT110100075]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council of Australia (#573715) (www.nhmrc.gov.au) and the National Heart Foundation of Australia (#G11S5829) (www.heartfoundation.org.au). JIV is supported by an NHMRC Senior Research Fellowship (#1019693) (www.nhmrc.gov.au) and APH is supported by an Australian Research Council Future Fellowship (FT110100075) (www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Barros F, 1997, PFLUG ARCH EUR J PHY, V435, P119; Bauer CK, 1998, RECEPTOR CHANNEL, V6, P19; Becchetti A, 2002, EUR J NEUROSCI, V16, P415, DOI 10.1046/j.1460-9568.2002.02079.x; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Carlson AE, 2013, J GEN PHYSIOL, V141, P347, DOI 10.1085/jgp.201210900; Case DA, 2012, AMBER 12; Cerutti DS, 2008, J CHEM THEORY COMPUT, V4, P1669, DOI 10.1021/ct8002173; Ng CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031640; Chiesa N, 1997, J PHYSIOL-LONDON, V501, P313, DOI 10.1111/j.1469-7793.1997.313bn.x; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Engeland B, 1998, J PHYSIOL-LONDON, V513, P647, DOI 10.1111/j.1469-7793.1998.647ba.x; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Greenwood IA, 2009, J PHYSIOL-LONDON, V587, P2313, DOI 10.1113/jphysiol.2009.171272; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gustina AS, 2013, J GEN PHYSIOL, V141, P229, DOI 10.1085/jgp.201210870; Harley CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032654; Heide J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045624; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ju PC, 2009, J BIOL CHEM, V284, P1000, DOI 10.1074/jbc.M806400200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Ng CA, 2009, J CHEM THEORY COMPUT, V5, P2886, DOI 10.1021/ct900190n; Ohya S, 2002, AM J PHYSIOL-GASTR L, V282, pG277, DOI 10.1152/ajpgi.00200.2001; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pardo LA, 2008, EXPERT OPIN THER TAR, V12, P837, DOI 10.1517/14728222.12.7.837 ; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schafer R, 1999, J PHYSIOL-LONDON, V518, P401, DOI 10.1111/j.1469-7793.1999.0401p.x; Sindhikara DJ, 2009, J CHEM THEORY COMPUT, V5, P1624, DOI 10.1021/ct800573m; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Tan PS, 2012, J GEN PHYSIOL, V140, P293, DOI 10.1085/jgp.201110761; Trudeau MC, 1999, J NEUROSCI, V19, P2906; Uberuaga BP, 2004, J CHEM PHYS, V120, P6363, DOI 10.1063/1.1667473; Vandenberg JI, 2006, AM J PHYSIOL-CELL PH, V291, pC165, DOI 10.1152/ajpcell.00596.2005; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Wang DT, 2011, NAT STRUCT MOL BIOL, V18, P35, DOI 10.1038/nsmb.1966; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhao JT, 2009, J CARDIOVASC ELECTR, V20, P923, DOI 10.1111/j.1540-8167.2009.01468.x	54	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77032	10.1371/journal.pone.0077032	http://dx.doi.org/10.1371/journal.pone.0077032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204727	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400025
J	Basta, NE; Stuart, JM; Nascimento, MC; Manigart, O; Trotter, C; Hassan-King, M; Chandramohan, D; Sow, SO; Berthe, A; Bedru, A; Tekletsion, YK; Collard, JM; Jusot, JF; Diallo, A; Bassene, H; Daugla, DM; Gamougam, K; Hodgson, A; Forgor, AA; Omotara, BA; Gadzama, GB; Watkins, ER; Rebbetts, LS; Diallo, K; Weiss, NS; Halloran, ME; Maiden, MCJ; Greenwood, B				Basta, Nicole E.; Stuart, James M.; Nascimento, Maria C.; Manigart, Olivier; Trotter, Caroline; Hassan-King, Musa; Chandramohan, Daniel; Sow, Samba O.; Berthe, Abdoulaye; Bedru, Ahmed; Tekletsion, Yenenesh K.; Collard, Jean-Marc; Jusot, Jean-Francois; Diallo, Aldiouma; Bassene, Hubert; Daugla, Doumagoum M.; Gamougam, Khadidja; Hodgson, Abraham; Forgor, Abudulai A.; Omotara, Babatunji A.; Gadzama, Galadima B.; Watkins, Eleanor R.; Rebbetts, Lisa S.; Diallo, Kanny; Weiss, Noel S.; Halloran, M. Elizabeth; Maiden, Martin C. J.; Greenwood, Brian			Methods for Identifying Neisseria meningitidis Carriers: A Multi-Center Study in the African Meningitis Belt	PLOS ONE			English	Article							MENINGOCOCCAL CONJUGATE VACCINE; CARRIAGE; SPECIFICITY; SENSITIVITY; SEROGROUP; EPIDEMIC	Objective: Detection of meningococcal carriers is key to understanding the epidemiology of Neisseria meningitidis, yet no gold standard has been established. Here, we directly compare two methods for collecting pharyngeal swabs to identify meningococcal carriers. Methods: We conducted cross-sectional surveys of schoolchildren at multiple sites in Africa to compare swabbing the posterior pharynx behind the uvula (U) to swabbing the posterior pharynx behind the uvula plus one tonsil (T). Swabs were cultured immediately and analyzed using molecular methods. Results: One thousand and six paired swab samples collected from schoolchildren in four countries were analyzed. Prevalence of meningococcal carriage was 6.9% (95% CI: 5.4-8.6%) based on the results from both swabs, but the observed prevalence was lower based on one swab type alone. Prevalence based on the T swab or the U swab alone was similar (5.2% (95% CI: 3.8-6.7%) versus 4.9% (95% CI: 3.6-6.4%) respectively (p=0.6)). The concordance between the two methods was 96.3% and the kappa was 0.61 (95% CI: 0.50-0.73), indicating good agreement. Conclusions: These two commonly used methods for collecting pharyngeal swabs provide consistent estimates of the prevalence of carriage, but both methods misclassified carriers to some degree, leading to underestimates of the prevalence.	[Basta, Nicole E.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Basta, Nicole E.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Basta, Nicole E.; Weiss, Noel S.; Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Stuart, James M.; Nascimento, Maria C.; Manigart, Olivier; Hassan-King, Musa; Chandramohan, Daniel; Greenwood, Brian] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London WC1, England; [Trotter, Caroline] Univ Cambridge, Dept Vet Med, Cambridge, England; [Sow, Samba O.; Berthe, Abdoulaye; Diallo, Kanny] Ctr Dev Vaccins, Bamako, Mali; [Bedru, Ahmed; Tekletsion, Yenenesh K.] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Tekletsion, Yenenesh K.; Watkins, Eleanor R.; Rebbetts, Lisa S.; Diallo, Kanny; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Collard, Jean-Marc; Jusot, Jean-Francois] Ctr Rech Med & Sanit, Niamey, Niger; [Diallo, Aldiouma; Bassene, Hubert] Inst Rech Dev, Dakar, Senegal; [Hodgson, Abraham] Ghana Hlth Serv, Div Res & Dev, Accra, Ghana; [Forgor, Abudulai A.] War Mem Hosp, Navrongo, Ghana; [Omotara, Babatunji A.] Univ Maiduguri, Dept Community Med, Maiduguri, Borno State, Nigeria; [Gadzama, Galadima B.] Univ Maiduguri, Dept Med Microbiol, Maiduguri, Borno State, Nigeria; [Weiss, Noel S.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Halloran, M. Elizabeth] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA	Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Fred Hutchinson Cancer Center; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; University of Oxford; Institut de Recherche pour le Developpement (IRD); Ghana Health Service; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Basta, NE (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA.	nbasta@princeton.edu	Maiden, Martin/N-6805-2019; Maiden, Martin C J/C-5055-2014; Collard, Jean-Marc/Q-2342-2019; Trotter, Caroline L/H-5077-2013	Maiden, Martin/0000-0001-6321-5138; Maiden, Martin C J/0000-0001-6321-5138; Collard, Jean-Marc/0000-0002-1490-3978; Trotter, Caroline/0000-0003-4000-2708; Diallo, Kanny/0000-0002-0905-3980	Bill & Melinda Gates Foundation [51251]; Wellcome Trust [086546]; NIH [R37A1032042]; NIH Early Independence Award [1DP5OD009162]; RAPIDD program of the Science & Technology Directorate (Department of Homeland Security and the Fogarty International Centre); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009162] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Early Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RAPIDD program of the Science & Technology Directorate (Department of Homeland Security and the Fogarty International Centre); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the Bill & Melinda Gates Foundation Grant 51251 (www.gatesfoundation.org), the Wellcome Trust Grant 086546 (www.wellcome.ac.uk), NIH Grant R37A1032042 (support for MEH, NEB), NIH Early Independence Award 1DP5OD009162 (Office of the Director and the National Institute of Dental and Craniofacial Research; support for NEB) (www.nih.gov), and the RAPIDD program of the Science & Technology Directorate (Department of Homeland Security and the Fogarty International Centre; support for NEB)(http://www.fic.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2013, TROP MED INT HEALTH, V18, P968, DOI 10.1111/tmi.12125; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; CHALMERS A. J., 1916, Journal of Tropical Medicine and Hygiene, V19, P101; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Georgiadis MP, 2003, J ROY STAT SOC C-APP, V52, P63, DOI 10.1111/1467-9876.00389; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Greenwood B, 2013, VACCINE, V31, P1453, DOI 10.1016/j.vaccine.2012.12.035; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Heymann DL, 2004, CONTROL COMMUNICABLE, V18th; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Jodar L, 2003, LANCET, V361, P1902, DOI 10.1016/S0140-6736(03)13494-0; Johnson WO, 2001, AM J EPIDEMIOL, V153, P921, DOI 10.1093/aje/153.9.921; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; Kristiansen PA, 2011, CLIN VACCINE IMMUNOL, V18, P435, DOI 10.1128/CVI.00479-10; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062; Lee CH, 2009, VACCINE, V27, P726, DOI 10.1016/j.vaccine.2008.11.065; Leimkugel J, 2007, PLOS MED, V4, P535, DOI 10.1371/journal.pmed.0040101; MacLennan J, 2006, EMERG INFECT DIS, V12, P950; MARTIN JE, 1974, APPL MICROBIOL, V27, P802, DOI 10.1128/AEM.27.4.802-805.1974; Okoko BJ, 2009, VACCINE, V27, P2023, DOI 10.1016/j.vaccine.2008.11.092; Raghunathan PL, 2006, J INFECT DIS, V193, P607, DOI 10.1086/499822; Roberts J, 2009, J INFECTION, V58, P103, DOI 10.1016/j.jinf.2008.12.005; Sim RJ, 2000, LANCET, V356, P1653, DOI 10.1016/S0140-6736(00)03162-7; Soriano-Gabarro M, 2011, EXPERT REV ANTI-INFE, V9, P761, DOI [10.1586/ERI.11.89, 10.1586/eri.11.89]; Trotter CL, 2007, LANCET INFECT DIS, V7, P797, DOI 10.1016/S1473-3099(07)70288-8	27	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78336	10.1371/journal.pone.0078336	http://dx.doi.org/10.1371/journal.pone.0078336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194921	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000326037000100
J	Chen, XY; Lu, MJ; Yin, G; Zhao, T; Shao, XN; Zhao, RX; Tang, Y; An, J; Jiang, SL; Zhao, SH				Chen, Xiuyu; Lu, Minjie; Yin, Gang; Zhao, Tao; Shao, Xiaoning; Zhao, Ranxu; Tang, Yue; An, Jing; Jiang, Shiliang; Zhao, Shihua			Three-Dimensional Phase-Sensitive Inversion-Recovery Turbo FLASH Sequence for the Assessment of Left Ventricular Myocardial Scar in Swine	PLOS ONE			English	Article							DELAYED CONTRAST ENHANCEMENT; INFARCT SIZE; BLOOD-FLOW; VIABILITY; MRI; 3D; 2D; VOLUME	Objectives: We sought to evaluate the feasibility and accuracy of free-breathing three-dimensional (3D) phase-sensitive inversion-recovery (PSIR) Turbo FLASH sequence for noninvasive assessment of left ventricular myocardial scar in swine models. Materials and Methods: Nine Chinese minipigs with experimentally induced acute myocardial infarction were studied. At 1 week and the study endpoint 4 weeks after myocardial infarction surgery, the 3D and 2D contrasted cardiac magnetic resonance (CMR) imaging were performed randomly by using a 1.5T clinical MR imaging system. Comparisons of myocardial scar volume (in cubic centimeters), scar transmurality (on a 5 points scale) and image quality (on a 4 points Likert scale) were performed by using the Pearson correlation and Bland-Altman analysis (for myocardial scar volume) or. statistics (for transmurality) or Wilcoxon signed rank test (for image quality). Results: In 6 of the 9 pigs, all procedures were successfully completed. In these pigs, a total of 48 segments with myocardial scars were detected by both 3D and 2D sequences, and there was good agreement for classification of scar transmurality (kappa=0.930). The scar volume determined by triphenyltetrazolium chloride (TTC) staining (3.52 +/- 1.40cm(3)) showed a good correlation with both 3D (3.54 +/- 1.36cm(3), r=0.957, P=0.003) and 2D sequence (3.53 +/- 1.26cm(3), r=0.942, P=0.005) at 4 weeks. And there were good correlation between scar volumes obtained from 3D and 2D techniques (r=0.859, P<0.001) at both time points. Both 3D and 2D images detected a small reduction of scar volume from week 1 to week 4 by a factor of 1.179 and 1.176, respectively. Although slightly more artifacts were observed on 2D PSIR images, the overall image quality was not significantly different between the two sequences (3.17 +/- 0.83 for 2D vs. 3.25 +/- 0.75 for 3D, P=0.655). Conclusions: The free-breathing 3D PSIR Turbo FLASH sequence enables accurate assessment of left ventricular myocardial scar.	[Chen, Xiuyu; Lu, Minjie; Yin, Gang; Zhao, Tao; Jiang, Shiliang; Zhao, Shihua] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Radiol,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Chen, Xiuyu; Lu, Minjie; Yin, Gang; Zhao, Tao; Zhao, Ranxu; Tang, Yue; Jiang, Shiliang; Zhao, Shihua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Shao, Xiaoning] Zhengzhou Univ, Dapartment Magnet Resonance Imaging, Affiliated Hosp 1, Zhengzhou 450052, Henan Province, Peoples R China; [Zhao, Ranxu] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Pathol,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Tang, Yue] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Anim Expt Ctr,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [An, Jing] Siemens Shenzhen Magnet Resonance Ltd, APPL Dept, Shenzhen, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Zhengzhou University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Siemens AG	Zhao, SH (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Radiol,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China.	zhaoshihua0202@126.com	Zhao, Shihua/A-7553-2019; Lu, Minjie/AAF-5091-2020	Zhao, Shihua/0000-0003-1339-7476; Lu, Minjie/0000-0001-8696-318X	National Natural Science Foundation of China [81130029, 81000604]; Peking Union Medical College Research Fund for Youth [2009-xhj04#]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking Union Medical College Research Fund for Youth	This study was supported by a research grant of National Natural Science Foundation of China (81130029 and 81000604) and Peking Union Medical College Research Fund for Youth (2009-xhj04#). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano Y, 2008, J MAGN RESON IMAGING, V28, P1361, DOI 10.1002/jmri.21595; Cheng HB, 2011, INT J CARDIOVAS IMAG, V27, P979, DOI 10.1007/s10554-010-9741-x; Cheng HB, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-15; Dewey M, 2006, RADIOLOGY, V239, P703, DOI 10.1148/radiol.2393050586; EHMAN RL, 1989, RADIOLOGY, V173, P255, DOI 10.1148/radiology.173.1.2781017; Fieno DS, 2004, J AM COLL CARDIOL, V43, P2124, DOI 10.1016/j.jacc.2004.01.043; Flett AS, 2011, JACC-CARDIOVASC IMAG, V4, P150, DOI 10.1016/j.jcmg.2010.11.015; Foo TKF, 2004, RADIOLOGY, V230, P845, DOI 10.1148/radiol.2303021411; Goetti R, 2011, RADIOLOGY, V259, P704, DOI 10.1148/radiol.11102216; Goldfarb JW, 2005, MAGNET RESON MED, V53, P367, DOI 10.1002/mrm.20369; Huber AM, 2005, RADIOLOGY, V237, P854, DOI 10.1148/radiol.2373041483; Hundley WG, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-5; Ishida M, 2009, CIRC J, V73, P1577, DOI 10.1253/circj.CJ-09-0524; Kellman P, 2002, MAGNET RESON MED, V47, P372, DOI 10.1002/mrm.10051; Kim RJ, 2008, CIRCULATION, V117, P629, DOI 10.1161/CIRCULATIONAHA.107.723262; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kino A, 2011, INT J CARDIOVAS IMAG, V27, P527, DOI 10.1007/s10554-010-9640-1; Kino A, 2009, AM J ROENTGENOL, V193, pW381, DOI 10.2214/AJR.08.1952; Klein C, 2004, J MAGN RESON IMAGING, V20, P588, DOI 10.1002/jmri.20164; Kuhl HP, 2004, RADIOLOGY, V230, P576, DOI 10.1148/radiol.2302021120; Nguyen TD, 2008, J MAGN RESON IMAGING, V27, P802, DOI 10.1002/jmri.21296; Ordovas KG, 2011, RADIOLOGY, V261, P358, DOI 10.1148/radiol.11091882; Peters DC, 2009, J MAGN RESON IMAGING, V30, P794, DOI 10.1002/jmri.21897; REIMER KA, 1979, CIRCULATION, V60, P866, DOI 10.1161/01.CIR.60.4.866; Saeed M, 2006, J AM COLL CARDIOL, V48, P1961, DOI 10.1016/j.jacc.2006.03.071; Selvanayagam JB, 2004, CIRCULATION, V110, P1535, DOI 10.1161/01.CIR.0000142045.22628.74; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; Viallon M, 2011, J MAGN RESON IMAGING, V34, P1374, DOI 10.1002/jmri.22783; Wagner A, 2003, LANCET, V361, P374, DOI 10.1016/S0140-6736(03)12389-6; Yin G, 2013, J MAGN RESON IMAGING, V38, P72, DOI 10.1002/jmri.23962	31	1	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78305	10.1371/journal.pone.0078305	http://dx.doi.org/10.1371/journal.pone.0078305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194917	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000096
J	Hansen, GJA; Vander Zanden, MJ; Blum, MJ; Clayton, MK; Hain, EF; Hauxwell, J; Izzo, M; Kornis, MS; McIntyre, PB; Mikulyuk, A; Nilsson, E; Olden, JD; Papes, M; Sharma, S				Hansen, Gretchen J. A.; Vander Zanden, M. Jake; Blum, Michael J.; Clayton, Murray K.; Hain, Ernie F.; Hauxwell, Jennifer; Izzo, Marit; Kornis, Matthew S.; McIntyre, Peter B.; Mikulyuk, Alison; Nilsson, Erika; Olden, Julian D.; Papes, Monica; Sharma, Sapna			Commonly Rare and Rarely Common: Comparing Population Abundance of Invasive and Native Aquatic Species	PLOS ONE			English	Article							SPATIAL VARIATION; IMPACTS; RISK; HISTORY; RANGE; TOOL	Invasive species are leading drivers of environmental change. Their impacts are often linked to their population size, but surprisingly little is known about how frequently they achieve high abundances. A nearly universal pattern in ecology is that species are rare in most locations and abundant in a few, generating right-skewed abundance distributions. Here, we use abundance data from over 24,000 populations of 17 invasive and 104 native aquatic species to test whether invasive species differ from native counterparts in statistical patterns of abundance across multiple sites. Invasive species on average reached significantly higher densities than native species and exhibited significantly higher variance. However, invasive and native species did not differ in terms of coefficient of variation, skewness, or kurtosis. Abundance distributions of all species were highly right skewed (skewness >0), meaning both invasive and native species occurred at low densities in most locations where they were present. The average abundance of invasive and native species was 6% and 2%, respectively, of the maximum abundance observed within a taxonomic group. The biological significance of the differences between invasive and native species depends on species-specific relationships between abundance and impact. Recognition of cross-site heterogeneity in population densities brings a new dimension to invasive species management, and may help to refine optimal prevention, containment, control, and eradication strategies.	[Hansen, Gretchen J. A.; Vander Zanden, M. Jake; Izzo, Marit; Kornis, Matthew S.; McIntyre, Peter B.; Mikulyuk, Alison; Nilsson, Erika; Papes, Monica; Sharma, Sapna] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Blum, Michael J.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Clayton, Murray K.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Clayton, Murray K.] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Hain, Ernie F.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Hansen, Gretchen J. A.; Hauxwell, Jennifer; Mikulyuk, Alison] Wisconsin Dept Nat Resources, Sci Serv, Madison, WI USA; [Olden, Julian D.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Wisconsin System; University of Wisconsin Madison; Tulane University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; North Carolina State University; University of Washington; University of Washington Seattle	Hansen, GJA (corresponding author), Wisconsin Dept Nat Resources, Sci Serv, Madison, WI USA.	gretchen.hansen@wisconsin.gov	Olden, Julian D/A-8535-2010; Kornis, Matt/GRF-0356-2022	Olden, Julian/0000-0003-2143-1187; Vander Zanden, Jake/0000-0002-8122-1416; Mikulyuk, Alison/0000-0002-6785-7880; Hansen, Gretchen/0000-0003-0241-7048; Sharma, Sapna/0000-0003-4571-2768	NSF [DEB-9632853]; Wisconsin Department of Natural Resources; Department of Defense Strategic Environmental Research and Development Program [RC-1646]; University of Wisconsin Sea Grant Institute [NA06OAR4170011, R/AI-3]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Natural Sciences and Engineering Research Council of Canada Post-Doctoral Fellowship (NSERC PDF)	NSF(National Science Foundation (NSF)); Wisconsin Department of Natural Resources; Department of Defense Strategic Environmental Research and Development Program; University of Wisconsin Sea Grant Institute; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Natural Sciences and Engineering Research Council of Canada Post-Doctoral Fellowship (NSERC PDF)(Natural Sciences and Engineering Research Council of Canada (NSERC))	GJAH and MJVZ were supported by the NSF-funded North Temperate Lakes Long Term Ecological Research Program (DEB-9632853). JH, AM, and MJVZ were supported by the Wisconsin Department of Natural Resources. MJB, EFH, and PBM were funded by the Department of Defense Strategic Environmental Research and Development Program under project RC-1646. MSK was funded by a grant from the University of Wisconsin Sea Grant Institute, federal grant number NA06OAR4170011 project number R/AI-3, to MJVZ. EN was funded with a post-doctoral scholarship from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning. SS was supported by the Natural Sciences and Engineering Research Council of Canada Post-Doctoral Fellowship (NSERC PDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, ESA BULL-EUR SPACE; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D. M., 2007, LME4 LINEAR MIXED EF; Brown J. H., 1995, MACROECOLOGY; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; DeVaney SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005451; Dick JTA, 2013, BIOL INVASIONS, V15, P837, DOI 10.1007/s10530-012-0332-8; Firn J, 2011, ECOL LETT, V14, P274, DOI 10.1111/j.1461-0248.2010.01584.x; Gaston KJ, 1998, ECOL LETT, V1, P38, DOI 10.1046/j.1461-0248.1998.00004.x; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Goodwin BJ, 1999, CONSERV BIOL, V13, P422, DOI 10.1046/j.1523-1739.1999.013002422.x; Ives AR, 1997, ECOLOGY, V78, P1907; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kramer M, 2005, P C APPL STAT AGR, V17, P148; Kueffer C, 2010, PERSPECT PLANT ECOL, V12, P145, DOI 10.1016/j.ppees.2009.06.002; Kulhanek SA, 2011, ECOL APPL, V21, P203, DOI 10.1890/09-1639.1; Kulhanek SA, 2011, ECOL APPL, V21, P189, DOI 10.1890/09-1452.1; Labra FA, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P421; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Leung B, 2012, ECOL LETT, V15, P1475, DOI 10.1111/ele.12003; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; McGill BJ, 2010, ECOL LETT, V13, P627, DOI 10.1111/j.1461-0248.2010.01449.x; McGill BJ, 2010, OIKOS, V119, P591, DOI 10.1111/j.1600-0706.2009.17771.x; Melbourne BA, 2007, ECOL LETT, V10, P77, DOI 10.1111/j.1461-0248.2006.00987.x; Mercado-Silva N, 2006, CONSERV BIOL, V20, P1740, DOI 10.1111/j.1523-1739.2006.00508.x; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Parker JD, 2013, ECOLOGY, V94, P985, DOI 10.1890/12-1810.1; Paull SH, 2012, FRONT ECOL ENVIRON, V10, P75, DOI 10.1890/110111; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Qian SS, 2007, ECOLOGY, V88, P2489, DOI 10.1890/06-2041.1; R Development Core Team, 2012, R LANG ENV STAT COMP; Ricciardi A, 2003, FRESHWATER BIOL, V48, P972, DOI 10.1046/j.1365-2427.2003.01071.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; Simberloff D, 2012, ECOLOGY, V93, P598, DOI 10.1890/11-1232.1; Simberloff D, 2011, NATURE, V475, P36, DOI 10.1038/475036a; Solomon CT, 2010, BIOL INVASIONS, V12, P1591, DOI 10.1007/s10530-009-9572-7; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; Thiele J, 2010, BIOL INVASIONS, V12, P2025, DOI 10.1007/s10530-009-9605-2; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Valery L, 2008, BIOL INVASIONS, V10, P1345, DOI 10.1007/s10530-007-9209-7; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Wilson KA, 2004, CAN J FISH AQUAT SCI, V61, P2255, DOI [10.1139/f04-170, 10.1139/F04-170]; Yokomizo H, 2009, ECOL APPL, V19, P376, DOI 10.1890/08-0442.1	53	59	59	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77415	10.1371/journal.pone.0077415	http://dx.doi.org/10.1371/journal.pone.0077415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194883	Green Published, gold			2022-12-27	WOS:000326037000062
J	Iyer, S; Karig, DK; Norred, SE; Simpson, ML; Doktycz, MJ				Iyer, Sukanya; Karig, David K.; Norred, S. Elizabeth; Simpson, Michael L.; Doktycz, Mitchel J.			Multi-Input Regulation and Logic with T7 Promoters in Cells and Cell-Free Systems	PLOS ONE			English	Article							SYNTHETIC BIOLOGY; RNA-POLYMERASE; ESCHERICHIA-COLI; TRANSCRIPTION; EXPRESSION; OPERATORS; NETWORK; INTEGRATION; INHIBITION; ACTIVATION	Engineered gene circuits offer an opportunity to harness biological systems for biotechnological and biomedical applications. However, reliance on native host promoters for the construction of circuit elements, such as logic gates, can make the implementation of predictable, independently functioning circuits difficult. In contrast, T7 promoters offer a simple orthogonal expression system for use in a variety of cellular backgrounds and even in cell-free systems. Here we develop a T7 promoter system that can be regulated by two different transcriptional repressors for the construction of a logic gate that functions in cells and in cell-free systems. We first present LacI repressible T7lacO promoters that are regulated from a distal lac operator site for repression. We next explore the positioning of a tet operator site within the T7lacO framework to create T7 promoters that respond to tet and lac repressors and realize an IMPLIES gate. Finally, we demonstrate that these dual input sensitive promoters function in an E. coli cell-free protein expression system. Our results expand the utility of T7 promoters in cell based as well as cell-free synthetic biology applications.	[Iyer, Sukanya; Doktycz, Mitchel J.] Univ Tennessee, Grad Program Genome Sci & Technol, Knoxville, TN USA; [Iyer, Sukanya; Doktycz, Mitchel J.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Karig, David K.; Simpson, Michael L.; Doktycz, Mitchel J.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN USA; [Norred, S. Elizabeth; Simpson, Michael L.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA; [Simpson, Michael L.] Univ Tennessee, Ctr Environm Biotechnol, Knoxville, TN 37932 USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Doktycz, MJ (corresponding author), Univ Tennessee, Grad Program Genome Sci & Technol, Knoxville, TN USA.	doktyczmj@ornl.gov	Simpson, Michael/A-8410-2011; Karig, David/AAT-9108-2020; Iyer, Sukanya/I-8283-2019; Karig, David/G-5703-2011; Doktycz, Mitchel J/A-7499-2011	Simpson, Michael/0000-0002-3933-3457; Karig, David/0000-0002-9508-6411; Iyer, Sukanya/0000-0001-8409-235X; Karig, David/0000-0002-9508-6411; Doktycz, Mitchel J/0000-0003-4856-8343; Norred, Sarah/0000-0001-7827-4050	NIH [EB000657]; Center for Nanophase Materials Sciences; Oak Ridge National Laboratory by the Division of Scientific User Facilities, U.S. Department of Energy; U.S. DOE [DE-AC05- 00OR22725]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000657] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Nanophase Materials Sciences(United States Department of Energy (DOE)); Oak Ridge National Laboratory by the Division of Scientific User Facilities, U.S. Department of Energy(United States Department of Energy (DOE)); U.S. DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	work was supported by NIH Grant EB000657 and by the in-house research program of the Center for Nanophase Materials Sciences, which is sponsored at Oak Ridge National Laboratory by the Division of Scientific User Facilities, U.S. Department of Energy. This work was performed at the Oak Ridge National Laboratory, managed by UT-Battelle, LLC, for the U.S. DOE under Contract No. DE-AC05- 00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WL, 2009, P NATL ACAD SCI USA, V106, P8477, DOI 10.1073/pnas.0900267106; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Bond LM, 2010, NUCLEIC ACIDS RES, V38, P8072, DOI 10.1093/nar/gkq755; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Borghetti J, 2010, NATURE, V464, P873, DOI 10.1038/nature08940; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; BUSBY S, 1994, CELL, V79, P743, DOI 10.1016/0092-8674(94)90063-9; CARRA JH, 1993, EMBO J, V12, P35, DOI 10.1002/j.1460-2075.1993.tb05629.x; CHAPMAN KA, 1987, NUCLEIC ACIDS RES, V15, P5413, DOI 10.1093/nar/15.13.5413; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Collier CP, 2011, CURR OPIN BIOTECH, V22, P516, DOI 10.1016/j.copbio.2011.05.002; Doktycz MJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100165; Dragosits M, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-2; DUBENDORFF JW, 1991, J MOL BIOL, V219, P45, DOI 10.1016/0022-2836(91)90856-2; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fletcher BL, 2004, NANO LETT, V4, P1809, DOI 10.1021/nl0493702; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005621; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Heyman Y, 2012, NAT NANOTECHNOL, V7, P374, DOI [10.1038/nnano.2012.65, 10.1038/NNANO.2012.65]; Hockenberry AJ, 2012, CURR OPIN CHEM BIOL, V16, P253, DOI 10.1016/j.cbpa.2012.05.179; Hunziker A, 2010, P NATL ACAD SCI USA, V107, P12998, DOI 10.1073/pnas.0915003107; Isalan M, 2005, PLOS BIOL, V3, P488, DOI 10.1371/journal.pbio.0030064; Ishikawa K, 2004, FEBS LETT, V576, P387, DOI 10.1016/j.febslet.2004.09.046; Karig D, 2005, BIOTECHNOL BIOENG, V89, P709, DOI 10.1002/bit.20371; Karig DK, 2012, NUCLEIC ACIDS RES, V40, P3763, DOI 10.1093/nar/gkr1191; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Lopez PJ, 1998, J MOL BIOL, V276, P861, DOI 10.1006/jmbi.1997.1576; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MAHER LJ, 1992, BIOCHEMISTRY-US, V31, P7587, DOI 10.1021/bi00148a021; McAllister W., 1997, MECH TRANSCRIPTION, P15; Michener JK, 2012, METAB ENG, V14, P212, DOI 10.1016/j.ymben.2011.09.004; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Niederholtmeyer H, 2013, ACS SYNTH BIOL, V2, P411, DOI 10.1021/sb300104f; Noireaux V, 2003, P NATL ACAD SCI USA, V100, P12672, DOI 10.1073/pnas.2135496100; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rao CV, 2012, CURR OPIN BIOTECH, V23, P689, DOI 10.1016/j.copbio.2011.12.015; RASKIN CA, 1993, P NATL ACAD SCI USA, V90, P3147, DOI 10.1073/pnas.90.8.3147; Retterer ST, 2010, LAB CHIP, V10, P1174, DOI 10.1039/b921592a; Revet B, 1999, CURR BIOL, V9, P151, DOI 10.1016/S0960-9822(99)80069-4; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Shin J, 2012, ACS SYNTH BIOL, V1, P29, DOI 10.1021/sb200016s; Shin Jonghyeon, 2010, J Biol Eng, V4, P8, DOI 10.1186/1754-1611-4-8; Shis DL, 2013, P NATL ACAD SCI USA, V110, P5028, DOI 10.1073/pnas.1220157110; Simpson ML, 2001, TRENDS BIOTECHNOL, V19, P317, DOI 10.1016/S0167-7799(01)01691-2; Sinha J, 2010, NAT CHEM BIOL, V6, P464, DOI 10.1038/nchembio.369; Siuti P, 2012, ANAL CHEM, V84, P1092, DOI 10.1021/ac202726n; Siuti P, 2011, LAB CHIP, V11, P3523, DOI 10.1039/c1lc20462a; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tabor S, 1992, Biotechnology, V24, P280; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Temme K, 2012, NUCLEIC ACIDS RES, V40, P8773, DOI 10.1093/nar/gks597; WEICKERT MJ, 1993, J BACTERIOL, V175, P251, DOI 10.1128/JB.175.1.251-258.1993; Xie Z, 2010, NUCLEIC ACIDS RES, V38, P2692, DOI 10.1093/nar/gkq117; Zhan JA, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.42	64	18	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78442	10.1371/journal.pone.0078442	http://dx.doi.org/10.1371/journal.pone.0078442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194933	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000112
J	Pilling, E; Campbell, P; Coulson, M; Ruddle, N; Tornier, I				Pilling, Edward; Campbell, Peter; Coulson, Mike; Ruddle, Natalie; Tornier, Ingo			A Four-Year Field Program Investigating Long-Term Effects of Repeated Exposure of Honey Bee Colonies to Flowering Crops Treated with Thiamethoxam	PLOS ONE			English	Article							HYMENOPTERA APIDAE; PESTICIDE-RESIDUES; DECLINES; LOSSES; IMPACT	Neonicotinoid residues in nectar and pollen from crop plants have been implicated as one of the potential factors causing the declines of honey bee populations. Median residues of thiamethoxam in pollen collected from honey bees after foraging on flowering seed treated maize were found to be between 1 and 7 mu g/kg, median residues of the metabolite CGA322704 (clothianidin) in the pollen were between 1 and 4 mu g/kg. In oilseed rape, median residues of thiamethoxam found in pollen collected from bees were between <1 and 3.5 mu g/kg and in nectar from foraging bees were between 0.65 and 2.4 mu g/kg. Median residues of CGA322704 in pollen and nectar in the oilseed rape trials were all below the limit of quantification (1 mu g/kg). Residues in the hive were even lower in both the maize and oilseed rape trials, being at or below the level of detection of 1 mu g/kg for bee bread in the hive and at or below the level of detection of 0.5 mu g/kg for hive nectar, honey and royal jelly samples. The long-term risk to honey bee colonies in the field was also investigated, including the sensitive overwintering stage, from four years consecutive single treatment crop exposures to flowering maize and oilseed rape grown from thiamethoxam treated seeds at rates recommended for insect control. Throughout the study, mortality, foraging behavior, colony strength, colony weight, brood development and food storage levels were similar between treatment and control colonies. Detailed examination of brood development throughout the year demonstrated that colonies exposed to the treated crop were able to successfully overwinter and had a similar health status to the control colonies in the following spring. We conclude that these data demonstrate there is a low risk to honey bees from systemic residues in nectar and pollen following the use of thiamethoxam as a seed treatment on oilseed rape and maize.	[Pilling, Edward] JSC Int Ltd, Harrogate, N Yorkshire, England; [Campbell, Peter; Coulson, Mike; Ruddle, Natalie] Syngenta Ltd, Jealotts Hill Res Stn, Bracknell, Berks, England; [Tornier, Ingo] EcoChem GmbH, Eurofins Agrosci Serv, Niefern Oschelbronn, Germany	Syngenta	Campbell, P (corresponding author), Syngenta Ltd, Jealotts Hill Res Stn, Bracknell, Berks, England.	peter.campbell@syngenta.com	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216				Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Anonymous, 2010, Bulletin OEPP, V40, P313, DOI 10.1111/j.1365-2338.2010.02418.x; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2752; Faucon JP, 2005, PEST MANAG SCI, V61, P111, DOI 10.1002/ps.957; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Greatti M, 2002, B INSECTOL, V56, P69; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; IMDORF A, 1987, APIDOLOGIE, V18, P137, DOI 10.1051/apido:19870204; Kluser S., 2011, UNEP EMERGING ISSUES; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Spivak M, 2011, ENVIRON SCI TECHNOL, V45, P34, DOI 10.1021/es101468w; Vanengelsdorp D, 2007, AM BEE J, V147, P599; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Winston M. L. L., 1991, BIOL HONEY BEE	29	151	156	4	218	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77193	10.1371/journal.pone.0077193	http://dx.doi.org/10.1371/journal.pone.0077193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194871	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000050
J	Saw, JHW; Schatz, M; Brown, MV; Kunkel, DD; Foster, JS; Shick, H; Christensen, S; Hou, SB; Wan, XH; Donachie, SP				Saw, Jimmy H. W.; Schatz, Michael; Brown, Mark V.; Kunkel, Dennis D.; Foster, Jamie S.; Shick, Harry; Christensen, Stephanie; Hou, Shaobin; Wan, Xuehua; Donachie, Stuart P.			Cultivation and Complete Genome Sequencing of Gloeobacter kilaueensis sp nov., from a Lava Cave in Kilauea Caldera, Hawai'i	PLOS ONE			English	Article							DNA-DNA HYBRIDIZATION; CAROTENOID BIOSYNTHESIS; OXYGENIC PHOTOSYNTHESIS; VANCOMYCIN RESISTANCE; PHYLOGENETIC ANALYSES; PHYTOENE DESATURASE; VIOLACEUS PCC-7421; SPECIES DEFINITION; LACKS THYLAKOIDS; CYANOBACTERIUM	The ancestor of Gloeobacter violaceus PCC 7421(T) is believed to have diverged from that of all known cyanobacteria before the evolution of thylakoid membranes and plant plastids. The long and largely independent evolutionary history of G. violaceus presents an organism retaining ancestral features of early oxygenic photoautotrophs, and in whom cyanobacteria evolution can be investigated. No other Gloeobacter species has been described since the genus was established in 1974 (Rippka et al., Arch Microbiol 100:435). Gloeobacter affiliated ribosomal gene sequences have been reported in environmental DNA libraries, but only the type strain's genome has been sequenced. However, we report here the cultivation of a new Gloeobacter species, G. kilaueensis JS1(T), from an epilithic biofilm in a lava cave in Kilauea Caldera, Hawai'i. The strain's genome was sequenced from an enriched culture resembling a low-complexity metagenomic sample, using 9 kb paired-end 454 pyrosequences and 400 bp paired-end Illumina reads. The JS1(T) and G. violaceus PCC 7421(T) genomes have little gene synteny despite sharing 2842 orthologous genes; comparing the genomes shows they do not belong to the same species. Our results support establishing a new species to accommodate JS1(T), for which we propose the name Gloeobacter kilaueensis sp. nov. Strain JS1(T) has been deposited in the American Type Culture Collection (BAA-2537), the Scottish Marine Institute's Culture Collection of Algae and Protozoa (CCAP 1431/1), and the Belgian Coordinated Collections of Microorganisms (ULC0316). The G. kilaueensis holotype has been deposited in the Algal Collection of the US National Herbarium (US# 217948). The JS1(T) genome sequence has been deposited in GenBank under accession number CP003587. The G+C content of the genome is 60.54 mol%. The complete genome sequence of G. kilaueensis JS1(T) may further understanding of cyanobacteria evolution, and the shift from anoxygenic to oxygenic photosynthesis.	[Saw, Jimmy H. W.; Hou, Shaobin; Wan, Xuehua; Donachie, Stuart P.] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA; [Schatz, Michael] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Brown, Mark V.] Univ Hawaii, NASA Astrobiol Inst, Honolulu, HI 96822 USA; [Brown, Mark V.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Kunkel, Dennis D.] Dennis Kunkel Microscopy Inc, Kailua, HI USA; [Foster, Jamie S.] Univ Florida, Space Life Sci Lab, Dept Microbiol & Cell Sci, Kennedy Space Ctr, Kennedy, FL USA; [Christensen, Stephanie] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA; [Hou, Shaobin; Wan, Xuehua] Univ Hawaii Manoa, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; Cold Spring Harbor Laboratory; National Aeronautics & Space Administration (NASA); University of Hawaii System; University of New South Wales Sydney; State University System of Florida; University of Florida; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Donachie, SP (corresponding author), Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA.	donachie@hawaii.edu	Saw, Jimmy/J-1360-2019; Donachie, Stuart P/O-6220-2016; Wan, Xuehua/AAE-4237-2022; Saw, Jimmy HW/A-9972-2009; Schatz, Michael/L-2690-2019; Wan, Xuehua/D-5433-2016	Saw, Jimmy/0000-0001-8353-3854; Wan, Xuehua/0000-0002-6367-848X; Saw, Jimmy HW/0000-0001-8353-3854; Schatz, Michael/0000-0002-4118-4446; Wan, Xuehua/0000-0002-6367-848X; Donachie, Stuart/0000-0002-8322-6915; Hou, Shaobin/0000-0003-3467-8242; Foster, Jamie/0000-0001-8603-4006	College of Natural Sciences; EPSCoR REAP award through NSF [0554657]; Lewis and Clark Fund for Exploration and Field Research in Astrobiology	College of Natural Sciences; EPSCoR REAP award through NSF; Lewis and Clark Fund for Exploration and Field Research in Astrobiology	Early investigations of the epilithic biofilm were supported by start-up funds to SPD from the Dean of the College of Natural Sciences, and by an EPSCoR REAP award to SPD, MVB, Gernot Presting and John M. Berestecky through NSF #0554657 IMUA 2: NSF Hawaii EPSCoR to James Gaines (PI), Kenneth Kaneshiro (Co-PI), and Donald Price (co-PI). Fieldwork was supported by a grant from The Lewis and Clark Fund for Exploration and Field Research in Astrobiology to JHWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JP, 2011, PHOTOSYNTH RES, V107, P59, DOI 10.1007/s11120-010-9552-x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Bidigare R.R., 2005, ALGAL CULTURING TECH, P327; Borriss R, 2011, INT J SYST EVOL MICR, V61, P1786, DOI 10.1099/ijs.0.023267-0; Brady A, 2011, NAT METHODS, V8, P367, DOI 10.1038/nmeth0511-367; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cohen O, 2010, BIOINFORMATICS, V26, P2914, DOI 10.1093/bioinformatics/btq549; Cohen O, 2010, MOL BIOL EVOL, V27, P703, DOI 10.1093/molbev/msp240; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Couradeau E, 2012, SCIENCE, V336, P459, DOI 10.1126/science.1216171; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; Cuzman OA, 2010, MICROB ECOL, V60, P81, DOI 10.1007/s00248-010-9672-z; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Guler S, 2000, J BACTERIOL, V182, P543, DOI 10.1128/JB.182.2.543-545.2000; Guler S, 1996, J BIOL CHEM, V271, P7501; Heidelberg JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004169; HOLMAN TR, 1994, BIOCHEMISTRY-US, V33, P4625, DOI 10.1021/bi00181a024; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lapage SP, 1992, INT CODE NOMENCLATUR; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mares J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066323; Mathies G, 2011, J PHYS CHEM A, V115, P9552, DOI 10.1021/jp112413d; McNeill J, 2011, TAXON, V60, P1495, DOI 10.1002/tax.605030; Mimuro M, 2008, PHOTOSYNTH RES, V97, P167, DOI 10.1007/s11120-008-9311-4; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; NELISSEN B, 1995, MOL BIOL EVOL, V12, P1166; Rexroth S, 2011, PLANT CELL, V23, P2379, DOI 10.1105/tpc.111.085779; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; RIPPKA R, 1974, ARCH MICROBIOL, V100, P419, DOI 10.1007/BF00446333; RosselloMora R., 2006, MOL IDENTIFICATION S, P23, DOI DOI 10.1007/978-3-540-31292-5_2; Rozen S, 2000, Methods Mol Biol, V132, P365; Saw JHW, 2012, STAND GENOMIC SCI, V6, P84, DOI 10.4056/sigs.2445005; Schirrmeister BE, 2013, P NATL ACAD SCI USA, V110, P1791, DOI 10.1073/pnas.1209927110; Schirrmeister BE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-45; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steiger S, 2005, ARCH MICROBIOL, V184, P207, DOI 10.1007/s00203-005-0004-5; Swingley Wesley D., 2008, P21; Tsuchiya T, 2005, FEBS LETT, V579, P2125, DOI 10.1016/j.febslet.2005.02.066; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Ulijasz AT, 2000, BIOCHEMISTRY-US, V39, P11417, DOI 10.1021/bi0012888; Westphal S, 2001, P NATL ACAD SCI USA, V98, P4243, DOI 10.1073/pnas.061501198; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhaxybayeva O, 2009, GENOME BIOL EVOL, V1, P325, DOI 10.1093/gbe/evp032	56	49	52	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76376	10.1371/journal.pone.0076376	http://dx.doi.org/10.1371/journal.pone.0076376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194836	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326037000015
J	Tang, QQ; Li, J; Zhang, SM; Yuan, BL; Sun, H; Wu, D; Lu, CC; Wu, W; Xia, YK; Ding, HJ; Hu, LQ; Chen, DZ; Sha, JH; Wang, XR				Tang, Qiuqin; Li, Jing; Zhang, Simin; Yuan, Beilei; Sun, Hong; Wu, Di; Lu, Chuncheng; Wu, Wei; Xia, Yankai; Ding, Hongjuan; Hu, Lingqing; Chen, Daozhen; Sha, Jiahao; Wang, Xinru			GSTM1 and GSTT1 Null Polymorphisms and Childhood Acute Leukemia Risk: Evidence from 26 Case-Control Studies	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; S-TRANSFERASE POLYMORPHISMS; GENETIC POLYMORPHISMS; CANCER INCIDENCE; BLADDER-CANCER; GLUTATHIONE; SUSCEPTIBILITY; GENOTYPES; CHILDREN; CYP1A1	Several molecular epidemiological studies have been conducted to examine the association between glutathione S-transferase mu-1 (GSTM1) and glutathione S-transferase theta-1 (GSTT1) null polymorphisms and childhood acute leukemia; however, the conclusions remain controversial. We performed an extensive meta-analysis on 26 published case-control studies with a total of 3252 cases and 5024 controls. Crude odds ratios (ORs) with 95% confidence interval were used to assess the strength of association between childhood acute leukemia risk and polymorphisms of GSTM1 and GSTT1. With respect to GSTM1 polymorphism, significantly increased risk of childhood acute leukemia was observed in the overall analysis (OR = 1.30; 95% CI, 1.11-1.51). Furthermore, a stratification analysis showed that the risk of GSTM1 polymorphism are associated with childhood acute leukemia in group of Asians (OR = 1.94; 95% CI, 1.53-2.46), Blacks (OR = 1.76; 95% CI, 1.07-2.91), ALL (OR = 1.33; 95% CI, 1.13-1.58), '< 100 cases and < 100 controls' (OR = 1.79; 95% CI, 1.21-2.64), '>= 100 cases and >= 100 controls' (OR = 1.25; 95% CI, 1.02-1.52), and population-based control source (OR = 1.40; 95% CI, 1.15-1.69). With respect to GSTT1 polymorphism, significant association with childhood acute leukemia risk was only found in subgroup of Asian. This meta-analysis supports that GSTM1 null polymorphism is capable of causing childhood acute leukemia susceptibility.	[Tang, Qiuqin; Ding, Hongjuan] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Dept Obstet, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Li, Jing; Yuan, Beilei; Wu, Di; Lu, Chuncheng; Wu, Wei; Xia, Yankai; Sha, Jiahao; Wang, Xinru] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Li, Jing; Zhang, Simin; Yuan, Beilei; Wu, Di; Lu, Chuncheng; Wu, Wei; Xia, Yankai; Wang, Xinru] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Li, Jing] Xuzhou Med Coll, Dept Publ Hlth, Xuzhou, Jiangsu, Peoples R China; [Sun, Hong] Dept Microbial & Mol SystemsLeuven, Leuven, Belgium; [Wu, Wei; Hu, Lingqing; Chen, Daozhen] Nanjing Med Univ, Wuxi Matern & Child Hlth Care Hosp, State Key Lab Reprod Med, Wuxi, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Xuzhou Medical University; Nanjing Medical University	Wu, W (corresponding author), Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	wwu@njmu.edu.cn; chendaozhen@163.com; shajh@njmu.edu.cn	hu, ling/GWC-1104-2022; Wu, Wei/C-4409-2012; Tang, Qiuqin/X-4817-2019; Wang, Xin/AAN-8435-2021	Wu, Wei/0000-0002-0267-1284; Tang, Qiuqin/0000-0001-9110-9973; Wang, Xin/0000-0002-4457-7376; chen, daozhen/0000-0003-4791-8065	China Postdoctoral Science Foundation [2013M531388]; Science and Technology Development Fund Key Project of Nanjing Medical University [2012NJMU002]; Key Project of National Natural Science Foundation of China [30930079]; National Basic Research Program of China (973 Program) [2009CB941703, 2011CB944304]; National Natural Science Foundation of China [81172696, 81072328]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Development Fund Key Project of Nanjing Medical University; Key Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by grants China Postdoctoral Science Foundation (No. 2013M531388), Science and Technology Development Fund Key Project of Nanjing Medical University (No. 2012NJMU002), Key Project of National Natural Science Foundation of China (No. 30930079), National Basic Research Program of China (973 Program) (2009CB941703, 2011CB944304), National Natural Science Foundation of China (No. 81172696, 81072328), and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves S, 2002, LEUKEMIA, V16, P1565, DOI 10.1038/sj.leu.2402543; Aydin-Sayitoglu M, 2006, AM J HEMATOL, V81, P162, DOI 10.1002/ajh.20434; Balta G, 2003, AM J HEMATOL, V73, P154, DOI 10.1002/ajh.10339; Barnette P, 2004, CANCER EPIDEM BIOMAR, V13, P304, DOI 10.1158/1055-9965.EPI-03-0178; Canalle R, 2004, ENVIRON MOL MUTAGEN, V43, P100, DOI 10.1002/em.20003; Chan JYS, 2011, HEMATOL ONCOL, V29, P116, DOI 10.1002/hon.965; Chen CL, 1997, BLOOD, V89, P1701, DOI 10.1182/blood.V89.5.1701.1701_1701_1707; Clavel J, 2005, EUR J CANCER PREV, V14, P531, DOI 10.1097/00008469-200512000-00007; Davies SM, 2000, CANCER EPIDEM BIOMAR, V9, P563; Davies SM, 2002, BLOOD, V100, P67, DOI 10.1182/blood.V100.1.67; Economopoulos KP, 2010, EUR J CANCER, V46, P1617, DOI 10.1016/j.ejca.2010.02.009; FRYER AA, 1993, CARCINOGENESIS, V14, P563, DOI 10.1093/carcin/14.4.563; Gao LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020157; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Joseph T, 2004, PEDIATR BLOOD CANCER, V43, P560, DOI 10.1002/pbc.20074; Krajinovic M, 2002, PHARMACOGENETICS, V12, P655, DOI 10.1097/00008571-200211000-00010; Krajinovic M, 1999, BLOOD, V93, P1496, DOI 10.1182/blood.V93.5.1496.405a36_1496_1501; Linet MS, 1999, JNCI-J NATL CANCER I, V91, P1051, DOI 10.1093/jnci/91.12.1051; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; Mo ZN, 2009, PROSTATE, V69, P662, DOI 10.1002/pros.20907; Pakakasama S, 2005, AM J HEMATOL, V79, P202, DOI 10.1002/ajh.20404; PEARSON WR, 1993, AM J HUM GENET, V53, P220; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Pigullo S, 2007, LEUKEMIA, V21, P1122, DOI 10.1038/sj.leu.2404617; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Rothman N, 1996, CANCER EPIDEM BIOMAR, V5, P979; Ruzzo A, 2007, CLIN CHEM LAB MED, V45, P822, DOI 10.1515/CCLM.2007.143; Saadat I, 2000, CANCER LETT, V158, P43, DOI 10.1016/S0304-3835(00)00504-8; Strange R C, 1999, IARC Sci Publ, P231; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Vijayakrishnan J, 2010, HAEMATOL-HEMATOL J, V95, P1405, DOI 10.3324/haematol.2010.022095; Webb G, 1996, GENOMICS, V33, P121, DOI 10.1006/geno.1996.0167; Woo MH, 2000, LEUKEMIA, V14, P232, DOI 10.1038/sj.leu.2401660; Ye Z, 2005, EUR J CANCER, V41, P980, DOI 10.1016/j.ejca.2005.01.014; Zhao B, 2001, CANCER EPIDEM BIOMAR, V10, P1063	36	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78810	10.1371/journal.pone.0078810	http://dx.doi.org/10.1371/journal.pone.0078810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194954	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000133
J	Wang, PW; Lai, WF; Li, MLJ; Xu, F; Yalamanchili, HK; Lovell-Badge, R; Wang, JW				Wang, Panwen; Lai, Wing-Fu; Li, Mulin Jun; Xu, Feng; Yalamanchili, Hari Krishna; Lovell-Badge, Robin; Wang, Junwen			Inference of Gene-Phenotype Associations via Protein-Protein Interaction and Orthology	PLOS ONE			English	Article							MOLECULAR-WEIGHT PROTEINURIA; JAPANESE CHILDREN; DISEASE; PRIORITIZATION; GENOME; DATABASE; NEPHROCALCINOSIS; PHENOMICDB; MUTATIONS; DISCOVERY	One of the fundamental goals of genetics is to understand gene functions and their associated phenotypes. To achieve this goal, in this study we developed a computational algorithm that uses orthology and protein-protein interaction information to infer gene-phenotype associations for multiple species. Furthermore, we developed a web server that provides genome-wide phenotype inference for six species: fly, human, mouse, worm, yeast, and zebrafish. We evaluated our inference method by comparing the inferred results with known gene-phenotype associations. The high Area Under the Curve values suggest a significant performance of our method. By applying our method to two human representative diseases, Type 2 Diabetes and Breast Cancer, we demonstrated that our method is able to identify related Gene Ontology terms and Kyoto Encyclopedia of Genes and Genomes pathways. The web server can be used to infer functions and putative phenotypes of a gene along with the candidate genes of a phenotype, and thus aids in disease candidate gene discovery. Our web server is available at http://jjwanglab.org/PhenoPPIOrth.	[Wang, Panwen; Lai, Wing-Fu; Li, Mulin Jun; Xu, Feng; Yalamanchili, Hari Krishna; Wang, Junwen] Univ Hong Kong, Dept Biochem, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [Wang, Panwen; Li, Mulin Jun; Xu, Feng; Yalamanchili, Hari Krishna; Wang, Junwen] Univ Hong Kong, Shenzhen Inst Res & Innovat, Shenzhen, Peoples R China; [Lovell-Badge, Robin] MRC Natl Inst Med Res, Div Dev Genet, London, England; [Wang, Junwen] Univ Hong Kong, Ctr Genom Sci, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; MRC National Institute for Medical Research; University of Hong Kong	Wang, JW (corresponding author), Univ Hong Kong, Dept Biochem, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China.	Junwen@hku.hk	Wang, Junwen/C-4432-2009; Wang, Junwen/D-3700-2011; Lai, Wing-Fu/J-3170-2015	Wang, Junwen/0000-0002-4432-4707; Lai, Wing-Fu/0000-0003-0585-6396; Lovell-Badge, Robin/0000-0001-9364-4179; Yalamanchili, Hari Krishna/0000-0001-9892-3054	Research Grants Council of Hong Kong [781511M, N_HKU752/10, AoE M-04/04]; Natural Science Foundation of China(NSFC) [91229105]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Natural Science Foundation of China(NSFC)(National Natural Science Foundation of China (NSFC))	Research Grants Council of Hong Kong (781511M, N_HKU752/10, AoE M-04/04) Natural Science Foundation of China(NSFC) (91229105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addou S, 2009, J MOL BIOL, V387, P416, DOI 10.1016/j.jmb.2008.12.045; Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Akuta N, 1997, KIDNEY INT, V52, P911, DOI 10.1038/ki.1997.412; Altenhoff AM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002514; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Chen J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-392; Cho SK, 2004, EUKARYOT CELL, V3, P302, DOI 10.1128/EC.3.2.302-310.2004; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Das J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-92; Date Shailesh V., 2007, V408, P109, DOI 10.1007/978-1-59745-547-3_7; Date SV, 2006, GENOME RES, V16, P542, DOI 10.1101/gr.4573206; Dolinski K, 2007, ANNU REV GENET, V41, P465, DOI 10.1146/annurev.genet.40.110405.090439; FAJANS SS, 1989, DIABETES METAB REV, V5, P579, DOI 10.1002/dmr.5610050705; Fang G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000703; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Freudenberg J, 2002, BIOINFORMATICS, V18, pS110, DOI 10.1093/bioinformatics/18.suppl_2.S110; Giallourakis C, 2005, ANNU REV GENOM HUM G, V6, P381, DOI 10.1146/annurev.genom.6.080604.162234; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Groth P, 2007, NUCLEIC ACIDS RES, V35, pD696, DOI 10.1093/nar/gkl662; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Hoehndorf R, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr538; Hwang T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks615; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Kahraman A, 2005, BIOINFORMATICS, V21, P418, DOI 10.1093/bioinformatics/bti010; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Li MLJ, 2013, NUCLEIC ACIDS RES, V41, pW150, DOI 10.1093/nar/gkt456; Li MJ, 2012, CELL RES, V22, P1505, DOI 10.1038/cr.2012.106; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lloyd SE, 1997, J CLIN INVEST, V99, P967, DOI 10.1172/JCI119262; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Nehrt NL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002073; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Parshad R, 1996, BRIT J CANCER, V74, P1, DOI 10.1038/bjc.1996.307; Patti ME, 1998, J BASIC CLIN PHYSL P, V9, P89, DOI DOI 10.1515/JBCPP.1998.9.2-4.89; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; POOK MA, 1993, HUM MOL GENET, V2, P2129, DOI 10.1093/hmg/2.12.2129; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rantamaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068722; Robinson PN, 2010, CLIN GENET, V77, P525, DOI 10.1111/j.1399-0004.2010.01436.x; SCHEINMAN SJ, 1993, J CLIN INVEST, V91, P2351, DOI 10.1172/JCI116467; Sergeev IN, 2012, ANTICANCER RES, V32, P299; Singh S, 2009, REJUV RES, V12, P185, DOI 10.1089/rej.2009.0850; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Studer RA, 2009, TRENDS GENET, V25, P210, DOI 10.1016/j.tig.2009.03.004; Sypecka J, 2005, ACTA NEUROBIOL EXP, V65, P221; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thompson VC, 2012, INT J CANCER, V131, P662, DOI 10.1002/ijc.26414; VAXILLAIRE M, 1995, NAT GENET, V9, P418, DOI 10.1038/ng0495-418; Ward CW, 2009, BIOESSAYS, V31, P422, DOI 10.1002/bies.200800210; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yalamanchili HK, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S1-S19; Yalamanchili HK, 2011, NRPROF NEURAL RESPON, V2011, P33; Yang P, 2012, BIOINFORMATICS, V28, P2640, DOI 10.1093/bioinformatics/bts504; Yang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021502	61	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77478	10.1371/journal.pone.0077478	http://dx.doi.org/10.1371/journal.pone.0077478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194887	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000066
J	Xu, ZQ; Zhao, L; Zhu, LY; He, M; Zheng, LM; Wu, Y				Xu, Zhenqun; Zhao, Lan; Zhu, Ling-Yan; He, Min; Zheng, Limin; Wu, Yan			MicroRNA-17, 20a Regulates the Proangiogenic Function of Tumor-Associated Macrophages via Targeting Hypoxia-Inducible Factor 2 alpha	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ACTIVATED MONOCYTES; TRANSCRIPTIONAL RESPONSE; PERITUMORAL STROMA; PROMOTE EXPANSION; CANCER; EXPRESSION; HIF-2-ALPHA; ANGIOGENESIS; INVASION	Tumor-associated macrophages (TAMs) constitute a major component of the leukocyte infiltrate of most solid tumors, and they usually exhibit a proangiogenic phenotype which facilitates tumor growth in most circumstances. However, the precise mechanisms regulating the proangiogenic properties of TAMs remain largely unclear. In the present study, we found that the expression of hypoxia-inducible factor 2 alpha (HIF-2 alpha) was significantly up-regulated in macrophages from tumor tissues of several solid tumors. Macrophages exposed to tumor cell line derived-culture supernatants (TSN) also expressed high levels of HIF-2 alpha in vitro, without a requirement for hypoxia. We identified miR-17 and miR-20a as the key regulators of HIF-2 alpha expression in TAMs, and autocrine IL-6 played an important role in mediating the expression of miR-17, miR-20a, and thereafter HIF-2 alpha in TAMs. Furthermore, the elevated HIF-2 alpha in TAMs stimulated transcription of a set of proangiogenic genes such as VEGFA and PDGFB, which might in turn contribute to the angiogenic process within tumors. Our data provide evidence in support of the critical role of HIF-2 alpha in the proangiogenic activity of TAMs and also reveal a novel mechanism by which miRNAs regulate TAM functions through modulation of HIF-2 alpha expression under non-hypoxic conditions.	[Xu, Zhenqun; Zhao, Lan; Zhu, Ling-Yan; Zheng, Limin; Wu, Yan] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Gene Engn,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [He, Min] Guangdong Prov Hosp Chinese Med, Dept Clin Lab, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou University of Chinese Medicine	Wu, Y (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Gene Engn,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	wuyan32@mail.sysu.edu.cn	zheng, limin/HGB-2510-2022	He, Min/0000-0003-0361-8984; Zheng, Limin/0000-0002-8281-1450	National Natural Science Foundation of China [31200663]; Natural Science Foundation of Guangdong Province, China [S2012040008103]; Fundamental Research Funds for the Central Universities [13lgpy37]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the project grants from the National Natural Science Foundation of China (31200663), the Natural Science Foundation of Guangdong Province, China (S2012040008103), and the Fundamental Research Funds for the Central Universities (13lgpy37). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Ding T, 2009, HUM PATHOL, V40, P381, DOI 10.1016/j.humpath.2008.08.011; Duluc D, 2007, BLOOD, V110, P4319, DOI 10.1182/blood-2007-02-072587; Elbarghati L, 2008, IMMUNOBIOLOGY, V213, P899, DOI 10.1016/j.imbio.2008.07.016; Fang HY, 2009, BLOOD, V114, P844, DOI 10.1182/blood-2008-12-195941; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; He M, 2009, CELL MOL IMMUNOL, V6, P343, DOI 10.1038/cmi.2009.45; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kees T, 2012, NEURO-ONCOLOGY, V14, P64, DOI 10.1093/neuonc/nor182; Knowles H, 2004, NOVART FDN SYMP, V256, P259; Knowles H, 2004, NOVART FDN SYMP, V256, P200; Knowles Helen, 2004, Novartis Found Symp, V256, P189; Koga F, 2004, J UROLOGY, V171, P1080, DOI 10.1097/01.ju.0000110541.62972.08; Kuang DM, 2007, BLOOD, V110, P587, DOI 10.1182/blood-2007-01-068031; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Kuang DM, 2010, J IMMUNOL, V185, P1544, DOI 10.4049/jimmunol.0904094; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Leek RD, 2002, CANCER RES, V62, P1326; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pan XQ, 2012, CHIN J CANCER, V31, P557, DOI 10.5732/cjc.012.10046; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rupaimoole Rajesha, 2011, Chin J Cancer, V30, P368; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Sowter HM, 2003, CANCER RES, V63, P6130; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; THOMASSEN MJ, 1991, CANCER RES, V51, P857; VIGNAUD JM, 1994, CANCER RES, V54, P5455; Wang B, 2011, ANN SURG ONCOL, V18, P2585, DOI 10.1245/s10434-011-1609-3; Wang R, 2011, LUNG CANCER, V74, P188, DOI 10.1016/j.lungcan.2011.04.009; White JR, 2004, GENOMICS, V83, P1, DOI 10.1016/S0888-7543(03)00215-5; Wilke CM, 2011, INT REV IMMUNOL, V30, P120, DOI 10.3109/08830185.2011.567362; Wu Y, 2012, CANCER MICROENVIRON, V5, P195, DOI 10.1007/s12307-012-0113-z; Wu Y, 2011, J PATHOL, V225, P438, DOI 10.1002/path.2947; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904; Zhao QY, 2012, J IMMUNOL, V188, P1117, DOI 10.4049/jimmunol.1100164; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	56	22	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77890	10.1371/journal.pone.0077890	http://dx.doi.org/10.1371/journal.pone.0077890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194900	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000079
J	Halbert, KMK; Goetze, E; Carlon, DB				Halbert, Kristin M. K.; Goetze, Erica; Carlon, David B.			High Cryptic Diversity across the Global Range of the Migratory Planktonic Copepods Pleuromamma piseki and P. gracilis	PLOS ONE			English	Article							INTEGUMENTAL PORE SIGNATURES; GENUS PLEUROMAMMA; ESTUARINE COPEPOD; SPECIES COMPLEX; PHYLOGEOGRAPHY; MITOCHONDRIAL; ZOOPLANKTON; SPECIATION; ATLANTIC; BIODIVERSITY	Although holoplankton are ocean drifters and exhibit high dispersal potential, a number of studies on single species are finding highly divergent genetic clades. These cryptic species complexes are important to discover and describe, as identification of common marine species is fundamental to understanding ecosystem dynamics. Here we investigate the global diversity within Pleuromamma piseki and P. gracilis, two dominant members of the migratory zooplankton assemblage in subtropical and tropical waters worldwide. Using DNA sequence data from the mitochondrial gene cytochrome c oxidase subunit II (mtCOII) from 522 specimens collected across the Pacific, Atlantic and Indian Oceans, we discover twelve well-resolved genetically distinct clades in this species complex (Bayesian posterior probabilities >0.7; 6.3-17% genetic divergence between clades). The morphologically described species P. piseki and P. gracilis did not form monophyletic groups, rather they were distributed throughout the phylogeny and sometimes co-occurred within well-resolved clades: this result suggests that morphological characters currently used for taxonomic identification of P. gracilis and P. piseki may be inaccurate as indicators of species' boundaries. Cryptic clades within the species complex ranged from being common to rare, and from cosmopolitan to highly restricted in distribution across the global ocean. These novel lineages appear to be ecologically divergent, with distinct biogeographic distributions across varied pelagic habitats. We hypothesize that these mtDNA lineages are distinct species and suggest that resolving their systematic status is important, given the ecological significance of the genus Pleuromamma in subtropical-tropical waters worldwide.	[Halbert, Kristin M. K.; Goetze, Erica] Univ Hawaii Manoa, Dept Oceanog, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; [Halbert, Kristin M. K.; Carlon, David B.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Goetze, E (corresponding author), Univ Hawaii Manoa, Dept Oceanog, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA.	egoetze@hawaii.edu			National Science Foundation [OCE-1029478]; Waitt Foundation - National Geographic grant [W119-10]; Division Of Ocean Sciences [1029478] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Waitt Foundation - National Geographic grant; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by National Science Foundation grant OCE-1029478 and a Waitt Foundation - National Geographic grant (W119-10) to E. Goetze. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mutairi H, 2001, DEEP-SEA RES PT II, V48, P2083, DOI 10.1016/S0967-0645(00)00174-0; AMBLER JW, 1987, MAR BIOL, V94, P561, DOI 10.1007/BF00431403; Andrews KR, MOL ECOLOGY; ANGEL MV, 1993, CONSERV BIOL, V7, P760, DOI 10.1046/j.1523-1739.1993.740760.x; Aurahs R, 2009, MOL ECOL, V18, P1692, DOI 10.1111/j.1365-294X.2009.04136.x; Avise JC, 2000, PHYLOGEOGRAPHY HIST, Vviii; Baird HP, 2011, MOL ECOL, V20, P3439, DOI 10.1111/j.1365-294X.2011.05173.x; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; BENNETT JL, 1989, CONTRIB MAR SCI, V31, P119; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bottger-Schnack R, 2011, HYDROBIOLOGIA, V666, P111, DOI 10.1007/s10750-010-0094-1; Bradford-Grieve JM, 1999, NIWA BIODIVERS MEM, P39; Brinton E., 1962, Bulletin Scripps Institution of Oceanography, V8, P51; Bucklin A, 2000, ICES J MAR SCI, V57, P1592, DOI 10.1006/jmsc.2000.0957; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P2234, DOI 10.1016/j.dsr2.2010.09.025; Burton RS, 2012, MOL ECOL, V21, P4942, DOI 10.1111/mec.12006; BUSKEY EJ, 1989, MAR ECOL PROG SER, V55, P207, DOI 10.3354/meps055207; Casteleyn G, 2008, HARMFUL ALGAE, V7, P241, DOI 10.1016/j.hal.2007.08.004; Chen G, 2008, MOL ECOL, V17, P1451, DOI 10.1111/j.1365-294X.2007.03657.x; Chen G, 2011, MOL ECOL, V20, P2425, DOI 10.1111/j.1365-294X.2011.05079.x; Claus C, 1863, FREILEBENDEN COPEPOD, DOI [10.5962/bhl.title.58676, DOI 10.5962/BHL.TITLE.58676]; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P9235, DOI 10.1073/pnas.0503635102; DiBattista JD, 2012, J HERED, V103, P617, DOI 10.1093/jhered/ess056; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farran G.P., 1936, GREAT BARRIER REEF E, V5, P73; Farran GP, 1929, 1910 NATURAL HIST RE, P203; Ferrari FD, 1984, CRUSTACEANA S, V7, P166; Ferrari Frank D., 1998, Plankton Biology and Ecology, V45, P203; Frost B., 1968, Bulletin Scripps Institution of Oceanography Technical Series, V12, P1; Goetze E, 2005, PROG OCEANOGR, V65, P55, DOI 10.1016/j.pocean.2005.02.015; Goetze E, 2003, P ROY SOC B-BIOL SCI, V270, P2321, DOI 10.1098/rspb.2003.2505; Goetze E, 2010, DEEP-SEA RES PT II, V57, P2110, DOI 10.1016/j.dsr2.2010.09.014; Goetze E, 2010, MOL ECOL, V19, P952, DOI 10.1111/j.1365-294X.2009.04520.x; Halbert KMK, 2013, GENETIC ISOLATION OP; HAURY LR, 1988, HYDROBIOLOGIA, V167, P335, DOI 10.1007/BF00026322; Hays GC, 2001, DEEP-SEA RES PT II, V48, P1063, DOI 10.1016/S0967-0645(00)00109-0; Hays GC, 1997, MAR ECOL PROG SER, V160, P57, DOI 10.3354/meps160057; HAYWARD TL, 1981, LIMNOL OCEANOGR, V26, P374, DOI 10.4319/lo.1981.26.2.0374; HAYWARD TL, 1980, MAR BIOL, V58, P295, DOI 10.1007/BF00390778; Holland BS, 2004, MAR BIOL, V145, P1119, DOI 10.1007/s00227-004-1409-4; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jarman SN, 2002, HEREDITY, V88, P280, DOI 10.1038/sj.hdy.6800041; Jennings RM, 2010, DEEP-SEA RES PT II, V57, P2199, DOI 10.1016/j.dsr2.2010.09.022; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Landry MR, 2001, DEEP-SEA RES PT II, V48, P2037, DOI 10.1016/S0967-0645(00)00172-7; Lang BT, 1965, TAXONOMIC REV GEOGRA, Vxvi; Lee CE, 2000, EVOLUTION, V54, P2014, DOI 10.1111/j.0014-3820.2000.tb01245.x; Lee CE, 2002, HYDROBIOLOGIA, V480, P111, DOI 10.1023/A:1021293203512; Maas AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053889; Machida RJ, 2004, GENE, V332, P71, DOI 10.1016/j.gene.2004.01.019; Machida RJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-438; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; Marletaz F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r94; Marrone F, 2013, MOL PHYLOGENET EVOL, V66, P190, DOI 10.1016/j.ympev.2012.09.016; Mathews LM, 2009, MOL PHYLOGENET EVOL, V50, P268, DOI 10.1016/j.ympev.2008.10.026; Milligan PJ, 2011, HYDROBIOLOGIA, V666, P155, DOI 10.1007/s10750-010-0097-y; Miyamoto H, 2012, PROG OCEANOGR, V104, P99, DOI 10.1016/j.pocean.2012.06.003; Miyamoto H, 2010, DEEP-SEA RES PT II, V57, P2211, DOI 10.1016/j.dsr2.2010.09.023; Norris RD, 2000, PALEOBIOLOGY, V26, P236, DOI 10.1666/0094-8373(2000)26[236:PSDBAE]2.0.CO;2; Park JS, 1996, J NAT HIST, V30, P1007, DOI 10.1080/00222939600770541; PARK JS, 1995, J MAR BIOL ASSOC UK, V75, P211, DOI 10.1017/S0025315400015319; PARK JS, 1994, MAR BIOL, V120, P107; Peijnenburg KTCA, 2006, MOL ECOL, V15, P3319, DOI 10.1111/j.1365-294X.2006.03002.x; Peijnenburg KTCA, 2013, ECOL EVOL, V3, P2765, DOI 10.1002/ece3.644; Peijnenburg KTCA, 2005, MAR BIOL, V147, P1279, DOI 10.1007/s00227-005-0041-2; Peijnenburg KTCA, 2004, EVOLUTION, V58, P1472; Pritchard VL, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-54; Rocha-Olivares A, 2001, MOL BIOL EVOL, V18, P1088, DOI 10.1093/oxfordjournals.molbev.a003880; ROE HSJ, 1972, J MAR BIOL ASSOC UK, V52, P525, DOI 10.1017/S0025315400021573; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saez AG, 2003, P NATL ACAD SCI USA, V100, P7163, DOI 10.1073/pnas.1132069100; Schmaus PH, 1927, WISSENSCHAFTLICHE ER, V1898-1899, P355; SchneiderBroussard R, 1997, MOL BIOL EVOL, V14, P156, DOI 10.1093/oxfordjournals.molbev.a025748; Schroth W, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinberg DK, 2000, DEEP-SEA RES PT I, V47, P137, DOI 10.1016/S0967-0637(99)00052-7; Steuer A., 1932, Wissenschaftliche Ergebnisse der Deutschen Tiefsee Expedition Jena, V24, P1; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thum RA, 2009, BIOL J LINN SOC, V96, P150, DOI 10.1111/j.1095-8312.2008.01105.x; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; Vervoort W., 1949, Temminckia Leiden, V8, P1; Weiner A, 2012, MOL ECOL, V21, P4063, DOI 10.1111/j.1365-294X.2012.05686.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williams ST, 2001, MOL BIOL EVOL, V18, P1484, DOI 10.1093/oxfordjournals.molbev.a003934; Wilson SE, 2010, MAR ECOL PROG SER, V412, P11, DOI 10.3354/meps08648; Yebra L, 2011, MAR ECOL PROG SER, V428, P135, DOI 10.3354/meps09056	91	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77011	10.1371/journal.pone.0077011	http://dx.doi.org/10.1371/journal.pone.0077011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167556	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500015
J	Alcaraz, ML; Hormaza, JI; Rodrigo, J				Librada Alcaraz, Maria; Ignacio Hormaza, Jose; Rodrigo, Javier			Pistil Starch Reserves at Anthesis Correlate with Final Flower Fate in Avocado (Persea americana)	PLOS ONE			English	Article							APRICOT PRUNUS-ARMENIACA; POLLEN-TUBE GROWTH; VITIS-VINIFERA L.; FRUIT-SET; CARBOHYDRATE AVAILABILITY; OUTCROSSING RATE; HASS AVOCADO; HERMAPHRODITIC PLANTS; ABSCISSION; CITRUS	A common observation in different plant species is a massive abscission of flowers and fruitlets even after adequate pollination, but little is known as to the reason for this drop. Previous research has shown the importance of nutritive reserves accumulated in the flower on fertilization success and initial fruit development but direct evidence has been elusive. Avocado (Persea americana) is an extreme case of a species with a very low fruit to flower ratio. In this work, the implications of starch content in the avocado flower on the subsequent fruit set are explored. Firstly, starch content in individual ovaries was analysed from two populations of flowers with a different fruit set capacity showing that the flowers from the population that resulted in a higher percentage of fruit set contained significantly more starch. Secondly, in a different set of flowers, the style of each flower was excised one day after pollination, once the pollen tubes had reached the base of the style, and individually fixed for starch content analysis under the microscope once the fate of its corresponding ovary (that remained in the tree) was known. A high variability in starch content in the style was found among flowers, with some flowers having starch content up to 1,000 times higher than others, and the flowers that successfully developed into fruits presented significantly higher starch content in the style at anthesis than those that abscised. The relationship between starch content in the ovary and the capacity of set of the flower together with the correlation found between the starch content in the style and the fate of the ovary support the hypothesis that the carbohydrate reserves accumulated in the flower at anthesis are related to subsequent abscission or retention of the developing fruit.	[Librada Alcaraz, Maria; Ignacio Hormaza, Jose] Univ Malaga, Consejo Super Invest Cient IHSM UMA CSIC, Inst Hortofruticultura Subtrop & Mediterranea La, Estac Expt La Mayora, E-29071 Malaga, Spain; [Rodrigo, Javier] Ctr Invest & Tecnol Agroalimentaria Aragon CITA, Unidad Fruticultura, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental La Mayora (EELM); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM)	Hormaza, JI (corresponding author), Univ Malaga, Consejo Super Invest Cient IHSM UMA CSIC, Inst Hortofruticultura Subtrop & Mediterranea La, Estac Expt La Mayora, E-29071 Malaga, Spain.	ihormaza@eelm.csic.es	Rodrigo, Javier/H-6383-2011; Hormaza, Jose/D-8066-2011	Rodrigo, Javier/0000-0002-8321-1764; Hormaza, Jose/0000-0001-5449-7444	Ministerio de Economia y Competitividad - European Regional Development Fund; European Union [AGL2010-15140]; Junta de Andalucia [FEDER P08-AGR-3694]; Gobierno de Aragon - European Social Fund, European Union (Grupo de Investigacion de Aragon A-43)	Ministerio de Economia y Competitividad - European Regional Development Fund; European Union(European Commission); Junta de Andalucia(Junta de Andalucia); Gobierno de Aragon - European Social Fund, European Union (Grupo de Investigacion de Aragon A-43)	This work was supported by Ministerio de Economia y Competitividad - European Regional Development Fund, European Union (AGL2010-15140), Junta de Andalucia (FEDER P08-AGR-3694) and Gobierno de Aragon - European Social Fund, European Union (Grupo de Investigacion de Aragon A-43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAO S, 1981, J JPN SOC HORTIC SCI, V50, P1, DOI 10.2503/jjshs.50.1; Alcaraz ML, 2011, ANN APPL BIOL, V158, P354, DOI 10.1111/j.1744-7348.2011.00469.x; Alcaraz ML, 2009, SCI HORTIC-AMSTERDAM, V121, P267, DOI 10.1016/j.scienta.2009.02.001; Alcaraz ML, 2010, PHYSIOL PLANTARUM, V140, P395, DOI 10.1111/j.1399-3054.2010.01410.x; Aloni B, 1996, ANN BOT-LONDON, V78, P163, DOI 10.1006/anbo.1996.0109; ALONI B, 1991, ANN BOT-LONDON, V67, P371, DOI 10.1093/oxfordjournals.aob.a088170; ARBELOA A, 1991, NEW PHYTOL, V118, P527, DOI 10.1111/j.1469-8137.1991.tb00992.x; AYRE DJ, 1989, TRENDS ECOL EVOL, V4, P267, DOI 10.1016/0169-5347(89)90197-3; Bennett J., 2002, AUSTR NZ GRAPEGROWER, V456, P70; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; CHARLESWORTH D, 1989, NATURE, V338, P21, DOI 10.1038/338021a0; Clement C, 1996, AM J BOT, V83, P459, DOI 10.2307/2446215; Davenport T. L., 1986, Horticultural Reviews, V8, P257, DOI 10.1002/9781118060810.ch7; Davie S. J., 1995, Yearbook - South African Avocado Growers' Association, V18, P51; Degani C, 1997, J AM SOC HORTIC SCI, V122, P813, DOI 10.21273/JASHS.122.6.813; DEGANI C, 1989, J AM SOC HORTIC SCI, V114, P106; Duchene E, 2003, J INT SCI VIGNE VIN, V37, P39; FALQUE M, 1995, SEX PLANT REPROD, V8, P354, DOI 10.1007/BF00243203; FINAZZO SF, 1994, TREE PHYSIOL, V14, P153, DOI 10.1093/treephys/14.2.153; GARCIALUIS A, 1988, ISRAEL J BOT, V37, P189; Garner LC, 2008, J AM SOC HORTIC SCI, V133, P648, DOI 10.21273/JASHS.133.5.648; Garner LC, 2008, J AM SOC HORTIC SCI, V133, P3, DOI 10.21273/JASHS.133.1.3; GRIGGS W. H., 1941, PROC AMER SOC HORT SCI, V38, P89; HERRERO M, 1979, J CELL SCI, V36, P1; HO LC, 1988, ANNU REV PLANT PHYS, V39, P355, DOI 10.1146/annurev.arplant.39.1.355; Iglesias DJ, 2003, TREE PHYSIOL, V23, P199, DOI 10.1093/treephys/23.3.199; Jean D, 2001, PHYSIOL PLANTARUM, V112, P379, DOI 10.1034/j.1399-3054.2001.1120311.x; JOHANSEN D.A., 1940, PLANT MICROTECHNIQUE; Julian C, 2011, ANN BOT-LONDON, V108, P617, DOI 10.1093/aob/mcr056; KOZLOWSKI TT, 1992, BOT REV, V58, P107, DOI 10.1007/BF02858600; Lahav E, 1971, J AM SOC HORTIC SCI, V96, P393; Lebon G, 2008, J EXP BOT, V59, P2565, DOI 10.1093/jxb/ern135; Lebon G, 2004, SEX PLANT REPROD, V17, P71, DOI 10.1007/s00497-004-0217-9; LINSKENS HF, 1957, NATURWISSENSCHAFTEN, V44, P16, DOI 10.1007/BF00629340; LLOYD DG, 1980, NEW PHYTOL, V86, P69, DOI 10.1111/j.1469-8137.1980.tb00780.x; Nirody BS, 1922, CALIFORNIA AVOCADO A, V7, P65; NOEL ARA, 1970, BOT REV, V36, P162, DOI 10.1007/BF02858959; Oliveira C. M., 1988, Horticultural Reviews, V10, P403, DOI 10.1002/9781118060834.ch10; RACKHAM R. L., 1966, California Citrograph, V51, P408; Reale L, 2009, SEX PLANT REPROD, V22, P109, DOI 10.1007/s00497-009-0096-1; Rodrigo J, 1998, SEX PLANT REPROD, V11, P86, DOI 10.1007/s004970050124; Rodrigo J, 1997, PHYSIOL PLANTARUM, V99, P105, DOI 10.1034/j.1399-3054.1997.990115.x; Rodrigo J, 2000, PHYSIOL PLANTARUM, V108, P35, DOI 10.1034/j.1399-3054.2000.108001035.x; Rodrigo J, 2002, J APPL BOT-ANGEW BOT, V76, P13; Rodrigo J, 2009, ANN APPL BIOL, V154, P365, DOI 10.1111/j.1744-7348.2008.00305.x; Ruiz R, 2001, ANN BOT-LONDON, V87, P805, DOI 10.1006/anbo.2001.1415; SCHOLEFIELD PB, 1985, SCI HORTIC-AMSTERDAM, V25, P99, DOI 10.1016/0304-4238(85)90081-0; SEDGLEY M, 1979, ANN BOT-LONDON, V44, P353, DOI 10.1093/oxfordjournals.aob.a085739; SEDGLEY M, 1980, ANN BOT-LONDON, V46, P771, DOI 10.1093/oxfordjournals.aob.a085974; SEDGLEY M, 1977, J HORTIC SCI, V52, P135, DOI 10.1080/00221589.1977.11514739; SEDGLEY M, 1981, SCI HORTIC-AMSTERDAM, V14, P27, DOI 10.1016/0304-4238(81)90075-3; SHIMIZU T, 1978, J JPN SOC HORTIC SCI, V46, P465, DOI 10.2503/jjshs.46.465; Silber A, 2012, AGR WATER MANAGE, V104, P95, DOI 10.1016/j.agwat.2011.12.003; SPRUGEL DG, 1991, ANNU REV ECOL SYST, V22, P309, DOI 10.1146/annurev.es.22.110191.001521; STEPHENSON AG, 1981, ANNU REV ECOL SYST, V12, P253, DOI 10.1146/annurev.es.12.110181.001345; Stout AB, 1923, CALIF AVOC ASS ANN R, V8, P29; SUTHERLAND S, 1987, EVOLUTION, V41, P750, DOI 10.1111/j.1558-5646.1987.tb05850.x; SUTHERLAND S, 1984, ECOLOGY, V65, P1093, DOI 10.2307/1938317; Syvertsen J.P., 1994, HDB ENV PHYSL FRUIT, P65; WARDLAW IF, 1990, NEW PHYTOL, V116, P341, DOI 10.1111/j.1469-8137.1990.tb00524.x; WILLIAMS RR, 1965, J HORTIC SCI BIOTECH, V40, P31, DOI 10.1080/00221589.1965.11514118; WOLSTENHOLME BN, 1990, SCI HORTIC-AMSTERDAM, V41, P315, DOI 10.1016/0304-4238(90)90112-R	62	25	25	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78467	10.1371/journal.pone.0078467	http://dx.doi.org/10.1371/journal.pone.0078467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167627	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500088
J	Stadelmann, K; Latshang, TD; Lo Cascio, CM; Tesler, N; Stoewhas, AC; Kohler, M; Bloch, KE; Huber, R; Achermann, P				Stadelmann, Katrin; Latshang, Tsogyal D.; Lo Cascio, Christian M.; Tesler, Noemi; Stoewhas, Anne-Christin; Kohler, Malcolm; Bloch, Konrad E.; Huber, Reto; Achermann, Peter			Quantitative Changes in the Sleep EEG at Moderate Altitude (1630 m and 2590 m)	PLOS ONE			English	Article							SLOW-WAVE ACTIVITY; SIMULATED ALTITUDE; APNEA SYNDROME; POWER-DENSITY; ACCLIMATIZATION; HYPOXIA; ELECTROENCEPHALOGRAM; ARCHITECTURE; DEPRIVATION; SATURATION	Background: Previous studies have observed an altitude-dependent increase in central apneas and a shift towards lighter sleep at altitudes >4000 m. Whether altitude-dependent changes in the sleep EEG are also prevalent at moderate altitudes of 1600 m and 2600 m remains largely unknown. Furthermore, the relationship between sleep EEG variables and central apneas and oxygen saturation are of great interest to understand the impact of hypoxia at moderate altitude on sleep. Methods: Fourty-four healthy men (mean age 25.0 +/- 5.5 years) underwent polysomnographic recordings during a baseline night at 490 m and four consecutive nights at 1630 m and 2590 m (two nights each) in a randomized cross-over design. Results: Comparison of sleep EEG power density spectra of frontal (F3A2) and central (C3A2) derivations at altitudes compared to baseline revealed that slow-wave activity (SWA, 0.8-4.6 Hz) in non-REM sleep was reduced in an altitude-dependent manner (similar to 4% at 1630 m and 15% at 2590 m), while theta activity (4.6-8 Hz) was reduced only at the highest altitude (10% at 2590 m). In addition, spindle peak height and frequency showed a modest increase in the second night at 2590 m. SWA and theta activity were also reduced in REM sleep. Correlations between spectral power and central apnea/hypopnea index (AHI), oxygen desaturation index (ODI), and oxygen saturation revealed that distinct frequency bands were correlated with oxygen saturation (6.4-8 Hz and 13-14.4 Hz) and breathing variables (AHI, ODI; 0.8-4.6 Hz). Conclusions: The correlation between SWA and AHI/ODI suggests that respiratory disturbances contribute to the reduction in SWA at altitude. Since SWA is a marker of sleep homeostasis, this might be indicative of an inability to efficiently dissipate sleep pressure.	[Stadelmann, Katrin; Achermann, Peter] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Stadelmann, Katrin; Kohler, Malcolm; Bloch, Konrad E.; Huber, Reto; Achermann, Peter] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Latshang, Tsogyal D.; Lo Cascio, Christian M.; Stoewhas, Anne-Christin; Kohler, Malcolm; Bloch, Konrad E.] Univ Zurich Hosp, Div Pulm, CH-8091 Zurich, Switzerland; [Tesler, Noemi; Huber, Reto] Univ Childrens Hosp Zurich, Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital; University Children's Hospital Zurich	Achermann, P (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland.	acherman@pharma.uzh.ch	Achermann, Peter/N-1215-2014	Achermann, Peter/0000-0002-0208-3511	University of Zurich Research Priority Program (URPP Integrative Human Physiology); SUVA (Swiss Accident Insurance Fund), Switzerland	University of Zurich Research Priority Program (URPP Integrative Human Physiology); SUVA (Swiss Accident Insurance Fund), Switzerland	This study was supported by a research grant from the University of Zurich Research Priority Program (URPP Integrative Human Physiology) and the SUVA (Swiss Accident Insurance Fund), Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHERMANN P, 1990, J BIOL RHYTHM, V5, P141, DOI 10.1177/074873049000500206; ACHERMANN P, 1993, BRAIN RES BULL, V31, P97, DOI 10.1016/0361-9230(93)90016-5; ACHERMANN P, 2009, EPILEPTOLOGIE, V26, P28; ANHOLM JD, 1992, AM REV RESPIR DIS, V145, P817, DOI 10.1164/ajrccm/145.4_Pt_1.817; Banks S, 2007, J CLIN SLEEP MED, V3, P519; BERSSENBRUGGE AD, 1984, J APPL PHYSIOL, V57, P1089, DOI 10.1152/jappl.1984.57.4.1089; Bloch KE, 2010, AM J RESP CRIT CARE, V182, P562, DOI 10.1164/rccm.200911-1694OC; BONNET MH, 1986, PSYCHOPHYSIOLOGY, V23, P263, DOI 10.1111/j.1469-8986.1986.tb00630.x; Borbely A A, 1982, Hum Neurobiol, V1, P195; Campbell I.G., 2009, Curr. Protoc. Neurosci.; DIJK DJ, 1989, ELECTROEN CLIN NEURO, V72, P312, DOI 10.1016/0013-4694(89)90067-9; DIJK DJ, 1987, EUR ARCH PSY CLIN N, V236, P323; FEINBERG I, 1979, PSYCHOPHYSIOLOGY, V16, P283, DOI 10.1111/j.1469-8986.1979.tb02991.x; Finelli LA, 2001, EUR J NEUROSCI, V13, P2282, DOI 10.1046/j.0953-816x.2001.01597.x; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Goncalves MA, 2004, CHEST, V125, P2091, DOI 10.1378/chest.125.6.2091; Gottselig JM, 2002, BRAIN, V125, P373, DOI 10.1093/brain/awf021; Guilleminault C, 2001, EUR RESPIR J, V17, P838, DOI 10.1183/09031936.01.17508380; Hoshikawa M, 2007, J APPL PHYSIOL, V103, P2005, DOI 10.1152/japplphysiol.00315.2007; Jenni OG, 2004, SLEEP, V27, P774; Johnson PL, 2010, J SLEEP RES, V19, P148, DOI 10.1111/j.1365-2869.2009.00745.x; Khoo MCK, 1996, RESP PHYSIOL, V103, P33, DOI 10.1016/0034-5687(95)00057-7; Kinsman TA, 2005, EUR J APPL PHYSIOL, V94, P569, DOI 10.1007/s00421-005-1368-6; Kinsman TA, 2005, J SCI MED SPORT, V8, P222, DOI 10.1016/S1440-2440(05)80013-1; Latshang TD, 2013, SLEEP IN PRESS; Marzano C, 2010, J SLEEP RES, V19, P260, DOI 10.1111/j.1365-2869.2009.00776.x; MIZUNO K, 1993, JPN J PHYSIOL, V43, P161, DOI 10.2170/jjphysiol.43.161; NORMAND H, 1990, AVIAT SPACE ENVIR MD, V61, P229; Nussbaumer-Ochsner Y, 2012, SLEEP, V35, P419, DOI 10.5665/sleep.1708; Nussbaumer-Ochsner Y, 2010, THORAX, V65, P429, DOI 10.1136/thx.2009.125849; Ondze B, 2003, CLIN NEUROPHYSIOL, V114, P867, DOI 10.1016/S1388-2457(02)00389-9; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; REITE M, 1975, ELECTROEN CLIN NEURO, V38, P463, DOI 10.1016/0013-4694(75)90188-1; Steriade M., 2005, ELECTROENCEPHALOGRAP, P31; Stowhas AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070081; Wickramasinghe Himanshu, 1999, Sleep Breath, V3, P89, DOI 10.1007/s11325-999-0089-1; Zielinski J, 2000, High Alt Med Biol, V1, P331	37	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76945	10.1371/journal.pone.0076945	http://dx.doi.org/10.1371/journal.pone.0076945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167552	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000326034500011
J	Word, DP; Young, JK; Cummings, DAT; Iamsirithaworn, S; Laird, CD				Word, Daniel P.; Young, James K.; Cummings, Derek A. T.; Iamsirithaworn, Sopon; Laird, Carl D.			Interior-Point Methods for Estimating Seasonal Parameters in Discrete-Time Infectious Disease Models	PLOS ONE			English	Article							MEASLES EPIDEMICS; LINE-SEARCH; TRANSMISSION; DYNAMICS; INFERENCE; ALGORITHM; RATES; NOISE	Infectious diseases remain a significant health concern around the world. Mathematical modeling of these diseases can help us understand their dynamics and develop more effective control strategies. In this work, we show the capabilities of interior-point methods and nonlinear programming (NLP) formulations to efficiently estimate parameters in multiple discrete-time disease models using measles case count data from three cities. These models include multiplicative measurement noise and incorporate seasonality into multiple model parameters. Our results show that nearly identical patterns are estimated even when assuming seasonality in different model parameters, and that these patterns show strong correlation to school term holidays across very different social settings and holiday schedules. We show that interior-point methods provide a fast and flexible approach to parameterizing models that can be an alternative to more computationally intensive methods.	[Word, Daniel P.; Young, James K.; Laird, Carl D.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA; [Cummings, Derek A. T.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Iamsirithaworn, Sopon] Minist Publ Hlth, Bur Epidemiol, Bangkok, Thailand	Texas A&M University System; Texas A&M University College Station; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Ministry of Public Health - Thailand	Laird, CD (corresponding author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.	carl.laird@tamu.edu			U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]; Scientic Interface from the Burroughs Wellcome Fund; NIH MIDAS Center of Excellence grant; National Science Foundation [5 R01 GM 090204]	U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration); Scientic Interface from the Burroughs Wellcome Fund; NIH MIDAS Center of Excellence grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	The authors gratefully acknowledge nancial support provided by Sandia National Laboratories and the Oce of Advanced Scientic Computing Research within the DOE Oce of Science as part of the Applied Mathematics program. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the U.S. Department of Energy's National Nuclear Security Administration under Contract DE-AC04-94AL85000. Derek Cummings holds a Career Award at the Scientic Interface from the Burroughs Wellcome Fund. DATC and DSB were funded by a NIH MIDAS Center of Excellence grant. DATC also received funding from the National Science Foundation (5 R01 GM 090204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; [Anonymous], 1999, EPIDEMIC MODELLING I; [Anonymous], BUR EP ANN EP SURV R; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Byrd RH, 2006, NONCONVEX OPTIM, V83, P35; Byrd RH, 1999, SIAM J OPTIMIZ, V9, P877, DOI 10.1137/S1052623497325107; Cauchemez S, 2008, J R SOC INTERFACE, V5, P885, DOI 10.1098/rsif.2007.1292; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Ellner SP, 1998, AM NAT, V151, P425, DOI 10.1086/286130; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Finkenstadt BF, 2002, BIOSTATISTICS, V3, P493, DOI 10.1093/biostatistics/3.4.493; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Fourer R., 1993, AMPL MODELING LANGUA; Gomes MC, 1999, EUR J EPIDEMIOL, V15, P791, DOI 10.1023/A:1007615513441; Gould NIM, 2004, RALTR2004032; Grenfell BT, 2002, ECOL MONOGR, V72, P185, DOI 10.1890/0012-9615(2002)072[0185:DOMESN]2.0.CO;2; Hart W.E., 2012, PYOMO OPTIMIZATION M, V67, DOI [10.1007/978-1-4614-3226-5, DOI 10.1007/978-1-4614-3226-5]; He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151; Hethcote H, 1994, FRONTIERS MATH BIOL, V1; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hooker G, 2010, J ROYAL SOC INTERFAC; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 1997, TRENDS MICROBIOL, V5, P513, DOI 10.1016/S0966-842X(97)01147-5; Laird C, 2006, P INT C HIGH PERF CO; LIU WM, 1987, J MATH BIOL, V25, P359, DOI 10.1007/BF00277162; MOLLISON D, 1993, MATH BIOSCI, V117, P155, DOI 10.1016/0025-5564(93)90021-2; Rooney WC, 2001, AICHE J, V47, P1794, DOI 10.1002/aic.690470811; Rosenthal RE, 2012, GAMS USERS GUIDE; Soper HE, 1929, J R STAT SOC, V92, P34, DOI 10.2307/2341437; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; Wachter A, 2002, THESIS CARNEGIE MELL; Waltz RA, 2006, MATH PROGRAM, V107, P391, DOI 10.1007/s10107-004-0560-5; Word DP, 2012, J R SOC INTERFACE, V9, P1983, DOI 10.1098/rsif.2011.0829; Word DP, 2010, P AMER CONTR CONF, P5137; YORKE JA, 1973, AM J EPIDEMIOL, V98, P469, DOI 10.1093/oxfordjournals.aje.a121576	35	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e74208	10.1371/journal.pone.0074208	http://dx.doi.org/10.1371/journal.pone.0074208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167542	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500001
J	Steinberger, JK; Krausmann, F; Getzner, M; Schandl, H; West, J				Steinberger, Julia K.; Krausmann, Fridolin; Getzner, Michael; Schandl, Heinz; West, Jim			Development and Dematerialization: An International Study	PLOS ONE			English	Article							ENVIRONMENTAL KUZNETS CURVE; CARBON-DIOXIDE EMISSIONS; RESOURCE USE; CONSUMPTION; POPULATION; TRADE; ECONOMY; GROWTH; ENERGY; FLOWS	Economic development and growth depend on growing levels of resource use, and result in environmental impacts from large scale resource extraction and emissions of waste. In this study, we examine the resource dependency of economic activities over the past several decades for a set of countries comprising developing, emerging and mature industrialized economies. Rather than a single universal industrial development pathway, we find a diversity of economic dependencies on material use, made evident through cluster analysis. We conduct tests for relative and absolute decoupling of the economy from material use, and compare these with similar tests for decoupling from carbon emissions, both for single countries and country groupings using panel analysis. We show that, over the longer term, emerging and developing countries tend to have significantly larger material-economic coupling than mature industrialized economies (although this effect may be enhanced by trade patterns), but that the contrary is true for short-term coupling. Moreover, we demonstrate that absolute dematerialization limits economic growth rates, while the successful industrialization of developing countries inevitably requires a strong material component. Alternative development priorities are thus urgently needed both for mature and emerging economies: reducing absolute consumption levels for the former, and avoiding the trap of resource-intensive economic and human development for the latter.	[Steinberger, Julia K.; Krausmann, Fridolin] Alpen Adria Univ Klagefurt Wien Graz, Inst Social Ecol, Vienna, Austria; [Steinberger, Julia K.] Univ Leeds, Sch Earth & Environm, Sustainabil Res Inst, Leeds, W Yorkshire, England; [Getzner, Michael] Vienna Univ Technol, Ctr Publ Finance & Infrastruct Policy, A-1040 Vienna, Austria; [Schandl, Heinz; West, Jim] Commonwealth Sci & Ind Res Org, Ecosyst Sci, Canberra, ACT, Australia	University of Leeds; Technische Universitat Wien; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Steinberger, JK (corresponding author), Alpen Adria Univ Klagefurt Wien Graz, Inst Social Ecol, Vienna, Austria.	julias@alum.mit.edu	Getzner, Michael/S-6765-2019; West, James/B-5487-2011; Steinberger, Julia K/B-3288-2011; Schandl, Heinz/C-5055-2008; Krausmann, Fridolin/N-1918-2015	West, James/0000-0002-1444-1080; Steinberger, Julia K/0000-0002-5925-9602; Schandl, Heinz/0000-0001-6399-4231; Krausmann, Fridolin/0000-0002-9995-2372; Getzner, Michael/0000-0003-1088-2652	GLOMETRA project [P-21012-G11]; Austrian Science Fund (FWF); United Nations Environment Program (UNEP) Bangkok office for Asia and the Pacific; ESRC [ES/K006576/1] Funding Source: UKRI; Austrian Science Fund (FWF) [P 21012] Funding Source: researchfish; Economic and Social Research Council [ES/K006576/1] Funding Source: researchfish	GLOMETRA project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); United Nations Environment Program (UNEP) Bangkok office for Asia and the Pacific; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported through the GLOMETRA project (P-21012-G11) funded by the Austrian Science Fund (FWF) and the United Nations Environment Program (UNEP) Bangkok office for Asia and the Pacific. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang BW, 2006, ENERG POLICY, V34, P2398, DOI 10.1016/j.enpol.2005.04.007; [Anonymous], 2013, ENOUGH IS ENOUGH; Ayres R. U., 2005, Structural Change and Economic Dynamics, V16, P181, DOI 10.1016/j.strueco.2003.10.003; Bringezu S, 2004, ECOL ECON, V51, P97, DOI 10.1016/j.ecolecon.2004.04.010; Bringezu S, 2009, SUSTAINABLE RESOURCE, P52; Bruckner M, 2012, GLOBAL ENVIRON CHANG, V22, P568, DOI 10.1016/j.gloenvcha.2012.03.011; Canas A, 2003, ECOL ECON, V46, P217, DOI 10.1016/S0921-8009(03)00123-X; CEC, 2005, COM2005670 CEC; Cleveland C.J., 1998, J IND ECOL, V2, P15, DOI [10.1162/jiec.1998.2.3.15, DOI 10.1162/JIEC.1998.2.3.15, DOI 10.1162/jiec.1998.2.3.15]; Davis SJ, 2011, P NATL ACAD SCI USA, V108, P18554, DOI 10.1073/pnas.1107409108; Dinda S, 2004, ECOL ECON, V49, P431, DOI 10.1016/j.ecolecon.2004.02.011; EEA, 2019, RES EFF EUR FLAGSH I; Eurostat, 2007, EC WID MAT FLOW ACC; Fischer-Kowalski M, 2011, J IND ECOL, V15, P855, DOI 10.1111/j.1530-9290.2011.00366.x; Fischer-Kowalski M, 2011, J IND ECOLOGY UNPUB, V8; FischerKowalski M, 2007, ADV ECOL ECON, P1; Getzner M, 2009, INT J ECOLOGICAL EC, V14, P3; Gierlinger S, 2012, J IND ECOL, V16, P365, DOI 10.1111/j.1530-9290.2011.00404.x; Jackson T., 2009, PROSPERITY GROWTH EC, DOI 10.4324/9781315677453; Jakob M, 2012, ENERG ECON, V34, P95, DOI 10.1016/j.eneco.2011.07.008; Jorgenson AK, 2010, POPUL ENVIRON, V32, P27, DOI 10.1007/s11111-010-0117-x; Kander A, 2005, ECOL ECON, V55, P119, DOI 10.1016/j.ecolecon.2004.10.008; Krausmann F, 2012, LONG TERM SOCIOECOLO; Krausmann F, 2008, ECOL ECON, V65, P471, DOI 10.1016/j.ecolecon.2007.07.012; Krausmann F, 2011, J IND ECOL, V15, P877, DOI 10.1111/j.1530-9290.2011.00376.x; Krausmann F, 2009, ECOL ECON, V68, P2696, DOI 10.1016/j.ecolecon.2009.05.007; MARLAND G, 2007, GLOBAL REGIONAL NATL; Mayer A, 2010, RESOURCE USE MAT FLO, P1; Muradian R, 2001, ECOL ECON, V36, P281, DOI 10.1016/S0921-8009(00)00229-9; Muradian R, 2012, GLOBAL ENV IN PRESS; OECD, 2008, MEAS MAT FLOWS RES P, V1; Peters GP, 2008, ENVIRON SCI TECHNOL, V42, P1401, DOI 10.1021/es072023k; Peters GP, 2011, P NATL ACAD SCI USA, V108, P8903, DOI 10.1073/pnas.1006388108; Preston SH, 2007, INT J EPIDEMIOL, V36, P484, DOI 10.1093/ije/dym075; Roberts JT, 2009, INT J COMP SOCIOL, V50, P385, DOI 10.1177/0020715209105147; Rosa EA, 2004, AMBIO, V33, P509, DOI 10.1639/0044-7447(2004)033[0509:TTADOE]2.0.CO;2; Rothman DS, 1998, ECOL ECON, V25, P177, DOI 10.1016/S0921-8009(97)00179-1; Schandl H, 2002, ECOL ECON, V41, P203, DOI 10.1016/S0921-8009(02)00031-9; Schandl H, 2010, GLOBAL ENVIRON CHANG, V20, P636, DOI 10.1016/j.gloenvcha.2010.06.003; Schandl H, 2008, J IND ECOL, V12, P669, DOI 10.1111/j.1530-9290.2008.00075.x; Seppala T, 2001, POPUL ENVIRON, V23, P217, DOI 10.1023/A:1012831804794; Shi AQ, 2003, ECOL ECON, V44, P29, DOI 10.1016/S0921-8009(02)00223-9; Singh SJ, 2012, ECOL ECON, V76, P60, DOI 10.1016/j.ecolecon.2012.01.022; Smith KR, 2005, ANNU REV ENV RESOUR, V30, P291, DOI 10.1146/annurev.energy.30.050504.144424; Steger S, 2011, J CLEAN PROD, V19, P816, DOI 10.1016/j.jclepro.2010.08.016; Steinberger JK, 2011, ENVIRON SCI TECHNOL, V45, P1169, DOI 10.1021/es1028537; Steinberger JK, 2010, ECOL ECON, V70, P425, DOI 10.1016/j.ecolecon.2010.09.014; Steinberger JK, 2010, ECOL ECON, V69, P1148, DOI 10.1016/j.ecolecon.2009.12.009; Stern DI, 2010, ECOL ECON, V69, P2173, DOI 10.1016/j.ecolecon.2010.06.024; Stern DI, 2004, WORLD DEV, V32, P1419, DOI 10.1016/j.worlddev.2004.03.004; Stiglitz J., 2010, MIS MEASURING OUR LI; Takiguchi H, 2008, J IND ECOL, V12, P792, DOI 10.1111/j.1530-9290.2008.00093.x; UNEP, 2011, RESOURCE EFFICIENCY; United Nations, 2011, NAT ACC MAIN AGGR DA; United Nations Environment Programme, 2011, GREEN EC PATHW SUST; Unruh GC, 2006, ENERG POLICY, V34, P1185, DOI 10.1016/j.enpol.2004.10.013; van der Voet E, 2005, POLICY REV DECOUPLIN; Wei TY, 2011, ECOL ECON, V72, P70, DOI 10.1016/j.ecolecon.2011.10.015; Weisz H, 2006, ECOL ECON, V58, P676, DOI 10.1016/j.ecolecon.2005.08.016; Wiedmann T, 2010, ECON SYST RES, V22, P19, DOI 10.1080/09535311003612591; York R, 2003, ECOL ECON, V46, P351, DOI 10.1016/S0921-8009(03)00188-5	61	100	100	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e70385	10.1371/journal.pone.0070385	http://dx.doi.org/10.1371/journal.pone.0070385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239NN	24204555	Green Published, gold, Green Accepted			2022-12-27	WOS:000326032600002
J	Detto, M; Muller-Landau, HC; Mascaro, J; Asner, GP				Detto, Matteo; Muller-Landau, Helene C.; Mascaro, Joseph; Asner, Gregory P.			Hydrological Networks and Associated Topographic Variation as Templates for the Spatial Organization of Tropical Forest Vegetation	PLOS ONE			English	Article							ABOVEGROUND BIOMASS; CARBON STOCKS; PATTERNS; DISTURBANCE; GRADIENTS; SOIL	An understanding of the spatial variability in tropical forest structure and biomass, and the mechanisms that underpin this variability, is critical for designing, interpreting, and upscaling field studies for regional carbon inventories. We investigated the spatial structure of tropical forest vegetation and its relationship to the hydrological network and associated topographic structure across spatial scales of 10-1000 m using high-resolution maps of LiDAR-derived mean canopy profile height (MCH) and elevation for 4930 ha of tropical forest in central Panama. MCH was strongly associated with the hydrological network: canopy height was highest in areas of positive convexity (valleys, depressions) close to channels draining 1 ha or more. Average MCH declined strongly with decreasing convexity (transition to ridges, hilltops) and increasing distance from the nearest channel. Spectral analysis, performed with wavelet decomposition, showed that the variance in MCH had fractal similarity at scales of similar to 30-600 m, and was strongly associated with variation in elevation, with peak correlations at scales of similar to 250 m. Whereas previous studies of topographic correlates of tropical forest structure conducted analyses at just one or a few spatial grains, our study found that correlations were strongly scale-dependent. Multi-scale analyses of correlations of MCH with slope, aspect, curvature, and Laplacian convexity found that MCH was most strongly related to convexity measured at scales of 20-300 m, a topographic variable that is a good proxy for position with respect to the hydrological network. Overall, our results support the idea that, even in these mesic forests, hydrological networks and associated topographical variation serve as templates upon which vegetation is organized over specific ranges of scales. These findings constitute an important step towards a mechanistic understanding of these patterns, and can guide upscaling and downscaling.	[Detto, Matteo; Muller-Landau, Helene C.] Smithsonian Trop Res Inst, Panama City, Panama; [Mascaro, Joseph; Asner, Gregory P.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA USA	Smithsonian Institution; Smithsonian Tropical Research Institute; Carnegie Institution for Science	Detto, M (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	dettom@si.edu	Asner, Gregory/G-9268-2013	Asner, Gregory/0000-0001-7893-6421; Muller-Landau, Helene C./0000-0002-3526-9021	Smithsonian Institution Global Earth Observatories; HSBC Climate Partnership; National Science Foundation [DEB 0614055]	Smithsonian Institution Global Earth Observatories; HSBC Climate Partnership; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Smithsonian Institution Global Earth Observatories and the HSBC Climate Partnership. The Carnegie Airborne Observatory is made possible by the Gordon and Betty Moore Foundation, the John D. and Catherine T. MacArthur Foundation, Avatar Alliance Foundation, W. M. Keck Foundation, the Margaret A. Cargill Foundation, Grantham Foundation for the Protection of the Environment, Mary Anne Nyburg Baker and G. Leonard Baker Jr., and William R. Hearst III. This material is based upon work supported by the National Science Foundation under Grant Number DEB 0614055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LF, 2010, FOREST ECOL MANAG, V260, P679, DOI 10.1016/j.foreco.2010.05.023; ASHTON PS, 1992, J ECOL, V80, P459, DOI 10.2307/2260691; Asner GP, 2012, BIOGEOSCIENCES, V9, P2683, DOI 10.5194/bg-9-2683-2012; Asner GP, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2794018; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Asner GP, 2009, ECOSYSTEMS, V12, P261, DOI 10.1007/s10021-008-9221-5; BECKER P, 1988, J TROP ECOL, V4, P173, DOI 10.1017/S0266467400002674; Bhatt MP, 2007, WATER RESOUR RES, V43, P1; Caylor KK, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020260; Chave J, 2003, J ECOL, V91, P240, DOI 10.1046/j.1365-2745.2003.00757.x; Chazdon RL, 2007, PHILOS T R SOC B, V362, P273, DOI 10.1098/rstb.2006.1990; Clark D, 2000, FOREST ECOLOGY MANAG, V137; Dahlin KM, 2012, ECOL APPL, V22, P104, DOI 10.1890/11-1401.1; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; de Toledo JJ, 2012, FOREST ECOL MANAG, V263, P253, DOI 10.1016/j.foreco.2011.09.017; Englund G, 2008, ECOL LETT, V11, P440, DOI 10.1111/j.1461-0248.2008.01159.x; Ferry B, 2010, J ECOL, V98, P106, DOI 10.1111/j.1365-2745.2009.01604.x; Gagnon JS, 2006, NONLINEAR PROC GEOPH, V13, P541, DOI 10.5194/npg-13-541-2006; Gale N, 2001, J VEGETATION SCI; Gibbon A, 2010, ECOSYSTEMS, V13, P1097, DOI 10.1007/s10021-010-9376-8; Hall CAS, 1995, J BIOGEOGR, V22, P753, DOI 10.2307/2845977; Heneghan C, 1996, PROCEEDINGS OF THE IEEE SOUTHWEST SYMPOSIUM ON IMAGE ANALYSIS AND INTERPRETATION, P213, DOI 10.1109/IAI.1996.493755; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; JENSON SK, 1988, PHOTOGRAMM ENG REM S, V54, P1593; Kellner JR, 2009, ECOL LETT, V12, P887, DOI 10.1111/j.1461-0248.2009.01345.x; KERSHAW KA, 1963, ECOLOGY, V44, P377, DOI 10.2307/1932185; KUMAR P, 1995, GEOPHYS RES LETT, V22, P2777, DOI 10.1029/95GL02934; Larsen MC, 1998, GEOMORPHOLOGY, V24, P309, DOI 10.1016/S0169-555X(98)00023-3; Lashermes B, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031140; Laumonier Y, 2010, FOREST ECOL MANAG, V259, P505, DOI 10.1016/j.foreco.2009.11.007; Laurance WF, 1999, FOREST ECOL MANAG, V118, P127, DOI 10.1016/S0378-1127(98)00494-0; Lefsky MA, 2002, GLOBAL ECOL BIOGEOGR, V11, P393, DOI 10.1046/j.1466-822x.2002.00303.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Li BL, 2000, ECOL MODEL, V132, P33, DOI 10.1016/S0304-3800(00)00303-3; LUGO AE, 1993, J BIOSCIENCE, V18, P475, DOI 10.1007/BF02703080; Luizao RCC, 2004, GLOBAL CHANGE BIOL, V10, P592, DOI 10.1111/j.1529-8817.2003.00757.x; MARDIA KV, 1976, BIOMETRIKA, V63, P403, DOI 10.2307/2335637; Marshall AR, 2012, BIOL CONSERV, V154, P20, DOI 10.1016/j.biocon.2012.03.017; Mascaro J, 2011, BIOGEOSCIENCES, V8, P1615, DOI 10.5194/bg-8-1615-2011; Mascaro J, 2011, REMOTE SENS ENVIRON, V115, P3770, DOI 10.1016/j.rse.2011.07.019; MITASOVA H, 1993, MATH GEOL, V25, P657, DOI 10.1007/BF00893172; MOORE ID, 1991, HYDROL PROCESS, V5, P3, DOI 10.1002/hyp.3360050103; Naiman RJ, 1998, RIPARIAN FORESTS RIV, P713; OCALLAGHAN JF, 1984, COMPUT VISION GRAPH, V28, P323, DOI [10.1016/S0734-189X(84)80011-0, 10.1016/0734-189X(89)90053-4]; RASTETTER EB, 1992, ECOL APPL, V2, P55, DOI 10.2307/1941889; Rinaldo A., 1997, FRACTAL RIVER BASINS, P547; Rodriguez-Iturbe I., 2009, Water Resources Research, V45, pW01413, DOI 10.1029/2008WR007124; SCATENA FN, 1995, GEOMORPHOLOGY, V13, P199, DOI 10.1016/0169-555X(95)00021-V; Schumm S.A., 1977, FLUVIAL SYSTEM, P338; SILVER WL, 1994, PLANT SOIL, V164, P129, DOI 10.1007/BF00010118; Sole R.V., 2006, SELF ORG COMPLEX ECO, DOI [10.1515/9781400842933, DOI 10.1515/9781400842933]; Stoy PC, 2009, LANDSCAPE ECOL, V24, P971, DOI 10.1007/s10980-009-9367-3; Takyu M, 2003, OECOLOGIA, V134, P397, DOI 10.1007/s00442-002-1115-1; Valencia R, 2009, J TROP ECOL, V25, P473, DOI 10.1017/S0266467409990095; Venema V, 2006, TELLUS A, V58, P104, DOI 10.1111/j.1600-0870.2006.00160.x; Vitousek P, 2003, ECOSYSTEMS, V6, P762, DOI 10.1007/s10021-003-0199-8; Weishampel JF, 2000, INT J REMOTE SENS, V21, P409, DOI 10.1080/014311600210939	58	49	49	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76296	10.1371/journal.pone.0076296	http://dx.doi.org/10.1371/journal.pone.0076296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204610	gold, Green Submitted, Green Published			2022-12-27	WOS:000326029300018
J	Dorelien, AM; Ballesteros, S; Grenfell, BT				Dorelien, Audrey M.; Ballesteros, Sebastien; Grenfell, Bryan T.			Impact of Birth Seasonality on Dynamics of Acute Immunizing Infections in Sub-Saharan Africa	PLOS ONE			English	Article							MEASLES; RATES; TRANSMISSION; VACCINATION	We analyze the impact of birth seasonality (seasonal oscillations in the birth rate) on the dynamics of acute, immunizing childhood infectious diseases. Previous research has explored the effect of human birth seasonality on infectious disease dynamics using parameters appropriate for the developed world. We build on this work by including in our analysis an extended range of baseline birth rates and amplitudes, which correspond to developing world settings. Additionally, our analysis accounts for seasonal forcing both in births and contact rates. We focus in particular on the dynamics of measles. In the absence of seasonal transmission rates or stochastic forcing, for typical measles epidemiological parameters, birth seasonality induces either annual or biennial epidemics. Changes in the magnitude of the birth fluctuations (birth amplitude) can induce significant changes in the size of the epidemic peaks, but have little impact on timing of disease epidemics within the year. In contrast, changes to the birth seasonality phase (location of the peak in birth amplitude within the year) significantly influence the timing of the epidemics. In the presence of seasonality in contact rates, at relatively low birth rates (20 per 1000), birth amplitude has little impact on the dynamics but does have an impact on the magnitude and timing of the epidemics. However, as the mean birth rate increases, both birth amplitude and phase play an important role in driving the dynamics of the epidemic. There are stronger effects at higher birth rates.	[Dorelien, Audrey M.] Univ Michigan, Ctr Social Epidemiol & Populat Hlth, Ann Arbor, MI 48109 USA; [Ballesteros, Sebastien; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Dorelien, AM (corresponding author), Univ Michigan, Ctr Social Epidemiol & Populat Hlth, Ann Arbor, MI 48109 USA.	dorelien@umich.edu		Dorelien, Audrey/0000-0002-0618-4782	National Institute for Child Health and Human Development [R24HD047879]; National Science Foundation [EF-0742373]; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Department of Homeland Security Science and Technology Directorate; Fogarty International Center, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER	National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Science Foundation(National Science Foundation (NSF)); Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Department of Homeland Security Science and Technology Directorate; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Audrey M. Dorelien was supported by the National Institute for Child Health and Human Development, Grant No. R24HD047879, to the Office of Population Research at Princeton University. Bryan Grenfell was supported by the National Science Foundation grant EF-0742373 and the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Department of Homeland Security Science and Technology Directorate and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON R M, 1991; BAILEY RC, 1992, J BIOSOC SCI, V24, P393, DOI 10.1017/S0021932000019957; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; Bauch CT, 2003, P ROY SOC B-BIOL SCI, V270, P1573, DOI 10.1098/rspb.2003.2410; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; BOLKER BM, 1993, P ROY SOC B-BIOL SCI, V251, P75, DOI 10.1098/rspb.1993.0011; Cancho-Candela R, 2007, J EPIDEMIOL COMMUN H, V61, P713, DOI 10.1136/jech.2006.050211; COWGILL UM, 1966, MAN, V1, P232, DOI 10.2307/2796349; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Ferrari MJ, 2010, P ROY SOC B-BIOL SCI, V277, P2775, DOI 10.1098/rspb.2010.0536; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; GUYER B, 1981, INT J EPIDEMIOL, V10, P263, DOI 10.1093/ije/10.3.263; He DH, 2007, THEOR POPUL BIOL, V72, P274, DOI 10.1016/j.tpb.2007.04.004; Hethcote H., 1984, LECT NOTES BIOMATHEM; ICF Macro, 2010, DEM HLTH SURV BIRTH; Ireland JM, 2004, J THEOR BIOL, V231, P229, DOI 10.1016/j.jtbi.2004.06.017; Kaler SG, 2008, ANN NY ACAD SCI, V1136, P28, DOI 10.1196/annals.1425.035; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Lam DA, 1996, DEMOGRAPHY, V33, P291, DOI 10.2307/2061762; Manfredini M, 2009, HUM ECOL, V37, P227, DOI 10.1007/s10745-009-9221-x; Metcalf CJE, 2009, P ROY SOC B-BIOL SCI, V276, P4111, DOI 10.1098/rspb.2009.1058; Pascual M, 2002, MICROBES INFECT, V4, P237, DOI 10.1016/S1286-4579(01)01533-7; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; YORKE JA, 1973, AM J EPIDEMIOL, V98, P469, DOI 10.1093/oxfordjournals.aje.a121576	32	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e75806	10.1371/journal.pone.0075806	http://dx.doi.org/10.1371/journal.pone.0075806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204580	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300004
J	Soltesz, F; Szucs, D; Leong, V; White, S; Goswami, U				Soltesz, Fruzsina; Szucs, Denes; Leong, Victoria; White, Sonia; Goswami, Usha			Differential Entrainment of Neuroelectric Delta Oscillations in Developmental Dyslexia	PLOS ONE			English	Article							CONTINGENT NEGATIVE-VARIATION; NEURONAL OSCILLATIONS; SPEECH-PERCEPTION; LANGUAGE-ACQUISITION; NEURAL RESPONSES; PHASE-LOCKING; CHILDREN; RHYTHMS; ADULTS; ATTENTION	Oscillatory entrainment to the speech signal is important for language processing, but has not yet been studied in developmental disorders of language. Developmental dyslexia, a difficulty in acquiring efficient reading skills linked to difficulties with phonology (the sound structure of language), has been associated with behavioural entrainment deficits. It has been proposed that the phonological 'deficit' that characterises dyslexia across languages is related to impaired auditory entrainment to speech at lower frequencies via neuroelectric oscillations (<10 Hz, 'temporal sampling theory'). Impaired entrainment to temporal modulations at lower frequencies would affect the recovery of the prosodic and syllabic structure of speech. Here we investigated event-related oscillatory EEG activity and contingent negative variation (CNV) to auditory rhythmic tone streams delivered at frequencies within the delta band (2 Hz, 1.5 Hz), relevant to sampling stressed syllables in speech. Given prior behavioural entrainment findings at these rates, we predicted functionally atypical entrainment of delta oscillations in dyslexia. Participants performed a rhythmic expectancy task, detecting occasional white noise targets interspersed with tones occurring regularly at rates of 2 Hz or 1.5 Hz. Both groups showed significant entrainment of delta oscillations to the rhythmic stimulus stream, however the strength of inter-trial delta phase coherence (ITC, 'phase locking') and the CNV were both significantly weaker in dyslexics, suggestive of weaker entrainment and less preparatory brain activity. Both ITC strength and CNV amplitude were significantly related to individual differences in language processing and reading. Additionally, the instantaneous phase of prestimulus delta oscillation predicted behavioural responding (response time) for control participants only.	[Soltesz, Fruzsina; Szucs, Denes; Leong, Victoria; White, Sonia; Goswami, Usha] Univ Cambridge, Ctr Neurosci Educ, Cambridge, England	University of Cambridge	Goswami, U (corresponding author), Univ Cambridge, Ctr Neurosci Educ, Cambridge, England.	ucg10@cam.ac.uk	Leong, Victoria/G-5778-2013	Leong, Victoria/0000-0003-0666-9445; White, Sonia/0000-0001-5828-5852; Szucs, Denes/0000-0002-9477-0801; Goswami, Usha/0000-0001-7858-2336	ANALOGY project (NEST program) [29088]; EC	ANALOGY project (NEST program); EC(European CommissionEuropean Commission Joint Research Centre)	This research was financially supported by the ANALOGY project (NEST program, contract 29088) funded by the EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DA, 2009, J NEUROSCI, V29, P7686, DOI 10.1523/JNEUROSCI.5242-08.2009; Arnal LH, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00225; Arvaniti A, 2009, PHONETICA, V66, P46, DOI 10.1159/000208930; Benjamini Y, 2001, ANN STAT, V29, P1165; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bhide A, 2013, MIND BRAIN EDUC, V7, P113, DOI 10.1111/mbe.12016; BORDA RP, 1970, ELECTROEN CLIN NEURO, V29, P173, DOI 10.1016/0013-4694(70)90120-3; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chapin HL, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00224; Facoetti A, 2010, J COGNITIVE NEUROSCI, V22, P1011, DOI 10.1162/jocn.2009.21232; Fisher NI, 1995, STAT ANAL CIRCULAR D; Frederickson N., 1997, PHONOLOGICAL ASSESSM; Fujioka T, 2012, ANN NY ACAD SCI, V1169, P89; Funderud I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048504; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Ghitza O, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00130; Ghitza O, 2009, PHONETICA, V66, P113, DOI 10.1159/000208934; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Golumbic EMZ, 2012, BRAIN LANG, V122, P151, DOI 10.1016/j.bandl.2011.12.010; Gomez CM, 2001, BRAIN TOPOGR, V13, P149, DOI 10.1023/A:1007816201345; Gomez-Ramirez M, 2011, J NEUROSCI, V31, P18556, DOI 10.1523/JNEUROSCI.2164-11.2011; Goswami U, 2013, LAB PHONOL, V4, P67, DOI 10.1515/lp-2013-0004; Goswami U, 2013, CORTEX, V49, P1363, DOI 10.1016/j.cortex.2012.05.005; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Goswami U, 2010, READ WRIT, V23, P995, DOI 10.1007/s11145-009-9186-6; Hamalainen JA, 2013, J LEARN DISABIL-US, V46, P413, DOI 10.1177/0022219411436213; Hamalainen JA, 2012, NEUROIMAGE, V59, P2952, DOI 10.1016/j.neuroimage.2011.09.075; Hurtado JM, 2004, J NEUROPHYSIOL, V91, P1883, DOI 10.1152/jn.00853.2003; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; Jusczyk PW, 1999, COGNITIVE PSYCHOL, V39, P159, DOI 10.1006/cogp.1999.0716; KELSO JAS, 1986, J PHONETICS, V14, P29, DOI 10.1016/S0095-4470(19)30608-4; Kerlin JR, 2010, J NEUROSCI, V30, P620, DOI 10.1523/JNEUROSCI.3631-09.2010; Kitzen K. R., 2001, DISS ABSTR INT A, V62, P460; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Lalor EC, 2010, EUR J NEUROSCI, V31, P189, DOI 10.1111/j.1460-9568.2009.07055.x; Lehongre K, 2011, NEURON, V72, P1080, DOI 10.1016/j.neuron.2011.11.002; Leong V, 2012, THESIS U CAMBRIDGE; Leong V, 2011, J MEM LANG, V64, P59, DOI 10.1016/j.jml.2010.09.003; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Luo H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000445; Mazaheri A, 2008, J NEUROSCI, V28, P7781, DOI 10.1523/JNEUROSCI.1631-08.2008; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Power AJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00216; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Serniclaes WI, 2004, J EXP CHILD PSYCHOL, V87, P336, DOI 10.1016/j.jecp.2004.02.001; Smith AB, 2008, J SPEECH LANG HEAR R, V51, P1300, DOI 10.1044/1092-4388(2008/06-0193); Snowling M., 2000, DYSLEXIA; Snyder JS, 2005, COGNITIVE BRAIN RES, V24, P117, DOI 10.1016/j.cogbrainres.2004.12.014; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; Tallal P, 2004, NAT REV NEUROSCI, V5, P721, DOI 10.1038/nrn1499; Telkemeyer S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00062; Thomson JM, 2008, J PHYSIOL-PARIS, V102, P120, DOI 10.1016/j.jphysparis.2008.03.007; Thomson JM, 2006, J RES READ, V29, P334, DOI 10.1111/j.1467-9817.2006.00312.x; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Wimmer H, 1996, J EXP CHILD PSYCHOL, V61, P80, DOI 10.1006/jecp.1996.0004; Wood C, 1998, BRIT J DEV PSYCHOL, V16, P397, DOI 10.1111/j.2044-835X.1998.tb00760.x; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	67	35	35	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76608	10.1371/journal.pone.0076608	http://dx.doi.org/10.1371/journal.pone.0076608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239MM	24204644	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000326029300039
J	Boutellis, A; Drali, R; Rivera, MA; Mumcuoglu, KY; Raoult, D				Boutellis, Amina; Drali, Rezak; Rivera, Mario A.; Mumcuoglu, Kosta Y.; Raoult, Didier			Evidence of Sympatry of Clade A and Clade B Head Lice in a Pre-Columbian Chilean Mummy from Camarones	PLOS ONE			English	Article							BARTONELLA-QUINTANA; INFESTATION; CAPITIS	Three different lineages of head lice are known to parasitize humans. Clade A, which is currently worldwide in distribution, was previously demonstrated to be present in the Americas before the time of Columbus. The two other types of head lice are geographically restricted to America and Australia for clade B and to Africa and Asia for clade C. In this study, we tested two operculated nits from a 4,000-year-old Chilean mummy of Camarones for the presence of the partial Cytb mitochondrial gene (270 bp). Our finding shows that clade B head lice were present in America before the arrival of the European colonists.	[Boutellis, Amina; Drali, Rezak; Raoult, Didier] Aix Marseille Univ, UMR CNRS 7278, URMITE, INSERM Fac Med 1095,IRD 198, Marseille, France; [Rivera, Mario A.] Univ Magallanes Mineduc, Programa Identidad Fin Mundo, Punta Arenas, Chile; [Mumcuoglu, Kosta Y.] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Hebrew University of Jerusalem	Raoult, D (corresponding author), Aix Marseille Univ, UMR CNRS 7278, URMITE, INSERM Fac Med 1095,IRD 198, 27 Bd Jean Moulin, Marseille, France.	didier.raoult@gmail.com	Drali, Rezak/AAR-3040-2020; Drali, Rezak/AAZ-9532-2020; RAOULT, Didier/A-8434-2008; Mumcuoglu, Kosta/AAY-2122-2020	RAOULT, Didier/0000-0002-0633-5974; Mumcuoglu, Kosta/0000-0001-8125-6099				Angelakis E, 2011, EMERG INFECT DIS, V17, P2357, DOI 10.3201/eid1712.110453; Araujo A, 2000, PARASITOL TODAY, V16, P269, DOI 10.1016/S0169-4758(00)01694-X; Arriaza B, 2012, J PARASITOL, V98, P433, DOI 10.1645/GE-2903.1; Boutellis A, 2013, AM J TROP MED HYG, V88, P1180, DOI 10.4269/ajtmh.12-0766; Boutellis A, 2012, VECTOR-BORNE ZOONOT, V12, P564, DOI 10.1089/vbz.2011.0845; Fornaciari G, 2009, MEM I OSWALDO CRUZ, V104, P671, DOI 10.1590/S0074-02762009000400026; Li WJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000641; Light JE, 2008, J PARASITOL, V94, P1275, DOI 10.1645/GE-1618.1; Mumcuoglu Kosta Y., 2008, P215, DOI 10.1007/978-3-540-75855-6_13; Raoult D, 2008, J INFECT DIS, V197, P535, DOI 10.1086/526520; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Rick FM, 2002, J PARASITOL, V88, P1266, DOI 10.1645/0022-3395(2002)088[1266:CLIIPC]2.0.CO;2; Rivera MA, 2008, CHUNGARA, V40, P31, DOI 10.4067/S0717-73562008000100004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	14	21	21	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e76818	10.1371/journal.pone.0076818	http://dx.doi.org/10.1371/journal.pone.0076818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204678	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500011
J	Clauss, M; Steuer, P; Muller, DWH; Codron, D; Hummel, J				Clauss, Marcus; Steuer, Patrick; Mueller, Dennis W. H.; Codron, Daryl; Hummel, Juergen			Herbivory and Body Size: Allometries of Diet Quality and Gastrointestinal Physiology, and Implications for Herbivore Ecology and Dinosaur Gigantism	PLOS ONE			English	Review							RABBITS ORYCTOLAGUS-CUNICULUS; PIGS CAVIA-PORCELLUS; HAY-ONLY DIET; MAMMALIAN HERBIVORES; SAUROPOD DINOSAURS; FOOD-INTAKE; FEEDING ECOLOGY; DIGESTIVE PHYSIOLOGY; RUMEN FERMENTATION; METHANE PRODUCTION	Digestive physiology has played a prominent role in explanations for terrestrial herbivore body size evolution and size-driven diversification and niche differentiation. This is based on the association of increasing body mass (BM) with diets of lower quality, and with putative mechanisms by which a higher BM could translate into a higher digestive efficiency. Such concepts, however, often do not match empirical data. Here, we review concepts and data on terrestrial herbivore BM, diet quality, digestive physiology and metabolism, and in doing so give examples for problems in using allometric analyses and extrapolations. A digestive advantage of larger BM is not corroborated by conceptual or empirical approaches. We suggest that explanatory models should shift from physiological to ecological scenarios based on the association of forage quality and biomass availability, and the association between BM and feeding selectivity. These associations mostly (but not exclusively) allow large herbivores to use low quality forage only, whereas they allow small herbivores the use of any forage they can physically manage. Examples of small herbivores able to subsist on lower quality diets are rare but exist. We speculate that this could be explained by evolutionary adaptations to the ecological opportunity of selective feeding in smaller animals, rather than by a physiologic or metabolic necessity linked to BM. For gigantic herbivores such as sauropod dinosaurs, other factors than digestive physiology appear more promising candidates to explain evolutionary drives towards extreme BM.	[Clauss, Marcus; Codron, Daryl] Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, Zurich, Switzerland; [Steuer, Patrick; Hummel, Juergen] Univ Bonn, Inst Anim Sci, Bonn, Germany; [Mueller, Dennis W. H.] Natl Pk Bavarian Forest, Grafenau, Germany; [Codron, Daryl] Florisbad Quaternary Res, Natl Museum, Bloemfontein, South Africa; [Hummel, Juergen] Univ Gottingen, Dept Anim Sci, D-37073 Gottingen, Germany	University of Zurich; University of Bonn; University of Gottingen	Clauss, M (corresponding author), Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, Zurich, Switzerland.	mclauss@vetclinics.uzh.ch	Clauss, Marcus/GRR-7996-2022; Clauss, Marcus/A-4710-2008; Codron, Daryl/B-8867-2008; Clauss, Marcus/M-8702-2019	Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Codron, Daryl/0000-0001-5223-9513; Clauss, Marcus/0000-0003-3841-6207; Hummel, Jurgen/0000-0002-8876-7745	German Science Foundation (DFG) [CL 182/3-1, CL 182/3-2, CL 182/5-1, CL 182/6-1, HU 1308/2-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was funded by the German Science Foundation (DFG, CL 182/3-1,3-2,5-1,6-1; HU 1308/2-1). It is publication no. 147 of the DFG Research Unit FOR 533 "The Biology of the Sauropod Dinosaurs: The Evolution of Gigantism''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault R, 2008, OIKOS, V117, P1711, DOI 10.1111/j.1600-0706.2008.16575.x; Ashworth US., 1934, U MO AGR EXP STA RES, V220, P1; Bakker RT., 1986, DINOSAUR HERESIES; Barboza PS, 2006, PHYSIOL BIOCHEM ZOOL, V79, P250, DOI 10.1086/499984; BARNES RFW, 1982, AFR J ECOL, V20, P123, DOI 10.1111/j.1365-2028.1982.tb00282.x; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Bhola N, 2012, BIODIVERS CONSERV, V21, P1509, DOI 10.1007/s10531-012-0261-y; Bourliere F., 1975, SMALL MAMMALS THEIR, P1; Butler RJ, 2009, J EVOLUTION BIOL, V22, P446, DOI 10.1111/j.1420-9101.2008.01680.x; Calvo Jorge O., 1994, Gaia, V10, P183; Capellini I, 2010, ECOLOGY, V91, P2783, DOI 10.1890/09-0817.1; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Christian A, 2011, UNDERSTANDING LIFE G, P251; Christiansen Per, 1999, Historical Biology, V13, P269; Christiansen Per, 2000, Historical Biology, V14, P137; Clauss M, 2005, MAMMAL REV, V35, P174, DOI 10.1111/j.1365-2907.2005.00062.x; Clauss M, 2013, MAMMALIAN B IN PRESS, DOI [10.1016/j.mambio.2013.01.002., DOI 10.1016/J.MAMBI0.2013.01.002]; Clauss M, 2011, UNDERSTANDING LIFE G, P3; Clauss M, 2007, COMP BIOCHEM PHYS A, V148, P249, DOI 10.1016/j.cbpa.2007.05.024; Clauss M, 2007, OIKOS, V116, P209, DOI [10.1111/j.2006.0030-1299.15461.x, 10.1111/j.0030-1299.2007.15461.x]; Clauss M, 2009, COMP BIOCHEM PHYS A, V154, P376, DOI 10.1016/j.cbpa.2009.07.016; CLEMENS ET, 1983, COMP BIOCHEM PHYS A, V76, P319, DOI 10.1016/0300-9629(83)90333-X; Codron D, 2007, J ANIM ECOL, V76, P526, DOI 10.1111/j.1365-2656.2007.01222.x; Cork S.J., 1991, P133; Cromsigt JPGM, 2006, ECOLOGY, V87, P1532, DOI 10.1890/0012-9658(2006)87[1532:RPASGM]2.0.CO;2; Cromsigt JPGM, 2009, DIVERS DISTRIB, V15, P513, DOI 10.1111/j.1472-4642.2008.00554.x; DEMMENT MW, 1983, AFR J ECOL, V21, P219, DOI 10.1111/j.1365-2028.1983.tb00323.x; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; DUNCAN P, 1990, OECOLOGIA, V84, P411, DOI 10.1007/BF00329768; DUTOIT JT, 1989, AM NAT, V133, P736, DOI 10.1086/284949; Erickson GM, 2012, SCIENCE, V338, P98, DOI 10.1126/science.1224495; Espinoza RE, 2004, P NATL ACAD SCI USA, V101, P16819, DOI 10.1073/pnas.0401226101; Farlow JO, 2010, HIST BIOL, V22, P403, DOI 10.1080/08912961003787598; FARLOW JO, 1987, PALEOBIOLOGY, V13, P60; FARLOW JO, 1976, ECOLOGY, V57, P841, DOI 10.2307/1941052; FIELD C R, 1970, Zoologica Africana, V5, P71; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; FOLEY WJ, 1992, TRENDS ECOL EVOL, V7, P159, DOI 10.1016/0169-5347(92)90210-3; Foose T.J., 1982, TROPHIC STRATEGIES R; Fortelius M., 2008, ZOOLOGICAL J LINNEAN, V108, P85, DOI [DOI 10.1111/J.1096-3642.1993.TB02560.X, 10.1111/j.1096-3642.1993.tb02560.x.]; Franz R, 2011, J ANIM PHYSIOL AN N, V95, P564, DOI 10.1111/j.1439-0396.2010.01084.x; Franz R, 2010, EVOL ECOL RES, V12, P727; Franz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017628; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P94, DOI 10.1016/j.cbpa.2010.09.007; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P177, DOI 10.1016/j.cbpa.2010.10.019; Franz R, 2009, P ROY SOC B-BIOL SCI, V276, P1731, DOI 10.1098/rspb.2008.1735; Freeland W.J., 1991, P61; Fritz J, 2012, COMP BIOCHEM PHYS A, V163, P56, DOI 10.1016/j.cbpa.2012.05.184; Fritz J, 2011, PALEOBIOLOGY, V37, P577, DOI 10.1666/10031.1; Fritz J, 2010, J EXP ZOOL PART A, V313A, P579, DOI 10.1002/jez.629; Fritz J, 2009, OIKOS, V118, P1623, DOI 10.1111/j.1600-0706.2009.17807.x; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P324; FURSTENBURG D, 1994, COMP BIOCHEM PHYS A, V107, P425, DOI 10.1016/0300-9629(94)90402-2; Galton P.M., 1986, P203; Gee CT, 2011, UNDERSTANDING LIFE G, P34; GEIST V, 1974, AM ZOOL, V14, P205, DOI 10.1093/icb/14.1.205; Gordon IJ, 1988, FUNCT ECOL, V2, P15, DOI 10.2307/2389455; GORDON IJ, 1994, OECOLOGIA, V98, P167, DOI 10.1007/BF00341469; Guthrie R.D., 1984, P259; Hackmann TJ, 2010, J DAIRY SCI, V93, P1320, DOI 10.3168/jds.2009-2071; HALL-MARTIN A J, 1974, Journal of the Southern African Wildlife Management Association, V4, P191; Hiiemae Karen M., 2000, P411, DOI 10.1016/B978-012632590-4/50014-9; HILLMAN JC, 1987, MAMMALIA, V51, P53, DOI 10.1515/mamm.1987.51.1.53; Hofmann R R, 1973, Bull Epizoot Dis Afr, V21, P385; HOLLEMAN DF, 1989, CAN J ZOOL, V67, P488, DOI 10.1139/z89-071; Hopcraft JGC, 2012, J ANIM ECOL, V81, P201, DOI 10.1111/j.1365-2656.2011.01885.x; Hoppe P.P., 1977, 13TH P INT C GAM BIO, P141; HOPPE PP, 1977, J ZOOL, V181, P1, DOI 10.1111/j.1469-7998.1977.tb04566.x; HOPPE PP, 1983, COMP BIOCHEM PHYS A, V75, P517, DOI 10.1016/0300-9629(83)90414-0; HOPPE PP, 1977, J AGR SCI, V89, P129, DOI 10.1017/S0021859600027283; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Hummel J, 2006, FUNCT ECOL, V20, P989, DOI 10.1111/j.1365-2435.2006.01206.x; Hummel J, 2011, UNDERSTANDING LIFE G, P11; Hummel J, 2008, P ROY SOC B-BIOL SCI, V275, P1015, DOI 10.1098/rspb.2007.1728; Illius A.W., 1999, P71; IRBY LR, 1977, E AFR WILDL J, V15, P289; IRWIN LL, 1993, J WILDLIFE MANAGE, V57, P413, DOI 10.2307/3809442; Jarman P.J., 1979, SERENGETI DYNAMICS E, P130, DOI DOI 10.1086/284321; Jhala YV, 1997, J APPL ECOL, V34, P1348, DOI 10.2307/2405252; JUSTICE KE, 1992, AM NAT, V139, P398, DOI 10.1086/285333; KARASOV WH, 1986, J COMP PHYSIOL B, V156, P599, DOI 10.1007/BF00691047; Karasov William, 2012, P212; Klaassen M, 2008, ECOL LETT, V11, P785, DOI 10.1111/j.1461-0248.2008.01180.x; Kleynhans EJ, 2011, OIKOS, V120, P591, DOI 10.1111/j.1600-0706.2010.18712.x; LINDSTEDT SL, 1985, AM NAT, V125, P873, DOI 10.1086/284385; LOEB SC, 1989, CAN J ZOOL, V67, P96, DOI 10.1139/z89-015; Lukas M, 2005, J ANIM SCI, V83, P1332; Marsh KJ, 2006, ECOLOGY, V87, P2103, DOI 10.1890/0012-9658(2006)87[2103:CDODPI]2.0.CO;2; McNab BK, 1999, PHYSIOL BIOCHEM ZOOL, V72, P642, DOI 10.1086/316701; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Mesochina P, 1998, GRASS FORAGE SCI, V53, P189, DOI 10.1046/j.1365-2494.1998.5320189.x; Meyer K, 2010, MAMMAL REV, V40, P221, DOI 10.1111/j.1365-2907.2010.00161.x; Midgley JJ, 2005, NEW PHYTOL, V168, P271, DOI 10.1111/j.1469-8137.2005.01564.x; Midgley JJ, 2002, EVOL ECOL RES, V4, P1093; MILLAR JS, 1990, FUNCT ECOL, V4, P5, DOI 10.2307/2389646; MORRIS JG, 1986, ARCH TIERERNAHR, V36, P234, DOI 10.1080/17450398609425268; Muller DWH, 2013, COMP BIOCHEM PHYS A, V164, P129, DOI 10.1016/j.cbpa.2012.09.018; Muller DWH, 2012, OIKOS, V121, P102, DOI 10.1111/j.1600-0706.2011.19505.x; Muller DWH, 2011, COMP BIOCHEM PHYS A, V160, P207, DOI 10.1016/j.cbpa.2011.06.004; Olff H, 2002, NATURE, V415, P901, DOI 10.1038/415901a; Olivier R. C. D., 1974, AFRICAN J ECOLOGY, V12, P249; Osborn RG, 2001, WILDLIFE SOC B, V29, P1131; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; Owen-Smith N, 2012, J MAMMAL, V93, P698, DOI 10.1644/11-MAMM-A-350.1; OWENSMITH N, 1982, AM NAT, V119, P151, DOI 10.1086/283902; Perez-Barberia FJ, 2004, P ROY SOC B-BIOL SCI, V271, P1081, DOI 10.1098/rspb.2004.2714; Potvin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044854; Robbins C. T., 1993, WILDLIFE FEEDING NUT; ROBBINS CT, 1987, ECOLOGY, V68, P98, DOI 10.2307/1938809; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schwarm A, 2006, J ANIM PHYSIOL AN N, V90, P300, DOI 10.1111/j.1439-0396.2005.00599.x; Schwarm A, 2009, J ANIM PHYSIOL AN N, V93, P596, DOI 10.1111/j.1439-0396.2008.00842.x; Schwarm A, 2009, COMP BIOCHEM PHYS A, V152, P504, DOI 10.1016/j.cbpa.2008.12.006; SCOTCHER JSB, 1978, S AFR J WILDL RES, V8, P1; Sensenig RL, 2010, ECOLOGY, V91, P2898, DOI 10.1890/09-1673.1; Shrader AM, 2006, FUNCT ECOL, V20, P376, DOI 10.1111/j.1365-2435.2006.01107.x; Sibly R. M., 2012, METABOLIC ECOLOGY SC; SMITH AP, 1987, PHYSIOL ZOOL, V60, P82, DOI 10.1086/physzool.60.1.30158630; Sorensen JS, 2004, INT CONGR SER, V1275, P313, DOI 10.1016/j.ics.2004.08.070; Sorensen JS, 2003, OECOLOGIA, V134, P88, DOI 10.1007/s00442-002-1085-3; Steuer P, LARGE HERBIVORE BODY; Steuer P, 2013, COMP BIOCHEM PHYS A, V164, P319, DOI 10.1016/j.cbpa.2012.10.026; Steuer P, 2011, COMP BIOCHEM PHYS A, V160, P355, DOI 10.1016/j.cbpa.2011.07.005; Stevens CE, 1998, PHYSIOL REV, V78, P393, DOI 10.1152/physrev.1998.78.2.393; Stevens KA, 2005, LIFE O PAST, P212; Taylor St C.S., 1987, P487; Tutken T, 2011, UNDERSTANDING LIFE G, P57; UDEN P, 1982, BRIT J NUTR, V47, P267, DOI 10.1079/BJN19820035; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; VanSoest PJ, 1996, ZOO BIOL, V15, P455, DOI 10.1002/(SICI)1098-2361(1996)15:5<455::AID-ZOO3>3.0.CO;2-A; Wang CJ, 2009, ANIM FEED SCI TECH, V149, P199, DOI 10.1016/j.anifeedsci.2008.06.005; WEHAUSEN JD, 1995, J WILDLIFE MANAGE, V59, P816, DOI 10.2307/3801962; Wenninger PS, 2000, OECOLOGIA, V123, P466, DOI 10.1007/s004420000338; WESTOBY M, 1974, AM NAT, V108, P290, DOI 10.1086/282908; Wilkinson DM, 2013, FUNCT ECOL, V27, P131, DOI 10.1111/1365-2435.12033; Wilkinson DM, 2012, CURR BIOL, V22, pR292, DOI 10.1016/j.cub.2012.03.042; Wings O, 2007, P ROY SOC B-BIOL SCI, V274, P635, DOI 10.1098/rspb.2006.3763; WOODALL PF, 1992, AFR J ECOL, V30, P181, DOI 10.1111/j.1365-2028.1992.tb00492.x; Wrench J. M., 1997, Koedoe, V40, P125; Zanno LE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2526	143	122	123	4	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e68714	10.1371/journal.pone.0068714	http://dx.doi.org/10.1371/journal.pone.0068714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204552	Green Published, Green Accepted, gold			2022-12-27	WOS:000326334500001
J	Khuong, A; Lecheval, V; Fournier, R; Blanco, S; Weitz, S; Bezian, JJ; Gautrais, J				Khuong, Anais; Lecheval, Valentin; Fournier, Richard; Blanco, Stephane; Weitz, Sebastian; Bezian, Jean-Jacques; Gautrais, Jacques			How Do Ants Make Sense of Gravity? A Boltzmann Walker Analysis of Lasius niger Trajectories on Various Inclines	PLOS ONE			English	Article							SPATIAL-PATTERNS; ANIMAL MOVEMENTS; DESERT ANTS; WALKING; BEHAVIOR; INSECTS; DISPLACEMENTS; ORIENTATION; HYMENOPTERA; LOCOMOTION	The goal of this study is to describe accurately how the directional information given by support inclinations affects the ant Lasius niger motion in terms of a behavioral decision. To this end, we have tracked the spontaneous motion of 345 ants walking on a 0.5x0.5 m plane canvas, which was tilted with 5 various inclinations by (0, pi/9, pi/6, pi/4, pi/3) rad (>845000 data points). At the population scale, support inclination favors dispersal along uphill and downhill directions. An ant's decision making process is modeled using a version of the Boltzmann Walker model, which describes an ant's random walk as a series of straight segments separated by reorientation events, and was extended to take directional influence into account. From the data segmented accordingly (>73000 segments), this extension allows us to test separately how average speed, segments lengths and reorientation decisions are affected by support inclination and current walking direction of the ant. We found that support inclination had a major effect on average speed, which appeared approximately three times slower on the pi/3 incline. However, we found no effect of the walking direction on speed. Contrastingly, we found that ants tend to walk longer in the same direction when they move uphill or downhill, and also that they preferentially adopt new uphill or downhill headings at turning points. We conclude that ants continuously adapt their decision making about where to go, and how long to persist in the same direction, depending on how they are aligned with the line of maximum declivity gradient. Hence, their behavioral decision process appears to combine klinokinesis with geomenotaxis. The extended Boltzmann Walker model parameterized by these effects gives a fair account of the directional dispersal of ants on inclines.	[Khuong, Anais; Lecheval, Valentin; Gautrais, Jacques] UPS, Univ Toulouse, Ctr Rech Cognit Anim, Toulouse, France; [Khuong, Anais; Lecheval, Valentin; Gautrais, Jacques] CRCA, French Natl Ctr Sci Res, Toulouse, France; [Fournier, Richard; Blanco, Stephane; Weitz, Sebastian] UPS, Univ Toulouse, Lab Plasma & Convers Energie, Toulouse, France; [Fournier, Richard; Blanco, Stephane; Weitz, Sebastian] French Natl Ctr Sci Res, Lab Plasma & Convers Energie, Toulouse, France; [Bezian, Jean-Jacques] Univ Toulouse, Ctr Rech Albi Genie Proc Solides Divses Energie &, Mines Albi, France; [Bezian, Jean-Jacques] French Natl Ctr Sci Res, Ctr Rech Albi Genie Proc Solides Divses Energie &, Albi, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; IMT - Institut Mines-Telecom; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; IMT Mines Albi	Khuong, A (corresponding author), UPS, Univ Toulouse, Ctr Rech Cognit Anim, Toulouse, France.	anais.khuong@univ-tlse3.fr; jacques.gautrais@univ-tlse3.fr	Lecheval, Valentin/ABG-9070-2020; Gautrais, Jacques/B-4523-2008	Lecheval, Valentin/0000-0001-6041-2718; Gautrais, Jacques/0000-0002-7002-9920; BEZIAN, Jean Jacques/0000-0001-5667-2488	PRES University of Toulouse/Region Midi-Pyrenees [APR 2010]	PRES University of Toulouse/Region Midi-Pyrenees(Region Occitanie)	This study was supported by a PhD grant from the PRES University of Toulouse/Region Midi-Pyrenees (APR 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C., 2011, R PACKAGE CIRCULAR C; AJNE B, 1968, BIOMETRIKA, V55, P343, DOI 10.1093/biomet/55.2.343; ALT W, 1995, BIOSYSTEMS, V34, P11, DOI 10.1016/0303-2647(94)01449-H; [Anonymous], 1959, INSECTES SOCIAUX; Apple, 2008, CICOLOR TRACK PROGR; Batschelet E, 1981, CIRCULAR STAT BIOL; BELL WJ, 1990, ANNU REV ENTOMOL, V35, P447, DOI 10.1146/annurev.en.35.010190.002311; Berens P., 2009, CIRCSTAT MATLAB TOOL; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bernadou A, 2008, J INSECT PHYSIOL, V54, P534, DOI 10.1016/j.jinsphys.2007.12.001; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; Brillinger DR, 2004, J STAT PLAN INFER, V122, P43, DOI 10.1016/j.jspi.2003.06.016; Case K., 1967, ADDISON WESLEY SERIE; Casellas E, 2008, J THEOR BIOL, V250, P424, DOI 10.1016/j.jtbi.2007.10.011; Challet M, 2005, INSECT SOC, V52, P309, DOI 10.1007/s00040-005-0821-1; Challet M, 2005, NATURWISSENSCHAFTEN, V92, P367, DOI 10.1007/s00114-005-0001-1; Challet M, 2005, THESIS U P SABATIER; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Devigne C, 2002, INSECT SOC, V49, P357, DOI 10.1007/PL00012659; Dussutour A, 2005, P ROY SOC B-BIOL SCI, V272, P705, DOI 10.1098/rspb.2004.2990; FULL RJ, 1990, J EXP BIOL, V149, P307; Galtier M, 2013, J QUANTITATIVE SPECT; Hillen T, 2000, SIAM J APPL MATH, V61, P751, DOI 10.1137/S0036139999358167; Himberg J, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P203, DOI 10.1109/ICDM.2001.989520; Holt NC, 2012, J EXP BIOL, V215, P2545, DOI 10.1242/jeb.057695; JANDER R, 1974, INSECT SOC, V21, P45, DOI 10.1007/BF02222979; Keogh E, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P289, DOI 10.1109/ICDM.2001.989531; Keogh E, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P115, DOI 10.1109/ICDM.2003.1250910; Keogh E. J., 1998, Proceedings Fourth International Conference on Knowledge Discovery and Data Mining, P239; Khuong A., 2011, ADV ARTIFICIAL LIFE, P404; Le Breton J, 2004, BEHAV ECOL SOCIOBIOL, V55, P242, DOI 10.1007/s00265-003-0704-2; Lenke R, 2000, SCATTERING IN POLYMERIC AND COLLOIDAL SYSTEMS, P1; Lenoir A, 2009, J CHEM ECOL, V35, P913, DOI 10.1007/s10886-009-9669-6; Lewis OT, 2008, BEHAV ECOL, V19, P805, DOI 10.1093/beheco/arn032; Lipp A, 2005, J EXP BIOL, V208, P707, DOI 10.1242/jeb.01434; Morales JM, 2002, ECOLOGY, V83, P2240; Othmer HG, 2002, SIAM J APPL MATH, V62, P1222, DOI 10.1137/S0036139900382772; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; PATLAK CLIFFORD S., 1953, BULL MATH BIOPHYS, V15, P431, DOI 10.1007/BF02476435; Pearce-Duvet JMC, 2011, BEHAV ECOL, V22, P501, DOI 10.1093/beheco/arr001; Pelletier Y, 2001, BIOL CYBERN, V84, P269, DOI 10.1007/s004220000214; Preisler HK, 2004, ENVIRONMETRICS, V15, P643, DOI 10.1002/env.636; Punskaya E, 2002, IEEE T SIGNAL PROCES, V50; R Development Core Team, 2010, R LANG ENV STAT COMP; Riveros AJ, 2008, ANIM BEHAV, V75, P1273, DOI 10.1016/j.anbehav.2007.09.030; Robinson EJH, 2008, ANIM BEHAV, V75, P1389, DOI 10.1016/j.anbehav.2007.09.013; Sandoval EL, 2012, J INSECT BEHAV, V25, P612, DOI 10.1007/s10905-012-9327-7; Saupe D, 1998, SPIE VISUAL COMMUNIC; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Schultheiss P, 2013, BEHAV ECOL, V24, P128, DOI 10.1093/beheco/ars143; Seidl T, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-8; Shimatani IK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050309; Theraulaz G, 2003, PHILOS T R SOC A, V361, P1263, DOI 10.1098/rsta.2003.1198; Theraulaz G, 2002, P NATL ACAD SCI USA, V99, P9645, DOI 10.1073/pnas.152302199; Theraulaz Guy, 1998, Complexity, V3, P15, DOI 10.1002/(SICI)1099-0526(199807/08)3:6<15::AID-CPLX3>3.0.CO;2-V; Vasko KT, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P466, DOI 10.1109/ICDM.2002.1183990; Vuilleumier S, 2006, ECOL MODEL, V190, P159, DOI 10.1016/j.ecolmodel.2005.04.017; Wajnberg E, 2010, J R SOC INTERFACE, V7, pS207, DOI 10.1098/rsif.2009.0526.focus; Weihmann T, 2009, J COMP PHYSIOL A, V195, P1011, DOI 10.1007/s00359-009-0475-y; Weitz S., 2012, THESIS U TOULOUSE 3; Weitz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038588; Winkler G, 2005, ST CLASS DAT ANAL, P295, DOI 10.1007/3-540-26981-9_34; Wintergerst S, 2012, J COMP PHYSIOL A, V198, P363, DOI 10.1007/s00359-012-0714-5; Wittlinger M, 2007, J EXP BIOL, V210, P375, DOI 10.1242/jeb.02674; Wohlgemuth S, 2001, NATURE, V411, P795, DOI 10.1038/35081069	65	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76531	10.1371/journal.pone.0076531	http://dx.doi.org/10.1371/journal.pone.0076531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204636	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700006
J	Hoffman, GE				Hoffman, Gabriel E.			Correcting for Population Structure and Kinship Using the Linear Mixed Model: Theory and Extensions	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; STRATIFICATION; HERITABILITY; FREEDOM; SIMILARITY; SELECTION; VARIANTS	Population structure and kinship are widespread confounding factors in genome-wide association studies (GWAS). It has been standard practice to include principal components of the genotypes in a regression model in order to account for population structure. More recently, the linear mixed model (LMM) has emerged as a powerful method for simultaneously accounting for population structure and kinship. The statistical theory underlying the differences in empirical performance between modeling principal components as fixed versus random effects has not been thoroughly examined. We undertake an analysis to formalize the relationship between these widely used methods and elucidate the statistical properties of each. Moreover, we introduce a new statistic, effective degrees of freedom, that serves as a metric of model complexity and a novel low rank linear mixed model (LRLMM) to learn the dimensionality of the correction for population structure and kinship, and we assess its performance through simulations. A comparison of the results of LRLMM and a standard LMM analysis applied to GWAS data from the Multi-Ethnic Study of Atherosclerosis (MESA) illustrates how our theoretical results translate into empirical properties of the mixed model. Finally, the analysis demonstrates the ability of the LRLMM to substantially boost the strength of an association for HDL cholesterol in Europeans.	[Hoffman, Gabriel E.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA	Cornell University	Hoffman, GE (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, Icahn Inst Genom & Multiscale Biol, New York, NY USA.	gabriel.homan@mssm.edu			National Science Foundation (NSF) [IOS1026555, DEB0922432]; Cornell Center for Comparative and Population Genomics; Division Of Integrative Organismal Systems [1026555] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Cornell Center for Comparative and Population Genomics; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation (NSF) grants IOS1026555 and DEB0922432 and a fellowship from the Cornell Center for Comparative and Population Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Ayers KL, 2010, GENET EPIDEMIOL, V34, P879, DOI 10.1002/gepi.20543; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Browning SR, 2011, AM J HUM GENET, V89, P191, DOI 10.1016/j.ajhg.2011.05.025; Cupples LA, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S1; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Efron B, 2004, J AM STAT ASSOC, V99, P619, DOI 10.1198/016214504000000692; HASTIE T, 2009, SPRINGER SERIES STAT; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Henderson C. R, 1984, APPL LINEAR MODELS A; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Ingrassia S, 2007, STUD CLASS DATA ANAL, P229, DOI 10.1007/978-3-540-70981-7_26; Janss L, 2012, GENETICS, V192, P693, DOI 10.1534/genetics.112.141143; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kenny EE, 2011, HUM MOL GENET, V20, P827, DOI 10.1093/hmg/ddq510; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Kruggel F, 2002, MED IMAGE ANAL, V6, P63, DOI 10.1016/S1361-8415(01)00052-4; Kutner M., 2004, APPL LINEAR STAT MOD; Lee S, 2011, BIOMETRICS, V67, P967, DOI 10.1111/j.1541-0420.2010.01520.x; Lesaffre E., 2012, BAYESIAN BIOSTATISTI, DOI [10.1002/9781119942412, DOI 10.1002/9781119942412]; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Listgarten J, 2013, NAT GENET, V45, P470, DOI 10.1038/ng.2620; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Lynch M., 1998, GENETICS ANAL QUANTI; Mazumder R, 2011, J AM STAT ASSOC, P1; McVean G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000686; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; PIRINEN M, 2012, ANN APPL ST IN PRESS; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Schaid DJ, 2010, HUM HERED, V70, P109, DOI 10.1159/000312641; Schaid DJ, 2010, HUM HERED, V70, P132, DOI 10.1159/000312643; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Sorensen DA., 2002, STAT BIOL HEALTH; Sul JH, 2013, NAT REV GENET, V14, P300, DOI 10.1038/nrg2813-c1; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tibshirani RJ, 2012, ANN STAT, V40, P1198, DOI 10.1214/12-AOS1003; Vilhjalmsson BJ, 2013, NAT REV GENET, V14, P1, DOI 10.1038/nrg3382; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wahba G., 1990, SPLINE MODELS OBSERV; Wand MP, 2011, ELECTRON J STAT, V5, P1654, DOI 10.1214/11-EJS652; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Wei JW, 2010, STAT PROBABIL LETT, V80, P1918, DOI 10.1016/j.spl.2010.08.020; Weissglas-Volkov D, 2010, J LIPID RES, V51, P2032, DOI 10.1194/jlr.R004739; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2013, BIOMETRIKA, V100, P221, DOI 10.1093/biomet/ass048; Wu CQ, 2011, ANN HUM GENET, V75, P418, DOI 10.1111/j.1469-1809.2010.00639.x; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Ye JM, 1998, J AM STAT ASSOC, V93, P120, DOI 10.2307/2669609; Zaitlen N, 2012, HUM GENET, V131, P1655, DOI 10.1007/s00439-012-1199-6; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zou H, 2007, ANN STAT, V35, P2173, DOI 10.1214/009053607000000127	67	42	43	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e75707	10.1371/journal.pone.0075707	http://dx.doi.org/10.1371/journal.pone.0075707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204578	gold, Green Submitted, Green Published			2022-12-27	WOS:000326241200006
J	Rafajlovic, M; Eriksson, A; Rimark, A; Hintz-Saltin, S; Charrier, G; Panova, M; Andre, C; Johannesson, K; Mehlig, B				Rafajlovic, Marina; Eriksson, Anders; Rimark, Anna; Hintz-Saltin, Sara; Charrier, Gregory; Panova, Marina; Andre, Carl; Johannesson, Kerstin; Mehlig, Bernhard			The Effect of Multiple Paternity on Genetic Diversity of Small Populations during and after Colonisation	PLOS ONE			English	Article							EVOLUTION; PATTERNS; NUMBER	Genetic variation within and among populations is influenced by the genetic content of the founders and the migrants following establishment. This is particularly true if populations are small, migration rate low and habitats arranged in a stepping-stone fashion. Under these circumstances the level of multiple paternity is critical since multiply mated females bring more genetic variation into founder groups than single mated females. One such example is the marine snail Littorina saxatilis that during postglacial times has invaded mainland refuge areas and thereafter small islands emerging due to isostatic uplift by occasional rafting of multiply mated females. We modelled effects of varying degrees of multiple paternity on the genetic variation of island populations colonised by the founders spreading from the mainland, by quantifying the population heterozygosity during both the transient colonisation process, and after a steady state (with migration) has been reached. During colonisation, multiple mating by 2 10 males increased the heterozygosity by 10 300% in comparison with single paternity, while in the steady state the increase was 10-50% compared with single paternity. In the steady state the increase of heterozygosity due to multiple paternity is determined by a corresponding increase in effective population size. During colonisation, by contrast, the increase in heterozygosity is larger and it cannot be explained in terms of the effective population size alone. During the steady-state phase bursts of high genetic variation spread through the system, and far from the mainland this led to short periods of high diversity separated by long periods of low diversity. The size of these fluctuations was boosted by multiple paternity. We conclude that following glacial periods of extirpation, recolonization of isolated habitats by this species has been supported by its high level of multiple paternity.	[Rafajlovic, Marina; Rimark, Anna; Mehlig, Bernhard] Univ Gothenburg, Dept Phys, Gothenburg, Sweden; [Eriksson, Anders] Univ Cambridge, Dept Zool, Cambridge, England; [Eriksson, Anders] King Abdullah Univ Sci & Technol, Integrat Syst Biol Lab, Thuwal, Saudi Arabia; [Hintz-Saltin, Sara; Charrier, Gregory; Panova, Marina; Andre, Carl; Johannesson, Kerstin] Univ Gothenburg, Dept Biol & Environm Sci Tjarno, Stromstad, Sweden	University of Gothenburg; University of Cambridge; King Abdullah University of Science & Technology; University of Gothenburg	Mehlig, B (corresponding author), Univ Gothenburg, Dept Phys, Gothenburg, Sweden.	Bernhard.Mehlig@physics.gu.se	Panova, Marina/D-2633-2015; Johannesson, Kerstin/X-7994-2019; Panova, Marina/V-3533-2019; Eriksson, Anders/C-9767-2010; Rafajlovic, Marina/ABB-8142-2021; Mehlig, Bernhard/N-6491-2013; Andre, Carl/B-4237-2010	Panova, Marina/0000-0002-4147-6473; Johannesson, Kerstin/0000-0003-0176-7986; Panova, Marina/0000-0002-4147-6473; Eriksson, Anders/0000-0003-3436-3726; Rafajlovic, Marina/0000-0003-2177-4622; Andre, Carl/0000-0003-4404-7292; Mehlig, Bernhard/0000-0002-3672-6538	Vetenskapsr\aa det; Goran Gustafsson Foundation for Research in Natural Sciences and Medicine; platform "Centre for Theoretical Biology" at the University of Gothenburg; Linnaeus Centre for Marine Evolutionary Biology (CeMEB)	Vetenskapsr\aa det; Goran Gustafsson Foundation for Research in Natural Sciences and Medicine; platform "Centre for Theoretical Biology" at the University of Gothenburg; Linnaeus Centre for Marine Evolutionary Biology (CeMEB)	The authors gratefully acknowledge financial support by Vetenskapsr\aa det, by the Goran Gustafsson Foundation for Research in Natural Sciences and Medicine, and by the platform "Centre for Theoretical Biology" at the University of Gothenburg. Further support was given from the Linnaeus Centre for Marine Evolutionary Biology (CeMEB, www.cemeb.science.gu.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Avise JC, 2011, P NATL ACAD SCI USA, V108, P11512, DOI 10.1073/pnas.1109216108; Balloux F, 2003, GENETICS, V165, P2313; Bensch S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000072; Birkhead T, 2000, PROMISCUITY EVOLUTIO; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Brante A, 2011, J EXP MAR BIOL ECOL, V396, P83, DOI 10.1016/j.jembe.2010.10.001; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Coleman SW, 2011, BIOL J LINN SOC, V103, P735, DOI 10.1111/j.1095-8312.2011.01673.x; Eriksson A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.040901; EWENS WJ, 1982, THEOR POPUL BIOL, V21, P373, DOI 10.1016/0040-5809(82)90024-7; Fisher, 1958, GENETICAL THEORY NAT; Gaggiotti OE, 1996, THEOR POPUL BIOL, V50, P178, DOI 10.1006/tpbi.1996.0028; JANSON K, 1987, HEREDITY, V58, P31, DOI 10.1038/hdy.1987.5; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; JOHANNESSON K, 1990, HYDROBIOLOGIA, V193, P99, DOI 10.1007/BF00028069; JOHANNESSON K, 1995, HYDROBIOLOGIA, V309, P173, DOI 10.1007/BF00014485; Johannesson K, 2010, PHILOS T R SOC B, V365, P1735, DOI 10.1098/rstb.2009.0256; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1964, GENETICS, V49, P561; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; Panova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009640; Paterson IG, 2001, BIOL BULL-US, V200, P261, DOI 10.2307/1543508; Pearse DE, 2009, MOL ECOL, V18, P3124, DOI 10.1111/j.1365-294X.2009.04268.x; Reid D. G., 1996, SYSTEMATICS EVOLUTIO; Schaper E, 2012, GENETICS, V190, P217, DOI 10.1534/genetics.111.134437; Trontti K, 2007, BEHAV ECOL, V18, P298, DOI 10.1093/beheco/arl083; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wright S, 1931, GENETICS, V16, P0097	32	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e75587	10.1371/journal.pone.0075587	http://dx.doi.org/10.1371/journal.pone.0075587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204577	Green Published, Green Submitted, gold			2022-12-27	WOS:000326241200005
J	Crost, EH; Tailford, LE; Le Gall, G; Fons, M; Henrissat, B; Juge, N				Crost, Emmanuelle H.; Tailford, Louise E.; Le Gall, Gwenaelle; Fons, Michel; Henrissat, Bernard; Juge, Nathalie			Utilisation of Mucin Glycans by the Human Gut Symbiont Ruminococcus gnavus Is Strain-Dependent	PLOS ONE			English	Article							HUMAN-MILK OLIGOSACCHARIDES; MUCOSA-ASSOCIATED MICROBIOTA; BIFIDOBACTERIUM-BIFIDUM; HUMAN-COLON; FAECALIBACTERIUM-PRAUSNITZII; GASTROINTESTINAL-TRACT; ULCERATIVE-COLITIS; O-GLYCOSYLATION; IN-VITRO; BACTERIA	Commensal bacteria often have an especially rich source of glycan-degrading enzymes which allow them to utilize undigested carbohydrates from the food or the host. The species Ruminococcus gnavus is present in the digestive tract of $ 90% of humans and has been implicated in gut-related diseases such as inflammatory bowel diseases (IBD). Here we analysed the ability of two R. gnavus human strains, E1 and ATCC 29149, to utilize host glycans. We showed that although both strains could assimilate mucin monosaccharides, only R. gnavus ATCC 29149 was able to grow on mucin as a sole carbon source. Comparative genomic analysis of the two R. gnavus strains highlighted potential clusters and glycoside hydrolases (GHs) responsible for the breakdown and utilization of mucin-derived glycans. Transcriptomic and functional activity assays confirmed the importance of specific GH33 sialidase, and GH29 and GH95 fucosidases in the mucin utilisation pathway. Notably, we uncovered a novel pathway by which R. gnavus ATCC 29149 utilises sialic acid from sialylated substrates. Our results also demonstrated the ability of R. gnavus ATCC 29149 to produce propanol and propionate as the end products of metabolism when grown on mucin and fucosylated glycans. These new findings provide molecular insights into the strain-specificity of R. gnavus adaptation to the gut environment advancing our understanding of the role of gut commensals in health and disease.	[Crost, Emmanuelle H.; Tailford, Louise E.; Le Gall, Gwenaelle; Juge, Nathalie] Inst Food Res, Gut Hlth & Food Safety Inst Strateg Programme, Norwich NR4 7UA, Norfolk, England; [Fons, Michel] CNRS, Inst Microbiol Mediterranee, Lab Chim Bacterienne, Marseille, France; [Fons, Michel; Henrissat, Bernard] Aix Marseille Univ, Marseille, France; [Henrissat, Bernard] CNRS, Marseille, France; [Henrissat, Bernard] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen, Denmark	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); University of Copenhagen	Juge, N (corresponding author), Inst Food Res, Gut Hlth & Food Safety Inst Strateg Programme, Norwich NR4 7UA, Norfolk, England.	nathalie.juge@ifr.ac.uk	Henrissat, Bernard/J-2475-2012; Le+Gall, Gwenaelle/AAC-6938-2019	Henrissat, Bernard/0000-0002-3434-8588; Le+Gall, Gwenaelle/0000-0002-1379-2196; Fons, Michel/0000-0001-8263-3669; Juge, Nathalie/0000-0001-8515-1315	Biotechnology and Biological Sciences Research Council (BBSRC); Newton International Fellowships; Royal Society; BBSRC Institute Strategic Programme [BB/J004529/1]; BBSRC [BBS/E/F/00044452] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044452] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newton International Fellowships; Royal Society(Royal Society of London); BBSRC Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors gratefully acknowledge the support of the Biotechnology and Biological Sciences Research Council (BBSRC). EC was a recipient of a Newton International Fellowships-2009. This research was partly funded by the Royal Society and the BBSRC Institute Strategic Programme BB/J004529/1: The Gut Health and Food Safety ISP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Baranyi J, 2000, MICROBIOLOGICAL SAFE, P342; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cervera-Tison M, 2012, APPL ENVIRON MICROB, V78, P7720, DOI 10.1128/AEM.01350-12; Chou MY, 1996, J BIOL CHEM, V271, P19219, DOI 10.1074/jbc.271.32.19219; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; Dabard J, 2001, APPL ENVIRON MICROB, V67, P4111, DOI 10.1128/AEM.67.9.4111-4118.2001; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; Ficko-Blean E, 2012, CURR OPIN STRUC BIOL, V22, P570, DOI 10.1016/j.sbi.2012.07.009; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; FURUHATA K, 1991, CHEM PHARM BULL, V39, P817; Gunning AP, 2013, FASEB J, V27, P2342, DOI 10.1096/fj.12-221416; Gut H, 2008, FEBS LETT, V582, P3348, DOI 10.1016/j.febslet.2008.08.026; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HOSKINS LC, 1985, J CLIN INVEST, V75, P944, DOI 10.1172/JCI111795; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jensen PH, 2010, FEBS J, V277, P81, DOI 10.1111/j.1742-4658.2009.07429.x; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Juge N, 2012, TRENDS MICROBIOL, V20, P30, DOI 10.1016/j.tim.2011.10.001; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kiyohara M, 2012, J BIOL CHEM, V287, P693, DOI 10.1074/jbc.M111.277384; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Lepage P, 2005, INFLAMM BOWEL DIS, V11, P473, DOI 10.1097/01.MIB.0000159662.62651.06; Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x; LI YT, 1990, J BIOL CHEM, V265, P21629; Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11; Lozupone CA, 2008, P NATL ACAD SCI USA, V105, P15076, DOI 10.1073/pnas.0807339105; Ludwig W, 2009, BERGEYS MANUAL SYSTE, V3, P1, DOI DOI 10.1007/978-0-387-68489-5_; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martinez C, 2008, AM J GASTROENTEROL, V103, P643, DOI 10.1111/j.1572-0241.2007.01592.x; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; MOORE WEC, 1974, AM J CLIN NUTR, V27, P1450, DOI 10.1093/ajcn/27.12.1450; Nielsen DS, 2003, APPL ENVIRON MICROB, V69, P7545, DOI 10.1128/AEM.69.12.7545-7548.2003; Nishikawa J, 2009, SCAND J GASTROENTERO, V44, P180, DOI 10.1080/00365520802433231; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Nyangale EP, 2012, J PROTEOME RES, V11, P5573, DOI 10.1021/pr300637d; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Prindiville T, 2004, INFLAMM BOWEL DIS, V10, P824, DOI 10.1097/00054725-200411000-00017; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; RAMARE F, 1993, APPL ENVIRON MICROB, V59, P2876, DOI 10.1128/AEM.59.9.2876-2883.1993; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tannock GW, 2013, APPL ENVIRON MICROB, V79, P3040, DOI 10.1128/AEM.03910-12; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Van den Abbeele P, 2011, FEMS MICROBIOL REV, V35, P681, DOI 10.1111/j.1574-6976.2011.00270.x; van Passel MWJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016876; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yoshida E, 2012, GLYCOBIOLOGY, V22, P361, DOI 10.1093/glycob/cwr116; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	69	167	177	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76341	10.1371/journal.pone.0076341	http://dx.doi.org/10.1371/journal.pone.0076341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204617	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000326155400013
J	Shi, W; Wei, S; Hu, XX; Hu, GJ; Chen, CL; Wang, XR; Giesy, JP; Yu, HX				Shi, Wei; Wei, Si; Hu, Xin-xin; Hu, Guan-jiu; Chen, Cu-lan; Wang, Xin-ru; Giesy, John P.; Yu, Hong-xia			Identification of Thyroid Receptor Ant/Agonists in Water Sources Using Mass Balance Analysis and Monte Carlo Simulation	PLOS ONE			English	Article							INDIVIDUAL POLYCHLORINATED NAPHTHALENES; ECOLOGICAL RISK-ASSESSMENT; PHTHALATE-ESTERS; DRINKING-WATER; RELATIVE POTENCIES; SUBTROPICAL CITY; MEILIANG BAY; WASTE-WATER; DIOXIN-LIKE; TAIHU LAKE	Some synthetic chemicals, which have been shown to disrupt thyroid hormone (TH) function, have been detected in surface waters and people have the potential to be exposed through water-drinking. Here, the presence of thyroid-active chemicals and their toxic potential in drinking water sources in Yangtze River Delta were investigated by use of instrumental analysis combined with cell-based reporter gene assay. A novel approach was developed to use Monte Carlo simulation, for evaluation of the potential risks of measured concentrations of TH agonists and antagonists and to determine the major contributors to observed thyroid receptor (TR) antagonist potency. None of the extracts exhibited TR agonist potency, while 12 of 14 water samples exhibited TR antagonistic potency. The most probable observed antagonist equivalents ranged from 1.4 to 5.6 mu g di-n-butyl phthalate (DNBP)/L, which posed potential risk in water sources. Based on Monte Carlo simulation related mass balance analysis, DNBP accounted for 64.4% for the entire observed antagonist toxic unit in water sources, while diisobutyl phthalate (DIBP), di-n-octyl phthalate (DNOP) and di-2-ethylhexyl phthalate (DEHP) also contributed. The most probable observed equivalent and most probable relative potency (REP) derived from Monte Carlo simulation is useful for potency comparison and responsible chemicals screening.	[Shi, Wei; Wei, Si; Hu, Xin-xin; Giesy, John P.; Yu, Hong-xia] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China; [Hu, Guan-jiu; Chen, Cu-lan] Jiangsu Prov Environm Monitoring Ctr, State Environm Protect Key Lab Monitoring & Anal, Nanjing, Jiangsu, Peoples R China; [Wang, Xin-ru] Nanjing Med Univ, Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wang, Xin-ru] Nanjing Med Univ, Inst Toxicol, Nanjing, Jiangsu, Peoples R China; [Giesy, John P.] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK, Canada; [Giesy, John P.] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK, Canada; [Giesy, John P.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Giesy, John P.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA; [Giesy, John P.] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China; [Giesy, John P.] City Univ Hong Kong, State Key Lab Marine Pollut, Kowloon, Hong Kong, Peoples R China; [Giesy, John P.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Nanjing University; Nanjing Medical University; Nanjing Medical University; University of Saskatchewan; University of Saskatchewan; Michigan State University; Michigan State University; City University of Hong Kong; City University of Hong Kong; University of Hong Kong	Yu, HX (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China.	yuhx@nju.edu.cn	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376; Shi, Wei/0000-0002-6263-5664; Giesy, John/0000-0003-1931-9962	National Natural Science Foundation of China [21307054]; Science Foundation in Jiangsu Province [BK20130551, BK2011032]; National High-tech R&D Program of China [2013AA062709]; Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07506-004-004]; Program for Environmental Monitoring in Jiangsu Province [1212]; program of 2012 "High Level Foreign Experts" [GDW20123200120]; State Administration of Foreign Experts Affairs, the P.R. China; Einstein Professor Program of the Chinese Academy of Sciences; Canada Research Chair program; Department of Biology and Chemistry, City University of Hong Kong; State Key Laboratory in Marine Pollution, City University of Hong Kong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation in Jiangsu Province; National High-tech R&D Program of China(National High Technology Research and Development Program of China); Major Science and Technology Program for Water Pollution Control and Treatment; Program for Environmental Monitoring in Jiangsu Province; program of 2012 "High Level Foreign Experts"; State Administration of Foreign Experts Affairs, the P.R. China; Einstein Professor Program of the Chinese Academy of Sciences; Canada Research Chair program(Canada Research Chairs); Department of Biology and Chemistry, City University of Hong Kong; State Key Laboratory in Marine Pollution, City University of Hong Kong(City University of Hong Kong)	This work was supported by the National Natural Science Foundation of China (21307054), the Science Foundation in Jiangsu Province (BK20130551), the National High-tech R&D Program of China (2013AA062709), the Science Foundation in Jiangsu Province (BK2011032), the Major Science and Technology Program for Water Pollution Control and Treatment (2012ZX07506-004-004) and the Program for Environmental Monitoring in Jiangsu Province (1212). Prof. Giesy was supported by the program of 2012 "High Level Foreign Experts" (#GDW20123200120) funded by the State Administration of Foreign Experts Affairs, the P.R. China to Nanjing University and the Einstein Professor Program of the Chinese Academy of Sciences. He was also supported by the Canada Research Chair program, and a large Chair Professorship at the Department of Biology and Chemistry and State Key Laboratory in Marine Pollution, City University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhoum N, 2004, SEP PURIF TECHNOL, V38, P233, DOI 10.1016/j.seppur.2003.11.011; Blankenship AL, 2000, ENVIRON SCI TECHNOL, V34, P3153, DOI 10.1021/es9914339; Brucker-Davis F, 1998, THYROID, V8, P827, DOI 10.1089/thy.1998.8.827; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Darnerud PO, 2010, ENVIRON INT, V36, P180, DOI 10.1016/j.envint.2009.11.001; Davis PJ, 2000, J BIOL CHEM, V275, P38032, DOI 10.1074/jbc.M002560200; Du GZ, 2010, TOXICOL SCI, V116, P58, DOI 10.1093/toxsci/kfq120; FINNEY D. J., 1978, STAT METHOD BIOL ASS; Ghisari M, 2005, MOL CELL ENDOCRINOL, V244, P31, DOI 10.1016/j.mce.2005.01.013; Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3788, DOI 10.1021/es2002106; Hladik ML, 2009, J AGR FOOD CHEM, V57, P9079, DOI 10.1021/jf9020448; Hoefling M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019791; Howdeshell KL, 2002, ENVIRON HEALTH PERSP, V110, P337, DOI 10.1289/ehp.02110s3337; Jang CS, 2006, ENVIRON SCI TECHNOL, V40, P1707, DOI 10.1021/es051875m; Jugan ML, 2009, SCI TOTAL ENVIRON, V407, P3579, DOI 10.1016/j.scitotenv.2009.01.027; Koh CH, 2005, ECOTOX ENVIRON SAFE, V61, P366, DOI 10.1016/j.ecoenv.2005.03.005; Li N, 2010, ENVIRON SCI TECHNOL, V44, P6863, DOI 10.1021/es101254c; Luo JP, 2011, WATER RES, V45, P3908, DOI 10.1016/j.watres.2011.04.045; Ma FJ, 2012, ENVIRON SCI TECHNOL, V46, P3236, DOI 10.1021/es204520b; Machala M, 2001, ENVIRON TOXICOL CHEM, V20, P2736, DOI 10.1002/etc.5620201212; National Research Council, 1994, NRC SCI JUDGM RISK A; Putzrath RM, 1997, REGUL TOXICOL PHARM, V25, P68, DOI 10.1006/rtph.1996.1063; Qiao M, 2006, ENVIRON SCI TECHNOL, V40, P1415, DOI 10.1021/es051456p; Qu CS, 2011, ECOL MODEL, V222, P287, DOI 10.1016/j.ecolmodel.2010.07.014; Qu CS, 2012, HUM ECOL RISK ASSESS, V18, P733, DOI 10.1080/10807039.2012.688697; Shen M, 2006, MAR POLLUT BULL, V52, P1299, DOI 10.1016/j.marpolbul.2006.05.023; Shen OX, 2009, TOXICOL LETT, V191, P9, DOI 10.1016/j.toxlet.2009.07.019; Shi W, 2012, ENVIRON SCI TECHNOL, V46, P1811, DOI 10.1021/es202625r; Song LR, 2007, WATER RES, V41, P2853, DOI 10.1016/j.watres.2007.02.013; Sun C, 2002, ENVIRON POLLUT, V117, P9, DOI 10.1016/S0269-7491(01)00169-5; Sun H, 2009, TOXICOL IN VITRO, V23, P950, DOI 10.1016/j.tiv.2009.05.004; Suzuki G, 2008, ENVIRON SCI TECHNOL, V42, P1794, DOI 10.1021/es7021895; USEPA, 1997, GUID PRINC MONT CARL; VIJAYAN MM, 1988, GEN COMP ENDOCR, V70, P312, DOI 10.1016/0016-6480(88)90151-7; Villeneuve DL, 2000, ARCH ENVIRON CON TOX, V39, P273; Villeneuve DL, 2000, ENVIRON TOXICOL CHEM, V19, P2835, DOI 10.1002/etc.5620191131; Wang B, 2009, ENVIRON MONIT ASSESS, V157, P29, DOI 10.1007/s10661-008-0512-2; Wu B, 2009, ECOTOXICOLOGY, V18, P707, DOI 10.1007/s10646-009-0331-4; Xu ZW, 2010, ENVIRON SCI TECHNOL, V44, P3130, DOI 10.1021/es100058j; Zeng F, 2008, ENVIRON INT, V34, P372, DOI 10.1016/j.envint.2007.09.002; Zeng F, 2008, ENVIRON POLLUT, V156, P425, DOI 10.1016/j.envpol.2008.01.045; Zeng F, 2009, J HAZARD MATER, V164, P1171, DOI 10.1016/j.jhazmat.2008.09.029	42	10	11	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e73883	10.1371/journal.pone.0073883	http://dx.doi.org/10.1371/journal.pone.0073883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204563	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400004
J	Mossbridge, JA; Grabowecky, M; Suzuki, S				Mossbridge, Julia A.; Grabowecky, Marcia; Suzuki, Satoru			Seeing the Song: Left Auditory Structures May Track Auditory-Visual Dynamic Alignment	PLOS ONE			English	Article							STEADY-STATE RESPONSES; MULTISENSORY INTEGRATION; 40 HZ; AUDIOVISUAL INTEGRATION; SUPERIOR COLLICULUS; DIVIDED ATTENTION; EVOKED-POTENTIALS; TEMPORAL FACTORS; CORTEX; SPEECH	Auditory and visual signals generated by a single source tend to be temporally correlated, such as the synchronous sounds of footsteps and the limb movements of a walker. Continuous tracking and comparison of the dynamics of auditory-visual streams is thus useful for the perceptual binding of information arising from a common source. Although language-related mechanisms have been implicated in the tracking of speech-related auditory-visual signals (e.g., speech sounds and lip movements), it is not well known what sensory mechanisms generally track ongoing auditory-visual synchrony for non-speech signals in a complex auditory-visual environment. To begin to address this question, we used music and visual displays that varied in the dynamics of multiple features (e.g., auditory loudness and pitch; visual luminance, color, size, motion, and organization) across multiple time scales. Auditory activity (monitored using auditory steady-state responses, ASSR) was selectively reduced in the left hemisphere when the music and dynamic visual displays were temporally misaligned. Importantly, ASSR was not affected when attentional engagement with the music was reduced, or when visual displays presented dynamics clearly dissimilar to the music. These results appear to suggest that left-lateralized auditory mechanisms are sensitive to auditory-visual temporal alignment, but perhaps only when the dynamics of auditory and visual streams are similar. These mechanisms may contribute to correct auditory-visual binding in a busy sensory environment.	[Mossbridge, Julia A.; Grabowecky, Marcia; Suzuki, Satoru] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Grabowecky, Marcia; Suzuki, Satoru] Northwestern Univ, Interdept Neurosci Program, Evanston, IL USA	Northwestern University; Northwestern University	Mossbridge, JA (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.	jmossbridge@gmail.com			NSF [BCS0643191]; NIH [R01 EY018197, 5T32NS047987-05]; NATIONAL EYE INSTITUTE [R01EY021184, R01EY018197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS047987] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	JM, MG, and SS were supported through NSF BCS0643191 (NSF.gov) and NIH R01 EY018197 (NIH.gov); JM was also supported through NIH 5T32NS047987-05 (NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Bernier PM, 2009, NEUROIMAGE, V47, P1767, DOI 10.1016/j.neuroimage.2009.05.028; Bolognini N, 2005, EXP BRAIN RES, V160, P273, DOI 10.1007/s00221-004-2005-z; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Carbonnell L, 2004, CLIN NEUROPHYSIOL, V115, P2164, DOI 10.1016/j.clinph.2004.04.012; de Jong R, 2010, INT J PSYCHOPHYSIOL, V75, P3, DOI 10.1016/j.ijpsycho.2009.09.013; Driver J, 1998, TRENDS COGN SCI, V2, P254, DOI 10.1016/S1364-6613(98)01188-7; Driver J, 1996, NATURE, V381, P66, DOI 10.1038/381066a0; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Gutschalk A, 1999, CLIN NEUROPHYSIOL, V110, P856, DOI 10.1016/S1388-2457(99)00019-X; Herdman AT, 2002, BRAIN TOPOGR, V15, P69, DOI 10.1023/A:1021470822922; Herrmann C. S., 2005, EVENT RELATED POTENT, P229; HUGHES HC, 1994, J EXP PSYCHOL HUMAN, V20, P131, DOI 10.1037/0096-1523.20.1.131; Iordanescu L, 2011, ACTA PSYCHOL, V137, P252, DOI 10.1016/j.actpsy.2010.07.017; Iordanescu L, 2010, ATTEN PERCEPT PSYCHO, V72, P1736, DOI 10.3758/APP.72.7.1736; Jenkins J, 2011, BRAIN TOPOGR, V24, P134, DOI 10.1007/s10548-011-0174-1; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Kayser J, 2006, PSYCHOPHYSIOLOGY, V43, P237, DOI 10.1111/j.1469-8986.2006.00398.x; LINDEN RD, 1987, ELECTROEN CLIN NEURO, V66, P145, DOI 10.1016/0013-4694(87)90184-2; Lordanescu L, 2008, PSYCHON B REV, V15, P548, DOI 10.3758/PBR.15.3.548; Luo H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000445; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; Molholm S, 2004, CEREB CORTEX, V14, P452, DOI 10.1093/cercor/bhh007; Nozaradan S, 2012, NEUROIMAGE, V60, P21, DOI 10.1016/j.neuroimage.2011.11.065; Pastor MA, 2002, J NEUROSCI, V22, P10501; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; RADEAU M, 1977, PERCEPT PSYCHOPHYS, V22, P137, DOI 10.3758/BF03198746; ROBIN DA, 1990, BRAIN LANG, V39, P539, DOI 10.1016/0093-934X(90)90161-9; Ross B, 2005, CEREB CORTEX, V15, P2029, DOI 10.1093/cercor/bhi078; Ross B, 2004, Neurol Clin Neurophysiol, V2004, P22; Ross B, 2008, J NEUROPHYSIOL, V100, P1265, DOI 10.1152/jn.00048.2008; Samson S, 2001, ANN NY ACAD SCI, V930, P166, DOI 10.1111/j.1749-6632.2001.tb05732.x; Saupe K, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.058.2009; Saupe K, 2009, PSYCHOPHYSIOLOGY, V46, P321, DOI 10.1111/j.1469-8986.2008.00765.x; Schall S, 2009, EXP BRAIN RES, V198, P137, DOI 10.1007/s00221-009-1867-5; Stein B E, 1989, J Cogn Neurosci, V1, P12, DOI 10.1162/jocn.1989.1.1.12; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Tenke CE, 2005, CLIN NEUROPHYSIOL, V116, P2826, DOI 10.1016/j.clinph.2005.08.007; Tenke CE, 2012, CLIN NEUROPHYSIOLOGY; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161	51	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77201	10.1371/journal.pone.0077201	http://dx.doi.org/10.1371/journal.pone.0077201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194873	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000052
J	Nie, Y; Yan, W; Xu, Y; Chen, WB; Mu, XQ; Wang, XY; Xiao, R				Nie, Yao; Yan, Wei; Xu, Yan; Chen, Wen Bo; Mu, Xiao Qing; Wang, Xinye; Xiao, Rong			High-Level Expression of Bacillus naganoensis Pullulanase from Recombinant Escherichia coli with Auto-Induction: Effect of lac Operator	PLOS ONE			English	Article							T7 RNA-POLYMERASE; I-PULLULANASE; THERMOLEOVORANS US105; PROTEIN-PRODUCTION; GENE-EXPRESSION; CLONED GENES; E.-COLI; CLONING; STABILITY; SECRETION	Pullulanase plays an important role in specific hydrolysis of branch points in amylopectin and is generally employed as an important enzyme in starch-processing industry. So far, however, the production level of pullulanase is still somewhat low from wide-type strains and even heterologous expression systems. Here the gene encoding Bacillus naganoensis pullulanase was amplified and cloned. For expression of the protein, two recombinant systems, Escherichia coli BL21(DE3)/pET-20b(+)-pul and E. coli BL21(DE3)/pET-22b(+)-pul, were constructed, both bearing T7 promoter and signal peptide sequence, but different in the existance of lac operator and lacI gene encoding lac repressor. Recombinant pullulanase was initially expressed with the activity of up to 14 U/mL by E. coli BL21(DE3)/pET-20b(+)-pul with IPTG induction in LB medium, but its expression level reduced continually with the extension of cryopreservation time and basal expression was observed. However, E. coli BL21(DE3)/pET-22b(+)-pul, involving lac operator downstream of T7 promoter to regulate foreign gene transcription, exhibited pullulanase activity consistently without detected basal expression. By investigating the effect of lac operator, basal expression of foreign protein was found to cause expression instability and negative effect on production of target protein. Thus double-repression strategy was proposed that lac operators in both chromosome and plasmid were bound with lac repressor to repress T7 RNA polymerase synthesis and target protein expression before induction. Consequently, the total activity of pullulanase was remarkably increased to 580 U/mL with auto-induction by lac operator-involved E. coli BL21(DE3)/pET-22b(+)-pul. When adding 0.6% glycine in culture, the extracellular production of pullulanase was significantly improved with the extracellular activity of 502 U/mL, which is a relatively higher level achieved to date for extracellular production of pullulanase. The successful expression of pullulanase with lac operator regulation provides an efficient way for enhancement of expression stability and hence high-level production of target protein in recombinant E. coli.	[Nie, Yao; Yan, Wei; Xu, Yan; Chen, Wen Bo; Mu, Xiao Qing; Wang, Xinye] Jiangnan Univ, Sch Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China; [Nie, Yao; Yan, Wei; Xu, Yan; Chen, Wen Bo; Mu, Xiao Qing; Wang, Xinye] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China; [Xu, Yan] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Xiao, Rong] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Jiangnan University; Jiangnan University; Jiangnan University; Rutgers State University New Brunswick	Xu, Y (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China.	yxu@jiangnan.edu.cn	mu, xiaoqing/GRE-6842-2022		Hi-Tech Research and Development Program of China (863 Program) [2012AA022207]; National Key Basic Research and Development Program of China (973 Program) [2011CB710800, 2009CB724706]; Program of Introducing Talents of Discipline to Universities (111 Project) [111-2-06]; High-end Foreign Experts Recruitment Program [GDW20123200113]	Hi-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Key Basic Research and Development Program of China (973 Program)(National Basic Research Program of China); Program of Introducing Talents of Discipline to Universities (111 Project); High-end Foreign Experts Recruitment Program	This work was supported by the grants from Hi-Tech Research and Development Program of China (863 Program) (2012AA022207), the National Key Basic Research and Development Program of China (973 Program) (2011CB710800 and 2009CB724706), the Program of Introducing Talents of Discipline to Universities (111 Project) (111-2-06), and the High-end Foreign Experts Recruitment Program (GDW20123200113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayadi DZ, 2008, APPL MICROBIOL BIOT, V78, P473, DOI 10.1007/s00253-007-1318-9; Ben Messaoud E, 2002, ENZYME MICROB TECH, V31, P827, DOI 10.1016/S0141-0229(02)00185-0; Bertoldo C, 2004, APPL ENVIRON MICROB, V70, P3407, DOI 10.1128/AEM.70.6.3407-3416.2004; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Chen WB, 2013, APPL BIOCHEM BIOTECH, V169, P41, DOI 10.1007/s12010-012-9948-5; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; Correa A, 2011, BIOTECHNOL J, V6, P715, DOI 10.1002/biot.201100025; Ding RR, 2010, PROCESS BIOCHEM, V45, P880, DOI 10.1016/j.procbio.2010.02.009; Doman-Pytka M, 2004, CRIT REV MICROBIOL, V30, P107, DOI 10.1080/10408410490435115; DUBENDORFF JW, 1991, J MOL BIOL, V219, P45, DOI 10.1016/0022-2836(91)90856-2; Friehs K, 2004, ADV BIOCHEM ENG BIOT, V86, P47; Gomes I, 2003, BIORESOURCE TECHNOL, V90, P207, DOI 10.1016/S0960-8524(03)00110-X; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Grossman TH, 1998, GENE, V209, P95, DOI 10.1016/S0378-1119(98)00020-1; Hii LS, 2012, FOOD BIOPROCESS TECH, V5, P729, DOI 10.1007/s11947-010-0368-7; Hii S.L., 2009, OPEN BIOTECHNOL J, V3, P1, DOI [DOI 10.2174/1874070700903010001, 10.2174/1874070700903010001]; Hii Siew Ling, 2012, Enzyme Res, V2012, P921362; Jana S, 2005, APPL MICROBIOL BIOT, V67, P289, DOI 10.1007/s00253-004-1814-0; Jiao YL, 2011, CURR MICROBIOL, V62, P222, DOI 10.1007/s00284-010-9690-6; Kang J, 2011, ENZYME MICROB TECH, V48, P260, DOI 10.1016/j.enzmictec.2010.11.006; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; Klosowski G, 2010, J BIOSCI BIOENG, V109, P466, DOI 10.1016/j.jbiosc.2009.10.024; Kunamneni A, 2006, ENZYME MICROB TECH, V39, P1399, DOI 10.1016/j.enzmictec.2006.03.023; Lee SY, 1996, TRENDS BIOTECHNOL, V14, P98, DOI 10.1016/0167-7799(96)80930-9; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Li ZF, 2009, J AGR FOOD CHEM, V57, P6231, DOI 10.1021/jf901239k; Mertens N, 1995, NAT BIOTECHNOL, V13, P175, DOI [10.1038/nbt0295-175, DOI 10.1038/NBT0295-175.PUBMED:9634760]; Nair SU, 2006, FOOD TECHNOL BIOTECH, V44, P275; NIGAM P, 1995, ENZYME MICROB TECH, V17, P770, DOI 10.1016/0141-0229(94)00003-A; NOVY R, 2001, BIOTECHNIQUES, V12, P1, DOI DOI 10.1002/9783527620937.CH; Ramesh B, 2001, BIORESOURCE TECHNOL, V76, P169, DOI 10.1016/S0960-8524(00)00082-1; Santi I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003787; Singh RS, 2011, CARBOHYD POLYM, V83, P672, DOI 10.1016/j.carbpol.2010.08.037; Singh RS, 2010, CARBOHYD POLYM, V80, P401, DOI 10.1016/j.carbpol.2009.11.040; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; van der Maarel MJEC, 2002, J BIOTECHNOL, V94, P137, DOI 10.1016/S0168-1656(01)00407-2; Vethanayagam JGG, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-3; Walia R, 2008, J CHEM TECHNOL BIOT, V83, P1120, DOI 10.1002/jctb.1885; Wong MT, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-38; Xu B, 2006, J MICROBIOL BIOTECHN, V16, P1185	43	25	37	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78416	10.1371/journal.pone.0078416	http://dx.doi.org/10.1371/journal.pone.0078416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194930	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000109
J	Xu, SY; Gao, B; Xing, Y; Ming, J; Bao, JX; Zhang, Q; Wan, Y; Ji, QH				Xu, Shaoyong; Gao, Bin; Xing, Ying; Ming, Jie; Bao, Junxiang; Zhang, Qiang; Wan, Yi; Ji, Qiuhe		China Natl Diabet Metab Disorders	Gender Differences in the Prevalence and Development of Metabolic Syndrome in Chinese Population with Abdominal Obesity	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ELEVATED SERUM-CHOLESTEROL; RISK-FACTOR; MEN; DEFINITION; ASSOCIATION; WOMEN; AGE; COMPONENTS; STROKE	Background: Not all the people with metabolic syndrome (MS) have abdominal obesity (AO). The study aimed to investigate gender differences in the prevalence and development of MS in Chinese population with abdominal obesity, which has rarely been reported. Methods: Data were obtained from the 2007-08 China National Diabetes and Metabolic Disorders Study, and participants were divided into two samples for analysis. Sample 1 consisted of 19,046 people with abdominal obesity, while sample 2 included 2,124 people meeting pre-specified requirements. Survival analysis was used to analyze the development of MS. Results: The age-standardized prevalence of MS in Chinese population with AO was 49.5%. The prevalence in males (73.7%) was significantly higher than that in females (36.9%). Males had significantly higher proportions of combinations of three or four MS components than females (36.4% vs. 30.2% and 18.4% vs. 5%, respectively). MS developed quick at first and became slow down later. Half of the participants with AO developed to MS after 3.9 years (95% CI: 3.7-4.1) from the initial metabolic abnormal component, whereas 75% developed to MS after 7.7 years (95% CI: 7.5-7.9). Conclusion: Compared with females, Chinese males with AO should receive more attention because of their higher prevalence of MS and its components, more complex and risky combinations of abnormal components, and faster development of MS.	[Xu, Shaoyong; Gao, Bin; Xing, Ying; Ming, Jie; Ji, Qiuhe] Fourth Mil Med Univ, Affiliated Hosp 1, Dept Endocrinol, Xian 710032, Peoples R China; [Bao, Junxiang] Fourth Mil Med Univ, Dept Aerosp Physiol, Xian 710032, Peoples R China; [Zhang, Qiang] Chinese Peoples Liberat Army Gen Hosp, Dept Orthoped, Beijing, Peoples R China; [Wan, Yi] Fourth Mil Med Univ, Sch Publ Hlth, Dept Hlth Stat, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Chinese People's Liberation Army General Hospital; Air Force Military Medical University	Wan, Y (corresponding author), Fourth Mil Med Univ, Sch Publ Hlth, Dept Hlth Stat, Xian 710032, Peoples R China.	wanyi@fmmu.edu.cn; jqiuhe@fmmu.edu.cn	Wan, Yi/G-3173-2010	Wan, Yi/0000-0002-4125-8396	Chinese Medical Association Foundation; Chinese Diabetes Society; National Natural Science Foundation of China [81101387]	Chinese Medical Association Foundation; Chinese Diabetes Society; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Chinese Medical Association Foundation and the Chinese Diabetes Society. QZ received funding from the National Natural Science Foundation of China (grant 81101387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alexander CM, 2008, DIABETES OBES METAB, V10, P246, DOI 10.1111/j.1463-1326.2006.00695.x; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; BENFANTE R, 1994, STROKE, V25, P814, DOI 10.1161/01.STR.25.4.814; BENFANTE R, 1990, JAMA-J AM MED ASSOC, V263, P393, DOI 10.1001/jama.263.3.393; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Correia Flora, 2006, Acta Med Port, V19, P289; Cui RZ, 2012, ATHEROSCLEROSIS, V221, P565, DOI 10.1016/j.atherosclerosis.2012.01.013; ERVIN RB, 2009, NATL HLTH STAT REPOR, V13, P1; Fan JG, 2005, J GASTROEN HEPATOL, V20, P1825, DOI 10.1111/j.1440-1746.2005.04058.x; Feng Y, 2006, OBESITY, V14, P2089, DOI 10.1038/oby.2006.244; Franco OH, 2009, CIRCULATION, V120, P1943, DOI 10.1161/CIRCULATIONAHA.109.855817; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Gause-Nilsson I, 2006, ACTA DIABETOL, V43, P120, DOI 10.1007/s00592-006-0226-2; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Hou XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057319; Hu FB, 2011, OBES REV, V12, P552, DOI 10.1111/j.1467-789X.2011.00863.x; Hwang LC, 2007, EUR J EPIDEMIOL, V22, P899, DOI 10.1007/s10654-007-9183-5; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Ko GTC, 2005, DIABETES RES CLIN PR, V69, P160, DOI 10.1016/j.diabres.2004.11.015; Kuk JL, 2010, DIABETES CARE, V33, P2457, DOI 10.2337/dc10-0942; Lafortuna CL, 2012, OBESITY FACTS, V5, P127, DOI 10.1159/000336700; Lao XQ, 2006, J ENDOCRINOL INVEST, V29, P989, DOI 10.1007/BF03349212; Li ZY, 2006, ATHEROSCLEROSIS, V184, P188, DOI 10.1016/j.atherosclerosis.2005.03.033; Liu Li-Sheng, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P579; Lu B, 2006, METABOLISM, V55, P1088, DOI 10.1016/j.metabol.2006.04.003; Martelli V, 2012, J SEX MED, V9, P434, DOI 10.1111/j.1743-6109.2011.02517.x; Mathieu P, 2010, CLIN PHARMACOL THER, V87, P407, DOI 10.1038/clpt.2009.311; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; NATIONAL B, 2006, STATISTICS, V26, P2010; Pei WD, 2007, INT J CARDIOL, V116, P194, DOI 10.1016/j.ijcard.2006.03.045; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Safar ME, 2011, HYPERTENS RES, V34, P91, DOI 10.1038/hr.2010.180; Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94; Saukkonen T, 2012, SCAND J PRIM HEALTH, V30, P29, DOI 10.3109/02813432.2012.654192; Shakir YA, 2007, FERTIL STERIL, V88, P163, DOI 10.1016/j.fertnstert.2006.11.111; Shen J, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/178675; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Yang WY, 2012, CIRCULATION, V125, P2212, DOI 10.1161/CIRCULATIONAHA.111.065904; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205	46	27	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78270	10.1371/journal.pone.0078270	http://dx.doi.org/10.1371/journal.pone.0078270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194915	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000094
J	Kornai, A				Kornai, Andras			Digital Language Death	PLOS ONE			English	Article								Of the approximately 7,000 languages spoken today, some 2,500 are generally considered endangered. Here we argue that this consensus figure vastly underestimates the danger of digital language death, in that less than 5% of all languages can still ascend to the digital realm. We present evidence of a massive die-off caused by the digital divide.	Hungarian Acad Sci, Comp & Automat Res Inst, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Computer Science & Control	Kornai, A (corresponding author), Hungarian Acad Sci, Comp & Automat Res Inst, Budapest, Hungary.	andras@kornai.com	Kornai, Andras/H-6815-2012	Kornai, Andras/0000-0001-6078-6840	OTKA grant [82333]	OTKA grant(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	Work supported by OTKA grant #82333. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ad hoc technical expert group on indicators for assessing progress towards the 2010 biodiversity target UNEPCoBD, 2004, IND ASS PROGR 2010 T; Bickerton D., 1981, ROOTS LANGUAGE; Bloomfield L., 1927, AM SPEECH, V2, P432, DOI [10.2307/451863, DOI 10.2307/451863]; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cazden CB, 2003, NUTURING NATIVE LANGUAGES, P53; Crystal D, 2002, LANGUAGE DEATH; Darwin C., 1871, P423; Davies Anna Morpurgo, 1998, HIST LINGUISTICS; Dorian N.C., 1981, LANGUAGE DEATH LIFE; Fishman J.A., 1991, REVERSING LANGUAGE S, V76; FRANK R., BODY LANGUAGE MIND, V2; Ginsburgh V., 2011, MANY LANGUAGES DO WE; Hiddinga A, 2011, LANG SOC, V40, P483, DOI 10.1017/S0047404511000480; HOSMER DW, 1989, APPL LOGISTIC REGRES; Izreel S, 2003, CORPUS LINGUISTICS M, P85; Kegl J., 1994, SIGNPOST, V7, P24; KRAUSS M, 1992, LANGUAGE, V68, P4, DOI 10.1353/lan.1992.0075; Lewis MP, 2010, REV ROUM LINGUIST, V55, P103; Menard S., 2002, APPL LOGISTIC REGRES, DOI DOI 10.4135/9781412983433; Mosley C, 2010, ATLAS WORLDS LANGUAG; Nemeth L, 2004, P SALTMIL WORKSH LRE, P56; NETTLE DANIEL, 2000, VANISHING VOICES EXT; Pajkossy K, 2013, THESIS E LORAND U; Poser W, 2012, COMMUNICATION; Prensky Marc., 2001, HORIZON, V5, P1, DOI [10.1108/10748120110424816, DOI 10.1108/10748120110424816]; Proszeky G, 2005, INQUIRIES WORDS CONS, P116; Quakenbush JS, 2012, P 12 ICAL; Rehm G, 2012, NORWEGIAN LANGUAGE D; Scannell K. P., 2007, BUILDING EXPLORING W, V4, P5; SCHMIDT A, 1985, LANGUAGE, V61, P378, DOI 10.2307/414150; Senghas A, 2004, SCIENCE, V305, P1779, DOI 10.1126/science.1100199; Simons GF, 2013, GLOBAL PROFILE LANGU; Spice B, 2012, CARNEGIE MELLON RELE; Thangali A, 2011, PROC CVPR IEEE, P521, DOI 10.1109/CVPR.2011.5995718; Varga D., 2007, AMSTERDAM STUDIES TH, V4, P247, DOI DOI 10.1075/CILT.292.32VAR; Zseder A, 2012, LREC 2012 - EIGHTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P1462	36	47	49	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77056	10.1371/journal.pone.0077056	http://dx.doi.org/10.1371/journal.pone.0077056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167559	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500018
J	Srivastava, A; Goldberger, H; Dimtchev, A; Ramalinga, M; Chijioke, J; Marian, C; Oermann, EK; Uhm, S; Kim, JS; Chen, LN; Li, X; Berry, DL; Kallakury, BVS; Chauhan, SC; Collins, SP; Suy, S; Kumar, D				Srivastava, Anvesha; Goldberger, Helle; Dimtchev, Alexander; Ramalinga, Malathi; Chijioke, Juliet; Marian, Catalin; Oermann, Eric K.; Uhm, Sunghae; Kim, Joy S.; Chen, Leonard N.; Li, Xin; Berry, Deborah L.; Kallakury, Bhaskar V. S.; Chauhan, Subhash C.; Collins, Sean P.; Suy, Simeng; Kumar, Deepak			MicroRNA Profiling in Prostate Cancer - The Diagnostic Potential of Urinary miR-205 and miR-214	PLOS ONE			English	Article							DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA; EXPRESSION PATTERNS; ANDROGEN RECEPTOR; GROWTH-FACTOR; LUNG-CANCER; CELL-GROWTH; METASTASIS; CONTRIBUTES; PROGRESSION	Prostate cancer (PCa) is the most common type of cancer in men in the United States, which disproportionately affects African American descents. While metastasis is the most common cause of death among PCa patients, no specific markers have been assigned to severity and ethnic biasness of the disease. MicroRNAs represent a promising new class of biomarkers owing to their inherent stability and resilience. In the present study, we investigated potential miRNAs that can be used as biomarkers and/or therapeutic targets and can provide insight into the severity and ethnic biasness of PCa. PCR array was performed in FFPE PCa tissues (5 Caucasian American and 5 African American) and selected differentially expressed miRNAs were validated by qRT-PCR, in 40 (15 CA and 25 AA) paired PCa and adjacent normal tissues. Significantly deregulated miRNAs were also analyzed in urine samples to explore their potential as non-invasive biomarker for PCa. Out of 8 miRNAs selected for validation from PCR array data, miR-205 (p<0.0001), mir-214 (p<0.0001), miR-221(p<0.001) and miR-99b (p<0.0001) were significantly downregulated in PCa tissues. ROC curve shows that all four miRNAs successfully discriminated between PCa and adjacent normal tissues. MiR-99b showed significant down regulation (p<0.01) in AA PCa tissues as compared to CA PCa tissues and might be related to the aggressiveness associated with AA population. In urine, miR-205 (p<0.05) and miR-214 (p<0.05) were significantly downregulated in PCa patients and can discriminate PCa patients from healthy individuals with 89% sensitivity and 80% specificity. In conclusion, present study showed that miR-205 and miR-214 are downregulated in PCa and may serve as potential non-invasive molecular biomarker for PCa.	[Srivastava, Anvesha; Goldberger, Helle; Dimtchev, Alexander; Ramalinga, Malathi; Chijioke, Juliet; Kumar, Deepak] Univ Dist Columbia, Dept Biol Chem & Phys, Canc Res Lab, Washington, DC USA; [Marian, Catalin] Victor Babes Univ Med & Pharm Timisoara, Dept Biochem, Timisoara, Romania; [Oermann, Eric K.; Uhm, Sunghae; Kim, Joy S.; Chen, Leonard N.; Li, Xin; Berry, Deborah L.; Kallakury, Bhaskar V. S.; Collins, Sean P.; Suy, Simeng; Kumar, Deepak] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Chauhan, Subhash C.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA	University of the District of Columbia; Victor Babes University of Medicine & Pharmacy, Timisoara; Georgetown University; University of Tennessee System; University of Tennessee Health Science Center	Kumar, D (corresponding author), Univ Dist Columbia, Dept Biol Chem & Phys, Canc Res Lab, Washington, DC USA.	dkumar@udc.edu	Marian, Catalin/B-1750-2012; Marian, Catalin/P-2885-2019; Oermann, Eric/AAD-9729-2020	Marian, Catalin/0000-0002-7749-1384; Oermann, Eric/0000-0002-1876-5963; Li, Xin/0000-0002-7414-5734	NIH [CA162264, CA141935]; PCRP program of the CDMRP [PC111314];  [CA162264-02S1]; NATIONAL CANCER INSTITUTE [SC1CA141935, R21CA162264] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PCRP program of the CDMRP; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the NIH (CA162264 and CA141935) and PCRP program of the CDMRP (PC111314). JC is supported by supplement on CA162264-02S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Backer H, 1999, PERMANENTE J, V3, P30; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhatnagar N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.85; Bitting RL, 2013, ENDOCR-RELAT CANCER, V20, pR83, DOI 10.1530/ERC-12-0394; Boll K, 2013, ONCOGENE, V32, P277, DOI 10.1038/onc.2012.55; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Burgio SL, 2012, CURR CANCER DRUG TAR, V12, P940; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702; Chen C, 2013, CLIN CANCER RES, V19, P1693, DOI 10.1158/1078-0432.CCR-12-2940; Chen PC, 2012, CARCINOGENESIS, V33, P937, DOI 10.1093/carcin/bgs108; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; De Luca P, 2013, PROSTATE CANC PROSTA; Djulbegovic M, 2010, BMJ, V341; Epstein RJ, 2007, CANCER METAST REV, V26, P443, DOI 10.1007/s10555-007-9071-1; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Feber A, 2011, ANN THORAC SURG, V91, P1523, DOI 10.1016/j.athoracsur.2011.01.056; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gidlof O, 2013, BMC CARDIOVASC DISOR, V13, P12; Gimenes-Teixeira HL, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-10; Gordanpour A, 2011, ANTICANCER RES, V31, P403; Hagman Z, 2013, BRIT J CANCER, V108, P1668, DOI 10.1038/bjc.2013.131; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Hisaoka M, 2011, GENE CHROMOSOME CANC, V50, P137, DOI 10.1002/gcc.20837; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Hulf T, 2013, ONCOGENE, V32, P2891, DOI 10.1038/onc.2012.300; Hulf T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-54; Jansen FH, 2010, EUR UROL, V57, P921, DOI 10.1016/j.eururo.2010.02.003; Kang J, 2012, EXP THER MED, V3, P149, DOI 10.3892/etm.2011.366; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuner R, 2013, METHODS, V59, P132, DOI 10.1016/j.ymeth.2012.05.004; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li B, 2012, FEBS J, V279, P2393, DOI 10.1111/j.1742-4658.2012.08618.x; Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351; Lin PC, 2013, CANCER RES, V73, P1232, DOI 10.1158/0008-5472.CAN-12-2968; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzen JM, 2012, CLIN J AM SOC NEPHRO, V7, P1528, DOI 10.2215/CJN.01170212; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lupini Laura, 2013, Frontiers in Genetics, V4, P64, DOI 10.3389/fgene.2013.00064; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Mitra AK, 2012, CANCER DISCOV, V2, P1100, DOI 10.1158/2159-8290.CD-12-0206; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nassirpour R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062170; Nguyen HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/pros.22572; Nishiyama N, 2010, CANCER SCI, V101, P231, DOI 10.1111/j.1349-7006.2009.01330.x; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Puerta-Gil P, 2012, AM J PATHOL, V180, P1808, DOI 10.1016/j.ajpath.2012.01.034; Puhr M, 2012, AM J PATHOL, V181, P2188, DOI 10.1016/j.ajpath.2012.08.011; Rong MH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-21; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shariat SF, 2011, ACTA ONCOL, V50, P61, DOI 10.3109/0284186X.2010.542174; Shih TC, 2012, J HEPATOL, V57, P584, DOI 10.1016/j.jhep.2012.04.031; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Vaksman O, 2011, J CELL MOL MED, V15, P1593, DOI 10.1111/j.1582-4934.2010.01148.x; Verdoodt B, 2013, INT J ONCOL, V43, P307, DOI 10.3892/ijo.2013.1915; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; von Brandenstein M, 2012, AM J PATHOL, V180, P1787, DOI 10.1016/j.ajpath.2012.01.014; Wang F, 2013, FEBS LETT, V587, P488, DOI 10.1016/j.febslet.2013.01.016; Wang SY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-163; Wang XJ, 2012, BIOCHEM BIOPH RES CO, V428, P525, DOI 10.1016/j.bbrc.2012.10.039; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Wu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045825; Xia HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044206; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang XJ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-46	82	136	140	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76994	10.1371/journal.pone.0076994	http://dx.doi.org/10.1371/journal.pone.0076994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167554	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500013
J	Alarcon, GJC; Venegas, YR; Narvaez, LB; Martinez, OEP; Casanova, LG; Gallegos, SS; Vargas, AN; Ramirez, AMO; Suazo, FM				Canto Alarcon, Germinal J.; Rubio Venegas, Yezenia; Bojorquez Narvaez, Luis; Pizano Martinez, Oscar E.; Garcia Casanova, Leticia; Sosa Gallegos, Susana; Nava Vargas, Alejandro; Olvera Ramirez, Andrea M.; Milian Suazo, Feliciano			Efficacy of a Vaccine Formula against Tuberculosis in Cattle	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; BACILLE CALMETTE-GUERIN; POSSUM TRICHOSURUS-VULPECULA; IMMUNE-RESPONSES; NEONATAL CALVES; ENVIRONMENTAL MYCOBACTERIA; INDUCED PROTECTION; PRIME; BOOST; INFECTION	"Test-and-slaughter" has been successful in industrialized countries to control and eradicate tuberculosis from cattle; however, this strategy is too expensive for developing nations, where the prevalence is especially high. Vaccination with the Calmette-Guerin (BCG) strain has been shown to protect against the development of lesions in vaccinated animals: mouse, cattle and wildlife species. In this study, the immune response and the pathology of vaccinated (BCG-prime and BCG prime-CFP-boosted) and unvaccinated (controls) calves were evaluated under experimental settings. A 10(6) CFU dose of the BCG strain was inoculated subcutaneously on the neck to two groups of ten animas each. Thirty days after vaccination, one of the vaccinated groups was boosted with an M. bovis culture filtrate protein (CFP). Three months after vaccination, the three groups of animals were challenged with 5 x 10(5) CFU via intranasal by aerosol with a field strain of M. bovis. The immune response was monitored throughout the study. Protection was assessed based on immune response (IFN-g release) prechallenge, presence of visible lesions in lymph nodes and lungs at slaughter, and presence of bacilli in lymph nodes and lung samples in histological analysis. Vaccinated cattle, either with the BCG alone or with BCG and boosted with CFP showed higher IFN-g response, fewer lesions, and fewer bacilli per lesion than unvaccinated controls after challenge. Animals with low levels of IFN-g postvaccine-prechallenge showed more lesions than animals with high levels. Results from this study support the argument that vaccination could be incorporated into control programs to reduce the incidence of TB in cattle in countries with high prevalence.	[Canto Alarcon, Germinal J.; Rubio Venegas, Yezenia; Sosa Gallegos, Susana; Olvera Ramirez, Andrea M.; Milian Suazo, Feliciano] Univ Autonoma Queretaro, Fac Ciencias Nat, Queretaro, Qro, Mexico; [Bojorquez Narvaez, Luis] Prod Nacl Biol Vet PRONABIVE, Mexico City, DF, Mexico; [Pizano Martinez, Oscar E.; Garcia Casanova, Leticia; Nava Vargas, Alejandro] INIFAP, Ctr Nacl Invest Disciplinaria Fisiol & Mejoramien, Ajuchitlan, Qro, Mexico	Universidad Autonoma de Queretaro	Alarcon, GJC (corresponding author), Univ Autonoma Queretaro, Fac Ciencias Nat, Queretaro, Qro, Mexico.	gcanto07@uaq.mx		PIZANO, OSCAR/0000-0003-3635-7071				Ameni G, 2002, J IMMUNOASS IMMUNOCH, V23, P245, DOI 10.1081/IAS-120003664; Ameni G, 2010, CLIN VACCINE IMMUNOL, V17, P1533, DOI 10.1128/CVI.00222-10; Bawinec F, 1996, ASSESSMENT SOCIOECON; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Buddle BM, 1999, CLIN DIAGN LAB IMMUN, V6, P1; BUDDLE BM, 1995, VACCINE, V13, P1123, DOI 10.1016/0264-410X(94)00055-R; Buddle BM, 2006, VET MICROBIOL, V112, P191, DOI 10.1016/j.vetmic.2005.11.027; Buddle BM, 2005, VET IMMUNOL IMMUNOP, V108, P45, DOI 10.1016/j.vetimm.2005.08.002; Buddle BM, 2003, INT J PARASITOL, V33, P555, DOI 10.1016/S0020-7519(03)00060-2; Buddle BM, 2003, INFECT IMMUN, V71, P6411, DOI 10.1128/IAI.71.11.6411-6419.2003; Buddle BM, 2002, VACCINE, V20, P1126, DOI 10.1016/S0264-410X(01)00436-4; Buddle BM, 2007, CAB REV, V73, P1; Cai H, 2006, DNA CELL BIOL, V25, P438, DOI 10.1089/dna.2006.25.438; Castillo-Rodal AI, 2006, INFECT IMMUN, V74, P1718, DOI 10.1128/IAI.74.3.1718-1724.2006; Corner LAL, 2002, VET MICROBIOL, V84, P327, DOI 10.1016/S0378-1135(01)00461-8; Corner LAL, 2001, VET MICROBIOL, V81, P181, DOI 10.1016/S0378-1135(01)00344-3; Elias D, 2005, T ROY SOC TROP MED H, V99, P363, DOI 10.1016/j.trstmh.2004.08.006; ELLWOOD DC, 1972, BRIT VET J, V128, P619, DOI 10.1016/S0007-1935(17)36634-4; Ferraz JC, 2004, INFECT IMMUN, V72, P6945, DOI 10.1128/IAI.72.12.6945-6950.2004; FINE PEM, 2001, TUBERCULOSIS COMPREH, P503; FRANCIS J, 1950, LANCET, V258, P34; Hope JC, 2011, CLIN VACCINE IMMUNOL, V18, P373, DOI 10.1128/CVI.00543-10; Hope JC, 2008, COMP IMMUNOL MICROB, V31, P77, DOI 10.1016/j.cimid.2007.07.003; Hope JC, 2005, CLIN EXP IMMUNOL, V139, P48, DOI 10.1111/j.1365-2249.2005.02668.x; Kaneene JB, 2006, VET MICROBIOL, V112, P273, DOI 10.1016/j.vetmic.2005.11.018; Kipnis A, 2005, INFECT IMMUN, V73, P7759, DOI 10.1128/IAI.73.11.7759-7764.2005; Langermans JAM, 2001, P NATL ACAD SCI USA, V98, P11497, DOI 10.1073/pnas.201404898; Logan KE, 2005, VACCINE, V23, P5526, DOI 10.1016/j.vaccine.2005.07.037; McShane H, 2005, TUBERCULOSIS, V85, P47, DOI 10.1016/j.tube.2004.09.015; McShane H, 2005, MICROBES INFECT, V7, P962, DOI 10.1016/j.micinf.2005.03.009; Milian-Suazo F, 2011, RES VET SCI, V90, P419, DOI 10.1016/j.rvsc.2010.07.018; Milian-Suazo F, 2000, AM J VET RES, V61, P86, DOI 10.2460/ajvr.2000.61.86; Nader A, 1988, REV MED VET, V68, P46; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; Pollock JM, 2006, VET MICROBIOL, V112, P141, DOI 10.1016/j.vetmic.2005.11.032; Skinner MA, 2003, INFECT IMMUN, V71, P4901, DOI 10.1128/IAI.71.9.4901-4907.2003; Skinner MA, 2001, REV SCI TECH OIE, V20, P112, DOI 10.20506/rst.20.1.1276; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vordermeier HM, 2004, IMMUNOLOGY, V112, P461, DOI 10.1111/j.1365-2567.2004.01903.x; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vordermeier HM, 2006, VET J, V171, P229, DOI 10.1016/j.tvjl.2004.11.001; Vordermeier HM, 2006, INFECT IMMUN, V74, P1416, DOI 10.1128/IAI.74.2.1416-1418.2006; Vordermeier M, 2011, EXPERT REV VACCINES, V10, P1083, DOI [10.1586/erv.11.22, 10.1586/ERV.11.22]; Vordermeier M, 2011, VET MICROBIOL, V151, P8, DOI 10.1016/j.vetmic.2011.02.020; WADDINGTON FG, 1972, BRIT VET J, V128, P541, DOI 10.1016/S0007-1935(17)36683-6; Waters WR, 2010, CLIN VACCINE IMMUNOL, V17, P247, DOI 10.1128/CVI.00442-09; Wedlock DN, 2007, VET IMMUNOL IMMUNOP, V118, P50, DOI 10.1016/j.vetimm.2007.04.005; Wedlock DN, 2005, INFECT IMMUN, V73, P3540, DOI 10.1128/IAI.73.6.3540-3546.2005; Wedlock DN, 2003, TUBERCULOSIS, V83, P339, DOI 10.1016/S1472-9792(03)00055-6	49	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76418	10.1371/journal.pone.0076418	http://dx.doi.org/10.1371/journal.pone.0076418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204624	Green Published, gold			2022-12-27	WOS:000326029300027
J	Halder, S; Ruf, CA; Furdea, A; Pasqualotto, E; De Massari, D; van der Heiden, L; Bogdan, M; Rosenstiel, W; Birbaumer, N; Kubler, A; Matuz, T				Halder, Sebastian; Ruf, Carolin Anne; Furdea, Adrian; Pasqualotto, Emanuele; De Massari, Daniele; van der Heiden, Linda; Bogdan, Martin; Rosenstiel, Wolfgang; Birbaumer, Niels; Kuebler, Andrea; Matuz, Tamara			Prediction of P300 BCI Aptitude in Severe Motor Impairment	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; AMYOTROPHIC-LATERAL-SCLEROSIS; EVENT-RELATED POTENTIALS; SELECTIVE ATTENTION; COMMUNICATION; CLASSIFICATION; PERFORMANCE; COMPONENT; ALS; TOPOGRAPHY	Brain-computer interfaces (BCIs) provide a non-muscular communication channel for persons with severe motor impairments. Previous studies have shown that the aptitude with which a BCI can be controlled varies from person to person. A reliable predictor of performance could facilitate selection of a suitable BCI paradigm. Eleven severely motor impaired participants performed three sessions of a P300 BCI web browsing task. Before each session auditory oddball data were collected to predict the BCI aptitude of the participants exhibited in the current session. We found a strong relationship of early positive and negative potentials around 200 ms (elicited with the auditory oddball task) with performance. The amplitude of the P2 (r = -0.77) and of the N2 (r = -0.86) had the strongest correlations. Aptitude prediction using an auditory oddball was successful. The finding that the N2 amplitude is a stronger predictor of performance than P3 amplitude was reproduced after initially showing this effect with a healthy sample of BCI users. This will reduce strain on the end-users by minimizing the time needed to find suitable paradigms and inspire new approaches to improve performance.	[Halder, Sebastian; Kuebler, Andrea] Univ Wurzburg, Inst Psychol, D-97070 Wurzburg, Germany; [Halder, Sebastian; Ruf, Carolin Anne; Furdea, Adrian; De Massari, Daniele; van der Heiden, Linda; Birbaumer, Niels; Matuz, Tamara] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Halder, Sebastian; Bogdan, Martin; Rosenstiel, Wolfgang] Univ Tubingen, Dept Comp Engn, Tubingen, Germany; Catholic Univ Louvain, Psychol Sci Res Inst, B-1348 Louvain, Belgium; [De Massari, Daniele; Birbaumer, Niels] Osped San Camillo, Ist Ricovero & Cura Carattere Sci Fdn, Venice, Italy; [Bogdan, Martin] Univ Leipzig, D-04109 Leipzig, Germany; [De Massari, Daniele] Int Max Planck Res Sch, Grad Training Ctr Neurosci, Tubingen, Germany; [van der Heiden, Linda] Univ Finance & Management, Dept Cognit Psychol, Warsaw, Poland	University of Wurzburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Universite Catholique Louvain; Fondazione IRCCS Istituto Nazionale Tumori Milan; Leipzig University; Max Planck Society; University of Finance & Management Warsaw	Halder, S (corresponding author), Univ Wurzburg, Inst Psychol, D-97070 Wurzburg, Germany.	sebastian.halder@uni-wuerzburg.de	Halder, Sebastian/G-3745-2012; Halder, Sebastian/J-6144-2019	Halder, Sebastian/0000-0003-1017-3696; Birbaumer, Niels/0000-0002-6786-5127; Kubler, Andrea/0000-0003-4876-0415	European ICT Programme Project FP7 [224631, SFB 550/B5, C6]; BMBF (Bundesministerium fuer Bildung und Forschung) Bernstein Center for Neurocomputation [Nr 01GQ0831]; European Research Council [ERC 227632-BCCI]; Deutsche Forschungsgemeinschaft [DFG Bi 195/58-1]; Centre for Integrative Neuroscience (CIN) Pool-project [2010-05]; European Community [288566]; German Research Foundation (DFG); University of Wuerzburg	European ICT Programme Project FP7; BMBF (Bundesministerium fuer Bildung und Forschung) Bernstein Center for Neurocomputation(Federal Ministry of Education & Research (BMBF)); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre for Integrative Neuroscience (CIN) Pool-project; European Community(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work is supported by the European ICT Programme Project FP7-224631, SFB 550/B5 and C6, BMBF (Bundesministerium fuer Bildung und Forschung) Bernstein Center for Neurocomputation (Nr 01GQ0831), the European Research Council Grant (ERC 227632-BCCI), Deutsche Forschungsgemeinschaft (DFG Bi 195/58-1) and Centre for Integrative Neuroscience (CIN) Pool-project 2010-05. The research leading to these results has also received funding from the European Community's Seventh Framework Programme FP7/2007-2013, BackHome project grant agreement number 288566. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1997, J NEUROL SCI, V148, P95, DOI 10.1016/S0022-510X(96)05338-5; [Anonymous], 1991, J CLIN NEUROPHYSIOL, V8, P200, DOI 10.1097/00004691-199104000-00007; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Brouwer AM, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00019; Burde W, 2006, P 3 INT BRAIN COMP I, P76; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Choularton S, 2004, P SST, V4; Cichocki A, 2005, CLIN NEUROPHYSIOL, V116, P729, DOI 10.1016/j.clinph.2004.09.017; Cipresso P, 2012, BRAIN BEHAV, V2, P479, DOI 10.1002/brb3.57; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; De Massari D, 2013, BRAIN, V136, P1989, DOI 10.1093/brain/awt102; De Massari D, 2013, BIOL PSYCHOL, V92, P267, DOI 10.1016/j.biopsycho.2012.10.015; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Furdea A, 2012, J NEUROSCI METH, V203, P233, DOI 10.1016/j.jneumeth.2011.09.013; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Halder S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00105; Halder S, 2011, NEUROIMAGE, V55, P1779, DOI 10.1016/j.neuroimage.2011.01.021; HALDER S, 2013, PLOS ONE, V7, DOI DOI 10.3389/FNHUM.2013.00105; Halder S, 2011, P 5 INT BRAIN COMP I, P144; Halder S, 2008, P 4 INT BRAIN COMP I, P8; Halder Sebastian, 2007, Comput Intell Neurosci, P82069, DOI 10.1155/2007/82069; Hammer EM, 2012, BIOL PSYCHOL, V89, P80, DOI 10.1016/j.biopsycho.2011.09.006; Hanagasi HA, 2002, COGNITIVE BRAIN RES, V14, P234, DOI 10.1016/S0926-6410(02)00110-6; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Hopkins RO, 2005, CURR OPIN CRIT CARE, V11, P369, DOI 10.1097/01.ccx.0000166399.88635.a5; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Katayama J, 1999, CLIN NEUROPHYSIOL, V110, P463, DOI 10.1016/S1388-2457(98)00035-2; Kaufmann T, 2013, FRONTIERS NEUROSCIEN; Kaufmann T, 2013, CLIN NEUROPHYSIOL, V124, P893, DOI 10.1016/j.clinph.2012.11.006; Kaufmann T, 2012, INT J PSYCHOPHYSIOL, V83, P336, DOI 10.1016/j.ijpsycho.2011.11.018; Kleih SC, 2010, CLIN NEUROPHYSIOL, V121, P1023, DOI 10.1016/j.clinph.2010.01.034; Kotchoubey B, 2003, EUR J NEUROL, V10, P551, DOI 10.1046/j.1468-1331.2003.00647.x; Kotchoubey B, 2001, NEUROSCI LETT, V301, P37, DOI 10.1016/S0304-3940(01)01600-7; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Kubler A, 2004, J PSYCHOPHYSIOL, V18, P121, DOI 10.1027/0269-8803.18.23.121; Kubler A, 2001, ARCH PHYS MED REHAB, V82, P1533, DOI 10.1053/apmr.2001.26621; Kubler A., 2011, P 5 INT BRAIN COMPUT, P100; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; LANG T, 1991, IEEE T CIRCUITS SYST, V38, P499, DOI 10.1109/31.76486; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Mak JN, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026014; Mellinger J, 2007, NEUROIMAGE, V36, P581, DOI 10.1016/j.neuroimage.2007.03.019; MICHIE PT, 1993, PSYCHOPHYSIOLOGY, V30, P205, DOI 10.1111/j.1469-8986.1993.tb01733.x; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Morita M, 2006, NEUROLOGY, V66, P839, DOI 10.1212/01.wnl.0000200048.53766.b4; Mugler EM, 2010, IEEE T NEUR SYS REH, V18, P599, DOI 10.1109/TNSRE.2010.2068059; Murguialday AR, 2011, CLIN NEUROPHYSIOL, V122, P925, DOI 10.1016/j.clinph.2010.08.019; Neumann N, 2003, J NEUROL NEUROSUR PS, V74, P1117, DOI 10.1136/jnnp.74.8.1117; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Ogawa T, 2009, CLIN NEUROPHYSIOL, V120, P659, DOI 10.1016/j.clinph.2009.01.013; Paulus KS, 2002, CLIN NEUROPHYSIOL, V113, P853, DOI 10.1016/S1388-2457(02)00082-2; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnpro.2010.00003; Piccione F, 2006, CLIN NEUROPHYSIOL, V117, P531, DOI 10.1016/j.clinph.2005.07.024; Pinkhardt EH, 2008, J NEUROL, V255, P532, DOI 10.1007/s00415-008-0734-9; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Polich J, 1997, BRAIN TOPOGR, V9, P275, DOI 10.1007/BF01464482; Polich J, 1996, INT J PSYCHOPHYSIOL, V23, P55, DOI 10.1016/0167-8760(96)00028-1; Raaphorst J, 2010, AMYOTROPH LATERAL SC, V11, P27, DOI 10.3109/17482960802645008; Raggi A, 2008, CLIN NEUROPHYSIOL, V119, P342, DOI 10.1016/j.clinph.2007.10.010; RIF J, 1991, ELECTROEN CLIN NEURO, V79, P464, DOI 10.1016/0013-4694(91)90166-2; Ruf CA, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00023; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Silvoni S, 2013, AMYOTROPH LATERAL SC; Sitaram Ranganatha, 2007, Comput Intell Neurosci, P25487, DOI 10.1155/2007/25487; Sorger B, 2009, PROG BRAIN RES, V177, P275, DOI 10.1016/S0079-6123(09)17719-1; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Spuler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051077; SQUIRES NK, 1977, J EXP PSYCHOL HUMAN, V3, P299, DOI 10.1037/0096-1523.3.2.299; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; van Gerven M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/041001; VIDAL JJ, 1973, ANNU REV BIOPHYS BIO, V2, P157, DOI 10.1146/annurev.bb.02.060173.001105; Vieregge P, 1999, COGNITIVE BRAIN RES, V8, P27, DOI 10.1016/S0926-6410(99)00004-X; Volpato C, 2010, J CLIN NEUROPHYSIOL, V27, P198, DOI 10.1097/WNP.0b013e3181e0aa14; Vuckovic A, 2013, CLIN NEUROPHYSIOL, V124, P1586, DOI 10.1016/j.clinph.2013.02.016; Wriessnegger SC, 2008, INT J PSYCHOPHYSIOL, V67, P54, DOI 10.1016/j.ijpsycho.2007.10.004; Zickler C, 2011, CLIN EEG NEUROSCI, V42, P236, DOI 10.1177/155005941104200409	87	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76148	10.1371/journal.pone.0076148	http://dx.doi.org/10.1371/journal.pone.0076148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239MM	24204597	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300010
J	Kesse-Guyot, E; Peneau, S; Mejean, C; de Edelenyi, FS; Galan, P; Hercberg, S; Lairon, D				Kesse-Guyot, Emmanuelle; Peneau, Sandrine; Mejean, Caroline; de Edelenyi, Fabien Szabo; Galan, Pilar; Hercberg, Serge; Lairon, Denis			Profiles of Organic Food Consumers in a Large Sample of French Adults: Results from the Nutrinet-Sante Cohort Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; NUTRITION; HEALTH; RELIABILITY; PATTERNS; NUTRIENT; QUALITY; OBESITY	Background: Lifestyle, dietary patterns and nutritional status of organic food consumers have rarely been described, while interest for a sustainable diet is markedly increasing. Methods: Consumer attitude and frequency of use of 18 organic products were assessed in 54,311 adult participants in the Nutrinet-Sante cohort. Cluster analysis was performed to identify behaviors associated with organic product consumption. Socio-demographic characteristics, food consumption and nutrient intake across clusters are provided. Cross-sectional association with overweight/obesity was estimated using polytomous logistic regression. Results: Five clusters were identified: 3 clusters of non-consumers whose reasons differed, occasional (OCOP, 51%) and regular (RCOP, 14%) organic product consumers. RCOP were more highly educated and physically active than other clusters. They also exhibited dietary patterns that included more plant foods and less sweet and alcoholic beverages, processed meat or milk. Their nutrient intake profiles (fatty acids, most minerals and vitamins, fibers) were healthier and they more closely adhered to dietary guidelines. In multivariate models (after accounting for confounders, including level of adherence to nutritional guidelines), compared to those not interested in organic products, RCOP participants showed a markedly lower probability of overweight (excluding obesity) (25 <= body mass index<30) and obesity (body mass index >= 30): -36% and -62% in men and -42% and -48% in women, respectively (P<0.0001). OCOP participants (%) generally showed intermediate figures. Conclusions: Regular consumers of organic products, a sizeable group in our sample, exhibit specific socio-demographic characteristics, and an overall healthy profile which should be accounted for in further studies analyzing organic food intake and health markers.	[Kesse-Guyot, Emmanuelle; Peneau, Sandrine; Mejean, Caroline; de Edelenyi, Fabien Szabo; Galan, Pilar; Hercberg, Serge] Univ Paris 13, Sorbonne Paris Cite Res Ctr, INSERM, U557,Inra,U1125,Cnam,Unite Rech Epidemiol Nutr, Bobigny, France; [Hercberg, Serge] Hop Avicenne, Dept Sante Publ, F-93009 Bobigny, France; [Lairon, Denis] Aix Marseille Univ, NORT, INSERM, UMR S 1062,INRA,UMR 1260, Marseille, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Kesse-Guyot, E (corresponding author), Univ Paris 13, Sorbonne Paris Cite Res Ctr, INSERM, U557,Inra,U1125,Cnam,Unite Rech Epidemiol Nutr, Bobigny, France.	e.kesse@uren.smbh.univ-paris13.fr	Pilar, Galan/F-2908-2017; Peneau, Sandrine/F-2701-2017; HERCBERG, Serge/B-4429-2008; Kesse-Guyot, Emmanuelle/K-4689-2012; Serge, Hercberg/F-3038-2017; Kesse-Guyot, Emmanuelle/ABH-7347-2020; Szabo de Edelenyi, Fabien/F-2715-2017; Mejean, Caroline/F-2792-2017; Kesse-Guyot, Emmanuelle/F-2692-2017	Pilar, Galan/0000-0003-1706-3107; Peneau, Sandrine/0000-0002-3463-0989; HERCBERG, Serge/0000-0002-3168-1350; Serge, Hercberg/0000-0002-3168-1350; Szabo de Edelenyi, Fabien/0000-0002-8487-6557; Mejean, Caroline/0000-0001-6467-5056; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Lairon, Denis/0000-0001-9941-3742	French Ministry of Health; Institut de Veille Sanitaire; Institut National de la Sante et de la Recherche Medicale; Institut National de la Recherche Agronomique; Conservatoire National des Arts et Metiers; Institut National de Prevention et d'Education pour la Sante; Fondation pour la Recherche Medicale; Paris 13 University	French Ministry of Health; Institut de Veille Sanitaire; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique; Conservatoire National des Arts et Metiers; Institut National de Prevention et d'Education pour la Sante; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Paris 13 University	The NutriNet-Sante Study is supported by the French Ministry of Health, the Institut de Veille Sanitaire, the Institut National de la Sante et de la Recherche Medicale, the Institut National de la Recherche Agronomique, the Conservatoire National des Arts et Metiers, the Institut National de Prevention et d'Education pour la Sante and the Fondation pour la Recherche Medicale and Paris 13 University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFSSA, 2003, REP EV NUTR SAN QUAL; Agriculture and rural development ministry website, ORG CONS PROF; [Anonymous], 2012, SUSTAINABLE DIETS BI; Arvola A, 2008, APPETITE, V50, P443, DOI 10.1016/j.appet.2007.09.010; Benbrook C, 2009, J AM DIET ASSOC, V109, P809, DOI 10.1016/j.jada.2009.03.019; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Brandt K, 2011, CRIT REV PLANT SCI, V30, P177, DOI 10.1080/07352689.2011.554417; Brown E, 2009, APPETITE, V53, P183, DOI 10.1016/j.appet.2009.06.006; Chauliac Michel, 2009, Rev Prat, V59, P10; CNERNA CNRS, 2000, APP NUTR CONS POP FR; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dangour AD, 2010, AM J CLIN NUTR, V92, P203, DOI 10.3945/ajcn.2010.29269; Der G, 2002, HDB STAT ANAL USING; Dirinck E, 2011, OBESITY, V19, P709, DOI 10.1038/oby.2010.133; Estaquio C, 2009, J AM DIET ASSOC, V109, P1031, DOI 10.1016/j.jada.2009.03.012; FSA (Food Standard Agency) (UK), 2009, COMP COMP NUTR OTH S; Gomiero T, 2011, CRIT REV PLANT SCI, V30, P95, DOI 10.1080/07352689.2011.554355; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Hallal PC, 2004, MED SCI SPORT EXER, V36, P556, DOI 10.1249/01.MSS.0000117161.66394.07; Hercberg S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-242; Hoefkens C, 2010, FOOD CHEM TOXICOL, V48, P3058, DOI 10.1016/j.fct.2010.07.044; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hughner RS, 2012, J CONSUM BEHAV, V6, P94; INSEE (Institut National de la Statistique et des Etudes Economiques) website, FRENCH NAT CENS DAT; Joint WHO/FAO Expert Consultation, 2003, DIET NUTR PREV CHRON; Kahl J, 2012, J SCI FOOD AGR, V92, P2760, DOI 10.1002/jsfa.5640; Khattree R., 2000, MULTIVARIATE DATA RE; Lairon D., 2012, Sustainable Diets and Biodiversity: Directions and Solutions for Policy, Research and Action. International Scientific Symposium, Biodiversity and Sustainable Diets United Against Hunger, FAO Headquarters, Rome, Italy, 3-5 November 2010, P30; Lairon D, 2013, FOOD QUALIT IN PRESS; LAIRON D, 2010, AGRON SUSTAIN DEV, V30, P33, DOI DOI 10.1051/AGRO/2009019; Lee DH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015977, 10.1371/journal.pone.0026172]; Legrand P, 2011, WORLD REV NUTR DIET, V102, P137, DOI 10.1159/000327800; Macdiarmid JI, 2012, AM J CLIN NUTR, V96, P632, DOI 10.3945/ajcn.112.038729; Maillot M, 2011, AM J CLIN NUTR, V94, P1127, DOI 10.3945/ajcn.111.016501; Moullec N. le, 1996, Cahiers de Nutrition et de Dietetique, V31, P158; Oates L, 2012, J SCI FOOD AGR, V92, P2782, DOI 10.1002/jsfa.5664; Organic World Website, KEY RES WORLD ORG AG; Rembialkowska E, 2007, J SCI FOOD AGR, V87, P2757, DOI 10.1002/jsfa.3000; Rothman K.J., 2008, MODERN EPIDEMIOLOGY, P128; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Simioni M, 2009, J AGR FOOD IND ORG, V7, P1, DOI 10.22004/ag.econ.53342; Smith-Spangler C, 2012, ANN INTERN MED, V157, P348, DOI 10.7326/0003-4819-157-5-201209040-00007; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Touvier M, 2011, BRIT J NUTR, V105, P1055, DOI 10.1017/S0007114510004617; Touvier M, 2010, EUR J EPIDEMIOL, V25, P287, DOI 10.1007/s10654-010-9433-9; van de Vijver LPL, 2012, J SCI FOOD AGR, V92, P2923, DOI 10.1002/jsfa.5614; Vergnaud AC, 2011, INT J PUBLIC HEALTH, V56, P407, DOI 10.1007/s00038-011-0257-5; WHO Europe, 2007, CHALL OB WHO EUR REG	48	83	85	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76998	10.1371/journal.pone.0076998	http://dx.doi.org/10.1371/journal.pone.0076998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204721	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300074
J	Ranger, M; Chau, CMY; Garg, A; Woodward, TS; Beg, MF; Bjornson, B; Poskitt, K; Fitzpatrick, K; Synnes, AR; Miller, SP; Grunau, RE				Ranger, Manon; Chau, Cecil M. Y.; Garg, Amanmeet; Woodward, Todd S.; Beg, Mirza Faisal; Bjornson, Bruce; Poskitt, Kenneth; Fitzpatrick, Kevin; Synnes, Anne R.; Miller, Steven P.; Grunau, Ruth E.			Neonatal Pain-Related Stress Predicts Cortical Thickness at Age 7 Years in Children Born Very Preterm	PLOS ONE			English	Article							PREEMPTIVE MORPHINE ANALGESIA; REGIONAL CEREBRAL DEVELOPMENT; PRINCIPAL COMPONENT ANALYSIS; LONG-TERM CONSEQUENCES; SURFACE-BASED ANALYSIS; INFLAMMATORY PAIN; PREMATURE-INFANTS; BRAIN-DEVELOPMENT; PROCEDURAL PAIN; MATERNAL-CARE	Background: Altered brain development is evident in children born very preterm (24-32 weeks gestational age), including reduction in gray and white matter volumes, and thinner cortex, from infancy to adolescence compared to term-born peers. However, many questions remain regarding the etiology. Infants born very preterm are exposed to repeated procedural pain-related stress during a period of very rapid brain development. In this vulnerable population, we have previously found that neonatal pain-related stress is associated with atypical brain development from birth to term-equivalent age. Our present aim was to evaluate whether neonatal pain-related stress (adjusted for clinical confounders of prematurity) is associated with altered cortical thickness in very preterm children at school age. Methods: 42 right-handed children born very preterm (24-32 weeks gestational age) followed longitudinally from birth underwent 3-D T1 MRI neuroimaging at mean age 7.9 yrs. Children with severe brain injury and major motor/sensory/cognitive impairment were excluded. Regional cortical thickness was calculated using custom developed software utilizing FreeSurfer segmentation data. The association between neonatal pain-related stress (defined as the number of skin-breaking procedures) accounting for clinical confounders (gestational age, illness severity, infection, mechanical ventilation, surgeries, and morphine exposure), was examined in relation to cortical thickness using constrained principal component analysis followed by generalized linear modeling. Results: After correcting for multiple comparisons and adjusting for neonatal clinical factors, greater neonatal pain-related stress was associated with significantly thinner cortex in 21/66 cerebral regions (p-values ranged from 0.00001 to 0.014), predominately in the frontal and parietal lobes. Conclusions: In very preterm children without major sensory, motor or cognitive impairments, neonatal pain-related stress appears to be associated with thinner cortex in multiple regions at school age, independent of other neonatal risk factors.	[Ranger, Manon; Woodward, Todd S.; Bjornson, Bruce; Poskitt, Kenneth; Synnes, Anne R.; Miller, Steven P.; Grunau, Ruth E.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Ranger, Manon; Chau, Cecil M. Y.; Bjornson, Bruce; Poskitt, Kenneth; Fitzpatrick, Kevin; Synnes, Anne R.; Miller, Steven P.; Grunau, Ruth E.] Child & Family Res Inst, Vancouver, BC, Canada; [Chau, Cecil M. Y.; Woodward, Todd S.] BC Mental Hlth & Addict Res Inst, Vancouver, BC, Canada; [Garg, Amanmeet; Beg, Mirza Faisal] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Synnes, Anne R.; Grunau, Ruth E.] BC Childrens & Womens Hosp, Vancouver, BC, Canada; [Miller, Steven P.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Miller, Steven P.] Univ Toronto, Toronto, ON, Canada	University of British Columbia; Child & Family Research Institute; Simon Fraser University; University of British Columbia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Grunau, RE (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	rgrunau@cw.bc.ca	Bjornson, Bruce Hal/A-8616-2010; Ranger, Manon/AAN-6753-2021	Bjornson, Bruce Hal/0000-0002-1465-6196; Ranger, Manon/0000-0001-8253-0686; Beg, Mirza Faisal/0000-0001-6706-8630; Miller, Steven/0000-0001-9102-9105; Woodward, Todd/0000-0001-8083-0079; Grunau, Ruth/0000-0002-5428-9212	Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD/NIH) [RO1 HD039783]; Canadian Institutes for Health Research (CIHR) [MOP86489, MOP79262]; Child & Family Research Institute; Bloorview Children's Hospital Chair in Paediatric Neuroscience; CIHR; Pain In Child Health CIHR Strategic Training Initiative in Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD039783] Funding Source: NIH RePORTER	Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD/NIH); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Child & Family Research Institute; Bloorview Children's Hospital Chair in Paediatric Neuroscience; CIHR(Canadian Institutes of Health Research (CIHR)); Pain In Child Health CIHR Strategic Training Initiative in Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD/NIH) grant RO1 HD039783 [R.E.G], the Canadian Institutes for Health Research (CIHR) grants MOP86489 [R.E.G.] and MOP79262 [R.E.G., S.P.M.]. Salary support includes a Senior Scientist award, Child & Family Research Institute [R.E.G]; Bloorview Children's Hospital Chair in Paediatric Neuroscience [S. P. M]; Post-doctoral Fellowships, CIHR and Pain In Child Health CIHR Strategic Training Initiative in Health Research [M.R.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand KJS, 2007, PEDIATR RES, V62, P283, DOI 10.1203/PDR.0b013e3180986d2f; Anand KJS, 1999, PHYSIOL BEHAV, V66, P627, DOI 10.1016/S0031-9384(98)00338-2; Anand KJS, 2004, LANCET, V363, P1673, DOI 10.1016/S0140-6736(04)16251-X; Anand KJS, 2000, PROG BRAIN RES, V122, P117; [Anonymous], 2008, PAIN, DOI DOI 10.1016/B978-012370880-9.00188-2; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Bellu R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004212.pub3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhutta AT, 2001, PHYSIOL BEHAV, V73, P51, DOI 10.1016/S0031-9384(01)00432-2; Bramen JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033850; Brummelte S, 2006, HORM BEHAV, V50, P370, DOI 10.1016/j.yhbeh.2006.04.008; Brummelte S, 2012, ANN NEUROL, V71, P385, DOI 10.1002/ana.22267; Casey KL, 2000, J NEUROPHYSIOL, V84, P525, DOI 10.1152/jn.2000.84.1.525; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Clarkson MJ, 2011, NEUROIMAGE, V57, P856, DOI 10.1016/j.neuroimage.2011.05.053; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Graaf J, 2013, PAIN, V154, P449, DOI 10.1016/j.pain.2012.12.006; de Graaf J, 2011, PAIN, V152, P1391, DOI 10.1016/j.pain.2011.02.017; de Medeiros CB, 2009, PEDIATR RES, V66, P272, DOI 10.1203/PDR.0b013e3181b1be06; Dean JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004669; Derbyshire SWG, 2007, NEUROIMAG CLIN N AM, V17, P485, DOI 10.1016/j.nic.2007.09.004; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Doesburg SM, 2013, PAIN, V154, P1946, DOI 10.1016/j.pain.2013.04.009; Doesburg SM, 2010, IFMBE PROC, V28, P250; Doesburg SM, 2011, PEDIATR RES, V70, P171, DOI 10.1203/PDR.0b013e3182225a9e; Duhrsen L, 2013, NEONATOLOGY, V103, P35, DOI 10.1159/000341769; Efron B., 1994, INTRO BOOTSTRAP; Ferguson SA, 2012, NEUROTOXICOL TERATOL, V34, P47, DOI 10.1016/j.ntt.2011.10.008; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Gibson E, 2009, ORG HUM BRAIN MAPP 1; Grunau RE, 2005, PAIN, V113, P293, DOI 10.1016/j.pain.2004.10.020; Grunau RE, 2007, J PEDIATR-US, V150, P151, DOI 10.1016/j.jpeds.2006.10.053; Grunau RE, 2006, SEMIN FETAL NEONAT M, V11, P268, DOI 10.1016/j.siny.2006.02.007; Grunau RE, 2009, PAIN, V143, P138, DOI 10.1016/j.pain.2009.02.014; Hamilton LS, 2007, NEUROREPORT, V18, P1427, DOI 10.1097/WNR.0b013e3282e9a5a2; Hatfield T, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.027; HODGE CJ, 1990, CRIT REV NEUROBIOL, V5, P363; Hohmeister J, 2010, PAIN, V150, P257, DOI 10.1016/j.pain.2010.04.004; Hunter M, 2002, J EDUC BEHAV STAT, V27, P41; Johnston CC, 1997, CLIN J PAIN, V13, P308, DOI 10.1097/00002508-199712000-00008; Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K; Juul SE, 2011, PEDIATR RES, V69, P285, DOI 10.1203/PDR.0b013e31820bd165; Kesler SR, 2008, J PEDIATR-US, V152, P513, DOI 10.1016/j.jpeds.2007.08.009; Kesler SR, 2004, PEDIATR NEUROL, V31, P318, DOI 10.1016/j.pediatrneurol.2004.06.008; Laprairie JL, 2008, PEDIATR RES, V64, P625, DOI 10.1203/PDR.0b013e31818702d4; Lax I, 2012, BRAIN STRUCT FUNCT, P1; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Low LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034316; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maccari S, 2007, PSYCHONEUROENDOCRINO, V32, pS10, DOI 10.1016/j.psyneuen.2007.06.005; Martinussen M, 2005, BRAIN, V128, P2588, DOI 10.1093/brain/awh610; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Miller SP, 2002, J MAGN RESON IMAGING, V16, P621, DOI 10.1002/jmri.10205; Nagy Z, 2011, CEREB CORTEX, V21, P300, DOI 10.1093/cercor/bhq095; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Nosarti C, 2011, HUM BRAIN MAPP, V32, P1615, DOI 10.1002/hbm.21133; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Phillips JP, 2011, PEDIATR NEUROL, V45, P215, DOI 10.1016/j.pediatrneurol.2011.06.001; Pryce CR, 2001, BEHAV NEUROSCI, V115, P71, DOI 10.1037//0735-7044.115.1.71; Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608; Rogers CE, 2012, J AM ACAD CHILD PSY, V51, P181, DOI 10.1016/j.jaac.2011.11.009; Roze JC, 2008, ARCH PEDIAT ADOL MED, V162, P728, DOI 10.1001/archpedi.162.8.728; Schlaepfer TE, 1998, AM J PSYCHIAT, V155, P470, DOI 10.1176/ajp.155.4.470; SHAO J, 1995, JACKNIFE BOOTSTRAP; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Simons SHP, 2003, JAMA-J AM MED ASSOC, V290, P2419, DOI 10.1001/jama.290.18.2419; Skranes J, 2012, EARLY HUM DEV, V88, P103, DOI 10.1016/j.earlhumdev.2011.07.017; Slater R, 2010, NEUROIMAGE, V52, P583, DOI 10.1016/j.neuroimage.2010.04.253; Smith GC, 2011, ANN NEUROL, V70, P541, DOI 10.1002/ana.22545; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; TAKANE Y, 1991, PSYCHOMETRIKA, V56, P97, DOI 10.1007/BF02294589; Takane Y, 2001, APPL ALGEBR ENG COMM, V12, P391, DOI 10.1007/s002000100081; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tukey JW, 1977, EXPLORATORY DATA ANA; Vinall J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004666; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Walker CD, 2008, PAIN, V140, P167, DOI 10.1016/j.pain.2008.08.004; Wechsler D, 1974, WECHSLER INTELLIGENC; Yezzi AJ, 2003, IEEE T MED IMAGING, V22, P1332, DOI 10.1109/TMI.2003.817775; Zubiaurre-Elorza L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042148; Zwicker JG, 2013, PEDIATR NEUROL, V48, P123, DOI 10.1016/j.pediatrneurol.2012.10.016	84	140	145	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76702	10.1371/journal.pone.0076702	http://dx.doi.org/10.1371/journal.pone.0076702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204657	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300044
J	Wang, KY; Chau, TT				Wang, Kuo-Ying; Chau, Tang-Tat			An Association between Air Pollution and Daily Outpatient Visits for Respiratory Disease in a Heavy Industry Area	PLOS ONE			English	Article							HOSPITAL ADMISSIONS; ALLERGIC RHINITIS; SUBTROPICAL CITY; ASTHMA; TAIPEI; CONSULTATIONS; QUALITY; MORTALITY; LONDON	In this work we used daily outpatient data from the Landseed Hospital in a heavily industrial area in northern Taiwan to study the associations between daily outpatient visits and air pollution in the context of a heavily polluted atmospheric environment in Chung-Li area during the period 2007-2011. We test the normality of each data set, control for the confounding factors, and calculate correlation coefficient between the outpatient visits and air pollution and meteorology, and use multiple linear regression analysis to seek significance of these associations. Our results show that temperature and relative humidity tend to be negatively associated with respiratory diseases. NO and NO2 are two main air pollutants that are positively associated with respiratory diseases, followed by PM10, PM2.5, O-3, CO, and SO2. Young outpatients (age 0-15 years) are most sensitive to changing air pollution and meteorology factors, followed by the eldest (age >= 66 years) and age 16-65 years of outpatients. Outpatients for COPD diseases are most sensitive to air pollution and meteorology factors, followed by allergic rhinitis, asthma, and pneumonia diseases. In the context of sex difference to air pollution and meteorological factors, male outpatients are more sensitive than female outpatients in the 16-65 age groups, while female outpatients are more sensitive than male outpatients in the young 0-15 age groups and in the eldest age groups. In total, female outpatients are more sensitive to air pollution and meteorological factors than male outpatients.	[Wang, Kuo-Ying] Natl Cent Univ, Dept Atmospher Sci, Chungli 32054, Taiwan; [Chau, Tang-Tat] Taiwan Landseed Hosp, Dept Community Med, Ping Jen, Taiwan	National Central University	Wang, KY (corresponding author), Natl Cent Univ, Dept Atmospher Sci, Chungli 32054, Taiwan.	kuoying@mail.atm.ncu.edu.tw			National Central University-Landseed Hospital [100-A-004, 101-A-006]	National Central University-Landseed Hospital	This work was supported by National Central University-Landseed Hospital-100-A-004 and National Central University-Landseed Hospital-101-A-006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens C.D., 2021, METEOROLOGY TODAY IN; Braga LHP, 2012, CAN J SURG, V55, P132, DOI 10.1503/cjs.036311; Brookhart MA, 2010, MED CARE, V48, pS114, DOI 10.1097/MLR.0b013e3181dbebe3; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Chang CC, 2005, ENVIRON RES, V98, P114, DOI 10.1016/j.envres.2004.07.005; Chang SC, 2008, J ENVIRON MANAGE, V86, P627, DOI 10.1016/j.jenvman.2006.12.029; Cheng MF, 2007, J TOXICOL ENV HEAL A, V70, P2021, DOI 10.1080/15287390701601020; Department of Health, 2011, 2010 STAT GEN HLTH; Department of Health, 2012, 2011 TAIW HLTH REP; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543; Enia G, 2007, NEPHROL DIAL TRANSPL, V22, P538, DOI 10.1093/ndt/gfl605; Executive Yuan, 2011, MONTHL B STAT REP CH; Fang SH, 1996, ATMOS ENVIRON, V30, P735; Hajat S, 2002, OCCUP ENVIRON MED, V59, P294, DOI 10.1136/oem.59.5.294; Hajat S, 2001, AM J EPIDEMIOL, V153, P704, DOI 10.1093/aje/153.7.704; Hajat S, 1999, THORAX, V54, P597, DOI 10.1136/thx.54.7.597; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Hwang JS, 2002, AM J EPIDEMIOL, V155, P1, DOI 10.1093/aje/155.1.1; Jager KJ, 2008, KIDNEY INT, V73, P256, DOI 10.1038/sj.ki.5002650; Bin J, 2006, J EXPO SCI ENV EPID, V16, P225, DOI 10.1038/sj.jea.7500451; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Krzyzanowski M, 2008, AIR QUAL ATMOS HLTH, V1, P7, DOI 10.1007/s11869-008-0008-9; Loomis D, 1999, EPIDEMIOLOGY, V10, P118, DOI 10.1097/00001648-199903000-00006; McConnell R, 1999, ENVIRON HEALTH PERSP, V107, P757, DOI 10.2307/3434662; McNamee R, 2005, OCCUP ENVIRON MED, V62, P500, DOI 10.1136/oem.2002.001115; More DS, 2000, STAT CONCEPTS CONTRO; Penna M L, 1991, Bull Pan Am Health Organ, V25, P47; Press W. H., 2007, NUMERICAL RECIPES, V3rd; SCHWARTZ J, 1993, AM REV RESPIR DIS, V147, P826, DOI 10.1164/ajrccm/147.4.826; SCHWARTZ J, 1994, ENVIRON RES, V64, P26, DOI 10.1006/enrs.1994.1004; Sheppard L, 1999, EPIDEMIOLOGY, V10, P23, DOI 10.1097/00001648-199901000-00006; Stone R, 2002, SCIENCE, V298, P2106; Sunyer J, 1997, THORAX, V52, P760, DOI 10.1136/thx.52.9.760; Taiwan Landseed Hospital, 2010, STAT ANN REP MED SER; Taiwan Landseed Hospital, 2011, STAT ANN REP MED SER; Taiwan Landseed Hospital, 2009, STAT ANN REP MED SER; Taiwan Landseed Hospital, 2008, STAT ANN REP MED SER; Tripepi G, 2008, KIDNEY INT, V73, P806, DOI 10.1038/sj.ki.5002787; Villeneuve PJ, 2006, ALLERGY, V61, P750, DOI 10.1111/j.1398-9995.2006.01070.x; Wang KY, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005326; Wang KY, 2004, WATER AIR SOIL POLL, V156, P29, DOI 10.1023/B:WATE.0000036788.41409.5b; WHITTEMORE AS, 1980, AM J PUBLIC HEALTH, V70, P687, DOI 10.2105/AJPH.70.7.687; Wong TW, 2006, THORAX, V61, P585, DOI 10.1136/thx.2005.051730; World Bank, 2007, COST POLL CHIN; Wu TY, 2010, LONDON J PRIM CARE, V3, P115, DOI 10.1080/17571472.2010.11493315; XU XP, 1995, ARCH ENVIRON HEALTH, V50, P214, DOI 10.1080/00039896.1995.9940390; XU XP, 1995, ENVIRON HEALTH PERSP, V103, P286, DOI 10.2307/3432550; Yang CY, 2007, J TOXICOL ENV HEAL A, V70, P1214, DOI 10.1080/15287390701380880; Yang CY, 2007, J TOXICOL ENV HEAL A, V70, P111, DOI 10.1080/15287390600755059	50	50	54	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e75220	10.1371/journal.pone.0075220	http://dx.doi.org/10.1371/journal.pone.0075220			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204573	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400007
J	Wang, W; Zhang, M; Sun, WM; Yang, SM; Su, Y; Zhang, HS; Liu, CM; Li, XF; Lin, L; Kim, S; Okunieff, P; Zhang, ZH; Zhang, LR				Wang, Wei; Zhang, Mei; Sun, Weimin; Yang, Shanmin; Su, Ying; Zhang, Hengshan; Liu, Chaomei; Li, Xinfeng; Lin, Ling; Kim, Sunghee; Okunieff, Paul; Zhang, Zhenhuan; Zhang, Lurong			Reduction of Decoy Receptor 3 Enhances TRAIL-Mediated Apoptosis in Pancreatic Cancer	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTOR; X-LINKED INHIBITOR; FAS LIGAND; CELL-LINES; T-CELL; ADENOCARCINOMA; EXPRESSION; RESISTANCE; DEATH; OVEREXPRESSION	Most human pancreatic cancer cells are resistant to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)mediated apoptosis. However, the mechanisms by which pancreatic cancer cells utilize their extracellular molecules to counteract the proapoptotic signaling mediated by the TNF family are largely unknown. In this study, we demonstrate for the first time that DcR3, a secreted decoy receptor that malignant pancreatic cancer cells express at a high level, acts as an extracellular antiapoptotic molecule by binding to TRAIL and counteracting its death-promoting function. The reduction of DcR3 with siRNA unmasked TRAIL and greatly enhanced TRAIL-induced apoptosis. Gemcitabine, a first-line drug for pancreatic cancer, also reduced the level of DcR3. The addition of DcR3 siRNA further enhanced gemcitabine-induced apoptosis. Notably, our in vivo study demonstrated that the therapeutic effect of gemcitabine could be enhanced via further reduction of DcR3, suggesting that downregulation of DcR3 in tumor cells could tip the balance of pancreatic cells towards apoptosis and potentially serve as a new strategy for pancreatic cancer therapy.	[Zhang, Mei; Sun, Weimin; Yang, Shanmin; Liu, Chaomei; Okunieff, Paul; Zhang, Zhenhuan; Zhang, Lurong] Univ Florida, Dept Radiat Oncol, Gainesville, FL USA; [Wang, Wei; Su, Ying; Li, Xinfeng; Lin, Ling] Fujian Med Univ, Affiliated Hosp 2, Dept Gen Surg, Quanzhou, Fujian, Peoples R China; [Sun, Weimin] Second Mil Med Coll, Dept Immunol, Shanghai, Peoples R China; [Kim, Sunghee] BioPowerTech, Tuscaloosa, AL USA; [Zhang, Hengshan; Zhang, Lurong] Fujian Med Univ, Affiliated Hosp 1, Cent Lab, Fuzhou, Fujian, Peoples R China	State University System of Florida; University of Florida; Fujian Medical University; Naval Medical University; Fujian Medical University	Wang, W (corresponding author), Fujian Med Univ, Affiliated Hosp 2, Dept Gen Surg, Quanzhou, Fujian, Peoples R China.	gianty2005@yahoo.com; lz8506@gmail.com		Zhang, Hengshan/0000-0002-2226-4774	National Natural Science Fund of China [81071968]; Key Program of Scientific Research of Fujian Medical University [09ZD014]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Key Program of Scientific Research of Fujian Medical University	This work was supported in part by the National Natural Science Fund of China Grants (81071968) to WW and the Key Program of Scientific Research of Fujian Medical University (09ZD014) to WW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, PANCR CANC OV; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Bai C, 2000, P NATL ACAD SCI USA, V97, P1230, DOI 10.1073/pnas.97.3.1230; Boehrer S, 2006, CURR MED CHEM, V13, P2091, DOI 10.2174/092986706777935294; Bratton SB, 2001, TRENDS PHARMACOL SCI, V22, P306, DOI 10.1016/S0165-6147(00)01718-1; Catz SD, 2003, APOPTOSIS, V8, P29, DOI 10.1023/A:1021692801278; Chang YC, 2008, BLOOD, V111, P5054, DOI 10.1182/blood-2007-12-130609; Chen JG, 2004, J IMMUNOL METHODS, V285, P63, DOI 10.1016/j.jim.2003.11.004; Chen PH, 2008, J IMMUNOL, V181, P8441, DOI 10.4049/jimmunol.181.12.8441; Connolly K, 2001, J PHARMACOL EXP THER, V298, P25; COSMAN D, 1994, STEM CELLS, V12, P440, DOI 10.1002/stem.5530120501; Farrelly N, 1999, J CELL BIOL, V144, P1337, DOI 10.1083/jcb.144.6.1337; Finnberg N, 2006, CLIN CANCER RES, V12, P4132, DOI 10.1158/1078-0432.CCR-06-0567; Flaherty KT, 2001, CURR OPIN ONCOL, V13, P499, DOI 10.1097/00001622-200111000-00013; Hall MA, 2007, CANCER CELL, V12, P4, DOI 10.1016/j.ccr.2007.06.011; Hylander BL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-22; Ibrahim SM, 2001, PANCREAS, V23, P72, DOI 10.1097/00006676-200107000-00011; Jacob D, 2005, CANCER GENE THER, V12, P109, DOI 10.1038/sj.cgt.7700773; Karikari CA, 2007, MOL CANCER THER, V6, P957, DOI 10.1158/1535-7163.MCT-06-0634; Li HX, 2005, AM J CLIN PATHOL, V124, P282, DOI 10.1309/XK594E4B5WU82QR6; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Mori T, 2005, SURGERY, V138, P71, DOI 10.1016/j.surg.2005.03.001; Mori T, 2007, J SURG RES, V142, P281, DOI 10.1016/j.jss.2007.03.068; Okamoto K, 2007, J CELL MOL MED, V11, P349, DOI 10.1111/j.1582-4934.2007.00013.x; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; She QB, 2001, CANCER RES, V61, P1604; Shi GX, 2005, J IMMUNOL, V174, P4727, DOI 10.4049/jimmunol.174.8.4727; Shrader M, 2007, CANCER RES, V67, P1430, DOI 10.1158/0008-5472.CAN-06-1224; Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200; Stauffer SR, 2007, CURR TOP MED CHEM, V7, P961, DOI 10.2174/156802607780906843; Tsuji S, 2003, INT J CANCER, V106, P17, DOI 10.1002/ijc.11170; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Xu ZW, 2003, ANTICANCER RES, V23, P251; Yu KY, 1999, J BIOL CHEM, V274, P13733, DOI 10.1074/jbc.274.20.13733; Zhan CY, 2011, STRUCTURE, V19, P162, DOI 10.1016/j.str.2010.12.004; Zhang J, 2001, J CLIN INVEST, V107, P1459, DOI 10.1172/JCI12159	39	17	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e74272	10.1371/journal.pone.0074272	http://dx.doi.org/10.1371/journal.pone.0074272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204567	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400006
J	Coenen, S; Francis, N; Kelly, M; Hood, K; Nuttall, J; Little, P; Verheij, TJM; Melbye, H; Goossens, H; Butler, CC				Coenen, Samuel; Francis, Nick; Kelly, Mark; Hood, Kerenza; Nuttall, Jacqui; Little, Paul; Verheij, Theo J. M.; Melbye, Hasse; Goossens, Herman; Butler, Christopher C.		GRACE Project Grp	Are Patient Views about Antibiotics Related to Clinician Perceptions, Management and Outcome? A Multi-Country Study in Outpatients with Acute Cough	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; GENERAL-PRACTICE; PATIENTS EXPECTATIONS; PRESCRIBING BEHAVIOR; DOCTORS PERCEPTIONS; EUROPEAN COUNTRIES; ACUTE BRONCHITIS; QUESTIONNAIRE	Background: Outpatients with acute cough who expect, hope for or ask for antibiotics may be more unwell, benefit more from antibiotic treatment, and be more satisfied with care when they are prescribed antibiotics. Clinicians may not accurately identify those patients. Objective: To explore whether patient views (expecting, hoping for or asking for antibiotics) are associated with illness presentation and resolution, whether patient views are accurately perceived by clinicians, and the association of all these factors with antibiotic prescribing and patient satisfaction with care. Methods: Prospective observational study of 3402 adult patients with acute cough presenting in 14 primary care networks. Correlations and associations tested with multilevel logistic regression and McNemar's tests, and Cohen's Kappa, positive agreement (PA) and negative agreement (NA) calculated as appropriate. Results: 1,213 (45.1%) patients expected, 1,093 (40.6%) hoped for, and 275 (10.2%) asked for antibiotics. Clinicians perceived 840 (31.3%) as wanting to be prescribed antibiotics (McNemar's test, p < 0.05). Their perception agreed modestly with the three patient views (Kappa's = 0.29, 0.32 and 0.21, PA's = 0.56, 0.56 and 0.33, NA's = 0.72, 0.75 and 0.82, respectively). 1,464 (54.4%) patients were prescribed antibiotics. Illness presentation and resolution were similar for patients regardless their views. These associations were not modified by antibiotic treatment. Patient expectation and hope (OR: 2.08, 95% CI:[1.48,2.93] and 2.48 [1.73,3.55], respectively), and clinician perception (12.18 [8.31,17.84]) were associated with antibiotic prescribing. 2,354 (92.6%) patients were satisfied. Only those hoping for antibiotics were less satisfied when antibiotics were not prescribed (0.39 [0.17,0.90]). Conclusion: Patient views about antibiotic treatment were not useful for identifying those who will benefit from antibiotics. Clinician perceptions did not match with patient views, but particularly influenced antibiotic prescribing. Patients were generally satisfied with care, but those hoping for but not prescribed antibiotics were less satisfied. Clinicians need to more effectively elicit and address patient views about antibiotics.	[Coenen, Samuel; Goossens, Herman] Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Med Microbiol, B-2020 Antwerp, Belgium; [Coenen, Samuel] Univ Antwerp, Fac Med & Hlth Sci, Dept Primary & Interdisciplinary Care Antwerp, Ctr Gen Practice, B-2020 Antwerp, Belgium; [Francis, Nick; Butler, Christopher C.] Cardiff Univ, Cochrane Inst Primary Care, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Francis, Nick; Butler, Christopher C.] Cardiff Univ, Cochrane Inst Publ Hlth, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Kelly, Mark; Hood, Kerenza; Nuttall, Jacqui] Cardiff Univ, South East Wales Trials Unit, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Little, Paul] Univ Southampton, Sch Med, Primary Care Med Grp, Southampton, Hants, England; [Verheij, Theo J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Melbye, Hasse] Univ Tromso, Inst Community Med, Gen Practice Res Unit, Tromso, Norway	University of Antwerp; University of Antwerp; Cardiff University; Cardiff University; Cardiff University; University of Southampton; Utrecht University; Utrecht University Medical Center; UiT The Arctic University of Tromso	Coenen, S (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Med Microbiol, B-2020 Antwerp, Belgium.	samuel.coenen@uantwerp.be	Kelson, Mark J/E-6753-2016; Francis, Nick/B-7413-2009; Hood, Kerenza/C-2528-2008; Moore, Michael/C-3447-2011; Coenen, Samuel JA/A-6410-2011	Kelson, Mark J/0000-0001-7744-3780; Francis, Nick/0000-0001-8939-7312; Hood, Kerenza/0000-0002-5268-8631; Moore, Michael/0000-0002-5127-4509; Coenen, Samuel JA/0000-0002-1238-8052; Coast, Joanna/0000-0002-3537-5166; Melbye, Hasse/0000-0002-9773-3141; Little, Paul/0000-0003-3664-1873; Butler, Christopher/0000-0002-0102-3453	European Commission [LSHM-CT-2005-518226]; National Institute for Social Care and Health Research; Research Foundation, Flanders [G.0274.08N]; Bond University (Australia); Research Foundation - Flanders; University of Antwerp; University of Ghent (Belgium); Chinese University of Hong Kong (China); University of Copenhagen (Denmark); Research Council of Health; Academy of Finland (Finland); College Azureen des Generalistes Enseignants; Comite Departemental d'Education pour la Sante (France); Rostock University (Germany); Netherlands Organisation for Scientific Research; AMC Amsterdam; Leiden UMC; UMC Utrecht (The Netherlands); Research Council of Norway; University of Oslo; University of Tromso (Norway); Medical University of Bialystok; Medical University of Lodz (Poland); National University Research Council (Romania); Civil Organization Zdrave Mesto (Slovakia); Osnovno zdravstvo Gorenjske (Slovenia); l'Institut d'Investigacions Biomediques August Pi i Sunyer (Spain); Swedish Research Council; Karolinska Institute (Sweden); Medical Research Council; Cardiff University; University of Oxford; University of Southampton (United Kingdom); Swiss National Science Foundation (Switzerland) through the European Science Foundation (ESF)	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute for Social Care and Health Research; Research Foundation, Flanders(FWO); Bond University (Australia); Research Foundation - Flanders(FWO); University of Antwerp; University of Ghent (Belgium)(Ghent University); Chinese University of Hong Kong (China)(Chinese University of Hong Kong); University of Copenhagen (Denmark); Research Council of Health; Academy of Finland (Finland)(Academy of Finland); College Azureen des Generalistes Enseignants; Comite Departemental d'Education pour la Sante (France); Rostock University (Germany); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); AMC Amsterdam; Leiden UMC; UMC Utrecht (The Netherlands)(Netherlands Government); Research Council of Norway(Research Council of Norway); University of Oslo; University of Tromso (Norway); Medical University of Bialystok; Medical University of Lodz (Poland); National University Research Council (Romania)(Consiliul National al Cercetarii Stiintifice (CNCS)); Civil Organization Zdrave Mesto (Slovakia); Osnovno zdravstvo Gorenjske (Slovenia); l'Institut d'Investigacions Biomediques August Pi i Sunyer (Spain); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institute (Sweden)(Karolinska Institutet); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cardiff University; University of Oxford; University of Southampton (United Kingdom); Swiss National Science Foundation (Switzerland) through the European Science Foundation (ESF)	This study was funded by 6th Framework Programme of the European Commission (LSHM-CT-2005-518226). The South East Wales Trials Unit is funded by the National Institute for Social Care and Health Research. In Flanders (Belgium) this work was supported by the Research Foundation, Flanders (G.0274.08N). This publication has been financially supported by Bond University (Australia), Research Foundation - Flanders, University of Antwerp, University of Ghent (Belgium), Chinese University of Hong Kong (China), University of Copenhagen (Denmark), Research Council of Health, Academy of Finland (Finland), College Azureen des Generalistes Enseignants, Comite Departemental d'Education pour la Sante (France), Rostock University (Germany), The Netherlands Organisation for Scientific Research, AMC Amsterdam, Leiden UMC, UMC Utrecht (The Netherlands), Research Council of Norway, University of Oslo, University of Tromso (Norway), Medical University of Bialystok, Medical University of Lodz (Poland), National University Research Council (Romania), Civil Organization Zdrave Mesto (Slovakia), Osnovno zdravstvo Gorenjske (Slovenia), l'Institut d'Investigacions Biomediques August Pi i Sunyer (Spain), Swedish Research Council, Karolinska Institute (Sweden), Medical Research Council, Cardiff University, University of Oxford, University of Southampton (United Kingdom), Swiss National Science Foundation (Switzerland) through the European Science Foundation (ESF), in the framework of the Research Networking Programme TRACE (www.esf.org/trace). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthierens S, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-101; Ashworth M, 2005, BRIT J GEN PRACT, V55, P603; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Britten N, 1997, BRIT MED J, V315, P1506, DOI 10.1136/bmj.315.7121.1506; Brookes-Howell L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000796; Butler CC, 2011, EUR RESPIR J, V38, P119, DOI 10.1183/09031936.00133910; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Butler CC, 1998, BRIT J GEN PRACT, V48, P1865; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Butler CC, 2012, BMJ-BRIT MED J, V344, DOI [10.1136/bmj.d8173, 10.1136/bmj.e682]; Butler CC, 2010, J ANTIMICROB CHEMOTH, V65, P2472, DOI 10.1093/jac/dkq336; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Cartwright A, 1979, J R Coll Gen Pract Occas Pap, P1; Cartwright Ann, 1967, PATIENTS THEIR DOCTO; Christiaens T, 2004, SCAND J PRIM HEALTH, V22, P141, DOI 10.1080/02813430410006521; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; Coenen S, 2006, BRIT J GEN PRACT, V56, P183; Coenen S, 2004, J ANTIMICROB CHEMOTH, V54, P661, DOI 10.1093/jac/dkh374; Coenen Samuel, 2002, BMC Fam Pract, V3, P16, DOI 10.1186/1471-2296-3-16; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Davey P, 2002, CLIN MICROBIOL INFEC, V8, P43, DOI 10.1046/j.1469-0691.8.s.2.6.x; de Vet HCW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2125; Dosh SA, 2000, J FAM PRACTICE, V49, P407; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Francis NA, 2013, EUR J GEN PRACT, V19, P77, DOI 10.3109/13814788.2012.733690; Francis NA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2885; Hamm RM, 1996, J FAM PRACTICE, V43, P56; Hueston WJ, 2000, J FAM PRACTICE, V49, P401; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Little P, 2004, BMJ-BRIT MED J, V328, P444, DOI 10.1136/bmj.38013.644086.7C; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 2013, LANCET INFECT DIS, V13, P123, DOI 10.1016/S1473-3099(12)70300-6; Macfarlane J, 1997, RESP MED, V91, P427, DOI 10.1016/S0954-6111(97)90258-4; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Mainous AG, 2003, AM J PUBLIC HEALTH, V93, P1910, DOI 10.2105/AJPH.93.11.1910; Rodrigues AT, 2013, INT J ANTIMICROB AG, V41, P203, DOI 10.1016/j.ijantimicag.2012.09.003; Saxena S, 2012, BRIT J GEN PRACT, V62, P340, DOI 10.3399/bjgp12X652166; Stanton N, 2010, EUR RESPIR J, V35, P761, DOI 10.1183/09031936.00168409; van Duijn HJ, 2005, J ANTIMICROB CHEMOTH, V56, P420, DOI 10.1093/jac/dki214; Welschen I, 2004, FAM PRACT, V21, P234, DOI 10.1093/fampra/cmh303; Wood J, 2011, EUR RESPIR J, V38, P112, DOI 10.1183/09031936.00145810	42	78	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76691	10.1371/journal.pone.0076691	http://dx.doi.org/10.1371/journal.pone.0076691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194845	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000326037000024
J	Mengistie, B; Berhane, Y; Worku, A				Mengistie, Bezatu; Berhane, Yemane; Worku, Alemayehu			Household Water Chlorination Reduces Incidence of Diarrhea among Under-Five Children in Rural Ethiopia: A Cluster Randomized Controlled Trial	PLOS ONE			English	Article							DRINKING-WATER; SAFE STORAGE; FLOCCULANT-DISINFECTANT; PREVENTION; INTERVENTIONS; QUALITY; DISEASE	Background: Household water treatment has been advocated as a means of decreasing the burden of diarrheal diseases among young children in areas where piped and treated water is not available. However, its effect size, the target population that benefit from the intervention, and its acceptability especially in rural population is yet to be determined. The objective of the study was to assess the effectiveness of household water chlorination in reducing incidence of diarrhea among children under-five years of age. Method: A cluster randomized community trial was conducted in 36 rural neighborhoods of Eastern Ethiopia. Households with at least one child under-five years of age were included in the study. The study compared diarrhea incidence among children who received sodium hypochlorite (liquid bleach) for household water treatment and children who did not receive the water treatment. Generalized Estimation Equation model was used to compute adjusted incidence rate ratio and the corresponding 95% confidence interval. Result: In this study, the incidence of diarrhea was 4.5 episodes/100 person week observations in the intervention arm compared to 10.4 episodes/100 person week observations in the control arm. A statistically significant reduction in incidence of diarrhea was observed in the intervention group compared to the control (Adjusted IRR = 0.42, 95% CI 0.36-0.48). Conclusion: Expanding access to household water chlorination can help to substantially reduce child morbidity and achieve millennium development goal until reliable access to safe water is achieved.	[Mengistie, Bezatu] Haramaya Univ, Coll Hlth Sci, Harar, Ethiopia; [Berhane, Yemane; Worku, Alemayehu] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia	Haramaya University; Addis Continental Institute of Public Health; Addis Ababa University	Mengistie, B (corresponding author), Haramaya Univ, Coll Hlth Sci, Harar, Ethiopia.	bezatum@gmail.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339	Haramaya University	Haramaya University	This study was financially supported by Haramaya University. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Brown J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038475, 10.1371/journal.pone.0036735]; Chiller TM, 2006, B WORLD HEALTH ORGAN, V84, P28, DOI 10.2471/BLT.04.016980; Clasen T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004794.pub2; Clasen T.F., 2008, WATER QUALITY INTERV; Clasen T, 2007, J WATER HEALTH, V5, P599, DOI 10.2166/wh.2007.010; Daniele S., 2008, SAFE WATER COMMUNITY; Doocy S, 2006, TROP MED INT HEALTH, V11, P1542, DOI 10.1111/j.1365-3156.2006.01704.x; Garrett V, 2008, EPIDEMIOL INFECT, V136, P1463, DOI 10.1017/S095026880700026X; Harshfield E, 2012, AM J TROP MED HYG, V87, P786, DOI 10.4269/ajtmh.2012.12-0010; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Jain S, 2010, AM J TROP MED HYG, V82, P16, DOI 10.4269/ajtmh.2010.08-0584; KIRCHHOFF LV, 1985, J HYG-CAMBRIDGE, V94, P173, DOI 10.1017/S0022172400061374; Luby SP, 2006, TROP MED INT HEALTH, V11, P479, DOI 10.1111/j.1365-3156.2006.01592.x; Lule JR, 2005, AM J TROP MED HYG, V73, P926, DOI 10.4269/ajtmh.2005.73.926; Mausezahl D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000125; Mengistie B, 2012, PREVALENCE IN PRESS; MORRIS SS, 1994, INT J EPIDEMIOL, V23, P617, DOI 10.1093/ije/23.3.617; Quick RE, 1999, EPIDEMIOL INFECT, V122, P83, DOI 10.1017/S0950268898001782; Quick RE, 2002, AM J TROP MED HYG, V66, P584, DOI 10.4269/ajtmh.2002.66.584; Reller ME, 2003, AM J TROP MED HYG, V69, P411, DOI 10.4269/ajtmh.2003.69.411; Rosa G, 2010, AM J TROP MED HYG, V82, P289, DOI 10.4269/ajtmh.2010.09-0382; Schmidt WP, 2011, INT J EPIDEMIOL, V40, P1678, DOI 10.1093/ije/dyr152; Schmidt WP, 2009, ENVIRON SCI TECHNOL, V43, P986, DOI 10.1021/es802232w; Semenza JC, 1998, AM J TROP MED HYG, V59, P941, DOI 10.4269/ajtmh.1998.59.941; UNEP/WHO, 1996, WAT QUAL MON PRACT G; UNICEF and WHO, 2012, PROGR DRINKING WATER; WHO/UNICEF, 2009, DIARRH WHY CHILDR AR; World Health Organization, 2012, RAP ASS DRINK WAT QU; World Health Organization, 2007, COMB WAT DIS HOUS LE; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x; Wright JA, 2006, J HEALTH POPUL NUTR, V24, P8	31	48	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77887	10.1371/journal.pone.0077887	http://dx.doi.org/10.1371/journal.pone.0077887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194899	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000078
J	Perez-Ramos, IM; Verdu, JR; Numa, C; Maranon, T; Lobo, JM				Perez-Ramos, Ignacio M.; Verdu, Jose R.; Numa, Catherine; Maranon, Teodoro; Lobo, Jorge M.			The Comparative Effectiveness of Rodents and Dung Beetles as Local Seed Dispersers in Mediterranean Oak Forests	PLOS ONE			English	Article							SPATIAL-PATTERNS; THORECTES-LUSITANICUS; ACORN PREFERENCE; CONSEQUENCES; RECRUITMENT; PREDATION; DYNAMICS; REMOVAL; DETERMINANTS; MICROHABITAT	The process of seed dispersal of many animal-dispersed plants is frequently mediated by a small set of biotic agents. However, the contribution that each of these dispersers makes to the overall recruitment may differ largely, with important ecological and management implications for the population viability and dynamics of the species implied in these interactions. In this paper, we compared the relative contribution of two local guilds of scatter-hoarding animals with contrasting metabolic requirements and foraging behaviours (rodents and dung beetles) to the overall recruitment of two Quercus species co-occurring in the forests of southern Spain. For this purpose, we considered not only the quantity of dispersed seeds but also the quality of the seed dispersal process. The suitability for recruitment of the microhabitats where the seeds were deposited was evaluated in a multi-stage demographic approach. The highest rates of seed handling and predation occurred in those microhabitats located under shrubs, mostly due to the foraging activity of rodents. However, the probability of a seed being successfully cached was higher in microhabitats located beneath a tree canopy as a result of the feeding behaviour of beetles. Rodents and beetles showed remarkable differences in their effectiveness as local acorn dispersers. Quantitatively, rodents were much more important than beetles because they dispersed the vast majority of acorns. However, they were qualitatively less effective because they consumed a high proportion of them (over 95%), and seeds were mostly dispersed under shrubs, a less suitable microhabitat for short-term recruitment of the two oak species. Our findings demonstrate that certain species of dung beetles (such as Thorectes lusitanicus), despite being quantitatively less important than rodents, can act as effective local seed dispersers of Mediterranean oak species. Changes in the abundance of beetle populations could thus have profound implications for oak recruitment and community dynamics.	[Perez-Ramos, Ignacio M.; Maranon, Teodoro] CSIC, IRNAS, E-41080 Seville, Spain; [Verdu, Jose R.; Numa, Catherine] Univ Alicante, IUI Ctr Iberoamer Biodiversidad, E-03080 Alicante, Spain; [Lobo, Jorge M.] CSIC, Museo Nacl Ciencias Nat, Dep Biogeog & Cambio Global, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Universitat d'Alacant; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Perez-Ramos, IM (corresponding author), CSIC, IRNAS, E-41080 Seville, Spain.	imperez@irnase.csic.es	Lobo, Jorge M/E-2309-2013; Perez-Ramos, Ignacio M/H-6048-2015; Numa, Catherine/H-7486-2015; Maranon, Teodoro/K-6648-2014; Verdú, José/F-8269-2010	Lobo, Jorge M/0000-0002-3152-4769; Perez-Ramos, Ignacio M/0000-0003-2332-7818; Numa, Catherine/0000-0003-3213-1980; Maranon, Teodoro/0000-0002-7751-9316; Verdú, José/0000-0002-0805-8341	Andalusian Government; Ministry of Education and Science [CGL2008/03878/BOS, CGL2011-25544]; Andalusian project "Anasinque'' [PE2010-RNM5782]	Andalusian Government; Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Andalusian project "Anasinque''	This study was supported by a postdoctoral contract of the Andalusian Government to IMPR, by the Projects of the Ministry of Education and Science entitled "Thorbellota" ("Analisis ecologico y fisiologico de la interaccion entre el coleoptero coprofago Thorectes lusitanicus y las bellotas de Quercus suber y Q. canariensis: implicaciones evolutivas y aplicadas''; CGL2008/03878/BOS) and "InTerDist" ("Influencia del nicho termico en la distribucion geografica de las especies''; CGL2011-25544), and the Andalusian project "Anasinque'' (PE2010-RNM5782). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beucke K, 2009, COLEOPTS BULL, V63, P228, DOI 10.1649/1168.1; BOSSEMA I, 1979, BEHAVIOUR, V70, P1, DOI 10.1163/156853979X00016; Calvino-Cancela M, 2009, ECOLOGY, V90, P3503, DOI 10.1890/08-1629.1; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; den Ouden J., 2005, SEED FATE PREDATION, P223, DOI [DOI 10.1079/9780851998060.0283, 10.1079/9780851998060.0283]; Dennis AJ, 2006, OECOLOGIA, V149, P620, DOI 10.1007/s00442-006-0475-3; Fedriani JM, 2009, ECOSCIENCE, V16, P311, DOI 10.2980/16-3-3253; Garcia D, 2011, ECOL MONOGR, V81, P103, DOI 10.1890/10-0470.1; Godinez-Alvarez H., 2007, Seed dispersal: theory and its application in a changing world, P391, DOI 10.1079/9781845931650.0391; Gomez JM, 2003, ECOGRAPHY, V26, P573, DOI 10.1034/j.1600-0587.2003.03586.x; Gomez JM, 2008, OECOLOGIA, V155, P529, DOI 10.1007/s00442-007-0928-3; Gomez-Aparicio L, 2012, NEW PHYTOL, V194, P1014, DOI 10.1111/j.1469-8137.2012.04108.x; Gribko L. S., 1995, Tree Planters' Notes, V46, P143; Hampe A, 2008, OECOLOGIA, V156, P137, DOI 10.1007/s00442-008-0979-0; Hanski I., 1991, DUNG BEETLE ECOLOGY; Herrera Carlos M., 2002, P185; Herrera CM, 1998, ECOL MONOGR, V68, P511, DOI 10.1890/0012-9615(1998)068[0511:LTDOMF]2.0.CO;2; Hollander JL, 2004, OECOLOGIA, V138, P57, DOI 10.1007/s00442-003-1393-2; Hulme PE, 1999, J ANIM ECOL, V68, P417, DOI 10.1046/j.1365-2656.1999.00294.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jordano P, 2000, ECOL MONOGR, V70, P591, DOI 10.1890/0012-9615(2000)070[0591:SDETQC]2.0.CO;2; JORDANO P, 1995, ECOSCIENCE, V2, P230, DOI 10.1080/11956860.1995.11682288; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; Loiselle BA, 1999, ECOLOGY, V80, P330, DOI 10.1890/0012-9658(1999)080[0330:DOMSBF]2.0.CO;2; Manson RH, 1998, OIKOS, V82, P37, DOI 10.2307/3546915; Martin-Piera F., 2000, Fauna Iberica, V14; McCullagh P, 1989, GEN LINEAR MODELS; Miriti MN, 2006, J ECOL, V94, P973, DOI 10.1111/j.1365-2745.2006.01138.x; Mohr K, 2003, OIKOS, V100, P459, DOI 10.1034/j.1600-0706.2003.11763.x; Moore JE, 2007, ECOLOGY, V88, P2529, DOI 10.1890/07-0247.1; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Ojeda F, 2000, BIODIVERS CONSERV, V9, P1323, DOI 10.1023/A:1008923213321; Pausas J., 2009, CORK OAK WOODLANDS E, P115; Perea R, 2012, EUR J FOREST RES, V131, P623, DOI 10.1007/s10342-011-0536-y; Perez-Ramos IM, 2008, OIKOS, V117, P1386, DOI 10.1111/j.0030-1299.2008.16370.x; Perez-Ramos IM, 2008, FOREST ECOL MANAG, V255, P3506, DOI 10.1016/j.foreco.2008.02.032; Perez-Ramos IM, 2007, ECOL ENTOMOL, V32, P349, DOI 10.1111/j.1365-2311.2007.00874.x; Perez-Ramos IM, 2013, PERSPECT PLANT ECOL, V15, P106, DOI 10.1016/j.ppees.2012.12.005; Perez-Ramos IM, 2012, J VEG SCI, V23, P526, DOI 10.1111/j.1654-1103.2011.01365.x; Perez-Ramos IM, 2012, J ECOL, V100, P467, DOI 10.1111/j.1365-2745.2011.01912.x; Perez-Ramos IM, 2009, ACTA OECOL, V35, P422, DOI 10.1016/j.actao.2009.01.007; Perez-Ramos IM, 2007, THESIS U SEVILLE SPA; Puerta-Pinero C, 2010, OIKOS, V119, P179, DOI 10.1111/j.1600-0706.2009.17793.x; Pulido FJ, 2005, ECOSCIENCE, V12, P92, DOI 10.2980/i1195-6860-12-1-92.1; Rey PJ, 2000, J ECOL, V88, P622, DOI 10.1046/j.1365-2745.2000.00472.x; Rodriguez-Perez J, 2010, PLANT ECOL, V207, P269, DOI 10.1007/s11258-009-9671-7; Schmull M, 2000, PLANT SOIL, V225, P227, DOI 10.1023/A:1026516027096; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; SCHUPP EW, 1993, VEGETATIO, V108, P15; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Thompson John N., 2002, P236; Urbieta IR, 2008, CAN J FOREST RES, V38, P2382, DOI 10.1139/X08-089; Urbieta IR, 2008, J BIOGEOGR, V35, P1688, DOI 10.1111/j.1365-2699.2008.01914.x; Verdu JR, 2007, ANIM BEHAV, V74, P1697, DOI 10.1016/j.anbehav.2007.03.016; Verdu JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069277; Verdu JR, 2011, ECOL ENTOMOL, V36, P104, DOI 10.1111/j.1365-2311.2010.01252.x; Verdu JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010114; Xiao ZS, 2006, FOREST ECOL MANAG, V223, P18, DOI 10.1016/j.foreco.2005.10.054	59	17	19	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77197	10.1371/journal.pone.0077197	http://dx.doi.org/10.1371/journal.pone.0077197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194872	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000051
J	Sato, T; Neschadim, A; Lavie, A; Yanagisawa, T; Medin, JA				Sato, Takeya; Neschadim, Anton; Lavie, Arnon; Yanagisawa, Teruyuki; Medin, Jeffrey A.			The Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis Offers Efficient Bystander Cell Killing for Suicide Gene Therapy of Cancer	PLOS ONE			English	Article							VIRUS THYMIDINE KINASE; PROSTATE-CANCER; GAP-JUNCTIONS; DEOXYCYTIDINE KINASE; COMMUNICATION; GANCICLOVIR; PANNEXIN-1	We previously described a novel suicide (or 'cell fate control') gene therapy enzyme/prodrug system based on an engineered variant of human thymidylate kinase (TMPK) that potentiates azidothymidine (AZT) activation. Delivery of a suicide gene sequence into tumors by lentiviral transduction embodies a cancer gene therapy that could employ bystander cell killing as a mechanism driving significant tumor regression in vivo. Here we present evidence of a significant bystander cell killing in vitro and in vivo mediated by the TMPK/AZT suicide gene axis that is reliant on the formation of functional gap-junctional intercellular communications (GJICs). Potentiation of AZT activation by the engineered TMPK expressed in the human prostate cancer cell line, PC-3, resulted in effective bystander killing of PC-3 cells lacking TMPK expression - an effect that could be blocked by the GJIC inhibitor, carbenoxolone. Although GJICs are mainly formed by connexins, a new family of GJIC molecules designated pannexins has been recently identified. PC-3 cells expressed both connexin43 (Cx43) and Pannexin1 (Panx1), but Panx1 expression predominated at the plasma membrane, whereas Cx43 expression was primarily localized to the cytosol. The contribution of bystander effects to the reduction of solid tumor xenografts established by the PC-3 cell line was evaluated in an animal model. We demonstrate the contribution of bystander cell killing to tumor regression in a xenograft model relying on the delivery of expression of the TMPK suicide gene into tumors via direct intratumoral injection of recombinant therapeutic lentivirus. Taken together, our data underscore that the TMPK/AZT enzyme-prodrug axis can be effectively utilized in suicide gene therapy of solid tumors, wherein significant tumor regression can be achieved via bystander effects mediated by GJICs.	[Sato, Takeya; Yanagisawa, Teruyuki] Tohoku Univ, Sendai, Miyagi 980, Japan; [Neschadim, Anton] Canadian Blood Serv, Toronto, ON, Canada; [Lavie, Arnon] Univ Illinois, Chicago, IL USA; [Medin, Jeffrey A.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Medin, Jeffrey A.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Medin, Jeffrey A.] Univ Hlth Network, Toronto, ON, Canada	Tohoku University; Canadian Blood Services; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Sato, T (corresponding author), Tohoku Univ, Sendai, Miyagi 980, Japan.	tksato@med.tohoku.ac.jp	Neschadim, Anton/G-3041-2011	Neschadim, Anton/0000-0003-1750-9703; Sato, Takeya/0000-0003-2409-1819; Lavie, Arnon/0000-0001-5591-8722	Japan Society for the Promotion of Science (JSPS) [20590533]; Saito Gratitude Foundation; Canadian Institutes of Health Research (CIHR)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Saito Gratitude Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was funded in part by Grant-in aid for Scientific Research (C) (20590533) to T. S. from the Japan Society for the Promotion of Science (JSPS) and by the research grant from the Saito Gratitude Foundation to T.S.. A.N. was funded by the Canadian Institutes of Health Research (CIHR) Training Program in Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade-Rozental AF, 2000, BRAIN RES REV, V32, P308, DOI 10.1016/S0165-0173(99)00099-5; Ardiani A, 2010, CANCER GENE THER, V17, P86, DOI 10.1038/cgt.2009.60; Beck C, 1995, HUM GENE THER, V6, P1525, DOI 10.1089/hum.1995.6.12-1525; Brundiers R, 1999, J BIOL CHEM, V274, P35289, DOI 10.1074/jbc.274.50.35289; Colombo F, 2005, CANCER GENE THER, V12, P835, DOI 10.1038/sj.cgt.7700851; Czyz J, 2012, NAT REV UROL, V9, P274, DOI 10.1038/nrurol.2012.14; Dachs GU, 2009, MOLECULES, V14, P4517, DOI 10.3390/molecules14114517; Denning C, 1997, HUM GENE THER, V8, P1825, DOI 10.1089/hum.1997.8.15-1825; Denny WA, 2003, J BIOMED BIOTECHNOL, P48; Dilber MS, 1997, CANCER RES, V57, P1523; FICK J, 1995, P NATL ACAD SCI USA, V92, P11071, DOI 10.1073/pnas.92.24.11071; GIAI M, 1991, European Journal of Gynaecological Oncology, V12, P359; Hodish I, 2009, CANCER BIOL THER, V8, P435, DOI 10.4161/cbt.8.5.7589; Hool LC, 2005, CARDIOVASC RES, V67, P624, DOI 10.1016/j.cardiores.2005.04.025; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Leinonen HM, 2012, CANCER RES, V72, P6227, DOI 10.1158/0008-5472.CAN-12-1166; Loimas S, 2001, CANCER GENE THER, V8, P137, DOI 10.1038/sj.cgt.7700286; Mesnil M, 2005, BBA-BIOMEMBRANES, V1719, P125, DOI 10.1016/j.bbamem.2005.11.004; Neschadim A, 2012, CANCER GENE THER, V19, P320, DOI 10.1038/cgt.2012.4; Neschadim A, 2012, MOL THER, V20, P1002, DOI 10.1038/mt.2011.298; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Romanov RA, 2012, J CELL SCI, V125, P5514, DOI 10.1242/jcs.111062; Sato T, 2007, MOL THER, V15, P962, DOI 10.1038/mt.sj.6300122; Sato T, 2009, J CARDIOL, V54, P245, DOI 10.1016/j.jjcc.2009.05.010; Satoh T, 2005, CURR GENE THER, V5, P111; Silvertown JD, 2007, FASEB J, V21, P754, DOI 10.1096/fj.06-6847com; Van Dillen Ingrid J., 2002, Current Gene Therapy, V2, P307, DOI 10.2174/1566523023347733; Wei SJ, 1998, EXP CELL RES, V241, P66, DOI 10.1006/excr.1998.4005; Xing YF, 2007, J HUAZHONG U SCI-MED, V27, P291, DOI 10.1007/s11596-007-0319-3	29	20	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78711	10.1371/journal.pone.0078711	http://dx.doi.org/10.1371/journal.pone.0078711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194950	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000129
J	Zeng, XT; Deng, AP; Li, C; Xia, LY; Niu, YM; Leng, WD				Zeng, Xian-Tao; Deng, Ai-Ping; Li, Cheng; Xia, Ling-Yun; Niu, Yu-Ming; Leng, Wei-Dong			Periodontal Disease and Risk of Head and Neck Cancer: A Meta-Analysis of Observational Studies	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HEALTH; MICROORGANISMS	Background: Many epidemiological studies have found a positive association of periodontal disease (PD) with risk of head and neck cancer (HNC), but the findings are varied or even contradictory. In this work, we performed a meta-analysis to ascertain the relationship between PD and HNC risk. Methods: We searched the PubMed, Embase, and Cochrane Library databases for relevant observational studies on the association between PD and HNC risk published up to March 23, 2013. Data from the included studies were extracted and analyzed independently by two authors. Meta-analysis was performed using RevMan 5.2 software. Results: We obtained seven observational studies involving two cohort and six case-control studies. Random-effects meta-analysis indicated a significant association between PD and HNC risk (odds ratio = 2.63, 95% confidence interval = 1.1.68 - 4.14; p < 0.001), with sensitivity analysis showing that the result was robust. Subgroup analyses based on adjustment for covariates, study design, PD assessment, tumor site, and ethnicity also revealed a significant association. Conclusions: Based on currently evidence, PD is probably a significant and independent risk factor of HNC.	[Zeng, Xian-Tao; Li, Cheng; Xia, Ling-Yun; Niu, Yu-Ming; Leng, Wei-Dong] Hubei Univ Med, Taihe Hosp, Dept Stomatol, Shiyan, Hubei Province, Peoples R China; [Zeng, Xian-Tao; Li, Cheng; Xia, Ling-Yun; Niu, Yu-Ming; Leng, Wei-Dong] Hubei Univ Med, Sch Stomatol, Shiyan, Hubei Province, Peoples R China; [Deng, Ai-Ping] Hubei Univ Med, Taihe Hosp, Dept Neurosurg, Shiyan, Hubei Province, Peoples R China; [Li, Cheng] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Wuhan 430072, Hubei Province, Peoples R China	Hubei University of Medicine; Hubei University of Medicine; Hubei University of Medicine; Wuhan University	Leng, WD (corresponding author), Hubei Univ Med, Taihe Hosp, Dept Stomatol, Shiyan, Hubei Province, Peoples R China.	lengtaihe@163.com		Zeng, Xian-Tao/0000-0003-1262-725X	Natural Science Foundation of Hubei Province [2012FFB03902]; Natural Science Foundation of Hubei Ministry of Education [D20122405]; Foundation of Education and Science Planning Project of Hubei Province [2012A050]; Hubei University of Medicine [2011CZX01]	Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Natural Science Foundation of Hubei Ministry of Education; Foundation of Education and Science Planning Project of Hubei Province; Hubei University of Medicine	This research was supported (in part) by the Natural Science Foundation of Hubei Province (2012FFB03902), the Natural Science Foundation of Hubei Ministry of Education (D20122405), the Foundation of Education and Science Planning Project of Hubei Province (2012A050), and the Intramural Research Program of the Hubei University of Medicine (2011CZX01), without commercial, or not-for-profit sectors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Blaizot A, 2009, INT DENT J, V59, P197, DOI 10.1922/IDJ_2114Sixou13; Conway DI, 2009, ORAL ONCOL, V45, P743, DOI 10.1016/j.oraloncology.2009.02.007; Corbella S, 2012, ODONTOLOGY, V100, P232, DOI 10.1007/s10266-011-0036-z; Coulthwaite L, 2007, BRIT J BIOMED SCI, V64, P180, DOI 10.1080/09674845.2007.11732784; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; CROXSON LJ, 1984, INT DENT J, V34, P28; Cullinan MP, 2009, AUST DENT J, V54, pS62, DOI 10.1111/j.1834-7819.2009.01144.x; Divaris K, 2010, CANCER CAUSE CONTROL, V21, P567, DOI 10.1007/s10552-009-9486-9; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Guha N, 2007, AM J EPIDEMIOL, V166, P1159, DOI 10.1093/aje/kwm193; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hooper SJ, 2009, HEAD NECK-J SCI SPEC, V31, P1228, DOI 10.1002/hed.21140; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Marron M, 2010, INT J EPIDEMIOL, V39, P182, DOI 10.1093/ije/dyp291; Mehanna H, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4684; Meurman JH, 2008, ACTA ODONTOL SCAND, V66, P321, DOI 10.1080/00016350802446527; Michaud DS, 2008, LANCET ONCOL, V9, P550, DOI 10.1016/S1470-2045(08)70106-2; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mojon Philippe, 2002, J Can Dent Assoc, V68, P340; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Rezende Caio Perrella de, 2008, Braz J Otorhinolaryngol, V74, P596; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P1327, DOI 10.1080/00016480510012273; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tezal M, 2005, J PERIODONTOL, V76, P406, DOI 10.1902/jop.2005.76.3.406; Tezal M, 2009, CANCER EPIDEM BIOMAR, V18, P2406, DOI 10.1158/1055-9965.EPI-09-0334; Zeng XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046508; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	31	82	88	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e79017	10.1371/journal.pone.0079017	http://dx.doi.org/10.1371/journal.pone.0079017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194957	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000136
J	Ibarrondo, FJ; Yang, OO; Chodon, T; Avramis, E; Lee, Y; Sazegar, H; Jalil, J; Chmielowski, B; Koya, RC; Schmid, I; Gomez-Navarro, J; Jamieson, BD; Ribas, A; Comin-Anduix, BA				Ibarrondo, F. Javier; Yang, Otto O.; Chodon, Thinle; Avramis, Earl; Lee, Yohan; Sazegar, Hooman; Jalil, Jason; Chmielowski, Bartosz; Koya, Richard C.; Schmid, Ingrid; Gomez-Navarro, Jesus; Jamieson, Beth D.; Ribas, Antoni; Comin-Anduix, Begon A.			Natural Killer T Cells in Advanced Melanoma Patients Treated with Tremelimumab	PLOS ONE			English	Article							ACTIVATION-INDUCED EXPRESSION; INVARIANT NKT CELLS; METASTATIC MELANOMA; DENDRITIC CELLS; IN-VITRO; PHASE-I; CANCER-IMMUNOTHERAPY; MONOCLONAL-ANTIBODY; CYTOKINE SECRETION; CYTOLYTIC ACTIVITY	A significant barrier to effective immune clearance of cancer is loss of antitumor cytotoxic T cell activity. Antibodies to block pro-apoptotic/downmodulatory signals to T cells are currently being tested. Because invariant natural killer T cells (iNKT) can regulate the balance of Th1/Th2 cellular immune responses, we characterized the frequencies of circulating iNKT cell subsets in 21 patients with melanoma who received the anti-CTLA4 monoclonal antibody tremelimumab alone and 8 patients who received the antibody in combination with MART-1(26-35) peptide-pulsed dendritic cells (MART-1/DC). Blood T cell phenotypes and functionality were characterized by flow cytometry before and after treatment. iNKT cells exhibited the central memory phenotype and showed polyfunctional cytokine production. In the combination treatment group, high frequencies of pro-inflammatory Th1 iNKT CD8(+) cells correlated with positive clinical responses. These results indicate that iNKT cells play a critical role in regulating effective antitumor T cell activity.	[Ibarrondo, F. Javier] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Ibarrondo, F. Javier; Yang, Otto O.; Jamieson, Beth D.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Chodon, Thinle; Avramis, Earl; Sazegar, Hooman; Jalil, Jason; Chmielowski, Bartosz; Koya, Richard C.; Schmid, Ingrid; Jamieson, Beth D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Lee, Yohan] NIMH, Dept Child Psychiat Branch, NIH, Bethesda, MD 20892 USA; [Gomez-Navarro, Jesus] PGRD, Dept Clin Res, New London, CT USA; [Ribas, Antoni; Comin-Anduix, Begon A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Ribas, Antoni; Comin-Anduix, Begon A.] Univ Calif Los Angeles, Dept Med, Dept Surg, Div Surg Oncol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Pfizer; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Ibarrondo, FJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	fibarrondo@mednet.ucla.edu; bcomin@mednet.ucla.edu		Avramis, Earl/0000-0002-4595-9536; Chmielowski, Bartosz/0000-0002-2374-3320	Pfizer Inc.; NIH [U54 CA119347]; National Institutes of Health [CA-16042, AI-28697]; NATIONAL CANCER INSTITUTE [U54CA119347, P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	Pfizer Inc.(Pfizer); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to the generosity of a grant from Mr. Gerald Oppenheimer and Ambassador Holden. The conduct of both clinical trials was supported by research grants from Pfizer Inc., and the ex vivo cellular analysis by the NIH grant U54 CA119347. Flow cytometry was performed at the UCLA Jonsson Comprehensive Cancer Center (JCCC) Flow Cytometry Core Facility supported by National Institutes of Health awards CA-16042 and AI-28697. None of those companies funded the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala SS, 2010, J IMMUNOTHER, V33, P557, DOI 10.1097/CJI.0b013e3181dcd260; ASSENMACHER M, 1994, EUR J IMMUNOL, V24, P1097, DOI 10.1002/eji.1830240513; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Butterfield LH, 2003, CLIN CANCER RES, V9, P998; Camacho LH, 2009, J CLIN ONCOL, V27, P1075, DOI 10.1200/JCO.2008.19.2435; Chan WL, 2003, IMMUNOL LETT, V85, P159, DOI 10.1016/S0165-2478(02)00223-7; Comin-Anduix B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012711; Comin-Anduix B, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-22; Crough T, 2004, BRIT J CANCER, V91, P1880, DOI 10.1038/sj.bjc.6602218; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; Emoto M, 2000, EUR J IMMUNOL, V30, P2300, DOI 10.1002/1521-4141(2000)30:8<2300::AID-IMMU2300>3.0.CO;2-2; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Exley MA, 2011, CLIN IMMUNOL, V140, P184, DOI 10.1016/j.clim.2011.04.017; Gansert JL, 2003, J IMMUNOL, V170, P3154, DOI 10.4049/jimmunol.170.6.3154; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Godfrey DI, 2011, J EXP MED, V208, P1121, DOI 10.1084/jem.20110983; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Ibarrondo FJ, 2013, MUCOSAL IMMUNOL, V6, P591, DOI 10.1038/mi.2012.101; Ishikawa A, 2005, CLIN CANCER RES, V11, P1910, DOI 10.1158/1078-0432.CCR-04-1453; Joyce S, 2011, J IMMUNOL, V187, P1081, DOI 10.4049/jimmunol.1001910; Kawano T, 1999, CANCER RES, V59, P5102; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Li XM, 2010, P NATL ACAD SCI USA, V107, P13010, DOI 10.1073/pnas.1006662107; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Milpied P, 2011, BLOOD, V118, P2993, DOI 10.1182/blood-2011-01-329268; Molling JW, 2008, CLIN IMMUNOL, V129, P182, DOI 10.1016/j.clim.2008.07.025; Molling JW, 2005, INT J CANCER, V116, P87, DOI 10.1002/ijc.20998; Montoya CJ, 2008, CLIN IMMUNOL, V127, P1, DOI 10.1016/j.clim.2007.12.006; Motohashi S, 2006, CLIN CANCER RES, V12, P6079, DOI 10.1158/1078-0432.CCR-06-0114; Motohashi S, 2011, CLIN IMMUNOL, V140, P167, DOI 10.1016/j.clim.2011.01.009; Nakai N, 2010, PIGM CELL MELANOMA R, V23, P607, DOI 10.1111/j.1755-148X.2010.00736.x; Peggs KS, 2006, CURR OPIN IMMUNOL, V18, P206, DOI 10.1016/j.coi.2006.01.011; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Ribas A, 2004, J IMMUNOTHER, V27, P354, DOI 10.1097/00002371-200409000-00004; Ribas A, 2005, J CLIN ONCOL, V23, P8968, DOI 10.1200/JCO.2005.01.109; Ribas A, 2007, ONCOLOGIST, V12, P873, DOI 10.1634/theoncologist.12-7-873; Ribas A, 2009, CLIN CANCER RES, V15, P6267, DOI 10.1158/1078-0432.CCR-09-1254; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Terabe M, 2008, ADV CANCER RES, V101, P277, DOI 10.1016/S0065-230X(08)00408-9; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2010, J IMMUNOTHER, V33, P759, DOI 10.1097/CJI.0b013e3181f1d644; van der Vliet HJJ, 2003, CANCER RES, V63, P4101; Vinay DS, 1998, SEMIN IMMUNOL, V10, P481, DOI 10.1006/smim.1998.0157; Watarai H, 2012, INT J HEMATOL, V95, P624, DOI 10.1007/s12185-012-1091-0; Watarai H, 2010, BLOOD, V115, P230, DOI 10.1182/blood-2009-04-217729; Wilson SB, 2003, NAT REV IMMUNOL, V3, P211, DOI 10.1038/nri1028; Wolfl M, 2007, BLOOD, V110, P201, DOI 10.1182/blood-2006-11-056168; Yang OO, 2000, J IMMUNOL, V165, P3756, DOI 10.4049/jimmunol.165.7.3756; Yang OO, 2007, AIDS RES HUM RETROV, V23, P913, DOI 10.1089/aid.2006.0253	60	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76829	10.1371/journal.pone.0076829	http://dx.doi.org/10.1371/journal.pone.0076829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167550	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500009
J	Schwer, CI; Lehane, C; Guelzow, T; Zenker, S; Strosing, KM; Spassov, S; Erxleben, A; Heimrich, B; Buerkle, H; Humar, M				Schwer, Christian I.; Lehane, Cornelius; Guelzow, Timo; Zenker, Simone; Strosing, Karl M.; Spassov, Sashko; Erxleben, Anika; Heimrich, Bernd; Buerkle, Hartmut; Humar, Matjaz			Thiopental Inhibits Global Protein Synthesis by Repression of Eukaryotic Elongation Factor 2 and Protects from Hypoxic Neuronal Cell Death	PLOS ONE			English	Article							ISCHEMIC BRAIN-INJURY; NITRIC-OXIDE; CEREBRAL-ISCHEMIA; FACTOR-II; RAT HIPPOCAMPAL; NMDA RECEPTORS; KINASE PATHWAY; NUCLEAR-FACTOR; EEF2 KINASE; IN-VITRO	Ischemic and traumatic brain injury is associated with increased risk for death and disability. The inhibition of penumbral tissue damage has been recognized as a target for therapeutic intervention, because cellular injury evolves progressively upon ATP-depletion and loss of ion homeostasis. In patients, thiopental is used to treat refractory intracranial hypertension by reducing intracranial pressure and cerebral metabolic demands; however, therapeutic benefits of thiopental-treatment are controversially discussed. In the present study we identified fundamental neuroprotective molecular mechanisms mediated by thiopental. Here we show that thiopental inhibits global protein synthesis, which preserves the intracellular energy metabolite content in oxygen-deprived human neuronal SK-N-SH cells or primary mouse cortical neurons and thus ameliorates hypoxic cell damage. Sensitivity to hypoxic damage was restored by pharmacologic repression of eukaryotic elongation factor 2 kinase. Translational inhibition was mediated by calcium influx, activation of the AMP-activated protein kinase, and inhibitory phosphorylation of eukaryotic elongation factor 2. Our results explain the reduction of cerebral metabolic demands during thiopental treatment. Cycloheximide also protected neurons from hypoxic cell death, indicating that translational inhibitors may generally reduce secondary brain injury. In conclusion our study demonstrates that therapeutic inhibition of global protein synthesis protects neurons from hypoxic damage by preserving energy balance in oxygen-deprived cells. Molecular evidence for thiopental-mediated neuroprotection favours a positive clinical evaluation of barbiturate treatment. The chemical structure of thiopental could represent a pharmacologically relevant scaffold for the development of new organ-protective compounds to ameliorate tissue damage when oxygen availability is limited.	[Schwer, Christian I.; Lehane, Cornelius; Strosing, Karl M.; Spassov, Sashko; Buerkle, Hartmut; Humar, Matjaz] Univ Med Ctr Freiburg, Dept Anesthesiol & Crit Care Med, Freiburg, Germany; [Guelzow, Timo] Univ Med Ctr Freiburg, Dept Gen Neurosurg Cellular Neurophysiol, Freiburg, Germany; [Erxleben, Anika] Univ Freiburg, Inst Pharmaceut Sci, D-79106 Freiburg, Germany; [Zenker, Simone; Heimrich, Bernd] Univ Freiburg, Dept Anat & Cell Biol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Humar, M (corresponding author), Univ Med Ctr Freiburg, Dept Anesthesiol & Crit Care Med, Freiburg, Germany.	matjaz.humar@uniklinik-freiburg.de	Spassov, Sashko/C-2105-2013; Buerkle, Hartmut/I-5785-2014	Spassov, Sashko/0000-0002-3585-3682; Erxleben, Anika/0000-0002-7427-6478; Lehane, Cornelius/0000-0001-5173-5216	Department of Anesthesiology and Critical Care Medicine, University Medical Center Freiburg, Germany	Department of Anesthesiology and Critical Care Medicine, University Medical Center Freiburg, Germany	This work was funded by the Department of Anesthesiology and Critical Care Medicine, University Medical Center Freiburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS49; ALDRIDGE WN, 1960, BIOCHEM J, V76, P47, DOI 10.1042/bj0760047; Almaas R, 2000, ANESTHESIOLOGY, V92, P764, DOI 10.1097/00000542-200003000-00020; Anderson CM, 2002, J NEUROSCI, V22, P9203; BECKER KE, 1976, ANESTHESIOLOGY, V45, P656, DOI 10.1097/00000542-197612000-00013; Bolanos JP, 1999, BBA-BIOENERGETICS, V1411, P415, DOI 10.1016/S0005-2728(99)00030-4; Bouaziz N, 2002, EUR J PHARMACOL, V441, P35, DOI 10.1016/S0014-2999(02)01490-5; Boutilier RG, 2000, COMP BIOCHEM PHYS A, V126, P481, DOI 10.1016/S1095-6433(00)00234-8; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Candelario-Jalil E, 2008, CURR PHARM DESIGN, V14, P1401, DOI 10.2174/138161208784480216; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Cole DJ, 2001, CAN J ANAESTH, V48, P807, DOI 10.1007/BF03016699; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; DESSI F, 1992, BRAIN RES, V581, P323, DOI 10.1016/0006-8993(92)90726-P; Diggle TA, 1998, BIOCHEM J, V336, P525, DOI 10.1042/bj3360525; Diggle TA, 2001, BIOCHEM J, V353, P621, DOI 10.1042/0264-6021:3530621; DOENICKE A, 1965, ACTA ANAESTH SCAND, P11; Du JH, 2008, BIOCHEM BIOPH RES CO, V368, P402, DOI 10.1016/j.bbrc.2008.01.099; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; GOTO K, 1990, BRAIN RES, V534, P299, DOI 10.1016/0006-8993(90)90144-Z; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; Hand SC, 1996, ANNU REV PHYSIOL, V58, P539, DOI 10.1146/annurev.ph.58.030196.002543; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hidaka Ikuhiro, 2009, Hiroshima Journal of Medical Sciences, V58, P9; Hizli AA, 2013, MOL CELL BIOL, V33, P596, DOI 10.1128/MCB.01270-12; Humar M, 2004, MOL PHARMACOL, V65, P350, DOI 10.1124/mol.65.2.350; Humar M, 2009, MOL PHARMACOL, V75, P667, DOI 10.1124/mol.108.052183; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Li J, 2010, J CEREBR BLOOD F MET, V30, P480, DOI 10.1038/jcbfm.2009.255; Lin CC, 2013, CELL MOL LIFE SCI; Loop T, 2003, ANESTHESIOLOGY, V99, P360, DOI 10.1097/00000542-200308000-00017; Michiels C, 2004, AM J PATHOL, V164, P1875, DOI 10.1016/S0002-9440(10)63747-9; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; NEUWELT EA, 1982, J NEUROSURG, V56, P254, DOI 10.3171/jns.1982.56.2.0254; NORDBY HK, 1984, ACTA NEUROCHIR, V72, P157, DOI 10.1007/BF01406868; Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006; Park WS, 2006, J KOREAN MED SCI, V21, P337, DOI 10.3346/jkms.2006.21.2.337; Pizzi M, 2002, EUR J NEUROSCI, V16, P2342, DOI 10.1046/j.1460-9568.2002.02403.x; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Py BF, 2009, AUTOPHAGY, V5, P393, DOI 10.4161/auto.5.3.7762; Roberts I, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000033; Roesslein M, 2008, J PHARMACOL EXP THER, V325, P217, DOI 10.1124/jpet.107.133108; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1987, FEBS LETT, V214, P331, DOI 10.1016/0014-5793(87)80081-9; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Salminen A, 2011, J NEUROCHEM, V118, P460, DOI 10.1111/j.1471-4159.2011.07331.x; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Shibuta S, 1998, BRIT J PHARMACOL, V124, P804, DOI 10.1038/sj.bjp.0701884; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; SMITH DS, 1980, ACTA PHYSIOL SCAND, P129; STEEN PA, 1980, ANESTHESIOLOGY, V53, P183; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Wilson JX, 2002, J NEUROSURG ANESTH, V14, P66, DOI 10.1097/00008506-200201000-00014; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Wong AKF, 2009, CLIN SCI, V116, P607, DOI 10.1042/CS20080066; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; YASUDA T, 1993, INT J LEGAL MED, V105, P239, DOI 10.1007/BF01642801; Ying WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P2728, DOI 10.2741/2267; ZAGER EL, 1988, J NEUROSURG, V69, P568, DOI 10.3171/jns.1988.69.4.0568; Zhan RZ, 1998, BRIT J ANAESTH, V81, P932, DOI 10.1093/bja/81.6.932; Zhan RZ, 1998, ANESTHESIOLOGY, V89, P456, DOI 10.1097/00000542-199808000-00023; Zhang XL, 2010, NEUROCHEM RES, V35, P1281, DOI 10.1007/s11064-010-0186-3	69	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77258	10.1371/journal.pone.0077258	http://dx.doi.org/10.1371/journal.pone.0077258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167567	gold, Green Published, Green Submitted			2022-12-27	WOS:000326034500026
J	Shimanuki, M; Uehara, L; Pluskal, T; Yoshida, T; Kokubu, A; Kawasaki, Y; Yanagida, M				Shimanuki, Mizuki; Uehara, Lisa; Pluskal, Tomas; Yoshida, Tomoko; Kokubu, Aya; Kawasaki, Yosuke; Yanagida, Mitsuhiro			Klf1, a C2H2 Zinc Finger-Transcription Factor, Is Required for Cell Wall Maintenance during Long-Term Quiescence in Differentiated G0 Phase	PLOS ONE			English	Article							KRUPPEL-LIKE FACTORS; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; GENETIC-CONTROL; SEXUAL-DIFFERENTIATION; DIVISION CYCLE; STEM-CELLS; PROTEIN; IDENTIFICATION; PHEROMONE	Fission yeast, Schizoaccharomyces pombe, is a model for studying cellular quiescence. Shifting to a medium that lacks a nitrogen-source induces proliferative cells to enter long-term G0 quiescence. Klf1 is a Kruppel-like transcription factor with a 7-amino acid Cys2His2-type zinc finger motif. The deletion mutant, Delta klf1, normally divides in vegetative medium, but proliferation is not restored after long-term G0 quiescence. Cell biologic, transcriptomic, and metabolomic analyses revealed a unique phenotype of the Delta klf1 mutant in quiescence. Mutant cells had diminished transcripts related to signaling molecules for switching to differentiation; however, proliferative metabolites for cell-wall assembly and antioxidants had significantly increased. Further, the size of Delta klf1 cells increased markedly during quiescence due to the aberrant accumulation of Calcofluor-positive, chitin-like materials beneath the cell wall. After 4 weeks of quiescence, reversible proliferation ability was lost, but metabolism was maintained. Klf1 thus plays a role in G0 phase longevity by enhancing the differentiation signal and suppressing metabolism for growth. If Klf1 is lost, S. pombe fails to maintain a constant cell size and normal cell morphology during quiescence.	[Shimanuki, Mizuki; Uehara, Lisa; Pluskal, Tomas; Yoshida, Tomoko; Kokubu, Aya; Kawasaki, Yosuke; Yanagida, Mitsuhiro] Okinawa Inst Sci & Technol Grad Univ OIST, Cell Unit G0, Onna, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Shimanuki, M (corresponding author), Okinawa Inst Sci & Technol Grad Univ OIST, Biol Resources Sect, Onna, Okinawa, Japan.	mizuki.shimanuki@oist.jp; myanagid@gmail.com	Pluskal, Tomáš/C-6247-2012	Pluskal, Tomáš/0000-0002-6940-3006	Okinawa Institute of Science and Technology Promotion Corporation; Okinawa Institute of Science and Technology Graduate University	Okinawa Institute of Science and Technology Promotion Corporation; Okinawa Institute of Science and Technology Graduate University(Okinawa Institute of Science & Technology Graduate University)	This study was funded by the Okinawa Institute of Science and Technology Promotion Corporation and the Okinawa Institute of Science and Technology Graduate University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC, 2006, YEAST VITAL STAINS C; AONO T, 1994, YEAST, V10, P757, DOI 10.1002/yea.320100607; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; COSTELLO G, 1986, CURR GENET, V11, P119, DOI 10.1007/BF00378203; De Virgilio C, 2012, FEMS MICROBIOL REV, V36, P306, DOI 10.1111/j.1574-6976.2011.00287.x; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Goddard A, 2006, FUNGAL GENET BIOL, V43, P840, DOI 10.1016/j.fgb.2006.06.005; Hanyu Y, 2009, GENES CELLS, V14, P539, DOI 10.1111/j.1365-2443.2009.01290.x; HARTWELL LH, 1973, GENETICS, V74, P267; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Jeyaraj D, 2012, CELL METAB, V15, P311, DOI 10.1016/j.cmet.2012.01.020; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; KITAMURA K, 1991, EMBO J, V10, P3743, DOI 10.1002/j.1460-2075.1991.tb04943.x; Kitamura K, 2001, DEV CELL, V1, P389, DOI 10.1016/S1534-5807(01)00037-5; Kunitomo H, 2000, MOL BIOL CELL, V11, P3205, DOI 10.1091/mbc.11.9.3205; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Nakamura T, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120117; NURSE P, 1981, NATURE, V292, P558, DOI 10.1038/292558a0; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; O'Farrell PH, 2011, PHILOS T R SOC B, V366, P3498, DOI 10.1098/rstb.2011.0079; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Okazaki K, 2000, DNA RES, V7, P27, DOI 10.1093/dnares/7.1.27; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Piper PW, 2006, YEAST, V23, P215, DOI 10.1002/yea.1354; Pluskal T, 2012, ANAL CHEM, V84, P4396, DOI 10.1021/ac3000418; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Pluskal T, 2010, MOL BIOSYST, V6, P182, DOI 10.1039/b908784b; Raponi M, 2002, NUCLEIC ACIDS RES, V30, P2546, DOI 10.1093/nar/30.11.2546; Sajiki K, 2009, J CELL SCI, V122, P1418, DOI 10.1242/jcs.046466; SAUER F, 1995, EMBO J, V14, P4773, DOI 10.1002/j.1460-2075.1995.tb00159.x; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Shimanuki M, 2007, GENES CELLS, V12, P677, DOI 10.1111/j.1365-2443.2007.01079.x; Su SSY, 1996, J CELL SCI, V109, P1347; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Sukegawa Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002387; Takeda K, 2010, AUTOPHAGY, V6, P564, DOI 10.4161/auto.6.4.11948; UZAWA S, 1992, J CELL SCI, V101, P267; Vilo J, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P384; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006	51	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78545	10.1371/journal.pone.0078545	http://dx.doi.org/10.1371/journal.pone.0078545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167631	gold, Green Submitted, Green Published			2022-12-27	WOS:000326034500092
J	Wu, J; Zhang, YY; Guo, L; Li, H; Chen, DF				Wu, Jian; Zhang, Yun-Yi; Guo, Li; Li, Hong; Chen, Dao-Feng			Bupleurum Polysaccharides Attenuates Lipopolysaccharide-Induced Inflammation via Modulating Toll-Like Receptor 4 Signaling	PLOS ONE			English	Article							NF-KAPPA-B; ACUTE LUNG INJURY; MOLECULAR-MECHANISMS; EXPRESSION; MACROPHAGES; INHIBITION; ACTIVATION; CYTOKINE; ALPHA; INTERLEUKIN-6	Background: Bupleurum polysaccharides (BPs), isolated from Bupleurum smithii var. parvifolium, possesses immunomodulatory activity, particularly on inflammation. Bacterial endotoxin lipopolysaccharide (LPS) triggers innate immune responses through Toll-like receptor 4 (TLR4) on host cell membrane. The present study was performed to evaluate whether the therapeutic efficacy of BPs on suppression of LPS's pathogenecity could be associated with the modulating of TLR4 signaling pathway. Methodology/Principal Findings: LPS stimulated expression and activation of factors in the TLR4 signaling system, including TLR4, CD14, IRAK4, TRAF6, NF-kappa B, and JNK, determined using immunocytochemical and/or Western blot assays. BPs significantly inhibited these effects of LPS. LPS increased pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1 beta, IL-12p40, and IFN-beta) and NO production, evaluated using ELISA and Griess reaction assays, respectively. BPs antagonized these effects of LPS. Interestingly, BPs alone augmented secretion of some pro-inflammatory cytokines of non-LPS stimulated macrophages and enhanced phagocytic activity towards fluorescent E. coli bioparticles. In a rat model of acute lung injury (ALI) with pulmonary hemorrhage and inflammation, BPs ameliorated lung injuries and suppressed TLR4 expression. Significance: The therapeutic properties of BPs in alleviating inflammatory diseases could be attributed to its inhibitory effect on LPS-mediated TLR4 signaling.	[Wu, Jian; Zhang, Yun-Yi; Guo, Li; Li, Hong] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China; [Chen, Dao-Feng] Fudan Univ, Sch Pharm, Dept Pharmacognosy, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Zhang, YY (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China.	zhcheng@shmu.edu.cn; dfchen@shmu.edu.cn		Wu, Jian/0000-0002-2333-1000	National Natural Science Foundation of China [30925042, 30572315, 81274165]; State Key Program for New Drugs from the Ministry of Science and Technology, China [2009ZX09502-013, 2012ZX09301001-003]; Science and Technology Commission of Shanghai Municipality [10XD1405900, 12JC1400800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program for New Drugs from the Ministry of Science and Technology, China; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (Grant No. 30925042, 30572315, 81274165), the State Key Program for New Drugs from the Ministry of Science and Technology, China (Grant No. 2009ZX09502-013, 2012ZX09301001-003), and the Science and Technology Commission of Shanghai Municipality (Grant No. 10XD1405900, 12JC1400800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bakker AD, 2009, ARTHRITIS RHEUM-US, V60, P3336, DOI 10.1002/art.24920; Barsness KA, 2004, AM J PHYSIOL-REG I, V287, pR592, DOI 10.1152/ajpregu.00412.2003; Bendjeddou D, 2003, J ETHNOPHARMACOL, V88, P155, DOI 10.1016/S0378-8741(03)00226-5; Chang HS, 2001, CLIN CHIM ACTA, V312, P49, DOI 10.1016/S0009-8981(01)00588-5; Cheng XQ, 2012, INFLAMMATION, V35, P1715, DOI 10.1007/s10753-012-9489-7; Cheng XQ, 2010, J ETHNOPHARMACOL, V130, P363, DOI 10.1016/j.jep.2010.05.019; de las Heras B, 2007, BRIT J PHARMACOL, V152, P249, DOI 10.1038/sj.bjp.0707382; de Santana AP, 2012, CARBOHYD POLYM, V87, P2730, DOI 10.1016/j.carbpol.2011.11.073; Fan J, 2002, J IMMUNOL, V168, P5252, DOI 10.4049/jimmunol.168.10.5252; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Graff JC, 2009, INT IMMUNOPHARMACOL, V9, P1313, DOI 10.1016/j.intimp.2009.07.015; Guo TJ, 2000, IMMUNOPHARMACOLOGY, V49, P307, DOI 10.1016/S0162-3109(00)00245-9; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Heumann D, 1998, CURR OPIN MICROBIOL, V1, P49, DOI 10.1016/S1369-5274(98)80142-2; Heumann D, 2001, INFECT IMMUN, V69, P378, DOI 10.1128/IAI.69.1.378-385.2001; Holderness J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017301; Jenkins SJ, 2005, INT IMMUNOL, V17, P1409, DOI 10.1093/intimm/dxh319; Jeyaseelan S, 2005, INFECT IMMUN, V73, P1754, DOI 10.1128/IAI.73.3.1754-1763.2005; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim JH, 2009, EUR J PHARMACOL, V602, P422, DOI 10.1016/j.ejphar.2008.10.062; Komatsu H, 2012, LIFE SCI, V91, P143, DOI 10.1016/j.lfs.2012.06.030; Lee JS, 2011, INT IMMUNOPHARMACOL, V11, P1226, DOI 10.1016/j.intimp.2011.04.001; Lee JK, 2009, BIOCHEM PHARMACOL, V77, P1391, DOI 10.1016/j.bcp.2009.01.009; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Manna SK, 2000, J IMMUNOL, V165, P4927, DOI 10.4049/jimmunol.165.9.4927; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Navarro P, 2001, LIFE SCI, V68, P1199, DOI 10.1016/S0024-3205(00)01019-5; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Pruett SB, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-49; Sato TA, 2003, J IMMUNOL, V170, P158, DOI 10.4049/jimmunol.170.1.158; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Sullivan AM, 2008, IMMUNOPHARM IMMUNOT, V30, P553, DOI 10.1080/08923970802135534; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Togbe D, 2006, J LEUKOCYTE BIOL, V80, P451, DOI 10.1189/jlb.0206099; USHIO Y, 1991, INT J IMMUNOPHARMACO, V13, P501, DOI 10.1016/0192-0561(91)90069-J; Wang NZ, 2010, FASEB J, V24, P2178, DOI 10.1096/fj.09-136895; Wang Z, 2009, J ETHNOPHARMACOL, V124, P481, DOI 10.1016/j.jep.2009.05.013; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zhou R, 2006, J PHARMACOL EXP THER, V316, P121, DOI 10.1124/jpet.105.093179	40	30	31	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78051	10.1371/journal.pone.0078051	http://dx.doi.org/10.1371/journal.pone.0078051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167596	gold, Green Published, Green Submitted			2022-12-27	WOS:000326034500056
J	Cheung, YF; Yu, W; Cheuk, DKL; Cheng, FWT; Yang, JYK; Yau, JPW; Ho, KKH; Li, CK; Li, RCH; Yuen, HL; Ling, ASC; Li, VWY; Wong, WK; Tsang, KC; Chan, GCF				Cheung, Yiu-fai; Yu, Wei; Cheuk, Daniel Ka-leung; Cheng, Frankie Wai-tsoi; Yang, Janet Yee-kwan; Yau, Jeffrey Ping-wa; Ho, Karin Ka-huen; Li, Chi-kong; Li, Rever Chak-ho; Yuen, Hui-leung; Ling, Alvin Siu-cheung; Li, Vivian Wing-yi; Wong, Wai-keung; Tsang, Kwong-cheong; Chan, Godfrey Chi-fung			Plasma High Sensitivity Troponin T Levels in Adult Survivors of Childhood Leukaemias: Determinants and Associations with Cardiac Function	PLOS ONE			English	Article							PEDIATRIC-PATIENTS; ISOVOLUMIC ACCELERATION; MYOCARDIAL INJURY; NAD(P)H OXIDASE; HEART-FAILURE; MORTALITY; RISK; CANCER; FORCE; CARDIOTOXICITY	Background: We sought to quantify plasma high sensitivity cardiac troponin (hs-cTnT) levels, their determinants, and their associations with left ventricular (LV) myocardial deformation in adult survivors of childhood acute leukaemias. Methods and Results: One hundred adult survivors (57 males) of childhood acute leukaemias, aged 24.1 +/- 4.2 years, and 42 age-matched controls (26 males) were studied. Plasma cTnT was determined using a highly sensitive assay. Genotyping of NAD(P)H oxidase and multidrug resistance protein polymorphisms was performed. Left ventricular function was assessed by conventional, three-dimensional, and speckle tracking echocardiography. The medians (interquartile range) of hs-cTnT in male and female survivors were 4.9 (4.2 to 7.2) ng/L and 1.0 (1.0 to 3.5) ng/L, respectively. Nineteen survivors (13 males, 6 females) (19%) had elevated hs-cTnT (>95th centile of controls). Compared to those without elevated hs-TnT levels, these subjects had received larger cumulative anthracycline dose and were more likely to have leukaemic relapse, stem cell transplant, and cardiac irradiation. Their LV systolic and early diastolic myocardial velocities, isovolumic acceleration, and systolic longitudinal strain rate were significantly lower. Survivors having CT/TT at CYBA rs4673 had higher hs-cTnT levels than those with CC genotype. Functionally, increased hs-cTnT levels were associated with worse LV longitudinal systolic strain and systolic and diastolic strain rates. Conclusions: Increased hs-cTnT levels occur in a significant proportion of adult survivors of childhood acute leukaemias and are associated with larger cumulative anthracycline dose received, history of leukaemic relapse, stem cell transplant, and cardiac irradiation, genetic variants in free radical metabolism, and worse LV myocardial deformation.	[Cheung, Yiu-fai; Yu, Wei; Cheuk, Daniel Ka-leung; Li, Vivian Wing-yi; Chan, Godfrey Chi-fung] Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Cheng, Frankie Wai-tsoi; Li, Chi-kong] Prince Wales Hosp, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; [Yang, Janet Yee-kwan; Li, Rever Chak-ho] Tuen Mun Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Yau, Jeffrey Ping-wa; Yuen, Hui-leung] Queen Elizabeth Hosp, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; [Ho, Karin Ka-huen; Ling, Alvin Siu-cheung] Princess Margaret Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Wai-keung; Tsang, Kwong-cheong] Queen Mary Hosp, Dept Pathol & Clin Biochem, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Tuen Mun Hospital; University of Hong Kong	Cheung, YF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	xfcheung@hku.hk	Li, Chi-kong/J-8456-2013; Cheung, Yiu Fai/C-4240-2009	Li, Chi-kong/0000-0002-2810-5758; Cheung, Yiu Fai/0000-0002-7279-4992; Cheuk, Daniel/0000-0001-9553-3528	Children's Cancer Foundation (Hong Kong)	Children's Cancer Foundation (Hong Kong)	Children's Cancer Foundation (Hong Kong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Armstrong GT, 2009, J CLIN ONCOL, V27, P2328, DOI 10.1200/JCO.2008.21.1425; Cheung YF, 2010, HEART, V96, P1137, DOI 10.1136/hrt.2010.194118; Daniels LB, 2008, J AM COLL CARDIOL, V52, P450, DOI 10.1016/j.jacc.2008.04.033; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Filusch A, 2010, CLIN SCI, V119, P207, DOI 10.1042/CS20100014; Gatta G, 2002, CANCER-AM CANCER SOC, V95, P1767, DOI 10.1002/cncr.10833; Goethals I, 2002, ANN ONCOL, V13, P1331, DOI 10.1093/annonc/mdf318; Huang CQ, 2010, CIRCULATION, V121, P675, DOI 10.1161/CIRCULATIONAHA.109.902221; Kawahara C, 2011, AM HEART J, V162, P639, DOI 10.1016/j.ahj.2011.07.007; Kawahara C, 2011, CIRC J, V75, P656, DOI 10.1253/circj.CJ-10-0837; Kremer LCM, 2002, EUR J CANCER, V38, P686, DOI 10.1016/S0959-8049(01)00431-2; Lipshultz SE, 1997, CIRCULATION, V96, P2641, DOI 10.1161/01.CIR.96.8.2641; Lipshultz SE, 2008, HEART, V94, P525, DOI 10.1136/hrt.2007.136093; Lipshultz SE, 2012, J CLIN ONCOL, V30, P1042, DOI 10.1200/JCO.2010.30.3404; Masson S, 2012, CIRCULATION, V125, P280, DOI 10.1161/CIRCULATIONAHA.111.044149; Mathew P, 2001, CANCER INVEST, V19, P352, DOI 10.1081/CNV-100103130; Otsuka T, 2010, AM HEART J, V159, P972, DOI 10.1016/j.ahj.2010.02.036; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; Roche SL, 2011, J AM COLL CARDIOL, V57, P1100, DOI 10.1016/j.jacc.2010.09.063; Saenger AK, 2011, CLIN CHIM ACTA, V412, P748, DOI 10.1016/j.cca.2010.12.034; Shankar SM, 2008, PEDIATRICS, V121, pE387, DOI 10.1542/peds.2007-0575; Shimo-Nakanishi Y, 2004, ATHEROSCLEROSIS, V175, P109, DOI 10.1016/j.atherosclerosis.2004.01.043; Sobel BE, 2000, J AM COLL CARDIOL, V35, P1355, DOI 10.1016/S0735-1097(00)00516-7; Thorburn A, 2006, MOL CANCER THER, V5, P197, DOI 10.1158/1535-7163.MCT-06-CO1; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Visscher H, 2012, J CLIN ONCOL, V30, P1422, DOI 10.1200/JCO.2010.34.3467; Vogel M, 2003, CIRCULATION, V107, P1647, DOI 10.1161/01.CIR.0000058171.62847.90; Wallace TW, 2006, CIRCULATION, V113, P1958, DOI 10.1161/CIRCULATIONAHA.105.609974; Wang TJ, 2007, CIRCULATION, V116, P1217, DOI 10.1161/CIRCULATIONAHA.107.721845; Wojnowski L, 2005, CIRCULATION, V112, P3754, DOI 10.1161/CIRCULATIONAHA.105.576850; Wu AHB, 1999, CLIN CHIM ACTA, V284, P161, DOI 10.1016/S0009-8981(99)00078-9; Wyche KE, 2004, HYPERTENSION, V43, P1246, DOI 10.1161/01.HYP.0000126579.50711.62; Xue Y, 2011, EUR J HEART FAIL, V13, P37, DOI 10.1093/eurjhf/hfq210	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77063	10.1371/journal.pone.0077063	http://dx.doi.org/10.1371/journal.pone.0077063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204736	gold, Green Published, Green Submitted			2022-12-27	WOS:000326032600019
J	de Almeida, RS; Hammoumi, S; Gil, P; Briand, FX; Molia, S; Gaidet, N; Cappelle, J; Chevalier, V; Balanca, G; Traore, A; Grillet, C; Maminiaina, OF; Guendouz, S; Dakouo, M; Samake, K; Bezeid, OE; Diarra, A; Chaka, H; Goutard, F; Thompson, P; Martinez, D; Jestin, V; Albina, E				de Almeida, Renata Servan; Hammoumi, Saliha; Gil, Patricia; Briand, Francois-Xavier; Molia, Sophie; Gaidet, Nicolas; Cappelle, Julien; Chevalier, Veronique; Balanca, Gilles; Traore, Abdallah; Grillet, Colette; Maminiaina, Olivier Fridolin; Guendouz, Samia; Dakouo, Marthin; Samake, Kassim; Bezeid, Ould El Mamy; Diarra, Abbas; Chaka, Hassen; Goutard, Flavie; Thompson, Peter; Martinez, Dominique; Jestin, Veronique; Albina, Emmanuel			New Avian Paramyxoviruses Type I Strains Identified in Africa Provide New Outcomes for Phylogeny Reconstruction and Genotype Classification	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; VIRULENT-STRAINS; FUSION PROTEIN; BRANCH LENGTH; OUTBREAKS; SEQUENCE; PPMV-1; SITE; TIME; RECOMBINATION	Newcastle disease (ND) is one of the most lethal diseases of poultry worldwide. It is caused by an avian paramyxovirus 1 that has high genomic diversity. In the framework of an international surveillance program launched in 2007, several thousand samples from domestic and wild birds in Africa were collected and analyzed. ND viruses (NDV) were detected and isolated in apparently healthy fowls and wild birds. However, two thirds of the isolates collected in this study were classified as virulent strains of NDV based on the molecular analysis of the fusion protein and experimental in vivo challenges with two representative isolates. Phylogenetic analysis based on the F and HN genes showed that isolates recovered from poultry in Mali and Ethiopia form new groups, herein proposed as genotypes XIV and sub-genotype VIf with reference to the new nomenclature described by Diel's group. In Madagascar, the circulation of NDV strains of genotype XI, originally reported elsewhere, is also confirmed. Full genome sequencing of five African isolates was generated and an extensive phylogeny reconstruction was carried out based on the nucleotide sequences. The evolutionary distances between groups and the specific amino acid signatures of each cluster allowed us to refine the genotype nomenclature.	[de Almeida, Renata Servan; Hammoumi, Saliha; Gil, Patricia; Grillet, Colette; Guendouz, Samia; Martinez, Dominique] CIRAD, UMR CMAEE, Montpellier, France; [de Almeida, Renata Servan; Hammoumi, Saliha; Gil, Patricia; Grillet, Colette; Guendouz, Samia; Martinez, Dominique; Albina, Emmanuel] INRA, CMAEE UMR1309, F-34060 Montpellier, France; [Briand, Francois-Xavier; Jestin, Veronique] Anses Ploufragan Plouzane, VIPAC, French Reference Lab Avian Influenza & Newcastle, Ploufragan, France; [Molia, Sophie; Gaidet, Nicolas; Cappelle, Julien; Chevalier, Veronique; Balanca, Gilles; Goutard, Flavie] CIRAD, UPR AGIRS, Montpellier, France; [Traore, Abdallah; Dakouo, Marthin; Samake, Kassim; Diarra, Abbas] Cent Vet Lab, Bamako, Mali; [Maminiaina, Olivier Fridolin] FOFIFA DRZV, Antananarivo, Madagascar; [Bezeid, Ould El Mamy] CNERV, Nouakchott, Mauritania; [Chaka, Hassen] NAHDIC, Sebeta, Ethiopia; [Thompson, Peter] Univ Pretoria, Fac Vet Sci, ZA-0002 Pretoria, South Africa; [Albina, Emmanuel] CIRAD, UMR CMAEE, Petit Bourg, Guadeloupe, France	CIRAD; INRAE; CIRAD; University of Pretoria; CIRAD	de Almeida, RS (corresponding author), CIRAD, UMR CMAEE, Montpellier, France.	renata.almeida@cirad.fr	Thompson, Peter N/J-2534-2013	Thompson, Peter/0000-0002-2268-9748; BRIAND, Francois-Xavier/0000-0002-8094-9368; goutard, flavie luce/0000-0002-8618-4132; Cappelle, Julien/0000-0001-7668-1971; Molia, Sophie/0000-0002-5695-7464; Albina, Emmanuel/0000-0002-6613-3047	French Ministry of Foreign Affairs (MAE) [GRIPAVI 2006-26]; EU network of excellence [EPIZONE (016236)]; French Ministry of Foreign Affairs (MAE) [GRIPAVI 2006-26]; EU network of excellence [EPIZONE (016236)]	French Ministry of Foreign Affairs (MAE); EU network of excellence(European Commission); French Ministry of Foreign Affairs (MAE); EU network of excellence(European Commission)	This study was mainly funded by the French Ministry of Foreign Affairs (MAE) via the Fonds de Solidarite Prioritaire project [GRIPAVI 2006-26] and partly by the EU network of excellence project [EPIZONE (016236, 01/06/2006-31/05/2011)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolnik C, 2008, ONDERSTEPOORT J VET, V75, P147; Abolnik C, 2004, ONDERSTEPOORT J VET, V71, P157; Aldous EW, 2003, AVIAN PATHOL, V32, P239, DOI 10.1080/030794503100009783; Alexander DJ, 2000, REV SCI TECH OIE, V19, P443, DOI 10.20506/rst.19.2.1231; BallagiPordany A, 1996, ARCH VIROL, V141, P243, DOI 10.1007/BF01718397; Cattoli G, 2010, VET MICROBIOL, V142, P168, DOI 10.1016/j.vetmic.2009.09.063; Chong YL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000872; Courtney SC, 2012, J CLIN MICROBIOL; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; de Almeida RS, 2009, VACCINE, V27, P3127, DOI 10.1016/j.vaccine.2009.03.076; de Leeuw OS, 2005, J GEN VIROL, V86, P1759, DOI 10.1099/vir.0.80822-0; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Dortmans JCFM, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-122; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fuller CM, 2007, ARCH VIROL, V152, P1575, DOI 10.1007/s00705-007-0963-8; GLICKMAN RL, 1988, J VIROL, V62, P354, DOI 10.1128/JVI.62.1.354-356.1988; HANNAN EJ, 1979, J ROY STAT SOC B MET, V41, P190; Herczeg J, 1999, ARCH VIROL, V144, P2087, DOI 10.1007/s007050050624; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Khan TA, 2010, J CLIN MICROBIOL, V48, P1892, DOI 10.1128/JCM.00148-10; Kwon HJ, 2003, VET MICROBIOL, V95, P39, DOI 10.1016/S0378-1135(03)00130-5; Lien YY, 2007, VET MICROBIOL, V123, P194, DOI 10.1016/j.vetmic.2007.03.006; Liu HL, 2007, J VIROL METHODS, V140, P206, DOI 10.1016/j.jviromet.2006.10.012; Lomniczi B, 1998, ARCH VIROL, V143, P49, DOI 10.1007/s007050050267; Maminiaina OF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013987; Martin DP, 2009, METHODS MOL BIOL, V537, P185, DOI 10.1007/978-1-59745-251-9_9; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Mohamed MHA, 2009, VIRUS GENES, V39, P234, DOI 10.1007/s11262-009-0385-7; Office International des Epizooties, 2008, MANUAL DIAGNOSTIC TE; Otim MO, 2004, J CLIN MICROBIOL, V42, P2802, DOI 10.1128/JCM.42.6.2802-2805.2004; Pchelkina IP, 2013, AVIAN DIS, V57, P2, DOI 10.1637/10246-051112-Reg.1; Pham HM, 2005, ARCH VIROL, V150, P2429, DOI 10.1007/s00705-005-0603-0; Qin ZM, 2008, VIRUS RES, V131, P299, DOI 10.1016/j.virusres.2007.10.001; Rannala B, 2012, MOL BIOL EVOL, V29, P325, DOI 10.1093/molbev/msr210; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rout SN, 2008, J VIROL, V82, P7828, DOI 10.1128/JVI.00578-08; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Snoeck CJ, 2009, ARCH VIROL, V154, P47, DOI 10.1007/s00705-008-0269-5; Soria-Carrasco V, 2007, BIOINFORMATICS, V23, P2954, DOI 10.1093/bioinformatics/btm466; STEWARD M, 1993, J GEN VIROL, V74, P2539, DOI 10.1099/0022-1317-74-12-2539; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarnagda Z, 2011, J INFECT DEV COUNTR, V5, P565, DOI 10.3855/jidc.1441; Ujvari D, 2003, VIRUS RES, V96, P63, DOI 10.1016/S0168-1702(03)00173-4; Wang ZL, 2006, ANN NY ACAD SCI, V1081, P228, DOI 10.1196/annals.1373.027; Wise MG, 2004, J CLIN MICROBIOL, V42, P329, DOI 10.1128/JCM.42.1.329-338.2004; Yu L, 2001, J CLIN MICROBIOL, V39, P3512, DOI 10.1128/JCM.39.10.3512-3519.2001; Zhang C, 2012, SYST BIOL, V61, P779, DOI 10.1093/sysbio/sys030; Zou J, 2005, VIRUS GENES, V30, P13, DOI 10.1007/s11262-004-4577-x	51	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76413	10.1371/journal.pone.0076413	http://dx.doi.org/10.1371/journal.pone.0076413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204623	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300026
J	Hanaoka, Y; Takebe, F; Nodasaka, Y; Hara, I; Matsuyama, H; Yumoto, I				Hanaoka, Yoshiko; Takebe, Fumihiko; Nodasaka, Yoshinobu; Hara, Isao; Matsuyama, Hidetoshi; Yumoto, Isao			Growth-Dependent Catalase Localization in Exiguobacterium oxidotolerans T-2-2(T) Reflected by Catalase Activity of Cells	PLOS ONE			English	Article							FACULTATIVELY PSYCHROPHILIC BACTERIUM; VIBRIO-RUMOIENSIS S-1(T); HYDROGEN-PEROXIDE; SUPEROXIDE-PRODUCTION; PROTEIN SECRETION; OXIDATIVE STRESS; DNA DAMAGE; PSYCHROBACTER; MECHANISM; H2O2	A psychrotolerant and H2O2-resistant bacterium, Exiguobacterium oxidotolerans T-2-2(T), exhibits extraordinary H2O2 resistance and produces catalase not only intracellularly but also extracellularly. The intracellular and extracellular catalases exhibited the same enzymatic characteristics, that is, they exhibited the temperature-dependent activity characteristic of a cold-adapted enzyme, their heat stabilities were similar to those of mesophilic enzymes and very high catalytic intensity. In addition, catalase gene analysis indicated that the bacterium possessed the sole clade 1 catalase gene corresponding to intracellular catalase. Hence, intracellular catalase is secreted into the extracellular space. In addition to intracellular and extracellular catalases, the inner circumference of the cells showed the localization of catalase in the mid-stationary growth phase, which was observed by immunoelectron microscopy using an antibody against the intracellular catalase of the strain. The cells demonstrated higher catalase activity in the mid-stationary growth phase than in the exponential growth phase. The catalase localized in the inner circumference can be dissociated by treatment with Tween 60. Thus, the localized catalase is not tightly bound to the inner circumference of the cells and may play a role in the oxidative defense of the cells under low metabolic state.	[Hanaoka, Yoshiko; Yumoto, Isao] Hokkaido Univ, Lab Environm Microbiol, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido, Japan; [Hanaoka, Yoshiko; Takebe, Fumihiko; Hara, Isao; Yumoto, Isao] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Toyohira Ku, Sapporo, Hokkaido, Japan; [Takebe, Fumihiko; Matsuyama, Hidetoshi] Tokai Univ, Sch Biol Sci & Engn, Minami Ku, Sapporo, Hokkaido, Japan; [Nodasaka, Yoshinobu] Hokkaido Univ, Grad Sch Dent, Lab Electron Microscopy, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; National Institute of Advanced Industrial Science & Technology (AIST); Tokai University; Hokkaido University	Yumoto, I (corresponding author), Hokkaido Univ, Lab Environm Microbiol, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido, Japan.	i.yumoto@aist.go.jp	Yumoto, Isao/N-2053-2018	Yumoto, Isao/0000-0001-9525-3155	National Institute of Advanced Industrial Science and Technology	National Institute of Advanced Industrial Science and Technology	Financial support was obtained from National Institute of Advanced Industrial Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Edman P, 1975, PROTEIN SEQUENCE DET, P232; EGELSEER E, 1995, J BACTERIOL, V177, P1444, DOI 10.1128/jb.177.6.1444-1451.1995; Halliwell B., 1999, FREE RADICAL BIOL ME; Hara I, 2007, BIOCHEMISTRY-US, V46, P11, DOI 10.1021/bi061519w; Harris AG, 2003, FEMS MICROBIOL LETT, V229, P283, DOI 10.1016/S0378-1097(03)00850-4; HILDEBRANDT AG, 1975, ARCH BIOCHEM BIOPHYS, V171, P385, DOI 10.1016/0003-9861(75)90047-8; Hoyoux A, 2004, J BIOSCI BIOENG, V98, P317; Ichise N, 1999, APPL ENVIRON MICROB, V65, P73; Ichise N, 2000, J BIOSCI BIOENG, V90, P530, DOI 10.1263/jbb.90.530; Ichise N, 2008, J BIOSCI BIOENG, V106, P39, DOI 10.1263/jbb.106.39; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; KATSUWON J, 1992, CAN J MICROBIOL, V38, P1026, DOI 10.1139/m92-169; Kimoto H, 2008, PROTEIN EXPRES PURIF, V59, P357, DOI 10.1016/j.pep.2008.03.016; Kimoto H, 2012, INT J MOL SCI, V13, P1733, DOI 10.3390/ijms13021733; Kong IS, 2004, FEMS MICROBIOL ECOL, V50, P133, DOI 10.1016/j.femsec.2004.06.004; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Lin PC, 2007, J BACTERIOL, V189, P3902, DOI 10.1128/JB.01651-06; Lorentzen MS, 2006, EXTREMOPHILES, V10, P427, DOI 10.1007/s00792-006-0518-z; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Orikasa Y, 2010, J BIOSCI BIOENG, V110, P397, DOI 10.1016/j.jbiosc.2010.04.007; POBINER H, 1961, ANAL CHEM, V33, P1423, DOI 10.1021/ac60178a045; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Raynaud C, 1998, MICROBIOL-SGM, V144, P577, DOI 10.1099/00221287-144-2-577; Rieske JS, 1967, METHOD ENZYMOL, V10, P488, DOI DOI 10.1016/0076-6879(67)10081-5; Rocha ER, 1996, J BACTERIOL, V178, P6895, DOI 10.1128/jb.178.23.6895-6903.1996; Rodrigues DF, 2009, ISME J, V3, P658, DOI 10.1038/ismej.2009.25; Rowe LA, 2008, FREE RADICAL BIO MED, V45, P1167, DOI 10.1016/j.freeradbiomed.2008.07.018; Sara M, 2001, TRENDS MICROBIOL, V9, P47, DOI 10.1016/S0966-842X(00)01905-3; SATO T, 1973, STAIN TECHNOL, V48, P223, DOI 10.3109/10520297309116628; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; SEEL WE, 1992, J EXP BOT, V43, P1031, DOI 10.1093/jxb/43.8.1031; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Takebe F, 2007, J BIOSCI BIOENG, V104, P464, DOI 10.1263/jbb.104.464; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; TSUJI S, 1990, J JPN SOC FOOD SCI, V37, P111; Vishnivetskaya TA, 2011, J BACTERIOL, V193, P2880, DOI 10.1128/JB.00303-11; Visick KL, 1998, J BACTERIOL, V180, P2087, DOI 10.1128/JB.180.8.2087-2092.1998; Yin Y, 2010, J BIOL CHEM, V285, P17038, DOI 10.1074/jbc.M110.104364; Yumoto I, 2000, J BACTERIOL, V182, P1903, DOI 10.1128/JB.182.7.1903-1909.2000; Yumoto I, 1998, J FERMENT BIOENG, V85, P113, DOI 10.1016/S0922-338X(97)80364-9; Yumoto I, 2004, INT J SYST EVOL MICR, V54, P2013, DOI 10.1099/ijs.0.63129-0; Yumoto I, 1999, APPL ENVIRON MICROB, V65, P67; Yumoto I, 2010, INT J SYST EVOL MICR, V60, P205, DOI 10.1099/ijs.0.010959-0	47	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76862	10.1371/journal.pone.0076862	http://dx.doi.org/10.1371/journal.pone.0076862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204687	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300056
J	Tsang, WP; Shu, YL; Kwok, PL; Zhang, FJ; Lee, KKH; Tang, MK; Li, G; Chan, KM; Chan, WY; Wan, C				Tsang, Wing Pui; Shu, Yinglan; Kwok, Po Lam; Zhang, Fengjie; Lee, Kenneth Ka Ho; Tang, Mei Kuen; Li, Gang; Chan, Kai Ming; Chan, Wai-Yee; Wan, Chao			CD146(+) Human Umbilical Cord Perivascular Cells Maintain Stemness under Hypoxia and as a Cell Source for Skeletal Regeneration	PLOS ONE			English	Article							MARROW STROMAL CELLS; IN-VITRO; ULTRASTRUCTURAL-CHANGES; GENE-EXPRESSION; BONE-MARROW; PROLIFERATION; DIFFERENTIATION; HIF-2-ALPHA; PRECURSORS; OXYGEN	The human umbilical cord perivascular cells (HUCPVCs) have been considered as an alternative source of mesenchymal progenitors for cell based regenerative medicine. However, the biological properties of these cells remain to be well characterized. In the present study, HUCPVCs were isolated and sorted by CD146(+) pericyte marker. The purified CD146(+) HUCPVCs were induced to differentiate efficiently into osteoblast, chondrocyte and adipocyte lineages in vitro. Six weeks following subcutaneous transplantation of CD146(+) HUCPVCs-Gelfoam-alginate 3D complexes in severe combined immunodeficiency (SCID) mice, newly formed bone matrix with embedded osteocytes of donor origin was observed. The functional engraftment of CD146(+) HUCPVCs in the new bone regenerates was further confirmed in a critical-sized bone defect model in SCID mice. Hypoxic conditions suppressed osteogenic differentiation while increased cell proliferation and colony-forming efficiency of CD146(+) HUCPVCs as compared to that under normoxic conditions. Re-oxygenation restored the multi-differentiation potential of the CD146(+) HUCPVCs. Western blot analysis revealed an upregulation of HIF-1 alpha, HIF-2 alpha, and OCT-4 protein expression in CD146(+) HUCPVCs under hypoxia, while there was no remarkable change in SOX2 and NANOG expression. The gene expression profiles of stem cell transcription factors between cells treated by normoxia and hypoxic conditions were compared by PCR array analysis. Intriguingly, PPAR-gamma was dramatically downregulated (20-fold) in mRNA expression under hypoxia, and was revealed to possess a putative binding site in the Hif-2 alpha gene promoter region. Chromatin immunoprecipitation assays confirmed the binding of PPAR-gamma protein to the Hif-2 alpha promoter and the binding was suppressed by hypoxia treatment. Luciferase reporter assay showed that the Hif-2 alpha promoter activity was suppressed by PPAR expression. Thus, PPAR-gamma may involve in the regulation of HIF-2 alpha for stemness maintenance and promoting the expansion of CD146(+) HUCPVCs in response to hypoxia. CD146(+) HUCPVCs may serve as a potential autologous cell source for bone regeneration.	[Tsang, Wing Pui; Shu, Yinglan; Kwok, Po Lam; Zhang, Fengjie; Lee, Kenneth Ka Ho; Tang, Mei Kuen; Li, Gang; Chan, Wai-Yee; Wan, Chao] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Key Lab Regenerat Med,Minist Educ, Hong Kong, Hong Kong, Peoples R China; [Tsang, Wing Pui; Zhang, Fengjie; Lee, Kenneth Ka Ho; Chan, Wai-Yee; Wan, Chao] Chinese Univ Hong Kong Shenzhen Res Inst, Sch Biomed Sci Core Lab, Shenzhen, Peoples R China; [Li, Gang; Chan, Kai Ming] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong	Wan, C (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Key Lab Regenerat Med,Minist Educ, Hong Kong, Hong Kong, Peoples R China.	cwan@cuhk.edu.hk	Wan, Chao/J-9277-2013; Li, Gang/J-7830-2018; Lee, Kenneth Ka Ho/H-6698-2013; Tang, Florence/AAW-4103-2021; Chan, Wai Yee/R-7442-2018	Wan, Chao/0000-0001-6780-2006; Li, Gang/0000-0002-3981-2239; Lee, Kenneth Ka Ho/0000-0002-6520-304X; Chan, Wai Yee/0000-0002-9714-0936	Hong Kong Research Grant Council General Research Fund [CUHK 475910]; NSFC-RGC Joint Research Scheme [CUHK445/10]; Chinese University of Hong Kong School of Biomedical Sciences Start-up Fund	Hong Kong Research Grant Council General Research Fund(Hong Kong Research Grants Council); NSFC-RGC Joint Research Scheme(National Natural Science Foundation of China (NSFC)); Chinese University of Hong Kong School of Biomedical Sciences Start-up Fund	The study was partly supported by Hong Kong Research Grant Council General Research Fund (CUHK 475910), NSFC-RGC Joint Research Scheme (CUHK445/10), and The Chinese University of Hong Kong School of Biomedical Sciences Start-up Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BRIGHTON CT, 1991, J BONE JOINT SURG AM, V73A, P832, DOI 10.2106/00004623-199173060-00006; Brighton CT, 1997, J ORTHOP TRAUMA, V11, P244, DOI 10.1097/00005131-199705000-00002; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828; Ennis J, 2008, CYTOTHERAPY, V10, P174, DOI 10.1080/14653240801891667; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Hamm JK, 1999, ANN NY ACAD SCI, V892, P134, DOI 10.1111/j.1749-6632.1999.tb07792.x; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Michiels C, 2001, IUBMB LIFE, V52, P49, DOI 10.1080/15216540252774766; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Solchaga LA, 2002, TISSUE ENG, V8, P333, DOI 10.1089/107632702753725085; Studer L, 2000, J NEUROSCI, V20, P7377; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Yang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023965; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zebardast N, 2010, ORGANOGENESIS, V6, P197, DOI 10.4161/org.6.4.12393	33	50	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76153	10.1371/journal.pone.0076153	http://dx.doi.org/10.1371/journal.pone.0076153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204598	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300011
J	Qiu, XW; Wu, XQ; Huang, L; Tian, MQ; Ye, JR				Qiu, Xiuwen; Wu, Xiaoqin; Huang, Lin; Tian, Minqi; Ye, Jianren			Specifically Expressed Genes of the Nematode Bursaphelenchus Xylophilus Involved with Early Interactions with Pine Trees	PLOS ONE			English	Article							WOOD NEMATODE; WILT DISEASE; MONOCHAMUS-ALTERNATUS; CELL WALLS; APHELENCHOIDIDAE; COLEOPTERA; VECTOR; SPREAD; CERAMBYCIDAE; SUPERFAMILY	As the causal agent of pine wilt disease (PWD), the pine wood nematode (PWN), Bursaphelenchus xylophilus, causes huge economic losses by devastating pine forests worldwide. However, the pathogenesis-related genes of B. xylophilus are not well characterized. Thus, DNA microarrays were used to investigate differential gene expression in PWN where Pinus thunbergii was inoculated with nematodes, compared with those cultured on Botrytis cinerea. The microarrays comprised 31121 probes, 1310 (4.2%) of which were differentially regulated (changes of >2-fold, P < 0.01) in the two growth conditions. Of these 1310 genes, 633 genes were upregulated, whereas 677 genes were downregulated. Gene Ontology (GO) categories were assigned to the classes Cellular Component, Molecular Function, and Biological Process. The comparative gene expression analysis showed that a large number of the pathogenesis-related genes of B. xylophilus, such as pectate lyase genes, cytochrome P450s, UGTs, and ABC transporter genes, were highly expressed when B. xylophilus infected P. thunbergii. Annotation analysis indicated that these genes contributed to cell wall degradation, detoxification, and the reproduction process. The microarray results were validated using quantitative RT-PCR (qRT-PCR). The microarray data confirmed the specific expression of B. xylophilus genes during infection of P. thunbergii, which provides basic information that facilitates a better understanding of the molecular mechanism of PWD.	[Qiu, Xiuwen; Wu, Xiaoqin; Huang, Lin; Tian, Minqi; Ye, Jianren] Nanjing Forestry Univ, Inst Forest Protect, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China; [Qiu, Xiuwen; Wu, Xiaoqin; Huang, Lin; Tian, Minqi; Ye, Jianren] Jiangsu Key Lab Prevent & Management Invas Specie, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Ye, JR (corresponding author), Nanjing Forestry Univ, Inst Forest Protect, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China.	jrye784@gmail.com			State Forest Administration of China [201204501]; National Science Research of Jiangsu University in China [11KJA220002]; National Nature Science Foundation of China [31000303]; Natural Science Foundation of Jiangsu Province [BK2010566]	State Forest Administration of China; National Science Research of Jiangsu University in China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the State Forest Administration of China (number 201204501), the project of National Science Research of Jiangsu University in China (number 11KJA220002), National Nature Science Foundation of China (number 31000303), the Natural Science Foundation of Jiangsu Province (number BK2010566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa T, 2006, FOREST PATHOL, V36, P1, DOI 10.1111/j.1439-0329.2006.00428.x; Aikawa T, 2003, ENVIRON ENTOMOL, V32, P96, DOI 10.1603/0046-225X-32.1.96; Aikawa T, 2007, NEMATOLOGY, V9, P371, DOI 10.1163/156854107781352007; Braasch H, 2001, FOREST PATHOL, V31, P129, DOI 10.1046/j.1439-0329.2001.00233.x; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Cheng H. R. (et al.), 1983, Forest Pest and Disease, P1; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Filho BPD, 2002, INSECT BIOCHEM MOLEC, V32, P1723, DOI 10.1016/S0965-1748(02)00112-1; Fukuda K., 1997, J RES, V2, P171, DOI [10.1007/BF02348216, DOI 10.1007/BF02348216]; Fukuda K, 2007, TREE PHYSIOL, V27, P969, DOI 10.1093/treephys/27.7.969; Gagou ME, 2002, INSECT BIOCHEM MOLEC, V32, P141, DOI 10.1016/S0965-1748(01)00101-1; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; Ichihara Y, 2000, PLANT DIS, V84, P675, DOI 10.1094/PDIS.2000.84.6.675; Jaubert S, 2002, FEBS LETT, V522, P109, DOI 10.1016/S0014-5793(02)02906-X; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; JONES TM, 1972, PHYSIOL PLANT PATHOL, V2, P153, DOI 10.1016/0048-4059(72)90023-9; Kang JS, 2012, INT J PARASITOL, V42, P63, DOI 10.1016/j.ijpara.2011.10.006; Kanzaki N, 2002, NEMATOLOGY, V4, P35, DOI 10.1163/156854102760082186; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kiyohara T., 1971, Journal of the Japanese Forestry Society, V53, P210; Kulas J, 2008, ARCH BIOCHEM BIOPHYS, V472, P65, DOI 10.1016/j.abb.2008.02.002; LANGENHEIM JH, 1994, J CHEM ECOL, V20, P1223, DOI 10.1007/BF02059809; Li HM, 2007, NEMATOLOGY, V9, P807, DOI 10.1163/156854107782331234; LINIT MJ, 1988, J NEMATOL, V20, P227; Mallez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059165; MAMIYA Y, 1972, NEMATOLOGICA, V18, P120, DOI 10.1163/187529272X00296; Mayer WE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-13; Menzel R, 2001, ARCH BIOCHEM BIOPHYS, V395, P158, DOI 10.1006/abbi.2001.2568; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mitreva-Dautova M, 2006, MOL PLANT MICROBE IN, V19, P521, DOI 10.1094/MPMI-19-0521; Mota MM, 2006, J NEMATOL, V38, P429; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Naves P, 2005, J PEST SCI, V78, P57, DOI 10.1007/s10340-004-0068-z; Nebert DW, 2000, PHARMACOLOGY, V61, P124, DOI 10.1159/000028393; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Ono N, 2000, MICROBIOL-UK, V146, P385, DOI 10.1099/00221287-146-2-385; Popeijus H, 2000, NATURE, V406, P36, DOI 10.1038/35017641; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Robinet C, 2011, BIOL INVASIONS, V13, P2981, DOI 10.1007/s10530-011-9983-0; Robinet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004646; RUTHERFORD TA, 1990, FOREST SCI, V36, P145; Santos CS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-599; Schuetz EG, 2001, CURR DRUG METAB, V2, P139, DOI 10.2174/1389200013338595; Shinya R, 2012, APPL ENTOMOL ZOOL, V47, P341, DOI 10.1007/s13355-012-0124-8; Soliman T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045505; Sousa E, 2001, NEMATOLOGY, V3, P89, DOI 10.1163/156854101300106937; Steiner G, 1934, J AGRIC RES, V48, P0949; Taga Y, 2011, NEMATOLOGY, V13, P701, DOI 10.1163/138855410X543166; TAIZ L, 1984, ANNU REV PLANT PHYS, V35, P585, DOI 10.1146/annurev.pp.35.060184.003101; Takeuchi Y, 2006, NEMATOLOGY, V8, P869, DOI 10.1163/156854106779799295; Tardy F, 1997, J BACTERIOL, V179, P2503, DOI 10.1128/jb.179.8.2503-2511.1997; Togashi K, 2006, POPUL ECOL, V48, P271, DOI 10.1007/s10144-006-0011-7; Tomassini A, 2009, PLANT PATHOL, V58, P556, DOI 10.1111/j.1365-3059.2008.02019.x; Tomminen J., 1989, Silva Fennica, V23, P271; Urlacher VB, 2012, TRENDS BIOTECHNOL, V30, P26, DOI 10.1016/j.tibtech.2011.06.012; Valadas V, 2012, NEMATOLOGY, V14, P899, DOI 10.1163/156854112X632673; Vanholme B, 2007, MOL PLANT PATHOL, V8, P267, DOI 10.1111/J.1364-3703.2007.00392.X; Wang Y, 2005, NEMATOLOGY, V7, P459, DOI 10.1163/156854105774355545; Wang Z, 2010, AFR J MICROBIOL RES, V4, P437; Yakoby N, 2001, MOL PLANT MICROBE IN, V14, P988, DOI 10.1094/MPMI.2001.14.8.988; YANG BJ, 1989, CAN J FOREST RES, V19, P1527, DOI 10.1139/x89-232; Yi C. K., 1989, Research Reports of the Forestry Research Institute (Seoul), P141; Zhang FuJia, 2013, American Journal of Plant Sciences, V4, P512; Zhu LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038095	67	19	25	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78063	10.1371/journal.pone.0078063	http://dx.doi.org/10.1371/journal.pone.0078063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155981	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300115
J	Zweitzig, DR; Riccardello, NM; Morrison, J; Rubino, J; Axelband, J; Jeanmonod, R; Sodowich, BI; Kopnitsky, MJ; O'Hara, SM				Zweitzig, Daniel R.; Riccardello, Nichol M.; Morrison, John; Rubino, Jason; Axelband, Jennifer; Jeanmonod, Rebecca; Sodowich, Bruce I.; Kopnitsky, Mark J.; O'Hara, S. Mark			Measurement of Microbial DNA Polymerase Activity Enables Detection and Growth Monitoring of Microbes from Clinical Blood Cultures	PLOS ONE			English	Article							UNITED-STATES; DIAGNOSIS; SEPSIS; EPIDEMIOLOGY; TECHNOLOGY; INFECTION; THERAPY	Surveillance of bloodstream infections (BSI) is a high priority within the hospital setting. Broth-based blood cultures are the current gold standard for detecting BSI, however they can require lengthy incubation periods prior to detection of positive samples. We set out to demonstrate the feasibility of using enzymatic template generation and amplification (ETGA)-mediated measurement of DNA polymerase activity to detect microbes from clinical blood cultures. In addition to routine-collected hospital blood cultures, one parallel aerobic blood culture was collected and immediately refrigerated until being transported for ETGA analysis. After refrigeration holding and transport, parallel-collected cultures were placed into a BACTEC incubator and ETGA time-course analysis was performed. Of the 308 clinical blood cultures received, 22 were BACTEC positive, and thus were initially selected for ETGA time course analysis. The ETGA assay detected microbial growth in all 22 parallel-positive blood cultures in less time than a BACTEC incubator and also yielded genomic DNA for qPCR-based organism identification. In summary, feasibility of detecting microbes from clinical blood culture samples using the ETGA blood culture assay was demonstrated. Additional studies are being considered towards development of clinically beneficial versions of this methodology.	[Zweitzig, Daniel R.; Riccardello, Nichol M.; Sodowich, Bruce I.; Kopnitsky, Mark J.; O'Hara, S. Mark] ZEUS Sci, Res & Dev, Raritan, NJ USA; [Morrison, John; Rubino, Jason; Axelband, Jennifer; Jeanmonod, Rebecca] St Lukes Univ Hlth Network, Bethlehem, PA USA		Zweitzig, DR (corresponding author), ZEUS Sci, Res & Dev, Raritan, NJ USA.	dzweitzig@zeusscientific.com			Zeus Scientific Inc.	Zeus Scientific Inc.	This study was funded by Zeus Scientific Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; ARONSON MD, 1987, ANN INTERN MED, V106, P246, DOI 10.7326/0003-4819-106-2-246; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Barie PS, 2012, SURG CLIN N AM, V92, P345, DOI 10.1016/j.suc.2012.01.015; Clinical and Laboratory Standards Institute, M47A CLIN LAB STAND, V27; Dark PM, 2009, CRIT CARE, V13, DOI 10.1186/cc7886; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Forney LJ, 2004, CURR OPIN MICROBIOL, V7, P210, DOI 10.1016/j.mib.2004.04.015; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Mancini N, 2010, CLIN MICROBIOL REV, V23, P235, DOI 10.1128/CMR.00043-09; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Munson EL, 2003, J CLIN MICROBIOL, V41, P495, DOI 10.1128/JCM.41.1.495-497.2003; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Reimer LG, 1997, CLIN MICROBIOL REV, V10, P444, DOI 10.1128/CMR.10.3.444; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Sautter RL, 2006, J CLIN MICROBIOL, V44, P1245, DOI 10.1128/JCM.44.4.1245-1249.2006; Seifert H, 2009, CLIN INFECT DIS, V48, pS238, DOI 10.1086/598188; Textoris J, 2011, EUR J ANAESTH, V28, P318, DOI 10.1097/EJA.0b013e328346c0de; Weinstein MP, 1996, CLIN INFECT DIS, V23, P40, DOI 10.1093/clinids/23.1.40; Wolk D. M., 2011, Journal of Clinical Microbiology, V49, pS62, DOI 10.1128/JCM.00834-11; Zweitzig DR, 2013, J MOL DIAGN, V15, P319, DOI 10.1016/j.jmoldx.2012.12.004; Zweitzig DR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks316	24	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78488	10.1371/journal.pone.0078488	http://dx.doi.org/10.1371/journal.pone.0078488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155986	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300121
J	Arevalo, O; Bornschlegl, MA; Eberhardt, S; Ernst, U; Pawelzik, K; Fahle, M				Arevalo, Orlando; Bornschlegl, Mona A.; Eberhardt, Sven; Ernst, Udo; Pawelzik, Klaus; Fahle, Manfred			Dynamics of Dual Prism Adaptation: Relating Novel Experimental Results to a Minimalistic Neural Model	PLOS ONE			English	Article							1ST-TRIAL ADAPTATION; CALIBRATION; EXPOSURE	In everyday life, humans interact with a dynamic environment often requiring rapid adaptation of visual perception and motor control. In particular, new visuo-motor mappings must be learned while old skills have to be kept, such that after adaptation, subjects may be able to quickly change between two different modes of generating movements ('dual-adaptation'). A fundamental question is how the adaptation schedule determines the acquisition speed of new skills. Given a fixed number of movements in two different environments, will dual-adaptation be faster if switches ('phase changes') between the environments occur more frequently? We investigated the dynamics of dual-adaptation under different training schedules in a virtual pointing experiment. Surprisingly, we found that acquisition speed of dual visuo-motor mappings in a pointing task is largely independent of the number of phase changes. Next, we studied the neuronal mechanisms underlying this result and other key phenomena of dual-adaptation by relating model simulations to experimental data. We propose a simple and yet biologically plausible neural model consisting of a spatial mapping from an input layer to a pointing angle which is subjected to a global gain modulation. Adaptation is performed by reinforcement learning on the model parameters. Despite its simplicity, the model provides a unifying account for a broad range of experimental data: It quantitatively reproduced the learning rates in dual-adaptation experiments for both direct effect, i.e. adaptation to prisms, and aftereffect, i.e. behavior after removal of prisms, and their independence on the number of phase changes. Several other phenomena, e.g. initial pointing errors that are far smaller than the induced optical shift, were also captured. Moreover, the underlying mechanisms, a local adaptation of a spatial mapping and a global adaptation of a gain factor, explained asymmetric spatial transfer and generalization of prism adaptation, as observed in other experiments.	[Arevalo, Orlando; Ernst, Udo; Pawelzik, Klaus] Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany; [Bornschlegl, Mona A.; Eberhardt, Sven; Fahle, Manfred] Univ Bremen, Inst Human Neurobiol, D-28359 Bremen, Germany; [Fahle, Manfred] City Univ London, Henry Wellcome Labs Vis Sci, London, England	University of Bremen; University of Bremen; City University London	Ernst, U (corresponding author), Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany.	udo@neuro.uni-bremen.de			BMBF [01GQ0705]	BMBF(Federal Ministry of Education & Research (BMBF))	This work has been supported by the BMBF (Grant 01GQ0705, Bernstein Group for Computational Neuroscience Bremen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Baddeley RJ, 2003, J NEUROSCI, V23, P3066; BEDFORD FL, 1989, J EXP PSYCHOL HUMAN, V15, P232, DOI 10.1037/0096-1523.15.2.232; Bornschlegl MA, 2011, THESIS U BREMEN; Braun D, 2011, FRONTIERS COMPUTATIO, V5, p[27, 1]; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; COHEN MM, 1973, PERCEPT MOTOR SKILL, V37, P599, DOI 10.2466/pms.1973.37.2.599; Donchin O, 2004, P ANN INT IEEE EMBS, V26, P4495; Donchin O, 2003, J NEUROSCI, V23, P9032; Fernandez-Ruiz J, 2004, COGNITIVE BRAIN RES, V20, P92, DOI 10.1016/j.cogbrainres.2004.01.007; Fernandez-Ruiz J, 1999, LEARN MEMORY, V6, P47; Fiete IR, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048104; Ghahramani Z, 1996, J NEUROSCI, V16, P7085; Ghahramani Z, 1997, SCIENCE, V269, P1880; Guigon E, 2002, J COGNITIVE NEUROSCI, V14, P538, DOI 10.1162/08989290260045792; HARRIS CS, 1965, PSYCHOL REV, V72, P419, DOI 10.1037/h0022616; Imamizu H, 2007, EXP BRAIN RES, V181, P395, DOI 10.1007/s00221-007-0940-1; JANSEN JKS, 1962, ACTA PHYSIOL SCAND, V55, P376, DOI 10.1111/j.1748-1716.1962.tb02451.x; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Korenberg AT, 2002, CAH PSYCHOL COGN, V21, P537; Martin TA, 1996, BRAIN, V119, P1199, DOI 10.1093/brain/119.4.1199; Mattar AAG, 2007, J NEUROPHYSIOL, V98, P3321, DOI 10.1152/jn.00576.2007; Michel C, 2008, EXP BRAIN RES, V185, P259, DOI 10.1007/s00221-007-1152-4; Redding GM, 2004, J MOTOR BEHAV, V36, P291, DOI 10.3200/JMBR.36.3.291-304; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Redding GM, 2003, J MOTOR BEHAV, V35, P399, DOI 10.1080/00222890309603159; Redding GM, 2003, J MOTOR BEHAV, V35, P229, DOI 10.1080/00222890309602137; Redding GM, 2002, J MOTOR BEHAV, V34, P126, DOI 10.1080/00222890209601935; Redding GM, 2006, J EXP PSYCHOL HUMAN, V32, P1006, DOI 10.1037/0096-1523.32.4.1006; ROCK I, 1966, PERCEPT PSYCHOPHYS, V1, P351, DOI 10.3758/BF03215803; ROSSETTI Y, 1993, PERCEPT PSYCHOPHYS, V54, P355, DOI 10.3758/BF03205270; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Southall J. P. C., 1866, HELMHOLTZS TREATISE, VIII; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; Welch R. B., 1978, PERCEPTUAL MODIFICAT; WELCH RB, 1993, PERCEPT PSYCHOPHYS, V54, P195, DOI 10.3758/BF03211756; Werfel J, 2005, NEURAL COMPUT, V17, P2699, DOI 10.1162/089976605774320539; Wischhusen S, 2008, THESIS U BREMEN; Wolpert DM, 2007, HUM MOVEMENT SCI, V26, P511, DOI 10.1016/j.humov.2007.05.005	43	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76601	10.1371/journal.pone.0076601	http://dx.doi.org/10.1371/journal.pone.0076601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204643	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700007
J	Tian, QY; Wang, XQ; Li, CF; Lu, WX; Yang, L; Jiang, YZ; Luo, KM				Tian, Qiaoyan; Wang, Xianqiang; Li, Chaofeng; Lu, Wanxiang; Yang, Li; Jiang, Yuanzhong; Luo, Keming			Functional Characterization of the Poplar R2R3-MYB Transcription Factor PtoMYB216 Involved in the Regulation of Lignin Biosynthesis during Wood Formation	PLOS ONE			English	Article							ACID O-METHYLTRANSFERASE; CELL-WALL BIOSYNTHESIS; PHENYLPROPANOID METABOLISM; GENE-EXPRESSION; DIRECT TARGET; LIGNIFICATION; MYB; DEPOSITION; PATHWAY; LOCALIZATION	Because of the importance of wood in many industrial applications, tremendous studies have been performed on wood formation, especially in lignin biosynthesis. MYB transcription factors (TFs), which consist of a large family of plant TFs, have been reported to directly regulate lignin biosynthetic genes in a number of plants. In this study, we describe the cloning and functional characterization of PtoMYB216, a cDNA isolated from Chinese white poplar (Populus tomentosa Carr.). PtoMYB216 encodes a protein belonging to the R2R3-MYB family and displays significant similarity with other MYB factors shown to regulate lignin synthesis in Arabidopsis. Gene expression profiling studies showed that PtoMYB216 mRNA is specifically expressed during secondary wall formation in wood. The 1.8-kb promoter sequence of PtoMYB216 was fused to the GUS coding sequence and introduced into wild-type A. thaliana. GUS expression was shown to be restricted to tissues undergoing secondary cell wall formation. Overexpression of PtoMYB216 specifically activated the expression of the upstream genes in the lignin biosynthetic pathway and resulted in ectopic deposition of lignin in cells that are normally unligninified. These results suggest that PtoMYB216 is specific transcriptional activators of lignin biosynthesis and involved in the regulation of wood formation in poplar.	[Tian, Qiaoyan; Wang, Xianqiang; Li, Chaofeng; Lu, Wanxiang; Yang, Li; Jiang, Yuanzhong; Luo, Keming] Southwest Univ, Chongqing Key Lab Transgen Plant & Safety Control, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Inst Resources Bot,Sch Life Sci, Chongqing, Peoples R China; [Lu, Wanxiang] Southwest Univ, Coll Hort & Landscape Architecture, Chongqing, Peoples R China; [Luo, Keming] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota, Xining, Peoples R China	Southwest University - China; Southwest University - China; Chinese Academy of Sciences	Luo, KM (corresponding author), Southwest Univ, Chongqing Key Lab Transgen Plant & Safety Control, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Inst Resources Bot,Sch Life Sci, Chongqing, Peoples R China.	kemingl@swu.edu.cn		Li, Chaofeng/0000-0002-0237-0350	National Natural Science Foundation of China [31171620]; program for New Century Excellent Talents in University [NCET-11-0700]; National Key Project for Research on Transgenic Plant [2011ZX08010-003]; Research Fund for the Dectoral Program of Higher Education [20110182110004]; 100 Talents Program of Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Key Project for Research on Transgenic Plant; Research Fund for the Dectoral Program of Higher Education; 100 Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (31171620), the program for New Century Excellent Talents in University (NCET-11-0700), the National Key Project for Research on Transgenic Plant (2011ZX08010-003), The Research Fund for the Dectoral Program of Higher Education (20110182110004) and 100 Talents Program of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum S, 2008, COLD SPRING HARB PRO, V10, P1101; Bedon F, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-17; Bhuiyan NH, 2009, PLANT SIGNAL BEHAV, V4, P158, DOI 10.4161/psb.4.2.7688; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bomal C, 2008, J EXP BOT, V59, P3925, DOI 10.1093/jxb/ern234; Bucciarelli B, 1998, CAN J BOT, V76, P1282, DOI 10.1139/cjb-76-7-1282; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Dence C.W., 1992, METHODS LIGNIN CHEM, P33, DOI [DOI 10.1007/978-3-642-74065-7_3, 10.1007/978-3-642-74065-7_3]; Derikvand MM, 2008, PLANTA, V227, P943, DOI 10.1007/s00425-007-0669-x; Do CT, 2007, PLANTA, V226, P1117, DOI 10.1007/s00425-007-0558-3; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Fitter DW, 2002, PLANT J, V31, P713, DOI 10.1046/j.1365-313X.2002.01390.x; Goicoechea M, 2005, PLANT J, V43, P553, DOI 10.1111/j.1365-313X.2005.02480.x; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; Hawkins S, 2003, PLANT SCI, V164, P165, DOI 10.1016/S0168-9452(02)00361-8; Kao YY, 2002, PLANT PHYSIOL, V130, P796, DOI 10.1104/pp.006262; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Lee CH, 2011, MOL PLANT, V4, P730, DOI 10.1093/mp/ssr035; Li XX, 2010, BIOTECHNOL LETT, V32, P1333, DOI [10.1007/s10529-010-0297-6, 10.1007/s10529-010-0281-1]; Liang YK, 2005, CURR BIOL, V15, P1201, DOI 10.1016/j.cub.2005.06.041; Lloyd GB, 1980, COMB P INT PLANT PRO, V30, P421; McCarthy RL, 2010, PLANT CELL PHYSIOL, V51, P1084, DOI 10.1093/pcp/pcq064; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; Mellerowicz EJ, 2008, CURR OPIN PLANT BIOL, V11, P293, DOI 10.1016/j.pbi.2008.03.003; Meyer K, 1998, P NATL ACAD SCI USA, V95, P6619, DOI 10.1073/pnas.95.12.6619; Newman LJ, 2004, PLANT J, V37, P239, DOI 10.1046/j.1365-313X.2003.01953.x; Patzlaff A, 2003, PLANT J, V36, P743, DOI 10.1046/j.1365-313X.2003.01916.x; Penfield S, 2001, PLANT CELL, V13, P2777, DOI 10.1105/tpc.13.12.2777; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Rahantamalala A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-130; Ro DK, 2001, PLANT PHYSIOL, V126, P317, DOI 10.1104/pp.126.1.317; Rogers LA, 2004, NEW PHYTOL, V164, P17, DOI 10.1111/j.1469-8137.2004.01143.x; Romano JM, 2012, NEW PHYTOL, V195, P774, DOI 10.1111/j.1469-8137.2012.04201.x; Sibout R, 2005, PLANT CELL, V17, P2059, DOI 10.1105/tpc.105.030767; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Voelker SL, 2010, PLANT PHYSIOL, V154, P874, DOI 10.1104/pp.110.159269; Wang HZ, 2010, P NATL ACAD SCI USA, V107, P22338, DOI 10.1073/pnas.1016436107; Wang Yuan, 2007, Plant Protection, V33, P50; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Zaragoza MV, 2004, GENE, V330, P9, DOI 10.1016/j.gene.2004.01.017; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhong RQ, 2005, PLANT CELL, V17, P3390, DOI 10.1105/tpc.105.035501; Zhong RQ, 2007, CURR OPIN PLANT BIOL, V10, P564, DOI 10.1016/j.pbi.2007.09.001; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	52	62	69	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76369	10.1371/journal.pone.0076369	http://dx.doi.org/10.1371/journal.pone.0076369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204619	Green Submitted, gold, Green Published			2022-12-27	WOS:000326241200011
J	Kang, CS; Ban, M; Choi, EJ; Moon, HG; Jeon, JS; Kim, DK; Park, SK; Jeon, SG; Roh, TY; Myung, SJ; Gho, YS; Kim, JG; Kim, YK				Kang, Chil-sung; Ban, Mingi; Choi, Eun-Jeong; Moon, Hyung-Geun; Jeon, Jun-Sung; Kim, Dae-Kyum; Park, Soo-Kyung; Jeon, Seong Gyu; Roh, Tae-Young; Myung, Seung-Jae; Gho, Yong Song; Kim, Jae Gyu; Kim, Yoon-Keun			Extracellular Vesicles Derived from Gut Microbiota, Especially Akkermansia muciniphila, Protect the Progression of Dextran Sulfate Sodium-Induced Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; OUTER-MEMBRANE VESICLES; INTESTINAL EPITHELIAL-CELLS; CROHNS-DISEASE; BACTERIA; MICE; TM7; PREVALENCE; MICROFLORA; RESPONSES	Gut microbiota play an important part in the pathogenesis of mucosal inflammation, such as inflammatory bowel disease (IBD). However, owing to the complexity of the gut microbiota, our understanding of the roles of commensal and pathogenic bacteria in the maintenance of immune homeostasis in the gut is evolving only slowly. Here, we evaluated the role of gut microbiota and their secreting extracellular vesicles (EV) in the development of mucosal inflammation in the gut. Experimental IBD model was established by oral application of dextran sulfate sodium (DSS) to C57BL/6 mice. The composition of gut microbiota and bacteria-derived EV in stools was evaluated by metagenome sequencing using bacterial common primer of 16S rDNA. Metagenomics in the IBD mouse model showed that the change in stool EV composition was more drastic, compared to the change of bacterial composition. Oral DSS application decreased the composition of EV from Akkermansia muciniphila and Bacteroides acidifaciens in stools, whereas increased EV from TM7 phylum, especially from species DQ777900_s and AJ400239_s. In vitro pretreatment of A. muciniphila-derived EV ameliorated the production of a pro-inflammatory cytokine IL-6 from colon epithelial cells induced by Escherichia coli EV. Additionally, oral application of A. muciniphila EV also protected DSS-induced IBD phenotypes, such as body weight loss, colon length, and inflammatory cell infiltration of colon wall. Our data provides insight into the role of gut microbiota-derived EV in regulation of intestinal immunity and homeostasis, and A. muciniphila-derived EV have protective effects in the development of DSS-induced colitis.	[Kang, Chil-sung; Ban, Mingi; Choi, Eun-Jeong; Moon, Hyung-Geun; Jeon, Jun-Sung; Kim, Dae-Kyum; Jeon, Seong Gyu; Roh, Tae-Young; Gho, Yong Song; Kim, Yoon-Keun] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea; [Park, Soo-Kyung; Myung, Seung-Jae] Univ Ulsan, Coll Med, Dept Gastroenterol, Asan Med Ctr, Seoul, South Korea; [Kim, Jae Gyu] Chung Ang Univ, Coll Med, Dept Med, Seoul 156756, South Korea	Pohang University of Science & Technology (POSTECH); University of Ulsan; Chung Ang University; Chung Ang University Hospital	Gho, YS (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea.	ysgho@postech.ac.kr; jgkimd@cau.ac.kr; juinea@postech.ac.kr		Jeon, Jinseong/0000-0003-1829-7319; Kim, Dae-Kyum/0000-0003-4568-8278; Roh, Tae-Young/0000-0001-5833-0844; Myung, Seung-Jae/0000-0003-0585-4016	National Research Foundation of Korea [2011-0000879, 2012-0005634]; KRIBB Research Initiative Program	National Research Foundation of Korea(National Research Foundation of Korea); KRIBB Research Initiative Program	This study was supported by grants from the National Research Foundation of Korea Grant funded by the Korean Government (No. 2011-0000879 and No. 2012-0005634) and by a grant from KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brinig MM, 2003, APPL ENVIRON MICROB, V69, P1687, DOI 10.1128/AEM.69.3.1687-1694.2003; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Elmi A, 2012, INFECT IMMUN, V80, P4089, DOI 10.1128/IAI.00161-12; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Greenhill Claire, 2010, Nat Rev Gastroenterol Hepatol, V7, P590, DOI 10.1038/nrgastro.2010.160; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Kihara N, 2003, GUT, V52, P713, DOI 10.1136/gut.52.5.713; Kim MR, 2012, ALLERGY, V67, P1271, DOI 10.1111/all.12001; Kuehbacher T, 2008, J MED MICROBIOL, V57, P1569, DOI 10.1099/jmm.0.47719-0; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Mangin I, 2004, FEMS MICROBIOL ECOL, V50, P25, DOI 10.1016/j.femsec.2004.05.005; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Nam YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022109; Neish AS, 2002, MICROBES INFECT, V4, P309, DOI 10.1016/S1286-4579(02)01543-5; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Ouverney CC, 2003, APPL ENVIRON MICROB, V69, P6294, DOI 10.1128/AEM.69.10.6294-6298.2003; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Samanta AK, 2012, J MICROBIOL, V50, P218, DOI 10.1007/s12275-012-1362-8; Sanders ME, 2011, J CLIN GASTROENTEROL, V45, pS115, DOI 10.1097/MCG.0b013e318227414a; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Stevceva L, 2001, GENES IMMUN, V2, P309, DOI 10.1038/sj.gene.6363782; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	36	299	312	21	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76520	10.1371/journal.pone.0076520	http://dx.doi.org/10.1371/journal.pone.0076520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204633	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300006
J	Aho, V; Ollila, HM; Rantanen, V; Kronholm, E; Surakka, I; van Leeuwen, WMA; Lehto, M; Matikainen, S; Ripatti, S; Harma, M; Sallinen, M; Salomaa, V; Jauhiainen, M; Alenius, H; Paunio, T; Porkka-Heiskanen, T				Aho, Vilma; Ollila, Hanna M.; Rantanen, Ville; Kronholm, Erkki; Surakka, Ida; van Leeuwen, Wessel M. A.; Lehto, Maili; Matikainen, Sampsa; Ripatti, Samuli; Harma, Mikko; Sallinen, Mikael; Salomaa, Veikko; Jauhiainen, Matti; Alenius, Harri; Paunio, Tiina; Porkka-Heiskanen, Tarja			Partial Sleep Restriction Activates Immune Response-Related Gene Expression Pathways: Experimental and Epidemiological Studies in Humans	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NF-KAPPA-B; TOLL-LIKE RECEPTORS; ENDOPLASMIC-RETICULUM; INSUFFICIENT SLEEP; NATURAL-KILLER; METABOLIC CONSEQUENCES; CARDIOMETABOLIC RISK; MACROPHAGE APOPTOSIS; TRANSCRIPTION FACTOR	Epidemiological studies have shown that short or insufficient sleep is associated with increased risk for metabolic diseases and mortality. To elucidate mechanisms behind this connection, we aimed to identify genes and pathways affected by experimentally induced, partial sleep restriction and to verify their connection to insufficient sleep at population level. The experimental design simulated sleep restriction during a working week: sleep of healthy men (N = 9) was restricted to 4 h/night for five nights. The control subjects (N = 4) spent 8 h/night in bed. Leukocyte RNA expression was analyzed at baseline, after sleep restriction, and after recovery using whole genome microarrays complemented with pathway and transcription factor analysis. Expression levels of the ten most up-regulated and ten most down-regulated transcripts were correlated with subjective assessment of insufficient sleep in a population cohort (N = 472). Experimental sleep restriction altered the expression of 117 genes. Eight of the 25 most up-regulated transcripts were related to immune function. Accordingly, fifteen of the 25 most up-regulated Gene Ontology pathways were also related to immune function, including those for B cell activation, interleukin 8 production, and NF-kappa B signaling (P<0.005). Of the ten most up-regulated genes, expression of STX16 correlated negatively with self-reported insufficient sleep in a population sample, while three other genes showed tendency for positive correlation. Of the ten most down-regulated genes, TBX21 and LGR6 correlated negatively and TGFBR3 positively with insufficient sleep. Partial sleep restriction affects the regulation of signaling pathways related to the immune system. Some of these changes appear to be long-lasting and may at least partly explain how prolonged sleep restriction can contribute to inflammation-associated pathological states, such as cardiometabolic diseases.	[Aho, Vilma; Ollila, Hanna M.; van Leeuwen, Wessel M. A.; Porkka-Heiskanen, Tarja] Univ Helsinki, Dept Physiol, Inst Biomed, Helsinki, Finland; [Ollila, Hanna M.; Surakka, Ida; Ripatti, Samuli; Jauhiainen, Matti; Paunio, Tiina] Natl Inst Hlth & Welf, Dept Mol Med, Helsinki, Finland; [Ollila, Hanna M.; Surakka, Ida; Ripatti, Samuli; Jauhiainen, Matti; Paunio, Tiina] Finnish Inst Mol Med, Helsinki, Finland; [Ollila, Hanna M.; Paunio, Tiina] HUCH, Dept Psychiat, Helsinki, Finland; [Rantanen, Ville] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Rantanen, Ville] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Kronholm, Erkki; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [van Leeuwen, Wessel M. A.; Harma, Mikko; Sallinen, Mikael] Finnish Inst Occupat Hlth, Ctr Expertise Human Factors Work, Helsinki, Finland; [van Leeuwen, Wessel M. A.] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Lehto, Maili; Matikainen, Sampsa; Alenius, Harri] Finnish Inst Occupat Hlth, Unit Syst Toxicol, Ctr Expertise Hlth & Work Abil, Helsinki, Finland; [Ripatti, Samuli] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ripatti, Samuli] Wellcome Trust Sanger Inst, Dept Human Genet, Hinxton, England; [Sallinen, Mikael] Univ Jyvaskyla, Agora Ctr, Jyvaskyla, Finland	University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Finnish Institute of Occupational Health; Stockholm University; Finnish Institute of Occupational Health; Karolinska Institutet; Wellcome Trust Sanger Institute; University of Jyvaskyla	Porkka-Heiskanen, T (corresponding author), Univ Helsinki, Dept Physiol, Inst Biomed, Helsinki, Finland.	tarja.stenberg@helsinki.fi	van Leeuwen, Wessel M.A./A-5812-2019; Ripatti, Samuli/H-9446-2014; Ollila, Hanna M/I-8552-2017; Matikainen, Sampsa/AAH-8654-2021; Ollila, Hanna M/GQA-6308-2022	van Leeuwen, Wessel M.A./0000-0003-0834-0811; Ripatti, Samuli/0000-0002-0504-1202; Ollila, Hanna M/0000-0002-5302-6429; Ollila, Hanna M/0000-0002-5302-6429; Rantanen, Ville/0000-0002-0105-7071; Stenberg, Tarja/0000-0003-1843-7625; Lammi, Vilma/0000-0002-3256-5239; Sallinen, Mikael/0000-0001-6507-3807; Alenius, Harri/0000-0003-0106-8923; Surakka, Ida/0000-0002-6669-5541	EU [LSHM-CT-2005-518189, QLK6-CT-2000-00499]; Finska Lakaresallskapet; Finnish Work Environment Fund; Instrumentarium Foundation; Jalmari and Rauha Ahokas Foundation; Biomedicum Helsinki Foundation; Emil Aaltonen Foundation; Finnish foundation for Cardiovascular research; Paavo Nurmi Foundation; Finnish Brain Foundation; GPBM graduate school; Marie Curie ESRS project [046036]; Academy of Finland Center of Excellence in Complex Disease Genetics [213506, 129680]; Sigrid Juselius Foundation; Academy of Finland [251217, 129494, 139635, 137575]	EU(European Commission); Finska Lakaresallskapet; Finnish Work Environment Fund; Instrumentarium Foundation; Jalmari and Rauha Ahokas Foundation; Biomedicum Helsinki Foundation; Emil Aaltonen Foundation; Finnish foundation for Cardiovascular research; Paavo Nurmi Foundation; Finnish Brain Foundation; GPBM graduate school; Marie Curie ESRS project; Academy of Finland Center of Excellence in Complex Disease Genetics(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	The authors gratefully acknowledge support for this work from the EU (LSHM-CT-2005-518189 and QLK6-CT-2000-00499), Finska Lakaresallskapet, and the Finnish Work Environment Fund (to VA), the Instrumentarium Foundation, the Jalmari and Rauha Ahokas Foundation, the Biomedicum Helsinki Foundation, the Emil Aaltonen Foundation, Finnish foundation for Cardiovascular research, the Paavo Nurmi Foundation, the Finnish Brain Foundation, and the GPBM graduate school (to HMO), the Marie Curie ESRS project (046036) (to WvL), the Academy of Finland Center of Excellence in Complex Disease Genetics (213506 and 129680) (to SR), the Sigrid Juselius Foundation (to SR and TP), and the Academy of Finland (251217 to SR, 129494 and 139635 to VS, and 137575 to TPH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman NG, 2012, SLEEP MED, V13, P1261, DOI 10.1016/j.sleep.2012.08.005; Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Basheer R, 2001, NEUROSCIENCE, V104, P731, DOI 10.1016/S0306-4522(01)00111-7; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chae M, 2008, BIOCHEM BIOPH RES CO, V370, P519, DOI 10.1016/j.bbrc.2008.03.136; Cuesta N, 2007, J IMMUNOL, V178, P3602, DOI 10.4049/jimmunol.178.6.3602; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Elliott JM, 2011, TRENDS IMMUNOL, V32, P364, DOI 10.1016/j.it.2011.06.001; EVERSON CA, 1993, AM J PHYSIOL, V265, pR1148, DOI 10.1152/ajpregu.1993.265.5.R1148; Everson CA, 2005, AM J PHYSIOL-REG I, V289, pR1054, DOI 10.1152/ajpregu.00021.2005; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Ferrie JE, 2007, SLEEP, V30, P1659, DOI 10.1093/sleep/30.12.1659; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hui L, 2007, BRAIN BEHAV IMMUN, V21, P308, DOI 10.1016/j.bbi.2006.09.005; Inouye M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001113; Irwin M, 1996, FASEB J, V10, P643, DOI 10.1096/fasebj.10.5.8621064; Irwin MR, 2008, BIOL PSYCHIAT, V64, P538, DOI 10.1016/j.biopsych.2008.05.004; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Jialal I, 2012, DIABETES CARE, V35, P900, DOI 10.2337/dc11-2375; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Kronholm E, 2011, SLEEP MED, V12, P215, DOI 10.1016/j.sleep.2010.07.021; Li N, 2010, J IMMUNOL, V185, P3041, DOI 10.4049/jimmunol.1000993; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Lim WS, 2008, CIRCULATION, V117, P940, DOI 10.1161/CIRCULATIONAHA.107.711275; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Liukkonen T, 2007, PSYCHOSOM MED, V69, P756, DOI 10.1097/PSY.0b013e318157cb96; Lusardi P, 1999, AM J HYPERTENS, V12, P63, DOI 10.1016/S0895-7061(98)00200-3; Martinez-Gomez D, 2011, SLEEP MED, V12, P997, DOI 10.1016/j.sleep.2011.05.009; Masat L, 2000, P NATL ACAD SCI USA, V97, P2180, DOI 10.1073/pnas.040374497; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Miller MA, 2009, SLEEP, V32, P857; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; Mullington JM, 2010, BEST PRACT RES CL EN, V24, P775, DOI 10.1016/j.beem.2010.08.014; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Naidoo N, 2005, J NEUROCHEM, V92, P1150, DOI 10.1111/j.1471-4159.2004.02952.x; Naidoo N, 2007, SLEEP, V30, P557, DOI 10.1093/sleep/30.5.557; Okun ML, 2009, BRAIN BEHAV IMMUN, V23, P351, DOI 10.1016/j.bbi.2008.10.008; Pannitteri G, 1997, AM J CARDIOL, V80, P622, DOI 10.1016/S0002-9149(97)00434-7; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Reynolds AC, 2010, PROG BRAIN RES, V185, P91, DOI 10.1016/B978-0-444-53702-7.00006-3; Rietzschel E, 2012, BIOMARK MED, V6, P19, DOI [10.2217/BMM.11.108, 10.2217/bmm.11.108]; Robinson DS, 2002, CURR BIOL, V12, pR322, DOI 10.1016/S0960-9822(02)00830-8; Sikorski K, 2011, AM J PHYSIOL-CELL PH, V300, pC1337, DOI 10.1152/ajpcell.00276.2010; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tochikubo O, 1996, HYPERTENSION, V27, P1318, DOI 10.1161/01.HYP.27.6.1318; TRAPANI JA, 1993, IMMUNOL CELL BIOL, V71, P201, DOI 10.1038/icb.1993.22; Tsujimura T, 2009, DIABETES RES CLIN PR, V85, P286, DOI 10.1016/j.diabres.2009.07.001; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; van Leeuwen WMA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/108641; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Wigmore SJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE720, DOI 10.1152/ajpendo.1997.273.4.E720; Wisor JP, 2011, SLEEP, V34, P1335, DOI 10.5665/SLEEP.1274; Wolk R, 2005, CURR PROB CARDIOLOGY, V30, P625, DOI 10.1016/j.cpcardiol.2005.07.002; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zager A, 2007, AM J PHYSIOL-REG I, V293, pR504, DOI 10.1152/ajpregu.00105.2007	68	52	53	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77184	10.1371/journal.pone.0077184	http://dx.doi.org/10.1371/journal.pone.0077184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194869	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000048
J	Kuang, ZC; Yao, YW; Shi, Y; Gu, Z; Sun, ZG; Tso, JK				Kuang, Zhichao; Yao, Yuwei; Shi, Yan; Gu, Zheng; Sun, Zhaogui; Tso, Jiake			Winter Hibernation and UCHL1-p34(cdc2) Association in Toad Oocyte Maturation Competence	PLOS ONE			English	Article							CARBOXYL-TERMINAL HYDROLASE; GENE-PRODUCT 9.5; MOUSE OVA; UBIQUITIN; SPERMATOGENESIS; PHOSPHORYLATION; IDENTIFICATION; POLYSPERMY; EXPRESSION; PGP9.5	Currently, it is believed that toad oocyte maturation is dependent on the physiological conditions of winter hibernation. Previous antibody-blocking experiments have demonstrated that toad ubiquitin carboxyl-terminal hydrolase L1 (tUCHL1) is necessary for germinal vesicle breakdown during toad oocyte maturation. In this paper, we first supply evidence that tUCHL1 is highly evolutionarily conserved. Then, we exclude protein availability and ubiquitin carboxyl-terminal hydrolase enzyme activity as factors in the response of oocytes to winter hibernation. In the context of MPF (maturation promoting factor) controlling oocyte maturation and to further understand the role of UCHL1 in oocyte maturation, we performed adsorption and co-immunoprecipitation experiments using toad oocyte protein extracts and determined that tUCHL1 is associated with MPF in toad oocytes. Recombinant tUCHL1 absorbed p34(cdc2), a component of MPF, in obviously larger quantities from mature oocytes than from immature oocytes, and p13(suc1) was isolated from tUCHL1 with a dependence on the ATP regeneration system, suggesting that still other functions may be involved in their association that require phosphorylation. In oocytes from hibernation-interrupted toads, the p34(cdc2) protein level was significantly lower than in oocytes from toads in artificial hibernation, providing an explanation for the different quantities isolated by recombinant tUCHL1 pull-down and, more importantly, identifying a mechanism involved in the toad oocyte's dependence on a low environmental temperature during winter hibernation. Therefore, in toads, tUCHL1 binds p34(cdc2) and plays a role in oocyte maturation. However, neither tUCHL1 nor cyclin B1 respond to low temperatures to facilitate oocyte maturation competence during winter hibernation.	[Kuang, Zhichao; Yao, Yuwei; Sun, Zhaogui] Fudan Univ, Inst Reprod & Dev, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Shi, Yan; Gu, Zheng; Sun, Zhaogui; Tso, Jiake] Shanghai Inst Planned Parenthood Res, Natl Populat & Family Planning Commiss China, Key Lab Contracept Drugs & Devices, Shanghai, Peoples R China	Fudan University	Sun, ZG (corresponding author), Fudan Univ, Inst Reprod & Dev, Shanghai Med Coll, Shanghai 200433, Peoples R China.	sunzgbio@126.com			National Natural Science Foundation of China [30370717, 81170569]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Project No. 30370717 and 81170569). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSOHN PA, 1993, J EXP ZOOL, V266, P603, DOI 10.1002/jez.1402660610; Benedit P, 2001, ONCOGENE, V20, P1455, DOI 10.1038/sj.onc.1204233; Britt KL, 2000, ENDOCRINOLOGY, V141, P2614, DOI 10.1210/en.141.7.2614; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj.onc.1205390; De Smedt V, 2002, J BIOL CHEM, V277, P28592, DOI 10.1074/jbc.M202742200; DRAETTA G, 1987, CELL, V50, P319, DOI 10.1016/0092-8674(87)90227-3; Holzenspies JJ, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-8; Ihara J, 1998, MOL REPROD DEV, V50, P499, DOI 10.1002/(SICI)1098-2795(199808)50:4<499::AID-MRD14>3.0.CO;2-Y; JACKSON P, 1985, J NEUROCHEM, V45, P185, DOI 10.1111/j.1471-4159.1985.tb05491.x; Jessus C, 2004, BIOL CELL, V96, P187, DOI 10.1016/j.biolcel.2003.12.007; Kong WH, 2000, CELL RES, V10, P289, DOI 10.1038/sj.cr.7290056; Kotani T, 2001, MOL REPROD DEV, P59; Koyanagi S, 2012, REPRODUCTION, V143, P271, DOI 10.1530/REP-11-0128; Kwon J, 2004, BIOL REPROD, V71, P515, DOI 10.1095/biolreprod.104.027565; Lu JN, 1996, CELL RES, V6, P115, DOI [10.1038/cr.1996.13, DOI 10.1038/CR.1996.13]; Mtango NR, 2012, J CELL PHYSIOL, V227, P2022, DOI 10.1002/jcp.22931; Piccinini M, 1996, BIOCHEM J, V318, P711, DOI 10.1042/bj3180711; REYNHOUT JK, 1974, DEV BIOL, V38, P394, DOI 10.1016/0012-1606(74)90016-5; Sekiguchi S, 2003, EXP ANIM TOKYO, V52, P365, DOI 10.1538/expanim.52.365; Sekiguchi S, 2006, AM J PATHOL, V169, P1722, DOI 10.2353/ajpath.2006.060301; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; Sun ZG, 2002, CELL RES, V12, P199, DOI 10.1038/sj.cr.7290125; Sun Zhao Gui, 2003, Shi Yan Sheng Wu Xue Bao, V36, P105; Susor A, 2010, BIOL REPROD, V82, P1151, DOI 10.1095/biolreprod.109.081547; TCHOU S, 1963, SCI SINICA, V12, P1165; TCHOU S, 1963, SCI SINICA, V12, P1161; WILKINSON KD, 1986, BIOCHEMISTRY-US, V25, P6644, DOI 10.1021/bi00369a047; Yao YW, 2011, HISTOCHEM CELL BIOL, V136, P205, DOI 10.1007/s00418-011-0825-z; Yi YJ, 2007, BIOL REPROD, V77, P780, DOI 10.1095/biolreprod.107.061275; Zhu G, 1993, Shi Yan Sheng Wu Xue Bao, V26, P469	30	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78785	10.1371/journal.pone.0078785	http://dx.doi.org/10.1371/journal.pone.0078785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194953	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000132
J	Lu, S; Peng, HY; Zhang, H; Zhang, L; Cao, QC; Li, R; Zhang, Y; Yan, LY; Duan, EK; Qiao, J				Lu, Shan; Peng, Hongying; Zhang, He; Zhang, Li; Cao, Qichen; Li, Rong; Zhang, Ying; Yan, Liying; Duan, Enkui; Qiao, Jie			Excessive Intrauterine Fluid Cause Aberrant Implantation and Pregnancy Outcome in Mice	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; UTERINE LUMINAL FLUID; EMBRYO IMPLANTATION; HYDROSALPINX; SALPINGECTOMY; IVF; EXPRESSION; WOMEN; RATES; PROGESTERONE	The normal intrauterine fluid environment is essential for embryo implantation. In hydrosalpinx patients, the implantation and pregnancy rates are markedly decreased after IVF-embryo transfer, while salpingectomy could significantly improve the pregnancy rates. The leakage of hydrosalpinx fluid into the endometrial cavity was supposed to be the major cause for impaired fertility. However, the underlying mechanisms of hydrosalpinx fluids on implantation and ongoing pregnancy were not fully understood and remain controversial regarding its toxicity. In present study, by infusing different volume of non-toxic fluid (0.9% saline) into uterine lumen before embryo implantation in mice (Day4 08: 30), we found that while the embryos were not "flushed out" from the uteri, the timing of implantation was deferred and normal intrauterine distribution (embryo spacing) was disrupted. The abnormal implantation at early pregnancy further lead to embryo growth retardation, miscarriage and increased pregnancy loss, which is similar to the adverse effects observed in hydrosalpinx patients undergoing IVF-ET. We further examined uterine receptivity related gene expression reported to be involved in human hydrosalpinx (Lif, Hoxa10, Integrin a(v) and beta(3)). The results showed that expression of integrin alpha(v) and beta(3) were increased in the fluid infused mouse uteri, implicating a compensatory effect to cope with the excessive fluid environment. Our data suggested that the adverse effects of excessive non-toxic luminal fluid on pregnancy are primarily due to the mechanical interference for normal timing and location of embryo apposition, which might be the major cause of decreased implantation rate in IVF-ET patients with hydrosalpinx.	[Lu, Shan; Li, Rong; Yan, Liying; Qiao, Jie] Peking Univ, Dept Obstet & Gynecol, Hosp 3, Beijing 100871, Peoples R China; [Peng, Hongying; Zhang, He; Zhang, Li; Cao, Qichen; Zhang, Ying; Duan, Enkui] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Li, Rong; Qiao, Jie] Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing, Peoples R China; [Li, Rong; Qiao, Jie] Minist Educ, Key Lab Assisted Reprod, Beijing, Peoples R China	Peking University; Chinese Academy of Sciences; Institute of Zoology, CAS	Zhang, Y (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	zhangying@ioz.ac.cn; yanliyingkind@aliyun.com		Zhang, Ying/0000-0003-4082-5026	National Natural Science Foundation of China [81000275, 31300957, 31300960]; National Basic Research Program of China [2011CB944503, 2011CB944401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (81000275, 31300957, 31300960) and National Basic Research Program of China (2011CB944503, 2011CB944401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajonuma LC, 2008, J OBSTET GYNAECOL RE, V34, P923, DOI 10.1111/j.1447-0756.2008.00826.x; Baba K, 2000, FERTIL STERIL, V73, P123, DOI 10.1016/S0015-0282(99)00454-9; Bildirici I, 2001, HUM REPROD, V16, P2422, DOI 10.1093/humrep/16.11.2422; Camus E, 1999, HUM REPROD, V14, P1243, DOI 10.1093/humrep/14.5.1243; Carson DD, 1998, HUM REPROD UPDATE, V4, P459, DOI 10.1093/humupd/4.5.459; Chen Q, 2013, MOL ASPECTS MED, V34, P1024, DOI 10.1016/j.mam.2012.07.017; Chen Q, 2011, J BIOL CHEM, V286, P4349, DOI 10.1074/jbc.M110.197202; Chen Q, 2011, CELL RES, V21, P922, DOI 10.1038/cr.2010.169; Chien LW, 2002, HUM REPROD, V17, P351, DOI 10.1093/humrep/17.2.351; CLEMETSO.CA, 1970, J ENDOCRINOL, V47, P309, DOI 10.1677/joe.0.0470309; CLEMETSON CAB, 1977, J REPROD FERTIL, V49, P183; Daftary GS, 2007, FERTIL STERIL, V87, P367, DOI 10.1016/j.fertnstert.2006.06.041; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Diao HL, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110106; Eytan O, 2001, HUM REPROD, V16, P2662, DOI 10.1093/humrep/16.12.2662; Hama K, 2007, BIOL REPROD, V77, P954, DOI 10.1095/biolreprod.107.060293; Hinckley MD, 2003, FERTIL STERIL, V80, P1268, DOI 10.1016/S0015-0282(03)01179-8; Johnson N, 2010, COCHRANE DB SYST REV, pD2125; Kontoravdis A, 2006, FERTIL STERIL, V86, P1642, DOI 10.1016/j.fertnstert.2006.05.032; Lu S, 2009, CHIN J CLIN OBSTET G, V10, P423; Magli MC, 2008, HUM REPROD, V23, P1253, DOI 10.1093/humrep/den068; Meyer WR, 1997, HUM REPROD, V12, P1393, DOI 10.1093/humrep/12.7.1393; Naftalin RJ, 2002, REPRODUCTION, V123, P633, DOI 10.1530/rep.0.1230633; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Pinborg A, 2005, HUM REPROD UPDATE, V11, P575, DOI 10.1093/humupd/dmi027; Pinborg A, 2006, BRIT J HOSP MED, V67, P417, DOI 10.12968/hmed.2006.67.8.21976; Soares SR, 2008, FERTIL STERIL, V90, DOI 10.1016/j.fertnstert.2007.07.1353; RESTALL BJ, 1971, J REPROD FERTIL, V24, P423, DOI 10.1530/jrf.0.0240423; Salleh N, 2005, J MEMBRANE BIOL, V206, P17, DOI 10.1007/s00232-005-0770-7; Savaris RF, 2007, SEMIN REPROD MED, V25, P476, DOI 10.1055/s-2007-991045; Seli E, 2005, HUM REPROD, V20, P3012, DOI 10.1093/humrep/dei188; Sharara FI, 1999, HUM REPROD, V14, P577, DOI 10.1093/humrep/14.3.577; Song H, 2002, DEVELOPMENT, V129, P2879; Strandell A, 2002, HUM REPROD, V17, P1141, DOI 10.1093/humrep/17.5.1141; Strandell A, 2001, HUM REPROD, V16, P2403, DOI 10.1093/humrep/16.11.2403; Strandell A, 2007, CURR OPIN OBSTET GYN, V19, P360, DOI 10.1097/GCO.0b013e32821642b9; Wang H, 2005, CHIN J MIN INV SURG, V5, P792; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Zeyneloglu HB, 1998, FERTIL STERIL, V70, P492, DOI 10.1016/S0015-0282(98)00200-3; Zhang D, 2012, MOL ASPECTS MED, V33, P676, DOI 10.1016/j.mam.2012.02.002; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011	41	23	29	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78446	10.1371/journal.pone.0078446	http://dx.doi.org/10.1371/journal.pone.0078446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194934	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000113
J	McCarty, DR; Latshaw, S; Wu, S; Suzuki, M; Hunter, CT; Avigne, WT; Koch, KE				McCarty, Donald R.; Latshaw, Sue; Wu, Shan; Suzuki, Masaharu; Hunter, Charles T.; Avigne, Wayne T.; Koch, Karen E.			Mu-seq: Sequence-Based Mapping and Identification of Transposon Induced Mutations	PLOS ONE			English	Article							MAIZE; GENOME; MUTAGENESIS; GENE; INSERTION; ELEMENTS; SYSTEM; TOOL	Mutations tagged by transposon insertions can be readily mapped and identified in organisms with sequenced genomes. Collections of such mutants allow a systematic analysis of gene function, and can be sequence-indexed to build invaluable resources. Here we present Mu-seq (Mutant-seq), a high-throughput NextGen sequencing method for harnessing high-copy transposons. We illustrate the efficacy of Mu-seq by applying it to the Robertson's Mutator system in a large population of maize plants. A single Mu-seq library, for example, constructed from 576 different families (2304 plants), enabled 4, 723 novel, germinal, transposon insertions to be detected, identified, and mapped with single base-pair resolution. In addition to the specificity, efficiency, and reproducibility of Mu-seq, a key feature of this method is its adjustable scale that can accomodate simultaneous profiling of transposons in thousands of individuals. We also describe a Mu-seq bioinformatics framework tailored to high-throughput, genome-wide, and population-wide analysis of transposon insertions.	[McCarty, Donald R.; Latshaw, Sue; Wu, Shan; Suzuki, Masaharu; Hunter, Charles T.; Avigne, Wayne T.; Koch, Karen E.] Univ Florida, Dept Hort Sci, Plant Mol & Cellular Biol Program, Genet Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	McCarty, DR (corresponding author), Univ Florida, Dept Hort Sci, Plant Mol & Cellular Biol Program, Genet Inst, Gainesville, FL 32610 USA.	drm@ufl.edu	Latshaw, Sue/GZB-1381-2022		US National Science Foundation [0703273, 1116561]; Direct For Biological Sciences [1116561] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	US National Science Foundation Grants: 0703273,1116561. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; CHANDLER VL, 1992, ADV GENET, V30, P77, DOI 10.1016/S0065-2660(08)60319-3; CRESSE AD, 1995, GENETICS, V140, P315; Das L, 1995, PLANT CELL, V3, P287; Fernandes J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r82; Hirochika H, 2004, PLANT MOL BIOL, V54, P325, DOI 10.1023/B:PLAN.0000036368.74758.66; Hunter CT, 2010, MU TRANSPOSONS ZEA M; LISCH D, 1995, GENETICS, V139, P1777; Liu SZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000733; May BP, 2003, P NATL ACAD SCI USA, V100, P11541, DOI 10.1073/pnas.1831119100; McCarty DR, 2005, PLANT J, V44, P52, DOI 10.1111/j.1365-313X.2005.02509.x; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; O'Malley RC, 2010, PLANT J, V61, P928, DOI 10.1111/j.1365-313X.2010.04119.x; Qu S, 2008, PLANT PHYSIOL, V146, P189, DOI 10.1104/pp.107.111427; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Settles AM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-116; Settles AM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh052; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Suzuki M, 2006, PLANT J, V45, P264, DOI 10.1111/j.1365-313X.2005.02620.x; Tan BC, 2011, G3-GENES GENOM GENET, V1, P293, DOI 10.1534/g3.111.000398; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Williams-Carrier R, 2010, PLANT J, V63, P167, DOI 10.1111/j.1365-313X.2010.04231.x	24	33	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77172	10.1371/journal.pone.0077172	http://dx.doi.org/10.1371/journal.pone.0077172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194867	Green Submitted, gold, Green Published			2022-12-27	WOS:000326037000046
J	Yang, SZ; Dai, P; Liu, X; Kang, DY; Zhang, X; Yang, WY; Zhou, CY; Yang, SM; Yuan, HJ				Yang, Shuzhi; Dai, Pu; Liu, Xin; Kang, Dongyang; Zhang, Xin; Yang, Weiyan; Zhou, Chengyong; Yang, Shiming; Yuan, Huijun			Genetic and Phenotypic Heterogeneity in Chinese Patients with Waardenburg Syndrome Type II	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MITF GENE; MUTATIONS; MICROPHTHALMIA; DELETIONS; LOCUS; CELLS	Waardenburg Syndrome (WS) is an autosomal-dominant disorder characterized by sensorineural hearing loss and pigmentary abnormalities of the eyes, hair, and skin. Microphthalmia-associated transcription factor (MITF) gene mutations account for about 15% of WS type II (WS2) cases. To date, fewer than 40 different MITF gene mutations have been identified in human WS2 patients, and few of these were of Chinese descent. In this study, we report clinical findings and mutation identification in the MITF gene of 20 Chinese WS2 patients from 14 families. A high level of clinical variability was identified. Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2 patients. Five affected individuals (5/20, 25.0%) had numerous brown freckles on the face, trunk, and limb extremities. Mutation screening of the MITF gene identified five mutations: c.20A>G, c.332C>T, c.647_649delGAA, c.649A>G, and c.763C>T. The total mutational frequency of the MITF gene was 21.4% (3/14), which is significantly higher than the 15.0% observed in the fair-skinned WS2 population. Our results indicate that MITF mutations are relatively common among Chinese WS2 patients.	[Yang, Shuzhi; Zhou, Chengyong] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Otolaryngol, Beijing, Peoples R China; [Dai, Pu; Kang, Dongyang; Zhang, Xin; Yang, Weiyan; Yang, Shiming; Yuan, Huijun] Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Beijing, Peoples R China; [Liu, Xin] 16 Hosp Chinese PLA, Dept Otolaryngol, Alatai, Xinjiang Autono, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Zhou, CY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Otolaryngol, Beijing, Peoples R China.	zhcyong@163bj.com; yangsm301@263.net; yuanhj301@yahoo.com.cn	yang, shuzhi/AAH-1933-2021		National Natural Science Foundation of China [81030017, 81200752]; National Natural Science Foundation [81125008]; National Basic Research Program of China (973 Program) [2013CB945402, 2012CB967900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	These investigations were supported by grants from the Key Project of National Natural Science Foundation of China (81030017), National Natural Science Foundation for Distinguished Young Scholars (81125008) and The National Basic Research Program of China (973 Program) (2013CB945402) to HY, a grant from The National Basic Research Program of China (973 Program) (2012CB967900) to Shiming Yang, and a grant from the National Natural Science Foundation of China (81200752) to Shuzhi Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bondurand N, 2007, AM J HUM GENET, V81, P1169, DOI 10.1086/522090; Chen HS, 2010, BIOCHEM BIOPH RES CO, V397, P70, DOI 10.1016/j.bbrc.2010.05.066; Chen Jing, 2008, Yi Chuan, V30, P433, DOI 10.3724/SP.J.1005.2008.00433; Chiang PW, 2009, AM J MED GENET A, V149A, P2739, DOI 10.1002/ajmg.a.33128; FARRER LA, 1992, AM J HUM GENET, V50, P902; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; HAGEMAN MJ, 1977, AM J HUM GENET, V29, P468; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Izumi K, 2008, CLIN GENET, V74, P93, DOI 10.1111/j.1399-0004.2008.01010.x; Lalwani A. K., 1994, American Journal of Human Genetics, V55, pA14; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Newton VE, 1995, AM J MED GENET, V55, P95; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Sanchez-Martin M, 2002, HUM MOL GENET, V11, P3231, DOI 10.1093/hmg/11.25.3231; Selicorni A, 2002, HUM GENET, V110, P64, DOI 10.1007/s00439-001-0643-9; Tachibana M, 1996, NAT GENET, V14, P50, DOI 10.1038/ng0996-50; Takebayashi K, 1996, MOL CELL BIOL, V16, P1203; Takeda K, 2000, HUM MOL GENET, V9, P125, DOI 10.1093/hmg/9.1.125; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TASSABEHJI M, 1995, HUM MOL GENET, V4, P2131, DOI 10.1093/hmg/4.11.2131; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058	26	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77149	10.1371/journal.pone.0077149	http://dx.doi.org/10.1371/journal.pone.0077149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194866	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000045
J	Karabeg, MM; Grauthoff, S; Kollert, SY; Weidner, M; Heiming, RS; Jansen, F; Popp, S; Kaiser, S; Lesch, KP; Sachser, N; Schmitt, AG; Lewejohann, L				Karabeg, Margherita M.; Grauthoff, Sandra; Kollert, Sina Y.; Weidner, Magdalena; Heiming, Rebecca S.; Jansen, Friederike; Popp, Sandy; Kaiser, Sylvia; Lesch, Klaus-Peter; Sachser, Norbert; Schmitt, Angelika G.; Lewejohann, Lars			5-HTT Deficiency Affects Neuroplasticity and Increases Stress Sensitivity Resulting in Altered Spatial Learning Performance in the Morris Water Maze but Not in the Barnes Maze	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; SEROTONIN TRANSPORTER GENE; LONG-TERM POTENTIATION; C-FOS EXPRESSION; HIPPOCAMPAL CA3C NEURONS; PITUITARY-ADRENAL AXIS; RAT DENTATE GYRUS; EARLY-LIFE STRESS; MESSENGER-RNA; PROTEIN EXPRESSION	The purpose of this study was to evaluate whether spatial hippocampus-dependent learning is affected by the serotonergic system and stress. Therefore, 5-HTT knockout (-/-), heterozygous (+/-) and wildtype (+/+) mice were subjected to the Barnes maze (BM) and the Morris water maze (WM), the latter being discussed as more aversive. Additionally, immediate early gene (IEG) expression, hippocampal adult neurogenesis (aN), and blood plasma corticosterone were analyzed. While the performance of 5-HTT-/- mice in the BM was undistinguishable from both other genotypes, they performed worse in the WM. However, in the course of the repeated WM trials 5-HTT-/- mice advanced to wildtype level. The experience of a single trial of either the WM or the BM resulted in increased plasma corticosterone levels in all genotypes. After several trials 5-HTT-/- mice exhibited higher corticosterone concentrations compared with both other genotypes in both tests. Corticosterone levels were highest in 5-HTT-/- mice tested in the WM indicating greater aversiveness of the WM and a greater stress sensitivity of 5-HTT deficient mice. Quantitative immunohistochemistry in the hippocampus revealed increased cell counts positive for the IEG products cFos and Arc as well as for proliferation marker Ki67 and immature neuron marker NeuroD in 5-HTT-/- mice compared to 5-HTT+/+ mice, irrespective of the test. Most differences were found in the suprapyramidal blade of the dentate gyrus of the septal hippocampus. Ki67-immunohistochemistry revealed a genotype x environment interaction with 5-HTT genotype differences in naive controls and WM experience exclusively yielding more Ki67-positive cells in 5-HTT+/+ mice. Moreover, in 5-HTT-/- mice we demonstrate that learning performance correlates with the extent of aN. Overall, higher baseline IEG expression and increased an in the hippocampus of 5-HTT-/- mice together with increased stress sensitivity may constitute the neurobiological correlate of raised alertness, possibly impeding optimal learning performance in the more stressful WM.	[Karabeg, Margherita M.; Kollert, Sina Y.; Weidner, Magdalena; Schmitt, Angelika G.] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany; [Karabeg, Margherita M.; Popp, Sandy; Lesch, Klaus-Peter] Univ Wurzburg, Div Mol Psychiat, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany; [Grauthoff, Sandra; Heiming, Rebecca S.; Jansen, Friederike; Kaiser, Sylvia; Sachser, Norbert; Lewejohann, Lars] Univ Munster, Dept Behav Biol, D-48149 Munster, Germany; [Grauthoff, Sandra; Heiming, Rebecca S.; Jansen, Friederike; Kaiser, Sylvia; Sachser, Norbert; Lewejohann, Lars] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, D-48149 Munster, Germany; [Lewejohann, Lars] Univ Osnabruck, Osnabruck, Germany	University of Wurzburg; University of Wurzburg; University of Munster; University of Munster; University Osnabruck	Schmitt, AG (corresponding author), Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany.	Schmitt_A3@klinik.uni-wuerzburg.de	Lesch, Klaus-Peter/J-4906-2013; Lewejohann, Lars/H-3717-2013; Kollert, Sina/Q-8737-2017	Lesch, Klaus-Peter/0000-0001-8348-153X; Lewejohann, Lars/0000-0002-0202-4351; Weidner, Magdalena/0000-0002-6195-8912; Kaiser, Sylvia/0000-0003-2770-7367	German Research Foundation (DFG) [SFB TRR 58]; Interdisciplinary Center for Clinical Research of the University of Wurzburg, (IZKF Wurzburg) [N-162-N]	German Research Foundation (DFG)(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research of the University of Wurzburg, (IZKF Wurzburg)	This study was supplied by the German Research Foundation (DFG, http://www.dfg.de/), SFB TRR 58/Project A1 and A5 to NS, AS, KPL and the Interdisciplinary Center for Clinical Research of the University of Wurzburg, (IZKF Wurzburg, http://www.izkf.uk-wuerzburg.de/), Project N-162-N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELL A, 1988, J NEUROCHEM, V50, P1678, DOI 10.1111/j.1471-4159.1988.tb02462.x; ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Armando I, 2003, NEUROENDOCRINOLOGY, V78, P217, DOI 10.1159/000073705; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bartolomucci A, 2010, DIS MODEL MECH, V3, P459, DOI 10.1242/dmm.004614; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Benninghoff J, 2010, NEUROPSYCHOPHARMACOL, V35, P893, DOI 10.1038/npp.2009.181; Bertaina-Anglade V, 2000, EUR J NEUROSCI, V12, P3803, DOI 10.1046/j.1460-9568.2000.00258.x; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Borg J, 2009, INT J NEUROPSYCHOPH, V12, P783, DOI 10.1017/S1461145708009759; Brezun JM, 2000, EUR J NEUROSCI, V12, P391, DOI 10.1046/j.1460-9568.2000.00932.x; Brigman JL, 2010, CEREB CORTEX, V20, P1955, DOI 10.1093/cercor/bhp266; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Calais JB, 2013, J NEURAL TRANSM, V120, P259, DOI 10.1007/s00702-012-0861-4; Callaghan CK, 2012, HIPPOCAMPUS, V22, P2127, DOI 10.1002/hipo.22033; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Carroll JC, 2007, BEHAV GENET, V37, P214, DOI 10.1007/s10519-006-9129-9; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; Choi YS, 2003, MOL CELLS, V16, P232; Choi YS, 2007, ARCH PHARM RES, V30, P646, DOI 10.1007/BF02977661; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Coras R, 2010, BRAIN, V133, P3359, DOI 10.1093/brain/awq215; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Ehninger D, 2006, GENES BRAIN BEHAV, V5, P29, DOI 10.1111/j.1601-183X.2005.00129.x; Eriksson TM, 2012, MOL PSYCHIATR, V17, P173, DOI 10.1038/mp.2010.131; Fabre V, 2000, EUR J NEUROSCI, V12, P2299, DOI 10.1046/j.1460-9568.2000.00126.x; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gardner KL, 2009, BRAIN RES, V1305, P47, DOI 10.1016/j.brainres.2009.09.065; Gould E, 1999, NEUROPSYCHOPHARMACOL, V21, pS46, DOI 10.1016/S0893-133X(99)00045-7; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Harvey JA, 2003, LEARN MEMORY, V10, P355, DOI 10.1101/lm.60803; Heiming RS, 2013, BEHAV BRAIN RES, V242, P135, DOI 10.1016/j.bbr.2012.12.045; Heiming RS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.026.2009; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; HENKE PG, 1990, BRAIN RES BULL, V25, P691, DOI 10.1016/0361-9230(90)90044-Z; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Herman JP, 1998, NEUROSCIENCE, V86, P449, DOI 10.1016/S0306-4522(98)00055-4; Hohoff C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058880; Holmes A, 2003, BIOL PSYCHIAT, V54, P953, DOI 10.1016/j.biopsych.2003.09.003; Holmes A, 2002, NEUROPSYCHOPHARMACOL, V27, P914, DOI 10.1016/S0893-133X(02)00374-3; Holmes A, 2008, NEUROSCI BIOBEHAV R, V32, P1293, DOI 10.1016/j.neubiorev.2008.03.006; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; Homberg JR, 2007, EUR J NEUROSCI, V26, P2066, DOI 10.1111/j.1460-9568.2007.05839.x; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Iivonen H, 2003, BEHAV BRAIN RES, V141, P207, DOI 10.1016/S0166-4328(02)00369-8; IMAKI T, 1995, MOL BRAIN RES, V32, P261, DOI 10.1016/0169-328X(95)00086-8; JANSEN F, 2009, BEHAV BRAIN RES, V207, P1, DOI DOI 10.1016/J.BBR.2009.09.033.PUBMED:19782704; Jedema HP, 2010, MOL PSYCHIATR, V15, P512, DOI 10.1038/mp.2009.90; Jiang X, 2009, PSYCHONEUROENDOCRINO, V34, P317, DOI 10.1016/j.psyneuen.2008.09.011; Kalueff AV, 2007, GENES BRAIN BEHAV, V6, P389, DOI 10.1111/j.1601-183X.2006.00270.x; Kalueff AV, 2006, NEUROREPORT, V17, P1347, DOI 10.1097/01.wnr.0000230514.08962.76; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Lanfumey L, 2008, NEUROSCI BIOBEHAV R, V32, P1174, DOI 10.1016/j.neubiorev.2008.04.006; Lawston J, 2000, BRAIN RES, V877, P407, DOI 10.1016/S0006-8993(00)02739-6; Lee Margherita M, 2013, Curr Top Behav Neurosci, V14, P153, DOI 10.1007/7854_2012_226; Lesch KP, 2012, NEURON, V76, P175, DOI 10.1016/j.neuron.2012.09.013; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 1998, NEUROSCIENTIST, V4, P25, DOI 10.1177/107385849800400110; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; LEWEJOHANN L, 2004, DIGITAL IMAGE PROCES; Lewejohann L, 2010, BEHAV BRAIN RES, V211, P220, DOI 10.1016/j.bbr.2010.03.035; Li Q, 1999, J PHARMACOL EXP THER, V291, P999; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Lowry CA, 2005, STRESS, V8, P233, DOI 10.1080/10253890500492787; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Madsen K, 2011, PSYCHOPHARMACOLOGY, V213, P573, DOI 10.1007/s00213-010-1926-4; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Matsuda S, 1996, NEUROSCI RES, V26, P157, DOI 10.1016/S0168-0102(96)01088-7; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McEwen BS, 2001, HUM PSYCHOPHARM CLIN, V16, pS7, DOI 10.1002/hup.266; Meneses A, 1999, NEUROSCI BIOBEHAV R, V23, P1111, DOI 10.1016/S0149-7634(99)00067-6; Meneses A, 2002, NEUROSCI BIOBEHAV R, V26, P309, DOI 10.1016/S0149-7634(02)00005-2; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Mifsud KR, 2011, BRAIN BEHAV IMMUN, V25, P1305, DOI 10.1016/j.bbi.2011.06.005; Miyashita T, 2009, J NEUROSCI, V29, P898, DOI 10.1523/JNEUROSCI.4588-08.2009; Molteni R, 2009, EUR NEUROPSYCHOPHARM, V19, P898, DOI 10.1016/j.euroneuro.2009.06.008; MORINOBU S, 1995, NEUROPSYCHOPHARMACOL, V12, P221, DOI 10.1038/sj.npp.1380254; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moser EI, 1995, BEHAV BRAIN RES, V71, P11, DOI 10.1016/0166-4328(95)00051-8; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Namestkova K, 2005, BEHAV BRAIN RES, V163, P26, DOI 10.1016/j.bbr.2005.04.013; Narayanan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022600; Nietzer SL, 2011, BEHAV BRAIN RES, V220, P42, DOI 10.1016/j.bbr.2011.01.011; Ogren SO, 2008, BEHAV BRAIN RES, V195, P54, DOI 10.1016/j.bbr.2008.02.023; Pei Q, 2003, NEUROSCIENCE, V121, P975, DOI 10.1016/S0306-4522(03)00504-9; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; PORSOLT RD, 1979, BIOMEDICINE, V30, P139; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; Ravinder S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.137; Rhodes RA, 2007, J NEUROSCI, V27, P9233, DOI 10.1523/JNEUROSCI.1175-07.2007; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Roiser JP, 2007, INT J NEUROPSYCHOPH, V10, P449, DOI 10.1017/S146114570600705X; Roiser JP, 2006, PSYCHOPHARMACOLOGY, V188, P213, DOI 10.1007/s00213-006-0495-z; Santin LJ, 2003, PHYSIOL BEHAV, V78, P733, DOI 10.1016/S0031-9384(03)00060-X; Schipper P, 2011, BEHAV PHARMACOL, V22, P324, DOI 10.1097/FBP.0b013e328347881b; Schmitt A, 2007, J NEURAL TRANSM, V114, P1107, DOI 10.1007/s00702-007-0724-6; Schmitt A, 2003, J NEUROSCI RES, V71, P701, DOI 10.1002/jnr.10521; Segal M, 2010, HIPPOCAMPUS, V20, P1332, DOI 10.1002/hipo.20751; SENBA E, 1994, MOL BRAIN RES, V24, P283, DOI 10.1016/0169-328X(94)90141-4; Senba E, 1997, NEUROSCI RES, V29, P183, DOI 10.1016/S0168-0102(97)00095-3; Shen HW, 2004, NEUROPSYCHOPHARMACOL, V29, P1790, DOI 10.1038/sj.npp.1300476; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SQUIRE LR, 1993, TRENDS NEUROSCI, V16, P56, DOI 10.1016/0166-2236(93)90016-F; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Streijger F, 2009, PHYSIOL BEHAV, V97, P76, DOI 10.1016/j.physbeh.2009.02.003; Strobel A, 2007, J COGNITIVE NEUROSCI, V19, P1923, DOI 10.1162/jocn.2007.19.12.1923; SUNANDA, 1995, BRAIN RES, V694, P312, DOI 10.1016/0006-8993(95)00822-8; Teather LA, 2005, NEUROBIOL LEARN MEM, V84, P75, DOI 10.1016/j.nlm.2005.03.006; Tjurmina OA, 2004, ANN NY ACAD SCI, V1018, P99, DOI 10.1196/annals.1296.011; Tjurmina OA, 2002, ENDOCRINOLOGY, V143, P4520, DOI 10.1210/en.2002-220416; Uceyler N, 2010, INT J OBESITY, V34, P701, DOI 10.1038/ijo.2009.289; VanElzakker M, 2008, LEARN MEMORY, V15, P899, DOI 10.1101/lm.1196508; Vertes RP, 1999, J COMP NEUROL, V407, P555; Wallace CS, 1998, J NEUROSCI, V18, P26; WATANABE Y, 1992, EUR J PHARMACOL, V222, P157, DOI 10.1016/0014-2999(92)90830-W; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WATANABE Y, 1992, HIPPOCAMPUS, V2, P431, DOI 10.1002/hipo.450020410; Weinberg MS, 2007, NEUROSCIENCE, V150, P478, DOI 10.1016/j.neuroscience.2007.09.013; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007; Williams SR, 2007, NEURON, V56, P947, DOI 10.1016/j.neuron.2007.12.004; Xie L, 2013, J NEUROCHEM, V125, P457, DOI 10.1111/jnc.12210; Zalsman G, 2006, AM J PSYCHIAT, V163, P1588, DOI 10.1176/appi.ajp.163.9.1588	143	33	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78238	10.1371/journal.pone.0078238	http://dx.doi.org/10.1371/journal.pone.0078238			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167611	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500072
J	Nakazato, T; Ohta, T; Bono, H				Nakazato, Takeru; Ohta, Tazro; Bono, Hidemasa			Experimental Design-Based Functional Mining and Characterization of High-Throughput Sequencing Data in the Sequence Read Archive	PLOS ONE			English	Article								High-throughput sequencing technology, also called next-generation sequencing (NGS), has the potential to revolutionize the whole process of genome sequencing, transcriptomics, and epigenetics. Sequencing data is captured in a public primary data archive, the Sequence Read Archive (SRA). As of January 2013, data from more than 14,000 projects have been submitted to SRA, which is double that of the previous year. Researchers can download raw sequence data from SRA website to perform further analyses and to compare with their own data. However, it is extremely difficult to search entries and download raw sequences of interests with SRA because the data structure is complicated, and experimental conditions along with raw sequences are partly described in natural language. Additionally, some sequences are of inconsistent quality because anyone can submit sequencing data to SRA with no quality check. Therefore, as a criterion of data quality, we focused on SRA entries that were cited in journal articles. We extracted SRA IDs and PubMed IDs (PMIDs) from SRA and full-text versions of journal articles and retrieved 2748 SRA ID-PMID pairs. We constructed a publication list referring to SRA entries. Since, one of the main themes of -omics analyses is clarification of disease mechanisms, we also characterized SRA entries by disease keywords, according to the Medical Subject Headings (MeSH) extracted from articles assigned to each SRA entry. We obtained 989 SRA ID-MeSH disease term pairs, and constructed a disease list referring to SRA data. We previously developed feature profiles of diseases in a system called "Gendoo". We generated hyperlinks between diseases extracted from SRA and the feature profiles of it. The developed project, publication and disease lists resulting from this study are available at our web service, called "DBCLS SRA" (http://sra.dbcls.jp/). This service will improve accessibility to high-quality data from SRA.	[Nakazato, Takeru; Ohta, Tazro; Bono, Hidemasa] ROIS, Database Ctr Life Sci DBCLS, Tokyo, Japan	Research Organization of Information & Systems (ROIS)	Nakazato, T (corresponding author), ROIS, Database Ctr Life Sci DBCLS, Tokyo, Japan.	nakazato@dbcls.rois.ac.jp	Bono, Hidemasa/AAF-3649-2020; Ohta, Tazro/HGE-5906-2022; Nakazato, Takeru/H-2732-2013	Bono, Hidemasa/0000-0003-4413-0651; Ohta, Tazro/0000-0003-3777-5945; Nakazato, Takeru/0000-0002-0706-2867	Life Science Database Integration Project of the National Bioscience Database Center (NBDC) of the Japan Science and Technology Agency (JST)	Life Science Database Integration Project of the National Bioscience Database Center (NBDC) of the Japan Science and Technology Agency (JST)	This work was supported by the Life Science Database Integration Project of the National Bioscience Database Center (NBDC) of the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; [Anonymous], 2008, NAT BIOTECHNOL, V26, P1099, DOI 10.1038/nbt1008-1099; Barrett T, 2012, NUCLEIC ACIDS RES, V40, pD57, DOI 10.1093/nar/gkr1163; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Karsch-Mizrachi I, 2012, NUCLEIC ACIDS RES, V40, pD33, DOI 10.1093/nar/gkr1006; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakazato T, 2009, NUCLEIC ACIDS RES, V37, pW166, DOI 10.1093/nar/gkp483; Nakazato Takeru, 2008, In Silico Biology, V8, P53; Nelson SJ, 2004, ST HEAL T, V107, P67; Neveol A, 2012, IMPROVING LINKS LIT; Neveol A, 2011, BIOINFORMATICS, V27, P3306, DOI 10.1093/bioinformatics/btr573; Piwowar Heather A, 2008, AMIA Annu Symp Proc, P596; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486	22	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77910	10.1371/journal.pone.0077910	http://dx.doi.org/10.1371/journal.pone.0077910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167589	gold, Green Published, Green Submitted			2022-12-27	WOS:000326034500048
J	Agoni, L; Lenz, J; Guha, C				Agoni, Lorenzo; Lenz, Jack; Guha, Chandan			Variant Splicing and Influence of Ionizing Radiation on Human Endogenous Retrovirus K (HERV-K) Transcripts in Cancer Cell Lines	PLOS ONE			English	Article							HUMAN PAPILLOMAVIRUS-16; GAMMA-IRRADIATION; PERIPHERAL-BLOOD; T-LYMPHOCYTES; TUMOR-CELLS; EXPRESSION; MELANOMA; PROTEIN; SEQUENCES; PROVIRUS	Human endogenous retrovirus K (HERV-K) is the most intact retrovirus in the human genome. There are multiple full-length or near full-length HERV-K proviruses in it. To analyze which HERV-K proviruses give rise to viral transcripts in cancer cell lines and to test whether ionizing radiation can alter the levels of HERV-K transcripts, RT-PCR studies were undertaken using multiple human cancer cell lines. Primers from several positions in the viral genome were used and included pairs designed to cross splice junctions in viral RNAs. In the absence of ionizing radiation, transcripts were detected from multiple HERV-K proviruses in cell lines from human prostate, cervical, head and neck, or breast cancers, and the proviruses from which the transcripts originated varied among the different lines. Only one of 13 cell lines tested (cervical cancer line C33A) failed to show HERV-K transcripts. Spliced RNAs detected included viral RNAs spliced as expected at the conventional viral splice sites, plus several alternatively spliced RNAs. Alternatively spliced transcripts arose from specific proviruses, and were detected in most of the cell lines used. Quantitative RT-PCR was performed to assess the effects of ionizing radiation. These analyses showed that HERV-K transcripts were elevated in four of twelve lines tested, specifically all three prostate cancer lines used and one breast cancer line. The increases were transient, peaking at 24 hours following a single dose of gamma-irradiation that ranged from 2.5 to 20 Gy, and returning to baseline levels by 72 hours. In summary, these studies showed that ionizing radiation can affect the levels of HERV-K transcripts in cells, and these effects vary among different cells. The changes in HERV-K transcript levels might affect multiple biological processes in cells, and future studies of the effects of ionizing radiation on HERV-K are worth pursuing.	[Agoni, Lorenzo; Guha, Chandan] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Lenz, Jack] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Guha, Chandan] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Guha, C (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	cguha@montefiore.org		Agoni, Lorenzo/0000-0003-0270-248X	NIBIB [1 R01 EB009040]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009040] Funding Source: NIH RePORTER	NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work was supported by NIBIB 1 R01 EB009040 (to CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoni L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00180; Agoni L, 2012, CURR BIOL, V22, pR437, DOI 10.1016/j.cub.2012.04.049; Armbruester V, 2002, CLIN CANCER RES, V8, P1800; ASTIER T, 1982, J GEN VIROL, V61, P55, DOI 10.1099/0022-1317-61-1-55; Barbulescu M, 1999, CURR BIOL, V9, P861, DOI 10.1016/S0960-9822(99)80390-X; Barbulescu M, 2001, CURR BIOL, V11, P779, DOI 10.1016/S0960-9822(01)00227-5; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Blikstad V, 2008, CELL MOL LIFE SCI, V65, P3348, DOI 10.1007/s00018-008-8495-2; Bogerd HP, 2000, J VIROL, V74, P9353, DOI 10.1128/JVI.74.20.9353-9361.2000; BOLLER K, 1993, VIROLOGY, V196, P349, DOI 10.1006/viro.1993.1487; Brudek T, 2007, J NEUROIMMUNOL, V187, P147, DOI 10.1016/j.jneuroim.2007.04.003; Buscher K, 2005, CANCER RES, V65, P4172, DOI 10.1158/0008-5472.CAN-04-2983; Chakraborty M, 2004, CANCER RES, V64, P4328, DOI 10.1158/0008-5472.CAN-04-0073; Chakraborty M, 2003, J IMMUNOL, V170, P6338, DOI 10.4049/jimmunol.170.12.6338; Contreras-Galindo R, 2006, AIDS RES HUM RETROV, V22, P979, DOI 10.1089/aid.2006.22.979; Contreras-Galindo R, 2012, J VIROL, V86, P262, DOI 10.1128/JVI.00602-11; de Parseval N, 2005, CYTOGENET GENOME RES, V110, P318, DOI 10.1159/000084964; Delgado FG, 2009, IMMUNOLOGY, V126, P523, DOI 10.1111/j.1365-2567.2008.02912.x; Demaria S, 2007, INT J RADIAT BIOL, V83, P819, DOI 10.1080/09553000701481816; Demaria S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00128; Demaria S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00095; Denne M, 2007, J VIROL, V81, P5607, DOI 10.1128/JVI.02771-06; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Etkind PR, 1997, VIROLOGY, V234, P304, DOI 10.1006/viro.1997.8670; Feng WJN, 2007, INT J CANCER, V120, P81, DOI 10.1002/ijc.22256; Flockerzi A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-354; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Formenti SC, 2009, LANCET ONCOL, V10, P718, DOI 10.1016/S1470-2045(09)70082-8; Frank O, 2008, J VIROL, V82, P1808, DOI 10.1128/JVI.02115-07; Freimanis G, 2010, CLIN EXP IMMUNOL, V160, P340, DOI 10.1111/j.1365-2249.2010.04110.x; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Goering W, 2011, CARCINOGENESIS, V32, P1484, DOI 10.1093/carcin/bgr181; Hahn S, 2008, AIDS RES HUM RETROV, V24, P717, DOI 10.1089/aid.2007.0286; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; HEO DS, 1989, CANCER RES, V49, P5167; Herbst H, 1998, APMIS, V106, P216, DOI 10.1111/j.1699-0463.1998.tb01338.x; Hermans KG, 2008, CANCER RES, V68, P7541, DOI 10.1158/0008-5472.CAN-07-5930; Heslin DJ, 2009, J VIROL, V83, P1105, DOI 10.1128/JVI.01439-08; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; Ishida Toshiaki, 2008, Cancer Immun, V8, P15; Jha AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020234; JOLICOEUR P, 1986, LEUKEMIA RES, V10, P843, DOI 10.1016/0145-2126(86)90305-X; Kaufmann S, 2010, J GEN VIROL, V91, P1494, DOI 10.1099/vir.0.014241-0; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim JH, 2007, INT J RADIAT ONCOL, V69, P813, DOI 10.1016/j.ijrobp.2007.04.005; Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010; LIEBERMAN M, 1959, SCIENCE, V130, P387, DOI 10.1126/science.130.3372.387; LIEBERMAN MIRIAM, 1966, NAT CANCER INST MONOGR, V22, P549; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; Magin C, 1999, J VIROL, V73, P9496, DOI 10.1128/JVI.73.11.9496-9507.1999; Mamedov I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf071; Mayer J, 1999, NAT GENET, V21, P257, DOI 10.1038/6766; Medstrand P, 1998, J VIROL, V72, P9782, DOI 10.1128/JVI.72.12.9782-9787.1998; Muster T, 2003, CANCER RES, V63, P8735; NOKTA M, 1992, P SOC EXP BIOL MED, V200, P402, DOI 10.3181/00379727-200-43448; Ohagen A, 2004, VOX SANG, V87, P1, DOI 10.1111/j.1423-0410.2004.00532.x; ONO M, 1986, J VIROL, V58, P937, DOI 10.1128/JVI.58.3.937-944.1986; ONO M, 1986, J VIROL, V60, P589, DOI 10.1128/JVI.60.2.589-598.1986; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Rakoff-Nahoum S, 2006, AIDS RES HUM RETROV, V22, P52, DOI 10.1089/aid.2006.22.52; Reiche J, 2010, MELANOMA RES, V20, P435, DOI 10.1097/CMR.0b013e32833c1b5d; Ruprecht K, 2008, CELL MOL LIFE SCI, V65, P3366, DOI 10.1007/s00018-008-8496-1; Santin AD, 1998, CANCER-AM CANCER SOC, V83, P2346, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2346::AID-CNCR14>3.0.CO;2-G; SAUTER M, 1995, J VIROL, V69, P414, DOI 10.1128/JVI.69.1.414-421.1995; Schiavetti F, 2002, CANCER RES, V62, P5510; Stevens RW, 1999, CLIN DIAGN LAB IMMUN, V6, P783, DOI 10.1128/CDLI.6.6.783-786.1999; Subramanian RP, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-90; Turner G, 2001, CURR BIOL, V11, P1531, DOI 10.1016/S0960-9822(01)00455-9; Vereecque R, 2003, GENE THER, V10, P227, DOI 10.1038/sj.gt.3301870; Wang-Johanning F, 2001, CLIN CANCER RES, V7, P1553; Wang-Johanning F, 2008, CANCER RES, V68, P5869, DOI 10.1158/0008-5472.CAN-07-6838; Wang-Johanning F, 2012, JNCI-J NATL CANCER I, V104, P189, DOI 10.1093/jnci/djr540; Xu Y, 1996, PHOTOCHEM PHOTOBIOL, V64, P238, DOI 10.1111/j.1751-1097.1996.tb02451.x	73	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76472	10.1371/journal.pone.0076472	http://dx.doi.org/10.1371/journal.pone.0076472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204631	gold, Green Submitted, Green Published			2022-12-27	WOS:000326029300030
J	Bowden, DA; Rowden, AA; Thurber, AR; Baco, AR; Levin, LA; Smith, CR				Bowden, David A.; Rowden, Ashley A.; Thurber, Andrew R.; Baco, Amy R.; Levin, Lisa A.; Smith, Craig R.			Cold Seep Epifaunal Communities on the Hikurangi Margin, New Zealand: Composition, Succession, and Vulnerability to Human Activities	PLOS ONE			English	Article							GULF-OF-MEXICO; TUBEWORM LAMELLIBRACHIA-LUYMESI; DEEP-SEA; FLUID-FLOW; VESICOMYID CLAMS; METHANE SEEPAGE; MONTEREY BAY; GROWTH; DIVERSITY; PATTERNS	Cold seep communities with distinctive chemoautotrophic fauna occur where hydrocarbon-rich fluids escape from the seabed. We describe community composition, population densities, spatial extent, and within-region variability of epifaunal communities at methane-rich cold seep sites on the Hikurangi Margin, New Zealand. Using data from towed camera transects, we match observations to information about the probable life-history characteristics of the principal fauna to develop a hypothetical succession sequence for the Hikurangi seep communities, from the onset of fluid flux to senescence. New Zealand seep communities exhibit taxa characteristic of seeps in other regions, including predominance of large siboglinid tubeworms, vesicomyid clams, and bathymodiolin mussels. Some aspects appear to be novel; however, particularly the association of dense populations of ampharetid polychaetes with high-sulphide, high-methane flux, soft-sediment microhabitats. The common occurrence of these ampharetids suggests they play a role in conditioning sulphide-rich sediments at the sediment-water interface, thus facilitating settlement of clam and tubeworm taxa which dominate space during later successional stages. The seep sites are subject to disturbance from bottom trawling at present and potentially from gas hydrate extraction in future. The likely life-history characteristics of the dominant megafauna suggest that while ampharetids, clams, and mussels exploit ephemeral resources through rapid growth and reproduction, lamellibrachid tubeworm populations may persist potentially for centuries. The potential consequences of gas hydrate extraction cannot be fully assessed until extraction methods and target localities are defined but any long-term modification of fluid flow to seep sites would have consequences for all chemoautotrophic fauna.	[Bowden, David A.; Rowden, Ashley A.] Natl Inst Water & Atmospher Res, Coasts & Oceans Ctr, Wellington, New Zealand; [Thurber, Andrew R.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Baco, Amy R.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Levin, Lisa A.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, Integrat Oceanog Div, La Jolla, CA 92093 USA; [Smith, Craig R.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI USA	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Oregon State University; State University System of Florida; Florida State University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hawaii System; University of Hawaii Manoa	Bowden, DA (corresponding author), Natl Inst Water & Atmospher Res, Coasts & Oceans Ctr, Wellington, New Zealand.	david.bowden@niwa.co.nz	Rowden, Ashley/ABG-6010-2020; Rowden, Ashley/O-9358-2019	Rowden, Ashley/0000-0003-2975-2524; Levin, Lisa/0000-0002-2858-8622	National Oceanic and Atmospheric Administration [NA05OAR4171076, NA17RJ1231/58]; National Institute of Water and Atmospheric Research (NIWA) Capability Fund project [CRFH073]; NIWA Capability Fund [CPDU073]; NIWA [GNS11304]; GNS [CO5X0908]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Institute of Water and Atmospheric Research (NIWA) Capability Fund project; NIWA Capability Fund; NIWA; GNS	Data and samples were collected during R/V Tangaroa voyage TAN0616 "New Zeeps" and R/V Sonne voyages SO191 "New Vents" and SO214 "NEMESYS." TAN0616 was funded by National Oceanic and Atmospheric Administration Ocean Exploration Grants NA05OAR4171076 and NA17RJ1231/58, and National Institute of Water and Atmospheric Research (NIWA) Capability Fund project CRFH073. DAB was funded on TAN0616 and SO191 by NIWA Capability Fund project CPDU073 and on SO214 by NIWA project GNS11304 under subcontract to GNS project CO5X0908 'Gas Hydrate Resources'. Support during analysis for DAB and AAR came from NIWA projects GNS11304 and DSCA113 Vulnerable Deep-Sea Communities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Baco AR, 2010, MAR GEOL, V272, P251, DOI 10.1016/j.margeo.2009.06.015; Baco AR, 2003, MAR ECOL PROG SER, V260, P109, DOI 10.3354/meps260109; Baird SJ, 2011, 73 NZ AQ ENV BIOD; Barnes PM, 2010, MAR GEOL, V272, P26, DOI 10.1016/j.margeo.2009.03.012; Barry JP, 2007, MAR ECOL-EVOL PERSP, V28, P169, DOI 10.1111/j.1439-0485.2007.00119.x; Barry JP, 1996, DEEP-SEA RES PT I, V43, P1739, DOI 10.1016/S0967-0637(96)00075-1; Barry JP, 2002, INVERTEBR BIOL, V121, P47; Barry JP, 1997, LIMNOL OCEANOGR, V42, P318, DOI 10.4319/lo.1997.42.2.0318; Bergquist DC, 2002, MAR ECOL PROG SER, V241, P89, DOI 10.3354/meps241089; Bernardino AF, 2010, MAR ECOL-EVOL PERSP, V31, P608, DOI 10.1111/j.1439-0485.2010.00389.x; Bertics VJ, 2007, AM GEOPH UN FALL M 2; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Boswell R, 2012, MAR PETROL GEOL, V34, P4, DOI 10.1016/j.marpetgeo.2011.10.003; Campbell KA, 2010, MAR GEOL, V272, P285, DOI 10.1016/j.margeo.2010.01.002; Cordes EE, 2005, PLOS BIOL, V3, P497, DOI 10.1371/journal.pbio.0030077; Cordes EE, 2003, ECOL LETT, V6, P212, DOI 10.1046/j.1461-0248.2003.00415.x; Cordes EE, 2007, DEEP-SEA RES PT I, V54, P637, DOI 10.1016/j.dsr.2007.01.001; Cordes EE, 2007, MAR ECOL-EVOL PERSP, V28, P160, DOI 10.1111/j.1439-0485.2006.00112.x; Cordes EE, 2006, J EXP MAR BIOL ECOL, V339, P159, DOI 10.1016/j.jembe.2006.07.017; Cordes EE, 2009, ANNU REV MAR SCI, V1, P143, DOI 10.1146/annurev.marine.010908.163912; Crutchley GJ, 2011, MAR PETROL GEOL, V28, P1915, DOI 10.1016/j.marpetgeo.2010.12.005; Dale AW, 2010, GEOCHIM COSMOCHIM AC, V74, P5763, DOI 10.1016/j.gca.2010.06.038; Dattagupta S, 2008, GEOCHIM COSMOCHIM AC, V72, P2298, DOI 10.1016/j.gca.2008.02.016; Dattagupta S, 2006, J EXP BIOL, V209, P3795, DOI 10.1242/jeb.02413; Domack E, 2005, T AM GEOPHYS UNION, V86, P269; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Fischer D, 2012, BIOGEOSCIENCES, V9, P2013, DOI 10.5194/bg-9-2013-2012; Fisher CR, 1997, MAR ECOL-P S Z N I, V18, P83, DOI 10.1111/j.1439-0485.1997.tb00428.x; Fohrmann M, 2012, MAR PETROL GEOL, V38, P19, DOI 10.1016/j.marpetgeo.2012.08.001; Freytag JK, 2001, P NATL ACAD SCI USA, V98, P13408, DOI 10.1073/pnas.231589498; Fujikura K, 2007, MAR ECOL PROG SER, V333, P185, DOI 10.3354/meps333185; German CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023259; Gorley C.K., 2006, GETTING STARTED PRIM; Govenar B, 2010, TOP GEOBIOL, V33, P403, DOI 10.1007/978-90-481-9572-5_13; Greinert J, 2010, MAR GEOL, V272, P6, DOI 10.1016/j.margeo.2010.01.017; Henrys SA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015772; Hill P, 2009, SEA TECHNOL, V50, P49; Jones AT, 2010, MAR GEOL, V272, P154, DOI 10.1016/j.margeo.2009.03.008; Klaucke I, 2010, MAR GEOL, V272, P49, DOI 10.1016/j.margeo.2009.02.009; Krabbenhoeft A, 2013, MAR PETROL GEOL, V39, P59, DOI 10.1016/j.marpetgeo.2012.09.008; Leon R, 2006, DEEP-SEA RES PT II, V53, P1464, DOI 10.1016/j.dsr2.2006.04.009; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; Levin LA, 2012, P ROY SOC B-BIOL SCI, V279, P2580, DOI 10.1098/rspb.2012.0205; Levin LA, 2010, MAR ECOL-EVOL PERSP, V31, P94, DOI 10.1111/j.1439-0485.2009.00335.x; Lewis KB, 1996, NEW ZEAL J GEOL GEOP, V39, P181, DOI 10.1080/00288306.1996.9514704; Liebetrau V, 2010, MAR GEOL, V272, P307, DOI 10.1016/j.margeo.2010.01.003; Lisin SE, 1997, INVERTEBR REPROD DEV, V31, P307, DOI 10.1080/07924259.1997.9672590; Luff R, 2005, CHEM GEOL, V216, P157, DOI 10.1016/j.chemgeo.2004.11.002; Naudts L, 2010, MAR GEOL, V272, P233, DOI 10.1016/j.margeo.2009.08.002; Navalpakam RS, 2012, J PETROL SCI ENG, V88-89, P29, DOI 10.1016/j.petrol.2012.01.008; Olu-Le Roy K, 2004, DEEP-SEA RES PT I, V51, P1915, DOI 10.1016/j.dsr.2004.07.004; Pecher IA, 2003, POTENTIAL GAS RESERV; Pecher IA, 2010, MAR GEOL, V272, P99, DOI 10.1016/j.margeo.2009.10.006; Plaza-Faverola A, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004228; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Ritt B, 2010, DEEP-SEA RES PT I, V57, P1120, DOI 10.1016/j.dsr.2010.05.011; Roy KOL, 2007, MAR ECOL-EVOL PERSP, V28, P115, DOI 10.1111/j.1439-0485.2006.00145.x; Sellanes J, 2008, ICES J MAR SCI, V65, P1102, DOI 10.1093/icesjms/fsn099; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Sommer S, 2007, GEOCHIM COSMOCHIM AC, V71, pA955; Sommer S, 2010, MAR GEOL, V272, P223, DOI 10.1016/j.margeo.2009.06.003; SOUTHWARD EC, 1991, J NAT HIST, V25, P859, DOI 10.1080/00222939100770571; Thurber AR, 2010, MAR GEOL, V272, P260, DOI 10.1016/j.margeo.2009.06.001; Thurber AR, LIMNOLOGY O IN PRESS; Tyler PA, 1999, J MAR BIOL ASSOC UK, V79, P193, DOI 10.1017/S0025315499000235; TYLER PA, 1992, INVERTEBR REPROD DEV, V22, P185, DOI 10.1080/07924259.1992.9672271; Van Dover CL, 2012, MAR POLICY, V36, P378, DOI 10.1016/j.marpol.2011.07.002; Wallmann K, 1997, GEOCHIM COSMOCHIM AC, V61, P5209, DOI 10.1016/S0016-7037(97)00306-2	69	44	46	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76869	10.1371/journal.pone.0076869	http://dx.doi.org/10.1371/journal.pone.0076869			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204691	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300058
J	Assmy, P; Ehn, JK; Fernandez-Mendez, M; Hop, H; Katlein, C; Sundfjord, A; Bluhm, K; Daase, M; Engel, A; Fransson, A; Granskog, MA; Hudson, SR; Kristiansen, S; Nicolaus, M; Peeken, I; Renner, AHH; Spreen, G; Tatarek, A; Wiktor, J				Assmy, Philipp; Ehn, Jens K.; Fernandez-Mendez, Mar; Hop, Haakon; Katlein, Christian; Sundfjord, Arild; Bluhm, Katrin; Daase, Malin; Engel, Anja; Fransson, Agneta; Granskog, Mats A.; Hudson, Stephen R.; Kristiansen, Svein; Nicolaus, Marcel; Peeken, Ilka; Renner, Angelika H. H.; Spreen, Gunnar; Tatarek, Agnieszka; Wiktor, Jozef			Floating Ice-Algal Aggregates below Melting Arctic Sea Ice	PLOS ONE			English	Article							TRANSPARENT EXOPOLYMER PARTICLES; POLYMERIC SUBSTANCES EPS; ATLANTIC-OCEAN; NATURAL-WATERS; CHLOROPHYLL-A; BARENTS SEA; PHYTOPLANKTON; CARBON; TEP; TRANSFORMATION	During two consecutive cruises to the Eastern Central Arctic in late summer 2012, we observed floating algal aggregates in the melt-water layer below and between melting ice floes of first-year pack ice. The macroscopic (1-15 cm in diameter) aggregates had a mucous consistency and were dominated by typical ice-associated pennate diatoms embedded within the mucous matrix. Aggregates maintained buoyancy and accumulated just above a strong pycnocline that separated meltwater and seawater layers. We were able, for the first time, to obtain quantitative abundance and biomass estimates of these aggregates. Although their biomass and production on a square metre basis was small compared to ice-algal blooms, the floating ice-algal aggregates supported high levels of biological activity on the scale of the individual aggregate. In addition they constituted a food source for the ice-associated fauna as revealed by pigments indicative of zooplankton grazing, high abundance of naked ciliates, and ice amphipods associated with them. During the Arctic melt season, these floating aggregates likely play an important ecological role in an otherwise impoverished near-surface sea ice environment. Our findings provide important observations and measurements of a unique aggregate-based habitat during the 2012 record sea ice minimum year.	[Assmy, Philipp; Hop, Haakon; Sundfjord, Arild; Daase, Malin; Fransson, Agneta; Granskog, Mats A.; Hudson, Stephen R.; Renner, Angelika H. H.; Spreen, Gunnar] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Ehn, Jens K.] Univ Manitoba, Ctr Earth Observat Sci, Winnipeg, MB, Canada; [Fernandez-Mendez, Mar; Katlein, Christian; Nicolaus, Marcel; Peeken, Ilka] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Bremerhaven, Germany; [Fernandez-Mendez, Mar] Max Planck Inst Marine Microbiol, Bremen, Germany; [Bluhm, Katrin] Akvaplan Niva, Fram Ctr, Tromso, Norway; [Engel, Anja] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Kristiansen, Svein] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Peeken, Ilka] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Tatarek, Agnieszka; Wiktor, Jozef] Polish Acad Sci, Inst Oceanol, Sopot, Poland	Norwegian Polar Institute; University of Manitoba; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society; Akvaplan-niva; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; UiT The Arctic University of Tromso; University of Bremen; Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences	Assmy, P (corresponding author), Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway.	Philipp.Assmy@npolar.no	Nicolaus, Marcel/A-3658-2013; Spreen, Gunnar/A-4533-2010; Hudson, Stephen/ABD-9923-2020; Katlein, Christian/AAY-8731-2020	Nicolaus, Marcel/0000-0003-0903-1746; Spreen, Gunnar/0000-0003-0165-8448; Hudson, Stephen/0000-0002-6498-9167; Peeken, Ilka/0000-0003-1531-1664; Fernandez-Mendez, Mar/0000-0002-4968-1156; Daase, Malin/0000-0001-8413-3924; Sundfjord, Arild/0000-0002-6913-3368; Tatarek, Agnieszka/0000-0003-1467-6362; Granskog, Mats/0000-0002-5035-4347; Renner, Angelika/0000-0002-9997-6366; Katlein, Christian/0000-0003-2422-0414; Engel, Anja/0000-0002-1042-1955	Centre for Ice, Climate and Ecosystems (ICE) at the Norwegian Polar Institute; Alfred-Wegener-Institut Helmholtz-Zentrum fur Polar- und Meeresforschung	Centre for Ice, Climate and Ecosystems (ICE) at the Norwegian Polar Institute; Alfred-Wegener-Institut Helmholtz-Zentrum fur Polar- und Meeresforschung	This work was supported by the Centre for Ice, Climate and Ecosystems (ICE) at the Norwegian Polar Institute and the Alfred-Wegener-Institut Helmholtz-Zentrum fur Polar- und Meeresforschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge AL, 1998, J PLANKTON RES, V20, P393, DOI 10.1093/plankt/20.3.393; ALLDREDGE AL, 1989, DEEP-SEA RES, V36, P159, DOI 10.1016/0198-0149(89)90131-3; Ambrose WG, 2005, POLAR BIOL, V28, P784, DOI 10.1007/s00300-005-0002-8; Arndt CE, 2005, J CRUSTACEAN BIOL, V25, P401, DOI 10.1651/C-2544; Arrigo KR., 2010, SEA ICE, P283, DOI DOI 10.1002/9781444317145.CH8; Aslam SN, 2012, J PHYCOL, V48, P1494, DOI 10.1111/jpy.12004; Bluhm K, 2010, AQUAT BIOL, V11, P1, DOI 10.3354/ab00284; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; Campos MLAM, 1997, MAR CHEM, V57, P107, DOI 10.1016/S0304-4203(96)00093-X; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Deal C, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006409; Ehn JK, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006908; Eicken H, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000583; Engel A, 2004, DEEP-SEA RES PT I, V51, P83, DOI 10.1016/j.dsr.2003.09.001; Engel A., 2009, PRACTICAL GUIDELINES, P125, DOI DOI 10.1201/9781420073072.CH7; Gran H.H., 1904, SCI RES NORW N POLAR, VIV, P1; GUTT J, 1995, POLAR BIOL, V15, P247; Haas C, 2006, ANN GLACIOL-SER, V44, P247, DOI 10.3189/172756406781811781; HALL PO, 1992, LIMNOL OCEANOGR, V37, P1113, DOI 10.4319/lo.1992.37.5.1113; HEAD EJH, 1992, MAR ECOL PROG SER, V86, P229, DOI 10.3354/meps086229; HOLMHANSEN O, 1978, OIKOS, V30, P438, DOI 10.2307/3543338; Hop H, 2006, PROG OCEANOGR, V71, P182, DOI 10.1016/j.pocean.2006.09.007; Hop H, 2011, POLAR BIOL, V34, P1947, DOI 10.1007/s00300-011-0991-4; HORNER RA, 1988, POLAR BIOL, V8, P249, DOI 10.1007/BF00263173; Hudson SR, 2013, GEOPHYS RES LETT, V40, P2679, DOI 10.1002/grl.50517; Ji RB, 2013, GLOBAL CHANGE BIOL, V19, P734, DOI 10.1111/gcb.12074; Juhl AR, 2011, MAR ECOL PROG SER, V436, P1, DOI 10.3354/meps09277; Krembs C, 2002, DEEP-SEA RES PT I, V49, P2163, DOI 10.1016/S0967-0637(02)00122-X; Krembs C, 2001, MAR BIOL, V138, P173, DOI 10.1007/s002270000396; Lee SH, 2011, OCEANOGRAPHY, V24, P302, DOI 10.5670/oceanog.2011.81; Lovejoy C, 2002, DEEP-SEA RES PT II, V49, P5027, DOI 10.1016/S0967-0645(02)00176-5; LUTHER GW, 1988, ANAL CHEM, V60, P1721, DOI 10.1021/ac00168a017; Meiners K, 2008, AQUAT MICROB ECOL, V52, P195, DOI 10.3354/ame01214; Melnikov I., 1997, ARCTIC SEA ICE ECOSY; Melnikov IA, 2002, DEEP-SEA RES PT I, V49, P1623, DOI 10.1016/S0967-0637(02)00042-0; Michel C, 2002, AQUAT MICROB ECOL, V30, P57, DOI 10.3354/ame030057; Mikkelsen DM, 2010, POLAR RES, V29, P451, DOI 10.1111/j.1751-8369.2010.00162.x; Mundy CJ, 2011, POLAR BIOL, V34, P1869, DOI 10.1007/s00300-011-0998-x; Nansen F., 1906, NORWEGIAN N POLAR EX, V1893-1896, P1; Nicolaus M, 2013, CRYOSPHERE, V7, P763, DOI 10.5194/tc-7-763-2013; Nicolaus M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053738; Nicolaus M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006074; OWENS TG, 1982, PHYTOCHEMISTRY, V21, P979, DOI 10.1016/S0031-9422(00)82401-2; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; Perovich DK., 1996, MONOGRAPH COLD REGIO; PLATT T, 1980, J MAR RES, V38, P687; Poltermann M, 2001, POLAR BIOL, V24, P89, DOI 10.1007/s003000000177; Renaud PE, 2007, J MARINE SYST, V67, P1, DOI 10.1016/j.jmarsys.2006.07.006; RIEBESELL U, 1991, POLAR BIOL, V11, P239; Riedel A, 2006, AQUAT MICROB ECOL, V45, P195, DOI 10.3354/ame045195; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Soreide JE, 2006, PROG OCEANOGR, V71, P59, DOI 10.1016/j.pocean.2006.06.001; Soreide JE, 2010, GLOBAL CHANGE BIOL, V16, P3154, DOI 10.1111/j.1365-2486.2010.02175.x; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; SYVERTSEN EE, 1991, POLAR RES, V10, P277, DOI 10.1111/j.1751-8369.1991.tb00653.x; Tamelander T, 2006, MAR ECOL PROG SER, V310, P33, DOI 10.3354/meps310033; Tamelander T, 2009, POLAR BIOL, V32, P1261, DOI 10.1007/s00300-009-0622-5; Taylor BB, 2011, BIOGEOSCIENCES, V8, P3609, DOI 10.5194/bg-8-3609-2011; Throndsen J., 1995, MANUAL HARMFUL MARIN, P63; TSUJI T, 1981, MAR BIOL, V64, P207, DOI 10.1007/BF00397110; Underwood GJC, 2010, MAR ECOL PROG SER, V404, P1, DOI 10.3354/meps08557; von Karman T, 1930, AHNLICHKEIT TURBULEN, V1, P58; Wassmann P, 2006, PROG OCEANOGR, V71, P232, DOI 10.1016/j.pocean.2006.10.003; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Werner I, 2005, MAR ECOL PROG SER, V292, P251, DOI 10.3354/meps292251	66	60	65	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76599	10.1371/journal.pone.0076599	http://dx.doi.org/10.1371/journal.pone.0076599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24204642	Green Published, Green Accepted, gold			2022-12-27	WOS:000326019400075
J	Gardener, EKT; Carr, AR; MacGregor, A; Felmingham, KL				Gardener, Elyse K. T.; Carr, Andrea R.; MacGregor, Amy; Felmingham, Kim L.			Sex Differences and Emotion Regulation: An Event-Related Potential Study	PLOS ONE			English	Article							GENDER-DIFFERENCES; NEGATIVE EMOTIONS; RESPONSES; VALENCE; AROUSAL; MEMORY; TASK	Difficulties in emotion regulation have been implicated as a potential mechanism underlying anxiety and mood disorders. It is possible that sex differences in emotion regulation may contribute towards the heightened female prevalence for these disorders. Previous fMRI studies of sex differences in emotion regulation have shown mixed results, possibly due to difficulties in discriminating the component processes of early emotional reactivity and emotion regulation. The present study used event-related potentials (ERPs) to examine sex differences in N1 and N2 components (reflecting early emotional reactivity) and P3 and LPP components (reflecting emotion regulation). N1, N2, P3, and LPP were recorded from 20 men and 23 women who were instructed to "increase,'' "decrease,'' and "maintain'' their emotional response during passive viewing of negative images. Results indicated that women had significantly greater N1 and N2 amplitudes (reflecting early emotional reactivity) to negative stimuli than men, supporting a female negativity bias. LPP amplitudes increased to the "increase'' instruction, and women displayed greater LPP amplitudes than men to the "increase'' instruction. There were no differences to the "decrease'' instruction in women or men. These findings confirm predictions of the female negativity bias hypothesis and suggest that women have greater up-regulation of emotional responses to negative stimuli. This finding is highly significant in light of the female vulnerability for developing anxiety disorders.	[Gardener, Elyse K. T.; Carr, Andrea R.; MacGregor, Amy; Felmingham, Kim L.] Univ Tasmania, Sch Psychol, Hobart, Tas, Australia	University of Tasmania	Felmingham, KL (corresponding author), Univ Tasmania, Sch Psychol, Hobart, Tas, Australia.	Kim.Felmingham@utas.edu.au		Carr, Andrea/0000-0001-8201-7890				Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Campanella S, 2004, NEUROSCI LETT, V367, P14, DOI 10.1016/j.neulet.2004.05.097; Campanella S, 2012, PSYCHIAT RES, V197, P145, DOI 10.1016/j.psychres.2011.12.026; Davies W, 2006, BRAIN RES, V1126, P36, DOI 10.1016/j.brainres.2006.09.105; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Gasbarri A, 2006, BEHAV BRAIN RES, V168, P177, DOI 10.1016/j.bbr.2005.07.034; Gross J.J., 2007, HDB EMOTION REGULATI, P3; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Han SH, 2008, BRAIN RES, V1196, P85, DOI 10.1016/j.brainres.2007.12.062; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Lang P.J., 2008, A8 U FLOR; Li H, 2008, NEUROIMAGE, V40, P1921, DOI 10.1016/j.neuroimage.2008.01.033; Lithari C, 2012, BIOMED SIGNAL PROCES, V7, P228, DOI 10.1016/j.bspc.2011.05.004; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Mcrae K, 2008, GROUP PROCESS INTERG, V11, P143, DOI 10.1177/1368430207088035; Mennin DS, 2007, BEHAV THER, V38, P284, DOI 10.1016/j.beth.2006.09.001; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Moser JS, 2010, COGN AFFECT BEHAV NE, V10, P195, DOI 10.3758/CABN.10.2.195; Moser JS, 2009, PSYCHOPHYSIOLOGY, V46, P17, DOI 10.1111/j.1469-8986.2008.00721.x; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Palomba D, 1997, INT J PSYCHOPHYSIOL, V27, P55, DOI 10.1016/S0167-8760(97)00751-4; Proverbio AM, 2009, NEUROPSYCHOLOGIA, V47, P2374, DOI 10.1016/j.neuropsychologia.2008.10.030; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Whittle S, 2011, BIOL PSYCHOL, V87, P319, DOI 10.1016/j.biopsycho.2011.05.003; Williams Leanne M., 2008, Journal of Integrative Neuroscience, V7, P367, DOI 10.1142/S0219635208001939; Williams LM, 2005, NEUROIMAGE, V28, P618, DOI 10.1016/j.neuroimage.2005.06.035	36	67	70	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e73475	10.1371/journal.pone.0073475	http://dx.doi.org/10.1371/journal.pone.0073475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24204562	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500003
J	Cao, MF; Zhang, H; Park, J; Daniels, NM; Crovella, ME; Cowen, LJ; Hescott, B				Cao, Mengfei; Zhang, Hao; Park, Jisoo; Daniels, Noah M.; Crovella, Mark E.; Cowen, Lenore J.; Hescott, Benjamin			Going the Distance for Protein Function Prediction: A New Distance Metric for Protein Interaction Networks	PLOS ONE			English	Article							GENE ONTOLOGY; SCALE-FREE; MODULARITY	In protein-protein interaction (PPI) networks, functional similarity is often inferred based on the function of directly interacting proteins, or more generally, some notion of interaction network proximity among proteins in a local neighborhood. Prior methods typically measure proximity as the shortest-path distance in the network, but this has only a limited ability to capture fine-grained neighborhood distinctions, because most proteins are close to each other, and there are many ties in proximity. We introduce diffusion state distance (DSD), a new metric based on a graph diffusion property, designed to capture finer-grained distinctions in proximity for transfer of functional annotation in PPI networks. We present a tool that, when input a PPI network, will output the DSD distances between every pair of proteins. We show that replacing the shortest-path metric by DSD improves the performance of classical function prediction methods across the board.	[Cao, Mengfei; Zhang, Hao; Park, Jisoo; Daniels, Noah M.; Cowen, Lenore J.; Hescott, Benjamin] Tufts Univ, Dept Comp Sci, Medford, MA 02155 USA; [Crovella, Mark E.] Boston Univ, Dept Comp Sci, Boston, MA 02215 USA	Tufts University; Boston University	Cowen, LJ (corresponding author), Tufts Univ, Dept Comp Sci, Medford, MA 02155 USA.	lenore.cowen@tufts.edu; benjamin.hescott@tufts.edu	Cao, Mengfei/V-6685-2018; Crovella, Mark/N-5423-2014; Crovella, Mark/AIB-6289-2022	Cao, Mengfei/0000-0002-1101-338X; Crovella, Mark/0000-0002-5005-7019; Crovella, Mark/0000-0002-5005-7019; Daniels, Noah/0000-0002-9538-825X	National Institutes of Health (NIH) [GM080330, R01 HD058880]; National Science Foundation [CNS-0905565, CNS-1018266, CNS-1012910, CNS-1117039]; Army Research Office [W911NF-11-1-0227]; Division Of Computer and Network Systems [1117039, 0905565] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080330] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Army Research Office; Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MC, HZ, NMD and LJC were supported in part by National Institutes of Health (NIH) R01 grant GM080330. JP was supported in part by NIH grant R01 HD058880. This material is based upon work supported by the National Science Foundation under grant numbers CNS-0905565, CNS-1018266, CNS-1012910, and CNS-1117039, and supported by the Army Research Office under grant W911NF-11-1-0227 (to MEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnau V, 2005, BIOINFORMATICS, V21, P364, DOI 10.1093/bioinformatics/bti021; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Chiang T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r186; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Darnell SJ, 2007, PROTEINS, V68, P813, DOI 10.1002/prot.21474; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; Deng MH, 2004, BIOINFORMATICS, V20, P895, DOI 10.1093/bioinformatics/btg500; Deng Minghua, 2003, Pac Symp Biocomput, P140; Erten S, 2011, J COMPUT BIOL, V18, P1561, DOI 10.1089/cmb.2011.0154; Friedel CC, 2006, NAT BIOTECHNOL, V24, P614, DOI 10.1038/nbt0606-614; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; He XL, 2006, GENETICS, V173, P1885, DOI 10.1534/genetics.106.060269; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Huang H, 2009, BIOINFORMATICS, V25, P372, DOI 10.1093/bioinformatics/btn640; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Khanin R, 2006, J COMPUT BIOL, V13, P810, DOI 10.1089/cmb.2006.13.810; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Song JM, 2009, BIOINFORMATICS, V25, P3143, DOI 10.1093/bioinformatics/btp551; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Wass MN, 2012, NUCLEIC ACIDS RES, V40, pW466, DOI 10.1093/nar/gks489	29	29	32	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76339	10.1371/journal.pone.0076339	http://dx.doi.org/10.1371/journal.pone.0076339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194834	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000013
J	Hu, ZP; Wang, ZW; Wu, HB; Yang, ZM; Jiang, WL; Li, LC; Hu, XP				Hu, Zhipeng; Wang, Zhiwei; Wu, Hongbing; Yang, Zhimin; Jiang, Wanli; Li, Luocheng; Hu, Xiaoping			Ang II Enhances Noradrenaline Release from Sympathetic Nerve Endings Thus Contributing to the Up-Regulation of Metalloprotease-2 in Aortic Dissection Patients' Aorta Wall	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; NOREPINEPHRINE; EXPRESSION; ANEURYSMS; LOSARTAN; PROGRESSION; DILATION; PRESSURE; BLOCKADE; RECEPTOR	Object: To test the hypothesis that angiotensin II (Ang II) could enhance noradrenaline (NA) release from sympathetic nerve endings of the aorta thus contributing to the up-regulation of matrix metalloproteinase 2 (MMP-2) during the formation of aortic dissection (AD). Methods: Ang II, NA, MMP-2, MMP-9 of the aorta sample obtained during operation from aortic dissection patients were detected by High Performance Liquid Chromatography and ELISA and compared with controls. Isotope labelling method was used to test the impact of exogenous Ang II and noradrenaline on the NA release and MMP-2, MMP-9 expression on Sprague Dawley (SD) rat aorta rings in vitro. Two kidneys, one clip, models were replicated for further check of that impact in SD rats in vivo. Results: The concentration of Ang II, MMP-2, 9 was increased and NA concentration was decreased in aorta samples from AD patients. Exogenous Ang II enhanced while exogenous NA restrained NA release from aortic sympathetic endings. The Ang II stimulated NA release and the following MMP-2 up-regulation could be weakened by Losartan and chemical sympathectomy. Beta blocker did not influence NA release but down-regulated MMP-2. Long term in vivo experiments confirmed that Ang II could enhance NA release and up-regulate MMP-2. Conclusions: AD is initiated by MMP-2 overexpression as a result of increased NA release from sympathetic nervous endings in response to Ang II. This indicates an interaction of RAS and SAS during the formation of AD.	[Hu, Zhipeng; Wang, Zhiwei; Wu, Hongbing; Jiang, Wanli; Li, Luocheng; Hu, Xiaoping] Wuhan Univ, Renmin Hosp, Dept Cardiothorac Surg, Wuhan 430072, Hubei Province, Peoples R China; [Hu, Zhipeng; Yang, Zhimin] Xiangyang Cent Hosp, Dept Cardiothorac Surg, Xiangyang, Hubei Province, Peoples R China	Wuhan University	Wang, ZW (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiothorac Surg, Wuhan 430072, Hubei Province, Peoples R China.	wangzhiwp@gmail.com		Hu, Zhipeng/0000-0002-6384-0037				Bealer SL, 2000, BRAIN RES, V864, P291, DOI 10.1016/S0006-8993(00)02197-1; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Cabassi A, 2005, J CLIN ENDOCR METAB, V90, P2888, DOI 10.1210/jc.2004-1995; Cassis LA, 2009, AM J PHYSIOL-HEART C, V296, pH1660, DOI 10.1152/ajpheart.00028.2009; Dab H, 2012, J RENIN-ANGIO-ALDO S, V13, P36, DOI 10.1177/1470320311428344; Dab H, 2011, GEN PHYSIOL BIOPHYS, V30, P271, DOI 10.4149/gpb_2011_03_271; Dab H, 2009, AUTON NEUROSCI-BASIC, V150, P27, DOI 10.1016/j.autneu.2009.04.002; DiBona GF, 2000, HYPERTENSION, V36, P1083, DOI 10.1161/01.HYP.36.6.1083; ELLIS JL, 1989, BRIT J PHARMACOL, V97, P1157, DOI 10.1111/j.1476-5381.1989.tb12574.x; Fabiani ME, 2001, J ENDOCRINOL, V171, P97, DOI 10.1677/joe.0.1710097; Falkay G, 2007, NEUROCHEM INT, V51, P306, DOI 10.1016/j.neuint.2007.06.012; Faugeroux J, 2013, HYPERTENSION; Forteza A, 2011, REV ESP CARDIOL, V64, P492, DOI [10.1016/j.rec.2011.02.013, 10.1016/j.recesp.2011.02.009]; Gersony DR, 2007, INT J CARDIOL, V114, P303, DOI 10.1016/j.ijcard.2005.11.116; Gironacci MM, 2004, REGUL PEPTIDES, V118, P45, DOI 10.1016/j.regpep.2003.10.026; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Head GA, 2004, HYPERTENSION, V43, P636, DOI 10.1161/01.HYP.0000116301.02975.aa; HEATH JW, 1977, J NEUROCYTOL, V6, P397, DOI 10.1007/BF01178225; Ikonomidis JS, 2006, CIRCULATION, V114, pI365, DOI 10.1161/CIRCULATIONAHA.105.000810; Koullias GJ, 2004, ANN THORAC SURG, V78, P2106, DOI 10.1016/j.athoracsur.2004.05.088; Kurihara T, 2012, CIRCULATION, V126, P3070, DOI 10.1161/CIRCULATIONAHA.112.097097; LIU FY, 1988, J CLIN INVEST, V82, P601, DOI 10.1172/JCI113638; Lu H, 2012, CLIN SCI, V123, P531, DOI 10.1042/CS20120097; Moller MN, 2010, LARYNGOSCOPE, V120, P657, DOI 10.1002/lary.20834; Rathore H. A., 2009, Autonomic & Autacoid Pharmacology, V29, P171, DOI 10.1111/j.1474-8665.2009.00445.x; Rodrigues DR, 2010, PLOS ONE, V5; Salman IM, 2010, INDIAN J MED RES, V131, P786; Scholze P, 2007, BRIT J PHARMACOL, V151, P414, DOI 10.1038/sj.bjp.0707236; Schulte K, 2011, PHARMACOL REP, V63, P102, DOI 10.1016/S1734-1140(11)70404-2; Segura AM, 1998, CIRCULATION, V98, pII331; Shen YH, 2013, CIRC RES, V112, P618, DOI 10.1161/CIRCRESAHA.112.300735; SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902; Tavares P, 2003, PHARMACOL RES, V47, P27, DOI 10.1016/S1043-6618(02)00257-8; Teisman ACH, 2000, J AUTONOM NERV SYST, V78, P117, DOI 10.1016/S0165-1838(99)00066-1; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Trivedi DB, 2013, CIRC RES, V112, P1219, DOI 10.1161/CIRCRESAHA.112.280399; Tulppo MP, 2005, AM J PHYSIOL-HEART C, V288, pH710, DOI 10.1152/ajpheart.00540.2004; Uresin Y, 2004, J RENIN-ANGIO-ALDO S, V5, P93, DOI 10.3317/jraas.2004.017; von Kodolitsch Y, 2003, CIRCULATION, V107, P1158, DOI 10.1161/01.CIR.0000052628.77047.EA; Yang EV, 2006, CANCER RES, V66, P10357, DOI 10.1158/0008-5472.CAN-06-2496; Yokoyama U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036724	41	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76922	10.1371/journal.pone.0076922	http://dx.doi.org/10.1371/journal.pone.0076922			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194850	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000029
J	Mason, MR; Nagaraja, HN; Camerlengo, T; Joshi, V; Kumar, PS				Mason, Matthew R.; Nagaraja, Haikady N.; Camerlengo, Terry; Joshi, Vinayak; Kumar, Purnima S.			Deep Sequencing Identifies Ethnicity-Specific Bacterial Signatures in the Oral Microbiome	PLOS ONE			English	Article							PERIODONTITIS; POLYMORPHISMS; PREVALENCE; HEAD	Oral infections have a strong ethnic predilection; suggesting that ethnicity is a critical determinant of oral microbial colonization. Dental plaque and saliva samples from 192 subjects belonging to four major ethnicities in the United States were analyzed using terminal restriction fragment length polymorphism (t-RFLP) and 16S pyrosequencing. Ethnicity-specific clustering of microbial communities was apparent in saliva and subgingival biofilms, and a machine-learning classifier was capable of identifying an individual's ethnicity from subgingival microbial signatures. The classifier identified African Americans with a 100% sensitivity and 74% specificity and Caucasians with a 50% sensitivity and 91% specificity. The data demonstrates a significant association between ethnic affiliation and the composition of the oral microbiome; to the extent that these microbial signatures appear to be capable of discriminating between ethnicities.	[Mason, Matthew R.] Ohio State Univ, Coll Dent, Div Oral Biol, Columbus, OH 43210 USA; [Nagaraja, Haikady N.] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA; [Camerlengo, Terry] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Joshi, Vinayak] Maratha Mandals NGH Inst Dent Sci & Res Ctr, Dept Periodont, Belgaum, India; [Kumar, Purnima S.] Ohio State Univ, Coll Dent, Div Periodontol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kumar, PS (corresponding author), Ohio State Univ, Coll Dent, Div Periodontol, Columbus, OH 43210 USA.	kumar.83@osu.edu	Kumar, Purnima/S-6312-2019; Joshi, Vinayak/AAP-1723-2020; Joshi, Vinayak M/C-8472-2015; Kumar, Purnima/F-6363-2013	Kumar, Purnima/0000-0001-5844-1341; Joshi, Vinayak/0000-0001-6215-4636; Joshi, Vinayak M/0000-0001-6215-4636; Kumar, Purnima/0000-0001-5844-1341	Ohio State University College of Dentistry CTOC [T32 DE 0143220, 1R01 DE022579-01]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022579] Funding Source: NIH RePORTER	Ohio State University College of Dentistry CTOC; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by The Ohio State University College of Dentistry CTOC T32 DE 0143220 training grant and 1R01 DE022579-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar JM, 2002, PERIODONTOL 2000, V29, P31, DOI 10.1034/j.1600-0757.2002.290103.x; Borrell LN, 2005, J DENT RES, V84, P924, DOI 10.1177/154405910508401010; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Cruz GD, 2009, AM J PUBLIC HEALTH, V99, pS474, DOI 10.2105/AJPH.2008.149799; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P401, DOI 10.1016/S0304-4165(02)00321-5; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; LAVELLE CLB, 1970, ARCH ORAL BIOL, V15, P1101, DOI 10.1016/0003-9969(70)90123-8; LAVELLE CLB, 1971, J DENT RES, V50, P1353, DOI 10.1177/00220345710500054501; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LEVINE MM, 1979, ANN HUM BIOL, V6, P369, DOI 10.1080/03014467900003751; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; McClellan DL, 1996, J CLIN MICROBIOL, V34, P2017, DOI 10.1128/JCM.34.8.2017-2019.1996; Miller MA, 2007, CURR MED CHEM, V14, P1409, DOI 10.2174/092986707780831131; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Nguyen DP, 2004, OBSTET GYNECOL, V104, P293, DOI 10.1097/01.AOG.0000133486.85400.5e; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rees GN, 2004, ANTON LEEUW INT J G, V86, P339, DOI 10.1007/s10482-004-0498-x; Salnikova LE, 2012, GENE; Shannon CE, 1997, M D COMPUT, V14, P306; Shchipkova AY, 2010, J DENT RES; Tateda M, 2000, INT J MOL MED, V6, P699; Tezal M, 2009, CANCER EPIDEM BIOMAR, V18, P2406, DOI 10.1158/1055-9965.EPI-09-0334; TURESKY S, 1970, J PERIODONTOL, V41, P41, DOI 10.1902/jop.1970.41.1.41; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	28	121	125	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77287	10.1371/journal.pone.0077287	http://dx.doi.org/10.1371/journal.pone.0077287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194878	Green Submitted, gold, Green Published			2022-12-27	WOS:000326037000057
J	Shahar, OD; Gabizon, R; Feine, O; Alhadeff, R; Ganoth, A; Argaman, L; Shimshoni, E; Friedler, A; Goldberg, M				Shahar, Or David; Gabizon, Ronen; Feine, Oren; Alhadeff, Raphael; Ganoth, Assaf; Argaman, Liron; Shimshoni, Elee; Friedler, Assaf; Goldberg, Michal			Acetylation of Lysine 382 and Phosphorylation of Serine 392 in p53 Modulate the Interaction between p53 and MDC1 In Vitro	PLOS ONE			English	Article							DNA-BINDING FUNCTION; TERMINAL DOMAIN; DAMAGE RESPONSE; C-TERMINUS; PROTEIN; ACTIVATION; COMPLEX; RAD51; REPAIR; 53BP1	Occurrence of DNA damage in a cell activates the DNA damage response, a survival mechanism that ensures genomics stability. Two key members of the DNA damage response are the tumor suppressor p53, which is the most frequently mutated gene in cancers, and MDC1, which is a central adaptor that recruits many proteins to sites of DNA damage. Here we characterize the in vitro interaction between p53 and MDC1 and demonstrate that p53 and MDC1 directly interact. The p53-MDC1 interaction is mediated by the tandem BRCT domain of MDC1 and the C-terminal domain of p53. We further show that both acetylation of lysine 382 and phosphorylation of serine 392 in p53 enhance the interaction between p53 and MDC1. Additionally, we demonstrate that the p53-MDC1 interaction is augmented upon the induction of DNA damage in human cells. Our data suggests a new role for acetylation of lysine 382 and phosphorylation of serine 392 in p53 in the cellular stress response and offers the first evidence for an interaction involving MDC1 that is modulated by acetylation.	[Shahar, Or David; Feine, Oren; Argaman, Liron; Shimshoni, Elee; Goldberg, Michal] Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel; [Gabizon, Ronen; Friedler, Assaf] Hebrew Univ Jerusalem, Dept Organ Chem, Jerusalem, Israel; [Alhadeff, Raphael] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Ganoth, Assaf] Interdisciplinary Ctr IDC, Herzliyya, Israel; [Ganoth, Assaf] Univ Haifa, Dept Biol & Environm, Fac Nat Sci, Tivon, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Reichman University; University of Haifa	Goldberg, M (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	goldbergm@mail.huji.ac.il	Shahar, Or/ABG-9168-2020	Goldberg, Michal/0000-0001-9397-2383; Shahar, Or/0000-0002-5039-8307; Gabizon, Ronen/0000-0002-3626-5073	Lejwa foundation; Rudin Fellowship Trust; European Research Council under the European Community [203413]; Israel Academy of Sciences and Humanities	Lejwa foundation; Rudin Fellowship Trust; European Research Council under the European Community(European Research Council (ERC)); Israel Academy of Sciences and Humanities	MG was supported by the Lejwa foundation. RA is supported by the Rudin Fellowship Trust and AF. is supported by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no 203413. RG is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Ahn J, 2001, NAT STRUCT BIOL, V8, P730, DOI 10.1038/nsb0901-730; Allen WJ, 2010, J PHYS CHEM B, V114, P13201, DOI 10.1021/jp1011445; Anderson ME, 1997, MOL CELL BIOL, V17, P6255, DOI 10.1128/MCB.17.11.6255; Arias-Lopez C, 2006, EMBO REP, V7, P219, DOI 10.1038/sj.embor.7400587; BAYLE JH, 1995, P NATL ACAD SCI USA, V92, P5729, DOI 10.1073/pnas.92.12.5729; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Beneke Sascha, 2012, Frontiers in Genetics, V3, P169, DOI 10.3389/fgene.2012.00169; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berger M, 2001, J BIOL CHEM, V276, P3785, DOI 10.1074/jbc.M008879200; Bradbury JM, 2003, BIOCHEM SOC T, V31, P40, DOI 10.1042/bst0310040; Canman CE, 2003, CURR BIOL, V13, pR488, DOI 10.1016/S0960-9822(03)00410-X; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Coster G, 2010, NUCLEUS-PHILA, V1, P166, DOI 10.4161/nucl.1.2.11176; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Eliezer Y, 2009, J BIOL CHEM, V284, P426, DOI 10.1074/jbc.M807375200; Friedler A, 2005, J BIOL CHEM, V280, P8051, DOI 10.1074/jbc.M411176200; Gabizon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038060; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HORIKOSHI N, 1995, MOL CELL BIOL, V15, P227, DOI 10.1128/MCB.15.1.227; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; HUPP TR, 1994, CURR BIOL, V4, P865, DOI 10.1016/S0960-9822(00)00195-0; HUPP TR, 1993, NUCLEIC ACIDS RES, V21, P3167, DOI 10.1093/nar/21.14.3167; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Jenkins LMM, 2012, CARCINOGENESIS, V33, P1441, DOI 10.1093/carcin/bgs145; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Jungmichel S, 2010, CHROMOSOMA, V119, P337, DOI 10.1007/s00412-010-0266-9; Kapoor M, 1998, P NATL ACAD SCI USA, V95, P2834, DOI 10.1073/pnas.95.6.2834; Lazaro-Trueba I, 2006, CELL CYCLE, V5, P1062, DOI 10.4161/cc.5.10.2764; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Linke SP, 2003, CANCER RES, V63, P2596; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2004, J BIOL CHEM, V279, P46359, DOI 10.1074/jbc.C400375200; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Nakanishi M, 2007, J BIOL CHEM, V282, P22993, DOI 10.1074/jbc.M611412200; OLINER JD, 1993, BIOESSAYS, V15, P703, DOI 10.1002/bies.950151102; Ozaki T, 2000, DNA CELL BIOL, V19, P475, DOI 10.1089/10445490050128403; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Romanova LY, 2004, ONCOGENE, V23, P9025, DOI 10.1038/sj.onc.1207982; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Sakaguchi K, 1997, J PROTEIN CHEM, V16, P553, DOI 10.1023/A:1026334116189; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Santos-Rosa H, 2005, EUR J CANCER, V41, P2381, DOI 10.1016/j.ejca.2005.08.010; Siu SWI, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2897760; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; STURZBECHER HW, 1992, ONCOGENE, V7, P1513; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; van den Bosch M, 2003, EMBO REP, V4, P844, DOI 10.1038/sj.embor.embor925; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verma S, 2013, J BIOCHEM, V154, P237, DOI 10.1093/jb/mvt040; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Weber PJA, 1998, BIOORG MED CHEM LETT, V8, P597, DOI 10.1016/S0960-894X(98)00084-5; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xu XZ, 2003, FASEB J, V17, P1842, DOI 10.1096/fj.03-0310com; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991	83	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78472	10.1371/journal.pone.0078472	http://dx.doi.org/10.1371/journal.pone.0078472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194938	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000117
J	Fomin, ME; Zhou, YC; Beyer, AI; Publicover, J; Baron, JL; Muench, MO				Fomin, Marina E.; Zhou, Yanchen; Beyer, Ashley I.; Publicover, Jean; Baron, Jody L.; Muench, Marcus O.			Production of Factor VIII by Human Liver Sinusoidal Endothelial Cells Transplanted in Immunodeficient uPA Mice	PLOS ONE			English	Article							HEMOPHILIA-A MICE; RAT-LIVER; EXPRESSION; VEGF; UROKINASE; CIRRHOSIS; ANGIOGENESIS; TOLERANCE; PHENOTYPE; THERAPY	Liver sinusoidal endothelial cells (LSECs) form a semi-permeable barrier between parenchymal hepatocytes and the blood. LSECs participate in liver metabolism, clearance of pathological agents, immunological responses, architectural maintenance of the liver and synthesis of growth factors and cytokines. LSECs also play an important role in coagulation through the synthesis of Factor VIII (FVIII). Herein, we phenotypically define human LSECs isolated from fetal liver using flow cytometry and immunofluorescence microscopy. Isolated LSECs were cultured and shown to express endothelial markers and markers specific for the LSEC lineage. LSECs were also shown to engraft the liver when human fetal liver cells were transplanted into immunodeficient mice with liver specific expression of the urokinase-type plasminogen activator (uPA) transgene (uPA-NOG mice). Engrafted cells expressed human Factor VIII at levels approaching those found in human plasma. We also demonstrate engraftment of adult LSECs, as well as hepatocytes, transplanted into uPA-NOG mice. We propose that overexpression of uPA provides beneficial conditions for LSEC engraftment due to elevated expression of the angiogenic cytokine, vascular endothelial growth factor. This work provides a detailed characterization of human midgestation LSECs, thereby providing the means for their purification and culture based on their expression of CD14 and CD32 as well as a lack of CD45 expression. The uPA-NOG mouse is shown to be a permissive host for human LSECs and adult hepatocytes, but not fetal hepatoblasts. Thus, these mice provide a useful model system to study these cell types in vivo. Demonstration of human FVIII production by transplanted LSECs encourages further pursuit of LSEC transplantation as a cellular therapy for the treatment of hemophilia A.	[Fomin, Marina E.; Zhou, Yanchen; Beyer, Ashley I.; Muench, Marcus O.] Blood Syst Res Inst, San Francisco, CA USA; [Fomin, Marina E.; Zhou, Yanchen; Muench, Marcus O.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Publicover, Jean; Baron, Jody L.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Publicover, Jean; Baron, Jody L.; Muench, Marcus O.] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA	Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Muench, MO (corresponding author), Blood Syst Res Inst, San Francisco, CA USA.	mmuench@bloodsystems.org	Muench, Marcus O./C-5025-2009	Muench, Marcus O./0000-0001-8946-6605	Blood Systems Inc.; Novartis Vaccines and Diagnostics, Inc; National Institutes of Health from National Institute of Diabetes and Digestive and Kidney Diseases [P01DK088760, P30DK026743]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK088760, P30DK026743] Funding Source: NIH RePORTER	Blood Systems Inc.; Novartis Vaccines and Diagnostics, Inc; National Institutes of Health from National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Blood Systems Inc.; Novartis Vaccines and Diagnostics, Inc; and the National Institutes of Health: grant numbers P01DK088760 and P30DK026743 from the National Institute of Diabetes and Digestive and Kidney Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RA, 2012, CARDIOVASC RES, V94, P125, DOI 10.1093/cvr/cvs017; Banshodani M, 2012, CELL TRANSPLANT; Benten D, 2005, HEPATOLOGY, V42, P140, DOI 10.1002/hep.20746; Bezerra JA, 2001, AM J PATHOL, V158, P921, DOI 10.1016/S0002-9440(10)64039-4; Bueno M, 2006, J GENE MED, V8, P1291, DOI 10.1002/jgm.961; Carpenter B, 2005, DEVELOPMENT, V132, P3293, DOI 10.1242/dev.01902; Cheluvappa R, 2010, INT J INFECT DIS, V14, pE857, DOI 10.1016/j.ijid.2010.02.2263; COUVELARD A, 1993, AM J PATHOL, V143, P738; Couvelard A, 1996, BLOOD, V87, P4568, DOI 10.1182/blood.V87.11.4568.bloodjournal87114568; Diehl L, 2008, HEPATOLOGY, V47, P296, DOI 10.1002/hep.21965; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Do H, 1999, J BIOL CHEM, V274, P19587, DOI 10.1074/jbc.274.28.19587; Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007; Follenzi A, 2008, J CLIN INVEST, V118, P935, DOI 10.1172/JCI32748; Fomin ME, 2011, STEM CELLS DEV, V20, P1247, DOI 10.1089/scd.2010.0218; Gong JP, 2002, WORLD J GASTROENTERO, V8, P551, DOI 10.3748/wjg.v8.i3.551; Gouw SC, 2013, NEW ENGL J MED, V368, P231, DOI 10.1056/NEJMoa1208024; Haridass D, 2009, AM J PATHOL, V175, P1483, DOI 10.2353/ajpath.2009.090117; Khan AA, 2010, CELL TRANSPLANT, V19, P409, DOI 10.3727/096368910X498241; Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x; Krause P, 2010, WORLD J GASTROENTERO, V16, P3928, DOI 10.3748/wjg.v16.i31.3928; Kumaran V, 2005, J THROMB HAEMOST, V3, P2022, DOI 10.1111/j.1538-7836.2005.01508.x; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Malhi H, 2002, HEPATOLOGY, V36, P112, DOI 10.1053/jhep.2002.33896; Mannucci PM, 2012, BLOOD, V119, P4108, DOI 10.1182/blood-2012-01-394411; Mohammed FF, 2005, TRENDS CELL BIOL, V15, P555, DOI 10.1016/j.tcb.2005.08.009; Muench MO, 2005, BONE MARROW TRANSPL, V35, P537, DOI 10.1038/sj.bmt.1704811; Nowak G, 2005, GUT, V54, P972, DOI 10.1136/gut.2005.064477; Onoe T, 2005, J IMMUNOL, V175, P139, DOI 10.4049/jimmunol.175.1.139; Plouet J, 1997, J BIOL CHEM, V272, P13390, DOI 10.1074/jbc.272.20.13390; Roth D, 2006, AM J PATHOL, V168, P670, DOI 10.2353/ajpath.2006.050372; Schildberg FA, 2008, EUR J IMMUNOL, V38, P957, DOI 10.1002/eji.200738060; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; SCOAZEC JY, 1991, HEPATOLOGY, V14, P789, DOI 10.1002/hep.1840140508; SCOAZEC JY, 1994, LIVER, V14, P113; Suemizu H, 2008, BIOCHEM BIOPH RES CO, V377, P248, DOI 10.1016/j.bbrc.2008.09.124; Uhrig A, 2005, J LEUKOCYTE BIOL, V77, P626, DOI 10.1189/jlb.0604332; Varga N. L., 2010, STEM CELL STUD, V1, pe5, DOI DOI 10.4081/SCS.2010.E5; von Oppen N, 2009, HEPATOLOGY, V49, P1664, DOI 10.1002/hep.22795; Wang L, 2012, GASTROENTEROLOGY, V143, P1555, DOI 10.1053/j.gastro.2012.08.008; Xu B, 2003, AM J PATHOL, V163, P1275, DOI 10.1016/S0002-9440(10)63487-6	42	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77255	10.1371/journal.pone.0077255	http://dx.doi.org/10.1371/journal.pone.0077255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167566	gold, Green Published, Green Submitted			2022-12-27	WOS:000326034500025
J	Jha, BA; Archer, SK; Clayton, CE				Jha, Bhaskar Anand; Archer, Stuart K.; Clayton, Christine E.			The Trypanosome Pumilio Domain Protein PUF5	PLOS ONE			English	Article							RNA-BINDING PROTEINS; MESSENGER-RNA; GENE-EXPRESSION; POSTTRANSCRIPTIONAL CONTROL; ELEGANS GERMLINE; BRUCEI; YEAST; FAMILY; LOCALIZATION; SPECIFICITY	PUF proteins are a conserved family of RNA binding proteins found in all eukaryotes examined so far. This study focussed on PUF5, one of 11 PUF family members encoded in the Trypanosoma brucei genome. Native PUF5 is present at less than 50000 molecules per cell in both bloodstream and procyclic form trypanosomes. C-terminally myc-tagged PUF5 was mainly found in the cytoplasm and could be cross-linked to RNA. PUF5 knockdown by RNA interference had no effect on the growth of bloodstream forms. Procyclic forms lacking PUF5 grew normally, but expression of PUF5 bearing a 21 kDa tandem affinity purification tag inhibited growth. Knockdown of PUF5 did not have any effect on the ability of trypanosomes to differentiate from the mammalian to the insect form of the parasite.	[Jha, Bhaskar Anand; Archer, Stuart K.; Clayton, Christine E.] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Allianz, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Clayton, CE (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Allianz, Heidelberg, Germany.	cclayton@zmbh.uni-heidelberg.de	Clayton, Christine/K-7700-2019	Clayton, Christine/0000-0002-6384-0731; Archer, Stuart/0000-0003-0450-1243	Deutsche Forschungsgemeinshaft (DFG) [Cl112/14-1]	Deutsche Forschungsgemeinshaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinshaft (DFG), mainly by Cl112/14-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Archer SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000565; Benz C, 2011, MOL BIOCHEM PARASIT, V177, P148, DOI 10.1016/j.molbiopara.2011.02.007; Bernstein D, 2005, RNA, V11, P447, DOI 10.1261/rna.7255805; Campbell ZT, 2012, J BIOL CHEM, V287, P18854, DOI 10.1074/jbc.M112.352815; Caro F, 2006, EXP PARASITOL, V113, P112, DOI 10.1016/j.exppara.2005.12.015; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Chritton JJ, 2011, J BIOL CHEM, V286, P33268, DOI 10.1074/jbc.M111.264572; Clayton C., 2012, NUCL ACIDS MOL BIOL, V28, P79; Clayton CE, 2005, METH MOL B, V309, P39; Colasante C, 2006, EUKARYOT CELL, V5, P1194, DOI 10.1128/EC.00096-06; Cristodero M, 2007, NUCLEIC ACIDS RES, V35, P7023, DOI 10.1093/nar/gkm736; Dallagiovanna B, 2008, J BIOL CHEM, V283, P8266, DOI 10.1074/jbc.M703097200; Droll D, 2010, FEBS LETT, V584, P1156, DOI 10.1016/j.febslet.2010.02.018; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; Fernandez-Moya SM, 2010, WIRES RNA, V1, P34, DOI 10.1002/wrna.6; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Haanstra JR, 2008, J BIOL CHEM, V283, P2495, DOI 10.1074/jbc.M705782200; Hafner M, 2010, J VIS EXP; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hartmann C, 2008, MOL BIOCHEM PARASIT, V157, P112, DOI 10.1016/j.molbiopara.2007.09.009; Hartmann C, 2007, EUKARYOT CELL, V6, P1964, DOI 10.1128/EC.00279-07; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Kolev NG, 2012, SCIENCE, V338, P1352, DOI 10.1126/science.1229641; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; Lamont LB, 2004, DEV CELL, V7, P697, DOI 10.1016/j.devcel.2004.09.013; Lu G, 2011, STRUCTURE, V19, P361, DOI 10.1016/j.str.2010.12.019; Luu VD, 2006, MOL BIOCHEM PARASIT, V150, P340, DOI 10.1016/j.molbiopara.2006.09.007; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Miller MA, 2011, WIRES RNA, V2, P471, DOI 10.1002/wrna.69; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Qiu C, 2012, J BIOL CHEM, V287, P6949, DOI 10.1074/jbc.M111.326264; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Sambrook J., 2002, MOL CLONING LAB MANU; Schumann Burkard G, 2013, MOL MICROBIOL; Steverding D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-3; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Thomson E, 2007, RNA, V13, P2165, DOI 10.1261/rna.747607; Ulbricht RJ, 2008, RNA, V14, P246, DOI 10.1261/rna.847408; Van Etten J, 2012, J BIOL CHEM, V287, P36370, DOI 10.1074/jbc.M112.373522; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wurst M, 2012, MOL MICROBIOL, V83, P1048, DOI 10.1111/j.1365-2958.2012.07988.x; Zamore PD, 1997, RNA, V3, P1421; Zhu DY, 2009, P NATL ACAD SCI USA, V106, P20192, DOI 10.1073/pnas.0812079106; Zipor G, 2009, P NATL ACAD SCI USA, V106, P19848, DOI 10.1073/pnas.0910754106	51	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77371	10.1371/journal.pone.0077371	http://dx.doi.org/10.1371/journal.pone.0077371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167571	Green Submitted, Green Published, gold			2022-12-27	WOS:000326034500030
J	Rabineau, M; Kocgozlu, L; Dujardin, D; Senger, B; Haikel, Y; Voegel, JC; Freund, JN; Schaaf, P; Lavalle, P; Vautier, D				Rabineau, Morgane; Kocgozlu, Leyla; Dujardin, Denis; Senger, Bernard; Haikel, Youssef; Voegel, Jean-Claude; Freund, Jean-Noel; Schaaf, Pierre; Lavalle, Philippe; Vautier, Dominique			Contribution of Soft Substrates to Malignancy and Tumor Suppression during Colon Cancer Cell Division	PLOS ONE			English	Article							CHROMOSOME SEGREGATION; ELASTICITY; GROWTH	In colon cancer, a highly aggressive disease, progression through the malignant sequence is accompanied by increasingly numerous chromosomal rearrangements. To colonize target organs, invasive cells cross several tissues of various elastic moduli. Whether soft tissue increases malignancy or in contrast limits invasive colon cell spreading remains an open question. Using polyelectrolyte multilayer films mimicking microenvironments of various elastic moduli, we revealed that human SW480 colon cancer cells displayed increasing frequency in chromosomal segregation abnormalities when cultured on substrates with decreasing stiffness. Our results show that, although decreasing stiffness correlates with increased cell lethality, a significant proportion of SW480 cancer cells did escape from the very soft substrates, even when bearing abnormal chromosome segregation, achieve mitosis and undergo a new cycle of replication in contrast to human colonic HCoEpiC cells which died on soft substrates. This observation opens the possibility that the ability of cancer cells to overcome defects in chromosome segregation on very soft substrates could contribute to increasing chromosomal rearrangements and tumor cell aggressiveness.	[Rabineau, Morgane; Kocgozlu, Leyla; Senger, Bernard; Haikel, Youssef; Voegel, Jean-Claude; Schaaf, Pierre; Lavalle, Philippe; Vautier, Dominique] INSERM, UMR 1121, Strasbourg, France; [Rabineau, Morgane; Kocgozlu, Leyla; Senger, Bernard; Haikel, Youssef; Voegel, Jean-Claude; Schaaf, Pierre; Lavalle, Philippe; Vautier, Dominique] Univ Strasbourg, Fac Chirurg Dentaire, Strasbourg, France; [Dujardin, Denis] CNRS, UMR 7213, Illkirch Graffenstaden, France; [Schaaf, Pierre] Inst Charles Sadron, CNRS, UPR 22, F-67083 Strasbourg, France; [Freund, Jean-Noel] Univ Strasbourg, INSERM, UMR S1113, Strasbourg, France; [Freund, Jean-Noel] Univ Strasbourg, Fac Med, Strasbourg, France; [Rabineau, Morgane; Senger, Bernard; Haikel, Youssef; Voegel, Jean-Claude; Freund, Jean-Noel; Schaaf, Pierre; Lavalle, Philippe; Vautier, Dominique] Federat Med Translat, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Vautier, D (corresponding author), INSERM, UMR 1121, Strasbourg, France.	vautier@unistra.fr	Lavalle, Philippe/E-6328-2016; Dujardin, Denis/GYA-0463-2022; Freund, Jean-Noel/R-4383-2016; SCHAAF, Pierre/J-2751-2016	Lavalle, Philippe/0000-0001-8798-912X; Freund, Jean-Noel/0000-0002-0971-3774; SCHAAF, Pierre/0000-0001-7423-5492; Dujardin, Denis/0000-0001-6372-5293; Rabineau, Morgane/0000-0001-7325-7518	Alsace Contre le Cancer; Faculte de Chirurgie Dentaire of Strasbourg	Alsace Contre le Cancer; Faculte de Chirurgie Dentaire of Strasbourg	The study was supported by a grant from Alsace Contre le Cancer. M. R. is indebted to the Faculte de Chirurgie Dentaire of Strasbourg for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellis J, 2012, J CELL BIOL, V198, P331, DOI 10.1083/jcb.201204086; Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Francius G, 2007, J PHYS CHEM C, V111, P8299, DOI 10.1021/jp070435+; Gisselsson D, 2008, CHROMOSOMA, V117, P511, DOI 10.1007/s00412-008-0169-1; Indra I, 2011, J CELL BIOCHEM, V112, P3151, DOI 10.1002/jcb.23241; Kocgozlu L, 2012, BIOMATERIALS, V33, P798, DOI 10.1016/j.biomaterials.2011.10.024; Kocgozlu L, 2010, J CELL SCI, V123, P29, DOI 10.1242/jcs.053520; Lavalle P, 2011, ADV MATER, V23, P1191, DOI 10.1002/adma.201003309; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liu J, 2012, NAT MATER, V11, P734, DOI [10.1038/nmat3361, 10.1038/NMAT3361]; Malanchi I, 2011, NATURE, V7, P85; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Reverte CG, 2006, J CELL BIOL, V174, P491, DOI 10.1083/jcb.200603069; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Tang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050443; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Tilghman RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037231; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zelikin AN, 2010, ACS NANO, V4, P2494, DOI 10.1021/nn100634r; Zhai L, 2008, ULTRASONIC IMAGING, V30, P95, DOI 10.1177/016173460803000203; Zhang JY, 2009, MOL BIOL CELL, V20, P2381, DOI 10.1091/mbc.E08-12-1206	29	2	2	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78468	10.1371/journal.pone.0078468	http://dx.doi.org/10.1371/journal.pone.0078468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167628	Green Published, gold, Green Submitted			2022-12-27	WOS:000326034500089
J	Refos, JM; Vonk, AG; Eadie, K; Lo-Ten-Foe, JR; Verbrugh, HA; van Diepeningen, AD; van de Sande, WWJ				Refos, Jeannine M.; Vonk, Alieke G.; Eadie, Kimberly; Lo-Ten-Foe, Jerome R.; Verbrugh, Henri A.; van Diepeningen, Anne D.; van de Sande, Wendy W. J.			Double-Stranded RNA Mycovirus Infection of Aspergillus fumigatus Is Not Dependent on the Genetic Make-Up of the Host	PLOS ONE			English	Article							DSRNA MYCOVIRUSES; RAPID ISOLATION; VIRUS; VIRULENCE	Aspergillus fumigatus is a fungus that causes opportunistic infections in immunocompromised patients, with high morbidity and mortality. In its turn, A. fumigatus can become infected with mycoviruses. Most mycoviruses have a dsRNA genome and can cause fungal hypovirulence. For that reason, mycoviruses could theoretically be used as therapeutic tools to combat fungal infections. We determined if a certain genetic make-up of A. fumigatus was associated with the presence of mycoviruses in 86 clinical A. fumigatus isolates. Mycovirus screening was performed by isolating dsRNA from mycelial cultures using a Trizol/Chloroform method. The genetic relatedness of dsRNA infected A. fumigatus was determined by cell surface protein (CSP) typing and determination of the mating type. Sixteen (18.6%) of the 86 clinical A. fumigatus isolates contained dsRNA. The A. fumigatus collection could be divided into 11 different CSP types. DsRNA infected A. fumigatus isolates had similar CSP types as non-infected isolates. In both cases, the CSP types t01, t02, t03 and t04 were the most prevalent and the distribution comparable to the CSP types observed in other Dutch collections. Mating types MAT1-1 and MAT1-2 were evenly distributed among all A. fumigatus strains, regardless of CSP type. No difference was observed in mycovirus infections between MAT1-1 and MAT1-2 isolates. DsRNA mycovirus infections in A. fumigatus are not related to either CSP or mating type and therefore represent an interesting future therapeutic tool to combat fungal infections.	[Refos, Jeannine M.; Vonk, Alieke G.; Eadie, Kimberly; Verbrugh, Henri A.; van de Sande, Wendy W. J.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Lo-Ten-Foe, Jerome R.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [van Diepeningen, Anne D.] Fungal Biodivers Ctr, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Groningen; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Refos, JM (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	j.refos@erasmusmc.nl	van de Sande, Wendy/AAS-4545-2021	van de Sande, Wendy/0000-0002-8652-8783				Bain JM, 2007, J CLIN MICROBIOL, V45, P1469, DOI 10.1128/JCM.00064-07; Balajee SA, 2007, EUKARYOT CELL, V6, P1392, DOI 10.1128/EC.00164-07; Bhatti MF, 2012, MYCOPATHOLOGIA, V174, P323, DOI 10.1007/s11046-012-9556-5; Bhatti MF, 2011, FUNGAL GENET BIOL, V48, P1071, DOI 10.1016/j.fgb.2011.07.008; Camps SMT, 2012, J CLIN MICROBIOL, V50, P2674, DOI 10.1128/JCM.00335-12; Castillo A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-38; Coenen A, 1997, GENETICAL RES CAMBRI, V67; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; de Felipe P, 2003, J BIOL CHEM, V278, P11441, DOI 10.1074/jbc.M211644200; Delhaes L, 2010, MED MYCOL, V48, pS77, DOI 10.3109/13693786.2010.514301; Delye C, 1998, J VIROL METHODS, V74, P149, DOI 10.1016/S0166-0934(98)00079-2; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Ghabrial SA, 2009, ANNU REV PHYTOPATHOL, V47, P353, DOI 10.1146/annurev-phyto-080508-081932; Hammond TM, 2008, EUKARYOT CELL, V7, P350, DOI 10.1128/EC.00356-07; Hurst SF, 2009, J CLIN MICROBIOL, V47, P1562, DOI 10.1128/JCM.00124-09; Jamal A, 2010, VIRUS RES, V153, P64, DOI 10.1016/j.virusres.2010.07.008; Kim JW, 2006, VIRUS RES, V120, P212, DOI 10.1016/j.virusres.2006.04.004; Klaassen CHW, 2009, J MICROBIOL METH, V77, P292, DOI 10.1016/j.mimet.2009.03.004; Knutsen AP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/843763; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Liu WX, 2008, VIRUS GENES, V37, P322, DOI 10.1007/s11262-008-0265-6; Mahdavinia M, 2012, THER ADV RESPIR DIS, V6, P173, DOI 10.1177/1753465812443094; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Peever TL, 2000, APPL ENVIRON MICROB, V66, P4863, DOI 10.1128/AEM.66.11.4863-4869.2000; Pfeiffer I, 1996, CURR GENET, V30, P294, DOI 10.1007/s002940050135; PONTECORVO G, 1953, J GEN MICROBIOL, V8, P198, DOI 10.1099/00221287-8-1-198; Ren YP, 2010, PHARM RES-DORDR, V27, P2509, DOI 10.1007/s11095-010-0251-2; van de Sande WWJ, 2010, EUR J CLIN MICROBIOL, V29, P755, DOI 10.1007/s10096-010-0946-7; van Diepeningen AD, 2006, FUNGAL GENET BIOL, V43, P446, DOI 10.1016/j.fgb.2006.01.014; van Diepeningen AD, 2000, FUNGAL GENETICS NEWS, V47; vanDiepeningen AD, 1997, CURR GENET, V32, P209, DOI 10.1007/s002940050268; Varga J, 1998, CAN J MICROBIOL, V44, P569, DOI 10.1139/cjm-44-6-569; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; Yusibov V, 1997, P NATL ACAD SCI USA, V94, P5784, DOI 10.1073/pnas.94.11.5784	35	16	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77381	10.1371/journal.pone.0077381	http://dx.doi.org/10.1371/journal.pone.0077381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167572	Green Published, gold, Green Submitted			2022-12-27	WOS:000326034500031
J	Wu, XJ; Bolger, WE; Anders, JJ				Wu, Xingjia; Bolger, William E.; Anders, Juanita J.			Fibroblasts Isolated from Human Middle Turbinate Mucosa Cause Neural Progenitor Cells to Differentiate into Glial Lineage Cells	PLOS ONE			English	Article							OLFACTORY ENSHEATHING CELLS; SPINAL-CORD-INJURY; CHONDROITIN SULFATE PROTEOGLYCANS; PROMOTE LOCOMOTOR RECOVERY; TRANSPLANT-MEDIATED REPAIR; AXONAL REGENERATION; SUPERIOR TURBINATE; SCHWANN-CELLS; ADULT RATS; IN-VITRO	Transplantation of olfactory ensheathing cells (OECs) is a potential therapy for repair of spinal cord injury (SCI). Autologous transplantation of OECs has been reported in clinical trials. However, it is still controversial whether purified OECs or olfactory mucosa containing OECs, fibroblasts and other cells should be used for transplantation. OECs and fibroblasts were isolated from olfactory mucosa of the middle turbinate from seven patients. The percentage of OECs with p75(NTR+) and GFAP(+) ranged from 9.2% to 73.2%. Fibroblasts were purified and co-cultured with normal human neural progenitors (NHNPs). Based on immunocytochemical labeling, NHNPs were induced into glial lineage cells when they were co-cultured with the mucosal fibroblasts. These results demonstrate that OECs can be isolated from the mucosa of the middle turbinate bone as well as from the dorsal nasal septum and superior turbinates, which are the typical sites for harvesting OECs. Transplantation of olfactory mucosa containing fibroblasts into the central nervous system (CNS) needs to be further investigated before translation to clinical application.	[Wu, Xingjia; Anders, Juanita J.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Bolger, William E.] Mayo Clin, Sch Med, Dept Otorhinolaryngol, Jacksonville, FL 32224 USA	Uniformed Services University of the Health Sciences - USA; Mayo Clinic	Anders, JJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.	juanita.anders@usuhs.edu	Anders, Juanita/U-8404-2019		Maryland State Board of Spinal Cord Injury Research, Department of Health and Mental Hygiene; USU [G170OA]	Maryland State Board of Spinal Cord Injury Research, Department of Health and Mental Hygiene; USU	This work was funded by Maryland State Board of Spinal Cord Injury Research, Department of Health and Mental Hygiene (http://dhmh.maryland.gov/SitePages/Home.aspx), USU grant number G170OA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au E, 2003, GLIA, V41, P224, DOI 10.1002/glia.10160; Barnett SC, 2004, TRENDS NEUROSCI, V27, P54, DOI 10.1016/j.tins.2003.10.011; Bartus K, 2012, EXP NEUROL, V235, P5, DOI 10.1016/j.expneurol.2011.08.008; Bianco JI, 2004, GLIA, V45, P111, DOI 10.1002/glia.10298; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Chhabra HS, 2009, SPINAL CORD, V47, P887, DOI 10.1038/sc.2009.54; Choi D, 2008, NEUROSURGERY, V62, P1140, DOI 10.1227/01.neu.0000325876.90623.df; DAVID G, 1989, J CELL BIOL, V108, P1165, DOI 10.1083/jcb.108.3.1165; DOUCETTE JR, 1984, ANAT REC, V210, P385, DOI 10.1002/ar.1092100214; Feron F, 1998, ARCH OTOLARYNGOL, V124, P861, DOI 10.1001/archotol.124.8.861; Feron F, 2005, BRAIN, V128, P2951, DOI 10.1093/brain/awh657; Garcia-Escudero V, 2012, NEUROSCI LETT, V509, P27, DOI 10.1016/j.neulet.2011.12.037; Gorrie CA, 2010, BRAIN RES, V1337, P8, DOI 10.1016/j.brainres.2010.04.019; Harrop JS, 2012, J NEUROSURG-SPINE, V17, P230, DOI 10.3171/2012.5.AOSPINE12115; Hashimoto-Uoshima M, 2002, J PERIODONTAL RES, V37, P42, DOI 10.1034/j.1600-0765.2002.00642.x; Higginson JR, 2011, EXP NEUROL, V229, P2, DOI 10.1016/j.expneurol.2010.08.020; Huang ZH, 2008, CELL RES, V18, P479, DOI 10.1038/cr.2008.38; Inoue H, 2011, J ARTIF ORGANS, V14, P375, DOI 10.1007/s10047-011-0598-0; JOHANSSON S, 1985, BIOCHEM J, V232, P161, DOI 10.1042/bj2320161; Kachramanoglou C, 2013, NEUROSURGERY, V72, P170, DOI 10.1227/NEU.0b013e31827b99be; Krudewig C, 2006, CELL TISSUE RES, V326, P687, DOI 10.1007/s00441-006-0238-9; Kwok JCF, 2012, INT J BIOCHEM CELL B, V44, P582, DOI 10.1016/j.biocel.2012.01.004; Lane AP, 2002, LARYNGOSCOPE, V112, P1183, DOI 10.1097/00005537-200207000-00007; LARJAVA H, 1992, BIOCHEM J, V284, P267, DOI 10.1042/bj2840267; Li BC, 2012, J MOL NEUROSCI, V48, P35, DOI 10.1007/s12031-012-9740-6; Li Y, 2005, GLIA, V52, P245, DOI 10.1002/glia.20241; Li Y, 2003, J NEUROSCI, V23, P727; Lima C, 2006, J SPINAL CORD MED, V29, P191, DOI 10.1080/10790268.2006.11753874; Lima C, 2010, NEUROREHAB NEURAL RE, V24, P10, DOI 10.1177/1545968309347685; Lindsay SL, 2010, GLIA, V58, P125, DOI 10.1002/glia.20917; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Lu J, 2001, BRAIN RES, V889, P344, DOI 10.1016/S0006-8993(00)03235-2; Mackay-Sim A, 2008, BRAIN, V131, P2376, DOI 10.1093/brain/awn173; Nash HH, 2002, J NEUROSCI, V22, P7111; Nash HH, 2001, GLIA, V34, P81, DOI 10.1002/glia.1043; Park WB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-119; Pfeifer K, 2004, EUR J NEUROSCI, V20, P1695, DOI 10.1111/j.1460-9568.2004.03657.x; RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099; Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251; Savchenko EA, 2005, B EXP BIOL MED+, V139, P510, DOI 10.1007/s10517-005-0332-0; Say P, 2004, AM J RHINOL, V18, P157, DOI 10.1177/194589240401800305; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Toft A, 2013, GLIA, V61, P513, DOI 10.1002/glia.22452; Van den Pol AN, 2003, J COMP NEUROL, V458, P175, DOI 10.1002/cne.10577; Vincent AJ, 2005, J NEUROCYTOL, V34, P65, DOI 10.1007/s11068-005-5048-6; Vroemen M, 2007, CELL TISSUE RES, V327, P1, DOI 10.1007/s00441-006-0252-y	46	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76926	10.1371/journal.pone.0076926	http://dx.doi.org/10.1371/journal.pone.0076926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204706	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600016
J	Nightingale, CM; Rudnicka, AR; Owen, CG; Donin, AS; Newton, SL; Furness, CA; Howard, EL; Gillings, RD; Wells, JCK; Cook, DG; Whincup, PH				Nightingale, Claire M.; Rudnicka, Alicja R.; Owen, Christopher G.; Donin, Angela S.; Newton, Sian L.; Furness, Cheryl A.; Howard, Emma L.; Gillings, Rachel D.; Wells, Jonathan C. K.; Cook, Derek G.; Whincup, Peter H.			Are Ethnic and Gender Specific Equations Needed to Derive Fat Free Mass from Bioelectrical Impedance in Children of South Asian, Black African-Caribbean and White European Origin? Results of the Assessment of Body Composition in Children Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; UK CHILDREN; AGE; ENGLAND; OBESITY; MODEL; INDEX; PREDICTION; MORTALITY; HYDRATION	Background: Bioelectrical impedance analysis (BIA) is a potentially valuable method for assessing lean mass and body fat levels in children from different ethnic groups. We examined the need for ethnic-and gender-specific equations for estimating fat free mass (FFM) from BIA in children from different ethnic groups and examined their effects on the assessment of ethnic differences in body fat. Methods: Cross-sectional study of children aged 8-10 years in London Primary schools including 325 South Asians, 250 black African-Caribbeans and 289 white Europeans with measurements of height, weight and arm-leg impedance (Z; Bodystat 1500). Total body water was estimated from deuterium dilution and converted to FFM. Multilevel models were used to derive three types of equation {A: FFM = linear combination(height+weight+Z); B: FFM = linear combination(height(2)/Z); C: FFM = linear combination(height(2)/Z+weight)}. Results: Ethnicity and gender were important predictors of FFM and improved model fit in all equations. The models of best fit were ethnicity and gender specific versions of equation A, followed by equation C; these provided accurate assessments of ethnic differences in FFM and FM. In contrast, the use of generic equations led to underestimation of both the negative South Asian-white European FFM difference and the positive black African-Caribbean-white European FFM difference (by 0.53 kg and by 0.73 kg respectively for equation A). The use of generic equations underestimated the positive South Asian-white European difference in fat mass (FM) and overestimated the positive black African-Caribbean-white European difference in FM (by 4.7% and 10.1% respectively for equation A). Consistent results were observed when the equations were applied to a large external data set. Conclusions: Ethnic-and gender-specific equations for predicting FFM from BIA provide better estimates of ethnic differences in FFM and FM in children, while generic equations can misrepresent these ethnic differences.	[Nightingale, Claire M.; Rudnicka, Alicja R.; Owen, Christopher G.; Donin, Angela S.; Newton, Sian L.; Furness, Cheryl A.; Howard, Emma L.; Gillings, Rachel D.; Cook, Derek G.; Whincup, Peter H.] Univ London, Div Populat Hlth Sci & Educ, London, England; [Wells, Jonathan C. K.] UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England	University of London; University of London; University College London	Nightingale, CM (corresponding author), Univ London, Div Populat Hlth Sci & Educ, London, England.	c.nightingale@sgul.ac.uk	Cook, Derek G/C-3271-2008; Wells, Jonathan/A-4604-2009	Wells, Jonathan/0000-0003-0411-8025; Donin, Angela/0000-0002-8238-9923; Nightingale, Claire/0000-0003-2408-757X; Nightingale, Claire/0000-0002-4803-7617; Cook, Derek/0000-0002-9723-5759; Owen, Christopher/0000-0003-1135-5977; Rudnicka, Alicja R/0000-0003-0369-8574; Whincup, Peter/0000-0002-5589-4107	National Institute for Health Research (NIHR) [DRF-2010-02-101]; NIHR; BUPA Foundation [TBF-S09-019]; British Heart Foundation [PG/11/42/28895]; Wellcome Trust [068362/Z/02/Z]; National Prevention Research Initiative (NPRI) [G0501295]; MRC [G0501295] Funding Source: UKRI; Medical Research Council [G0501295] Funding Source: researchfish; National Institute for Health Research [DRF-2010-03-101] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); BUPA Foundation; British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Prevention Research Initiative (NPRI); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Claire Nightingale was supported by a National Institute for Health Research (NIHR) fellowship (grant reference DRF-2010-02-101). Data collection in the ABCC Study was supported by the NIHR fellowship grant and the BUPA Foundation (grant reference TBF-S09-019). Deuterium analyses were funded by a project grant from the British Heart Foundation (grant reference PG/11/42/28895). Data collection in CHASE was supported by grants from the Wellcome Trust (grant reference 068362/Z/02/Z) and the National Prevention Research Initiative (NPRI) (grant reference G0501295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aksglaede L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002728; [Anonymous], 2001, LANCET, V357, P1989; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Clasey JL, 2011, OBESITY, V19, P1813, DOI 10.1038/oby.2011.158; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; DEURENBERG P, 1991, INT J OBESITY, V15, P17; Deurenberg P, 2002, EUR J CLIN NUTR, V56, P214, DOI 10.1038/sj.ejcn.1601303; DEURENBERG P, 1990, EUR J CLIN NUTR, V44, P261; Deurenberg-Yap M, 2001, BRIT J NUTR, V85, P491, DOI 10.1079/BJN2000276; Donin AS, 2010, AM J CLIN NUTR, V92, P776, DOI 10.3945/ajcn.2010.29533; Ehtisham S, 2005, J CLIN ENDOCR METAB, V90, P3963, DOI 10.1210/jc.2004-2001; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; Ford ES, 2008, J CLIN ENDOCR METAB, V93, pS1, DOI 10.1210/jc.2008-1356; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Haroun D, 2010, OBESITY, V18, P1252, DOI 10.1038/oby.2009.344; Health Survey for England, 2011, HLTH SURV ENGL 2010; Health Survey for England, 2006, HLTH SURV ENGL 2004; Jakicic JM, 1998, INT J OBESITY, V22, P243, DOI 10.1038/sj.ijo.0800576; KUSHNER RF, 1992, AM J CLIN NUTR, V56, P835, DOI 10.1093/ajcn/56.5.835; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Lear SA, 2009, J CLIN ENDOCR METAB, V94, P4696, DOI 10.1210/jc.2009-1030; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Nightingale CM, 2013, DIABETES CARE, V36, P1712, DOI 10.2337/dc12-1726; Nightingale CM, 2011, INT J EPIDEMIOL, V40, P33, DOI 10.1093/ije/dyq180; RACETTE SB, 1994, AM J PHYSIOL-ENDOC M, V267, pE585, DOI 10.1152/ajpendo.1994.267.4.E585; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Unni US, 2009, EUR J CLIN NUTR, V63, P1206, DOI 10.1038/ejcn.2009.32; Wells JCK, 1999, AM J CLIN NUTR, V69, P904; Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522; Wells JCK, 2010, AM J CLIN NUTR, V91, P610, DOI 10.3945/ajcn.2009.28428; Whincup PH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000263; Wild S, 1997, BRIT MED J, V314, P705, DOI 10.1136/bmj.314.7082.705; Wild SH, 2007, J PUBLIC HEALTH-UK, V29, P191, DOI 10.1093/pubmed/fdm010; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; Zhu SK, 2005, AM J CLIN NUTR, V81, P409	39	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76426	10.1371/journal.pone.0076426	http://dx.doi.org/10.1371/journal.pone.0076426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204625	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300028
J	Ruyra, A; Cano-Sarabia, M; MacKenzie, SA; Maspoch, D; Roher, N				Ruyra, Angels; Cano-Sarabia, Mary; MacKenzie, Simon A.; Maspoch, Daniel; Roher, Nerea			A Novel Liposome-Based Nanocarrier Loaded with an LPS-dsRNA Cocktail for Fish Innate Immune System Stimulation	PLOS ONE			English	Article							AEROMONAS-SALMONICIDA; ORAL IMMUNIZATION; VACCINE ADJUVANTS; DELIVERY-SYSTEMS; CATIONIC LIPIDS; EXPRESSION; RESPONSES; LIPOPOLYSACCHARIDE; RECOGNITION; MICROPARTICLES	Development of novel systems of vaccine delivery is a growing demand of the aquaculture industry. Nano- and microencapsulation systems are promising tools to achieve efficient vaccines against orphan vaccine fish diseases. In this context, the use of liposomal based-nanocarriers has been poorly explored in fish; although liposomal nanocarriers have successfully been used in other species. Here, we report a new similar to 125 nm-in-diameter unilamellar liposome-encapsulated immunostimulant cocktail containing crude lipopolysaccharide (LPS) from E. coli and polyinosinic: polycytidylic acid [ poly (I: C)], a synthetic analog of dsRNA virus, aiming to be used as a non-specific vaccine nanocarrier in different fish species. This liposomal carrier showed high encapsulation efficiencies and low toxicity not only in vitro using three different cellular models but also in vivo using zebrafish embryos and larvae. We showed that such liposomal LPS-dsRNA cocktail is able to enter into contact with zebrafish hepatocytes (ZFL cell line) and trout macrophage plasma membranes, being preferentially internalized through caveolae-dependent endocytosis, although clathrin-mediated endocytosis in ZFL cells and macropinocytocis in macrophages also contribute to liposome uptake. Importantly, we also demonstrated that this liposomal LPS-dsRNA cocktail elicits a specific pro-inflammatory and anti-viral response in both zebrafish hepatocytes and trout macrophages. The design of a unique delivery system with the ability to stimulate two potent innate immunity pathways virtually present in all fish species represents a completely new approach in fish health.	[Ruyra, Angels; MacKenzie, Simon A.; Roher, Nerea] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Parc Recerca UAB, E-08193 Barcelona, Spain; [Cano-Sarabia, Mary; Maspoch, Daniel] Inst Catala Nanociencia & Nanotecnol, ICN2, Barcelona, Spain; [Maspoch, Daniel] ICREA, Barcelona, Spain	Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); ICREA	Maspoch, D (corresponding author), Inst Catala Nanociencia & Nanotecnol, ICN2, Campus UAB, Barcelona, Spain.	daniel.maspoch@icn.cat; nerea.roher@uab.cat	MacKenzie, Simon/Q-2362-2019; Maspoch, Daniel/AFI-3557-2022; Cano-Sarabia, Mary/A-1648-2015; Maspoch, Daniel/AAF-3727-2022; Roher, Nerea/F-3216-2016; Maspoch, Daniel/O-9266-2015	MacKenzie, Simon/0000-0003-1845-6826; Cano-Sarabia, Mary/0000-0003-4254-8157; Roher, Nerea/0000-0002-6659-4038; Maspoch, Daniel/0000-0003-1325-9161	Fundacion Ramon Areces; Fundacio Amics de la Universitat Autonoma de Barcelona-Programa Aposta; Ministry of Industry and Competitiveness (Spain); ICREA Funding Source: Custom	Fundacion Ramon Areces; Fundacio Amics de la Universitat Autonoma de Barcelona-Programa Aposta; Ministry of Industry and Competitiveness (Spain); ICREA(ICREA)	This work was supported by the Fundacion Ramon Areces (2010) and the Fundacio Amics de la Universitat Autonoma de Barcelona-Programa Aposta (2011). NR wishes to thank the Ministry of Industry and Competitiveness (Spain) for the Ramon y Cajal grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021076; Balazs DA, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/326497; Bassity E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033196; Bennett-Guerrero E, 2000, INFECT IMMUN, V68, P6202, DOI 10.1128/IAI.68.11.6202-6208.2000; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Donate C, 2007, FISH SHELLFISH IMMUN, V23, P877, DOI 10.1016/j.fsi.2007.03.016; Dow SW, 2008, EXPERT OPIN DRUG DEL, V5, P11, DOI 10.1517/17425247.5.1.11; Evensen O., 2009, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P177; Fent K, 2010, AQUAT TOXICOL, V100, P218, DOI 10.1016/j.aquatox.2010.02.019; Filion MC, 1997, BBA-BIOMEMBRANES, V1329, P345, DOI 10.1016/S0005-2736(97)00126-0; Fredriksen BN, 2012, VACCINE, V30, P656, DOI 10.1016/j.vaccine.2011.10.105; Galindo-Villegas J, 2012, P NATL ACAD SCI USA, V109, pE2605, DOI 10.1073/pnas.1209920109; George S, 2011, ACS NANO, V5, P1805, DOI 10.1021/nn102734s; Goetz FW, 2004, DEV COMP IMMUNOL, V28, P487, DOI 10.1016/j.dci.2003.09.008; Harper SL, 2011, ACS NANO, V5, P4688, DOI 10.1021/nn200546k; Iliev DB, 2005, FEBS LETT, V579, P6519, DOI 10.1016/j.febslet.2005.10.061; Irie T, 2005, FISH SHELLFISH IMMUN, V18, P235, DOI 10.1016/j.fsi.2004.07.006; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jess TJ, 1996, CELL SIGNAL, V8, P297, DOI 10.1016/0898-6568(96)00054-X; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Khan M. A., 2011, Biology and Medicine, V3, P291; KLIBANOV AL, 1990, FEBS LETT, V268, P235, DOI 10.1016/0014-5793(90)81016-H; Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y; Lieschke GJ, 2009, CURR BIOL, V19, pR678, DOI 10.1016/j.cub.2009.06.068; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonez C, 2012, ADV DRUG DELIVER REV, V64, P1749, DOI 10.1016/j.addr.2012.05.009; MacKenzie S, 2003, DEV COMP IMMUNOL, V27, P393, DOI 10.1016/S0145-305X(02)00135-0; MacKenzie SA, 2010, MOL IMMUNOL, V47, P1450, DOI 10.1016/j.molimm.2010.02.009; Milla P, 2012, CURR DRUG METAB, V13, P105, DOI 10.2174/138920012798356934; Moghimi SM, 2011, ACS NANO, V5, P8454, DOI 10.1021/nn2038252; Nakhla Anthony N., 1996, Journal of Liposome Research, V6, P141, DOI 10.3109/08982109609037209; Nordly P, 2009, EXPERT OPIN DRUG DEL, V6, P657, DOI 10.1517/17425240903018863; Palti Y, 2011, DEV COMP IMMUNOL, V35, P1263, DOI 10.1016/j.dci.2011.03.006; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; PUYAL C, 1995, EUR J BIOCHEM, V228, P697, DOI 10.1111/j.1432-1033.1995.0697m.x; Rodrigues AP, 2006, PROCESS BIOCHEM, V41, P638, DOI 10.1016/j.procbio.2005.08.010; Roher N, 2011, INNATE IMMUN-LONDON, V17, P16, DOI 10.1177/1753425909348232; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Takano S, 2003, PHARMACEUT RES, V20, P962, DOI 10.1023/A:1024441702398; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thim HL, 2012, VACCINE, V30, P4828, DOI 10.1016/j.vaccine.2012.05.010; Tian JY, 2008, VET IMMUNOL IMMUNOP, V126, P220, DOI 10.1016/j.vetimm.2008.07.002; Wang KY, 2011, AFR J BIOTECHNOL, V10, P2751; Wang WL, 2011, FISH SHELLFISH IMMUN, V31, P10, DOI 10.1016/j.fsi.2011.01.015; Watson DS, 2012, VACCINE, V30, P2256, DOI 10.1016/j.vaccine.2012.01.070; Whyte SK, 2007, FISH SHELLFISH IMMUN, V23, P1127, DOI 10.1016/j.fsi.2007.06.005; Wieber A, 2011, INT J PHARMACEUT, V421, P151, DOI 10.1016/j.ijpharm.2011.09.011; Zhu LY, 2013, DEV COMP IMMUNOL, V39, P39, DOI 10.1016/j.dci.2012.04.001	49	32	33	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76338	10.1371/journal.pone.0076338	http://dx.doi.org/10.1371/journal.pone.0076338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204616	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300023
J	Griebeler, EM				Griebeler, Eva Maria			Body Temperatures in Dinosaurs: What Can Growth Curves Tell Us?	PLOS ONE			English	Article							METABOLIC-RATE; LIFE-HISTORY; BONE-GROWTH; SEASONAL ACCLIMATIZATION; EVOLUTIONARY ADAPTATION; PATTERNS; SIZE; THERMOREGULATION; DEHYDROGENASES; PHYSIOLOGY	To estimate the body temperature (BT) of seven dinosaurs Gillooly, Alleen, and Charnov (2006) used an equation that predicts BT from the body mass and maximum growth rate (MGR) with the latter preserved in ontogenetic growth trajectories (BT-equation). The results of these authors evidence inertial homeothermy in Dinosauria and suggest that, due to overheating, the maximum body size in Dinosauria was ultimately limited by BT. In this paper, I revisit this hypothesis of Gillooly, Alleen, and Charnov (2006). I first studied whether BTs derived from the BT-equation of today's crocodiles, birds and mammals are consistent with core temperatures of animals. Second, I applied the BT-equation to a larger number of dinosaurs than Gillooly, Alleen, and Charnov (2006) did. In particular, I estimated BT of Archaeopteryx (from two MGRs), ornithischians (two), theropods (three), prosauropods (three), and sauropods (nine). For extant species, the BT value estimated from the BT-equation was a poor estimate of an animal's core temperature. For birds, BT was always strongly overestimated and for crocodiles underestimated; for mammals the accuracy of BT was moderate. I argue that taxon-specific differences in the scaling of MGR (intercept and exponent of the regression line, log-log-transformed) and in the parameterization of the Arrhenius model both used in the BT-equation as well as ecological and evolutionary adaptations of species cause these inaccuracies. Irrespective of the found inaccuracy of BTs estimated from the BT-equation and contrary to the results of Gillooly, Alleen, and Charnov (2006) I found no increase in BT with increasing body mass across all dinosaurs (Sauropodomorpha, Sauropoda) studied. This observation questions that, due to overheating, the maximum size in Dinosauria was ultimately limited by BT. However, the general high inaccuracy of dinosaurian BTs derived from the BT-equation makes a reliable test of whether body size in dinosaurs was ultimately limited by overheating impossible.	Johannes Gutenberg Univ Mainz, Inst Zool, Dept Ecol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Griebeler, EM (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Dept Ecol, D-55122 Mainz, Germany.	em.griebeler@uni-mainz.de			Deutsche Forschungsgemeinschaft [GR2625/2-1, GR2625/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The author's research was generously funded by the Deutsche Forschungsgemeinschaft (GR2625/2-1, GR2625/2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiot R, 2006, EARTH PLANET SC LETT, V246, P41, DOI 10.1016/j.epsl.2006.04.018; Andrews R.M., 1982, Biology of Reptilia, V13, P273; AVERY RA, 1994, GERONTOLOGY, V40, P193, DOI 10.1159/000213587; BRATTSTROM BH, 1965, AM MIDL NAT, V73, P376, DOI 10.2307/2423461; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Clarke A, 2008, FUNCT ECOL, V22, P58, DOI 10.1111/j.1365-2435.2007.01341.x; Clarke A, 2010, BIOL REV, V85, P703, DOI 10.1111/j.1469-185X.2010.00122.x; COLBERT EH, 1947, COPEIA, P141; Cooper Ross G., 2004, Animal Science Journal, V75, P491, DOI 10.1111/j.1740-0929.2004.00218.x; CRAWFORD DL, 1992, MOL BIOL EVOL, V9, P806; CRAWFORD DL, 1989, P NATL ACAD SCI USA, V86, P9365, DOI 10.1073/pnas.86.23.9365; Cubo J, 2008, EVOL DEV, V10, P217, DOI 10.1111/j.1525-142X.2008.00229.x; de Buffrenil V, 2002, J HERPETOL, V36, P419, DOI 10.2307/1566186; Dial KP, 2003, AUK, V120, P941, DOI 10.1642/0004-8038(2003)120[0941:EOALCO]2.0.CO;2; Downs CJ, 2008, FUNCT ECOL, V22, P239, DOI 10.1111/j.1365-2435.2007.01371.x; Eagle RA, 2011, SCIENCE, V333, P443, DOI 10.1126/science.1206196; Eaton MJ, 2011, ECOL APPL, V21, P2487, DOI 10.1890/10-0626.1; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Erickson GM, 2009, ANAT REC, V292, P1514, DOI 10.1002/ar.20992; Fields PA, 1997, J EXP BIOL, V200, P1839; FITZHUGH HA, 1976, J ANIM SCI, V42, P1036, DOI 10.2527/jas1976.4241036x; FRAZER NB, 1985, COPEIA, P73; Gaillard JM, 1997, P ROY SOC B-BIOL SCI, V264, P859, DOI 10.1098/rspb.1997.0120; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Griebeler EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067012; Guderley H.E., 1996, Society for Experimental Biology Seminar Series, V59, P127; Hailey A, 1999, CAN J ZOOL, V77, P181, DOI 10.1139/cjz-77-2-181; James CD, 1996, AUST J ZOOL, V44, P177, DOI 10.1071/ZO9960177; KERKHOFF AJ, METABOLIC ECOLOGY SC, P48; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Lance VA, 2003, EXP GERONTOL, V38, P801, DOI 10.1016/S0531-5565(03)00112-8; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; LIN JJ, 1995, J EXP BIOL, V198, P551; LOWELL BB, 2000, NATURE, V353, P748; MAGNUSSON WE, 1995, COPEIA, P498; MCNAB BK, 1966, CONDOR, V68, P47, DOI 10.2307/1365174; McNab BK, 2009, P NATL ACAD SCI USA, V106, P12184, DOI 10.1073/pnas.0904000106; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Mcnab BK, 2009, COMP BIOCHEM PHYS A, V152, P22, DOI 10.1016/j.cbpa.2008.08.021; Montes L, 2007, BIOL J LINN SOC, V92, P63, DOI 10.1111/j.1095-8312.2007.00881.x; O'Connor MP, 1999, PALEOBIOLOGY, V25, P341, DOI 10.1017/S0094837300021321; Pough F.H., 2003, HERPETOLOGY, V3rd; RICKLEFS RE, 1984, ECOLOGY, V65, P1602, DOI 10.2307/1939139; RICKLEFS RE, 1979, BIOL REV, V54, P269, DOI 10.1111/j.1469-185X.1979.tb01013.x; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; Ritz J, 2010, HERPETOL J, V20, P213; RODBARD S, 1950, SCIENCE, V111, P465, DOI 10.1126/science.111.2887.465; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Sander P. Martin, 2011, P276; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; SCHMIDTNIELSON K, 1997, ANIMAL PHYSL; Seebacher F, 1999, J EXP BIOL, V202, P77; Seebacher F, 2005, J COMP PHYSIOL B, V175, P533, DOI 10.1007/s00360-005-0007-1; Seebacher F, 2003, J EXP BIOL, V206, P1193, DOI 10.1242/jeb.00223; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Seebacher F, 1997, COPEIA, P549; Seebacher F, 2001, J COMP PHYSIOL B, V171, P395; Seebacher F, 2004, J COMP PHYSIOL B, V174, P205, DOI 10.1007/s00360-003-0331-2; SHINE R, 1992, AM NAT, V139, P1257, DOI 10.1086/285385; SPOTILA JR, 1973, AM NAT, V107, P391, DOI 10.1086/282842; St-Pierre J, 1998, J EXP BIOL, V201, P2961; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; WERNER J, PLOS ONE UNPUB; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; WESTERN D, 1982, OECOLOGIA, V54, P281, DOI 10.1007/BF00379994; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378; WILKINSON DM, 2003, FUNC ECOL, V27, P131; Willmer P, 2005, ENV PHYSL ANIMALS; ZULLINGER EM, 1984, J MAMMAL, V65, P607, DOI 10.2307/1380844	76	11	11	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e74317	10.1371/journal.pone.0074317	http://dx.doi.org/10.1371/journal.pone.0074317			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204568	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500004
J	He, WM; Chen, F				He, Wenming; Chen, Fang			Evaluating Status Change of Soil Potassium from Path Model	PLOS ONE			English	Article							WEATHERING DESERT PLANTS; MICROBIAL-POPULATIONS; EXCHANGE EQUILIBRIA; PHOSPHORUS; ADSORPTION; ROCK; ENVIRONMENT; RHIZOPLANE; ANDISOLS; NITROGEN	The purpose of this study is to determine critical environmental parameters of soil K availability and to quantify those contributors by using a proposed path model. In this study, plot experiments were designed into different treatments, and soil samples were collected and further analyzed in laboratory to investigate soil properties influence on soil potassium forms (water soluble K, exchangeable K, non-exchangeable K). Furthermore, path analysis based on proposed path model was carried out to evaluate the relationship between potassium forms and soil properties. Research findings were achieved as followings. Firstly, key direct factors were soil S, ratio of sodium-potassium (Na/K), the chemical index of alteration (CIA), Soil Organic Matter in soil solution (SOM), Na and total nitrogen in soil solution (TN), and key indirect factors were Carbonate (CO3), Mg, pH, Na, S, and SOM. Secondly, path model can effectively determine direction and quantities of potassium status changes between Exchangeable potassium (eK), Non-exchangeable potassium (neK) and water-soluble potassium (wsK) under influences of specific environmental parameters. In reversible equilibrium state of wsK reversible arrow(alpha)(beta) neK reversible arrow(gamma)(chi) eK, K balance state was inclined to be moved into beta and chi directions in treatments of potassium shortage. However in reversible equilibrium of wsK reversible arrow(epsilon)(theta) eK reversible arrow(lambda)(omega) neK, K balance state was inclined to be moved into theta and lambda directions in treatments of water shortage. Results showed that the proposed path model was able to quantitatively disclose moving direction of K status and quantify its equilibrium threshold. It provided a theoretical and practical basis for scientific and effective fertilization in agricultural plants growth.	[He, Wenming; Chen, Fang] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei Province, Peoples R China; [He, Wenming] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Chen, Fang] Int Plant Nutr Inst, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, F (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei Province, Peoples R China.	fchen@ipni.ac.cn			National Natural Science Foundation of China [41171243]; National Key Technology RD Program [2012BAD15B01]; International Plant Nutrition Institute [IPNI-HB-33]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); International Plant Nutrition Institute	The study was supported by the National Natural Science Foundation of China (41171243), the National Key Technology R&D Program (2012BAD15B01) and the Cooperated Program with the International Plant Nutrition Institute (IPNI-HB-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; BROUDER SM, 1994, SOIL SCI SOC AM J, V58, P1174, DOI 10.2136/sssaj1994.03615995005800040024x; EICK MJ, 1990, SOIL SCI SOC AM J, V54, P1278, DOI 10.2136/sssaj1990.03615995005400050013x; Han MY, 2011, SOIL SCI PLANT NUTR, V57, P549, DOI 10.1080/00380768.2011.593481; Hashimoto Y, 2012, SOIL SCI SOC AM J, V76, P441, DOI 10.2136/sssaj2011.0196; He CY, 2012, ECOL EVOL, V2, P1996, DOI 10.1002/ece3.299; He HM, 2008, ENVIRON FORENSICS, V9, P215, DOI 10.1080/15275920802122759; He HM, 2012, ENERG POLICY, V43, P235, DOI 10.1016/j.enpol.2011.12.060; He HM, 2010, ECOL MODEL, V221, P2949, DOI 10.1016/j.ecolmodel.2010.09.002; Hinsinger P, 2001, GEOCHIM COSMOCHIM AC, V65, P137, DOI 10.1016/S0016-7037(00)00524-X; Kamewada K, 1996, SOIL SCI PLANT NUTR, V42, P801, DOI 10.1080/00380768.1996.10416627; Kang J, 2009, SOIL SCI SOC AM J, V73, P360, DOI 10.2136/sssaj2008.0113; Kobayashi H, 2007, SOIL SCI PLANT NUTR, V53, P764, DOI 10.1111/j.1747-0765.2007.00192.x; Kocev D, 2010, ECOL MODEL, V221, P330, DOI 10.1016/j.ecolmodel.2009.09.002; Kulahci F, 2011, J HAZARD MATER, V191, P349, DOI 10.1016/j.jhazmat.2011.04.083; Lambers H, 2009, PLANT SOIL, V321, P83, DOI 10.1007/s11104-009-0042-x; Mahmood-Ul-Hassan M, 2011, SOIL SCI PLANT NUTR, V57, P331, DOI 10.1080/00380768.2011.559576; McCune B, 2009, ECOLOGY, V90, P567, DOI 10.1890/08-0344.1; NAKAHARA O, 1995, SOIL SCI PLANT NUTR, V41, P671, DOI 10.1080/00380768.1995.10417017; Osaki M, 1996, SOIL SCI PLANT NUTR, V42, P289; Puente ME, 2004, PLANT BIOLOGY, V6, P629, DOI 10.1055/s-2004-821100; Puente ME, 2004, PLANT BIOLOGY, V6, P643, DOI 10.1055/s-2004-821101; Schneider AK, 2012, APPL SOIL ECOL, V58, P29, DOI 10.1016/j.apsoil.2012.02.020; Uroz S, 2009, TRENDS MICROBIOL, V17, P378, DOI 10.1016/j.tim.2009.05.004; WADA SI, 1994, SOIL SCI PLANT NUTR, V40, P629, DOI 10.1080/00380768.1994.10414302; WADA SI, 1995, SOIL SCI PLANT NUTR, V41, P377, DOI 10.1080/00380768.1995.10419597; Wright S, 1921, GENETICS, V6, P124; Wright S, 1921, GENETICS, V6, P111; Wright S, 1920, P NATL ACAD SCI USA, V6, P320, DOI 10.1073/pnas.6.6.320; Wright SS, 1921, J AGR RES, V20, P557	30	7	7	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e76712	10.1371/journal.pone.0076712	http://dx.doi.org/10.1371/journal.pone.0076712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204659	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500009
J	Hou, XJ; Xu, JH; Wang, J; Yu, YY				Hou, Xin-Jiang; Xu, Jing-Hang; Wang, Jun; Yu, Yan-Yan			Can Antidepressants Prevent Pegylated Interferon-alpha/Ribavirin-Associated Depression in Patients with Chronic Hepatitis C: Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials?	PLOS ONE			English	Article							ALPHA-INDUCED DEPRESSION; PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2A; SUSTAINED RESPONSE; MAJOR DEPRESSION; THERAPY; SYMPTOMS; VIRUS; ESCITALOPRAM; CITALOPRAM	Background: Antidepressants are effective in treating interferon-alpha/ribavirin (IFN-alpha/RBV)-associated depression during or after treatment of chronic hepatitis C (CHC). Whether antidepressant prophylaxis is necessary in this population remains under debate. Methods: Comprehensive searches were performed in Medline, Embase, Cochrane Controlled Trials Register and PubMed. Reference lists were searched manually. The methodology was in accordance with the 2009 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) Statement. Results: We identified six randomized, double-blind, placebo-controlled trials involving 522 CHC patients treated with pegylated (PEG)-IFN-alpha plus RBV. The antidepressants used were escitalopram, citalopram, and paroxetine, which are selective serotonin reuptake inhibitors (SSRIs). The rates of depression (17.9% vs. 31.0%, P = 0.0005), and rescue therapy (27.4% vs. 42.7%, P<0.0001) in the SSRI group were significantly lower than those in the placebo group. The rate of sustained virological response (SVR) (56.8% vs. 50.0%, P = 0.60) and drug discontinuation (18.7% vs. 21.1%, P = 0.63) in the SSRI group did not differ significantly to those in the placebo group. In terms of safety, the incidence of muscle and joint pain (40.8% vs. 52.4%, P = 0.03) and respiratory problems (29.3% vs. 40.1%, P = 0.03) were lower, but the incidence of dizziness was significantly higher (22.3% vs. 10.2%, P = 0.001) in the SSRI group. Conclusion: Prophylactic SSRI antidepressants can significantly reduce the incidence of PEG-IFN-alpha/RBV-associated depression in patients with CHC, with good safety and tolerability, without reduction of SVR.	[Hou, Xin-Jiang; Xu, Jing-Hang; Wang, Jun; Yu, Yan-Yan] Peking Univ, Hosp 1, Dept Infect Dis, Beijing 100871, Peoples R China	Peking University	Yu, YY (corresponding author), Peking Univ, Hosp 1, Dept Infect Dis, Beijing 100871, Peoples R China.	yyy@bjmu.edu.cn	Yu, Yan/GYV-4514-2022					Asnis GM, 2006, J CLIN GASTROENTEROL, V40, P322, DOI 10.1097/01.mcg.0000210099.36500.fe; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bernstein D, 2002, HEPATOLOGY, V35, P704, DOI 10.1053/jhep.2002.31311; Cacoub P, 2002, J HEPATOL, V36, P812, DOI 10.1016/S0168-8278(02)00067-3; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; de Knegt RJ, 2011, ALIMENT PHARM THER, V34, P1306, DOI 10.1111/j.1365-2036.2011.04867.x; Dieperink E, 2000, AM J PSYCHIAT, V157, P867, DOI 10.1176/appi.ajp.157.6.867; Diez-Quevedo C, 2011, J CLIN PSYCHIAT, V72, P522, DOI 10.4088/JCP.09m05282blu; Farah A, 2002, J CLIN PSYCHIAT, V63, P166, DOI 10.4088/JCP.v63n0213c; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gleason OC, 1999, PSYCHOSOMATICS, V40, P510, DOI 10.1016/S0033-3182(99)71190-4; Gleason OC, 2004, PSYCHOSOMATICS, V45, P29, DOI 10.1176/appi.psy.45.1.29; Gleason OC, 2002, J CLIN PSYCHIAT, V63, P194, DOI 10.4088/JCP.v63n0304; Gleason OC, 2007, DIGEST DIS SCI, V52, P2557, DOI 10.1007/s10620-006-9729-5; Guadagnino V, 2006, DIGEST LIVER DIS, V38, P119, DOI 10.1016/j.dld.2005.10.008; Hauser P, 2002, MOL PSYCHIATR, V7, P942, DOI 10.1038/sj.mp.4001119; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kraus MR, 2008, GUT, V57, P531, DOI 10.1136/gut.2007.131607; Kraus MR, 2005, J VIRAL HEPATITIS, V12, P96, DOI 10.1111/j.1365-2893.2005.00554.x; Kraus MR, 2002, ALIMENT PHARM THER, V16, P1091, DOI 10.1046/j.1365-2036.2002.01265.x; Kraus MR, 2001, DIGEST DIS SCI, V46, P2060, DOI 10.1023/A:1011973823032; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Maddock C, 2005, MOL PSYCHIATR, V10, P332, DOI 10.1038/sj.mp.4001634; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morasco BJ, 2007, J AFFECT DISORDERS, V103, P83, DOI 10.1016/j.jad.2007.01.007; Morasco BJ, 2010, PSYCHOSOMATICS, V51, P401, DOI 10.1176/appi.psy.51.5.401; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Raison CL, 2007, ALIMENT PHARM THER, V25, P1163, DOI 10.1111/j.1365-2036.2007.03316.x; Raison CL, 2005, BRAIN BEHAV IMMUN, V19, P23, DOI 10.1016/j.bbi.2004.05.001; Reichenberg A, 2005, AIDS, V19, pS174, DOI 10.1097/01.aids.0000192087.64432.ae; Schafer A, 2007, INT J METH PSYCH RES, V16, P186, DOI 10.1002/mpr.229; Schaefer M, 2005, J HEPATOL, V42, P793, DOI 10.1016/j.jhep.2005.01.020; Schaefer M, 2002, PROG NEURO-PSYCHOPH, V26, P731, DOI 10.1016/S0278-5846(01)00324-4; Schaefer M, 2012, ANN INTERN MED, V157, P94, DOI 10.7326/0003-4819-157-2-201207170-00006; Schramm TM, 2000, MED J AUSTRALIA, V173, P359, DOI 10.5694/j.1326-5377.2000.tb125687.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P1015, DOI 10.1053/j.gastro.2004.01.014; Sockalingam S, 2011, J VIRAL HEPATITIS, V18, P153, DOI 10.1111/j.1365-2893.2010.01393.x; Trkulja V, 2010, CROAT MED J, V51, P61, DOI 10.3325/cmj.2010.51.61; Zdilar D, 2000, HEPATOLOGY, V31, P1207, DOI 10.1053/jhep.2000.7880	43	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e76799	10.1371/journal.pone.0076799	http://dx.doi.org/10.1371/journal.pone.0076799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204676	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500010
J	Bassuk, JA; Washington, IM				Bassuk, James A.; Washington, Ida M.			The A3 Problem Solving Report: A 10-Step Scientific Method to Execute Performance Improvements in an Academic Research Vivarium	PLOS ONE			English	Article								The purpose of this study was to illustrate the application of A3 Problem Solving Reports of the Toyota Production System to our research vivarium through the methodology of Continuous Performance Improvement, a lean approach to healthcare management at Seattle Children's (Hospital, Research Institute, Foundation). The Report format is described within the perspective of a 10-step scientific method designed to realize measurable improvements of Issues identified by the Report's Author, Sponsor and Coach. The 10-step method (Issue, Background, Current Condition, Goal, Root Cause, Target Condition, Countermeasures, Implementation Plan, Test, and Follow-up) was shown to align with Shewhart's Plan-Do-Check-Act process improvement cycle in a manner that allowed for quantitative analysis of the Countermeasure's outcomes and of Testing results. During fiscal year 2012, 9 A3 Problem Solving Reports were completed in the vivarium under the teaching and coaching system implemented by the Research Institute. Two of the 9 reports are described herein. Report #1 addressed the issue of the vivarium's veterinarian not being able to provide input into sick animal cases during the work day, while report #7 tackled the lack of a standard in keeping track of weekend/holiday animal health inspections. In each Report, a measurable Goal that established the basis for improvement recognition was present. A Five Whys analysis identified the Root Cause for Report #1 as historical work patterns that existed before the veterinarian was hired on and that modern electronic communication tools had not been implemented. The same analysis identified the Root Cause for Report #7 as the vivarium had never standardized the process for weekend/holiday checks. Successful outcomes for both Reports were obtained and validated by robust audit plans. The collective data indicate that vivarium staff acquired a disciplined way of reporting on, as well as solving, problems in a manner consistent with high level A3 Thinking.	[Bassuk, James A.] Seattle Childrens Res Inst, Dept Res Continuous Performance Improvement, Seattle, WA USA; [Washington, Ida M.] Seattle Childrens Res Inst, Off Anim Care, Seattle, WA USA	Seattle Children's Hospital; Seattle Children's Hospital	Bassuk, JA (corresponding author), Seattle Childrens Res Inst, Dept Res Continuous Performance Improvement, Seattle, WA USA.	james.bassuk@seattlechildrens.org			Center for Clinical and Translational Research at Seattle Children's Research Institute; NIH National Center for Research Resources [UL1RR025014]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002319] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER	Center for Clinical and Translational Research at Seattle Children's Research Institute; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The Authors acknowledge the expert instruction and coaching in A3 Thinking by Delila Katzka and Lucinda Getz, CPI consultants and project managers in the Department of Research Continuous Performance Improvement at Seattle Children's Research Institute. The suggestion by Stephanie Axelrod that the IACUC is a stakeholder at the Institute is also acknowledged. The OAC staff is also acknowledged, specifically the OAC CPI team (Jonathan "JD'' Pedersen and Lindsey Jackson) and Euclid Curioso, for helpful support while CPI was reintroduced to their department. Statistical analysis was provided by the Seattle Children's Core for Biomedical Statistics, which is supported by the Center for Clinical and Translational Research at Seattle Children's Research Institute and grant UL1RR025014 from the NIH National Center for Research Resources. The authors appreciate a critical reading of the manuscript by Lucinda Getz, Stephanie Axelrod and Delila Katzka, and a proofreading review by Kori J. Flajole.	AXELROD SS, 2011, LEADING LEAN HEALTHC; *COMM UPD GUI CARE, 2013, GUIDE CARE USE LAB A; Deming W., 1950, ELEMENTARY PRINCIPLE; Doran GT., 1981, MANAGE REV, V70, P35; Ishikawa K., 1986, GUIDE QUALITY CONTRO; Jarrell DM, 2005, CONT TOP 56 ANN M AM, V44, P61; Jimmerson C., 2007, A3 PROBLEM SOLVING H; JIMMERSON C, 2004, REVIEW REALIZING EXC; JIMMERSON C, 2007, A3 PROBLEM SOLVING H, P145; KELLY H, 2011, ALN MAGAZIN; Khan Nabeel, 2008, ILAR J, V49, pE15; Liker J, 2004, TOYOTA WAY 14 MANAGE, P35; LIKER JK, 2004, TOYOT WAY 14 MAN PRI; LIKER JK, 2004, TOYOTA WAY 14 MANAGE, P28; Moen R. D., 2010, QUAL PROG; National Institutes of Health, 2012, TYP GRANT PROGR; Ohno T., 2019, TOYOTA PRODUCTION SY, V1st ed., DOI [10.4324/9780429273018, DOI 10.4324/9780429273018]; Rampersad SE, 2011, LEADING LEAN HEALTHC, P69; ROTHER M, 2010, TOYOTA KATA MANAGING, P220; Shewhart DA, 1939, STAT METHOD VIEWPOIN; SHOOK J, 2012, MANAGING LEARN USING; Sobek D.K., 2008, UNDERSTANDING A3 THI; SOBEK DK, 2008, UNDERSTANDING A3 THI, P50; Spear S, 1999, HARVARD BUS REV, V77, P96; Stapleton FB, 2009, PEDIATR CLIN N AM, V56, P799, DOI 10.1016/j.pcl.2009.05.015; SUN TT, 2012, WRIT RES GRANT APPL	26	29	29	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76833	10.1371/journal.pone.0076833	http://dx.doi.org/10.1371/journal.pone.0076833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204681	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700012
J	Shahriyari, L; Komarova, NL				Shahriyari, Leili; Komarova, Natalia L.			Symmetric vs. Asymmetric Stem Cell Divisions: An Adaptation against Cancer?	PLOS ONE			English	Article							IMMORTAL STRAND HYPOTHESIS; MATHEMATICAL-MODEL; SELF-RENEWAL; TUMOR-GROWTH; COLONIC CRYPT; DIFFERENTIATION; MUTATION; NEUROGENESIS; MECHANISMS; INITIATION	Traditionally, it has been held that a central characteristic of stem cells is their ability to divide asymmetrically. Recent advances in inducible genetic labeling provided ample evidence that symmetric stem cell divisions play an important role in adult mammalian homeostasis. It is well understood that the two types of cell divisions differ in terms of the stem cells' flexibility to expand when needed. On the contrary, the implications of symmetric and asymmetric divisions for mutation accumulation are still poorly understood. In this paper we study a stochastic model of a renewing tissue, and address the optimization problem of tissue architecture in the context of mutant production. Specifically, we study the process of tumor suppressor gene inactivation which usually takes place as a consequence of two "hits'', and which is one of the most common patterns in carcinogenesis. We compare and contrast symmetric and asymmetric (and mixed) stem cell divisions, and focus on the rate at which double-hit mutants are generated. It turns out that symmetrically-dividing cells generate such mutants at a rate which is significantly lower than that of asymmetrically-dividing cells. This result holds whether single-hit (intermediate) mutants are disadvantageous, neutral, or advantageous. It is also independent on whether the carcinogenic double-hit mutants are produced only among the stem cells or also among more specialized cells. We argue that symmetric stem cell divisions in mammals could be an adaptation which helps delay the onset of cancers. We further investigate the question of the optimal fraction of stem cells in the tissue, and quantify the contribution of non-stem cells in mutant production. Our work provides a hypothesis to explain the observation that in mammalian cells, symmetric patterns of stem cell division seem to be very common.	[Shahriyari, Leili; Komarova, Natalia L.] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA	University of California System; University of California Irvine	Komarova, NL (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	komarova@uci.edu			National Institutes of Health (NIH) [1R01CA129286]; NATIONAL CANCER INSTITUTE [R01CA129286] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grant 1R01CA129286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2008, GENE THER, V15, P96, DOI 10.1038/sj.gt.3303063; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Aparicio S, 2009, CELL, V138, P1060, DOI 10.1016/j.cell.2009.09.004; Ashkenazi R, 2008, NEOPLASIA, V10, P1170, DOI 10.1593/neo.08572; Boman BM, 2007, CLIN PHARMACOL THER, V81, P893, DOI 10.1038/sj.clpt.6100202; Boman BM, 2008, CANCER RES, V68, P3304, DOI 10.1158/0008-5472.CAN-07-2061; Cairns J, 2002, P NATL ACAD SCI USA, V99, P10567, DOI 10.1073/pnas.162369899; Cairns J, 2006, SCI AGING KNOWLEDGE, V2006, pcp1; Campbell F, 1996, GUT, V39, P569, DOI 10.1136/gut.39.4.569; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Caussinus Emmanuel, 2007, Prog Mol Subcell Biol, V45, P205; Clarke RB, 2003, CELL PROLIFERAT, V36, P45, DOI 10.1046/j.1365-2184.36.s.1.5.x; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; d'Onofrio A, 2007, J THEOR BIOL, V244, P367, DOI 10.1016/j.jtbi.2006.08.022; de Graaf CA, 2010, P NATL ACAD SCI USA, V107, P21689, DOI 10.1073/pnas.1016166108; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Dingli D, 2007, PLOS COMPUT BIOL, V3, P482, DOI 10.1371/journal.pcbi.0030053; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Egger B, 2011, FLY, V5, P237, DOI 10.4161/fly.5.3.15640; Egger B, 2010, DEVELOPMENT, V137, P2981, DOI 10.1242/dev.051250; Enderling H, 2009, MATH MODEL NAT PHENO, V4, P117, DOI 10.1051/mmnp/20094305; Enderling H, 2009, BRIT J CANCER, V100, P1917, DOI 10.1038/sj.bjc.6605071; Enderling H, 2011, PROGR BIOPHYSICS MOL; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Enderling H, 2009, CANCER RES, V69, P8814, DOI 10.1158/0008-5472.CAN-09-2115; Frank S. A., 2007, DYNAMICS CANC INCIDE; Frank SA, 2003, NATURE, V422, P494, DOI 10.1038/422494a; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Ganguly R, 2007, CELL PROLIFERAT, V40, P338, DOI 10.1111/j.1365-2184.2007.00434.x; Ganguly R, 2006, CELL PROLIFERAT, V39, P3, DOI 10.1111/j.1365-2184.2006.00369.x; Gonzalez C, 2013, NAT REV CANCER, V13, P172, DOI 10.1038/nrc3461; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hardy K, 2002, APOPTOSIS, V7, P373, DOI 10.1023/A:1016183731694; Ho AD, 2005, EXP HEMATOL, V33, P1, DOI 10.1016/j.exphem.2004.09.004; Hormoz S, 2013, J THEOR BIOL, V331, P19, DOI 10.1016/j.jtbi.2013.04.018; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Iwasa Y, 2004, GENETICS, V166, P1571, DOI 10.1534/genetics.166.3.1571; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Karpowicz P, 2005, J CELL BIOL, V170, P721, DOI 10.1083/jcb.200502073; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Komarova NL, 2007, MATH MOD METH APPL S, V17, P1647, DOI 10.1142/S021820250700242X; Komarova NL, 2006, B MATH BIOL, V68, P1573, DOI 10.1007/s11538-005-9046-8; Komarova NL, 2004, CELL CYCLE, V3, P1558, DOI 10.4161/cc.3.12.1186; Komarova NL, 2003, J THEOR BIOL, V223, P433, DOI 10.1016/S0022-5193(03)00120-6; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Lavado A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000460; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Loeffler M, 2002, CELLS TISSUES ORGANS, V171, P8, DOI 10.1159/000057688; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Michor F, 2003, P ROY SOC B-BIOL SCI, V270, P2017, DOI 10.1098/rspb.2003.2483; Michor F, 2008, J CLIN ONCOL, V26, P2854, DOI 10.1200/JCO.2007.15.2421; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Nicolas P, 2007, PLOS COMPUT BIOL, V3, P364, DOI 10.1371/journal.pcbi.0030028; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Nowak MA, 2003, P NATL ACAD SCI USA, V100, P14966, DOI 10.1073/pnas.2535419100; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Ordonez-Moran P, 2012, EMBO J; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Piotrowska M, 2008, COMPLEX SYSTEMS BIOM; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Saha S, 2006, J CELL PHYSIOL, V206, P126, DOI 10.1002/jcp.20441; Saha S, 2008, BIOPHYS J, V94, P4123, DOI 10.1529/biophysj.107.119891; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Spiegel A, 2008, CELL STEM CELL, V3, P484, DOI 10.1016/j.stem.2008.10.006; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tomasetti C, 2010, P NATL ACAD SCI USA, V107, P16766, DOI 10.1073/pnas.1007726107; TOMLINSON IPM, 1995, P NATL ACAD SCI USA, V92, P11130, DOI 10.1073/pnas.92.24.11130; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; Vogelstein B, 2002, GENETIC BASIS HUMAN, V821; Weissman DB, 2009, THEOR POPUL BIOL, V75, P286, DOI 10.1016/j.tpb.2009.02.006; Wodarz D, 2005, COMPUTATIONAL BIOLOGY OF CANCER: LECTURE NOTES AND MATHEMATICAL MODELING, P1, DOI 10.1142/9789812701367; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004; Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002	95	78	78	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76195	10.1371/journal.pone.0076195	http://dx.doi.org/10.1371/journal.pone.0076195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204602	Green Submitted, gold, Green Published			2022-12-27	WOS:000326270700004
J	Lu, J; Zang, JJ; Li, HH				Lu, Jin; Zang, Jiajie; Li, Huihua			Impact of Three Oral Antidiabetic Drugs on Markers of beta-Cell Function in Patients with Type 2 Diabetes: A Meta-Analysis	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; INITIAL COMBINATION THERAPY; GLYCEMIC CONTROL; INSULIN-RESISTANCE; SITAGLIPTIN; METFORMIN; EFFICACY; MONOTHERAPY; PIOGLITAZONE; SAFETY	Background: The effect of metformin, pioglitazone and sitagliptin on beta-cell function in the treatment of type 2 diabetes is controversial. Therefore, we performed a systematic review and meta-analysis to obtain a better understanding in the beta-cell effects of metformin, pioglitazone and sitagliptin. Methods: We searched Pubmed and the Cochrane Center Register of Controlled Trials to identify relevant studies. Trials investigating effects of sitagliptin, metformin or pioglitazone on beta-cell function were identified. The primary outcomes were homeostasis model assessment of beta-cells (HOMA-beta) and proinsulin/insulin ratio (PI/IR). Secondary outcome was hemoglobin A1c level. We used version 2 of the Comprehensive Meta Analysis software for all statistical analyses. Results: Metformin monotherapy was more effective than sitagliptin in improving HOMA-beta (18.01% (95% CI 11.09% to 24.94%) vs. 11.29% (95% CI 9.21% to 13.37%), P = 0.040) and more effective (-0.13 (95% CI -0.082 to -0.192)) than both sitagliptin (-0.064 (95% CI -0.036 to -0.092), P = 0.019) and pioglitazone (-0.068 (95% CI -0.044 to -0.093), P = 0.015) in decreasing PI/IR. Metformin and sitagliptin combined (40.23% (95% CI 32.30% to 48.16%)) were more effective than sitagliptin and pioglitazone (11.82% (95% CI 6.61% to 17.04%), P = 0.000) and pioglitazone and metformin(9.81% (95% CI 1.67% to 17.95%), P = 0.022) in improving HOMA-beta and decreasing PI/IR (20.177 (95% CI -0.118 to -0.237); -0.080 (95% CI -0.045 to -0.114), P = 0.007; -0.038 (95% CI, -0.005 to 0.071), P = 0.023). Limitations: The included RCTs were of short duration (12-54 weeks). We could not determine long term effects on beta-cells. Conclusions: Metformin improves beta-cell function more effectively than pioglitazone or sitagliptin in type 2 diabetes patients. Metformin and sitagliptin improved HOMA-beta and PI/IR more than other combinations.	[Lu, Jin; Li, Huihua] Second Mil Med Univ, Changhai Hosp, Dept Endocrinol, Shanghai, Peoples R China; [Zang, Jiajie] Shanghai Municipal Ctr Dis Control & Prevent, Dept Nutr Hyg, Shanghai, Peoples R China	Naval Medical University; Shanghai Center for Disease Control & Prevention	Lu, J (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Endocrinol, Shanghai, Peoples R China.	lujin12@gmail.com		Zang, Jiajie/0000-0003-2476-2176				Akkan A G, 1994, Diabetes Res, V25, P13; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Aschner P, 2010, DIABETES OBES METAB, V12, P252, DOI 10.1111/j.1463-1326.2009.01187.x; Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; Baggio LL, 2006, ANNU REV MED, V57, P265, DOI 10.1146/annurev.med.57.110104.115624; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Charpentier G, 2009, DIABETES OBES METAB, V11, P844, DOI 10.1111/j.1463-1326.2009.01055.x; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; Del Prato S, 2004, HORM METAB RES, V36, P775, DOI 10.1055/s-2004-826163; Derosa G, 2010, METABOLISM, V59, P887, DOI 10.1016/j.metabol.2009.10.007; Dorkhan M, 2006, J INTERN MED, V260, P125, DOI 10.1111/j.1365-2796.2006.01665.x; Ehses JA, 2003, ENDOCRINOLOGY, V144, P4433, DOI 10.1210/en.2002-0068; Ferrannini E, 2007, DIABETOLOGIA, V50, P2342, DOI 10.1007/s00125-007-0806-x; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Goldstein BJ, 2007, DIABETES CARE, V30, P1979, DOI 10.2337/dc07-0627; Hanefeld M, 2007, CURR MED RES OPIN, V23, P1329, DOI 10.1185/030079907X188152; Harrison LB, 2012, DIABETES CARE, V35, P1406, DOI 10.2337/dc11-2170; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kutoh E, 2009, ENDOCRINE, V35, P333, DOI 10.1007/s12020-009-9174-2; Lim S, 2012, CLIN ENDOCRINOL, V77, P215, DOI 10.1111/j.1365-2265.2011.04240.x; Lupi R, 2002, DIABETES, V51, pS134, DOI 10.2337/diabetes.51.2007.S134; Migoya EM, 2010, CLIN PHARMACOL THER, V88, P801, DOI 10.1038/clpt.2010.184; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Nonaka K, 2008, DIABETES RES CLIN PR, V79, P291, DOI 10.1016/j.diabres.2007.08.021; Pfutzner Andreas, 2004, Diabetes Technol Ther, V6, P405, DOI 10.1089/152091504774198124; Pospisilik JA, 2003, DIABETES, V52, P741, DOI 10.2337/diabetes.52.3.741; Raz I, 2006, DIABETOLOGIA, V49, P2564, DOI 10.1007/s00125-006-0416-z; Reasner C, 2011, DIABETES OBES METAB, V13, P644, DOI 10.1111/j.1463-1326.2011.01390.x; Riche DM, 2009, AM J MED SCI, V337, P321, DOI 10.1097/MAJ.0b013e31818eb721; Rosenstock J, 2006, CLIN THER, V28, P1556, DOI 10.1016/j.clinthera.2006.10.007; Saisho Y, 2007, DIABETES RES CLIN PR, V78, P182, DOI 10.1016/j.diabres.2007.03.014; Scott R, 2008, DIABETES OBES METAB, V10, P959, DOI 10.1111/j.1463-1326.2007.00839.x; Scott R, 2007, INT J CLIN PRACT, V61, P171, DOI 10.1111/j.1742-1241.2006.01246.x; Standl E, 2007, INT J CLIN PRACT, V61, P10, DOI 10.1111/j.1742-1241.2007.01360.x; Tura A, 2003, AM J PHYSIOL-ENDOC M, V285, pE155, DOI 10.1152/ajpendo.00104.2002; Wainstein J, 2012, DIABETES OBES METAB, V14, P409, DOI 10.1111/j.1463-1326.2011.01530.x; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Wallace TM, 2004, DIABETIC MED, V21, P568, DOI 10.1111/j.1464-5491.2004.01218.x; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Williams-Herman D, 2009, CURR MED RES OPIN, V25, P569, DOI 10.1185/03007990802705679 ; Xiang AH, 2006, DIABETES, V55, P517, DOI 10.2337/diabetes.55.02.06.db05-1066	43	10	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76713	10.1371/journal.pone.0076713	http://dx.doi.org/10.1371/journal.pone.0076713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204660	gold, Green Submitted, Green Published			2022-12-27	WOS:000326155400016
J	Saint-Beat, B; Dupuy, C; Bocher, P; Chalumeau, J; De Crignis, M; Fontaine, C; Guizien, K; Lavaud, J; Lefebvre, S; Montanie, H; Mouget, JL; Orvain, F; Pascal, PY; Quaintenne, G; Radenac, G; Richard, P; Robin, F; Vezina, AF; Niquil, N				Saint-Beat, Blanche; Dupuy, Christine; Bocher, Pierrick; Chalumeau, Julien; De Crignis, Margot; Fontaine, Camille; Guizien, Katell; Lavaud, Johann; Lefebvre, Sebastien; Montanie, Helene; Mouget, Jean-Luc; Orvain, Francis; Pascal, Pierre-Yves; Quaintenne, Gwenael; Radenac, Gilles; Richard, Pierre; Robin, Frederic; Vezina, Alain F.; Niquil, Nathalie			Key Features of Intertidal Food Webs That Support Migratory Shorebirds	PLOS ONE			English	Article							MARENNES-OLERON BAY; GASTROPOD HYDROBIA-ULVAE; FRESH-WATER INFLOW; NETWORK ANALYSIS; CONTINENTAL-SHELF; BROUAGE MUDFLAT; AIGUILLON COVE; WADDEN SEA; ECOSYSTEM; CONSUMPTION	The migratory shorebirds of the East Atlantic flyway land in huge numbers during a migratory stopover or wintering on the French Atlantic coast. The Brouage bare mudflat (Marennes-Oleron Bay, NE Atlantic) is one of the major stopover sites in France. The particular structure and function of a food web affects the efficiency of carbon transfer. The structure and functioning of the Brouage food web is crucial for the conservation of species landing within this area because it provides sufficient food, which allows shorebirds to reach the north of Europe where they nest. The aim of this study was to describe and understand which food web characteristics support nutritional needs of birds. Two food-web models were constructed, based on in situ measurements that were made in February 2008 (the presence of birds) and July 2008 (absence of birds). To complete the models, allometric relationships and additional data from the literature were used. The missing flow values of the food web models were estimated by Monte Carlo Markov Chain - Linear Inverse Modelling. The flow solutions obtained were used to calculate the ecological network analysis indices, which estimate the emergent properties of the functioning of a food-web. The total activities of the Brouage ecosystem in February and July are significantly different. The specialisation of the trophic links within the ecosystem does not appear to differ between the two models. In spite of a large export of carbon from the primary producer and detritus in winter, the higher recycling leads to a similar retention of carbon for the two seasons. It can be concluded that in February, the higher activity of the ecosystem coupled with a higher cycling and a mean internal organization, ensure the sufficient feeding of the migratory shorebirds.	[Saint-Beat, Blanche; Dupuy, Christine; Bocher, Pierrick; Chalumeau, Julien; De Crignis, Margot; Fontaine, Camille; Lavaud, Johann; Montanie, Helene; Quaintenne, Gwenael; Radenac, Gilles; Richard, Pierre; Robin, Frederic; Niquil, Nathalie] Univ La Rochelle, CNRS, UMR 7266, Littoral Environm & Soc LIENSs, La Rochelle, France; [Guizien, Katell] Lab Oceanog Biol Banyuls, Banyuls Sur Mer, France; [Lefebvre, Sebastien] Univ Lille 1, Lab Oceanog & Geosci, Wimereux, France; [Mouget, Jean-Luc] Univ Maine, F-72017 Le Mans, France; [Pascal, Pierre-Yves] UFR Sci Exactes & Nat SEN, Dept Biol, Pointe a Pitre, France; [Vezina, Alain F.] Bedford Inst Oceanog, Dartmouth, NS, Canada; [Orvain, Francis; Niquil, Nathalie] CNRS, UMR Biol Organismes & Ecosyst Aquat BOREA 7208, Lab Biol Mollusques Marins & Ecosyst Associes Bio, Caen, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; Universite de Lille; Le Mans Universite; Bedford Institute of Oceanography; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Saint-Beat, B (corresponding author), Univ La Rochelle, CNRS, UMR 7266, Littoral Environm & Soc LIENSs, La Rochelle, France.	blanche.saint-beat@univ-lr.fr	Niquil, Nathalie/N-2561-2013; Lefebvre, Sébastien/G-8562-2011; Guizien, Katell/D-1534-2013; RADENAC, Gilles/O-9760-2014; Richard, Pierre J/N-6482-2014; Niquil, Nathalie/C-8233-2009; Lavaud, Johann/N-6185-2014; Montanié, Hélène/N-9832-2014; Guizien, Katell/I-7061-2016	Lefebvre, Sébastien/0000-0002-7152-5897; Guizien, Katell/0000-0001-9884-7506; RADENAC, Gilles/0000-0002-7906-6453; Richard, Pierre J/0000-0002-0393-9967; Lavaud, Johann/0000-0002-4704-2502; Montanié, Hélène/0000-0001-7574-7828; Guizien, Katell/0000-0001-9884-7506; Saint-Beat, Blanche/0000-0002-2401-2052; Dupuy, Christine/0000-0002-5634-1336; Robin, Frederic/0000-0003-0232-1142; Niquil, Nathalie/0000-0002-0772-754X	French ANR (Agence Nationale de la Recherche); CNRS; Region Poitou-Charentes; French ANR (Agence Nationale de la Recherche); CNRS; Region Poitou-Charentes	French ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Poitou-Charentes(Region Nouvelle-Aquitaine); French ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Poitou-Charentes(Region Nouvelle-Aquitaine)	This work was supported by a grant from the French ANR (Agence Nationale de la Recherche) programme blanc "Vasiremi: Trophic significance of microbial biofilms in tidal flats," coordinated by CD. BSB was supported by a PhD fellowship from the CNRS and Region Poitou-Charentes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2005, ECOL MODEL, V189, P221, DOI 10.1016/j.ecolmodel.2005.04.002; BAIRD D, 1993, MAR ECOL PROG SER, V99, P221, DOI 10.3354/meps099221; Baird D, 2004, MAR ECOL PROG SER, V279, P45, DOI 10.3354/meps279045; Baird D, 1996, WATER SA, V22, P307; BAIRD D, 1991, PHILOS T R SOC B, V333, P15, DOI 10.1098/rstb.1991.0058; Baird D, 2007, MAR ECOL PROG SER, V351, P25, DOI 10.3354/meps07137; Blanchard GF, 1997, J PHYCOL, V33, P723, DOI 10.1111/j.0022-3646.1997.00723.x; Bocher P, 2007, MAR BIOL, V151, P577, DOI 10.1007/s00227-006-0500-4; Bocher P, 2012, J ORNITHOL, V153, P103, DOI 10.1007/s10336-011-0702-5; Boileau N, 2011, ALAUDA, V80, P13; Brey T., 2001, VIRTUAL HDB POPULATI; Brey T, 2010, METHODS ECOL EVOL, V1, P92, DOI 10.1111/j.2041-210X.2009.00008.x; CARIOULEGALL V, 1995, MAR ECOL-PROG SER, V121, P171, DOI DOI 10.3354/MEPS121171; CHRISTENSEN V, 1995, ECOL MODEL, V77, P3, DOI 10.1016/0304-3800(93)E0073-C; Christensen V, 2009, ECOL MODEL, V220, P1984, DOI 10.1016/j.ecolmodel.2009.04.041; Corinaldesi C, 2010, FEMS MICROBIOL ECOL, V72, P208, DOI 10.1111/j.1574-6941.2010.00840.x; Crisp D. J., 1971, P197; Degre D, 2006, ESTUAR COAST SHELF S, V69, P107, DOI 10.1016/j.ecss.2006.04.001; DEJONGE VN, 1980, MAR ECOL PROG SER, V2, P345, DOI 10.3354/meps002345; DEKINGA A, 1993, BIRD STUDY, V40, P144, DOI 10.1080/00063659309477140; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Delany S, 2009, ATLAS WADERS POPULAT; Dwyer RG, 2010, ECOLOGICAL ANTHROPOG; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; Folmer EO, 2010, J ANIM ECOL, V79, P747, DOI 10.1111/j.1365-2656.2010.01680.x; FUHRMAN JA, 1981, MAR ECOL PROG SER, V5, P103, DOI 10.3354/meps005103; Gouleau D, 2000, CONT SHELF RES, V20, P1513, DOI 10.1016/S0278-4343(00)00035-2; Guarini JM, 2000, CONT SHELF RES, V20, P1771, DOI 10.1016/S0278-4343(00)00047-9; Haubois AG, 2005, ESTUAR COAST SHELF S, V64, P385, DOI 10.1016/j.ecss.2005.03.004; Haubois AG, 2004, J SEA RES, V51, P63, DOI 10.1016/j.seares.2003.02.001; Herlory O, 2004, MAR ECOL PROG SER, V282, P33, DOI 10.3354/meps282033; HIRATA H, 1984, INT J SYST SCI, V15, P261, DOI 10.1080/00207728408926559; Johnson GA, 2009, ECOL MODEL, V220, P3448, DOI 10.1016/j.ecolmodel.2009.08.003; Kay JJ, 1989, COAST ESTUARINE STUD, V32; KERSTEN M, 1987, ARDEA, V75, P175; Kones JK, 2009, ECOL MODEL, V220, P370, DOI 10.1016/j.ecolmodel.2008.10.012; Kuwae T, 2008, ECOLOGY, V89, P599, DOI 10.1890/07-1442.1; Kuwae T, 2012, ECOL LETT, V15, P347, DOI 10.1111/j.1461-0248.2012.01744.x; Lassalle G, 2011, PROG OCEANOGR, V91, P561, DOI 10.1016/j.pocean.2011.09.002; Lassalle G, 2012, ICES J MAR SCI, V69, P925, DOI 10.1093/icesjms/fss049; Leguerrier D, 2004, MAR ECOL PROG SER, V273, P147, DOI 10.3354/meps273147; Leguerrier D, 2003, MAR ECOL PROG SER, V246, P17, DOI 10.3354/meps246017; Leguerrier D, 2007, ESTUAR COAST SHELF S, V74, P403, DOI 10.1016/j.ecss.2007.04.014; Leloup FA, 2008, ESTUAR COAST SHELF S, V76, P111, DOI 10.1016/j.ecss.2007.06.011; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Lourenco PM, 2008, ACTA OECOL, V34, P122, DOI 10.1016/j.actao.2008.04.005; Luis A., 2001, Wader Study Group Bulletin, V96, P71; Maheo R, 2008, LIMICOLES SEJOURNANT; Mouget JL, 2008, AQUAT MICROB ECOL, V52, P223, DOI 10.3354/ame01218; Niquil N, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 9: ESTUARINE AND COASTAL ECOSYSTEM MODELLING, P115; Niquil N, 2012, ESTUAR COAST SHELF S, V108, P132, DOI 10.1016/j.ecss.2011.12.031; Nolet BA, 2006, J ANIM ECOL, V75, P1285, DOI 10.1111/j.1365-2656.2006.01150.x; Orvain F, 2007, CONT SHELF RES, V27, P1153, DOI 10.1016/j.csr.2006.05.013; Pascal PY, 2008, J SEA RES, V60, P151, DOI 10.1016/j.seares.2008.05.003; Pascal PY, 2008, MAR BIOL, V154, P671, DOI 10.1007/s00227-008-0960-9; Pascal PY, 2008, J EXP MAR BIOL ECOL, V359, P55, DOI 10.1016/j.jembe.2008.02.018; Pascal PY, 2008, J EXP MAR BIOL ECOL, V355, P18, DOI 10.1016/j.jembe.2007.11.012; Pascal PY, 2009, LIMNOL OCEANOGR, V54, P1048, DOI 10.4319/lo.2009.54.4.1048; Ponsero A, 2011, REV ECOL-TERRE VIE, V66, P383; Quaintenne G, 2010, J ANIM ECOL, V79, P53, DOI 10.1111/j.1365-2656.2009.01608.x; Robin F, CONDOR IN PRESS; Romanova ND, 2010, OCEANOLOGY+, V50, P522, DOI 10.1134/S0001437010040089; Rzeznik-Orignac J, 2012, J EXP MAR BIOL ECOL, V432, P179, DOI 10.1016/j.jembe.2012.06.019; Saint-Beat B, 2013, ECOL MODEL, V258, P53, DOI 10.1016/j.ecolmodel.2013.01.023; Scharler UM, 2005, J MARINE SYST, V56, P283, DOI 10.1016/j.jmarsys.2004.12.003; Scheiffarth G, 2001, ARDEA, V89, P481; Scheiffarth G, 1997, HELGOLANDER MEERESUN, V51, P373, DOI 10.1007/BF02908721; Schiemer F, 1987, ANIMAL ENERGETICS, P185; Serodio J, 2009, AQUAT MICROB ECOL; Serodio J, 2008, CONT SHELF RES, V28, P1363, DOI 10.1016/j.csr.2008.03.019; Stillman RA, 2007, IBIS, V149, P73, DOI 10.1111/j.1474-919X.2007.00649.x; Sueur Francois, 2003, Alauda, V71, P49; SUTHERLAND WJ, 1983, J ANIM ECOL, V52, P821, DOI 10.2307/4456; Tortajada S, 2012, ACTA OECOL, V40, P40, DOI 10.1016/j.actao.2012.02.002; TURPIE JK, 1993, IBIS, V135, P156, DOI 10.1111/j.1474-919X.1993.tb02827.x; Ulanowicz R. E., 1991, Environmental Software, V6, P131, DOI 10.1016/0266-9838(91)90024-K; Ulanowicz R.E., 1997, ECOLOGY ASCENDENT PE; Ulanowicz R. E., 1986, GROWTH DEV ECOSYSTEM; Van den Meersche K., 2009, J STAT SOFTW, V30, P1, DOI [DOI 10.18637/JSS.V030.C01, 10.1002/wics.10., DOI 10.18637/jss.v030.c01]; van Gils JA, 2005, P ROY SOC B-BIOL SCI, V272, P2609, DOI 10.1098/rspb.2005.3245; van Oevelen D, 2006, J MAR RES, V64, P453, DOI 10.1357/002224006778189581; Verger F, 2005, MARAIS ESTUAIRES LIT; Vezina A.F., 1989, Coastal and Estuarine Studies, P62; VEZINA AF, 1988, MAR ECOL PROG SER, V42, P269, DOI 10.3354/meps042269; Viain Anouck, 2011, Wildfowl, V61, P121; Vieira S, 2010, BIOL J LINN SOC, V100, P439, DOI 10.1111/j.1095-8312.2010.01428.x; WARWICK RM, 1979, ESTUAR COAST MAR SCI, V9, P257, DOI 10.1016/0302-3524(79)90039-2; ZWARTS L, 1993, NETH J SEA RES, V31, P441, DOI 10.1016/0077-7579(93)90059-2	88	23	23	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76739	10.1371/journal.pone.0076739	http://dx.doi.org/10.1371/journal.pone.0076739			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204666	gold, Green Published			2022-12-27	WOS:000326155400018
J	Becker, S; Kribben, A; Meister, S; Diamantidis, CJ; Unger, N; Mitchell, A				Becker, Stefan; Kribben, Andreas; Meister, Sven; Diamantidis, Clarissa Jonas; Unger, Nicole; Mitchell, Anna			User Profiles of a Smartphone Application to Support Drug Adherence -Experiences from the iNephro Project	PLOS ONE			English	Article							HEALTH INFORMATION-TECHNOLOGY; MOBILE PHONE TECHNOLOGY; IMPROVE ADHERENCE; DIGITAL DIVIDE; MEDICATION; INTERVENTIONS; USABILITY; REMINDERS; INTERNET; SYSTEM	Purpose: One of the key problems in the drug therapy of patients with chronic conditions is drug adherence. In 2010 the initiative iNephro was launched (www.inephro.de). A software to support regular and correct drug intake was developed for a smartphone platform (iOS). The study investigated whether and how smartphone users deployed such an application. Methods: Together with cooperating partners the mobile application "Medikamentenplan" ("Medication Plan") was developed. Users are able to keep and alter a list of their regular medication. A memory function supports regular intake. The application can be downloaded free of charge from the App Store (TM) by Apple (TM). After individual consent of users from December 2010 to April 2012 2042338 actions were recorded and analysed from the downloaded applications. Demographic data were collected from 2279 users with a questionnaire. Results: Overall the application was used by 11688 smartphone users. 29% (3406/11688) used it at least once a week for at least four weeks. 27% (3209/11688) used the application for at least 84 days. 68% (1554/2279) of users surveyed were male, the stated age of all users was between 6-87 years (mean 44). 74% of individuals (1697) declared to be suffering from cardiovascular disease, 13% (292) had a previous history of transplantation, 9% (205) were suffering from cancer, 7% (168) reported an impaired renal function and 7% (161) suffered from diabetes mellitus. 69% (1568) of users were on,6 different medications, 9% (201) on 6 - 0 and 1% (26) on more than 10. Conclusion: A new smartphone application, which supports drug adherence, was used regularly by chronically ill users with a wide range of diseases over a longer period of time. The majority of users so far were middle-aged and male.	[Becker, Stefan; Unger, Nicole] Ruhr Univ Bochum, Dept Internal Med 1, Marienhosp Herne, Univ Hosp, Herne, Germany; [Becker, Stefan; Kribben, Andreas; Mitchell, Anna] Univ Duisburg Essen, Dept Nephrol, Essen, Germany; [Meister, Sven] Fraunhofer Inst Software & Syst Engn, Dortmund, Germany; [Diamantidis, Clarissa Jonas] Univ Maryland, Sch Med, Div Nephrol, Baltimore, MD 21201 USA	Ruhr University Bochum; St. Marien Hospital; University of Duisburg Essen; Fraunhofer Gesellschaft; University System of Maryland; University of Maryland Baltimore	Becker, S (corresponding author), Ruhr Univ Bochum, Dept Internal Med 1, Marienhosp Herne, Univ Hosp, Herne, Germany.	stefan.becker@uk-essen.de		Meister, Sven/0000-0003-0522-986X	Roche Pharma, Grenzach-Wyhlen, Germany	Roche Pharma, Grenzach-Wyhlen, Germany	The iNephro project was financed by an unrestricted grant from Roche Pharma, Grenzach-Wyhlen, Germany (http://www.roche.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MED TRIBUNE; Arora S, 2012, DIABETES TECHNOL THE, V14, P492, DOI 10.1089/dia.2011.0252; Becker S, 2012, HERZ; Boulos MNK, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-24; Bundesverband Informationswirtschaft, 2012, ZEIT HAND MARKT; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Choi NG, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2645; Consumer Health Information Corporation, 2011, MOT PAT US SMARTPH H; Diamantidis CJ, 2013, AM J KIDNEY DIS, V61, P644, DOI 10.1053/j.ajkd.2012.09.016; Diamantidis CJ, 2012, CLIN J AM SOC NEPHRO, V7, P1553, DOI 10.2215/CJN.03690412; Downer Sean R, 2006, Aust Health Rev, V30, P389; Federal Statistical Office, 2011, BEV NACH BILD DEUTSC; Federal Statistical Office, 2011, MOB INT HAND 2010 ST; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; FOCUS Magazin, 2011, FOCUS MAGAZIN; Fortney JC, 2011, J GEN INTERN MED, V26, pS639, DOI 10.1007/s11606-011-1806-6; Fronstin Paul, 2011, EBRI Issue Brief, P1; Gesundheit.nrw, 2011, APPS TEST INEPHRO ME; Hurling R, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.2.e7; Kelly JD, 2011, AIDS, V25, P1137, DOI 10.1097/QAD.0b013e32834670d7; Kerwin Maureen, 2012, Stud Health Technol Inform, V177, P254; Kripalani S, 2007, ARCH INTERN MED, V167, P540, DOI 10.1001/archinte.167.6.540; Lane Shannon J, 2006, BMC Med Inform Decis Mak, V6, P23, DOI 10.1186/1472-6947-6-23; Lopez L, 2011, JT COMM J QUAL PATIE, V37, P437, DOI 10.1016/S1553-7250(11)37055-9; Mulvaney SA, 2012, J TELEMED TELECARE, V18, P115, DOI 10.1258/jtt.2011.111006; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; PriceWaterhouseCoopers, 2012, EM MHEALTH PATHS GRO; Rai A, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2635; Robert Koch Institut, 2012, BEITR GES BUND RKI; Rodgers A, 2005, TOB CONTROL, V14, P255, DOI 10.1136/tc.2005.011577; Rogers EM, 1962, DIFFUSION INNOVATION; Rundfunk Berlin-Brandenburg, 2011, PRAXIS SERV APP MED; Sarasohn-Kahn J, 2010, SMARTPHONES ARE CHAN; Schafer I, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-89; Smith A., 2013, SMARTPHONE OWNERSHIP; Stiftung Warentest, 2011, APP MED TEST 06 2011; TechCrunch, 2013, ABI 43 6B APP DOWNL; Trill R, 2008, TELEMEDIZINFUHRER DT, P102; Vervloet M, 2012, INT J MED INFORM, V81, P594, DOI 10.1016/j.ijmedinf.2012.05.005; Vervloet M, 2012, J AM MED INFORM ASSN, V19, P696, DOI 10.1136/amiajnl-2011-000748; Vrijens B, 2008, BMJ-BRIT MED J, V336, P1114, DOI 10.1136/bmj.39553.670231.25; Weaver A, 2007, ANN ONCOL, V18, P1887, DOI 10.1093/annonc/mdm354; Wojciechowski M, 2011, AAL KONGRESS 2011, V1	44	53	54	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78547	10.1371/journal.pone.0078547	http://dx.doi.org/10.1371/journal.pone.0078547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194946	Green Published, gold			2022-12-27	WOS:000326037000125
J	Beguin, J; McIntire, EJB; Fortin, D; Cumming, SG; Raulier, F; Racine, P; Dussault, C				Beguin, Julien; McIntire, Eliot J. B.; Fortin, Daniel; Cumming, Steven G.; Raulier, Frederic; Racine, Pierre; Dussault, Claude			Explaining Geographic Gradients in Winter Selection of Landscapes by Boreal Caribou with Implications under Global Changes in Eastern Canada	PLOS ONE			English	Article							WOODLAND CARIBOU; BEHAVIORAL-RESPONSE; RANGIFER-TARANDUS; CLIMATE-CHANGE; FIRE REGIMES; FOREST; MODELS; BIODIVERSITY; AVOIDANCE; PREDATION	Many animal species exhibit broad-scale latitudinal or longitudinal gradients in their response to biotic and abiotic components of their habitat. Although knowing the underlying mechanism of these patterns can be critical to the development of sound measures for the preservation or recovery of endangered species, few studies have yet identified which processes drive the existence of geographical gradients in habitat selection. Using extensive spatial data of broad latitudinal and longitudinal extent, we tested three hypotheses that could explain the presence of geographical gradients in landscape selection of the endangered boreal woodland caribou (Rangifer tarandus caribou) during winter in Eastern Canadian boreal forests: 1) climate-driven selection, which postulates that geographic gradients are surrogates for climatic gradients; 2) road-driven selection, which proposes that boreal caribou adjust their selection for certain habitat classes as a function of proximity to roads; and 3) an additive effect of both roads and climate. Our data strongly supported road-driven selection over climate influences. Thus, direct human alteration of landscapes drives boreal caribou distribution and should likely remain so until the climate changes sufficiently from present conditions. Boreal caribou avoided logged areas two-fold more strongly than burnt areas. Limiting the spread of road networks and accounting for the uneven impact of logging compared to wildfire should therefore be integral parts of any habitat management plan and conservation measures within the range of the endangered boreal caribou. The use of hierarchical spatial models allowed us to explore the distribution of spatially-structured errors in our models, which in turn provided valuable insights for generating alternative hypotheses about processes responsible for boreal caribou distribution.	[Beguin, Julien; McIntire, Eliot J. B.; Cumming, Steven G.; Raulier, Frederic; Racine, Pierre] Univ Laval, Dept Sci Bois & Foret, Quebec City, PQ, Canada; [Beguin, Julien; McIntire, Eliot J. B.; Fortin, Daniel; Cumming, Steven G.; Raulier, Frederic; Racine, Pierre] Univ Laval, Ctr Etud Foret, Quebec City, PQ, Canada; [McIntire, Eliot J. B.] Nat Resources Canada, Pacific Forestry Ctr, Canadian Forest Serv, Victoria, BC, Canada; [Fortin, Daniel] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Dussault, Claude] Minist Ressources Nat & Faune, Direct Expertise Energie Faune Forets Mines Terr, Joncquiere, PQ, Canada	Laval University; Laval University; Natural Resources Canada; Canadian Forest Service; Laval University	Beguin, J (corresponding author), Univ Laval, Dept Sci Bois & Foret, Quebec City, PQ, Canada.	julien.beguin.1@ulaval.ca	Racine, Pierre/K-7399-2012; Fortin, Daniel/ABG-3554-2020; McIntire, Eliot/F-7995-2011	Racine, Pierre/0000-0003-0658-1945; Beguin, Julien/0000-0002-1168-4407; McIntire, Eliot/0000-0002-6914-8316	NSERC (Natural Sciences and Engineering Research Council of Canada)	NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research was provided by an NSERC (Natural Sciences and Engineering Research Council of Canada) scholarship to J.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton KG, 2000, AM NAT, V156, P390, DOI 10.1086/303400; Balshi MS, 2009, GLOBAL CHANGE BIOL, V15, P578, DOI 10.1111/j.1365-2486.2008.01679.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bastille-Rousseau G., 2012, SELECTION HABITAT CA; Bergeron Y, 2004, ECOLOGY, V85, P1916, DOI 10.1890/02-0716; Bouchard M, 2008, CAN J FOREST RES, V38, P1621, DOI 10.1139/X07-201; Boulet M, 2007, MOL ECOL, V16, P4223, DOI 10.1111/j.1365-294X.2007.03476.x; COSEWIC, 2002, COSEWIC ASS UPD STAT; Courbin N, 2009, LANDSCAPE ECOL, V24, P1375, DOI 10.1007/s10980-009-9389-x; Courtois R, 2004, FOREST CHRON, V80, P598, DOI 10.5558/tfc80598-5; Courtois R, 2003, CAN FIELD NAT, V117, P546, DOI 10.22621/cfn.v117i4.823; Courtois R, 2008, CAN J FOREST RES, V38, P2837, DOI 10.1139/X08-119; Couturier S, 2010, J WILDLIFE MANAGE, V74, P395, DOI 10.2193/2008-384; Cyr D, 2009, FRONT ECOL ENVIRON, V7, P519, DOI 10.1890/080088; DeCesare NJ, 2012, P ROY SOC B-BIOL SCI, V279, P4626, DOI 10.1098/rspb.2012.1698; Dussault C, 2012, P ROY SOC B-BIOL SCI, V279, P4481, DOI 10.1098/rspb.2012.1700; Dyer SJ, 2001, J WILDLIFE MANAGE, V65, P531, DOI 10.2307/3803106; Environment Canada, 2012, REC STAT WOODL CAR B; Environment Canada, 2008, SCI REV IDENTIFICATI; Environment Canada, 2011, NAT CLIM DAT INF ARC; Equipe de retablissement du caribou forestier du Quebec, 2008, PLAN RETABLISSEMENT; Faille G, 2010, BIOL CONSERV, V143, P2840, DOI 10.1016/j.biocon.2010.08.001; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/z11-025, 10.1139/Z11-025]; Fortin D, 2008, J APPL ECOL, V45, P1392, DOI 10.1111/j.1365-2664.2008.01542.x; Fortin D, 2013, AM NAT, V181, P827, DOI 10.1086/670243; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Gauthier S., 2009, ECOSYSTEM MANAGEMENT; Government of Quebec, 2010, LOI AMENAGEMENT DURA; Herfindal I, 2006, OECOLOGIA, V150, P213, DOI 10.1007/s00442-006-0519-8; Houle M, 2010, LANDSCAPE ECOL, V25, P419, DOI 10.1007/s10980-009-9420-2; HUNTER ML, 1993, BIOL CONSERV, V65, P115, DOI 10.1016/0006-3207(93)90440-C; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; MacArthur R.H., 1972, pvii; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; McKenney DW, 2006, AGR FOREST METEOROL, V138, P69, DOI 10.1016/j.agrformet.2006.03.012; Ministere des ressources naturelles et; de la Faune du Quebec, 2003, NORM CART EC TROIS I, P109; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Oliver T, 2009, ECOL LETT, V12, P1091, DOI 10.1111/j.1461-0248.2009.01367.x; Oliver TH, 2012, J APPL ECOL, V49, P581, DOI 10.1111/j.1365-2664.2012.02138.x; Panel Intergovernmentalon Climate Change - IPCC, 2007, CLIM CHANG SYNTHE RE; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Post E, 2005, ECOLOGY, V86, P2320, DOI 10.1890/04-0823; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Schaefer JA, 2003, CONSERV BIOL, V17, P1435, DOI 10.1046/j.1523-1739.2003.02288.x; SCHAEFER JA, 1991, WILDLIFE MONOGR, P1; Sharma S, 2009, GLOBAL CHANGE BIOL, V15, P2549, DOI 10.1111/j.1365-2486.2009.01945.x; Thomas DC, 2011, RANGIFER, V16, P337; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Vors LS, 2007, J WILDLIFE MANAGE, V71, P1249, DOI 10.2193/2006-263; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Zuur Alain F., 2009, P1	55	4	4	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78510	10.1371/journal.pone.0078510	http://dx.doi.org/10.1371/journal.pone.0078510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194942	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000121
J	Hadass, O; Tomlinson, BN; Gooyit, M; Chen, SY; Purdy, JJ; Walker, JM; Zhang, CY; Giritharan, AB; Purnell, W; Robinson, CR; Shin, D; Schroeder, VA; Suckow, MA; Simonyi, A; Sun, GY; Mobashery, S; Cui, JK; Chang, M; Gu, ZZ				Hadass, Orr; Tomlinson, Brittany N.; Gooyit, Major; Chen, Shanyan; Purdy, Justin J.; Walker, Jennifer M.; Zhang, Chunyang; Giritharan, Andrew B.; Purnell, Whitley; Robinson, Christopher R., II; Shin, Dmitriy; Schroeder, Valerie A.; Suckow, Mark A.; Simonyi, Agnes; Sun, Grace Y.; Mobashery, Shahriar; Cui, Jiankun; Chang, Mayland; Gu, Zezong			Selective Inhibition of Matrix Metalloproteinase-9 Attenuates Secondary Damage Resulting from Severe Traumatic Brain Injury	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; GELATINASE INHIBITOR; KNOCK-OUT; BLOOD; DEGRADATION; EXPRESSION; NEURODEGENERATION; ACTIVATION; MICROGLIA; MECHANISM	Traumatic brain injury (TBI) is a leading cause of death and long-term disability. Following the initial insult, severe TBI progresses to a secondary injury phase associated with biochemical and cellular changes. The secondary injury is thought to be responsible for the development of many of the neurological deficits observed after TBI and also provides a window of opportunity for therapeutic intervention. Matrix metalloproteinase-9 (MMP-9 or gelatinase B) expression is elevated in neurological diseases and its activation is an important factor in detrimental outcomes including excitotoxicity, mitochondrial dysfunction and apoptosis, and increases in inflammatory responses and astrogliosis. In this study, we used an experimental mouse model of TBI to examine the role of MMP-9 and the therapeutic potential of SB-3CT, a mechanism-based gelatinase selective inhibitor, in ameliorating the secondary injury. We observed that activation of MMP-9 occurred within one day following TBI, and remained elevated for 7 days after the initial insult. SB-3CT effectively attenuated MMP-9 activity, reduced brain lesion volumes and prevented neuronal loss and dendritic degeneration. Pharmacokinetic studies revealed that SB-3CT and its active metabolite, p-OH SB-3CT, were rapidly absorbed and distributed to the brain. Moreover, SB-3CT treatment mitigated microglial activation and astrogliosis after TBI. Importantly, SB-3CT treatment improved long-term neurobehavioral outcomes, including sensorimotor function, and hippocampus-associated spatial learning and memory. These results demonstrate that MMP-9 is a key target for therapy to attenuate secondary injury cascades and that this class of mechanism-based gelatinase inhibitor-with such desirable pharmacokinetic properties-holds considerable promise as a potential pharmacological treatment of TBI.	[Hadass, Orr; Tomlinson, Brittany N.; Chen, Shanyan; Purdy, Justin J.; Zhang, Chunyang; Giritharan, Andrew B.; Purnell, Whitley; Robinson, Christopher R., II; Shin, Dmitriy; Cui, Jiankun; Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO USA; [Simonyi, Agnes; Sun, Grace Y.] Univ Missouri, Sch Med, Dept Biochem, Columbia, MO USA; [Hadass, Orr; Tomlinson, Brittany N.; Chen, Shanyan; Purdy, Justin J.; Zhang, Chunyang; Giritharan, Andrew B.; Purnell, Whitley; Robinson, Christopher R., II; Simonyi, Agnes; Sun, Grace Y.; Cui, Jiankun; Gu, Zezong] Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO USA; [Hadass, Orr; Tomlinson, Brittany N.] Univ Missouri, MS Pathol Program, Grad Sch, Columbia, MO USA; [Chen, Shanyan] Univ Missouri, Interdisciplinary Neurosci Program, Grad Sch, Columbia, MO USA; [Walker, Jennifer M.] Univ Missouri, Dept Psychol Sci, Columbia, MO USA; [Gooyit, Major; Mobashery, Shahriar; Chang, Mayland] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Suckow, Mark A.] Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Suckow, Mark A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Notre Dame; University of Notre Dame; University of Notre Dame	Chang, M (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	mchang@nd.edu; guze@health.missouri.edu	Suckow, Mark/C-2696-2014	Suckow, Mark/0000-0001-7317-697X; Shin, Dmitriy/0000-0002-5571-9384	Mizzou Advantage; Department of Pathology and Anatomical Sciences; ICATS; NFL Charities Foundation; Indiana Department of Health Spinal Cord and Brain Fund; National Institutes of Health [GM075762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762] Funding Source: NIH RePORTER	Mizzou Advantage; Department of Pathology and Anatomical Sciences; ICATS; NFL Charities Foundation; Indiana Department of Health Spinal Cord and Brain Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funding from Mizzou Advantage, the Department of Pathology and Anatomical Sciences (to ZG) and ICATS Fellowship (to JP) at the University of Missouri; the NFL Charities Foundation and the Indiana Department of Health Spinal Cord and Brain Fund (to MC and ZG) and National Institutes of Health Training Grant GM075762 (to MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brown S, 2000, J AM CHEM SOC, V122, P6799, DOI 10.1021/ja001461n; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Cui JK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-21; del Zoppo GJ, 2007, STROKE, V38, P646, DOI 10.1161/01.STR.0000254477.34231.cb; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Forbes C, 2009, CHEM BIOL DRUG DES, V74, P527, DOI 10.1111/j.1747-0285.2009.00881.x; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; Gooyit M, 2012, ACS CHEM NEUROSCI, V3, P730, DOI 10.1021/cn300062w; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Guo ZD, 2010, NEUROL RES, V32, P715, DOI 10.1179/016164109X12478302362491; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Horstmann S, 2003, STROKE, V34, P2165, DOI 10.1161/01.STR.0000088062.86084.F2; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kettenmann H, 2007, NATURE, V446, P987, DOI 10.1038/nature05713; Kim GW, 2003, J NEUROSCI, V23, P8733; Lam CK, 2010, NATURE, V465, P478, DOI 10.1038/nature09001; Lee M, 2007, CHEM BIOL DRUG DES, V70, P371, DOI 10.1111/j.1747-0285.2007.00577.x; Lee M, 2009, CHEM BIOL DRUG DES, V73, P189, DOI 10.1111/j.1747-0285.2008.00750.x; Liu HQ, 2011, EXP NEUROL, V231, P236, DOI 10.1016/j.expneurol.2011.06.015; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Montaner J, 2001, STROKE, V32, P2762, DOI 10.1161/hs1201.99512; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Noble LJ, 2002, J NEUROSCI, V22, P7526; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Pardridge William M, 2005, NeuroRx, V2, P3; Qiu LB, 2011, TOXICOLOGY, V285, P31, DOI 10.1016/j.tox.2011.03.019; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Switzer JA, 2011, STROKE, V42, P2633, DOI 10.1161/STROKEAHA.111.618215; Toth M, 2000, J BIOL CHEM, V275, P41415, DOI 10.1074/jbc.M006871200; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Yagi Y, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-S1-S12; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Yu F, 2008, J NEUROTRAUM, V25, P184, DOI 10.1089/neu.2007.0438; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	48	81	88	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76904	10.1371/journal.pone.0076904	http://dx.doi.org/10.1371/journal.pone.0076904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194849	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000028
J	Nyegaard, S; Novakovic, VA; Rasmussen, JT; Gilbert, GE				Nyegaard, Steffen; Novakovic, Valerie A.; Rasmussen, Jan T.; Gilbert, Gary E.			Lactadherin Inhibits Secretory Phospholipase A(2) Activity on Pre-Apoptotic Leukemia Cells	PLOS ONE			English	Article							INTERFACIAL BINDING SURFACE; GROUP-V; GROUP-II; PHOSPHATIDYLSERINE EXPOSURE; INFLAMMATORY DISEASES; EMERGING ROLES; GROWTH-FACTOR; IN-VIVO; MEMBRANE; EXPRESSION	Secretory phospholipase A(2) (sPLA(2)) is a critical component of insect and snake venoms and is secreted by mammalian leukocytes during inflammation. Elevated secretory PLA(2) concentrations are associated with autoimmune diseases and septic shock. Many sPLA(2)'s do not bind to plasma membranes of quiescent cells but bind and digest phospholipids on the membranes of stimulated or apoptotic cells. The capacity of these phospholipases to digest membranes of stimulated or apoptotic cells correlates to the exposure of phosphatidylserine. In the present study, the ability of the phosphatidyl-L-serine-binding protein, lactadherin to inhibit phospholipase enzyme activity has been assessed. Inhibition of human secretory phospholipase A(2)-V on phospholipid vesicles exceeded 90%, whereas inhibition of Naja mossambica sPLA(2) plateaued at 50-60%. Lactadherin inhibited 45% of activity of Naja mossambica sPLA(2) and >70% of human secretory phospholipase A(2)-V on the membranes of human NB4 leukemia cells treated with calcium ionophore A23187. The data indicate that lactadherin may decrease inflammation by inhibiting sPLA(2).	[Nyegaard, Steffen; Rasmussen, Jan T.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Nyegaard, Steffen; Novakovic, Valerie A.; Gilbert, Gary E.] Brigham & Womens Hosp, Dept Med, Vet Adm Boston Healthcare Syst, Boston, MA 02115 USA; [Nyegaard, Steffen; Novakovic, Valerie A.; Gilbert, Gary E.] Harvard Univ, Sch Med, Boston, MA USA	Aarhus University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Rasmussen, JT (corresponding author), Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark.	jatr@mb.au.dk		Novakovic, Valerie/0000-0002-9846-0907; Rasmussen, Jan Trige/0000-0002-2809-7225	Arla Foods (amba); Aarhus University; Danish Council for Independent Research | Natural Sciences; Veterans Administration Merit Award	Arla Foods (amba); Aarhus University; Danish Council for Independent Research | Natural Sciences(Det Frie Forskningsrad (DFF)); Veterans Administration Merit Award	This study was funded by Arla Foods (amba) (http://www.arla.dk/), Aarhus University (http://www.au.dk/en/) and The Danish Council for Independent Research | Natural Sciences (FNU) (http://fivu.dk/en) and a Veterans Administration Merit Award (http://www.research.va.gov/services/csrd/#.UYp_kcozooE) to GEG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsman AJ, 2000, BBA-MOL BASIS DIS, V1502, P257, DOI 10.1016/S0925-4439(00)00050-8; Andersen MH, 2000, BIOCHEMISTRY-US, V39, P6200, DOI 10.1021/bi992221r; Andersen MH, 1997, BIOCHEMISTRY-US, V36, P5441, DOI 10.1021/bi963119m; AXELSSON G, 1976, THROMB HAEMOSTASIS, V36, P517, DOI 10.1055/s-0038-1648071; Bailey RW, 2007, BIOPHYS J, V93, P2350, DOI 10.1529/biophysj.107.104679; Balboa MA, 1996, J BIOL CHEM, V271, P32381, DOI 10.1074/jbc.271.50.32381; Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; BAYBURT T, 1993, BIOCHEMISTRY-US, V32, P573, DOI 10.1021/bi00053a024; BERG OG, 1991, BIOCHEMISTRY-US, V30, P7283, DOI 10.1021/bi00243a034; BEVERS EM, 1983, BIOCHIM BIOPHYS ACTA, V736, P57, DOI 10.1016/0005-2736(83)90169-4; Boccellino M, 2002, LIPIDS, V37, P1047, DOI 10.1007/s11745-002-0999-7; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BRETSCHER MS, 1972, NATURE-NEW BIOL, V236, P11, DOI 10.1038/newbio236011a0; Burke JR, 1999, ARCH BIOCHEM BIOPHYS, V365, P239, DOI 10.1006/abbi.1999.1151; CHEN J, 1994, J BIOL CHEM, V269, P2365; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Cheng M, 2012, DIABETES RES CLIN PR, V95, P125, DOI 10.1016/j.diabres.2011.09.030; Clark SR, 2013, P NATL ACAD SCI USA, V110, P5875, DOI 10.1073/pnas.1222419110; Cui TP, 2010, AM J RESP CRIT CARE, V181, P238, DOI 10.1164/rccm.200804-625OC; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Dennis EA, 2000, AM J RESP CRIT CARE, V161, pS32, DOI 10.1164/ajrccm.161.supplement_1.ltta-7; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; FADOK VA, 1992, J IMMUNOL, V148, P2207; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GREEN JA, 1991, INFLAMMATION, V15, P355, DOI 10.1007/BF00917352; Haapamaki MM, 1999, AM J GASTROENTEROL, V94, P713, DOI 10.1111/j.1572-0241.1999.00941.x; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; HARA S, 1989, J BIOCHEM-TOKYO, V105, P395, DOI 10.1093/oxfordjournals.jbchem.a122675; Hvarregaard J, 1996, EUR J BIOCHEM, V240, P628, DOI 10.1111/j.1432-1033.1996.0628h.x; Jain MK, 2006, CURR OPIN CHEM BIOL, V10, P473, DOI 10.1016/j.cbpa.2006.08.015; JAIN MK, 1986, BIOCHIM BIOPHYS ACTA, V860, P435, DOI 10.1016/0005-2736(86)90541-9; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; KAUFMANN SH, 1989, CANCER RES, V49, P5870; KUIPERS OP, 1990, ADV EXP MED BIOL, V279, P65; LANOTTE M, 1991, BLOOD, V77, P1080; Lapointe S, 2010, J CELL PHYSIOL, V224, P127, DOI 10.1002/jcp.22106; Lecoeur H, 2002, EXP CELL RES, V277, P1, DOI 10.1006/excr.2002.5537; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Masuda S, 2005, BBA-MOL CELL BIOL L, V1736, P200, DOI 10.1016/j.bbalip.2005.08.014; Masuda S, 2005, BIOCHEM J, V387, P27, DOI 10.1042/BJ20041307; Masuda S, 2005, FEBS J, V272, P655, DOI 10.1111/j.1742-4658.2004.04489.x; MINAMI T, 1994, GUT, V35, P1593, DOI 10.1136/gut.35.11.1593; Munoz NM, 2007, J IMMUNOL, V179, P4800, DOI 10.4049/jimmunol.179.7.4800; Munoz NM, 2003, J BIOL CHEM, V278, P38813, DOI 10.1074/jbc.M302476200; Murakami M, 2013, BIOCHIMIE, V95, P43, DOI 10.1016/j.biochi.2012.09.007; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; Nelson J, 2012, BBA-BIOMEMBRANES, V1818, P1196, DOI 10.1016/j.bbamem.2012.01.005; Nelson J, 2011, BBA-BIOMEMBRANES, V1808, P1913, DOI 10.1016/j.bbamem.2011.04.003; Nevalainen TJ, 2000, BBA-MOL CELL BIOL L, V1488, P83, DOI 10.1016/S1388-1981(00)00112-8; Nielson KH, 2000, BBA-MOL CELL BIOL L, V1484, P163, DOI 10.1016/S1388-1981(00)00004-4; Olson ED, 2010, J BIOL CHEM, V285, P10993, DOI 10.1074/jbc.M109.070797; Otzen DE, 2012, BBA-BIOMEMBRANES, V1818, P1019, DOI 10.1016/j.bbamem.2011.08.032; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Schlegel RA, 2001, CELL DEATH DIFFER, V8, P551, DOI 10.1038/sj.cdd.4400817; SCHROIT AJ, 1985, J BIOL CHEM, V260, P5131; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Shi J, 2008, J THROMB HAEMOST, V6, P1167, DOI 10.1111/j.1538-7836.2008.03010.x; Shi J, 2006, CYTOM PART A, V69A, P1193, DOI 10.1002/cyto.a.20345; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Snitko Y, 1997, BIOCHEMISTRY-US, V36, P14325, DOI 10.1021/bi971200z; TAIT JF, 1988, BIOCHEMISTRY-US, V27, P6268, DOI 10.1021/bi00417a011; Tannert A, 2003, J BIOL CHEM, V278, P40631, DOI 10.1074/jbc.M302131200; VERGER R, 1976, ANNU REV BIOPHYS BIO, V5, P77, DOI 10.1146/annurev.bb.05.060176.000453; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Waehrens LN, 2009, J HISTOCHEM CYTOCHEM, V57, P907, DOI 10.1369/jhc.2009.953729; Wilson HA, 1999, J BIOL CHEM, V274, P11494, DOI 10.1074/jbc.274.17.11494; Winget JM, 2006, BBA-MOL CELL BIOL L, V1761, P1260, DOI 10.1016/j.bbalip.2006.08.002; Wolfs JLN, 2005, CELL MOL LIFE SCI, V62, P1514, DOI 10.1007/s00018-005-5099-y; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Yamaguchi H, 2008, J LEUKOCYTE BIOL, V83, P1300, DOI 10.1189/jlb.1107730; ZWAAL RFA, 1975, BIOCHIM BIOPHYS ACTA, V406, P83, DOI 10.1016/0005-2736(75)90044-9	80	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77143	10.1371/journal.pone.0077143	http://dx.doi.org/10.1371/journal.pone.0077143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194865	gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000044
J	O'Shea, RP; Chandler, NP; Roy, R				O'Shea, Robert P.; Chandler, Nicholas P.; Roy, Rajneesh			Dentists Make Larger Holes in Teeth Than They Need to If the Teeth Present a Visual Illusion of Size	PLOS ONE			English	Article							MEDICAL DECISION-MAKING; NONMEDICAL INFLUENCES; EBBINGHAUS ILLUSION; OPTICAL ILLUSIONS; DECREMENT; CONTRAST; ASSIMILATION; SIMILARITY	Background: Health care depends, in part, on the ability of a practitioner to see signs of disease and to see how to treat it. Visual illusions, therefore, could affect health care. Yet there is very little prospective evidence that illusions can influence treatment. We sought such evidence. Methods and Results: We simulated treatment using dentistry as a model system. We supplied eight, practicing, specialist dentists, endodontists, with at least 21 isolated teeth each, randomly sampled from a much larger sample of teeth they were likely to encounter. Teeth contained holes and we asked the endodontists to cut cavities in preparation for filling. Each tooth presented a more or less potent version of a visual illusion of size, the Delboeuf illusion, that made the holes appear smaller than they were. Endodontists and the persons measuring the cavities were blind to the parameters of the illusion. We found that the size of cavity endodontists made was linearly related to the potency of the Delboeuf illusion (p<.01) with an effect size (Cohen's d) of 1.41. When the illusion made the holes appear smaller, the endodontists made cavities larger than needed. Conclusions: The visual context in which treatment takes place can influence the treatment. Undesirable effects of visual illusions could be counteracted by a health practitioner's being aware of them and by using measurement.	[O'Shea, Robert P.] Univ Otago, Dept Psychol, Dunedin, New Zealand; [O'Shea, Robert P.] So Cross Univ, Sch Hlth & Human Sci, Discipline Psychol, Coffs Harbour, Australia; [O'Shea, Robert P.] So Cross Univ, Sch Hlth & Human Sci, Cognit Neurosci Res Cluster, Coffs Harbour, Australia; [Chandler, Nicholas P.; Roy, Rajneesh] Univ Otago, Fac Dent, Sir John Walsh Res Inst, Dunedin, New Zealand	University of Otago; Southern Cross University; Southern Cross University; University of Otago	O'Shea, RP (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	robert.oshea@scu.edu.au	O'Shea, Robert P./C-5723-2008	O'Shea, Robert P./0000-0003-3132-7199	University of Otago; Southern Cross University	University of Otago; Southern Cross University	This study was funded from general sources from University of Otago and from Southern Cross University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKESON BM, 1978, EXP AGING RES, V4, P55, DOI 10.1080/03610737808257126; Bach M, 2013, 106 OPTICAL ILLUSION; Blake  R., 2006, PERCEPTION; Chandler NP, 2002, J ROY COLL SURG EDIN, V47, P660; Choplin JM, 1999, PERCEPT PSYCHOPHYS, V61, P3, DOI 10.3758/BF03211944; COREN S, 1972, PERCEPT PSYCHOPHYS, V12, P224, DOI 10.3758/BF03212877; COREN S, 1974, PERCEPT PSYCHOPHYS, V16, P355, DOI 10.3758/BF03203955; Coren S., 1978, SEEING IS DECEIVING; Daffner R H, 1989, Curr Probl Diagn Radiol, V18, P62, DOI 10.1016/0363-0188(89)90030-3; DELBOEUF J, 1865, B ACADEMIE ROYALE SC, V19, P195; Delboeuf J., 1892, B ACAD ROYALE BELGIQ, V24, P545; Dental Council of New Zealand (DCNZ), 2006, REG; Epstein SA, 2008, MED CARE RES REV, V65, P674, DOI 10.1177/1077558708320987; Feldman HA, 1997, HEALTH SERV RES, V32, P343; Fialkow MF, 2009, J MINIM INVAS GYN, V16, P136, DOI 10.1016/j.jmig.2008.11.013; Goto T, 2007, JPN PSYCHOL RES, V49, P33, DOI 10.1111/j.1468-5884.2007.00330.x; Gutmann JL, 1993, INT ENDOD J, V262, P73; Harris KM, 1996, PERCEPT MOTOR SKILL, V82, P79, DOI 10.2466/pms.1996.82.1.79; Imhotep, E SMITH SURG PAPYRUS; Jaffe C C, 1984, Med Radiogr Photogr, V60, P1; Kahol K, 2009, J AM COLL SURGEONS, V208, P255, DOI 10.1016/j.jamcollsurg.2008.09.029; Kramer G A, 1989, J Dent Educ, V53, P119; McKinlay JB, 1996, SOC SCI MED, V42, P769, DOI 10.1016/0277-9536(95)00342-8; McKinney P, 2000, PLAST RECONSTR SURG, V106, P906, DOI 10.1097/00006534-200009040-00029; McPhee E R, 1978, J Mich Dent Assoc, V60, P565; MORINAGA S, 1966, PSYCHOL FORSCH, V29, P161, DOI 10.1007/BF00510815; MOUNTJOY PT, 1965, PSYCHOL REC, V15, P7; Murdoch-Kinch CA, 2003, J AM DENT ASSOC, V134, P87, DOI 10.14219/jada.archive.2003.0021; Nielsen CJ, 2001, J ENDODONT, V27, P687, DOI 10.1097/00004770-200111000-00009; Ridolfi Marcello, 2005, Rays, V30, P279; Robinson J. O, 1972, PSYCHOL VISUAL ILLUS; Rose D, 2002, SPATIAL VISION, V15, P191, DOI 10.1163/15685680252875165; ROSE SC, 1990, AM J EMERG MED, V8, P109, DOI 10.1016/0735-6757(90)90195-6; Rosen JM, 2009, PLAST RECONSTR SURG, V123, P729, DOI 10.1097/PRS.0b013e3181958ec4; Ross HE, 2002, MYSTERY MOON ILLUSIO; Roy R, 2008, ORAL SURG ORAL MED O, V105, P263, DOI 10.1016/j.tripleo.2007.08.010; Roy R, 2007, ENDO-ENDOD PRACT TOD, V1, P91; Seckel A, 2000, ART OPTICAL ILLUSION; Seymour NE, 2002, ANN SURG, V236, P458, DOI 10.1097/00000658-200210000-00008; Singer B A, 1994, Curr Opin Cosmet Dent, P6; Slavkin HC, 1999, J AM DENT ASSOC, V130, P1115, DOI 10.14219/jada.archive.1999.0346; Spodick David H, 2003, Am Heart Hosp J, V1, P192, DOI 10.1111/j.1541-9215.2003.02484.x; von Arx T, 2011, INT ENDOD J, V44, P290, DOI 10.1111/j.1365-2591.2010.01811.x; WAGNER RF, 1992, DERMATOLOGY, V184, P245; Way LW, 2003, ANN SURG, V237, P460, DOI 10.1097/00000658-200304000-00004; World Medical Association, 2004, DECL HELS ETH PRINC; Youn G, 1978, EXPT AGING RES, V13, P53	47	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77343	10.1371/journal.pone.0077343	http://dx.doi.org/10.1371/journal.pone.0077343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194880	gold, Green Published			2022-12-27	WOS:000326037000059
J	Veerasamy, C; Sambasivan, M; Kumar, N				Veerasamy, Chanthiran; Sambasivan, Murali; Kumar, Naresh			Individual Skills Based Volunteerism and Life Satisfaction among Healthcare Volunteers in Malaysia: Role of Employer Encouragement, Self-Esteem and Job Performance, A Cross-Sectional Study	PLOS ONE			English	Article							WORK-FAMILY CONFLICT; MANAGEMENT; RESOURCES; EFFICACY; CONTEXT; SERVICE; PEOPLE	The purpose of this paper is to analyze two important outcomes of individual skills-based volunteerism (ISB-V) among healthcare volunteers in Malaysia. The outcomes are: job performance and life satisfaction. This study has empirically tested the impact of individual dimensions of ISB-V along with their inter-relationships in explaining the life satisfaction and job performance. Besides, the effects of employer encouragement to the volunteers, demographic characteristics of volunteers, and self-esteem of volunteers on job performance and life satisfaction have been studied. The data were collected through a questionnaire distributed to 1000 volunteers of St. John Ambulance in Malaysia. Three hundred and sixty six volunteers responded by giving their feedback. The model was tested using Structural Equation Modeling (SEM). The main results of this study are: (1) Volunteer duration and nature of contact affects life satisfaction, (2) volunteer frequency has impact on volunteer duration, (3) self-esteem of volunteers has significant relationships with volunteer frequency, job performance and life satisfaction, (4) job performance of volunteers affect their life satisfaction and (5) current employment level has significant relationships with duration of volunteering, self esteem, employer encouragement and job performance of volunteers. The model in this study has been able to explain 39% of the variance in life satisfaction and 45% of the variance in job performance. The current study adds significantly to the body of knowledge on healthcare volunteerism.	[Veerasamy, Chanthiran] Linton Univ Coll, Nilai, Malaysia; [Sambasivan, Murali] Taylors Univ, Taylors Business Sch, Subang Jaya, Malaysia; [Sambasivan, Murali; Kumar, Naresh] Univ Malaysia Kelantan, GERIC, Putrajaya, Malaysia	Taylor's University; Universiti Malaysia Kelantan	Sambasivan, M (corresponding author), Taylors Univ, Taylors Business Sch, Subang Jaya, Malaysia.	sambasivan@hotmail.com	Sambasivan, Murali/F-7622-2013; SAMY, NARESH KUMAR/AAW-2187-2020	Sambasivan, Murali/0000-0002-5779-4126; SAMY, NARESH KUMAR/0000-0003-2031-3381				Adams GA, 1996, J APPL PSYCHOL, V81, P411, DOI 10.1037/0021-9010.81.4.411; [Anonymous], 2001, PEOPLE STRATEGY; ANSBACHER HL, 1991, INDIV PSYCHOL, V47, P28; Austin J. E., 1998, LEADER LEADER, V8, P38; Barlow J, 2001, AGEING SOC, V21, P203, DOI 10.1017/S0144686X01008145; Batson CD, 2002, J SOC ISSUES, V58, P429, DOI 10.1111/1540-4560.00269; Bierstedt R., 1964, EXCHANGE POWER SOCIA; Bond Jr JB, 2012, CANADIAN J COUNSELLI, V16; Boyar SL, 2007, J VOCAT BEHAV, V71, P265, DOI 10.1016/j.jvb.2007.06.001; Calvo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042793; Clark, 1991, REV PERSONALITY SOCI, V12, P119; Clary EG, 1998, J PERS SOC PSYCHOL, V74, P1516, DOI 10.1037/0022-3514.74.6.1516; Cnaan RA, 2011, NONPROF VOLUNT SEC Q, V40, P497, DOI 10.1177/0899764010365741; Cobey JC, 2002, CLIN ORTHOP RELAT R, P65; Cooper S, 2006, THESIS NEW YORK U; Cromer KW, 2009, THESIS TUI U; Diener E, 2009, SOC INDIC RES SER, V38, P1, DOI 10.1007/978-90-481-2352-0; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Erdogan B, 2012, J MANAGE, V38, P1038, DOI 10.1177/0149206311429379; Frisch MB, 2000, SOC INDIC RES SER, V4, P207; Fuller JB, 2006, J SOC PSYCHOL, V146, P327, DOI 10.3200/SOCP.146.3.327-347; Gardner DG, 1998, GROUP ORGAN MANAGE, V23, P48, DOI 10.1177/1059601198231004; Geroy G. D., 2000, MANAGE DECIS, V38, P280, DOI DOI 10.1108/00251740010326333; Gilman R, 2001, J YOUTH ADOLESCENCE, V30, P749, DOI 10.1023/A:1012285729701; Grant A, 2012, ACAD MANAGE REV, V37, P569; Greenhaus JH, 2006, ACAD MANAGE REV, V31, P72, DOI 10.5465/amr.2006.19379625; Grube J, 1996, ANN M SOC PSYCH STUD; Hackl F, 2007, KYKLOS, V60, P77, DOI 10.1111/j.1467-6435.2007.00360.x; Hainsworth J, 2001, ARTHRIT RHEUM-ARTHR, V45, P378, DOI 10.1002/1529-0131(200108)45:4<378::AID-ART351>3.0.CO;2-T; Hair J., 2010, MULTIVARIATE DATA AN, V7; Harrison DA, 2006, ACAD MANAGE J, V49, P305, DOI [10.2307/20159765, 10.5465/AMJ.2006.20786077]; Hunt J, 2002, DOING OTHERS SOCIAL; Hybels JH, 1978, VOLUNTEER JOBS PAID; Johnson J.K., 2008, QUALITY EMPLOYMENT L; Jones KS, 2006, NONPROF VOLUNT SEC Q, V35, P249, DOI 10.1177/0899764006287464; Judge TA, 2001, PSYCHOL BULL, V127, P376, DOI 10.1037//0033-2909.127.3.376; Judge TA, 2001, J APPL PSYCHOL, V86, P80, DOI 10.1037/0021-9010.86.1.80; Katz E., 2005, EUR J POLIT ECON, V21, P429, DOI [https://doi.org/10.1016/j.ejpoleco.2004.06.004, DOI 10.1016/J.EJPOLECO.2004.06.004]; Leftwich RH, 1970, PRICE SYSTEM RESOURC; Loeser H, 1974, WOMEN WORK VOLUNTEER; Luks A, 2003, SPIRITUALITY HLTH, P30; Maranta A., 2010, CHANGING CULTURE VOL; Measham TG, 2007, 200703 SEED CSIRO; Muse L.A., 2007, J MANAG ISSUES, V19, P517; Musick MA, 2003, SOC SCI MED, V56, P259, DOI 10.1016/S0277-9536(02)00025-4; OMOTO AM, 1995, J PERS SOC PSYCHOL, V68, P671, DOI 10.1037/0022-3514.68.4.671; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Parasuraman S., 2002, HUMAN RESOURCE MANAG, V12, P299, DOI [10.1016/S1053-4822(02)00062-1, DOI 10.1016/S1053-4822(02)00062-1]; Peelle III HE, 2007, J MANAGERIAL ISSUES, V19, P554; Phillips AS, 2000, J BUS PSYCHOL, V14, P573, DOI 10.1023/A:1022986113164; Piliavin JA, 2005, CLAR SYMP, P29; Points of Light Foundation, 2006, BENCHM EXC SER, V2; Poppleton S, 2008, J OCCUP ORGAN PSYCH, V81, P481, DOI 10.1348/096317908X295182; Primavera J., 1999, J PREVENTION INTERVE, V18, P125, DOI DOI 10.1300/J005V18N01_10; Rich B.L., 2006, THESIS U FLORIDA FL; Rodell JB, 2010, THESIS NOVA SE U; Rosenberg M., 1979, CONCEIVING SELF; Rosenberg M., 1985, DEV SELF, P205; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Ross JA, 1997, HARVARD BUS REV, V75, P14; Ryder JA, 2005, THESIS U KANSAS; Saks A. M., 2006, J MANAGERIAL PSYCHOL, V21; Schram VR, 1985, J VOLUNTEER ADM, V3, P28; Shuang LS, 2011, MALAYSIAN J YOUTH ST, V5, P1; Singh S, 2004, THESIS U PUTRA MALAY; Smith DH, 1982, VOLUNTEERISM 80S FUN; SNYDER M, 1992, CLAR SYMP, P213; Stone-Romero EF, 2008, ORGAN RES METHODS, V11, P326, DOI 10.1177/1094428107300342; Suikkanen, 2011, INT J WELLBEING, V1, P1; TAIT M, 1989, J APPL PSYCHOL, V74, P502, DOI 10.1037/0021-9010.74.3.502; Tatarkiewicz W., 1976, ANAL HAPPINESS; The Star online, 2013, EMPL DRIV; Thoits PA, 2001, J HEALTH SOC BEHAV, V42, P115, DOI 10.2307/3090173; Tuffrey M., 1997, CAREER DEV INT, V2, P33; Volkmann B, 2006, CHILD SCH, V28, P145, DOI 10.1093/cs/28.3.145; Waikayi L, 2012, MANAGE DECIS, V50, P349, DOI 10.1108/00251741211216188; Wheeler JA, 1998, INT J AGING HUM DEV, V47, P69, DOI 10.2190/VUMP-XCMF-FQYU-V0JH; Wilson J, 2000, ANNU REV SOCIOL, V26, P215, DOI 10.1146/annurev.soc.26.1.215; Wilson J, 2012, NONPROF VOLUNT SEC Q, V41, P176, DOI 10.1177/0899764011434558; Wright CE, 2000, THESIS U TULSA; Zhou J, 2001, ACAD MANAGE J, V44, P682, DOI 10.2307/3069410	81	12	12	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77698	10.1371/journal.pone.0077698	http://dx.doi.org/10.1371/journal.pone.0077698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194894	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000073
J	Mao, WG; He, HQ; Xu, Y; Chen, PY; Zhou, JY				Mao, Wei-Gao; He, Hai-Qiang; Xu, Yan; Chen, Ping-Yan; Zhou, Ji-Yuan			Powerful Haplotype-Based Hardy-Weinberg Equilibrium Tests for Tightly Linked Loci	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; DISEASE ASSOCIATIONS; FREQUENCY ESTIMATION; INFERENCE; ALGORITHM; TRAITS	Recently, there have been many case-control studies proposed to test for association between haplotypes and disease, which require the Hardy-Weinberg equilibrium (HWE) assumption of haplotype frequencies. As such, haplotype inference of unphased genotypes and development of haplotype-based HWE tests are crucial prior to fine mapping. The goodness-of-fit test is a frequently-used method to test for HWE for multiple tightly-linked loci. However, its degrees of freedom dramatically increase with the increase of the number of loci, which may lack the test power. Therefore, in this paper, to improve the test power for haplotype-based HWE, we first write out two likelihood functions of the observed data based on the Niu's model (NM) and inbreeding model (IM), respectively, which can cause the departure from HWE. Then, we use two expectation-maximization algorithms and one expectation-conditional-maximization algorithm to estimate the model parameters under the HWE, IM and NM models, respectively. Finally, we propose the likelihood ratio tests LRT1 and LRT2 for haplotype-based HWE under the NM and IM models, respectively. We simulate the HWE, Niu's, inbreeding and population stratification models to assess the validity and compare the performance of these two LRT tests. The simulation results show that both of the tests control the type I error rates well in testing for haplotype-based HWE. If the NM model is true, then LRT1 is more powerful. While, if the true model is the IM model, then LRT2 has better performance in power. Under the population stratification model, LRT2 is still more powerful. To this end, LRT2 is generally recommended. Application of the proposed methods to a rheumatoid arthritis data set further illustrates their utility for real data analysis.	[Mao, Wei-Gao; He, Hai-Qiang; Xu, Yan; Chen, Ping-Yan; Zhou, Ji-Yuan] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Zhou, JY (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, Guangzhou, Guangdong, Peoples R China.	zhoujiyuan@gmail.com	Zhou, Ji-Yuan/AAI-4623-2020	Zhou, Ji-Yuan/0000-0003-0866-4402	National Natural Science Foundation of China [81072386]; School of Public Health and Tropical Medicine of Southern Medical University, China [GW201219, GW201237]; National Institutes of Health [R01 GM031575, NO1-AR-2-2263, RO1-AR-44422]; National Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR022263, R01AR044422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); School of Public Health and Tropical Medicine of Southern Medical University, China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Natural Science Foundation of China (81072386) and grants from School of Public Health and Tropical Medicine of Southern Medical University, China (grant numbers: GW201219 and GW201237). The Genetic Analysis Workshops are supported by the National Institutes of Health grant R01 GM031575. The RA data were gathered with the support of grants from the National Institutes of Health (NO1-AR-2-2263 and RO1-AR-44422), and the National Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amos Christopher I, 2007, BMC Proc, V1 Suppl 1, pS3; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker T, 2004, GENET EPIDEMIOL, V27, P21, DOI 10.1002/gepi.10323; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Epstein MP, 2003, AM J HUM GENET, V73, P1316, DOI 10.1086/380204; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Fan SJ, 1989, NATURAL SCI J HAINAN, V2, P91; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Huang BE, 2007, GENET EPIDEMIOL, V31, P803, DOI 10.1002/gepi.20242; Jawaheer D, 2003, ARTHRITIS RHEUM-US, V48, P906, DOI 10.1002/art.10989; Kuk AYC, 2009, BIOINFORMATICS, V25, P379, DOI 10.1093/bioinformatics/btn623; MENG XL, 1993, BIOMETRIKA, V80, P267, DOI 10.2307/2337198; Min JY, 2010, J RHEUMATOL, V37, P291, DOI 10.3899/jrheum.090526; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Yu ZX, 2007, GENET EPIDEMIOL, V31, P553, DOI 10.1002/gepi.20228; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zeng D, 2005, GENET EPIDEMIOL, V28, P70, DOI 10.1002/gepi.20040; Zhang K, 2006, GENET EPIDEMIOL, V30, P423, DOI 10.1002/gepi.20154; Zhao HY, 2000, AM J HUM GENET, V67, P936, DOI 10.1086/303073; Zhao LP, 2003, AM J HUM GENET, V72, P1231, DOI 10.1086/375140; Zheng G, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4614-2245-7	26	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77399	10.1371/journal.pone.0077399	http://dx.doi.org/10.1371/journal.pone.0077399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167573	gold, Green Published, Green Submitted			2022-12-27	WOS:000326034500032
J	Fregni, G; Messaoudene, M; Fourmentraux-Neves, E; Mazouz-Dorval, S; Chanal, J; Maubec, E; Marinho, E; Scheer-Senyarich, I; Cremer, I; Avril, MF; Caignard, A				Fregni, Giulia; Messaoudene, Meriem; Fourmentraux-Neves, Emmanuelle; Mazouz-Dorval, Sarra; Chanal, Johan; Maubec, Eve; Marinho, Eduardo; Scheer-Senyarich, Isabelle; Cremer, Isabelle; Avril, Marie-Francoise; Caignard, Anne			Phenotypic and Functional Characteristics of Blood Natural Killer Cells from Melanoma Patients at Different Clinical Stages	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; DENDRITIC CELLS; METASTATIC MELANOMA; RECEPTOR NKP46/NCR1; NK RECEPTORS; EXPRESSION; CARCINOMA; RECOGNITION; ENVIRONMENT; LIGANDS	Melanomas are aggressive skin tumors characterized by high metastatic potential. Immunotherapy is a valuable alternative for metastatic melanoma patients resistant to chemotherapy. Natural Killer (NK) cells are efficient anti-tumor cytotoxic effectors. We previously showed that blood NK cells from stage IV metastatic melanoma patients display decreased NK receptors and that chemotherapy modifies the functional status of blood NK cells. To investigate the role of NK cells along melanoma progression, we have here studied NK cells from patients at different stages of the disease. First, we showed that ex vivo NK cells from certain stage III-IV patients displayed low degranulation potential. Using a dynamic label-free assay, we found that immunoselected IL-2 activated blood NK cells from patients efficiently lysed melanoma cells through NKp46 and NKG2D receptors, independently to the clinical stage. Moreover, the ex vivo phenotype of circulating NK cells from 33 patients (stage I to IV) was extensively analyzed. NK cells from patients displayed higher variability in the percentages of Natural Cytotoxicity Receptors (NCR) and Natural Killer Group 2D (NKG2D) receptor expression compared to donor NK cells. The main defect was the decreased expression of NCR1 (NKp46) by NK cells from metastatic patients. Interestingly, we found a positive correlation between the NK cell percentages of NKp46 and the duration of stage IV in melanoma patients. Finally, we showed that NK cells infiltrated primary melanomas and displayed a predominant peritumoral distribution. These results are new arguments for the development of NK-based therapies in melanoma patients.	[Fregni, Giulia; Messaoudene, Meriem; Fourmentraux-Neves, Emmanuelle; Mazouz-Dorval, Sarra; Chanal, Johan; Avril, Marie-Francoise; Caignard, Anne] Univ Paris 05, CNRS, INSERM, U1016,UMR 8104,Cochin Inst, Paris, France; [Chanal, Johan; Avril, Marie-Francoise] Univ Paris 05, Cochin Hosp, AP HP, Dept Dermatol, Paris, France; [Maubec, Eve; Marinho, Eduardo; Scheer-Senyarich, Isabelle] Univ Paris 05, AP HP, Dept Dermatol, Paris, France; [Maubec, Eve; Marinho, Eduardo; Scheer-Senyarich, Isabelle] Hop Xavier Bichat, Dept Pathol, Paris, France; [Cremer, Isabelle] Inst Rech Cordeliers, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Caignard, A (corresponding author), Univ Paris 05, CNRS, INSERM, U1016,UMR 8104,Cochin Inst, Paris, France.	anne.caignard@inserm.fr	Cremer, Isabelle/D-4278-2017; Maubec, Eve/V-4296-2017; Caignard, Anne/F-8159-2013	Cremer, Isabelle/0000-0002-0963-1031; Maubec, Eve/0000-0003-1658-6686; Caignard, Anne/0000-0001-9923-6045	INSERM; l'Association pour la Recherche contre le Cancer (ARC) [3964]; la Societe Francaise de Dermatologie (SFD); la Ligue Nationale contre le Cancer; l'Institut National du Cancer (Canceropole Ile de France); la Fondation de France [20363]; Canceropole IdF; Ligue Nationale contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); l'Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); la Societe Francaise de Dermatologie (SFD); la Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); l'Institut National du Cancer (Canceropole Ile de France); la Fondation de France(Fondation de France); Canceropole IdF(Region Ile-de-France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	Grant Support: This work was supported by grants from INSERM, l'Association pour la Recherche contre le Cancer (ARC, 3964), la Societe Francaise de Dermatologie (SFD, grant for Dr JC), la Ligue Nationale contre le Cancer (grant to AC, Comite Ile de France), l'Institut National du Cancer (Canceropole Ile de France), la Fondation de France (Grant 20363 to AC). GF had a grant from Canceropole IdF and Ligue Nationale contre le Cancer. MM is recipient of a PhD grant from Ligue Nationale contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021118; Cagnano E, 2008, J INVEST DERMATOL, V128, P972, DOI 10.1038/sj.jid.5701111; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Coupel S, 2007, BLOOD, V109, P2806, DOI 10.1182/blood-2006-06-030213; Della Chiesa M, 2006, BLOOD, V108, P4118, DOI 10.1182/blood-2006-06-006700; Elliott JM, 2010, J EXP MED, V207, P2073, DOI 10.1084/jem.20100986; Erdag G, 2012, CANC RES; FERRADINI L, 1993, J CLIN INVEST, V91, P1183, DOI 10.1172/JCI116278; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fregni G, 2012, ONCOIMMUNOLOGY, V1, P38, DOI 10.4161/onci.1.1.18312; Fregni G, 2011, CLIN CANCER RES, V17, P2628, DOI 10.1158/1078-0432.CCR-10-2084; Glasner A, 2012, J IMMUNOL, V188, P2509, DOI 10.4049/jimmunol.1102461; Godefroy E, 2011, CANCER CELL, V19, P333, DOI 10.1016/j.ccr.2011.01.037; Halfteck GG, 2009, J IMMUNOL, V182, P2221, DOI 10.4049/jimmunol.0801878; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; Konjevic G, 2010, BIOMED PHARMACOTHER, V64, P663, DOI 10.1016/j.biopha.2010.06.013; Konjevic G, 2007, CLIN EXP METASTAS, V24, P1, DOI 10.1007/s10585-006-9043-9; KORNSTEIN MJ, 1987, CANCER RES, V47, P1411; Lakshmikanth T, 2009, J CLIN INVEST; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Lopez-Botet M, 1998, CURR TOP MICROBIOL, V230, P41; Mamessier E, 2011, CANCER RES, V71, P6621, DOI 10.1158/0008-5472.CAN-11-0792; Martinovic KM, 2011, J SURG RES, V171, P637, DOI 10.1016/j.jss.2010.05.012; McCarter M, 2005, SURGERY, V138, P321, DOI 10.1016/j.surg.2005.06.011; McKay K, 2011, HUM PATHOL, V42, P1960, DOI 10.1016/j.humpath.2011.02.019; Miller G, 2003, FASEB J, V17, P728, DOI 10.1096/fj.02-0900fje; Moretta L, 2004, CURR OPIN IMMUNOL, V16, P626, DOI 10.1016/j.coi.2004.07.010; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Movassagh M, 2004, CANCER RES, V64, P2192, DOI 10.1158/0008-5472.CAN-03-2969; Perier A, 2011, ONCOGENE, V30, P2622, DOI 10.1038/onc.2010.638; Pietra G, 2012, CANC RES; Pittari G, 2010, BONE MARROW TRANSPL, V45, P862, DOI 10.1038/bmt.2009.265; Platonova S, 2011, CANCER RES, V71, P5412, DOI 10.1158/0008-5472.CAN-10-4179; Remark R, 2013, CLIN CANC RES; Rusakiewicz S, 2013, CANCER RES, V73, P3499, DOI 10.1158/0008-5472.CAN-13-0371; Schleypen JS, 2006, CLIN CANCER RES, V12, P718, DOI 10.1158/1078-0432.CCR-05-0857; Sun JC, 2011, J EXP MED, V208, P357, DOI 10.1084/jem.20100479; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vetter CS, 2000, J INVEST DERMATOL, V114, P941, DOI 10.1046/j.1523-1747.2000.00958.x; Wang E, 2001, EXPERT OPIN BIOL TH, V1, P277, DOI 10.1517/14712598.1.2.277; Wong JL, 2011, J IMMUNOTHER, V34, P270, DOI 10.1097/CJI.0b013e31820b370b; Zhu J, 2006, J IMMUNOL METHODS, V309, P25, DOI 10.1016/j.jim.2005.10.018	43	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76928	10.1371/journal.pone.0076928	http://dx.doi.org/10.1371/journal.pone.0076928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204708	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300069
J	Kramer, JR; Matsumura, I				Kramer, Joseph R.; Matsumura, Ichiro			Directed Evolution of Aminoglycoside Phosphotransferase (3 ') Type IIIa Variants That Inactivate Amikacin but Impose Significant Fitness Costs	PLOS ONE			English	Article							IN-VITRO; ANTIBIOTIC-RESISTANCE; ENZYME; GENES; PURIFICATION; ENTEROCOCCUS; PROMISCUITY; ADAPTATION; EXPRESSION; MUTATIONS	The rules that govern adaptive protein evolution remain incompletely understood. Aminoglycoside aminotransferase (3') type IIIa (hereafter abbreviated APH(3')-IIIa) is a good model enzyme because it inactivates kanamycin efficiently; it recognizes other aminoglycoside antibiotics, including amikacin, but not nearly as well. Here we direct the evolution of APH(3')-IIIa variants with increased activity against amikacin. After four rounds of random mutation and selection in Escherichia coli, the minimum inhibitory concentration of amikacin rose from 18 micrograms/mL (wild-type enzyme) to over 1200 micrograms/mL (clone 4.1). The artificially evolved 4.1 APH(3')-IIIa variant exhibited 19-fold greater catalytic efficiency (k(cat)/K-M) than did the wild-type enzyme in reactions with amikacin. E. coli expressing the evolved 4.1 APH(3')-IIIa also exhibited a four-fold decrease in fitness (as measured by counting colony forming units in liquid cultures with the same optical density) compared with isogenic cells expressing the wild-type protein under non-selective conditions. We speculate that these fitness costs, in combination with the prevalence of other amikacin-modifying enzymes, hinder the evolution of APH(3')-IIIa in clinical settings.	[Kramer, Joseph R.; Matsumura, Ichiro] Emory Univ, Sch Med, Dept Biochem, Rollins Res Ctr, Atlanta, GA 30322 USA	Emory University	Matsumura, I (corresponding author), Emory Univ, Sch Med, Dept Biochem, Rollins Res Ctr, Atlanta, GA 30322 USA.	imatsum@emory.edu			National Instutite of Health [1 R01 GM086824]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490, R01GM086824] Funding Source: NIH RePORTER	National Instutite of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors were supported by a grant from the National Instutite of Health (1 R01 GM086824). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Atwal KS, 2004, J MED CHEM, V47, P1081, DOI 10.1021/jm030291x; Barlow M, 2002, GENETICS, V160, P823; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bryksin AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013244; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Doi Y, 2004, ANTIMICROB AGENTS CH, V48, P2075, DOI 10.1128/AAC.48.6.2075-2080.2004; EASTERBY JS, 1973, BIOCHIM BIOPHYS ACTA, V293, P552, DOI 10.1016/0005-2744(73)90362-8; Fasan R, 2008, J MOL BIOL, V383, P1069, DOI 10.1016/j.jmb.2008.06.060; Fasan R, 2007, ANGEW CHEM INT EDIT, V46, P8414, DOI 10.1002/anie.200702616; Fong DH, 2002, EMBO J, V21, P2323, DOI 10.1093/emboj/21.10.2323; Gerlt JA, 1998, CURR OPIN CHEM BIOL, V2, P607, DOI 10.1016/S1367-5931(98)80091-4; Goldsmith M, 2012, CURR OPIN STRUC BIOL, V22, P406, DOI 10.1016/j.sbi.2012.03.010; Gould S. J., 1989, WONDERFUL LIFE BURGE; GRIMM E, 1995, NUCLEIC ACIDS RES, V23, P4518, DOI 10.1093/nar/23.21.4518; JACOBY GA, 1990, ANTIMICROB AGENTS CH, V34, P2381, DOI 10.1128/AAC.34.12.2381; Kaul M, 2007, J MOL BIOL, V369, P142, DOI 10.1016/j.jmb.2007.02.103; KAWAGUCHI H, 1976, J INFECT DIS, V134, pS242, DOI 10.1093/infdis/135.Supplement_2.S242; Kobayashi N, 2001, EPIDEMIOL INFECT, V126, P197, DOI 10.1017/S0950268801005271; Levin BR, 2000, GENETICS, V154, P985; Lindsley JE, 2000, METH MOL B, V95, P57; Maisnier-Patin S, 2004, RES MICROBIOL, V155, P360, DOI 10.1016/j.resmic.2004.01.019; Matsumura Ichiro, 2002, Methods Mol Biol, V182, P259; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P6936, DOI 10.1021/bi00188a024; McKay GA, 1996, BIOCHEMISTRY-US, V35, P8680, DOI 10.1021/bi9603884; Moore JC, 1996, NAT BIOTECHNOL, V14, P458, DOI 10.1038/nbt0496-458; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; O'Loughlin TL, 2006, MOL BIOL EVOL, V23, P764, DOI 10.1093/molbev/msj098; Petrosino J, 1998, TRENDS MICROBIOL, V6, P323, DOI 10.1016/S0966-842X(98)01317-1; Rozen DE, 2007, ANTIMICROB AGENTS CH, V51, P412, DOI 10.1128/AAC.01161-06; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; SARUBBI FA, 1978, ANN INTERN MED, V89, P612, DOI 10.7326/0003-4819-89-5-612; Schmitz FJ, 1999, J ANTIMICROB CHEMOTH, V43, P253, DOI 10.1093/jac/43.2.253; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Toth M, 2010, ANTIMICROB AGENTS CH, V54, P1590, DOI 10.1128/AAC.01444-09; Varadarajan N, 2005, P NATL ACAD SCI USA, V102, P6855, DOI 10.1073/pnas.0500063102; VERHAMME IMA, 1988, EUR J BIOCHEM, V172, P615, DOI 10.1111/j.1432-1033.1988.tb13933.x; Vila J, 1999, J CLIN MICROBIOL, V37, P758, DOI 10.1128/JCM.37.3.758-761.1999; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wright Gerard D., 1999, Frontiers in Bioscience, V4, pD9, DOI 10.2741/Wright; Yano T, 1998, P NATL ACAD SCI USA, V95, P5511, DOI 10.1073/pnas.95.10.5511; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258	49	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76687	10.1371/journal.pone.0076687	http://dx.doi.org/10.1371/journal.pone.0076687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204655	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300042
J	Eldai, H; Periyasamy, S; Al Qarni, S; Al Rodayyan, M; Mustafa, SM; Deeb, A; Al Sheikh, E; Khan, MA; Johani, M; Yousef, Z; Aziz, MA				Eldai, Hisham; Periyasamy, Sathish; Al Qarni, Saeed; Al Rodayyan, Maha; Mustafa, Sabeena Muhammed; Deeb, Ahmad; Al Sheikh, Ebthehal; Khan, Mohammed Afzal; Johani, Mishal; Yousef, Zeyad; Aziz, Mohammad Azhar			Novel Genes Associated with Colorectal Cancer Are Revealed by High Resolution Cytogenetic Analysis in a Patient Specific Manner	PLOS ONE			English	Article							HETEROZYGOSITY; PROFILES	Genomic abnormalities leading to colorectal cancer (CRC) include somatic events causing copy number aberrations (CNAs) as well as copy neutral manifestations such as loss of heterozygosity (LOH) and uniparental disomy (UPD). We studied the causal effect of these events by analyzing high resolution cytogenetic microarray data of 15 tumor-normal paired samples. We detected 144 genes affected by CNAs. A subset of 91 genes are known to be CRC related yet high GISTIC scores indicate 24 genes on chromosomes 7, 8, 18 and 20 to be strongly relevant. Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC. Pathway and target prediction analysis of CNA affected genes and microRNAs, respectively indicates TGF-beta signaling pathway to be involved in causing CRC. Finally, LOH and UPD collectively affected nine cancer related genes. Transcription factor binding sites on regions of >35% copy number loss/gain influenced 16 CRC genes. Our analysis shows patient specific CRC manifestations at the genomic level and that these different events affect individual CRC patients differently.	[Eldai, Hisham; Periyasamy, Sathish; Al Qarni, Saeed; Al Rodayyan, Maha; Mustafa, Sabeena Muhammed; Al Sheikh, Ebthehal; Aziz, Mohammad Azhar] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Deeb, Ahmad] King Abdullah Int Med Res Ctr, Res Off, Riyadh, Saudi Arabia; [Khan, Mohammed Afzal; Johani, Mishal; Yousef, Zeyad] Natl Guard Hlth Affairs, Riyadh, Saudi Arabia	King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Ministry of National Guard - Health Affairs; National Guard Health Affairs - Saudi Arabia	Aziz, MA (corresponding author), King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.	azizmo@ngha.med.sa	Periyasamy, Sathish/AHD-9115-2022; Aziz, Mohammad Azhar/F-7486-2013	Periyasamy, Sathish/0000-0002-8132-5717; Aziz, Mohammad Azhar/0000-0002-0798-5063; Deeb, Ahmad/0000-0002-3680-7338	King Abdullah International Medical Research Center [RC10/083]	King Abdullah International Medical Research Center	This study was supported by a research grant # RC10/083 awarded to MAA by King Abdullah International Medical Research Center. All the authors are employed by King Abdullah International Medical Research Center or National Guard Health Affairs. Both the institutions are part of King Abdul Aziz Medical City. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix Inc, 2011, CL00704 PN AFF INC; Affymetrix Inc, 2011, AFF CYTOSCAN ASS US; Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Al-Eid HS, 2004, CANC INCIDENCE REPOR; Al-Mulla F, 2006, J CLIN PATHOL, V59, P624, DOI 10.1136/jcp.2005.033167; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Bavi PP, 2008, SAUDI MED J, V29, P75; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Brosens RPM, 2010, ANAL CELL PATHOL, V33, P95, DOI [10.1155/2010/161608, 10.3233/ACP-CLO-2010-0531]; Corvalan AH, 2012, PLOS ONE, V7; Fleming N, 2012, CANC RES; Ghadimi BM, 2006, CELL ONCOL, V28, P273; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Haya S, 2007, CANC INCIDENCE SURVI; Heinrichs S, 2010, BLOOD, V115, P4157, DOI 10.1182/blood-2009-11-203182; Ho JW, 2011, BRIT J CANCER, V104, P369, DOI 10.1038/sj.bjc.6605977; Jasmine F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031968; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kurashina K, 2008, CANCER SCI, V99, P1835, DOI 10.1111/j.1349-7006.2008.00881.x; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Lin C-H, 2011, J BIOMEDICAL SCI, V18, P1; Mao X, 2006, CANCER GENET CYTOGEN, V167, P1, DOI 10.1016/j.cancergencyto.2005.08.030; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ninomiya S, 2012, CYTOGENET GENOME RES, V136, P246, DOI 10.1159/000337297; Niv Y, 2008, WORLD J GASTROENTERO, V14, P2139, DOI 10.3748/wjg.14.2139; Oikonomou E, 2006, ANTICANCER RES, V26, P1077; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Postma C, 2009, ANN ONCOL, V20, P1048, DOI 10.1093/annonc/mdn738; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Prokunina-Olsson L., 2009, BIOMED CENTRAL, V8, P1; Sapkota Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053850; Siraj AK, 2012, GENETICS MED; Spain SL, 2009, CANCER RES, V69, P7422, DOI 10.1158/0008-5472.CAN-09-0659; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Xie T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042001, 10.1371/journal.pone.0047577]	35	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e76251	10.1371/journal.pone.0076251	http://dx.doi.org/10.1371/journal.pone.0076251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204606	gold, Green Submitted, Green Published			2022-12-27	WOS:000326334500006
J	Henderson, DM				Henderson, Donald M.			Sauropod Necks: Are They Really for Heat Loss?	PLOS ONE			English	Article							TEMPERATURE REGULATION; BODY-SIZE; DINOSAURS; MASS; PNEUMATICITY; STEGOSAURUS; PHYSIOLOGY; ANIMALS; CENTERS; MAMMALS	Three-dimensional digital models of 16 different sauropods were used to examine the scaling relationship between metabolism and surface areas of the whole body, the neck, and the tail in an attempt to see if the necks could have functioned as radiators for the elimination of excess body heat. The sauropod taxa sample ranged in body mass from a 639 kg juvenile Camarasaurus to a 25 t adult Brachiosaurus. Metabolism was assumed to be directly proportional to body mass raised to the 3/4 power, and estimates of body mass accounted for the presence of lungs and systems of air sacs in the trunk and neck. Surface areas were determined by decomposing the model surfaces into triangles and their areas being computed by vector methods. It was found that total body surface area was almost isometric with body mass, and that it showed negative allometry when plotted against metabolic rate. In contrast, neck area showed positive allometry when plotted against metabolic rate. Tail area show negative allometry with respect to metabolic rate. The many uncertainties about the biology of sauropods, and the variety of environmental conditions that different species experienced during the groups 150 million years of existence, make it difficult to be absolutely certain about the function of the neck as a radiator. However, the functional combination of the allometric increase of neck area, the systems of air sacs in the neck and trunk, the active control of blood flow between the core and surface of the body, changing skin color, and strategic orientation of the neck with respect to wind, make it plausible that the neck could have functioned as a radiator to avoid over-heating.	Royal Tyrrell Museum Palaeontol, Drumheller, AB, Canada		Henderson, DM (corresponding author), Royal Tyrrell Museum Palaeontol, Drumheller, AB, Canada.	don.henderson@gov.ab.ca						Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; BAKKER RT, 1971, EVOLUTION, V25, P636, DOI 10.1111/j.1558-5646.1971.tb01922.x; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Benedict F. G., 1934, Ergebnisse der Physiologie, V86, P300, DOI 10.1007/BF02322526; Bennett SC, 1996, PALEOBIOLOGY, V22, P496, DOI 10.1017/S0094837300016481; BRAMWELL CD, 1974, PHILOS T R SOC B, V267, P503, DOI 10.1098/rstb.1974.0007; BRAMWELL CD, 1973, NATURE, V242, P203, DOI 10.1038/242203a0; CZERKAS SA, 1992, GEOLOGY, V20, P1068, DOI 10.1130/0091-7613(1992)020<1068:DODSRA>2.3.CO;2; DANIELS CB, 1992, COMP BIOCHEM PHYS A, V101, P43, DOI 10.1016/0300-9629(92)90625-Z; DODSON P, 1980, PALEOBIOLOGY, V6, P6, DOI 10.1017/S0094837300012446; Farlow J.O., 1990, P43; Farlow JO, 2010, SWISS J GEOSCI, V103, P173, DOI 10.1007/s00015-010-0021-5; FARLOW JO, 1976, SCIENCE, V192, P1123, DOI 10.1126/science.192.4244.1123; Gee C.T., 2010, BIOL SAUROPOD DINOSA, P34; HAACK SC, 1986, PALEOBIOLOGY, V12, P450, DOI 10.1017/S009483730000316X; Harvey Pough F, 1999, VERTEBRATE LIFE; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Henderson DM, 2006, J VERTEBR PALEONTOL, V26, P907, DOI 10.1671/0272-4634(2006)26[907:BGCOMS]2.0.CO;2; Henderson DM, 2010, J VERTEBR PALEONTOL, V30, P768, DOI 10.1080/02724631003758334; Mannion PD, 2010, PALEOBIOLOGY, V36, P253, DOI 10.1666/08085.1; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; O'Connor MP, 1999, PALEOBIOLOGY, V25, P341, DOI 10.1017/S0094837300021321; Paul Gregory S., 1997, P129; Paul GS, 1987, DINOSAURS PAST PRESE, VII, P5; Perry S, 2009, J EXPT ZOOLOGY A, V14, P115; PHILLIPS PK, 1995, J THERM BIOL, V20, P281, DOI 10.1016/0306-4565(94)00061-M; Preuschoft Holger, 2011, P197; Proctor NS, 1993, MANUAL ORNITHOLOGY; Romer A. S., 1940, GEOLOGICAL SOC AM SP, V28, P1, DOI DOI 10.1130/SPE28-P1; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SCHMIDTN.K, 1969, CONDOR, V71, P341, DOI 10.2307/1365733; Senter P, 2007, J ZOOL, V271, P45, DOI 10.1111/j.1469-7998.2006.00197.x; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Taylor MP, 2011, J ZOOL, V285, P150, DOI 10.1111/j.1469-7998.2011.00824.x; Tomkins JL, 2010, AM NAT, V176, P1; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wedel M, 2007, SPEC PAP PALAEONTOL, P207; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Weissenbock NM, 2010, J THERM BIOL, V35, P182, DOI 10.1016/j.jtherbio.2010.03.002; WHEELER PE, 1978, NATURE, V275, P441, DOI 10.1038/275441a0; White CR, 2007, ECOLOGY, V88, P315, DOI 10.1890/05-1883; WRIGHT PG, 1984, S AFR J ZOOL, V19, P266	44	8	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77108	10.1371/journal.pone.0077108	http://dx.doi.org/10.1371/journal.pone.0077108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204747	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500015
J	Karlsson, K; Sikstrom, S; Willander, J				Karlsson, Kristina; Sikstrom, Sverker; Willander, Johan			The Semantic Representation of Event Information Depends on the Cue Modality: An Instance of Meaning-Based Retrieval	PLOS ONE			English	Article							AUTOBIOGRAPHICAL MEMORIES; VISUAL DOMINANCE; PROUST; SPACE; ODORS; BUMP; SELF	The semantic content, or the meaning, is the essence of autobiographical memories. In comparison to previous research, which has mainly focused on the phenomenological experience and the age distribution of retrieved events, the present study provides a novel view on the retrieval of event information by quantifying the information as semantic representations. We investigated the semantic representation of sensory cued autobiographical events and studied the modality hierarchy within the multimodal retrieval cues. The experiment comprised a cued recall task, where the participants were presented with visual, auditory, olfactory or multimodal retrieval cues and asked to recall autobiographical events. The results indicated that the three different unimodal retrieval cues generate significantly different semantic representations. Further, the auditory and the visual modalities contributed the most to the semantic representation of the multimodally retrieved events. Finally, the semantic representation of the multimodal condition could be described as a combination of the three unimodal conditions. In conclusion, these results suggest that the meaning of the retrieved event information depends on the modality of the retrieval cues.	[Karlsson, Kristina; Willander, Johan] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Sikstrom, Sverker] Lund Univ, Dept Psychol, Lund, Sweden; [Willander, Johan] Aarhus Univ, Ctr Autobiog Memory Res, Aarhus, Denmark	Stockholm University; Lund University; Aarhus University	Willander, J (corresponding author), Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden.	jwill@psychology.su.se	Karlsson, Kristina Petersen/X-7619-2019	Sikstrom, Sverker/0000-0003-2644-9626	Swedish Research Council (SRC) [2008 2415, 80212103]; Danish National Research Foundation	Swedish Research Council (SRC)(Swedish Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond)	The present study was funded by grants from the Swedish Research Council (www.vr.se) to JW (SRC grant #2008 2415, "Multimodal processes in the retrieval of autobiographical memory") and SS (SRC grant #80212103, "Semantic spaces as a research tool in psychology"). JW was also supported by the Danish National Research Foundation (www.dg.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshamian A, 2013, NEUROPSYCHOLOGIA, V51, P123, DOI 10.1016/j.neuropsychologia.2012.10.023; Arvidsson D, 2011, PSYCHOTHER RES, V21, P430, DOI 10.1080/10503307.2011.577824; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Cady ET, 2008, PSYCHOL MUSIC, V36, P157, DOI 10.1177/0305735607085010; Chu S, 2000, COGNITION, V75, pB41, DOI 10.1016/S0010-0277(00)00065-2; Chu S, 2002, MEM COGNITION, V30, P511, DOI 10.3758/BF03194952; COLAVITA FB, 1979, PERCEPT PSYCHOPHYS, V25, P345, DOI 10.3758/BF03198814; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 1999, J ADULT DEV, V6, P35, DOI 10.1023/A:1021672208155; Garcia D, 2013, J HAPPINESS IN PRESS, DOI [10.1007/s10902-012-9385-8, DOI 10.1007/S10902-012-9385-8.IN]; Gardenfors P, 1996, PHILOS COGNITIVE SCI, P159; Goddard L, 2005, MEMORY, V13, P79, DOI 10.1080/09658210344000594; Gustafsson Senden M, 2013, SOCIAL PSYC IN PRESS; Herz RS, 2004, CHEM SENSES, V29, P217, DOI 10.1093/chemse/bjh025; Herz RS, 2002, AM J PSYCHOL, V115, P21, DOI 10.2307/1423672; Herz RS, 2004, NEUROPSYCHOLOGIA, V42, P371, DOI 10.1016/j.neuropsychologia.2003.08.009; Holmes NP, 2005, CURR BIOL, V15, pR762, DOI 10.1016/j.cub.2005.08.058; Koppen C, 2007, BRAIN RES, V1186, P224, DOI 10.1016/j.brainres.2007.09.076; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Lundstrom JN, 2011, ACS CHEM NEUROSCI, V2, P5, DOI 10.1021/cn1000843; Martin DI, 2007, HDB LATENT SEMANTIC, P17; NORMAN DA, 1979, COGNITIVE PSYCHOL, V11, P107, DOI 10.1016/0010-0285(79)90006-9; Rasmussen AS, 2009, MEM COGNITION, V37, P477, DOI 10.3758/MC.37.4.477; Reese E, 1996, RES LANG SOC INTERAC, V29, P27, DOI 10.1207/s15327973rlsi2901_3; Rosenberg P, 2013, SCHOOL PSYCHOL INT, V34, P566, DOI 10.1177/0143034312471468; Rubin DC, 1997, PSYCHOL AGING, V12, P524, DOI 10.1037/0882-7974.12.3.524; Rubin DC, 2005, AM PSYCHOL ASS, P219; Schmid C, 2011, NEUROIMAGE, V55, P304, DOI 10.1016/j.neuroimage.2010.11.051; Willander J, 2007, MEM COGNITION, V35, P1659, DOI 10.3758/BF03193499; Willander J, 2006, PSYCHON B REV, V13, P240, DOI 10.3758/BF03193837; Williams JMG, 1999, Q J EXP PSYCHOL-A, V52, P555, DOI 10.1080/027249899390963	34	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e73378	10.1371/journal.pone.0073378	http://dx.doi.org/10.1371/journal.pone.0073378			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KW	24204561	Green Published, gold			2022-12-27	WOS:000326241200001
J	Calixto, MC; Lintomen, L; Andre, DM; Leiria, LO; Ferreira, D; Lellis-Santos, C; Anhe, GF; Bordin, S; Landgraf, RG; Antunes, E				Calixto, Marina Ciarallo; Lintomen, Leticia; Andre, Diana Majoli; Leiria, Luiz Osorio; Ferreira, Danilo; Lellis-Santos, Camilo; Anhe, Gabriel Forato; Bordin, Silvana; Landgraf, Richardt Gama; Antunes, Edson			Metformin Attenuates the Exacerbation of the Allergic Eosinophilic Inflammation in High Fat-Diet-Induced Obesity in Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; ADHESION MOLECULE EXPRESSION; AIRWAY EPITHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; TNF-ALPHA; LUNG INFLAMMATION; ENDOTHELIAL-CELLS	A positive relationship between obesity and asthma has been well documented. The AMP-activated protein kinase (AMPK) activator metformin reverses obesity-associated insulin resistance (IR) and inhibits different types of inflammatory responses. This study aimed to evaluate the effects of metformin on the exacerbation of allergic eosinophilic inflammation in obese mice. Male C57BL6/J mice were fed for 10 weeks with high-fat diet (HFD) to induce obesity. The cell infiltration and inflammatory markers in bronchoalveolar lavage (BAL) fluid and lung tissue were evaluated at 48 h after ovalbumin (OVA) challenge. HFD obese mice displayed peripheral IR that was fully reversed by metformin (300 mg/kg/day, two weeks). OVA-challenge resulted in higher influx of total cell and eosinophils in lung tissue of obese mice compared with lean group. As opposed, the cell number in BAL fluid of obese mice was reduced compared with lean group. Metformin significantly reduced the tissue eosinophil infiltration and prevented the reduction of cell counts in BAL fluid. In obese mice, greater levels of eotaxin, TNF-alpha and NOx, together with increased iNOS protein expression were observed, all of which were normalized by metformin. In addition, metformin nearly abrogated the binding of NF-kappa B subunit p65 to the iNOS promoter gene in lung tissue of obese mice. Lower levels of phosphorylated AMPK and its downstream target acetyl CoA carboxylase (ACC) were found in lung tissue of obese mice, which were restored by metformin. In separate experiments, the selective iNOS inhibitor aminoguanidine (20 mg/kg, 3 weeks) and the anti-TNF-alpha mAb (2 mg/kg) significantly attenuated the aggravation of eosinophilic inflammation in obese mice. In conclusion, metformin inhibits the TNF-alpha-induced inflammatory signaling and NF-kappa B-mediated iNOS expression in lung tissue of obese mice. Metformin may be a good pharmacological strategy to control the asthma exacerbation in obese individuals.	[Calixto, Marina Ciarallo; Lintomen, Leticia; Andre, Diana Majoli; Leiria, Luiz Osorio; Ferreira, Danilo; Anhe, Gabriel Forato; Antunes, Edson] State Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil; [Lellis-Santos, Camilo; Bordin, Silvana] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Landgraf, Richardt Gama] Univ Fed Sao Paulo, Dept Biol Sci, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Antunes, E (corresponding author), State Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil.	antunes@fcm.unicamp.br	Bordin, Silvana/G-3147-2012; ANTUNES, EDSON/F-6731-2012; Anhe, Gabriel F/C-1980-2012; André, Diana/N-3160-2013; Lellis-Santos, Camilo/D-9195-2015; Landgraf, Richardt/F-7146-2012; Lintomen, Leticia/C-4643-2015	Bordin, Silvana/0000-0002-0192-8869; ANTUNES, EDSON/0000-0003-2201-8247; Lellis-Santos, Camilo/0000-0002-7882-7548; Landgraf, Richardt/0000-0001-7774-7880; Lintomen, Leticia/0000-0002-2110-367X; Anhe, Gabriel/0000-0002-7694-8397	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/14225-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant number 2012/14225-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Arshi M, 2010, RESPIROLOGY, V15, P779, DOI 10.1111/j.1440-1843.2010.01767.x; Babu SK, 2011, CLIN IMMUNOL, V140, P18, DOI 10.1016/j.clim.2011.03.005; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; BONORA E, 1987, DIABETES METAB, V13, P116; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Calixto MC, 2010, BRIT J PHARMACOL, V159, P617, DOI 10.1111/j.1476-5381.2009.00560.x; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; Connelly L, 2001, J IMMUNOL, V166, P3873, DOI 10.4049/jimmunol.166.6.3873; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; delPozo V, 1997, J IMMUNOL, V158, P859; Deveci F, 2008, RESPIROLOGY, V13, P488, DOI 10.1111/j.1440-1843.2008.01278.x; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Feder LS, 1997, AM J RESP CELL MOL, V17, P436, DOI 10.1165/ajrcmb.17.4.2845; GALUSKA D, 1994, DIABETOLOGIA, V37, P826, DOI 10.1007/s001250050184; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hoogendijk AJ, 2013, J BIOL CHEM, V288, P7047, DOI 10.1074/jbc.M112.413138; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; Johnston RA, 2007, AM J RESP CRIT CARE, V176, P650, DOI 10.1164/rccm.200702-323OC; Kinote A, 2012, ENDOCRINOLOGY, V153, P3633, DOI 10.1210/en.2012-1341; LASSALLE P, 1993, CLIN EXP IMMUNOL, V94, P105; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lintomen L, 2012, OBESITY, V20, P1959, DOI 10.1038/oby.2012.93; Lintomen L, 2009, PULM PHARMACOL THER, V22, P1, DOI 10.1016/j.pupt.2008.10.003; Matsukura S, 1999, J IMMUNOL, V163, P6876; Molfino NA, 2012, CLIN EXP ALLERGY, V42, P712, DOI 10.1111/j.1365-2222.2011.03854.x; Mosen DM, 2008, J ALLERGY CLIN IMMUN, V122, P507, DOI 10.1016/j.jaci.2008.06.024; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Myerburg MM, 2010, AM J RESP CELL MOL, V42, P676, DOI 10.1165/2009-0147OC; Nakamura H, 1999, AM J RESP CRIT CARE, V160, P1952, DOI 10.1164/ajrccm.160.6.9811089; Nakamura H, 1998, AM J PHYSIOL-LUNG C, V275, pL601, DOI 10.1152/ajplung.1998.275.3.L601; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Palframan RT, 1998, BLOOD, V91, P2240, DOI 10.1182/blood.V91.7.2240.2240_2240_2248; Park CS, 2012, BIOCHEM PHARMACOL, V84, P1660, DOI 10.1016/j.bcp.2012.09.025; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Peters-Golden M, 2006, EUR RESPIR J, V27, P495, DOI 10.1183/09031936.06.00077205; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Salt IP, 2012, EXPERT OPIN INV DRUG, V21, P1155, DOI 10.1517/13543784.2012.696609; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shore SA, 2003, J APPL PHYSIOL, V95, P938, DOI 10.1152/japplphysiol.00336.2003; Shore SA, 2008, J APPL PHYSIOL, V105, P1127, DOI 10.1152/japplphysiol.00117.2008; Shore SA, 2007, J APPL PHYSIOL, V102, P516, DOI 10.1152/japplphysiol.00847.2006; Sousa LP, 2009, BIOCHEM PHARMACOL, V78, P396, DOI 10.1016/j.bcp.2009.04.030; Sugiura H, 2011, NITRIC OXIDE-BIOL CH, V25, P138, DOI 10.1016/j.niox.2011.03.079; Sutherland ER, 2008, AM J RESP CRIT CARE, V178, P682, DOI 10.1164/rccm.200801-076OC; Thuesen BH, 2009, CLIN EXP ALLERGY, V39, P700, DOI 10.1111/j.1365-2222.2008.03197.x; Tsuchiya K, 2007, ENDOCRINOLOGY, V148, P4548, DOI 10.1210/en.2006-1371; Vasudevan AR, 2006, J CLIN ENDOCR METAB, V91, P256, DOI 10.1210/jc.2005-1280; Weiss ST, 2005, NAT IMMUNOL, V6, P537, DOI 10.1038/ni0605-537; Xiong YL, 1999, J IMMUNOL, V162, P445; Zanardo RCO, 1997, P NATL ACAD SCI USA, V94, P14111, DOI 10.1073/pnas.94.25.14111; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008	57	91	94	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76786	10.1371/journal.pone.0076786	http://dx.doi.org/10.1371/journal.pone.0076786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204674	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300010
J	Laughner, JI; Marrus, SB; Zellmer, ER; Weinheimer, CJ; MacEwan, MR; Cui, SX; Nerbonne, JM; Efimov, IR				Laughner, Jacob I.; Marrus, Scott B.; Zellmer, Erik R.; Weinheimer, Carla J.; MacEwan, Matthew R.; Cui, Sophia X.; Nerbonne, Jeanne M.; Efimov, Igor R.			A Fully Implantable Pacemaker for the Mouse: From Battery to Wireless Power	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; CARDIAC MEMORY; HEART-FAILURE; ANIMAL-MODELS; STIMULATION	Animal models have become a popular platform for the investigation of the molecular and systemic mechanisms of pathological cardiovascular physiology. Chronic pacing studies with implantable pacemakers in large animals have led to useful models of heart failure and atrial fibrillation. Unfortunately, molecular and genetic studies in these large animal models are often prohibitively expensive or not available. Conversely, the mouse is an excellent species for studying molecular mechanisms of cardiovascular disease through genetic engineering. However, the large size of available pacemakers does not lend itself to chronic pacing in mice. Here, we present the design for a novel, fully implantable wireless-powered pacemaker for mice capable of long-term (>30 days) pacing. This design is compared to a traditional battery-powered pacemaker to demonstrate critical advantages achieved through wireless inductive power transfer and control. Battery-powered and wireless-powered pacemakers were fabricated from standard electronic components in our laboratory. Mice (n = 24) were implanted with endocardial, battery-powered devices (n = 14) and epicardial, wireless-powered devices (n = 10). Wireless-powered devices were associated with reduced implant mortality and more reliable device function compared to battery-powered devices. Eight of 14 (57.1%) mice implanted with battery-powered pacemakers died following device implantation compared to 1 of 10 (10%) mice implanted with wireless-powered pacemakers. Moreover, device function was achieved for 30 days with the wireless-powered device compared to 6 days with the battery-powered device. The wireless-powered pacemaker system presented herein will allow electrophysiology studies in numerous genetically engineered mouse models as well as rapid pacing-induced heart failure and atrial arrhythmia in mice.	[Laughner, Jacob I.; Zellmer, Erik R.; MacEwan, Matthew R.; Cui, Sophia X.; Efimov, Igor R.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Marrus, Scott B.; Weinheimer, Carla J.] Washington Univ, Dept Internal Med, Div Cardiovasc Sci, St Louis, MO USA; [Nerbonne, Jeanne M.] Washington Univ, Dept Dev Biol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Efimov, IR (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.	igor@wustl.edu	Efimov, Igor R./AAJ-3234-2021; Efimov, Igor/R-5544-2017; Efimov, Igor R/B-8040-2010	Efimov, Igor/0000-0002-1483-5039; Efimov, Igor R/0000-0002-1483-5039; Cui, Sophia/0000-0002-5133-4903	National Institutes of Health (NIH) [R21 HL10861701]; American Heart Association [12FTF12040261]; NIH NHLBI Cardiovascular Biology Training Program [T32HL007275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH NHLBI Cardiovascular Biology Training Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors gratefully acknowledge a National Institutes of Health (NIH) R21 HL10861701 grant (to IE and JMN), American Heart Association Fellow-to-Faculty Award 12FTF12040261 (SBM) and NIH NHLBI Cardiovascular Biology Training Program T32HL007275 for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfin SK, 2009, J NEUROPHYSIOL, V102, P598, DOI 10.1152/jn.00017.2009; Bilchick KC, 2006, PHYSIOL GENOMICS, V26, P109, DOI 10.1152/physiolgenomics.00281.2005; Cameron T, 1997, IEEE T BIO-MED ENG, V44, P781, DOI 10.1109/10.623047; Marrus SB, 2008, CHANNELS, V2, P117, DOI 10.4161/chan.2.2.6104; Monnet E, 2005, ANN THORAC SURG, V79, P1445, DOI 10.1016/j.athoracsur.2004.04.002; Nishida K, 2010, EUROPACE, V12, P160, DOI 10.1093/europace/eup328; Ozgen N, 2009, HEART RHYTHM, V6, P564, DOI 10.1016/j.hrthm.2009.01.008; Richmond FJR, 2004, IEEE, V2, P4182, DOI [10.1109/IEMBS.2004.1404167, DOI 10.1109/IEMBS.2004.1404167]; ROSENBAUM MB, 1982, AM J CARDIOL, V50, P213, DOI 10.1016/0002-9149(82)90169-2; Sweeney MO, 2003, CIRCULATION, V107, P2932, DOI 10.1161/01.CIR.0000072769.17295.B1	10	22	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76291	10.1371/journal.pone.0076291	http://dx.doi.org/10.1371/journal.pone.0076291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194832	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000011
J	White, P; Thornton, H; Pinnock, H; Georgopoulou, S; Booth, HP				White, Patrick; Thornton, Hannah; Pinnock, Hilary; Georgopoulou, Sofia; Booth, Helen P.			Overtreatment of COPD with Inhaled Corticosteroids - Implications for Safety and Costs: Cross-Sectional Observational Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; METERED-DOSE INHALER; LONG-TERM USE; PRIMARY-CARE; SALMETEROL/FLUTICASONE PROPIONATE; CLINICAL-TRIAL; EXACERBATIONS; SPIROMETRY; SALMETEROL; MANAGEMENT	Introduction: Combined inhaled long-acting beta-agonists and corticosteroids (LABA+ICS) are costly. They are recommended in severe or very severe chronic obstructive pulmonary disease (COPD). They should not be prescribed in mild or moderate disease. In COPD ICS are associated with side-effects including risk of pneumonia. We quantified appropriateness of prescribing and examined the risks and costs associated with overuse. Methods: Data were extracted from the electronic and paper records of 41 London general practices (population 310,775) including spirometry, medications and exacerbations. We classified severity, assessed appropriateness of prescribing using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines for 2009, and performed a sensitivity analysis using the broader recommendations of the 2011 revision. Results: 3537 patients had a diagnosis of COPD. Spirometry was recorded for 2458(69%). 709(29%) did not meet GOLD criteria. 1749(49%) with confirmed COPD were analysed: 8.6% under-treated, 38% over-treated. Over-prescription of ICS in GOLD stage I or II (n=403, 38%) and in GOLD III or IV without exacerbations (n=231, 33.6%) was common. An estimated 12 cases (95% CI 7-19) annually of serious pneumonia were likely among 897 inappropriately treated. 535 cases of overtreatment involved LABA+ICS with a mean per patient cost of 553.56 pound/year ((sic)650.03). Using the broader indications for ICS in the 2011 revised GOLD guideline 25% were still classified as over-treated. The estimated risk of 15 cases of pneumonia (95% CI 8-22) in 1074 patients currently receiving ICS would rise by 20% to 18 (95% CI 9.8-26.7) in 1305 patients prescribed ICS if all with GOLD grade 3 and 4 received LABA+ICS. Conclusion: Over-prescription of ICS in confirmed COPD was widespread with considerable potential for harm. In COPD where treatment is often escalated in the hope of easing the burden of disease clinicians should consider both the risks and benefits of treatment and the costs where the benefits are unproven.	[White, Patrick; Thornton, Hannah; Georgopoulou, Sofia; Booth, Helen P.] Kings Coll London, Kings Hlth Partners, Dept Primary Care & Publ Hlth Sci, London, England; [Pinnock, Hilary] Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, London, England	University of London; King's College London; University of Edinburgh	White, P (corresponding author), Kings Coll London, Kings Hlth Partners, Dept Primary Care & Publ Hlth Sci, London, England.	Patrick.white@kcl.ac.uk	White, Patrick/AAN-7799-2020	White, Patrick/0000-0002-2047-8787; Thornton, Hannah/0000-0003-0899-4102	Dunhill Medical Trust [R82/0708]; Chief Scientist Office [PCRCA/08/01] Funding Source: researchfish	Dunhill Medical Trust(Dunhill Medical Trust); Chief Scientist Office	This work was supported by Dunhill Medical Trust Grant R82/0708 (http://www.dunhillmedical.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB STRAT DIAGN MAN; Bourbeau J, 2008, CAN RESPIR J, V15, P13, DOI 10.1155/2008/173904; British Medical Association and Royal Pharmaceutical Society of Great Britain, 2011, BRIT NATL FORMULARY; British Standards Institution, 2011, BS ISO 121362011 REA, P1, DOI [10.3969/j.issn.1006-8082.2011.06.013, DOI 10.3969/J.ISSN.1006-8082.2011.06.013]; Britton M, 2003, RESP MED, V97, pS71, DOI 10.1016/S0954-6111(03)80027-6; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; de Miguel-Diez J, 2011, LUNG, V189, P199, DOI 10.1007/s00408-011-9289-0; Ferguson GT, 2008, RESP MED, V102, P1099, DOI 10.1016/j.rmed.2008.04.019; Global Initiative for Chronic Obstructive Lung Disease, 2009, GLOB STRAT DIAGN MAN; Jebrak G, 2010, REV MAL RESPIR, V27, P11, DOI 10.1016/j.rmr.2009.08.002; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; Jones RCM, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-62; Kardos P, 2007, AM J RESP CRIT CARE, V175, P144, DOI 10.1164/rccm.200602-244OC; Loke YK, 2011, THORAX, V66, P699, DOI 10.1136/thx.2011.160028; Lucas A, 2007, BRIT J GEN PRACT, V57, P892, DOI 10.3399/096016407782317883; Miravitlles M, 2007, RESP MED, V101, P1753, DOI 10.1016/j.rmed.2007.02.019; National Clinical Guideline Centre, 2010, CHRON HEART FAIL NAT; Neighbourhood Statistics and Census Output, 2011, QS201EW; Noble M, 2008, ENGLISH INDICES DEPR; Rabe KF, 2007, NEW ENGL J MED, V356, P851, DOI 10.1056/NEJMe068307; Rabe KF, 2011, LANCET, V378, P1038, DOI 10.1016/S0140-6736(11)61295-6; Rennard SI, 2009, DRUGS, V69, P549, DOI 10.2165/00003495-200969050-00004; Sin DD, 2010, EUR RESPIR J, V35, P949, DOI 10.1183/09031936.00006710; Singh S, 2009, ARCH INTERN MED, V169, P219, DOI 10.1001/archinternmed.2008.550; Singh Sonal, 2010, Int J Chron Obstruct Pulmon Dis, V5, P189; Singh S, 2010, CURR OPIN PULM MED, V16, P118, DOI 10.1097/MCP.0b013e328334c085; Strong M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-108; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Tashkin DP, 2008, DRUGS, V68, P1975, DOI 10.2165/00003495-200868140-00004; the NHS Information Centre, 2011, PRESCR PRIM CAR SERV; Trappenburg JCA, 2011, EUR RESPIR J, V37, P1260, DOI 10.1183/09031936.00130910; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; White P, 2007, BRIT J GEN PRACT, V57, P701; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x	34	87	89	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e75221	10.1371/journal.pone.0075221	http://dx.doi.org/10.1371/journal.pone.0075221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194824	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000003
J	Wikenros, C; Sand, H; Ahlqvist, P; Liberg, O				Wikenros, Camilla; Sand, Hakan; Ahlqvist, Per; Liberg, Olof			Biomass Flow and Scavengers Use of Carcasses after Re-Colonization of an Apex Predator	PLOS ONE			English	Article							MOOSE ALCES-ALCES; SNOW DEPTH; POPULATION-DYNAMICS; NATIONAL-PARK; CANIS-LUPUS; KILL RATES; WOLVES; YELLOWSTONE; WINTER; AGE	Background: Reestablishment of apex predators influences the availability and distribution of biomass for scavengers and can therefore be an important agent for structuring species communities. We studied how the re-colonization of the Scandinavian Peninsula by wolves (Canis lupus) affected the amount and temporal variation in use of moose (Alces alces) carcasses. Methodology/Principal Findings: We compared the availability of biomass from remains at wolf kills with those killed by hunters, vehicle collisions and natural death. Movement-triggered cameras monitored patterns of use on wolf kills and remains from hunter harvest by scavengers (n = 15 276) in relation to time of year, available carcass biomass, time since the death of the moose and presence of wolves. Remains from hunter harvest were the largest food source for scavengers both within wolf territories (57%) and in areas without wolves (81%). The total annual biomass available were similar in areas with (25 648 kg) and without (24 289 kg) wolves. Presence of wolves lowered the peak biomass available from hunter harvest in October (20%) and increased biomass available during December to August (38-324% per month). The probability of scavengers being present decreased faster with time at remains from hunter harvest compared to wolf kills and both the probability of being present and the number of visits by scavengers to wolf kills increased as the amount of biomass available on the carcass increased. Conclusions/Significance: Wolves reduced the seasonal variation of biomass from moose carcasses and most important increased it during spring. Scavengers also visited wolf kills most frequently during spring when most scavenging species have young, which may lead to an increase in survival and/or reproductive success of scavengers within wolf territories. This applies both for abundant scavenging species that were the most frequent visitors at wolf kills and threatened scavengers with lower visit frequency.	[Wikenros, Camilla; Sand, Hakan; Ahlqvist, Per; Liberg, Olof] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden	Swedish University of Agricultural Sciences	Wikenros, C (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden.	camilla.wikenros@slu.se			Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Swedish Environmental Protection Agency; Swedish Association for Hunting and Wildlife Management; World Wildlife Fund for Nature (Sweden); Swedish University for Agricultural Sciences; Olle and Signhild Engkvists Stiftelser; Carl Tryggers Stiftelse; Swedish Carnivore Association	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish Environmental Protection Agency; Swedish Association for Hunting and Wildlife Management; World Wildlife Fund for Nature (Sweden); Swedish University for Agricultural Sciences; Olle and Signhild Engkvists Stiftelser; Carl Tryggers Stiftelse; Swedish Carnivore Association	The study was funded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Swedish Environmental Protection Agency, Swedish Association for Hunting and Wildlife Management, World Wildlife Fund for Nature (Sweden), Swedish University for Agricultural Sciences, Olle and Signhild Engkvists Stiftelser, Carl Tryggers Stiftelse, and Swedish Carnivore Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almkvist B, 1980, SLUTRAPPORT VILTOLYC; Berger J, 2001, ECOL APPL, V11, P947, DOI 10.2307/3061004; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Broman E, 2002, WILDLIFE BIOL, V8, P219, DOI 10.2981/wlb.2002.036; CEDERLUND GN, 1991, J WILDLIFE MANAGE, V55, P675, DOI 10.2307/3809517; Dahlstrom B., 1995, KLIMAT SJOAR VATTEND, P91; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Elbroch LM, 2012, BIOL LETTERS, V8, P776, DOI 10.1098/rsbl.2012.0423; Ericsson G, 2001, ECOSCIENCE, V8, P157, DOI 10.1080/11956860.2001.11682641; Gardenfors U., 2010, RED LIST SWEDISH SPE; Gavashelishvili A, 2006, J ZOOL, V269, P365, DOI 10.1111/j.1469-7998.2006.00062.x; Haglund B., 1968, VILTREVY, V5, P213; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; Houston D.C., 1979, SERENGETI DYNAMICS E, P263; HUGGARD DJ, 1993, J WILDLIFE MANAGE, V57, P382, DOI 10.2307/3809437; JEDRZEJEWSKI W, 1992, ECOGRAPHY, V15, P212, DOI 10.1111/j.1600-0587.1992.tb00027.x; Karlsson J, 2007, J ZOOL, V272, P276, DOI 10.1111/j.1469-7998.2006.00267.x; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Lavsund Sten, 2003, Alces, V39, P109; LINDSTROM ER, 1994, OIKOS, V70, P156, DOI 10.2307/3545711; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020248; MARKGREN G, 1969, Viltrevy (Stockholm), V6, P127; Mattisson J, 2011, J MAMMAL, V92, P1321, DOI 10.1644/11-MAMM-A-099.1; Metz MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017332; Nilsen EB, 2005, J APPL ECOL, V42, P389, DOI 10.1111/j.1365-2664.2005.01018.x; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Persson J, 2005, CAN J ZOOL, V83, P1453, DOI 10.1139/Z05-143; Peterson Rolf O., 2003, P104; Promberger C, 1992, THESIS MAXIMILIAMS U; Ronnegard L, 2008, WILDLIFE BIOL, V14, P358, DOI 10.2981/0909-6396(2008)14[358:EOFMUT]2.0.CO;2; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Sand H, 2006, P R SOC B, V273, P1421, DOI 10.1098/rspb.2005.3447; Sand H, 2005, WILDLIFE SOC B, V33, P914, DOI 10.2193/0091-7648(2005)33[914:UGTAGC]2.0.CO;2; Sand H, 2012, CAN J ZOOL, V90, P403, DOI 10.1139/Z2012-007; Sand H, 2007, VARGEN ARTFAKTA SAMM; Sand H, 2008, OECOLOGIA, V156, P53, DOI 10.1007/s00442-008-0969-2; Sand H, 2006, ANIM BEHAV, V72, P781, DOI 10.1016/j.anbehav.2005.11.030; Sand H, 2012, OIKOS, V121, P1454, DOI 10.1111/j.1600-0706.2012.20082.x; Seiler A, 2004, WILDLIFE BIOL, V10, P301, DOI 10.2981/wlb.2004.036; Seiler A, 2011, UNGULATE TRAIN COLLI, P21; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Selva N, 2003, ECOSCIENCE, V10, P303, DOI 10.1080/11956860.2003.11682778; Smith DW, 2003, BIOSCIENCE, V53, P330, DOI 10.1641/0006-3568(2003)053[0330:YAW]2.0.CO;2; Stahler D, 2002, ANIM BEHAV, V64, P283, DOI 10.1006/anbe.2002.3047; van Dijk J, 2008, J ANIM ECOL, V77, P1183, DOI 10.1111/j.1365-2656.2008.01445.x; Vedin H., 1995, KLIMAT SJOAR VATTEND, P44; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Wabakken P., 2010, WOLF SCANDINAVIA STA; WIDEN P, 1987, HOLARCTIC ECOL, V10, P104; Wikenros C., 2011, THESIS SWEDISH U AGR; Wilmers CC, 2005, PLOS BIOL, V3, P571, DOI 10.1371/journal.pbio.0030092; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x; Zalewski A, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P77	54	42	42	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77373	10.1371/journal.pone.0077373	http://dx.doi.org/10.1371/journal.pone.0077373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194881	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000326037000060
J	Eigemann, F; Vanormelingen, P; Hilt, S				Eigemann, Falk; Vanormelingen, Pieter; Hilt, Sabine			Sensitivity of the Green Alga Pediastrum duplex Meyen to Allelochemicals Is Strain-Specific and Not Related to Co-Occurrence with Allelopathic Macrophytes	PLOS ONE			English	Article							MARINE-PHYTOPLANKTON; POLYPHENOLIC ALLELOCHEMICALS; CHLOROPHYLL FLUORESCENCE; SUBMERGED MACROPHYTES; GENETIC ADAPTATION; INHIBITION; GROWTH; PHOTOSYNTHESIS; SPHAEROPLEALES; EVOLUTION	Interspecific differences in the response of microalgae to stress have numerous ecological implications. However, little is known of intraspecific sensitivities and the potential role of local genetic adaptation of populations. We compared the allelochemical sensitivity of 23 Pediastrum duplex Meyen strains, a common component of the freshwater phytoplankton. In order to test for local genetic adaptation, strains were isolated from water bodies with and without the allelopathically-active submerged macrophyte Myriophyllum. Strains were assigned to P. duplex on the basis of cell shape and colony morphology and only P. duplex strains that belonged to the same lineage in an ITS rDNA phylogeny were used. Inhibition of strain growth rates and maximum quantum yields of photosystem II were measured after exposure to tannic acid (TA) and co-culture with Myriophyllum spicatum. Growth rate inhibition varied over one order of magnitude between the P. duplex strains. There was no correlation between the presence of Myriophyllum in the source location and the sensitivity of the strains to TA or the presence of Myriophyllum, suggesting that at least strong unidirectional local adaptation to Myriophyllum had not taken place in the studied water bodies. The maximum quantum yield of photosystem II of TA exposed algae decreased, whereas the yield of algae exposed to M. spicatum was slightly higher than that of the controls. The ranking of P. duplex strain sensitivities differed between the types of exposure (single additions of TA versus co-existence with M. spicatum) and the parameter measured (growth rate versus maximum quantum yield), emphasizing the importance of measuring multiple traits when analysing strain-specific sensitivities towards allelochemicals. The observation that sensitivities to allelochemicals vary widely among strains of a single freshwater algal species should be taken into account if evaluating ecological consequences of allelopathic interactions.	[Eigemann, Falk; Hilt, Sabine] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Berlin, Germany; [Eigemann, Falk] Free Univ Berlin, Inst Biol, Berlin, Germany; [Vanormelingen, Pieter] Univ Ghent, Lab Protistol & Aquat Ecol, Ghent, Belgium	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Free University of Berlin; Ghent University	Eigemann, F (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Berlin, Germany.	eigemann@igb-berlin.de	Hilt, Sabine/C-4783-2011	Eigemann, Falk/0000-0002-4499-5682	German Research Foundation (DFG) [HI 1380/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	PD Dr. Sabine Hilt and Falk Eigemann were funded by the German Research Foundation (DFG, HI 1380/3-1). Dr. Pieter Vanormelingen is a postdoctoral research fellow with the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehri A. M., 2010, J APPL SCI, V10, P1769, DOI [10.3923/jas.2010.1769.1774, DOI 10.3923/JAS.2010.1769.1774]; Bahrs H, 2012, ENVIRON SCI POLLUT R, V19, P335, DOI 10.1007/s11356-011-0564-7; Bauer N, 2009, AQUAT BOT, V91, P110, DOI 10.1016/j.aquabot.2009.03.005; Behra R, 1999, ARCH ENVIRON CON TOX, V37, P36, DOI 10.1007/s002449900487; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; Buchheim M, 2005, J PHYCOL, V41, P1039, DOI 10.1111/j.1529-8817.2005.00129.x; Bucolo P, 2012, J PHYCOL, V48, P1403, DOI 10.1111/j.1529-8817.2012.01221.x; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Carrillo E, 2003, PHYCOLOGIA, V42, P269, DOI 10.2216/i0031-8884-42-3-269.1; DeMeester L, 1996, ECOSCIENCE, V3, P385, DOI 10.1080/11956860.1996.11682356; Eigemann F, 2013, AQUAT BOT, V104, P5, DOI 10.1016/j.aquabot.2012.10.005; FALKOWSKI PG, 1984, PHOTOSYNTHETICA, V18, P62; FISHER NS, 1973, NATURE, V241, P548, DOI 10.1038/241548a0; FOSTER PL, 1982, FRESHWATER BIOL, V12, P41, DOI 10.1111/j.1365-2427.1982.tb00602.x; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gross EM, 1996, PHYTOCHEMISTRY, V41, P133, DOI 10.1016/0031-9422(95)00598-6; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Harnstrom K, 2011, P NATL ACAD SCI USA, V108, P4252, DOI 10.1073/pnas.1013528108; Hilt S, 2006, J PHYCOL, V42, P1189, DOI 10.1111/j.1529-8817.2006.00286.x; Hilt S, 2012, J PHYCOL, V48, P40, DOI 10.1111/j.1529-8817.2011.01106.x; Hilt S, 2008, BASIC APPL ECOL, V9, P422, DOI 10.1016/j.baae.2007.04.003; Hilt S, 2006, AQUAT BOT, V85, P252, DOI 10.1016/j.aquabot.2006.05.004; Hoffman A.A., 1997, EXTREME ENV CHANGE E; Inderjit Wardle DA, 2011, TRENDS ECOL EVOL, V1442, P1; JENSEN A, 1974, J EXP MAR BIOL ECOL, V15, P145, DOI 10.1016/0022-0981(74)90040-9; Jensen CG, 2010, OECOLOGIA, V162, P1017, DOI 10.1007/s00442-009-1501-z; Juneau P, 2005, PHOTOCHEM PHOTOBIOL, V81, P649, DOI 10.1562/2005-01-13-RA-414.1; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Komarek J., 1983, BINNENGEWASSER PHY 1, P1044; Korner S, 2002, J PHYCOL, V38, P862, DOI 10.1046/j.1529-8817.2002.t01-1-02001.x; Lakeman MB, 2009, HARMFUL ALGAE, V8, P746, DOI 10.1016/j.hal.2008.11.011; Leu E, 2002, PLANT PHYSIOL, V130, P2011, DOI 10.1104/pp.011593; Lopez-Rodas V, 2007, EVOL ECOL, V21, P535, DOI 10.1007/s10682-006-9134-8; Lopez-Rodas V, 2011, J PHYCOL, V47, P1036, DOI 10.1111/j.1529-8817.2011.01035.x; Low-Decarie E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2598; Loxdale HD, 2003, BIOL J LINN SOC, V79, P3, DOI 10.1046/j.1095-8312.2003.00177.x; Lurling M, 2003, HYDROBIOLOGIA, V491, P145, DOI 10.1023/A:1024436508387; Marshall JA, 2002, J EXP MAR BIOL ECOL, V272, P13, DOI 10.1016/S0022-0981(02)00034-5; McManus HA, 2011, J PHYCOL, V47, P152, DOI 10.1111/j.1529-8817.2010.00940.x; MENZEL DW, 1970, SCIENCE, V167, P1724, DOI 10.1126/science.167.3926.1724; Mulderij G, 2005, AQUAT BOT, V82, P284, DOI 10.1016/j.aquabot.2005.04.001; MURPHY LS, 1980, LIMNOL OCEANOGR, V25, P160, DOI 10.4319/lo.1980.25.1.0160; NICKLISCH A, 1992, ARCH HYDROBIOL, P1; Planas D., 1981, VERH INT VEREIN LIMN, V21, P492; Rabotnov TA., 1982, EKOLOGIA, V3, P5; Reed DH, 2003, EVOLUTION, V57, P1822; Reigosa MJ, 1999, CRIT REV PLANT SCI, V18, P577, DOI [10.1016/S0735-2689(99)00392-5, 10.1080/07352689991309405]; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rynearson TA, 2005, MOL ECOL, V14, P1631, DOI 10.1111/j.1365-294X.2005.02526.x; SCHREIBER U, 1986, PHOTOSYNTH RES, V9, P261, DOI 10.1007/BF00029749; Spijkerman E, 2010, J PHYCOL, V46, P658, DOI 10.1111/j.1529-8817.2010.00859.x; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; TING CS, 1992, PLANT PHYSIOL, V100, P367, DOI 10.1104/pp.100.1.367; Vanormelingen P, 2007, J PHYCOL, V43, P378, DOI 10.1111/j.1529-8817.2007.00325.x; Vanormelingen P, 2009, LIMNOL OCEANOGR, V54, P503, DOI 10.4319/lo.2009.54.2.0503; WOOD AM, 1992, J PHYCOL, V28, P723, DOI 10.1111/j.0022-3646.1992.00723.x; ZECHMAN FW, 1994, J PHYCOL, V30, P507, DOI 10.1111/j.0022-3646.1994.00507.x	60	19	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78463	10.1371/journal.pone.0078463	http://dx.doi.org/10.1371/journal.pone.0078463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167626	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500087
J	Lee, MJ; Shin, DH; Kim, SJ; Yoo, DE; Ko, KI; Koo, HM; Kim, CH; Doh, FM; Oh, HJ; Park, JT; Han, SH; Yoo, TH; Choi, KH; Kang, SW				Lee, Mi Jung; Shin, Dong Ho; Kim, Seung Jun; Yoo, Dong Eun; Ko, Kwang Il; Koo, Hyang Mo; Kim, Chan Ho; Doh, Fa Mee; Oh, Hyung Jung; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Choi, Kyu Hun; Kang, Shin-Wook			Sagittal Abdominal Diameter Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Incident Peritoneal Dialysis Patients	PLOS ONE			English	Article							BODY-MASS INDEX; CORONARY-ARTERY-DISEASE; VISCERAL ADIPOSE-TISSUE; TO-HIP RATIO; WAIST CIRCUMFERENCE; RISK-FACTORS; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; PROSPECTIVE COHORT; OBESITY	Backgrounds and Aims: Visceral fat has a crucial role in the development and progression of cardiovascular disease, the major cause of death in end-stage renal disease (ESRD). Although sagittal abdominal diameter (SAD), as an index of visceral fat, significantly correlated with mortality in the general population, the impact of SAD on clinical outcomes has never been explored in ESRD patients. Therefore, we sought to elucidate the prognostic value of SAD in incident peritoneal dialysis (PD) patients. Methods: We prospectively determined SAD by lateral abdominal X-ray at PD initiation, and evaluated the association of SAD with all-cause and cardiovascular mortality in 418 incident PD patients. Results: The mean SAD was 24.5 +/- 4.3 cm, and during a mean follow-up of 39.4 months, 97 patients (23.2%) died, and 49.4% of them died due to cardiovascular disease. SAD was a significant independent predictor of all-cause [3rd versus 1st tertile, HR (hazard ratio): 3.333, 95% CI (confidence interval): 1.514-7.388, P = 0.01; per 1 cm increase, HR: 1.071, 95% CI: 1.005-1.141, P = 0.03] and cardiovascular mortality (3rd versus 1st tertile, HR: 8.021, 95% CI: 1.994-32.273, P = 0.01; per 1 cm increase, HR: 1.106, 95% CI: 1.007-1.214, P = 0.03). Multivariate fractional polynomial analysis also showed that all-cause and cardiovascular mortality risk increased steadily with higher SAD values. In addition, SAD provided higher predictive value for all-cause (AUC: 0.691 vs. 0.547, P<0.001) and cardiovascular mortality (AUC: 0.644 vs. 0.483, P<0.001) than body mass index (BMI). Subgroup analysis revealed higher SAD (>= 24.2 cm) was significantly associated with all-cause mortality in men, women, younger patients (<65 years), and patients with lower BMI (<22.3 kg/m(2)). Conclusions: SAD determined by lateral abdominal X-ray at PD initiation was a significant independent predictor of all-cause and cardiovascular mortality in incident PD patients. Estimating visceral fat by SAD could be useful to stratify mortality risk in these patients.	[Lee, Mi Jung; Shin, Dong Ho; Kim, Seung Jun; Yoo, Dong Eun; Ko, Kwang Il; Koo, Hyang Mo; Kim, Chan Ho; Doh, Fa Mee; Oh, Hyung Jung; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Choi, Kyu Hun; Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yoo, Tae-Hyun; Kang, Shin-Wook] Yonsei Univ, Brain Korea 21, Severance Biomed Sci Inst, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University	Kang, SW (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	kswkidney@yuhs.ac	Han, Seung Hyeok/W-8825-2019; Kim, Seung Jun/N-5248-2019; Han, Seung Hyeok/K-4559-2018	Han, Seung Hyeok/0000-0001-7923-5635; Kim, Seung Jun/0000-0002-6913-6358; Han, Seung Hyeok/0000-0001-7923-5635; doh, fa mee/0000-0002-4780-6728; Lee, Mi Jung/0000-0001-8888-029X; Choi, Kyu Hun/0000-0003-0095-9011; Kang, Shin-Wook/0000-0002-5677-4756; Yoo, Tae-Hyun/0000-0002-9183-4507; Park, Jung Tak/0000-0002-2325-8982	Brain Korea 21 Project for Medical Science, Yonsei University; National Research Foundation of Korea (NRF); Korea government (MEST) [2011-0030711]; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A102065]	Brain Korea 21 Project for Medical Science, Yonsei University(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Brain Korea 21 Project for Medical Science, Yonsei University, by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0030711), and by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KC, 2004, KIDNEY INT, V65, P597, DOI 10.1111/j.1523-1755.2004.00385.x; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Clasey JL, 1999, OBES RES, V7, P256, DOI 10.1002/j.1550-8528.1999.tb00404.x; Coutinho T, 2011, J AM COLL CARDIOL, V57, P1877, DOI 10.1016/j.jacc.2010.11.058; CuetoManzano AM, 1997, AM J KIDNEY DIS, V30, P229, DOI 10.1016/S0272-6386(97)90057-3; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Elsayed EF, 2008, AM J KIDNEY DIS, V52, P49, DOI 10.1053/j.ajkd.2008.04.002; Empana JP, 2004, CIRCULATION, V110, P2781, DOI 10.1161/01.CIR.0000146395.64065.BA; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Greenberg JA, 2006, OBESITY, V14, P2071, DOI 10.1038/oby.2006.242; Gustat J, 2000, AM J EPIDEMIOL, V151, P885, DOI 10.1093/oxfordjournals.aje.a010292; Guzzaloni G, 2009, INT J OBESITY, V33, P233, DOI 10.1038/ijo.2008.271; Hwu CM, 2003, J HUM HYPERTENS, V17, P193, DOI 10.1038/sj.jhh.1001532; Iribarren C, 2006, AM J EPIDEMIOL, V164, P1150, DOI 10.1093/aje/kwj341; Kalantar-Zadeh K, 2005, AM J KIDNEY DIS, V46, P489, DOI 10.1053/j.ajkd.2005.05.020; Kalantar-Zadeh K, 2006, AM J CLIN NUTR, V83, P202; Kim SK, 2009, INT J OBESITY, V33, P131, DOI 10.1038/ijo.2008.222; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; LamonFava S, 1996, ARTERIOSCL THROM VAS, V16, P1509, DOI 10.1161/01.ATV.16.12.1509; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leavey SF, 2001, NEPHROL DIAL TRANSPL, V16, P2386, DOI 10.1093/ndt/16.12.2386; Lee MJ, 2012, OBESITY, V20, P1301, DOI 10.1038/oby.2011.245; Mcdonald SP, 2003, J AM SOC NEPHROL, V14, P2894, DOI 10.1097/01.ASN.0000091587.55159.5F; Nakata K, 2010, METABOLISM, V59, P1742, DOI 10.1016/j.metabol.2010.04.019; Oreopoulos A, 2009, EUR HEART J, V30, P2584, DOI 10.1093/eurheartj/ehp288; Petersson H, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-10; Postorino M, 2009, J AM COLL CARDIOL, V53, P1265, DOI 10.1016/j.jacc.2008.12.040; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Ribeiro FF, 2001, HYPERTENSION, V38, P713, DOI 10.1161/01.HYP.38.3.713; RICHELSEN B, 1995, INT J OBESITY, V19, P169; Riserus U, 2004, DIABETES CARE, V27, P2041, DOI 10.2337/diacare.27.8.2041; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; SEIDELL JC, 1994, INT J OBESITY, V18, P61; Shioya M, 2013, NEPHROLOGY, V18, P539, DOI 10.1111/nep.12106; Snyder JJ, 2003, KIDNEY INT, V64, P1838, DOI 10.1046/j.1523-1755.2003.00287.x; Su WS, 2010, INT J NEPHROL, V2010, DOI 10.4061/2010/831243; VANDERKOOY K, 1993, BRIT J NUTR, V70, P47, DOI 10.1079/BJN19930104; Wolk R, 2003, CIRCULATION, V108, P2206, DOI 10.1161/01.CIR.0000095270.85646.E8; Yim JY, 2010, DIABETES CARE, V33, P2665, DOI 10.2337/dc10-0606; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zeller M, 2008, CIRCULATION, V118, P482, DOI 10.1161/CIRCULATIONAHA.107.753483; Zoccali C, 2004, NEPHROL DIAL TRANSPL, V19, P67, DOI 10.1093/ndt/gfh1059	44	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77082	10.1371/journal.pone.0077082	http://dx.doi.org/10.1371/journal.pone.0077082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167560	gold, Green Submitted, Green Published			2022-12-27	WOS:000326034500019
J	Meleg, IN; Zaksek, V; Fiser, C; Kelemen, BS; Moldovan, OT				Meleg, Ioana Nicoleta; Zaksek, Valerija; Fiser, Cene; Kelemen, Beatrice Simona; Moldovan, Oana Teodora			Can Environment Predict Cryptic Diversity? The Case of Niphargus Inhabiting Western Carpathian Groundwater	PLOS ONE			English	Article							SUBTERRANEAN DIVING BEETLES; CAVE SHRIMP TROGLOCARIS; MOLECULAR PHYLOGENY; CRUSTACEA; WATER; PHYLOGEOGRAPHY; TAXONOMY; GENUS; DNA; SPECIATION	In the last decade, several studies have shown that subterranean aquatic habitats harbor cryptic species with restricted geographic ranges, frequently occurring as isolated populations. Previous studies on aquatic subterranean species have implied that habitat heterogeneity can promote speciation and that speciation events can be predicted from species' distributions. We tested the prediction that species distributed across different drainage systems and karst sectors comprise sets of distinct species. Amphipods from the genus Niphargus from 11 caves distributed along the Western Carpathians (Romania) were investigated using three independent molecular markers (COI, H3 and 28S). The results showed that: 1) the studied populations belong to eight different species that derive from two phylogenetically unrelated Niphargus clades; 2) narrow endemic species in fact comprise complexes of morphologically similar species that are indistinguishable without using a molecular approach. The concept of monophyly, concordance between mitochondrial and nuclear DNA, and the value of patristic distances were used as species delimitation criteria. The concept of cryptic species is discussed within the framework of the present work and the contribution of these species to regional biodiversity is also addressed.	[Meleg, Ioana Nicoleta; Moldovan, Oana Teodora] Romanian Acad, Emil Racovita Inst Speleol, Cluj Napoca, Romania; [Zaksek, Valerija; Fiser, Cene] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Kelemen, Beatrice Simona] Univ Babes Bolyai, Interdisciplinary Res Inst Bionanosci, Ctr Mol Biol, R-3400 Cluj Napoca, Romania	Emil Racovita Institute of Speleology; Romanian Academy of Sciences; University of Ljubljana; Babes Bolyai University from Cluj	Meleg, IN (corresponding author), Romanian Acad, Emil Racovita Inst Speleol, Cluj Napoca, Romania.	ioana.meleg@hasdeu.ubbcluj.ro	Moldovan, Oana/A-6646-2011; Meleg, Ioana Nicoleta/O-7397-2019; Kelemen, Beatrice/AAK-3413-2021; Kelemen, Beatrice Simona/C-5385-2012	Moldovan, Oana/0000-0002-1262-0675; Kelemen, Beatrice/0000-0002-2989-2941; Kelemen, Beatrice Simona/0000-0002-2989-2941; Meleg, Ioana Nicoleta/0000-0002-0836-4971	KARSTHIVES Project [PCCE_ID_31/2010]; CNCS-UEFISCDI; Slovenian Research Agency [P1-0184, 1000-11-214275]	KARSTHIVES Project; CNCS-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported through the KARSTHIVES Project PCCE_ID_31/2010 funded by CNCS-UEFISCDI for INM, BSK and OTM and by the Slovenian Research Agency through the program P1-0184 for VZ and CF. During the preparation of this paper VZ was financed by the Slovenian Research Agency (contract 1000-11-214275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Brad T, 1999, STUDII SI CERCETARI, V5, P157; Bradford T, 2010, MOL ECOL RESOUR, V10, P41, DOI 10.1111/j.1755-0998.2009.02706.x; Bucur Ruxandra, 2003, Atti del Museo Civico di Storia Naturale di Trieste, V50, P231; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P121, DOI 10.1651/08-3089.1; Camacho AI, 2012, J CRUSTACEAN BIOL, V32, P816, DOI 10.1163/193724012X638473; Colgan DJ, 2000, ZOOL SCR, V29, P29, DOI 10.1046/j.1463-6409.2000.00021.x; Cook BD, 2008, BIOL CONSERV, V141, P2821, DOI 10.1016/j.biocon.2008.08.018; de Queiroz K, 2005, BIOESSAYS, V27, P1263, DOI 10.1002/bies.20325; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dinca V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1329; Dudich E., 1943, Annales Historico-Naturales Musei Hungarici Zool, V36, P47; Finston TL, 2007, MOL ECOL, V16, P355, DOI 10.1111/j.1365-294X.2006.03123.x; Fiser C, 2008, ZOOL SCR, V37, P665, DOI 10.1111/j.1463-6409.2008.00347.x; Fiser C, 2007, LIMNOLOGY, V8, P297, DOI 10.1007/s10201-007-0221-5; Fiser C, 2006, J NAT HIST, V40, P2265, DOI 10.1080/00222930601086572; Fiser C, 2013, OIKOS, V122, P770, DOI 10.1111/j.1600-0706.2012.20644.x; Fiser C, 2010, ORG DIVERS EVOL, V10, P5, DOI 10.1007/s13127-010-0006-2; Fiser C, 2009, ZOOTAXA, P1; Fiser C, 2009, CRUSTACEANA, V82, P593, DOI 10.1163/156854009X407704; Flot JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-171; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Garcia-Machado E, 2011, MOL PHYLOGENET EVOL, V61, P470, DOI 10.1016/j.ympev.2011.06.015; Gibert J, 2009, FRESHWATER BIOL, V54, P930, DOI 10.1111/j.1365-2427.2009.02201.x; Gomez A, 2002, EVOLUTION, V56, P1431; Goricki S, 2006, GENE, V378, P31, DOI 10.1016/j.gene.2006.04.016; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guzik MT, 2009, MOL ECOL, V18, P3683, DOI 10.1111/j.1365-294X.2009.04296.x; Hartke TR, 2011, J CRUSTACEAN BIOL, V31, P701, DOI 10.1651/10-3434.1; Jaafar TNAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049623; Juan C, 2010, MOL ECOL, V19, P3865, DOI 10.1111/j.1365-294X.2010.04759.x; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Knox MA, 2012, MOL ECOL, V21, P4885, DOI 10.1111/j.1365-294X.2012.05729.x; Lefebure T, 2007, MOL PHYLOGENET EVOL, V42, P676, DOI 10.1016/j.ympev.2006.08.020; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lefebure T, 2006, MOL ECOL, V15, P1797, DOI 10.1111/j.1365-294X.2006.02888.x; Leys R, 2003, EVOLUTION, V57, P2819, DOI 10.1111/j.0014-3820.2003.tb01523.x; Mardulyn P, 2012, MOL ECOL, V21, P3385, DOI 10.1111/j.1365-294X.2012.05622.x; Moldovan OT, 2007, ACTA CARSOLOGICA, V36, P77; Murphy NP, 2009, MOL ECOL, V18, P109, DOI 10.1111/j.1365-294X.2008.04007.x; Oliver P, 2011, AUSTR SCI, V32, P20; Oraseanu I, 2010, KARST HYDROGEOLOGY A; Page TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001618; Pfenninger M, 2003, MOL ECOL, V12, P2731, DOI 10.1046/j.1365-294X.2003.01943.x; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Plesa C., 1969, BIOGEOGRAFIA ROMANIE, P354; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schellenberg A., 1940, Zoologische Jahrbuecher Jena Systematik, V74, P243; Schlick-Steiner BC, 2007, TRENDS ECOL EVOL, V22, P391, DOI 10.1016/j.tree.2007.05.004; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Trontelj P, 2012, EVOLUTION, V66, P3852, DOI 10.1111/j.1558-5646.2012.01734.x; Trontelj P, 2009, SYST BIODIVERS, V7, P1, DOI 10.1017/S1477200008002909; Trontelj P, 2009, FRESHWATER BIOL, V54, P727, DOI 10.1111/j.1365-2427.2007.01877.x; Vainola R, 2008, HYDROBIOLOGIA, V595, P241, DOI 10.1007/s10750-007-9020-6; Verovnik R, 2005, MOL ECOL, V14, P4355, DOI 10.1111/j.1365-294X.2005.02745.x; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Zaksek V, 2007, MOL PHYLOGENET EVOL, V42, P223, DOI 10.1016/j.ympev.2006.07.009; Zaksek V, 2009, MOL ECOL, V18, P931, DOI 10.1111/j.1365-294X.2008.04061.x; Zou SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047276	66	45	46	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76760	10.1371/journal.pone.0076760	http://dx.doi.org/10.1371/journal.pone.0076760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204671	gold, Green Submitted, Green Published			2022-12-27	WOS:000326032600009
J	Vittal, R; Mickler, EA; Fisher, AJ; Zhang, C; Rothhaar, K; Gu, HM; Brown, KM; Emtiazdjoo, A; Lott, JM; Frye, SB; Smith, GN; Sandusky, GE; Cummings, OW; Wilkes, DS				Vittal, Ragini; Mickler, Elizabeth A.; Fisher, Amanda J.; Zhang, Chen; Rothhaar, Katia; Gu, Hongmei; Brown, Krista M.; Emtiazdjoo, Amir; Lott, Jeremy M.; Frye, Sarah B.; Smith, Gerald N.; Sandusky, George E.; Cummings, Oscar W.; Wilkes, David S.			Type V Collagen Induced Tolerance Suppresses Collagen Deposition, TGF-beta and Associated Transcripts in Pulmonary Fibrosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MESSENGER-RNA; IN-VIVO; LUNG; MYOFIBROBLAST; AUTOREACTIVITY; IDENTIFICATION; INFLAMMATION; FIBROBLASTS; INHIBITION	Rationale: Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterized by progressive scarring and matrix deposition. Recent reports highlight an autoimmune component in IPF pathogenesis. We have reported anti-col(V) immunity in IPF patients. The objective of our study was to determine the specificity of col(V) expression profile and anti-col(V) immunity relative to col(I) in clinical IPF and the efficacy of nebulized col(V) in pre-clinical IPF models. Methods: Col(V) and col(I) expression profile was analyzed in normal human and IPF tissues. C57-BL6 mice were intratracheally instilled with bleomycin (0.025 U) followed by col(V) nebulization at pre-/post-fibrotic stage and analyzed for systemic and local responses. Results: Compared to normal lungs, IPF lungs had higher protein and transcript expression of the alpha 1 chain of col(V) and col(I). Systemic anti-col(V) antibody concentrations, but not of anti-col(I), were higher in IPF patients. Nebulized col(V), but not col(I), prevented bleomycin-induced fibrosis, collagen deposition, and myofibroblast differentiation. Col(V) treatment suppressed systemic levels of anti-col(V) antibodies, IL-6 and TNF-alpha; and local Il-17a transcripts. Compared to controls, nebulized col(V)-induced tolerance abrogated antigen-specific proliferation in mediastinal lymphocytes and production of IL-17A, IL-6, TNF-alpha and IFN-gamma. In a clinically relevant established fibrosis model, nebulized col(V) decreased collagen deposition. mRNA array revealed downregulation of genes specific to fibrosis (Tgf-beta, Il-1 beta, Pdgfb), matrix (Acta2, Col1a2, Col3a1, Lox, Itgb1/6, Itga2/3) and members of the TGF-beta superfamily (Tgfbr1/2, Smad2/3, Ltbp1, Serpine1, Nfkb/Sp1/Cebpb). Conclusions: Anti-col(V) immunity is pathogenic in IPF, and col(V)-induced tolerance abrogates bleomycin-induced fibrogenesis and down regulates TGF- beta-related signaling pathways.	[Vittal, Ragini; Mickler, Elizabeth A.; Fisher, Amanda J.; Gu, Hongmei; Brown, Krista M.; Emtiazdjoo, Amir; Lott, Jeremy M.; Smith, Gerald N.; Wilkes, David S.] Indiana Univ Sch Med, Ctr Immunobiol, Indianapolis, IN 46202 USA; [Rothhaar, Katia; Frye, Sarah B.] ImmuneWorks Inc, Indianapolis, IN USA; [Zhang, Chen; Sandusky, George E.; Cummings, Oscar W.] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Wilkes, DS (corresponding author), Indiana Univ Sch Med, Ctr Immunobiol, Indianapolis, IN 46202 USA.	dwilkes@iupui.edu	VITTAL, RAGINI/AAE-9052-2020		NIH-NHLBI-Lung Tissue Research Consortium; NIAID [P01AI084853];  [NIH-NHLBI-HL109288];  [NIH-NCAATS-KL2 TR000163];  [NIH-NHLBI-HL067177]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, KL2TR000163, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067177, R01HL109288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI084853] Funding Source: NIH RePORTER	NIH-NHLBI-Lung Tissue Research Consortium; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH-NHLBI-Lung Tissue Research Consortium and NIH-NHLBI-HL109288 to RV; NIH-NCAATS-KL2 TR000163 (A. Shekhar, PI; Co-investigator: RV); and by the NIH-NHLBI-HL067177 and NIAID P01AI084853 to DSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobadilla JL, 2008, AM J RESP CRIT CARE, V177, P660, DOI 10.1164/rccm.200612-1901OC; Braun RK, 2010, J HEART LUNG TRANSPL; Braun RK, 2009, TRANSPLANTATION, V88, P1341, DOI 10.1097/TP.0b013e3181bcde7b; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; Chapman HA, 1999, J CLIN INVEST, V104, P1, DOI 10.1172/JCI7576; CRYSTAL RG, 1984, NEW ENGL J MED, V310, P154, DOI 10.1056/NEJM198401193100304; Delacoux F, 1998, J BIOL CHEM, V273, P15069, DOI 10.1074/jbc.273.24.15069; Feghali-Bostwick CA, 2007, J IMMUNOL, V179, P2592, DOI 10.4049/jimmunol.179.4.2592; Fujimoto H, 2006, AM J PATHOL, V168, P1086, DOI 10.2353/ajpath.2006.050610; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hu BA, 2012, AM J PATHOL, V180, P2257, DOI 10.1016/j.ajpath.2012.02.010; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Iwata T, 2008, J IMMUNOL, V181, P5738, DOI 10.4049/jimmunol.181.8.5738; Katsumoto TR, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/208219; Kenyon NJ, 2003, THORAX, V58, P772, DOI 10.1136/thorax.58.9.772; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Labiris NR, 2003, BRIT J CLIN PHARMACO, V56, P588, DOI 10.1046/j.1365-2125.2003.01892.x; Lin X, 2011, AM J RESP CRIT CARE, V183, P1689, DOI 10.1164/rccm.201002-0232OC; Liu TJ, 2011, J IMMUNOL, V187, P450, DOI 10.4049/jimmunol.1000964; Lo Re S, 2011, AM J RESP CRIT CARE, V184, P1270, DOI 10.1164/rccm.201103-0516OC; Moodley YP, 2003, AM J RESP CELL MOL, V29, P490, DOI 10.1165/rcmb.2002-0262OC; Munger JS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005017; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; NAGAYA H, 1973, AM REV RESPIR DIS, V107, P826; Parra ER, 2006, J HISTOCHEM CYTOCHEM, V54, P1315, DOI 10.1369/jhc.6A6969.2006; Puthawala K, 2008, AM J RESP CRIT CARE, V177, P82, DOI 10.1164/rccm.200706-806OC; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Shum AK, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000284; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; SMITH GN, 1991, MATRIX, V11, P36, DOI 10.1016/S0934-8832(11)80225-8; STAATZ WD, 1991, J BIOL CHEM, V266, P7363; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Sueblinvong V, 2012, AM J MED SCI, V344, P41, DOI 10.1097/MAJ.0b013e318234c132; Sysa P, 2009, DNA CELL BIOL, V28, P425, DOI 10.1089/dna.2009.0884; Taille C, 2011, AM J RESP CRIT CARE, V183, P759, DOI 10.1164/rccm.201001-0076OC; Ulsamer A, 2012, J BIOL CHEM, V287, P5164, DOI 10.1074/jbc.M111.322123; Vancheri C, 2000, AM J RESP CELL MOL, V22, P628, DOI 10.1165/ajrcmb.22.5.3948; Velosa APP, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-1; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Yamada Y, 2009, J IMMUNOL, V183, P237, DOI 10.4049/jimmunol.0804028; Yamaguchi Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003421	48	57	60	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76451	10.1371/journal.pone.0076451	http://dx.doi.org/10.1371/journal.pone.0076451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204629	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600006
J	Jostins, L; Levine, AP; Barrett, JC				Jostins, Luke; Levine, Adam P.; Barrett, Jeffrey C.			Using Genetic Prediction from Known Complex Disease Loci to Guide the Design of Next-Generation Sequencing Experiments	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RARE VARIANTS; RISK PREDICTION; TRAITS	A central focus of complex disease genetics after genome-wide association studies (GWAS) is to identify low frequency and rare risk variants, which may account for an important fraction of disease heritability unexplained by GWAS. A profusion of studies using next-generation sequencing are seeking such risk alleles. We describe how already-known complex trait loci (largely from GWAS) can be used to guide the design of these new studies by selecting cases, controls, or families who are most likely to harbor undiscovered risk alleles. We show that genetic risk prediction can select unrelated cases from large cohorts who are enriched for unknown risk factors, or multiply-affected families that are more likely to harbor high-penetrance risk alleles. We derive the frequency of an undiscovered risk allele in selected cases and controls, and show how this relates to the variance explained by the risk score, the disease prevalence and the population frequency of the risk allele. We also describe a new method for informing the design of sequencing studies using genetic risk prediction in large partially-genotyped families using an extension of the Inside-Outside algorithm for inference on trees. We explore several study design scenarios using both simulated and real data, and show that in many cases genetic risk prediction can provide significant increases in power to detect low-frequency and rare risk alleles. The same approach can also be used to aid discovery of non-genetic risk factors, suggesting possible future utility of genetic risk prediction in conventional epidemiology. Software implementing the methods in this paper is available in the R package Mangrove.	[Jostins, Luke; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Cambridge, England; [Jostins, Luke] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Levine, Adam P.] UCL, Div Med, London, England	Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London	Jostins, L (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	lj4@well.ox.ac.uk		Barrett, Jeffrey/0000-0002-1152-370X; Levine, Adam/0000-0003-1333-9938	Wellcome Trust [WT089120/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust (WT089120/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Brady Kristina, 2011, BMC Proc, V5 Suppl 9, pS77, DOI 10.1186/1753-6561-5-S9-S77; Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; BAKER JK, 1979, J ACOUST SOC AM, V65, pS132, DOI 10.1121/1.2017061; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Durbin R., 1998, BIOL SEQUENCE ANAL P; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Guey LT, 2011, GENET EPIDEMIOL; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hosmer D.W., 2000, APPL LOGISTIC REGRES, V354; Janssens ACJW, 2011, EUR J CLIN INVEST, V41, P1004, DOI 10.1111/j.1365-2362.2011.02494.x; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Kwan JSH, 2011, BEHAV GENET, V41, P776, DOI 10.1007/s10519-011-9475-0; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mehers KL, 2008, BRIT MED BULL, V88, P115, DOI 10.1093/bmb/ldn045; Molven A, 2011, EXPERT REV MOL DIAGN, V11, P313, DOI [10.1586/ERM.10.123, 10.1586/erm.10.123]; Morris JA, 2012, BIOINFORMATICS; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Peto R, 2011, BRIT J CANCER, V105, pI, DOI 10.1038/bjc.2011.473; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Shi G, 2011, GENET EPIDEMIOL, V35, P572, DOI 10.1002/gepi.20597; Spencer C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001337; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Talmud PJ, 2013, LANCET; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wei Z, 2013, AM J HUM GENET; Xing Chao, 2009, BMC Proc, V3 Suppl 7, pS23; Zhu XF, 2010, GENET EPIDEMIOL, V34, P171, DOI 10.1002/gepi.20449	36	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76328	10.1371/journal.pone.0076328	http://dx.doi.org/10.1371/journal.pone.0076328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204614	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300022
J	Lee, WI; Lin, JJ; Hsieh, MY; Lin, SJ; Jaing, TH; Chen, SH; Hung, IJ; Yang, CP; Chen, CJ; Huang, YC; Li, SP; Huang, JL				Lee, Wen-I; Lin, Jainn-Jim; Hsieh, Meng-Ying; Lin, Syh-Jae; Jaing, Tang-Her; Chen, Shih-Hsiang; Hung, Iou-Jih; Yang, Chao-Ping; Chen, Chin-Jung; Huang, Yhu-Chering; Li, Shin-Pai; Huang, Jing-Long			Immunologic Difference between Hypersensitivity to Mosquito Bite and Hemophagocytic Lymphohistiocytosis Associated with Epstein-Barr Virus Infection	PLOS ONE			English	Article							LINKED LYMPHOPROLIFERATIVE SYNDROME; NATURAL-KILLER-CELLS; VIROLOGICAL CHARACTERISTICS; EBV INFECTION; VIRAL-DNA; NK-CELLS; T-CELLS; LYMPHOCYTES; DEFICIENCY; CHILDREN	Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening, virus-triggered immune disease. Hypersensitivity to mosquito bite (HMB), a presentation of Chronic Active Epstein-Barr Virus infection (CAEBV), may progress to HLH. This study aimed to investigate the immunologic difference between the HMB episodes and the HLH episodes associated with EBV infection. Immunologic changes of immunoglobulins, lymphocyte subsets, cytotoxicity, intracellular perforin and granzyme expressions, EBV virus load and known candidate genes for hereditary HLH were evaluated and compared. In 12 HLH episodes (12 patients) and 14 HMB episodes (4 patients), there were both decreased percentages of CD4+ and CD8+ and increased memory CD4+ and activated (CD2+HLADR+) lymphocytes. In contrast to HMB episodes that had higher IgE levels and EBV virus load predominantly in NK cells, those HLH episodes with virus load predominantly in CD3+ lymphocyte had decreased perforin expression and cytotoxicity that were recovered in the convalescence period. However, there was neither significant difference of total virus load in these episodes nor candidate genetic mutations responsible for hereditary HLH. In conclusion, decreased perforin expression in the HLH episodes with predominant-CD3+ EBV virus load is distinct from those HMB episodes with predominant-NK EBV virus load. Whether the presence of non-elevated memory CD4+ cells or activated lymphocytes (CD2+HLADR+) increases the mortality rate in the HLH episodes remains to be further warranted through larger-scale studies.	[Lee, Wen-I; Jaing, Tang-Her; Huang, Jing-Long] Chang Gung Childrens Hosp, PICAR Inst, Tao Yuan, Taiwan; [Lee, Wen-I; Lin, Syh-Jae; Huang, Jing-Long] Chang Gung Univ, Coll Med, Chang Gung Childrens Hosp, Dept Pediat,Div Allergy Asthma & Rheumatol, Tao Yuan, Taiwan; [Lin, Jainn-Jim; Hsieh, Meng-Ying] Chang Gung Univ, Coll Med, Grad Inst Med Clin, Tao Yuan, Taiwan; [Hsieh, Meng-Ying] Chang Gung Childrens Hosp, Dept Pediat, Div Neurol, Tao Yuan, Taiwan; [Jaing, Tang-Her; Chen, Shih-Hsiang; Hung, Iou-Jih; Yang, Chao-Ping] Chang Gung Childrens Hosp, Dept Pediat, Div Hematol Oncol, Tao Yuan, Taiwan; [Lin, Jainn-Jim] Chang Gung Childrens Hosp, Dept Pediat, Div Crit Care & Emergency Med, Tao Yuan, Taiwan; [Chen, Chin-Jung; Huang, Yhu-Chering] Chang Gung Childrens Hosp, Dept Pediat, Div Infect, Tao Yuan, Taiwan; [Li, Shin-Pai] Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lee, WI (corresponding author), Chang Gung Childrens Hosp, PICAR Inst, Tao Yuan, Taiwan.	wen2707@hotmail.com; long@adm.cgmh.org.tw	Jaing, Tang-Her/AAB-1430-2021; Li, Hsin-Pai/C-7305-2014; Chen, Shih-Hsiang/AAG-4976-2020	Huang, Jing-Long/0000-0001-9280-920X; Huang, Jing-Long/0000-0002-3530-7753	Chang-Gung Medical Research Progress Grant [CMRPG 450022, 490012, 4B0051]; National Science Council [NSC99-2314-B-182-003-MY3, 102-2314-B-182A-039-MY3]	Chang-Gung Medical Research Progress Grant; National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by a Chang-Gung Medical Research Progress Grant (CMRPG 450022, 490012, and 4B0051) and a National Science Council Grant (NSC99-2314-B-182-003-MY3 and 102-2314-B-182A-039-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2003, CELLULAR MOL IMMUNOL, P105; Abbas AK, 2003, CELLULAR MOL IMMUNOL, P163; Asada H, 2003, ARCH DERMATOL, V139, P1601, DOI 10.1001/archderm.139.12.1601; Asada H, 2007, J DERMATOL SCI, V45, P153, DOI 10.1016/j.jdermsci.2006.11.002; CHANG YS, 1990, J CLIN MICROBIOL, V28, P2398, DOI 10.1128/JCM.28.11.2398-2402.1990; Chuang HC, 2005, BLOOD, V106, P3090, DOI 10.1182/blood-2005-04-1406; Cohen JI, 2009, ANN ONCOL, V20, P1472, DOI 10.1093/annonc/mdp064; Cote M, 2009, J CLIN INVEST, V119, P3765, DOI 10.1172/JCI40732; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; Gotoh K, 2008, CLIN INFECT DIS, V46, P1525, DOI 10.1086/587671; Huang ZZ, 2012, PEDIATR BLOOD CANCER, V58, P410, DOI 10.1002/pbc.23216; Huck K, 2009, J CLIN INVEST, V119, P1350, DOI 10.1172/JCI37901; Imadome KI, 2005, J INFECT DIS, V192, P1340, DOI 10.1086/466530; ISHIHARA S, 1995, ACTA PAEDIATR, V84, P1271, DOI 10.1111/j.1651-2227.1995.tb13547.x; Janka GE, 2004, BRIT J HAEMATOL, V124, P4, DOI 10.1046/j.1365-2141.2003.04726.x; Jones J F, 1989, Adv Pediatr, V36, P307; JONES JF, 1988, NEW ENGL J MED, V318, P733, DOI 10.1056/NEJM198803243181203; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; KAWAHA K, 1989, J CLIN INVEST, V84, P51, DOI 10.1172/JCI114168; KIKUTA H, 1988, NATURE, V333, P455, DOI 10.1038/333455a0; Kimura H, 2001, BLOOD, V98, P280, DOI 10.1182/blood.V98.2.280; Kimura H, 2005, J INFECT DIS, V191, P531, DOI 10.1086/427239; Kimura H, 2012, BLOOD, V119, P673, DOI 10.1182/blood-2011-10-381921; Lee WI, 2005, J CLIN IMMUNOL, V25, P162, DOI 10.1007/s10875-005-2822-2; Lee WI, 2005, BLOOD, V105, P1881, DOI 10.1182/blood-2003-12-4420; Lin SJ, 2004, PEDIAT ALLERG IMM-UK, V15, P79, DOI 10.1046/j.0905-6157.2003.00103.x; Nichols KE, 2007, BLOOD, V110, P1705, DOI 10.1182/blood-2007-06-093773; OKANO M, 1991, CLIN MICROBIOL REV, V4, P129, DOI 10.1128/CMR.4.1.129-135.1991; Pacheco SE, 2005, J ALLERGY CLIN IMMUN, V116, P470, DOI 10.1016/j.jaci.2005.04.044; Park S, 2010, J CLIN ONCOL, V28, pE148, DOI 10.1200/JCO.2009.25.0357; Quintanilla-Martinez L, 2000, BLOOD, V96, P443; RICKINSON A, 1996, FIELDS VIROLOGY, V2, P2397; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; RICKINSON AB, 1986, IMMUNOL TODAY, V7, P13, DOI 10.1016/0167-5699(86)90183-0; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Schmid JP, 2011, BLOOD, V117, P1522, DOI 10.1182/blood-2010-07-298372; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; STRAUS SE, 1988, J INFECT DIS, V157, P405, DOI 10.1093/infdis/157.3.405; Tokura Y, 2001, J AM ACAD DERMATOL, V45, P569, DOI 10.1067/mjd.2001.114751; Tsai W C, 1989, Taiwan Yi Xue Hui Za Zhi, V88, P639; Voskoboinik I, 2005, BLOOD, V105, P4700, DOI 10.1182/blood-2004-12-4935; Voskoboinik I, 2007, BLOOD, V110, P1184, DOI 10.1182/blood-2007-02-072850; Wilson AD, 1998, INT IMMUNOL, V10, P1149, DOI 10.1093/intimm/10.8.1149; Zhang ZX, 2009, J PEDIAT HEMATOL ONC, V31, P855, DOI 10.1097/MPH.0b013e31819c1fdb	44	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76711	10.1371/journal.pone.0076711	http://dx.doi.org/10.1371/journal.pone.0076711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204658	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300045
J	Mori, T; Hayashi, T; Hayashi, E; Su, TP				Mori, Tomohisa; Hayashi, Teruo; Hayashi, Eri; Su, Tsung-Ping			Sigma-1 Receptor Chaperone at the ER-Mitochondrion Interface Mediates the Mitochondrion-ER-Nucleus Signaling for Cellular Survival	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; DYNAMIC INTERACTION; IRE1; ACTIVATION; APOPTOSIS; CAPACITY; DOMAIN	The membrane of the endoplasmic reticulum (ER) of a cell forms contacts directly with mitochondria whereby the contact is referred to as the mitochondrion-associated ER membrane or the MAM. Here we found that the MAM regulates cellular survival via an MAM-residing ER chaperone the sigma-1 receptor (Sig-1R) in that the Sig-1R chaperones the ER stress sensor IRE1 to facilitate inter-organelle signaling for survival. IRE1 is found in this study to be enriched at the MAM in CHO cells. We found that IRE1 is stabilized at the MAM by Sig-1Rs when cells are under ER stress. Sig-1Rs stabilize IRE1 and thus allow for conformationally correct IRE1 to dimerize into the long-lasting, activated endonuclease. The IRE1 at the MAM also responds to reactive oxygen species derived from mitochondria. Therefore, the ER-mitochondrion interface serves as an important subcellular entity in the regulation of cellular survival by enhancing the stress-responding signaling between mitochondria, ER, and nucleus.	[Mori, Tomohisa; Hayashi, Teruo; Hayashi, Eri; Su, Tsung-Ping] NIDA, Cellular Pathobiol Sect, Intramural Res Program, NIH,DHHS, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Su, TP (corresponding author), NIDA, Cellular Pathobiol Sect, Intramural Res Program, NIH,DHHS, Baltimore, MD USA.	TSU@intra.nida.nih.gov			Intramural Research Program, NIDA, NIH, DHHS; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000206] Funding Source: NIH RePORTER	Intramural Research Program, NIDA, NIH, DHHS; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Intramural Research Program, NIDA, NIH, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmo CT, 2006, CURR NEUROVASC RES, V3, P89, DOI 10.2174/156720206776875849; Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Csordas G, 2006, J CELL BIOL, V281, P17347; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Hajnoczky G, 2007, SCIENCE, V315, P607, DOI 10.1126/science.1138825; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Heldens L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023512; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Ji YL, 2011, TOXICOL SCI, V124, P446, DOI 10.1093/toxsci/kfr232; Kakiuchi C, 2006, J NEUROCHEM, V97, P545, DOI 10.1111/j.1471-4159.2006.03772.x; Katayama T, 2004, J CHEM NEUROANAT, V28, P67, DOI 10.1016/j.jchemneu.2003.12.004; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Kourrich S, 2013, CELL, V152, P236, DOI 10.1016/j.cell.2012.12.004; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Liu CY, 2003, J BIOL CHEM, V278, P17680, DOI 10.1074/jbc.M300418200; Liu CY, 2002, J BIOL CHEM, V277, P18346, DOI 10.1074/jbc.M112454200; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Maurice T, 1997, PROG NEURO-PSYCHOPH, V21, P69, DOI 10.1016/S0278-5846(96)00160-1; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Ruscher K, 2011, BRAIN, V134, P732, DOI 10.1093/brain/awq367; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Slodzinski H, 2009, CLIN NEUROPATHOL, V28, P333, DOI 10.2379/NPX08162; Sorensen S, 2006, J BIOL CHEM, V281, P468, DOI 10.1074/jbc.M507071200; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tsai SY, 2009, P NATL ACAD SCI USA, V106, P22468, DOI 10.1073/pnas.0909089106; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Urano F, 2000, J CELL SCI, V113, P3697; Yasuda Y, 2002, BIOCHEM BIOPH RES CO, V296, P313, DOI 10.1016/S0006-291X(02)00859-8; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yung HW, 2007, FASEB J, V21, P872, DOI 10.1096/fj.06-6054com; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	47	192	201	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76941	10.1371/journal.pone.0076941	http://dx.doi.org/10.1371/journal.pone.0076941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204710	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300070
J	Xue, SX; Liu, YC; Zhang, YC; Sun, Y; Geng, XY; Sun, JS				Xue, Shuxia; Liu, Yichen; Zhang, Yichen; Sun, Yan; Geng, Xuyun; Sun, Jinsheng			Sequencing and De Novo Analysis of the Hemocytes Transcriptome in Litopenaeus vannamei Response to White Spot Syndrome Virus Infection	PLOS ONE			English	Article							SHRIMP PENAEUS-JAPONICUS; IMMEDIATE-EARLY GENES; RNA-SEQ; FUNCTIONAL GENOMICS; PROFILING ANALYSIS; KURUMA PRAWN; EXPRESSION; IDENTIFICATION; MONODON; TOOL	Background: White spot syndrome virus (WSSV) is a causative pathogen found in most shrimp farming areas of the world and causes large economic losses to the shrimp aquaculture. The mechanism underlying the molecular pathogenesis of the highly virulent WSSV remains unknown. To better understand the virus-host interactions at the molecular level, the transcriptome profiles in hemocytes of unchallenged and WSSV-challenged shrimp (Litopenaeus vannamei) were compared using a short-read deep sequencing method (Illumina). Results: RNA-seq analysis generated more than 25.81 million clean pair end (PE) reads, which were assembled into 52,073 unigenes (mean size = 520 bp). Based on sequence similarity searches, 23,568 (45.3%) genes were identified, among which 6,562 and 7,822 unigenes were assigned to gene ontology (GO) categories and clusters of orthologous groups (COG), respectively. Searches in the Kyoto Encyclopedia of Genes and Genomes Pathway database (KEGG) mapped 14,941 (63.4%) unigenes to 240 KEGG pathways. Among all the annotated unigenes, 1,179 were associated with immune-related genes. Digital gene expression (DGE) analysis revealed that the host transcriptome profile was slightly changed in the early infection (5 hours post injection) of the virus, while large transcriptional differences were identified in the late infection (48 hpi) of WSSV. The differentially expressed genes mainly involved in pattern recognition genes and some immune response factors. The results indicated that antiviral immune mechanisms were probably involved in the recognition of pathogen-associated molecular patterns. Conclusions: This study provided a global survey of host gene activities against virus infection in a non-model organism, pacific white shrimp. Results can contribute to the in-depth study of candidate genes in white shrimp, and help to improve the current understanding of host-pathogen interactions.	[Liu, Yichen; Zhang, Yichen; Sun, Jinsheng] Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China; [Xue, Shuxia; Sun, Yan; Geng, Xuyun; Sun, Jinsheng] Tianjin Ctr Control & Prevent Aquat Anim Infect D, Tianjin, Peoples R China	Tianjin Normal University; Tianjin Center for Disease Control & Prevention	Sun, JS (corresponding author), Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China.	jinshsun@163.com	liu, yichen/GVT-6262-2022; liu, yang/HHY-8583-2022		Grants of the Major State Basic Research Development Program of China (973 programs) [2012CB114405]; National High-Tech Research and Development Program of China (863 programs) [2012AA10A401, 2012AA092205]; National Key Technology RD Program [2011BAD13B07, 2011BAD13B04]	Grants of the Major State Basic Research Development Program of China (973 programs)(National Basic Research Program of China); National High-Tech Research and Development Program of China (863 programs)(National High Technology Research and Development Program of China); National Key Technology RD Program(National Key Technology R&D Program)	This work was financially supported by Grants of the Major State Basic Research Development Program of China (973 programs, 2012CB114405), National High-Tech Research and Development Program of China (863 programs, 2012AA10A401 and 2012AA092205) and National Key Technology R&D Program (2011BAD13B07 and 2011BAD13B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Chang LK, 2012, DEV COMP IMMUNOL, V36, P121, DOI 10.1016/j.dci.2011.06.008; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffitt RJ, 2007, ENVIRON TOXICOL CHEM, V26, P2413, DOI 10.1897/07-158R.1; Han F, 2007, VIRUS GENES, V34, P193, DOI 10.1007/s11262-006-0053-0; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Leelatanawit R, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-15; Lei KY, 2008, DEV COMP IMMUNOL, V32, P808, DOI 10.1016/j.dci.2007.11.010; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Li F, 2009, VIROLOGY, V385, P267, DOI 10.1016/j.virol.2008.12.007; Li Q, 2004, J GEN VIROL, V85, P2035, DOI 10.1099/vir.0.80048-0; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li TD, 2013, COMP BIOCHEM PHYS D, V8, P1, DOI 10.1016/j.cbd.2012.10.003; Li ZJ, 2007, MOL CELL PROTEOMICS, V6, P1609, DOI 10.1074/mcp.M600327-MCP200; Lightner D.V, 1996, HDB SHRIMP PATHOLOGY; Liu WJ, 2007, J VIROL, V81, P1461, DOI 10.1128/JVI.01880-06; Liu WJ, 2005, VIROLOGY, V334, P327, DOI 10.1016/j.virol.2005.01.047; Lo CF, 1996, DIS AQUAT ORGAN, V25, P133, DOI 10.3354/dao025133; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Rojtinnakorn J, 2002, FISH SHELLFISH IMMUN, V13, P69, DOI 10.1006/fsim.2001.0382; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Supungul P, 2002, MAR BIOTECHNOL, V4, P487, DOI 10.1007/s10126-002-0043-8; Takahashi Y, 1998, FISH PATHOL, V33, P357, DOI 10.3147/jsfp.33.357; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tassanakajon A, 2006, GENE, V384, P104, DOI 10.1016/j.gene.2006.07.012; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tsai MF, 2000, VIROLOGY, V277, P92, DOI 10.1006/viro.2000.0596; Veitch NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-124; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Xue SX, 2013, FISH SHELLFISH IMMUN, V34, P403, DOI 10.1016/j.fsi.2012.10.017; Yamano K, 2006, COMP BIOCHEM PHYS A, V143, P155, DOI 10.1016/j.cbpa.2005.11.005; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW6, DOI 10.1093/nar/gkl164; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhu YB, 2007, VIRUS RES, V125, P145, DOI 10.1016/j.virusres.2006.12.013	47	53	59	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76718	10.1371/journal.pone.0076718	http://dx.doi.org/10.1371/journal.pone.0076718			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204661	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300046
J	Yang, Y; Zhang, F; Skrip, L; Wang, Y; Liu, SC				Yang, Yuan; Zhang, Fan; Skrip, Laura; Wang, Yang; Liu, Shengchun			Lack of an Association between Passive Smoking and Incidence of Female Breast Cancer in Non-Smokers: Evidence from 10 Prospective Cohort Studies	PLOS ONE			English	Article							N-ACETYLTRANSFERASE 2; CIGARETTE-SMOKING; ACTIVE SMOKING; LUNG-CANCER; POSTMENOPAUSAL WOMEN; REPLACEMENT THERAPY; TOBACCO-SMOKE; RISK; METAANALYSIS; EXPOSURE	Background: Several case-control studies have suggested that passive smoking may increase the incidence of female breast cancer. However, the results of cohort studies have been inconsistent in establishing an association. The present study evaluated the association between passive smoking and incidence of female breast cancer through a meta-analysis of prospective cohort studies. Methods: Relevant articles published before August 2012 were identified by searching the electronic databases PubMed, Embase, and Web of Science. Pooled relative risks (RRs) were determined with either a fixed or random effects model and were used to assess the strength of the association. Sensitivity and subgroup analyses according to ethnicity, menopausal status, and the period and place of exposure to passive smoking were also performed. Results: Ten prospective cohort studies involving 782 534 female non-smokers were included in the meta-analysis and 14 831 breast cancer cases were detected. Compared with the women without exposure to passive smoking, the overall combined RR of breast cancer was 1.01 (95% confidence interval: 0.96 to 1.06, P = 0.73) among women with exposure to passive smoking. Similar results were achieved through the subgroup analyses. No evidence of publication bias was observed. Conclusion: The results suggest that passive smoking may not be associated with increased incidence of breast cancer. However, the present conclusion should be considered carefully and confirmed with further studies.	[Yang, Yuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Chongqing, Peoples R China; [Zhang, Fan; Wang, Yang] Chongqing Med Univ, Sch Publ Hlth & Hlth Management, Chongqing, Peoples R China; [Skrip, Laura] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Liu, Shengchun] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Yale University; Chongqing Medical University	Liu, SC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China.	liushengchun1968@126.com			National Natural Science Foundation of China [NSFC 81272265]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC 81272265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Delaimy WK, 2004, CANCER EPIDEM BIOMAR, V13, P398; BARON JA, 1990, AM J OBSTET GYNECOL, V162, P502, DOI 10.1016/0002-9378(90)90420-C; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brennan P, 2007, HUM MOL GENET, V16, P1794, DOI 10.1093/hmg/ddm127; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Chuang SC, 2011, CANCER CAUSE CONTROL, V22, P487, DOI 10.1007/s10552-010-9723-2; Conlon MSC, 2010, CANCER EPIDEMIOL, V34, P142, DOI 10.1016/j.canep.2010.02.001; Cui Y, 2006, BREAST CANCER RES TR, V100, P293, DOI 10.1007/s10549-006-9255-3; Delfino RJ, 2000, PHARMACOGENETICS, V10, P461, DOI 10.1097/00008571-200007000-00009; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Egan KM, 2002, EPIDEMIOLOGY, V13, P138, DOI 10.1097/00001648-200203000-00007; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ELBAYOUMY K, 1992, CHEM RES TOXICOL, V5, P585, DOI 10.1021/tx00029a001; GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047; Gram IT, 2005, CANCER EPIDEM BIOMAR, V14, P61; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Hanaoka T, 2005, INT J CANCER, V114, P317, DOI 10.1002/ijc.20709; Jee SH, 1999, INT J EPIDEMIOL, V28, P824, DOI 10.1093/ije/28.5.824; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; JENSEN J, 1985, NEW ENGL J MED, V313, P973, DOI 10.1056/NEJM198510173131602; Johnson KC, 2008, PREV MED, V46, P492, DOI 10.1016/j.ypmed.2007.11.016; Johnson KC, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.035931; Kabat GC, 2011, CANCER CAUSE CONTROL, V22, P775, DOI 10.1007/s10552-011-9750-7; Kabat GC, 2010, AM J EPIDEMIOL, V172, P591, DOI 10.1093/aje/kwq159; Key TJA, 1996, BRIT J CANCER, V74, P1313, DOI 10.1038/bjc.1996.536; Kiechl S, 2002, STROKE, V33, P2170, DOI 10.1161/01.STR.0000027209.59821.98; Lee PN, 2006, INHAL TOXICOL, V18, P1053, DOI 10.1080/08958370600945432; Lin Y, 2008, J EPIDEMIOL, V18, P77, DOI 10.2188/jea.18.77; Luo JH, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1016; MACMAHON B, 1982, NEW ENGL J MED, V307, P1062, DOI 10.1056/NEJM198210213071707; Millikan RC, 1998, CANCER EPIDEM BIOMAR, V7, P371; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nishino Y, 2001, CANCER CAUSE CONTROL, V12, P797, DOI 10.1023/A:1012273806199; Overton RC, 1998, PSYCHOL METHODS, V3, P354, DOI 10.1037/1082-989X.3.3.354; PETRAKIS NL, 1978, SCIENCE, V199, P303, DOI 10.1126/science.619458; Pirie K, 2008, INT J EPIDEMIOL, V37, P1069, DOI 10.1093/ije/dyn110; Pukkala E, 2009, ACTA ONCOL, V48, P646, DOI 10.1080/02841860902913546; Reynolds P, 2004, JNCI-J NATL CANCER I, V96, P29, DOI 10.1093/jnci/djh002; Reynolds P, 2009, CANCER EPIDEM BIOMAR, V18, P3389, DOI 10.1158/1055-9965.EPI-09-0936; Rushton L, 2010, BRIT J CANCER, V102, P1428, DOI 10.1038/sj.bjc.6605637; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; STEINBERG KK, 1991, JAMA-J AM MED ASSOC, V265, P1985, DOI 10.1001/jama.265.15.1985; Wartenberg D, 2000, J NATL CANCER I, V92, P1666, DOI 10.1093/jnci/92.20.1666; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Xue F, 2011, ARCH INTERN MED, V171, P125, DOI 10.1001/archinternmed.2010.503; Yang Y, 2012, ASIAN PAC J CANCER P, V13, P3501, DOI 10.7314/APJCP.2012.13.7.3501; Zhang J, 2010, BREAST CANCER RES TR, V123, P877, DOI 10.1007/s10549-010-0807-1; Zheng W, 1999, CANCER EPIDEM BIOMAR, V8, P233	49	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77029	10.1371/journal.pone.0077029	http://dx.doi.org/10.1371/journal.pone.0077029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204725	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300076
J	Abdolvahabi, A; Taylor, BW; Holden, RL; Shaw, EV; Kentsis, A; Rodriguez-Galindo, C; Mukai, S; Shaw, BF				Abdolvahabi, Alireza; Taylor, Brandon W.; Holden, Rebecca L.; Shaw, Elizabeth V.; Kentsis, Alex; Rodriguez-Galindo, Carlos; Mukai, Shizuo; Shaw, Bryan F.			Colorimetric and Longitudinal Analysis of Leukocoria in Recreational Photographs of Children with Retinoblastoma	PLOS ONE			English	Article							UNSATURATED FATTY-ACIDS; DIAGNOSIS; CHEMOREDUCTION; SURVIVAL; THERAPY; IMPACT; CANCER; CELLS; BIRTH	Retinoblastoma is the most common primary intraocular tumor in children. The first sign that is often reported by parents is the appearance of recurrent leukocoria (i.e., "white eye'') in recreational photographs. A quantitative definition or scale of leukocoria - as it appears during recreational photography - has not been established, and the amount of clinical information contained in a leukocoric image (collected by a parent) remains unknown. Moreover, the hypothesis that photographic leukocoria can be a sign of early stage retinoblastoma has not been tested for even a single patient. This study used commercially available software (Adobe Photoshop (R)) and standard color space conversion algorithms (operable in Microsoft Excel (R)) to quantify leukocoria in actual "baby pictures'' of 9 children with retinoblastoma (that were collected by parents during recreational activities i.e., in nonclinical settings). One particular patient with bilateral retinoblastoma ("Patient Zero'') was photographed >7, 000 times by his parents (who are authors of this study) over three years: from birth, through diagnosis, treatment, and remission. This large set of photographs allowed us to determine the longitudinal and lateral frequency of leukocoria throughout the patient's life. This study establishes: (i) that leukocoria can emerge at a low frequency in early-stage retinoblastoma and increase in frequency during disease progression, but decrease upon disease regression, (ii) that Hue, Saturation and Value (i. e., HSV color space) are suitable metrics for quantifying the intensity of retinoblastoma-linked leukocoria; (iii) that different sets of intraocular retinoblastoma tumors can produce distinct leukocoric reflections; and (iv) the Saturation-Value plane of HSV color space represents a convenient scale for quantifying and classifying pupillary reflections as they appear during recreational photography.	[Abdolvahabi, Alireza; Taylor, Brandon W.; Holden, Rebecca L.; Shaw, Elizabeth V.; Shaw, Bryan F.] Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA; [Kentsis, Alex] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Rodriguez-Galindo, Carlos] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Mukai, Shizuo] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Mukai, Shizuo] Massachusetts Eye & Ear Infirm, Retina Serv, Boston, MA 02114 USA	Baylor University; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Shaw, BF (corresponding author), Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA.	Bryan_Shaw@baylor.edu	Shaw, Bryan/A-7001-2008; Rodriguez-Galindo, Carlos/N-8071-2018	Kentsis, Alex/0000-0002-8063-9191	College of Arts and Sciences at Baylor University; Mukai Fund, at Massachusetts Eye and Ear Infirmary	College of Arts and Sciences at Baylor University; Mukai Fund, at Massachusetts Eye and Ear Infirmary	This work was supported by a laboratory start-up fund provided to Bryan F. Shaw from the College of Arts and Sciences at Baylor University. This work was also supported by the Mukai Fund, at Massachusetts Eye and Ear Infirmary. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abramson DH, 2003, PEDIATRICS, V112, P1248, DOI 10.1542/peds.112.6.1248; [Anonymous], 2006, MICROWAVES RF, V45, P22; Bowman RJC, 2008, PEDIATR BLOOD CANCER, V50, P160, DOI 10.1002/pbc.21080; Broaddus E, 2009, BRIT J OPHTHALMOL, V93, P24, DOI 10.1136/bjo.2008.143842; Broaddus E, 2009, BRIT J OPHTHALMOL, V93, P21, DOI 10.1136/bjo.2008.138750; Canturk S, 2010, BRIT J OPHTHALMOL, V94, P1432, DOI 10.1136/bjo.2009.168062; Cha S B, 1993, J Ophthalmic Nurs Technol, V12, P189; Dimaras H, 2012, LANCET, V379, P1436, DOI 10.1016/S0140-6736(11)61137-9; Epelman S, 2012, CURR ONCOL REP, V14, P213, DOI 10.1007/s11912-012-0226-z; Gombos DS, 2000, ARCH OPHTHALMOL-CHIC, V118, P440, DOI 10.1001/archopht.118.3.440; Goustard-Langelier B, 2000, J NEUROSCI RES, V60, P678, DOI 10.1002/(SICI)1097-4547(20000601)60:5<678::AID-JNR13>3.0.CO;2-T; Haider S, 2008, J PEDIAT OPHTH STRAB, V45, P179, DOI 10.3928/01913913-20080501-13; HAIK BG, 1985, OPHTHALMOLOGY, V92, P1143; Houston Samuel K, 2011, Int Ophthalmol Clin, V51, P77, DOI 10.1097/IIO.0b013e3182010f29; HYMAN BT, 1982, J NEUROCHEM, V38, P650, DOI 10.1111/j.1471-4159.1982.tb08680.x; HYMAN BT, 1981, J NEUROCHEM, V37, P60, DOI 10.1111/j.1471-4159.1981.tb05291.x; Kiss Szilard, 2008, Int Ophthalmol Clin, V48, P135, DOI 10.1097/IIO.0b013e3181693670; Kivela T, 2009, BRIT J OPHTHALMOL, V93, P1129, DOI 10.1136/bjo.2008.150292; Kumar A, 2010, J AAPOS, V14, P345, DOI 10.1016/j.jaapos.2010.05.007; Leander C, 2007, PEDIATR BLOOD CANCER, V49, P817, DOI 10.1002/pbc.21052; Li J, 2010, PEDIATRICS, V126, pE202, DOI 10.1542/peds.2009-0882; Lim Z, 2010, AM J OPHTHALMOL, V149, P887, DOI 10.1016/j.ajo.2010.01.012; Luna-Fineman S, 2012, PEDIATR BLOOD CANCER, V58, P545, DOI 10.1002/pbc.23307; Maki JL, 2009, OPHTHALMIC GENET, V30, P199, DOI 10.3109/13816810903258837; Makky A, 2010, LANGMUIR, V26, P11145, DOI 10.1021/la101040q; Marshall J, 2003, AM J OPHTHALMOL, V135, P709, DOI 10.1016/S0002-9394(02)02079-2; Molineux A, 2012, SPEECH, IMAGE, AND LANGUAGE PROCESSING FOR HUMAN COMPUTER INTERACTION: MULTI-MODAL ADVANCEMENTS, P292, DOI 10.4018/978-1-4666-0954-9.ch014; Murphy D, 2012, LANCET, V379, P2465, DOI 10.1016/S0140-6736(11)61644-9; Narang S, 2012, CLIN EXP OPHTHALMOL, V40, P736, DOI 10.1111/j.1442-9071.2012.02757.x; Ollivier FJ, 2004, VET OPHTHALMOL, V7, P11, DOI 10.1111/j.1463-5224.2004.00318.x; Phan IT, 2010, J PEDIATR-US, V157, P858, DOI 10.1016/j.jpeds.2010.08.010; Poulaki Vasiliki, 2009, Int Ophthalmol Clin, V49, P155, DOI 10.1097/IIO.0b013e3181924bc2; Rodriguez-Galindo C, 2010, RETINOBLASTOMA; Rodriguez-Galindo C, 2008, PEDIATRICS, V122, pE763, DOI 10.1542/peds.2008-0518; Rodriguez-Galindo C, 2011, PEDIATR BLOOD CANCER, V57, P1093, DOI 10.1002/pbc.23305; Rubin Michael P, 2008, Int Ophthalmol Clin, V48, P149, DOI 10.1097/IIO.0b013e3181693467; Russell HC, 2010, J PEDIATR OPHTHALMOL, V1, P1; Seregard S, 2004, OPHTHALMOLOGY, V111, P1228, DOI 10.1016/j.ophtha.2003.10.023; Shoji K, 2010, J PEDIATR-US, V157, P331, DOI 10.1016/j.jpeds.2010.02.020; Shrestha A, 2010, Kathmandu Univ Med J (KUMJ), V8, P247; SMIRNIOTOPOULOS JG, 1994, RADIOGRAPHICS, V14, P1059, DOI 10.1148/radiographics.14.5.7991814; Smith A., 1978, COMPUT GRAPH-UK, V12, P12; Smith A., 2013, SMARTPHONE OWNERSHIP; Sussman DA, 2003, ARCH OPHTHALMOL-CHIC, V121, P979, DOI 10.1001/archopht.121.7.979; Swaminathan I, 2008, INT J CANCER, V122, P2607, DOI 10.1002/ijc.23428; Tillmann K, 2012, DIGITAL CAMERA MARKE; Ventura G, 2012, LANCET, V380, P803, DOI 10.1016/S0140-6736(12)61445-7; Wang SQ, 2011, LAB CHIP, V11, P3411, DOI 10.1039/c1lc20479c; Wessels G, 1996, MED PEDIATR ONCOL, V27, P160, DOI 10.1002/(SICI)1096-911X(199609)27:3<160::AID-MPO5>3.0.CO;2-C; Wilson MW, 2011, BRIT J OPHTHALMOL, V95, P553, DOI 10.1136/bjo.2009.177444; YOREK MA, 1985, INVEST OPHTH VIS SCI, V26, P1148; YOREK MA, 1984, BIOCHIM BIOPHYS ACTA, V795, P277, DOI 10.1016/0005-2760(84)90076-6; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhu HY, 2011, LAB CHIP, V11, P315, DOI [10.1039/c0lc00358a, 10.1039/c01c00358a]	54	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e76677	10.1371/journal.pone.0076677	http://dx.doi.org/10.1371/journal.pone.0076677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204654	gold, Green Submitted, Green Published			2022-12-27	WOS:000326334500008
J	Codron, D; Carbone, C; Clauss, M				Codron, Daryl; Carbone, Chris; Clauss, Marcus			Ecological Interactions in Dinosaur Communities: Influences of Small Offspring and Complex Ontogenetic Life Histories	PLOS ONE			English	Article							BODY-SIZE; REPRODUCTIVE EFFORT; NICHE SHIFTS; AVIAN EGG; DEMOGRAPHY; LIZARD; PATTERNS; EVOLUTION; FOOD; MASS	Because egg-laying meant that even the largest dinosaurs gave birth to very small offspring, they had to pass through multiple ontogenetic life stages to adulthood. Dinosaurs' successors as the dominant terrestrial vertebrate life form, the mammals, give birth to live young, and have much larger offspring and less complex ontogenetic histories. The larger number of juveniles in dinosaur as compared to mammal ecosystems represents both a greater diversity of food available to predators, and competitors for similar-sized individuals of sympatric species. Models of population abundances across different-sized species of dinosaurs and mammals, based on simulated ecological life tables, are employed to investigate how differences in predation and competition pressure influenced dinosaur communities. Higher small-to medium-sized prey availability leads to a normal body mass-species richness (M-S) distribution of carnivorous dinosaurs (as found in the theropod fossil record), in contrast to the right-skewed M-S distribution of carnivorous mammals (as found living members of the order Carnivora). Higher levels of interspecific competition leads to a left-skewed M-S distribution in herbivorous dinosaurs (as found in sauropods and ornithopods), in contrast to the normal M-S distribution of large herbivorous mammals. Thus, our models suggest that differences in reproductive strategy, and consequently ontogeny, explain observed differences in community structure between dinosaur and mammal faunas. Models also show that the largest dinosaurian predators could have subsisted on similar-sized prey by including younger life stages of the largest herbivore species, but that large predators likely avoided prey much smaller than themselves because, despite predicted higher abundances of smaller than larger-bodied prey, contributions of small prey to biomass intake would be insufficient to satisfy meat requirements. A lack of large carnivores feeding on small prey exists in mammals larger than 21.5 kg, and it seems a similar minimum prey-size threshold could have affected dinosaurs as well.	[Codron, Daryl; Clauss, Marcus] Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, Zurich, Switzerland; [Codron, Daryl] Florisbad Quaternary Res, Natl Museum, Bloemfontein, South Africa; [Codron, Daryl] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Pietermaritzburg, South Africa; [Codron, Daryl] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA; [Carbone, Chris] Zool Soc London, Inst Zool, London NW1 4RY, England	University of Zurich; University of Kwazulu Natal; University of Colorado System; University of Colorado Boulder; Zoological Society of London	Codron, D (corresponding author), Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, Zurich, Switzerland.	d.codron@nasmus.co.za	Codron, Daryl/B-8867-2008; Clauss, Marcus/GRR-7996-2022; Clauss, Marcus/M-8702-2019; Clauss, Marcus/A-4710-2008	Codron, Daryl/0000-0001-5223-9513; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207				Abts ML, 1985, LIFE HIST STRATEGY S; Akû║akaya H.R., 1999, APPL POPULATION ECOL; AR A, 1979, CONDOR, V81, P331, DOI 10.2307/1366955; Archibald J.D., 1996, DINOSAUR EXTINCTION; ARMITAGE KB, 1974, ECOLOGY, V55, P1233, DOI 10.2307/1935452; BARKALOW FS, 1970, J WILDLIFE MANAGE, V34, P489, DOI 10.2307/3798852; BARLOW J, 1991, MAR MAMMAL SCI, V7, P50, DOI 10.1111/j.1748-7692.1991.tb00550.x; Begon M., 2009, ECOLOGY INDIVIDUALS; Benton MJ, 2006, VERTEBRATE PALAEONTO; Berglind Sven-Ake, 2000, Ecological Bulletins, V48, P123; Birchard GF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0036; BLACKBURN TM, 1994, PHILOS T ROY SOC B, V343, P135, DOI 10.1098/rstb.1994.0016; BLACKBURN TM, 1994, OIKOS, V70, P127, DOI 10.2307/3545707; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Brett-Surman MK, 1997, COMPLETE DINOSAUR, P350; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Brown CM, 2013, PALAEOGEOGR PALAEOCL, V372, P108, DOI 10.1016/j.palaeo.2012.06.027; BROWN JH, 1989, SCIENCE, V243, P1145, DOI 10.1126/science.243.4895.1145; CABANA G, 1982, AM NAT, V120, P17, DOI 10.1086/283966; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Carbone C, 2011, P ROY SOC B-BIOL SCI, V278, P2682, DOI 10.1098/rspb.2010.2497; Carrano Matthew T., 2006, P225; Chiappe LM, 2001, SCIENCE, V293, P2444, DOI 10.1126/science.1063723; Clarke A, 2013, AM NAT, V182, P283, DOI 10.1086/671259; Codron D, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0922; Codron D, 2012, BIOL LETTERS, V8, P620, DOI 10.1098/rsbl.2012.0240; Codron J, 2013, CAN J ZOOL, V91, P124, DOI 10.1139/cjz-2012-0155; CONGDON JD, 1994, AM ZOOL, V34, P397; DAMUTH J, 1981, BIOL J LINN SOC, V15, P185, DOI 10.1111/j.1095-8312.1981.tb00758.x; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Damuth J, 2007, AM NAT, V169, P621, DOI 10.1086/513495; Dunning JB, 2013, UPDATES 2 EDITION CR; DunningJr J. B., 2007, CRC HDB AVIAN BODY M, VSecond; Erickson GM, 2006, SCIENCE, V313, P213, DOI 10.1126/science.1125721; Erickson GM, 2009, ANAT REC, V292, P1514, DOI 10.1002/ar.20992; Ericsson G, 2001, ECOLOGY, V82, P1613, DOI 10.1890/0012-9658(2001)082[1613:ARREAS]2.0.CO;2; Farlow James O., 2002, Paleontological Society Papers, V8, P251; Feduccia A, 2003, TRENDS ECOL EVOL, V18, P172, DOI 10.1016/S0169-5347(03)00017-X; Foster J., 2007, JURASSIC W DINOSAURS; Gadsden H, 2008, WEST N AM NATURALIST, V68, P46, DOI 10.3398/1527-0904(2008)68[46:DOTYSL]2.0.CO;2; Galan P, 1999, J ZOOL, V249, P203; Hendriks AJ, 2008, OECOLOGIA, V155, P705, DOI 10.1007/s00442-007-0952-3; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Horner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016574; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; Hummel J, 2008, EVOL ECOL RES, V10, P925; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Lang E, 2013, PALAEOGEOGR PALAEOCL, V381, P26, DOI 10.1016/j.palaeo.2013.04.011; LEVINS RICHARD, 1968; Lockley Martin G., 1994, P347; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; O'Gorman EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051925; Ortega-Rubio A, 2000, HERPETOL J, V10, P33; Parker WS, 1974, COPEIA, V1994, P136; Paul GS, 1999, DINOSAUR EGGS BABIES, P244; Punzo F, 2007, AMPHIBIA-REPTILIA, V28, P65, DOI 10.1163/156853807779798974; Radloff FGT, 2012, ISOT ENVIRON HEALT S, V48, P439, DOI 10.1080/10256016.2012.667808; RAHN H, 1975, AUK, V92, P750, DOI 10.2307/4084786; Robertson DS, 2004, GEOL SOC AM BULL, V116, P760, DOI 10.1130/B25402.1; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2008, PALAEONTOGR ABT A, V284, P69; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; SEYMOUR RS, 1979, PALEOBIOLOGY, V5, P1; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Smith FA, 2004, AM NAT, V163, P672, DOI 10.1086/382898; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Sookias RB, 2012, BIOL LETTERS, V8, P674, DOI 10.1098/rsbl.2012.0060; Statsoft_Inc, 2007, STAT VERS 8 0 COMP P; Steinsaltz D, 2011, PALEOBIOLOGY, V37, P113, DOI 10.1666/08056.1; TINKLE DW, 1983, COPEIA, P585; Troost TA, 2008, EVOL ECOL, V22, P771, DOI 10.1007/s10682-007-9209-1; VANDEVENDER RW, 1982, HERPETOLOGICA, V38, P189; VINEGAR MB, 1975, ECOLOGY, V56, P172, DOI 10.2307/1935309; Weishampel DB., 2004, DINOSAURIA; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Werner J, 2010, REPROD DINOSAURIERN; Werner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028442; WISSINGER SA, 1992, ECOLOGY, V73, P1431, DOI 10.2307/1940688; Woolley LA, 2011, BIOTROPICA, V43, P489, DOI 10.1111/j.1744-7429.2010.00733.x; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; [No title captured]	85	22	22	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77110	10.1371/journal.pone.0077110	http://dx.doi.org/10.1371/journal.pone.0077110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204749	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000326334500017
J	Lyngdoh, T; Bochud, M; Glaus, J; Castelao, E; Waeber, G; Vollenweider, P; Preisig, M				Lyngdoh, Tanica; Bochud, Murielle; Glaus, Jennifer; Castelao, Enrique; Waeber, Gerard; Vollenweider, Peter; Preisig, Martin			Associations of Serum Uric Acid and SLC2A9 Variant with Depressive and Anxiety Disorders: A Population-Based Study	PLOS ONE			English	Article							OXIDATIVE STRESS; DIAGNOSTIC INTERVIEW; PSYCHIATRIC-DISORDERS; SHORT-TERM; CHOLESTEROL; RISK; DISEASE; VARIABILITY; COMORBIDITY; RELIABILITY	Background: Limited information exists regarding the association between serum uric acid (SUA) and psychiatric disorders. We explored the relationship between SUA and subtypes of major depressive disorder (MDD) and specific anxiety disorders. Additionally, we examined the association of SLC2A9 rs6855911 variant with anxiety disorders. Methods: We conducted a cross-sectional analysis on 3,716 individuals aged 35-66 years previously selected for the population-based CoLaus survey and who agreed to undergo further psychiatric evaluation. SUA was measured using uricase-PAP method. The French translation of the semi-structured Diagnostic Interview for Genetic Studies was used to establish lifetime and current diagnoses of depression and anxiety disorders according to the DSM-IV criteria. Results: Men reported significantly higher levels of SUA compared to women (357674 mmol/L vs. 263664 mmol/L). The prevalence of lifetime and current MDD was 44% and 18% respectively while the corresponding estimates for any anxiety disorders were 18% and 10% respectively. A quadratic hockey-stick shaped curve explained the relationship between SUA and social phobia better than a linear trend. However, with regards to the other specific anxiety disorders and other subtypes of MDD, there was no consistent pattern of association. Further analyses using SLC2A9 rs6855911 variant, known to be strongly associated with SUA, supported the quadratic relationship observed between SUA phenotype and social phobia. Conclusions: A quadratic relationship between SUA and social phobia was observed consistent with a protective effect of moderately elevated SUA on social phobia, which disappears at higher concentrations. Further studies are needed to confirm our observations.	[Lyngdoh, Tanica; Bochud, Murielle] Lausanne Univ Hosp CHUV, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Glaus, Jennifer; Castelao, Enrique; Preisig, Martin] CHU Vaudois, Dept Psychiat, Lausanne, Switzerland; [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Med, Lausanne, Switzerland; [Waeber, Gerard; Vollenweider, Peter] Fac Biol & Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Bochud, M (corresponding author), Lausanne Univ Hosp CHUV, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	Murielle.Bochud@chuv.ch	Bochud, Murielle/A-3981-2010; Colaus, PsyColaus/K-6607-2013; Glaus, Jennifer/C-7887-2017	Bochud, Murielle/0000-0002-5727-0218; Glaus, Jennifer/0000-0001-8883-9473; Castelao, Enrique/0000-0003-1966-3683; Preisig, Martin/0000-0001-5689-4259; Waeber, Gerard/0000-0003-4193-788X	Swiss National Science Foundation [3200B0-105993]; GlaxoSmithKline (Psychiatry Center of Excellence for Drug Discovery and Genetics Division, Drug Discovery - Verona, RD); GlaxoSmithKline	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); GlaxoSmithKline (Psychiatry Center of Excellence for Drug Discovery and Genetics Division, Drug Discovery - Verona, RD)(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline)	The PsyCoLaus study was supported by grants from the Swiss National Science Foundation (#3200B0-105993) and from GlaxoSmithKline (Psychiatry Center of Excellence for Drug Discovery and Genetics Division, Drug Discovery - Verona, R&D). Profs PV and GW received an unrestricted grant from GlaxoSmithKline to build the CoLaus study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Angst J, 2006, EUR ARCH PSY CLIN N, V256, P44, DOI 10.1007/s00406-005-0600-z; Bettschart W, 1996, EVALUATION CLIN STAN, VI; Bouayed J, 2009, OXID MED CELL LONGEV, V2, P63, DOI 10.4161/oxim.2.2.7944; Bove M, 2010, AGING MENT HEALTH, V14, P801, DOI 10.1080/13607861003713299; Brandstatter A, 2008, DIABETES CARE, V31, P1662, DOI 10.2337/dc08-0349; Chaudhari K, 2010, INDIAN J CLIN BIOCHE, V25, P77, DOI 10.1007/s12291-010-0016-z; CHURCH WH, 1994, BRAIN RES BULL, V33, P419, DOI 10.1016/0361-9230(94)90285-2; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Cumurcu BE, 2009, PSYCHIAT CLIN NEUROS, V63, P639, DOI 10.1111/j.1440-1819.2009.02004.x; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Fendri C, 2006, ENCEPHALE, V32, P244; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; FRANCIS KT, 1979, PSYCHOSOM MED, V41, P617, DOI 10.1097/00006842-197912000-00003; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; Hettema JM, 2008, AM J MED GENET C, V148C, P140, DOI 10.1002/ajmg.c.30171; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Hovatta I, 2010, NEUROSCI RES, V68, P261, DOI 10.1016/j.neures.2010.08.007; Irie M, 2003, BIOCHEM BIOPH RES CO, V311, P1014, DOI 10.1016/j.bbrc.2003.10.105; Kessler RC, 1996, BRIT J PSYCHIAT, V168, P17, DOI 10.1192/S0007125000298371; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kim TS, 2006, INT J GERIATR PSYCH, V21, P344, DOI 10.1002/gps.1469; Klandorf H, 2001, COMP BIOCHEM PHYS C, V129, P93, DOI 10.1016/S1532-0456(01)00186-7; LEBOYER M, 1991, EUR ARCH PSY CLIN N, V241, P165, DOI 10.1007/BF02219716; Leboyer M., 1995, INTERVIEW DIAGNOSTIQ; Lei MT, 2008, NEPHROL DIAL TRANSPL, V23, P2746, DOI 10.1093/ndt/gfn349; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Matsushita M, 2010, PSYCHIAT CLIN NEUROS, V64, P435, DOI 10.1111/j.1440-1819.2010.02109.x; NICHOLLS A, 1973, BRIT MED J, V1, P449, DOI 10.1136/bmj.1.5851.449; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Preisig M, 1999, EUR ARCH PSY CLIN N, V249, P174, DOI 10.1007/s004060050084; Preisig M, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-9; RAHE RH, 1967, J AMER MED ASSOC, V202, P1052, DOI 10.1001/jama.202.11.1052; RAHE RH, 1968, J AMER MED ASSOC, V206, P2875, DOI 10.1001/jama.206.13.2875; RAHE RH, 1974, PSYCHOSOM MED, V36, P258, DOI 10.1097/00006842-197405000-00009; Rougemont-Buecking A, 2008, PSYCHIAT RES, V157, P211, DOI 10.1016/j.psychres.2006.04.022; Salim S, 2011, BRAIN RES, V1404, P63, DOI 10.1016/j.brainres.2011.06.024; Sarandol A, 2007, HUM PSYCHOPHARM CLIN, V22, P67, DOI 10.1002/hup.829; Spitsin SV, 2002, FREE RADICAL BIO MED, V33, P1363, DOI 10.1016/S0891-5849(02)01048-1; SPYCKERELLE Y, 1992, ARCH FR PEDIATR, V49, P875; Tochigi M, 2002, NEUROSCI RES, V44, P267, DOI 10.1016/S0168-0102(02)00146-3; Toncev G, 2002, EUR J NEUROL, V9, P221, DOI 10.1046/j.1468-1331.2002.00384.x; Trevisan M, 1997, PSYCHOSOM MED, V59, P109, DOI 10.1097/00006842-199703000-00001; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wen SL, 2012, CLIN BIOCHEM, V45, P49, DOI 10.1016/j.clinbiochem.2011.10.010; Yanik M, 2004, ACTA NEUROPSYCHIATR, V16, P200, DOI 10.1111/j.0924-2708.2004.00090.x; ZIR LM, 1973, ARCH INTERN MED, V132, P808, DOI 10.1001/archinte.132.6.808	55	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76336	10.1371/journal.pone.0076336	http://dx.doi.org/10.1371/journal.pone.0076336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204615	Green Submitted, gold, Green Published			2022-12-27	WOS:000326270700005
J	Posokhova, E; Ng, D; Opel, A; Masuho, I; Tinker, A; Biesecker, LG; Wickman, K; Martemyanov, KA				Posokhova, Ekaterina; Ng, David; Opel, Aaisha; Masuho, Ikuo; Tinker, Andrew; Biesecker, Leslie G.; Wickman, Kevin; Martemyanov, Kirill A.			Essential Role of the m(2)R-RGS6-I-KACh Pathway in Controlling Intrinsic Heart Rate Variability	PLOS ONE			English	Article							ENDOGENOUS RGS PROTEINS; I-KACH; PARASYMPATHETIC REGULATION; GATING KINETICS; POINCARE PLOT; K+-CHANNEL; ACTIVATION; SUBTYPES; ABSENCE; COMPLEX	Normal heart function requires generation of a regular rhythm by sinoatrial pacemaker cells and the alteration of this spontaneous heart rate by the autonomic input to match physiological demand. However, the molecular mechanisms that ensure consistent periodicity of cardiac contractions and fine tuning of this process by autonomic system are not completely understood. Here we examined the contribution of the m(2)R-I-KACh intracellular signaling pathway, which mediates the negative chronotropic effect of parasympathetic stimulation, to the regulation of the cardiac pacemaking rhythm. Using isolated heart preparations and single-cell recordings we show that the m(2)R-I-KACh signaling pathway controls the excitability and firing pattern of the sinoatrial cardiomyocytes and determines variability of cardiac rhythm in a manner independent from the autonomic input. Ablation of the major regulator of this pathway, Rgs6, in mice results in irregular cardiac rhythmicity and increases susceptibility to atrial fibrillation. We further identify several human subjects with variants in the RGS6 gene and show that the loss of function in RGS6 correlates with increased heart rate variability. These findings identify the essential role of the m(2)R-I-KACh signaling pathway in the regulation of cardiac sinus rhythm and implicate RGS6 in arrhythmia pathogenesis.	[Posokhova, Ekaterina; Masuho, Ikuo; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL USA; [Ng, David; Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, Bethesda, MD 20892 USA; [Opel, Aaisha] UCL, Dept Med, London, England; [Tinker, Andrew] Barts & London Queen Marys Sch Med & Dent, Ctr Heart, William Harvey Res Inst, London, England; [Wickman, Kevin] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of London; University College London; University of London; Queen Mary University London; University of Minnesota System; University of Minnesota Twin Cities	Martemyanov, KA (corresponding author), Scripps Res Inst, Dept Neurosci, Jupiter, FL USA.	kirill@scripps.edu	Masuho, Ikuo/J-6115-2014	Wickman, Kevin/0000-0002-5179-9540	NIH [HL105550]; British Heart Foundation [FS/09/042/27860]; Welcome Trust [081475/Z/06/Z]; NHGRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105550] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Welcome Trust(Wellcome Trust); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH grant HL105550 (KW and KAM), the British Heart Foundation, FS/09/042/27860 (AT) and Welcome Trust, 081475/Z/06/Z (AT). DN and LB are supported by the Intramural Research Program of the NHGRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Brennan M, 2002, AM J PHYSIOL-HEART C, V283, pH1873, DOI 10.1152/ajpheart.00405.2000; Buccelletti F, 2009, EUR REV MED PHARMACO, V13, P299; Camm AJ, 1996, CIRCULATION, V93, P1043; Cifelli C, 2008, CIRC RES, V103, P527, DOI 10.1161/CIRCRESAHA.108.180984; Dobrev D, 2005, CIRCULATION, V112, P3697, DOI 10.1161/circulationaha.105.575332; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Frey B, 1996, PACE, V19, P1882, DOI 10.1111/j.1540-8159.1996.tb03245.x; Fu Y, 2006, CIRC RES, V98, P659, DOI 10.1161/01.RES.0000207497.50477.60; Fu Y, 2007, AM J PHYSIOL-HEART C, V292, pH2532, DOI 10.1152/ajpheart.01391.2006; Gehrmann J, 2000, AM J PHYSIOL-HEART C, V279, pH733, DOI 10.1152/ajpheart.2000.279.2.H733; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hashimoto N, 2008, J CARDIOVASC PHARM, V51, P162, DOI 10.1097/FJC.0b013e31815e854c; Herrmann S, 2007, EMBO J, V26, P4423, DOI 10.1038/sj.emboj.7601868; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Jakubik J, 1995, FEBS LETT, V377, P275, DOI 10.1016/0014-5793(95)01360-1; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Kamen PW, 1996, CLIN SCI, V91, P201, DOI 10.1042/cs0910201; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Kovoor P, 2001, J AM COLL CARDIOL, V37, P2136, DOI 10.1016/S0735-1097(01)01304-3; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Lombardi F, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00095; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Machida N, 2001, J VET MED SCI, V63, P873, DOI 10.1292/jvms.63.873; Maier SKG, 2003, P NATL ACAD SCI USA, V100, P3507, DOI 10.1073/pnas.2627986100; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Mighiu AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00204; Podrid PJ., 2001, CARDIAC ARRHYTHMIA M, V2; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Schumacher AM, 2006, BIOL RES NURS, V8, P55, DOI 10.1177/1099800406289775; Singh JP, 2002, AM J CARDIOL, V90, P1290, DOI 10.1016/S0002-9149(02)02865-5; Stein PK, 1999, ANNU REV MED, V50, P249, DOI 10.1146/annurev.med.50.1.249; Stewart A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00095; Stieber J, 2004, TRENDS CARDIOVAS MED, V14, P23, DOI 10.1016/j.tcm.2003.09.006; van de Borne P, 1999, CIRCULATION, V99, P1606, DOI 10.1161/01.CIR.99.12.1606; Voigt N, 2008, CARDIOVASC RES, V77, P35, DOI 10.1093/cvr/cvm051; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; Wickman K, 1999, ANN NY ACAD SCI, V868, P386, DOI 10.1111/j.1749-6632.1999.tb11300.x; Xie KQ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002922; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Yang Yanzong, 2010, Am J Hum Genet, V86, P872; Zuberi Z, 2010, CIRC-ARRHYTHMIA ELEC, V3, P391, DOI 10.1161/CIRCEP.109.894329	46	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76973	10.1371/journal.pone.0076973	http://dx.doi.org/10.1371/journal.pone.0076973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204714	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700014
J	Baker, JHE; Kyle, AH; Bartels, KL; Methot, SP; Flanagan, EJ; Balbirnie, A; Cran, JD; Minchinton, AI				Baker, Jennifer H. E.; Kyle, Alastair H.; Bartels, Kirsten L.; Methot, Stephen P.; Flanagan, Erin J.; Balbirnie, Andrew; Cran, Jordan D.; Minchinton, Andrew I.			Targeting the Tumour Vasculature: Exploitation of Low Oxygenation and Sensitivity to NOS Inhibition by Treatment with a Hypoxic Cytotoxin	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PHASE-III TRIAL; OXYHEMOGLOBIN SATURATIONS; DISRUPTING AGENTS; BLOOD-VESSELS; MURINE TUMORS; L-ARGININE; IN-VIVO; TIRAPAZAMINE; CANCER	Many cancer research efforts focus on exploiting genetic-level features that may be targeted for therapy. Tissue-level features of the tumour microenvironment also represent useful therapeutic targets. Here we investigate the presence of low oxygen tension and sensitivity to NOS inhibition of tumour vasculature as potential tumour-specific features that may be targeted by hypoxic cytotoxins, a class of therapeutics currently under investigation. We have previously demonstrated that tirapazamine (TPZ) mediates central vascular dysfunction in tumours. TPZ is a hypoxic cytotoxin that is also a competitive inhibitor of NOS. Here we further investigated the vascular-targeting activity of TPZ by combining it with NOS inhibitor L-NNA, or with low oxygen content gas breathing. Tumours were analyzed via multiplex immunohistochemical staining that revealed irreversible loss of perfusion and enhanced tumour cell death when TPZ was combined with either low oxygen or a NOS inhibitor. Tumour growth rate was reduced by TPZ + NOS inhibition, and tumours previously resistant to TPZ-mediated vascular dysfunction were sensitized by low oxygen breathing. Additional mapping analysis suggests that tumours with reduced vascular-associated stroma may have greater sensitivity to these effects. These results indicate that poorly oxygenated tumour vessels, also being abnormally organized and with inadequate smooth muscle, may be successfully targeted for significant anti-cancer effects by inhibition of NOS and hypoxia-activated prodrug toxicity. This strategy illustrates a novel use of hypoxia-activated cytotoxic prodrugs as vascular targeting agents, and also represents a novel mechanism for targeting tumour vessels.	[Baker, Jennifer H. E.; Kyle, Alastair H.; Bartels, Kirsten L.; Methot, Stephen P.; Flanagan, Erin J.; Balbirnie, Andrew; Cran, Jordan D.; Minchinton, Andrew I.] BC Canc Res Ctr, Integrat Oncol Radiat Biol Unit, Vancouver, BC, Canada	British Columbia Cancer Agency	Minchinton, AI (corresponding author), BC Canc Res Ctr, Integrat Oncol Radiat Biol Unit, Vancouver, BC, Canada.	aim@bccrc.ca		Methot, Stephen/0000-0003-2854-2226	Michael Smith Foundation for Health Research; Canadian Institutes for Health Research	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	JB and AK are supported by Michael Smith Foundation for Health Research Senior Graduate Studentships (http://www.msfhr.org/funding). Funding for this research was provided by the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Anderson RF, 2005, ORG BIOMOL CHEM, V3, P2167, DOI 10.1039/b502586a; Bains LJ, 2009, INT J RADIAT ONCOL, V74, P957, DOI 10.1016/j.ijrobp.2008.11.068; Baker JHE, 2008, CLIN CANCER RES, V14, P2171, DOI 10.1158/1078-0432.CCR-07-4465; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BOUCHER Y, 1990, CANCER RES, V50, P4478; BROWN JM, 1990, CANCER RES, V50, P7745; Butler SA, 1997, BRIT J CANCER, V76, P438, DOI 10.1038/bjc.1997.407; Cao YT, 2005, CANCER RES, V65, P5498, DOI 10.1158/0008-5472.CAN-04-4553; Dewhirst MW, 1999, BRIT J CANCER, V79, P1717, DOI 10.1038/sj.bjc.6690273; Dewhirst MW, 2003, ADV EXP MED BIOL, V510, P51; DORIE MJ, 1993, CANCER RES, V53, P4633; Elwell JH, 1997, BIOCHEM PHARMACOL, V54, P249, DOI 10.1016/S0006-2952(97)00171-8; Evans JW, 1998, CANCER RES, V58, P2098; FENTON BM, 1988, J NATL CANCER I, V80, P1612, DOI 10.1093/jnci/80.20.1612; Fukumura D, 1997, AM J PATHOL, V150, P713; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; GABOURY JP, 1994, AM J PHYSIOL, V266, pH637, DOI 10.1152/ajpheart.1994.266.2.H637; Garner AP, 1999, CANCER RES, V59, P1929; Graham MA, 1997, CANCER CHEMOTH PHARM, V40, P1, DOI 10.1007/s002800050617; Horsman MR, 1996, BRIT J CANCER, V74, pS168; Huxham LA, 2006, RADIOTHER ONCOL, V78, P138, DOI 10.1016/j.radonc.2006.01.002; Huxham LA, 2008, MICROVASC RES, V75, P247, DOI 10.1016/j.mvr.2007.09.006; Kyle AH, 2007, CLIN CANCER RES, V13, P2804, DOI 10.1158/1078-0432.CCR-06-1941; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Marcu L, 2006, CURR CLIN PHARMACOL, V1, P71, DOI 10.2174/157488406775268192; Maseide K, 2001, CANCER LETT, V162, P245, DOI 10.1016/S0304-3835(00)00670-4; MINCHINTON AI, 1992, BRIT J CANCER, V66, P1053, DOI 10.1038/bjc.1992.409; Ng QS, 2007, LANCET ONCOL, V8, P111, DOI 10.1016/S1470-2045(07)70001-3; Patterson LH, 2000, BRIT J CANCER, V83, P1589, DOI 10.1054/bjoc.2000.1564; Peters KB, 2002, CANCER RES, V62, P5248; Le QT, 2012, CLIN CANCER RES, V18, P1798, DOI 10.1158/1078-0432.CCR-11-2094; Rischin D, 2010, J CLIN ONCOL, V28, P2989, DOI 10.1200/JCO.2009.27.4449; Seshadri M, 2007, NEOPLASIA, V9, P128, DOI 10.1593/neo.06748; Siemann DW, 2011, CANCER TREAT REV, V37, P63, DOI 10.1016/j.ctrv.2010.05.001; Siim BG, 2004, CANCER RES, V64, P736, DOI 10.1158/0008-5472.CAN-03-2488; Siim BG, 1997, CANCER RES, V57, P2922; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Thorpe PE, 2004, CLIN CANCER RES, V10, P415, DOI 10.1158/1078-0432.CCR-0642-03; Tozer GM, 2008, BRIT J RADIOL, V81, pS12, DOI 10.1259/bjr/36205483; Tozer GM, 2008, CANCER RES, V68, P2301, DOI 10.1158/0008-5472.CAN-07-2011; Tozer GM, 1997, CANCER RES, V57, P948; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; WOOD PJ, 1994, CANCER RES, V54, P6458; Wouters BG, 2001, CANCER RES, V61, P145; ZEMAN EM, 1986, INT J RADIAT ONCOL, V12, P1239, DOI 10.1016/0360-3016(86)90267-1	50	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76832	10.1371/journal.pone.0076832	http://dx.doi.org/10.1371/journal.pone.0076832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204680	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200015
J	Lee, EY; Schultz, KLW; Griffin, DE				Lee, Eun-Young; Schultz, Kimberly L. W.; Griffin, Diane E.			Mice Deficient in Interferon-Gamma or Interferon-Gamma Receptor 1 Have Distinct Inflammatory Responses to Acute Viral Encephalomyelitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEUROADAPTED SINDBIS-VIRUS; WEST-NILE-VIRUS; T-CELL HOMEOSTASIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; IFN-GAMMA; IMMUNE-RESPONSE; AUTOIMMUNE ENCEPHALOMYELITIS; DEMYELINATING DISEASE; TRANSGENIC MICE	Interferon (IFN)-gamma is an important component of the immune response to viral infections that can have a role both in controlling virus replication and inducing inflammatory damage. To determine the role of IFN-gamma in fatal alphavirus encephalitis, we have compared the responses of wild type C57BL/6 (WTB6) mice with mice deficient in either IFN-gamma (GKO) or the alpha-chain of the IFN-gamma receptor (GRKO) after intranasal infection with a neuroadapted strain of sindbis virus. Mortalities of GKO and GRKO mice were similar to WTB6 mice. Both GKO and GRKO mice had delayed virus clearance from the brain and spinal cord, more infiltrating perforin(+) cells and lower levels of tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 mRNAs than WTB6 mice. However, inflammation was more intense in GRKO mice than WTB6 or GKO mice with more infiltrating CD3(+) T cells, greater expression of major histocompatibility complex-II and higher levels of interleukin-17A mRNA. Fibroblasts from GRKO embryos did not develop an antiviral response after treatment with IFN-gamma, but showed increases in TNF-alpha, IL-6, CXCL9 and CXCL10 mRNAs although these increases developed more slowly and were less intense than those of WTB6 fibroblasts. These data indicate that both GKO and GRKO mice fail to develop an IFN-gamma-mediated antiviral response, but differ in regulation of the inflammatory response to infection. Therefore, GKO and GRKO cannot be considered equivalent when assessing the role of IFN-gamma in CNS viral infections.	[Lee, Eun-Young; Schultz, Kimberly L. W.; Griffin, Diane E.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Griffin, DE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	dgriffin@jhsph.edu		, Kimberly/0000-0002-5826-6886	National Institutes of Health [R01 NS038932, T32 AI007247]; Chungbuk National University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chungbuk National University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by research grant R01 NS038932 (DEG) and training grant T32 AI007247 (KLWS) from the National Institutes of Health and a sabbatical fellowship from Chungbuk National University (E-YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronsson F, 2003, VIRAL IMMUNOL, V16, P415, DOI 10.1089/088282403322396208; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Bartholdy C, 2000, J VIROL, V74, P10304, DOI 10.1128/JVI.74.22.10304-10311.2000; Becher B, 2011, CURR OPIN IMMUNOL, V23, P707, DOI 10.1016/j.coi.2011.08.005; Bergmann CC, 2003, J IMMUNOL, V170, P3204, DOI 10.4049/jimmunol.170.6.3204; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Binder GK, 2001, SCIENCE, V293, P303, DOI 10.1126/science.1059742; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; Burdeinick-Kerr R, 2007, J VIROL, V81, P5628, DOI 10.1128/JVI.01152-06; Byrnes AP, 2000, J VIROL, V74, P3905, DOI 10.1128/JVI.74.8.3905-3908.2000; Cantin E, 1999, J VIROL, V73, P5196, DOI 10.1128/JVI.73.6.5196-5200.1999; Chesler DA, 2002, CYTOKINE GROWTH F R, V13, P441, DOI 10.1016/S1359-6101(02)00044-8; Christensen JP, 2001, J IMMUNOL, V166, P3384, DOI 10.4049/jimmunol.166.5.3384; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Corbin JG, 1996, MOL CELL NEUROSCI, V7, P354, DOI 10.1006/mcne.1996.0026; Costa-Pereira AP, 2005, J IMMUNOL, V175, P5958, DOI 10.4049/jimmunol.175.9.5958; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Ferber IA, 1996, J IMMUNOL, V156, P5; FIETTE L, 1995, J EXP MED, V181, P2069, DOI 10.1084/jem.181.6.2069; Garcia CS, 2006, J IMMUNOL, V177, P2707, DOI 10.4049/jimmunol.177.4.2707; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; GRAHAM MB, 1993, J EXP MED, V178, P1725, DOI 10.1084/jem.178.5.1725; Greene IP, 2008, P NATL ACAD SCI USA, V105, P3575, DOI 10.1073/pnas.0712390105; GRIFFIN DE, 1977, J IMMUNOL, V118, P1070; GRIFFIN DE, 1976, J INFECT DIS, V133, P456, DOI 10.1093/infdis/133.4.456; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hausmann A, 2005, J GEN VIROL, V86, P399, DOI 10.1099/vir.0.80566-0; Hausmann J, 2005, J VIROL, V79, P13509, DOI 10.1128/JVI.79.21.13509-13518.2005; Hou WQ, 2009, J EXP MED, V206, P313, DOI 10.1084/jem.20082030; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; JACKSON AC, 1987, LAB INVEST, V56, P418; JACKSON AC, 1988, LAB INVEST, V58, P503; Kelchtermans H, 2008, TRENDS IMMUNOL, V29, P479, DOI 10.1016/j.it.2008.07.002; Kim BS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-217; Kim IJ, 2002, J NEUROSCI, V22, P4530, DOI 10.1523/JNEUROSCI.22-11-04530.2002; Kimura T, 2003, VIROLOGY, V311, P28, DOI 10.1016/S0042-6822(03)00110-7; Kimura T, 2000, J VIROL, V74, P6117, DOI 10.1128/JVI.74.13.6117-6125.2000; KOTENKO SV, 1995, J BIOL CHEM, V270, P20915, DOI 10.1074/jbc.270.36.20915; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Krause CD, 2006, CELL RES, V16, P55, DOI 10.1038/sj.cr.7310008; LaFerla FM, 2000, J MOL NEUROSCI, V15, P45, DOI 10.1385/JMN:15:1:45; Leon C, 2006, J IMMUNOL, V176, P5934, DOI 10.4049/jimmunol.176.10.5934; LEVINE B, 1991, SCIENCE, V254, P856, DOI 10.1126/science.1658936; Licinio J, 1997, J CLIN INVEST, V100, P2941, DOI 10.1172/JCI119846; Lin MT, 1997, J VIROL, V71, P383, DOI 10.1128/JVI.71.1.383-391.1997; Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001; Liu ZQ, 2005, NEUROSCIENCE, V131, P283, DOI 10.1016/j.neuroscience.2004.10.043; Lobigs M, 2003, J GEN VIROL, V84, P567, DOI 10.1099/vir.0.18654-0; LUSTIG S, 1988, J VIROL, V62, P2329, DOI 10.1128/JVI.62.7.2329-2336.1988; Metcalf TU, 2011, J VIROL, V85, P11490, DOI 10.1128/JVI.05379-11; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nansen A, 1999, J IMMUNOL, V163, P6114; Nargi-Aizenman JL, 2004, ANN NEUROL, V55, P541, DOI 10.1002/ana.20033; Paessler S, 2007, VIROLOGY, V367, P307, DOI 10.1016/j.virol.2007.05.041; Park E, 2009, VIROLOGY, V388, P305, DOI 10.1016/j.virol.2009.03.031; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; RAMSAY AJ, 1993, IMMUNOL TODAY, V14, P155, DOI 10.1016/0167-5699(93)90277-R; Rodriguez M, 2003, J VIROL, V77, P12252, DOI 10.1128/JVI.77.22.12252-12265.2003; Rossi CP, 1998, J VIROL, V72, P4515; Rottenberg M, 2002, VIRAL IMMUNOL, V15, P247, DOI 10.1089/08828240260066206; Rowell JF, 2002, J NEUROIMMUNOL, V127, P106, DOI 10.1016/S0165-5728(02)00108-X; Savarin C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-104; Schijns VECJ, 1996, J IMMUNOL, V157, P815; SCHIJNS VECJ, 1994, J IMMUNOL, V153, P2029; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06; SOH J, 1994, CELL, V76, P793, DOI 10.1016/0092-8674(94)90354-9; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Takei Y, 2000, J AM SOC NEPHROL, V11, P250, DOI 10.1681/ASN.V112250; Tewari K, 2007, J IMMUNOL, V179, P2115, DOI 10.4049/jimmunol.179.4.2115; Thach DC, 2001, J VIROL, V75, P8674, DOI 10.1128/JVI.75.18.8674-8680.2001; Thach DC, 2000, J VIROL, V74, P6156, DOI 10.1128/JVI.74.13.6156-6161.2000; Topham DJ, 1997, J IMMUNOL, V159, P5197; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; TUCKER PC, 1993, J VIROL, V67, P4605, DOI 10.1128/JVI.67.8.4605-4610.1993; Tucker PC, 1996, J VIROL, V70, P3972, DOI 10.1128/JVI.70.6.3972-3977.1996; Turner SJ, 2007, J IMMUNOL, V178, P7616, DOI 10.4049/jimmunol.178.12.7616; UBOL S, 1994, P NATL ACAD SCI USA, V91, P5202, DOI 10.1073/pnas.91.11.5202; Wang HP, 2004, MOL CELL NEUROSCI, V27, P489, DOI 10.1016/j.mcn.2004.08.004; Wang T, 2003, J IMMUNOL, V171, P2524, DOI 10.4049/jimmunol.171.5.2524; Wang Y, 2006, J GEN VIROL, V87, P3599, DOI 10.1099/vir.0.81306-0; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Zepp J, 2011, TRENDS IMMUNOL, V32, P232, DOI 10.1016/j.it.2011.02.007	86	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76412	10.1371/journal.pone.0076412	http://dx.doi.org/10.1371/journal.pone.0076412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204622	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300005
J	Chai, ZT; Kong, J; Zhu, XD; Zhang, YY; Lu, L; Zhou, JM; Wang, LR; Zhang, KZ; Zhang, QB; Ao, JY; Wang, M; Wu, WZ; Wang, L; Tang, ZY; Sun, HC				Chai, Zong-Tao; Kong, Jian; Zhu, Xiao-Dong; Zhang, Yuan-Yuan; Lu, Lu; Zhou, Jia-Min; Wang, Long-Rong; Zhang, Ke-Zhi; Zhang, Qiang-Bo; Ao, Jian-Yang; Wang, Miao; Wu, Wei-Zhong; Wang, Lu; Tang, Zhao-You; Sun, Hui-Chuan			MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2 alpha/Akt/HIF-1 alpha Pathway in Hepatocellular Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COLONY-STIMULATING FACTOR; PERITUMORAL LIVER-TISSUE; TUMOR ANGIOGENESIS; HIGH EXPRESSION; METASTASIS; CANCER; HYPOXIA; MIR-26A; GENES	Background & Aims: microRNAs (miRNAs) have been reported to regulate angiogenesis by down-regulating the expression of pro-angiogenic or anti-angiogenic factors. The aims of this study were to investigate whether miR-26a inhibited angiogenesis by down-regulating vascular endothelial growth factor A (VEGFA) and its clinical relevance in hepatocellular carcinoma (HCC). Methods: The expression of miR-26a was modified in HepG2 and HCCLM3 cell lines respectively, and a panel of angiogenic factors was measured by real-time PCR in the cells. A luciferase reporter assay was used to validate the target gene of miR-26a. Specific inhibitors of signal transduction pathway and siRNA approaches were used to explore the regulatory mechanism of miR-26a. Migration and tube forming assays were conducted to show the changes of angiogenesis induced by miR-26a and its target genes. Finally animal studies were used to further validate those findings. Results: Ectopic expression of miR-26a exhibited decreased levels of VEGFA in HepG2 cells. Migration and tube forming of human umbilical vein endothelial cells (HUVECs) were decreased in the conditioned medium from ectopic expression of miR-26a in HepG2 cells compared to control HepG2 cells. The pro-angiogenic effects of the conditioned medium of HepG2 cells on HUVECs were specifically decreased by LY294002, YC-1, and bevacizumab. Integrated analysis disclosed PIK3C2 alpha as a downstream target gene of miR-26a. Ectopic expression of miR-26a suppressed ectopic and orthotopic tumor growth and vascularity in nude mice. The results in HCCLM3 were consistent with those in HepG2. miR-26a expression was inversely correlated with VEGFA expression in HCC patients. Conclusions: miR-26a modulated angiogenesis of HCC through the PIK3C2 alpha/Akt/HIF-1 alpha/VEGFA pathway. The expression of VEGFA was inversely correlated with miR-26a expression in HCC tumors.	[Chai, Zong-Tao; Zhu, Xiao-Dong; Zhang, Yuan-Yuan; Lu, Lu; Zhou, Jia-Min; Wang, Long-Rong; Zhang, Ke-Zhi; Zhang, Qiang-Bo; Wang, Miao; Wu, Wei-Zhong; Wang, Lu; Tang, Zhao-You; Sun, Hui-Chuan] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China; [Kong, Jian; Ao, Jian-Yang] Capital Med Univ, Beijing Chaoyang Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China	Fudan University; Capital Medical University	Sun, HC (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China.	sun.huichuan@zs-hospital.sh.cn	zhang, yuanyuan/GYA-4428-2022; Zhu, Xiao-Dong/A-8197-2010	Zhu, Xiao-Dong/0000-0001-9864-6763; Sun, Hui-Chuan/0000-0003-3761-7058	National Natural Science Foundation of China [81101564, 81020108025]; Shanghai Natural Science Fund for Youth Scholars [12ZR1442300]; National Key Project for Infectious Diseases [2012ZX10002012-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Fund for Youth Scholars; National Key Project for Infectious Diseases	This project was supported by the National Natural Science Foundation of China (grant number: 81101564, 81020108025), Shanghai Natural Science Fund for Youth Scholars (12ZR1442300), the National Key Project for Infectious Diseases (2012ZX10002012-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-2; Biswas K, 2013, J BIOL CHEM, V288, P2325, DOI 10.1074/jbc.M112.409656; Chen LZ, 2011, MOL THER, V19, P1521, DOI 10.1038/mt.2011.64; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Fang L, 2012, CELL CYCLE, V11, P4352, DOI 10.4161/cc.22670; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jia JB, 2010, ONCOLOGIST, V15, P732, DOI 10.1634/theoncologist.2009-0170; Jiang BH, 1997, CANCER RES, V57, P5328; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037266; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lages E, 2012, FRONT BIOSCI-LANDMRK, V17, P2508, DOI 10.2741/4068; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma Y, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-11; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Santhekadur PK, 2012, J BIOL CHEM, V287, P13952, DOI 10.1074/jbc.M111.321646; Shih TC, 2012, J HEPATOL, V57, P584, DOI 10.1016/j.jhep.2012.04.031; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Stahlhut C, 2012, DEVELOPMENT, V139, P4356, DOI 10.1242/dev.083774; Sun CY, 2013, CARCINOGENESIS, V34, P426, DOI 10.1093/carcin/bgs333; Sun FX, 1996, INT J CANCER, V66, P239, DOI 10.1002/(SICI)1097-0215(19960410)66:2<239::AID-IJC17>3.3.CO;2-G; Tang ZY, 2005, J SURG ONCOL, V91, P95, DOI 10.1002/jso.20291; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WANG Y, 2012, FEBS J; Weiss L, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-38; Wu J, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-30; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; YANG X, 2013, HEPATOLOGY; Yu L, 2013, ONCOL LETT, V5, P1223, DOI 10.3892/ol.2013.1173; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhang JQ, 2012, GASTROENTEROLOGY, V143, P246, DOI 10.1053/j.gastro.2012.03.045; Zhou BS, 2013, CANCER LETT, V333, P159, DOI 10.1016/j.canlet.2013.01.028; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697; Zhu N, 2011, MOL CELL BIOCHEM, V351, P157, DOI 10.1007/s11010-011-0723-7; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521; Zhu XL, 2012, ACTA BIOCH BIOPH SIN, V44, P519, DOI 10.1093/abbs/gms026; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	52	96	103	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77957	10.1371/journal.pone.0077957	http://dx.doi.org/10.1371/journal.pone.0077957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194905	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000084
J	Cordoba-Aguilar, A; Munguia-Steyer, R				Cordoba-Aguilar, Alex; Munguia-Steyer, Roberto			The Sicker Sex: Understanding Male Biases in Parasitic Infection, Resource Allocation and Fitness	PLOS ONE			English	Article							LIFE-HISTORY; EUGREGARINE PARASITISM; ECOLOGICAL IMMUNOLOGY; EVOLUTIONARY ECOLOGY; NATURAL-POPULATIONS; SIZE DIMORPHISM; IMMUNE DEFENSE; MATING SYSTEM; TRADE-OFFS; BODY-SIZE	The "sicker sex" idea summarizes our knowledge of sex biases in parasite burden and immune ability whereby males fare worse than females. The theoretical basis of this is that because males invest more on mating effort than females, the former pay the costs by having a weaker immune system and thus being more susceptible to parasites. Females, conversely, have a greater parental investment. Here we tested the following: a) whether both sexes differ in their ability to defend against parasites using a natural host-parasite system; b) the differences in resource allocation conflict between mating effort and parental investment traits between sexes; and, c) effect of parasitism on survival for both sexes. We used a number of insect damselfly species as study subjects. For (a), we quantified gregarine and mite parasites, and experimentally manipulated gregarine levels in both sexes during adult ontogeny. For (b), first, we manipulated food during adult ontogeny and recorded thoracic fat gain (a proxy of mating effort) and abdominal weight (a proxy of parental investment) in both sexes. Secondly for (b), we manipulated food and gregarine levels in both sexes when adults were about to become sexually mature, and recorded gregarine number. For (c), we infected male and female adults of different ages and measured their survival. Males consistently showed more parasites than females apparently due to an increased resource allocation to fat production in males. Conversely, females invested more on abdominal weight. These differences were independent of how much food/infecting parasites were provided. The cost of this was that males had more parasites and reduced survival than females. Our results provide a resource allocation mechanism for understanding sexual differences in parasite defense as well as survival consequences for each sex.	[Cordoba-Aguilar, Alex; Munguia-Steyer, Roberto] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Cordoba-Aguilar, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico.	acordoba@ecologia.unam.mx	Munguía-Steyer, Roberto/U-3935-2019	Munguía-Steyer, Roberto/0000-0002-2951-4684	PAPIIT UNAM [222312]; Direccion General de Asuntos del Personal Academico (PASPA-UNAM); Consejo Nacional de Ciencia y Tecnologia (Mexico)	PAPIIT UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Direccion General de Asuntos del Personal Academico (PASPA-UNAM); Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partly financed by a PAPIIT UNAM (Project No. 222312) grant. During analysis and manuscript preparation, AC-A had a sabbatical grant from Direccion General de Asuntos del Personal Academico (PASPA-UNAM) and Consejo Nacional de Ciencia y Tecnologia (Mexico). These funders, however, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ABRO A, 1990, Odonatologica, V19, P223; Adamo SA, 2001, ANIM BEHAV, V62, P417, DOI 10.1006/anbe.2001.1786; Andres JA, 1998, ECOL ENTOMOL, V23, P103, DOI 10.1046/j.1365-2311.1998.00125.x; ANHOLT BR, 1991, CAN J ZOOL, V69, P1156, DOI 10.1139/z91-164; Bacelar FS, 2011, J THEOR BIOL, V269, P131, DOI 10.1016/j.jtbi.2010.10.004; Benavides JA, 2012, AM J PHYS ANTHROPOL, V147, P52, DOI 10.1002/ajpa.21627; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Callander S, 2013, BEHAV ECOL, V24, P1251, DOI 10.1093/beheco/art059; Canales-Lazcano J, 2005, ODONATOLOGICA, V34, P123; Contreras-Garduno J, 2011, EVOL ECOL, V25, P845, DOI 10.1007/s10682-010-9438-6; Corallini Carla, 2002, Nova Supplementa Entomologica, V15, P9; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Cordoba-Aguilar A, 2006, J INSECT PHYSIOL, V52, P861, DOI 10.1016/j.jinsphys.2006.05.008; Cordoba-Aguilar A, 2009, BEHAVIOUR, V146, P189, DOI 10.1163/156853909X410739; Dmitriew C, 2007, CAN J ZOOL, V85, P310, DOI 10.1139/Z07-004; FORBES M R L, 1991, Oecologia (Berlin), V86, P335, DOI 10.1007/BF00317598; Forbes Mark R., 2008, P175; Forbes MR, 1999, INT J PARASITOL, V29, P991, DOI 10.1016/S0020-7519(99)00061-2; Gonzalez-Soriano E, 2001, ODONATOLOGICA, V30, P335; Gonzalez-Tokman DM, 2012, EVOLUTION, V66, P3294, DOI 10.1111/j.1558-5646.2012.01678.x; Jimenez-Cortes JG, 2012, J INSECT PHYSIOL, V58, P318, DOI 10.1016/j.jinsphys.2011.11.004; Hecker KR, 2002, CAN J ZOOL, V80, P162, DOI 10.1139/Z01-213; Houston AI, 2007, P ROY SOC B-BIOL SCI, V274, P2835, DOI 10.1098/rspb.2007.0934; Iserbyt A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-139; Iserbyt A, 2011, P ROY SOC B-BIOL SCI, V278, P3116, DOI 10.1098/rspb.2011.0126; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Krasnov BR, 2005, OECOLOGIA, V146, P209, DOI 10.1007/s00442-005-0189-y; Lachish S, 2011, J ANIM ECOL, V80, P1207, DOI 10.1111/j.1365-2656.2011.01893.x; Lajeunesse MJ, 2004, OIKOS, V106, P501, DOI 10.1111/j.0030-1299.2004.13076.x; Locklin JL, 2010, ODONATOLOGICA, V39, P319; Manjerovic MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038524; Marden JH, 2004, ANIM BEHAV, V68, P857, DOI 10.1016/j.anbehav.2003.09.019; MARDEN JH, 1989, PHYSIOL ZOOL, V62, P505, DOI 10.1086/physzool.62.2.30156182; McCurdy DG, 1998, OIKOS, V82, P303, DOI 10.2307/3546970; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Nagel Laura, 2010, BMC Ecology, V10, P5, DOI 10.1186/1472-6785-10-5; Niemela PT, 2012, FUNCT ECOL, V26, P450, DOI 10.1111/j.1365-2435.2011.01939.x; Oksuzyan A, 2008, AGING CLIN EXP RES, V20, P91; Pekar S, 2010, ANIM BEHAV, V79, P1301, DOI 10.1016/j.anbehav.2010.03.002; Pitala N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010814; Plaistow SJ, 2000, P ROY SOC B-BIOL SCI, V267, P969, DOI 10.1098/rspb.2000.1098; Poulin R, 2000, Q REV BIOL, V75, P277, DOI 10.1086/393500; Poulin R, 2012, EVOL ECOL, V26, P1169, DOI 10.1007/s10682-011-9544-0; Richardson JML, 1997, OIKOS, V79, P477, DOI 10.2307/3546890; Robb Tonia, 2006, BMC Ecology, V6, P15, DOI 10.1186/1472-6785-6-15; ROBINSON J V, 1986, Odonatologica, V15, P211; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Sanchez MI, 2013, PARASITOL RES, V112, P1913, DOI 10.1007/s00436-013-3347-x; Sanchez-Guillen RA, 2013, OECOLOGIA, V171, P105, DOI 10.1007/s00442-012-2388-7; Scantlebury M, 2010, J ZOOL, V282, P246, DOI 10.1111/j.1469-7998.2010.00734.x; Schilder RJ, 2006, P NATL ACAD SCI USA, V103, P18805, DOI 10.1073/pnas.0603156103; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Serrano-Meneses MA, 2008, J EVOLUTION BIOL, V21, P1259, DOI 10.1111/j.1420-9101.2008.01567.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sheridan LAD, 2000, OIKOS, V88, P327, DOI 10.1034/j.1600-0706.2000.880211.x; Siva-Jothy MT, 2000, P ROY SOC B-BIOL SCI, V267, P2523, DOI 10.1098/rspb.2000.1315; Siva-Jothy MT, 1999, ECOL ENTOMOL, V24, P465, DOI 10.1046/j.1365-2311.1999.00222.x; Stoehr AM, 2006, BEHAV ECOL, V17, P751, DOI 10.1093/beheco/ark018; Stoks R, 2012, ANNU REV ENTOMOL, V57, P249, DOI 10.1146/annurev-ento-120710-100557; Taylor PD, 1996, LANDSCAPE ECOL, V11, P181, DOI 10.1007/BF02447516; Uller T, 2006, EVOL ECOL, V20, P1, DOI 10.1007/s10682-005-2006-9; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131; Zuk M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000267	64	33	34	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76246	10.1371/journal.pone.0076246	http://dx.doi.org/10.1371/journal.pone.0076246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194830	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000009
J	Kim, H; Jang, SJ; Chung, DH; Yoo, SB; Sun, P; Jin, Y; Nam, KH; Paik, JH; Chung, JH				Kim, Hyojin; Jang, Se Jin; Chung, Doo Hyun; Yoo, Seol Bong; Sun, Pingli; Jin, Yan; Nam, Kyung Han; Paik, Jin-Ho; Chung, Jin-Haeng			A Comprehensive Comparative Analysis of the Histomorphological Features of ALK-Rearranged Lung Adenocarcinoma Based on Driver Oncogene Mutations: Frequent Expression of Epithelial-Mesenchymal Transition Markers than Other Genotype	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EGFR MUTATIONS; GENE REARRANGEMENT; CLINICAL-FEATURES; CANCER; P63; DELTA-NP63; IMMUNOREACTIVITY; DIFFERENTIATION; EML4-ALK	Molecular classification of lung cancer correlates well with histomorphological features. However, specific histomorphological features that differentiate anaplastic lymphoma kinase (ALK)-rearranged tumors from ALK-negative tumors have not been fully evaluated. Eighty ALK-rearranged and 213 ALK-negative (91 epidermal growth factor receptor-mutated; 29 K-ras-mutated; 93 triple-negative) resected lung adenocarcinomas were analyzed for several histomorphological parameters and histological subtype. ALK-rearranged tumors were associated with younger age at presentation, frequent nodal metastasis, and higher stage of disease at diagnosis. ALK-rearranged tumors were more likely to show a solid predominant pattern than ALK-negative tumors (43.8%; 35/80; p>0.001). Unlike ALK-negative tumors, a lepidic predominant pattern was not observed in ALK-rearranged tumors (p>0.001). In multivariate analysis, the most significant morphological features that distinguished ALK-rearranged tumors from ALK-negative tumors were cribriform formation (odds ratio [OR], 3.253; p=0.028), presence of mucin-containing cells (OR, 4.899; p=0.008), close relationship to adjacent bronchioles (OR, 5.361; p= 0.001), presence of psammoma bodies (OR, 4.026; p=0.002), and a solid predominant pattern (OR, 13.685; p=0.023). ALK-rearranged tumors exhibited invasive histomorphological features, aggressive behavior and frequent expression of epithelial-mesenchymal transition markers (loss of E-cadherin and expression of vimentin) compared with other genotype (p=0.015). Spatial proximity between bronchus and ALK-rearranged tumors and frequent solid histologic subtype with p63 expression may cause diagnostic difficulties to differentiate squamous cell carcinoma in the small biopsy, whereas p40 was rarely expressed in ALK-rearranged adenocarcinoma. Knowledge of these features may improve the diagnostic accuracy and lead to a better understanding of the characteristic behavior of ALK-rearranged tumors.	[Kim, Hyojin; Jin, Yan; Nam, Kyung Han; Paik, Jin-Ho; Chung, Jin-Haeng] Seoul Natl Univ, Dept Pathol, Bundang Hosp, Songnam, South Korea; [Kim, Hyojin; Chung, Doo Hyun; Sun, Pingli; Jin, Yan; Nam, Kyung Han; Paik, Jin-Ho; Chung, Jin-Haeng] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Jang, Se Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Yoo, Seol Bong] Presbyterian Med Ctr, Dept Pathol, Jeonju, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Ulsan; Asan Medical Center	Chung, JH (corresponding author), Seoul Natl Univ, Dept Pathol, Bundang Hosp, Songnam, South Korea.	chungjh@snu.ac.kr			Korea Healthcare technology Research & Development project, Ministry of Health & Welfare, Republic of Korea [A111405]	Korea Healthcare technology Research & Development project, Ministry of Health & Welfare, Republic of Korea	This work was supported by a Grant-in-Aid from the Korea Healthcare technology Research & Development project, Ministry of Health & Welfare, Republic of Korea (A111405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilal H, 2003, J HISTOCHEM CYTOCHEM, V51, P133, DOI 10.1177/002215540305100201; Bishop JA, 2012, MODERN PATHOL, V25, P405, DOI 10.1038/modpathol.2011.173; Chung JH, 2009, J THORAC ONCOL, V4, P1490, DOI 10.1097/JTO.0b013e3181bc9731; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Finberg KE, 2007, J MOL DIAGN, V9, P320, DOI 10.2353/jmoldx.2007.060182; Hsieh RK, 2005, CHEST, V128, P317, DOI 10.1378/chest.128.1.317; Inamura K, 2009, MODERN PATHOL, V22, P508, DOI 10.1038/modpathol.2009.2; Kim H, 2013, KOREAN J PATHOL, V47, P44, DOI 10.4132/KoreanJPathol.2013.47.1.44; Kim H, 2011, J THORAC ONCOL, V6, P1359, DOI 10.1097/JTO.0b013e31821cfc73; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Motoi N, 2008, AM J SURG PATHOL, V32A, P810, DOI 10.1097/PAS.0b013e31815cb162; Ninomiya H, 2009, LUNG CANCER, V63, P235, DOI 10.1016/j.lungcan.2008.04.017; Nishino M, 2012, MODERN PATHOL, V25, P1462, DOI 10.1038/modpathol.2012.109; Nonaka D, 2012, AM J SURG PATHOL, V36, P895, DOI 10.1097/PAS.0b013e3182498f2b; Paik JH, 2011, J THORAC ONCOL, V6, P466, DOI 10.1097/JTO.0b013e31820b82e8; Pelosi G, 2002, J PATHOL, V198, P100, DOI 10.1002/path.1166; Pelosi G, 2013, INT J SURG PATHOL, V21, P229, DOI 10.1177/1066896913476750; Popat S, 2012, LUNG CANCER, V75, P300, DOI 10.1016/j.lungcan.2011.07.017; Rekhtman N, 2013, MODERN PATHOL, DOI [10.1038/mod-pathol.2013.74., DOI 10.1038/M0D-PATH0L.2013.74]; Rekhtman N, 2011, MODERN PATHOL, V24, P1348, DOI 10.1038/modpathol.2011.92; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Sakai Y, 2013, INT J SURG PATHOL, V21, P476, DOI 10.1177/1066896913489345; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Sobin L, 2009, TNM CLASSIFICATION M; Sun PL, 2012, J THORAC ONCOL, V7, P323, DOI 10.1097/JTO.0b013e3182381515; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Tsutsumida H, 2004, HISTOPATHOLOGY, V44, P147, DOI 10.1111/j.1365-2559.2004.01797.x; Wang BY, 2002, HUM PATHOL, V33, P921, DOI 10.1053/hupa.2002.126878; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yoshida A, 2011, AM J SURG PATHOL, V35, P1226, DOI 10.1097/PAS.0b013e3182233e06; Yoshida A, 2011, LUNG CANCER, V72, P309, DOI 10.1016/j.lungcan.2010.09.013	33	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76999	10.1371/journal.pone.0076999	http://dx.doi.org/10.1371/journal.pone.0076999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194854	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000033
J	Luder, HU; Gerth-Kahlert, C; Ostertag-Benzinger, S; Schorderet, DF				Luder, Hans U.; Gerth-Kahlert, Christina; Ostertag-Benzinger, Silke; Schorderet, Daniel F.			Dental Phenotype in Jalili Syndrome Due to a c.1312 dupC Homozygous Mutation in the CNNM4 Gene	PLOS ONE			English	Article							CONE-ROD DYSTROPHY; AMELOGENESIS IMPERFECTA; MAGNESIUM; ENAMEL	Jalili syndrome denotes a recessively inherited combination of an eye disease (cone-rod dystrophy) and a dental disorder (amelogenesis imperfecta), which is caused by mutations in the CNNM4 gene. Whereas the ophthalmic consequences of these mutations have been studied comprehensively, the dental phenotype has obtained less attention. A defective transport of magnesium ions by the photoreceptors of the retina is assumed to account for the progressive visual impairment. Since magnesium is also incorporated in the mineral of dental hard tissues, we hypothesized that magnesium concentrations in defective enamel resulting from mutations in CNNM4 would be abnormal, if a similar deficiency of magnesium transport also accounted for the amelogenesis imperfecta. Thus, a detailed analysis of the dental hard tissues was performed in two boys of Kosovan origin affected by Jalili syndrome. Retinal dystrophy of the patients was diagnosed by a comprehensive eye examination and full-field electroretinography. A mutational analysis revealed a c. 1312 dupC homozygous mutation in CNNM4, a genetic defect which had already been identified in other Kosovan families and putatively results in loss-of-function of the protein. The evaluation of six primary teeth using light and scanning electron microscopy as well as energydispersive X-ray spectroscopy showed that dental enamel was thin and deficient in mineral, suggesting a hypoplastic/hypomineralized type of amelogenesis imperfecta. The reduced mineral density of enamel was accompanied by decreased amounts of calcium, but significantly elevated levels of magnesium. In dentin, however, a similar mineral deficiency was associated with reduced magnesium and normal calcium levels. It is concluded that the c. 1312 dupC mutation of CNNM4 results in mineralization defects of both enamel and dentin, which are associated with significantly abnormal magnesium concentrations. Thus, we could not disprove the hypothesis that a disrupted magnesium transport is involved in the development of the dental abnormalities observed in Jalili syndrome.	[Luder, Hans U.] Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland; [Gerth-Kahlert, Christina] Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland; [Ostertag-Benzinger, Silke] Univ Zurich, Clin Orthodont & Pedodont, Ctr Dent Med, Zurich, Switzerland; [Schorderet, Daniel F.] Inst Rech Ophtalmol, Sion, Switzerland; [Schorderet, Daniel F.] Univ Lausanne, Dept Ophthalmol, Lausanne, Switzerland; [Schorderet, Daniel F.] Ecole Polytech Fed Lausanne, Fac Life Sci, Lausanne, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Luder, HU (corresponding author), Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland.	bhdk.luder@bluewin.ch		Gerth-Kahlert, Christina/0000-0001-6298-615X				Downey LM, 2002, EUR J HUM GENET, V10, P865, DOI 10.1038/sj.ejhg.5200884; Goldstein DC, 2003, SCANNING ELECT MICRO, P391; Jalili IK, 2010, EYE, V24, P1659, DOI 10.1038/eye.2010.103; JALILI IK, 1988, J MED GENET, V25, P738, DOI 10.1136/jmg.25.11.738; Luder Hans U, 2012, Methods Mol Biol, V887, P81, DOI 10.1007/978-1-61779-860-3_9; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Michaelides M, 2004, J MED GENET, V41, P468, DOI 10.1136/jmg.2003.015792; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; ROBINSON C, 1995, INT J DEV BIOL, V39, P145; ROBINSON C, 1981, CARIES RES, V15, P70, DOI 10.1159/000260502; Schroeder HE, 1977, MONOGRAPHS DEV BIOL, V2, P146; STEINFORT J, 1991, J DENT RES, V70, P187, DOI 10.1177/00220345910700030601; Wolff A, 2010, PEDIATR DENT, V32, P386; Zobor D, 2012, OPHTHALMIC GENET, V33, P34, DOI 10.3109/13816810.2011.592178	15	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78529	10.1371/journal.pone.0078529	http://dx.doi.org/10.1371/journal.pone.0078529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194943	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000326037000122
J	Touwslager, RNH; Gielen, M; Tan, FES; Mulder, ALM; Gerver, WJM; Zimmermann, LJ; Houben, AJHM; Zeegers, MP; Derom, C; Vlietinck, R; Maes, HH; Stehouwer, CDA; Thomis, M				Touwslager, Robbert N. H.; Gielen, Marij; Tan, Frans E. S.; Mulder, Antonius L. M.; Gerver, Willem J. M.; Zimmermann, Luc J.; Houben, Alfons J. H. M.; Zeegers, Maurice P.; Derom, Catherine; Vlietinck, Robert; Maes, Hermine H.; Stehouwer, Coen D. A.; Thomis, Martine			Genetic, Maternal and Placental Factors in the Association between Birth Weight and Physical Fitness: A Longitudinal Twin Study	PLOS ONE			English	Article							CARDIORESPIRATORY FITNESS; BODY-COMPOSITION; MUSCLE STRENGTH; BLOOD-PRESSURE; GRIP STRENGTH; RISK-FACTORS; SIZE; MORTALITY; DISEASE; GROWTH	Background: Adult cardiorespiratory fitness and muscle strength are related to all-cause and cardiovascular mortality. Both are possibly related to birth weight, but it is unclear what the importance is of genetic, maternal and placental factors in these associations. Design: Peak oxygen uptake and measures of strength, flexibility and balance were obtained yearly during adolescence (10-18 years) in 114 twin pairs in the Leuven Longitudinal Twin Study. Their birth weights had been collected prospectively within the East Flanders Prospective Twin Survey. Results: We identified linear associations between birth weight and adolescent vertical jump (b = 1.96 cm per kg birth weight, P = 0.02), arm pull (b = 1.85 kg per kg birth weight P = 0.03) and flamingo balance (b = -1.82 attempts to stand one minute per kg birth weight, P = 0.03). Maximum oxygen uptake appeared to have a U-shaped association with birth weight (the smallest and largest children had the lowest uptake, P = 0.01), but this association was no longer significant after adjustment for parental BMI. Using the individual twin's deviation from his own twin pair's average birth weight, we found positive associations between birth weight and adolescent vertical jump (b = 3.49, P = 0.0007) and arm pull (b = 3.44, P = 0.02). Delta scores were calculated within the twin pairs as first born twin minus second born twin. Delta birth weight was associated with Delta vertical jump within MZ twin pairs only (b = 2.63, P = 0.009), which indicates importance of placental factors. Conclusions: We found evidence for an association between adolescent physical performance (strength, balance and possibly peak oxygen uptake) and birth weight. The associations with vertical jump and arm pull were likely based on individual, more specifically placental (in the case of vertical jump) factors. Our results should be viewed as hypothesis-generating and need confirmation, but potentially support preventive strategies to optimize birth weight, for example via placental function, to target later fitness and health.	[Touwslager, Robbert N. H.; Mulder, Antonius L. M.; Gerver, Willem J. M.; Zimmermann, Luc J.] Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands; [Touwslager, Robbert N. H.; Mulder, Antonius L. M.; Gerver, Willem J. M.; Zimmermann, Luc J.] Sch Oncol & Dev Biol, Maastricht, Netherlands; [Touwslager, Robbert N. H.; Gielen, Marij; Zeegers, Maurice P.; Stehouwer, Coen D. A.] Nutr & Toxicol Res Inst Maastricht, Maastricht, Netherlands; [Gielen, Marij; Zeegers, Maurice P.] Maastricht Univ, Sect Complex Genet, Dept Genet & Cell Biol, Maastricht, Netherlands; [Tan, Frans E. S.] Maastricht Univ, Dept Methodol & Stat, Maastricht, Netherlands; [Tan, Frans E. S.] Care & Publ Hlth Res Inst, Maastricht, Netherlands; [Houben, Alfons J. H. M.; Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Houben, Alfons J. H. M.; Stehouwer, Coen D. A.] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Derom, Catherine; Vlietinck, Robert] Catholic Univ Louvain, Fac Med, Dept Human Genet, B-3000 Louvain, Belgium; [Thomis, Martine] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Kinesiol, Louvain, Belgium; [Maes, Hermine H.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Human & Mol Genet, Richmond, VA USA	Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University; Universite Catholique Louvain; KU Leuven; Virginia Commonwealth University	Touwslager, RNH (corresponding author), Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands.	bob.touwslager@mumc.nl	Mulder, Antonius/AAJ-5935-2021; Houben, Alfons J/C-1913-2014; Stehouwer, Coen/AAB-3435-2021	Mulder, Antonius/0000-0001-8625-4359; Stehouwer, Coen/0000-0001-8752-3223; Thomis, Martine/0000-0001-9093-2191; Derom, Catherine/0000-0001-5574-796X; Zeegers, Maurice/0000-0002-2387-083X	Fund of Scientific Research, Flanders (Belgium); Marguerite-Marie Delacroix Foundation; Association for Scientific Research in Multiple Births (Belgium); Research Fund KU Leuven [OT/86/80]; Nationale Bank van Belgie; Fund for Medical Research (Belgium) [3.0038.82, 3.0008.90, 3.0098.91]; NATO [860823]; University of Maastricht; University Hospital of Maastricht	Fund of Scientific Research, Flanders (Belgium)(FWO); Marguerite-Marie Delacroix Foundation; Association for Scientific Research in Multiple Births (Belgium); Research Fund KU Leuven(KU Leuven); Nationale Bank van Belgie; Fund for Medical Research (Belgium)(Fonds de la Recherche Scientifique - FNRS); NATO(NATO (North Atlantic Treaty Organisation)); University of Maastricht; University Hospital of Maastricht	Since its origin the East Flanders Prospective Survey has been partly supported by grants from the Fund of Scientific Research, Flanders (Belgium), the Marguerite-Marie Delacroix Foundation, and by the Association for Scientific Research in Multiple Births (Belgium). The Leuven Longitudinal Twin Study was supported by Research Fund KU Leuven (OT/86/80), Nationale Bank van Belgie, Fund for Medical Research (Belgium) (3.0038.82,3.0008.90,3.0098.91), and NATO (860823). The funding sources had no role in the design and conduct of the study, in the collection, analysis and interpretation of the data, or in the preparation, review or approval of the manuscript. RNHT is supported by a Kootstra Fellowship from the University of Maastricht and a 'Profileringsfonds' grant from the University Hospital of Maastricht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C., 1988, EUROFIT HDB EUROFIT; BARKER DJP, 1989, LANCET, V2, P577; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Boreham CA, 2001, PUBLIC HEALTH, V115, P373; BRUCE R A, 1963, Pediatrics, V32, P742; Carlin JB, 2005, INT J EPIDEMIOL, V34, P1089, DOI 10.1093/ije/dyi153; Carnethon MR, 2003, JAMA-J AM MED ASSOC, V290, P3092, DOI 10.1001/jama.290.23.3092; Derom C, 2013, TWIN RES HUM GENET, V16, P58, DOI 10.1017/thg.2012.75; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Ferreira I, 2002, EUR J CLIN INVEST, V32, P723, DOI 10.1046/j.1365-2362.2002.01066.x; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Geithner CA, 2004, MED SCI SPORT EXER, V36, P1616, DOI 10.1249/01.MSS.0000139807.72229.41; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; Grunnet L, 2007, J INTERN MED, V262, P96, DOI 10.1111/j.1365-2796.2007.01793.x; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Inskip HM, 2007, J INTERN MED, V262, P368, DOI 10.1111/j.1365-2796.2007.01812.x; Laaksonen DE, 2003, DIABETES CARE, V26, P2156, DOI 10.2337/diacare.26.7.2156; Lawlor DA, 2008, EUR J EPIDEMIOL, V23, P411, DOI 10.1007/s10654-008-9259-x; Loke YJ, 2013, TWIN RES HUM GENET, V16, P13, DOI 10.1017/thg.2012.114; Loos RJF, 2005, PAEDIATR PERINAT EP, V19, P15, DOI 10.1111/j.1365-3016.2005.00611.x; Martin HJ, 2009, GERONTOLOGY, V55, P186, DOI 10.1159/000174823; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; Ortega FB, 2009, J PEDIATR, V154, P61, DOI 10.1016/j.jpeds.2008.07.041; Poulter NR, 1999, BRIT MED J, V319, P1330, DOI 10.1136/bmj.319.7221.1330; Ridgway CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017955; Ridgway CL, 2009, MED SCI SPORT EXER, V41, P1212, DOI 10.1249/MSS.0b013e31819794ab; Salonen MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022302; SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; Scheet P, 2012, TWIN RES HUM GENET, V15, P737, DOI 10.1017/thg.2012.61; SIMONS J, 1990, HKP SPORT SCI MONOGR, V3, P1; Simons J, 1969, KINANTHROPOLOGIE, V1, P323; Talens RP, 2012, AGING CELL, V11, P694, DOI 10.1111/j.1474-9726.2012.00835.x; Thornburg KL, 2010, PLACENTA, V31, pS54, DOI 10.1016/j.placenta.2010.01.002; Wen XZ, 2011, HYPERTENSION, V57, P48, DOI 10.1161/HYPERTENSIONAHA.110.162792; Yliharsila H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612	38	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76423	10.1371/journal.pone.0076423	http://dx.doi.org/10.1371/journal.pone.0076423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194838	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000017
J	Holfelder, B; Brown, N; Bubeck, D				Holfelder, Benjamin; Brown, Niklas; Bubeck, Dieter			The Influence of Sex, Stroke and Distance on the Lactate Characteristics in High Performance Swimming	PLOS ONE			English	Article							ANALYZING LONGITUDINAL DATA; SKELETAL-MUSCLE; HIGH-INTENSITY; THRESHOLD; GENDER; SWIMMERS; MODELS; SIZE; CELL; MEN	Background: In order to achieve world-class performances, regular performance diagnostics is required as an essential prerequisite for guiding high performance sport. In high performance swimming, the lactate performance diagnostic is an important instrument in testing the sport specific endurance capacity. Although the role of lactate as a signaling molecule, fuel and a gluconeogenic substrate is accepted, lactate parameters are discussed concerning stability, explanatory power and interpretability. Methods: We calculated the individual anaerobic threshold (IAT) of Bunc using the swimming-specific lactate threshold test by Pansold. Results: The cross-sectional analysis (ANOVA) of n = 398 high performance swimmers showed significant effects for sex, stroke and distance on the IAT, the percentage of personal best time on the IAT (% of PB on IAT) and maximal lactate values (max. bLA). For the freestyle events the IAT decreased, % of PB on IAT and max. bLA increased from 100 to 400 m significantly in men and women. Women showed significantly higher % of PB on IAT with descriptive lower IAT in 7 of 8 analyzed events. Men showed significantly higher max. bLA in 5 of 8 events. In the second step, the analysis of 1902 data sets of these 398 athletes with a multi-level analysis (MLA) showed also significant effects for sex, swimming distance and stroke. For initial status and development over time, the effect sizes for the variables distance and sex were medium to large, whereas for stroke there were no or small effect sizes. Discussion: These significant results suggest that lactate tests in swimming specifically have to consider the lactate affecting factors sex and distance under consideration of the time period between measurements. Anthropometrical factors and the physiology of women are possible explanations for the relative better performance for lower lactate concentrations compared to men.	[Holfelder, Benjamin; Brown, Niklas; Bubeck, Dieter] Univ Stuttgart, Dept Sport & Exercise Sci, D-70174 Stuttgart, Germany	University of Stuttgart	Holfelder, B (corresponding author), Univ Stuttgart, Dept Sport & Exercise Sci, D-70174 Stuttgart, Germany.	benjamin.holfelder@inspo.uni-stuttgart.de			German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) within the funding programme Open Access Publishing. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2011, SCAND J MED SCI SPOR, V21, pE298, DOI 10.1111/j.1600-0838.2010.01283.x; Baar K, 2010, ACTA PHYSIOL, V199, P477, DOI 10.1111/j.1748-1716.2010.02121.x; Barbosa TM, 2006, INT J SPORTS MED, V27, P894, DOI 10.1055/s-2006-923776; Barbosa TM, 2008, EUR J APPL PHYSIOL, V103, P139, DOI 10.1007/s00421-008-0676-z; Barbosa TM, 2012, J HUM KINET, V32, P21, DOI 10.2478/v10078-012-0020-x; Barbosa TM, 2010, J SCI MED SPORT, V13, P262, DOI 10.1016/j.jsams.2009.01.003; Beneke R, 2011, INT J SPORT PHYSIOL, V6, P8, DOI 10.1123/ijspp.6.1.8; Bosquet L, 2001, EUR J APPL PHYSIOL, V84, P107, DOI 10.1007/s004210000343; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Bunc V, 1985, ACTA U CAROLINAE GYM, V21, P73; Capelli C, 1998, EUR J APPL PHYSIOL, V78, P385, DOI 10.1007/s004210050435; Caspersen C, 2010, J BIOMECH, V43, P2369, DOI 10.1016/j.jbiomech.2010.04.022; Chatard J-C, 2011, WORLD BOOK SWIMMING, P359; CHATTERJEE S, 1995, SOC BIOL, V42, P124; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cormie P, 2011, SPORTS MED, V41, P125, DOI 10.2165/11538500-000000000-00000; Cormie P, 2011, SPORTS MED, V41, P17, DOI 10.2165/11537690-000000000-00000; Crewther B, 2006, SPORTS MED, V36, P215, DOI 10.2165/00007256-200636030-00004; Dekerle J, 2011, WORLD BOOK SWIMMING, P277; Di Michele R, 2012, J STRENGTH COND RES, V26, P3059, DOI 10.1519/JSC.0b013e318245bde1; Faude O, 2009, SPORTS MED, V39, P469, DOI 10.2165/00007256-200939060-00003; Freitag W, 2000, SCHWIMMEN LERNEN OPT, V17, P168; Gladden LB, 2008, MED SCI SPORT EXER, V40, P477, DOI [10.1249/mss.0b013e31815fa580, 10.1249/MSS.0b013e31815fa580]; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Guzun R, 2010, INT J MOL SCI, V11, P982, DOI 10.3390/ijms11030982; Harridge SDR, 2007, EXP PHYSIOL, V92, P783, DOI 10.1113/expphysiol.2006.036525; Holfelder B, 2012, SCHWEIZ Z SPORTMED S, V60, P32; Hoppeler H, 2011, COMPREHENSIVE PHYSL; Issurin VB, 2001, J SPORT MED PHYS FIT, V41, P433; Kiely J, 2012, INT J SPORT PHYSIOL, V7, P242, DOI 10.1123/ijspp.7.3.242; Koulmann N, 2006, PFLUG ARCH EUR J PHY, V452, P125, DOI 10.1007/s00424-005-0030-9; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Laursen PB, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01184.x; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Meckel Y, 2012, J STRENGTH COND RES, V26, P3426, DOI 10.1519/JSC.0b013e3182473df3; Mujika I., 2011, WORLD BOOK SWIMMING, P203; Olbrecht J, 2011, WORLD BOOK SWIMMING, P255; Onodera S, 1999, BIOMECHANICS MED SWI, VVIII, P355; Pansold B, 1994, STELLENWERT LAKTATBE, P47; Philp A, 2005, J EXP BIOL, V208, P4561, DOI 10.1242/jeb.01961; Pyne DB, 2001, MED SCI SPORT EXER, V33, P291; Rodriguez FA, 2011, WORLD BOOK SWIMMING, P225; Rudolph K, 2000, SCHWIMMEN LERNEN OPT, V17, P33; Sanders RH, 2011, WORLD BOOK SWIMMING, P191; SAWKA MN, 1979, EUR J APPL PHYSIOL O, V41, P93, DOI 10.1007/BF00421656; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Seifert L, 2011, WORLD BOOK SWIMMING, P135; Seiler KS, 2006, SCAND J MED SCI SPOR, V16, P49, DOI 10.1111/j.1600-0838.2004.00418.x; Skorski S, 2012, J STRENGTH COND RES, V26, P3304, DOI 10.1519/JSC.0b013e31824b6014; Stanula A, 2012, J HUM KINET, V32, P97, DOI 10.2478/v10078-012-0027-3; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; Thibault V, 2010, J SPORT SCI MED, V9, P214; Toigo M, 2006, EUR J APPL PHYSIOL, V97, P643, DOI 10.1007/s00421-006-0238-1; van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0; Vescovi JD, 2011, INT J SPORT PHYSIOL, V6, P106, DOI 10.1123/ijspp.6.1.106; Vilas-Boas J.P., 2011, WORLD BOOK SWIMMING, P119; West BT, 2009, EVAL HEALTH PROF, V32, P207, DOI 10.1177/0163278709338554; Zamparo P, 1996, SCAND J MED SCI SPOR, V6, P273, DOI 10.1111/j.1600-0838.1996.tb00470.x	59	11	11	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77185	10.1371/journal.pone.0077185	http://dx.doi.org/10.1371/journal.pone.0077185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167563	gold, Green Published			2022-12-27	WOS:000326034500022
J	Liu, JH; Guo, LX; Yin, F; Zhang, YL; Liu, ZX; Wang, YW				Liu, Jianhui; Guo, Lixia; Yin, Fei; Zhang, Yonglan; Liu, Zixuan; Wang, Yanwen			Geniposide Regulates Glucose-Stimulated Insulin Secretion Possibly through Controlling Glucose Metabolism in INS-1 Cells	PLOS ONE			English	Article							PEPTIDE-1 RECEPTOR PLAYS; PYRUVATE-CARBOXYLASE; PANCREATIC-ISLETS; BETA-CELLS; DIABETIC MICE; MALIC ENZYME; PC12 CELLS; RESISTANCE; GLUCOTOXICITY; ANAPLEROSIS	Glucose-stimulated insulin secretion (GSIS) is essential to the control of metabolic fuel homeostasis. The impairment of GSIS is a key element of beta-cell failure and one of causes of type 2 diabetes mellitus (T2DM). Although the K-ATP channel-dependent mechanism of GSIS has been broadly accepted for several decades, it does not fully describe the effects of glucose on insulin secretion. Emerging evidence has suggested that other mechanisms are involved. The present study demonstrated that geniposide enhanced GSIS in response to the stimulation of low or moderately high concentrations of glucose, and promoted glucose uptake and intracellular ATP levels in INS-1 cells. However, in the presence of a high concentration of glucose, geniposide exerted a contrary role on both GSIS and glucose uptake and metabolism. Furthermore, geniposide improved the impairment of GSIS in INS-1 cells challenged with a high concentration of glucose. Further experiments showed that geniposide modulated pyruvate carboxylase expression and the production of intermediates of glucose metabolism. The data collectively suggest that geniposide has potential to prevent or improve the impairment of insulin secretion in beta-cells challenged with high concentrations of glucose, likely through pyruvate carboxylase mediated glucose metabolism in beta-cells.	[Liu, Jianhui; Guo, Lixia; Yin, Fei; Zhang, Yonglan; Liu, Zixuan] Chongqing Technol & Business Univ, Chongqing Key Lab Catalysis & Funct Organ Mol, Chongqing, Peoples R China; [Liu, Jianhui; Guo, Lixia; Yin, Fei; Zhang, Yonglan; Liu, Zixuan] Chongqing Technol & Business Univ, Chongqing Key Lab Nat Med Res, Chongqing, Peoples R China; [Liu, Jianhui; Yin, Fei; Wang, Yanwen] Natl Res Council Canada, Charlottetown, PE, Canada; [Zhang, Yonglan] Chongqing Univ, Coll Chem & Chem Engn, Chongqing 630044, Peoples R China	Chongqing Technology & Business University; Chongqing Technology & Business University; National Research Council Canada; Chongqing University	Liu, JH (corresponding author), Chongqing Technol & Business Univ, Chongqing Key Lab Catalysis & Funct Organ Mol, Chongqing, Peoples R China.	jhliu@ctbu.edu.cn	Liu, Jianhui/X-6679-2019		National Natural Science Foundation of China [30973576]; Chongqing Science & Technology committee (CSTC) [2012jjB10033, 2011jjA1396]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science & Technology committee (CSTC)	This work was supported by grants from National Natural Science Foundation of China (30973576) and Chongqing Science & Technology committee (CSTC, 2012jjB10033, 2011jjA1396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Asghar Z, 2006, DIABETOLOGIA, V49, P90, DOI 10.1007/s00125-005-0045-y; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Buchanan Thomas A., 2003, Clinical Therapeutics, V25, pB32, DOI 10.1016/S0149-2918(03)80241-2; Chang-Chen KJ, 2008, REV ENDOCR METAB DIS, V9, P329, DOI 10.1007/s11154-008-9101-5; Conget I, 2001, MED CLIN-BARCELONA, V116, P491, DOI 10.1016/S0025-7753(01)71882-9; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fex M, 2007, DIABETOLOGIA, V50, P74, DOI 10.1007/s00125-006-0464-4; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; Grassiolli S, 2006, ENDOCRINE, V30, P191, DOI 10.1385/ENDO:30:2:191; Guo LX, 2012, ACTA PHARMACOL SIN, V33, P237, DOI 10.1038/aps.2011.146; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Heart E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1354, DOI 10.1152/ajpendo.90836.2008; Hollingdal M, 2000, DIABETES, V49, P1334, DOI 10.2337/diabetes.49.8.1334; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jitrapakdee S, 2006, CELL MOL LIFE SCI, V63, P843, DOI 10.1007/s00018-005-5410-y; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kaiser N, 2003, J PEDIATR ENDOCR MET, V16, P5, DOI 10.1515/JPEM.2003.16.1.5; Khaldi MZ, 2004, AM J PHYSIOL-ENDOC M, V287, pE207, DOI 10.1152/ajpendo.00426.2003; Kojima K, 2011, BIOL PHARM BULL, V34, P1613, DOI 10.1248/bpb.34.1613; Koster JC, 2005, DIABETES, V54, P3065, DOI 10.2337/diabetes.54.11.3065; Leibowitz G, 2001, DIABETES, V50, pS113, DOI 10.2337/diabetes.50.2007.S113; Li CH, 2008, J BIOL CHEM, V283, P17238, DOI 10.1074/jbc.M709235200; Liu JH, 2012, DIABET MED IN PRESS; Liu JH, 2009, ACTA PHARMACOL SIN, V30, P159, DOI 10.1038/aps.2008.25; Liu JH, 2007, NEUROCHEM INT, V51, P361, DOI 10.1016/j.neuint.2007.04.021; Liu JH, 2006, INT J DEV NEUROSCI, V24, P419, DOI 10.1016/j.ijdevneu.2006.08.009; Liu JH, 2012, TOXICOL IN VITRO, V26, P1093, DOI 10.1016/j.tiv.2012.07.004; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; MacDonald MJ, 2011, J BIOL CHEM, V286, P18383, DOI 10.1074/jbc.M111.241182; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; MACDONALD MJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P128, DOI 10.1006/abbi.1995.1274; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald MJ, 1996, DIABETES, V45, P1626, DOI 10.2337/diabetes.45.11.1626; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Newgard CB, 2002, DIABETES, V51, pS389, DOI 10.2337/diabetes.51.2007.S389; Nolan CJ, 2006, DIABETOLOGIA, V49, P2120, DOI 10.1007/s00125-006-0305-5; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Prentki M, 1996, EUR J ENDOCRINOL, V134, P272, DOI 10.1530/eje.0.1340272; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Smith AJ, 2006, BIOCHEM BIOPH RES CO, V348, P1123, DOI 10.1016/j.bbrc.2006.07.170; Spacek T, 2008, INT J BIOCHEM CELL B, V40, P1522, DOI 10.1016/j.biocel.2007.11.015; TAL M, 1992, P NATL ACAD SCI USA, V89, P5744, DOI 10.1073/pnas.89.13.5744; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Wu SY, 2009, ACTA PHARMACOL SIN, V30, P202, DOI 10.1038/aps.2008.17; Yin F, 2010, BIOL PHARM BULL, V33, P1841, DOI 10.1248/bpb.33.1841; Yin F, 2010, ACTA PHARMACOL SIN, V31, P540, DOI 10.1038/aps.2010.28	52	15	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78315	10.1371/journal.pone.0078315	http://dx.doi.org/10.1371/journal.pone.0078315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167617	Green Published, gold, Green Submitted			2022-12-27	WOS:000326034500078
J	Ramaswami, G; Sukumar, R				Ramaswami, Geetha; Sukumar, Raman			Long-Term Environmental Correlates of Invasion by Lantana camara (Verbenaceae) in a Seasonally Dry Tropical Forest	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; PLANT INVASIONS; SUCCESS; DISTURBANCE; MANAGEMENT; GRASSES; ECOLOGY	Invasive species, local plant communities and invaded ecosystems change over space and time. Quantifying this change may lead to a better understanding of the ecology and the effective management of invasive species. We used data on density of the highly invasive shrub Lantana camara (lantana) for the period 1990-2008 from a 50 ha permanent plot in a seasonally dry tropical forest of Mudumalai in southern India. We used a cumulative link mixed-effects regression approach to model the transition of lantana from one qualitative density state to another as a function of biotic factors such as indicators of competition from local species (lantana itself, perennial grasses, invasive Chromolaena odorata, the native shrub Helicteres isora and basal area of native trees) and abiotic factors such as fire frequency, inter-annual variability of rainfall and relative soil moisture. The density of lantana increased substantially during the study period. Lantana density was negatively associated with the density of H. isora, positively associated with basal area of native trees, but not affected by the presence of grasses or other invasive species. In the absence of fire, lantana density increased with increasing rainfall. When fires occurred, transitions to higher densities occurred at low rainfall values. In drier regions, lantana changed from low to high density as rainfall increased while in wetter regions of the plot, lantana persisted in the dense category irrespective of rainfall. Lantana seems to effectively utilize resources distributed in space and time to its advantage, thus outcompeting local species and maintaining a population that is not yet self-limiting. High-risk areas and years could potentially be identified based on inferences from this study for facilitating management of lantana in tropical dry forests.	[Ramaswami, Geetha; Sukumar, Raman] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Sukumar, Raman] Indian Inst Sci, Divecha Ctr Climate Change, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Sukumar, R (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	rsuku@ces.iisc.ernet.in	Raman, Sukumar/C-9809-2013		Ministry of Environment and Forests, Government of India	Ministry of Environment and Forests, Government of India(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of India)	The Ministry of Environment and Forests, Government of India has funded this project since 1989. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu Suresh, 2009, Ecological Restoration, V27, P467, DOI 10.3368/er.27.4.467; Banasiak SE, 2009, BIOL INVASIONS, V11, P215, DOI 10.1007/s10530-008-9226-1; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Bhagwat SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032407; Blossey B., 1999, Biological Invasions, V1, P301, DOI 10.1023/A:1010084724526; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Buckley YM, 2003, J APPL ECOL, V40, P481, DOI 10.1046/j.1365-2664.2003.00821.x; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Castillo JM, 2007, BIODIVERS CONSERV, V16, P2123, DOI 10.1007/s10531-006-9131-9; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Cleverly JR, 1997, OECOLOGIA, V111, P12, DOI 10.1007/s004420050202; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Duggin JA, 1998, FOREST ECOL MANAG, V109, P279, DOI 10.1016/S0378-1127(98)00252-7; Eagan JS, 1911, NILGIRI GUIDE DIRECT; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Hiremath A.J., 2005, CONSERV SOC, V1, P26; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kulmatiski A, 2006, PLANT ECOL, V187, P261, DOI 10.1007/s11258-006-9140-5; Mandle L, 2011, BIOL INVASIONS, V13, P1815, DOI 10.1007/s10530-011-0001-3; Meekins JF, 2001, ECOL APPL, V11, P1336, DOI 10.2307/3060924; Melbourne BA, 2007, ECOL LETT, V10, P77, DOI 10.1111/j.1461-0248.2006.00987.x; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Moles AT, 2012, J ECOL, V100, P116, DOI 10.1111/j.1365-2745.2011.01915.x; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Prasad AE, 2012, J TROP ECOL, V28, P55, DOI 10.1017/S0266467411000563; Raizada P, 2008, CURR SCI INDIA, V94, P180; Ramaswami G, 2013, PLANT ECOL, V214, P397, DOI 10.1007/s11258-013-0177-y; Sharma GR, 2005, WEED BIOL MANAG, V5, P157, DOI 10.1111/j.1445-6664.2005.00178.x; Stevens JT, 2009, NEW PHYTOL, V184, P365, DOI 10.1111/j.1469-8137.2009.02965.x; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Sundaram B, 2012, BIOL INVASIONS, V14, P1127, DOI 10.1007/s10530-011-0144-2; Suresh H.S., 2011, ECOLOGY CONSERVATION, P37; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Thomsen MA, 2006, PLANT ECOL, V186, P23, DOI 10.1007/s11258-006-9109-4; Totland O, 2005, FOREST ECOL MANAG, V215, P329, DOI 10.1016/j.foreco.2005.05.023; van Wilgen NJ, 2011, DIVERS DISTRIB, V17, P172, DOI 10.1111/j.1472-4642.2010.00717.x	44	18	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76995	10.1371/journal.pone.0076995	http://dx.doi.org/10.1371/journal.pone.0076995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167555	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326034500014
J	Shen, B; Zhang, X; Du, YN; Wang, JY; Gong, J; Zhang, XD; Tate, PH; Li, HL; Huang, XX; Zhang, WS				Shen, Bin; Zhang, Xin; Du, Yinan; Wang, Jianying; Gong, Jun; Zhang, Xiaodong; Tate, Peri H.; Li, Hongliang; Huang, Xingxu; Zhang, Wensheng			Efficient Knockin Mouse Generation by ssDNA Oligonucleotides and Zinc-Finger Nuclease Assisted Homologous Recombination in Zygotes	PLOS ONE			English	Article							TARGETED GENE DISRUPTION; EMBRYO MICROINJECTION; MAMMALIAN-CELLS; DISEASE-MODELS; ZEBRAFISH; TALENS; MUTATIONS; SYSTEM; ZIFIT; RATS	The generation of specific mutant animal models is critical for functional analysis of human genes. The conventional gene targeting approach in embryonic stem cells (ESCs) by homologous recombination is however laborious, slow, expensive, and limited to species with functional ESCs. It is therefore a long-sought goal to develop an efficient and simple alternative gene targeting strategy. Here we demonstrate that, by combining an efficient ZFN pair and ssODN, a restriction site and a loxP site were successfully introduced into a specific genomic locus. A targeting efficiency up to 22.22% was achieved by coinciding the insertion site and the ZFN cleavage site isogenic and keeping the length of the homology arms equal and isogenic to the endogenous target locus. Furthermore, we determine that ZFN and ssODN-assisted HR is ssODN homology arm length dependent. We further show that mutant alleles generated by ZFN and ssODN-assisted HR can be transmitted through the germline successfully. This study establishes an efficient gene targeting strategy by ZFN and ssODN-assisted HR in mouse zygotes, and provides a potential avenue for genome engineering in animal species without functional ES cell lines.	[Shen, Bin; Du, Yinan; Wang, Jianying; Huang, Xingxu] Nanjing Univ, Natl Resource Ctr Mutant Mice, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Xin; Gong, Jun; Zhang, Xiaodong; Li, Hongliang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Tate, Peri H.; Zhang, Wensheng] Wellcome Trust Sanger Inst, Cambridge, England	Nanjing University; Wuhan University; Wellcome Trust Sanger Institute	Huang, XX (corresponding author), Nanjing Univ, Natl Resource Ctr Mutant Mice, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210008, Jiangsu, Peoples R China.	wz1@sanger.ac.uk; xingxuhuang@mail.nju.edu.cn	Du, Yinan/GPK-0826-2022; Shen, Bin/ABD-5084-2021	Du, Yinan/0000-0002-7678-7546; Shen, Bin/0000-0002-8946-8448; huang, xingxu/0000-0001-8934-1247	973 program [2009CB918703]	973 program(National Basic Research Program of China)	This work was supported by grants from the 973 program (2009CB918703)(http://www.973.gov.cn/English/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Dow LE, 2012, CELL, V148, P1099, DOI 10.1016/j.cell.2012.02.023; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Meyer M, 2012, P NATL ACAD SCI USA, V109, P9354, DOI 10.1073/pnas.1121203109; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	35	12	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77696	10.1371/journal.pone.0077696	http://dx.doi.org/10.1371/journal.pone.0077696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167580	gold, Green Published, Green Submitted			2022-12-27	WOS:000326034500039
J	Wu, ML; Huang, Z; Xie, HJ; Zhou, ZJ				Wu, Muli; Huang, Zheng; Xie, Haojun; Zhou, Zhongjiang			Nicorandil in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							LONG-TERM OUTCOMES; INTRAVENOUS NICORANDIL; REPERFUSION INJURY; ANGIOPLASTY; FLOW; PREDICTOR; IMPACT; TIMI	Background: Nicorandil, as an adjunctive therapy with primary percutaneous coronary intervention (PCI), had controversial benefits in cardioprotection in patients with acute myocardial infarction (AMI). Methods and Results: We performed a systematic review of randomized controlled trials (RCTs) comparing treatment with nicorandil prior to reperfusion therapy with control (placebo or no nicorandil) in patients who suffered from AMI and performed primary PCI. PubMed, EMBASE and CENTRAL databases and other sources were searched without language and publication restriction. 14 trials involving 1680 patients were included into this meta-analysis. Nicorandil significantly reduced the incidence of thrombolysis in myocardial infarction (TIMI) flow grade <= 2 (risk ratio [RR], 0.57; 95% confidence interval [CI]: 0.42 to 0.79), the Timi frame count (TFC) (mean difference [MD], -5.19; 95% CI: -7.13 to -3.26), increased left ventricular ejection fraction (LVEF) (%) (MD, 3.08; 95% CI: 0.79 to 5.36), and reduced the incidence of ventricular arrhythmia (RR, 0.53; 95% CI: 0.37 to 0.76) and congestive heart failure (CHF) (RR, 0.41; 95% CI: 0.22 to 0.75). No difference in the pear creatine kinase (CK) value (MD, -290.19; 95% CI: -793.75 to 213.36) or cardiac death (RR, 0.39; 95% CI: 0.09 to 1.67) was observed. Conclusions: Nicorandil prior to reperfusion is associated with improvement of coronary reflow as well as suppression of ventricular arrhythmia, and further improves left ventricular function in patients who suffered from AMI and underwent primary PCI. But the definite clinical benefits of nicorandil were not found, which may be due to the small sample size of the selected studies.	[Wu, Muli; Huang, Zheng; Zhou, Zhongjiang] Southern Med Univ, Nanfang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Xie, Haojun] Southern Med Univ, Nanfang Hosp, Dept Resp & Crit Care Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Huang, Z (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	drhuangzheng@163.com						Akagi T, 2006, INT HEART J, V47, P351, DOI 10.1536/ihj.47.351; AKAI K, 1995, J CARDIOVASC PHARM, V26, P541, DOI 10.1097/00005344-199510000-00006; [Anonymous], 1988, LANCET, V2, P349; Atsuchi N, 2007, J AM COLL CARDIOL, V49, p215A; Betriu A, 1997, NEW ENGL J MED, V336, P1621; Fujiwara T, 2007, HEART VESSELS, V22, P303, DOI 10.1007/s00380-007-0975-z; Fukuzawa S, 2000, J NUCL CARDIOL, V7, P447, DOI 10.1067/mnc.2000.107273; Gibson CM, 2002, CIRCULATION, V105, P1909, DOI 10.1161/01.CIR.0000014683.52177.B5; GROSS G, 1989, AM J CARDIOL, V63, pJ11, DOI 10.1016/0002-9149(89)90199-9; Hayat SA, 2008, EUR HEART J, V29, P299, DOI 10.1093/eurheartj/ehm621; HIGGINS JPT, 2011, COCHRANE COLLABORATI, V2011, P182; Imagawa J, 1998, J CARDIOVASC PHARM, V31, P74, DOI 10.1097/00005344-199801000-00011; Ishii H, 2005, CIRCULATION, V112, P1284, DOI 10.1161/CIRCULATIONAHA.104.530329; Ishii H, 2004, CIRCULATION, V110, P106; Ishii H, 2007, AM J CARDIOL, V99, P1203, DOI 10.1016/j.amjcard.2006.12.034; Ito H, 1999, J AM COLL CARDIOL, V33, P654, DOI 10.1016/S0735-1097(98)00604-4; ITO H, 1992, CIRCULATION, V85, P1699, DOI 10.1161/01.CIR.85.5.1699; Kawai Y, 2009, EUR HEART J, V30, P765, DOI 10.1093/eurheartj/ehp077; Kitakaze M, 2007, LANCET, V370, P1483, DOI 10.1016/S0140-6736(07)61634-1; KLONER RA, 1993, J AM COLL CARDIOL, V21, P537, DOI 10.1016/0735-1097(93)90700-B; Lee HC, 2008, CIRC J, V72, P1425, DOI 10.1253/circj.CJ-08-0212; LIM YJ, 1994, AM HEART J, V128, P649, DOI 10.1016/0002-8703(94)90260-7; Miyazawa Akiyoshi, 2006, EuroIntervention, V2, P211; Monassier JP, 2008, ARCH CARDIOVASC DIS, V101, P565, DOI 10.1016/j.acvd.2008.06.013; Morishima I, 2000, J AM COLL CARDIOL, V36, P1202, DOI 10.1016/S0735-1097(00)00865-2; Nameki M, 2004, CIRC J, V68, P192; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Niccoli G, 2013, JACC-CARDIOVASC INTE, V6, P580, DOI 10.1016/j.jcin.2013.02.009; Nicolosi GL, 1996, EUR HEART J, V17, P1646; Ono H, 2004, AM HEART J, V148, DOI 10.1016/j.ahj.2004.05.014; Ota S, 2006, CIRC J, V70, P1099, DOI 10.1253/circj.70.1099; Ozcan C, 2002, AM J PHYSIOL-HEART C, V282, pH531, DOI 10.1152/ajpheart.00552.2001; PIEPER GM, 1992, CARDIOVASC DRUG THER, V6, P225, DOI 10.1007/BF00051143; ROBINSON AJ, 2013, BMJ-BRIT MED J, V347, P4295, DOI DOI 10.1136/BMJ.F4295.PUBMED:23861409; Smith VM, 2013, BRIT J DERMATOL, V168, P1136, DOI 10.1111/bjd.12199; Suematsu Y, 2013, CARDIOVASC INTERV TH, V28, P352, DOI 10.1007/s12928-013-0182-z; Sugimoto K, 2003, CIRC J, V67, P295; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Takahashi K, 2000, J CARDIOVASC PHARM, V36, P417, DOI 10.1097/00005344-200010000-00001; Toyama T, 2006, ANN NUCL MED, V20, P277, DOI 10.1007/BF02984644; Yasu T, 2002, J CARDIOVASC PHARM, V40, P684, DOI 10.1097/00005344-200211000-00006	41	26	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78231	10.1371/journal.pone.0078231	http://dx.doi.org/10.1371/journal.pone.0078231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167609	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500069
J	Chao, DL; Longini, IM; Halloran, ME				Chao, Dennis L.; Longini, Ira M., Jr.; Halloran, M. Elizabeth			The Effects of Vector Movement and Distribution in a Mathematical Model of Dengue Transmission	PLOS ONE			English	Article							SPACE-TIME ANALYSIS; AEDES-AEGYPTI; VIRUS TRANSMISSION; PUERTO-RICO; VACCINES; PATTERN; DISPERSAL; EFFICACY; IMMUNITY	Background: Mathematical models have been used to study the dynamics of infectious disease outbreaks and predict the effectiveness of potential mass vaccination campaigns. However, models depend on simplifying assumptions to be tractable, and the consequences of making such assumptions need to be studied. Two assumptions usually incorporated by mathematical models of vector-borne disease transmission is homogeneous mixing among the hosts and vectors and homogeneous distribution of the vectors. Methodology/Principal Findings: We explored the effects of mosquito movement and distribution in an individual-based model of dengue transmission in which humans and mosquitoes are explicitly represented in a spatial environment. We found that the limited flight range of the vector in the model greatly reduced its ability to transmit dengue among humans. A model that does not assume a limited flight range could yield similar attack rates when transmissibility of dengue was reduced by 39%. A model in which mosquitoes are distributed uniformly across locations behaves similarly to one in which the number of mosquitoes per location is drawn from an exponential distribution with a slightly higher mean number of mosquitoes per location. When the models with different assumptions were calibrated to have similar human infection attack rates, mass vaccination had nearly identical effects. Conclusions/Significance: Small changes in assumptions in a mathematical model of dengue transmission can greatly change its behavior, but estimates of the effectiveness of mass dengue vaccination are robust to some simplifying assumptions typically made in mathematical models of vector-borne disease.	[Chao, Dennis L.; Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Ctr Stat & Quantitat Infect Dis, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Longini, Ira M., Jr.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL USA; [Longini, Ira M., Jr.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Halloran, M. Elizabeth] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Washington; University of Washington Seattle	Chao, DL (corresponding author), Fred Hutchinson Canc Res Ctr, Ctr Stat & Quantitat Infect Dis, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	dchao@fhcrc.org		Chao, Dennis/0000-0002-8253-6321	National Institute of General Medical Sciences [U01-GM070749]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences grant U01-GM070749. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study	Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103; Aldstadt J, 2012, TROP MED INT HEALTH, V17, P1076, DOI 10.1111/j.1365-3156.2012.03040.x; Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085; Beatty M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001450; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chao DL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001876; CIESIN, 2004, GLOB RUR URB MAPP PR; Coudeville L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051244; Douglas DL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002127; Durbin AP, 2011, VIRUSES-BASEL, V3, P1800, DOI 10.3390/v3101800; Dussart P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001482; Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; HALLORAN ME, 1992, AM J EPIDEMIOL, V136, P328, DOI 10.1093/oxfordjournals.aje.a116498; Halloran ME., 2010, DESIGN ANAL VACCINE; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Johansson MA, 2011, VACCINE, V29, P5860, DOI 10.1016/j.vaccine.2011.06.042; Konishi Eiji, 2011, Trop Med Health, V39, P63, DOI 10.2149/tmh.2011-S01; Liew C, 2004, MED VET ENTOMOL, V18, P351, DOI 10.1111/j.0269-283X.2004.00517.x; LIKOSKY WH, 1973, AM J EPIDEMIOL, V97, P264, DOI 10.1093/oxfordjournals.aje.a121508; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Minnesota Population Center, 2011, INT PUBL US MICR SER; Morrison AC, 1998, AM J TROP MED HYG, V58, P287, DOI 10.4269/ajtmh.1998.58.287; Padmanabha H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001799; Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921; Ross R, 1916, P R SOC LOND A-CONTA, V92, P204, DOI 10.1098/rspa.1916.0007; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Teurlai M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001957; Tsuda Y, 2001, J MED ENTOMOL, V38, P93, DOI 10.1603/0022-2585-38.1.93; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103; Xu CG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000830; Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730; Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357	37	20	20	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76044	10.1371/journal.pone.0076044	http://dx.doi.org/10.1371/journal.pone.0076044			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204590	gold, Green Published, Green Submitted			2022-12-27	WOS:000326032600005
J	Berry, JA; Hood, WM; Pietravalle, S; Delaplane, KS				Berry, Jennifer A.; Hood, W. Michael; Pietravalle, Stephane; Delaplane, Keith S.			Field-Level Sublethal Effects of Approved Bee Hive Chemicals on Honey Bees (Apis mellifera L)	PLOS ONE			English	Article							COLONY COLLAPSE DISORDER; VARROA-DESTRUCTOR; HYMENOPTERA; MITICIDES; COUMAPHOS; APIDAE; INFESTATION; FLUVALINATE; PESTICIDES; JACOBSONI	In a study replicated across two states and two years, we tested the sublethal effects on honey bees of the miticides Apistan (tau fluvalinate) and Check Mite+ (coumaphos) and the wood preservative copper naphthenate applied at label rates in field conditions. A continuous covariate, a colony Varroa mite index, helped us disambiguate the effects of the chemicals on bees while adjusting for a presumed benefit of controlling mites. Mite levels in colonies treated with Apistan or Check Mite+ were not different from levels in non-treated controls. Experimental chemicals significantly decreased 3-day brood survivorship and increased construction of queen supercedure cells compared to non-treated controls. Bees exposed to Check Mite+ as immatures had higher legacy mortality as adults relative to non-treated controls, whereas bees exposed to Apistan had improved legacy mortality relative to non-treated controls. Relative to non-treated controls, Check Mite+ increased adult emergence weight. Although there was a treatment effect on a test of associative learning, it was not possible to statistically separate the treatment means, but bees treated with Apistan performed comparatively well. And finally, there were no detected effects of bee hive chemical on colony bee population, amount of brood, amount of honey, foraging rate, time required for marked released bees to return to their nest, percentage of released bees that return to the nest, and colony Nosema spore loads. To our knowledge, this is the first study to examine sublethal effects of bee hive chemicals applied at label rates under field conditions while disambiguating the results from mite control benefits realized from the chemicals. Given the poor performance of the miticides at reducing mites and their inconsistent effects on the host, these results defend the use of bee health management practices that minimize use of exotic hive chemicals.	[Berry, Jennifer A.; Delaplane, Keith S.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Hood, W. Michael] Clemson Univ, Sch Agr Forest & Environm Sci, Clemson, SC USA; [Pietravalle, Stephane] Food & Environm Res Agcy, Sand Hutton, N Yorkshire, England	University System of Georgia; University of Georgia; Clemson University; Food & Environment Research Agency	Delaplane, KS (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	ksd@uga.edu	Delaplane, Keith/AAN-5197-2021	Delaplane, Keith/0000-0001-9323-441X	United States Department of Agriculture, Cooperative States Research and Education Service, Critical Issues Initiative [2008-37610-18834]	United States Department of Agriculture, Cooperative States Research and Education Service, Critical Issues Initiative	This research was funded by a primary contract (no. 2008-37610-18834) awarded to Clemson University by the United States Department of Agriculture, Cooperative States Research and Education Service, Critical Issues Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Charles I., 2011, P25; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; BURGETT M, 1985, J ECON ENTOMOL, V78, P1154, DOI 10.1093/jee/78.5.1154; Burley LM, 2008, J ECON ENTOMOL, V101, P1081, DOI 10.1603/0022-0493(2008)101[1081:SOHBHA]2.0.CO;2; BUTLER C. G., 1957, INSECTES SOCIAUX, V4, P211, DOI 10.1007/BF02222154; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; COX DR, 1972, J R STAT SOC B, V34, P187; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; DEJONG D, 1982, J APICULT RES, V21, P165, DOI 10.1080/00218839.1982.11100535; DOULL KM, 1965, J INVERTEBR PATHOL, V7, P1, DOI 10.1016/0022-2011(65)90143-6; Elzen PJ, 2000, APIDOLOGIE, V31, P437, DOI 10.1051/apido:2000134; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Hardin JW, 2012, GEN ESTIMATING EQUAT; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kralj J, 2006, APIDOLOGIE, V37, P577, DOI 10.1051/apido:2006040; Locke B, 2012, APPL ENVIRON MICROB, V78, P227, DOI 10.1128/AEM.06094-11; Mariani Fernando, 2012, Zootecnia Trop., V30, P081; McCullagh P, 1989, GEN LINEAR MODELS; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Murilhas AM, 2002, APIDOLOGIE, V33, P271, DOI 10.1051/apido:2002013; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Pettis JS, 2004, APIDOLOGIE, V35, P605, DOI 10.1051/apido:2004056; Pettis JS, 2004, APIDOLOGIE, V35, P91, DOI 10.1051/apido:2003060; Picard-Nizou AL, 1997, J ECON ENTOMOL, V90, P1710, DOI 10.1093/jee/90.6.1710; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Rinderer TE, 1999, AM BEE J, V139, P134; Shimanuki H, 2000, USDA HDB, VAH-690, P61; Skinner JA, 2001, J APICULT RES, V40, P81, DOI 10.1080/00218839.2001.11101055; SMITH BH, 1991, J EXP BIOL, V161, P367; Teeters BS, 2012, ENVIRON TOXICOL CHEM, V31, P1349, DOI 10.1002/etc.1830; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; VSN International, 2012, GENSTAT WINDOWS; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720	39	47	49	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76536	10.1371/journal.pone.0076536	http://dx.doi.org/10.1371/journal.pone.0076536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204638	Green Published, gold			2022-12-27	WOS:000326029300035
J	Clausen, FB; Jakobsen, TR; Rieneck, K; Krog, GR; Nielsen, LK; Tabor, A; Dziegiel, MH				Clausen, Frederik Banch; Jakobsen, Tanja Roien; Rieneck, Klaus; Krog, Grethe Risum; Nielsen, Leif Kofoed; Tabor, Ann; Dziegiel, Morten Hanefeld			Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD	PLOS ONE			English	Article							MATERNAL PLASMA; PREGNANT-WOMEN; DNA DETECTION; RHESUS D; BLOOD; METHODOLOGY; REQUIREMENT; EXTRACTION; PREDICTION; DIAGNOSIS	Background: Non-invasive prenatal testing of cell-free fetal DNA (cffDNA) in maternal plasma can predict the fetal RhD type in D negative pregnant women. In Denmark, routine antenatal screening for the fetal RhD gene (RHD) directs the administration of antenatal anti-D prophylaxis only to women who carry an RhD positive fetus. Prophylaxis reduces the risk of immunization that may lead to hemolytic disease of the fetus and the newborn. The reliability of predicting the fetal RhD type depends on pre-analytical factors and assay sensitivity. We evaluated the testing setup in the Capital Region of Denmark, based on data from routine antenatal RHD screening. Methods: Blood samples were drawn at gestational age 25 weeks. DNA extracted from 1 mL of plasma was analyzed for fetal RHD using a duplex method for exon 7/10. We investigated the effect of blood sample transportation time (n = 110) and ambient outdoor temperatures (n = 1539) on the levels of cffDNA and total DNA. We compared two different quantification methods, the delta Ct method and a universal standard curve. PCR pipetting was compared on two systems (n = 104). Results: The cffDNA level was unaffected by blood sample transportation for up to 9 days and by ambient outdoor temperatures ranging from -10 degrees C to 28 degrees C during transport. The universal standard curve was applicable for cffDNA quantification. Identical levels of cffDNA were observed using the two automated PCR pipetting systems. We detected a mean of 100 fetal DNA copies/mL at a median gestational age of 25 weeks (range 10-39, n = 1317). Conclusion: The setup for real-time PCR-based, non-invasive prenatal testing of cffDNA in the Capital Region of Denmark is very robust. Our findings regarding the transportation of blood samples demonstrate the high stability of cffDNA. The applicability of a universal standard curve facilitates easy cffDNA quantification.	[Clausen, Frederik Banch; Rieneck, Klaus; Krog, Grethe Risum; Nielsen, Leif Kofoed; Dziegiel, Morten Hanefeld] Rigshosp, Copenhagen Univ Hosp, Sect 2034, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; [Jakobsen, Tanja Roien; Tabor, Ann] Rigshosp, Copenhagen Univ Hosp, Ctr Fetal Med, Dept Obstet, DK-2100 Copenhagen, Denmark; [Tabor, Ann; Dziegiel, Morten Hanefeld] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Clausen, FB (corresponding author), Rigshosp, Copenhagen Univ Hosp, Sect 2034, Dept Clin Immunol, DK-2100 Copenhagen, Denmark.	frederik.banch.clausen@rh.regionh.dk		Tabor, Ann/0000-0001-7450-1543; Nielsen, Leif Kofoed/0000-0002-6956-1821; Clausen, Frederik Banch/0000-0003-2487-5373; Dziegiel, Morten Hanefeld/0000-0001-8034-1523	Lundbeck Foundation; Blood Donors' Research Foundation; Aase and Ejnar Danielsen Foundation; Arvid Nilsson Foundation; Copenhagen University Hosiptal, Rigshospitalet; Lundbeck Foundation [R54-2010-5526] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Blood Donors' Research Foundation; Aase and Ejnar Danielsen Foundation; Arvid Nilsson Foundation; Copenhagen University Hosiptal, Rigshospitalet; Lundbeck Foundation(Lundbeckfonden)	This study was supported by The Lundbeck Foundation, The Blood Donors' Research Foundation, The Aase and Ejnar Danielsen Foundation, and The Arvid Nilsson Foundation, and Copenhagen University Hosiptal, Rigshospitalet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolekar R, 2011, FETAL DIAGN THER, V29, P301, DOI 10.1159/000322959; Angert RM, 2003, CLIN CHEM, V49, P195, DOI 10.1373/49.1.195; Bianchi DW, 2012, NAT MED, V18, P1041, DOI 10.1038/nm.2829; Birch L, 2005, CLIN CHEM, V51, P312, DOI 10.1373/clinchem.2004.042713; Chitty LS, 2011, ARCH DIS CHILD FE S1, V96, pFa1; Clausen FB, 2005, PRENATAL DIAG, V25, P1040, DOI 10.1002/pd.1248; Clausen FB, 2007, PRENATAL DIAG, V27, P6, DOI 10.1002/pd.1605; Clausen FB, 2012, TRANSFUSION, V52, P752, DOI 10.1111/j.1537-2995.2011.03362.x; Clausen FB, 2011, FETAL DIAGN THER, V29, P155, DOI 10.1159/000321347; Damkjaer MB, 2012, VOX SANG, V103, P145, DOI 10.1111/j.1423-0410.2012.01602.x; Daniels G, 2013, BRIT J HAEMATOL, V161, P461, DOI 10.1111/bjh.12275; Daniels G, 2010, CLIN LAB MED, V30, P431, DOI 10.1016/j.cll.2010.02.006; de, 2012, ISBT SCI SERIES, V7, P164; Faas BHW, 1998, LANCET, V352, P1196, DOI 10.1016/S0140-6736(05)60534-X; Fernando MR, 2010, PRENATAL DIAG, V30, P418, DOI 10.1002/pd.2484; Finning K, 2004, ANN NY ACAD SCI, V1022, P119, DOI 10.1196/annals.1318.019; Finning K, 2008, BRIT MED J, V336, P816, DOI 10.1136/bmj.39518.463206.25; Finning KM, 2002, TRANSFUSION, V42, P1079, DOI 10.1046/j.1537-2995.2002.00165.x; Galbiati S, 2005, HUM GENET, V117, P243, DOI 10.1007/s00439-005-1330-z; Hill M, 2011, CLIN GENET, V80, P68, DOI 10.1111/j.1399-0004.2010.01533.x; Hill M, 2012, BEST PRACT RES CL OB, V26, P639, DOI 10.1016/j.bpobgyn.2012.03.004; Horinek A, 2008, FETAL DIAGN THER, V24, P15, DOI 10.1159/000132400; Hui LS, 2013, TRENDS GENET, V29, P84, DOI 10.1016/j.tig.2012.10.013; Jakobsen TR, 2012, PRENATAL DIAG, V32, P840, DOI 10.1002/pd.3917; Jakobsen TR, 2013, TRANSFUSION, V53, P1956, DOI 10.1111/trf.12073; Johnson KL, 2004, CLIN CHEM, V50, P516, DOI 10.1373/clinchem.2003.024380; Jorgez CJ, 2006, GENET MED, V8, P615, DOI 10.1097/01.gim.0000241904.32039.6f; Legler TJ, 2007, PRENATAL DIAG, V27, P824, DOI 10.1002/pd.1783; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Lo YMD, 2012, ANNU REV GENOM HUM G, V13, P285, DOI 10.1146/annurev-genom-090711-163806; Metcalfe P, 2012, VOX SANG, V102, P243, DOI 10.1111/j.1423-0410.2011.01543.x; Muller SP, 2008, TRANSFUSION, V48, P2292, DOI 10.1111/j.1537-2995.2008.01843.x; Muller SP, 2011, PRENATAL DIAG, V31, P1300, DOI 10.1002/pd.2889; Randen I, 2003, VOX SANG, V85, P300, DOI 10.1111/j.0042-9007.2003.00371.x; Repiska G, 2012, CLIN CHEM LAB MED, V8, P1; Rieneck K, 2013, TRANSFUSION, V53, P2892, DOI 10.1111/trf.12172; Rijnders RJP, 2003, PRENATAL DIAG, V23, P1042, DOI 10.1002/pd.750; Scheffer PG, 2011, BJOG-INT J OBSTET GY, V118, P1340, DOI 10.1111/j.1471-0528.2011.03028.x; Shih DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016090; Simpson JL, 2013, FERTIL STERIL, V99, P1124, DOI 10.1016/j.fertnstert.2013.02.012; Urbaniak SJ, 2000, BLOOD REV, V14, P44, DOI 10.1054/blre.1999.0123; Van der Schoot CE, 2006, TRANSFUS CLIN BIOL, V13, P53, DOI 10.1016/j.tracli.2006.02.021; Wikman AT, 2012, OBSTET GYNECOL, V120, P227, DOI 10.1097/AOG.0b013e31825d33d9; Zhang J, 2000, ANN NY ACAD SCI, V906, P153; Zhang Y, 2008, CLIN CHIM ACTA, V397, P60, DOI 10.1016/j.cca.2008.07.017	47	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76990	10.1371/journal.pone.0076990	http://dx.doi.org/10.1371/journal.pone.0076990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204719	Green Submitted, gold, Green Published			2022-12-27	WOS:000326029300073
J	Downing, AS; Galic, N; Goudswaard, KPC; van Nes, EH; Scheffer, M; Witte, F; Mooij, WM				Downing, Andrea S.; Galic, Nika; Goudswaard, Kees P. C.; van Nes, Egbert H.; Scheffer, Marten; Witte, Frans; Mooij, Wolf M.			Was Lates Late? A Null Model for the Nile Perch Boom in Lake Victoria	PLOS ONE			English	Article							EAST-AFRICA; NILOTICUS L; FISHERIES; IMPACT; ECOSYSTEMS; RESURGENCE; LESSONS; TILAPIA; KYOGA; L.	Nile perch (Lates niloticus) suddenly invaded Lake Victoria between 1979 and 1987, 25 years after its introduction in the Ugandan side of the lake. Nile perch then replaced the native fish diversity and irreversibly altered the ecosystem and its role to lakeshore societies: it is now a prised export product that supports millions of livelihoods. The delay in the Nile perch boom led to a hunt for triggers of the sudden boom and generated several hypotheses regarding its growth at low abundances - all hypotheses having important implications for the management of Nile perch stocks. We use logistic growth as a parsimonious null model to predict when the Nile perch invasion should have been expected, given its growth rate, initial stock size and introduction year. We find the first exponential growth phase can explain the timing of the perch boom at the scale of Lake Victoria, suggesting that complex mechanisms are not necessary to explain the Nile perch invasion or its timing. However, the boom started in Kenya before Uganda, indicating perhaps that Allee effects act at smaller scales than that of the whole Lake. The Nile perch invasion of other lakes indicates that habitat differences may also have an effect on invasion success. Our results suggest there is probably no single management strategy applicable to the whole lake that would lead to both efficient and sustainable exploitation of its resources.	[Downing, Andrea S.; Galic, Nika; van Nes, Egbert H.; Scheffer, Marten; Mooij, Wolf M.] Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, NL-6700 AP Wageningen, Netherlands; [Downing, Andrea S.] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Goudswaard, Kees P. C.] Wageningen UR, Inst Marine Resource & Ecosyst Studies IMARES, Yerseke, Netherlands; [Witte, Frans] Leiden Univ, Inst Biol, Leiden, Netherlands; [Mooij, Wolf M.] Netherlands Inst Ecol NIOO, Dept Aquat Ecol, Wageningen, Netherlands	Wageningen University & Research; Stockholm University; Wageningen University & Research; Leiden University; Leiden University - Excl LUMC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Downing, AS (corresponding author), Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, NL-6700 AP Wageningen, Netherlands.	aeadowning@gmail.com	Mooij, Wolf M/C-2677-2008; van Nes, Egbert H/F-2681-2011; downing, andrea s./H-4465-2012; KNAW, NIOO-KNAW/A-4320-2012	Mooij, Wolf M/0000-0001-5586-8200; downing, andrea s./0000-0002-5206-9355; KNAW, NIOO-KNAW/0000-0002-3835-159X; Galic, Nika/0000-0002-4344-3464; van Nes, Egbert/0000-0002-6345-104X	Netherlands Organization for Scientific Research (NWO/WOTRO) [W01.65.304.00]	Netherlands Organization for Scientific Research (NWO/WOTRO)(Netherlands Organization for Scientific Research (NWO))	This work is part of the integrated project 'Exploitation or eutrophication as threats for fisheries? Disentangling social and ecological drivers of ecosystem changes in Lake Victoria (SEDEC)', supported by the Netherlands Organization for Scientific Research (NWO/WOTRO) grant number W01.65.304.00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHIENG AP, 1990, J FISH BIOL, V37, P17, DOI 10.1111/j.1095-8649.1990.tb05016.x; Balirwa JS, 2007, AFR J ECOL, V45, P120, DOI 10.1111/j.1365-2028.2007.00753.x; Chapman LJ, 2008, INT VER THEOR ANGEW, V30, P16; Chapman LJ, 2003, CONSERV BIOL, V17, P500, DOI 10.1046/j.1523-1739.2003.01519.x; Chapman LJ, 1996, BIOL CONSERV, V78, P263, DOI 10.1016/S0006-3207(96)00030-4; Claessen D, 2000, AM NAT, V155, P219, DOI 10.1086/303315; Downing AS, 2013, FRESHWATER BIOL, V58, P828, DOI 10.1111/fwb.12089; Downing AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046135; Gee J. M., 1969, Revue de Zoologie et de Botanique Africaines, V80, P244; Gee J.M, 1964, E AFRICAN FRESHWATER, P14; Goudswaard KPC, 2008, ENVIRON BIOL FISH, V81, P127, DOI 10.1007/s10641-006-9180-7; KAUFMAN L, 1992, BIOSCIENCE, V42, P846, DOI 10.2307/1312084; Kayanda R., 2009, AFR J TROP HYDROB F, V21, P15, DOI [10.4314/ajthf.v12i1.57366, DOI 10.4314/AJTHF.V12I1.57366]; Kishe-Machumu MA, 2012, HYDROBIOLOGIA, V682, P111, DOI 10.1007/s10750-011-0822-1; Kitchell JF, 1997, ECOL APPL, V7, P653; KUDHONGANIA A W, 1974, African Journal of Tropical Hydrobiology and Fisheries, V3, P15; Ligtvoet W, 1990, 1 SESS SUBC DEV MAN; Mkumbo OC, 2007, AQUAT ECOSYST HEALTH, V10, P449, DOI 10.1080/14634980701708057; Njiru M, 2007, AFR J ECOL, V45, P315, DOI 10.1111/j.1365-2028.2006.00712.x; Ogutu-Ohwayo R., 1995, IMPACT SPECIES CHANG, P59, DOI [10.1007/978-94-011-0563-7_5., DOI 10.1007/978-94-011-0563-7_5]; OGUTUOHWAYO R, 1990, ENVIRON BIOL FISH, V27, P81, DOI 10.1007/BF00001938; OGUTUOHWAYO R, 1988, HYDROBIOLOGIA, V162, P193, DOI 10.1007/BF00016667; Pitcher T.J., 1995, IMPACT SPECIES CHANG; Pringle RM, 2005, AFRICA, V75, P510, DOI 10.3366/afr.2005.75.4.510; Pringle RM, 2005, BIOSCIENCE, V55, P780, DOI 10.1641/0006-3568(2005)055[0780:TOOTNP]2.0.CO;2; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Van Zwieten P. A. M., 2011, REV TROPICAL RESERVO; Verschuren D, 2002, P ROY SOC B-BIOL SCI, V269, P289, DOI 10.1098/rspb.2001.1850; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; Witte F, 2007, T AM FISH SOC, V136, P1146, DOI 10.1577/T05-179.1; Witte F, 2000, REV FISH BIOL FISHER, V10, P233, DOI 10.1023/A:1016677515930; WITTE F, 1995, IMPACT SPECIES CHANG, P83; Witte F., 1995, HDB FIELD OBSERVATIO	34	15	16	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76847	10.1371/journal.pone.0076847	http://dx.doi.org/10.1371/journal.pone.0076847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204684	Green Submitted, gold, Green Published			2022-12-27	WOS:000326029300053
J	Hu, LR; Luo, HQ; Wang, WJ; Li, HJ; He, TP				Hu, Liren; Luo, Haiqing; Wang, Wenjuan; Li, Hongjiao; He, Taiping			Poor Prognosis of Phosphatase of Regenerating Liver 3 Expression in Gastric Cancer: A Meta-Analysis	PLOS ONE			English	Article							PRL-3 EXPRESSION; GLOBAL BURDEN; METASTASIS; PROTEIN; ASSOCIATION; OVEREXPRESSION; INCONSISTENCY; MARKER; IMPACT	Background: Overexpression of phosphatase of regenerating liver 3 (PRL-3) has been implicated in gastric cancer (GC) metastasis. Epidemiological studies have evaluated the relationship between PRL-3 expression and prognosis in GC. However, results still remains controversial. In this study, a meta-analysis was performed to evaluate the association of PRL-3 expression with overall survival (OS) and clinicopathological characteristics. Methods: Literature databases were searched to identify eligible studies dated until April 2013. Summary hazard ratios (HRs) or odds ratios (ORs) with 95% confidence interval (95% CI) were calculated to estimate the association. Results: A total of 1380 GC patients from six studies were included in the meta-analysis. Overall, the combined HR estimate for OS in a random-effect model was 1.89 (95% CI = 1.38-2.60; P<0.001). Results showed that PRL-3 overexpression was significantly associated with OS, indicating that it may be a biomarker for poor prognosis of GC. Both subgroup and sensitivity analyses further identified the prognostic role of PRL-3 expression in GC patients. Moreover, PRL-3 overexpression was significantly associated with tumor stage (OR = 2.25; 95% CI = 1.63-3.12; P<0.001), depth of invasion (OR = 2.03; 95% CI = 1.38-2.98; P<0.001), vascular invasion (OR = 2.52; 95% CI = 1.79-3.56; P<0.001), lymphatic invasion (OR = 3.74; 95% CI = 2.49-5.63; P<0.001), and lymph node metastasis (OR = 4.56; 95% CI = 2.37-8.76; P<0.001). However, when age, sex, tumor size, and tumor differentiation were considered, no obvious association was observed. Conclusions: This meta-analysis reveals significant association of PRL-3 overexpression with OS and some clinicopathological features in GC. PRL-3 may be a predicative factor of poor prognosis and aggressive tumor behavior in GC patients.	[Hu, Liren] Guangdong Med Coll, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Zhanjiang, Guangdong, Peoples R China; [Luo, Haiqing] Guangdong Med Coll, Ctr Oncol, Affiliated Hosp, Zhanjiang, Guangdong, Peoples R China; [Wang, Wenjuan; Li, Hongjiao] Guangdong Med Coll, Dept Biochem & Mol Biol, Zhanjiang, Guangdong, Peoples R China; [He, Taiping] Guangdong Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Dongguan, Guangdong, Peoples R China	Guangdong Medical University; Guangdong Medical University; Guangdong Medical University; Guangdong Medical University	He, TP (corresponding author), Guangdong Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Dongguan, Guangdong, Peoples R China.	taipinghe@163.com		taiping, He/0000-0001-6213-0837	Guangdong Medical College Leading Academic Discipline Project [XZ1105]; Guangdong Natural Science Foundation [S2011010004146]	Guangdong Medical College Leading Academic Discipline Project; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This study was supported by Guangdong Medical College Leading Academic Discipline Project (Project No. XZ1105) and Guangdong Natural Science Foundation (Grant No. S2011010004146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aidaroos AQO, 2010, J CELL BIOCHEM, V111, P1087, DOI 10.1002/jcb.22913; Bardelli A, 2003, CLIN CANCER RES, V9, P5607; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Bilici A, 2012, DIGEST DIS SCI, V57, P1568, DOI 10.1007/s10620-012-2076-9; Neves EH, 2012, PATHOBIOLOGY, V79, P323, DOI 10.1159/000338436; Da N, 2009, WORLD J GASTROENTERO, V15, P1499, DOI 10.3748/wjg.15.1499; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Guzinska-Ustymowicz K, 2011, ANTI-CANCER AGENT ME, V11, P99, DOI 10.2174/187152011794941145; Hashimoto K, 2013, GASTRIC CANC; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jansen JP, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-152; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kozlov G, 2004, J BIOL CHEM, V279, P11882, DOI 10.1074/jbc.M312905200; Li ZR, 2007, SURG TODAY, V37, P646, DOI 10.1007/s00595-006-3437-9; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MANTEL N, 1959, J NATL CANCER I, V22, P719; Maxwell L, 2006, J RHEUMATOL, V33, P2304; Mayinuer A, 2013, ANN SURG ONCOL, V20, P305, DOI 10.1245/s10434-012-2395-2; Miskad UA, 2007, VIRCHOWS ARCH, V450, P303, DOI 10.1007/s00428-006-0361-8; Mollevi DG, 2008, BRIT J CANCER, V99, P1718, DOI 10.1038/sj.bjc.6604747; Ooki A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-122; Ooki A, 2009, ONCOL REP, V21, P1467, DOI 10.3892/or_00000376; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pryczynicz A, 2010, FOLIA HISTOCHEM CYTO, V48, P632, DOI 10.2478/v10042-010-0070-7; Reich R, 2011, INT J MOL SCI, V12, P1133, DOI 10.3390/ijms12021133; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Scott LM, 2010, CURR PHARM DESIGN, V16, P1843; Shin NR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-521; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Wang L, 2006, ANN ONCOL, V17, P1517, DOI 10.1093/annonc/mdl159; Wang Z, 2009, ANN SURG ONCOL, V16, P208, DOI 10.1245/s10434-008-0214-6; Wang Z, 2009, J CANCER RES CLIN, V135, P1041, DOI 10.1007/s00432-008-0541-9; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Woo S, 2011, PATHOBIOLOGY, V78, P295, DOI 10.1159/000321696; Zhou J, 2009, INT J CANCER, V124, P1879, DOI 10.1002/ijc.24096	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76927	10.1371/journal.pone.0076927	http://dx.doi.org/10.1371/journal.pone.0076927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204707	gold, Green Submitted, Green Published			2022-12-27	WOS:000326029300068
J	Laugier, GJM; Le Moguedec, G; Tayeh, A; Loiseau, A; Osawa, N; Estoup, A; Facon, B				Laugier, Guillaume J. M.; Le Moguedec, Gilles; Tayeh, Ashraf; Loiseau, Anne; Osawa, Naoya; Estoup, Arnaud; Facon, Benoit			Increase in Male Reproductive Success and Female Reproductive Investment in Invasive Populations of the Harlequin Ladybird Harmonia axyridis	PLOS ONE			English	Article							GENETIC-VARIATION; BIOLOGICAL INVASION; SPERM COMPETITION; SEXUAL SELECTION; DROSOPHILA-MELANOGASTER; INBREEDING DEPRESSION; ADAPTIVE EVOLUTION; PALLAS COLEOPTERA; PLANT; COCCINELLIDAE	Reproductive strategy affects population dynamics and genetic parameters that can, in turn, affect evolutionary processes during the course of biological invasion. Life-history traits associated with reproductive strategy are therefore potentially good candidates for rapid evolutionary shifts during invasions. In a series of mating trials, we examined mixed groups of four males from invasive and native populations of the harlequin ladybird Harmonia axyridis mating freely during 48 hours with one female of either type. We recorded the identity of the first male to copulate and after the 48 h-period, we examined female fecundity and share of paternity, using molecular markers. We found that invasive populations have a different profile of male and female reproductive output. Males from invasive populations are more likely to mate first and gain a higher proportion of offspring with both invasive and native females. Females from invasive populations reproduce sooner, lay more eggs, and have offspring sired by a larger number of fathers than females from native populations. We found no evidence of direct inbreeding avoidance behaviour in both invasive and native females. This study highlights the importance of investigating evolutionary changes in reproductive strategy and associated traits during biological invasions.	[Laugier, Guillaume J. M.; Tayeh, Ashraf; Loiseau, Anne; Estoup, Arnaud; Facon, Benoit] INRA, Ctr Biol Gest Populat, F-34060 Montpellier, France; [Le Moguedec, Gilles] INRA, Bot & Bioinformat Architecture Plantes, F-34060 Montpellier, France; [Osawa, Naoya] Kyoto Univ, Grad Sch Agr, Lab Forest Ecol, Kyoto, Japan	INRAE; Institut de Recherche pour le Developpement (IRD); CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; Kyoto University	Laugier, GJM (corresponding author), INRA, Ctr Biol Gest Populat, F-34060 Montpellier, France.	guillaume.laugier@supagro.inra.fr	Osawa, Naoya/ABG-1684-2020	Osawa, Naoya/0000-0002-6355-1948	Agropolis Fondation ["BIOFIS" 1001-001]	Agropolis Fondation	This work was supported by Agropolis Fondation under the reference ID "BIOFIS" 1001-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Barrett SCH, 2008, MOL ECOL, V17, P373, DOI 10.1111/j.1365-294X.2007.03503.x; Barry KL, 2011, EVOL ECOL, V25, P107, DOI 10.1007/s10682-010-9384-3; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; BIRKHEAD TR, 1990, TRENDS ECOL EVOL, V5, P48, DOI 10.1016/0169-5347(90)90047-H; Blair AC, 2004, ECOLOGY, V85, P3035, DOI 10.1890/04-0341; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Brown JS, 2005, AM J BOT, V92, P495, DOI 10.3732/ajb.92.3.495; Buckley YM, 2003, ECOLOGY, V84, P1434, DOI 10.1890/0012-9658(2003)084[1434:AIBAGS]2.0.CO;2; Bufford JL, 2011, ENCY BIOL INVASIONS; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Calsbeek R, 2007, EVOL ECOL RES, V9, P495; Carroll SP, 1995, ANIM BEHAV, V50, P1463, DOI 10.1016/0003-3472(95)80003-4; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; CRAWLEY MJ, 1987, WHAT MAKES COMMUNITY, P00429; Daehler CC, 1998, EVOL ECOL, V12, P553, DOI 10.1023/A:1006556709662; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; Danzmann RG, 1997, J HERED, V88, P333, DOI 10.1093/oxfordjournals.jhered.a023112; Davis HG, 2005, EVOL ECOL, V19, P255, DOI 10.1007/s10682-005-0912-5; De Carvalho D, 2010, MOL ECOL, V19, P1638, DOI 10.1111/j.1365-294X.2010.04595.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Elam DR, 2007, P NATL ACAD SCI USA, V104, P549, DOI 10.1073/pnas.0607306104; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Facon B, 2011, CURR BIOL, V21, P424, DOI 10.1016/j.cub.2011.01.068; Facon B, 2011, EVOL APPL, V4, P71, DOI 10.1111/j.1752-4571.2010.00134.x; Fedina TY, 2008, BIOL REV, V83, P151, DOI 10.1111/j.1469-185X.2008.00037.x; Fiumera AC, 2005, GENETICS, V169, P243, DOI 10.1534/genetics.104.032870; Head ML, 2005, PLOS BIOL, V3, P289, DOI 10.1371/journal.pbio.0030033; HOGLUND J, 1998, COST REPROD SEXUAL S, V83, P478; Horvitz CC, 2011, ENCY BIOL INVASIONS, P147; House CM, 2006, BEHAV ECOL SOCIOBIOL, V60, P131, DOI 10.1007/s00265-005-0149-x; Jullien B, 2000, J POLIT ECON, V108, P503, DOI 10.1086/262127; Kanarek AR, 2010, EVOL APPL, V3, P122, DOI 10.1111/j.1752-4571.2009.00112.x; Kirkpatrick M, 2000, AM NAT, V155, P154, DOI 10.1086/303312; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lee CE, 2011, ENCY BIOL INVASIONS; Loiseau A, 2009, MOL ECOL RESOUR, V9, P934, DOI 10.1111/j.1755-0998.2009.02517.x; Lombaert E, 2011, SYSTEMES INTEGRES BI; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; MAC ARTHUR ROBERT H., 1967; MOORE J, 1984, ANIM BEHAV, V32, P94, DOI 10.1016/S0003-3472(84)80328-0; OBATA S, 1987, APPL ENTOMOL ZOOL, V22, P434, DOI 10.1303/aez.22.434; Osawa N, 2000, POPUL ECOL, V42, P115, DOI 10.1007/PL00011990; OSAWA N, 1994, J ETHOL, V12, P63, DOI 10.1007/BF02350081; Pardoe I, 2008, J R STAT SOC A STAT, V171, P375, DOI 10.1111/j.1467-985X.2007.00518.x; PARKER GA, 1978, ANNU REV ENTOMOL, V23, P173, DOI 10.1146/annurev.en.23.010178.001133; Parker MA, 2002, J EVOLUTIONARY BIOL, V7, P567; Pattarini JA, 2006, EVOLUTION, V60, P2064, DOI 10.1111/j.0014-3820.2006.tb01844.x; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Pischedda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031683; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; R Core Team, 2012, R LANG ENV STAT COMP; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Reznik SY, 2011, EUR J ENTOMOL, V108, P385, DOI 10.14411/eje.2011.048; Shen Z, 2011, J MOUNTAIN AGR BIOL, V1; Simmons LW, 2007, MOL ECOL, V16, P4613, DOI 10.1111/j.1365-294X.2007.03528.x; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Stathas GJ, 2001, EUR J ENTOMOL, V98, P547, DOI 10.14411/eje.2001.069; Tayeh A, 2013, ECOLOGY EVOLUTION; Tobin PC, 2007, ECOL LETT, V10, P36, DOI 10.1111/j.1461-0248.2006.00991.x; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Ueno H, 1998, FUNCT ECOL, V12, P757, DOI 10.1046/j.1365-2435.1998.00245.x; UENO H, 1994, J ETHOL, V12, P169, DOI 10.1007/BF02350061; Ueno H, 1996, APPL ENTOMOL ZOOL, V31, P621, DOI 10.1303/aez.31.621; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; VANDENBERG SG, 1972, BEHAV GENET, V2, P127, DOI 10.1007/BF01065686; Wang S, 2009, ECOL ENTOMOL, V34, P483, DOI 10.1111/j.1365-2311.2008.01075.x; Whitlock MC, 2009, LIKELIHOOD, P567	74	22	24	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77083	10.1371/journal.pone.0077083	http://dx.doi.org/10.1371/journal.pone.0077083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204741	Green Submitted, gold, Green Published			2022-12-27	WOS:000326029300081
J	Ryan, SJ; Jones, JH; Dobson, AP				Ryan, Sadie J.; Jones, James H.; Dobson, Andrew P.			Interactions between Social Structure, Demography, and Transmission Determine Disease Persistence in Primates	PLOS ONE			English	Article							INFECTIOUS-DISEASES; MODELS; SPREAD; EXTINCTION; PATHOGENS; DYNAMICS; PATTERNS; INVASION; DECLINE	Catastrophic declines in African great ape populations due to disease outbreaks have been reported in recent years, yet we rarely hear of similar disease impacts for the more solitary Asian great apes, or for smaller primates. We used an age-structured model of different primate social systems to illustrate that interactions between social structure and demography create 'dynamic constraints' on the pathogens that can establish and persist in primate host species with different social systems. We showed that this varies by disease transmission mode. Sexually transmitted infections (STIs) require high rates of transmissibility to persist within a primate population. In particular, for a unimale social system, STIs require extremely high rates of transmissibility for persistence, and remain at extremely low prevalence in small primates, but this is less constrained in longer-lived, larger-bodied primates. In contrast, aerosol transmitted infections (ATIs) spread and persist at high prevalence in medium and large primates with moderate transmissibility;, establishment and persistence in small-bodied primates require higher relative rates of transmissibility. Intragroup contact structure - the social network - creates different constraints for different transmission modes, and our model underscores the importance of intragroup contacts on infection prior to intergroup movement in a structured population. When alpha males dominate sexual encounters, the resulting disease transmission dynamics differ from when social interactions are dominated by mother-infant grooming events, for example. This has important repercussions for pathogen spread across populations. Our framework reveals essential social and demographic characteristics of primates that predispose them to different disease risks that will be important for disease management and conservation planning for protected primate populations.	[Ryan, Sadie J.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Ryan, Sadie J.] SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Dept Immunol & Microbiol, Syracuse, NY 13210 USA; [Ryan, Sadie J.] Univ KwaZulu Natal, Sch Life Sci, Dept Agr Engn & Sci, Pietermaritzburg, South Africa; [Jones, James H.] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Dobson, Andrew P.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Dobson, Andrew P.] Santa Fe Inst, Santa Fe, NM 87501 USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Kwazulu Natal; Stanford University; Princeton University; The Santa Fe Institute	Ryan, SJ (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA.	sjryan@esf.edu	Ryan, Sadie Jane/H-7488-2019	Ryan, Sadie Jane/0000-0002-4308-6321; Jones, James/0000-0003-1680-6757	NSF Bioinformatics Fellowship [0630709]; James S. McDonnell Foundation; NSF [EF-0553768]; University of California, Santa Barbara; State of California	NSF Bioinformatics Fellowship; James S. McDonnell Foundation; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California	This work was supported by an NSF Bioinformatics Fellowship #0630709 to SJR. APD was supported by the James S. McDonnell Foundation. This work was also conducted while SJR was a Postdoctoral Associate at the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS SC, 1995, AM NAT, V145, P279, DOI 10.1086/285740; ANDERSON R M, 1991; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Boots M, 1999, P ROY SOC B-BIOL SCI, V266, P1933, DOI 10.1098/rspb.1999.0869; Cable JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001130; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; Corner LAL, 2003, PREV VET MED, V59, P147, DOI 10.1016/S0167-5877(03)00075-8; Craft ME, 2008, J ANIM ECOL, V77, P1257, DOI 10.1111/j.1365-2656.2008.01410.x; Cross PC, 2007, J R SOC INTERFACE, V4, P315, DOI 10.1098/rsif.2006.0185; Cross PC, 2005, ECOL LETT, V8, P587, DOI 10.1111/j.1461-0248.2005.00760.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; DOBSON AP, 1992, J ANIM ECOL, V61, P487, DOI 10.2307/5339; Eames KTD, 2003, P ROY SOC B-BIOL SCI, V270, P2565, DOI 10.1098/rspb.2003.2554; Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299; Eames KTD, 2008, THEORETICAL POPULATI, V73, P111; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Ferguson NM, 2000, SEX TRANSM DIS, V27, P600, DOI 10.1097/00007435-200011000-00008; Gerber LR, 2005, ECOL APPL, V15, P1402, DOI 10.1890/04-0880; GETZ WM, 1983, AM NAT, V121, P892, DOI 10.1086/284112; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; GRENFELL BT, 1992, J ROY STAT SOC B MET, V54, P383; Harvey P.H., 1987, P181; Heesterbeek J. A. P., 1995, P90, DOI 10.1017/CBO9780511629396.004; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; HESS GR, 1994, CONSERV BIOL, V8, P256, DOI 10.1046/j.1523-1739.1994.08010256.x; Hess GR, 1996, AM NAT, V148, P226, DOI 10.1086/285922; Holt RD, 2003, ECOL LETT, V6, P837, DOI 10.1046/j.1461-0248.2003.00501.x; Jones J.H., 2008, EXPLAINING CULTURE S; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Marshall AR, 2005, INT J PRIMATOL, V26, P127, DOI 10.1007/s10764-005-0011-z; McCallum H, 2002, P ROY SOC B-BIOL SCI, V269, P2041, DOI 10.1098/rspb.2002.2079; McCallum H, 2006, CONNECTIVITY CONSERV; MORRIS M, 1991, MATH BIOSCI, V107, P349, DOI 10.1016/0025-5564(91)90014-A; Morris M., 1995, EPIDEMIC MODELS THEI; Morris M, 1996, MODELS INFECT HUMAN; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Pusey A.E., 1992, P243; Richard AF, 1985, PRIMATES NATURE; Roberts M, 1993, Trends Microbiol, V1, P343, DOI 10.1016/0966-842X(93)90075-3; Ryan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029030; Thrall PH, 2000, P ROY SOC B-BIOL SCI, V267, P1555, DOI 10.1098/rspb.2000.1178; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Williams JM, 2008, AM J PRIMATOL, V70, P766, DOI 10.1002/ajp.20573; Wolfe N., 2005, EMERGING INFECT DIS, V11; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; WRANGHAM RW, 1979, SOC SCI INFORM, V18, P335; [No title captured]	54	10	10	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76863	10.1371/journal.pone.0076863	http://dx.doi.org/10.1371/journal.pone.0076863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204688	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300057
J	Weegman, BP; Nash, P; Carlson, AL; Voltzke, KJ; Geng, ZH; Jahani, M; Becker, BB; Papas, KK; Firpo, MT				Weegman, Bradley P.; Nash, Peter; Carlson, Alexandra L.; Voltzke, Kristin J.; Geng, Zhaohui; Jahani, Marjan; Becker, Benjamin B.; Papas, Klearchos K.; Firpo, Meri T.			Nutrient Regulation by Continuous Feeding Removes Limitations on Cell Yield in the Large-Scale Expansion of Mammalian Cell Spheroids	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BIOARTIFICIAL PANCREAS; CULTURE; OXYGEN; OPTIMIZATION; BIOREACTORS; SECRETION; LINES	Cellular therapies are emerging as a standard approach for the treatment of several diseases. However, realizing the promise of cellular therapies across the full range of treatable disorders will require large-scale, controlled, reproducible culture methods. Bioreactor systems offer the scale-up and monitoring needed, but standard stirred bioreactor cultures do not allow for the real-time regulation of key nutrients in the medium. In this study, beta-TC6 insulinoma cells were aggregated and cultured for 3 weeks as a model of manufacturing a mammalian cell product. Cell expansion rates and medium nutrient levels were compared in static, stirred suspension bioreactors (SSB), and continuously fed (CF) SSB. While SSB cultures facilitated increased culture volumes, no increase in cell yields were observed, partly due to limitations in key nutrients, which were consumed by the cultures between feedings, such as glucose. Even when glucose levels were increased to prevent depletion between feedings, dramatic fluctuations in glucose levels were observed. Continuous feeding eliminated fluctuations and improved cell expansion when compared with both static and SSB culture methods. Further improvements in growth rates were observed after adjusting the feed rate based on calculated nutrient depletion, which maintained physiological glucose levels for the duration of the expansion. Adjusting the feed rate in a continuous medium replacement system can maintain the consistent nutrient levels required for the large-scale application of many cell products. Continuously fed bioreactor systems combined with nutrient regulation can be used to improve the yield and reproducibility of mammalian cells for biological products and cellular therapies and will facilitate the translation of cell culture from the research lab to clinical applications.	[Weegman, Bradley P.; Nash, Peter; Carlson, Alexandra L.; Voltzke, Kristin J.; Geng, Zhaohui; Jahani, Marjan; Becker, Benjamin B.; Firpo, Meri T.] Univ Minnesota, Dept Med, Div Endocrinol, Stem Cell Inst, Minneapolis, MN 55455 USA; [Weegman, Bradley P.; Nash, Peter; Carlson, Alexandra L.; Voltzke, Kristin J.; Geng, Zhaohui; Jahani, Marjan; Becker, Benjamin B.; Papas, Klearchos K.; Firpo, Meri T.] Univ Minnesota, Dept Surg, Schulze Diabet Inst, Minneapolis, MN 55455 USA; [Papas, Klearchos K.] Univ Arizona, Dept Surg, Inst Cellular Transplantat, Tucson, AZ USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Arizona	Firpo, MT (corresponding author), Univ Minnesota, Dept Med, Div Endocrinol, Stem Cell Inst, Box 736 UMHC, Minneapolis, MN 55455 USA.	firpo001@umn.edu			Richard M. Schulze Family Foundation	Richard M. Schulze Family Foundation	This research was funded by the Richard M. Schulze Family Foundation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptista RP, 2013, BIOTECHNOL BIOENG, V110, P648, DOI 10.1002/bit.24717; Campos C, 2012, POSTGRAD MED, V124, P90, DOI 10.3810/pgm.2012.11.2615; Dazey B, 2005, STEM CELLS DEV, V14, P6, DOI 10.1089/scd.2005.14.6; De Coppi P, 2013, J PEDIATR SURG, V48, P273, DOI 10.1016/j.jpedsurg.2012.11.005; Eve DJ, 2010, MED SCI MONITOR, V16, pRA197; Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712; Galvez J, 2012, J BIOTECHNOL, V157, P214, DOI 10.1016/j.jbiotec.2011.11.007; Gastens MH, 2007, CELL TRANSPLANT, V16, P685, DOI 10.3727/000000007783465172; HAY RJ, 1991, DEV BIOLOGICALS, V75, P193; Hsiao LC, 2013, CELL TRANSP IN PRESS; HU WS, 1994, CYTOTECHNOLOGY, V14, P155, DOI 10.1007/BF00749611; Kehoe DE, 2010, TISSUE ENG PT A, V16, P405, DOI [10.1089/ten.tea.2009.0454, 10.1089/ten.TEA.2009.0454]; Klueh U, 2006, DIABETES TECHNOL THE, V8, P402, DOI 10.1089/dia.2006.8.402; KNAACK D, 1994, DIABETES, V43, P1413, DOI 10.2337/diabetes.43.12.1413; Krawetz R, 2010, TISSUE ENG PART C-ME, V16, P573, DOI [10.1089/ten.tec.2009.0228, 10.1089/ten.TEC.2009.0228]; Liu H, 2009, J BIOSCI BIOENG, V107, P524, DOI 10.1016/j.jbiosc.2009.01.004; Lock LT, 2011, J BIOTECHNOL, V151, P278, DOI 10.1016/j.jbiotec.2010.12.015; Marchenko S, 2007, J VIS EXP, V262; Masters JR, 2007, NAT PROTOC, V2, P2276, DOI 10.1038/nprot.2007.319; Moos Malcolm Jr, 2008, Trends Pharmacol Sci, V29, P591, DOI 10.1016/j.tips.2008.09.003; Murdoch TB, 2004, CELL TRANSPLANT, V13, P605, DOI 10.3727/000000004783983602; Naing MW, 2011, CYTOTHERAPY, V13, P391, DOI 10.3109/14653249.2011.556352; Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005; Oldershaw RA, 2012, INT J EXP PATHOL, V93, P389, DOI 10.1111/j.1365-2613.2012.00837.x; Olmer R, 2012, TISSUE ENG PART C-ME, V18, P772, DOI 10.1089/ten.tec.2011.0717; Papas KK, 1999, BIOTECHNOL BIOENG, V66, P219; Papas KK, 1999, BIOTECHNOL BIOENG, V66, P231, DOI 10.1002/(SICI)1097-0290(1999)66:4<231::AID-BIT4>3.0.CO;2-U; Papas KK, 1997, BIOCHEM J, V326, P807, DOI 10.1042/bj3260807; PAPAS KK, 1993, CYTOTECHNOLOGY, V13, P1, DOI 10.1007/BF00749970; PAPAS KK, 1992, THESIS GEORGIA I TEC; Poitout V, 1996, DIABETES METAB, V22, P7; POITOUT V, 1995, DIABETES, V44, P306, DOI 10.2337/diabetes.44.3.306; REUVENY S, 1986, J IMMUNOL METHODS, V86, P53, DOI 10.1016/0022-1759(86)90264-4; SAMBANIS A, 1994, CYTOTECHNOLOGY, V15, P351, DOI 10.1007/BF00762410; Serra M, 2010, J BIOTECHNOL, V148, P208, DOI 10.1016/j.jbiotec.2010.06.015; Shafa M, 2011, J TISSUE ENG REGEN M, V6, P4; Sharma S, 2011, BIOTECHNOL J, V6, P1317, DOI 10.1002/biot.201000435; Sidoli FR, 2004, CYTOTECHNOLOGY, V44, P27, DOI 10.1023/B:CYTO.0000043397.94527.84; Skelin M, 2010, ALTEX-ALTERN ANIM EX, V27, P105; Stacey GN, 2011, METHODS MOL BIOL, V731, P79, DOI 10.1007/978-1-61779-080-5_7; Suzuki R, 2002, LIFE SCI, V71, P1717, DOI 10.1016/S0024-3205(02)01724-1; TARLETON RL, 1991, BIOTECHNIQUES, V11, P590; Trabelsi K, 2012, APPL MICROBIOL BIOT, V93, P1031, DOI 10.1007/s00253-011-3574-y; TZIAMPAZIS E, 1994, CYTOTECHNOLOGY, V14, P191, DOI 10.1007/BF00749616; Woodside SM, 1998, CYTOTECHNOLOGY, V28, P163, DOI 10.1023/A:1008050202561; Yim R, 2005, TRANSFUSION, V45, pS144, DOI 10.1111/j.1537-2995.2005.00616.x; Zhi ZL, 2010, BIOMACROMOLECULES, V11, P610, DOI 10.1021/bm901152k; zur Nieden NI, 2007, J BIOTECHNOL, V129, P421, DOI 10.1016/j.jbiotec.2007.01.006	48	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76611	10.1371/journal.pone.0076611	http://dx.doi.org/10.1371/journal.pone.0076611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204645	Green Submitted, gold, Green Published			2022-12-27	WOS:000326029300040
J	Whyte, JL; Smith, AA; Liu, B; Manzano, WR; Evans, ND; Dhamdhere, GR; Fang, MY; Chang, HY; Oro, AE; Helms, JA				Whyte, Jemima L.; Smith, Andrew A.; Liu, Bo; Manzano, Wilfred R.; Evans, Nick D.; Dhamdhere, Girija R.; Fang, Mark Y.; Chang, Howard Y.; Oro, Anthony E.; Helms, Jill A.			Augmenting Endogenous Wnt Signaling Improves Skin Wound Healing	PLOS ONE			English	Article							HAIR FOLLICLE; BETA-CATENIN; STEM-CELLS; PROLIFERATION; TRANSCRIPTION; REGENERATION; ACTIVATION; GROWTH; ROLES; AXIN2	Wnt signaling is required for both the development and homeostasis of the skin, yet its contribution to skin wound repair remains controversial. By employing Axin2(LacZ/+) reporter mice we evaluated the spatial and temporal distribution patterns of Wnt responsive cells, and found that the pattern of Wnt responsiveness varies with the hair cycle, and correlates with wound healing potential. Using Axin2(LacZ/LacZ) mice and an ear wound model, we demonstrate that amplified Wnt signaling leads to improved healing. Utilizing a biochemical approach that mimics the amplified Wnt response of Axin2(LacZ/LacZ) mice, we show that topical application of liposomal Wnt3a to a non-healing wound enhances endogenous Wnt signaling, and results in better skin wound healing. Given the importance of Wnt signaling in the maintenance and repair of skin, liposomal Wnt3a may have widespread application in clinical practice.	[Whyte, Jemima L.; Smith, Andrew A.; Liu, Bo; Manzano, Wilfred R.; Evans, Nick D.; Dhamdhere, Girija R.; Fang, Mark Y.; Helms, Jill A.] Stanford Univ, Div Plast & Reconstruct Surg, Dept Surg, Stanford Sch Med, Stanford, CA 94305 USA; [Chang, Howard Y.; Oro, Anthony E.] Stanford Univ, Dept Dermatol, Stanford Sch Med, Stanford, CA 94305 USA; [Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Helms, JA (corresponding author), Stanford Univ, Div Plast & Reconstruct Surg, Dept Surg, Stanford Sch Med, Stanford, CA 94305 USA.	aasmith@stanford.edu		Helms, Jill/0000-0002-0463-396X; Evans, Nicholas/0000-0002-3255-4388; Oro, Anthony/0000-0002-6261-138X; Smith, Andrew/0000-0003-1307-4677	California Institute for Regenerative Medicine (CIRM); Scleroderma Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054780] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Scleroderma Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported by grants from the California Institute for Regenerative Medicine (CIRM) to JAH, AO, and HYC. AAS is a CIRM Bridges Scholar. HYC is also supported by Scleroderma Research Foundation, and is an Early Career Scientist of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber C, 2011, J INVEST DERMATOL, V131, P278, DOI 10.1038/jid.2010.409; Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Ansell DM, 2011, J INVEST DERMATOL, V131, P518, DOI 10.1038/jid.2010.291; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; CHANG J, 1995, AESTHET PLAST SURG, V19, P237, DOI 10.1007/BF00451096; Chen DM, 2012, DEVELOPMENT, V139, P1522, DOI 10.1242/dev.076463; Chua AWC, 2011, J INVEST DERMATOL, V131, P644, DOI 10.1038/jid.2010.371; Clark RAF, 1988, MOL CELLULAR BIOL WO, Vxxii; Darby IA, 1997, INT J BIOCHEM CELL B, V29, P191, DOI 10.1016/S1357-2725(96)00131-8; DasGupta R, 1999, DEVELOPMENT, V126, P4557; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Helms JA, 2005, DEVELOPMENT, V132, P851, DOI 10.1242/dev.01705; Helms JA, 1996, DEVELOPMENT, V122, P1385; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hu D, 2003, DEVELOPMENT, V130, P1749, DOI 10.1242/dev.00397; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kabashima K, 2010, AM J PATHOL, V176, P721, DOI 10.2353/ajpath.2010.090454; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kishimoto J, 2000, GENE DEV, V14, P1181; KSANDER GA, 1977, PLAST RECONSTR SURG, V59, P398, DOI 10.1097/00006534-197703000-00015; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Liu B, 2007, DEV BIOL, V301, P298, DOI 10.1016/j.ydbio.2006.10.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Osorio KM, 2011, J CELL BIOL, V193, P235, DOI 10.1083/jcb.201006068; Ouhtit A, 2000, AM J PATHOL, V156, P201, DOI 10.1016/S0002-9440(10)64720-7; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; Seifert AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032875; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Sumiyoshi K, 2004, J INVEST DERMATOL, V123, P229, DOI 10.1111/j.0022-202X.2004.22730.x; Tanaka EM, 2012, NATURE, V489, P508, DOI 10.1038/489508a; Telgenhoff D, 2005, CELL DEATH DIFFER, V12, P695, DOI 10.1038/sj.cdd.4401632; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Zhao L, 2009, METHOD ENZYMOL, V465, P331, DOI 10.1016/S0076-6879(09)65017-5	48	48	47	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76883	10.1371/journal.pone.0076883	http://dx.doi.org/10.1371/journal.pone.0076883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204695	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000326029300061
J	Brooks, ME; McCoy, MW; Bolker, BM				Brooks, Mollie E.; McCoy, Michael W.; Bolker, Benjamin M.			A Method for Detecting Positive Growth Autocorrelation without Marking Individuals	PLOS ONE			English	Article							MEAN EFFECT SIZE; DEMOGRAPHIC STOCHASTICITY; ECOLOGICAL PROCESSES; POPULATION-MODELS; CONSEQUENCES; VARIANCE; VARIABILITY; DYNAMICS; METAMORPHOSIS; MORTALITY	In most ecological studies, within-group variation is a nuisance that obscures patterns of interest and reduces statistical power. However, patterns of within-group variability often contain information about ecological processes. In particular, such patterns can be used to detect positive growth autocorrelation (consistent variation in growth rates among individuals in a cohort across time), even in samples of unmarked individuals. Previous methods for detecting autocorrelated growth required data from marked individuals. We propose a method that requires only estimates of within-cohort variance through time, using maximum likelihood methods to obtain point estimates and confidence intervals of the correlation parameter. We test our method on simulated data sets and determine the loss in statistical power due to the inability to identify individuals. We show how to accommodate nonlinear growth trajectories and test the effects of size-dependent mortality on our method's accuracy. The method can detect significant growth autocorrelation at moderate levels of autocorrelation with moderate-sized cohorts (for example, statistical power of 80% to detect growth autocorrelation rho(2) = 0.5 in a cohort of 100 individuals measured on 16 occasions). We present a case study of growth in the red-eyed tree frog. Better quantification of the processes driving size variation will help ecologists improve predictions of population dynamics. This work will help researchers to detect growth autocorrelation in cases where marking is logistically infeasible or causes unacceptable decreases in the fitness of marked individuals.	[Brooks, Mollie E.; McCoy, Michael W.; Bolker, Benjamin M.] Univ Florida, Dept Biol, Gainesville, FL USA	State University System of Florida; University of Florida	Brooks, ME (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	mollieebrooks@gmail.com	Brooks, Mollie Elizabeth/AAM-5509-2021	Brooks, Mollie Elizabeth/0000-0001-6963-8326; McCoy, Michael/0000-0002-7993-6236; Bolker, Benjamin/0000-0002-2127-0443	NSF IGERT [0801544]; NSERC	NSF IGERT(National Science Foundation (NSF)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors acknowledge the University of Florida High-Performance Computing Center (http://hpc.ufl.edu) for providing computational resources. MEB was supported by NSF IGERT #0801544, Quantitative spatial ecology, evolution and environment. BMB was supported by an NSERC Discovery grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, EVOLUTION, V50, P1052, DOI 10.1111/j.1558-5646.1996.tb02346.x; Bates D, 2012, LME4 LINEAR MIXED EF; Benedetti-Cecchi L, 2003, ECOLOGY, V84, P2335, DOI 10.1890/02-8011; Bolker B., 2012, R2ADMB ADMB R INTERF; Bolker B., 2012, BBMLE TOOLS GEN MAXI; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Brienen RJW, 2006, FOREST ECOL MANAG, V237, P179, DOI 10.1016/j.foreco.2006.09.042; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Day T, 2002, AM NAT, V159, P338, DOI 10.1086/338989; de Valpine P, 2009, ECOLOGY, V90, P2889, DOI 10.1890/08-0703.1; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Fox GA, 2002, ECOLOGY, V83, P1928, DOI 10.2307/3071775; Gonzalez-Suarez M, 2011, AM NAT, V178, P525, DOI 10.1086/661906; Inouye BD, 2005, ECOLOGY, V86, P262, DOI 10.1890/03-3180; Kendall BE, 2011, ECOLOGY, V92, P1985, DOI 10.1890/11-0079.1; LAIRD AK, 1965, GROWTH, V29, P233; Lavine M, 2002, J AGR BIOL ENVIR ST, V7, P21, DOI 10.1198/108571102317475044; Mangel M, 2001, EVOL ECOL RES, V3, P583; Marshall DJ, 2005, AUSTRAL ECOL, V30, P275, DOI 10.1111/j.1442-9993.2005.01463.x; May RM, 2004, NATURE, V431, P403, DOI 10.1038/431403a; McCarthy MA, 2004, J APPL ECOL, V41, P780, DOI 10.1111/j.0021-8901.2004.00919.x; Morris W. F., 2002, QUANTITATIVE CONSERV; Peacor SD, 2007, ECOLOGY, V88, P1536, DOI 10.1890/06-1066; Peacor SD, 2006, J ANIM ECOL, V75, P990, DOI 10.1111/j.1365-2656.2006.01119.x; Persson L, 1998, THEOR POPUL BIOL, V54, P270, DOI 10.1006/tpbi.1998.1380; Pfister CA, 2005, ECOLOGY, V86, P2673, DOI 10.1890/04-1952; Pfister CA, 2002, ECOLOGY, V83, P59; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; RICKLEFS RE, 1973, COPEIA, P296; RICKLEFS RE, 1967, ECOLOGY, V48, P978, DOI 10.2307/1934545; Roff Derek A., 1992; ROWE L, 1991, ECOLOGY, V72, P413, DOI 10.2307/2937184; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Scheipl F, 2008, COMPUT STAT DATA AN, V52, P3283, DOI 10.1016/j.csda.2007.10.022; Shelton AO, 2013, AM NAT, V181, P799, DOI 10.1086/670198; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Wearing HJ, 2004, AM NAT, V164, P543, DOI 10.1086/424040; WEINER J, 1985, ECOLOGY, V66, P743, DOI 10.2307/1940535; Weitz JS, 2006, ECOL LETT, V9, P548, DOI 10.1111/j.1461-0248.2006.00900.x; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Zuidema PA, 2001, J ECOL, V89, P995, DOI 10.1111/j.1365-2745.2001.00621.x; Zuidema PA, 2009, AM NAT, V174, P709, DOI 10.1086/605981	46	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76389	10.1371/journal.pone.0076389	http://dx.doi.org/10.1371/journal.pone.0076389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204620	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000326241200012
J	Oliveira, LJ; Mansourri-Attia, N; Fahey, AG; Browne, J; Forde, N; Roche, JF; Lonergan, P; Fair, T				Oliveira, Lilian J.; Mansourri-Attia, Nadera; Fahey, Alan G.; Browne, John; Forde, Niamh; Roche, James F.; Lonergan, Patrick; Fair, Trudee			Characterization of the Th Profile of the Bovine Endometrium during the Oestrous Cycle and Early Pregnancy	PLOS ONE			English	Article							INDUCED TRANSCRIPTOME CHANGES; GENE-EXPRESSION PROFILES; NATURAL-KILLER-CELLS; NK CELLS; FETOMATERNAL INTERFACE; TROPHOBLAST CELLS; FETAL INTERFACE; DENDRITIC CELLS; MESSENGER-RNA; IMMUNE-SYSTEM	Despite extensive research in the area of cow fertility, the extent to which the maternal immune system is modulated during pregnancy in cattle remains unclear. Therefore, the objective of the current study was to characterize the presence and response profile of B, T-helper (LTh), T-cytotoxic (LTc), gamma delta-T (gamma delta T) and natural killer (NK) lymphocytes in terms of cell number, distribution and cytokine expression in bovine endometrial tissue to pregnancy. Endometrial tissue samples were collected from beef heifers on Days 5, 7, 13 and 16 of the estrous cycle or pregnancy. Samples were analysed by immunofluorescence to identify the presence and abundance of B-B7 (B-cells), CD4 (LTh), CD8 (LTc), gamma delta T cell receptor (TCR) and CD335/NKp46 (NK cells) -positive immune cells. Quantitative real time PCR (QPCR) was carried out to analyse mRNA relative abundance of FOXP3 (a marker of regulatory T (Treg) cells) and a panel of immune factors, including MHC-I, LIF, Interleukins 1, 2, 6, 8, 10, 11,12A, IFNa and IFNG. Results indicate that B-B7+ cells are quite populous in bovine endometrial tissue, CD4+ and CD8+-cells are present in moderate numbers and gamma delta TCR+ and CD335+ cells are present in low numbers. Pregnancy affected the total number and distribution pattern of the NK cell population, with the most significant variation observed on Day 16 of pregnancy. Neither B lymphocytes nor T lymphocyte subsets were regulated temporally during the oestrous cycle or by pregnancy prior to implantation. mRNA transcript abundance of the immune factors LIF, IL1b, IL8 and IL12A, IFNa and IFNG, expression was regulated temporally during the estrous cycle and LIF, IL1b, IL-10, IL11, IL12A were also temporally regulated during pregnancy. In conclusion, the endometrial immune profile of the oestrous cycle favours a Th2 environment in anticipation of pregnancy and the presence of an embryo acts to fine tune this environment.	[Oliveira, Lilian J.] Univ Sao Paulo, Fac Food Engn & Anim Sci, Sao Paulo, Brazil; [Mansourri-Attia, Nadera; Fahey, Alan G.; Browne, John; Forde, Niamh; Roche, James F.; Lonergan, Patrick; Fair, Trudee] Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland	Universidade de Sao Paulo; University College Dublin	Fair, T (corresponding author), Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland.	trudee.fair@ucd.ie	Fahey, Alan/AAY-6113-2020; J., Oliveira L./V-9028-2017; Fahey, Alan G/B-5566-2009	Fahey, Alan/0000-0002-4594-5767; J., Oliveira L./0000-0003-1402-8373; Forde, Niamh/0000-0002-3539-9643; Fair, Trudee/0000-0002-5079-8589	Science Foundation Ireland [05/PICA/B813]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland grant 05/PICA/B813 (www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain R, 2004, DEV DYNAM, V231, P700, DOI 10.1002/dvdy.20183; Al Naib A, 2011, J REPROD IMMUNOL, V91, P31, DOI 10.1016/j.jri.2011.05.005; ARICI A, 1995, J CLIN ENDOCR METAB, V80, P1908, DOI 10.1210/jc.80.6.1908; Arruvito L, 2007, J IMMUNOL, V178, P2572, DOI 10.4049/jimmunol.178.4.2572; Bainbridge DRJ, 2001, REPRODUCTION, V122, P907, DOI 10.1530/rep.0.1220907; Bauersachs S, 2006, REPRODUCTION, V132, P319, DOI 10.1530/rep.1.00996; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Bazer FW, 2009, REPRODUCTION, V138, P195, DOI 10.1530/REP-09-0158; Bosschaerts T, 2011, EUR J IMMUNOL, V41, P3270, DOI 10.1002/eji.201041307; Cerri RLA, 2012, J DAIRY SCI, V95, P5657, DOI 10.3168/jds.2011-5114; Chaouat G, 2002, J REPROD IMMUNOL, V53, P241, DOI 10.1016/S0165-0378(01)00119-X; Chaouat G, 1999, AM J REPROD IMMUNOL, V42, P1; Chaouat G, 2007, SEMIN IMMUNOPATHOL, V29, P95, DOI 10.1007/s00281-007-0069-0; CHARNOCKJONES DS, 1994, J REPROD FERTIL, V101, P421; COBB SP, 1995, RES VET SCI, V59, P238, DOI 10.1016/0034-5288(95)90010-1; Connelley T, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-37; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Davies CJ, 2006, AM J REPROD IMMUNOL, V55, P188, DOI 10.1111/j.1600-0897.2005.00364.x; Davies CJ, 2000, PLACENTA, V21, P194, DOI 10.1053/plac.1999.0475; De Mestre A, 2010, INT J DEV BIOL, V54, P445, DOI 10.1387/ijdb.082795ad; Dietl J, 2006, PLACENTA, V27, P341, DOI 10.1016/j.placenta.2005.05.001; Dimitriadis E, 2010, INT J DEV BIOL, V54, P313, DOI 10.1387/ijdb.082772ed; Doyle J, 2009, J REPROD IMMUNOL, V82, P48, DOI 10.1016/j.jri.2009.06.125; Fahey AG, 2007, POULTRY SCI, V86, P1312, DOI 10.1093/ps/86.7.1312; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Fouladi-Nashta AA, 2005, DEV BIOL, V281, P1, DOI 10.1016/j.ydbio.2005.01.033; Fox A, 2010, J REPROD IMMUNOL, V84, P52, DOI 10.1016/j.jri.2009.10.003; Groebner AE, 2011, REPROD FERT DEVELOP, V23, P619, DOI 10.1071/RD10230; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev; Ishiwata H, 2003, MOL REPROD DEV, V65, P9, DOI 10.1002/mrd.10292; Kallikourdis M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000382; Kimber SJ, 2008, REPRODUCTION, V135, P635, DOI 10.1530/REP-07-0359; King A, 2000, EUR J IMMUNOL, V30, P1623, DOI 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M; Klein C, 2006, BIOL REPROD, V74, P253, DOI 10.1095/biolreprod.105.046748; Leung ST, 2000, J REPROD FERTIL, V119, P25, DOI 10.1530/jrf.0.1190025; Majewski AC, 2001, IMMUNOLOGY, V102, P317, DOI 10.1046/j.1365-2567.2001.01182.x; Mansouri-Attia N, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101121; Mansouri-Attia N, 2009, PHYSIOL GENOMICS, V39, P14, DOI 10.1152/physiolgenomics.90404.2008; MEEUSEN E, 1993, EUR J IMMUNOL, V23, P1112, DOI 10.1002/eji.1830230520; Miyoshi M, 2004, REPROD DOMEST ANIM, V39, P125, DOI 10.1111/j.1439-0531.2004.00484.x; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; Ntrivalas EI, 2005, AM J REPROD IMMUNOL, V53, P215, DOI 10.1111/j.1600-0897.2005.00268.x; O'Driscoll KKM, 2009, J DAIRY SCI, V92, P4249, DOI 10.3168/jds.2008-1906; O'Gorman GM, 2010, BIOL REPROD, V83, P296, DOI 10.1095/biolreprod.109.082560; Oliveira LJ, 2008, REPRODUCTION, V136, P481, DOI 10.1530/REP-08-0218; Paiva P, 2009, CYTOKINE GROWTH F R, V20, P319, DOI 10.1016/j.cytogfr.2009.07.001; Raghupathy R, 1997, IMMUNOL TODAY, V18, P478, DOI 10.1016/S0167-5699(97)01127-4; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Robertson SA, 2007, BIOL REPROD, V76, P738, DOI 10.1095/biolreprod.106.056143; Rossi M, 2005, REPRODUCTION, V130, P721, DOI 10.1530/rep.1.00688; Salamonsen LA, 1996, HUM REPROD, V11, P124, DOI 10.1093/humrep/11.suppl_2.124; Oliveira LHS, 2010, REV SOC BRAS MED TRO, V43, P4, DOI 10.1590/S0037-86822010000100002; Shuya LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025288; SKOPETS B, 1992, VET IMMUNOL IMMUNOP, V34, P81, DOI 10.1016/0165-2427(92)90153-H; Svensson J, 2011, J IMMUNOL, V187, P3671, DOI 10.4049/jimmunol.1100130; Vasudevan SKM, 2013, AM J REPROD IMMUNOL, V69, P157; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Yang ZY, 2011, INT IMMUNOPHARMACOL, V11, P1442, DOI 10.1016/j.intimp.2011.04.024	60	50	51	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e75571	10.1371/journal.pone.0075571	http://dx.doi.org/10.1371/journal.pone.0075571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204576	gold, Green Submitted, Green Published			2022-12-27	WOS:000326155400008
J	Griffiths, KL; Stylianou, E; Poyntz, HC; Betts, GJ; Fletcher, HA; McShane, H				Griffiths, Kristin L.; Stylianou, Elena; Poyntz, Hazel C.; Betts, Gareth J.; Fletcher, Helen A.; McShane, Helen			Cholera Toxin Enhances Vaccine-Induced Protection against Mycobacterium Tuberculosis Challenge in Mice	PLOS ONE			English	Article							BOVIS BCG VACCINATION; T-CELLS; VIRUS ANKARA; IFN-GAMMA; IL-17; TH17; EXPRESSION; INDUCTION; RESPONSES; EFFICACY	Interleukin (IL)-17 is emerging as an important cytokine in vaccine-induced protection against tuberculosis disease in animal models. Here we show that compared to parenteral delivery, BCG delivered mucosally enhances cytokine production, including interferon gamma and IL-17, in the lungs. Furthermore, we find that cholera toxin, delivered mucosally along with BCG, further enhances IL-17 production by CD4(+) T cells over mucosal BCG alone both in the lungs and systemically. This boosting effect of CT is also observed using a vaccine regimen of BCG followed by the candidate vaccine MVA85A. Using a murine Mycobacterium tuberculosis (M.tb) aerosol challenge model, we demonstrate the ability of cholera toxin delivered at the time of a priming BCG vaccination to improve protection against tuberculosis disease in a manner at least partially dependent on the observed increase in IL-17. This observed increase in IL-17 in the lungs has no adverse effect on lung pathology following M.tb challenge, indicating that IL-17 can safely be boosted in murine lungs in a vaccine/M.tb challenge setting.	[Griffiths, Kristin L.; Stylianou, Elena; Poyntz, Hazel C.; Betts, Gareth J.; Fletcher, Helen A.; McShane, Helen] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	McShane, H (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	helen.mcshane@ndm.ox.ac.uk		/0000-0002-6008-2955; Fletcher, Helen/0000-0002-0435-1006; McShane, Helen/0000-0002-2126-5142	KLG's Wellcome Trust [WT086338RP]; HM's Wellcome Trust Senior Fellowship [WT076943MA]	KLG's Wellcome Trust; HM's Wellcome Trust Senior Fellowship	Funding was provided by KLG's Wellcome Trust studentship (www.wellcome.ac.uk; WT086338RP) and HM's Wellcome Trust Senior Fellowship (www.wellcome.ac.uk; WT076943MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LH, 2004, INFECT IMMUN, V72, P238, DOI 10.1128/IAI.72.1.238-246.2004; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Cowan J, 2012, CLIN EXP IMMUNOL, V167, P317, DOI 10.1111/j.1365-2249.2011.04520.x; Cubillos S, 2010, TOXINS, V2, P428, DOI 10.3390/toxins2040428; Datta SK, 2010, P NATL ACAD SCI US; de Cassan SC, 2010, CLIN VACCINE IMMUNOL, V17, P1066, DOI 10.1128/CVI.00047-10; Deroulers C, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-92; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Gopal R, 2012, EUR J IMMUNOL, V42, P364, DOI 10.1002/eji.201141569; Griffiths KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023463; Jurado JO, 2012, J LEUKOCYTE BIOL, V91, P991, DOI 10.1189/jlb.1211619; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khader SA, 2011, J IMMUNOL, V187, P5402, DOI 10.4049/jimmunol.1101377; la Sala A, 2009, J EXP MED, V206, P1227, DOI 10.1084/jem.20080912; Lee JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005190; LEFFORD MJ, 1977, INFECT IMMUN, V18, P646, DOI 10.1128/IAI.18.3.646-653.1977; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Lyadova IV, 2001, CLIN EXP IMMUNOL, V126, P274, DOI 10.1046/j.1365-2249.2001.01667.x; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Minassian AM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000223; Parra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028164; Qiao D, 2011, SCAND J IMMUNOL; Santos A.J., 2013, IMMUNOBIOLOGY; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Streicher EM, 2012, INFECT GENET EVOL, V12, P686, DOI 10.1016/j.meegid.2011.07.019; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; WHO, 2012, TUBERCULOSIS; Yu J, 2009, AM J PHYSIOL-GASTR L, V296, pG563, DOI 10.1152/ajpgi.90502.2008	33	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78312	10.1371/journal.pone.0078312	http://dx.doi.org/10.1371/journal.pone.0078312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194918	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326037000097
J	Klein, N; Sefe, D; Mosconi, I; Zanchetta, M; Castro, H; Jacobsen, M; Jones, H; Bernardi, S; Pillay, D; Giaquinto, C; Walker, AS; Gibb, DM; De Rossi, A				Klein, Nigel; Sefe, Delali; Mosconi, Ilaria; Zanchetta, Marisa; Castro, Hannah; Jacobsen, Marianne; Jones, Hannah; Bernardi, Stefania; Pillay, Deenan; Giaquinto, Carlo; Walker, A. Sarah; Gibb, Diana M.; De Rossi, Anita		PENTA 11 Trial Team	The Immunological and Virological Consequences of Planned Treatment Interruptions in Children with HIV Infection	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; STRUCTURED TREATMENT INTERRUPTION; T-CELL RECONSTITUTION; HIV-1-INFECTED CHILDREN; IMMUNE RECONSTITUTION; THYMIC OUTPUT; 1-INFECTED CHILDREN; PERIPHERAL-BLOOD; RANDOMIZED-TRIAL; COUNT	Objectives: To evaluate the immunological and viral consequences of planned treatment interruptions (PTI) in children with HIV. Design: This was an immunological and virological sub-study of the Paediatric European Network for Treatment of AIDS (PENTA) 11 trial, which compared CD4-guided PTI of antiretroviral therapy (ART) with continuous therapy (CT) in children. Methods: HIV-1 RNA and lymphocyte subsets, including CD4 and CD8 cells, were quantified on fresh samples collected during the study; CD45RA, CD45RO and CD31 subpopulations were evaluated in some centres. For 36 (18 PTI, 18 CT) children, immunophenotyping was performed and cell-associated HIV-1 DNA analysed on stored samples to 48 weeks. Results: In the PTI group, CD4 cell count fell rapidly in the first 12 weeks off ART, with decreases in both naive and memory cells. However, the proportion of CD4 cells expressing CD45RA and CD45RO remained constant in both groups. The increase in CD8 cells in the first 12 weeks off ART in the PTI group was predominantly due to increases in RO-expressing cells. PTI was associated with a rapid and sustained increase in CD4 cells expressing Ki67 and HLA-DR, and increased levels of HIV-1 DNA. Conclusions: PTI in children is associated with rapid changes in CD4 and CD8 cells, likely due to increased cell turnover and immune activation. However, children off treatment may be able to maintain stable levels of naive CD4 cells, at least in proportion to the memory cell pool, which may in part explain the observed excellent CD4 cell recovery with reintroduction of ART.	[Klein, Nigel; Sefe, Delali; Jacobsen, Marianne; Jones, Hannah] UCL, Inst Child Hlth, London, England; [Mosconi, Ilaria; Zanchetta, Marisa; De Rossi, Anita] Univ Padua, AIDS Reference Ctr, Padua, Italy; [Castro, Hannah; Walker, A. Sarah; Gibb, Diana M.] MRC, Clin Trials Unit, London, England; [Bernardi, Stefania] Bambino Gesu Pediat Hosp, Rome, Italy; [Pillay, Deenan] UCL, Sch Med, MRC, Ctr Med Mol Virol, London W1N 8AA, England; [Giaquinto, Carlo] Univ Padua, Dept Paediat, Padua, Italy	University of London; University College London; University of Padua; Medical Research Council Clinical Trials Unit; IRCCS Bambino Gesu; University of London; University College London; UCL Medical School; University of Padua	Klein, N (corresponding author), UCL, Inst Child Hlth, London, England.	n.klein@ucl.ac.uk	Cressey, Tim R./U-6428-2019; Marczynska, Magdalena/V-6904-2018; De Rossi, A./L-3128-2015; Thorne, Claire/C-5943-2008; VELLA, STEFANO/V-8440-2019; De Rossi, Anita/Q-4845-2019; Jourdain, Gonzague/F-9117-2017; Popielska, Jolanta/P-2206-2018; Walker, Sarah/HDM-8717-2022; treluyer, Jean-Marc/F-8036-2010; Bernardi, stefania/AAA-2803-2020; Giaquinto, Carlo/AAB-5016-2020	Cressey, Tim R./0000-0002-8106-0974; Marczynska, Magdalena/0000-0001-5731-6346; De Rossi, A./0000-0001-6435-7509; Thorne, Claire/0000-0003-0389-1956; VELLA, STEFANO/0000-0003-2347-5984; De Rossi, Anita/0000-0001-6435-7509; Jourdain, Gonzague/0000-0002-3365-7020; Popielska, Jolanta/0000-0001-9996-2178; Jacqz-Aigrain, Evelyne/0000-0002-4285-7067; Nunez Cuadros, Esmeralda/0000-0003-1938-1678; Munoz-Fernandez/0000-0002-0813-4500; GIAQUINTO, CARLO/0000-0001-9365-0413; Klein, Nigel/0000-0003-3925-9258; Castro, Hannah/0000-0001-9086-8687; Bernardi, Stefania/0000-0001-5672-0881	Paediatric European Network for Treatment of AIDS (PENTA); Great Ormond Street Children's Charity; European Union [201057]; MRC [G0400858, MC_U122886353] Funding Source: UKRI; Medical Research Council [G0400858, MC_U122886353] Funding Source: researchfish; National Institute for Health Research [11/136/108] Funding Source: researchfish	Paediatric European Network for Treatment of AIDS (PENTA); Great Ormond Street Children's Charity; European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Paediatric European Network for Treatment of AIDS (PENTA). Professor Nigel Klein was funded by Great Ormond Street Children's Charity. The work has also received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement n. 201057 (PENTA LABNET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander TH, 2003, JAIDS-J ACQ IMM DEF, V34, P475, DOI 10.1097/00126334-200312150-00005; Ananworanich J, 2006, LANCET, V368, P459, DOI 10.1016/S0140-6736(06)69153-8; Anselmi A, 2007, CLIN EXP IMMUNOL, V150, P442, DOI 10.1111/j.1365-2249.2007.03526.x; Baker JV, 2011, JAIDS-J ACQ IMM DEF, V56, P36, DOI 10.1097/QAI.0b013e3181f7f61a; Borkowsky W, 2008, VACCINE, V26, P3086, DOI 10.1016/j.vaccine.2007.12.017; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Bunupuradah T, 2013, AIDS, V27, P579, DOI 10.1097/QAD.0b013e32835c1181; Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; Castro H, 2010, AIDS, V24, P231, DOI 10.1097/QAD.0b013e328333d343; Catalfamo M, 2008, P NATL ACAD SCI USA, V105, P19851, DOI 10.1073/pnas.0810032105; Cotton M, 2012, 19 C RETR OPP INF SE; Danel C, 2006, LANCET, V367, P1981, DOI 10.1016/S0140-6736(06)68887-9; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; De Rossi A, 2002, J INFECT DIS, V186, P312, DOI 10.1086/341657; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fitzgerald F, 2013, AIDS RES HUM RETROVI; Gibb DM, 2000, LANCET, V355, P1331, DOI 10.1016/S0140-6736(00)02117-6; Gibb DM, 2004, PEDIATR INFECT DIS J, V23, P446, DOI 10.1097/01.inf.0000122601.62358.74; Junge S, 2007, EUR J IMMUNOL, V37, P3270, DOI 10.1002/eji.200636976; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Le Campion A, 2012, J IMMUNOL, V189, P3339, DOI 10.4049/jimmunol.1103152; Lewis J, 2012, CLIN INFECT DIS, V55, P304, DOI 10.1093/cid/cis374; Lewis J, 2012, J INFECT DIS, V205, P548, DOI 10.1093/infdis/jir787; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Libois A, 2006, AIDS RES HUM RETROV, V22, P657, DOI 10.1089/aid.2006.22.657; Lichtenstein KA, 2010, CLIN INFECT DIS, V51, P435, DOI 10.1086/655144; Ometto L, 2002, AIDS, V16, P839, DOI 10.1097/00002030-200204120-00003; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Palmisano L, 2007, JAIDS-J ACQ IMM DEF, V46, P39; Prendergast A, 2011, 18 C RETR OPP INF BO; Prendergast A, 2012, AIDS RES HUM RETROV, V28, P465, DOI [10.1089/AID.2011.0113, 10.1089/aid.2011.0113]; Steinmann G G, 1986, Curr Top Pathol, V75, P43; Stuart JWTC, 1998, AIDS, V12, P2155, DOI 10.1097/00002030-199816000-00010; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Thiebaut R, 2005, AIDS, V19, P53, DOI 10.1097/00002030-200501030-00006; van Rossum AMC, 2001, AIDS, V15, P2267, DOI 10.1097/00002030-200111230-00008; Walker AS, 2008, AIDS, V22, P237, DOI 10.1097/QAD.0b013e3282f2d760	39	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76582	10.1371/journal.pone.0076582	http://dx.doi.org/10.1371/journal.pone.0076582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194841	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000020
J	Lu, P; Struijs, MC; Mei, JP; Witte-Bouma, J; Korteland-van Male, AM; de Bruijn, ACJM; van Goudoever, JB; Renes, IB				Lu, Peng; Struijs, Marie-Chantal; Mei, Jiaping; Witte-Bouma, Janneke; Korteland-van Male, Anita M.; de Bruijn, Adrianus C. J. M.; van Goudoever, Johannes B.; Renes, Ingrid B.			Endoplasmic Reticulum Stress, Unfolded Protein Response and Altered T Cell Differentiation in Necrotizing Enterocolitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CRITICALLY-ILL INFANTS; ER STRESS; INTESTINAL INFLAMMATION; PLASMA INTERLEUKIN-6; PANETH CELLS; DEFENSINS; EXPRESSION; SEVERITY; COLITIS	Background: Endoplasmic reticulum (ER) stress and activation of the unfolded protein response (UPR) play important roles in chronic intestinal inflammation. Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency in preterm infants and is characterized by acute intestinal inflammation and necrosis. The objective of the study is to investigate the role of ER stress and the UPR in NEC patients. Methods: Ileal tissues from NEC and control patients were obtained during surgical resection and/or at stoma closure. Splicing of XBP1 was detected using PCR, and gene expression was quantified using qPCR and Western blot. Results: Splicing of XBP1 was only detected in a subset of acute NEC (A-NEC) patients, and not in NEC patients who had undergone reanastomosis (R-NEC). The other ER stress and the UPR pathways, PERK and ATF6, were not activated in NEC patients. A-NEC patients showing XBP1 splicing (A-NEC-XBP1s) had increased mucosal expression of GRP78, CHOP, IL6 and IL8. Similar results were obtained by inducing ER stress and the UPR in vitro. A-NEC-XBP1s patients showed altered T cell differentiation indicated by decreased mucosal expression of RORC, IL17A and FOXP3. A-NEC-XBP1s patients additionally showed more severe morphological damage and a worse surgical outcome. Compared with A-NEC patients, R-NEC patients showed lower mucosal IL6 and IL8 expression and higher mucosal FOXP3 expression. Conclusions: XBP1 splicing, ER stress and the UPR in NEC are associated with increased IL6 and IL8 expression levels, altered T cell differentiation and severe epithelial injury.	[Lu, Peng; Witte-Bouma, Janneke; Korteland-van Male, Anita M.; de Bruijn, Adrianus C. J. M.; Renes, Ingrid B.] Erasmus MC Sophia, Div Neonatol, Dept Pediat, Rotterdam, Netherlands; [Lu, Peng; van Goudoever, Johannes B.; Renes, Ingrid B.] Emma Childrens Hosp AMC, Dept Pediat, Amsterdam, Netherlands; [Struijs, Marie-Chantal] Erasmus MC Sophia, Dept Pediat Surg, Rotterdam, Netherlands; [Mei, Jiaping] Southern Med Univ, Neonatal Intens Care Unit, Shenzhen Maternal & Child Healthcare Hosp, Affiliated Hosp, Shenzhen, Guangdong, Peoples R China; [van Goudoever, Johannes B.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Southern Medical University - China; Vrije Universiteit Amsterdam	Renes, IB (corresponding author), Erasmus MC Sophia, Div Neonatol, Dept Pediat, Rotterdam, Netherlands.	i.b.renes@amc.uva.nl	Renes, Ingrid/C-4801-2013; van Goudoever, Johannes Bernard/Y-4520-2018	van Goudoever, Johannes (Hans)/0000-0003-3960-1703				Afonyushkin T, 2010, ARTERIOSCL THROM VAS, V30, P1007, DOI 10.1161/ATVBAHA.110.204354; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Barmada MM, 2004, INFLAMM BOWEL DIS, V10, P513, DOI 10.1097/00054725-200409000-00004; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Berman L, 2011, SEMIN FETAL NEONAT M, V16, P145, DOI 10.1016/j.siny.2011.02.002; Black A, 2012, EUR J IMMUNOL, V42, P311, DOI 10.1002/eji.201141847; Bogaert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025589; Chang SH, 2010, J BIOL CHEM, V285, P38751, DOI 10.1074/jbc.C110.185777; Coutinho HB, 1998, J CLIN PATHOL, V51, P512, DOI 10.1136/jcp.51.7.512; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Goepfert AR, 2004, AM J OBSTET GYNECOL, V191, P1375, DOI 10.1016/j.ajog.2004.06.086; Gregory Katherine E, 2011, Adv Neonatal Care, V11, P155, DOI 10.1097/ANC.0b013e31821baaf4; Guner YS, 2011, LAB INVEST, V91, P1668, DOI 10.1038/labinvest.2011.113; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Harris MC, 2005, J PEDIATR-US, V147, P462, DOI 10.1016/j.jpeds.2005.04.037; HARRIS MC, 1994, J PEDIATR-US, V124, P105, DOI 10.1016/S0022-3476(94)70264-0; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kaser A, 2010, MUCOSAL IMMUNOL, V3, P11, DOI 10.1038/mi.2009.122; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Lu P, 2011, INFLAMM BOWEL DIS, V17, P2047, DOI 10.1002/ibd.21592; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Mallow EB, 1996, J BIOL CHEM, V271, P4038; Markel TA, 2006, SHOCK, V25, P329, DOI 10.1097/01.shk.0000192126.33823.87; Martino MEB, 2009, J BIOL CHEM, V284, P14904, DOI 10.1074/jbc.M809180200; McGuckin MA, 2010, AM J PHYSIOL-GASTR L, V298, pG820, DOI 10.1152/ajpgi.00063.2010; MORECROFT J, 1994, ACTA PAEDIATR, V83, P18, DOI 10.1111/j.1651-2227.1994.tb13235.x; MORECROFT JA, 1994, J PEDIATR SURG, V29, P798, DOI 10.1016/0022-3468(94)90374-3; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; OUELLETTE AJ, 2010, NEOREV, V11, pE551, DOI DOI 10.1542/NE0.11-10-E551; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Putman PJ, 2011, PEDIATR RES, V69, P217, DOI 10.1203/PDR.0b013e3182092a9a; Ribeiro Carla M P, 2010, Proc Am Thorac Soc, V7, P387, DOI 10.1513/pats.201001-017AW; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Schaart MW, 2009, J PEDIATR GASTR NUTR, V49, P31, DOI 10.1097/MPG.0b013e318186d341; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Vermeire S, 2004, GUT, V53, P980, DOI 10.1136/gut.2003.034033; Weitkamp JH, 2013, GUT, V62, P73, DOI 10.1136/gutjnl-2011-301551; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Zenewicz LA, 2009, TRENDS MOL MED, V15, P199, DOI 10.1016/j.molmed.2009.03.002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	45	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78491	10.1371/journal.pone.0078491	http://dx.doi.org/10.1371/journal.pone.0078491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194940	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000119
J	Pereira, M; Verma, CS; Fuentes, G				Pereira, Mariana; Verma, Chandra S.; Fuentes, Gloria			Differences in the Binding Affinities of ErbB Family: Heterogeneity in the Prediction of Resistance Mutants	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; MOLECULAR-DYNAMICS; GENERALIZED BORN; LAPATINIB; MODEL; AMBER; EGFR; SIMULATIONS	The pressure exerted by drugs targeted to a protein in any therapy inevitably leads to the emergence of drug resistance. One major mechanism of resistance involves the mutation of key residues in the target protein. Drugs that competitively replace a natural substrate are often made ineffective by mutations that reduce the drug's affinity relative to that of the natural substrate. Hence atomic level understanding of the mechanisms that underlie this behavior is of utmost importance in efforts to design new drugs that can target such mutant proteins. Methods that can predict these mutations before they appear in clinic would be a major advance in the selection of the appropriate treatment strategy in patients. The present computational approach aims to model this emergence in EGFR and ErbB2 after treatment with the drug lapatinib, by investigating the structural, dynamic and energetic effects on these kinases when bound to the natural substrate ATP and to lapatinib. The study reveals binding modes and subpopulations that are presumably normally cryptic and these have been analyzed extensively here with respect to sites that are predicted to be hotspots for resisting mutations. These positions are compared in the context of currently available data from laboratory-based experiments and mechanistic details, at the atomistic level, of the origin of resistance are developed. The prediction of novel mutations, if validated by their emergence in the clinic, will make these methods as a powerful predictive tool which can be used in the design of new kinase inhibitors.	[Pereira, Mariana; Verma, Chandra S.; Fuentes, Gloria] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Verma, Chandra S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Verma, Chandra S.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Verma, CS (corresponding author), Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore.	chandra@bii.a-star.edu.sg; gfuentes@bii.a-star.edu.sg			Biomedical Sciences Institutes, Singapore	Biomedical Sciences Institutes, Singapore	Funding provided by The Biomedical Sciences Institutes, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avizienyte E, 2008, BIOCHEM J, V415, P197, DOI 10.1042/BJ20080728; Balius TE, 2009, BIOCHEMISTRY-US, V48, P8435, DOI 10.1021/bi900729a; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Boyce SE, 2009, J MOL BIOL, V394, P747, DOI 10.1016/j.jmb.2009.09.049; Case DA, 2012, AMBER 12; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eck MJ, 2010, BBA-PROTEINS PROTEOM, V1804, P559, DOI 10.1016/j.bbapap.2009.12.010; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Gilmer TM, 2008, CANCER RES, V68, P571, DOI 10.1158/0008-5472.CAN-07-2404; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Hayes JM, 2011, PROTEINS, V79, P703, DOI 10.1002/prot.22890; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang YL, 2012, BIOCHEMISTRY-US, V51, P2390, DOI 10.1021/bi2016553; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kancha RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026760; Muzzioli E, 2011, CHEM BIOL DRUG DES, V78, P252, DOI 10.1111/j.1747-0285.2011.01140.x; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V319, P1, DOI 10.1016/j.bbrc.2004.04.150; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Schrodinger LCC, 2010, PYMOL MOL GRAPHICS S; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Spector N, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1652; Strausberg RL, 2004, NATURE, V429, P469, DOI 10.1038/nature02627; Trowe T, 2008, CLIN CANCER RES, V14, P2465, DOI 10.1158/1078-0432.CCR-07-4367; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; Xia W, 2006, P NATL ACAD SCI USA, V103, P7795, DOI 10.1073/pnas.0602468103; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhou WZ, 2012, J CHEM INF MODEL, V52, P2319, DOI 10.1021/ci300341v	37	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77054	10.1371/journal.pone.0077054	http://dx.doi.org/10.1371/journal.pone.0077054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194858	Green Published, gold			2022-12-27	WOS:000326037000037
J	Sambroni, E; Lareyre, JJ; Le Gac, F				Sambroni, Elisabeth; Lareyre, Jean-Jacques; Le Gac, Florence			Fsh Controls Gene Expression in Fish both Independently of and through Steroid Mediation	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; RAINBOW-TROUT; JAPANESE EEL; IN-VITRO; SALMO-GAIRDNERI; LEYDIG-CELLS; GERM-CELLS; SPERMATOGENESIS; GONADOTROPIN; ANDROGEN	The mechanisms and the mediators relaying Fsh action on testicular functions are poorly understood. Unlike in mammals, in fish both gonadotropins (Fsh and Lh) are able to efficiently stimulate steroidogenesis, likely through a direct interaction with their cognate receptors present on the Leydig cells. In this context, it is crucial to understand if Fsh effects are mediated through the production of steroids. To address this issue we performed transcriptome studies after in vitro incubations of rainbow trout testis explants in the presence of Fsh alone or in combination with trilostane, an inhibitor of Delta 4-steroidogenesis. Trilostane significantly reduced or suppressed the response of many genes to Fsh (like wisp1, testis gapdhs, cldn11, inha, vt1 or dmrt1) showing that, in fish, important aspects of Fsh action follow indirect pathways and require the production of Delta 4-steroids. What is more, most of the genes regulated by Fsh through steroid mediation were similarly regulated by Lh (and/or androgens). In contrast, the response to Fsh of other genes was not suppressed in the presence of trilostane. These latter included genes encoding for anti-mullerian hormone, midkine a (pleiotrophin related), angiopoietine-related protein, cyclins E1 and G1, hepatocyte growth factor activator, insulin-like growth factor 1b/3. A majority of those genes were preferentially regulated by Fsh, when compared to Lh, suggesting that specific regulatory effects of Fsh did not depend on steroid production. Finally, antagonistic effects between Fsh and steroids were found, in particular for genes encoding key factors of steroidogenesis (star, hsd3b1, cyp11b2-2) or for genes of the Igf system (igf1b/3). Our study provides the first clear evidence that, in fish, Fsh exerts Delta 4-steroid-independent regulatory functions on many genes which are highly relevant for the onset of spermatogenesis.	[Sambroni, Elisabeth; Lareyre, Jean-Jacques; Le Gac, Florence] INRA, UR1037, LPGP, SFR BIOSIT, F-35042 Rennes, France	INRAE	Sambroni, E (corresponding author), INRA, UR1037, LPGP, SFR BIOSIT, Campus Beaulieu, F-35042 Rennes, France.	elisabeth.sambroni@rennes.inra.fr			French National Research Agency [ANR-06-GANI-014]; European Community [222719]	French National Research Agency(French National Research Agency (ANR)); European Community(European Commission)	This research received funding from the French National Research Agency (ANR-06-GANI-014 "Spermgen") and from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no222719, project LIFECYCLE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2008, ENDOCRINOLOGY, V149, P3279, DOI 10.1210/en.2008-0086; Alam MA, 2010, COMP BIOCHEM PHYS A, V156, P364, DOI 10.1016/j.cbpa.2010.03.001; Baccetti B, 1998, FASEB J, V12, P1045, DOI 10.1096/fasebj.12.11.1045; Baines H, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-4; Berishvili G, 2010, GEN COMP ENDOCR, V167, P128, DOI 10.1016/j.ygcen.2010.01.023; Borg B, 1994, TOXICOLOGY ENDOCRINO, V109, P219; Catizone A, 2006, J ENDOCRINOL, V189, P137, DOI 10.1677/joe.1.06528; Chalmel F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-86; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Chauvigne F, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100784; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; FOSTIER A, 1982, GEN COMP ENDOCR, V46, P428, DOI 10.1016/0016-6480(82)90096-X; FOSTIER A, 1987, P 3 INT S REPR PHYS, P239; Garcia-Lopez A, 2009, ENDOCRINOLOGY, V150, P357, DOI 10.1210/en.2008-0447; Garcia-Lopez A, 2010, ENDOCRINOLOGY, V151, P2349, DOI 10.1210/en.2009-1227; Gomez JM, 1999, GEN COMP ENDOCR, V113, P413, DOI 10.1006/gcen.1998.7222; Kazeto Y, 2008, BIOL REPROD, V79, P938, DOI 10.1095/biolreprod.108.070052; Li MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096248; Loir M, 1999, MOL REPROD DEV, V53, P434, DOI 10.1002/(SICI)1098-2795(199908)53:4&lt;434::AID-MRD9&gt;3.0.CO;2-L; LOIR M, 1994, BIOL REPROD, V51, P1154, DOI 10.1095/biolreprod51.6.1154; Loir M, 1999, MOL REPROD DEV, V53, P422, DOI 10.1002/(SICI)1098-2795(199908)53:4&lt;422::AID-MRD8&gt;3.0.CO;2-V; Lopez F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-38; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Mazon M.J., 2011, P143; McLean DJ, 2002, MOL ENDOCRINOL, V16, P2780, DOI 10.1210/me.2002-0059; MIURA T, 1991, P NATL ACAD SCI USA, V88, P5774, DOI 10.1073/pnas.88.13.5774; Miura T, 2002, DEVELOPMENT, V129, P2689; Nelson SN, 2010, GEN COMP ENDOCR, V168, P103, DOI 10.1016/j.ygcen.2010.04.021; O'Shaughnessy PJ, 2010, REPRODUCTION, V139, P177, DOI 10.1530/REP-09-0377; O'Shaughnessy PJ, 2009, MOL CELL ENDOCRINOL, V306, P2, DOI 10.1016/j.mce.2008.11.005; Ohta T, 2007, BIOL REPROD, V77, P970, DOI 10.1095/biolreprod.107.062299; OSHAUGHNESSY PJ, 1992, J ENDOCRINOL, V135, P517, DOI 10.1677/joe.0.1350517; PLANAS JV, 1992, GEN COMP ENDOCR, V87, P1, DOI 10.1016/0016-6480(92)90142-7; PLANAS JV, 1995, BIOL REPROD, V52, P697, DOI 10.1095/biolreprod52.3.697; Rescan PY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-438; Rolland AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053302; Rolland AD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-546; Sambroni E, 2007, J ENDOCRINOL, V195, P213, DOI 10.1677/JOE-06-0122; Sambroni E, 2013, J MOL ENDOCRINOL, V50, P1, DOI 10.1530/JME-12-0197; Schulz RW, 2008, GEN COMP ENDOCR, V156, P154, DOI 10.1016/j.ygcen.2008.01.002; Shen W, 2012, ENDOCRINOLOGY, V153, P3482, DOI 10.1210/en.2011-1456; Skaar KS, 2011, ENDOCRINOLOGY, V152, P3527, DOI 10.1210/en.2010-1469; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; SUZUKI K, 1988, GEN COMP ENDOCR, V71, P452, DOI 10.1016/0016-6480(88)90274-2; VANBOHEMEN CG, 1979, J ENDOCRINOL, V80, pP37; VANDENHURK R, 1982, REPROD NUTR DEV, V22, P413, DOI 10.1051/rnd:19820313; VANDERKRAAK G, 1992, GEN COMP ENDOCR, V85, P217, DOI 10.1016/0016-6480(92)90005-5; Wang DS, 2008, BIOCHEM BIOPH RES CO, V367, P336, DOI 10.1016/j.bbrc.2007.12.136; Xia Y, 2004, MOL ENDOCRINOL, V18, P979, DOI 10.1210/me.2003-0364; Zachow R, 2007, J ENDOCRINOL, V195, P359, DOI 10.1677/JOE-07-0466; Zhang N, 1999, P NATL ACAD SCI USA, V96, P6734, DOI 10.1073/pnas.96.12.6734	51	52	52	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76684	10.1371/journal.pone.0076684	http://dx.doi.org/10.1371/journal.pone.0076684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194844	Green Published, gold			2022-12-27	WOS:000326037000023
J	Vivek, PJ; Tuteja, N; Soniya, EV				Vivek, Padmanabhan Jayanthi; Tuteja, Narendra; Soniya, Eppurathu Vasudevan			CDPK1 from Ginger Promotes Salinity and Drought Stress Tolerance without Yield Penalty by Improving Growth and Photosynthesis in Nicotiana tabacum	PLOS ONE			English	Article							DEPENDENT-PROTEIN-KINASE; CALMODULIN-LIKE DOMAIN; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; LOW-TEMPERATURE; OVER-EXPRESSION; GENE-EXPRESSION; CROSS-TALK; PLANT; COLD	In plants, transient changes in calcium concentrations of cytosol have been observed during stress conditions like high salt, drought, extreme temperature and mechanical disturbances. Calcium-dependent protein kinases (CDPKs) play important roles in relaying these calcium signatures into downstream effects. In this study, a stress-responsive CDPK gene, ZoCDPK1 was isolated from a stress cDNA generated from ginger using rapid amplification of cDNA ends (RLM-RACE) - PCR technique and characterized its role in stress tolerance. An important aspect seen during the analysis of the deduced protein is a rare coupling between the presence of a nuclear localization sequence in the junction domain and consensus sequence in the EF-hand loops of calmodulin-like domain. ZoCDPK1 is abundantly expressed in rhizome and is rapidly induced by high-salt stress, drought, and jasmonic acid treatment but not by low temperature stress or abscissic acid treatment. The sub-cellular localization of ZoCDPK1-GFP fusion protein was studied in transgenic tobacco epidermal cells using confocal laser scanning microscopy. Over-expression of ginger CDPK1 gene in tobacco conferred tolerance to salinity and drought stress as reflected by the high percentage of seed germination, higher relative water content, expression of stress responsive genes, higher leaf chlorophyll content, increased photosynthetic efficiency and other photosynthetic parameters. In addition, transgenic tobacco subjected to salinity/drought stress exhibited 50% more growth during stress conditions as compared to wild type plant during normal conditions. T3 transgenic plants are able to grow to maturity, flowers early and set viable seeds under continuous salinity or drought stress without yield penalty. The ZoCDPK1 up-regulated the expression levels of stress-related genes RD21A and ERD1 in tobacco plants. These results suggest that ZoCDPK1 functions in the positive regulation of the signaling pathways that are involved in the response to salinity and drought stress in ginger and it is likely operating in a DRE/CRT independent manner.	[Vivek, Padmanabhan Jayanthi; Soniya, Eppurathu Vasudevan] Rajiv Gandhi Ctr Biotechnol, Plant Mol Biol Div, Thiruvananthapuram, Kerala, India; [Tuteja, Narendra] Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, New Delhi, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Soniya, EV (corresponding author), Rajiv Gandhi Ctr Biotechnol, Plant Mol Biol Div, Thiruvananthapuram, Kerala, India.	evsoniya@rgcb.res.in			Kerala State Council for Science, Technology and Environment [1418/C3/06/KSCSTE]; University Grant Commission (UGC), New Delhi, India [10-2(5)/2005(ii)-E.U.II]	Kerala State Council for Science, Technology and Environment; University Grant Commission (UGC), New Delhi, India(University Grants Commission, India)	The current work was supported by Kerala State Council for Science, Technology and Environment [grant number: 1418/C3/06/KSCSTE]. P. J. Vivek received fellowship from University Grant Commission (UGC), New Delhi, India [F.No. 10-2(5)/2005(ii)-E.U.II]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2004, PLANT MOL BIOL, V55, P541, DOI 10.1007/s11103-004-1178-y; Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Anil VS, 2000, PLANT PHYSIOL, V122, P1035, DOI 10.1104/pp.122.4.1035; Asano T, 2005, PLANT CELL PHYSIOL, V46, P356, DOI 10.1093/pcp/pci035; Asano T, 2012, PLANT SIGNAL BEHAV, V7, P817, DOI 10.4161/psb.20351; Asano T, 2012, PLANT J, V69, P26, DOI 10.1111/j.1365-313X.2011.04766.x; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Christodoulou J, 2004, J BIOL CHEM, V279, P29092, DOI 10.1074/jbc.M401297200; Chung E, 2007, PLANT PATHOLOGY J, V23, P76, DOI 10.5423/PPJ.2007.23.2.076; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dammann C, 2003, PLANT PHYSIOL, V132, P1840, DOI 10.1104/pp.103.020008; Dang HQ, 2011, PLANT MOL BIOL, V76, P19, DOI 10.1007/s11103-011-9758-0; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; GANG DR, 2008, GENOMICS TROPICAL CR; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Goel D, 2010, PROTOPLASMA, V245, P133, DOI 10.1007/s00709-010-0158-0; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Harmon Alice C, 2003, Gravit Space Biol Bull, V16, P83; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hubbard KE, 2012, ANN BOT-LONDON, V109, P5, DOI 10.1093/aob/mcr252; Jaworski K, 2012, J PLANT PHYSIOL, V169, P1578, DOI 10.1016/j.jplph.2012.05.025; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; KIYOSUE T, 1993, BIOCHEM BIOPH RES CO, V196, P1214, DOI 10.1006/bbrc.1993.2381; KIYOSUE T, 1994, PLANT MOL BIOL, V25, P791, DOI 10.1007/BF00028874; KOIZUMI M, 1993, GENE, V129, P175, DOI 10.1016/0378-1119(93)90266-6; Komatsu S, 2007, MOL GENET GENOMICS, V277, P713, DOI 10.1007/s00438-007-0220-6; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu GS, 2006, PLANT CELL ENVIRON, V29, P2091, DOI 10.1111/j.1365-3040.2006.01582.x; Lu SX, 2002, PLANT PHYSIOL, V128, P1008, DOI 10.1104/pp.010770; Ma SY, 2007, PLANT MOL BIOL, V65, P511, DOI 10.1007/s11103-007-9187-2; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mahajan S, 2008, ARCH BIOCHEM BIOPHYS, V471, P146, DOI 10.1016/j.abb.2008.01.010; Mechin Valerie, 2007, V355, P1; MEHLMER N, 2010, PLANT J, P97378; Milla MAR, 2006, FEBS LETT, V580, P904, DOI 10.1016/j.febslet.2006.01.013; Garcia MNM, 2012, PLANTA, V235, P761, DOI 10.1007/s00425-011-1540-7; Nakashima K, 1997, PLANT J, V12, P851, DOI 10.1046/j.1365-313X.1997.12040851.x; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pareek A, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P1, DOI 10.1007/978-90-481-3112-9; Patharkar OR, 2006, PLANTA, V225, P57, DOI 10.1007/s00425-006-0330-0; PICAL C, 1993, FEBS LETT, V336, P347, DOI 10.1016/0014-5793(93)80835-I; Prakash SRS, 2006, J PLANT PHYSIOL, V163, P1135, DOI 10.1016/j.jplph.2006.04.002; Raices M, 2003, PLANT MOL BIOL, V52, P1011, DOI 10.1023/A:1025478315648; Raichaudhuri A, 2006, J BIOL CHEM, V281, P10399, DOI 10.1074/jbc.M511001200; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Rutschmann F, 2002, PLANT PHYSIOL, V129, P156, DOI 10.1104/pp.000869; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Sanan-Mishra N, 2005, P NATL ACAD SCI USA, V102, P509, DOI 10.1073/pnas.0406485102; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; SCHREIBER U, 1988, Z NATURFORSCH C, V43, P686; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Silva EN, 2010, J PLANT PHYSIOL, V167, P1157, DOI 10.1016/j.jplph.2010.03.005; Szczegielniak J, 2012, PHYSIOL PLANTARUM, V146, P1, DOI 10.1111/j.1399-3054.2012.01587.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P79, DOI 10.4161/psb.2.2.4176; Tuteja N, 2010, METHODS MOL BIOL, V587, P377, DOI 10.1007/978-1-60327-355-8_26; Ulloa RM, 2002, PHYSIOL PLANTARUM, V115, P417, DOI 10.1034/j.1399-3054.2002.1150312.x; URAO T, 1994, MOL GEN GENET, V244, P331, DOI 10.1007/BF00286684; Vitart V, 2000, BIOCHEMISTRY-US, V39, P4004, DOI 10.1021/bi992373m; Wan BL, 2007, FEBS LETT, V581, P1179, DOI 10.1016/j.febslet.2007.02.030; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Witte CP, 2010, J BIOL CHEM, V285, P9740, DOI 10.1074/jbc.M109.052126; Wurzinger B, 2011, PLANT SIGNAL BEHAV, V6, P8, DOI 10.4161/psb.6.1.14012; Wydro M, 2006, ACTA BIOCHIM POL, V53, P289; Xu J, 2010, PLANTA, V231, P1251, DOI 10.1007/s00425-010-1122-0; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yoon GM, 1999, PLANT MOL BIOL, V39, P991, DOI 10.1023/A:1006170512542; Yu XC, 2006, PLANT PHYSIOL, V140, P558, DOI 10.1104/pp.105.074971; Zhao R, 2011, NEW PHYTOL, V192, P61, DOI 10.1111/j.1469-8137.2011.03793.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666; Zou JJ, 2010, PLANT PHYSIOL, V154, P1232, DOI 10.1104/pp.110.157545	82	42	45	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76392	10.1371/journal.pone.0076392	http://dx.doi.org/10.1371/journal.pone.0076392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194837	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000016
J	Seo, S; Takayama, K; Uno, K; Ohi, K; Hashimoto, R; Nishizawa, D; Ikeda, K; Ozaki, N; Nabeshima, T; Miyamoto, Y; Nitta, A				Seo, Seunghee; Takayama, Kanako; Uno, Kyosuke; Ohi, Kazutaka; Hashimoto, Ryota; Nishizawa, Daisuke; Ikeda, Kazutaka; Ozaki, Norio; Nabeshima, Toshitaka; Miyamoto, Yoshiaki; Nitta, Atsumi			Functional Analysis of Deep Intronic SNP rs13438494 in Intron 24 of PCLO Gene	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; BIPOLAR DISORDER; PROTEIN PICCOLO; DISEASE	The single nucleotide polymorphism (SNP) rs13438494 in intron 24 of PCLO was significantly associated with bipolar disorder in a meta-analysis of genome-wide association studies. In this study, we performed functional minigene analysis and bioinformatics prediction of splicing regulatory sequences to characterize the deep intronic SNP rs13438494. We constructed minigenes with A and C alleles containing exon 24, intron 24, and exon 25 of PCLO to assess the genetic effect of rs13438494 on splicing. We found that the C allele of rs13438494 reduces the splicing efficiency of the PCLO minigene. In addition, prediction analysis of enhancer/silencer motifs using the Human Splice Finder web tool indicated that rs13438494 induces the abrogation or creation of such binding sites. Our results indicate that rs13438494 alters splicing efficiency by creating or disrupting a splicing motif, which functions by binding of splicing regulatory proteins, and may ultimately result in bipolar disorder in affected people.	[Seo, Seunghee; Takayama, Kanako; Uno, Kyosuke; Miyamoto, Yoshiaki; Nitta, Atsumi] Toyama Univ, Fac Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama 930, Japan; [Seo, Seunghee] Toyama Univ, Fac Pharmaceut Sci, Dept Pharmaceut Educ, Toyama 930, Japan; [Ohi, Kazutaka; Hashimoto, Ryota] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan; [Hashimoto, Ryota] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Osaka, Japan; [Nishizawa, Daisuke; Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Tokyo 113, Japan; [Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan; [Nabeshima, Toshitaka] Meijo Univ, Dept Reg Pharmaceut Care & Sci, Nagoya, Aichi, Japan	University of Toyama; University of Toyama; Osaka University; Osaka University; Tokyo Metropolitan Institute of Medical Science; Nagoya University; Meijo University	Nitta, A (corresponding author), Toyama Univ, Fac Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama 930, Japan.	nitta@pha.u-toyama.ac.jp	Ozaki, Norio/M-8908-2014; Hashimoto, Ryota/P-8572-2014; Ohi, Kazutaka/J-7851-2019; Nitta, Atsumi/AAF-4211-2019; Hashimoto, Ryota/AAE-3200-2019	Ozaki, Norio/0000-0002-7360-4898; Hashimoto, Ryota/0000-0002-5941-4238; Ohi, Kazutaka/0000-0001-9577-9640; Hashimoto, Ryota/0000-0002-5941-4238	Program for Next Generation World-Leading Researchers (NEXT Program) [LS047]; Ministry of Education, Science, Sports and Culture of Japan; Japan Society for the Promotion of Science (JSPS); Ministry of Health, Labour and Welfare (MHLW); SRF Grant for Biomedical Research	Program for Next Generation World-Leading Researchers (NEXT Program); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); SRF Grant for Biomedical Research	This study was supported by the Program for Next Generation World-Leading Researchers (NEXT Program LS047), Grants-in-aid Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan, and for Scientific Research (KAKENHI)(B)(C) and Grant-in-Aid for Exploratory Research from Japan Society for the Promotion of Science (JSPS), Research on Regulatory Science of Pharmaceuticals, and Health and Labour Science Research Grants from the Ministry of Health, Labour and Welfare (MHLW), and a SRF Grant for Biomedical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Barnett JH, 2009, NEUROSCIENCE, V164, P331, DOI 10.1016/j.neuroscience.2009.03.080; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bochdanovits Z, 2009, MOL PSYCHIATR, V14, P650, DOI 10.1038/mp.2009.37; Bray NJ, 2012, WORLD PSYCHIATRY, V11, P153; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cen X, 2008, MOL PSYCHIATR, V13, P451, DOI 10.1038/sj.mp.4002132; Chasin LA, 2007, ADV EXP MED BIOL, V623, P85, DOI 10.1007/978-0-387-77374-2_6; Choi KH, 2011, BIOL PSYCHIAT, V69, P353, DOI 10.1016/j.biopsych.2010.09.042; Furukawa-Hibi Y, 2010, NEUROREPORT, V21, P1177, DOI 10.1097/WNR.0b013e3283411685; Hek K, 2010, HUM MOL GENET, V19, P731, DOI 10.1093/hmg/ddp529; Insel TR, 2003, AM J PSYCHIAT, V160, P616, DOI 10.1176/appi.ajp.160.4.616; Kleinman JE, 2011, BIOL PSYCHIAT, V69, P298, DOI 10.1016/j.biopsych.2010.12.008; Liu Y, 2011, MOL PSYCHIATR, V16, P2, DOI 10.1038/mp.2009.107; Nitta A, 2010, United States Patent US, Patent No. [7776538B2, 7776538]; Savas Sevtap, 2006, Human Genomics, V2, P274; Shyn SI, 2010, PSYCHIAT CLIN N AM, V33, P125, DOI 10.1016/j.psc.2009.10.004; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; Spitali P, 2012, CELL, V148, P1085, DOI 10.1016/j.cell.2012.02.014; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125	22	45	45	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76960	10.1371/journal.pone.0076960	http://dx.doi.org/10.1371/journal.pone.0076960			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167553	gold, Green Published, Green Submitted			2022-12-27	WOS:000326034500012
J	So, BI; Song, YS; Fang, CH; Park, JY; Lee, Y; Shin, JH; Kim, H; Kim, KS				So, Byung-Im; Song, Yi-Sun; Fang, Cheng-Hu; Park, Jun-Young; Lee, Yonggu; Shin, Jeong Hun; Kim, Hyuck; Kim, Kyung-Soo			G-CSF Prevents Progression of Diabetic Nephropathy in Rat	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; BONE-MARROW-TRANSPLANTATION; ACUTE MYOCARDIAL-INFARCTION; FOOT PROCESS EFFACEMENT; STEM-CELL MOBILIZATION; VERSUS-HOST-DISEASE; OLETF RATS; EXTRACELLULAR-MATRIX; RENAL-DISEASE; TGF-BETA	Background: The protective effects of granulocyte colony-stimulating factor (G-CSF) have been demonstrated in a variety of renal disease models. However, the influence of G-CSF on diabetic nephropathy (DN) remains to be examined. In this study, we investigated the effect of G-CSF on DN and its possible mechanisms in a rat model. Methods: Otsuka Long-Evans Tokushima Fatty (OLETF) rats with early DN were administered G-CSF or saline intraperitoneally. Urine albumin creatinine ratio (UACR), creatinine clearance, mesangial matrix expansion, glomerular basement membrane (GBM) thickness, and podocyte foot process width (FPW) were measured. The levels of interleukin (IL)-1 beta, transforming growth factor (TGF)-beta 1, and type IV collagen genes expression in kidney tissue were also evaluated. To elucidate the mechanisms underlying G-CSF effects, we also assessed the expression of G-CSF receptor (G-CSFR) in glomeruli as well as mobilization of bone marrow (BM) cells to glomeruli using sex-mismatched BM transplantation. Results: After four weeks of treatment, UACR was lower in the G-CSF treatment group than in the saline group (p<0.05), as were mesangial matrix expansion, GBM thickness, and FPW (p<0.05). In addition, the expression of TGF-beta 1 and type IV collagen and IL-1 beta levels was lower in the G-CSF treatment group (p<0.05). G-CSFR was not present in glomerular cells, and G-CSF treatment increased the number of BM-derived cells in glomeruli (p<0.05). Conclusions: G-CSF can prevent the progression of DN in OLETF rats and its effects may be due to mobilization of BM cells rather than being a direct effect.	[So, Byung-Im; Song, Yi-Sun; Park, Jun-Young; Kim, Kyung-Soo] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Fang, Cheng-Hu; Lee, Yonggu; Shin, Jeong Hun; Kim, Kyung-Soo] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea; [Fang, Cheng-Hu] Yanbian Univ, Coll Med, Dept Internal Med, Yanji, Peoples R China; [Kim, Hyuck] Hanyang Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul 133791, South Korea	Hanyang University; Hanyang University; Yanbian University; Hanyang University	Kim, KS (corresponding author), Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea.	kskim@hanyang.ac.kr	Lee, Yonggu/Q-3832-2018; Shin, Jeong Hun/O-1273-2019	Lee, Yonggu/0000-0002-3757-3692; Shin, Jeong Hun/0000-0002-6718-9763				ADLER S, 1994, J AM SOC NEPHROL, V5, P1165; Alpdogan O, 2001, BLOOD, V98, P2256, DOI 10.1182/blood.V98.7.2256; Alsaad KO, 2007, J CLIN PATHOL, V60, P18, DOI 10.1136/jcp.2005.035592; Belmiro CLR, 2011, BRAZ J MED BIOL RES, V44, P624, DOI [10.1590/S0100-879X2011007500077, 10.1590/S0100-879X2011000700003]; BENNETT PH, 1995, AM J KIDNEY DIS, V25, P107; Blom D, 2010, BBA-MOL CELL BIOL L, V1801, P1349, DOI 10.1016/j.bbalip.2010.08.013; Deegens JKJ, 2008, KIDNEY INT, V74, P1568, DOI 10.1038/ki.2008.413; Fang TC, 2005, J AM SOC NEPHROL, V16, P1723, DOI 10.1681/ASN.2004121089; Flaquer M, 2012, DIABETOLOGIA, V55, P2059, DOI 10.1007/s00125-012-2535-z; Fukuzawa Y, 1996, J LAB CLIN MED, V128, P568, DOI 10.1016/S0022-2143(96)90129-8; GABRILOVE JL, 1988, NEW ENGL J MED, V318, P1414, DOI 10.1056/NEJM198806023182202; Giunti S, 2006, HYPERTENSION, V48, P519, DOI 10.1161/01.HYP.0000240331.32352.0c; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Ho CC, 2010, ONCOTARGET, V1, P583; Hou XW, 2009, TOXICOL LETT, V187, P40, DOI 10.1016/j.toxlet.2009.01.025; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Kilkenny C, 2012, VET CLIN PATH, V41, P27, DOI 10.1111/j.1939-165X.2012.00418.x; Kim SY, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/945123; Ko GJ, 2008, NEPHROL DIAL TRANSPL, V23, P2750, DOI 10.1093/ndt/gfn157; Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076; Lim YH, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-92; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; MOGENSEN CE, 1987, KIDNEY INT, V31, P673, DOI 10.1038/ki.1987.50; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Park KW, 2008, J MOL CELL CARDIOL, V45, P670, DOI 10.1016/j.yjmcc.2008.07.002; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Prodromidi EI, 2006, STEM CELLS, V24, P2448, DOI 10.1634/stemcells.2006-0201; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; SHERIDAN WP, 1989, LANCET, V2, P891; Shoji E, 1997, DIGEST DIS SCI, V42, P915, DOI 10.1023/A:1018860313674; Song YS, 2013, ANN HEPATOL, V12, P115, DOI 10.1016/S1665-2681(19)31393-6; Sugimoto K, 2001, CLIN EXP PHARMACOL P, V28, P826, DOI 10.1046/j.1440-1681.2001.03530.x; Tai CY, 2004, TRANSPLANTATION, V77, P316, DOI 10.1097/01.TP.0000101511.11171.EF; Thomson SE, 2008, J DIABETES COMPLICAT, V22, P284, DOI 10.1016/j.jdiacomp.2007.07.001; van den Berg JG, 2004, KIDNEY INT, V66, P1901, DOI 10.1111/j.1523-1755.2004.00964.x; Tavares AMV, 2010, LIFE SCI, V87, P699, DOI 10.1016/j.lfs.2010.10.008; Wei QQ, 2011, AM J PHYSIOL-RENAL, V301, pF162, DOI 10.1152/ajprenal.00438.2010; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Yi-Sun S, 2013, ANN HEPATOL, V12, P115; Zhang HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032746; ZIYADEH FN, 1993, AM J KIDNEY DIS, V22, P736, DOI 10.1016/S0272-6386(12)80440-9; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B; Zohlnhofer D, 2006, JAMA-J AM MED ASSOC, V295, P1003, DOI 10.1001/jama.295.9.1003	43	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77048	10.1371/journal.pone.0077048	http://dx.doi.org/10.1371/journal.pone.0077048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167558	gold, Green Submitted, Green Published			2022-12-27	WOS:000326034500017
J	Nakajima, T; Mezzarane, RA; Klarner, T; Barss, TS; Hundza, SR; Komiyama, T; Zehr, EP				Nakajima, Tsuyoshi; Mezzarane, Rinaldo A.; Klarner, Taryn; Barss, Trevor S.; Hundza, Sandra R.; Komiyama, Tomoyoshi; Zehr, E. Paul			Neural Mechanisms Influencing Interlimb Coordination during Locomotion in Humans: Presynaptic Modulation of Forearm H-Reflexes during Leg Cycling	PLOS ONE			English	Article							CUTANEOUS REFLEXES; MUSCLE AFFERENTS; INHIBITION; ARM; AMPLITUDE; MOVEMENT; SUPPRESSION; FEEDBACK; GAIN	Presynaptic inhibition of transmission between Ia afferent terminals and alpha motoneurons (Ia PSI) is a major control mechanism associated with soleus H-reflex modulation during human locomotion. Rhythmic arm cycling suppresses soleus H-reflex amplitude by increasing segmental Ia PSI. There is a reciprocal organization in the human nervous system such that arm cycling modulates H-reflexes in leg muscles and leg cycling modulates H-reflexes in forearm muscles. However, comparatively little is known about mechanisms subserving the effects from leg to arm. Using a conditioning-test (C-T) stimulation paradigm, the purpose of this study was to test the hypothesis that changes in Ia PSI underlie the modulation of H-reflexes in forearm flexor muscles during leg cycling. Subjects performed leg cycling and static activation while H-reflexes were evoked in forearm flexor muscles. H-reflexes were conditioned with either electrical stimuli to the radial nerve (to increase Ia PSI; C-T interval = 20 ms) or to the superficial radial (SR) nerve (to reduce Ia PSI; C-T interval = 37-47 ms). While stationary, H-reflex amplitudes were significantly suppressed by radial nerve conditioning and facilitated by SR nerve conditioning. Leg cycling suppressed H-reflex amplitudes and the amount of this suppression was increased with radial nerve conditioning. SR conditioning stimulation removed the suppression of H-reflex amplitude resulting from leg cycling. Interestingly, these effects and interactions on H-reflex amplitudes were observed with subthreshold conditioning stimulus intensities (radial n. similar to 0.6xMT; SR n., similar to perceptual threshold) that did not have clear post synaptic effects. That is, did not evoke reflexes in the surface EMG of forearm flexor muscles. We conclude that the interaction between leg cycling and somatosensory conditioning of forearm H-reex amplitudes is mediated by modulation of Ia PSI pathways. Overall our results support a conservation of neural control mechanisms between the arms and legs during locomotor behaviors in humans.	[Nakajima, Tsuyoshi] Kyorin Univ, Sch Med, Dept Integrat Physiol, Mitaka, Tokyo 181, Japan; [Nakajima, Tsuyoshi; Mezzarane, Rinaldo A.; Klarner, Taryn; Barss, Trevor S.; Zehr, E. Paul] Univ Victoria, Rehabil Neurosci Lab, Victoria, BC, Canada; [Nakajima, Tsuyoshi] Univ Brasilia, Coll Phys Educ, Lab Signal Proc & Motor Control, Brasilia, DF, Brazil; [Klarner, Taryn; Barss, Trevor S.; Hundza, Sandra R.; Zehr, E. Paul] Int Collaborat Repair Discoveries ICORD, Human Discovery Sci, Vancouver, BC, Canada; [Klarner, Taryn; Barss, Trevor S.; Hundza, Sandra R.; Zehr, E. Paul] Univ Victoria, Ctr Biomed Res, Victoria, BC, Canada; [Hundza, Sandra R.] Univ Victoria, Mot & Mobil Lab, Victoria, BC, Canada; [Komiyama, Tomoyoshi] Chiba Univ, Div Sports & Hlth Sci, Chiba, Japan; [Zehr, E. Paul] Univ Victoria, Div Med Sci, Victoria, BC, Canada	Kyorin University; University of Victoria; Universidade de Brasilia; University of Victoria; University of Victoria; Chiba University; University of Victoria	Zehr, EP (corresponding author), Univ Victoria, Rehabil Neurosci Lab, Victoria, BC, Canada.	pzehr@uvic.ca	MEZZARANE, Rinaldo A/I-2862-2013; Barss, Trevor/L-7045-2019	Barss, Trevor/0000-0003-3466-2750; Mezzarane, Rinaldo/0000-0001-9659-4015	Japan Society for the Promotion of Science (JSPS) for young Scientists; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada (BC Yukon)	Japan Society for the Promotion of Science (JSPS) for young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation of Canada (BC Yukon)(Heart & Stroke Foundation of Canada)	Japan Society for the Promotion of Science (JSPS) for young Scientists; the Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada (BC & Yukon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERARDELLI A, 1987, J PHYSIOL-LONDON, V391, P71, DOI 10.1113/jphysiol.1987.sp016726; Brooke JD, 2006, EXERC SPORT SCI REV, V34, P22, DOI 10.1097/00003677-200601000-00006; Brooke JD, 1997, PROG NEUROBIOL, V51, P393, DOI 10.1016/S0301-0082(96)00061-5; CALANCIE B, 1994, BRAIN, V117, P1143, DOI 10.1093/brain/117.5.1143; CAPADAY C, 1995, CAN J PHYSIOL PHARM, V73, P436, DOI 10.1139/y95-056; Cote MP, 2003, J NEUROSCI, V23, P2789; de Ruiter GC, 2010, NEUROSCI LETT, V475, P7, DOI 10.1016/j.neulet.2010.03.025; Dietz V, 2002, TRENDS NEUROSCI, V25, P462, DOI 10.1016/S0166-2236(02)02229-4; ECCLES JC, 1962, J PHYSIOL-LONDON, V161, P258, DOI 10.1113/jphysiol.1962.sp006885; Frigon A, 2004, J NEUROPHYSIOL, V91, P1516, DOI 10.1152/jn.00695.2003; FUKUSHIMA Y, 1982, J NEUROPHYSIOL, V48, P1079, DOI 10.1152/jn.1982.48.5.1079; HULTBORN H, 1987, J PHYSIOL-LONDON, V389, P757, DOI 10.1113/jphysiol.1987.sp016681; Hundza SR, 2012, J NEUROPHYSIOL, V108, P3049, DOI 10.1152/jn.00485.2011; Hundza SR, 2009, EXP BRAIN RES, V193, P297, DOI 10.1007/s00221-008-1625-0; Juvin L, 2005, J NEUROSCI, V25, P6025, DOI 10.1523/JNEUROSCI.0696-05.2005; Klarner T, 2011, SOC NEUR M; Loadman PM, 2007, EXP BRAIN RES, V179, P199, DOI 10.1007/s00221-006-0782-2; MATTHEWS PBC, 1986, J PHYSIOL-LONDON, V374, P73, DOI 10.1113/jphysiol.1986.sp016066; Mezzarane RA, 2011, EXP BRAIN RES, V208, P157, DOI 10.1007/s00221-010-2467-0; Mezzarane RA, 2007, EXP BRAIN RES, V180, P377, DOI 10.1007/s00221-007-0865-8; Mezzarane RA, 2012, J NEUROPHYSIOL, V108, P1176, DOI 10.1152/jn.00831.2011; MIZUNO Y, 1971, J NEUROPHYSIOL, V34, P1010, DOI 10.1152/jn.1971.34.6.1010; Nakajima T, 2011, J NEUROPHYSIOL, V106, P1679, DOI 10.1152/jn.01049.2010; NAKASHIMA K, 1990, J PHYSIOL-LONDON, V426, P369, DOI 10.1113/jphysiol.1990.sp018143; Palomino AF, 2011, EXP BRAIN RES, V214, P529, DOI 10.1007/s00221-011-2851-4; Pang MYC, 2001, J PHYSIOL-LONDON, V533, P617, DOI 10.1111/j.1469-7793.2001.0617a.x; Pierrot-Deseilligny E, 2012, CIRCUITRY OF THE HUMAN SPINAL CORD: SPINAL AND CORTICOSPINAL MECHANISMS OF MOVEMENT, P334; RUDOMIN P, 1990, TRENDS NEUROSCI, V13, P499, DOI 10.1016/0166-2236(90)90084-N; Sakamoto M, 2007, EXP BRAIN RES, V176, P188, DOI 10.1007/s00221-006-0742-x; Sasada S, 2010, J NEUROPHYSIOL, V104, P210, DOI 10.1152/jn.00774.2009; Stein RB, 1995, PROG NEUROBIOL, V47, P533, DOI 10.1016/0301-0082(95)00036-4; STUART GJ, 1992, J PHYSIOL-LONDON, V447, P675, DOI 10.1113/jphysiol.1992.sp019023; Tazoe T, 2013, EUR J NEUROSCI, V37, P96, DOI 10.1111/ejn.12026; Tsushima E, 2007, ANAL MED DATA SPSS, P159; Zehr EP, 2007, NEUROSCI LETT, V419, P10, DOI 10.1016/j.neulet.2007.03.045; Zehr EP, 2009, EXERC SPORT SCI REV, V37, P102, DOI 10.1097/JES.0b013e31819c2ed6; Zehr EP, 1997, J NEUROPHYSIOL, V77, P3311, DOI 10.1152/jn.1997.77.6.3311; Zehr EP, 2004, NEUROSCIENTIST, V10, P347, DOI 10.1177/1073858404264680; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5	39	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76313	10.1371/journal.pone.0076313	http://dx.doi.org/10.1371/journal.pone.0076313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204611	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300019
J	Westman, G; Lidehall, AK; Magnusson, P; Ingelsson, M; Kilander, L; Lannfelt, L; Korsgren, O; Eriksson, BM				Westman, Gabriel; Lidehall, Anna-Karin; Magnusson, Peetra; Ingelsson, Martin; Kilander, Lena; Lannfelt, Lars; Korsgren, Olle; Eriksson, Britt-Marie			Decreased Proportion of Cytomegalovirus Specific CD8 T-Cells but No Signs of General Immunosenescence in Alzheimer's Disease	PLOS ONE			English	Article							ELDERLY INDIVIDUALS; ASSOCIATION; INFECTION; IMPACT; IMMUNE; CMV; SEROPOSITIVITY; LYMPHOCYTES; VIRUS; OLD	Cytomegalovirus (CMV) has been suggested as a contributing force behind the impaired immune responsiveness in the elderly, with decreased numbers of naive T-cells and an increased proportion of effector T-cells. Immunological impairment is also implicated as a part of the pathogenesis in Alzheimer's disease (AD). The aim of this study was to investigate whether AD patients present with a different CMV-specific CD8 immune profile compared to non-demented controls. Blood samples from 50 AD patients and 50 age-matched controls were analysed for HLA-type, CMV serostatus and systemic inflammatory biomarkers. Using multi-colour flow cytometry, lymphocytes from peripheral blood mononuclear cells were analysed for CMV-specific CD8 immunity with MHC-I tetramers A01, A02, A24, B07, B08 and B35 and further classified using CD27, CD28, CD45RA and CCR7 antibodies. Among CMV seropositive subjects, patients with AD had significantly lower proportions of CMV-specific CD8 T-cells compared to controls, 1.16 % vs. 4.13 % (p=0.0057). Regardless of dementia status, CMV seropositive subjects presented with a lower proportion of naive CD8 cells and a higher proportion of effector CD8 cells compared to seronegative subjects. Interestingly, patients with AD showed a decreased proportion of CMV-specific CD8 cells but no difference in general CD8 differentiation.	[Westman, Gabriel; Eriksson, Britt-Marie] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Westman, Gabriel; Lidehall, Anna-Karin; Magnusson, Peetra; Korsgren, Olle] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Ingelsson, Martin; Kilander, Lena; Lannfelt, Lars] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Westman, G (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	gabriel.westman@medsci.uu.se		Korsgren, Olle/0000-0002-8524-9547	Family Ohlinder-Nielsen's Foundation; Uppsala University; Landstinget i Uppsala lan; Swedish Research Council [2006-2822, 2006-6326, 2006-3464]; Swedish Brain Foundation; Swedish Alzheimer Foundation; Swedish Society of Medicine	Family Ohlinder-Nielsen's Foundation; Uppsala University; Landstinget i Uppsala lan; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Swedish Alzheimer Foundation; Swedish Society of Medicine	This work was funded by grants from The Family Ohlinder-Nielsen's Foundation, Uppsala University, Landstinget i Uppsala lan, Swedish Research Council (2006-2822, 2006-6326 and 2006-3464), Swedish Brain Foundation, Swedish Alzheimer Foundation and Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLFORS K, 1984, SCAND J INFECT DIS, V16, P335, DOI 10.3109/00365548409073957; Arias RA, 2013, J VIROL, V87, P4486, DOI 10.1128/JVI.02425-12; Bartlett DB, 2012, AGING CELL, V11, P912, DOI 10.1111/j.1474-9726.2012.00849.x; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Boeckh M, 2004, BLOOD, V103, P2003, DOI 10.1182/blood-2003-10-3616; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Colonna-Romano G, 2007, EXP GERONTOL, V42, P995, DOI 10.1016/j.exger.2007.05.006; Derhovanessian E, 2011, J GEN VIROL, V92, P2746, DOI 10.1099/vir.0.036004-0; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Gratama JW, 2001, BLOOD, V98, P1358, DOI 10.1182/blood.V98.5.1358; Herndler-Brandstetter D, 2012, J LEUKOCYTE BIOL, V91, P197, DOI 10.1189/jlb.0611299; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Larbi A, 2009, J ALZHEIMERS DIS, V17, P91, DOI 10.3233/JAD-2009-1015; Mansouri H, 1995, COMPUT STAT DATA ANA; Marques AR, 2001, J NEUROVIROL, V7, P82; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nilsson Lars, 1998, Frontiers in Bioscience, V3, pD436; Pellicano M, 2012, J NEUROIMMUNOL, V242, P52, DOI 10.1016/j.jneuroim.2011.11.005; PIRTTILA T, 1992, J NEUROL SCI, V107, P160, DOI 10.1016/0022-510X(92)90284-R; Pita-Lopez Maria Luisa, 2009, Immun Ageing, V6, P11, DOI 10.1186/1742-4933-6-11; Premkumar DRD, 1996, AM J PATHOL, V148, P2083; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Solana R, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-23; Sund F, 2010, CLIN TRANSPLANT, V24, P401, DOI 10.1111/j.1399-0012.2009.00976.x; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; Vescovini R, 2004, EXP GERONTOL, V39, P1233, DOI 10.1016/j.exger.2004.04.004; Vescovini R, 2007, J IMMUNOL, V179, P4283, DOI 10.4049/jimmunol.179.6.4283; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6	32	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77921	10.1371/journal.pone.0077921	http://dx.doi.org/10.1371/journal.pone.0077921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155977	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300111
J	Lienau, EK; Blazar, JM; Wang, C; Brown, EW; Stones, R; Musser, S; Allard, MW				Lienau, E. Kurt; Blazar, Jeffrey M.; Wang, Charles; Brown, Eric W.; Stones, Robert; Musser, Steven; Allard, Marc W.			Phylogenomic Analysis Identifies Gene Gains That Define Salmonella enterica Subspecies I	PLOS ONE			English	Article							TREE; EVOLUTION; CLASSIFICATION; PATHOGENS; LIFE	Comparative methods for analyzing whole genome sequence (WGS) data enable us to assess the genetic information available for reconstructing the evolutionary history of pathogens. We used the comparative approach to determine diagnostic genes for Salmonella enterica subspecies I. S. enterica subsp. I strains are known to infect warm-blooded organisms regularly while its close relatives tend to infect only cold-blooded organisms. We found 71 genes gained by the common ancestor of Salmonella enterica subspecies I and not subsequently lost by any member of this subspecies sequenced to date. These genes included many putative functional phenotypes. Twenty-seven of these genes are found only in Salmonella enterica subspecies I; we designed primers to test these genes for use as diagnostic sequence targets and data mined the NCBI Sequence Read Archive (SRA) database for draft genomes which carried these genes. We found that the sequence specificity and variability of these amplicons can be used to detect and discriminate among 317 different serovars and strains of Salmonella enterica subspecies I.	[Lienau, E. Kurt; Blazar, Jeffrey M.; Wang, Charles; Brown, Eric W.; Musser, Steven; Allard, Marc W.] US FDA, Off Ctr Director, Ctr Food Safety & Appl Nutr, College Pk, MD USA; [Lienau, E. Kurt] Evolut Ind LLC, Frederick, MD USA; [Blazar, Jeffrey M.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Stones, Robert] Food & Environm Res Agcy, York, N Yorkshire, England	US Food & Drug Administration (FDA); University System of Maryland; University of Maryland College Park; Food & Environment Research Agency	Lienau, EK (corresponding author), US FDA, Off Ctr Director, Ctr Food Safety & Appl Nutr, College Pk, MD USA.	kurt.lienau@evolutionindustriesllc.com; marc.allard@fda.hhs.gov			Center for Food Safety and Applied Nutrition (CFSAN) of the United States Internal Food and Drug Administration (FDA); Oak Ridge Institute for Science Education; Evolution Industries LLC	Center for Food Safety and Applied Nutrition (CFSAN) of the United States Internal Food and Drug Administration (FDA); Oak Ridge Institute for Science Education(United States Department of Energy (DOE)); Evolution Industries LLC	All funds for this research came from The Center for Food Safety and Applied Nutrition (CFSAN) of the United States Internal Food and Drug Administration (FDA) research funds. E. Kurt Lienau was partially supported by a grant from the Oak Ridge Institute for Science Education and by Evolution Industries LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Bapteste Eric, 2009, V532, P55, DOI 10.1007/978-1-60327-853-9_4; Baumler AJ, 1998, INFECT IMMUN, V66, P4579; Baumler AJ, 1997, TRENDS MICROBIOL, V5, P318, DOI 10.1016/S0966-842X(97)01082-2; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Creevey CJ, 2004, P ROY SOC B-BIOL SCI, V271, P2551, DOI 10.1098/rspb.2004.2864; Desai PT, 2013, MBIO, V4; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fookes M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002191; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Gilliss Debra, 2011, Morbidity and Mortality Weekly Report, V60, P749; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kurland CG, 2005, BIOESSAYS, V27, P741, DOI 10.1002/bies.20258; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; LEMINOR L, 1987, INT J SYST BACTERIOL, V37, P465, DOI 10.1099/00207713-37-4-465; Lienau EK, 2010, CLADISTICS, V26, P195, DOI 10.1111/j.1096-0031.2009.00288.x; Lienau EK, 2006, SYST BIOL, V55, P441, DOI 10.1080/10635150600697416; Lienau EK, 2011, CLADISTICS, V27, P417, DOI 10.1111/j.1096-0031.2010.00337.x; Lienau EK, 2011, NEW ENGL J MED, V364, P981, DOI 10.1056/NEJMc1100443; Lienau EK, 2012, APPLICATION; Lienau EK, 2011, CLADISTICS IN PRESS; Muller K, 2004, MOL PHYLOGENET EVOL, V31, P780, DOI 10.1016/j.ympev.2003.12.006; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593	28	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76821	10.1371/journal.pone.0076821	http://dx.doi.org/10.1371/journal.pone.0076821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204679	Green Published, Green Submitted, gold			2022-12-27	WOS:000326241200014
J	Molina-Montenegro, MA; Salgado-Luarte, C; Oses, R; Torres-Diaz, C				Molina-Montenegro, Marco A.; Salgado-Luarte, Cristian; Oses, Romulo; Torres-Diaz, Cristian			Is Physiological Performance a Good Predictor for Fitness? Insights from an Invasive Plant Species	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; MESOPHYLL CONDUCTANCE; TARAXACUM-OFFICINALE; PHOTOSYSTEM-II; WATER-STRESS; OAK TREES; PHOTOSYNTHESIS; DROUGHT; PLASTICITY; LIMITATIONS	Is physiological performance a suitable proxy of fitness in plants? Although, several studies have been conducted to measure some fitness-related traits and physiological performance, direct assessments are seldom found in the literature. Here, we assessed the physiology-fitness relationship using second-generation individuals of the invasive plant species Taraxacum officinale from 17 localities distributed in five continents. Specifically, we tested if i) the maximum quantum yield is a good predictor for seed-output ii) whether this physiology-fitness relationship can be modified by environmental heterogeneity, and iii) if this relationship has an adaptive consequence for T. officinale individuals from different localities. Overall, we found a significant positive relationship between the maximum quantum yield and fitness for all localities evaluated, but this relationship decreased in T. officinale individuals from localities with greater environmental heterogeneity. Finally, we found that those individuals from localities where environmental conditions are highly seasonal performed better under heterogeneous environmental conditions. Contrarily, under homogeneous controlled conditions, those individuals from localities with low environmental seasonality performed much better. In conclusion, our results suggest that the maximum quantum yield seem to be good predictors for plant fitness. We suggest that rapid measurements, such as those obtained from the maximum quantum yield, could provide a straightforward proxy of individual's fitness in changing environments.	[Molina-Montenegro, Marco A.; Oses, Romulo] Univ Catolica Norte, Fac Ciencias Mar, CEAZA, Coquimbo, Chile; [Salgado-Luarte, Cristian] Univ La Serena, Dept Biol, La Serena, Chile; [Torres-Diaz, Cristian] Univ Bio Bio, Dept Ciencias Nat, LGB, Chillan, Chile	Universidad Catolica del Norte; Universidad de La Serena; Universidad del Bio-Bio	Molina-Montenegro, MA (corresponding author), Univ Catolica Norte, Fac Ciencias Mar, CEAZA, Coquimbo, Chile.	marco.molina@ceaza.cl		Oses-Pedraza, Romulo/0000-0003-2310-3339; Molina-Montenegro, Marco/0000-0001-6801-8942				Angelopoulos K, 1996, J EXP BOT, V47, P1093, DOI 10.1093/jxb/47.8.1093; Arntz AM, 2000, ECOLOGY, V81, P2567, DOI 10.1890/0012-9658(2000)081[2567:FFTFVI]2.0.CO;2; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Bolhar-Nordenkampf H. R., 1993, P193; Case Andrea L., 2005, P126; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; CORNIC G, 1992, PHOTOSYNTHETICA, V27, P295; DIJKSTRA P, 1989, FUNCT ECOL, V3, P577, DOI 10.2307/2389572; EPRON D, 1992, PLANT CELL ENVIRON, V15, P809, DOI 10.1111/j.1365-3040.1992.tb02148.x; FARRIS MA, 1990, ECOLOGY, V71, P548, DOI 10.2307/1940308; Figueroa ME, 1997, J VEG SCI, V8, P881, DOI 10.2307/3237033; Flexas J, 2004, PLANT BIOLOGY, V6, P269, DOI 10.1055/s-2004-820867; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Franks SJ, 2011, NEW PHYTOL, V190, P249, DOI 10.1111/j.1469-8137.2010.03603.x; Fryer MJ, 1998, PLANT PHYSIOL, V117, P335; Godoy O, 2009, ANN BOT-LONDON, V103, P485, DOI 10.1093/aob/mcn232; Goltsev V, 2009, PHOTOSYNTH RES, V101, P217, DOI 10.1007/s11120-009-9451-1; Grassi G, 2005, PLANT CELL ENVIRON, V28, P834, DOI 10.1111/j.1365-3040.2005.01333.x; Grzesiak MT, 2007, PHOTOSYNTHETICA, V45, P606, DOI 10.1007/s11099-007-0104-3; HE JX, 1995, PHYSIOL PLANTARUM, V93, P771, DOI 10.1111/j.1399-3054.1995.tb05130.x; Holm L, 1997, WORLD WEEDS N HISTOR; HORMANN H, 1994, PHOTOSYNTH RES, V40, P93, DOI 10.1007/BF00019048; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Molina-Montenegro MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047620; Molina-Montenegro MA, 2012, CONSERV BIOL, V26, P717, DOI 10.1111/j.1523-1739.2012.01865.x; Molina-Montenegro MA, 2011, PLANT ECOL DIVERS, V4, P37, DOI 10.1080/17550874.2011.577459; Molina-Montenegro MA, 2008, OIKOS, V117, P1833, DOI 10.1111/j.0030-1299.2008.16896.x; Osmond CB, 1994, PHOTOINHIBITION PHOT, P1; Pastenes C, 1996, PLANT PHYSIOL, V112, P1245, DOI 10.1104/pp.112.3.1245; Pedersen JF, 2005, CROP SCI, V45, P812, DOI 10.2135/cropsci2004.0155; PIGLIUCCI M, 1995, J EVOLUTION BIOL, V8, P421, DOI 10.1046/j.1420-9101.1995.8040421.x; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Rohacek K, 1999, PHOTOSYNTHETICA, V37, P339, DOI 10.1023/A:1007172424619; Samson DA, 1986, AM NAT, V127, P670; Valladares F, 2005, J EXP BOT, V56, P483, DOI 10.1093/jxb/eri037; Valladares F, 1999, HANDBOOK OF FUNCTIONAL PLANT ECOLOGY, P121; van Dijk PJ, 2004, GENETICS, V166, P483, DOI 10.1534/genetics.166.1.483	40	19	19	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76432	10.1371/journal.pone.0076432	http://dx.doi.org/10.1371/journal.pone.0076432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204626	Green Submitted, gold, Green Published			2022-12-27	WOS:000326155400014
J	Armenta-Medina, A; Huanca-Mamani, W; Sanchez-Leon, N; Rodriguez-Arevalo, I; Vielle-Calzada, JP				Armenta-Medina, Alma; Huanca-Mamani, Wilson; Sanchez-Leon, Nidia; Rodriguez-Arevalo, Isaac; Vielle-Calzada, Jean-Philippe			Functional Analysis of Sporophytic Transcripts Repressed by the Female Gametophyte in the Ovule of Arabidopsis thaliana	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; GENE-EXPRESSION; FLORAL-DIP; SPOROGENESIS; PROTEINS; REVEALS; GENOME; CELLS; GAMETOGENESIS; INTEGUMENT	To investigate the genetic and molecular regulation that the female gametophyte could exert over neighboring sporophytic regions of the ovule, we performed a quantitative comparison of global expression in wild-type and nozzle/sporocyteless (spl) ovules of Arabidopsis thaliana (Arabidopsis), using Massively Parallel Signature Sequencing (MPSS). This comparison resulted in 1517 genes showing at least 3-fold increased expression in ovules lacking a female gametophyte, including those encoding 89 transcription factors, 50 kinases, 25 proteins containing a RNA-recognition motif (RRM), and 20 WD40 repeat proteins. We confirmed that eleven of these genes are either preferentially expressed or exclusive of spl ovules lacking a female gametophyte as compared to wild-type, and showed that six are also upregulated in determinant infertile1 (dif1), a meiotic mutant affected in a REC8-like cohesin that is also devoided of female gametophytes. The sporophytic misexpression of IOREMPTE, a WD40/transducin repeat gene that is preferentially expressed in the L1 layer of spl ovules, caused the arrest of female gametogenesis after differentiation of a functional megaspore. Our results show that in Arabidopsis, the sporophytic-gametophytic cross talk includes a negative regulation of the female gametophyte over specific genes that are detrimental for its growth and development, demonstrating its potential to exert a repressive control over neighboring regions in the ovule.	[Armenta-Medina, Alma; Sanchez-Leon, Nidia; Rodriguez-Arevalo, Isaac; Vielle-Calzada, Jean-Philippe] CINVESTAV, Grp Desarrollo Reprod & Apomixis, Lab Nacl Genom & Biodiversidad, Irapuato, Mexico; [Huanca-Mamani, Wilson] Univ Tarapaca, Fac Ciencias Agronom, Lab Biotechnol Vegetal, Arica, Chile; [Armenta-Medina, Alma; Sanchez-Leon, Nidia; Rodriguez-Arevalo, Isaac] CINVESTAV, Dept Ingn Genet Plantas, Irapuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad de Tarapaca; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Vielle-Calzada, JP (corresponding author), CINVESTAV, Grp Desarrollo Reprod & Apomixis, Lab Nacl Genom & Biodiversidad, Irapuato, Mexico.	vielle@ira.cinvestav.mx	Vielle-Calzada, Jean-Philippe/AAG-4036-2019	Vielle-Calzada, Jean-Philippe/0000-0002-3017-2490	Consejo Nacional de Ciencia y Tecnologia; Consejo Estatal de Ciencia y Tecnologia de Guanajuato; Howard Hughes Medical Institute; UC-MEXUS initiative	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Estatal de Ciencia y Tecnologia de Guanajuato; Howard Hughes Medical Institute(Howard Hughes Medical Institute); UC-MEXUS initiative	This work was financially supported by grants from Consejo Nacional de Ciencia y Tecnologia, Consejo Estatal de Ciencia y Tecnologia de Guanajuato, the Howard Hughes Medical Institute, and the UC-MEXUS initiative. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GH, 2004, PLANT MOL BIOL, V54, P653, DOI 10.1023/B:PLAN.0000040819.33383.b6; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Bai XF, 1999, PLANT CELL, V11, P417, DOI 10.1105/tpc.11.3.417; Baker SC, 1997, GENETICS, V145, P1109; Bechtold N, 2000, GENETICS, V155, P1875; Bellaoui M, 2001, PLANT CELL, V13, P2455, DOI 10.1105/tpc.13.11.2455; Bencivenga S, 2011, SEX PLANT REPROD, V24, P113, DOI 10.1007/s00497-011-0162-3; Bhatt AM, 1999, PLANT J, V19, P463, DOI 10.1046/j.1365-313X.1999.00548.x; Bjerkan KN, 2012, PLANT CELL, V24, P1013, DOI 10.1105/tpc.111.089425; Bou-Torrent J, 2008, PLANT SIGNAL BEHAV, V3, P453, DOI 10.4161/psb.3.7.5599; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Desfeux C, 2000, PLANT PHYSIOL, V123, P895, DOI 10.1104/pp.123.3.895; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Estrada-Luna AA, 2002, IN VITRO CELL DEV-PL, V38, P146, DOI 10.1079/IVP2001278; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; GAISER JC, 1995, PLANT CELL, V7, P333, DOI 10.1105/tpc.7.3.333; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Gross-Hardt R, 2007, PLOS BIOL, V5, P494, DOI 10.1371/journal.pbio.0050047; Guitton AE, 2005, CURR BIOL, V15, P750, DOI 10.1016/j.cub.2005.02.066; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Harscoet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012829; HERR JM, 1995, AM J BOT, V82, P547, DOI 10.2307/2445703; Johnston AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r204; Jones-Rhoades MW, 2007, PLOS GENET, V3, P1848, DOI 10.1371/journal.pgen.0030171; Kaur J, 2006, PLANT CELL, V18, P545, DOI 10.1105/tpc.105.039156; Lee JH, 2011, PLANT SCI, V180, P352, DOI 10.1016/j.plantsci.2010.10.008; Lee JH, 2008, CELL, V133, P829, DOI 10.1016/j.cell.2008.04.028; Lee SH, 2006, PLANT CELL, V18, P1604, DOI 10.1105/tpc.105.035972; LEONKLOOSTERZIEL KM, 1994, PLANT CELL, V6, P385, DOI 10.1105/tpc.6.3.385; Li HJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-169; Meyers BC, 2004, NAT BIOTECHNOL, V22, P1006, DOI 10.1038/nbt992; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Nonomura KI, 2003, PLANT CELL, V15, P1728, DOI 10.1105/tpc.012401; Ohnishi T, 2011, PLANT PHYSIOL, V155, P881, DOI 10.1104/pp.110.167502; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Pillitteri LJ, 2007, DEVELOPMENT, V134, P3099, DOI 10.1242/dev.004788; REISER L, 1993, PLANT CELL, V5, P1291, DOI 10.1105/tpc.5.10.1291; ROBINSONBEERS K, 1992, PLANT CELL, V4, P1237, DOI 10.1105/tpc.4.10.1237; Sanchez-Leon N, 2012, J EXP BOT, V63, P3829, DOI 10.1093/jxb/ers075; Schiefthaler U, 1999, P NATL ACAD SCI USA, V96, P11664, DOI 10.1073/pnas.96.20.11664; Schmidt A, 2012, PLANT J, V70, P18, DOI 10.1111/j.1365-313X.2012.04897.x; Schneitz K, 1997, DEVELOPMENT, V124, P1367; SCHNEITZ K, 1995, PLANT J, V7, P731, DOI 10.1046/j.1365-313X.1995.07050731.x; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; Skinner DJ, 2004, PLANT CELL, V16, pS32, DOI 10.1105/tpc.015933; Steffen JG, 2007, PLANT J, V51, P281, DOI 10.1111/j.1365-313X.2007.03137.x; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Wang YB, 2012, PLANT J, V69, P227, DOI 10.1111/j.1365-313X.2011.04785.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192; Yang WC, 1999, GENE DEV, V13, P2108, DOI 10.1101/gad.13.16.2108; Yu HJ, 2005, PLANT PHYSIOL, V139, P1853, DOI 10.1104/pp.105.067314; Zhao XA, 2008, PLANT J, V54, P375, DOI 10.1111/j.1365-313X.2008.03426.x; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	62	6	6	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76977	10.1371/journal.pone.0076977	http://dx.doi.org/10.1371/journal.pone.0076977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194852	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000031
J	Ogawa, A; Bordier, C; Macaluso, E				Ogawa, Akitoshi; Bordier, Cecile; Macaluso, Emiliano			Audio-Visual Perception of 3D Cinematography: An fMRI Study Using Condition-Based and Computation-Based Analyses	PLOS ONE			English	Article							INFERIOR TEMPORAL NEURONS; SURFACE-ORIENTATION; HUMAN BRAIN; DEPTH-PERCEPTION; DISPARITY CUES; SOUND LOCATION; SHAPE; MOTION; CORTEX; RECOGNITION	The use of naturalistic stimuli to probe sensory functions in the human brain is gaining increasing interest. Previous imaging studies examined brain activity associated with the processing of cinematographic material using both standard "condition-based" designs, as well as "computational" methods based on the extraction of time-varying features of the stimuli (e.g. motion). Here, we exploited both approaches to investigate the neural correlates of complex visual and auditory spatial signals in cinematography. In the first experiment, the participants watched a piece of a commercial movie presented in four blocked conditions: 3D vision with surround sounds (3D-Surround), 3D with monaural sound (3D-Mono), 2D-Surround, and 2D-Mono. In the second experiment, they watched two different segments of the movie both presented continuously in 3D-Surround. The blocked presentation served for standard condition-based analyses, while all datasets were submitted to computation-based analyses. The latter assessed where activity co-varied with visual disparity signals and the complexity of auditory multi-sources signals. The blocked analyses associated 3D viewing with the activation of the dorsal and lateral occipital cortex and superior parietal lobule, while the surround sounds activated the superior and middle temporal gyri (S/MTG). The computation-based analyses revealed the effects of absolute disparity in dorsal occipital and posterior parietal cortices and of disparity gradients in the posterior middle temporal gyrus plus the inferior frontal gyrus. The complexity of the surround sounds was associated with activity in specific sub-regions of S/MTG, even after accounting for changes of sound intensity. These results demonstrate that the processing of naturalistic audio-visual signals entails an extensive set of visual and auditory areas, and that computation-based analyses can track the contribution of complex spatial aspects characterizing such life-like stimuli.	[Ogawa, Akitoshi; Bordier, Cecile; Macaluso, Emiliano] Santa Lucia Fdn, Ist Ricovero & Cura Carattere Sci, Neuroimaging Lab, Rome, Italy	IRCCS Santa Lucia	Ogawa, A (corresponding author), Santa Lucia Fdn, Ist Ricovero & Cura Carattere Sci, Neuroimaging Lab, Rome, Italy.	a.ogawa@hsantalucia.it	Macaluso, Emiliano/AAE-9185-2019; Ogawa, Akitoshi/AAB-6930-2020; Macaluso, Emiliano/H-3139-2017; Ogawa, Akitoshi/D-6287-2011	Macaluso, Emiliano/0000-0002-1919-5288; Ogawa, Akitoshi/0000-0003-1247-445X; Macaluso, Emiliano/0000-0002-1919-5288; Bordier, Cecile/0000-0003-2376-5922	Italian Ministry of Health; European Research Council under the European Union [242809]	Italian Ministry of Health(Ministry of Health, Italy); European Research Council under the European Union(European Research Council (ERC))	The Neuroimaging Laboratory, Santa Lucia Foundation, is supported by The Italian Ministry of Health. The research project including this study has received funding from the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement 242809. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi RO, CEREB CORTE IN PRESS; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Alink A, 2012, HUM BRAIN MAPP, V33, P969, DOI 10.1002/hbm.21263; Altmann CF, 2008, NEUROIMAGE, V41, P69, DOI 10.1016/j.neuroimage.2008.02.013; Amit S., 2001, IEEE DATA ENG B, V24, P35; Anzai A, 2011, J NEUROSCI, V31, P10270, DOI 10.1523/JNEUROSCI.5956-10.2011; Anzai A, 2010, CURR OPIN NEUROBIOL, V20, P367, DOI 10.1016/j.conb.2010.04.006; Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; Ban H, 2012, NAT NEUROSCI, V15, P636, DOI 10.1038/nn.3046; Bartels A, 2008, CEREB CORTEX, V18, P705, DOI 10.1093/cercor/bhm107; Bartels A, 2004, HUM BRAIN MAPP, V21, P75, DOI 10.1002/hbm.10153; Beer AL, 2009, EUR J NEUROSCI, V30, P703, DOI 10.1111/j.1460-9568.2009.06857.x; Bordier C, 2013, NEUROIMAGE, V67, P213, DOI 10.1016/j.neuroimage.2012.11.031; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brett M, 2002, REG INT AN US SPM TO; Callan A, 2013, NEUROIMAGE, V66, P22, DOI 10.1016/j.neuroimage.2012.10.057; Chandrasekaran C, 2007, J NEUROPHYSIOL, V97, P1553, DOI 10.1152/jn.01074.2006; Costantini M, 2010, EXP BRAIN RES, V207, P95, DOI 10.1007/s00221-010-2435-8; Cumming B, 2002, CURR BIOL, V12, pR93, DOI 10.1016/S0960-9822(02)00669-3; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; Deouell LY, 2007, NEURON, V55, P985, DOI 10.1016/j.neuron.2007.08.019; Durand JB, 2009, NEUROIMAGE, V46, P1114, DOI 10.1016/j.neuroimage.2009.03.023; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Georgieva SS, 2008, CEREB CORTEX, V18, P2416, DOI 10.1093/cercor/bhn002; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Getzmann S, 2010, HEARING RES, V259, P44, DOI 10.1016/j.heares.2009.09.021; Gilaie-Dotan S, 2002, HUM BRAIN MAPP, V15, P67, DOI 10.1002/hbm.10008; GREENSPAN H, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P222, DOI 10.1109/CVPR.1994.323833; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Hasson U, 2008, NEURON, V57, P452, DOI 10.1016/j.neuron.2007.12.009; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2001, J NEUROSCI, V21, P9419, DOI 10.1523/JNEUROSCI.21-23-09419.2001; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; Joly O, 2009, NEUROIMAGE, V47, P262, DOI 10.1016/j.neuroimage.2009.04.043; Kayser C, 2004, CURR OPIN NEUROBIOL, V14, P468, DOI 10.1016/j.conb.2004.06.002; Kopco N, 2012, P NATL ACAD SCI USA, V109, P11019, DOI 10.1073/pnas.1119496109; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Krug K, 2004, J NEUROPHYSIOL, V92, P1586, DOI 10.1152/jn.00851.2003; Krumbholz K, 2005, EUR J NEUROSCI, V21, P230, DOI 10.1111/j.1460-9568.2004.03836.x; Lahnakoski JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035215; Lewald J, 2008, EUR J NEUROSCI, V27, P1261, DOI 10.1111/j.1460-9568.2008.06094.x; Liu C, 2011, IEEE T PATTERN ANAL, V33, P978, DOI 10.1109/TPAMI.2010.147; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Minini L, 2010, J NEUROPHYSIOL, V104, P169, DOI 10.1152/jn.00790.2009; Neri P, 2004, J NEUROPHYSIOL, V92, P1880, DOI 10.1152/jn.01042.2003; Ning QA, 1997, NEURON, V18, P359, DOI 10.1016/S0896-6273(00)81238-6; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; POGGIO GF, 1988, J NEUROSCI, V8, P4531; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Press C, 2012, NEUROIMAGE, V60, P1671, DOI 10.1016/j.neuroimage.2012.01.118; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Preston TJ, 2009, J NEUROSCI, V29, P1688, DOI 10.1523/JNEUROSCI.5021-08.2009; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Read J, 2005, PROG BIOPHYS MOL BIO, V87, P77, DOI 10.1016/j.pbiomolbio.2004.06.005; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Rust NC, 2005, NAT NEUROSCI, V8, P1647, DOI 10.1038/nn1606; Sakata H, 2005, NEUROPSYCHOLOGIA, V43, P151, DOI 10.1016/j.neuropsychologia.2004.11.003; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Scheperjans F, 2008, CEREB CORTEX, V18, P846, DOI 10.1093/cercor/bhm116; Shamma S, 2001, TRENDS COGN SCI, V5, P340, DOI 10.1016/S1364-6613(00)01704-6; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Tsutsui KI, 2001, J NEUROPHYSIOL, V86, P2856, DOI 10.1152/jn.2001.86.6.2856; Uka T, 2006, J NEUROSCI, V26, P6791, DOI 10.1523/JNEUROSCI.5435-05.2006; Warren JD, 2003, J NEUROSCI, V23, P5799; Warren JD, 2003, P NATL ACAD SCI USA, V100, P10038, DOI 10.1073/pnas.1730682100; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Welchman AE, 2005, NAT NEUROSCI, V8, P820, DOI 10.1038/nn1461; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904; Zatorre RJ, 2004, J NEUROSCI, V24, P3637, DOI 10.1523/JNEUROSCI.5458-03.2004; Zimmer U, 2005, NEURON, V47, P893, DOI 10.1016/j.neuron.2005.07.019; Zundorf IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064259	82	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76003	10.1371/journal.pone.0076003	http://dx.doi.org/10.1371/journal.pone.0076003			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194828	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000007
J	Steinke, SIB; Peitsch, WK; Ludwig, A; Goebeler, M				Steinke, Sabine I. B.; Peitsch, Wiebke K.; Ludwig, Alexander; Goebeler, Matthias			Cost-of-Illness in Psoriasis: Comparing Inpatient and Outpatient Therapy	PLOS ONE			English	Article							PLAQUE-TYPE PSORIASIS; HEALTH-CARE COSTS; PATIENT PREFERENCES; DISEASE SEVERITY; UNITED-STATES; MODERATE; LIFE; MULTICENTER; BIOLOGICS; GERMANY	Treatment modalities of chronic plaque psoriasis have dramatically changed over the past ten years with a still continuing shift from inpatient to outpatient treatment. This development is mainly caused by outpatient availability of highly efficient and relatively well-tolerated systemic treatments, in particular BioLogicals. In addition, inpatient treatment is time-and cost-intense, conflicting with the actual burst of health expenses and with patient preferences. Nevertheless, inpatient treatment with dithranol and UV light still is a major mainstay of psoriasis treatment in Germany. The current study aims at comparing the total costs of inpatient treatment and outpatient follow-up to mere outpatient therapy with different modalities (topical treatment, phototherapy, classic systemic therapy or BioLogicals) over a period of 12 months. To this end, a retrospective cost-of-illness study was conducted on 120 patients treated at the University Medical Centre Mannheim between 2005 and 2006. Inpatient therapy caused significantly higher direct medical, indirect and total annual costs than outpatient treatment (13,042 (sic) versus 2,984 (sic)). Its strong influence on cost levels was confirmed by regression analysis, with total costs rising by 104.3% in case of inpatient treatment. Patients receiving BioLogicals produced the overall highest costs, whereas outpatient treatment with classic systemic antipsoriatic medications was less cost-intense than other alternatives.	[Steinke, Sabine I. B.] Univ Munster, Dept Dermatol, Univ Hosp Munster, D-48149 Munster, Germany; [Steinke, Sabine I. B.; Peitsch, Wiebke K.; Goebeler, Matthias] Heidelberg Univ, Dept Dermatol, Univ Med Ctr Mannheim, Heidelberg, Germany; [Ludwig, Alexander] Univ Cologne, Ctr Macroecon Res, D-50931 Cologne, Germany; [Ludwig, Alexander] Max Planck Inst Munich, Munich Res Inst Econ Aging, Munich, Germany; [Goebeler, Matthias] Univ Wurzburg, Dept Dermatol Venereol & Allergol, Univ Hosp Wurzburg, Wurzburg, Germany	University of Munster; Ruprecht Karls University Heidelberg; University of Cologne; Max Planck Society; University of Wurzburg	Steinke, SIB (corresponding author), Univ Munster, Dept Dermatol, Univ Hosp Munster, Von Esmarch Str 56, D-48149 Munster, Germany.	sabine.steinke@ukmuenster.de	Goebeler, Matthias/P-3612-2019; Goebeler, Matthias/F-7118-2013		Deutsche Forschungsgemeinschaft; University of Muenster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Muenster	The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anis AH, 2011, J DERMATOL TREAT, V22, P65, DOI 10.3109/09546630903551258; Augustin M, 2008, DERMATOLOGY, V216, P366, DOI 10.1159/000119415; Balkrishnan R, 2006, J UROLOGY, V175, P1067, DOI 10.1016/S0022-5347(05)00352-6; Berger Karin, 2005, J Dtsch Dermatol Ges, V3, P511, DOI 10.1111/j.1610-0387.2005.05729.x; Beyer V, 2010, ARCH DERMATOL, V146, P46, DOI 10.1001/archdermatol.2009.319; Braun-Falco O, 2005, DERMATOL VENEROL, P476; de Miguel R, 2009, INT J DERMATOL, V48, P653, DOI 10.1111/j.1365-4632.2009.04012.x; Deutsche Agentur fur Health Technology Assessment des Deutschen Instituts fur Medizinische Dokumentation und Information, 2006, SCHRIFT HLTH TECHN A, V15-46, P91; Feldman SR, 2003, EXPERT OPIN PHARMACO, V4, P1525, DOI 10.1517/eoph.4.9.1525.21059; Finzi AF, 2001, J EUR ACAD DERMATOL, V15, P320, DOI 10.1046/j.1468-3083.2001.00256.x; Fluhr JW, 2007, DERMATOLOGY, V214, P6, DOI 10.1159/000096905; Fonia A, 2010, BRIT J DERMATOL, V163, P807, DOI 10.1111/j.1365-2133.2010.09944.x; Fowler JF, 2008, J AM ACAD DERMATOL, V59, P772, DOI 10.1016/j.jaad.2008.06.043; Galadari I, 2001, J EUR ACAD DERMATOL, V15, P290, DOI 10.1046/j.1468-3083.2001.00257.x; Ghatnekar O, 2012, EUR J DERMATOL, V22, P238, DOI 10.1684/ejd.2011.1635; Hahn M, 2005, HAUTARZT, V56, P576, DOI 10.1007/s00105-005-0946-1; Hartman M, 2002, BRIT J DERMATOL, V147, P538, DOI 10.1046/j.1365-2133.2002.04920.x; Javitz HS, 2002, J AM ACAD DERMATOL, V46, P850, DOI 10.1067/mjd.2002.119669; Kimball AB, 2011, J EUR ACAD DERMATOL, V25, P157, DOI 10.1111/j.1468-3083.2010.03730.x; Koo J, 1999, J AM ACAD DERMATOL, V41, P51, DOI 10.1016/S0190-9622(99)70406-8; Morrow Thomas, 2006, Manag Care, V15, P61; Nast A, 2011, J DTSCH DERMATOL GES, V9, pS1, DOI [10.1111/j.1610-0379.2011.07680.x, 10.1111/j.1610-0379.2011.07681.x]; Nelson A, 2005, PLOUGHSHARES, V31, P5; Opmeer BC, 2004, ARCH DERMATOL, V140, P685, DOI 10.1001/archderm.140.6.685; Pearce DJ, 2006, J DERMATOL TREAT, V17, P29, DOI 10.1080/09546630500504754; Poulin Y, 2009, J CUTAN MED SURG, V13, pS49, DOI 10.2310/7750.2009.00021; Schaarschmidt ML, 2013, J EUR ACAD DERMATOL, V27, P187, DOI 10.1111/j.1468-3083.2011.04440.x; Schaarschmidt ML, 2011, ARCH DERMATOL, V147, P1285, DOI 10.1001/archdermatol.2011.309; Schmitt J, 2007, DERMATOLOGY, V214, P68, DOI 10.1159/000096916; Schmitt JM, 2006, DERMATOLOGY, V213, P102, DOI 10.1159/000093848; Schoffski Oliver, 2007, J Dtsch Dermatol Ges, V5, P209, DOI 10.1111/j.1610-0387.2007.06240.x; Schwartz F, 2003, PUBLIC HLTH BUCH EFF, P461; Sizto S, 2009, BRIT J DERMATOL, V160, P1264, DOI 10.1111/j.1365-2133.2008.08962.x; Sohn S, 2006, DERMATOLOGY, V212, P137, DOI 10.1159/000090654; Stern RS, 2003, J AM ACAD DERMATOL, V49, P445, DOI 10.1067/S0190-9622(03)00858-2; Young Jai Il, 1998, Journal of Dermatology (Tokyo), V25, P112	36	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78152	10.1371/journal.pone.0078152	http://dx.doi.org/10.1371/journal.pone.0078152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194911	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000090
J	van der Kooi, AW; Kappen, TH; Raijmakers, RJ; Zaal, IJ; Slooter, AJC				van der Kooi, Arendina W.; Kappen, Teus H.; Raijmakers, Rosa J.; Zaal, Irene J.; Slooter, Arjen J. C.			Temperature Variability during Delirium in ICU Patients: An Observational Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CONFUSION ASSESSMENT METHOD; CURVE COMPLEXITY; ORGAN FAILURE; SEPSIS; GUIDELINES; PREDICTOR; AGITATION	Introduction: Delirium is an acute disturbance of consciousness and cognition. It is a common disorder in the intensive care unit (ICU) and associated with impaired long-term outcome. Despite its frequency and impact, delirium is poorly recognized by ICU-physicians and - nurses using delirium screening tools. A completely new approach to detect delirium is to use monitoring of physiological alterations. Temperature variability, a measure for temperature regulation, could be an interesting component to monitor delirium, but whether temperature regulation is different during ICU delirium has not yet been investigated. The aim of this study was to investigate whether ICU delirium is related to temperature variability. Furthermore, we investigated whether ICU delirium is related to absolute body temperature. Methods: We included patients who experienced both delirium and delirium free days during ICU stay, based on the Confusion Assessment method for the ICU conducted by a research- physician or - nurse, in combination with inspection of medical records. We excluded patients with conditions affecting thermal regulation or therapies affecting body temperature. Daily temperature variability was determined by computing the mean absolute second derivative of the temperature signal. Temperature variability (primary outcome) and absolute body temperature (secondary outcome) were compared between delirium-and non-delirium days with a linear mixed model and adjusted for daily mean Richmond Agitation and Sedation Scale scores and daily maximum Sequential Organ Failure Assessment scores. Results: Temperature variability was increased during delirium-days compared to days without delirium (beta(unadjusted)=0.007, 95% confidence interval (CI)= 0.004 to 0.011, p<0.001). Adjustment for confounders did not alter this result (beta(adjusted)=0.005, 95% CI=0.002 to 0.008, p<0.001). Delirium was not associated with absolute body temperature (beta(unadjusted)=-0.03, 95% CI=-0.17 to 0.10, p=0.61). This did not change after adjusting for confounders (beta(adjusted)=-0.03, 95% CI=-0.17 to 0.10, p=0.63). Conclusions: Our study suggests that temperature variability is increased during ICU delirium.	[van der Kooi, Arendina W.; Raijmakers, Rosa J.; Zaal, Irene J.; Slooter, Arjen J. C.] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Kappen, Teus H.] Univ Med Ctr Utrecht, Dept Anesthesiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van der Kooi, AW (corresponding author), Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands.	a.w.vanderkooi@umcutrecht.nl	Kappen, Teus H/J-8733-2015	Kappen, Teus H/0000-0003-1895-0998; van Diem-Zaal, Irene/0000-0002-8946-7920	ZonMw, the Netherlands organisation for health research and development [80-82305-98-08109]; Netherlands Brain Foundation [2008(1).30]; Novartis, Basel, Switzerland	ZonMw, the Netherlands organisation for health research and development(Netherlands Organization for Health Research and Development); Netherlands Brain Foundation; Novartis, Basel, Switzerland	None of the author's received funding for the study "temperature variability during delirium in ICU patients: an observational study" or for the preparation of the manuscript. Of the three studies from which patient data was used, only the Rivastigmine trial received funding. The Rivastigmine trial was funded by ZonMw, the Netherlands organisation for health research and development (grant number 80-82305-98-08109), the Netherlands Brain Foundation (grant number 2008(1).30), and Novartis, Basel, Switzerland (unrestricted grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Psychiat Assoc, 1999, AM J PSYCHIAT, V156, P1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brenner R P, 1991, Int Psychogeriatr, V3, P211, DOI 10.1017/S1041610291000686; BROWN CG, 1983, WESTERN J MED, V138, P579; Chong TW, 2004, SCHIZOPHR RES, V69, P149, DOI 10.1016/S0920-9964(03)00222-6; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Gusmao-Flores D, 2012, CRIT CARE, V16, DOI 10.1186/cc11407; Heymann A, 2010, J INT MED RES, V38, P1584, DOI 10.1177/147323001003800503; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; Kelly G, 2006, ALTERN MED REV, V11, P278; Martin BJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9273; Milbrandt EB, 2004, CRIT CARE MED, V32, P955, DOI 10.1097/01.CCM.0000119429.16055.92; Papaioannou VE, 2012, CRIT CARE, V16, DOI 10.1186/cc11255; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Tanev KS, 2008, AM J ALZHEIMERS DIS, V23, P563, DOI 10.1177/1533317508323479; TEASDALE G, 1974, LANCET, V2, P81; Thomason JWW, 2005, CRIT CARE, V9, pR375, DOI 10.1186/cc3729; van der Kooi AW, 2012, J NEUROPSYCH CLIN N, V24, P472, DOI 10.1176/appi.neuropsych.11110347; van Eijk MM, 2011, AM J RESP CRIT CARE, V184, P340, DOI 10.1164/rccm.201101-0065OC; van Eijk MMJ, 2010, LANCET, V376, P1829, DOI 10.1016/S0140-6736(10)61855-7; van Eijk MMJ, 2009, CRIT CARE MED, V37, P1881, DOI 10.1097/CCM.0b013e3181a00118; Varela M, 2005, CRIT CARE MED, V33, P2764, DOI 10.1097/01.CCM.0000190157.64486.03; Varela M, 2006, AM J RESP CRIT CARE, V174, P290, DOI 10.1164/rccm.200601-058OC; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Zaal IJ, 2011, CRIT CARE, V15, pP335, DOI [10.1186/cc9755, DOI 10.1186/CC9755]; Zaal IJ, 2013, INTENS CARE MED, V39, P481, DOI 10.1007/s00134-012-2726-6	29	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78923	10.1371/journal.pone.0078923	http://dx.doi.org/10.1371/journal.pone.0078923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194955	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000134
J	Couturier, LIE; Rohner, CA; Richardson, AJ; Marshall, AD; Jaine, FRA; Bennett, MB; Townsend, KA; Weeks, SJ; Nichols, PD				Couturier, Lydie I. E.; Rohner, Christoph A.; Richardson, Anthony J.; Marshall, Andrea D.; Jaine, Fabrice R. A.; Bennett, Michael B.; Townsend, Kathy A.; Weeks, Scarla J.; Nichols, Peter D.			Stable Isotope and Signature Fatty Acid Analyses Suggest Reef Manta Rays Feed on Demersal Zooplankton	PLOS ONE			English	Article							SHARKS RHINCODON-TYPUS; DISCRIMINATION FACTORS; TROPHIC POSITION; FISH; ECOLOGY; DIET; LIPIDS; MOVEMENTS; PROFILES; TISSUES	Assessing the trophic role and interaction of an animal is key to understanding its general ecology and dynamics. Conventional techniques used to elucidate diet, such as stomach content analysis, are not suitable for large threatened marine species. Non-lethal sampling combined with biochemical methods provides a practical alternative for investigating the feeding ecology of these species. Stable isotope and signature fatty acid analyses of muscle tissue were used for the first time to examine assimilated diet of the reef manta ray Manta alfredi, and were compared with different zooplankton functional groups (i.e. near-surface zooplankton collected during manta ray feeding events and non-feeding periods, epipelagic zooplankton, demersal zooplankton and several different zooplankton taxa). Stable isotope delta N-15 values confirmed that the reef manta ray is a secondary consumer. This species had relatively high levels of docosahexaenoic acid (DHA) indicating a flagellate-based food source in the diet, which likely reflects feeding on DHA-rich near-surface and epipelagic zooplankton. However, high levels of omega 6 polyunsaturated fatty acids and slightly enriched delta C-13 values in reef manta ray tissue suggest that they do not feed solely on pelagic zooplankton, but rather obtain part of their diet from another origin. The closest match was with demersal zooplankton, suggesting it is an important component of the reef manta ray diet. The ability to feed on demersal zooplankton is likely linked to the horizontal and vertical movement patterns of this giant planktivore. These new insights into the habitat use and feeding ecology of the reef manta ray will assist in the effective evaluation of its conservation needs.	[Couturier, Lydie I. E.; Bennett, Michael B.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Couturier, Lydie I. E.; Rohner, Christoph A.; Richardson, Anthony J.; Jaine, Fabrice R. A.] CSIRO Marine & Atmospher Res, Climate Adaptat Flagship, Dutton Pk, Qld, Australia; [Rohner, Christoph A.; Marshall, Andrea D.] Marine Megafauna Fdn, Manta Ray & Whale Shark Res Ctr, Praia Do Tofo, Inhambane, Mozambique; [Rohner, Christoph A.; Jaine, Fabrice R. A.; Weeks, Scarla J.] Univ Queensland, Sch Geog Planning & Environm Management, Biophys Oceanog Grp, St Lucia, Qld, Australia; [Richardson, Anthony J.] Univ Queensland, Ctr Applicat Nat Resource Math, St Lucia, Qld, Australia; [Marshall, Andrea D.] Wild Me, Praia Do Tofo, Inhambane, Mozambique; [Townsend, Kathy A.] Univ Queensland, Sch Biol Sci, Moreton Bay Res Stn, Dunwich, PQ, Canada; [Nichols, Peter D.] CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Couturier, LIE (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	l.couturier@uq.edu.au	Richardson, Anthony J/B-3649-2010; Weeks, Scarla J/E-8632-2013; Couturier, Lydie I. E./J-9695-2014; Couturier, Lydie/I-9793-2019; Rohner, Chris/AAJ-1661-2020; Bennett, Michael/L-4483-2019; Jaine, Fabrice/D-1622-2016; Bennett, Michael/A-7218-2012; Nichols, Peter D/C-5128-2011; Townsend, Kathy Ann/K-9486-2016	Richardson, Anthony J/0000-0002-9289-7366; Weeks, Scarla J/0000-0002-0579-7069; Couturier, Lydie I. E./0000-0002-3885-3397; Couturier, Lydie/0000-0002-3885-3397; Rohner, Chris/0000-0001-8760-8972; Bennett, Michael/0000-0001-8051-0040; Jaine, Fabrice/0000-0002-9304-5034; Townsend, Kathy Ann/0000-0002-2581-2158; Marshall, Andrea/0000-0003-1886-5355	Australian Research Council [LP110100712]; Earthwatch Institute Australia; Sea World Research and Rescue Foundation Inc.; Sibelco Pty Ltd.	Australian Research Council(Australian Research Council); Earthwatch Institute Australia; Sea World Research and Rescue Foundation Inc.; Sibelco Pty Ltd.	This study was supported by the Australian Research Council Linkage Grant (LP110100712), Earthwatch Institute Australia, Sea World Research and Rescue Foundation Inc. and Sibelco Pty Ltd. Field work was supported by Casa Barry Lodge and Peri-Peri Divers in Mozambique, and Lady Elliot Island Eco Resort and Manta Lodge and Scuba Centre in Australia. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1980, J EXP MAR BIOL ECOL, V44, P133, DOI 10.1016/0022-0981(80)90150-1; ALLDREDGE AL, 1977, MAR BIOL, V41, P317, DOI 10.1007/BF00389098; Anderson RC, 2011, FISH OCEANOGR, V20, P104, DOI 10.1111/j.1365-2419.2011.00571.x; Beckmann CL, 2013, PHYSIOL BIOCHEM ZOOL, V86, P266, DOI 10.1086/669539; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borrell A, 2011, ICES J MAR SCI, V68, P547, DOI 10.1093/icesjms/fsq170; BURCHMORE JJ, 1988, AUST J MAR FRESH RES, V39, P709; Canese S, 2006, J MAR BIOL ASSOC UK, V86, P903, DOI 10.1017/S0025315406013853; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Chang KJL, 2012, APPL MICROBIOL BIOT, V93, P2215, DOI 10.1007/s00253-011-3856-4; Clark T.B., 2010, THESIS U HAWAII MANO; Cortes E, 1997, CAN J FISH AQUAT SCI, V54, P726, DOI 10.1139/cjfas-54-3-726; Couturier LIE, 2013, LIPIDS, V48, P1029, DOI 10.1007/s11745-013-3829-8; Couturier LIE, 2012, J FISH BIOL, V80, P1075, DOI 10.1111/j.1095-8649.2012.03264.x; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Estrada JA, 2003, J MAR BIOL ASSOC UK, V83, P1347, DOI 10.1017/S0025315403008798; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Fry B, 1984, GONTRIB MAR SCI, V27, P13; Gorley C.K., 2006, GETTING STARTED PRIM; Hall D, 2006, J EXP MAR BIOL ECOL, V336, P42, DOI 10.1016/j.jembe.2006.04.004; Hansson S, 1997, ECOLOGY, V78, P2249, DOI 10.2307/2265961; Herman DP, 2005, MAR ECOL PROG SER, V302, P275, DOI 10.3354/meps302275; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Hornberger GM, 1995, WATER RESOUR RES, V31, P2895; Howell KL, 2003, MAR ECOL PROG SER, V255, P193, DOI 10.3354/meps255193; Hudson IR, 2004, MAR ECOL PROG SER, V281, P109, DOI 10.3354/meps281109; Hussey NE, 2010, HYDROBIOLOGIA, V654, P1, DOI 10.1007/s10750-010-0361-1; Hussey NE, 2010, COMP BIOCHEM PHYS A, V155, P445, DOI 10.1016/j.cbpa.2009.09.023; Hyndes GA, 1997, MAR BIOL, V128, P585, DOI 10.1007/s002270050125; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; Kelly JR, 2012, MAR ECOL PROG SER, V446, P1, DOI 10.3354/meps09559; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kim SL, 2012, J EXP BIOL, V215, P2495, DOI 10.1242/jeb.070656; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; Logan JM, 2010, HYDROBIOLOGIA, V644, P231, DOI 10.1007/s10750-010-0120-3; Lopez-Mendilaharsu M, 2005, AQUAT CONSERV, V15, P259, DOI 10.1002/aqc.676; MacNeill MA, 2005, MAR ECOL PROG SER, V302, P199, DOI 10.3354/meps302199; Malpica-Cruz L, 2012, CAN J FISH AQUAT SCI, V69, P551, DOI 10.1139/F2011-172; Marshall A, 2011, IUCN 2011 IUCN RED L; Marshall AD, 2011, MAR BIOL, V158, P1111, DOI 10.1007/s00227-011-1634-6; Marshall AD, 2008, THESIS U QUEENSLAND; Marshall AD, 2009, ZOOTAXA, P1; McMeans BC, 2012, J EXP MAR BIOL ECOL, V429, P55, DOI 10.1016/j.jembe.2012.06.017; Melo PAMC, 2010, MAR BIOL RES, V6, P530, DOI 10.1080/17451000903426557; Nelson JD, 2007, FISH RES, V84, P47, DOI 10.1016/j.fishres.2006.11.013; Nichols DS, 2003, FEMS MICROBIOL LETT, V219, P1, DOI 10.1016/S0378-1097(02)01200-4; Osada, 2010, RELATIONSHIP ZOOPLAN; Papastamatiou YP, 2012, MAR ECOL PROG SER, V456, P233, DOI 10.3354/meps09721; Parrish CC, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P309, DOI 10.1007/978-0-387-89366-2_13; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pethybridge H, 2011, J EXP MAR BIOL ECOL, V409, P290, DOI 10.1016/j.jembe.2011.09.009; Pethybridge H, 2010, MAR BIOL, V157, P1367, DOI 10.1007/s00227-010-1416-6; Phleger CF, 2001, MAR FRESHWATER RES, V52, P1475, DOI 10.1071/MF01071; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; Pitt KA, 2008, ESTUAR COAST SHELF S, V76, P827, DOI 10.1016/j.ecss.2007.08.011; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Core Team, 2018, R LANG ENV STAT COMP; Raghukumar S, 2002, EUR J PROTISTOL, V38, P127, DOI 10.1078/0932-4739-00832; Regost C, 2003, AQUACULTURE, V217, P465, DOI 10.1016/S0044-8486(02)00259-4; Revill AT, 2009, MAR BIOL, V156, P1241, DOI 10.1007/s00227-009-1166-5; Richardson A.J., 2000, Naga, V23, P29; Rohner CA, 2013, MAR ECOL PROG SER, V493, P219, DOI 10.3354/meps10500; Sargent J.R., 1987, P119; SARGENT JR, 1988, HYDROBIOLOGIA, V167, P101, DOI 10.1007/BF00026297; Schaufler L, 2005, ICES CM ELASMOBRANCH, V19; SHERIDAN MA, 1988, COMP BIOCHEM PHYS B, V90, P679, DOI 10.1016/0305-0491(88)90322-7; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Sims DW, 1997, J FISH BIOL, V51, P436; STOECKER DK, 1990, J PLANKTON RES, V12, P891, DOI 10.1093/plankt/12.5.891; Syvaranta J, 2010, CAN J FISH AQUAT SCI, V67, P1721, DOI 10.1139/F10-091; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; WADA E, 1991, CRIT REV FOOD SCI, V30, P361, DOI 10.1080/10408399109527547; Whitley G. P., 1936, Australian Zoologist, V8, P164	79	78	78	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77152	10.1371/journal.pone.0077152	http://dx.doi.org/10.1371/journal.pone.0077152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167562	Green Submitted, gold, Green Published			2022-12-27	WOS:000326034500021
J	Liu, ZG; Ni, SY; Chen, GM; Cai, J; Guo, ZH; Chang, P; Li, YS				Liu, Zhan-Guo; Ni, Shu-Yuan; Chen, Gui-Ming; Cai, Jing; Guo, Zhen-Hui; Chang, Ping; Li, Yu-Sheng			Histones-Mediated Lymphocyte Apoptosis during Sepsis Is Dependent on p38 Phosphorylation and Mitochondrial Permeability Transition	PLOS ONE			English	Article							IMPROVES SURVIVAL; CELL-DEATH; EXTRACELLULAR HISTONES; CECAL LIGATION; T-LYMPHOCYTES; PREVENTION; BCL-2; SHOCK; MICE; INHIBITION	Lymphocyte apoptosis is one reason for immunoparalysis seen in sepsis, although the triggers are unknown. We hypothesized that molecules in plasma, which are up-regulated during sepsis, may be responsible for this. In this study, peripheral lymphocyte apoptosis caused by extracellular histones was confirmed both in mouse and human primary lymphocytes, in which histones induced lymphocyte apoptosis dose-dependently and time-dependently. To identify which intracellular signal pathways were activated, phosphorylation of various mitogen-activated protein kinases (MAPKs) were evaluated during this process, and p38 inhibitor (SB203580) was used to confirm the role of p38 in lymphocyte apoptosis induced by histones. To investigate the mitochondrial injury during these processes, we analyzed Bcl2 degradation and Rhodamine 123 to assess mitochondrial-membrane stability, via cyclosporin A as an inhibitor for mitochondrial permeability transition (MPT). Then, caspase 3 activation was also checked by western-blotting. We found that p38 phosphorylation, mitochondrial injury and caspase 3 activation occurred dose-dependently in histones-mediated lymphocyte apoptosis. We also observed that p38 inhibitor SB203580 decreased lymphocyte apoptotic ratio by 49% (P<0.05), and inhibition of MPT protected lymphocytes from apoptosis. Furthermore, to investigate whether histones are responsible for lymphocyte apoptosis, various concentrations of histone H4 neutralization antibodies were co-cultured with human primary lymphocytes and plasma from cecal ligation and puncture (CLP) mice or sham mice. The results showed that H4 neutralization antibody dose-dependently blocked lymphocyte apoptosis caused by septic plasma in vitro. These data demonstrate for the first time that extracellular histones, especially H4, play a vital role in lymphocyte apoptosis during sepsis which is dependent on p38 phosphorylation and mitochondrial permeability transition. Neutralizing H4 can inhibit lymphocyte apoptosis, indicating that it could be a potential target in clinical interventions for sepsis associated immunoparalysis.	[Liu, Zhan-Guo; Chen, Gui-Ming; Cai, Jing; Chang, Ping] Southern Med Univ, Zhujiang Hosp, Dept ICU, Guangzhou, Guangdong, Peoples R China; [Ni, Shu-Yuan] Guangzhou Med Univ, Affiliated Hosp 3, Dept ICU, Guangzhou, Guangdong, Peoples R China; [Guo, Zhen-Hui] Guangzhou Mil Command, Gen Hosp, Dept Med Intens Care Unit, Guangdong Prov Key Lab Geriatr Infect & Organ Fun, Guangzhou, Guangdong, Peoples R China; [Li, Yu-Sheng] Southern Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Guangzhou Medical University; Southern Theater Command General Hospital; Southern Medical University - China	Chang, P (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept ICU, Guangzhou, Guangdong, Peoples R China.	changp963@163.com; tobyaron@163.com		Chang, Ping/0000-0002-5974-7956	National Natural Science Foundation for Youth of China [81101451, 81100008]; Natural Science Foundation of Guangdong Province [S2011010003106]; Guangdong Medical Science and Technology Research Fund [B2011208]	National Natural Science Foundation for Youth of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Medical Science and Technology Research Fund	This work was supported by grants from the National Natural Science Foundation for Youth of China (81101451 and 81100008), the Natural Science Foundation of Guangdong Province (S2011010003106) and the Guangdong Medical Science and Technology Research Fund (B2011208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam R, 2012, J AM SOC NEPHROL, V23, P1375, DOI 10.1681/ASN.2011111077; Alves JC, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e3181818466; Atmatzidis S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-321; AYALA A, 1995, SHOCK, V3, P259, DOI 10.1097/00024382-199504000-00003; Chang KC, 2007, FASEB J, V21, P708, DOI 10.1096/fj.06-6805com; Chaput C, 2009, NAT MED, V15, P1245, DOI 10.1038/nm1109-1245; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; Deitch EA, 1998, SHOCK, V9, P1, DOI 10.1097/00024382-199801000-00001; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Gendron S, 2003, J BIOL CHEM, V278, P48633, DOI 10.1074/jbc.M305169200; Hiramatsu M, 1997, SHOCK, V7, P247, DOI 10.1097/00024382-199704000-00002; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2005, J IMMUNOL, V174, P5110, DOI 10.4049/jimmunol.174.8.5110; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 1999, J IMMUNOL, V162, P4148; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 2005, CLIN INFECT DIS, V41, pS465, DOI 10.1086/431998; Hotchkiss RS, 2003, P NATL ACAD SCI USA, V100, P6724, DOI 10.1073/pnas.1031788100; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Lang JD, 2009, CRIT CARE, V13, DOI 10.1186/cc7144; Larche J, 2006, J AM COLL CARDIOL, V48, P377, DOI 10.1016/j.jacc.2006.02.069; Le Tulzo Y, 2002, SHOCK, V18, P487, DOI 10.1097/00024382-200212000-00001; Lee DY, 2009, J INVEST DERMATOL, V129, P2489, DOI 10.1038/jid.2009.106; Li YS, 2010, AM J PHYSIOL-LUNG C, V298, pL558, DOI 10.1152/ajplung.00225.2009; Muenzer JT, 2010, INFECT IMMUN, V78, P1582, DOI 10.1128/IAI.01213-09; O'Sullivan AW, 2009, J SURG RES, V152, P46, DOI 10.1016/j.jss.2008.04.030; Oberholzer C, 2001, P NATL ACAD SCI USA, V98, P11503, DOI 10.1073/pnas.181338198; Ren GW, 2008, J IMMUNOL, V181, P3277, DOI 10.4049/jimmunol.181.5.3277; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Song GY, 2001, AM J PHYSIOL-CELL PH, V281, pC662, DOI 10.1152/ajpcell.2001.281.2.C662; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Torcia M, 2001, J BIOL CHEM, V276, P39027, DOI 10.1074/jbc.M102970200; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053	38	21	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77131	10.1371/journal.pone.0077131	http://dx.doi.org/10.1371/journal.pone.0077131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167561	Green Submitted, Green Published, gold			2022-12-27	WOS:000326034500020
J	Tran, TD; Biggs, BA; Tran, T; Casey, GJ; Hanieh, S; Simpson, JA; Dwyer, T; Fisher, J				Thach Duc Tran; Biggs, Beverley-Ann; Tuan Tran; Casey, Gerard J.; Hanieh, Sarah; Simpson, Julie Anne; Dwyer, Terence; Fisher, Jane			Psychological and Social Factors Associated with Late Pregnancy Iron Deficiency Anaemia in Rural Viet Nam: A Population-Based Prospective Study	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; DEPRESSIVE SYMPTOMS; RISK-FACTORS; HEALTH-CARE; WOMEN; SUPPLEMENTATION; DETERMINANTS; PREVALENCE; INCOME; NORTH	Objectives: The aim of this study was to examine the relationships between psychological and social factors and late pregnancy IDA among pregnant women in rural Viet Nam. Methods: Pregnant women from 50 randomly-selected communes within Ha Nam province were recruited and assessed at 12 - 20 weeks gestation (Wave 1, W1). They were followed up in the last trimester (Wave 2, W2). IDA was defined as Haemoglobin < 11 g/dL and serum ferritin < 15 ng/mL. Symptoms of Common Mental Disorders (CMD) were assessed by the Edinburgh Postnatal Depression Scale-Vietnam (EPDS-V). Persistent antenatal CMD was defined as having an EPDS-V score >= 4 in both W1 and W2. Hypothesis models were tested by Structural Equation Modeling analyses. Results: A total of 378 women provided complete data at both W1 and W2. The incidence risk of IDA in the third trimester was 13.2% (95% confidence interval (CI): 9.8-16.7). Persistent CMD was found in 16.9% (95% CI: 13.1-20.7) pregnant women and predicted by intimate partner violence, fear of other family members, experience of childhood abuse, coincidental life adversity, and having a preference for the sex of the baby. There was a significant pathway from persistent CMD to IDA in late pregnancy via the length of time that iron supplements had been taken. Receiving advice to take iron supplements and higher household wealth index were indirectly related to lower risk of late pregnancy IDA. Early pregnancy IDA and being multi-parous also contributed to late pregnancy IDA. Conclusions: Antenatal IDA and CMD are prevalent public health problems among women in Viet Nam. The link between them suggests that while direct recommendations to use iron supplements are important, the social factors associated with common mental disorders should be addressed in antenatal care in order to improve the health of pregnant women and their infants.	[Thach Duc Tran; Tuan Tran] Res & Training Ctr Community Dev, Hanoi, Vietnam; [Thach Duc Tran; Fisher, Jane] Monash Univ, Jean Hailes Res Unit, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Thach Duc Tran; Fisher, Jane] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Womens Hlth Gender & Soc, Melbourne, Vic, Australia; [Biggs, Beverley-Ann; Casey, Gerard J.; Hanieh, Sarah] Univ Melbourne, Royal Melbourne Hosp, Dept Med RMH WH, Melbourne, Vic 3050, Australia; [Biggs, Beverley-Ann] Royal Melbourne Hosp, CCREID, Melbourne, Vic, Australia; [Simpson, Julie Anne] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Dwyer, Terence] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Monash University; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Tran, TD (corresponding author), Res & Training Ctr Community Dev, Hanoi, Vietnam.	indthach@yahoo.com	Simpson, Julie A/P-7299-2014; TRAN, THACH DUC/H-7734-2014; Fisher, Jane/I-1569-2014	TRAN, THACH DUC/0000-0002-4686-8601; Tran, Tuan/0000-0002-4947-9169; Simpson, Julie/0000-0002-2660-2013; Biggs, Beverley-Ann/0000-0002-2961-9793; Fisher, Jane/0000-0002-1959-6807	Australian Research Council [DP0986594]; University of Melbourne	Australian Research Council(Australian Research Council); University of Melbourne(University of Melbourne)	The study was funded by Australian Research Council Discovery Project Grant DP0986594. TDT is supported by a University of Melbourne International Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2011, INT J FOOD SCI NUTR, V62, P585, DOI 10.3109/09637486.2011.566848; Aikawa R, 2006, PUBLIC HEALTH NUTR, V9, P443, DOI 10.1079/PHN2005851; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Beard JL, 2005, J NUTR, V135, P267, DOI 10.1093/jn/135.2.267; Beard JL, 2003, ANNU REV NUTR, V23, P41, DOI 10.1146/annurev.nutr.23.020102.075739; Black RE, 2008, LANCET, V371, P17, DOI DOI 10.1016/S0140-6736(08)60052-5.PUBMED:18183655; Bodnar LM, 2005, BIOL PSYCHIAT, V58, P679, DOI 10.1016/j.biopsych.2005.05.009; Corwin EJ, 2003, J NUTR, V133, P4139, DOI 10.1093/jn/133.12.4139; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; DeMaeyer EM., 1989, PREVENTING CONTROLLI; Ferreira HD, 2008, REV BRAS GINECOL OBS, V30, P445, DOI 10.1590/S0100-72032008000900004; FISHER J, 2013, ASIA PACIFI IN PRESS, DOI DOI 10.1111/APPY.12011:IN; Fisher J, 2011, B WORLD HEALTH ORGAN, V89, P813, DOI 10.2471/BLT.11.089763; Fisher J, 2010, B WORLD HEALTH ORGAN, V88, P737, DOI 10.2471/BLT.09.067066; Fisher JRW, 2004, BJOG-INT J OBSTET GY, V111, P1353, DOI 10.1111/j.1471-0528.2004.00394.x; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; General Statistic Office (GSO), 2011, STAT YB VIETN; Habib F, 2009, J OBSTET GYNAECOL, V29, P487, DOI 10.1080/01443610902984961; Hoa P. Thuy, 2005, Food and Nutrition Bulletin, V26, P32; Jennifer C, 2007, HOUSEHOLD FOOD INSEC; Kline R.B., 2011, PRINCIPLES PRACTICE; Long JS, 1997, REGRESSION MODELS CA; Lutsey PL, 2008, PUBLIC HEALTH NUTR, V11, P76, DOI 10.1017/S1368980007000237; McLennan JD, 2000, PEDIATRICS, V105, P1090, DOI 10.1542/peds.105.5.1090; *MIN HLTH, 2001, VIETN NAT NUTR STRAT, P2001; Minkovitz CS, 2005, PEDIATRICS, V115, P306, DOI 10.1542/peds.2004-0341; *MOH NIN, 2010, GEN NUTR SURV 2009 2; Murray-Kolb LE, 2011, J NUTR, V141, p747S, DOI 10.3945/jn.110.130658; Nakamori M, 2009, J NUTR SCI VITAMINOL, V55, P338, DOI 10.3177/jnsv.55.338; Okwu G. N., 2008, Pakistan Journal of Nutrition, V7, P151; Pena-Rosas JP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub3; Rahman A, 2013, B WORLD HEALTH ORGAN, V91, P593, DOI 10.2471/BLT.12.109819; Seck BC, 2008, PUBLIC HEALTH NUTR, V11, P596, DOI 10.1017/S1368980007000924; Senanayake HM, 2010, J OBSTET GYNAECOL RE, V36, P646, DOI 10.1111/j.1447-0756.2010.01197.x; Shariatpanaahi MV, 2007, EUR J CLIN NUTR, V61, P532, DOI 10.1038/sj.ejcn.1602542; Tran TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074876; Tran TD, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-148; Tran TD, 2012, J AFFECT DISORDERS, V136, P104, DOI 10.1016/j.jad.2011.08.012; TRAN T, 2003, YOUNG LIVES PRELIMIN, P57; Tran T, 2004, COMMUNITY BASED EVID; Tran TD, 2011, J AFFECT DISORDERS, V133, P281, DOI 10.1016/j.jad.2011.03.038; Van Thuy P, 2005, J NUTR, V135, P2596, DOI 10.1093/jn/135.11.2596; Wachs TD, 2009, AM J CLIN NUTR, V89, p935S, DOI 10.3945/ajcn.2008.26692B; WILHELM K, 1988, PSYCHOL MED, V18, P225, DOI 10.1017/S0033291700002051; World Health Organization United Nations Children's Fund United Nations University, 2001, IRON DEF AN ASS PREV; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	46	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78162	10.1371/journal.pone.0078162	http://dx.doi.org/10.1371/journal.pone.0078162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239OF	24167605	gold, Green Published, Green Submitted			2022-12-27	WOS:000326034500065
J	Totaro, F; Cimmino, F; Pignataro, P; Acierno, G; De Mariano, M; Longo, L; Tonini, GP; Iolascon, A; Capasso, M				Totaro, Francesca; Cimmino, Flora; Pignataro, Piero; Acierno, Giovanni; De Mariano, Marilena; Longo, Luca; Tonini, Gian Paolo; Iolascon, Achille; Capasso, Mario			Impact of Interleukin-6-174 G > C Gene Promoter Polymorphism on Neuroblastoma	PLOS ONE			English	Article							CELL-LINES; COLORECTAL-CANCER; COMMON VARIATION; EXPRESSION; ASSOCIATION; IL-6; SUSCEPTIBILITY; RISK; PROGNOSIS; RECEPTOR	Background: Common variants in DNA may predispose to onset and progression of neuroblastoma (NB). The genotype GG of single nucleotide polymorphism (SNP) rs1800795 (-174 G>C) in interleukin (IL)-6 promoter has been associated with lower survival of high-risk NB. Result: To evaluate the impact of IL-6 SNP rs1800795 on disease risk and phenotype, we analyzed 326 Italian NB patients and 511 controls. Moreover, we performed in silico and quantitative Real Time (qRT)-PCR analyses to evaluate the influence of the SNP on gene expression in 198 lymphoblastoid cell lines (LCLs) and in 31 NB tumors, respectively. Kaplan-Meier analysis was used to verify the association between IL-6 gene expression and patient survival. We found that IL-6 SNP is not involved in susceptibility to NB development. However, our results show that a low frequency of genotype CC is significantly associated with a low overall survival, advanced stage, and high-risk phenotype. The in silico (p = 2.61x10(-5)) and qRT-PCR (p = 0.03) analyses showed similar trend indicating that the CC genotype is correlated with increased level of IL-6 expression. In report gene assay, we showed that the -174 C variant had a significantly increased transcriptional activity compared with G allele (p = 0.0006). Moreover, Kaplan-Meier analysis demonstrated that high levels of IL-6 are associated with poor outcome in children with NB in two independent gene expression array datasets. Conclusions: The biological effect of SNP IL-6-174 G>C in relation to promotion of cancer progression is consistent with the observed decreased survival time. The present study suggests that SNP IL-6-174 G>C may be a useful marker for NB prognosis.	[Totaro, Francesca; Cimmino, Flora; Acierno, Giovanni; Iolascon, Achille; Capasso, Mario] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Totaro, Francesca; Cimmino, Flora; Pignataro, Piero; Acierno, Giovanni; Iolascon, Achille; Capasso, Mario] CEINGE Biotecnol Avanzate, Naples, Italy; [De Mariano, Marilena; Longo, Luca] IRCCS AOU San Martino IST Ist Nazl Ric Canc, Genoa, Italy; [De Mariano, Marilena; Longo, Luca] Natl Inst Canc Res, IRCCS AOU San Martino IST, Genoa, Italy; [Tonini, Gian Paolo] Univ Padua, Pediat Res Inst, Oncohematol Dept SDB, Lab Neuroblastoma, Padua, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Padua	Capasso, M (corresponding author), Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy.	capasso@ceinge.unina.it	Cimmino, FLORA/K-6205-2016; Capasso, Mario/D-1617-2014; Iolascon, Achille/A-4461-2014; Longo, Luca/K-6156-2018; Cimmino, Flora/AAA-2378-2020	Cimmino, FLORA/0000-0003-1538-9285; Longo, Luca/0000-0002-5153-4243; Cimmino, Flora/0000-0003-1538-9285; Capasso, Mario/0000-0003-3306-1259; iolascon, achille/0000-0002-9558-0356	Associazione Italiana per la Ricerca sul Cancro [10537]; MIUR- FIRB Ricerca in Futuro [RBFR08DWQ3]; Fondazione Italiana per la Lotta al Neuroblastoma; Associazione Oncologia Pediatrica e Neuroblastoma; Italian Ministry of Health [GR-2010-2311890]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); MIUR- FIRB Ricerca in Futuro; Fondazione Italiana per la Lotta al Neuroblastoma; Associazione Oncologia Pediatrica e Neuroblastoma; Italian Ministry of Health(Ministry of Health, Italy)	Associazione Italiana per la Ricerca sul Cancro (10537), MIUR- FIRB Ricerca in Futuro (RBFR08DWQ3), Fondazione Italiana per la Lotta al Neuroblastoma, Associazione Oncologia Pediatrica e Neuroblastoma and Italian Ministry of Health (GR-2010-2311890). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara T, 2009, CANCER RES, V69, P329, DOI 10.1158/0008-5472.CAN-08-0613; Belluco C, 2003, CLIN CANCER RES, V9, P2173; Boiardi L, 2006, J RHEUMATOL, V33, P703; Bosse KR, 2012, CANCER RES, V72, P2068, DOI 10.1158/0008-5472.CAN-11-3703; Bruunsgaard H, 2004, EXP GERONTOL, V39, P255, DOI 10.1016/j.exger.2003.10.012; Bullaughey K, 2009, HUM MOL GENET, V18, P4296, DOI 10.1093/hmg/ddp382; Capasso M, 2007, PEDIATR RES, V61, P313, DOI 10.1203/pdr.0b013e318030d108; Capasso M, 2013, CARCINOGENESIS, V34, P605, DOI 10.1093/carcin/bgs380; Capasso M, 2010, CANCER TREAT RES, V155, P65, DOI 10.1007/978-1-4419-6033-7_4; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Chen MF, 2013, MOL CANC IN PRESS; Deans C, 2007, ANN SURG ONCOL, V14, P329, DOI 10.1245/s10434-006-9122-9; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Diskin SJ, 2012, NAT GENET, V44, P1126, DOI 10.1038/ng.2387; Egler RA, 2008, CLIN CANCER RES, V14, P7028, DOI 10.1158/1078-0432.CCR-07-5017; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Heikkila K, 2008, EUR J CANCER, V44, P937, DOI 10.1016/j.ejca.2008.02.047; Hirano T, 1997, CYTOKINE HDB, P197; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; HUTCHINS D, 1994, INT J CANCER, V58, P80, DOI 10.1002/ijc.2910580114; Jones KG, 2001, CIRCULATION, V103, P2260; Lagmay JP, 2009, CLIN CANCER RES, V15, P5234, DOI 10.1158/1078-0432.CCR-08-2953; Landi S, 2003, CANCER RES, V63, P3560; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Nguyen LB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002026; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Plagnol V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002966; SIDELL N, 1991, J IMMUNOL, V146, P3809; Sohara Y, 2005, CANCER RES, V65, P1129, DOI 10.1158/0008-5472.CAN-04-2853; Terry CF, 2000, J BIOL CHEM, V275, P18138, DOI 10.1074/jbc.M000379200; Upadhyay R, 2008, CLIN IMMUNOL, V128, P199, DOI 10.1016/j.clim.2008.03.519; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609	33	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76810	10.1371/journal.pone.0076810	http://dx.doi.org/10.1371/journal.pone.0076810			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204677	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600012
J	Si, XX; Chen, W; Guo, XD; Chen, L; Wang, GY; Xu, YX; Kang, JH				Si, Xiaoxing; Chen, Wen; Guo, Xudong; Chen, Long; Wang, Guiying; Xu, Yanxin; Kang, Jiuhong			Activation of GSK3b by Sirt2 Is Required for Early Lineage Commitment of Mouse Embryonic Stem Cell	PLOS ONE			English	Article							DIFFERENTIATION; PLURIPOTENCY; INHIBITION; DEACETYLASE; EXPRESSION; GENERATION; SURVIVAL; GENES; WNT	Sirt2, a member of the NAD(+)-dependent protein deacetylase family, is increasingly recognized as a critical regulator of the cell cycle, cellular necrosis and cytoskeleton organization. However, its role in embryonic stem cells (ESCs) remains unclear. Here we demonstrate that Sirt2 is up-regulated during RA (retinoic acid)-induced and embryoid body (EB) differentiation of mouse ESCs. Using lentivirus-mediated shRNA methods, we found that knockdown of Sirt2 compromises the differentiation of mouse ESCs into ectoderm while promoting mesoderm and endoderm differentiation. Knockdown of Sirt2 expression also leads to the activation of GSK3 beta through decreased phosphorylation of the serine at position 9 (Ser9) but not tyrosine at position 216 (Tyr216). Moreover, the constitutive activation of GSK3 beta during EB differentiation mimics the effect of Sirt2 knockdown, while down-regulation of GSK3 beta rescues the effect of Sirt2 knockdown on differentiation. In contrast to the effect on lineage differentiation, Sirt2 knockdown and GSK3 beta up-regulation do not change the self-renewal state of mouse ESCs. Overall, our report reveals a new function for Sirt2 in regulating the proper lineage commitment of mouse ESCs.	[Si, Xiaoxing; Chen, Wen; Guo, Xudong; Chen, Long; Wang, Guiying; Xu, Yanxin; Kang, Jiuhong] Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Shanghai Key Lab Signaling & Dis Res, Clin & Translat Res Ctr,Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Tongji University	Kang, JH (corresponding author), Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Shanghai Key Lab Signaling & Dis Res, Clin & Translat Res Ctr,Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	jhkang@tongji.edu.cn		Xu, Yanxin/0000-0003-3651-6909	Ministry of Science and Technology [2011CB965100, 2011CBA01100, 2010CB944900, 2010CB945000, 2012CB966603]; National Natural Science Foundation of China [91219305, 31210103905, 31101061, 31201107, 31171432, 81170499]; Science and Technology Commission of Shanghai Municipality [11ZR1438500, 12ZR1450900]; Ministry of Education [IRT1168, 20110072110039]; Shanghai Municipal Education Commission; Shanghai Education Development Foundation [12CG19]; Fundamental Research Funds for the Central Universities [2000219067, 2000219066]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Education; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from Ministry of Science and Technology (2011CB965100, 2011CBA01100, 2010CB944900, 2010CB945000, and 2012CB966603), National Natural Science Foundation of China (91219305, 31210103905, 31101061, 31201107, 31171432, and 81170499), Science and Technology Commission of Shanghai Municipality (11ZR1438500, 12ZR1450900), IRT1168 and 20110072110039 from Ministry of Education, and also supported by "Chen Guang" project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation (12CG19) and the Fundamental Research Funds for the Central Universities (2000219067 and 2000219066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binetruy B, 2007, STEM CELLS, V25, P1090, DOI 10.1634/stemcells.2006-0612; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bone HK, 2011, J CELL SCI, V124, P1992, DOI 10.1242/jcs.081679; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Chen HP, 2011, J CELL BIOCHEM, V112, P3246, DOI 10.1002/jcb.23251; Dan L, 2012, HAEMATOL-HEMATOL J, V97, P551, DOI 10.3324/haematol.2011.055236; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hezroni H, 2011, NUCLEUS-PHILA, V2, P300, DOI 10.4161/nucl.2.4.16767; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Karantzali E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r65; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Li YZ, 2011, GENES CELLS, V16, P34, DOI 10.1111/j.1365-2443.2010.01460.x; Nakanishi M, 2009, FASEB J, V23, P114, DOI 10.1096/fj.08-111203; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Wang H, 2010, BIOCHEM PHARMACOL, V80, P1386, DOI 10.1016/j.bcp.2010.07.034; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167	25	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76699	10.1371/journal.pone.0076699	http://dx.doi.org/10.1371/journal.pone.0076699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204656	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300043
J	Borozan, I; Watt, SN; Ferretti, V				Borozan, Ivan; Watt, Stuart N.; Ferretti, Vincent			Evaluation of Alignment Algorithms for Discovery and Identification of Pathogens Using RNA-Seq	PLOS ONE			English	Article							READ ALIGNMENT; SEQUENCES; ULTRAFAST; IDENTIFY; SOFTWARE; VIRUSES; SEARCH	Next-generation sequencing technologies provide an unparallelled opportunity for the characterization and discovery of known and novel viruses. Because viruses are known to have the highest mutation rates when compared to eukaryotic and bacterial organisms, we assess the extent to which eleven well-known alignment algorithms (BLAST, BLAT, BWA, BWA-SW, BWA-MEM, BFAST, Bowtie2, Novoalign, GSNAP, SHRiMP2 and STAR) can be used for characterizing mutated and non-mutated viral sequences - including those that exhibit RNA splicing - in transcriptome samples. To evaluate aligners objectively we developed a realistic RNA-Seq simulation and evaluation framework (RiSER) and propose a new combined score to rank aligners for viral characterization in terms of their precision, sensitivity and alignment accuracy. We used RiSER to simulate both human and viral read sequences and suggest the best set of aligners for viral sequence characterization in human transcriptome samples. Our results show that significant and substantial differences exist between aligners and that a digital-subtraction-based viral identification framework can and should use different aligners for different parts of the process. We determine the extent to which mutated viral sequences can be effectively characterized and show that more sensitive aligners such as BLAST, BFAST, SHRiMP2, BWA-SW and GSNAP can accurately characterize substantially divergent viral sequences with up to 15% overall sequence mutation rate. We believe that the results presented here will be useful to researchers choosing aligners for viral sequence characterization using next-generation sequencing data.	[Borozan, Ivan; Watt, Stuart N.; Ferretti, Vincent] Ontario Inst Canc Res, Toronto, ON, Canada	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Borozan, I (corresponding author), Ontario Inst Canc Res, Toronto, ON, Canada.	Ivan.Borozan@oicr.on.ca		Borozan, Ivan/0000-0002-3145-3550	Ontario Institute for Cancer Research (OICR) through government of Ontario	Ontario Institute for Cancer Research (OICR) through government of Ontario	The authors received support for their work from the Ontario Institute for Cancer Research (OICR) through funding provided by the government of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bhaduri A, 2012, BIOINFORMATICS, V28, P1174, DOI 10.1093/bioinformatics/bts100; Borozan I, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-206; Chen YX, 2013, BIOINFORMATICS, V29, P266, DOI 10.1093/bioinformatics/bts665; Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drake JW, 1998, GENETICS, V148, P1667; Feng HC, 2007, J VIROL, V81, P11332, DOI 10.1128/JVI.00875-07; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H., 2013, ARXIV13033997 Q BIO; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu SJ, 2011, VIRUSES-BASEL, V3, P1849, DOI 10.3390/v3101849; Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024758; McLoughlin KS, 2011, BRIEF FUNCT GENOMICS, V10, P342, DOI 10.1093/bfgp/elr027; Moore RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019838; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Nachman MW, 2000, GENETICS, V156, P297; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Rijsbergen CJV, 1976, INFORM RETRIEVAL; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Studholme DJ, 2011, ANNU REV PHYTOPATHOL, V49, P87, DOI 10.1146/annurev-phyto-072910-095408; Wang XH, 2011, J VIROL, V85, P8080, DOI 10.1128/JVI.00670-11; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; zur Hausen H., 2006, INFECT CAUSING HUMAN	36	27	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e76935	10.1371/journal.pone.0076935	http://dx.doi.org/10.1371/journal.pone.0076935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204709	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500012
J	Harttgen, K; Kowal, P; Strulik, H; Chatterji, S; Vollmer, S				Harttgen, Kenneth; Kowal, Paul; Strulik, Holger; Chatterji, Somnath; Vollmer, Sebastian			Patterns of Frailty in Older Adults: Comparing Results from Higher and Lower Income Countries Using the Survey of Health, Ageing and Retirement in Europe (SHARE) and the Study on Global AGEing and Adult Health (SAGE)	PLOS ONE			English	Article							PREVALENCE; DISABILITY	We use the method of deficit accumulation to describe prevalent and incident levels of frailty in community-dwelling older persons and compare prevalence rates in higher income countries in Europe, to prevalence rates in six lower income countries. Two multi-country data collection efforts, SHARE and SAGE, provide nationally representative samples of adults aged 50 years and older. Forty items were used to construct the frailty index in each data set. Our study shows that the level of frailty was distributed along the socioeconomic gradient in both higher and lower income countries such that those individuals with less education and income were more likely to be frail. Frailty increased with age and women were more likely to be frail in most countries. Across samples we find that the level of frailty was higher in the higher income countries than in the lower income countries.	[Harttgen, Kenneth] ETH, NADEL, Zurich, Switzerland; [Kowal, Paul; Chatterji, Somnath] World Hlth Org, Geneva, Switzerland; [Strulik, Holger; Vollmer, Sebastian] Univ Gottingen, Dept Econ, D-37073 Gottingen, Germany; [Vollmer, Sebastian] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; World Health Organization; University of Gottingen; Harvard University; Harvard T.H. Chan School of Public Health	Vollmer, S (corresponding author), Univ Gottingen, Dept Econ, D-37073 Gottingen, Germany.	svollmer@uni-goettingen.de	Vollmer, Sebastian/U-6496-2017; CHATTERJI, Somnath/ABE-6832-2020	Vollmer, Sebastian/0000-0002-7863-0462; Strulik, Holger/0000-0002-5615-2412; Kowal, Paul/0000-0002-6314-8753	European Commission within the project "Long-Run Economic Perspectives of an Aging Society'' (LEPAS) in the Seventh Framework Programme under the Socio-economic Sciences and Humanities theme [SSH7-CT-2009-217275]	European Commission within the project "Long-Run Economic Perspectives of an Aging Society'' (LEPAS) in the Seventh Framework Programme under the Socio-economic Sciences and Humanities theme	The work of SV and HS was supported by the European Commission within the project "Long-Run Economic Perspectives of an Aging Society'' (LEPAS) in the Seventh Framework Programme under the Socio-economic Sciences and Humanities theme (Grant Agreement: SSH7-CT-2009-217275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD O, 2001, 31 GPE WHO; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Ferguson B, 2003, HLTH SYSTEMS PERFORM; Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2; Gakidou E, 2007, JAMA-J AM MED ASSOC, V298, P1876, DOI 10.1001/jama.298.16.1876; Heuberger Roschelle A., 2011, Journal of Nutrition in Gerontology and Geriatrics, V30, P315, DOI 10.1080/21551197.2011.623931; Hosseinpoor AR, 2005, B WORLD HEALTH ORGAN, V83, P837; Klevmarken NA, 2005, SURVEY HLTH AGEING R; Lang PO, 2009, GERONTOLOGY, V55, P539, DOI 10.1159/000211949; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Mitnitski Arnold B, 2002, BMC Geriatr, V2, P1; Pijpers E, 2012, EUR J INTERN MED, V23, P118, DOI 10.1016/j.ejim.2011.09.003; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P738, DOI 10.1093/gerona/62.7.738; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rodriguez-Manas L, 2013, J GERONTOL A-BIOL, V68, P62, DOI 10.1093/gerona/gls119; Romero-Ortuno R, 2012, AGE AGEING, V41, P684, DOI 10.1093/ageing/afs051; Satariano WA, 1997, AM J PUBLIC HEALTH, V87, P331, DOI 10.2105/AJPH.87.3.331; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Song XW, 2010, J AM GERIATR SOC, V58, P681, DOI 10.1111/j.1532-5415.2010.02764.x; Sternberg SA, 2011, J AM GERIATR SOC, V59, P2129, DOI 10.1111/j.1532-5415.2011.03597.x; Strawbridge WJ, 1998, J GERONTOL B-PSYCHOL, V53, pS9, DOI 10.1093/geronb/53B.1.S9; UNESCO Institute for Statistics, 2006, INT STAND CLASS ED I; United Nations, 2011, WORLD POP PROSP 2010; Van Kan GA, 2008, J NUTR HEALTH AGING, V12, P29, DOI 10.1007/BF02982161; van Kan GA, 2010, CLIN GERIATR MED, V26, P275, DOI 10.1016/j.cger.2010.02.002; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x	30	90	92	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e75847	10.1371/journal.pone.0075847	http://dx.doi.org/10.1371/journal.pone.0075847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242VF	24204581	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700002
J	Zhao, Y; Gentekaki, E; Yi, ZZ; Lin, XF				Zhao, Yan; Gentekaki, Eleni; Yi, Zhenzhen; Lin, Xiaofeng			Genetic Differentiation of the Mitochondrial Cytochrome Oxidase c Subunit I Gene in Genus Paramecium (Protista, Ciliophora)	PLOS ONE			English	Article							DNA-SEQUENCE; HETEROPLASMY; GENOME; NUCLEAR; DIVERSITY; PROTOZOA; NUMTS; OLIGOHYMENOPHOREA; AMPLIFICATION; LIKELIHOOD	Background: The mitochondrial cytochrome c oxidase subunit I (COI) gene is being used increasingly for evaluating inter- and intra-specific genetic diversity of ciliated protists. However, very few studies focus on assessing genetic divergence of the COI gene within individuals and how its presence might affect species identification and population structure analyses. Methodology/Principal findings: We evaluated the genetic variation of the COI gene in five Paramecium species for a total of 147 clones derived from 21 individuals and 7 populations. We identified a total of 90 haplotypes with several individuals carrying more than one haplotype. Parsimony network and phylogenetic tree analyses revealed that intra-individual diversity had no effect in species identification and only a minor effect on population structure. Conclusions: Our results suggest that the COI gene is a suitable marker for resolving inter-and intra-specific relationships of Paramecium spp.	[Zhao, Yan] Ocean Univ China, Inst Evolut & Marine Biodivers, Lab Protozool, Qingdao, Peoples R China; [Zhao, Yan; Yi, Zhenzhen; Lin, Xiaofeng] S China Normal Univ, Lab Protozool, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Gentekaki, Eleni] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada	Ocean University of China; South China Normal University; Dalhousie University	Gentekaki, E (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	eleni@dal.ca; zyi@scnu.edu.cn	Zhao, Yan/G-4714-2015		Natural Science Foundation of China [31030059, 31222050, 41110104011]; Research Fund for the Doctoral Program of Higher Education [20104407120006]; China Postdoctoral Science Foundation [20110491623]; Royal Society; Direct For Biological Sciences [1136580] Funding Source: National Science Foundation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Royal Society(Royal Society of London); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Natural Science Foundation of China (Project No. 31030059, 31222050, 41110104011), the Research Fund for the Doctoral Program of Higher Education Project No. 20104407120006), China Postdoctoral Science Foundation (Project No. 20110491623), and the Royal Society Joint Projects scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CL, 2005, MOL ECOL, V14, P3605, DOI 10.1111/j.1365-294X.2005.02672.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barth D, 2006, J EUKARYOT MICROBIOL, V53, P20, DOI 10.1111/j.1550-7408.2005.00068.x; Barth D, 2008, ENVIRON MICROBIOL, V10, P626, DOI 10.1111/j.1462-2920.2007.01486.x; Barth D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-272; Berthier K, 2011, SYST ENTOMOL, V36, P285, DOI 10.1111/j.1365-3113.2010.00561.x; Boscaro V, 2012, MOL PHYLOGENET EVOL, V65, P1004, DOI 10.1016/j.ympev.2012.09.001; Burger G, 2000, J MOL BIOL, V297, P365, DOI 10.1006/jmbi.2000.3529; Catania F, 2009, MOL BIOL EVOL, V26, P421, DOI 10.1093/molbev/msn266; Chantangsi C, 2007, INT J SYST EVOL MICR, V57, P2412, DOI 10.1099/ijs.0.64865-0; Chen XR, 2012, EUR J PROTISTOL, V48, P63, DOI 10.1016/j.ejop.2011.07.005; CORLISS J O, 1979, P455; Coyer JA, 2004, MOL ECOL, V13, P1323, DOI 10.1111/j.1365-294X.2004.02128.x; de Graaf RM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-514; Drake JW, 1998, GENETICS, V148, P1667; Drummond AJ, 2010, GENEIOUS V5 1; EHRENBERG CG, 1838, INFUSIONSTHIERCHEN V; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fan XP, 2013, EUR J PROTISTOL, V49, P312, DOI 10.1016/j.ejop.2012.06.003; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Finlay BJ, 2006, PROTIST, V157, P377, DOI 10.1016/j.protis.2006.05.012; Foissner W, 2008, BIODIVERS CONSERV, V17, P345, DOI 10.1007/s10531-007-9254-7; Fokin SI, 2004, EUR J PROTISTOL, V40, P225, DOI 10.1016/j.ejop.2004.02.001; Frey JE, 2004, HEREDITAS, V140, P92, DOI 10.1111/j.1601-5223.2004.01748.x; Gao F, 2012, MOL PHYLOGENET EVOL, V64, P308, DOI 10.1016/j.ympev.2012.04.008; Gao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033198; Gentekaki E, 2009, APPL ENVIRON MICROB, V75, P3187, DOI 10.1128/AEM.00178-09; Gentekaki E, 2012, EUR J PROTISTOL, V48, P305, DOI 10.1016/j.ejop.2012.04.001; Gjerde B, 2013, PARASITOL RES, V112, P1493, DOI 10.1007/s00436-013-3296-4; Greczek-Stachura M, 2012, PROTIST, V163, P671, DOI 10.1016/j.protis.2011.10.009; Grun P., 1976, CYTOPLASMIC GENETICS; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hikosaka K, 2010, MOL BIOL EVOL, V27, P1107, DOI 10.1093/molbev/msp320; Kher CP, 2011, PROTIST, V162, P2, DOI 10.1016/j.protis.2010.03.004; Kudo RR, 1966, PROTOZOOLOGY; Lee JS, 2001, GENE, V280, P1, DOI 10.1016/S0378-1119(01)00765-X; Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Lynn D.H, 2008, CIL PROT CHAR CLASS, V3rd ed.; Magnacca KN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-174; Messenger LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001584; Miraldo A, 2012, MOL ECOL, V21, P1005, DOI 10.1111/j.1365-294X.2011.05422.x; Nardi F, 2001, MOL BIOL EVOL, V18, P1293, DOI 10.1093/oxfordjournals.molbev.a003914; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Petri B, 1996, BIOL CHEM, V377, P661, DOI 10.1515/bchm3.1996.377.10.661; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Przybos E, 2012, PROTIST, V163, P263, DOI 10.1016/j.protis.2011.06.006; Reiner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014359; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Snoke MS, 2006, MOL BIOL EVOL, V23, P2474, DOI 10.1093/molbev/msl128; SOLIGNAC M, 1983, P NATL ACAD SCI-BIOL, V80, P6942, DOI 10.1073/pnas.80.22.6942; Song W.B., 2009, FREE LIVING CILIATES; Struder-Kypke MC, 2000, MOL PHYLOGENET EVOL, V14, P122, DOI 10.1006/mpev.1999.0686; Struder-Kypke MC, 2010, SYST BIODIVERS, V8, P131, DOI 10.1080/14772000903507744; Swart EC, 2012, GENOME BIOL EVOL, V4, P136, DOI 10.1093/gbe/evr136; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarcz S, 2013, EUR J PROTISTOL, V49, P50, DOI 10.1016/j.ejop.2012.05.004; Tarcz S, 2012, MOL PHYLOGENET EVOL, V63, P500, DOI 10.1016/j.ympev.2012.01.024; Vollmer NL, 2011, CURR GENET, V57, P115, DOI 10.1007/s00294-010-0331-1; Xu Y, 2012, SYST BIODIVERS, V10, P207, DOI 10.1080/14772000.2012.681713; Zhang QQ, 2011, ZOOL SCR, V40, P317, DOI 10.1111/j.1463-6409.2011.00473.x; Zufall RA, 2013, MOL ECOL, V22, P1081, DOI 10.1111/mec.12066	67	34	39	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77044	10.1371/journal.pone.0077044	http://dx.doi.org/10.1371/journal.pone.0077044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204730	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700016
J	Degenhardt, L; Ferrari, AJ; Calabria, B; Hall, WD; Norman, RE; McGrath, J; Flaxman, AD; Engell, RE; Freedman, GD; Whiteford, HA; Vos, T				Degenhardt, Louisa; Ferrari, Alize J.; Calabria, Bianca; Hall, Wayne D.; Norman, Rosana E.; McGrath, John; Flaxman, Abraham D.; Engell, Rebecca E.; Freedman, Greg D.; Whiteford, Harvey A.; Vos, Theo			The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; DISABILITY WEIGHTS; HEALTH OUTCOMES; MENTAL-HEALTH; RISK-FACTORS; 21 REGIONS; SCHIZOPHRENIA; PREVALENCE; DISORDERS; INJURIES	Aims: Estimate the prevalence of cannabis dependence and its contribution to the global burden of disease. Methods: Systematic reviews of epidemiological data on cannabis dependence (1990-2008) were conducted in line with PRISMA and meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Culling and data extraction followed protocols, with cross-checking and consistency checks. DisMod-MR, the latest version of generic disease modelling system, redesigned as a Bayesian meta-regression tool, imputed prevalence by age, year and sex for 187 countries and 21 regions. The disability weight associated with cannabis dependence was estimated through population surveys and multiplied by prevalence data to calculate the years of life lived with disability (YLDs) and disability-adjusted life years (DALYs). YLDs and DALYs attributed to regular cannabis use as a risk factor for schizophrenia were also estimated. Results: There were an estimated 13.1 million cannabis dependent people globally in 2010 (point prevalence0.19% (95% uncertainty: 0.17-0.21%)). Prevalence peaked between 20-24 yrs, was higher in males (0.23% (0.2-0.27%)) than females (0.14% (0.12-0.16%)) and in high income regions. Cannabis dependence accounted for 2 million DALYs globally (0.08%; 0.05-0.12%) in 2010; a 22% increase in crude DALYs since 1990 largely due to population growth. Countries with statistically higher age-standardised DALY rates included the United States, Canada, Australia, New Zealand and Western European countries such as the United Kingdom; those with lower DALY rates were from Sub-Saharan Africa-West and Latin America. Regular cannabis use as a risk factor for schizophrenia accounted for an estimated 7,000 DALYs globally. Conclusion: Cannabis dependence is a disorder primarily experienced by young adults, especially in higher income countries. It has not been shown to increase mortality as opioid and other forms of illicit drug dependence do. Our estimates suggest that cannabis use as a risk factor for schizophrenia is not a major contributor to population-level disease burden.	[Degenhardt, Louisa; Calabria, Bianca] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Degenhardt, Louisa] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Ferrari, Alize J.; Whiteford, Harvey A.] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Ferrari, Alize J.; Norman, Rosana E.; Whiteford, Harvey A.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Hall, Wayne D.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Hall, Wayne D.] Kings Coll London, Natl Addict Ctr, London WC2R 2LS, England; [Norman, Rosana E.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [McGrath, John] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Flaxman, Abraham D.; Engell, Rebecca E.; Freedman, Greg D.; Vos, Theo] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	University of New South Wales Sydney; University of Melbourne; Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; University of London; King's College London; University of Queensland; University of Queensland; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Degenhardt, L (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia.	l.degenhardt@unsw.edu.au	Whiteford, Harvey A/A-4840-2009; Degenhardt, Louisa J/D-4515-2012; Hall, Wayne D/A-3283-2008; McGrath, John Joseph/G-5493-2010; Ferrari, Alize J/G-1746-2011; PACELLA, ROSANA E./F-2774-2010	Whiteford, Harvey A/0000-0003-4667-6623; Degenhardt, Louisa J/0000-0002-8513-2218; Hall, Wayne D/0000-0003-1984-0096; McGrath, John Joseph/0000-0002-4792-6068; Ferrari, Alize J/0000-0002-7863-9117; PACELLA, ROSANA E./0000-0002-9742-1957; Calabria, Bianca/0000-0001-6444-4696; O'donnell, Colm/0000-0002-8004-450X	Australian National Health and Medical Research Council (NHMRC); NHMRC Australia; Australian Government; Queensland Department of Health; Bill and Melinda Gates Foundation	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Government(Australian GovernmentCGIAR); Queensland Department of Health; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Louisa Degenhardt is supported by an Australian National Health and Medical Research Council (NHMRC) Principal Research Fellowship. Wayne Hall is funded by an NHMRC Australia Fellowship. The National Drug and Alcohol Research Centre at the University of NSW is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund. Harvey A Whiteford and Alize J Ferrari are affiliated with the Queensland Centre for Mental Health Research, which receives its core funding from the Queensland Department of Health. Abraham D Flaxman, Theo Vos, Rebecca Engell, Greg Freedman and Christopher JL Murray received funding for their work on the Global Burden of Disease 2010 Study from the Bill and Melinda Gates Foundation. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOOD ME, 1992, TRENDS PHARMACOL SCI, V13, P201, DOI 10.1016/0165-6147(92)90064-D; Ajdacic-Gross V, 2007, SCHIZOPHR RES, V95, P9, DOI 10.1016/j.schres.2007.06.001; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], PLOS MED; [Anonymous], HLTH EFFECTS CANNABI; [Anonymous], 2000, SCI MARIJUANA; [Anonymous], WORLD DEV REP 1993 I; [Anonymous], CAN J PSYCHIAT; [Anonymous], 2001, HLTH PSYCHOL CONSEQU; [Anonymous], WORLD DRUG REP; [Anonymous], 307 NDARC U NSW; [Anonymous], 3 U NSW NAT DRUG ALC; [Anonymous], 1996, GLOBAL BURDEN DIS CO; [Anonymous], DRUG ALCOHO IN PRESS; [Anonymous], INTEGRATIVE METAREGR; [Anonymous], LANCET; [Anonymous], WORLD DRUG REP 2008; [Anonymous], 1999, HLTH EFFECTS CANNABI; [Anonymous], ARCH GEN PSYCHIAT AR; Arseneault L, 2004, BRIT J PSYCHIAT, V184, P110, DOI 10.1192/bjp.184.2.110; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Calabria B, 2010, ADDICT BEHAV, V35, P741, DOI 10.1016/j.addbeh.2010.03.019; Calabria B, 2010, DRUG ALCOHOL REV, V29, P318, DOI 10.1111/j.1465-3362.2009.00149.x; Degenhardt L, 2003, DRUG ALCOHOL DEPEN, V71, P37, DOI 10.1016/S0376-8716(03)00064-4; Degenhardt L, 2004, COMP QUANTIFICATION, P1109; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V117, P85, DOI 10.1016/j.drugalcdep.2010.11.032; Denis C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005194.pub2; Ferrari AJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-16; Foti DJ, 2010, AM J PSYCHIAT, V167, P987, DOI 10.1176/appi.ajp.2010.09020189; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; Green B, 2005, BRIT J PSYCHIAT, V187, P306, DOI 10.1192/bjp.187.4.306; Hall W, 1998, DRUG ALCOHOL REV, V17, P433, DOI 10.1080/09595239800187271; Hall W, 2007, CURR OPIN PSYCHIATR, V20, P393, DOI 10.1097/YCO.0b013e32812144cc; Hall W, 2006, CAN J PSYCHIAT, V51, P566, DOI 10.1177/070674370605100904; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Hambrecht M, 2000, AUST NZ J PSYCHIAT, V34, P468, DOI 10.1080/j.1440-1614.2000.00736.x; Henquet C, 2008, SCHIZOPHRENIA BULL, V34, P1111, DOI 10.1093/schbul/sbn108; Hickman M, 2007, ADDICTION, V102, P597, DOI 10.1111/j.1360-0443.2006.01710.x; Knapp WP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003023.pub2; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2010, B WORLD HEALTH ORGAN, V88, P879, DOI 10.2471/BLT.10.084301; Stinson FS, 2006, PSYCHOL MED, V36, P1447, DOI 10.1017/S0033291706008361; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WHO, 2012, ICD 10 CLASS MENT BE; World Health Organization, 2008, The global burden of disease: 2004 update; Zammit S, 2008, BRIT J PSYCHIAT, V193, P357, DOI 10.1192/bjp.bp.107.046375	56	180	181	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76635	10.1371/journal.pone.0076635	http://dx.doi.org/10.1371/journal.pone.0076635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241FR	24204649	Green Published, gold			2022-12-27	WOS:000326152300009
J	Cuk, K; Zucknick, M; Madhavan, D; Schott, S; Golatta, M; Heil, J; Marme, F; Turchinovich, A; Sinn, P; Sohn, C; Junkermann, H; Schneeweiss, A; Burwinkel, B				Cuk, Katarina; Zucknick, Manuela; Madhavan, Dharanija; Schott, Sarah; Golatta, Michael; Heil, Joerg; Marme, Frederik; Turchinovich, Andrey; Sinn, Peter; Sohn, Christof; Junkermann, Hans; Schneeweiss, Andreas; Burwinkel, Barbara			Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer	PLOS ONE			English	Article							BLOOD-BASED MARKERS; CIRCULATING MICRORNAS; MAMMOGRAPHIC DENSITY; EXPRESSION; SERUM; PROLIFERATION; MIR-376A; ORIGIN; MIRNAS; CELLS	Over the last few years, circulating microRNAs (miRNAs) have emerged as promising novel and minimally invasive markers for various diseases, including cancer. We already showed that certain miRNAs are deregulated in the plasma of breast cancer patients when compared to healthy women. Herein we have further explored their potential to serve as breast cancer early detection markers in blood plasma. Circulating miR-127-3p, miR-376a and miR-652, selected as candidates from a miRNA array-based screening, were found to be associated with breast cancer for the first time (n = 417). Further we validated our previously reported circulating miRNAs (miR-148b, miR-376c, miR-409-3p and miR-801) in an independent cohort (n = 210) as elevated in the plasma of breast cancer patients compared to healthy women. We described, for the first time in breast cancer, an over-representation of deregulated miRNAs (miR-127-3p, miR-376a, miR-376c and miR-409-3p) originating from the chromosome 14q32 region. The inclusion of patients with benign breast tumors enabled the observation that miR-148b, miR-652 and miR-801 levels are even elevated in the plasma of women with benign tumors when compared to healthy controls. Furthermore, an analysis of samples stratified by cancer stage demonstrated that miR-127-3p, miR-148b, miR-409-3p, miR-652 and miR-801 can detect also stage I or stage II breast cancer thus making them attractive candidates for early detection. Finally, ROC curve analysis showed that a panel of these seven circulating miRNAs has substantial diagnostic potential with an AUC of 0.81 for the detection of benign and malignant breast tumors, which further increased to 0.86 in younger women (up to 50 years of age).	[Cuk, Katarina; Madhavan, Dharanija; Turchinovich, Andrey; Burwinkel, Barbara] German Canc Res Ctr, Heidelberg, Germany; [Cuk, Katarina; Madhavan, Dharanija; Turchinovich, Andrey; Burwinkel, Barbara] Univ Womens Clin, Heidelberg, Germany; [Zucknick, Manuela] German Canc Res Ctr, Div Biostat, Heidelberg, Germany; [Schott, Sarah; Golatta, Michael; Heil, Joerg; Marme, Frederik; Sohn, Christof; Junkermann, Hans; Schneeweiss, Andreas] Univ Womens Clin, Dept Gynecol & Obstet, Heidelberg, Germany; [Marme, Frederik; Schneeweiss, Andreas; Burwinkel, Barbara] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Sinn, Peter] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Cuk, K (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	katarina_cuk2@yahoo.de	Heil, Joerg/M-4998-2017; Turchinovich, Andrey/C-8213-2018; Sinn, Hans-Peter/C-5661-2008; Schott, Sarah/D-5242-2018; Schneeweiss, Andreas/HHS-4098-2022; Golatta, Michael/AAH-8735-2021; Junkermann, Hans/AAJ-3865-2021; turchinovich, andrey/B-2700-2014	Heil, Joerg/0000-0002-4684-9099; Sinn, Hans-Peter/0000-0003-2836-6699; Schott, Sarah/0000-0002-1714-1147; Golatta, Michael/0000-0002-2605-0060; Turchinovich, Andrey/0000-0003-4153-0895; Zucknick, Manuela/0000-0003-1317-7422	Dietmar-Hopp Foundation; Helmholtz Society; German Cancer Research Center (DKFZ)	Dietmar-Hopp Foundation; Helmholtz Society(Helmholtz Association); German Cancer Research Center (DKFZ)(Helmholtz Association)	This study was supported by the Dietmar-Hopp Foundation, Helmholtz Society and German Cancer Research Center (DKFZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agueli C, 2010, AM J HEMATOL, V85, P575, DOI 10.1002/ajh.21758; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Checka CM, 2012, AM J ROENTGENOL, V198, pW292, DOI 10.2214/AJR.10.6049; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Devor EJ, 2012, EXP THER MED, V3, P677, DOI 10.3892/etm.2012.458; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Duan ZF, 2011, MOL CANCER THER, V10, P1337, DOI 10.1158/1535-7163.MCT-11-0096; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; FLETCHER SW, 1993, J NATL CANCER I, V85, P1644, DOI 10.1093/jnci/85.20.1644; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Guo LJ, 2012, INT J MOL MED, V30, P680, DOI 10.3892/ijmm.2012.1021; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Howlader N, 2011, SEER CANC STAT REV 1; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lajer CB, 2011, BRIT J CANCER, V104, P830, DOI 10.1038/bjc.2011.29; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Leucci E, 2010, INT J CANCER, V126, P1316, DOI 10.1002/ijc.24655; Lin S, 2012, MOL CELLS, V33, P277, DOI 10.1007/s10059-012-2252-y; MacGrogan G, 2003, VIRCHOWS ARCH, V443, P609, DOI 10.1007/s00428-003-0888-x; Madhavan D, 2012, CLIN CANCER RES, V18, P5972, DOI 10.1158/1078-0432.CCR-12-1407; Millar EKA, 2011, BRIT J CANCER, V105, P272, DOI 10.1038/bjc.2011.228; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mosakhani N, 2012, GENE CHROMOSOME CANC, V51, P1, DOI 10.1002/gcc.20925; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Song WJ, 2012, J BREAST CANCER, V15, P218, DOI 10.4048/jbc.2012.15.2.218; Sukata T, 2011, TOXICOL LETT, V200, P46, DOI 10.1016/j.toxlet.2010.10.013; Tsai KW, 2011, INT J CANCER, V129, P2600, DOI 10.1002/ijc.25919; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valdes EK, 2005, AM SURGEON, V71, P348; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zehavi L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-44; Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zheng YX, 2012, FEBS LETT, V586, P2396, DOI 10.1016/j.febslet.2012.05.054	48	94	103	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76729	10.1371/journal.pone.0076729	http://dx.doi.org/10.1371/journal.pone.0076729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194846	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000025
J	Tio, D; Leter, E; Boerrigter, B; Boonstra, A; Vonk-Noordegraaf, A; Bogaard, HJ				Tio, Darryl; Leter, Edward; Boerrigter, Bart; Boonstra, Anco; Vonk-Noordegraaf, Anton; Bogaard, Harm Jan			Risk Factors for Hemoptysis in Idiopathic and Hereditary Pulmonary Arterial Hypertension	PLOS ONE			English	Article							EMBOLIZATION; DILATATION	Introduction: When hemoptysis complicates pulmonary arterial hypertension (PAH), it is assumed to result from bronchial artery hypertrophy. In heritable PAH, the most common mutation is in the BMPR2 gene, which regulates growth, differentiation and apoptosis of mesenchymal cells. The aim of this study is to determine the relationship in PAH between the occurrence of hemoptysis, and disease progression, bronchial artery hypertrophy, pulmonary artery dilation and BMPR2 mutations. Methods: 129 IPAH patients underwent baseline pulmonary imaging (CT angio or MRI) and repeated right-sided heart catheterization. Gene mutations were assessed in a subset of patients. Results: Hemoptysis was associated with a greater presence of hypertrophic bronchial arteries and more rapid hemodynamic deterioration. The presence of a BMPR2 mutation did not predispose to the development of hemoptysis, but was associated with a greater number of hypertrophic bronchial arteries and a worse baseline hemodynamic profile. Conclusion: Hemoptysis in PAH is associated with bronchial artery hypertrophy and faster disease progression. Although the presence of a BMPR2 mutation did not correlate with a greater incidence of hemoptysis in our patient cohort, its association with worse hemodynamics and a trend of greater bronchial arterial hypertrophy may increase the risk of hemoptysis.	[Tio, Darryl; Boerrigter, Bart; Boonstra, Anco; Vonk-Noordegraaf, Anton; Bogaard, Harm Jan] Vrije Univ Amsterdam Med Ctr, Dept Pulmonol, Amsterdam, Netherlands; [Leter, Edward] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Bogaard, HJ (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pulmonol, Amsterdam, Netherlands.	HJ.bogaard@vumc.nl	boonstra, anco/J-5446-2014	Tio, Darryl/0000-0002-9819-1612; Bogaard, Harm Jan/0000-0001-5371-0346				Boerrigter B, 2010, CHEST, V138, P1395, DOI 10.1378/chest.10-0363; Devaraj A, 2010, RADIOLOGY, V254, P609, DOI 10.1148/radiol.09090548; Edwards PD, 1998, BRIT J RADIOL, V71, P1018, DOI 10.1259/bjr.71.850.10211060; Endrys J, 1997, AM J ROENTGENOL, V182, P67; Galie N, 2004, EUR HEART J, V25, P2243, DOI 10.1016/j.ehj.2004.09.014; Girerd B, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-73; Grosse C, 2010, RADIOGRAPHICS, V30, P1753, DOI 10.1148/rg.307105710; Hiraki T, 2004, CARDIOVASC INTER RAD, V27, P186, DOI 10.1007/s00270-003-2722-x; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Khalil A, 2008, CHEST, V133, P212, DOI 10.1378/chest.07-1159; Khalil A, 2012, AM J ROENTGENOL, V198, P207, DOI 10.2214/AJR.10.5370; Li Wei, 2010, Proc Am Thorac Soc, V7, P395, DOI 10.1513/pats.201002-024AW; Majka S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-84; Reesink HJ, 2007, CARDIOVASC INTER RAD, V30, P136, DOI 10.1007/s00270-005-0382-8; Remy-Jardin M, 2005, RADIOLOGY, V235, P274, DOI 10.1148/radiol.2351040335; Reynolds AM, 2012, EUR RESPIR J, V39, P329, DOI 10.1183/09031936.00187310; Senbaklavaci O, 2001, J THORAC CARDIOV SUR, V121, P1006, DOI 10.1067/mtc.2001.112634; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; WALLEY VM, 1990, PATHOLOGY, V22, P1; Zylkowska J, 2012, CHEST, V142, P1406, DOI 10.1378/chest.11-2794; Zylkowska J, 2011, CHEST, V139, P690, DOI 10.1378/chest.10-1134	22	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78132	10.1371/journal.pone.0078132	http://dx.doi.org/10.1371/journal.pone.0078132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194909	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000088
J	Beisner, BA; McCowan, B				Beisner, Brianne A.; McCowan, Brenda			Policing in Nonhuman Primates: Partial Interventions Serve a Prosocial Conflict Management Function in Rhesus Macaques	PLOS ONE			English	Article							COMPETITION; REPRESSION; EVOLUTION	Studies of prosocial policing in nonhuman societies traditionally focus on impartial interventions because of an underlying assumption that partial support implies a direct benefit to the intervener, thereby negating the potential for being prosocial in maintaining social stability for the benefit of the group. However, certain types of partial interventions have significant potential to be prosocial in controlling conflict, e. g. support of non-kin subordinates. Here, we propose a policing support hypothesis that some types of agonistic support serve a prosocial policing function that maintains group stability. Using seven large captive groups of rhesus macaques, we investigated the relationship between intervention type and group-level costs and benefits (rates of trauma, severe aggression, social relocation) and individual level costs and benefits (preferential sex-dyad targeting, dominance ambiguity reduction, access to mates, and return aggression). Our results show that impartial interventions and support of subordinate non-kin represent prosocial policing as both (1) were negatively associated with group-level rates of trauma and severe aggression, respectively, (2) showed no potential to confer individual dominance benefits, (3) when performed outside the mating season, they did not increase chances of mating with the beneficiary, and (4) were low-cost for the highest-ranking interveners. We recommend expanding the definition of 'policing' in nonhumans to include these 'policing support interventions'.	[Beisner, Brianne A.; McCowan, Brenda] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Beisner, Brianne A.; McCowan, Brenda] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Beisner, BA (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	babeisner@ucdavis.edu			NIH [R24 RR024396, PR 51 RR000169]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068335] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011136, P51OD011107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by NIH grants #R24 RR024396 (BM) and #PR 51 RR000169 (CNPRC base grant), and conducted under IACUC protocol #11843. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R., 2008, ESSAYS PEDAGOGY; Alexander RD, 1974, ANNU REV ECOL SYST, V5, P324; Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Boehm C., 1981, PRIMATE BEHAV SOCIOB, P161; Boehm Christopher, 1994, P211; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Datta S. B., 1992, P61; Dedeo S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000782; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Flack J.C., 2004, MACAQUE SOC, P157; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2005, P ROY SOC B-BIOL SCI, V272, P1091, DOI 10.1098/rspb.2004.3019; Flack JC, 2005, AM NATURALIST, V165, pE000; Frank SA, 2003, EVOLUTION, V57, P693; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Fushing H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017817; Harcourt A.H., 2007, GORILLA SOC CONFLICT; Jennings DJ, 2011, ANIM BEHAV, V81, P1217, DOI 10.1016/j.anbehav.2011.03.007; Jennings DJ, 2009, ANIM BEHAV, V77, P343, DOI 10.1016/j.anbehav.2008.10.006; KAPLAN JR, 1978, AM J PHYS ANTHROPOL, V49, P241, DOI 10.1002/ajpa.1330490212; Kummerli R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024350; Kummer H, 1967, SOCIAL COMMUNICATION; Kurland JA, 1977, KIN SELECTION JAPANE; McCowan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022350; McCullagh P, 1989, GEN LINEAR MODELS; Parks MJ, 2013, AGGRESSIVE IN PRESS; PETIT O, 1994, ANIM BEHAV, V48, P1427, DOI 10.1006/anbe.1994.1378; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; Sicotte P, 1995, FOLIA PRIMATOL, V65, P14, DOI 10.1159/000156871; Tajima T, 2010, PRIMATES, V51, P179, DOI 10.1007/s10329-009-0180-z; Vervaecke H, 2000, PRIMATES, V41, P249, DOI 10.1007/BF02557595; von Rohr CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032494	32	27	27	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77369	10.1371/journal.pone.0077369	http://dx.doi.org/10.1371/journal.pone.0077369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167570	Green Published, gold			2022-12-27	WOS:000326034500029
J	Koya, T; Nishizawa, S; Ohno, Y; Goto, A; Ikuta, A; Suzuki, M; Ohira, T; Egawa, T; Nakai, A; Sugiura, T; Ohira, Y; Yoshioka, T; Beppu, M; Goto, K				Koya, Tomoyuki; Nishizawa, Sono; Ohno, Yoshitaka; Goto, Ayumi; Ikuta, Akihiro; Suzuki, Miho; Ohira, Tomotaka; Egawa, Tatsuro; Nakai, Akira; Sugiura, Takao; Ohira, Yoshinobu; Yoshioka, Toshitada; Beppu, Moroe; Goto, Katsumasa			Heat Shock Transcription Factor 1-Deficiency Attenuates Overloading-Associated Hypertrophy of Mouse Soleus Muscle	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SKELETAL-MUSCLE; MOLECULAR CHAPERONES; RAT PLANTARIS; EXPRESSION; STRESS; CELL; INTERLEUKIN-6; PROTEINS; REGENERATION	Hypertrophic stimuli, such as mechanical stress and overloading, induce stress response, which is mediated by heat shock transcription factor 1 (HSF1), and up-regulate heat shock proteins (HSPs) in mammalian skeletal muscles. Therefore, HSF1-associated stress response may play a key role in loading-associated skeletal muscle hypertrophy. The purpose of this study was to investigate the effects of HSF1-deficiency on skeletal muscle hypertrophy caused by overloading. Functional overloading on the left soleus was performed by cutting the distal tendons of gastrocnemius and plantaris muscles for 4 weeks. The right muscle served as the control. Soleus muscles from both hindlimbs were dissected 2 and 4 weeks after the operation. Hypertrophy of soleus muscle in HSF1-null mice was partially inhibited, compared with that in wild-type (C57BL/6J) mice. Absence of HSF1 partially attenuated the increase of muscle wet weight and fiber cross-sectional area of overloaded soleus muscle. Population of Pax7-positive muscle satellite cells in HSF1-null mice was significantly less than that in wild-type mice following 2 weeks of overloading (p<0.05). Significant up-regulations of interleukin (IL)-1 beta and tumor necrosis factor mRNAs were observed in HSF1-null, but not in wild-type, mice following 2 weeks of overloading. Overloading-related increases of IL-6 and AFT3 mRNA expressions seen after 2 weeks of overloading tended to decrease after 4 weeks in both types of mice. In HSF1-null mice, however, the significant overloading-related increase in the expression of IL-6, not ATF3, mRNA was noted even at 4th week. Inhibition of muscle hypertrophy might be attributed to the greater and prolonged enhancement of IL-6 expression. HSF1 and/or HSF1-mediated stress response may, in part, play a key role in loading-induced skeletal muscle hypertrophy.	[Koya, Tomoyuki; Nishizawa, Sono; Beppu, Moroe] St Marianna Univ, Sch Med, Dept Orthopaed Surg, Kawasaki, Kanagawa, Japan; [Ohno, Yoshitaka; Goto, Katsumasa] Toyohashi SOZO Univ, Sch Hlth Sci, Physiol Lab, Toyohashi, Aichi, Japan; [Goto, Ayumi; Ikuta, Akihiro; Suzuki, Miho; Ohira, Tomotaka; Egawa, Tatsuro; Goto, Katsumasa] Toyohashi SOZO Univ, Grad Sch Hlth Sci, Dept Physiol, Toyohashi, Aichi, Japan; [Nakai, Akira] Yamaguchi Univ, Grad Sch Med, Dept Mol Biol, Ube, Yamaguchi 755, Japan; [Sugiura, Takao] Yamaguchi Univ, Dept Exercise & Hlth Sci, Yamaguchi, Japan; [Ohira, Yoshinobu] Osaka Univ, Grad Sch Med, Toyonaka, Osaka 560, Japan; [Yoshioka, Toshitada] Hirosaki Gakuin Univ, Hirosaki, Aomori, Japan	Saint Marianna University; Yamaguchi University; Yamaguchi University; Osaka University	Goto, K (corresponding author), Toyohashi SOZO Univ, Sch Hlth Sci, Physiol Lab, Toyohashi, Aichi, Japan.	gotok@sepia.ocn.ne.jp	Goto, Katsumasa/T-6789-2019	Goto, Katsumasa/0000-0001-5380-4561; Egawa, Tatsuro/0000-0001-9363-1589	Japan Society for the Promotion of Science [24650411, 24650407, 18200042]; Science Research Promotion Fund from The Promotion and Mutual Aid Corporation for Private Schools of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Science Research Promotion Fund from The Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This study was supported, in part, by Grants-in-Aid for Challenging Exploratory Research (24650411, KG; 24650407, Y Ohira) and Grants-in-Aid for Scientific Research (A, 18200042, TY) from Japan Society for the Promotion of Science, and the Science Research Promotion Fund from The Promotion and Mutual Aid Corporation for Private Schools of Japan (KG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter J, 2008, J BIOL CHEM, V283, P23224, DOI 10.1074/jbc.M801379200; Alvarez B, 2002, BBA-MOL CELL RES, V1542, P66, DOI 10.1016/S0167-4889(01)00167-7; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; Carson JA, 2001, FASEB J, V15, P207, DOI 10.1096/fj.01-0544fje; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; Del Aguila LF, 2000, AM J PHYSIOL-ENDOC M, V279, pE206, DOI 10.1152/ajpendo.2000.279.1.E206; Dodd SL, 2009, FASEB J, V23, P3415, DOI 10.1096/fj.08-124602; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Goto K, 2003, PFLUG ARCH EUR J PHY, V447, P247, DOI 10.1007/s00424-003-1177-x; Goto K, 2007, BIOCHEM BIOPH RES CO, V358, P331, DOI 10.1016/j.bbrc.2007.04.129; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Hiscock N, 2004, FASEB J, V18, P992, DOI 10.1096/fj.03-1259fje; Huey KA, 2006, J APPL PHYSIOL, V100, P451, DOI 10.1152/japplphysiol.01022.2005; Huey KA, 2010, EXP PHYSIOL, V95, P1145, DOI 10.1113/expphysiol.2010.054692; Jackson JR, 2012, AM J PHYSIOL-CELL PH, V303, pC854, DOI 10.1152/ajpcell.00207.2012; Jonsdottir IH, 2000, J PHYSIOL-LONDON, V528, P157, DOI 10.1111/j.1469-7793.2000.00157.x; Katsuki K, 2004, FEBS LETT, V571, P187, DOI 10.1016/j.febslet.2004.06.087; Keller C, 2001, FASEB J, V15, P2748, DOI 10.1096/fj.01-0507fje; KILGORE JL, 1994, J APPL PHYSIOL, V76, P598, DOI 10.1152/jappl.1994.76.2.598; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kojima A, 2007, J ORTHOP SCI, V12, P74, DOI 10.1007/s00776-006-1083-0; Locke M, 2008, ACTA PHYSIOL, V192, P403, DOI 10.1111/j.1748-1716.2007.01764.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsuba Y, 2009, ACTA PHYSIOL, V196, P329, DOI 10.1111/j.1748-1716.2008.01943.x; McArdle A, 2006, EXP GERONTOL, V41, P497, DOI 10.1016/j.exger.2006.02.002; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; MIZZEN LA, 1988, J CELL BIOL, V106, P1105, DOI 10.1083/jcb.106.4.1105; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morioka S, 2008, J PHYSIOL SCI, V58, P397, DOI 10.2170/physiolsci.RP004008; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Nishizawa S, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.71; Ogata T, 2009, AM J PHYSIOL-REG I, V296, pR1557, DOI 10.1152/ajpregu.90911.2008; Oguro A, 2006, GENES CELLS, V11, P1253, DOI 10.1111/j.1365-2443.2006.01021.x; Oishi Y, 2003, JPN J PHYSIOL, V53, P281, DOI 10.2170/jjphysiol.53.281; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; PETERSEN RB, 1989, CELL REGUL, V1, P135, DOI 10.1091/mbc.1.1.135; Santoro MG, 2008, BIOCHEM PHARMACOL, V59, P55; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Senf SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062687; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shen WH, 2004, J IMMUNOL, V172, P7272, DOI 10.4049/jimmunol.172.12.7272; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; Uehara K, 2004, JPN J PHYSIOL, V54, P263, DOI 10.2170/jjphysiol.54.263; Welch WJ, 1991, CURR OPIN CELL BIOL, V3, P1033, DOI 10.1016/0955-0674(91)90125-I; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; Yasuhara K, 2011, J APPL PHYSIOL, V111, P1142, DOI 10.1152/japplphysiol.00471.2011; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232	57	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77788	10.1371/journal.pone.0077788	http://dx.doi.org/10.1371/journal.pone.0077788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167582	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500041
J	Chisaguano, AM; Montes, R; Perez-Berezo, T; Castellote, AI; Guerendiain, M; Bustamante, M; Morales, E; Garcia-Esteban, R; Sunyer, J; Franch, A; Lopez-Sabater, MC				Maribel Chisaguano, Aida; Montes, Rosa; Perez-Berezo, Teresa; Isabel Castellote, Ana; Guerendiain, Marcela; Bustamante, Mariona; Morales, Eva; Garcia-Esteban, Raquel; Sunyer, Jordi; Franch, Angels; Carmen Lopez-Sabater, M.			Gene Expression of Desaturase (FADS1 and FADS2) and Elongase (ELOVL5) Enzymes in Peripheral Blood: Association with Polyunsaturated Fatty Acid Levels and Atopic Eczema in 4-Year-Old Children	PLOS ONE			English	Article							BREAST-MILK; METABOLISM; VARIANTS; DISEASES; CLUSTER; SERUM; DERMATITIS; PLASMA; SUPPLEMENTATION; PHOSPHOLIPIDS	Background: It is unknown if changes in the gene expression of the desaturase and elongase enzymes are associated with abnormal n-6 long chain polyunsaturated fatty acid (LC-PUFA) levels in children with atopic eczema (AE). We analyzed whether mRNA-expression of genes encoding key enzymes of LC-PUFA synthesis (FADS1, FADS2 and ELOVL5) is associated with circulating LC-PUFA levels and risk of AE in 4-year-old children. Methods: AE (n=20) and non-AE (n=104) children participating in the Sabadell cohort within the INfancia y Medio Ambiente (INMA) Project were included in the present study. RT-PCR with TaqMan Low-Density Array cards was used to measure the mRNA-expression of FADS1, FADS2 and ELOVL5. LC-PUFA levels were measured by fast gas chromatography in plasma phospholipids. The relationship of gene expression with LC-PUFA levels and enzyme activities was evaluated by Pearson's rank correlation coefficient, and logistic regression models were used to study its association with risk of developing AE. Results: Children with AE had lower levels of several n-6 PUFA members, dihomo-gamma-linolenic (DGLA) and arachidonic (AA) acids. mRNA-expression levels of FADS1 and 2 strongly correlated with DGLA levels and with D6D activity. FADS2 and ELOVL5 mRNA-expression levels were significantly lower in AE than in non-AE children (-40.30% and -20.36%; respectively), but no differences were found for FADS1. Conclusions and Significance: Changes in the mRNA-expression levels of FADS1 and 2 directly affect blood DGLA levels and D6D activity. This study suggests that lower mRNA-expressions of FADS2 and ELOVL5 are associated with higher risk of atopic eczema in young children.	[Maribel Chisaguano, Aida; Montes, Rosa; Isabel Castellote, Ana; Guerendiain, Marcela; Carmen Lopez-Sabater, M.] Univ Barcelona, Fac Pharm, Dept Nutr & Food Sci, Barcelona, Spain; [Maribel Chisaguano, Aida; Montes, Rosa; Isabel Castellote, Ana; Carmen Lopez-Sabater, M.] Spanish Govt, Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain; [Perez-Berezo, Teresa; Franch, Angels] Univ Barcelona, Fac Pharm, Dept Physiol, Barcelona, Spain; [Bustamante, Mariona; Morales, Eva; Garcia-Esteban, Raquel; Sunyer, Jordi] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Bustamante, Mariona; Morales, Eva; Garcia-Esteban, Raquel; Sunyer, Jordi] Hosp del Mar Res Inst IMIM, Barcelona, Spain; [Bustamante, Mariona; Morales, Eva; Garcia-Esteban, Raquel; Sunyer, Jordi] Spanish Govt, Inst Salud Carlos III, CIBERESP, Madrid, Spain; [Sunyer, Jordi] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Barcelona, Spain; [Bustamante, Mariona] Ctr Genom Regulat CRG, Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Barcelona; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Lopez-Sabater, MC (corresponding author), Univ Barcelona, Fac Pharm, Dept Nutr & Food Sci, Barcelona, Spain.	mclopez@ub.edu	Montes, Rosa/AAW-2021-2020; Bustamante, Mariona/ABB-9142-2021; Sunyer, Jordi/G-6909-2014; Bustamante, Mariona/M-7277-2015; Franch, Àngels/G-5669-2019; Morales, Eva/HHS-0651-2022	Montes, Rosa/0000-0002-4154-3541; Bustamante, Mariona/0000-0003-0127-2860; Sunyer, Jordi/0000-0002-2602-4110; Bustamante, Mariona/0000-0003-0127-2860; Franch, Àngels/0000-0002-2362-1374; Morales, Eva/0000-0003-3145-7022; Castellote-Bargallo, Ana Isabel/0000-0003-3805-9094; Perez-Berezo, Teresa/0000-0003-0348-914X; Lopez-Sabater, Maria Carmen/0000-0002-8670-7044; Guerendiain, Marcela/0000-0001-8990-7976; Garcia, Raquel/0000-0002-5663-6388; Chisaguano Tonato, Aida Maribel/0000-0001-7905-1764	Spanish Ministry of Science and Innovation [AGL2009-09730/ALI]; Spanish Ministry of Economy and Competitiveness [BUF2012-40254-C03-02]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government)	The following sources of funding supported the work: The Spanish Ministry of Science and Innovation for the financial support given to the research project AGL2009-09730/ALI. www.micinn.es. The Spanish Ministry of Economy and Competitiveness for the financial support given to the research project BUF2012-40254-C03-02. www.mineco.gob.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Calder PC, 2006, CLIN EXP ALLERGY, V36, P138, DOI 10.1111/j.1365-2222.2006.02433.x; Calder PC, 2000, PEDIAT ALLERG IMM-UK, V11, P29, DOI 10.1034/j.1399-3038.2000.00508.x; Church RJ, 2012, J IMMUNOL, V188, P4093, DOI 10.4049/jimmunol.1101873; Dorris SL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/926968; Dunder T, 2001, ALLERGY, V56, P425, DOI 10.1034/j.1398-9995.2001.056005425.x; Fan YY, 2012, J LIPID RES, V53, P1287, DOI 10.1194/jlr.M024216; FEDENKO ES, 2010, SELF NONSELF, V2, P120; Focke M, 2005, WIEN KLIN WOCHENSCHR, V117, P485, DOI 10.1007/s00508-005-0394-z; Glaser C, 2011, MATERN CHILD NUTR, V7, P27, DOI 10.1111/j.1740-8709.2011.00319.x; Goulter AB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-34; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Guxens M, 2012, INT J EPIDEMIOL, V41, P930, DOI 10.1093/ije/dyr054; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Khnykin D, 2011, DERM-ENDOCRINOL, V3, P53, DOI 10.4161/derm.3.2.14816; Laitinen K, 2006, CLIN EXP ALLERGY, V36, P166, DOI 10.1111/j.1365-2222.2006.02417.x; Lattka E, 2012, ANN NUTR METAB, V60, P8, DOI 10.1159/000337308; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Chisaguano AM, 2013, ANAL METHODS-UK, V5, P1264, DOI 10.1039/c2ay26236c; Merino DM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-63; Mesko B, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-15; Morales E, 2012, CLIN EXP ALLERGY, V42, P918, DOI 10.1111/j.1365-2222.2012.03969.x; Morales E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017181; Rzehak P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013261; Saaf AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004017; Sala-Vila A, 2008, CLIN EXP ALLERGY, V38, P1432, DOI 10.1111/j.1365-2222.2008.03072.x; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Singmann P, 2010, ALLERGY, V65, P1627, DOI 10.1111/j.1398-9995.2010.02457.x; Standl M, 2011, CLIN EXP ALLERGY, V41, P1757, DOI 10.1111/j.1365-2222.2011.03833.x; Thijs C, 2011, ALLERGY, V66, P58, DOI 10.1111/j.1398-9995.2010.02445.x; Tu WC, 2010, PROSTAG LEUKOTR ESS, V83, P61, DOI 10.1016/j.plefa.2010.04.001; Umeda-Sawada R, 2006, BIOSCI BIOTECH BIOCH, V70, P2121, DOI 10.1271/bbb.60057; van Gool CJAW, 2003, AM J CLIN NUTR, V77, P943, DOI 10.1093/ajcn/77.4.943; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37; Williams HC, 2005, NEW ENGL J MED, V352, P2314, DOI 10.1056/NEJMcp042803; Xiaoping Wang, 2012, Lipids in Health and Disease, V11; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156; Yen CH, 2008, ANN ALLERG ASTHMA IM, V100, P66, DOI 10.1016/S1081-1206(10)60407-3; Ziboh VA, 2000, AM J CLIN NUTR, V71, p361S, DOI 10.1093/ajcn/71.1.361s	41	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78245	10.1371/journal.pone.0078245	http://dx.doi.org/10.1371/journal.pone.0078245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167612	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500073
J	Bianchi, M; Clavenna, A; Sequi, M; Bortolotti, A; Fortino, I; Merlino, L; Bonati, M				Bianchi, Marina; Clavenna, Antonio; Sequi, Marco; Bortolotti, Angela; Fortino, Ida; Merlino, Luca; Bonati, Maurizio			Childhood Asthma Management Pre- and Post-Incident Asthma Hospitalization	PLOS ONE			English	Article							CHILDREN; EXACERBATIONS; POPULATION; SPIROMETRY; PREDICTORS; SYMPTOMS; OUTCOMES	Many hospitalizations for asthma could potentially be avoided with appropriate management. The aim of this study was to analyze data on disease management of a paediatric population with a hospitalization for asthma. The study population comprised 6-17 year old subjects belonging to three local health units of the Lombardy Region, northern Italy. Regional administrative databases were used to collect data on: the number of children with an incident hospitalization for asthma during the 2004-2006 period, anti-asthma therapy, specialist visit referrals, and claims for spirometry, released in the 12 months before and after hospitalization. Each patient's asthma management profile was compared with GINA guideline recommendations. Among the 183 hospitalized subjects, 101 (55%) received therapy before hospitalization and 82 (45%) did not. 10% did not receive any therapy either before or after hospital admission and in 13% the therapy was discontinued afterward. Based on GINA guidelines, asthma management adhered to recommendations only for 55% of subjects. Results may suggest that for half of hospitalized subjects, inaccurate diagnosis, under-treatment/scarce compliance with asthma guidelines by physicians, and/or scarce compliance to therapy by patients/their parents occurred. In all these cases, hospitalization would be a proxy indicator of preventable poor control of disease, rather than a proxy indicator of severity.	[Bianchi, Marina; Clavenna, Antonio; Sequi, Marco; Bortolotti, Angela; Fortino, Ida; Merlino, Luca; Bonati, Maurizio] IRCCS, Ist Ric Farmacol Mario Negri, Dept Publ Hlth, Lab Mother & Child Hlth, Milan, Italy; [Bortolotti, Angela; Fortino, Ida; Merlino, Luca] Reg Hlth Minist, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Bianchi, M (corresponding author), IRCCS, Ist Ric Farmacol Mario Negri, Dept Publ Hlth, Lab Mother & Child Hlth, Milan, Italy.	marina.bianchi@marionegri.it	Bonati, Maurizio/K-8980-2016; Clavenna, Antonio/J-6830-2018	Bonati, Maurizio/0000-0003-3997-3726; Clavenna, Antonio/0000-0001-5536-4192; MERLINO, Luca Giuseppe/0000-0001-9232-9994	Regione Lombardia (Progetto Epidemiologia dei farmaci - EPIFARM)	Regione Lombardia (Progetto Epidemiologia dei farmaci - EPIFARM)(Regione Lombardia)	This study has been funded in part by Regione Lombardia (Progetto Epidemiologia dei farmaci - EPIFARM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2012, GLOB STRAT ASTHM MAN; Bianchi M, 2012, RESP MED, V106, P1383, DOI 10.1016/j.rmed.2012.06.005; Bianchi M, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-48; Bianchi M, 2011, EUR J CLIN PHARMACOL, V67, P967, DOI 10.1007/s00228-011-1033-4; Bianchi M, 2009, PEDIAT ALLERG IMM-UK, V20, P585, DOI 10.1111/j.1399-3038.2008.00797.x; Cabana M, 2006, PEDIATRICS, V118, pE151, DOI 10.1542/peds.2005-2352; Cates CJ, 2013, COCHRANE DB SYST REV, V6; Chipps BE, 2012, J ALLERGY CLIN IMMUN, V130, P332, DOI 10.1016/j.jaci.2012.04.014; Chroinin M Ni, 2009, COCHRANE DB SYST REV, V4; Covar RA, 2008, J ALLERGY CLIN IMMUN, V122, P741, DOI 10.1016/j.jaci.2008.08.021; Delmas M-C, 2011, Rev Mal Respir, V28, pe115, DOI 10.1016/j.rmr.2011.09.023; Ducharme FM, 2010, COCHRANE DB SYST REV, V5; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Friedman HS, 2009, CLIN THER, V31, P1056, DOI 10.1016/j.clinthera.2009.05.008; Galant SP, 2006, PEDIATRICS, V117, P1038, DOI 10.1542/peds.2005-1076; Gershon AS, 2012, CHEST, V141, P1190, DOI 10.1378/chest.11-0831; Lu S, 2012, ACAD PEDIATR, V12, P436, DOI 10.1016/j.acap.2012.06.006; Tierney WM, 2004, J GEN INTERN MED, V19, P237, DOI 10.1111/j.1525-1497.2004.30311.x; Wu AC, 2011, CHEST, V140, P100, DOI 10.1378/chest.10-2794	19	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76439	10.1371/journal.pone.0076439	http://dx.doi.org/10.1371/journal.pone.0076439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204628	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300029
J	Masoodi, M; Pearl, DS; Eiden, M; Shute, JK; Brown, JF; Calder, PC; Trebble, TM				Masoodi, Mojgan; Pearl, Daniel S.; Eiden, Michael; Shute, Janis K.; Brown, James F.; Calder, Philip C.; Trebble, Timothy M.			Altered Colonic Mucosal Polyunsaturated Fatty Acid (PUFA) Derived Lipid Mediators in Ulcerative Colitis: New Insight into Relationship with Disease Activity and Pathophysiology	PLOS ONE			English	Article							LEUKOTRIENE B-4 PRODUCTION; FISH-OIL SUPPLEMENTATION; PROSTAGLANDIN D-2; ARACHIDONIC-ACID; POLYMORPHONUCLEAR LEUKOCYTES; ACUTE-INFLAMMATION; ACTIVITY INDEXES; RELEASE; LIPOXYGENASE; METABOLISM	Objectives: Ulcerative colitis (UC) is a relapsing inflammatory disorder of unconfirmed aetiology, variable severity and clinical course, characterised by progressive histological inflammation and with elevation of eicosanoids which have a known pathophysiological role in inflammation. Therapeutic interventions targetting eicosanoids (5-aminosalicylates (ASA)) are effective first line and adjunctive treatments in mild-moderate UC for achieving and sustaining clinical remission. However, the variable clinical response to 5-ASA and frequent deterioration in response to cyclo-oxygenase (COX) inhibitors, has prompted an in depth simultaneous evaluation of multiple lipid mediators (including eicosanoids) within the inflammatory milieu in UC. We hypothesised that severity of inflammation is associated with alteration of lipid mediators, in relapsing UC. Design: Study was case-control design. Mucosal lipid mediators were determined by LC-MS/MS lipidomics analysis on mucosal biopsies taken from patients attending outpatients with relapsing UC. Univariate and multivariate statistical analyses were used to investigate the association of mucosal lipid mediators, with the disease state and severity graded histologically. Results: Levels of PGE(2), PGD(2), TXB2, 5-HETE, 11-HETE, 12-HETE and 15-HETE are significantly elevated in inflamed mucosa and correlate with severity of inflammation, determined using validated histological scoring systems. Conclusions: Our approach of capturing inflammatory mediator signature at different stages of UC by combining comprehensive lipidomics analysis and computational modelling could be used to classify and predict mild-moderate inflammation; however, predictive index is diminished in severe inflammation. This new technical approach could be developed to tailor drug treatments to patients with active UC, based on the mucosal lipid mediator profile.	[Masoodi, Mojgan] Nestle Inst Hlth Sci, Lausanne, Switzerland; [Masoodi, Mojgan; Eiden, Michael] MRC, Cambridge, England; [Masoodi, Mojgan] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 1A1, Canada; [Pearl, Daniel S.; Trebble, Timothy M.] Portsmouth Hosp NHS Trust, Dept Gastroenterol, Portsmouth, Hants, England; [Pearl, Daniel S.; Shute, Janis K.; Brown, James F.] Univ Portsmouth, Inst Biomed & Biomol Sci, Portsmouth, Hants, England; [Pearl, Daniel S.] Taunton & Somerset NHS Fdn Trust, Dept Gastroenterol, Taunton, Somerset, England; [Calder, Philip C.] Univ Southampton, Human Dev & Hlth Acad Unit, Southampton, Hants, England; [Calder, Philip C.] Univ Hosp Southampton NHS Fdn Trust, NIHR Biomed Res Ctr Nutr, Southampton, Hants, England; [Calder, Philip C.] Univ Southampton, Southampton, Hants, England	Nestle SA; University of Toronto; Portsmouth Hospitals NHS Trust; University of Portsmouth; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton	Masoodi, M (corresponding author), Nestle Inst Hlth Sci, Lausanne, Switzerland.	mojgan.masoodi@rd.nestle.com; daniel.pearl@porthosp.nhs.uk	MASOODI, MOJGAN/P-1499-2019; Calder, Philip C/E-9739-2013	MASOODI, MOJGAN/0000-0001-9840-1731; Calder, Philip C/0000-0002-6038-710X; Brown, James/0000-0002-3901-6814	Portsmouth Hospitals National Health Service (NHS) Trust; University of Portsmouth, Portsmouth, United Kingdom; Medical Research Council; MRC [MC_PC_13030, MC_UP_A090_1006] Funding Source: UKRI; Medical Research Council [MC_UP_A090_1006, MC_PC_13030] Funding Source: researchfish	Portsmouth Hospitals National Health Service (NHS) Trust; University of Portsmouth, Portsmouth, United Kingdom; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Salary and research bursary provided by Portsmouth Hospitals National Health Service (NHS) Trust and University of Portsmouth, Portsmouth, United Kingdom and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 2000, AM J PHYSIOL-GASTR L, V279, pG238; Ananthakrishnan AN, 2012, ANN INTERN MED, V156, P350, DOI 10.7326/0003-4819-156-5-201203060-00007; Azad S, 2011, SAUDI J GASTROENTERO, V17, P194, DOI 10.4103/1319-3767.80383; BORGEAT P, 1979, P NATL ACAD SCI USA, V76, P3213, DOI 10.1073/pnas.76.7.3213; BORGEAT P, 1979, J BIOL CHEM, V254, P7865; BOUGHTONSMITH NK, 1983, GUT, V24, P1176, DOI 10.1136/gut.24.12.1176; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Carty E, 2000, GUT, V46, P487, DOI 10.1136/gut.46.4.487; CASELLAS F, 1995, EUR J GASTROEN HEPAT, V7, P221; Cole AT, 1996, GUT, V39, P248, DOI 10.1136/gut.39.2.248; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; D'Haens GR, 2011, AM J GASTROENTEROL, V106, P199, DOI 10.1038/ajg.2010.392; ELIAKIM R, 1992, SCAND J GASTROENTERO, V27, P968, DOI 10.3109/00365529209000172; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; Geboes K., 2003, INFLAMM BOWEL DIS, V18, P255; GERTNER DJ, 1994, GUT, V35, P1429, DOI 10.1136/gut.35.10.1429; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; GOMES P, 1986, GUT, V27, P92, DOI 10.1136/gut.27.1.92; GOULD SR, 1976, PROSTAGLANDINS, V11, P489, DOI 10.1016/0090-6980(76)90095-2; Harizi H, 2003, J IMMUNOL, V170, P139, DOI 10.4049/jimmunol.170.1.139; HAWTHORNE AB, 1992, GUT, V33, P922, DOI 10.1136/gut.33.7.922; IKEHATA A, 1995, SCAND J GASTROENTERO, V30, P44, DOI 10.3109/00365529509093234; Jakobovits SL, 2005, BRIT MED BULL, V75-76, P131, DOI 10.1093/bmb/ldl001; Jansen JJ, 2005, J CHEMOMETR, V19, P469, DOI 10.1002/cem.952; Jupp J, 2007, INFLAMM BOWEL DIS, V13, P537, DOI 10.1002/ibd.20094; LANGHOLZ E, 1994, GASTROENTEROLOGY, V107, P3, DOI 10.1016/0016-5085(94)90054-X; Langholz Ebbe, 2010, Therap Adv Gastroenterol, V3, P77, DOI 10.1177/1756283X10361304; Lawson MM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005112.pub2; LEE TH, 1988, CLIN SCI, V74, P467, DOI 10.1042/cs0740467; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; LOBOS EA, 1987, DIGEST DIS SCI, V32, P1380, DOI 10.1007/BF01296664; Marteau P, 2005, GUT, V54, P960, DOI 10.1136/gut.2004.060103; Masoodi M, 2010, ANAL CHEM, V82, P8176, DOI 10.1021/ac1015563; NEEDLEMAN P, 1979, P NATL ACAD SCI USA, V76, P944, DOI 10.1073/pnas.76.2.944; NIELSEN OH, 1987, SCAND J CLIN LAB INV, V47, P605; Palmblad J, 1984, SCAND J RHEUMATOL; PALMER RMJ, 1980, PROSTAGLANDINS, V20, P411, DOI 10.1016/S0090-6980(80)80058-X; Pearl DS, 2014, J CROHNS COLITIS, V8, P70, DOI 10.1016/j.crohns.2013.03.013; Pearl DS, 2012, J CROHNS COLITIS S, DOI [10.1016/j.crohns.2012.07.022, DOI 10.1016/J.CR0HNS.2012.07.022]; Peyrin-Biroulet L, 2011, ALIMENT PHARM THER, V33, P870, DOI 10.1111/j.1365-2036.2011.04599.x; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; RAMPTON DS, 1980, GASTROENTEROLOGY, V78, P192; RAMPTON DS, 1980, GUT, V21, P591, DOI 10.1136/gut.21.7.591; RASK-MADSEN J, 1992, Agents and Actions, pC37; SHARON P, 1984, GASTROENTEROLOGY, V86, P453; Shimizu T, 2003, J PEDIATR GASTR NUTR, V37, P581, DOI 10.1097/00005176-200311000-00015; STONNINGTON CM, 1987, GUT, V28, P402, DOI 10.1136/gut.28.4.402; Sutherland L, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000543, DOI 10.1002/14651858.CD000543]; SUTHERLAND LR, 1987, GASTROENTEROLOGY, V92, P1894, DOI 10.1016/0016-5085(87)90621-4; Trebble TM, 2004, AM J CLIN NUTR, V80, P1137, DOI 10.1093/ajcn/80.5.1137; Trebble TM, 2003, AM J CLIN NUTR, V78, P376, DOI 10.1093/ajcn/78.3.376; Turner D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006443; TURNER SR, 1975, NATURE, V257, P680, DOI 10.1038/257680a0; Vachier I, 2002, BIOCHEM BIOPH RES CO, V290, P219, DOI 10.1006/bbrc.2001.6155; van Velzen EJJ, 2008, J PROTEOME RES, V7, P4483, DOI 10.1021/pr800145j; Vong L, 2010, P NATL ACAD SCI USA, V107, P12023, DOI 10.1073/pnas.1004982107; Zamuner SR, 2003, GUT, V52, P1714, DOI 10.1136/gut.52.12.1714	59	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76532	10.1371/journal.pone.0076532	http://dx.doi.org/10.1371/journal.pone.0076532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204637	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326029300034
J	Ou, F; Rao, NN; Jiang, XD; Qian, MY; Feng, W; Yin, LX; Chen, X				Ou, Feng; Rao, Nini; Jiang, Xudong; Qian, Mengyao; Feng, Wei; Yin, Lixue; Chen, Xu			Analysis on Differential Gene Expression Data for Prediction of New Biological Features in Permanent Atrial Fibrillation	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; MECHANISMS; FIBROSIS	Permanent Atrial fibrillation (pmAF) has largely remained incurable since the existing information for explaining precise mechanisms underlying pmAF is not sufficient. Microarray analysis offers a broader and unbiased approach to identify and predict new biological features of pmAF. By considering the unbalanced sample numbers in most microarray data of case control, we designed an asymmetric principal component analysis algorithm and applied it to re-analyze differential gene expression data of pmAF patients and control samples for predicting new biological features. Finally, we identified 51 differentially expressed genes using the proposed method, in which 42 differentially expressed genes are new findings compared with two related works on the same data and the existing studies. The enrichment analysis illustrated the reliability of identified differentially expressed genes. Moreover, we predicted three new pmAF-related signaling pathways using the identified differentially expressed genes via the KO-Based Annotation System. Our analysis and the existing studies supported that the predicted signaling pathways may promote the pmAF progression. The results above are worthy to do further experimental studies. This work provides some new insights into molecular features of pmAF. It has also the potentially important implications for improved understanding of the molecular mechanisms of pmAF.	[Ou, Feng; Rao, Nini; Qian, Mengyao; Feng, Wei] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Jiang, Xudong] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Yin, Lixue; Chen, Xu] Sichuan Acad Med Sci, Cardiovasc Dept, Chengdu, Peoples R China; [Yin, Lixue; Chen, Xu] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China	University of Electronic Science & Technology of China; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Rao, NN (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China.	raonn@uestc.edu.cn	Jiang, Xudong/B-1555-2008	Jiang, Xudong/0000-0002-9104-2315	National Natural Science Foundation [81171411]; Key Technology Research and Development Program of Sichuan Province [2011FZ0034]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Technology Research and Development Program of Sichuan Province	This work was supported by grants from National Natural Science Foundation (Grant No. 81171411) and Key Technology Research and Development Program of Sichuan Province (Grant No. 2011FZ0034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLESSIE M, 1991, CIRCULATION, V84, P1689, DOI 10.1161/01.CIR.84.4.1689; Ausma J, 1997, AM J PATHOL, V151, P985; Barbier O, 2002, ARTERIOSCL THROM VAS, V22, P717, DOI 10.1161/01.ATV.0000015598.86369.04; Barth AS, 2005, CIRC RES, V96, P1022, DOI 10.1161/01.RES.0000165480.82737.33; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Censi F, 2011, IEEE T BIOMEDICAL EN, V58; Censi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013668; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Everett TH, 2007, HEART RHYTHM, V4, pS24, DOI 10.1016/j.hrthm.2006.12.040; Fraley SI, 2010, NATURE CELL BIOL, V12; Goette A, 2000, J AM COLL CARDIOL, V35, P1669, DOI 10.1016/S0735-1097(00)00611-2; Goudis CA, 2012, EUROPACE, V14, P623, DOI 10.1093/europace/eur398; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Jiang XD, 2011, IEEE SIGNAL PROC MAG, V28, P16, DOI 10.1109/MSP.2010.939041; Jiang XD, 2009, IEEE T PATTERN ANAL, V31, P931, DOI 10.1109/TPAMI.2008.258; Kim YH, 2003, EXP MOL MED, V35, P336, DOI 10.1038/emm.2003.45; Kneller J, 2002, CIRC RES, V90, pE73, DOI 10.1161/01.RES.0000019783.88094.BA; Korantzopoulos Panagiotis, 2003, Med Sci Monit, V9, pRA225; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Ohki-Kaneda R, 2004, BIOCHEM BIOPH RES CO, V320, P1328, DOI 10.1016/j.bbrc.2004.06.090; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Sata N, 2004, JPN HEART J, V45, P441, DOI 10.1536/jhj.45.441; Schotten U, 2001, CIRCULATION, V103, P691; Shimano M, 2008, HEART RHYTHM, V5, P451, DOI 10.1016/j.hrthm.2007.12.010; Wall ME, 2003, PRACTICAL APPROACH M, P91, DOI DOI 10.1007/0-306-47815-3_5; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52	28	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76166	10.1371/journal.pone.0076166	http://dx.doi.org/10.1371/journal.pone.0076166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204599	Green Published, gold			2022-12-27	WOS:000326029300012
J	Sastalla, I; Fattah, R; Coppage, N; Nandy, P; Crown, D; Pomerantsev, AP; Leppla, SH				Sastalla, Inka; Fattah, Rasem; Coppage, Nicole; Nandy, Poulomi; Crown, Devorah; Pomerantsev, Andrei P.; Leppla, Stephen H.			The Bacillus cereus Hbl and Nhe Tripartite Enterotoxin Components Assemble Sequentially on the Surface of Target Cells and Are Not Interchangeable	PLOS ONE			English	Article							3 EXOPROTEIN COMPONENTS; PLCR VIRULENCE REGULON; RAY CRYSTAL-STRUCTURE; HEMOLYSIN E HLYE; PHOSPHOLIPASE-C; ESCHERICHIA-COLI; TOXINS; BL; ANTHRACIS; ENDOPHTHALMITIS	Bacillus cereus is a spore-forming, Gram-positive bacterium commonly associated with outbreaks of food poisoning. It is also known as an opportunistic pathogen causing clinical infections such as bacteremia, meningitis, pneumonia, and gas gangrene-like cutaneous infections, mostly in immunocompromised patients. B. cereus secretes a plethora of toxins of which four are associated with the symptoms of food poisoning. Two of these, the non-hemolytic enterotoxin Nhe and the hemolysin BL (Hbl) toxin, are predicted to be structurally similar and are unique in that they require the combined action of three toxin proteins to induce cell lysis. Despite their dominant role in disease, the molecular mechanism of their toxic function is still poorly understood. We report here that B. cereus strain ATCC 10876 harbors not only genes encoding Nhe, but also two copies of the hbl genes. We identified Hbl as the major secreted toxin responsible for inducing rapid cell lysis both in cultured cells and in an intraperitoneal mouse toxicity model. Antibody neutralization and deletion of Hbl-encoding genes resulted in significant reductions of cytotoxic activity. Microscopy studies with Chinese Hamster Ovary cells furthermore showed that pore formation by both Hbl and Nhe occurs through a stepwise, sequential binding of toxin components to the cell surface and to each other. This begins with binding of Hbl-B or NheC to the eukaryotic membrane, and is followed by the recruitment of Hbl-L-1 or NheB, respectively, followed by the corresponding third protein. Lastly, toxin component complementation studies indicate that although Hbl and Nhe can be expressed simultaneously and are predicted to be structurally similar, they are incompatible and cannot complement each other.	[Sastalla, Inka; Fattah, Rasem; Coppage, Nicole; Nandy, Poulomi; Crown, Devorah; Pomerantsev, Andrei P.; Leppla, Stephen H.] NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sastalla, I (corresponding author), NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sastallai@niaid.nih.gov		Sastalla, Inka/0000-0003-4128-0742	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001031] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alouf JE, 2003, FOLIA MICROBIOL, V48, P5, DOI 10.1007/BF02931271; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Beecher DJ, 2000, INFECT IMMUN, V68, P5269, DOI 10.1128/IAI.68.9.5269-5276.2000; BEECHER DJ, 1995, INFECT IMMUN, V63, P632, DOI 10.1128/IAI.63.2.632-639.1995; Beecher DJ, 1997, J BIOL CHEM, V272, P233; BEECHER DJ, 1991, INFECT IMMUN, V59, P1778, DOI 10.1128/IAI.59.5.1778-1784.1991; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Callegan MC, 2003, INFECT IMMUN, V71, P3116, DOI 10.1128/IAI.71.6.3116-3124.2003; Phung D, 2012, FEMS MICROBIOL LETT, V330, P98, DOI 10.1111/j.1574-6968.2012.02538.x; Didier A, 2012, INFECT IMMUN, V80, P832, DOI 10.1128/IAI.05681-11; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Durand ML, 2013, CLIN MICROBIOL INFEC, V19, P227, DOI 10.1111/1469-0691.12118; Ehling-Schulz M, 2004, MOL NUTR FOOD RES, V48, P479, DOI 10.1002/mnfr.200400055; ESSER AF, 1994, TOXICOLOGY, V87, P229, DOI 10.1016/0300-483X(94)90253-4; Fagerlund A, 2008, MICROBIOL-SGM, V154, P693, DOI 10.1099/mic.0.2007/014134-0; GHOSH AC, 1978, J HYG-CAMBRIDGE, V80, P233; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Guinebretiere MH, 2002, J CLIN MICROBIOL, V40, P3053, DOI 10.1128/JCM.40.8.3053-3056.2002; HANDELSMAN J, 1990, APPL ENVIRON MICROB, V56, P713, DOI 10.1128/AEM.56.3.713-718.1990; Heilkenbrinker U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063104; Henkel JS, 2010, EXPERIENTIA SUPPL, V100, P1; Hunt S, 2010, ADV EXP MED BIOL, V677, P116; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Kolsto AB, 2002, CURR TOP MICROBIOL, V264, P95; Lereclus D, 1996, J BACTERIOL, V178, P2749, DOI 10.1128/jb.178.10.2749-2756.1996; Lereclus D, 2000, INT J MED MICROBIOL, V290, P295, DOI 10.1016/S1438-4221(00)80024-7; Lindback T, 1999, MICROBIOL-SGM, V145, P3139, DOI 10.1099/00221287-145-11-3139; Lindback T, 2004, MICROBIOL-SGM, V150, P3959, DOI 10.1099/mic.0.27359-0; Lindback T, 2010, INFECT IMMUN, V78, P3813, DOI 10.1128/IAI.00247-10; Liu SH, 2003, MOL CELL, V12, P603, DOI 10.1016/j.molcel.2003.08.003; Ludwig A, 2010, J BACTERIOL, V192, P4001, DOI 10.1128/JB.01283-09; Lund T, 2000, MOL MICROBIOL, V38, P254, DOI 10.1046/j.1365-2958.2000.02147.x; Lund T, 1996, FEMS MICROBIOL LETT, V141, P151, DOI 10.1016/0378-1097(96)00208-X; Madegowda M, 2008, PROTEINS, V71, P534, DOI 10.1002/prot.21888; Moravek M, 2006, FEMS MICROBIOL LETT, V257, P293, DOI 10.1111/j.1574-6968.2006.00185.x; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Okstad OA, 1999, MICROBIOL-UK, V145, P3129, DOI 10.1099/00221287-145-11-3129; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Pomerantsev AP, 2009, J BACTERIOL, V191, P5134, DOI 10.1128/JB.00422-09; Pomerantsev AP, 2006, INFECT IMMUN, V74, P682, DOI 10.1128/IAI.74.1.682-693.2006; Pomerantsev AP, 2003, INFECT IMMUN, V71, P6591, DOI 10.1128/IAI.71.11.6591-6606.2003; REDDY A, 1987, J BACTERIOL, V169, P5263, DOI 10.1128/jb.169.11.5263-5270.1987; Sastalla I, 2010, MICROBIOL-SGM, V156, P2982, DOI 10.1099/mic.0.041418-0; Sastalla I, 2009, APPL ENVIRON MICROB, V75, P2099, DOI 10.1128/AEM.02066-08; Slamti L, 2002, EMBO J, V21, P4550, DOI 10.1093/emboj/cdf450; THOMPSON NE, 1984, INFECT IMMUN, V43, P887, DOI 10.1128/IAI.43.3.887-894.1984; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Williams LD, 2009, REGUL TOXICOL PHARM, V55, P236, DOI 10.1016/j.yrtph.2009.07.009; Yoong P, 2013, CURR OPIN MICROBIOL, V16, P63, DOI 10.1016/j.mib.2013.01.012	51	64	64	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76955	10.1371/journal.pone.0076955	http://dx.doi.org/10.1371/journal.pone.0076955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204713	Green Submitted, gold, Green Published			2022-12-27	WOS:000326029300071
J	van Overbeek, EC; Staals, J; van Oostenbrugge, RJ				van Overbeek, Ellen C.; Staals, Julie; van Oostenbrugge, Robert J.			Vitamin B12 and Progression of White Matter Lesions. A 2-Year Follow-Up Study in First-Ever Lacunar Stroke Patients	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; HOMOCYSTEINE; MRI; DISEASE	In cross-sectional studies periventricular white matter lesions (WML) were related to low plasma levels of vitamin B12. Whether low vitamin B12 levels are also related to progression of WML is still unknown. We studied baseline vitamin B12 levels and its association with progression of WML over 2 years of follow-up in first-ever lacunar stroke patients. In 107 first-ever lacunar stroke patients in whom baseline brain MRI and vitamin B12 status were available, we obtained a follow-up brain MRI after 2 years. We assessed progression of periventricular WML (pWML) and deep WML (dWML) using a visual WML change scale. We studied the relationship between baseline levels of plasma vitamin B12 and progression of WML after 2 years of follow-up by binary logistic regression analyses. Vitamin B12 deficiency was more frequent in patients with progression of pWML compared to those without progression (41.9% and 19.7% respectively, p = 0.02). Corrected for sex and age, progression of pWML was associated with lower baseline levels of vitamin B12 (OR 1.42 per 50 unit decrease, 95% CI 1.00-1.92). Vitamin B12 levels were not associated with progression of dWML. In conclusion progression of pWML after 2 years of follow-up relates to low levels of vitamin B12 at baseline in first-ever lacunar stroke patients. Whether this population could benefit from vitamin B12 supplementation is unknown and requires further investigation.	[van Overbeek, Ellen C.; Staals, Julie; van Oostenbrugge, Robert J.] Maastricht Univ Med Ctr, Dept Neurol, Maastricht, Netherlands; [Staals, Julie; van Oostenbrugge, Robert J.] Maastricht Univ Med Ctr, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	van Overbeek, EC (corresponding author), Maastricht Univ Med Ctr, Dept Neurol, Maastricht, Netherlands.	e.overbeek@mumc.nl						BAMFORD J, 1987, STROKE, V18, P545, DOI 10.1161/01.STR.18.3.545; Cavalieri M, 2012, STROKE, V43, P3266, DOI 10.1161/STROKEAHA.112.665703; de Lau LML, 2009, J NEUROL NEUROSUR PS, V80, P149, DOI 10.1136/jnnp.2008.149286; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Gianazza E, 2003, BIOCHEM J, V374, P239, DOI 10.1042/BJ20030059; Gouw AA, 2008, CEREBROVASC DIS, V25, P247, DOI 10.1159/000113863; Hankey GJ, 2010, LANCET NEUROL, V9, P855, DOI 10.1016/S1474-4422(10)70187-3; Hassan A, 2004, BRAIN, V127, P212, DOI 10.1093/brain/awh023; Kuo HK, 2004, J GERONTOL A-BIOL, V59, P818; Lehmann M, 2003, DEMENT GERIATR COGN, V16, P145, DOI 10.1159/000071002; Mayhan WG, 2002, BRAIN RES, V927, P144, DOI 10.1016/S0006-8993(01)03348-0; Pieters B, 2009, STROKE, V40, P1623, DOI 10.1161/STROKEAHA.108.523431; Poggesi A, 2013, J NEUROL, V260, P1014, DOI 10.1007/s00415-012-6748-3; Prins ND, 2004, NEUROLOGY, V62, P1533, DOI 10.1212/01.WNL.0000123264.40498.B6; Refsum H, 2004, CLIN CHEM, V50, P3, DOI 10.1373/clinchem.2003.021634; Scalabrino G, 2005, EXP NEUROL, V192, P463, DOI 10.1016/j.expneurol.2004.12.020; Scalabrino G, 2009, PROG NEUROBIOL, V88, P203, DOI 10.1016/j.pneurobio.2009.04.004; Schmidt R, 2011, ACTA NEUROPATHOL, V122, P171, DOI 10.1007/s00401-011-0851-x; Spence JD, 2006, STROKE, V37, P2430, DOI 10.1161/01.STR.0000236633.40160.ee; Spence JD, 2011, JAMA-J AM MED ASSOC, V306, P2610, DOI 10.1001/jama.2011.1834; Spence JD, 2005, STROKE, V36, P2404, DOI 10.1161/01.STR.0000185929.38534.f3; Verhaaren BFJ, 2013, HYPERTENSION, V61, P1354, DOI 10.1161/HYPERTENSIONAHA.111.00430; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111; Wardlaw JM, 2010, J NEUROL SCI, V299, P66, DOI 10.1016/j.jns.2010.08.042; Wardlaw JM, 2012, EUR RADIOL, V22, P2295, DOI 10.1007/s00330-012-2500-8	27	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78100	10.1371/journal.pone.0078100	http://dx.doi.org/10.1371/journal.pone.0078100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155983	gold, Green Submitted, Green Published			2022-12-27	WOS:000325887300117
J	Christian, A; Peng, GZ; Sekiya, T; Ye, Y; Wulf, MG; Steuer, T				Christian, Andreas; Peng, Guangzhao; Sekiya, Toru; Ye, Yong; Wulf, Marco G.; Steuer, Thorsten			Biomechanical Reconstructions and Selective Advantages of Neck Poses and Feeding Strategies of Sauropods with the Example of Mamenchisaurus youngi	PLOS ONE			English	Article							LONG NECKS; DINOSAURIA SAUROPODA; POSTURE; KEPT	A very long neck is a characteristic feature of most sauropod dinosaurs. In the genus Mamenchisaurus, neck length is extreme, greater than 40 percent of total body length. However, the posture, utilization, and selective advantage of very long necks in sauropods are still controversial. An excellently preserved skeleton of Mamenchisaurus youngi, including a complete neck, provides an opportunity for a comprehensive biomechanical analysis of neck posture and mobility. The biomechanical evidence indicates that Mamenchisaurus youngi had a nearly straight, near horizontal neck posture and browsed at low or medium heights. The results differ from the findings for some other sauropod species, like Euhelopus, Diplodocus, and Giraffatitan (Brachiosaurus) that had been analyzed in previous studies with similar methods. The selective advantage of extreme neck length in sauropods is likely advantageous for different feeding strategies.	[Christian, Andreas; Wulf, Marco G.; Steuer, Thorsten] Univ Flensburg, Abt Biol & Ihre Didakt, Flensburg, Germany; [Peng, Guangzhao; Sekiya, Toru; Ye, Yong] Zigong Dinosaur Museum, Zigong City, Sichuan Provinc, Peoples R China		Christian, A (corresponding author), Univ Flensburg, Abt Biol & Ihre Didakt, Flensburg, Germany.	christian@uni-flensburg.de			DFG (Deutsche Forschungsgemeinschaft) [FOR 533]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study has been funded by DFG (Deutsche Forschungsgemeinschaft) FOR 533 "Biology of the Sauropod Dinosaurs: The Evolution of Gigantism''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; Bakker RT., 1986, DINOSAUR HERESIES; Berman DS, 2005, LIFE O PAST, P233; Christian A, 1996, PALAEONTOLOGY, V39, P801; Christian A, 2002, MITTEILUNGEN MUSEUMS, V5, P269; Christian A., 2007, FOSS REC, V10, P37; Christian Andreas, 2011, P251; Christian A, 2010, BIOL LETTERS, V6, P823, DOI 10.1098/rsbl.2010.0359; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; Dodson P., 1990, P402; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Gee Carole T., 2011, P34; Henderson DM, 2004, P ROY SOC B-BIOL SCI, V271, pS180, DOI 10.1098/rsbl.2003.0136; Klein N, 2012, BIOL LETTERS, V8, P1032, DOI 10.1098/rsbl.2012.0778; Mallison Heinrich, 2011, P237; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Martin J, 1987, 4 S MES TERR EC, P154; Ouyang H., 2002, 1 MAMENCHISAURID SKE, P111; Parrish J. Michael, 2006, P201; Paul G.S., 1988, HUNTERIA, V2, P1; Pi L.-Z., 1996, DEP SPATIAL PLANNING, P87; Preuschoft H, 1976, AUFSATZE REDEN SENCK, V28, P98; Preuschoft Holger, 2011, P197; Rauhut OWM, 2005, NATURE, V435, P670, DOI 10.1038/nature03623; Ruxton GD, 2011, BIOL LETTERS, V7, P779, DOI 10.1098/rsbl.2011.0116; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2009, SCIENCE, V323, P1671; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sekiya Toru, 2011, Memoir of the Fukui Prefectural Dinosaur Museum, V10, P1; Sereno PC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P157; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Seymour RS, 2009, BIOL LETTERS, V5, P317, DOI 10.1098/rsbl.2009.0096; Seymour RS, 2009, SCIENCE, V323, P1671, DOI 10.1126/science.323.5922.1671; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Stevens KA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P178; Sverdlova NS, 2010, J BIOMECH, V43, P387, DOI 10.1016/j.jbiomech.2009.09.049; Taylor MP, 2011, J ZOOL, V285, P150, DOI 10.1111/j.1469-7998.2011.00824.x; Taylor MP, 2013, PEERJ, V1, DOI 10.7717/peerj.36; Taylor MP, 2009, J VERTEBR PALEONTOL, V29, P787, DOI 10.1671/039.029.0309; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; VIDAL PP, 1986, EXP BRAIN RES, V61, P549; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Wilkinson DM, 2012, BIOL REV, V87, P616, DOI 10.1111/j.1469-185X.2011.00212.x; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; Wiman C., 1929, Palaeontologia Sinica C vi, V1, P1; Wolff J, 1892, GESETZ TRANSFORMATIO; Young C.C., 1972, I VERTEBRATE PALEO A, V8, P1	51	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e71172	10.1371/journal.pone.0071172	http://dx.doi.org/10.1371/journal.pone.0071172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204557	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500002
J	Park, B; Ma, SH; Shin, A; Chang, MC; Choi, JY; Kim, S; Han, W; Noh, DY; Ahn, SH; Kang, D; Yoo, KY; Park, SK				Park, Boyoung; Ma, Seung Hyun; Shin, Aesun; Chang, Myung-Chul; Choi, Ji-Yeob; Kim, Sungwan; Han, Wonshik; Noh, Dong-Young; Ahn, Sei-Hyun; Kang, Daehee; Yoo, Keun-Young; Park, Sue K.			Korean Risk Assessment Model for Breast Cancer Risk Prediction	PLOS ONE			English	Article							MORTALITY; WOMEN; AGE; POPULATION; STATISTICS; VALIDATION; PREVENTION; OBESITY; MEN	Purpose: We evaluated the performance of the Gail model for a Korean population and developed a Korean breast cancer risk assessment tool (KoBCRAT) based upon equations developed for the Gail model for predicting breast cancer risk. Methods: Using 3,789 sets of cases and controls, risk factors for breast cancer among Koreans were identified. Individual probabilities were projected using Gail's equations and Korean hazard data. We compared the 5-year and lifetime risk produced using the modified Gail model which applied Korean incidence and mortality data and the parameter estimators from the original Gail model with those produced using the KoBCRAT. We validated the KoBCRAT based on the expected/observed breast cancer incidence and area under the curve (AUC) using two Korean cohorts: the Korean Multicenter Cancer Cohort (KMCC) and National Cancer Center (NCC) cohort. Results: The major risk factors under the age of 50 were family history, age at menarche, age at first full-term pregnancy, menopausal status, breastfeeding duration, oral contraceptive usage, and exercise, while those at and over the age of 50 were family history, age at menarche, age at menopause, pregnancy experience, body mass index, oral contraceptive usage, and exercise. The modified Gail model produced lower 5-year risk for the cases than for the controls (p = 0.017), while the KoBCRAT produced higher 5-year and lifetime risk for the cases than for the controls (p<0.001 and <0.001, respectively). The observed incidence of breast cancer in the two cohorts was similar to the expected incidence from the KoBCRAT (KMCC, p = 0.880; NCC, p = 0.878). The AUC using the KoBCRAT was 0.61 for the KMCC and 0.89 for the NCC cohort. Conclusions: Our findings suggest that the KoBCRAT is a better tool for predicting the risk of breast cancer in Korean women, especially urban women.	[Park, Boyoung] Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea; [Ma, Seung Hyun; Shin, Aesun; Kang, Daehee; Yoo, Keun-Young; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Choi, Ji-Yeob; Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Ma, Seung Hyun; Han, Wonshik; Noh, Dong-Young; Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Shin, Aesun] Natl Canc Ctr, Res Inst, Mol Epidemiol Branch, Goyang, South Korea; [Chang, Myung-Chul] Dankook Univ Hosp, Dept Surg, Seoul, South Korea; [Kim, Sungwan] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea; [Kim, Sungwan] Seoul Natl Univ, Med Res Ctr, Inst Med & Biol Engn, Seoul, South Korea; [Han, Wonshik; Noh, Dong-Young] Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea; [Han, Wonshik; Noh, Dong-Young] Coll Med, Seoul, South Korea; [Ahn, Sei-Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea	National Cancer Center - Korea (NCC); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC); Dankook University; Dankook University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; University of Ulsan; Asan Medical Center	Park, SK (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	suepark@snu.ac.kr	Han, Wonshik/B-3699-2008; Shin, Aesun/E-9145-2014; Noh, Dong-Young/G-5531-2011	Han, Wonshik/0000-0001-7310-0764; Shin, Aesun/0000-0002-6426-1969; Kang, Daehee/0000-0003-4031-5878	Basic Research Laboratory program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0001564]; Seoul National University Brain Fusion Program Research Grant; National Cancer Center, Korea [0910220]	Basic Research Laboratory program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Seoul National University Brain Fusion Program Research Grant; National Cancer Center, Korea	This study was supported by a grant from the Basic Research Laboratory program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology [2011-0001564]; the 2010 Seoul National University Brain Fusion Program Research Grant; and a grant from the National Cancer Center, Korea (No. 0910220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle P, 2004, EUR J CANCER PREV, V13, P183, DOI 10.1097/01.cej.0000130014.83901.53; Chen JB, 2006, J NATL CANCER I, V98, P1215, DOI 10.1093/jnci/djj332; Claus E B, 2001, Fam Cancer, V1, P197, DOI 10.1023/A:1021135807900; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; Decarli A, 2006, J NATL CANCER I, V98, P1686, DOI 10.1093/jnci/djj463; Ferlay J, 2009, GLOBOCAN 2008; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Freedman AN, 2005, JNCI-J NATL CANCER I, V97, P715, DOI 10.1093/jnci/dji128; Freedman AN, 2009, J CLIN ONCOL, V27, P686, DOI 10.1200/JCO.2008.17.4797; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; Gail MH, 2007, J NATL CANCER I, V99, P1782, DOI 10.1093/jnci/djm223; Hong JS, 2007, MATURITAS, V56, P411, DOI 10.1016/j.maturitas.2006.11.004; Jee SH, 2004, J EPIDEMIOL, V26, P50; Jee SH, 2008, INT J CANCER, V123, P1892, DOI 10.1002/ijc.23719; Jeon JH, 2011, CANCER RES TREAT, V43, P42, DOI 10.4143/crt.2011.43.1.42; Jung KW, 2013, CANCER RES TREAT, V45, P15, DOI 10.4143/crt.2013.45.1.15; Jung KW, 2012, CANCER RES TREAT, V44, P11, DOI 10.4143/crt.2012.44.1.11; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Lee Chung Yul, 2004, Nurs Health Sci, V6, P201, DOI 10.1111/j.1442-2018.2004.00193.x; Lee EO, 2004, CANCER NURS, V27, P400; Lee JH, 2007, J KOREAN MED SCI, V22, pS11, DOI 10.3346/jkms.2007.22.S.S11; Lee SY, 2003, INT J CANCER, V105, P390, DOI 10.1002/ijc.11078; MACMAHON B, 1982, INT J CANCER, V30, P427, DOI 10.1002/ijc.2910300408; Mahoney MC, 2008, CA-CANCER J CLIN, V58, P347, DOI 10.3322/CA.2008.0016; McTiernan A, 2003, ONCOLOGIST, V8, P326, DOI 10.1634/theoncologist.8-4-326; Meads C, 2012, BREAST CANCER RES TR, V132, P365, DOI 10.1007/s10549-011-1818-2; Novotny J, 2006, BREAST CANCER RES TR, V95, P29, DOI 10.1007/s10549-005-9027-5; Park Sue Kyung, 2003, Cancer Res Treat, V35, P35, DOI 10.4143/crt.2003.35.1.35; Park Y, 2009, J CLIN ONCOL, V27, P694, DOI 10.1200/JCO.2008.17.4813; Pastor Climente Ismael Pascual, 2005, Clin Transl Oncol, V7, P336; Pronk A, 2011, BRIT J CANCER, V105, P1443, DOI 10.1038/bjc.2011.370; Shin A, 2009, CANCER EPIDEM BIOMAR, V18, P1894, DOI 10.1158/1055-9965.EPI-08-1228; SIMPSON ER, 1987, AM J CLIN NUTR, V45, P290, DOI 10.1093/ajcn/45.1.290; Suh Jun Suk, 1996, Journal of Korean Medical Science, V11, P501; Veronesi U, 2005, LANCET, V365, P1727, DOI 10.1016/S0140-6736(05)66546-4; Won YJ, 2009, CANCER RES TREAT, V41, P122, DOI 10.4143/crt.2009.41.3.122; Yoo Keun Young, 2002, Asian Pac J Cancer Prev, V3, P85; Yoo Keun-Young, 2005, Asian Pac J Cancer Prev, V6, P238; Yoo KY, 2001, CANCER LETT, V167, P57, DOI 10.1016/S0304-3835(01)00463-3; Yoo KY, 2002, J KOREAN MED SCI, V17, P1; Yoo KY, 1998, J KOREAN CANC ASS, V17, P435; Yoo KY, 2002, J BREAST CANCER, V5, P209	43	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76736	10.1371/journal.pone.0076736	http://dx.doi.org/10.1371/journal.pone.0076736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204664	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400017
J	Plaza, V; Ramos-Barbon, D; Munoz, AM; Fortuna, AM; Crespo, A; Murio, C; Palomino, R				Plaza, Vicente; Ramos-Barbon, David; Maria Munoz, Ana; Maria Fortuna, Ana; Crespo, Astrid; Murio, Cristina; Palomino, Rosa		EOLO Study Investigators	Exhaled Nitric Oxide Fraction as an Add-On to ACQ-7 for Not Well Controlled Asthma Detection	PLOS ONE			English	Article							UNCONTROLLED ASTHMA; SPANISH VERSION; CHILDREN; VALIDATION; NO	Background: The measurement of fractional nitric oxide concentration in exhaled breath (FeNO), a noninvasive indicator of airway inflammation, remains controversial as a tool to assess asthma control. Guidelines currently limit asthma control assessment to symptom and spirometry based appraisals such as the Asthma Control Questionnaire-7 (ACQ-7). We aimed at determining whether adding FeNO to ACQ-7 improves current asthma clinical control assessment, through enhanced detection of not well controlled asthma. Methods: Asthmatic subjects, classified as not well controlled as per ACQ-7 on regular clinical practice, were included in a prospective, multicenter fashion, and had their maintenance treatment adjusted on visit 1. On follow-up (visit 2) four weeks later, the subjects were reevaluated as controlled or not well controlled using ACQ-7 versus a combination of FeNO and ACQ-7. Results: Out of 381 subjects enrolled, 225 (59.1%) had not well controlled asthma on visit 2 as determined by ACQ-7, and 264 (69.3%) as per combined FeNO and ACQ-7. The combination of FeNO to ACQ-7 increased by 14.8% the detection of not well controlled asthma following maintenance therapy adjustment. Conclusions: The addition of FeNO to ACQ-7 increased the detectability of not well controlled asthma upon adjustment of maintenance therapy. Adding a measure of airway inflammation to usual symptom and spirometry based scores increases the efficacy of current asthma clinical control assessment.	[Plaza, Vicente; Ramos-Barbon, David; Maria Munoz, Ana; Maria Fortuna, Ana; Crespo, Astrid] Univ Autonoma Barcelona, IIB St Pau, Hosp Santa Creu & St Pau, Serv Neumol,BRN, E-08193 Barcelona, Spain; [Murio, Cristina] Chiesi Spain, Dept Med, Barcelona, Spain; [Palomino, Rosa] GOC Networking, Area Invest Aplicada, Barcelona, Spain	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Chiesi Pharmaceuticals Inc	Plaza, V (corresponding author), Univ Autonoma Barcelona, IIB St Pau, Hosp Santa Creu & St Pau, Serv Neumol,BRN, E-08193 Barcelona, Spain.	vplaza@santpau.cat	RAMOS-BARBON, DAVID/C-6624-2009	RAMOS-BARBON, DAVID/0000-0002-9615-6557; Crespo Lessmann, Astrid/0000-0002-2238-6851; Plaza, Vicente/0000-0003-2567-5496; Munoz, Xavier/0000-0002-8693-022X	Chiesi Spain	Chiesi Spain(Chiesi Pharmaceuticals Inc)	This work was supported by an independent investigator-driven grant from Chiesi Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agache I, 2012, J INVEST ALLERG CLIN, V22, P419; de Llano LAP, 2012, ARCH BRONCONEUMOL, V48, P35, DOI 10.1016/j.arbres.2011.01.006; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Boulet LP, 2002, CHEST, V122, P2217, DOI 10.1378/chest.122.6.2217; Deykin A, 2005, J ALLERGY CLIN IMMUN, V115, P720, DOI 10.1016/j.jaci.2004.12.1129; Donohue JF, 2013, RESP MED, V107, P943, DOI 10.1016/j.rmed.2013.02.018; Dupont LJ, 2003, CHEST, V123, P751, DOI 10.1378/chest.123.3.751; Fortuna AM, 2007, ARCH BRONCONEUMOL, V43, P176, DOI 10.1016/S1579-2129(07)60044-5; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Green RJ, 2012, CHEST, DOI [10.1378/chest.1312-1070, DOI 10.1378/CHEST.1312-1070]; Holt EW, 2008, J ALLERGY CLIN IMMUN, V121, P1175, DOI 10.1016/j.jaci.2008.02.015; Jatakanon A, 2000, AM J RESP CRIT CARE, V161, P64, DOI 10.1164/ajrccm.161.1.9809100; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; KOLLER DY, 1995, ARCH DIS CHILD, V73, P413, DOI 10.1136/adc.73.5.413; Kostikas K, 2011, RESP MED, V105, P526, DOI 10.1016/j.rmed.2010.10.015; Michils A, 2008, EUR RESPIR J, V31, P539, DOI 10.1183/09031936.00020407; Panel Expert Report; National Asthma Education and Prevention Program, 2007, J ALLERGY CLIN IMMUN, V120, pS94, DOI [10.1016/j.jaci.2007.09.029, DOI 10.1016/J.JACI.2007.09.029.PUBMED:17983880.D0I:10.1016/J.JACI.2007.09.029]; Perez-de-Llano LA, 2010, EUR RESPIR J, V35, P1221, DOI 10.1183/09031936.00118809; Petsky HL, 2009, COCHRANE DB SYST REV, V4; Picado C, 2008, CLIN THER, V30, P1918, DOI 10.1016/j.clinthera.2008.10.005; Pijnenburg MW, 2005, THORAX, V60, P215, DOI 10.1136/thx.2004.023374; Pike K, 2012, CLIN RESPIR  J, DOI [10.1111/j.1752-1699X.2012.00306.x, DOI 10.1111/J.1752-1699X.2012.00306.X]; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Rodrigo GJ, 2008, ANN ALLERG ASTHMA IM, V100, P17, DOI 10.1016/S1081-1206(10)60399-7; Sanchis J., 1989, ARCH BRONCONEUMOL, V25, P132; Schatz M, 2012, J ASTHMA, V49, P172, DOI 10.3109/02770903.2011.654024; Sociedad Espanola de Neumologia y Cirugia Toracica, 2009, ARCH BRONCONEUMOL, V45, P1; van der Valk RJP, 2012, ALLERGY, V67, P265, DOI 10.1111/j.1398-9995.2011.02734.x; Vijverberg SJH, 2012, PEDIAT ALLERG IMM-UK, V23, P529, DOI 10.1111/j.1399-3038.2012.01279.x; Yavuz ST, 2012, ANN ALLERG ASTHMA IM, V109, P36, DOI 10.1016/j.anai.2012.05.011; Zeiger RS, 2011, J ALLERGY CLIN IMMUN, V128, P412, DOI 10.1016/j.jaci.2011.06.008; Zeiger RS, 2011, J ASTHMA, V48, P8, DOI 10.3109/02770903.2010.539295	32	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77085	10.1371/journal.pone.0077085	http://dx.doi.org/10.1371/journal.pone.0077085			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204742	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400027
J	Heron-Milhavet, L; Franckhauser, C; Fernandez, A; Lamb, NJ				Heron-Milhavet, Lisa; Franckhauser, Celine; Fernandez, Anne; Lamb, Ned J.			Characterization of the Akt2 Domain Essential for Binding Nuclear p21cip1 to Promote Cell Cycle Arrest during Myogenic Differentiation	PLOS ONE			English	Article							PROTEIN-KINASE; FIBROBLASTS; MECHANISM	The binding of the cdk inhibitor p21cip1 to Akt2 in the nucleus is an essential component in determining the specific role of Akt2 in the cell cycle arrest that precedes myogenic differentiation. Here, through a combination of biochemical and cell biology approaches, we have addressed the molecular basis of this binding. Using amino-terminal truncation of Akt2, we show that p21cip1 binds at the carboxy terminal of Akt2 since deletion of the first 400 amino acids did not affect the interaction between Akt2 and p21cip1. Pull down using carboxy terminal-truncated Akt2 protein revealed the importance of the region between amino acids 400 and 445 for the binding to p21cip1. Since Akt2_400-445 and Akt2_ 420-445 peptides could both bind p21cip1, this refines the binding domain on Akt2 between amino acids 420 and 445. In order to confirm these data in living cells, we developed a protocol to synchronize myoblasts at the cell cycle exit point when p21cip1 expression is induced by MyoD before myogenic differentiation. When a synthetic Akt2 peptide spanning the region (410-437) was microinjected in p21-expressing myoblasts, p21cip1 no longer localized exclusively in the nucleus, instead being redistributed throughout the cell, thus showing that injected peptide 410-437 acts to compete with the binding of endogenous Akt2 to p21cip1. Taken together, our data suggest that this 27 amino acid sequence on Akt2 is necessary and sufficient to bind p21cip1 both in vitro and in living cells.	[Heron-Milhavet, Lisa; Franckhauser, Celine; Fernandez, Anne; Lamb, Ned J.] CNRS, Inst Human Genet, UPR1142, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Lamb, NJ (corresponding author), CNRS, Inst Human Genet, UPR1142, Montpellier, France.	ned.lamb@acrux.igh.cnrs.fr	Heron-Milhavet, Lisa/O-4339-2017	Heron-Milhavet, Lisa/0000-0002-7099-0850	ARC [3976]; LNCC	ARC(Australian Research Council); LNCC	This work was supported by ARC grant #3976 (http://www.arc-cancer.net/) and LNCC Grant (Herault et Aude) (http://www.ligue-cancer.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; FERNANDEZ A, 1991, EXP CELL RES, V195, P468, DOI 10.1016/0014-4827(91)90398-E; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Heron-Milhavet L, 2008, J CELL PHYSIOL, V214, P158, DOI 10.1002/jcp.21177; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Heron-Milhavet L, 2011, HISTOL HISTOPATHOL, V26, P651, DOI 10.14670/HH-26.651; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; STAAL SP, 1977, P NATL ACAD SCI USA, V74, P3065, DOI 10.1073/pnas.74.7.3065; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	12	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76987	10.1371/journal.pone.0076987	http://dx.doi.org/10.1371/journal.pone.0076987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194853	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000032
J	Miller, S; Bergel, EF; El Ayadi, AM; Gibbons, L; Butrick, EA; Magwali, T; Mkumba, G; Kaseba, C; Huong, NTM; Geissler, JD; Merialdi, M				Miller, Suellen; Bergel, Eduardo F.; El Ayadi, Alison M.; Gibbons, Luz; Butrick, Elizabeth A.; Magwali, Thulani; Mkumba, Gricelia; Kaseba, Christine; Huong, N. T. My; Geissler, Jillian D.; Merialdi, Mario			Non-Pneumatic Anti-Shock Garment (NASG), a First-Aid Device to Decrease Maternal Mortality from Obstetric Hemorrhage: A Cluster Randomized Trial	PLOS ONE			English	Article							POSTPARTUM HEMORRHAGE; BASE-LINE	Background: Obstetric hemorrhage is the leading cause of maternal mortality. Using a cluster randomized design, we investigated whether application of the Non-pneumatic Anti-Shock Garment (NASG) before transport to referral hospitals (RHs) from primary health care centers (PHCs) decreased adverse outcomes among women with hypovolemic shock. We hypothesized the NASG group would have a 50% reduction in adverse outcomes. Methods and Findings: We randomly assigned 38 PHCs in Zambia and Zimbabwe to standard obstetric hemorrhage/shock protocols or the same protocols plus NASG prior to transport. All women received the NASG at the RH. The primary outcomes were maternal mortality; severe, end-organ failure maternal morbidity; and a composite mortality/morbidity outcome, which we labeled extreme adverse outcome (EAO). We also examined whether the NASG contributed to negative side effects and secondary outcomes. The sample size for statistical power was not reached; of a planned 2400 women, 880 were enrolled, 405 in the intervention group. The intervention was associated with a non-significant 46% reduced odds of mortality (OR 0.54, 95% CI 0.14-2.05, p = 0.37) and 54% reduction in composite EAO (OR 0.46, 95% CI 0.13-1.62, p = 0.22). Women with NASGs recovered from shock significantly faster (HR 1.25, 95% CI 1.02-1.52, p = 0.03). No differences were observed in secondary outcomes or negative effects. The main limitation was small sample size. Conclusions: Despite a lack of statistical significance, the 54% reduced odds of EAO and the significantly faster shock recovery suggest there might be treatment benefits from earlier application of the NASG for women experiencing delays obtaining definitive treatment for hypovolemic shock. As there are no other tools for shock management outside of referral facilities, and no safety issues found, consideration of NASGs as a temporizing measure during delays may be warranted. A pragmatic study with rigorous evaluation is suggested for further research.	[Miller, Suellen; El Ayadi, Alison M.; Butrick, Elizabeth A.; Geissler, Jillian D.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Bergel, Eduardo F.; Gibbons, Luz] Inst Efectividad Clin & Sanit, Buenos Aires, DF, Argentina; [Magwali, Thulani] Univ Zimbabwe, Dept Obstet & Gynecol, Harare, Zimbabwe; [Mkumba, Gricelia; Kaseba, Christine] Univ Teaching Hosp, Dept Obstet & Gynecol, Lusaka, Zambia; [Huong, N. T. My; Merialdi, Mario] World Hlth Org, World Bank Special Programme Res Dev & Res Traini, Dept Reprod Hlth & Res,United Nations Dev Program, United Nations Populat Fund,United Nations Childr, Geneva, Switzerland	University of California System; University of California San Francisco; University of Zimbabwe; University of Zambia; The World Bank; United Nations Population Fund; World Health Organization	Miller, S (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA.	suellenmiller@gmail.com		Gibbons, Luz/0000-0002-0235-1635	National Institutes Of Child Health And Human Development [R01HD053129]; Bill and Melinda Gates Foundation [48541]; United Nations Development Programme/United Nations Population Fund/United Nations Children's Fund/World Health Organization (WHO)/World Bank Special programme of research, development and research training in human reproduction (HRP/WHO); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053129] Funding Source: NIH RePORTER	National Institutes Of Child Health And Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); United Nations Development Programme/United Nations Population Fund/United Nations Children's Fund/World Health Organization (WHO)/World Bank Special programme of research, development and research training in human reproduction (HRP/WHO); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project described was supported by Grant Number R01HD053129 from the National Institutes Of Child Health And Human Development. Additional funding was provided by the Bill and Melinda Gates Foundation, Grant #48541. Technical and financial support was provided by the United Nations Development Programme/United Nations Population Fund/United Nations Children's Fund/World Health Organization (WHO)/World Bank Special programme of research, development and research training in human reproduction (HRP/WHO). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes Of Child Health And Human Development or the National Institutes of Health, the Bill and Melinda Gates Foundation, or the World Health Organization. Other than EFB, NTMH and MM, who are authors, HRP/WHO staff had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	[Anonymous], 2010, CLIN ULTIMATE REFERE; [Anonymous], 2007, ZAMB DEM HLTH SURV; [Anonymous], 2010, ZIMB DEM HLTH SURV; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; CHRISTENSEN KS, 1986, J TRAUMA, V26, P1102, DOI 10.1097/00005373-198612000-00008; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; DICKINSON K, 2000, COCHRANE DB SYST REV; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Fathalla MF, 2011, ISRN OBSTET GYNECOL, V2011; Goudar SS, 2008, J MATERN-FETAL NEO M, V21, P559, DOI 10.1080/14767050802132158; HAUSWALD M, 1986, ANN EMERG MED, V15, P1297, DOI 10.1016/S0196-0644(86)80613-8; Hauswald Mark, 2003, Prehosp Emerg Care, V7, P225, DOI 10.1080/10903120390936824; Hensleigh P, 2005, TROPICAL J OBSTET GY, V22, pS14; Hensleigh PA, 2002, BJOG-INT J OBSTET GY, V109, P1377, DOI 10.1046/j.1471-0528.2002.02197.x; Ivers NM, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-120; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Lalonde A, 2012, INT J GYNECOL OBSTET, V117, P108, DOI 10.1016/j.ijgo.2012.03.001; Lester F, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.054; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x; MCCARTHY J, 1992, STUD FAMILY PLANN, V23, P23, DOI 10.2307/1966825; McSwain MJ, 2000, TRAUMA, V2, P63; MCSWAIN NE, 1988, ANN EMERG MED, V17, P506, DOI 10.1016/S0196-0644(88)80248-8; Miller S, 2006, BJOG-INT J OBSTET GY, V113, P424, DOI 10.1111/j.1471-0528.2006.00873.x; Miller S, 2003, J MIDWIFERY WOM HEAL, V48, P10, DOI 10.1016/S1526-9523(02)00369-0; Miller S, 2007, Glob Public Health, V2, P110, DOI 10.1080/17441690601012536; Miller S, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-64; Miller S, 2010, INT J GYNECOL OBSTET, V109, P20, DOI 10.1016/j.ijgo.2009.11.016; Miller S, 2009, INT J GYNECOL OBSTET, V107, P121, DOI 10.1016/j.ijgo.2009.06.005; Mitra B, 2013, INJURY; Mobeen N, 2010, BRIT J OBSTET GYNAEC, V118, P353; Morris J, 2011, AFR J MIDWIFERY WOME, V5, P37; Nixon RM, 2003, STAT MED, V22, P2673, DOI 10.1002/sim.1483; O'Connor R E, 1997, Prehosp Emerg Care, V1, P36, DOI 10.1080/10903129708958783; Pelligra R, 1994, EMERGENCY, P53; Ransom EI, 2002, MAKING MOTHERHOOD SA; Stenson A, 2012, COMPREHENSIVE TXB PO; Sutherland T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062282; Turan J, 2011, J WOMENS HEALTH, V20, P91, DOI 10.1089/jwh.2010.2081; West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570; World Health Organization WHO, 2012, RECOMMENDATIONS PREV	43	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76477	10.1371/journal.pone.0076477	http://dx.doi.org/10.1371/journal.pone.0076477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194839	Green Submitted, gold, Green Published			2022-12-27	WOS:000326037000018
J	Steffens, NK; Haslam, SA				Steffens, Niklas K.; Haslam, S. Alexander			Power through 'Us': Leaders' Use of We-Referencing Language Predicts Election Victory	PLOS ONE			English	Article							SOCIAL IDENTITY; ORGANIZATIONAL IDENTIFICATION; PERSPECTIVE; PERFORMANCE; CHARISMA; BEHAVIOR; SELF	Leaders have been observed to use distinct rhetorical strategies, but it is unclear to what extent such strategies are effective. To address this issue we analyzed the official election campaign speeches of successful and unsuccessful Prime Ministerial candidates in all 43 Australian Federal elections since independence from Britain in 1901 and measured candidates' use of personal ('I', 'me') and collective pronouns ('we', 'us'). Victors used more collective pronouns than their unsuccessful opponents in 80% of all elections. Across all elections, victors made 61% more references to 'we' and 'us' and used these once every 79 words (vs. every 136 words for losers). Extending social identity theorizing, this research suggests that electoral endorsement is associated with leaders' capacity to engage with, and speak on behalf of, a collective identity that is shared with followers whose support and energies they seek to mobilize.	[Steffens, Niklas K.; Haslam, S. Alexander] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia	University of Queensland	Steffens, NK (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	n.steffens@uq.edu.au	Steffens, Niklas/D-3609-2016; Haslam, Alex/AAA-2512-2019	Steffens, Niklas/0000-0002-3990-2592; Haslam, Alex/0000-0001-9523-7921	Australian Research Council [FL110100199]	Australian Research Council(Australian Research Council)	This research was supported by grant FL110100199 of the Australian Research Council awarded to the second author [http://www.arc.gov.au/ncgp/laureate/laureate_default.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAIR J., 2011, J ADAIRS 100 GREATES; Antonakis J, 2009, SCIENCE, V323, P1183, DOI 10.1126/science.1167748; Atkinson M, 1984, OUR MASTERS VOICES L; Augoustinos M, 2012, EUR J SOC PSYCHOL, V42, P564, DOI 10.1002/ejsp.1868; Bass B. M., 2006, TRANSFORMATIONAL LEA, DOI DOI 10.4324/9781410617095; Carlyle Thomas, 1840, HEROES HERO WORSHIP, P39; Chiao JY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003666; Ellemers N, 2004, ACAD MANAGE REV, V29, P459, DOI 10.2307/20159054; Ellemers N, 2012, SCIENCE, V336, P848, DOI 10.1126/science.1220987; Emrich CG, 2001, ADMIN SCI QUART, V46, P527, DOI 10.2307/3094874; Haslam SA, 2011, NEW PSYCHOLOGY OF LEADERSHIP: IDENTITY, INFLUENCE, AND POWER, P1; Haslam SA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001426; Haslam S. Alexander, 2001, PSYCHOL ORG SOCIAL I; Haslam SA, 2001, PERS SOC PSYCHOL B, V27, P1469, DOI 10.1177/01461672012711008; Kraus F, 2012, ORGAN BEHAV HUM DEC, V118, P162, DOI 10.1016/j.obhdp.2012.03.010; Lim ET, 2002, PRESIDENTIAL STUDIES, V32, P326; Little G., 1988, STRONG LEADERSHIP TH; Pennebaker, 2011, SECRET LIFE PRONOUNS, DOI 10.1387/gogoa.17916; Platow MJ, 2006, BRIT J SOC PSYCHOL, V45, P303, DOI 10.1348/014466605X41986; Postmes T., 2010, REDISCOVERING SOCIAL; Reicher S, 2005, LEADERSHIP QUART, V16, P547, DOI 10.1016/j.leaqua.2005.06.007; Reicher S., 2001, SELF NATION CATEGORI; Reicher S.D., 2003, LEADERSHIP POWER IDE, P197, DOI DOI 10.4135/9781446216170.N15; Seyranian V, 2008, LEADERSHIP QUART, V19, P54, DOI 10.1016/j.leaqua.2007.12.005; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Turner JC, 2005, EUR J SOC PSYCHOL, V35, P1, DOI 10.1002/ejsp.244; Turner JC, 1987, REDISCOVERING SOCIAL, P239; Van Dick R, 2007, J OCCUP ORGAN PSYCH, V80, P133, DOI 10.1348/096317905X71831; van Knippenberg D, 2011, LEADERSHIP QUART, V22, P1078, DOI 10.1016/j.leaqua.2011.09.004; Wieseke J, 2009, J MARKETING, V73, P123, DOI 10.1509/jmkg.73.2.123; Willis G, 1992, LINCOLN GETTYSBURG W; Wong EM, 2011, PSYCHOL SCI, V22, P1478, DOI 10.1177/0956797611418838; Yammarino FJ, 2012, IND ORGAN PSYCHOL-US, V5, P382, DOI 10.1111/j.1754-9434.2012.01467.x	33	54	54	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77952	10.1371/journal.pone.0077952	http://dx.doi.org/10.1371/journal.pone.0077952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194904	gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000083
J	Yan, J; Gan, L; Chen, D; Sun, C				Yan, Jun; Gan, Lu; Chen, Di; Sun, Chao			Adiponectin Impairs Chicken Preadipocytes Differentiation through p38 MAPK/ATF-2 and TOR/p70 S6 Kinase Pathways	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ADIPOSE TRIGLYCERIDE LIPASE; PIMA INDIAN POPULATION; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; VISCERAL ADIPOSITY; TISSUE; RECEPTORS; RAPAMYCIN; ATF-2	Adiponectin is a protein hormone secreted exclusively by adipocytes that plays an important role in the modulation of glucose and lipid metabolism. In the present study, we investigated the ability of adiponectin to stimulate chicken preadipocyte differentiation and its effect on cellular signaling pathways associated with adipocyte differentiation. Data showed that over-expression of adiponectin inhibited adipocyte differentiation and the expression of adipogenic marker gene, while activated the expression of lipolytic marker gene. Meanwhile, adiponectin led to activation of p38 mitogen-activated protein kinase (p38 MAPK)/activating transcription factor 2 (ATF-2) signaling pathway and down-regulation of target of rapamycin (TOR)/p70 S6 Kinase signaling pathway. Furthermore, the activation of p38 MAPK/ATF-2 signaling pathway was blocked by the p38 MAPK inhibitor SB253580, whereas adiponectin had a synergistic effect on the suppression of TOR/p70 S6 Kinase signaling pathway with the TOR inhibitor rapamycin. In conclusion, the results demonstrate the ability of adiponectin to inhibit chicken preadipocyte differentiation, which depends on the p38 MAPK/ATF-2 and TOR/p70 S6 Kinase pathways.	[Yan, Jun; Gan, Lu; Chen, Di; Sun, Chao] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Sun, C (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	sunchao2775@163.com	Sánchez-Margalet, Victor/AAB-9986-2021	Sánchez-Margalet, Victor/0000-0001-8638-8680	National Nature Science Foundation of China [31172185]; Agriculture Technology Innovation in Shaanxi Province of China [2012NKC01-13]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture Technology Innovation in Shaanxi Province of China	This work was supported by National Nature Science Foundation of China (31172185) and Agriculture Technology Innovation in Shaanxi Province of China (2012NKC01-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bauche IB, 2007, ENDOCRINOLOGY, V148, P1539, DOI 10.1210/en.2006-0838; Chabrolle C, 2007, DOMEST ANIM ENDOCRIN, V33, P480, DOI 10.1016/j.domaniend.2006.08.002; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Cho HJ, 2004, BIOCHEM BIOPH RES CO, V321, P942, DOI 10.1016/j.bbrc.2004.07.050; Coppola A, 2009, INT J CARDIOL, V134, P414, DOI 10.1016/j.ijcard.2007.12.087; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hendricks GL, 2009, ENDOCRINOLOGY, V150, P3092, DOI 10.1210/en.2008-1558; Lindsay RS, 2003, DIABETES, V52, P2419, DOI 10.2337/diabetes.52.9.2419; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Liu QQ, 2012, P NATL ACAD SCI USA, V109, P14568, DOI 10.1073/pnas.1211611109; Luo XH, 2005, EXP CELL RES, V309, P99, DOI 10.1016/j.yexcr.2005.05.021; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maekawa T, 2008, ONCOGENE, V27, P1045, DOI 10.1038/sj.onc.1210727; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Masaki T, 2003, DIABETES, V52, P2266, DOI 10.2337/diabetes.52.9.2266; Nogalska A, 2005, METABOLISM, V54, P1041, DOI 10.1016/j.metabol.2005.03.007; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Qiao LP, 2006, ENDOCRINOLOGY, V147, P865, DOI 10.1210/en.2005-1030; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shuman JD, 1997, J BIOL CHEM, V272, P12793, DOI 10.1074/jbc.272.19.12793; Sun C, 2011, MOL BIOL REP, V38, P731, DOI 10.1007/s11033-010-0160-9; Tahmoorespur M, 2010, POULTRY SCI, V89, P2092, DOI 10.3382/ps.2010-00772; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Wanninger J, 2009, AM J PHYSIOL-GASTR L, V297, P16; Xin X, 2011, AM J PHYSIOL-ENDOC M, V300, pE103, DOI 10.1152/ajpendo.00427.2010; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	36	20	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77716	10.1371/journal.pone.0077716	http://dx.doi.org/10.1371/journal.pone.0077716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194895	gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000074
J	Andersson, DA; Gentry, C; Light, E; Vastani, N; Vallortigara, J; Bierhaus, A; Fleming, T; Bevan, S				Andersson, David A.; Gentry, Clive; Light, Emily; Vastani, Nisha; Vallortigara, Julie; Bierhaus, Angelika; Fleming, Thomas; Bevan, Stuart			Methylglyoxal Evokes Pain by Stimulating TRPA1	PLOS ONE			English	Article							RENAL TUBULAR CELLS; ION-CHANNEL TRPA1; OXIDATIVE STRESS; DIABETIC-NEUROPATHY; PERIPHERAL NEUROPATHY; COVALENT MODIFICATION; ACTIVATE TRPA1; CALCIUM LEVELS; SERUM-ALBUMIN; GLYOXALASE-I	Diabetic neuropathy is a severe complication of long-standing diabetes and one of the major etiologies of neuropathic pain. Diabetes is associated with an increased formation of reactive oxygen species and the electrophilic dicarbonyl compound methylglyoxal (MG). Here we show that MG stimulates heterologously expressed TRPA1 in CHO cells and natively expressed TRPA1 in MDCK cells and DRG neurons. MG evokes [Ca2+](i)-responses in TRPA1 expressing DRG neurons but is without effect in neurons cultured from Trpa1(-/-) mice. Consistent with a direct, intracellular action, we show that methylglyoxal is significantly more potent as a TRPA1 agonist when applied to the intracellular face of excised membrane patches than to intact cells. Local intraplantar administration of MG evokes a pain response in Trpa1(+/+) but not in Trpa1(-/-) mice. Furthermore, persistently increased MG levels achieved by two weeks pharmacological inhibition of glyoxalase-1 (GLO-1), the rate-limiting enzyme responsible for detoxification of MG, evokes a progressive and marked thermal (cold and heat) and mechanical hypersensitivity in wildtype but not in Trpa1(-/-) mice. Our results thus demonstrate that TRPA1 is required both for the acute pain response evoked by topical MG and for the long-lasting pronociceptive effects associated with elevated MG in vivo. In contrast to our observations in DRG neurons, MG evokes indistinguishable [Ca2+](i)-responses in pancreatic beta-cells cultured from Trpa1(+/+) and Trpa1(-/-) mice. In vivo, the TRPA1 antagonist HC030031 impairs glucose clearance in the glucose tolerance test both in Trpa1(+/+) and Trpa1(-/-)mice, indicating a non-TRPA1 mediated effect and suggesting that results obtained with this compound should be interpreted with caution. Our results show that TRPA1 is the principal target for MG in sensory neurons but not in pancreatic beta-cells and that activation of TRPA1 by MG produces a painful neuropathy with the behavioral hallmarks of diabetic neuropathy.	[Andersson, David A.; Gentry, Clive; Light, Emily; Vastani, Nisha; Vallortigara, Julie; Bevan, Stuart] Kings Coll London, Wolfson CARD, London, England; [Bierhaus, Angelika; Fleming, Thomas] Univ Heidelberg Hosp, Dept Med & Clin Chem 1, Heidelberg, Germany	University of London; King's College London; Ruprecht Karls University Heidelberg	Andersson, DA (corresponding author), Kings Coll London, Wolfson CARD, London, England.	david.andersson@kcl.ac.uk	Andersson, David A/C-3435-2008; Bevan, Stuart/A-8821-2008	Andersson, David A/0000-0001-7451-8548; Vastani, Nisha/0000-0003-0919-713X; Bevan, Stuart John/0000-0002-8977-1797	Medical Research Council [G0500847]; Deutsche Forschungsgemeinschaft [BI-1281/3-1, NA 138/7-1]; Dietmar-Hopp-Stiftung; MRC [G0500847] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dietmar-Hopp-Stiftung; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by grants from the Medical Research Council (G0500847), Deutsche Forschungsgemeinschaft (BI-1281/3-1; NA 138/7-1) and the Dietmar-Hopp-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, J BIOL CHEM, V280, P5724, DOI 10.1074/jbc.M410973200; Ahmed N, 2005, DIABETES CARE, V28, P2465, DOI 10.2337/diacare.28.10.2465; Aldini G, 2007, MED RES REV, V27, P817, DOI 10.1002/med.20073; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Andersson DA, 2009, P NATL ACAD SCI USA, V106, P8374, DOI 10.1073/pnas.0812675106; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; BEVAN S, 1995, J NEUROSCI, V15, P4918; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Blanco M, 2005, STROKE, V36, P1189, DOI 10.1161/01.STR.0000166054.55993.e5; Calabrese V, 2007, CELL STRESS CHAPERON, V12, P299, DOI 10.1379/CSC-270.1; Cao DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038005; Coughlan MT, 2008, ANN NY ACAD SCI, V1126, P190, DOI 10.1196/annals.1433.018; Cruz-Orengo L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-30; DeFalco J, 2010, BIOORG MED CHEM LETT, V20, P276, DOI 10.1016/j.bmcl.2009.10.113; Devigili G, 2008, BRAIN, V131, P1912, DOI 10.1093/brain/awn093; Eberhardt MJ, 2012, J BIOL CHEM, V287, P28291, DOI 10.1074/jbc.M111.328674; Eberhardt MJ, 2012, J BIOL CHEM; Edwards JL, 2008, PHARM THER; Fleming T, 2012, DIABETOLOGIA, V55, P1151, DOI 10.1007/s00125-012-2452-1; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Frischmann M, 2005, CHEM RES TOXICOL, V18, P1586, DOI 10.1021/tx0501278; Gentry C, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-4; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Jack MM, 2011, DIABETOLOGIA, V54, P2174, DOI 10.1007/s00125-011-2196-3; Jan CR, 2005, CELL SIGNAL, V17, P847, DOI 10.1016/j.cellsig.2004.11.007; Jan CR, 2003, PHARMACOL TOXICOL, V93, P123, DOI 10.1034/j.1600-0773.2003.930303.x; Jan CR, 1999, N-S ARCH PHARMACOL, V360, P249, DOI 10.1007/s002109900055; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Koivisto A, 2012, PHARMACOL RES, V65, P149, DOI 10.1016/j.phrs.2011.10.006; Kramer HH, 2004, DIABETES CARE, V27, P2386, DOI 10.2337/diacare.27.10.2386; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LO TWC, 1994, J BIOL CHEM, V269, P32299; LO TWC, 1992, BIOCHEM PHARMACOL, V44, P2357, DOI 10.1016/0006-2952(92)90680-H; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717; Nozawa K, 2009, P NATL ACAD SCI USA, V106, P3408, DOI 10.1073/pnas.0805323106; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Sommer C, 2007, LANCET NEUROL, V6, P632, DOI 10.1016/S1474-4422(07)70172-2; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Taylor-Clark TE, 2007, MOL PHARM; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Thornalley PJ, 1996, BIOCHEM PHARMACOL, V51, P1365, DOI 10.1016/0006-2952(96)00059-7; Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Turk Z, 2006, DIABETES METAB, V32, P176, DOI 10.1016/S1262-3636(07)70266-5; VINCE R, 1971, J MED CHEM, V14, P402, DOI 10.1021/jm00287a006; Vincent AM, 2005, FASEB J, V19, P638, DOI 10.1096/fj.04-2513fje; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Wang LW, 2012, J BIOL CHEM, V287, P6169, DOI 10.1074/jbc.M111.329748; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Xiao WH, 2012, NEUROSCIENCE, V203, P194, DOI 10.1016/j.neuroscience.2011.12.023	62	81	82	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77986	10.1371/journal.pone.0077986	http://dx.doi.org/10.1371/journal.pone.0077986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167592	Green Published, gold, Green Submitted			2022-12-27	WOS:000326034500052
J	Bethunaickan, R; Berthier, CC; Zhang, WJ; Kretzler, M; Davidson, A				Bethunaickan, Ramalingam; Berthier, Celine C.; Zhang, Weijia; Kretzler, Matthias; Davidson, Anne			Comparative Transcriptional Profiling of 3 Murine Models of SLE Nephritis Reveals Both Unique and Shared Regulatory Networks	PLOS ONE			English	Article							LUPUS-ERYTHEMATOSUS NEPHRITIS; LANGERHANS CELLS; ACTIVATION; EXPRESSION; INHIBITOR; DISEASE; CLOCK; ALPHA; MICE; INFLAMMATION	Objective: To define shared and unique features of SLE nephritis in mouse models of proliferative and glomerulosclerotic renal disease. Methods: Perfused kidneys from NZB/W F1, NZW/BXSB and NZM2410 mice were harvested before and after nephritis onset. Affymetrix based gene expression profiles of kidney RNA were analyzed using Genomatix Pathway Systems and Ingenuity Pathway Analysis software. Gene expression patterns were confirmed using real-time PCR. Results: 955, 1168 and 755 genes were regulated in the kidneys of nephritic NZB/W F1, NZM2410 and NZW/BXSB mice respectively. 263 genes were regulated concordantly in all three strains reflecting immune cell infiltration, endothelial cell activation, complement activation, cytokine signaling, tissue remodeling and hypoxia. STAT3 was the top associated transcription factor, having a binding site in the gene promoter of 60/263 regulated genes. The two strains with proliferative nephritis shared a macrophage/DC infiltration and activation signature. NZB/W and NZM2410 mice shared a mitochondrial dysfunction signature. Dominant T cell and plasma cell signatures in NZB/W mice reflected lymphoid aggregates; this was the only strain with regulatory T cell infiltrates. NZW/BXSB mice manifested tubular regeneration and NZM2410 mice had the most metabolic stress and manifested loss of nephrin, indicating podocyte loss. Conclusions: These findings identify shared inflammatory mechanisms of SLE nephritis that can be therapeutically targeted. Nevertheless, the heterogeneity of effector mechanisms suggests that individualized therapy might need to be based on biopsy findings. Some common mechanisms are shared with non-immune-mediated renal diseases, suggesting that strategies to prevent tissue hypoxia and remodeling may be useful in SLE nephritis.	[Bethunaickan, Ramalingam; Davidson, Anne] Feinstein Inst Med Res, Ctr Autoimmun & Musculoskeletal Dis, New York, NY USA; [Berthier, Celine C.; Kretzler, Matthias] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Zhang, Weijia] Mt Sinai Med Ctr, Dept Med, New York, NY 10029 USA	Northwell Health; University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai	Davidson, A (corresponding author), Feinstein Inst Med Res, Ctr Autoimmun & Musculoskeletal Dis, New York, NY USA.	adavidson1@nshs.edu	Bethunaickan, Ramalingam/AAZ-6429-2020; Bethunaickan, Ramalingam/N-6463-2015	Davidson, Anne/0000-0002-4081-6464; Bethunaickan, Ramalingam/0000-0003-4595-5233	NIH [R01 DK085241-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085241, P30DK081943] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH R01 DK085241-01. (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Berthier CC, 2012, J IMMUNOL, V189, P988, DOI 10.4049/jimmunol.1103031; Bethunaickan R, 2011, J IMMUNOL, V186, P4994, DOI 10.4049/jimmunol.1003010; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Chang A, 2011, J IMMUNOL, V186, P1849, DOI 10.4049/jimmunol.1001983; Chiang CK, 2011, MOL MED, V17, P1295, DOI 10.2119/molmed.2011.00131; Davidson A, 2010, NAT REV RHEUMATOL, V6, P13, DOI 10.1038/nrrheum.2009.240; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Fismen S, 2011, IMMUNOL CELL BIOL, V89, P90, DOI 10.1038/icb.2010.75; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Giannico G, 2013, CLIN J AM SOC NEPHRO, V8, P138, DOI 10.2215/CJN.03400412; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; HANG LM, 1981, J EXP MED, V154, P216, DOI 10.1084/jem.154.1.216; Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284; Hill GS, 2001, KIDNEY INT, V59, P304, DOI 10.1046/j.1523-1755.2001.00492.x; Hotta K, 2011, KIDNEY INT, V79, P179, DOI 10.1038/ki.2010.379; Hsieh C, 2011, ARTHRIT CARE RES, V63, P865, DOI 10.1002/acr.20441; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Ichii O, 2010, LAB INVEST, V90, P459, DOI 10.1038/labinvest.2009.148; Jeong S, 2012, AM J PATHOL, V180, P2028, DOI 10.1016/j.ajpath.2012.01.025; Jung GS, 2012, J AM SOC NEPHROL, V23, P73, DOI 10.1681/ASN.2011010048; Kahn P, 2008, ARTHRITIS RHEUM, V58, P2824, DOI 10.1002/art.23764; Karpurapu M, 2011, BLOOD, V118, P5255, DOI 10.1182/blood-2011-03-341123; Kelkka T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/730469; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Liu J, 2006, GENES IMMUN, V7, P156, DOI 10.1038/sj.gene.6364286; Liu N, 2004, FEBS LETT, V569, P49, DOI 10.1016/j.febslet.2004.05.061; Liu Z, 2011, J IMMUNOL, V187, P1506, DOI 10.4049/jimmunol.1004142; Lu LD, 2011, J IMMUNOL, V187, P3840, DOI 10.4049/jimmunol.1101228; Martin-Martin N, 2010, AM J PHYSIOL-RENAL, V298, pF672, DOI 10.1152/ajprenal.00199.2009; Matsui F, 2012, J SURG RES, V178, P339, DOI 10.1016/j.jss.2012.06.050; Matsuura K, 2007, HUM PATHOL, V38, P410, DOI 10.1016/j.humpath.2006.09.006; Palm F, 2011, AM J PHYSIOL-REG I, V301, pR1229, DOI 10.1152/ajpregu.00720.2010; Pedersen A, 2005, DEV BIOL, V288, P571, DOI 10.1016/j.ydbio.2005.09.027; Peterson KS, 2004, J CLIN INVEST, V113, P1722, DOI 10.1172/JCI200419139; Petrzilka S, 2009, J BIOL RHYTHM, V24, P283, DOI 10.1177/0748730409336579; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Ramanujam M, 2010, ARTHRITIS RHEUM-US, V62, P1457, DOI 10.1002/art.27368; Rerolle JP, 2000, KIDNEY INT, V58, P1841, DOI 10.1046/j.1523-1755.2000.00355.x; Richters L, 2011, J APPL PHYSIOL, V111, P1431, DOI 10.1152/japplphysiol.01392.2010; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schiffer L, 2003, J IMMUNOL, V171, P489, DOI 10.4049/jimmunol.171.1.489; Schiffer L, 2008, J IMMUNOL, V180, P1938, DOI 10.4049/jimmunol.180.3.1938; Schiffer L, 2009, NEPHROL DIAL TRANSPL, V24, P3708, DOI 10.1093/ndt/gfp343; Singh RR, 2003, J IMMUNOL, V170, P4818, DOI 10.4049/jimmunol.170.9.4818; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Turgeon J, 2012, ATHEROSCLEROSIS, V223, P122, DOI 10.1016/j.atherosclerosis.2012.05.003; Ueland JM, 2004, AM J PHYSIOL-RENAL, V286, pF581, DOI 10.1152/ajprenal.00289.2003; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Yasuda T, 2012, MOL BIOL CELL, V23, P3229, DOI 10.1091/mbc.E12-02-0104; Zykova SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012096	55	34	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77489	10.1371/journal.pone.0077489	http://dx.doi.org/10.1371/journal.pone.0077489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167575	Green Submitted, gold, Green Published			2022-12-27	WOS:000326034500034
J	Gomez, AJC; Campos, NV; Belenguer, A; Avila, C; Forn, C				Cruz Gomez, Alvaro Javier; Ventura Campos, Noelia; Belenguer, Antonio; Avila, Cesar; Forn, Cristina			Regional Brain Atrophy and Functional Connectivity Changes Related to Fatigue in Multiple Sclerosis	PLOS ONE			English	Article							RESTING-STATE NETWORKS; CORTICAL ATROPHY; MRI; ACTIVATION; LESIONS; SCALE; HAND	Fatigue is one of the most frequent symptoms in multiple sclerosis (MS), and recent studies have described a relationship between the sensorimotor cortex and its afferent and efferent pathways as a substrate of fatigue. The objectives of this study were to assess the neural correlates of fatigue in MS through gray matter (GM) and white matter (WM) atrophy, and resting state functional connectivity (rs-FC) of the sensorimotor network (SMN). Eighteen healthy controls (HCs) and 60 relapsing-remitting patients were assessed with the Fatigue Severity Scale (FSS). Patients were classified as fatigued (F) or nonfatigued (NF). We investigated GM and WM atrophy using voxel-based morphometry, and rs-FC changes with a seed-based method and independent component analysis (ICA). F patients showed extended GM and WM atrophy focused on areas related to the SMN. High FSS scores were associated with reductions of WM in the supplementary motor area. Seed analysis of GM atrophy in the SMN showed that HCs presented increased rs-FC between the primary motor and somatosensory cortices while patients with high FSS scores were associated with decreased rs-FC between the supplementary motor area and associative somatosensory cortex. ICA results showed that NF patients presented higher rs-FC in the primary motor cortex compared to HCs and in the premotor cortex compared to F patients. Atrophy reduced functional connectivity in SMN pathways and MS patients consequently experienced high levels of fatigue. On the contrary, NF patients experienced high synchronization in this network that could be interpreted as a compensatory mechanism to reduce fatigue sensation.	[Cruz Gomez, Alvaro Javier; Ventura Campos, Noelia; Avila, Cesar; Forn, Cristina] Univ Jaume 1, Dept Psicol Basica Clin & Psicobiol, Castellon de La Plana, Castellon, Spain; [Belenguer, Antonio] Hosp Gen Castellon, Serv Neurol, Castellon de La Plana, Castellon, Spain	Universitat Jaume I	Forn, C (corresponding author), Univ Jaume 1, Dept Psicol Basica Clin & Psicobiol, Castellon de La Plana, Castellon, Spain.	forn@psb.uji.es	Avila, Cesar/B-4370-2011; Belenguer, Antonio/HGE-4520-2022; 2010, BRAINGLOT Consolider Ingenio/D-1235-2009; Campos, Noelia Ventura/L-4877-2014; Forn, Cristina/L-6208-2014	Avila, Cesar/0000-0002-5840-605X; Belenguer, Antonio/0000-0003-2763-8218; Campos, Noelia Ventura/0000-0002-0443-8048; Forn, Cristina/0000-0002-6292-5303; Cruz Gomez, Alvaro Javier/0000-0001-9105-5100	Brainglot project of the CONSOLIDER-INGENIO Program [CSD2007-00012]; MINECO [PSI2010-20168]; Universitat Jaume I [P1.1B2011-09]; Biogen Idec; commercial company (Biogen Idec); government agency (MINECO)	Brainglot project of the CONSOLIDER-INGENIO Program; MINECO(Spanish Government); Universitat Jaume I; Biogen Idec(Biogen); commercial company (Biogen Idec); government agency (MINECO)	This work was supported by Brainglot project of the CONSOLIDER-INGENIO 2010 Program grant number CSD2007-00012; by grants PSI2010-20168 from MINECO and P1.1B2011-09 from Universitat Jaume I as well as an educational grant from Biogen Idec to CA. The authors take the opportunity to clarify that the funders of this research did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Finally, the authors state that receiving funding from a commercial company (Biogen Idec) or a government agency (MINECO) does not alter their adherence to all the PLOS ONE polices on sharing data and materials.	ANDREASENA K, 2010, NEUROIMAGE, V50, P608, DOI DOI 10.1016/J.NEUR0IMAGE.2009.12.118.PUBMED:20060048; Bakshi R, 1999, NEUROLOGY, V53, P1151, DOI 10.1212/WNL.53.5.1151; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benwell NM, 2007, EXP BRAIN RES, V179, P255, DOI 10.1007/s00221-006-0790-2; Calabrese M, 2010, MULT SCLER J, V16, P1220, DOI 10.1177/1352458510376405; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2008, 2008 IEEE SOUTHWEST SYMPOSIUM ON IMAGE ANALYSIS & INTERPRETATION, P201, DOI 10.1109/SSIAI.2008.4512320; Ceccarelli A, 2012, CURR OPIN NEUROL, V25, P402, DOI 10.1097/WCO.0b013e328354f63f; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; DOGONOWSKI AM, 2013, ACTA NEUROL SCAND, DOI DOI 10.1111/ANE.12121.PUBMED:23461607; Faivre A, 2012, MULT SCLER J, V18, P1251, DOI 10.1177/1352458511435930; Filippi M, 2002, NEUROIMAGE, V15, P559, DOI 10.1006/nimg.2001.1011; FILIPPI M, 2012, J NEUROL, V259, P1; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gelineau-Morel R, 2012, HUM BRAIN MAPP, V33, P2802, DOI 10.1002/hbm.21402; Induruwa I, 2012, J NEUROL SCI, V323, P9, DOI 10.1016/j.jns.2012.08.007; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Krupp LB, 2003, CNS DRUGS, V17, P225, DOI 10.2165/00023210-200317040-00002; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Leavitt VM, 2010, PM&R, V2, P332, DOI 10.1016/j.pmrj.2010.03.027; Leocani L, 2008, NEUROL SCI, V29, pS241, DOI 10.1007/s10072-008-0950-1; Lerdal A, 2007, EUR J NEUROL, V14, P1338, DOI 10.1111/j.1468-1331.2007.01974.x; Marrie RA, 2005, J NEUROL SCI, V228, P161, DOI 10.1016/j.jns.2004.11.046; Okada T, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-14; Pellicano C, 2010, ARCH NEUROL-CHICAGO, V67, P447, DOI 10.1001/archneurol.2010.48; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Riccitelli G, 2011, AM J NEURORADIOL, V32, P874, DOI 10.3174/ajnr.A2412; Rocca MA, 2009, J NEUROL, V256, P470, DOI 10.1007/s00415-009-0116-y; Roosendaal SD, 2009, MULT SCLER, V15, P708, DOI 10.1177/1352458509102907; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Sepulcre J, 2009, MULT SCLER J, V15, P337, DOI 10.1177/1352458508098373; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; van der Werf SP, 1998, J NEUROL SCI, V160, P164, DOI 10.1016/S0022-510X(98)00251-2; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004	40	49	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77914	10.1371/journal.pone.0077914	http://dx.doi.org/10.1371/journal.pone.0077914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167590	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500049
J	Fukuda, T; Sanui, T; Toyoda, K; Tanaka, U; Taketomi, T; Uchiumi, T; Nishimura, F				Fukuda, Takao; Sanui, Terukazu; Toyoda, Kyosuke; Tanaka, Urara; Taketomi, Takaharu; Uchiumi, Takeshi; Nishimura, Fusanori			Identification of Novel Amelogenin-Binding Proteins by Proteomics Analysis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM CHAPERONE; ENAMEL MATRIX PROTEINS; PERIODONTAL TISSUE REGENERATION; EPITHELIAL ROOT SHEATH; OSTEOGENIC DIFFERENTIATION; MESSENGER-RNA; IN-VITRO; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; CELLS	Emdogain (enamel matrix derivative, EMD) is well recognized in periodontology. It is used in periodontal surgery to regenerate cementum, periodontal ligament, and alveolar bone. However, the precise molecular mechanisms underlying periodontal regeneration are still unclear. In this study, we investigated the proteins bound to amelogenin, which are suggested to play a pivotal role in promoting periodontal tissue regeneration. To identify new molecules that interact with amelogenin and are involved in osteoblast activation, we employed coupling affinity chromatography with proteomic analysis in fractionated SaOS-2 osteoblastic cell lysate. In SaOS-2 cells, many of the amelogenin-interacting proteins in the cytoplasm were mainly cytoskeletal proteins and several chaperone molecules of heat shock protein 70 (HSP70) family. On the other hand, the proteomic profiles of amelogenin-interacting proteins in the membrane fraction of the cell extracts were quite different from those of the cytosolic-fraction. They were mainly endoplasmic reticulum (ER)-associated proteins, with lesser quantities of mitochondrial proteins and nucleoprotein. Among the identified amelogenin-interacting proteins, we validated the biological interaction of amelogenin with glucose-regulated protein 78 (Grp78/Bip), which was identified in both cytosolic and membrane-enriched fractions. Confocal co-localization experiment strongly suggested that Grp78/Bip could be an amelogenin receptor candidate. Further biological evaluations were examined by Grp78/Bip knockdown analysis with and without amelogenin. Within the limits of the present study, the interaction of amelogenin with Grp78/Bip contributed to cell proliferation, rather than correlate with the osteogenic differentiation in SaOS-2 cells. Although the biological significance of other interactions are not yet explored, these findings suggest that the differential effects of amelogenin-derived osteoblast activation could be of potential clinical significance for understanding the cellular and molecular bases of amelogenin-induced periodontal tissue regeneration.	[Fukuda, Takao; Sanui, Terukazu; Toyoda, Kyosuke; Tanaka, Urara; Nishimura, Fusanori] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Dept Periodontol, Fukuoka 812, Japan; [Taketomi, Takaharu] Kurume Univ, Sch Med, Dent & Oral Med Ctr, Kurume, Fukuoka 830, Japan; [Uchiumi, Takeshi] Kyushu Univ, Dept Clin Chem & Lab Med, Grad Sch Med Sci, Fukuoka 812, Japan	Kyushu University; Kurume University; Kyushu University	Sanui, T (corresponding author), Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Dept Periodontol, Fukuoka 812, Japan.	sanuteru@dent.kyushu-u.ac.jp			Japan Society for the Promotion of Science [21792124, 23792480]; Grants-in-Aid for Scientific Research [23792480] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Young Scientists (B) (projects 21792124 and 23792480) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin HD, 2013, ACTA BIOMATER, V9, P4796, DOI 10.1016/j.actbio.2012.09.008; Amin HD, 2012, TISSUE ENG PT A, V18, P1193, DOI [10.1089/ten.TEA.2011.0375, 10.1089/ten.tea.2011.0375]; Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Ashizuka M, 2002, MOL CELL BIOL, V22, P6375, DOI 10.1128/MCB.22.18.6375-6383.2002; Beaulieu V, 2005, J BIOL CHEM, V280, P8452, DOI 10.1074/jbc.M412750200; Bosshardt DD, 2004, J CLIN PERIODONTOL, V31, P184, DOI 10.1111/j.0303-6979.2004.00473.x; Chang YJ, 2010, ANN SURG ONCOL, V17, P1703, DOI 10.1245/s10434-010-0912-8; CHEN EH, 1994, DEV DYNAM, V199, P189, DOI 10.1002/aja.1001990304; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Drabek K, 2011, J BONE MINER RES, V26, P2045, DOI 10.1002/jbmr.435; Du C, 2005, J DENT RES, V84, P1070, DOI 10.1177/154405910508401120; Duan XJ, 2011, J CELL PHYSIOL, V226, P150, DOI 10.1002/jcp.22316; Eapen A, 2010, J BIOL CHEM, V285, P36339, DOI 10.1074/jbc.M110.145607; Fukuda T, 2004, NUCLEIC ACIDS RES, V32, P611, DOI 10.1093/nar/gkh223; Gestrelius S, 2000, Clin Oral Investig, V4, P120, DOI 10.1007/s007840050127; Grandin HM, 2012, TISSUE ENG PART B-RE, V18, P181, DOI [10.1089/ten.teb.2011.0365, 10.1089/ten.TEB.2011.0365]; Greene SR, 2002, ARCH ORAL BIOL, V47, P211, DOI 10.1016/S0003-9969(01)00111-X; Gruenbaum-Cohen Y, 2009, J EXP ZOOL PART B, V312B, P445, DOI 10.1002/jez.b.21255; Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P658, DOI 10.1111/j.1600-051X.1997.tb00247.x; Hatakeyama J, 2003, J BIOL CHEM, V278, P35743, DOI 10.1074/jbc.M306284200; Haze A, 2009, J CELL MOL MED, V13, P1110, DOI 10.1111/j.1582-4934.2009.00700.x; Hino S, 2010, J BONE MINER METAB, V28, P131, DOI 10.1007/s00774-009-0117-z; Janones DS, 2005, ARCH ORAL BIOL, V50, P527, DOI 10.1016/j.archoralbio.2004.10.004; Kim J, 2006, AM J GASTROENTEROL, V101, P2051, DOI 10.1111/j.1572-0241.2006.00679.x; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; LYNGSTADAAS SP, 1990, J COMP PHYSIOL B, V160, P469, DOI 10.1007/BF00258973; Miron RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023375; Misra UK, 2005, J IMMUNOL, V175, P2525, DOI 10.4049/jimmunol.175.4.2525; Murakami S, 2011, PERIODONTOL 2000, V56, P188, DOI 10.1111/j.1600-0757.2010.00365.x; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Prakash SK, 2005, CALCIFIED TISSUE INT, V77, P23, DOI 10.1007/s00223-004-1213-7; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Ramseier CA, 2012, PERIODONTOL 2000, V59, P185, DOI 10.1111/j.1600-0757.2011.00432.x; Ravindran S, 2008, J BIOL CHEM, V283, P29658, DOI 10.1074/jbc.M800786200; Ravindran S, 2012, HISTOCHEM CELL BIOL, V138, P113, DOI 10.1007/s00418-012-0952-1; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Saito M, 2012, EXPERT OPIN BIOL TH, V12, P299, DOI 10.1517/14712598.2012.655267; Saldana L, 2011, ACTA BIOMATER, V7, P4210, DOI 10.1016/j.actbio.2011.07.019; Sanui T, 2009, ORAL MICROBIOL IMMUN, V24, P361, DOI 10.1111/j.1399-302X.2009.00523.x; Schwartz Z, 2000, J PERIODONTOL, V71, P1287, DOI 10.1902/jop.2000.71.8.1287; Sculean A, 2008, J CLIN PERIODONTOL, V35, P817, DOI 10.1111/j.1600-051X.2008.01295.x; SENGER DR, 1979, CELL, V16, P885, DOI 10.1016/0092-8674(79)90103-X; Shang SF, 2012, HEPATOLOGY, V55, P483, DOI 10.1002/hep.24703; Shapiro JL, 2007, CELL MOL LIFE SCI, V64, P244, DOI 10.1007/s00018-006-6429-4; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Tanimoto K, 2012, CELLS TISSUES ORGANS, V196, P411, DOI 10.1159/000335912; Tribl F, 2005, MOL CELL PROTEOMICS, V4, P945, DOI 10.1074/mcp.M400117-MCP200; Wang HJ, 2005, J BONE MINER RES, V20, P1032, DOI 10.1359/JBMR.050111; Xiao GQ, 1999, MOL BRAIN RES, V72, P121, DOI 10.1016/S0169-328X(99)00188-6; Xu L, 2008, J BIOCHEM, V144, P531, DOI 10.1093/jb/mvn096; Xu LM, 2006, J BIOL CHEM, V281, P2257, DOI 10.1074/jbc.M507695200; Zeichner-David M, 2003, DEV DYNAM, V228, P651, DOI 10.1002/dvdy.10404; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	56	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78129	10.1371/journal.pone.0078129	http://dx.doi.org/10.1371/journal.pone.0078129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167599	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500059
J	Jennings, BA; Loke, YK; Skinner, J; Keane, M; Chu, GS; Turner, R; Epurescu, D; Barrett, A; Willis, G				Jennings, Barbara A.; Loke, Yoon K.; Skinner, Jane; Keane, Melanie; Chu, Gavin S.; Turner, Richard; Epurescu, Daniel; Barrett, Ann; Willis, Gavin			Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; GENE POLYMORPHISMS; ADJUVANT CHEMOTHERAPY; FUNCTIONAL-ANALYSIS; FOLATE METABOLISM; REPEAT SEQUENCE; SEVERE TOXICITY; RISK-FACTOR; 5-FLUOROURACIL; CAPECITABINE	The potential clinical utility of genetic markers associated with response to fluoropyrimidine treatment in colorectal cancer patients remains controversial despite extensive study. Our aim was to test the clinical validity of both novel and previously identified markers of adverse events in a broad clinical setting. We have conducted an observational pharmacogenetic study of early adverse events in a cohort study of 254 colorectal cancer patients treated with 5-fluorouracil or capecitabine. Sixteen variants of nine key folate (pharmacodynamic) and drug metabolising (pharmacokinetic) enzymes have been analysed as individual markers and/or signatures of markers. We found a significant association between TYMP S471L (rs11479) and early dose modifications and/or severe adverse events (adjusted OR = 2.02 [1.03; 4.00], p = 0.042, adjusted OR = 2.70 [1.23; 5.92], p = 0.01 respectively). There was also a significant association between these phenotypes and a signature of DPYD mutations (Adjusted OR = 3.96 [1.17; 13.33], p = 0.03, adjusted OR = 6.76 [1.99; 22.96], p = 0.002 respectively). We did not identify any significant associations between the individual candidate pharmacodynamic markers and toxicity. If a predictive test for early adverse events analysed the TYMP and DPYD variants as a signature, the sensitivity would be 45.5 %, with a positive predictive value of just 33.9 % and thus poor clinical validity. Most studies to date have been under-powered to consider multiple pharmacokinetic and pharmacodynamic variants simultaneously but this and similar individualised data sets could be pooled in meta-analyses to resolve uncertainties about the potential clinical utility of these markers.	[Jennings, Barbara A.; Loke, Yoon K.; Skinner, Jane] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Keane, Melanie; Chu, Gavin S.; Turner, Richard; Epurescu, Daniel; Barrett, Ann; Willis, Gavin] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England	University of East Anglia; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Jennings, BA (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	b.jennings@uea.ac.uk	Jennings, Barbara/GPG-3869-2022	Jennings, Barbara/0000-0003-3792-9182	H.A. Andrews Memorial Fund; National Institute for Health Research [ACF-2012-07-001] Funding Source: researchfish	H.A. Andrews Memorial Fund; National Institute for Health Research(National Institute for Health Research (NIHR))	The H.A. Andrews Memorial Fund (Oddfellows) funded our sample collection and genotyping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2011, PHARMACOGENOMICS, V12, P1257, DOI [10.2217/PGS.11.83, 10.2217/pgs.11.83]; Afzal S, 2011, CLIN CANCER RES, V17, P3822, DOI 10.1158/1078-0432.CCR-11-0304; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Boisdron-Celle M, 2007, CANCER LETT, V249, P271, DOI 10.1016/j.canlet.2006.09.006; Braun MS, 2009, J CLIN ONCOL, V27, P5519, DOI 10.1200/JCO.2008.21.6283; Caronia D, 2011, CLIN CANCER RES, V17, P2006, DOI 10.1158/1078-0432.CCR-10-1741; Cassidy J, 2002, ANN ONCOL, V13, P566, DOI 10.1093/annonc/mdf089; de Bock CE, 2011, PHARMACOGENOMICS J, V11, P307, DOI 10.1038/tpj.2010.43; Deenen MJ, 2011, CLIN CANCER RES, V17, P3455, DOI 10.1158/1078-0432.CCR-10-2209; Derwinger K, 2009, CLIN COLORECTAL CANC, V8, P43, DOI 10.3816/CCC.2009.n.007; Farina-Sarasqueta A, 2010, CANCER CHEMOTH PHARM, V66, P1167, DOI 10.1007/s00280-010-1403-0; Fernandez-Contreras ME, 2010, ONCOL REP, V23, P1393, DOI 10.3892/or_00000776; Fernandez-Rozadilla C, 2013, PHARMACOGENOMICS J, V13, P209, DOI 10.1038/tpj.2012.2; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gellekink H, 2007, EUR J HUM GENET, V15, P103, DOI 10.1038/sj.ejhg.5201713; Glimelius B, 2011, PHARMACOGENOMICS J, V11, P61, DOI 10.1038/tpj.2010.10; Goodwin Rachel A, 2009, Clin Colon Rectal Surg, V22, P251, DOI 10.1055/s-0029-1242465; Gusella M, 2009, BRIT J CANCER, V100, P1549, DOI 10.1038/sj.bjc.6605052; Hitre E, 2005, PHARMACOGENET GENOM, V15, P723, DOI 10.1097/01.fpc.0000175598.42141.59; HORIE N, 1995, CELL STRUCT FUNCT, V20, P191, DOI 10.1247/csf.20.191; Ichikawa W, 2006, CLIN CANCER RES, V12, P3928, DOI 10.1158/1078-0432.CCR-05-2665; Jennings BA, 2012, PHARMACOGENET GENOM, V22, P290, DOI 10.1097/FPC.0b013e328351875d; Johnson WG, 2005, AM J CLIN NUTR, V81, P664; KANEDA S, 1987, NUCLEIC ACIDS RES, V15, P1259, DOI 10.1093/nar/15.3.1259; Kawakami K, 2001, CLIN CANCER RES, V7, P4096; Kawakami K, 2003, CANCER RES, V63, P6004; Loganayagam A, 2010, CANCER CHEMOTH PHARM, V65, P403, DOI 10.1007/s00280-009-1147-x; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Mandola MV, 2004, PHARMACOGENETICS, V14, P319, DOI 10.1097/00008571-200405000-00007; Mandola MV, 2003, CANCER RES, V63, P2898; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; PETER L, 1999, AM J MED GENET, V86, P380, DOI DOI 10.1002/(SICI)1096-8628(19991008)86:4<380::AID-AJMG13>3.0.CO;2-9; Pullmann R, 2006, J BIOL CHEM, V281, P23456, DOI 10.1074/jbc.M600282200; Ruzzo A, 2008, PHARMACOGENOMICS J, V8, P278, DOI 10.1038/sj.tpj.6500463; Ruzzo A, 2007, J CLIN ONCOL, V25, P1247, DOI 10.1200/JCO.2006.08.1844; Scartozzi M, 2011, PHARMACOGENOMICS, V12, P251, DOI 10.2217/PGS.10.167; SCHEITHAUER W, 1993, BRIT MED J, V306, P752, DOI 10.1136/bmj.306.6880.752; Schwab M, 2008, J CLIN ONCOL, V26, P2131, DOI 10.1200/JCO.2006.10.4182; Sharp L, 2004, AM J EPIDEMIOL, V159, P423, DOI 10.1093/aje/kwh066; Sulzyc-Bielicka V, 2008, PHARMACOL REP, V60, P238; Taflin H, 2011, ANTICANCER RES, V31, P3057; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P237, DOI 10.1097/FPC.0b013e32833c6107; Van Cutsem E, 2001, J CLIN ONCOL, V19, P4097, DOI 10.1200/JCO.2001.19.21.4097; Vignoli M, 2011, PHARMACOL RES, V64, P242, DOI 10.1016/j.phrs.2011.04.006; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Willis G, 2002, RHEUMATOLOGY, V41, P176, DOI 10.1093/rheumatology/41.2.176; Yawata A, 2005, CANCER CHEMOTH PHARM, V56, P465, DOI 10.1007/s00280-005-1018-z; Zaniboni A, 1997, J CLIN ONCOL, V15, P2432, DOI 10.1200/JCO.1997.15.6.2432; Zhang CY, 2012, ONCOL LETT, V3, P831, DOI 10.3892/ol.2012.567	49	26	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78053	10.1371/journal.pone.0078053	http://dx.doi.org/10.1371/journal.pone.0078053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167597	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000326034500057
J	Ku, YS; Koo, NSC; Li, FWY; Li, MW; Wang, HM; Tsai, SN; Sun, F; Lim, BL; Ko, WH; Lam, HM				Ku, Yee-Shan; Koo, Nicolas Siu-Chung; Li, Francisca Wing-Yen; Li, Man-Wah; Wang, Hongmei; Tsai, Sau-Na; Sun, Feng; Lim, Boon Leong; Ko, Wing-Hung; Lam, Hon-Ming			GmSAL1 Hydrolyzes Inositol-1,4,5-Trisphosphate and Regulates Stomatal Closure in Detached Leaves and Ion Compartmentalization in Plant Cells	PLOS ONE			English	Article							INOSITOL POLYPHOSPHATE 1-PHOSPHATASE; TOBACCO NICOTIANA-TABACUM; TIME RT-PCR; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; SALT TOLERANCE; MOLECULAR CHARACTERIZATION; NEGATIVE REGULATOR; PHYTASE ACTIVITY; K+ CHANNELS	Inositol polyphosphatases are important regulators since they control the catabolism of phosphoinositol derivatives, which are often signaling molecules for cellular processes. Here we report on the characterization of one of their members in soybean, GmSAL1. In contrast to the substrate specificity of its Arabidopsis homologues (AtSAL1 and AtSAL2), GmSAL1 only hydrolyzes inositol-1,4,5-trisphosphate (IP3) but not inositol-1,3,4-trisphosphate or inositol-1,4-bisphosphate. The ectopic expression of GmSAL1 in transgenic Arabidopsis thaliana led to a reduction in IP3 signals, which was inferred from the reduction in the cytoplasmic signals of the in vivo biomarker pleckstrin homology domain-green florescent protein fusion protein and the suppression of abscisic acid-induced stomatal closure. At the cellular level, the ectopic expression of GmSAL1 in transgenic BY-2 cells enhanced vacuolar Na+ compartmentalization and therefore could partially alleviate salinity stress.	[Ku, Yee-Shan; Koo, Nicolas Siu-Chung; Li, Francisca Wing-Yen; Li, Man-Wah; Wang, Hongmei; Tsai, Sau-Na; Lam, Hon-Ming] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Ctr Soybean Res, Shatin, Hong Kong, Peoples R China; [Ku, Yee-Shan; Koo, Nicolas Siu-Chung; Li, Francisca Wing-Yen; Li, Man-Wah; Wang, Hongmei; Tsai, Sau-Na; Lam, Hon-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Sun, Feng; Lim, Boon Leong] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Ko, Wing-Hung] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong	Lam, HM (corresponding author), Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Ctr Soybean Res, Shatin, Hong Kong, Peoples R China.	honming@cuhk.edu.hk	Lam, Hon-Ming/A-9866-2008; Ko, Hung/R-1802-2018; Li, Man-Wah/AAZ-5724-2021; Li, Man-Wah/AAZ-5631-2021; Ku, Yee-Shan/ABZ-5538-2022; Lim, Boon Leong/D-3104-2009	Lam, Hon-Ming/0000-0002-6673-8740; Ko, Hung/0000-0002-2041-402X; Li, Man-Wah/0000-0003-4859-5683; Ku, Yee-Shan/0000-0002-9587-5648; Lim, Boon Leong/0000-0002-2720-2353	Hong Kong Research Grants Council General Research Fund [468409]; Lo Kwee-Seong Biomedical Research Fund; Lee Hysan Foundation	Hong Kong Research Grants Council General Research Fund(Hong Kong Research Grants Council); Lo Kwee-Seong Biomedical Research Fund; Lee Hysan Foundation	Sources of funding: Hong Kong Research Grants Council General Research Fund (Grant no. 468409), Lo Kwee-Seong Biomedical Research Fund, and Lee Hysan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; AN GH, 1985, PLANT PHYSIOL, V79, P568, DOI 10.1104/pp.79.2.568; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Assmann S. M., 2010, PLANT HORMONES BIOSY, P399; ATACK JR, 1995, FEBS LETT, V361, P1, DOI 10.1016/0014-5793(95)00063-F; Bechtold N, 1993, ARABIDOPSIS PROTOCOL, P259; Berdy SE, 2001, PLANT PHYSIOL, V126, P801, DOI 10.1104/pp.126.2.801; Berridge MJ, 1995, ANN NY ACAD SCI, V766, P31, DOI 10.1111/j.1749-6632.1995.tb26646.x; BLATT MR, 1990, NATURE, V346, P766, DOI 10.1038/346766a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREARS T, 1993, PLANT PHYSIOL, V103, P1285, DOI 10.1104/pp.103.4.1285; Burnette RN, 2003, PLANT PHYSIOL, V132, P1011, DOI 10.1104/pp.019000; Chen H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026661, 10.1093/ecam/neq002]; Cheung MY, 2008, NEW PHYTOL, V179, P530, DOI 10.1111/j.1469-8137.2008.02473.x; CHEUNG MY, 2013, PLANT CELL IN PRESS; DeWald DB, 2001, PLANT PHYSIOL, V126, P759, DOI 10.1104/pp.126.2.759; Ercetin ME, 2004, PLANT PHYSIOL, V135, P938, DOI 10.1104/pp.104.040253; Gil-Mascarell R, 1999, PLANT J, V17, P373, DOI 10.1046/j.1365-313X.1999.00385.x; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; INOUE H, 1985, PLANT PHYSIOL, V79, P389, DOI 10.1104/pp.79.2.389; Jiang XY, 2010, PLANT SIGNAL BEHAV, V5, P792, DOI 10.4161/psb.5.7.11767; Kader MA, 2010, PLANT SIGNAL BEHAV, V5, P233, DOI 10.4161/psb.5.3.10740; Kaur N, 2005, CURR SCI INDIA, V88, P1771; Kaye Y, 2011, PLANT PHYSIOL, V157, P229, DOI 10.1104/pp.111.176883; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kuang RB, 2009, PLANT PHYSIOL, V151, P199, DOI 10.1104/pp.109.143180; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Li WYF, 2008, NEW PHYTOL, V178, P80, DOI 10.1111/j.1469-8137.2007.02356.x; Li WYF, 2006, PLANT CELL ENVIRON, V29, P1122, DOI 10.1111/j.1365-3040.2005.01487.x; Lung SC, 2008, PHYTOCHEMISTRY, V69, P365, DOI 10.1016/j.phytochem.2007.06.036; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Moore DD, 1995, GLOB MOB SURV; MORAN R, 1980, PLANT PHYSIOL, V65, P478, DOI 10.1104/pp.65.3.478; MORAN R, 1982, PLANT PHYSIOL, V69, P1376, DOI 10.1104/pp.69.6.1376; Munnik T, 2010, PLANT CELL ENVIRON, V33, P655, DOI 10.1111/j.1365-3040.2009.02097.x; Murguia JR, 1996, J BIOL CHEM, V271, P29029, DOI 10.1074/jbc.271.46.29029; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; NAGATA T, 1981, MOL GEN GENET, V184, P161, DOI 10.1007/BF00272899; Pilot G, 2001, J BIOL CHEM, V276, P3215, DOI 10.1074/jbc.M007303200; Quintero FJ, 1996, PLANT CELL, V8, P529, DOI 10.1105/tpc.8.3.529; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez JP, 2001, PLANT CELL, V13, P1143, DOI 10.1105/tpc.13.5.1143; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; SCHROEDER JI, 1987, P NATL ACAD SCI USA, V84, P4108, DOI 10.1073/pnas.84.12.4108; SmolenskaSym G, 1996, PHYSIOL PLANTARUM, V96, P692, DOI 10.1111/j.1399-3054.1996.tb00244.x; Sukumvanich P, 2004, CELL MOTIL CYTOSKEL, V59, P141, DOI 10.1002/cm.20030; Tang RH, 2007, SCIENCE, V315, P1423, DOI 10.1126/science.1134457; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wilson PB, 2009, PLANT J, V58, P299, DOI 10.1111/j.1365-313X.2008.03780.x; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; Zhang HX, 2001, P NATL ACAD SCI USA, V98, P12832, DOI 10.1073/pnas.231476498; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	55	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78181	10.1371/journal.pone.0078181	http://dx.doi.org/10.1371/journal.pone.0078181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167607	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500067
J	Nacoulma, AP; Megalizzi, V; Pottier, LR; De Lorenzi, M; Thoret, S; Dubois, J; Vandeputte, OM; Duez, P; Vereecke, D; El Jaziri, M				Nacoulma, Aminata P.; Megalizzi, Veronique; Pottier, Laurent R.; De Lorenzi, Manuela; Thoret, Sylviane; Dubois, Joelle; Vandeputte, Olivier M.; Duez, Pierre; Vereecke, Danny; El Jaziri, Mondher			Potent Antiproliferative Cembrenoids Accumulate in Tobacco upon Infection with Rhodococcus fascians and Trigger Unusual Microtubule Dynamics in Human Glioblastoma Cells	PLOS ONE			English	Article							NICOTIANA-TABACUM; IN-VITRO; TUBULIN; POLYMERIZATION; INHIBITION; COLCHICINE; TRICHOMES; EXTRACTS; CANCER; DEATH	Aims: Though plant metabolic changes are known to occur during interactions with bacteria, these were rarely challenged for pharmacologically active compounds suitable for further drug development. Here, the occurrence of specific chemicals with antiproliferative activity against human cancer cell lines was evidenced in hyperplasia (leafy galls) induced when plants interact with particular phytopathogens, such as the Actinomycete Rhodococcus fascians. Methods: We examined leafy galls fraction F3.1.1 on cell proliferation, cell division and cytoskeletal disorganization of human cancer cell lines using time-lapse videomicroscopy imaging, combined with flow cytometry and immunofluorescence analysis. We determined the F3.1.1-fraction composition by gas chromatography coupled to mass spectrometry. Results: The leafy galls induced on tobacco by R. fascians yielded fraction F3.1.1 which inhibited proliferation of glioblastoma U373 cells with an IC50 of 4.5 mu g/mL, F.3.1.1 was shown to increase cell division duration, cause nuclear morphological deformations and cell enlargement, and, at higher concentrations, karyokinesis defects leading to polyploidization and apoptosis. F3.1.1 consisted of a mixture of isomers belonging to the cembrenoids. The cellular defects induced by F3.1.1 were caused by a peculiar cytoskeletal disorganization, with the occurrence of fragmented tubulin and strongly organized microtubule aggregates within the same cell. Colchicine, paclitaxel, and cembrene also affected U373 cell proliferation and karyokinesis, but the induced microtubule rearrangement was very different from that provoked by F3.1.1. Altogether our data indicate that the cembrenoid isomers in F3.1.1 have a unique mode of action and are able to simultaneously modulate microtubule polymerization and stability.	[Nacoulma, Aminata P.; Megalizzi, Veronique; De Lorenzi, Manuela] Univ Libre Brussels, Fac Pharm, Toxicol Lab, Brussels, Belgium; [Pottier, Laurent R.; Duez, Pierre] Univ Libre Brussels, Fac Pharm, Lab Pharmacognosie Bromatol & Nutr Humaine, Brussels, Belgium; [Thoret, Sylviane; Dubois, Joelle] Ctr Natl Rech Sci, Inst Chim Subst Nat, Unite PR 2301, Gif Sur Yvette, France; [Vandeputte, Olivier M.; El Jaziri, Mondher] Univ Libre Brussels, Fac Sci, Lab Biotechnol Vegetale, Gosselies, Belgium; [Vereecke, Danny] Univ Ghent, Univ Coll Ghent, Dept Plant Prod, B-9000 Ghent, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); Ghent University; HOGENT University College of Applied Sciences & Arts	Megalizzi, V (corresponding author), Univ Libre Brussels, Fac Pharm, Toxicol Lab, Brussels, Belgium.	vmegaliz@ulb.ac.be		Duez, Pierre/0000-0002-0484-1478; El Jaziri, Mondher/0000-0001-5787-6319	Belgian National Fund for Scientific Research (FNRS) [FRFC 2.4.593.09]	Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS)	O.M.V. is a post-doctoral researcher of the F.R.S.-F.N.R.S. (Fonds de la Recherche Scientifique, Belgium). The authors gratefully thank the Belgian National Fund for Scientific Research (FNRS) (FRFC 2.4.593.09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraka HN, 2011, PLANTA MED, V77, P467, DOI 10.1055/s-0030-1250478; Bekier ME, 2009, MOL CANCER THER, V8, P1646, DOI 10.1158/1535-7163.MCT-08-1084; Bhattacharyya B, 2010, METHOD CELL BIOL, V95, P301, DOI 10.1016/S0091-679X(10)95017-6; Bombuwala K, 2006, BEILSTEIN J ORG CHEM, V2, DOI 10.1186/1860-5397-2-13; Bury M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.85; Capo-Chichi CD, 2009, MOL CELL BIOL, V29, P4766, DOI 10.1128/MCB.00087-09; Clarke SJ, 1999, CLIN PHARMACOKINET, V36, P99, DOI 10.2165/00003088-199936020-00002; Cui H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-76; Debeir O, 2008, EXP CELL RES, V314, P2985, DOI 10.1016/j.yexcr.2008.06.010; Forizs L, 2009, CURR MICROBIOL, V58, P483, DOI 10.1007/s00284-008-9352-0; GUO ZH, 1995, PLANT SCI, V110, P1, DOI 10.1016/0168-9452(95)04174-S; Hamm S, 2005, PHYTOCHEMISTRY, V66, P1499, DOI 10.1016/j.phytochem.2005.04.025; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; KEATES RAB, 1981, CAN J BIOCHEM CELL B, V59, P361, DOI 10.1139/o81-050; Kwiatkowski N, 2012, ACS CHEM BIOL, V7, P185, DOI 10.1021/cb200305u; Lin KL, 2011, CHEM-BIOL INTERACT, V194, P148, DOI 10.1016/j.cbi.2011.10.002; Megalizzi V, 2011, THESIS U LIBRE BRUXE; Moussaieff A, 2008, J CEREBR BLOOD F MET, V28, P1341, DOI 10.1038/jcbfm.2008.28; Nacoulma AP, 2013, INT J MOL SCI, V14, P12533, DOI 10.3390/ijms140612533; Nacoulma AP, 2012, J PHYTOPATHOL, V160, P617, DOI 10.1111/j.1439-0434.2012.01953.x; Rajaonson S, 2011, ENVIRON MICROBIOL, V13, P1236, DOI 10.1111/j.1462-2920.2011.02424.x; Stes E, 2011, ANNU REV PHYTOPATHOL, V49, P69, DOI 10.1146/annurev-phyto-072910-095217; Villanueva HE, 2010, REC NAT PROD, V4, P115; WAHLBERG I, 1987, NAT PROD REP, V4, P237, DOI 10.1039/np9870400237; ZAVALA F, 1980, J MED CHEM, V23, P546, DOI 10.1021/jm00179a014	25	7	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77529	10.1371/journal.pone.0077529	http://dx.doi.org/10.1371/journal.pone.0077529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167576	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500035
J	Falagas, ME; Karageorgopoulos, DE; Tansarli, GS				Falagas, Matthew E.; Karageorgopoulos, Drosos E.; Tansarli, Giannoula S.			Continuous versus Conventional Infusion of Amphotericin B Deoxycholate: A Meta-Analysis	PLOS ONE			English	Article							ANTIFUNGAL PHARMACODYNAMIC CHARACTERISTICS; FUNGAL-INFECTIONS; CRYPTOCOCCAL MENINGITIS; CANDIDA-ALBICANS; CANCER-PATIENTS; RISK-FACTORS; TRIAL; PHARMACOKINETICS; NEPHROTOXICITY; FLUCONAZOLE	Background: Treatment with Amphotericin B (AmB) deoxycholate, which is still used widely, particularly in low-resource countries, has been challenged due to nephrotoxicity. We sought to study whether continuous infusion of AmB deoxycholate reduces nephrotoxicity retaining, however, the effectiveness of the drug. Methods: PubMed and Scopus databases were systematically searched to identify studies comparing the outcomes of patients receiving 24-h infusion of AmB ("continuous group") and those receiving 2-6-h infusion of AmB ("conventional group"). Nephrotoxicity and all-cause mortality were the primary outcomes of the review, while treatment failure was the secondary outcome. Results: Five studies met the inclusion criteria; one randomized controlled trial, two prospective cohort studies, and two retrospective cohort studies. The majority of patients were neutropenic with an underlying hematologic malignancy. All 5 studies (392 patients) provided data regarding the development of nephrotoxicity. A non-significant trend towards lower nephrotoxicity was observed for patients receiving continuous infusion of AmB compared with those receiving conventional infusion [RR = 0.61 (95% CI 0.36, 1.02)]. Four studies (365 patients) provided data regarding mortality; no relevant difference was detected between patients receiving continuous and those receiving conventional infusion of AmB [RR = 0.81 (95% CI 0.36, 1.83)]. Data on treatment failure of the two methods of administration was insufficient for meaningful conclusions. Conclusion: The available evidence from mainly non-randomized studies suggests that continuous infusion of AmB deoxycholate might offer an advantage over the conventional infusion regarding the development of nephrotoxicity, without compromising patient survival. Further randomized studies are needed to investigate this issue.	[Falagas, Matthew E.; Karageorgopoulos, Drosos E.; Tansarli, Giannoula S.] Alfa Inst Biomed Sci, Athens, Greece; [Falagas, Matthew E.] Mitera Hosp, Dept Internal Med Infect Dis, Hygeia Grp, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; Tufts University	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr	Karageorgopoulos, Drosos/K-9241-2018	Karageorgopoulos, Drosos/0000-0002-9959-9978				Altmannsberger P, 2007, J ANTIMICROB CHEMOTH, V60, P180, DOI 10.1093/jac/dkm147; Bekersky I, 2002, ANTIMICROB AGENTS CH, V46, P834, DOI 10.1128/AAC.46.3.834-840.2002; Bicanic T, 2008, CLIN INFECT DIS, V47, P123, DOI 10.1086/588792; CHABOT GG, 1989, J PHARM SCI, V78, P307, DOI 10.1002/jps.2600780409; COLLETTE N, 1989, ANTIMICROB AGENTS CH, V33, P362, DOI 10.1128/AAC.33.3.362; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Denning DW, 2002, J ANTIMICROB CHEMOTH, V49, P889, DOI 10.1093/jac/dkf045; ELLIS ME, 1992, ANTIMICROB AGENTS CH, V36, P172, DOI 10.1128/AAC.36.1.172; Eriksson U, 2001, BMJ-BRIT MED J, V322, P579, DOI 10.1136/bmj.322.7286.579; Falagas ME, 2006, EUR J CLIN MICROBIOL, V25, P419, DOI 10.1007/s10096-006-0159-2; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P136, DOI 10.1016/j.ijantimicag.2006.09.018; Falagas ME, 2013, CLIN INFECT DIS, V56, P272, DOI 10.1093/cid/cis857; Fisher JF, 2011, CLIN INFECT DIS, V52, pS457, DOI 10.1093/cid/cir112; Furrer K, 2002, SWISS MED WKLY, V132, P316; Girois SB, 2005, EUR J CLIN MICROBIOL, V24, P119, DOI 10.1007/s10096-005-1281-2; Groll AH, 2000, J INFECT DIS, V182, P274, DOI 10.1086/315643; Imhof A, 2003, CLIN INFECT DIS, V36, P943, DOI 10.1086/368312; Johnson PC, 2002, ANN INTERN MED, V137, P105, DOI 10.7326/0003-4819-137-2-200207160-00008; Klepser ME, 1998, J ANTIMICROB CHEMOTH, V41, P397, DOI 10.1093/jac/41.3.397; Klepser ME, 1997, ANTIMICROB AGENTS CH, V41, P1392, DOI 10.1128/AAC.41.6.1392; Lewis RE, 2003, CLIN INFECT DIS, V37, P871, DOI 10.1086/377279; Maertens JA, 2004, CLIN MICROBIOL INFEC, V10, P1, DOI 10.1111/j.1470-9465.2004.00841.x; Maharom Pasri, 2006, J Med Assoc Thai, V89 Suppl 5, pS118; Maschmeyer G, 2002, J ANTIMICROB CHEMOTH, V49, P239, DOI 10.1093/jac/49.2.239; OLDFIELD EC, 1990, ANTIMICROB AGENTS CH, V34, P1402, DOI 10.1128/AAC.34.7.1402; Peleg AY, 2004, J ANTIMICROB CHEMOTH, V54, P803, DOI 10.1093/jac/dkh403; SABRA R, 1990, DRUG SAFETY, V5, P94, DOI 10.2165/00002018-199005020-00003; Schulenburg A, 2005, LEUKEMIA LYMPHOMA, V46, P1163, DOI 10.1080/10428190500085214; Sloan DJ, 2009, CURR OPIN INFECT DIS, V22, P455, DOI 10.1097/QCO.0b013e32832fa214; Uehara Roberto Palermo, 2005, Sao Paulo Med. J., V123, P219, DOI 10.1590/S1516-31802005000500004; Vardakas KZ, 2009, CLIN MICROBIOL INFEC, V15, P289, DOI 10.1111/j.1469-0691.2008.02653.x; Voss A, 1997, INFECTION, V25, P8, DOI 10.1007/BF02113499	32	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77075	10.1371/journal.pone.0077075	http://dx.doi.org/10.1371/journal.pone.0077075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204739	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600020
J	Figlerowicz, M; Urbanowicz, A; Lewandowski, D; Jodynis-Liebert, J; Sadowski, C				Figlerowicz, Marek; Urbanowicz, Anna; Lewandowski, Dominik; Jodynis-Liebert, Jadwiga; Sadowski, Czeslaw			Functional Insights into Recombinant TROSPA Protein from Ixodes ricinus	PLOS ONE			English	Article							TICK-BORNE PATHOGENS; BORRELIA-BURGDORFERI; LYME BORRELIOSIS; OSPA-TYPES; SCAPULARIS; VECTOR; IDENTIFICATION; POLAND	Lyme disease (also called borreliosis) is a prevalent chronic disease transmitted by ticks and caused by Borrelia burgdorferi s. l. spirochete. At least one tick protein, namely TROSPA from I. scapularis, commonly occurring in the USA, was shown to be required for colonization of the vector by bacteria. Located in the tick gut, TROSPA interacts with the spirochete outer surface protein A (OspA) and initiates the tick colonization. Ixodes ricinus is a primary vector involved in B. burgdorferi s. l. transmission in most European countries. In this study, we characterized the capacities of recombinant TROSPA protein from I. ricinus to interact with OspA from different Borrelia species and to induce an immune response in animals. We also showed that the N-terminal part of TROSPA (a putative transmembrane domain) is not involved in the interaction with OspA and that reduction of the total negative charge on the TROSPA protein impaired TROSPA-OspA binding. In general, the data presented in this paper indicate that recombinant TROSPA protein retains the capacity to form a complex with OspA and induces a significant level of IgG in orally immunized rats. Thus, I. ricinus TROSPA may be considered a good candidate component for an animal vaccine against Borrelia.	[Figlerowicz, Marek; Urbanowicz, Anna; Lewandowski, Dominik] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Jodynis-Liebert, Jadwiga; Sadowski, Czeslaw] Poznan Univ Med Sci, Dept Toxicol, Poznan, Poland; [Figlerowicz, Marek] Poznan Univ Tech, Inst Comp Sci, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Poznan University of Medical Sciences; Poznan University of Technology	Figlerowicz, M (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.	Marek.Figlerowicz@ibch.poznan.pl	Urbanowicz, Anna/C-9550-2016; Figlerowicz, Marek/B-9550-2015	Urbanowicz, Anna/0000-0002-6854-7737; Figlerowicz, Marek/0000-0002-6392-0192; Jodynis-Liebert, Jadwiga/0000-0002-5008-4877; Lewandowski, Dominik/0000-0002-2233-5501	European Union; Polish Government [N N302 041536]; European Regional Development Fund under the Operational Programme Innovative Economy - Grants for innovation	European Union(European Commission); Polish Government; European Regional Development Fund under the Operational Programme Innovative Economy - Grants for innovation	The research described in this work was co-funded by European Union within European Regional Development Fund through MPD programme and by the Polish Government through grant N N302 041536. The publication costs were covered by the European Regional Development Fund under the Operational Programme Innovative Economy - Grants for innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2006, NATURE, V439, P524, DOI 10.1038/439524a; Capelli G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-61; Chmielewska-Badora J, 2012, ANN AGR ENV MED, V19, P271; Devriendt B, 2012, J CONTROL RELEASE, V160, P431, DOI 10.1016/j.jconrel.2012.02.006; Earnhart CG, 2007, VACCINE, V25, P466, DOI 10.1016/j.vaccine.2006.07.052; Egelkrout E, 2012, PLANT SCI, V184, P83, DOI 10.1016/j.plantsci.2011.12.005; Eisen L, 2002, VECTORS BORRELIA BUR, P91; Franke J, 2013, TICKS TICK-BORNE DIS, V4, P11, DOI 10.1016/j.ttbdis.2012.06.007; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Hamer SA, 2007, EMERG INFECT DIS, V13, P1131, DOI 10.3201/eid1307.070046; Hamer SA, 2010, ECOHEALTH, V7, P47, DOI 10.1007/s10393-010-0287-0; HURKMAN WJ, 1986, PLANT PHYSIOL, V81, P802, DOI 10.1104/pp.81.3.802; Konnai S, 2012, TICKS TICK-BORNE DIS, V3, P75, DOI 10.1016/j.ttbdis.2012.02.001; Kung F, 2013, FUTURE MICROBIOL, V8, P41, DOI [10.2217/FMB.12.121, 10.2217/fmb.12.121]; Lencakova D, 2006, INT J MED MICROBIOL, V296, P108, DOI 10.1016/j.ijmm.2005.12.012; Michel H, 2004, MED MICROBIOL IMMUN, V193, P219, DOI 10.1007/s00430-003-0196-8; Paduraru OA, 2012, EMERG INFECT DIS, V18, P2089, DOI 10.3201/eid1812.120711; Pal U, 2000, J CLIN INVEST, V106, P561, DOI 10.1172/JCI9427; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Rar VA, 2005, EMERG INFECT DIS, V11, P1708, DOI 10.3201/eid1111.041195; Saluja V, 2010, EUR J PHARM BIOPHARM, V76, P470, DOI 10.1016/j.ejpb.2010.08.003; Sambrook J, 2001, PROT 3; Schuijt TJ, 2011, TRENDS PARASITOL, V27, P40, DOI 10.1016/j.pt.2010.06.006; Scott JD, 2012, J PARASITOL, V98, P49, DOI 10.1645/GE-2874.1; Welc-Faleciak R, 2010, ANN AGR ENV MED, V17, P309	25	12	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76848	10.1371/journal.pone.0076848	http://dx.doi.org/10.1371/journal.pone.0076848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204685	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300054
J	Kuramoto, L; Cragg, J; Nandhagopal, R; Mak, E; Sossi, V; de la Fuente-Fernandez, R; Stoessl, AJ; Schulzer, M				Kuramoto, Lisa; Cragg, Jacquelyn; Nandhagopal, Ramachandiran; Mak, Edwin; Sossi, Vesna; de la Fuente-Fernandez, Raul; Stoessl, A. Jon; Schulzer, Michael			The Nature of Progression in Parkinson's Disease: An Application of Non-Linear, Multivariate, Longitudinal Random Effects Modelling	PLOS ONE			English	Article							COMPENSATORY CHANGES; IMPACT	Background: To date, statistical methods that take into account fully the non-linear, longitudinal and multivariate aspects of clinical data have not been applied to the study of progression in Parkinson's disease (PD). In this paper, we demonstrate the usefulness of such methodology for studying the temporal and spatial aspects of the progression of PD. Extending this methodology further, we also explore the presymptomatic course of this disease. Methods: Longitudinal Positron Emission Tomography (PET) measurements were collected on 78 PD patients, from 4 subregions on each side of the brain, using 3 different radiotracers. Non-linear, multivariate, longitudinal random effects modelling was applied to analyze and interpret these data. Results: The data showed a non-linear decline in PET measurements, which we modelled successfully by an exponential function depending on two patient-related covariates duration since symptom onset and age at symptom onset. We found that the degree of damage was significantly greater in the posterior putamen than in the anterior putamen throughout the disease. We also found that over the course of the illness, the difference between the less affected and more affected sides of the brain decreased in the anterior putamen. Younger patients had significantly poorer measurements than older patients at the time of symptom onset suggesting more effective compensatory mechanisms delaying the onset of symptoms. Cautious extrapolation showed that disease onset had occurred some 8 to 17 years prior to symptom onset. Conclusions: Our model provides important biological insights into the pathogenesis of PD, as well as its preclinical aspects. Our methodology can be applied widely to study many other chronic progressive diseases.	[Kuramoto, Lisa; Schulzer, Michael] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Cragg, Jacquelyn; Nandhagopal, Ramachandiran; Mak, Edwin; de la Fuente-Fernandez, Raul; Stoessl, A. Jon; Schulzer, Michael] Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Sossi, Vesna] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada	Vancouver Coastal Health Research Institute; University of British Columbia; University of British Columbia	Kuramoto, L (corresponding author), Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada.	lisa.kuramoto@ubc.ca	Stoessl, A Jon/J-9661-2015	Stoessl, A Jon/0000-0002-9778-7246; Ramachandiran, Nandhagopal/0000-0002-2379-0055	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; Canada Research Chairs; James A. Moore Chair in Parkinson's Research; Pacific Parkinson's Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Research Chairs(Canada Research ChairsCGIAR); James A. Moore Chair in Parkinson's Research; Pacific Parkinson's Research Institute	The authors gratefully acknowledge financial support from the Canadian Institutes of Health Research for funding operating costs of studies and infrastructure (PET, statistics), the Michael Smith Foundation for Health Research for infrastructure support (imaging, statistics) and salary support (VS), Canada Research Chairs for salary support (AJS), James A. Moore Chair in Parkinson's Research for salary support (RFF), and the Pacific Parkinson's Research Institute for infrastructure support for research operations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Jr, 2005, BRAIN, V128, P2777, DOI 10.1093/brain/awh607; Armitage P, 1998, ENCY BIOSTATISTICS C, P1125; Au WL, 2005, MOL BRAIN RES, V134, P24, DOI 10.1016/j.molbrainres.2004.09.028; Brent R. P., 1973, ALGORITHMS MINIMIZAT; Brooks DJ, 2003, EXP NEUROL, V184, pS68, DOI 10.1016/j.expneurol.2003.08.008; Bruck A, 2006, MOVEMENT DISORD, V21, P958, DOI 10.1002/mds.20855; Davidian M., 1995, NONLINEAR MODELS REP; de la Fuente-Fernandez R, 2011, ANN NEUROL, V69, P803, DOI 10.1002/ana.22284; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Fleiss J.L., 2013, STAT METHODS RATES P; Hilker R, 2005, ARCH NEUROL-CHICAGO, V62, P378, DOI 10.1001/archneur.62.3.378; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Huang CR, 2007, BRAIN, V130, P1834, DOI 10.1093/brain/awm086; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lee CS, 2004, ARCH NEUROL-CHICAGO, V61, P1920, DOI 10.1001/archneur.61.12.1920; Lee CS, 2000, ANN NEUROL, V47, P493, DOI 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Marshall G, 2006, STAT MED, V25, P2817, DOI 10.1002/sim.2361; Morrish PK, 1998, J NEUROL NEUROSUR PS, V64, P314, DOI 10.1136/jnnp.64.3.314; Morrish PK, 1996, BRAIN, V119, P585, DOI 10.1093/brain/119.2.585; Nandhagopal R, 2008, NEUROLOGY, V70, P1478, DOI 10.1212/01.wnl.0000310432.92489.90; Nandhagopal R, 2009, BRAIN, V132, P2970, DOI 10.1093/brain/awp209; Nandhagopal R, 2011, BRAIN, V134, P3290, DOI 10.1093/brain/awr233; R Development Core Team, 2006, R LANG ENV STAT COMP; Ratkowsky D.A, 1990, HDB NONLINEAR REGRES; Rubenstein LM, 1997, PHARMACOECONOMICS, V12, P486, DOI 10.2165/00019053-199712040-00006; Scheife RT, 2000, AM J HEALTH-SYST PH, V57, P953, DOI 10.1093/ajhp/57.10.953; Schwarz J, 2004, J NUCL MED, V45, P1694; SPINKS TJ, 1992, PHYS MED BIOL, V37, P1637, DOI 10.1088/0031-9155/37/8/002	30	27	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76595	10.1371/journal.pone.0076595	http://dx.doi.org/10.1371/journal.pone.0076595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204641	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300038
J	Lin, C; Katanaev, VL				Lin, Chen; Katanaev, Vladimir L.			Kermit Interacts with G alpha o, Vang, and Motor Proteins in Drosophila Planar Cell Polarity	PLOS ONE			English	Article							TRIMERIC G-PROTEIN; ASYMMETRIC LOCALIZATION; TISSUE POLARITY; RAT FRIZZLED-1; MORPHOGENESIS; PRICKLE; GENES; IDENTIFICATION; REGULATORS; MUTATIONS	In addition to the ubiquitous apical-basal polarity, epithelial cells are often polarized within the plane of the tissue - the phenomenon known as planar cell polarity (PCP). In Drosophila, manifestations of PCP are visible in the eye, wing, and cuticle. Several components of the PCP signaling have been characterized in flies and vertebrates, including the heterotrimeric Go protein. However, Go signaling partners in PCP remain largely unknown. Using a genetic screen we uncover Kermit, previously implicated in G protein and PCP signaling, as a novel binding partner of Go. Through pull-down and genetic interaction studies, we find that Kermit interacts with Go and another PCP component Vang, known to undergo intracellular relocalization during PCP establishment. We further demonstrate that the activity of Kermit in PCP differentially relies on the motor proteins: the microtubule-based dynein and kinesin motors and the actin-based myosin VI. Our results place Kermit as a potential transducer of Go, linking Vang with motor proteins for its delivery to dedicated cellular compartments during PCP establishment.	[Lin, Chen; Katanaev, Vladimir L.] Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, Lausanne, Switzerland; [Katanaev, Vladimir L.] Russian Acad Sci, Inst Prot Res, Pushchino 142292, Russia	University of Lausanne; Russian Academy of Sciences	Katanaev, VL (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, Lausanne, Switzerland.	vladimir.katanaev@unil.ch	Chuu, Chih-Pin/B-1086-2010; Tseng, Jen-Chih/AAK-3386-2020; Chen, Ya-Wen/AAG-7549-2019; Katanaev, Vladimir/F-9480-2014; Chuu, Chih-Pin/N-6697-2019; Fukui, Yasuhisa/E-8806-2010; Chen, Linyi/AAV-2632-2020; Lin, Ching Yu/AAN-9581-2020; Chen, Ya-Wen/B-1100-2010; Chang, Jang-Yang/D-2099-2010; Tsai, Kun-Chih/C-1371-2010	Chen, Ya-Wen/0000-0002-6080-8859; Katanaev, Vladimir/0000-0002-7909-5617; Chen, Linyi/0000-0001-7258-8817; Lin, Ching Yu/0000-0001-9041-5653; 	Deutsche Forschungsgemeinschaft [KA 2721/2-1]; Swiss National Science Foundation [31003A_138350]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was funded by the grants from Deutsche Forschungsgemeinschaft (grant #KA 2721/2-1) and Swiss National Science Foundation (grant # 31003A_138350) to VLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bikkavilli RK, 2008, J CELL SCI, V121, P234, DOI 10.1242/jcs.021964; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Courbard JR, 2009, DEV BIOL, V333, P67, DOI 10.1016/j.ydbio.2009.06.024; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Djiane A, 2005, CELL, V121, P621, DOI 10.1016/j.cell.2005.03.014; Djiane A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011228; Egger-Adam D, 2008, FRONT BIOSCI-LANDMRK, V13, P4740, DOI 10.2741/3036; Egger-Adam D, 2010, DEV DYNAM, V239, P168, DOI 10.1002/dvdy.22060; Feigin ME, 2007, J CELL SCI, V120, P3404, DOI 10.1242/jcs.011254; Giese AP, 2012, DEVELOPMENT, V139, P3775, DOI 10.1242/dev.074229; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Jernigan KK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000647; Jones KH, 1996, GENETICS, V142, P205; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Katanaev VL, 2006, P NATL ACAD SCI USA, V103, P6524, DOI 10.1073/pnas.0601853103; Katanaev VL, 2009, FRIZZLED PROTEINS AR; Katanaev VL, 2006, CELL CYCLE, V5, P2464, DOI 10.4161/cc.5.21.3410; Katanayeva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012331; Kilander MBC, 2011, CELL SIGNAL, V23, P550, DOI 10.1016/j.cellsig.2010.11.004; Kopein D, 2009, MOL BIOL CELL, V20, P3865, DOI 10.1091/mbc.E09-01-0021; Koval A, 2011, BIOCHEM PHARMACOL, V82, P1311, DOI 10.1016/j.bcp.2011.06.005; Koval A, 2011, BIOCHEM J, V433, P435, DOI 10.1042/BJ20101878; Liu T, 1999, J BIOL CHEM, V274, P33539, DOI 10.1074/jbc.274.47.33539; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Nunn C, 2006, SEMIN CELL DEV BIOL, V17, P390, DOI 10.1016/j.semcdb.2006.04.001; Oh SW, 2003, GENETICS, V163, P195; Purvanov V, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000877; Ren N, 2005, GENETICS, V171, P625, DOI 10.1534/genetics.105.043687; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Schertel C, 2013, DEV CELL, V25, P207, DOI 10.1016/j.devcel.2013.02.019; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Singh J, 2012, WIRES DEV BIOL, V1, P479, DOI 10.1002/wdev.32; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Strutt H, 2009, SEMIN CELL DEV BIOL, V20, P957, DOI 10.1016/j.semcdb.2009.03.006; Tan C, 2001, DEVELOPMENT, V128, P3665; Toba G, 1999, GENETICS, V151, P725; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0	48	4	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76885	10.1371/journal.pone.0076885	http://dx.doi.org/10.1371/journal.pone.0076885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24204696	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600080
J	Anthony, J; Kelkar, A; Wilankar, C; Ranjith, V; Bhumra, SK; Mutt, S; Deka, N; Sivaramakrishnan, H; Sharma, S; Marita, AR				Anthony, Jessy; Kelkar, Aditya; Wilankar, Chandan; Ranjith, Vijayalakshmi; Bhumra, Sujit Kaur; Mutt, Shivaprakash; Deka, Nabajyoti; Sivaramakrishnan, Hariharan; Sharma, Somesh; Marita, Adaikalasamy Rosalind			Discovery of P1736, a Novel Antidiabetic Compound That Improves Peripheral Insulin Sensitivity in Mice Models	PLOS ONE			English	Article							PPAR-GAMMA; GLYCOGEN-SYNTHESIS; 3T3-L1 ADIPOCYTES; GLUCOSE-UPTAKE; RESISTANCE; IDENTIFICATION; ROSIGLITAZONE; TROGLITAZONE; INHIBITION; EXPRESSION	Insulin resistance is a characteristic feature of Type 2 diabetes. Insulin resistance has also been implicated in the pathogenesis of cardiovascular disease. Currently used thiazolidinedione (TZD) insulin sensitizers although effective, have adverse side effects of weight gain, fluid retention and heart failure. Using fat cell-based phenotypic drug discovery approach we identified P1736, a novel antidiabetic molecule that has completed Phase II clinical trials. The present study evaluated the in vitro and in vivo pharmacological properties of P1736. P1736 is a non-TZD and it did not activate human PPAR(Peroxisome Proliferator Activated Receptor Gamma) receptors. P1736 caused dose dependent increase in glucose uptake (EC50-400nM) in the insulin resistant 3T3 adipocytes. The compound (10 mu M) induced translocation of GLUT-4 (Glucose Transporter type 4) transporters in these adipocytes while metformin (1.0mM) was inactive. In diabetic db/db mice, P1736 (150mg/kg) was more efficacious than metformin in lowering plasma glucose (35% vs 25%) and triglyceride levels (38% vs 31%). P1736 tested at 5mg/kg, twice daily doses, reduced glucose by 41% and triglycerides by 32%, in db/db mice. These effects were not associated with adverse effects on body weight or liver function. Rosiglitazone (5mg/kg, twice daily) caused 60% and 40 % decreases in glucose and triglyceride levels, respectively. However, rosiglitazone induced 13% weight gain (p<0.05) in db/db mice. P1736 was also efficacious in ob/ob mice wherein 30-35% decrease in glucose and significant improvement in hyperinsulinemia were observed. Administration of P1736 to ob/ob mice resulted in 70% increase in glucose uptake in soleus muscles while metformin caused 38% increase. P1736 exhibited excellent safety profile and was weight neutral in all preclinical models of diabetes. Thus, P1736 with its unique pharmacology coupled with PPAR-independent mode of action could represent an alternative option in the management of insulin resistant Type 2 diabetic patients.	[Anthony, Jessy; Kelkar, Aditya; Wilankar, Chandan; Ranjith, Vijayalakshmi; Bhumra, Sujit Kaur; Mutt, Shivaprakash; Sharma, Somesh; Marita, Adaikalasamy Rosalind] Piramal Enterprises Ltd, NCE Div, Dept Pharmacol, Mumbai, Maharashtra, India; [Deka, Nabajyoti; Sivaramakrishnan, Hariharan; Sharma, Somesh] Piramal Enterprises Ltd, NCE Div, Dept Chem, Mumbai, Maharashtra, India; [Marita, Adaikalasamy Rosalind] Haffkine Inst Training Res & Testing, Mumbai, Maharashtra, India		Marita, AR (corresponding author), Piramal Enterprises Ltd, NCE Div, Dept Pharmacol, Mumbai, Maharashtra, India.	maritarosalind@gmail.com	Mutt, Shivaprakash Jagalur/AAC-9768-2019	Mutt, Shivaprakash Jagalur/0000-0001-8285-551X				Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; BELCHER EH, 1957, J PHYSIOL-LONDON, V139, P64, DOI 10.1113/jphysiol.1957.sp005875; Choi YM, 2003, J BIOL CHEM, V278, P7320, DOI 10.1074/jbc.M210283200; Cooper MS, 2009, J CLIN ENDOCR METAB, V94, P4645, DOI 10.1210/jc.2009-1412; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Funk C, 2001, TOXICOLOGY, V167, P83, DOI 10.1016/S0300-483X(01)00460-7; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Hausdorff SF, 1999, J BIOL CHEM, V274, P24677, DOI 10.1074/jbc.274.35.24677; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Konstantopoulos N, 2012, DIABETES, V61, P2146, DOI 10.2337/db11-0578; Konstantopoulos N, 2011, PHYSIOL GENOMICS, V43, P110, DOI 10.1152/physiolgenomics.00115.2010; Kumar KLA, 2000, BRIT J PHARMACOL, V130, P351, DOI 10.1038/sj.bjp.0703313; Lundgren M, 2004, J CLIN ENDOCR METAB, V89, P2989, DOI 10.1210/jc.2003-031157; Marita AR, 2001, DIABETES OBES METAB, V3, P271, DOI 10.1046/j.1463-1326.2001.00130.x; Marita AR, 2008, 68 SCI SESS AM DIAB; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; Sakoda H, 2000, DIABETES, V49, P1700, DOI 10.2337/diabetes.49.10.1700; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Singh S, 2008, EXPERT OPIN DRUG SAF, V7, P579, DOI [10.1517/14740338.7.5.579, 10.1517/14740338.7.5.579 ]; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Taskinen MR, 1997, DIABETES METAB REV, V13, P93, DOI 10.1002/(SICI)1099-0895(199706)13:2&lt;93::AID-DMR187&gt;3.0.CO;2-6; Taygerly JP, 2013, BIOORGAN MED CHEM, V21, P979, DOI 10.1016/j.bmc.2012.11.058; Tomlinson JW, 2001, ENDOCRINOLOGY, V142, P1982, DOI 10.1210/en.142.5.1982; Webster SP, 2007, BIOORG MED CHEM LETT, V17, P2838, DOI 10.1016/j.bmcl.2007.02.057; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031811; Zierath JR, 1998, ENDOCRINOLOGY, V139, P5034, DOI 10.1210/en.139.12.5034	30	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77946	10.1371/journal.pone.0077946	http://dx.doi.org/10.1371/journal.pone.0077946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194903	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000082
J	Anunciacao, O; Vinga, S; Oliveira, AL				Anunciacao, Orlando; Vinga, Susana; Oliveira, Arlindo L.			Using Information Interaction to Discover Epistatic Effects in Complex Diseases	PLOS ONE			English	Article							LOGISTIC-REGRESSION; SELECTION	It is widely agreed that complex diseases are typically caused by the joint effects of multiple instead of a single genetic variation. These genetic variations may show stronger effects when considered together than when considered individually, a phenomenon known as epistasis or multilocus interaction. In this work, we explore the applicability of information interaction to discover pairwise epistatic effects related with complex diseases. We start by showing that traditional approaches such as classification methods or greedy feature selection methods (such as the Fleuret method) do not perform well on this problem. We then compare our information interaction method with BEAM and SNPHarvester in artificial datasets simulating epistatic interactions and show that our method is more powerful to detect pairwise epistatic interactions than its competitors. We show results of the application of information interaction method to the WTCCC breast cancer dataset. Our results are validated using permutation tests. We were able to find 89 statistically significant pairwise interactions with a p-value lower than 10(-3). Even though many recent algorithms have been designed to find epistasis with low marginals, we observed that all (except one) of the SNPs involved in statistically significant interactions have moderate or high marginals. We also report that the interactions found in this work were not present in gene-gene interaction network STRING.	[Anunciacao, Orlando; Vinga, Susana; Oliveira, Arlindo L.] Univ Lisbon, INESC ID Inst Super Tecn, P-1699 Lisbon, Portugal	INESC-ID; Universidade de Lisboa	Anunciacao, O (corresponding author), Univ Lisbon, INESC ID Inst Super Tecn, P-1699 Lisbon, Portugal.	orlando@kdbio.inesc-id.pt	Vinga, Susana/B-8450-2008; Oliveira, Arlindo L/C-1700-2008	Vinga, Susana/0000-0002-1954-5487; Oliveira, Arlindo L/0000-0001-8638-5594; Anunciacao, Orlando/0000-0002-5929-5523	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/41984/2007, PTDC/EIA-EIA/111239/2009, PEst-OE/EEI/LA0021/2011]; Susana Vinga's Program Investigador FCT from FCT [IF/00653/2012]; European Social Fund through the Operational Program Human Potential	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Susana Vinga's Program Investigador FCT from FCT; European Social Fund through the Operational Program Human Potential	Funding was provided by Fundacao para a Ciencia e Tecnologia (FCT) - http://www.fct.pt, particularly by Orlando Anunciacao's grant SFRH/BD/41984/2007, Projects Neuroclinomics PTDC/EIA-EIA/111239/2009, INESC-ID PEst-OE/EEI/LA0021/2011 and Susana Vinga's Program Investigador FCT (IF/00653/2012) from FCT, co-funded by the European Social Fund through the Operational Program Human Potential. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anunciacao O, 2010, ADV INTEL SOFT COMPU, V74, P43, DOI 10.1007/978-3-642-13214-8_6; Davis NA, 2013, GENETIC EPIDEMIOLOGY; Fleuret F, 2004, J MACH LEARN RES, V5, P1531; Freund Y, 1999, MACHINE LEARNING, PROCEEDINGS, P124; Freund Y, 1999, MACH LEARN, V37, P277, DOI 10.1023/A:1007662407062; Heidema AG, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-23; Holmes G, 2002, LECT NOTES ARTIF INT, V2430, P161; Knijnenburg TA, 2009, BIOINFORMATICS, V25, pI161, DOI 10.1093/bioinformatics/btp211; Krishnapuram B, 2005, IEEE T PATTERN ANAL, V27, P957, DOI 10.1109/TPAMI.2005.127; Li MY, 2009, BIOINFORMATICS, V25, P497, DOI 10.1093/bioinformatics/btn641; Listgarten J, 2004, CLIN CANCER RES, V10, P2725, DOI 10.1158/1078-0432.CCR-1115-03; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; McKinney BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000432; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Nagelkerke N, 2005, STAT MED, V24, P121, DOI 10.1002/sim.1997; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Platt J., 1999, FAST TRAINING SUPPOR; Vapnik V., 1998, STAT LEARNING THEORY; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Wan X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-13; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Yang C, 2009, BIOINFORMATICS, V25, P504, DOI 10.1093/bioinformatics/btn652; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	25	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76300	10.1371/journal.pone.0076300	http://dx.doi.org/10.1371/journal.pone.0076300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194833	Green Submitted, gold, Green Published			2022-12-27	WOS:000326037000012
J	Kurtenbach, S; Prochnow, N; Kurtenbach, S; Klooster, J; Zoidl, C; Dermietzel, R; Kamermans, M; Zoidl, G				Kurtenbach, Sarah; Prochnow, Nora; Kurtenbach, Stefan; Klooster, Jan; Zoidl, Christiane; Dermietzel, Rolf; Kamermans, Maarten; Zoidl, Georg			Pannexin1 Channel Proteins in the Zebrafish Retina Have Shared and Unique Properties	PLOS ONE			English	Article							GAP-JUNCTION HEMICHANNELS; HORIZONTAL CELLS; OUTER RETINA; DANIO-RERIO; PH; ATP; EXPRESSION; COMMUNICATION; ACTIVATION; MEMBRANE	In mammals, a single pannexin1 gene (Panx1) is widely expressed in the CNS including the inner and outer retinae, forming large-pore voltage-gated membrane channels, which are involved in calcium and ATP signaling. Previously, we discovered that zebrafish lack Panx1 expression in the inner retina, with drPanx1a exclusively expressed in horizontal cells of the outer retina. Here, we characterize a second drPanx1 protein, drPanx1b, generated by whole-genome duplications during teleost evolution. Homology searches strongly support the presence of pannexin sequences in cartilaginous fish and provide evidence that pannexins evolved when urochordata and chordata evolution split. Further, we confirm Panx1 ohnologs being solely present in teleosts. A hallmark of differential expression of drPanx1a and drPanx1b in various zebrafish brain areas is the non-overlapping protein localization of drPanx1a in the outer and drPanx1b in the inner fish retina. A functional comparison of the evolutionary distant fish and mouse Panx1s revealed both, preserved and unique properties. Preserved functions are the capability to form channels opening at resting potential, which are sensitive to known gap junction and hemichannel blockers, intracellular calcium, extracellular ATP and pH changes. However, drPanx1b is unique due to its highly complex glycosylation pattern and distinct electrophysiological gating kinetics. The existence of two Panx1 proteins in zebrafish displaying distinct tissue distribution, protein modification and electrophysiological properties, suggests that both proteins fulfill different functions in vivo.	[Kurtenbach, Sarah; Prochnow, Nora; Zoidl, Christiane; Dermietzel, Rolf; Zoidl, Georg] Ruhr Univ Bochum, Fac Med, Bochum, Germany; [Klooster, Jan; Kamermans, Maarten] Netherlands Inst Neurosci, Res Unit Retinal Signal Proc, Amsterdam, Netherlands; [Kamermans, Maarten] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Kurtenbach, Sarah; Kurtenbach, Stefan; Zoidl, Christiane; Zoidl, Georg] York Univ, Fac Hlth, Toronto, ON M3J 2R7, Canada	Ruhr University Bochum; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; York University - Canada	Zoidl, G (corresponding author), Ruhr Univ Bochum, Fac Med, Univ Str 150, Bochum, Germany.	gzoidl@yorku.ca	Kurtenbach, Stefan/H-3786-2019	Kurtenbach, Stefan/0000-0002-7445-596X	CIHR/CRC; NSERC (Georg Zoidl); International Graduate School of Neuroscience (IGSN), Research School; "Heinrich und Alma Vogelsang Stiftung" of the Ruhr University Bochum, Germany	CIHR/CRC; NSERC (Georg Zoidl); International Graduate School of Neuroscience (IGSN), Research School; "Heinrich und Alma Vogelsang Stiftung" of the Ruhr University Bochum, Germany	This study was funded by CIHR/CRC, NSERC (Georg Zoidl), International Graduate School of Neuroscience (IGSN), Research School and the "Heinrich und Alma Vogelsang Stiftung" of the Ruhr University Bochum, Germany (Sarah Kurtenbach). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alberto AVP, 2013, N-S ARCH PHARMACOL, V386, P775, DOI 10.1007/s00210-013-0868-x; Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bargiotas P, 2012, CHANNELS, V6, P453, DOI 10.4161/chan.22315; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bond SR, 2012, J MEMBRANE BIOL, V245, P483, DOI 10.1007/s00232-012-9497-4; Bonnet U, 2000, EUR NEUROPSYCHOPHARM, V10, P97, DOI 10.1016/S0924-977X(99)00063-2; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Dmitriev AV, 2001, J NEUROSCI, V21, P2897, DOI 10.1523/JNEUROSCI.21-08-02897.2001; Dvoriantchikova G, 2006, FEBS LETT, V580, P2178, DOI 10.1016/j.febslet.2006.03.026; Fahrenfort I, 2004, VISUAL NEUROSCI, V21, P501, DOI 10.1017/S095252380421402X; Fahrenfort I, 2009, PLOS ONE, V4, pe6090, DOI [10.1371/journal.pone.0006090, DOI 10.1371/J0URNAL.P0NE.0006090.PUBMED:19564917]; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Grundken C, 2011, J NEUROSCI METH, V199, P15, DOI 10.1016/j.jneumeth.2011.04.016; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Hirasawa H, 2003, J GEN PHYSIOL, V122, P657, DOI 10.1085/jgp.200308863; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; INAMURA K, 1989, J CEREBR BLOOD F MET, V9, P821, DOI 10.1038/jcbfm.1989.116; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kienitz MC, 2011, J BIOL CHEM, V286, P290, DOI 10.1074/jbc.M110.163477; Klaassen LJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001107; Kraaij DA, 2000, J GEN PHYSIOL, V115, P3, DOI 10.1085/jgp.115.1.3; Kranz K, 2013, J COMP NEUROL, V521, P1119, DOI 10.1002/cne.23223; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma M. L., 2010, 2010 GAT COMP ENV WO, P1, DOI [DOI 10.1109/GCE.2010.5676129, 10.1109/GCE.2010.5676129]; Martin PEM, 2001, J CELL SCI, V114, P3845; Nottingham S, 2001, AM J PHYSIOL-REG I, V281, pR1940, DOI 10.1152/ajpregu.2001.281.6.R1940; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Prochnow N, 2009, NEUROSCIENCE, V162, P1039, DOI 10.1016/j.neuroscience.2009.04.064; Prochnow N, 2009, EXP BRAIN RES, V199, P255, DOI 10.1007/s00221-009-1957-4; Qiu F, 2012, PURINERG SIGNAL, V8, P81, DOI 10.1007/s11302-011-9263-6; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Ray A, 2005, EUR J NEUROSCI, V21, P3277, DOI 10.1111/j.1460-9568.2005.04139.x; Shields CR, 2007, J COMP NEUROL, V501, P765, DOI 10.1002/cne.21282; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Trexler EB, 1999, J GEN PHYSIOL, V113, P721; Vanden Abeele F, 2006, J CELL BIOL, V174, P535, DOI 10.1083/jcb.200601115; Vroman R, 2013, EXTRACELLUL IN PRESS; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Xiong ZQ, 2000, J NEUROPHYSIOL, V83, P3519, DOI 10.1152/jn.2000.83.6.3519; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061; Zoidl G, 2008, CELL COMMUN ADHES, V15, P169, DOI 10.1080/15419060802014081	53	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77722	10.1371/journal.pone.0077722	http://dx.doi.org/10.1371/journal.pone.0077722			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194896	gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000075
J	Tovar-Lopez, FJ; Rosengarten, G; Nasabi, M; Sivan, V; Khoshmanesh, K; Jackson, SP; Mitchell, A; Nesbitt, WS				Tovar-Lopez, Francisco Javier; Rosengarten, Gary; Nasabi, Mahyar; Sivan, Vijay; Khoshmanesh, Khashayar; Jackson, Shaun P.; Mitchell, Arnan; Nesbitt, Warwick S.			An Investigation on Platelet Transport during Thrombus Formation at Micro-Scale Stenosis	PLOS ONE			English	Article							LATERAL MIGRATION; WALL; BLOOD	This paper reports on an investigation of mass transport of blood cells at micro-scale stenosis where local strain-rate micro-gradients trigger platelet aggregation. Using a microfluidic flow focusing platform we investigate the blood flow streams that principally contribute to platelet aggregation under shear micro-gradient conditions. We demonstrate that relatively thin surface streams located at the channel wall are the primary contributor of platelets to the developing aggregate under shear gradient conditions. Furthermore we delineate a role for red blood cell hydrodynamic lift forces in driving enhanced advection of platelets to the stenosis wall and surface of developing aggregates. We show that this novel microfluidic platform can be effectively used to study the role of mass transport phenomena driving platelet recruitment and aggregate formation and believe that this approach will lead to a greater understanding of the mechanisms underlying shear-gradient dependent discoid platelet aggregation in the context of cardiovascular diseases such as acute coronary syndromes and ischemic stroke.	[Tovar-Lopez, Francisco Javier; Nasabi, Mahyar; Sivan, Vijay; Khoshmanesh, Khashayar; Mitchell, Arnan] RMIT Univ, Sch Elect & Comp Engn, Microplatforms Res Grp, Melbourne, Vic 3001, Australia; [Rosengarten, Gary] RMIT Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic 3001, Australia; [Khoshmanesh, Khashayar] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Jackson, Shaun P.; Nesbitt, Warwick S.] Monash Univ, Alfred Med Res & Educ Precinct, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Nesbitt, Warwick S.] Bion Inst, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Stanford University; Monash University; Bionics Institute	Tovar-Lopez, FJ (corresponding author), RMIT Univ, Sch Elect & Comp Engn, Microplatforms Res Grp, Melbourne, Vic 3001, Australia.	tovar.lopez.fj@gmail.com	Tovar, Francisco/AGG-3400-2022; Mitchell, Arnan/C-5017-2008	Mitchell, Arnan/0000-0002-2463-2956; Tovar-Lopez, Francisco J/0000-0001-8578-7786; Jackson, Shaun/0000-0002-4750-1991; Nesbitt, Warwick/0000-0001-5644-7053; Khoshmanesh, Khashayar/0000-0001-6036-7371	Australian Research Council [DE120101302, DE120101402]	Australian Research Council(Australian Research Council)	FJTL and KK acknowledge Australian Research Council for funding under Discovery Early Career Researcher Award scheme under DE120101302 and DE120101402 projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARTS PAMM, 1988, ARTERIOSCLEROSIS, V8, P819, DOI 10.1161/01.ATV.8.6.819; Asakura T, 1990, CIRC RES, V66; Asmolov ES, 1999, J FLUID MECH, V381, P63, DOI 10.1017/S0022112098003474; Balasubramanian V, 2002, JOURNAL OF BIOMATERI, V13; Bluestein D, 1997, ANN BIOMED ENG, V25, P344, DOI 10.1007/BF02648048; Bluestein D, 1999, ANNALSBIOMEDICAL ENG, V27; Cox R, 1968, CHEM ENG SCI, V23; Crowl L, 2010, INT J NUMERICAL METH, V26; Dhinakaran S, 2013, J NONNEWTONIAN FLUID; Di Carlo D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.094503; ECKSTEIN EC, 1991, BIOPHYS J, V60, P53, DOI 10.1016/S0006-3495(91)82030-6; Flachskampf FA, 2012, J AM COLL CARDIOL, V59; Goldsmith H, 1975, ANN REV UID MECH, V7; Goldsmith H, 1977, ASAIO J, V23; GOLDSMITH HL, 1989, AM J PHYSIOL, V257, pH1005, DOI 10.1152/ajpheart.1989.257.3.H1005; Goldsmith HL, 1986, THROMB HAEMOSTASIS, V55; Hathcock JJ, 2006, ARTERIOSCLER THROMB, V26; Holz M, 2000, PHYS CHEM CHEM PHYS, V2; Kang DH, 2010, CIRCULATION, V121, P1502, DOI 10.1161/CIRCULATIONAHA.109.909903; KARINO T, 1984, BIORHEOLOGY, V21, P587; Kilimnik A, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3664402; Lancellotti P, 2012, J AM COLL CARDIOL, V59; Mach A, 2011, LAB CHIP, V11; Magnaudet J, 2003, J FLUID MECH, V476, P115, DOI 10.1017/S0022112002002902; Matas JP, 2004, OIL GAS SCI TECHNOL, V59, P59, DOI 10.2516/ogst:2004006; Merten M, 2000, CIRCULATION, V102; Michelson A.D, 2006, PLATELETS, VSecond; Mody N, 2008, BIOPHYS J, V95; MOFFATT HK, 1964, J FLUID MECH, V18, P1, DOI 10.1017/S0022112064000015; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Packham MA, 1994, CANADIAN J PHYSL PHA, V72; Saffman P, 1965, J FLUID MECH, V22; SCHOEPHOERSTER RT, 1993, ARTERIOSCLER THROMB, V13, P1806, DOI 10.1161/01.ATV.13.12.1806; SEGRE G, 1961, NATURE, V189, P209, DOI 10.1038/189209a0; Shin SJ, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046321; Sorensen EN, 1999, ANN BIOMED ENG, V27; Tovar-Lopez F, 2011, J BIOMECH, V44; Tovar-Lopez F, 2011, 15 INT C MIN SYST CH; Tovar-Lopez FJ, 2010, LAB CHIP, V10; UIJTTEWAAL WSJ, 1993, AM J PHYSIOL, V264, pH1239, DOI 10.1152/ajpheart.1993.264.4.H1239; Unger M, 2000, SCIENCE, V288; Wu Z, 2009, LAB CHIP, V9; Zeng LY, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3082232; Zhao H, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.3677935; Zhao R, 2007, BIORHEOLOGY, V44, P161	45	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e74123	10.1371/journal.pone.0074123	http://dx.doi.org/10.1371/journal.pone.0074123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194822	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000001
J	Zhao, GJ; Zhao, B; Tong, ZX; Mu, RQ; Guan, YF				Zhao, Guojie; Zhao, Bin; Tong, Zhaoxue; Mu, Runqing; Guan, Yifu			Effects of 2 '-O-Methyl Nucleotide Substitution on EcoRI Endonuclease Cleavage Activities	PLOS ONE			English	Article							RESTRICTION-ENDONUCLEASE; CHIRAL PHOSPHOROTHIOATES; RECOGNITION SEQUENCE; PROTEIN INTERACTIONS; RNA TARGETS; DNA-BINDING; OLIGONUCLEOTIDES; COMPLEX; SPECIFICITY; MECHANISM	To investigate the effect of sugar pucker conformation on DNA-protein interactions, we used 2'-O-methyl nucleotide (2'-OMeN) to modify the EcoRI recognition sequence -TGAATTCT-, and monitored the enzymatic cleavage process using FRET method. The 2'-O-methyl nucleotide has a C3'-endo sugar pucker conformation different from the C2'-endo sugar pucker conformation of native DNA nucleotides. The initial reaction velocities were measured and the kinetic parameters, Km and V-max were derived using Michaelis-Menten equation. Experimental results showed that 2'-OMeN substitutions for the EcoRI recognition sequence decreased the cleavage efficiency for A2, A3 and T4 substitutions significantly, and 2'-OMeN substitution for T5 residue inhibited the enzymatic activity completely. In contrast, substitutions for G1 and C6 could maintain the original activity. 2'-fluoro nucleic acid (2'-FNA) and locked nucleic acid (LNA) having similar C3'-endo sugar pucker conformation also demonstrated similar enzymatic results. This position-dependent enzymatic cleavage property might be attributed to the phosphate backbone distortion caused by the switch from C2'-endo to C3'-endo sugar pucker conformation, and was interpreted on the basis of the DNA-EcoRI structure. These 2'-modified nucleotides could behave as a regulatory element to modulate the enzymatic activity in vitro, and this property will have potential applications in genetic engineering and biomedicine.	[Zhao, Guojie; Tong, Zhaoxue; Guan, Yifu] China Med Univ, Dept Biochem & Mol Biol, Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China; [Zhao, Bin] Shenyang Sport Univ, Dept Movement Sci, Shenyang, Peoples R China; [Mu, Runqing] China Med Univ, Affiliated Hosp 1, Dept Lab Med, Shenyang, Peoples R China	China Medical University; Shenyang Sport University; China Medical University	Guan, YF (corresponding author), China Med Univ, Dept Biochem & Mol Biol, Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China.	yfguan@mail.cmu.edu.cn	zhao, guojie/I-4238-2012		National Natural Science Foundation of China [31070705]; Doctoral Startup Found of Liaoning Province [20131139]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Startup Found of Liaoning Province	This work was supported by a grant from the National Natural Science Foundation of China (No. 31070705) and Doctoral Startup Found of Liaoning Province (No. 20131139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL AK, 1995, CURR OPIN STRUC BIOL, V5, P11, DOI 10.1016/0959-440X(95)80004-K; ALVES J, 1984, EUR J BIOCHEM, V140, P83, DOI 10.1111/j.1432-1033.1984.tb08069.x; BRENNAN CA, 1986, J BIOL CHEM, V261, P7270; CAMPBELL JM, 1990, J BIOCHEM BIOPH METH, V20, P259, DOI 10.1016/0165-022X(90)90084-P; CONNOLLY BA, 1984, J BIOL CHEM, V259, P760; CONNOLLY BA, 1984, BIOCHEMISTRY-US, V23, P3443, DOI 10.1021/bi00310a010; Dominick PK, 2004, J AM CHEM SOC, V126, P5050, DOI 10.1021/ja039192z; Eisenschmidt K, 2002, J BIOTECHNOL, V96, P185, DOI 10.1016/S0168-1656(02)00029-9; FRATINI AV, 1982, J BIOL CHEM, V257, P4686; FREDERICK CA, 1984, NATURE, V309, P327, DOI 10.1038/309327a0; Freier SM, 1997, NUCLEIC ACIDS RES, V25, P4429, DOI 10.1093/nar/25.22.4429; Geahigan KB, 2000, BIOCHEMISTRY-US, V39, P4939, DOI 10.1021/bi9917636; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Gohda K, 1997, J BIOCHEM, V121, P219; HALFORD SE, 1980, BIOCHEM J, V191, P581, DOI 10.1042/bj1910581; Huang Y, 2011, ANAL CHEM, V83, P8913, DOI 10.1021/ac2013114; JELTSCH A, 1993, J MOL BIOL, V229, P221, DOI 10.1006/jmbi.1993.1019; KAWASAKI AM, 1993, J MED CHEM, V36, P831, DOI 10.1021/jm00059a007; KIM YC, 1990, SCIENCE, V249, P1307, DOI 10.1126/science.2399465; KOZIOLKIEWICZ M, 1992, BIOCHEMISTRY-US, V31, P9460, DOI 10.1021/bi00154a019; Kurpiewski MR, 1996, BIOCHEMISTRY-US, V35, P8846, DOI 10.1021/bi960261e; Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x; LESSER DR, 1993, P NATL ACAD SCI USA, V90, P7548, DOI 10.1073/pnas.90.16.7548; LESSER DR, 1992, J BIOL CHEM, V267, P24810; LESSER DR, 1990, SCIENCE, V250, P776, DOI 10.1126/science.2237428; Li XM, 2008, ANAL BIOCHEM, V381, P1, DOI 10.1016/j.ab.2008.06.027; Macickova-Cahova H, 2009, NUCLEIC ACIDS RES, V37, P7612, DOI 10.1093/nar/gkp845; Majlessi M, 1998, NUCLEIC ACIDS RES, V26, P2224, DOI 10.1093/nar/26.9.2224; MCCLARIN JA, 1986, SCIENCE, V234, P1526, DOI 10.1126/science.3024321; MILLIGAN JF, 1989, BIOCHEMISTRY-US, V28, P2849, DOI 10.1021/bi00433a016; Nathan D, 2002, J MOL BIOL, V316, P7, DOI 10.1006/jmbi.2001.5247; Pallan PS, 2011, NUCLEIC ACIDS RES, V39, P3482, DOI 10.1093/nar/gkq1270; Phillips MI, 2000, METHOD ENZYMOL, V313, P46; Piao XY, 2008, ACTA BIOCHIM POL, V55, P713; PIEKEN WA, 1991, SCIENCE, V253, P314, DOI 10.1126/science.1857967; Prakash TP, 2007, CURR TOP MED CHEM, V7, P641, DOI 10.2174/156802607780487713; Robinson CR, 1998, P NATL ACAD SCI USA, V95, P2186, DOI 10.1073/pnas.95.5.2186; Rosati O, 2002, BIOCHEM BIOPH RES CO, V295, P198, DOI 10.1016/S0006-291X(02)00645-9; RUBIN RA, 1978, NUCLEIC ACIDS RES, V5, P2991, DOI 10.1093/nar/5.8.2991; SEELA F, 1986, NUCLEIC ACIDS RES, V14, P2319, DOI 10.1093/nar/14.5.2319; Sen S, 1999, BIOPHYS J, V77, P1782, DOI 10.1016/S0006-3495(99)77024-4; Urata H, 2009, BIOCHEM BIOPH RES CO, V390, P192, DOI 10.1016/j.bbrc.2009.08.164; Watrob H, 2001, BIOCHEMISTRY-US, V40, P683, DOI 10.1021/bi002055j; WILLIAMS DM, 1991, BIOCHEMISTRY-US, V30, P4001, DOI 10.1021/bi00230a027; Wilson C, 2006, CURR OPIN CHEM BIOL, V10, P607, DOI 10.1016/j.cbpa.2006.10.001; Wright DJ, 1999, J BIOL CHEM, V274, P31896, DOI 10.1074/jbc.274.45.31896	46	7	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77111	10.1371/journal.pone.0077111	http://dx.doi.org/10.1371/journal.pone.0077111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194862	gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000041
J	Zhou, YF; Collinson, A; Laidlaw, A; Humphris, G				Zhou, Yuefang; Collinson, Alex; Laidlaw, Anita; Humphris, Gerry			How Do Medical Students Respond to Emotional Cues and Concerns Expressed by Simulated Patients during OSCE Consultations? - A Multilevel Study	PLOS ONE			English	Article							VERONA CODING DEFINITIONS; SEQUENCES VR-CODES; CENTERED CARE; COMMUNICATION; HEALTH; PHYSICIAN; IMPACT; SATISFACTION; PSYCHIATRY; SYMPTOMS	Objectives: How medical students handle negative emotions expressed by simulated patients during Objective Structured Clinical Examinations (OSCE) has not been fully investigated. We aim to explore (i) whether medical students respond differently to different types of patients' emotional cues; and (2) possible effects of patients' progressive disclosure of emotional cues on students' responses. Methods: Forty OSCE consultations were video recorded and coded for patients' expressions of emotional distress and students' responses using a validated behavioural coding scheme (the Verona Coding Definitions of Emotional Sequence). Logistic multilevel regression was adopted to model the probability of the occurrence of student reduce space response behaviour as a function of the number of patients' expressions of emotional cues. Results: We found that medical students offered responses that differed to emotional cue types expressed by simulated patients. Students appeared to provide space to emotional cues when expressed in vague and unspecific words and reduce space to cues emphasizing physiological or cognitive correlates. We also found that medical students were less likely to explore patients' emotional distress nearer the end of the consultation and when the duration of a patient speech turn got larger. Cumulative frequency of patients' emotional cues also predicted students' reduce space behaviour. Practical Implications: Understanding how medical students manage negative emotions has significant implications for training programme development focusing on emotion recognition skills and patient-centred communication approach. In addition, the statistical approaches adopted by this study will encourage researchers in healthcare communication to search for appropriate analytical techniques to test theoretical propositions.	[Zhou, Yuefang; Collinson, Alex; Laidlaw, Anita; Humphris, Gerry] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland	University of St Andrews	Zhou, YF (corresponding author), Univ St Andrews, Sch Med, St Andrews, Fife, Scotland.	yz10@st-andrews.ac.uk	Humphris, Gerry/AAX-8013-2020; Laidlaw, Anita/AAN-8644-2021; Laidlaw, Anita H/A-2985-2010	Humphris, Gerry/0000-0002-4601-8834; Laidlaw, Anita/0000-0003-1214-4100; Zhou, Yuefang/0000-0003-3489-2900	University of St Andrews	University of St Andrews(Deutsche KrebshilfeHelmholtz Association)	This study was conducted as part of the communication skill teaching programme within the School of Medicine, University of St Andrews. All authors' salaries were paid by their employer, the University of St Andrews. Additional external funding was not required. The University of St Andrews, as the employer of all authors, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams K, 2012, PATIENT EDUC COUNS, V89, P44, DOI 10.1016/j.pec.2012.04.005; Agresti A, 2007, WILEY SERIES PROBABI, P357; Altman D.G., 1991, PRACTICAL STATISTIC; Blanch-Hartigan D, 2012, PATIENT EDUC COUNS, V89, P274, DOI 10.1016/j.pec.2012.08.002; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Connor M, 2009, PATIENT EDUC COUNS, V75, P169, DOI 10.1016/j.pec.2008.10.006; Del Piccolo L, 1999, Epidemiol Psichiatr Soc, V8, P56; Del Piccolo L, 2007, SOC SCI MED, V65, P2357, DOI 10.1016/j.socscimed.2007.07.010; Del Piccolo L, 2012, PATIENT EDUC COUNS, V88, P29, DOI 10.1016/j.pec.2012.01.010; Del Piccolo L, 2011, PATIENT EDUC COUNS, V82, P149, DOI 10.1016/j.pec.2010.02.024; Eide Hilde, 2003, Epidemiol Psichiatr Soc, V12, P109; Finset A, 2012, PATIENT EDUC COUNS, V89, P217, DOI 10.1016/j.pec.2012.10.006; Grimsbo GH, 2012, PATIENT EDUC COUNS, V88, P36, DOI 10.1016/j.pec.2012.01.007; Hojat M, 2011, ACAD MED, V86, P359, DOI 10.1097/ACM.0b013e3182086fe1; Kim SS, 2004, EVAL HEALTH PROF, V27, P237, DOI 10.1177/0163278704267037; Langewitz Wolf, 2003, Epidemiol Psichiatr Soc, V12, P103; Little P, 2001, BMJ-BRIT MED J, V322, P468, DOI 10.1136/bmj.322.7284.468; McCabe R, 2002, BRIT MED J, V325, P1148, DOI 10.1136/bmj.325.7373.1148; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Neal RM, 1996, LECT NOTES STAT, V118; Norfolk T, 2007, MED EDUC, V41, P690, DOI 10.1111/j.1365-2923.2007.02789.x; Rimondini M, 2006, PSYCHOTHER PSYCHOSOM, V75, P161, DOI 10.1159/000091773; Rimondini M, 2004, PATIENT EDUC COUNS, V55, P311, DOI [10.1016/S0738-3991(04)00331-3, DOI 10.1016/S0738-3991(04)00331-3]; Salmon P, 2006, PSYCHOSOM MED, V68, P570, DOI 10.1097/01.psy.0000227690.95757.64; Satterfield JM, 2007, MED EDUC, V41, P935, DOI 10.1111/j.1365-2923.2007.02835.x; Schindler BA, 2006, ACAD MED, V81, P27, DOI 10.1097/00001888-200601000-00008; Smith A, 2011, PATIENT EDUC COUNS, V82, P233, DOI 10.1016/j.pec.2010.04.001; SQUIER RW, 1990, SOC SCI MED, V30, P325, DOI 10.1016/0277-9536(90)90188-X; Stewart M, 2000, J FAM PRACTICE, V49, P796; Stewart M, 2005, BMJ-BRIT MED J, V322, P444; Street RL, 2012, PATIENT EDUC COUNS, V89, P245, DOI 10.1016/j.pec.2012.06.032; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; van den Brink-Muinen Atie, 2003, Epidemiol Psichiatr Soc, V12, P92; van Dulmen Sandra, 2004, Patient Educ Couns, V55, P149; van Dulmen Sandra, 2003, Epidemiol Psichiatr Soc, V12, P98; Vatne TM, 2010, PATIENT EDUC COUNS, V80, P399, DOI 10.1016/j.pec.2010.06.026; Wright A, 2012, PATIENT EDUC COUNS, V89, P205, DOI 10.1016/j.pec.2012.05.006; Zachariae R, 2003, BRIT J CANCER, V88, P658, DOI 10.1038/sj.bjc.6600798; Zimmermann Christa, 2003, Epidemiol Psichiatr Soc, V12, P115; Zimmermann C, 2011, PATIENT EDUC COUNS, V82, P141, DOI 10.1016/j.pec.2010.03.017	40	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e79166	10.1371/journal.pone.0079166	http://dx.doi.org/10.1371/journal.pone.0079166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194960	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000139
J	Bag, P; Ojha, D; Mukherjee, H; Halder, UC; Mondal, S; Chandra, NS; Nandi, S; Sharon, A; Sarkar, MC; Chakrabarti, S; Chattopadhyay, D				Bag, Paromita; Ojha, Durbadal; Mukherjee, Hemanta; Halder, Umesh Chandra; Mondal, Supriya; Chandra, Nidhi S.; Nandi, Suman; Sharon, Ashoke; Sarkar, Mamta Chawla; Chakrabarti, Sekhar; Chattopadhyay, Debprasad			An Indole Alkaloid from a Tribal Folklore Inhibits Immediate Early Event in HSV-2 Infected Cells with Therapeutic Efficacy in Vaginally Infected Mice	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACYCLOVIR-RESISTANT; GENITAL HERPES; IN-VITRO; SIMPLEX; HARMALINE; GENE; ACTIVATION; MECHANISMS; HARMINE	Herpes genitalis, caused by HSV-2, is an incurable genital ulcerative disease transmitted by sexual intercourse. The virus establishes life-long latency in sacral root ganglia and reported to have synergistic relationship with HIV-1 transmission. Till date no effective vaccine is available, while the existing therapy frequently yielded drug resistance, toxicity and treatment failure. Thus, there is a pressing need for non-nucleotide antiviral agent from traditional source. Based on ethnomedicinal use we have isolated a compound 7-methoxy-1-methyl-4,9-dihydro-3H-pyrido[3,4-b]indole (HM) from the traditional herb Ophiorrhiza nicobarica Balkr, and evaluated its efficacy on isolates of HSV-2 in vitro and in vivo. The cytotoxicity (CC50), effective concentrations (EC50) and the mode of action of HM was determined by MTT, plaque reduction, time-of-addition, immunofluorescence (IFA), Western blot, qRT-PCR, EMSA, supershift and co-immunoprecipitation assays; while the in vivo toxicity and efficacy was evaluated in BALB/c mice. The results revealed that HM possesses significant anti-HSV-2 activity with EC50 of 1.1-2.8 mu g/ml, and selectivity index of >20. The time kinetics and IFA demonstrated that HM dose dependently inhibited 50-99% of HSV-2 infection at 1.5-5.0 mu g/ml at 2-4 h post-infection. Further, HM was unable to inhibit viral attachment or penetration and had no synergistic interaction with acyclovir. Moreover, Western blot and qRT-PCR assays demonstrated that HM suppressed viral IE gene expression, while the EMSA and co-immunoprecipitation studies showed that HM interfered with the recruitment of LSD-1 by HCF-1. The in vivo studies revealed that HM at its virucidal concentration was nontoxic and reduced virus yield in the brain of HSV-2 infected mice in a concentration dependent manner, compared to vaginal tissues. Thus, our results suggest that HM can serve as a prototype to develop non-nucleotide antiviral lead targeting the viral IE transcription for the management of HSV-2 infections.	[Bag, Paromita; Ojha, Durbadal; Mukherjee, Hemanta; Mondal, Supriya; Chandra, Nidhi S.; Chakrabarti, Sekhar; Chattopadhyay, Debprasad] ID & BG Hosp, ICMR Virus Unit, Kolkata, India; [Halder, Umesh Chandra; Nandi, Suman; Sarkar, Mamta Chawla; Chakrabarti, Sekhar] Natl Inst Cholera & Enter Dis, Kolkata, India; [Sharon, Ashoke] Birla Inst Technol, Dept Appl Chem, Ranchi, Bihar, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Birla Institute of Technology Mesra	Chattopadhyay, D (corresponding author), ID & BG Hosp, ICMR Virus Unit, Kolkata, India.	debprasadc@yahoo.co.in	Sharon, Ashoke/C-3916-2009; Sharon, Ashoke/GYU-7600-2022	Sharon, Ashoke/0000-0001-5738-1607; Sharon, Ashoke/0000-0001-5738-1607; CHATTOPADHYAY, Dr DEBPRASAD/0000-0002-7999-329X	Department of Biotechnology [BT/PR13759/PBD/ 17/686/2010]; Indian Council of Medical Research, New Delhi [45/2 /2010/PHA -BMS]	Department of Biotechnology; Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	The authors acknowledge financial support from the Department of Biotechnology (BT/PR13759/PBD/ 17/686/2010) and the Indian Council of Medical Research (45/2 /2010/PHA -BMS), New Delhi. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Bag P, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-98; Berrougui H, 2006, PHARMACOL RES, V54, P150, DOI 10.1016/j.phrs.2006.04.001; CHATIS PA, 1991, VIROLOGY, V180, P793, DOI 10.1016/0042-6822(91)90093-Q; Chattopadhyay D, 2006, CHEMOTHERAPY, V52, P151, DOI 10.1159/000092859; Chattopadhyay Debprasad, 2007, Oriental Pharmacy and Experimental Medicine, V7, P395; Chiang LC, 2003, J ANTIMICROB CHEMOTH, V52, P194, DOI 10.1093/jac/dkg291; COCKTON JR, 1952, J PHARM PHARMACOL, V4, P959, DOI 10.1111/j.2042-7158.1952.tb13229.x; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; DAGAR HS, 1991, ECON BOT, V45, P114, DOI 10.1007/BF02860056; FELSER JM, 1988, J VIROL, V62, P2076, DOI 10.1128/JVI.62.6.2076-2082.1988; Frazia SL, 2006, ANTIVIR THER, V11, P995; Ghosh S, 2012, J ETHNOPHARMACOL, V142, P714, DOI 10.1016/j.jep.2012.05.048; GIUS D, 1989, J VIROL, V63, P555, DOI 10.1128/JVI.63.2.555-563.1989; GNANN JW, 1983, PHARMACOTHERAPY, V3, P275; Habif T, 2004, WARTS HERPES SIMPLEX, P381; Jahaniani F, 2005, PHYTOCHEMISTRY, V66, P1581, DOI 10.1016/j.phytochem.2005.04.035; Kanekiyo K, 2007, BIOL PHARM BULL, V30, P1573, DOI 10.1248/bpb.30.1573; Khandelwal M, 2006, OBSTET GYNECOL, V107, P740, DOI 10.1097/01.AOG.0000202543.49213.6c; King NJC, 1998, J IMMUNOL, V160, P1173; Kleymann Gerald, 2003, Herpes, V10, P46; Kurokawa M, 2001, J PHARMACOL EXP THER, V297, P372; Liang Y, 2009, NAT MED, V15, P1312, DOI 10.1038/nm.2051; Lin LT, 2011, J VIROL, V85, P4386, DOI 10.1128/JVI.01492-10; Mayaud P, 2001, BRIT MED BULL, V58, P129, DOI 10.1093/bmb/58.1.129; Morfin F, 2003, J CLIN VIROL, V26, P29, DOI 10.1016/S1386-6532(02)00263-9; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; OSTROVE JM, 1987, J VIROL, V61, P3726, DOI 10.1128/JVI.61.12.3726-3732.1987; Piret J, 2002, ANTIMICROB AGENTS CH, V46, P2933, DOI 10.1128/AAC.46.9.2933-2942.2002; Posavad CM, 1997, P NATL ACAD SCI USA, V94, P10289, DOI 10.1073/pnas.94.19.10289; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reyes M, 2003, ARCH INTERN MED, V163, P76, DOI 10.1001/archinte.163.1.76; Sandri-Goldin RM., 2006, ALPH HERP MOL CELL; Shia SY, 2007, J CHROMATOGR B, V859, P119, DOI 10.1016/j.jchromb.2007.09.016; Stanberry LR, 2004, HERPES S3, V11, p161A; Stanford JA, 1998, NEUROSCI LETT, V241, P41, DOI 10.1016/S0304-3940(97)00974-9; Swetter SM, 1998, J INFECT DIS, V177, P543, DOI 10.1086/514229; VILLAMIL SM, 1995, ANTIVIR CHEM CHEMOTH, V6, P239, DOI 10.1177/095632029500600406; Wang QY, 2005, P NATL ACAD SCI USA, V102, P16055, DOI 10.1073/pnas.0505850102; Wang X, 2008, J SEP SCI, V31, P3543, DOI 10.1002/jssc.200800322; Zheng XY, 2009, ARCH PHARM RES, V32, P1245, DOI 10.1007/s12272-009-1910-x; Zhou CH, 2002, J VIROL, V76, P5893, DOI 10.1128/JVI.76.12.5893-5904.2002	42	19	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77937	10.1371/journal.pone.0077937	http://dx.doi.org/10.1371/journal.pone.0077937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167591	Green Published, gold, Green Submitted			2022-12-27	WOS:000326034500050
J	Berger, L; Wilde, A				Berger, Lloyd; Wilde, Andrew			Glycolytic Metabolites Are Critical Modulators of Oocyte Maturation and Viability	PLOS ONE			English	Article							XENOPUS-LAEVIS OOCYTES; FROG OOCYTES; CELL-DEATH; IN-VIVO; APOPTOSIS; CARBON; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; AVAILABILITY; CASPASE-2; NEURONS	The maturation of an oocyte into an egg is a key step in preparation for fertilization. In Xenopus, oocyte maturation is independent of transcription, being regulated at the level of translation and post-translational modifications of proteins. To identify factors involved in the maturation process we used two-dimensional differential gel electrophoresis to compare the proteome of oocytes and eggs. Protein abundance changes were observed in multiple cellular pathways during oocyte maturation. Most prominent was a general reduction in abundance of enzymes in the glycolytic pathway. Injection into oocytes of the glycolytic intermediates glyceraldehyde-3-phosphate, phosphoenolpyruvate and glucose-6-phosphate prevented oocyte maturation. Instead, these metabolites stimulated ROS production and subsequent apoptosis of the oocyte. In contrast, all other metabolites tested had no effect on oocyte maturation and did not induce apoptosis. These data suggest that a subset of glycolytic metabolites have the capacity to regulate oocyte viability.	[Wilde, Andrew] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University of Toronto	Wilde, A (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	andrew.wilde@utoronto.ca		Wilde, Andrew/0000-0002-9812-3847	Canadian Institute for Health Research [CTP-79838]; Canadian Cancer Society [2011-700741]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS))	The work was supported by Canadian Institute for Health Research, team grant CTP-79838 and Canadian Cancer Society, 2011-700741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRACHET J, 1975, DIFFERENTIATION, V3, P3, DOI 10.1111/j.1432-0436.1975.tb00840.x; CICIRELLI MF, 1985, DEV BIOL, V108, P254, DOI 10.1016/0012-1606(85)90029-6; Coll O, 2007, J LIPID RES, V48, P1924, DOI 10.1194/jlr.M700069-JLR200; Covarrubias L, 2008, DEV BIOL, V320, P1, DOI 10.1016/j.ydbio.2008.04.041; DESCHEPPER GG, 1987, HISTOCHEM J, V19, P467, DOI 10.1007/BF01675415; Dumollard R, 2007, DEVELOPMENT, V134, P455, DOI 10.1242/dev.02744; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; DWORKIN MB, 1991, TRENDS BIOCHEM SCI, V16, P229, DOI 10.1016/0968-0004(91)90091-9; DWORKIN MB, 1989, DEV BIOL, V132, P524, DOI 10.1016/0012-1606(89)90247-9; DWORKIN MB, 1990, DEV BIOL, V138, P177, DOI 10.1016/0012-1606(90)90187-N; Hammes SR, 2004, MOL ENDOCRINOL, V18, P769, DOI 10.1210/me.2003-0317; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Jessus C, 2004, BIOL CELL, V96, P187, DOI 10.1016/j.biolcel.2003.12.007; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Maller J L, 1980, Curr Top Cell Regul, V16, P271; Nutt LK, 2012, SEMIN CELL DEV BIOL, V23, P412, DOI 10.1016/j.semcdb.2012.03.015; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Pan James G, 2007, Sci STKE, V2007, ppe14; Preller A, 1999, FEBS LETT, V446, P149, DOI 10.1016/S0014-5793(99)00192-1; Preller A, 2007, FEBS LETT, V581, P663, DOI 10.1016/j.febslet.2007.01.029; Sen A, 2011, STEROIDS, V76, P822, DOI 10.1016/j.steroids.2011.02.016; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; Ureta T, 2000, FEBS LETT, V475, P145, DOI 10.1016/S0014-5793(00)01646-X; Ureta T, 2001, IUBMB LIFE, V51, P5, DOI 10.1080/15216540152034993; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhou Y, 2009, MOL CELL BIOL, V29, P1786, DOI 10.1128/MCB.01815-08	30	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77612	10.1371/journal.pone.0077612	http://dx.doi.org/10.1371/journal.pone.0077612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167578	Green Submitted, Green Published, gold			2022-12-27	WOS:000326034500037
J	Hol, FJH; Galajda, P; Nagy, K; Woolthuis, RG; Dekker, C; Keymer, JE				Hol, Felix J. H.; Galajda, Peter; Nagy, Krisztina; Woolthuis, Rutger G.; Dekker, Cees; Keymer, Juan E.			Spatial Structure Facilitates Cooperation in a Social Dilemma: Empirical Evidence from a Bacterial Community	PLOS ONE			English	Article							STATIONARY-PHASE; ESCHERICHIA-COLI; PRISONERS-DILEMMA; EXPONENTIAL-GROWTH; SIMPSONS PARADOX; GENE-EXPRESSION; EVOLUTION; COMPETITION; GAME; DISPERSAL	Cooperative organisms are ubiquitous in nature, despite their vulnerability to exploitation by cheaters. Although numerous theoretical studies suggest that spatial structure is critical for cooperation to persist, the spatial ecology of microbial cooperation remains largely unexplored experimentally. By tracking the community dynamics of cooperating (rpoS wildtype) and cheating (rpoS mutant) Escherichia coli in well-mixed flasks and microfabricated habitats, we demonstrate that spatial structure stabilizes coexistence between wild-type and mutant and thus facilitates cooperator maintenance. We develop a method to interpret our experimental results in the context of game theory, and show that the game wild-type and mutant bacteria play in an unstructured environment changes markedly over time, and eventually obeys a prisoner's dilemma leading to cheater dominance. In contrast, when wild-type and mutant E. coli co-inhabit a spatially-structured habitat, cooperators and cheaters coexist at intermediate frequencies. Our findings show that even in microhabitats lacking patchiness or spatial heterogeneities in resource availability, surface growth allows cells to form multi-cellular aggregates, yielding a self-structured community in which cooperators persist.	[Hol, Felix J. H.; Galajda, Peter; Woolthuis, Rutger G.; Dekker, Cees; Keymer, Juan E.] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands; [Galajda, Peter; Nagy, Krisztina] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Keymer, Juan E.] Inst Ecol & Biodiversidad, Santiago, Chile	Delft University of Technology; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Hol, FJH (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands.	f.j.h.hol@tudelft.nl; juan.keymer@gmail.com	Hol, Felix/AAL-3588-2021	Hol, Felix/0000-0001-8061-0826; Galajda, Peter/0000-0003-3308-088X; Dekker, Cees/0000-0001-6273-071X	European Research Council [247072]; Hungarian Academy of Sciences	European Research Council(European Research Council (ERC)European Commission); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by a European Research Council grant NanoforBio (no. 247072) to CD. PG was supported by the Lendulet' program of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; Chuang JS, 2009, SCIENCE, V323, P272, DOI 10.1126/science.1166739; Diard M, 2013, NATURE, V494, P353, DOI 10.1038/nature11913; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4; Edelstein A., 2010, CURR PROTOC MOL BIOL, V14, P20; Fiegna F, 2003, P ROY SOC B-BIOL SCI, V270, P1527, DOI 10.1098/rspb.2003.2387; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Frey E, 2010, PHYSICA A, V389, P4265, DOI 10.1016/j.physa.2010.02.047; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Greig D, 2004, P R SOC LONDON B, V271; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HUISMAN GW, 1994, SCIENCE, V265, P537, DOI 10.1126/science.7545940; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P17290, DOI 10.1073/pnas.0607971103; Keymer JE, 2008, P NATL ACAD SCI USA, V105, P20269, DOI 10.1073/pnas.0810792105; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Kummerli R, 2009, EVOLUTION, V63, P939, DOI 10.1111/j.1558-5646.2008.00548.x; Lambert G, 2011, J BACTERIOL, V193, P1878, DOI 10.1128/JB.01430-10; LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x; Lenski R., 2001, SELECTION, V1, P89; Lion S, 2008, ECOL LETT, V11, P277, DOI 10.1111/j.1461-0248.2007.01132.x; MacLean RC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000486; Maynard Smith J., 1982, pi; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Penn AS, 2012, FEMS IMMUNOL MED MIC, V65, P226, DOI 10.1111/j.1574-695X.2012.00970.x; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Popat R, 2012, P ROY SOC B-BIOL SCI, V279, P4765, DOI 10.1098/rspb.2012.1976; Rahman M, 2006, BIOTECHNOL BIOENG, V94, P585, DOI 10.1002/bit.20858; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; SCHUSTER P, 1983, J THEOR BIOL, V100, P533, DOI 10.1016/0022-5193(83)90445-9; Skyrms B, 2003, STAG HUNT EVOLUTION; Turner PE, 1999, NATURE, V398, P441, DOI 10.1038/18913; Turner PE, 2003, AM NAT, V161, P497, DOI 10.1086/367880; Vulic M, 2001, GENETICS, V158, P519; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Wingreen NS, 2006, PLOS BIOL, V4, P1486, DOI 10.1371/journal.pbio.0040299; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	49	43	44	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77042	10.1371/journal.pone.0077042	http://dx.doi.org/10.1371/journal.pone.0077042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167557	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500016
J	Magombedze, G; Ngonghala, CN; Lanzas, C				Magombedze, Gesgam; Ngonghala, Calistus N.; Lanzas, Cristina			Evalution of the "Iceberg Phenomenon" in Johne's Disease through Mathematical Modelling	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; DAIRY-CATTLE; TRANSMISSION; CALVES; REPRODUCTION; ENVIRONMENT; INFECTION; MAP	Johne's disease (JD) is a chronic, enteric disease in ruminants caused by Mycobacterium avium subsp. paratuberculosis (MAP). Disease progression follows four distinct stages: silent, subclinical, clinical and advanced. Available diagnostic tests have poor sensitivity and cannot detect early stages of the infection; as a result, only animals in the clinical and advanced stages, which represent the tip of the 'iceberg', are identified through testing. The Iceberg Phenomenon is then applied to provide estimates for JD prevalence. For one animal in the advanced stage, it is assumed that there are one to two in the clinical stage, four to eight in the subclinical stage, and ten to fourteen in the silent stage. These ratios, however, are based on little evidence. To evaluate the ratios, we developed a deterministic ordinary differential equation model of JD transmission and disease progression dynamics. When duration periods associated with the natural course of the disease progression are used, the above ratios do not hold. The ratios used to estimate JD prevalence need to be further investigated.	[Magombedze, Gesgam; Ngonghala, Calistus N.; Lanzas, Cristina] Univ Tennessee, Natl Inst Math & Biol Synth NIMBioS, Knoxville, TN USA; [Lanzas, Cristina] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Magombedze, G (corresponding author), Univ Tennessee, Natl Inst Math & Biol Synth NIMBioS, Knoxville, TN USA.	gmagombedze@nimbios.org	Ngonghala, Calistus/AAL-5812-2021; Ngonghala, Calistus N/C-5543-2014	Ngonghala, Calistus/0000-0002-8441-9495; Ngonghala, Calistus N/0000-0002-8441-9495; Magombedze, Gesham/0000-0003-2745-3475; Lanzas, Cristina/0000-0002-4039-0336	National Institute for Mathematical and Biological Synthesis (NIMBioS); National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF [EF-250832858]; University of Tennessee, Knoxville; Direct For Biological Sciences [1300426] Funding Source: National Science Foundation	National Institute for Mathematical and Biological Synthesis (NIMBioS)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF(National Science Foundation (NSF)); University of Tennessee, Knoxville; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors acknowledge the support of the National Institute for Mathematical and Biological Synthesis (NIMBioS), an Institute sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF Award #EF-250832858, with additional support from The University of Tennessee, Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedictus A, 2008, PREV VET MED, V83, P215, DOI 10.1016/j.prevetmed.2007.07.008; Buergelt C. D., 2003, International Journal of Applied Research in Veterinary Medicine, V1, P279; Calder R, WHAT IS JOHNES DIS; Chacon O, 2004, ANNU REV MICROBIOL, V58, P329, DOI 10.1146/annurev.micro.58.030603.123726; Council of Agricultural Science and Technology, 2001, JOHN DIS CATTL; Coussens Paul M., 2001, Animal Health Research Reviews, V2, P141; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Humphry RW, 2006, VET J, V172, P432, DOI 10.1016/j.tvjl.2005.07.017; Jubb T, 2000, VET MICROBIOL, V77, P423, DOI 10.1016/S0378-1135(00)00327-8; Marce C, 2010, J DAIRY SCI, V93, P4455, DOI 10.3168/jds.2010-3139; Marce C, 2011, PREVENTIVE VET MED; Mitchell RM, 2008, PREV VET MED, V83, P360, DOI 10.1016/j.prevetmed.2007.09.006; Mitchell RM, 2012, EPIDEMIOL INFECT, V140, P231, DOI 10.1017/S0950268811000689; Smith RL, 2010, J DAIRY SCI, V93, P3513, DOI 10.3168/jds.2009-2742; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Stabel J. R., 2006, Animal Health Research Reviews, V7, P61, DOI 10.1017/S1466252307001168; Stabel JR, 2011, CLIN VACCINE IMMUNOL, V18, P1139, DOI 10.1128/CVI.00058-11; Stabel JR, 2011, CLIN VACCINE IMMUNOL, V18, P393, DOI 10.1128/CVI.00359-10; Stewart DJ, 2004, VET MICROBIOL, V104, P165, DOI 10.1016/j.vetmic.2004.09.007; USDA, 2011, NATL JOHNES ED INITI, V2; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; van Roermund HJW, 2007, VET MICROBIOL, V122, P270, DOI 10.1016/j.vetmic.2007.01.016; Waters WR, 2003, INFECT IMMUN, V71, P5130, DOI 10.1128/IAI.71.9.5130-5138.2003; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2; Whittington R, 2011, VET IMMUNOLOGY IMMUN; Whittington RJ, 2004, APPL ENVIRON MICROB, V70, P2989, DOI 10.1128/AEM.70.5.2989-3004.2004; Whittington RJ, 2001, AUST VET J, V79, P267, DOI 10.1111/j.1751-0813.2001.tb11980.x	27	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76636	10.1371/journal.pone.0076636	http://dx.doi.org/10.1371/journal.pone.0076636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167547	Green Published, gold, Green Submitted			2022-12-27	WOS:000326034500006
J	Mendonca, C; Campos, G; Dias, P; Santos, JA				Mendonca, Catarina; Campos, Guilherme; Dias, Paulo; Santos, Jorge A.			Learning Auditory Space: Generalization and Long-Term Effects	PLOS ONE			English	Article							SOUND LOCALIZATION	Background: Previous findings have shown that humans can learn to localize with altered auditory space cues. Here we analyze such learning processes and their effects up to one month on both localization accuracy and sound externalization. Subjects were trained and retested, focusing on the effects of stimulus type in learning, stimulus type in localization, stimulus position, previous experience, externalization levels, and time. Method: We trained listeners in azimuth and elevation discrimination in two experiments. Half participated in the azimuth experiment first and half in the elevation first. In each experiment, half were trained in speech sounds and half in white noise. Retests were performed at several time intervals: just after training and one hour, one day, one week and one month later. In a control condition, we tested the effect of systematic retesting over time with post-tests only after training and either one day, one week, or one month later. Results: With training all participants lowered their localization errors. This benefit was still present one month after training. Participants were more accurate in the second training phase, revealing an effect of previous experience on a different task. Training with white noise led to better results than training with speech sounds. Moreover, the training benefit generalized to untrained stimulus-position pairs. Throughout the post-tests externalization levels increased. In the control condition the long-term localization improvement was not lower without additional contact with the trained sounds, but externalization levels were lower. Conclusion: Our findings suggest that humans adapt easily to altered auditory space cues and that such adaptation spreads to untrained positions and sound types. We propose that such learning depends on all available cues, but each cue type might be learned and retrieved differently. The process of localization learning is global, not limited to stimulus-position pairs, and it differs from externalization processes.	[Mendonca, Catarina] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, D-26111 Oldenburg, Germany; [Mendonca, Catarina] Aalto Univ, Dept Signal Proc & Acoust, Espoo, Finland; [Mendonca, Catarina; Santos, Jorge A.] Univ Minho, Sch Engn, Ctr Algoritmi, Guimaraes, Portugal; [Campos, Guilherme; Dias, Paulo] Univ Aveiro, Inst Elect & Telemat Engn, P-3800 Aveiro, Portugal; [Santos, Jorge A.] Univ Minho, Dept Basic Psychol, Braga, Portugal	Carl von Ossietzky Universitat Oldenburg; Aalto University; Universidade do Minho; Universidade de Aveiro; Universidade do Minho	Mendonca, C (corresponding author), Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, D-26111 Oldenburg, Germany.	catarina.mendonca@uni-oldenburg.de	Dias, Paulo PMD/G-3681-2013; Campos, Guilherme/AAD-1804-2021; Mendonça, Catarina/L-8877-2013	Dias, Paulo PMD/0000-0002-3754-2749; Campos, Guilherme/0000-0001-6018-6191; Mendonça, Catarina/0000-0002-4333-898X; Santos, Jorge/0000-0001-5881-8567	Portuguese Foundation for Science and Technology; FEDER [SFRH/BD/36345/2007, PTDC/EEA-ELC/112137/2009, FCOMP-01-0124-FEDER-007560, FCOMP-01-0124-FEDER-022674, PEst-OE/ECI/UI4047/2011]; Fundação para a Ciência e a Tecnologia [PTDC/EEA-ELC/112137/2009] Funding Source: FCT	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FEDER(European Commission); Fundação para a Ciência e a Tecnologia	This work was supported by the Portuguese Foundation for Science and Technology and FEDER, with the research grant SFRH/BD/36345/2007 and the funded projects PTDC/EEA-ELC/112137/2009, FCOMP-01-0124-FEDER-007560, FCOMP-01-0124-FEDER-022674 and PEst-OE/ECI/UI4047/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algazi VR, 2001, PROCEEDINGS OF THE 2001 IEEE WORKSHOP ON THE APPLICATIONS OF SIGNAL PROCESSING TO AUDIO AND ACOUSTICS, P99, DOI 10.1109/ASPAA.2001.969552; Dorman MF, 2003, EAR HEARING, V24, P457, DOI 10.1097/01.AUD.0000090438.20404.D9; Fozard JL, 2011, HDB PSYCHOL AGING; Gross Liza, 2006, PLoS Biol, V4, pe104, DOI 10.1371/journal.pbio.0040104; Hofman PM, 1998, NAT NEUROSCI, V1, P417, DOI 10.1038/1633; Honda A, 2007, APPL ACOUST, V68, P885, DOI 10.1016/j.apacoust.2006.08.007; Irving S, 2001, HEARING RES, V280, P100; Kacelnik O, 2006, PLOS BIOL, V4, P627, DOI 10.1371/journal.pbio.0040071; King AJ, 2001, AUDIOL NEURO-OTOL, V6, P182, DOI 10.1159/000046829; Mendonca C, 2012, J AUDIO ENG SOC, V60, P821; Shinn-Cunningham B, 2000, PERCEPT PSYCHOPHYS, V62, P33, DOI 10.3758/BF03212059; Smith MW, 2006, J ACOUST SOC AM, V120, P4019, DOI 10.1121/1.2359235; Tyler R S, 1979, Br J Audiol Suppl, V2, P29, DOI 10.3109/03005367909076374; Wright BA, 2009, PHILOS T R SOC B, V364, P301, DOI 10.1098/rstb.2008.0262; Zahorik P, 2006, J ACOUST SOC AM, V120, P343, DOI 10.1121/1.2208429	15	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77900	10.1371/journal.pone.0077900	http://dx.doi.org/10.1371/journal.pone.0077900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167588	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500047
J	Takahashi, H; Nakayama, R; Hayashi, S; Nemoto, T; Murase, Y; Nomura, K; Takahashi, T; Kubo, K; Marui, S; Yasuhara, K; Nakamura, T; Sueo, T; Takahashi, A; Tsutsumiuchi, K; Ohta, T; Kawai, A; Sugita, S; Yamamoto, S; Kobayashi, T; Honda, H; Yoshida, T; Hasegawa, T				Takahashi, Hiro; Nakayama, Robert; Hayashi, Shuhei; Nemoto, Takeshi; Murase, Yasuyuki; Nomura, Koji; Takahashi, Teruyoshi; Kubo, Kenji; Marui, Shigetaka; Yasuhara, Koji; Nakamura, Tetsuro; Sueo, Takuya; Takahashi, Anna; Tsutsumiuchi, Kaname; Ohta, Tsutomu; Kawai, Akira; Sugita, Shintaro; Yamamoto, Shinjiro; Kobayashi, Takeshi; Honda, Hiroyuki; Yoshida, Teruhiko; Hasegawa, Tadashi			Macrophage Migration Inhibitory Factor and Stearoyl-CoA Desaturase 1: Potential Prognostic Markers for Soft Tissue Sarcomas Based on Bioinformatics Analyses	PLOS ONE			English	Article							ADAPTIVE RESONANCE THEORY; MALIGNANT FIBROUS HISTIOCYTOMA; BOOSTED FUZZY CLASSIFIER; GENE-EXPRESSION ANALYSIS; PART FILTERING METHOD; SWEEP OPERATOR METHOD; LUNG-CANCER CELLS; ARABIDOPSIS-THALIANA; POOR-PROGNOSIS; TUMOR-GROWTH	The diagnosis and treatment of soft tissue sarcomas (STSs) has been particularly difficult, because STSs are a group of highly heterogeneous tumors in terms of histopathology, histological grade, and primary site. Recent advances in genome technologies have provided an excellent opportunity to determine the complete biological characteristics of neoplastic tissues, resulting in improved diagnosis, treatment selection, and investigation of therapeutic targets. We had previously developed a novel bioinformatics method for marker gene selection and applied this method to gene expression data from STS patients. This previous analysis revealed that the extracted gene combination of macrophage migration inhibitory factor (MIF) and stearoyl-CoA desaturase 1 (SCD1) is an effective diagnostic marker to discriminate between subtypes of STSs with highly different outcomes. In the present study, we hypothesize that the combination of MIF and SCD1 is also a prognostic marker for the overall outcome of STSs. To prove this hypothesis, we first analyzed microarray data from 88 STS patients and their outcomes. Our results show that the survival rates for MIF- and SCD1-positive groups were lower than those for negative groups, and the p values of the log-rank test are 0.0146 and 0.00606, respectively. In addition, survival rates are more significantly different (p = 0.000116) between groups that are double-positive and double-negative for MIF and SCD1. Furthermore, in vitro cell growth inhibition experiments by MIF and SCD1 inhibitors support the hypothesis. These results suggest that the gene set is useful as a prognostic marker associated with tumor progression.	[Takahashi, Hiro] Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan; [Takahashi, Hiro; Takahashi, Teruyoshi; Kubo, Kenji; Marui, Shigetaka; Yasuhara, Koji; Nakamura, Tetsuro; Tsutsumiuchi, Kaname; Kobayashi, Takeshi] Chubu Univ, Grad Sch Biosci & Biotechnol, Kasugai, Aichi 487, Japan; [Takahashi, Hiro; Sueo, Takuya; Takahashi, Anna; Kobayashi, Takeshi] Chubu Univ, Plant Biol Res Ctr, Kasugai, Aichi 487, Japan; [Takahashi, Hiro; Nakayama, Robert; Nemoto, Takeshi; Ohta, Tsutomu; Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 104, Japan; [Nakayama, Robert] Natl Canc Ctr, Res Inst, Canc Transcriptome Project, Tokyo 104, Japan; [Nakayama, Robert] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Hayashi, Shuhei; Yamamoto, Shinjiro] Sojo Univ, Fac Biotechnol & Life Sci, Dept Appl Life Sci, Kumamoto, Japan; [Nemoto, Takeshi] Tokyo Med & Dent Univ, Dept Dermatol, Tokyo, Japan; [Murase, Yasuyuki; Nomura, Koji; Honda, Hiroyuki] Nagoya Univ, Sch Engn, Dept Biotechnol, Nagoya, Aichi, Japan; [Kawai, Akira] Natl Canc Ctr, Orthoped Div, Tokyo, Japan; [Sugita, Shintaro; Hasegawa, Tadashi] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Sapporo, Hokkaido, Japan; [Hasegawa, Tadashi] Natl Canc Ctr, Div Pathol, Tokyo, Japan	Chiba University; Chubu University; Chubu University; National Cancer Center - Japan; National Cancer Center - Japan; Keio University; Sojo University; Tokyo Medical & Dental University (TMDU); Nagoya University; National Cancer Center - Japan; Sapporo Medical University; National Cancer Center - Japan	Takahashi, H (corresponding author), Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan.	hiro.takahashi@chiba-u.jp	Takahashi, Hiro/E-6746-2013	Takahashi, Hiro/0000-0002-8230-9524	Ministry of Education, Culture and Sports, Science and Technology of Japan [21710211, 24710222]; Futaba Electronics Memorial Foundation	Ministry of Education, Culture and Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Futaba Electronics Memorial Foundation	This work was supported by the Ministry of Education, Culture and Sports, Science and Technology of Japan [Grants-in-Aid for Scientific Research to Young Scientists (B) (No. 21710211 and 24710222 to HT) and by Futaba Electronics Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong ME, 2008, J IMMUNOL, V180, P7125, DOI 10.4049/jimmunol.180.11.7125; Baron N, 2011, J NEUROSCI RES, V89, P711, DOI 10.1002/jnr.22595; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Castro LFC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-132; Chiba Y, 2013, PLANT CELL PHYSIOL, V54, P180, DOI 10.1093/pcp/pcs164; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Cross JV, 2009, BIOCHEM J, V423, P315, DOI 10.1042/BJ20091170; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Dessein AF, 2010, CANCER RES, V70, P4644, DOI 10.1158/0008-5472.CAN-09-3828; Du XN, 2012, CANCER RES, V72, P5843, DOI 10.1158/0008-5472.CAN-12-1329; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Fletcher CDM., 2002, WHO CLASSIFICATION T; Gatta G, 2011, EUR J CANCER, V47, P2493, DOI 10.1016/j.ejca.2011.08.008; GEORGE M, 1962, P SOC EXP BIOL MED, V111, P514; GUSTAFSON P, 1994, ACTA ORTHOP SCAND, V65, P1; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Han I, 2008, CLIN ORTHOP RELAT R, V466, P2107, DOI 10.1007/s11999-008-0333-1; He XX, 2009, MOL MED, V15, P1, DOI 10.2119/molmed.2008.00107; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Igal R Ariel, 2011, Cancers (Basel), V3, P2462, DOI 10.3390/cancers3022462; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Iwasaki M, 2013, DEVELOPMENT, V140, P1958, DOI 10.1242/dev.085365; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kawamura T, 2008, J BIOSCI BIOENG, V105, P81, DOI 10.1263/jbb.105.81; Kojima S, 2011, PLANT CELL PHYSIOL, V52, P1259, DOI 10.1093/pcp/pcr083; Kotooka N, 2013, INT J CARDIOL, V167, P1068, DOI 10.1016/j.ijcard.2012.10.066; Krockenberger M, 2012, ANTICANCER RES, V32, P5233; Leech M, 1999, ARTHRITIS RHEUM, V42, P1601, DOI 10.1002/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B; LI J, 1994, INT J CANCER, V57, P348, DOI 10.1002/ijc.2910570310; Liao B, 2010, J SURG ONCOL, V102, P844, DOI 10.1002/jso.21728; Lin SG, 2000, CIRC RES, V87, P1202, DOI 10.1161/01.RES.87.12.1202; Liu H, 2013, J CANCER RES CLIN, V139, P287, DOI 10.1007/s00432-012-1330-z; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; Matsuo N, 2009, PLANT BIOTECHNOL-NAR, V26, P385, DOI 10.5511/plantbiotechnology.26.385; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakagawa A, 2012, PLANT MOL BIOL, V79, P569, DOI 10.1007/s11103-012-9929-7; Nakayama R, 2007, MODERN PATHOL, V20, P749, DOI 10.1038/modpathol.3800794; Nashed M, 2012, EXP BIOL MED, V237, P1007, DOI 10.1258/ebm.2012.012126; Oballa RM, 2011, J MED CHEM, V54, P5082, DOI 10.1021/jm200319u; Piette C, 2009, J BIOL CHEM, V284, P32483, DOI 10.1074/jbc.M109.014589; Rendon BE, 2007, J BIOL CHEM, V282, P29910, DOI 10.1074/jbc.M704898200; Rolan P, 2008, BRIT J CLIN PHARMACO, V66, P792, DOI 10.1111/j.1365-2125.2008.03270.x; Roongta UV, 2011, MOL CANCER RES, V9, P1551, DOI 10.1158/1541-7786.MCR-11-0126; Sano M, 2010, INT J ONCOL, V36, P321, DOI 10.3892/ijo_00000503; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Scaglia N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006812; Schrader J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-464; Simpson KD, 2012, J IMMUNOL, V189, P5533, DOI 10.4049/jimmunol.1201161; Sun B, 2005, CLIN CANCER RES, V11, P1050; Sun BL, 2003, INT J MOL MED, V12, P633; Takahashi H, 2003, J BIOSCI BIOENG, V96, P154, DOI 10.1263/jbb.96.154; Takahashi H, 2005, BIOINFORMATICS, V21, P179, DOI 10.1093/bioinformatics/bth473; Takahashi H, 2006, J BIOSCI BIOENG, V101, P137, DOI 10.1263/jbb.101.137; Takahashi H, 2005, J CHEM ENG JPN, V38, P763, DOI 10.1252/jcej.38.763; Takahashi H, 2013, J BIOSCI BIOENG, DOI [10.1016/j.jbiosc.2013.05.021, DOI 10.1016/J.JBI0SC.2013.05.021.PUBMED:23816762]; Takahashi H, 2008, J BIOSCI BIOENG, V106, P587, DOI 10.1263/jbb.106.587; Takahashi H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-399; Takahashi H, 2007, BIOCHEM ENG J, V33, P100, DOI 10.1016/j.bej.2006.08.004; Takahashi H, 2006, J BIOSCI BIOENG, V102, P46, DOI 10.1263/jbb.102.46; Takahashi H, 2006, BIOINFORMATICS, V22, P1662, DOI 10.1093/bioinformatics/btl156; Takahashi H, 2013, PLANT CELL PHYSIOL, V54, P418, DOI 10.1093/pcp/pct027; Takahashi H, 2012, J BIOSCI BIOENG, V114, P570, DOI 10.1016/j.jbiosc.2012.05.017; Takahashi H, 2012, BIOINFORMATICS, V28, P2231, DOI 10.1093/bioinformatics/bts303; Takahashi H, 2006, J CHEM ENG JPN, V39, P767, DOI 10.1252/jcej.39.767; Wang XB, 2012, J NEURO-ONCOL, V106, P43, DOI 10.1007/s11060-011-0640-3; Watanabe I, 1998, TOHOKU J EXP MED, V184, P173, DOI 10.1620/tjem.184.173; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Yajima I, 2012, AM J CANCER RES, V2, P322; Yoshimura K, 2011, PLANT CELL PHYSIOL, V52, P1786, DOI 10.1093/pcp/pcr115; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125	75	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78250	10.1371/journal.pone.0078250	http://dx.doi.org/10.1371/journal.pone.0078250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167613	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500074
J	Lonardo, E; Cioffi, M; Sancho, P; Sanchez-Ripoll, Y; Trabulo, SM; Dorado, J; Balic, A; Hidalgo, M; Heeschen, C				Lonardo, Enza; Cioffi, Michele; Sancho, Patricia; Sanchez-Ripoll, Yolanda; Maria Trabulo, Sara; Dorado, Jorge; Balic, Anamaria; Hidalgo, Manuel; Heeschen, Christopher			Metformin Targets the Metabolic Achilles Heel of Human Pancreatic Cancer Stem Cells	PLOS ONE			English	Article							STELLATE CELLS; SELF-RENEWAL; EPIDEMIOLOGY; INHIBITION; RISK	Pancreatic ductal adenocarcinomas contain a subset of exclusively tumorigenic cancer stem cells (CSCs), which are capable of repopulating the entire heterogeneous cancer cell populations and are highly resistant to standard chemotherapy. Here we demonstrate that metformin selectively ablated pancreatic CSCs as evidenced by diminished expression of pluripotency-associated genes and CSC-associated surface markers. Subsequently, the ability of metformin-treated CSCs to clonally expand in vitro was irreversibly abrogated by inducing apoptosis. In contrast, non-CSCs preferentially responded by cell cycle arrest, but were not eliminated by metformin treatment. Mechanistically, metformin increased reactive oxygen species production in CSC and reduced their mitochondrial transmembrane potential. The subsequent induction of lethal energy crisis in CSCs was independent of AMPK/mTOR. Finally, in primary cancer tissue xenograft models metformin effectively reduced tumor burden and prevented disease progression; if combined with a stroma-targeting smoothened inhibitor for enhanced tissue penetration, while gemcitabine actually appeared dispensable.	[Lonardo, Enza; Cioffi, Michele; Sancho, Patricia; Sanchez-Ripoll, Yolanda; Maria Trabulo, Sara; Dorado, Jorge; Balic, Anamaria; Heeschen, Christopher] Spanish Natl Canc Res Ctr CNIO, Stem Cells & Canc Grp, Mol Pathol Programme, Madrid, Spain; [Hidalgo, Manuel] Spanish Natl Canc Res Ctr, Clin Res Programme CNIO, Gastrointestinal Canc Clin Res Unit, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Heeschen, C (corresponding author), Spanish Natl Canc Res Ctr CNIO, Stem Cells & Canc Grp, Mol Pathol Programme, Madrid, Spain.	cheeschen@cnio.es	Guba, Markus/M-4309-2019; lonardo, enza/AAI-5726-2020; HIDALGO, MANUEL/I-4995-2015; Sancho, Patricia/ABH-5258-2020	HIDALGO, MANUEL/0000-0002-3765-3318; Sancho, Patricia/0000-0002-1092-5395; Lonardo, Enza/0000-0001-6654-1043; Heeschen, Christopher/0000-0002-1158-8554; Balic, Anamaria/0000-0001-6796-1197; Cioffi, Michele/0000-0003-4180-5369	ERC [Pa-CSC 233460]; European Community [256974]; Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria [PS09/02129]; Ministerio de Ciencia e Innovacion, Spain [PLE2009-0105]; Roche; La Caixa	ERC(European Research Council (ERC)European Commission); European Community(European Commission); Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Roche(Roche Holding); La Caixa(La Caixa Foundation)	The research was supported by the ERC Advanced Investigator Grant (Pa-CSC 233460), European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no256974, the Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria (PS09/02129), and the Programa Nacional de Internacionalizacion de la I+D, Subprogramma: FCCI 2009 (PLE2009-0105; both Ministerio de Ciencia e Innovacion, Spain). E.L. is supported by the Roche Postdoctoral Fellowship Program. M.C. is supported by the La Caixa Predoctoral Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007; Bao B, 2012, CANCER PREV RES, V5, P355, DOI 10.1158/1940-6207.CAPR-11-0299; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Gallmeier E, 2011, STEM CELLS, V29, P418, DOI 10.1002/stem.595; Garrido-Laguna I, 2010, BRIT J CANCER, V103, P649, DOI 10.1038/sj.bjc.6605819; Hamada S, 2012, BIOCHEM BIOPH RES CO, V421, P349, DOI 10.1016/j.bbrc.2012.04.014; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Li DH, 2012, MOL CARCINOGEN, V51, P64, DOI 10.1002/mc.20771; Lonardo E, 2012, CELL CYCLE, V11, P1282, DOI 10.4161/cc.19679; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Lowenfels AB, 2006, BEST PRACT RES CL GA, V20, P197, DOI 10.1016/j.bpg.2005.10.001; Martin-Castillo B, 2010, CELL CYCLE, V9, P1057, DOI 10.4161/cc.9.6.10994; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Michaud D S, 2004, Minerva Chir, V59, P99; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Ouslimani N, 2005, METABOLISM, V54, P829, DOI 10.1016/j.metabol.2005.01.029; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Sadeghi N, 2012, CLIN CANC RES; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Von Hoff DD, 2011, CELL STEM CELL; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262	32	116	120	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76518	10.1371/journal.pone.0076518	http://dx.doi.org/10.1371/journal.pone.0076518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204632	Green Submitted, gold, Green Published			2022-12-27	WOS:000326029300031
J	Grama, CN; Suryanarayana, P; Patil, MA; Raghu, G; Balakrishna, N; Kumar, MNVR; Reddy, GB				Grama, Charitra N.; Suryanarayana, Palla; Patil, Madhoosudan A.; Raghu, Ganugula; Balakrishna, Nagalla; Kumar, M. N. V. Ravi; Reddy, Geereddy Bhanuprakash			Efficacy of Biodegradable Curcumin Nanoparticles in Delaying Cataract in Diabetic Rat Model	PLOS ONE			English	Article							OXIDATIVE STRESS; IN-VITRO; BIOAVAILABILITY; OFFICINALIS	Curcumin, the active principle present in the yellow spice turmeric, has been shown to exhibit various pharmacological actions such as antioxidant, anti-inflammatory, antimicrobial, and anti-carcinogenic activities. Previously we have reported that dietary curcumin delays diabetes-induced cataract in rats. However, low peroral bioavailability is a major limiting factor for the success of clinical utilization of curcumin. In this study, we have administered curcumin encapsulated nanoparticles in streptozotocin (STZ) induced diabetic cataract model. Oral administration of 2 mg/day nanocurcumin was significantly more effective than curcumin in delaying diabetic cataracts in rats. The significant delay in progression of diabetic cataract by nanocurcumin is attributed to its ability to intervene the biochemical pathways of disease progression such as protein insolubilization, polyol pathway, protein glycation, crystallin distribution and oxidative stress. The enhanced performance of nanocurcumin can be attributed probably to its improved oral bioavailability. Together, the results of the present study demonstrate the potential of nanocurcumin in managing diabetic cataract.	[Grama, Charitra N.; Kumar, M. N. V. Ravi] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Suryanarayana, Palla; Patil, Madhoosudan A.; Raghu, Ganugula; Balakrishna, Nagalla; Reddy, Geereddy Bhanuprakash] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India	University of Strathclyde; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Kumar, MNVR (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	mnvrkumar@strath.ac.uk; geereddy@yahoo.com	Patil, Madhoosudan/Y-9859-2019; Reddy, G Bhanuprakash/AAJ-3494-2020; Nagalla, Balakrishna/GRR-4393-2022	Patil, Madhoosudan/0000-0002-1586-2792; Reddy, G Bhanuprakash/0000-0003-4787-3944; Nagalla, Balakrishna/0000-0002-5613-0942	Indian Council of Medical Research, Department of Science & Technology, Department of Biotechnology, Government of India; University of Strathclyde; Indian Council of Medical Research, India	Indian Council of Medical Research, Department of Science & Technology, Department of Biotechnology, Government of India; University of Strathclyde; Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	GBR received grants from the Indian Council of Medical Research, Department of Science & Technology, Department of Biotechnology, Government of India; MNVR received from the University of Strathclyde; MAP received a research fellowship from Indian Council of Medical Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Anand P, 2010, BIOCHEM PHARMACOL, V79, P330, DOI 10.1016/j.bcp.2009.09.003; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Gabir MM, 2000, DIABETES CARE, V23, P1113, DOI 10.2337/diacare.23.8.1113; Grama CN, 2011, CURR OPIN COLLOID IN, V16, P238, DOI 10.1016/j.cocis.2010.11.005; Italia JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025744; Kowluru RA, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-8; Krishnaswamy K, 1998, INDIAN J MED RES, V108, P167; Kumar MNVR, 2012, DRUG DISCOV TODAY, V17, P407, DOI 10.1016/j.drudis.2012.01.024; Kumar PA, 2009, J NUTR BIOCHEM, V20, P553, DOI 10.1016/j.jnutbio.2008.05.015; Kyselova Z, 2004, J DIABETES COMPLICAT, V18, P129, DOI 10.1016/S1056-8727(03)00009-6; Mares JA, 2004, NUTR REV, V62, P28, DOI 10.1301/nr.2004.jan.28-32; Mittal G, 2011, J CONTROL RELEASE, V150, P220, DOI 10.1016/j.jconrel.2010.11.013; Mrudula T, 2007, BIOCHEM BIOPH RES CO, V361, P528, DOI 10.1016/j.bbrc.2007.07.059; Muthenna P, 2009, FEBS LETT, V583, P3637, DOI 10.1016/j.febslet.2009.10.042; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Premanand C, 2006, INVEST OPHTH VIS SCI, V47, P2179, DOI 10.1167/iovs.05-0580; Reddy PY, 2012, MOL VIS, V18, P495; Saraswat M, 2010, MOL VIS, V16, P1525; Shaikh J, 2009, EUR J PHARM SCI, V37, P223, DOI 10.1016/j.ejps.2009.02.019; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Sharma RA, 2007, ADV EXP MED BIOL, V595, P453; Spector A, 2000, J OCUL PHARMACOL TH, V16, P193, DOI 10.1089/jop.2000.16.193; Suryanarayana P, 2007, MOL VIS, V13, P1291; Suryanarayana P, 2005, INVEST OPHTH VIS SCI, V46, P2092, DOI 10.1167/iovs.04-1304; Suryanarayana P, 2003, MOL VIS, V9, P223; Takahashi M, 2009, J AGR FOOD CHEM, V57, P9141, DOI 10.1021/jf9013923; TAYLOR A, 1995, AM J CLIN NUTR, V62, P1439, DOI 10.1093/ajcn/62.6.1439S; Vasireddy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021193	33	69	72	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78217	10.1371/journal.pone.0078217	http://dx.doi.org/10.1371/journal.pone.0078217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155984	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000325887300118
J	Leung, KH; Lu, LH; Wang, MD; Mak, TY; Chan, DSH; Tang, FK; Leung, CH; Kwan, HY; Yu, ZL; Ma, DL				Leung, Ka-Ho; Lu, Lihua; Wang, Modi; Mak, Tsun-Yin; Chan, Daniel Shiu-Hin; Tang, Fung-Kit; Leung, Chung-Hang; Kwan, Hiu-Yee; Yu, Zhiling; Ma, Dik-Lung			A Label-Free Luminescent Switch-On Assay for ATP Using a G-Quadruplex-Selective Iridium(III) Complex	PLOS ONE			English	Article							MOLECULAR LIGHT SWITCH; APTAMER; PROBE; IONS	We report herein the G-quadruplex-selective property of a luminescent cyclometallated iridium(III) complex for the detection of adenosine-5'-triphosphate (ATP) in aqueous solution. The ATP-binding aptamer was employed as the ATP recognition unit, while the iridium(III) complex was used to monitor the formation of the G-quadruplex structure induced by ATP. The sensitivity and fold enhancement of the assay were higher than those of the previously reported assay using the organic dye crystal violet as a fluorescent probe. This label-free luminescent switch-on assay exhibits high sensitivity and selectivity towards ATP with a limit of detection of 2.5 mu M.	[Leung, Ka-Ho; Lu, Lihua; Wang, Modi; Mak, Tsun-Yin; Chan, Daniel Shiu-Hin; Tang, Fung-Kit; Ma, Dik-Lung] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China; [Leung, Chung-Hang] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China; [Kwan, Hiu-Yee; Yu, Zhiling] Hong Kong Baptist Univ, Sch Chinese Med, Ctr Canc & Inflammat Res, Hong Kong, Hong Kong, Peoples R China	Hong Kong Baptist University; University of Macau; Hong Kong Baptist University	Ma, DL (corresponding author), Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China.	edmondma@hkbu.edu.hk	Wang, Modi/ABG-9659-2021; Leung, KaHo/AAB-9337-2019	Leung, KaHo/0000-0002-2998-669X; Yu, Zhiling/0000-0002-2979-9608; Ma, Dik-Lung/0000-0002-9515-340X; KWAN, Hiu Yee/0000-0002-6088-7323	Hong Kong Baptist University [FRG2/11-12/009, FRG2/12-13/021]; Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund [HMRF/11101212]; Research Grants Council [HKBU/201811, HKBU/204612]; French National Research Agency/Research Grants Council Joint Research Scheme [A-HKBU201/12]; Science and Technology Development Fund, Macao SAR [001/2012/A]; University of Macau [MYRG091(Y2-L2)-ICMS12-LCH, MYRG121(Y2-L2)-ICMS12-LCH]	Hong Kong Baptist University; Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund; Research Grants Council(Hong Kong Research Grants Council); French National Research Agency/Research Grants Council Joint Research Scheme(French National Research Agency (ANR)); Science and Technology Development Fund, Macao SAR; University of Macau	This work is supported by Hong Kong Baptist University (FRG2/11-12/009, FRG2/12-13/021), Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU), the Health and Medical Research Fund (HMRF/11101212), the Research Grants Council (HKBU/201811 and HKBU/204612), the French National Research Agency/Research Grants Council Joint Research Scheme (A-HKBU201/12), the Science and Technology Development Fund, Macao SAR (001/2012/A) and the University of Macau (MYRG091(Y2-L2)-ICMS12-LCH and MYRG121(Y2-L2)-ICMS12-LCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Callan JF, 2008, J FLUORESC, V18, P1157, DOI 10.1007/s10895-008-0367-5; Chan DSH, 2009, CHEM COMMUN, P7479, DOI 10.1039/b913995h; Chen Z, 2008, ANAL BIOANAL CHEM, V392, P1185, DOI 10.1007/s00216-008-2342-z; Famulok M, 2011, ACCOUNTS CHEM RES, V44, P1349, DOI 10.1021/ar2000293; Guan XA, 2010, BIOMED MICRODEVICES, V12, P683, DOI 10.1007/s10544-010-9421-6; He HZ, 2013, NUCLEIC ACIDS RES, V41, P4345, DOI 10.1093/nar/gkt108; He HZ, 2013, BIOSENS BIOELECTRON, V41, P871, DOI 10.1016/j.bios.2012.08.060; He HZ, 2012, CHEM COMMUN, V48, P9462, DOI 10.1039/c2cc32253f; He HZ, 2012, ANALYST, V137, P1538, DOI 10.1039/c2an15999f; Leung CH, 2013, CHEM SCI, V4, P3781, DOI 10.1039/c3sc51228b; Leung CH, 2012, NUCLEIC ACIDS RES, V40, P941, DOI 10.1093/nar/gkr763; Leung KH, 2013, CHEM COMMUN, V49, P5630, DOI 10.1039/c3cc41129j; Leung KH, 2013, CHEM COMMUN, V49, P771, DOI 10.1039/c2cc37710a; Leung KH, 2012, RSC ADV, V2, P8273, DOI 10.1039/c2ra21119j; Liu F, 2011, CHEM BIODIVERS, V8, P311, DOI 10.1002/cbdv.201000130; Liu JW, 2009, CHEM REV, V109, P1948, DOI 10.1021/cr030183i; Ma DL, 2013, CHEM SCI, V4, P3366, DOI 10.1039/c3sc50924a; Ma DL, 2013, ANGEW CHEM INT EDIT, V52, P7666, DOI 10.1002/anie.201208414; Ma DL, 2013, CHEM SOC REV, V42, P3427, DOI 10.1039/c2cs35472a; Ma DL, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr106; Man BYW, 2010, CHEM COMMUN, V46, P8534, DOI 10.1039/c0cc01201g; Manikandan M, 2012, ANALYST, V137, P5128, DOI 10.1039/c2an35754b; Nakano S, 2013, J AM CHEM SOC, V135, P3465, DOI 10.1021/ja3097652; Perez-Ruiz T, 2003, ANAL BIOANAL CHEM, V377, P189, DOI 10.1007/s00216-003-2071-2; Shi S, 2012, DALTON T, V41, P5789, DOI 10.1039/c2dt30076a; Shi S, 2010, DALTON T, V39, P2490, DOI 10.1039/b916094a; Sitaula S, 2012, CHEM COMMUN, V48, P9284, DOI 10.1039/c2cc34279k; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang J, 2005, ANAL CHEM, V77, P3542, DOI 10.1021/ac050165w; Wang J, 2007, ADV MATER, V19, P3943, DOI 10.1002/adma.200602256; Wang YY, 2008, ANALYST, V133, P1593, DOI 10.1039/b806908e; Wang Y, 2013, ANAL CHEM, V85, P6775, DOI 10.1021/ac400858g; Wilner OI, 2012, CHEM REV, V112, P2528, DOI 10.1021/cr200104q; Yang YM, 2013, CHEM REV, V113, P192, DOI 10.1021/cr2004103; Yao JL, 2013, DALTON T, V42, P5661, DOI 10.1039/c3dt32640c; Zhang HF, 2012, J MATER CHEM, V22, P23900, DOI 10.1039/c2jm35379b; Zhang HQ, 2013, CHEM REV, V113, P2812, DOI 10.1021/cr300340p; Zhang ZX, 2012, ANAL CHEM, V84, P4789, DOI 10.1021/ac300348v; Zhao Q, 2006, INORG CHEM, V45, P6152, DOI 10.1021/ic052034j; Zhao Q, 2011, CHEM SOC REV, V40, P2508, DOI 10.1039/c0cs00114g; Zhao QA, 2010, CHEM SOC REV, V39, P3007, DOI 10.1039/b915340c; Zhou ZX, 2011, ANAL CHEM, V83, P5122, DOI 10.1021/ac200120g; Zinellu A, 2010, ELECTROPHORESIS, V31, P2854, DOI 10.1002/elps.201000138; Zuo XL, 2007, J AM CHEM SOC, V129, P1042, DOI 10.1021/ja067024b; Zuo XL, 2009, J AM CHEM SOC, V131, P6944, DOI 10.1021/ja901315w	45	23	23	5	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77021	10.1371/journal.pone.0077021	http://dx.doi.org/10.1371/journal.pone.0077021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204723	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400023
J	Antanasijevic, A; Cheng, H; Wardrop, DJ; Rong, LJ; Caffrey, M				Antanasijevic, Aleksandar; Cheng, Han; Wardrop, Duncan J.; Rong, Lijun; Caffrey, Michael			Inhibition of Influenza H7 Hemagglutinin-Mediated Entry	PLOS ONE			English	Article							VIRUS HEMAGGLUTININ; TERT-BUTYLHYDROQUINONE; CONFORMATIONAL-CHANGE; RECEPTOR-BINDING; MEMBRANE-FUSION; IDENTIFICATION; EMERGENCE; COMPLEX; ORIGIN; REGION	The recent outbreak of H7N9 influenza in China is of high concern to public health. H7 hemagglutinin (HA) plays a critical role in influenza entry and thus HA presents an attractive target for antivirals. Previous studies have suggested that the small molecule tert-butyl hydroquinone (TBHQ) inhibits the entry of influenza H3 HA by binding to the stem loop of HA and stabilizing the neutral pH conformation of HA, thereby disrupting the membrane fusion step. Based on amino acid sequence, structure and immunogenicity, H7 is a related Group 2 HA. In this work we show, using a pseudovirus entry assay, that TBHQ inhibits H7 HA-mediated entry, as well as H3 HA-mediated entry, with an IC50 similar to 6 mu M. Using NMR, we show that TBHQ binds to the H7 stem loop region. STD NMR experiments indicate that the aromatic ring of TBHQ makes extensive contact with the H7 HA surface. Limited proteolysis experiments indicate that TBHQ inhibits influenza entry by stabilizing the H7 HA neutral pH conformation. Together, this work suggests that the stem loop region of H7 HA is an attractive target for therapeutic intervention and that TBHQ, which is a widely used food preservative, is a promising lead compound.	[Antanasijevic, Aleksandar; Caffrey, Michael] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Cheng, Han; Rong, Lijun] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Wardrop, Duncan J.] Univ Illinois, Dept Chem, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Caffrey, M (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	caffrey@uic.edu		Cheng, Han/0000-0002-9464-8611; Wardrop, Duncan/0000-0002-1234-5626				BODIAN DL, 1993, BIOCHEMISTRY-US, V32, P2967, DOI 10.1021/bi00063a007; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cianci C, 1999, J VIROL, V73, P1785, DOI 10.1128/JVI.73.3.1785-1794.1999; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshpande MS, 2001, BIOORG MED CHEM LETT, V11, P2393, DOI 10.1016/S0960-894X(01)00459-0; Dreyfus C, 2013, J VIROL, V87, P7149, DOI 10.1128/JVI.02975-12; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gharavi N, 2007, CURR DRUG METAB, V8, P1, DOI 10.2174/138920007779315035; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Guo Y, 2009, J MOL BIOL, V394, P600, DOI 10.1016/j.jmb.2009.10.032; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Han T, 2011, ANN NY ACAD SCI, V1217, P178, DOI 10.1111/j.1749-6632.2010.05829.x; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hoffman LR, 1997, J VIROL, V71, P8808, DOI 10.1128/JVI.71.11.8808-8820.1997; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Ilyushina NA, 2007, J GEN VIROL, V88, P1266, DOI 10.1099/vir.0.82256-0; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Lagoja IM, 2008, MED RES REV, V28, P1, DOI 10.1002/med.20096; Lamb RA, 2013, AM J RESP CRIT CARE, V188, P1, DOI 10.1164/rccm.201305-0914ED; Lu SH, 2013, BIOSCI TRENDS, V7, P109, DOI 10.5582/bst.2013.v7.2.109; McCullough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033958; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Oka M, 2001, CHEM PHARM BULL, V49, P379, DOI 10.1248/cpb.49.379; Ramirez B, 2013, METH MOL BI IN PRESS; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Staschke KA, 1998, VIROLOGY, V248, P264, DOI 10.1006/viro.1998.9273; Ueda M, 1998, J CLIN MICROBIOL, V36, P340, DOI 10.1128/JCM.36.2.340-344.1998; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; VANESCH GJ, 1986, FOOD CHEM TOXICOL, V24, P1063, DOI 10.1016/0278-6915(86)90289-9; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Wang MX, 2012, J VIROL, V86, P4455, DOI 10.1128/JVI.07187-11; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yermolina MV, 2011, J MED CHEM, V54, P765, DOI 10.1021/jm1008715; Yu KL, 2002, BIOORG MED CHEM LETT, V12, P3379, DOI 10.1016/S0960-894X(02)00761-8; Zhu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029120	42	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76363	10.1371/journal.pone.0076363	http://dx.doi.org/10.1371/journal.pone.0076363			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194835	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000014
J	Guignard, R; Wilquin, JL; Richard, JB; Beck, F				Guignard, Romain; Wilquin, Jean-Louis; Richard, Jean-Baptiste; Beck, Francois			Tobacco Smoking Surveillance: Is Quota Sampling an Efficient Tool for Monitoring National Trends? A Comparison with a Random Cross-Sectional Survey	PLOS ONE			English	Article							PREVALENCE; ALCOHOL; TELEPHONE; NONRESPONSE; DRINKING; MODE	Objectives: It is crucial for policy makers to monitor the evolution of tobacco smoking prevalence. In France, this monitoring is based on a series of cross-sectional general population surveys, the Health Barometers, conducted every five years and based on random samples. A methodological study has been carried out to assess the reliability of a monitoring system based on regular quota sampling surveys for smoking prevalence. Design/Outcome Measures: In 2010, current and daily tobacco smoking prevalences obtained in a quota survey on 8,018 people were compared with those of the 2010 Health Barometer carried out on 27,653 people. Prevalences were assessed separately according to the telephone equipment of the interviewee (landline phone owner vs "mobile-only"), and logistic regressions were conducted in the pooled database to assess the impact of the telephone equipment and of the survey mode on the prevalences found. Finally, logistic regressions adjusted for sociodemographic characteristics were conducted in the random sample in order to determine the impact of the needed number of calls to interwiew "hard-to-reach" people on the prevalence found. Results: Current and daily prevalences were higher in the random sample (respectively 33.9% and 27.5% in 15-75 years-old) than in the quota sample (respectively 30.2% and 25.3%). In both surveys, current and daily prevalences were lower among landline phone owners (respectively 31.8% and 25.5% in the random sample and 28.9% and 24.0% in the quota survey). The required number of calls was slightly related to the smoking status after adjustment for sociodemographic characteristics. Conclusion: Random sampling appears to be more effective than quota sampling, mainly by making it possible to interview hard-to-reach populations.	[Guignard, Romain; Wilquin, Jean-Louis; Richard, Jean-Baptiste; Beck, Francois] Natl Inst Hlth Promot & Hlth Educ INPES, Sci Affairs Dept, St Denis, France; [Beck, Francois] Univ Paris 05, Cesames Team Cermes3, Med Res Ctr, CNRS,UMR 8211,INSERM,U988,Sorbonne Paris Cite,EHE, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Guignard, R (corresponding author), Natl Inst Hlth Promot & Hlth Educ INPES, Sci Affairs Dept, St Denis, France.	romain.guignard@inpes.sante.fr		Beck, Francois/0000-0002-4880-1638; Richard, Jean-Baptiste/0000-0002-4193-9159	French Institute for Health Promotion and Health Education (INPES)	French Institute for Health Promotion and Health Education (INPES)	The study was financially supported by the French Institute for Health Promotion and Health Education (INPES). The funder had no role in study design, data collection and analysis, or preparation of the manuscript, and allowed the publication of the study.	AQUILINO WS, 1990, PUBLIC OPIN QUART, V54, P362, DOI 10.1086/269212; BECK F, 2013, HLTH BAROMETER 2010; BECK F, 2011, WEEKLY EPIDEMIOL B, V21, P101; BECK F, 2008, METHODES SONDAGES CO, P254; BECK F, 2004, EUROPEAN STUDIES DRU, P113; Bogdanovica I, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.036103; Caetano R, 2003, ADDICTION, V98, P791, DOI 10.1046/j.1360-0443.2003.00407.x; CUMMING RG, 1994, COMMUNITY HEALTH ST, V14, P132; Delnevo Cristine D, 2009, Prev Med, V48, pS16, DOI 10.1016/j.ypmed.2008.09.008; Faugier J, 1997, J ADV NURS, V26, P790, DOI 10.1046/j.1365-2648.1997.00371.x; FIRDION JM, 1995, POPULATION, V5, P1281; GAUTIER A, 2006, SURVEY METHODS EUROP, P60; Gmel G, 2000, ADDICTION, V95, P123, DOI 10.1046/j.1360-0443.2000.95112313.x; Greenfield TK, 2000, ADDICTION, V95, P277, DOI 10.1046/j.1360-0443.2000.95227714.x; Grucza RA, 2007, ADDICTION, V102, P623, DOI 10.1111/j.1360-0443.2007.01745.x; Guilbert P, 1999, REV EPIDEMIOL SANTE, V47, P129; Hu SS, 2011, AM J EPIDEMIOL, V173, P703, DOI 10.1093/aje/kwq442; HUSKY MM, 2013, J AFFECT DI IN PRESS; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Midanik LT, 2003, DRUG ALCOHOL DEPEN, V72, P209, DOI 10.1016/S0376-8716(03)00204-7; Miller JW, 2004, AM J PREV MED, V27, P197, DOI 10.1016/j.amepre.2004.05.004; ORDEN SR, 1992, AM J EPIDEMIOL, V135, P697, DOI 10.1093/oxfordjournals.aje.a116349; Peretti-Watel P, 2009, ADDICTION, V104, P1718, DOI 10.1111/j.1360-0443.2009.02682.x; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; TURNER CF, 1992, US DEP HLTH HUMAN SE, V92; Van Loon AJM, 2003, ANN EPIDEMIOL, V13, P105, DOI 10.1016/S1047-2797(02)00257-0; World Health Organization, 2003, WHO FRAM CONV TOB CO; [No title captured]	28	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78372	10.1371/journal.pone.0078372	http://dx.doi.org/10.1371/journal.pone.0078372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194924	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000103
J	Li, MH; Tian, LL; Wang, L; Yao, HC; Zhang, JR; Lu, JG; Sun, YN; Gao, X; Xiao, H; Liu, M				Li, MingHua; Tian, LinLi; Wang, Lin; Yao, HongChao; Zhang, JiaRui; Lu, JianGuang; Sun, YaNan; Gao, Xu; Xiao, Hui; Liu, Ming			Down-Regulation of miR-129-5p Inhibits Growth and Induces Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting APC	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; BETA-CATENIN; MICRORNA EXPRESSION; CANCER; PROLIFERATION; TUMORIGENESIS; INVASION; MIRNAS; ROLES; LEADS	miRNAs regulate gene expression and are key mediators of tumourigenesis. miR-129 has diverse effects in tumours, but its role in laryngeal squamous cell carcinoma (LSCC) remains unknown. This article focuses on the role of miR-129-5p in LSCC. We show miR-129-5p is upregulated in primary LSCC tumours and correlated with advanced disease. Down-regulating miR-129-5p suppressed cell proliferation and migration, and caused cell cycle arrest in Hep-2 cell lines. Downregulation of miR-129-5p alone is sufficient to induce apoptosis both in vivo and in vitro. Moreover, the growth of LSCC xenograft exposed to miR-129-5p antisense oligonucleotides (ASO) in BALB/c mice was markedly inhibited. In addition, we found that miR-129-5p targeted adenomatous polyposis coli (APC) to release inhibition of Wnt signalling causing cell growth and tumourigenesis. Our results suggest miR-129-5p functions as an oncogene in LSCC by repressing APC and is a potential therapeutic target for LSCC.	[Li, MingHua; Wang, Lin; Yao, HongChao; Sun, YaNan; Liu, Ming] Harbin Med Univ, Affiliated Hosp 2, Dept Otolaryngol Head & Neck Surg, Serv Head & Neck Surg, Harbin, Peoples R China; [Tian, LinLi; Zhang, JiaRui; Lu, JianGuang; Xiao, Hui] Harbin Med Univ, Affiliated Hosp 2, Dept Otolaryngol Head & Neck Surg, Serv Laryngol, Harbin, Peoples R China; [Gao, Xu] Harbin Med Univ, Dept Biochem & Mol Biol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Xiao, H (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Otolaryngol Head & Neck Surg, Serv Laryngol, Harbin, Peoples R China.	ybbxuz2001@163.com; liumingorl@qq.com	gao, xu/U-4765-2019		National Science Foundation of China [81241085]; Key Project of Natural Science Foundation of Heilongjiang Province [ZD201215/H1302]; Research Fund for the Doctoral Program of Higher Education of China [20102307110007]; Science and Technology Innovation Talent Research Funds of Harbin [2012RFXXS072]; Postdoctoral Science Foundation of Heilongjiang Province [LBH-Z11087]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science and Technology Innovation Talent Research Funds of Harbin; Postdoctoral Science Foundation of Heilongjiang Province(China Postdoctoral Science Foundation)	This work was supported by grants from the National Science Foundation of China (81241085); the Key Project of Natural Science Foundation of Heilongjiang Province (ZD201215/H1302); the Research Fund for the Doctoral Program of Higher Education of China (20102307110007); the Science and Technology Innovation Talent Research Funds of Harbin (2012RFXXS072); and the Postdoctoral Science Foundation of Heilongjiang Province (LBH-Z11087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birks DK, 2011, PEDIATR BLOOD CANCER, V56, P211, DOI 10.1002/pbc.22723; Chen XD, 2012, INT J CANCER, V130, P1607, DOI 10.1002/ijc.26171; Chiang YP, 2011, J GASTROINTEST SURG, V15, P63, DOI 10.1007/s11605-010-1367-8; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dreher A, 2011, BIOCHEM BIOPH RES CO, V412, P20, DOI 10.1016/j.bbrc.2011.07.011; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Ebert MPA, 2003, J CLIN ONCOL, V21, P1708, DOI 10.1200/JCO.2003.10.017; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Guillen-Ahlers H, 2008, CURR DRUG TARGETS, V9, P591, DOI 10.2174/138945008784911813; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Huang ZM, 2009, J DIGEST DIS, V10, P188, DOI 10.1111/j.1751-2980.2009.00384.x; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035800; Luscher B, 2012, GENE, V494, P145, DOI 10.1016/j.gene.2011.12.027; Mirisola V, 2011, CANCER LETT, V307, P37, DOI 10.1016/j.canlet.2011.03.013; Mukherjee N, 2012, CANCER SCI, V103, P210, DOI 10.1111/j.1349-7006.2011.02131.x; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Ogawa R, 2009, MED MOL MORPHOL, V42, P102, DOI 10.1007/s00795-009-0443-1; Ren JY, 2010, EUR J CANCER, V46, P3409, DOI 10.1016/j.ejca.2010.07.047; Scholer-Dahirel A, 2011, P NATL ACAD SCI USA, V108, P17135, DOI 10.1073/pnas.1104182108; Shen RZ, 2010, BIOCHEM BIOPH RES CO, V394, P1047, DOI 10.1016/j.bbrc.2010.03.121; Tsuchiya R, 2004, ORAL ONCOL, V40, P932, DOI 10.1016/j.oraloncology.2004.04.011; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; Zhang TH, 2011, ANTICANCER RES, V31, P3859; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	36	60	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77829	10.1371/journal.pone.0077829	http://dx.doi.org/10.1371/journal.pone.0077829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194897	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000076
J	Macey, PM; Kumar, R; Woo, MA; Yan-Go, FL; Harper, RM				Macey, Paul M.; Kumar, Rajesh; Woo, Mary A.; Yan-Go, Frisca L.; Harper, Ronald M.			Heart Rate Responses to Autonomic Challenges in Obstructive Sleep Apnea	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; MAGNETIC-RESONANCE-SPECTROSCOPY; MEDIAL PREFRONTAL CORTEX; GENDER-DIFFERENCES; BRAIN MORPHOLOGY; BLOOD-PRESSURE; HYPERTENSIVE PATIENTS; CLINICAL PRESENTATION; INTERMITTENT HYPOXIA; NEURAL ALTERATIONS	Obstructive sleep apnea (OSA) is accompanied by structural alterations and dysfunction in central autonomic regulatory regions, which may impair dynamic and static cardiovascular regulation, and contribute to other syndrome pathologies. Characterizing cardiovascular responses to autonomic challenges may provide insights into central nervous system impairments, including contributions by sex, since structural alterations are enhanced in OSA females over males. The objective was to assess heart rate responses in OSA versus healthy control subjects to autonomic challenges, and, separately, characterize female and male patterns. We studied 94 subjects, including 37 newly-diagnosed, untreated OSA patients (6 female, age mean +/- std: 52.1 +/- 8.1 years; 31 male aged 54.3 +/- 8.4 years), and 57 healthy control subjects (20 female, 50.5 +/- 8.1 years; 37 male, 45.6 +/- 9.2 years). We measured instantaneous heart rate with pulse oximetry during cold pressor, hand grip, and Valsalva maneuver challenges. All challenges elicited significant heart rate differences between OSA and control groups during and after challenges (repeated measures ANOVA, p < 0.05). In post-hoc analyses, OSA females showed greater impairments than OSA males, which included: for cold pressor, lower initial increase (OSA vs. control: 9.5 vs. 7.3 bpm in females, 7.6 vs. 3.7 bpm in males), OSA delay to initial peak (2.5 s females/0.9 s males), slower mid-challenge rate-of-increase (OSA vs. control: -0.11 vs. 0.09 bpm/s in females, 0.03 vs. 0.06 bpm/s in males); for hand grip, lower initial peak (OSA vs. control: 2.6 vs. 4.6 bpm in females, 5.3 vs. 6.0 bpm in males); for Valsalva maneuver, lower Valsalva ratio (OSA vs. control: 1.14 vs. 1.30 in females, 1.29 vs. 1.34 in males), and OSA delay during phase II (0.68 s females/1.31 s males). Heart rate responses showed lower amplitude, delayed onset, and slower rate changes in OSA patients over healthy controls, and impairments may be more pronounced in females. The dysfunctions may reflect central injury in the syndrome, and suggest autonomic deficiencies that may contribute to further tissue and functional pathologies.	[Macey, Paul M.; Woo, Mary A.] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA; [Macey, Paul M.; Harper, Ronald M.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90024 USA; [Kumar, Rajesh; Harper, Ronald M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90024 USA; [Yan-Go, Frisca L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Macey, PM (corresponding author), Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA.	pmacey@ucla.edu	Macey, Paul M./B-5037-2008	Macey, Paul M./0000-0003-4093-7458	National Institutes of Health [NR013693]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Supported by the National Institutes of Health NR013693 (http://www.ninr.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, CLIN AUTON RES, V6, P125; Arsenos P, 2012, INT J CARDIOL, V154, P358, DOI 10.1016/j.ijcard.2011.11.007; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Barbe F, 2010, AM J RESP CRIT CARE, V181, P718, DOI 10.1164/rccm.200901-0050OC; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chesler M, 2005, GLIA, V50, P398, DOI 10.1002/glia.20141; Cortelli P, 1994, Clin Auton Res, V4, P57, DOI 10.1007/BF01828839; Cross RL, 2008, SLEEP, V31, P1103; [Diagnostic Classification Steering Committee American Sleep Disorders Association], 1990, INT CLASS SLEEP DIS, Vxii; Durgan DJ, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000091; GLOBUS MYT, 1991, J NEUROCHEM, V57, P470, DOI 10.1111/j.1471-4159.1991.tb03775.x; Greenberg-Dotan S, 2007, SLEEP, V30, P1173, DOI 10.1093/sleep/30.9.1173; Grimaldi D, 2013, CHRONOBIOL INT, V30, P31, DOI 10.3109/07420528.2012.701139; Gustin SM, 2011, J NEUROSCI, V31, P5956, DOI 10.1523/JNEUROSCI.5980-10.2011; Harper RM, 2003, J APPL PHYSIOL, V94, P1583, DOI 10.1152/japplphysiol.00881.2002; Harper RM, 2000, J COMP NEUROL, V417, P195, DOI 10.1002/(SICI)1096-9861(20000207)417:2<195::AID-CNE5>3.0.CO;2-V; Henderson LA, 2003, J APPL PHYSIOL, V94, P1063, DOI 10.1152/japplphysiol.00702.2002; HIRANO T, 1993, NEUROSURGERY, V32, P675, DOI 10.1227/00006123-199304000-00029; Imadojemu VA, 2007, CHEST, V131, P1406, DOI 10.1378/chest.06-2580; Ito R, 2005, CLIN EXP HYPERTENS, V27, P259, DOI 10.1081/CEH-200048874; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Joo E, 2012, SLEEP, V35, pA184; Joo EY, 2010, SLEEP, V33, P235, DOI 10.1093/sleep/33.2.235; Jordan AS, 2005, J APPL PHYSIOL, V99, P2020, DOI 10.1152/japplphysiol.00410.2004; Jordan AS, 2003, SLEEP MED REV, V7, P377, DOI 10.1053/smrv.2002.0260; Kalaria RN, 2004, RESP PHYSIOL NEUROBI, V140, P53, DOI 10.1016/j.resp.2004.01.003; Kasiakogias A, 2013, J HYPERTENS, V31, P352, DOI 10.1097/HJH.0b013e32835bdcda; Kim H, 2013, SLEEP, V36, P709, DOI 10.5665/sleep.2632; Kim HA, 2013, J NEUROL SCI, V325, P61, DOI 10.1016/j.jns.2012.11.019; Kimmerly DS, 2005, J PHYSIOL-LONDON, V569, P331, DOI 10.1113/jphysiol.2005.091637; King AB, 1999, J COMP NEUROL, V413, P572; Kufoy E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033769; Kumar R, 2008, NEUROSCI LETT, V438, P330, DOI 10.1016/j.neulet.2008.04.071; Kumar R, 2012, J NEUROSCI RES, V90, P2043, DOI 10.1002/jnr.23083; Kumar R, 2009, DEPRESS ANXIETY, V26, P480, DOI 10.1002/da.20531; Lafleche AB, 1998, AM J PHYSIOL-HEART C, V275, pH409, DOI 10.1152/ajpheart.1998.275.2.H409; Lehericy S, 1998, ANN NEUROL, V44, P398, DOI 10.1002/ana.410440319; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Low PA, 2013, J CLIN NEUROL, V9, P1, DOI 10.3988/jcn.2013.9.1.1; LUTHERER LO, 1989, J AUTONOM NERV SYST, V27, P101, DOI 10.1016/0165-1838(89)90092-1; LUTHERER LO, 1983, BRAIN RES, V269, P251, DOI 10.1016/0006-8993(83)90134-8; Macey KE, 2006, RESP PHYSIOL NEUROBI, V151, P44, DOI 10.1016/j.resp.2005.05.024; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2012, SLEEP, V35, P1603, DOI 10.5665/sleep.2228; Macey PM, 2012, AUTON NEUROSCI-BASIC, V168, P72, DOI 10.1016/j.autneu.2012.01.009; Macey PM, 2012, SLEEP, V35, P9, DOI 10.5665/sleep.1572; Macey PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010211; Macey PM, 2003, RESP PHYSIOL NEUROBI, V138, P275, DOI 10.1016/j.resp.2003.09.002; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; MARKS JD, 1987, EXP NEUROL, V95, P730, DOI 10.1016/0014-4886(87)90312-8; Mohsenin V, 2003, SLEEP MED, V4, P523, DOI 10.1016/S1389-9457(03)00168-0; Morrell MJ, 2010, THORAX, V65, P908, DOI 10.1136/thx.2009.126730; Morrell MJ, 2003, SLEEP MED, V4, P451, DOI 10.1016/S1389-9457(03)00159-X; Murakami E, 1996, Hypertens Res, V19, P133, DOI 10.1291/hypres.19.133; O'Donoghue FJ, 2012, SLEEP, V35, P41, DOI 10.5665/sleep.1582; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Pae EK, 2005, NEUROSCI LETT, V375, P123, DOI 10.1016/j.neulet.2004.10.091; Pillar G, 1998, CHEST, V114, P697, DOI 10.1378/chest.114.3.697; Pinto S, 2012, MUSCLE NERVE, V46, P341, DOI 10.1002/mus.23313; PORTH CJM, 1984, HEART LUNG, V13, P507; Quintana-Gallego E, 2004, RESP MED, V98, P984, DOI 10.1016/j.rmed.2004.03.002; Resstel LBM, 2005, EUR J NEUROSCI, V21, P2513, DOI 10.1111/j.1460-9568.2005.04078.x; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; Santarnecchi E, 2013, J SLEEP RES, V22, P337, DOI 10.1111/jsr.12006; Shepertycky MR, 2005, SLEEP, V28, P309; Smith R, 2002, CHEST, V121, P164, DOI 10.1378/chest.121.1.164; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Tonon C, 2007, SLEEP, V30, P305, DOI 10.1093/sleep/30.3.305; Torelli F, 2011, NEUROIMAGE, V54, P787, DOI 10.1016/j.neuroimage.2010.09.065; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Waravdekar NV, 1996, AM J RESP CRIT CARE, V153, P1333, DOI 10.1164/ajrccm.153.4.8616563; WILLIAMS JL, 1994, NEUROSURGERY, V34, P379, DOI 10.1227/00006123-199402000-00035; Wong SW, 2007, J APPL PHYSIOL, V103, P1402, DOI 10.1152/japplphysiol.00171.2007; Wong SW, 2007, NEUROIMAGE, V35, P698, DOI 10.1016/j.neuroimage.2006.12.027; Woodson BT, 2004, OTOLARYNG HEAD NECK, V130, P643, DOI 10.1016/S0194-5998(03)01318-4; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 1996, ARCH INTERN MED, V156, P2445, DOI 10.1001/archinte.156.21.2445; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; Zhang ZH, 1998, BRAIN RES, V813, P73, DOI 10.1016/S0006-8993(98)00996-2; Zhou D, 2008, PHYSIOL GENOMICS, V32, P370, DOI 10.1152/physiolgenomics.00147.2007	84	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76631	10.1371/journal.pone.0076631	http://dx.doi.org/10.1371/journal.pone.0076631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194842	Green Published, gold, Green Submitted			2022-12-27	WOS:000326037000021
J	Yang, NN; Sun, YH; Wang, YR; Long, C; Li, YY; Li, Y				Yang, Nina; Sun, Yuhan; Wang, Yaru; Long, Cui; Li, Yingyue; Li, Yun			Proteomic Analysis of the Low Mutation Rate of Diploid Male Gametes Induced by Colchicine in Ginkgo biloba L.	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; GLUTATHIONE S-TRANSFERASES; DYNAMIC INSTABILITY; STRESS RESPONSES; OXIDATIVE STRESS; XENOPUS EGGS; ARABIDOPSIS; EXPRESSION; GENES; COLD	Colchicine treatment of G. biloba microsporocytes results in a low mutation rate in the diploid (2n) male gamete. The mutation rate is significantly lower as compared to other tree species and impedes the breeding of new economic varieties. Proteomic analysis was done to identify the proteins that influence the process of 2n gamete formation in G. biloba. The microsporangia of G. biloba were treated with colchicine solution for 48 h and the proteins were analyzed using 2-D gel electrophoresis and compared to protein profiles of untreated microsporangia. A total of 66 proteins showed difference in expression levels. Twenty-seven of these proteins were identified by mass spectrometry. Among the 27 proteins, 14 were found to be up-regulated and the rest 13 were down-regulated. The identified proteins belonged to five different functional classes: ATP generation, transport and carbohydrate metabolism; protein metabolism; ROS scavenging and detoxifying enzymes; cell wall remodeling and metabolism; transcription, cell cycle and signal transduction. The identification of these differentially expressed proteins and their function could help in analysing the mechanism of lower mutation rate of diploid male gamete when the microsporangium of G. biloba was induced by colchicine.	[Yang, Nina; Sun, Yuhan; Wang, Yaru; Long, Cui; Li, Yingyue; Li, Yun] Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Natl Engn Lab Tree Breeding, Minist Educ,Coll Biol Sci & Technol, Beijing, Peoples R China; [Wang, Yaru] Hebei Acad Agr & Forestry Sci, Shijiazhuang Pomol Inst, Shijiazhuang, Peoples R China	Beijing Forestry University; Hebei Academy of Agricultural & Forestry Sciences	Li, Y (corresponding author), Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Natl Engn Lab Tree Breeding, Minist Educ,Coll Biol Sci & Technol, Beijing, Peoples R China.	yunli63@gmail.com		Li, Yun/0000-0002-8426-565X	Research funds for the Doctoral Program of Higher Education of China [20110014110005]; National Natural Science Foundation of China [30771747]	Research funds for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Research funds for the Doctoral Program of Higher Education of China (20110014110005) (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm) and the National Natural Science Foundation of China (30771747) (http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal GK, 2002, PROTEOMICS, V2, P947, DOI 10.1002/1615-9861(200208)2:8<947::AID-PROT947>3.0.CO;2-J; Agrawal GK, 2002, PLANT PHYSIOL BIOCH, V40, P1061, DOI 10.1016/S0981-9428(02)01471-7; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BEALE SI, 1974, PLANT PHYSIOL, V53, P297, DOI 10.1104/pp.53.2.297; Brosche M, 1999, BBA-GENE STRUCT EXPR, V1447, P185, DOI 10.1016/S0167-4781(99)00154-2; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; CHAPIN SJ, 1992, CELL MOTIL CYTOSKEL, V23, P236, DOI 10.1002/cm.970230403; Chen YM, 2006, PLANT J, V47, P174, DOI 10.1111/j.1365-313X.2006.02783.x; [程金新 CHENG Jinxin], 2006, [北京林业大学学报, Journal of Beijing Forestry University], V28, P15; Chevalier C, 1996, PLANT SCI, V117, P95, DOI 10.1016/0168-9452(96)04399-3; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cui SX, 2005, PROTEOMICS, V5, P3162, DOI 10.1002/pmic.200401148; Cummins I, 1997, PESTIC BIOCHEM PHYS, V59, P35, DOI 10.1006/pest.1997.2308; Davies J, 1999, PESTIC SCI, V55, P1043, DOI 10.1002/(SICI)1096-9063(199911)55:11&lt;1043::AID-PS60&gt;3.0.CO;2-L; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; DHAMODHARAN R, 1995, J CELL SCI, V108, P1679; Dhugga KS, 1997, P NATL ACAD SCI USA, V94, P7679, DOI 10.1073/pnas.94.14.7679; Dixon D, 1997, PESTIC SCI, V50, P72, DOI 10.1002/(SICI)1096-9063(199705)50:1&lt;72::AID-PS553&gt;3.0.CO;2-Z; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Drazkiewicz M, 2003, CELL MOL BIOL LETT, V8, P777; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DUBIEL W, 1995, MOL BIOL REP, V21, P27, DOI 10.1007/BF00990967; DURSO NA, 1994, PLANT CELL, V6, P893, DOI 10.1105/tpc.6.6.893; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Feussner K, 1997, FEBS LETT, V409, P211, DOI 10.1016/S0014-5793(97)00509-7; Gamblin TC, 1996, BIOCHEMISTRY-US, V35, P12576, DOI 10.1021/bi961135d; Gao Peng, 2004, Journal of Beijing Forestry University, V26, P39; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; GENSCHIK P, 1992, PLANT MOL BIOL, V20, P897, DOI 10.1007/BF00027161; Gomez MJR, 2000, J PHYSIOL BIOCHEM, V56, P33, DOI 10.1007/BF03179774; Gorg A, 1999, ELECTROPHORESIS, V20, P712; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; HOGETSU T, 1978, PLANTA, V140, P15, DOI 10.1007/BF00389374; JEPSON I, 1994, PLANT MOL BIOL, V26, P1855, DOI 10.1007/BF00019498; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Jiang YQ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-25; Jung YH, 2006, J PROTEOME RES, V5, P2586, DOI 10.1021/pr060092c; Kang XiangYang, 1999, Scientia Silvae Sinicae, V35, P21; KRAPP AR, 1995, ARCH BIOCHEM BIOPHYS, V317, P215, DOI 10.1006/abbi.1995.1156; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; [李云 Li Yun], 2005, [植物学通报, Chinese Bulletin of Botany], V22, P375; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Olmsted JB, 1991, CURR OPIN CELL BIOL, V3, P52, DOI 10.1016/0955-0674(91)90165-U; Parker R, 2006, J EXP BOT, V57, P1109, DOI 10.1093/jxb/erj134; PRYER NK, 1992, J CELL SCI, V103, P965; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Riechers DE, 1997, PLANT PHYSIOL, V114, P1461, DOI 10.1104/pp.114.4.1461; Sagi G, 2005, PLANT CELL, V17, P1788, DOI 10.1105/tpc.105.031823; Salekdeh GH, 2002, PROTEOMICS, V2, P1131, DOI 10.1002/1615-9861(200209)2:9<1131::AID-PROT1131>3.0.CO;2-1; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; SHERRIER DJ, 1994, PLANT J, V5, P185, DOI 10.1046/j.1365-313X.1994.05020185.x; SHIN M, 1965, J BIOL CHEM, V240, P1405; Sun CW, 1997, PLANT J, V11, P1017, DOI 10.1046/j.1365-313X.1997.11051017.x; Sun YH, 2011, AFR J BIOTECHNOL, V10, P5476; Taylor NL, 2005, MOL CELL PROTEOMICS, V4, P1122, DOI 10.1074/mcp.M400210-MCP200; Teixeira FK, 2006, PLANTA, V224, P300, DOI 10.1007/s00425-005-0214-8; Tunc-Ozdemir M, 2009, PLANT PHYSIOL, V151, P421, DOI 10.1104/pp.109.140046; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Vellas B, 2012, LANCET NEUROL, V11, P851, DOI 10.1016/S1474-4422(12)70206-5; Wang JY, 2003, BIOCHEMISTRY; Wang YaRu, 2010, Journal of Southwest Forestry University, V30, P45; Wang ZF, 2010, PLANT MOL BIOL, V74, P265, DOI 10.1007/s11103-010-9671-y; Wanke M, 2000, BBA-BIOMEMBRANES, V1463, P188, DOI 10.1016/S0005-2736(99)00191-1; Wegener A, 1997, CAN J FOREST RES, V27, P945, DOI 10.1139/cjfr-27-6-945; Weinmann S, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-14; Xu FX, 2002, PLANT PHYSIOL, V130, P362, DOI 10.1104/pp.004796; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Zhang JF, 2006, THESIS BEIJING FOR U, P2	71	3	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76088	10.1371/journal.pone.0076088	http://dx.doi.org/10.1371/journal.pone.0076088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167543	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500002
J	Jahfari, S; Ridderinkhof, KR; Scholte, HS				Jahfari, Sara; Ridderinkhof, K. Richard; Scholte, H. Steven			Spatial Frequency Information Modulates Response Inhibition and Decision-Making Processes	PLOS ONE			English	Article							STOP-SIGNAL; DIFFUSION-MODEL; FACE PERCEPTION; BASAL GANGLIA; ACCURACY; CORTEX; SPEED; NEUROBIOLOGY; STIMULATION; MECHANISMS	We interact with the world through the assessment of available, but sometimes imperfect, sensory information. However, little is known about how variance in the quality of sensory information affects the regulation of controlled actions. In a series of three experiments, comprising a total of seven behavioral studies, we examined how different types of spatial frequency information affect underlying processes of response inhibition and selection. Participants underwent a stop-signal task, a two choice speed/accuracy balance experiment, and a variant of both these tasks where prior information was given about the nature of stimuli. In all experiments, stimuli were either intact, or contained only high-, or low-spatial frequencies. Overall, drift diffusion model analysis showed a decreased rate of information processing when spatial frequencies were removed, whereas the criterion for information accumulation was lowered. When spatial frequency information was intact, the cost of response inhibition increased (longer SSRT), while a correct response was produced faster (shorter reaction times) and with more certainty (decreased errors). When we manipulated the motivation to respond with a deadline (i.e., be fast or accurate), removal of spatial frequency information slowed response times only when instructions emphasized accuracy. However, the slowing of response times did not improve error rates, when compared to fast instruction trials. These behavioral studies suggest that the removal of spatial frequency information differentially affects the speed of response initiation, inhibition, and the efficiency to balance fast or accurate responses. More generally, the present results indicate a task-independent influence of basic sensory information on strategic adjustments in action control.	[Jahfari, Sara; Ridderinkhof, K. Richard; Scholte, H. Steven] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Jahfari, Sara; Ridderinkhof, K. Richard; Scholte, H. Steven] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Jahfari, S (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	sara.jahfari@gmail.com	Scholte, H.Steven/ABD-1737-2020	Scholte, H.Steven/0000-0002-9839-1788	Netherlands Organization for Scientific Research (NWO) [017.005.107]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Mozaiek grant 017.005.107 (SJ) from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Bogacz R, 2007, TRENDS COGN SCI, V11, P118, DOI 10.1016/j.tics.2006.12.006; Broggin E, 2012, Q J EXP PSYCHOL, V65, P151, DOI 10.1080/17470218.2011.594896; Cheung OS, 2008, J EXP PSYCHOL HUMAN, V34, P1327, DOI 10.1037/a0011752; de Gardelle V, 2011, P NATL ACAD SCI USA, V108, P13341, DOI 10.1073/pnas.1104517108; de Gardelle V, 2010, PSYCHOL SCI, V21, P58, DOI 10.1177/0956797609354064; Drugowitsch J, 2012, J NEUROSCI, V32, P3612, DOI 10.1523/JNEUROSCI.4010-11.2012; Egner T, 2008, J NEUROSCI, V28, P6141, DOI 10.1523/JNEUROSCI.1262-08.2008; Egner T, 2010, J NEUROSCI, V30, P16601, DOI 10.1523/JNEUROSCI.2770-10.2010; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Gelman A., 2004, BAYESIAN DATA ANAL; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Huizenga HM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00126; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Jahfari S, 2012, J NEUROSCI, V32, P10870, DOI 10.1523/JNEUROSCI.0902-12.2012; Jahfari S, 2011, J NEUROSCI, V31, P6891, DOI 10.1523/JNEUROSCI.5253-10.2011; Kok P, 2012, CEREB CORTEX, V22, P2197, DOI 10.1093/cercor/bhr310; Krypotos AM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00278; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Leotti LA, 2010, J EXP PSYCHOL HUMAN, V36, P430, DOI 10.1037/a0016802; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; LOGAN GD, 1986, J EXP PSYCHOL HUMAN, V12, P549, DOI 10.1037/0096-1523.12.4.549; Logan Gordon D., 1994, P189; Maguire MJ, 2009, BRAIN COGNITION, V71, P196, DOI 10.1016/j.bandc.2009.08.018; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Mirabella G, 2009, EXP BRAIN RES, V192, P199, DOI 10.1007/s00221-008-1570-y; Mirabella G, 2007, NEURON, V54, P303, DOI 10.1016/j.neuron.2007.04.007; MORGAN MJ, 1980, VISION RES, V20, P431, DOI 10.1016/0042-6989(80)90033-4; Mulder MJ, 2010, BIOL PSYCHIAT, V68, P1114, DOI 10.1016/j.biopsych.2010.07.031; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Nieuwenhuis S, 2004, PSYCHOPHYSIOLOGY, V41, P157, DOI 10.1046/j.1469-8986.2003.00128.x; O'Connell RG, 2012, NAT NEUROSCI, V15, P1729, DOI 10.1038/nn.3248; Ocklenburg S, 2011, NEUROIMAGE, V55, P1771, DOI 10.1016/j.neuroimage.2011.01.035; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Philiastides MG, 2011, CURR BIOL, V21, P980, DOI 10.1016/j.cub.2011.04.034; Purcell BA, 2010, PSYCHOL REV, V117, P1113, DOI 10.1037/a0020311; Ratcliff R, 2002, PSYCHON B REV, V9, P438, DOI 10.3758/BF03196302; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ratcliff R, 2010, J EXP PSYCHOL GEN, V139, P70, DOI 10.1037/a0018128; Rauss K, 2011, NEUROSCI BIOBEHAV R, V35, P1237, DOI 10.1016/j.neubiorev.2010.12.011; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Richler JJ, 2011, VISION RES, V51, P333, DOI 10.1016/j.visres.2010.11.014; RIDDERINKHOF KR, 1995, BIOL PSYCHOL, V41, P29, DOI 10.1016/0301-0511(95)05125-T; Rousselet G, 2006, PSYCHOL RES, V70, P273; Rousselet GA, 2005, VIS COGN, V12, P852, DOI 10.1080/13506280444000553; Schmidt R, 2013, NAT NEUROSCI, V16, P1118, DOI 10.1038/nn.3456; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; Shenoy PYu AJ, 2010, FRONTIERS HUMAN NEUR, V5; Siegel M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00021; Sinha P, 2006, P IEEE, V94, P1948, DOI 10.1109/JPROC.2006.884093; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spratling MW, 2010, J NEUROSCI, V30, P3531, DOI 10.1523/JNEUROSCI.4911-09.2010; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Tosoni A, 2008, NAT NEUROSCI, V11, P1446, DOI 10.1038/nn.2221; van den Wildenberg WPM, 2006, J COGNITIVE NEUROSCI, V18, P626, DOI 10.1162/jocn.2006.18.4.626; van Ravenzwaaij D, 2009, J MATH PSYCHOL, V53, P463, DOI 10.1016/j.jmp.2009.09.004; Vandekerckhove J, 2007, PSYCHON B REV, V14, P1011, DOI 10.3758/BF03193087; VASSILEV A, 1976, VISION RES, V16, P89, DOI 10.1016/0042-6989(76)90081-X; Verbruggen F, 2005, ACTA PSYCHOL, V120, P307, DOI 10.1016/j.actpsy.2005.05.003; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Verbruggen F, 2007, COGNITION EMOTION, V21, P391, DOI 10.1080/02699930600625081; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wagenmakers EJ, 2009, EUR J COGN PSYCHOL, V21, P641, DOI 10.1080/09541440802205067; White CN, 2011, COGNITIVE PSYCHOL, V63, P210, DOI 10.1016/j.cogpsych.2011.08.001; Wiecki TV, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00014; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774	76	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76467	10.1371/journal.pone.0076467	http://dx.doi.org/10.1371/journal.pone.0076467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239NN	24204630	Green Published, gold			2022-12-27	WOS:000326032600007
J	Kaspar, P; Ilencikova, K; Zikova, M; Horvath, O; Cermak, V; Bartunek, P; Strnad, H				Kaspar, Petr; Ilencikova, Kristina; Zikova, Martina; Horvath, Ondrej; Cermak, Vladimir; Bartunek, Petr; Strnad, Hynek			c-Myb Inhibits Myoblast Fusion	PLOS ONE			English	Article							CELL PROLIFERATION; DIFFERENTIATION; EXPRESSION; MYOGENESIS; P300; BETA	Satellite cells represent a heterogeneous population of stem and progenitor cells responsible for muscle growth, repair and regeneration. We investigated whether c-Myb could play a role in satellite cell biology because our previous results using satellite cell-derived mouse myoblast cell line C2C12 showed that c-Myb was expressed in growing cells and downregulated during differentiation. We detected c-Myb expression in activated satellite cells of regenerating muscle. c-Myb was also discovered in activated satellite cells associated with isolated viable myofiber and in descendants of activated satellite cells, proliferating myoblasts. However, no c-Myb expression was detected in multinucleated myotubes originated from fusing myoblasts. The constitutive expression of c-Myb lacking the 3' untranslated region (3' UTR) strongly inhibited the ability of myoblasts to fuse. The inhibition was dependent on intact c-Myb transactivation domain as myoblasts expressing mutated c-Myb in transactivation domain were able to fuse. The absence of 3' UTR of c-Myb was also important because the expression of c-Myb coding region with its 3' UTR did not inhibit myoblast fusion. The same results were repeated in C2C12 cells as well. Moreover, it was documented that 3' UTR of c-Myb was responsible for downregulation of c-Myb protein levels in differentiating C2C12 cells. DNA microarray analysis of C2C12 cells revealed that the expression of several muscle-specific genes was downregulated during differentiation of c-Myb-expressing cells, namely: ACTN2, MYH8, TNNC2, MYOG, CKM and LRRN1. A detailed qRT-PCR analysis of MYOG, TNNC2 and LRRN1 is presented. Our findings thus indicate that c-Myb is involved in regulating the differentiation program of myogenic progenitor cells as its expression blocks myoblast fusion.	[Kaspar, Petr; Ilencikova, Kristina; Zikova, Martina; Horvath, Ondrej; Cermak, Vladimir; Bartunek, Petr; Strnad, Hynek] Acad Sci Czech Republic, Inst Mol Genet, Prague 4, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Kaspar, P (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Prague 4, Czech Republic.	kaspar@img.cas.cz	Strnad, Hynek/B-7361-2008; Cermak, Vladimir/C-2991-2013; Zikova, Martina/A-3276-2012; Bartunek, Petr/J-3897-2014; Kaspar, Petr/J-1705-2014	Strnad, Hynek/0000-0002-0141-8340; Cermak, Vladimir/0000-0002-2754-3000; Bartunek, Petr/0000-0002-6202-7650; 	Grant Agency of the Czech Republic [P305/10/2133]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by grant P305/10/2133 from the Grant Agency of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm-Kristiansen AH, 2008, ONCOGENE, V27, P4644, DOI 10.1038/onc.2008.105; Basu U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029376; Cesi V, 2011, CELL CYCLE, V10, P4149, DOI 10.4161/cc.10.23.18346; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Collins Charlotte A., 2009, V482, P319, DOI 10.1007/978-1-59745-060-7_20; Grabher C, 2011, LEUKEMIA, V25, P506, DOI 10.1038/leu.2010.280; Kaspar P, 2008, DIFFERENTIATION, V76, P245, DOI 10.1111/j.1432-0436.2007.00222.x; Kopecki Z, 2007, J PATHOL, V211, P351, DOI 10.1002/path.2113; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lu LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027596; Malaterre J, 2008, STEM CELLS, V26, P173, DOI 10.1634/stemcells.2007-0293; Malaterre J, 2007, P NATL ACAD SCI USA, V104, P3829, DOI 10.1073/pnas.0610055104; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Navarro F, 2009, BLOOD, V114, P2181, DOI 10.1182/blood-2009-02-205062; Nomura T, 2004, J BIOL CHEM, V279, P16715, DOI 10.1074/jbc.M313069200; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Pasut A, 2013, JOVE-J VIS EXP, DOI 10.3791/50074; Pattabiraman DR, 2009, MOL CANCER RES, V7, P1477, DOI 10.1158/1541-7786.MCR-09-0070; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yang CC, 2012, EMBO J, V31, P1739, DOI 10.1038/emboj.2012.24; Zhang YY, 2011, BLOOD, V118, P4093, DOI 10.1182/blood-2011-03-342501; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218	25	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76742	10.1371/journal.pone.0076742	http://dx.doi.org/10.1371/journal.pone.0076742			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204667	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600008
J	Liu, R; Yang, M; Meng, YL; Liao, J; Sheng, JY; Pu, YP; Yin, LH; Kim, SJ				Liu, Ran; Yang, Miao; Meng, Yanli; Liao, Juan; Sheng, Jingyi; Pu, Yuepu; Yin, Lihong; Kim, Sun Jung			Tumor-Suppressive Function of miR-139-5p in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							MICRORNAS; CANCER; LRH-1; EXPRESSION; ONCOMIRS; HLRH-1; GROWTH; CYCLE	Recent studies have demonstrated the possible function of miR-139-5p in tumorigenesis. However, the exact mechanism of miR-139-5p in cancer remains unclear. In this study, the association of miR-139-5p expression with esophageal squamous cell carcinoma (ESCC) was evaluated in 106 pairs of esophageal cancer and adjacent non-cancerous tissue from ESCC patients. The tumor suppressive features of miR-139-5p were measured by evaluating cell proliferation and cell cycle state, migratory activity and invasion capability, as well as apoptosis. Luciferase reporter assay and Western blot analysis were performed to determine the target gene regulated by miR-139-5p. The mRNA level of NR5A2, the target gene of miR-139-5p, was determined in ESCC patients. Results showed that reduced miR-139-5p level was associated with lymph node metastases of ESCC. MiR-139-5p was investigated to induce cell cycle arrest in the G0/G1 phase and to suppress the invasive capability of esophageal carcinoma cells by targeting the 3'UTR of oncogenic NR5A2. Cyclin E1 and MMP9 were confirmed to participate in cell cycle arrest and invasive suppression induced by NR5A2, respectively. Pearson correlation analysis further confirmed the significantly negative correlation between miR-139-5p and NR5A2 expression. The results suggest that miR-139-5p exerts a growth-and invasiveness-suppressing function in human ESCCs, which demonstrates that miR-139-5p is a potential biomarker for early diagnosis and prognosis and is a therapeutic target for ESCC.	[Liu, Ran; Yang, Miao; Liao, Juan; Sheng, Jingyi; Pu, Yuepu; Yin, Lihong] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China; [Meng, Yanli] Gen Hosp, North China Petr Bur, Renqiu, Peoples R China; [Kim, Sun Jung] Dongguk Univ, Dept Life Sci, Seoul, South Korea	Southeast University - China; Dongguk University	Liu, R (corresponding author), Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China.	ranliu@seu.edu.cn; sunjungk@dongguk.edu	Meng, Yan/HGC-0394-2022; kim, sun jung/T-1013-2019; ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X	National Natural Science Foundation of China [81172747, 81072259, 30800891, 81111140396]; National Research Foundation of Korea (NRF) [NRF-2011-C00056]; Natural Science Foundation of Jiangsu province, China [BK2010407]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Natural Science Foundation of Jiangsu province, China(Natural Science Foundation of Jiangsu Province)	This study is supported by the National Natural Science Foundation of China (No. 81172747, 81072259, 30800891, 81111140396; http://www.nsfc.gov.cn), the National Research Foundation of Korea (NRF) Grant (NRF-2011-C00056; http://www.nrf.re.kr), and Natural Science Foundation of Jiangsu province, China (No. BK2010407; http://www.jstd.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bader AG, 2011, GENE THER, V18, P1121, DOI 10.1038/gt.2011.79; Baquie M, 2011, HUM MOL GENET, V20, P2823, DOI 10.1093/hmg/ddr193; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benod C, 2011, P NATL ACAD SCI USA, V108, P16927, DOI 10.1073/pnas.1112047108; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chand AL, 2010, ENDOCR-RELAT CANCER, V17, P965, DOI 10.1677/ERC-10-0179; Chand AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031593; Dalmay T, 2008, J INTERN MED, V263, P366, DOI 10.1111/j.1365-2796.2008.01926.x; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Guo HY, 2012, INT J BIOCHEM CELL B, V44, P1465, DOI 10.1016/j.biocel.2012.05.015; Hasseine LK, 2009, BIOCHEM BIOPH RES CO, V390, P1278, DOI 10.1016/j.bbrc.2009.10.135; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Kwak PB, 2010, CANCER SCI, V101, P2309, DOI 10.1111/j.1349-7006.2010.01683.x; Liu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033987; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Manikandan J, 2008, BIOINFORMATION, V2, P330, DOI 10.6026/97320630002330; Matsushima K, 2010, DIGESTION, V82, P138, DOI 10.1159/000310918; Schoonjans K, 2005, P NATL ACAD SCI USA, V102, P2058, DOI 10.1073/pnas.0409756102; Shen K, 2012, BIOCHEM PHARMACOL, V84, P320, DOI 10.1016/j.bcp.2012.04.017; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang SL, 2008, MOL CELL BIOCHEM, V308, P93, DOI 10.1007/s11010-007-9616-1; Wang SL, 2005, BIOCHEM BIOPH RES CO, V333, P917, DOI 10.1016/j.bbrc.2005.05.186; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23	30	56	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77068	10.1371/journal.pone.0077068	http://dx.doi.org/10.1371/journal.pone.0077068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204738	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300079
J	Schwank, G; Andersson-Rolf, A; Koo, BK; Sasaki, N; Clevers, H				Schwank, Gerald; Andersson-Rolf, Amanda; Koo, Bon-Kyoung; Sasaki, Nobuo; Clevers, Hans			Generation of BAC Transgenic Epithelial Organoids	PLOS ONE			English	Article							FLUORESCENT PROTEIN; STEM-CELLS; IN-VITRO; EXPANSION; LIFETIME	Under previously developed culture conditions, mouse and human intestinal epithelia can be cultured and expanded over long periods. These so-called organoids recapitulate the three-dimensional architecture of the gut epithelium, and consist of all major intestinal cell types. One key advantage of these ex vivo cultures is their accessibility to live imaging. So far the establishment of transgenic fluorescent reporter organoids has required the generation of transgenic mice, a laborious and time-consuming process, which cannot be extended to human cultures. Here we present a transfection protocol that enables the generation of recombinant mouse and human reporter organoids using BAC (bacterial artificial chromosome) technology.	[Schwank, Gerald; Andersson-Rolf, Amanda; Koo, Bon-Kyoung; Sasaki, Nobuo; Clevers, Hans] KNAW, Hubrecht Inst, Utrecht, Netherlands; [Schwank, Gerald; Andersson-Rolf, Amanda; Koo, Bon-Kyoung; Sasaki, Nobuo; Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Andersson-Rolf, Amanda; Koo, Bon-Kyoung] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Cambridge	Clevers, H (corresponding author), KNAW, Hubrecht Inst, Utrecht, Netherlands.	h.clevers@hubrecht.eu	Schwank, Gerald/AAE-6640-2020; Schwank, Gerald/A-8586-2018; Koo, Bon-Kyoung/V-5219-2017; Sasaki, Nobuo/HDO-8251-2022	Schwank, Gerald/0000-0003-0767-2953; Schwank, Gerald/0000-0003-0767-2953; Koo, Bon-Kyoung/0000-0002-4134-8033; Sasaki, Nobuo/0000-0002-8798-7244	European Research Council [EU/232814-StemCeLLMark]; KNAW/3V-fund; SNF [PA00P3 139732]; Human Frontiers in Science Program long-term fellowship [LT000422/2012]; National Research Foundation of Korea [NRF-2011-357-C00093]	European Research Council(European Research Council (ERC)European Commission); KNAW/3V-fund; SNF; Human Frontiers in Science Program long-term fellowship; National Research Foundation of Korea(National Research Foundation of Korea)	This work was funded by grants from the European Research Council (EU/232814-StemCeLLMark), the KNAW/3V-fund, the SNF fellowship for advanced researchers PA00P3 139732 (G. S.), the Human Frontiers in Science Program long-term fellowship LT000422/2012 (G. S.), and the National Research Foundation of Korea NRF-2011-357-C00093 (B.-K.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ciotta G, METHODS, V53, P113; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kaartinen V, 2001, GENESIS, V31, P126, DOI 10.1002/gene.10015; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Koo BK, NAT METHODS, V9, P81; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Park F, 2007, PHYSIOL GENOMICS, V31, P159, DOI 10.1152/physiolgenomics.00069.2007; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935	17	53	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76871	10.1371/journal.pone.0076871	http://dx.doi.org/10.1371/journal.pone.0076871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204693	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300059
J	Duell, BL; Carey, AJ; Dando, SJ; Schembri, MA; Ulett, GC				Duell, Benjamin L.; Carey, Alison J.; Dando, Samantha J.; Schembri, Mark A.; Ulett, Glen C.			Human Bladder Uroepithelial Cells Synergize with Monocytes to Promote IL-10 Synthesis and Other Cytokine Responses to Uropathogenic Escherichia coli	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; ALVEOLAR EPITHELIAL-CELLS; URINARY-TRACT-INFECTION; INNATE IMMUNE-RESPONSE; GENE-EXPRESSION; HOST; MODEL; INTERLEUKIN-10; MACROPHAGES; MIGRATION	Urinary tract infections are a major source of morbidity for women and the elderly, with Uropathogenic Escherichia coli (UPEC) being the most prevalent causative pathogen. Studies in recent years have defined a key anti-inflammatory role for Interleukin-10 (IL-10) in urinary tract infection mediated by UPEC and other uropathogens. We investigated the nature of the IL-10-producing interactions between UPEC and host cells by utilising a novel coculture model that incorporated lymphocytes, mononuclear and uroepithelial cells in histotypic proportions. This coculture model demonstrated synergistic IL-10 production effects between monocytes and uroepithelial cells following infection with UPEC. Membrane inserts were used to separate the monocyte and uroepithelial cell types during infection and revealed two synergistic IL-10 production effects based on contact-dependent and soluble interactions. Analysis of a comprehensive set of immunologically relevant biomarkers in monocyte-uroepithelial cell co-cultures highlighted that multiple cytokine, chemokine and signalling factors were also produced in a synergistic or antagonistic fashion. These results demonstrate that IL-10 responses to UPEC occur via multiple interactions between several cells types, implying a complex role for infection-related IL-10 during UTI. Development and application of the co-culture model described in this study is thus useful to define the degree of contact dependency of biomarker production to UPEC, and highlights the relevance of histotypic co-cultures in studying complex host-pathogen interactions.	[Duell, Benjamin L.; Carey, Alison J.; Ulett, Glen C.] Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia; [Dando, Samantha J.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	Griffith University; Griffith University; University of Queensland	Ulett, GC (corresponding author), Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia.	g.ulett@griffith.edu.au	Schembri, Mark A/C-7262-2009	Schembri, Mark A/0000-0003-4863-9260; Ulett, Glen/0000-0002-9638-8091; Dando, Samantha/0000-0002-5119-1711; /0000-0003-0660-8909	Australian National Health and Medical Research Council (NHMRC); Griffith University; Australian Research Council Future Fellowship; NHMRC Peter Doherty Australian Biomedical Fellowship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Griffith University(Griffith University); Australian Research Council Future Fellowship(Australian Research Council); NHMRC Peter Doherty Australian Biomedical Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC), and Griffith University. GCU is the recipient of an Australian Research Council Future Fellowship. AJC is the recipient of a NHMRC Peter Doherty Australian Biomedical Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboderin OA, 2009, J NATL MED ASSOC, V101, P1268, DOI 10.1016/S0027-9684(15)31138-X; Andersen TE, 2012, INFECT IMMUN, V80, P1858, DOI 10.1128/IAI.06075-11; Andersson M, 2012, INNATE IMMUN-LONDON, V18, P531, DOI 10.1177/1753425911426591; Bacheller CD, 1997, MED CLIN N AM, V81, P719, DOI 10.1016/S0025-7125(05)70542-3; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; BENJAMIN D, 1992, BLOOD, V80, P1289; Bien J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/681473; Billips BK, 2007, INFECT IMMUN, V75, P5353, DOI 10.1128/IAI.00922-07; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; Bokil NJ, 2011, IMMUNOBIOLOGY, V216, P1164, DOI 10.1016/j.imbio.2011.05.011; CAVAILLON JM, 1990, INFECT IMMUN, V58, P2375, DOI 10.1128/IAI.58.7.2375-2382.1990; Chan CY, 2013, IMMUNITY, V38, P349, DOI 10.1016/j.immuni.2012.10.019; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; DeFrances Carol J, 2004, Adv Data, P1; Duell BL, 2012, FEMS IMMUNOL MED MIC, V64, P295, DOI 10.1111/j.1574-695X.2012.00931.x; Duell BL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/852419; Duell BL, 2012, J IMMUNOL, V188, P781, DOI 10.4049/jimmunol.1101231; Eghtesad M, 2001, IMMUNOLOGY, V102, P157, DOI 10.1046/j.1365-2567.2001.01172.x; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Fazliana M, 2011, J ETHNOPHARMACOL, V136, P111, DOI 10.1016/j.jep.2011.04.018; Fedele G, 2011, J IMMUNOL, V186, P5388, DOI 10.4049/jimmunol.1003765; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; GARDINER RA, 1986, BRIT J UROL, V58, P19, DOI 10.1111/j.1464-410X.1986.tb05420.x; Gouwy M, 2005, CYTOKINE GROWTH F R, V16, P561, DOI 10.1016/j.cytogfr.2005.03.005; Hannan TJ, 2012, FEMS MICROBIOL REV, V36, P616, DOI 10.1111/j.1574-6976.2012.00339.x; Hannan TJ, 2013, CLIN SCI ADV UR TRAC; Herold S, 2006, J IMMUNOL, V177, P1817, DOI 10.4049/jimmunol.177.3.1817; Hilbert DW, 2008, MICROBES INFECT, V10, P114, DOI 10.1016/j.micinf.2007.10.012; Hilbert DW, 2012, MICROBES INFECT, V14, P628, DOI 10.1016/j.micinf.2012.01.010; Ingersoll MA, 2008, CELL MICROBIOL, V10, P2568, DOI 10.1111/j.1462-5822.2008.01230.x; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Ipe DS, 2013, FEMS MICROBIOL LETT, V346, P1, DOI 10.1111/1574-6968.12204; Khalil A, 1997, J UROLOGY, V158, P1576, DOI 10.1016/S0022-5347(01)64282-4; Kline KA, 2011, INFECT IMMUN, V79, P3588, DOI 10.1128/IAI.00122-11; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; Krueger S, 2009, J PATHOL, V217, P581, DOI 10.1002/path.2485; Lloyd AL, 2009, INFECT IMMUN, V77, P5322, DOI 10.1128/IAI.00779-09; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Mittal Rahul, 2009, J Infect Public Health, V2, P136, DOI 10.1016/j.jiph.2009.06.002; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ronald A, 2002, AM J MED, V113, p14S; Sawant KV, 2007, INFECT IMMUN, V75, P1870, DOI 10.1128/IAI.00858-06; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; Smith YC, 2006, INFECT IMMUN, V74, P750, DOI 10.1128/IAI.74.1.750-757.2006; Stanley AC, 2012, J LEUKOCYTE BIOL, V92, P1227, DOI 10.1189/jlb.0412191; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Svanborg C, 2006, CURR OPIN MICROBIOL, V9, P33, DOI 10.1016/j.mib.2005.12.012; Tan CK, 2012, INFECT IMMUN, V80, P3145, DOI 10.1128/IAI.00023-12; Tan RST, 2013, IMMUNOL CELL BIOL, V91, P377, DOI 10.1038/icb.2013.13; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Ulett GC, 2005, J INFECT DIS, V191, P1761, DOI 10.1086/429693; Ulett GC, 1998, FEMS IMMUNOL MED MIC, V21, P283, DOI 10.1111/j.1574-695X.1998.tb01175.x; Ulett GC, 2007, INFECT IMMUN, V75, P3233, DOI 10.1128/IAI.01952-06; Ulett GC, 2013, CURR OPIN MICROBIOL, V16, P100, DOI 10.1016/j.mib.2013.01.005; Ulett GC, 2010, J INFECT DIS, V201, P866, DOI 10.1086/650696; Vargas-Inchaustegui DA, 2010, INFECT IMMUN, V78, P301, DOI 10.1128/IAI.00959-09; Yadav M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001120	64	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78013	10.1371/journal.pone.0078013	http://dx.doi.org/10.1371/journal.pone.0078013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155979	Green Published, gold			2022-12-27	WOS:000325887300113
J	Danovi, D; Folarin, A; Gogolok, S; Ender, C; Elbatsh, AMO; Engstrom, PG; Stricker, SH; Gagrica, S; Georgian, A; Yu, D; U, KP; Harvey, KJ; Ferretti, P; Paddison, PJ; Preston, JE; Abbott, NJ; Bertone, P; Smith, A; Pollard, SM				Danovi, Davide; Folarin, Amos; Gogolok, Sabine; Ender, Christine; Elbatsh, Ahmed M. O.; Engstroem, Paer G.; Stricker, Stefan H.; Gagrica, Sladjana; Georgian, Ana; Yu, Ding; U, Kin Pong; Harvey, Kevin J.; Ferretti, Patrizia; Paddison, Patrick J.; Preston, Jane E.; Abbott, N. Joan; Bertone, Paul; Smith, Austin; Pollard, Steven M.			A High-Content Small Molecule Screen Identifies Sensitivity of Glioblastoma Stem Cells to Inhibition of Polo-Like Kinase 1	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; INTEGRATED GENOMIC ANALYSIS; CENTRAL-NERVOUS-SYSTEM; BRAIN-BARRIER MODEL; IMAGE-BASED SCREENS; CANCER-CELLS; ADHERENT CULTURE; HUMAN GLIOMAS; SOLID TUMORS; PHASE-I	Glioblastoma multiforme (GBM) is the most common primary brain cancer in adults and there are few effective treatments. GBMs contain cells with molecular and cellular characteristics of neural stem cells that drive tumour growth. Here we compare responses of human glioblastoma-derived neural stem (GNS) cells and genetically normal neural stem (NS) cells to a panel of 160 small molecule kinase inhibitors. We used live-cell imaging and high content image analysis tools and identified JNJ-10198409 (J101) as an agent that induces mitotic arrest at prometaphase in GNS cells but not NS cells. Antibody microarrays and kinase profiling suggested that J101 responses are triggered by suppression of the active phosphorylated form of polo-like kinase 1 (Plk1) (phospho T210), with resultant spindle defects and arrest at prometaphase. We found that potent and specific Plk1 inhibitors already in clinical development (BI 2536, BI 6727 and GSK 461364) phenocopied J101 and were selective against GNS cells. Using a porcine brain endothelial cell blood-brain barrier model we also observed that these compounds exhibited greater blood-brain barrier permeability in vitro than J101. Our analysis of mouse mutant NS cells (INK4a/ARF(-/-), or p53(-/-)), as well as the acute genetic deletion of p53 from a conditional p53 floxed NS cell line, suggests that the sensitivity of GNS cells to BI 2536 or J101 may be explained by the lack of a p53-mediated compensatory pathway. Together these data indicate that GBM stem cells are acutely susceptible to proliferative disruption by Plk1 inhibitors and that such agents may have immediate therapeutic value.	[Danovi, Davide; Folarin, Amos; Gogolok, Sabine; Ender, Christine; Elbatsh, Ahmed M. O.; Stricker, Stefan H.; Gagrica, Sladjana; Pollard, Steven M.] UCL, UCL Canc Inst, Samantha Dickson Brain Canc Unit, London, England; [Danovi, Davide; Folarin, Amos; Gogolok, Sabine; Ender, Christine; Elbatsh, Ahmed M. O.; Stricker, Stefan H.; Gagrica, Sladjana; Pollard, Steven M.] UCL, UCL Canc Inst, Dept Canc Biol, London, England; [Engstroem, Paer G.; Bertone, Paul] European Mol Biol Lab, European Bioinformat Inst, Cambridge, England; [Georgian, Ana; Preston, Jane E.; Abbott, N. Joan] Kings Coll London, Inst Pharmaceut Sci, London WC2R 2LS, England; [Yu, Ding; Paddison, Patrick J.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Harvey, Kevin J.] EMD Millipore Corp, San Diego, CA USA; [U, Kin Pong; Ferretti, Patrizia] UCL, Inst Child Hlth, London, England; [Bertone, Paul] European Mol Biol Lab, Genome Biol Unit, D-69012 Heidelberg, Germany; [Bertone, Paul] European Mol Biol Lab, Dev Biol Unit, D-69012 Heidelberg, Germany; [Bertone, Paul; Smith, Austin] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England	University of London; University College London; University of London; University College London; European Molecular Biology Laboratory (EMBL); University of London; King's College London; Fred Hutchinson Cancer Center; Merck KGaA; MilliporeSigma; University of London; University College London; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of Cambridge	Pollard, SM (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.	steven.pollard@ed.ac.uk	Stricker, Stefan H/A-4930-2015; Ferretti, Patrizia/E-9375-2010; Danovi, Davide/P-2874-2019; Bertone, Paul/Z-3734-2019; Folarin, Amos/AAD-5525-2020; Ding, Yu/A-2949-2013; Bertone, Paul/A-6600-2013; Pollard, Steven/B-7966-2010	Stricker, Stefan H/0000-0002-5488-8530; Ferretti, Patrizia/0000-0002-3590-6772; Danovi, Davide/0000-0003-4119-5337; Bertone, Paul/0000-0001-5059-4829; Folarin, Amos/0000-0002-0333-1927; Bertone, Paul/0000-0001-5059-4829; Preston, Jane/0000-0002-8018-9637; Harvey, Kevin/0000-0002-4479-1575; Pollard, Steven/0000-0001-6428-0492; Engstrom, Par/0000-0001-5265-2121; Smith, Austin/0000-0002-3029-4682	EC; EMBL; Cancer Research UK; Children with Cancer; Brain Tumour Charity; FP7 Marie Curie Intra-European Fellowship; Alex Bolt Research Fellowship; Medical Research Council [MC_PC_12009, G1001028, G1100526] Funding Source: researchfish; The Brain Tumour Charity [8/105] Funding Source: researchfish; MRC [G1001028] Funding Source: UKRI	EC(European CommissionEuropean Commission Joint Research Centre); EMBL; Cancer Research UK(Cancer Research UK); Children with Cancer; Brain Tumour Charity; FP7 Marie Curie Intra-European Fellowship; Alex Bolt Research Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Brain Tumour Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the EC-funded STREP project 'Neuroscreen,' EMBL, and grants from Cancer Research UK, Children with Cancer, and The Brain Tumour Charity. CE was supported by a FP7 Marie Curie Intra-European Fellowship. AS is an MRC Professor. SP was supported by an Alex Bolt Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; DAHLSTRAND J, 1992, CANCER RES, V52, P5334; Danovi D, 2012, METHOD ENZYMOL, V506, P311, DOI 10.1016/B978-0-12-391856-7.00040-8; Degenhardt Y, 2010, MOL CANCER THER, V9, P2079, DOI 10.1158/1535-7163.MCT-10-0095; Dietzmann K, 2001, J NEURO-ONCOL, V53, P1, DOI 10.1023/A:1011808200978; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Engstrom PG, 2012, GENOME MED, V4, DOI 10.1186/gm377; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Grinshtein N, 2011, CANCER RES, V71, P1385, DOI 10.1158/0008-5472.CAN-10-2484; He J, 2001, J NEUROPATH EXP NEUR, V60, P863, DOI 10.1093/jnen/60.9.863; Hofheinz RD, 2010, CLIN CANCER RES, V16, P4666, DOI 10.1158/1078-0432.CCR-10-0318; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Lee C, 2012, STEM CELLS, V30, P1064, DOI 10.1002/stem.1081; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li AG, 2008, MOL CANCER RES, V6, P21, DOI 10.1158/1541-7786.MCR-07-0280; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Masica DL, 2011, CANCER RES, V71, P4550, DOI 10.1158/0008-5472.CAN-11-0180; Moralli D, 2011, STEM CELL REV REP, V7, P471, DOI 10.1007/s12015-010-9224-4; Olmos D, 2011, CLIN CANCER RES, V17, P3420, DOI 10.1158/1078-0432.CCR-10-2946; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Patabendige A, 2013, BRAIN RES, V1521, P1, DOI 10.1016/j.brainres.2012.06.057; Patabendige A, 2013, BRAIN RES, V1521, P16, DOI 10.1016/j.brainres.2013.04.006; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Raab M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1395; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Schoffski P, 2010, EUR J CANCER, V46, P2206, DOI 10.1016/j.ejca.2010.03.039; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Stricker SH, 2013, GENE DEV, V27, P654, DOI 10.1101/gad.212662.112; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Szczurek E, 2013, INT J CANCER, V133, P2123, DOI 10.1002/ijc.28235; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yan T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-524; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	54	43	44	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77053	10.1371/journal.pone.0077053	http://dx.doi.org/10.1371/journal.pone.0077053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204733	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500014
J	Silal, SP; Barnes, KI; Kok, G; Mabuza, A; Little, F				Silal, Sheetal Prakash; Barnes, Karen I.; Kok, Gerdalize; Mabuza, Aaron; Little, Francesca			Exploring the Seasonality of Reported Treated Malaria Cases in Mpumalanga, South Africa	PLOS ONE			English	Article							CLIMATE-CHANGE; PROVINCE; TRANSMISSION	South Africa, having met the World Health Organisation's pre-elimination criteria, has set a goal to achieve malaria elimination by 2018. Mpumalanga, one of three provinces where malaria transmission still occurs, has a malaria season subject to unstable transmission that is prone to sporadic outbreaks. As South Africa prepares to intensify efforts towards malaria elimination, there is a need to understand patterns in malaria transmission so that efforts may be targeted appropriately. This paper describes the seasonality of transmission by exploring the relationship between malaria cases and three potential drivers: rainfall, geography (physical location) and the source of infection (local/imported). Seasonal decomposition of the time series by Locally estimated scatterplot smoothing is applied to the case data for the geographical and source of infection sub-groups. The relationship between cases and rainfall is assessed using a cross-correlation analysis. The malaria season was found to have a short period of no/low level of reported cases and a triple peak in reported cases between September and May; the three peaks occurring in October, January and May. The seasonal pattern of locally-sourced infection mimics the triple-peak characteristic of the total series while imported infections contribute mostly to the second and third peak of the season (Christmas and Easter respectively). Geographically, Bushbuckridge municipality, which exhibits a different pattern of cases, contributed mostly to the first and second peaks in cases while Maputo province (Mozambique) experienced a similar pattern in transmission to the imported cases. Though rainfall lagged at 4 weeks was significantly correlated with malaria cases, this effect was dampened due to the growing proportion of imported cases since 2006. These findings may be useful as they enhance the understanding of the current incidence pattern and may inform mathematical models that enable one to predict the impact changes in these drivers will have on malaria transmission.	[Silal, Sheetal Prakash; Little, Francesca] Univ Cape Town, Dept Stat Sci, ZA-7925 Cape Town, South Africa; [Barnes, Karen I.] Univ Cape Town, Div Clin Pharmacol, Dept Med, ZA-7925 Cape Town, South Africa; [Kok, Gerdalize; Mabuza, Aaron] Mpumalanga Dept Hlth, Malaria Eliminat Programme, Nelspruit, South Africa	University of Cape Town; University of Cape Town	Silal, SP (corresponding author), Univ Cape Town, Dept Stat Sci, ZA-7925 Cape Town, South Africa.	Sheetal.Silal@uct.ac.za	Silal, Sheetal/O-5991-2015; Silal, Sheetal/AAB-1873-2020	Silal, Sheetal/0000-0002-3007-5383; Silal, Sheetal/0000-0002-3007-5383; Little, Francesca/0000-0002-5917-9928	National Research Foundation (NRF) in South Africa	National Research Foundation (NRF) in South Africa(National Research Foundation - South Africa)	This material is based upon work supported financially by the Thuthuka Grant from the National Research Foundation (NRF) in South Africa. Any opinion, findings and conclusions or recommendations expressed in this material are those of the authors and therefore the NRF does not accept any liability in regard thereto (www.nrf.ac.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, R PROJECT STAT COMPU; [Anonymous], 2013, STATA DATA ANAL STAT; Barnes KI, 2008, J INFECT DIS, V197, P1605, DOI 10.1086/587645; Blumberg L, 2007, MALARIA CONTROL S AF; Brockwell P.J., 2009, TIME SERIES THEORY M; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Govere J, 2000, AFR ENTOMOL, V8, P91; Govere JM, 2001, S AFR J SCI, V97, P55; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Mabuza A, 2005, S AFRICAN MED J, V95; Maharaj R, 2012, MALARIA J, V11, DOI [10.1186/1475-2875-11-320, 10.1186/1475-2875-11-423]; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; Moonasar D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-294; Ngomane L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-19; Pankratz A., 1991, FORECASTING DYNAMIC; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sharp B, 2001, TECHNICAL REPORT; Sharp BL, 1996, S AFR MED J, V86, P83; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; South Africa National Department of Health, 2011, TECHNICAL REPORT; South Africa National Department of Health, 2010, TECHNICAL REPORT; Statistics South Africa, 2011, TECHNICAL REPORT; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Tumwiine J, 2010, J MATH ANAL APPL, V361, P139, DOI 10.1016/j.jmaa.2009.09.005; WHO, 2012, WHO FACTSH WORLD MAL; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x	28	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76640	10.1371/journal.pone.0076640	http://dx.doi.org/10.1371/journal.pone.0076640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204650	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700009
J	Wine, JJ; Char, JE; Chen, J; Cho, HJ; Dunn, C; Frisbee, E; Joo, NS; Milla, C; Modlin, SE; Park, IH; Thomas, EAC; Tran, KV; Verma, R; Wolfe, MH				Wine, Jeffrey J.; Char, Jessica E.; Chen, Jonathan; Cho, Hyung-ju; Dunn, Colleen; Frisbee, Eric; Joo, Nam Soo; Milla, Carlos; Modlin, Sara E.; Park, Il-Ho; Thomas, Ewart A. C.; Tran, Kim V.; Verma, Rohan; Wolfe, Marlene H.			In Vivo Readout of CFTR Function: Ratiometric Measurement of CFTR-Dependent Secretion by Individual, Identifiable Human Sweat Glands	PLOS ONE			English	Article							TRANSMEMBRANE-CONDUCTANCE-REGULATOR; CYSTIC-FIBROSIS HETEROZYGOTES; MESSENGER-RNA TRANSCRIPTS; POTENTIAL DIFFERENCE; CHRONIC-PANCREATITIS; SUBMUCOSAL GLANDS; CODING SEQUENCES; FLUID SECRETION; MUCUS SECRETION; GENE-MUTATIONS	To assess CFTR function in vivo, we developed a bioassay that monitors and compares CFTR-dependent and CFTR-independent sweat secretion in parallel for multiple (similar to 50) individual, identified glands in each subject. Sweating was stimulated by intradermally injected agonists and quantified by optically measuring spherical sweat bubbles in an oil-layer that contained dispersed, water soluble dye particles that partitioned into the sweat bubbles, making them highly visible. CFTR-independent secretion (M-sweat) was stimulated with methacholine, which binds to muscarinic receptors and elevates cytosolic calcium. CFTR-dependent secretion (C-sweat) was stimulated with a beta-adrenergic cocktail that elevates cytosolic cAMP while blocking muscarinic receptors. A C-sweat/M-sweat ratio was determined on a gland-by-gland basis to compensate for differences unrelated to CFTR function, such as gland size. The average ratio provides an approximately linear readout of CFTR function: the heterozygote ratio is similar to 0.5 the control ratio and for CF subjects the ratio is zero. During assay development, we measured C/M ratios in 6 healthy controls, 4 CF heterozygotes, 18 CF subjects and 4 subjects with 'CFTR-related' conditions. The assay discriminated all groups clearly. It also revealed consistent differences in the C/M ratio among subjects within groups. We hypothesize that these differences reflect, at least in part, levels of CFTR expression, which are known to vary widely. When C-sweat rates become very low the C/M ratio also tended to decrease; we hypothesize that this nonlinearity reflects ductal fluid absorption. We also discovered that M-sweating potentiates the subsequent C-sweat response. We then used potentiation as a surrogate for drugs that can increase CFTR-dependent secretion. This bioassay provides an additional method for assessing CFTR function in vivo, and is well suited for within-subject tests of systemic, CFTR-directed therapeutics.	[Wine, Jeffrey J.; Char, Jessica E.; Chen, Jonathan; Cho, Hyung-ju; Frisbee, Eric; Joo, Nam Soo; Modlin, Sara E.; Park, Il-Ho; Tran, Kim V.; Verma, Rohan; Wolfe, Marlene H.] Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA; [Wine, Jeffrey J.; Dunn, Colleen; Milla, Carlos] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Wine, Jeffrey J.; Thomas, Ewart A. C.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Wine, JJ (corresponding author), Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA.	wine@stanford.edu	Park, Il-Ho/AAI-1394-2019	Park, Il-Ho/0000-0002-7011-6071; Milla, Carlos/0000-0001-5515-3053	Cystic Fibrosis Foundation Therapeutic [WINE08A0]	Cystic Fibrosis Foundation Therapeutic	Supported by Cystic Fibrosis Foundation Therapeutics, Grant WINE08A0 to J.J.W. http://www.cff.org/research/cfft/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1997, BRIT MED J, V314, P1874, DOI 10.1136/bmj.314.7098.1874; Andersen B, 1990, METHODOLOGICAL ERROR; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Barlow D., 1984, SINGLE CASE EXPT DES; Bates D. M., 2007, LME4 LINEAR MIXED EF; BEHM JK, 1987, PEDIATR RES, V22, P271, DOI 10.1203/00006450-198709000-00007; Bishop MD, 2005, HUM GENET, P1; Bronsveld I, 2001, J CLIN INVEST, V108, P1705; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; CHU CS, 1991, EMBO J, V10, P1355, DOI 10.1002/j.1460-2075.1991.tb07655.x; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; CHU CS, 1992, J CLIN INVEST, V90, P785, DOI 10.1172/JCI115952; Clancy JP, 2011, THORAX; Cohn JA, 2005, HUM MUTAT, V26, P303, DOI 10.1002/humu.20232; Cohn JA, 2004, GASTROENTEROL CLIN N, V33, P817, DOI 10.1016/j.gtc.2004.07.008; DISANTAGNESE PA, 1953, PEDIATRICS, V12, P549; Dohle GR, 1999, HUM REPROD, V14, P371, DOI 10.1093/humrep/14.2.371; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Du M, 2006, J MOL MED, V84, P573, DOI 10.1007/s00109-006-0045-5; GIBSON LE, 1959, PEDIATRICS, V23, P545; GOCHBERG SH, 1956, PEDIATRICS, V18, P701; Guo XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025452; Hirawat S, 2007, J CLIN PHARMACOL, V47, P430, DOI 10.1177/0091270006297140; Howard M, 1996, NAT MED, V2, P467, DOI 10.1038/nm0496-467; Joo NS, 2001, AM J PHYSIOL-LUNG C, V281, pL458, DOI 10.1152/ajplung.2001.281.2.L458; Kazdin A., 2021, SINGLE CASE RES DESI, V3rd; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; Kuno Y., 1956, HUMAN PERSPIRATION; Lee RJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412817; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Lillie EO, 2011, PERS MED, V8, P161, DOI 10.2217/PME.11.7; Luisetti M, 2003, SEMIN RESP CRIT CARE, V24, P179, DOI 10.1055/s-2003-39028; Moran O, 2005, FEBS LETT, V579, P3979, DOI 10.1016/j.febslet.2005.06.026; National Research Council (US) Committee on a Framework for Developing a New Taxonomy of Disease, 2011, PREC MED BUILD KNOWL; Quinton P, 2012, BETA ADRENERGIC SWEA; Quinton PM, 2007, PHYSIOLOGY, V22, P212, DOI 10.1152/physiol.00041.2006; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raman V, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e13; Ramsey Bonnie W, 2007, Proc Am Thorac Soc, V4, P367, DOI 10.1513/pats.200703-038BR; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; ROCHON J, 1990, J CLIN EPIDEMIOL, V43, P499, DOI 10.1016/0895-4356(90)90139-G; Sanders DB, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e79; SATO K, 1983, AM J PHYSIOL, V245, pC189, DOI 10.1152/ajpcell.1983.245.3.C189; SATO K, 1981, AM J PHYSIOL, V240, pR44, DOI 10.1152/ajpregu.1981.240.1.R44; SATO K, 1984, J CLIN INVEST, V73, P1763, DOI 10.1172/JCI111385; SATO K, 1981, AM J PHYSIOL, V241, pC113, DOI 10.1152/ajpcell.1981.241.3.C113; SATO K, 1988, J LAB CLIN MED, V111, P511; SCHWARZ V, 1967, BIBL PAEDIATR, P89; Sermet-Gaudelus I, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-5; SPIEGELHALTER DJ, 1988, SCAND J GASTROENTERO, V23, P40, DOI 10.3109/00365528809099158; Standaert TA, 2004, PEDIATR PULM, V37, P385, DOI 10.1002/ppul.10448; Suen YF, 2006, BIOORG MED CHEM LETT, V16, P537, DOI 10.1016/j.bmcl.2005.10.050; TRAPNELL BC, 1991, P NATL ACAD SCI USA, V88, P6565, DOI 10.1073/pnas.88.15.6565; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; VEEZE HJ, 1994, J CLIN INVEST, V93, P461, DOI 10.1172/JCI116993; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; WILSCHANSKI M, 1995, J PEDIATR-US, V127, P705, DOI 10.1016/S0022-3476(95)70157-5; Wine JJ, 2011, METHODS MOL BIOL, V742, P93, DOI 10.1007/978-1-61779-120-8_6	60	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77114	10.1371/journal.pone.0077114	http://dx.doi.org/10.1371/journal.pone.0077114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204751	gold, Green Submitted, Green Published			2022-12-27	WOS:000326152300015
J	Baranyi, M; Cervenak, J; Bender, B; Kacskovics, I				Baranyi, Maria; Cervenak, Judit; Bender, Balazs; Kacskovics, Imre			Transgenic Rabbits That Overexpress the Neonatal Fc Receptor (FcRn) Generate Higher Quantities and Improved Qualities of Anti-Thymocyte Globulin (ATG)	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; ANTITHYMOCYTE GLOBULIN; POLYCLONAL ANTILYMPHOCYTE; MONOCLONAL-ANTIBODIES; MEDIATED PRESENTATION; DENDRITIC CELLS; FLOW-CYTOMETRY; MYELOMA CELLS; B-CELL; APOPTOSIS	Immune suppression with rabbit anti-thymocyte globulin (rATG) is a well-established therapeutic concept for preventing host rejection of transplanted organs and graft versus host disease. Increasing the efficiency of rATG production by reducing the number of animals would be highly beneficial to lower cost and to improve quality standards. We have developed transgenic (Tg) mice and rabbits that overexpress the neonatal Fc receptor (FcRn) and have shown an augmented humoral immune response in these animals. To test whether our FcRn Tg rabbits produced rATG more efficiently, we immunized them and their New Zealand White controls with live Jurkat cells. By day 21 after immunization, Tg animals produced significantly, 1.5 times higher amount of total IgG compared to their wt littermates. Also, the binding efficiency of Tg sera to Jurkat cells and their complement-mediated cytotoxicity was significantly higher. The purified Tg IgG preparation contained 2.6 the amount of Jurkat specific IgG as the wt preparation analyzed by complement-mediated lysis, suggesting greater antigen-specific B cell activation in the Tg rabbits. To test this hypothesis, immunization with ovalbumin and human alpha(1)-antitrypsin was performed, resulting in significantly greater numbers of antigen-specific B-cells in the FcRn Tg rabbits as compared with wt controls. The shift towards significantly larger populations of antigen-specific B cells relative to the nonspecific B cell pool is further corroborated by our previous findings in FcRn Tg mice. Consequently, our FcRn Tg rabbits have the potential to offer substantial qualitative and quantitative improvements for the production of rATG and other polyclonal or monoclonal antibodies.	[Baranyi, Maria; Cervenak, Judit; Bender, Balazs; Kacskovics, Imre] ImmunoGenes Kft, Budakeszi, Hungary		Kacskovics, I (corresponding author), ImmunoGenes Kft, Budakeszi, Hungary.	kacskovics@immunogenes.com	Kacskovics, Imre/J-8449-2013	Kacskovics, Imre/0000-0002-0402-3862	Hungarian Economic Development Centre [KMOP-1.1.4-11/B-2011-0226]	Hungarian Economic Development Centre	This work was supported by the grant KMOP-1.1.4-11/B-2011-0226 from the Hungarian Economic Development Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; Ayuk FA, 2005, EXP HEMATOL, V33, P1531, DOI 10.1016/j.exphem.2005.08.004; Ayuk F, 2009, ANN HEMATOL, V88, P401, DOI 10.1007/s00277-009-0696-8; Baker K, 2011, P NATL ACAD SCI USA, V108, P9927, DOI 10.1073/pnas.1019037108; Beiras-Fernandez A, 2003, Exp Clin Transplant, V1, P79; Bender B, 2007, TRANSGENIC RES, V16, P613, DOI 10.1007/s11248-007-9108-9; BonnefoyBerard N, 1996, J HEART LUNG TRANSPL, V15, P435; BONNEFOYBERARD N, 1991, TRANSPLANTATION, V51, P669, DOI 10.1097/00007890-199103000-00024; BONNEFOYBERARD N, 1994, BLOOD, V83, P1051; BOURDAGE JS, 1995, TRANSPLANTATION, V59, P1194, DOI 10.1097/00007890-199504270-00020; Brambell FWR., 1970, N HOLL RES MONOGR FR, V18; Brennan DC, 2003, TRANSPLANTATION, V75, P577, DOI 10.1097/01.TP.0000053199.45370.4C; Cervenak J, 2011, J IMMUNOL, V186, P959, DOI 10.4049/jimmunol.1000353; Cosimi AB, 1988, ANTILYMPHOCYTE GLOBU; DEEG HJ, 1985, TRANSPLANTATION, V40, P162, DOI 10.1097/00007890-198508000-00011; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Genestier L, 1998, BLOOD, V91, P2360, DOI 10.1182/blood.V91.7.2360.2360_2360_2368; Groves DJ, 2000, HYBRIDOMA, V19, P201, DOI 10.1089/02724570050109602; JOOSTE SV, 1968, IMMUNOLOGY, V15, P697; Lemos APC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028869; LEVEY RH, 1966, P NATL ACAD SCI USA, V56, P1130, DOI 10.1073/pnas.56.4.1130; Liu XD, 2011, J IMMUNOL, V186, P4674, DOI 10.4049/jimmunol.1003584; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Lopez M, 2006, J AM SOC NEPHROL, V17, P2844, DOI 10.1681/ASN.2006050422; Lowsky R, 2005, NEW ENGL J MED, V353, P1321, DOI 10.1056/NEJMoa050642; Lu W, 2007, IMMUNOLOGY, V122, P401, DOI 10.1111/j.1365-2567.2007.02654.x; Marsh J, 1999, BLOOD, V93, P2191, DOI 10.1182/blood.V93.7.2191.407a03_2191_2195; Mi WT, 2008, J IMMUNOL, V181, P7550, DOI 10.4049/jimmunol.181.11.7550; Michallet MC, 2003, TRANSPLANTATION, V75, P657, DOI 10.1097/01.TP.0000053198.99206.E6; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; Preville X, 2000, J IMMUNOL METHODS, V245, P45, DOI 10.1016/S0022-1759(00)00271-4; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Ringden O, 1998, TRANSPLANTATION, V66, P620, DOI 10.1097/00007890-199809150-00013; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Schneider Z, 2011, IMMUNOL LETT, V137, P62, DOI 10.1016/j.imlet.2011.02.018; SPIEGELB.HL, 1965, J EXP MED, V121, P323, DOI 10.1084/jem.121.3.323; STORB R, 1974, BLOOD, V44, P57, DOI 10.1182/blood.V44.1.57.57; Theurich S, 2010, BIOL BLOOD MARROW TR, V16, pS220, DOI 10.1016/j.bbmt.2009.12.204; Timm MM, 2006, LEUKEMIA, V20, P1863, DOI 10.1038/sj.leu.2404359; Vegh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036286; Vegh A, 2011, MABS-AUSTIN, V3, P173, DOI 10.4161/mabs.3.2.14462; Vidarsson G, 2006, BLOOD, V108, P3573, DOI 10.1182/blood-2006-05-024539; Zand MS, 2006, BLOOD, V107, P2895, DOI 10.1182/blood-2005-06-2269; Zand MS, 2005, TRANSPLANTATION, V79, P1507, DOI 10.1097/01.TP.0000164159.20075.16	46	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76839	10.1371/journal.pone.0076839	http://dx.doi.org/10.1371/journal.pone.0076839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194847	Green Submitted, Green Published, gold			2022-12-27	WOS:000326037000026
J	Chen, WW; Liu, PX; Wang, YD; Nie, WM; Li, ZW; Xu, W; Li, FY; Zhou, ZP; Zhao, M; Liu, HG				Chen, Weiwei; Liu, Peixin; Wang, Yedong; Nie, Weimin; Li, Zhiwei; Xu, Wen; Li, Fengyi; Zhou, Zhiping; Zhao, Min; Liu, Henggui			Characterization of a Soluble B7-H3 (sB7-H3) Spliced from the Intron and Analysis of sB7-H3 in the Sera of Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							B7 FAMILY; PROSTATE-CANCER; T-CELLS; TUMOR VASCULATURE; LIGAND EXPRESSION; BREAST-CANCER; MEMBER; PROLIFERATION; ACTIVATION; MOLECULE	B7-H3 is a recently discovered member of the B7 superfamily molecules and has been found to play a negative role in T cell responses. In this study, we identified a new B7-H3 isoform that is produced by alternative splicing from the forth intron of B7-H3 and encodes the sB7-H3 protein. Protein sequence analysis showed that sB7-H3 contains an additional four amino acids, encoded by the intron sequence, at the C-terminus compared to the ectodomain of 2Ig-B7-H3. We further found that this spliced sB7-H3 plays a negative regulatory role in T cell responses and serum sB7-H3 is higher in patients with hepatocellular carcinoma (HCC) than in healthy donors. Furthermore, we found that the expression of the spliced sb7-h3 gene is higher in carcinoma and peritumor tissues than in PBMCs of both healthy controls and patients, indicating that the high level of serum sB7-H3 in patients with HCC is caused by the increased expression of this newly discovered spliced sB7-H3 isoform in carcinoma and peritumor tissues.	[Chen, Weiwei; Liu, Peixin; Liu, Henggui] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Chen, Weiwei; Wang, Yedong; Nie, Weimin; Li, Zhiwei; Xu, Wen; Li, Fengyi; Zhou, Zhiping; Zhao, Min] 302 Hosp PLA, Treatment & Res Ctr Infect Dis, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Fifth Medical Center of Chinese PLA General Hospital	Liu, HG (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	drzhaomin@sina.com; lhg@hvri.ac.cn			State Key Laboratory of Veterinary Biotechnology Research Fund [SKLVBP201217]; Chinese Special Fund for Agro-scientific Research in the Public Interest [201303033]; National Nature Science Foundation of China [81072423]; National Grand Program on Key Infectious Disease [2012ZX10005-006]	State Key Laboratory of Veterinary Biotechnology Research Fund; Chinese Special Fund for Agro-scientific Research in the Public Interest; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Grand Program on Key Infectious Disease	This work was supported by the grants from State Key Laboratory of Veterinary Biotechnology Research Fund (SKLVBP201217), Chinese Special Fund for Agro-scientific Research in the Public Interest (201303033), the National Nature Science Foundation of China (81072423), and National Grand Program on Key Infectious Disease (2012ZX10005-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arigami T, 2011, CANCER SCI, V102, P1019, DOI 10.1111/j.1349-7006.2011.01877.x; Arigami T, 2010, ANN SURG, V252, P1044, DOI 10.1097/SLA.0b013e3181f1939d; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chavin G, 2009, CLIN CANCER RES, V15, P2174, DOI 10.1158/1078-0432.CCR-08-2262; Chen WW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021341; Crispen PL, 2008, CLIN CANCER RES, V14, P5150, DOI 10.1158/1078-0432.CCR-08-0536; Dong HD, 1999, NAT MED, V5, P1365; Gehring AJ, 2009, GASTROENTEROLOGY, V137, P682, DOI 10.1053/j.gastro.2009.04.045; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Gregorio A, 2008, HISTOPATHOLOGY, V53, P73, DOI 10.1111/j.1365-2559.2008.03070.x; Hashiguchi M, 2008, P NATL ACAD SCI USA, V105, P10495, DOI 10.1073/pnas.0802423105; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kakoulidou M, 2007, J NEUROIMMUNOL, V185, P150, DOI 10.1016/j.jneuroim.2007.01.007; Katayama A, 2011, INT J ONCOL; Krambeck AE, 2006, P NATL ACAD SCI USA, V103, P10391, DOI 10.1073/pnas.0600937103; Kryczek I, 2007, CANCER RES, V67, P8900, DOI 10.1158/0008-5472.CAN-07-1866; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Leitner J, 2009, EUR J IMMUNOL; Ling V, 2003, GENOMICS, V82, P365, DOI 10.1016/S0888-7543(03)00126-5; Liu HG, 2007, CLIN IMMUNOL, V125, P337, DOI 10.1016/j.clim.2007.06.010; Luan Y, 2012, J VIRAL HEPATITIS, V19, P23, DOI 10.1111/j.1365-2893.2010.01421.x; Luo LQ, 2004, J IMMUNOL, V173, P5445, DOI 10.4049/jimmunol.173.9.5445; Peng JM, 2010, VET IMMUNOL IMMUNOP, V136, P157, DOI 10.1016/j.vetimm.2010.03.001; Prasad DVR, 2004, J IMMUNOL, V173, P2500, DOI 10.4049/jimmunol.173.4.2500; Roth TJ, 2007, CANCER RES, V67, P7893, DOI 10.1158/0008-5472.CAN-07-1068; Sadanandam A, 2012, BREAST CANCER RES TR, V136, P693, DOI 10.1007/s10549-012-2290-3; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Sun J, 2010, CANCER IMMUNOL IMMUN, V59, P1163, DOI 10.1007/s00262-010-0841-1; Sun X, 2003, GENE THER, V10, P1728, DOI 10.1038/sj.gt.3302070; Sun YP, 2006, LUNG CANCER-J IASLC, V53, P143, DOI 10.1016/j.lungcan.2006.05.012; Wang LH, 2010, CHINESE MED J-PEKING, V123, P3545, DOI 10.3760/cma.j.issn.0366-6999.2010.24.008; Wang LQ, 2005, EUR J IMMUNOL, V35, P428, DOI 10.1002/eji.200425518; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Yamato I, 2009, BRIT J CANCER, V101, P1709, DOI 10.1038/sj.bjc.6605375; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zang X, 2007, P NATL ACAD SCI USA, V104, P19458, DOI 10.1073/pnas.0709802104; Zhang GB, 2004, ACTA BIOCH BIOPH SIN, V36, P430, DOI 10.1093/abbs/36.6.430; Zhang GB, 2008, IMMUNOLOGY, V123, P538, DOI 10.1111/j.1365-2567.2007.02723.x; Zhang GB, 2010, J IMMUNOL, V185, P3677, DOI 10.4049/jimmunol.0904020; Zhang GB, 2009, LUNG CANCER, V66, P245, DOI 10.1016/j.lungcan.2009.01.017; Zhou YH, 2007, TISSUE ANTIGENS, V70, P96, DOI 10.1111/j.1399-0039.2007.00853.x	44	22	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76965	10.1371/journal.pone.0076965	http://dx.doi.org/10.1371/journal.pone.0076965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194851	Green Submitted, gold, Green Published			2022-12-27	WOS:000326037000030
J	Eady, TN; Khoutorova, L; Anzola, DV; Hong, SH; Obenaus, A; Mohd-Yusof, A; Bazan, NG; Belayev, L				Eady, Tiffany N.; Khoutorova, Larissa; Anzola, Daniela V.; Hong, Sung-Ha; Obenaus, Andre; Mohd-Yusof, Alena; Bazan, Nicolas G.; Belayev, Ludmila			Acute Treatment with Docosahexaenoic Acid Complexed to Albumin Reduces Injury after a Permanent Focal Cerebral Ischemia in Rats	PLOS ONE			English	Article							MARKED NEUROPROTECTIVE EFFICACY; ARTERY OCCLUSION; FATTY-ACIDS; TRANSIENT; THERAPY; BRAIN; RESPONSES; BENEFITS; STROKE; MODEL	Docosahexaenoic acid complexed to albumin (DHA-Alb) is highly neuroprotective after temporary middle cerebral artery occlusion (MCAo), but whether a similar effect occurs in permanent MCAo is unknown. Male Sprague-Dawley rats (270-330 g) underwent permanent MCAo. Neurological function was evaluated on days 1, 2 and 3 after MCAo. We studied six groups: DHA (5 mg/kg), Alb (0.63 or 1.25 g/kg), DHA-Alb (5 mg/kg + 0.63 g/kg or 5 mg/kg + 1.25 g/kg) or saline. Treatment was administered i.v. at 3 h after onset of stroke (n = 7-10 per group). Ex vivo imaging of brains and histopathology were conducted on day 3. Saline-and Alb-treated rats developed severe neurological deficits but were not significantly different from one another. In contrast, rats treated with low and moderate doses of DHA-Alb showed improved neurological score compared to corresponding Alb groups on days 2 and 3. Total, cortical and subcortical lesion volumes computed from T2 weighted images were reduced following a moderate dose of DHA-Alb (1.25 g/kg) by 25%, 22%, 34%, respectively, compared to the Alb group. The total corrected, cortical and subcortical infarct volumes were reduced by low (by 36-40%) and moderate doses (by 34-42%) of DHA-Alb treatment compared to the Alb groups. In conclusion, DHA-Alb therapy is highly neuroprotective in permanent MCAo in rats. This treatment can provide the basis for future therapeutics for patients suffering from ischemic stroke.	[Eady, Tiffany N.; Khoutorova, Larissa; Anzola, Daniela V.; Hong, Sung-Ha; Bazan, Nicolas G.; Belayev, Ludmila] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; [Belayev, Ludmila] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Neurosurg, New Orleans, LA USA; [Obenaus, Andre; Mohd-Yusof, Alena] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Loma Linda University	Belayev, L (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA.	lbelay@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [R01 NS065786]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065786] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) grant R01 NS065786 (LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2002, PEDIATR NEUROL, V26, P210, DOI 10.1016/S0887-8994(01)00383-6; Bazan NG, 2003, J LIPID RES, V44, P2221, DOI 10.1194/jlr.R300013-JLR200; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Belayev L, 2005, STROKE, V36, P326, DOI 10.1161/01.STR.0000152949.31366.3d; Belayev L, 2005, STROKE, V36, P118, DOI 10.1161/01.STR.0000149620.74770.2e; Belayev L, 1998, STROKE, V29, P2587, DOI 10.1161/01.STR.29.12.2587; Belayev L, 2002, STROKE, V33, P1077, DOI 10.1161/hs0402.105555; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Belayev L, 1997, J NEUROSURG, V87, P595, DOI 10.3171/jns.1997.87.4.0595; Belayev L, 2011, TRANSL STROKE RES, V2, P33, DOI 10.1007/s12975-010-0046-0; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Bogaert YE, 2000, EXP NEUROL, V161, P115, DOI 10.1006/exnr.1999.7250; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; de Turco EBR, 2002, J NEUROCHEM, V83, P515, DOI 10.1046/j.1471-4159.2002.01121.x; Eady Tiffany N, 2012, Exp Transl Stroke Med, V4, P19, DOI 10.1186/2040-7378-4-19; Eady TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046151; Fernandes JS, 2008, NUTR RES, V28, P798, DOI 10.1016/j.nutres.2008.09.004; Liu YT, 2001, EUR J PHARMACOL, V428, P193, DOI 10.1016/S0014-2999(01)01255-9; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Obenaus A, 2011, ANN NEUROL, V69, P282, DOI 10.1002/ana.22168; Palesch YY, 2006, STROKE, V37, P2107, DOI 10.1161/01.STR.0000231389.34701.b5; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Siegel G, 2012, ATHEROSCLEROSIS, V225, P291, DOI 10.1016/j.atherosclerosis.2012.09.006; Virtanen JK, 2008, AM J CLIN NUTR, V88, P1618, DOI 10.3945/ajcn.2007.25816; Yurko-Mauro K, 2010, CURR ALZHEIMER RES, V7, P190, DOI 10.2174/156720510791050911; ZHANG JP, 1995, J NEUROCHEM, V64, P1688	27	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77237	10.1371/journal.pone.0077237	http://dx.doi.org/10.1371/journal.pone.0077237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194876	gold, Green Published, Green Submitted			2022-12-27	WOS:000326037000055
J	Liu, LL; Zhang, ZJ; Mei, Q; Chen, M				Liu, Lili; Zhang, Zijun; Mei, Qian; Chen, Ming			PSI: A Comprehensive and Integrative Approach for Accurate Plant Subcellular Localization Prediction	PLOS ONE			English	Article							WEB SERVER; PROTEINS; LOCATION; DATABASE; SUITE; TOOL	Predicting the subcellular localization of proteins conquers the major drawbacks of high-throughput localization experiments that are costly and time-consuming. However, current subcellular localization predictors are limited in scope and accuracy. In particular, most predictors perform well on certain locations or with certain data sets while poorly on others. Here, we present PSI, a novel high accuracy web server for plant subcellular localization prediction. PSI derives the wisdom of multiple specialized predictors via a joint-approach of group decision making strategy and machine learning methods to give an integrated best result. The overall accuracy obtained (up to 93.4%) was higher than best individual (CELLO) by similar to 10.7%. The precision of each predicable subcellular location (more than 80%) far exceeds that of the individual predictors. It can also deal with multi-localization proteins. PSI is expected to be a powerful tool in protein location engineering as well as in plant sciences, while the strategy employed could be applied to other integrative problems. A user-friendly web server, PSI, has been developed for free access at http://bis.zju.edu.cn/psi/.	[Liu, Lili; Zhang, Zijun; Mei, Qian; Chen, Ming] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Chen, M (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	mchen@zju.edu.cn	Chen, Ming/AAV-3682-2020; Liu, Lili/I-7619-2019	Chen, Ming/0000-0002-9677-1699; Liu, Lili/0000-0002-2622-9669; Mei, Qian/0000-0003-4648-7232	National Natural Sciences Foundation of China [30771326, 30971743]; Program for New Century Excellent Talents in University of China [NCET-07-0740]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Sciences Foundation of China [30771326, 30971743], the Program for New Century Excellent Talents in University of China [NCET-07-0740]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bau D, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-402; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Boden M, 2005, BIOINFORMATICS, V21, P2279, DOI 10.1093/bioinformatics/bti372; Brady Scott, 2008, Pac Symp Biocomput, P604; Carugo O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-380; Chen H, 2006, BIOINFORMATICS, V22, P376, DOI 10.1093/bioinformatics/bti822; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Doennes Pierre, 2004, Genomics Proteomics & Bioinformatics, V2, P209; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fyshe A, 2008, BIOINFORMATICS, V24, P2512, DOI 10.1093/bioinformatics/btn463; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; Guda C, 2006, NUCLEIC ACIDS RES, V34, pW210, DOI 10.1093/nar/gkl093; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang WL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-80; Laurila K, 2011, AMINO ACIDS, V40, P975, DOI 10.1007/s00726-010-0724-y; Lin HN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S8; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Niu B, 2008, MOL DIVERS, V12, P41, DOI 10.1007/s11030-008-9073-0; Petsalaki Evangelia I., 2006, Genomics Proteomics & Bioinformatics, V4, P48, DOI 10.1016/S1672-0229(06)60016-8; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Scott MS, 2004, GENOME RES, V14, P1957, DOI 10.1101/gr.2650004; Shen YQ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-420; Shen YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-563; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Szafron D, 2004, NUCLEIC ACIDS RES, V32, pW365, DOI 10.1093/nar/gkh485; Tanz SK, 2013, NUCLEIC ACIDS RES, V41, pD1185, DOI 10.1093/nar/gks1151; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604	33	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e75826	10.1371/journal.pone.0075826	http://dx.doi.org/10.1371/journal.pone.0075826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194827	Green Submitted, gold, Green Published			2022-12-27	WOS:000326037000006
J	Reddy, DS; Bhatnagar-Mathur, P; Cindhuri, KS; Sharma, KK				Reddy, Dumbala Srinivas; Bhatnagar-Mathur, Pooja; Cindhuri, Katamreddy Sri; Sharma, Kiran K.			Evaluation and Validation of Reference Genes for Normalization of Quantitative Real-Time PCR Based Gene Expression Studies in Peanut	PLOS ONE			English	Article							INTERNAL CONTROL GENES; ARACHIS-HYPOGAEA L.; RT-PCR; HOUSEKEEPING GENES; ACCURATE NORMALIZATION; CROP IMPROVEMENT; IDENTIFICATION; SELECTION; RESISTANCE; NUMBER	The quantitative real-time PCR (qPCR) based techniques have become essential for gene expression studies and high-throughput molecular characterization of transgenic events. Normalizing to reference gene in relative quantification make results from qPCR more reliable when compared to absolute quantification, but requires robust reference genes. Since, ideal reference gene should be species specific, no single internal control gene is universal for use as a reference gene across various plant developmental stages and diverse growth conditions. Here, we present validation studies of multiple stably expressed reference genes in cultivated peanut with minimal variations in temporal and spatial expression when subjected to various biotic and abiotic stresses. Stability in the expression of eight candidate reference genes including ADH3, ACT11, ATPsyn, CYP2, ELF1B, G6PD, LEC and UBC1 was compared in diverse peanut plant samples. The samples were categorized into distinct experimental sets to check the suitability of candidate genes for accurate and reliable normalization of gene expression using qPCR. Stability in expression of the references genes in eight sets of samples was determined by geNorm and NormFinder methods. While three candidate reference genes including ADH3, G6PD and ELF1B were identified to be stably expressed across experiments, LEC was observed to be the least stable, and hence must be avoided for gene expression studies in peanut. Inclusion of the former two genes gave sufficiently reliable results; nonetheless, the addition of the third reference gene ELF1B may be potentially better in a diverse set of tissue samples of peanut.	[Reddy, Dumbala Srinivas; Bhatnagar-Mathur, Pooja; Cindhuri, Katamreddy Sri; Sharma, Kiran K.] Int Crops Res Inst Semi Arid Trop, Patancheru, Andhra Pradesh, India	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Bhatnagar-Mathur, P (corresponding author), Int Crops Res Inst Semi Arid Trop, Patancheru, Andhra Pradesh, India.	p.bhatnagar@cgiar.org	Sharma, Kiran/C-5715-2014; Sharma, Kiran/GZL-1834-2022; Bhatnagar-Mathur, Pooja/C-5730-2014	Sharma, Kiran/0000-0002-1200-8857; Bhatnagar-Mathur, Pooja/0000-0002-4150-8287	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was undertaken as part of the CGIAR Research Program on Grain Legumes and partly supported by a grant from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Bhatnagar-Mathur P, 2007, PLANT CELL REP, V26, P2071, DOI 10.1007/s00299-007-0406-8; Boava Leonardo P, 2010, BMC Res Notes, V3, P43, DOI 10.1186/1756-0500-3-43; Brand Yael, 2010, Peanut Science, V37, P12, DOI 10.3146/PS09-014.1; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; FAO, 2009, FAO STAT DAT; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6; Gutierrez N, 2011, MOL BREEDING, V28, P13, DOI 10.1007/s11032-010-9456-7; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Kumar PL, 2007, PATANCHERU; LEDT, 2012, PLOS ONE, V0007; Li Q, 2012, PLANT CELL REP, V31, P1789, DOI 10.1007/s00299-012-1282-4; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Mason Giovanna, 2002, BMC Biotechnol, V2, P20, DOI 10.1186/1472-6750-2-20; Morgante Carolina V, 2011, BMC Res Notes, V4, P339, DOI 10.1186/1756-0500-4-339; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Peterhansel C., 2004, Biomedical Engineering, Applications Basis Communications, V16, P1; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Schmidt MA, 2001, PLANT CELL REP, V20, P422, DOI 10.1007/s002990100326; Sharma HC, 2002, PLANT SCI, V163, P381, DOI 10.1016/S0168-9452(02)00133-4; Sharma KK, 2000, IN VITRO CELL DEV-PL, V36, P83, DOI 10.1007/s11627-000-0019-1; SUBRAHMANYAM P, 1985, PLANT DIS, V69, P951, DOI 10.1094/PD-69-951; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tsai HF, 2010, ANTIMICROB AGENTS CH, V54, P3308, DOI 10.1128/AAC.00535-10; Tunbridge EM, 2011, BIOL PSYCHIAT, V69, P173, DOI 10.1016/j.biopsych.2010.05.023; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang Y, 2012, MOL BIOL REP, V39, P1585, DOI 10.1007/s11033-011-0897-9; Weng H, 2004, PLANT MOL BIOL REP, V22, P289, DOI 10.1007/BF02773139; Yi CX, 2008, ANAL BIOCHEM, V375, P150, DOI 10.1016/j.ab.2007.11.022; YOKOYAMA S, 1993, MOL BIOL EVOL, V10, P1215	54	58	62	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78555	10.1371/journal.pone.0078555	http://dx.doi.org/10.1371/journal.pone.0078555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167633	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326034500094
J	Wang, Y; Chen, CF; Zhang, LJ				Wang, Yong; Chen, Chuangfu; Zhang, Lijuan			Molecular Characterization of msp2/p44 of Anaplasma phagocytophilum Isolated from Infected Patients and Haemaphysalis longicornis in Laizhou Bay, Shandong Province, China	PLOS ONE			English	Article							HUMAN GRANULOCYTIC ANAPLASMOSIS; EHRLICHIA-CHAFFEENSIS; SURFACE PROTEIN-2; NEW-YORK; EXPRESSION; TICKS; TRANSCRIPTION; DIVERSITY; WISCONSIN; OUTCOMES	Molecular characterization of the MSP2/P44 protein of Anaplasma phagocytophilum may determine not only if the bacterium is capable of invading hosts but also whether it generates antigenic variation for the purpose of escaping the host immune response, resulting in various pathologic injuries and serious clinical outcomes. Chinese anaplasmosis patients usually present with serious manifestations, and the fatality rate is as high as 26.5%. In this study, we amplified, cloned and sequenced the msp2/p44 genes of three Chinese A. phagocytophilum isolates from Laizhou Bay, Shandong Province, where human granulocytic anaplasmosis (HGA) patients present severe clinical manifestations, and analyzed their genetic characterization and structural features. We also compared them with the HZ and Webster A. phagocytophilum strains. The sequences for both strains are available in GenBank. Analyses indicated that Chinese A. phagocytophilum isolates were significantly different from the HZ and Webster strains in terms of nucleotide sequences, amino acid sequences and protein secondary and tertiary structures. Moreover, the number of immunologic B-cell epitopes (19) of the MSP2 protein of the Chinese isolates was higher than that of the A. phagocytophilum strains HZ (16) and Webster (9). This genetic diversity of the MSP2/P44 protein of Chinese A. phagocytophilum isolates might be relevant and might have serious clinical outcomes. This observation could provide a clue to further understand the pathogenesis of Chinese A. phagocytophilum.	[Wang, Yong; Chen, Chuangfu] Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang Provin, Peoples R China; [Wang, Yong; Zhang, Lijuan] China CDC, Natl Inst Communicable Dis Control & Prevent, Dept Rickettsiol, Beijing, Peoples R China	Shihezi University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Chen, CF (corresponding author), Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang Provin, Peoples R China.	ccf-xb@163.com; zhanglijuan@icdc.cn			National Basic Research Program of China (973 Program) [2010CB530206]; China Mega-Project for Infectious Disease [2011ZX10004-001]; National Key Science and Technology Projects of China [2012ZX10004215]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); China Mega-Project for Infectious Disease; National Key Science and Technology Projects of China	This study was supported by the National Basic Research Program of China (973 Program, 2010CB530206) and China Mega-Project for Infectious Disease (2011ZX10004-001) and National Key Science and Technology Projects of China (Project no. 2012ZX10004215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khedery B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-678; Asanovich KM, 1997, J INFECT DIS, V176, P1029, DOI 10.1086/516529; Bakken Johan S., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bakken JS, 1998, CLIN INFECT DIS, V27, P1491, DOI 10.1086/515048; Carlyon JA, 2003, CELL MICROBIOL, V5, P743, DOI 10.1046/j.1462-5822.2003.00323.x; Caspersen K, 2002, INFECT IMMUN, V70, P1230, DOI 10.1128/IAI.70.3.1230-1234.2002; Dumler JS, 2007, CLIN INFECT DIS, V45, pS45, DOI 10.1086/518146; Dumler JS, 2012, FEMS IMMUNOL MED MIC, V64, P13, DOI 10.1111/j.1574-695X.2011.00909.x; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Foley J, 2008, ANN NY ACAD SCI, V1149, P94, DOI 10.1196/annals.1428.066; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008265; Guero-Rosenfeld M. E., 2003, MANUAL CLIN MICROBIO, P1015; Inokuma H, 2003, CLIN DIAGN LAB IMMUN, V10, P969, DOI 10.1128/CDLI.10.5.969-972.2003; Kim CM, 2003, VECTOR-BORNE ZOONOT, V3, P17, DOI 10.1089/153036603765627424; Li HY, 2011, INT J INFECT DIS, V15, pE859, DOI 10.1016/j.ijid.2011.09.008; Lin MQ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00024; Lin Q, 2006, INFECT IMMUN, V74, P2052, DOI 10.1128/IAI.74.4.2052-2062.2006; Lin Q, 2005, INFECT IMMUN, V73, P5106, DOI 10.1128/IAI.73.8.5106-5114.2005; Lin Q, 2004, INFECT IMMUN, V72, P5574, DOI 10.1128/IAI.72.10.5574-5581.2004; Michalski M, 2006, PARASITOL RES, V99, P694, DOI 10.1007/s00436-006-0217-9; 오재영, 2009, Journal of Bacteriology and Virology, V39, P257; Ohashi N, 2005, EMERG INFECT DIS, V11, P1780, DOI 10.3201/eid1111.050407; Rikihisa Y, 1997, J INFECT DIS, V175, P210, DOI 10.1093/infdis/175.1.210; Rikihisa Y, 2011, CLIN MICROBIOL REV, V24, P469, DOI 10.1128/CMR.00064-10; Rikihisa Y, 2010, NAT REV MICROBIOL, V8, P328, DOI 10.1038/nrmicro2318; Scharf W, 2011, J CLIN MICROBIOL, V49, P790, DOI 10.1128/JCM.02051-10; Scorpio DG, 2008, CLIN VACCINE IMMUNOL, V15, P418, DOI 10.1128/CVI.00417-07; Sun JM, 2008, VECTOR-BORNE ZOONOT, V8, P791, DOI 10.1089/vbz.2008.0005; Troese MJ, 2009, INFECT IMMUN, V77, P1746, DOI 10.1128/IAI.01530-08; WALKER DH, 1994, NEW ENGL J MED, V331, P1651, DOI 10.1056/NEJM199412153312410; Woldehiwet Z, 2006, ANN NY ACAD SCI, V1078, P446, DOI 10.1196/annals.1374.084; Wuritu, 2009, J MED MICROBIOL, V58, P1638, DOI 10.1099/jmm.0.011775-0; Yoshimoto K, 2010, VET PARASITOL, V168, P170, DOI 10.1016/j.vetpar.2009.10.008; Yu Q, 2012, CLIN VACCINE IMMUNOL, V19, P919, DOI 10.1128/CVI.05709-11; Zhan L, 2008, VECTOR-BORNE ZOONOT, V8, P369, DOI 10.1089/vbz.2007.0211; Zhan L, 2010, VET MICROBIOL, V144, P405, DOI 10.1016/j.vetmic.2010.02.018; Zhan L, 2010, EMERG INFECT DIS, V16, P764, DOI [10.3201/eid1605.021293, 10.3201/eid1605.091293]; Zhan L, 2009, EMERG INFECT DIS, V15, P1904, DOI 10.3201/eid1512.081141; Zhang LJ, 2008, JAMA-J AM MED ASSOC, V300, P2263, DOI 10.1001/jama.2008.626; Zhang LJ, 2008, EMERG INFECT DIS, V14, P938, DOI 10.3201/eid1406.071502; Zhang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057155; Zhang LJ, 2012, AM J TROP MED HYG, V87, P185, DOI 10.4269/ajtmh.2012.12-0005	43	0	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78189	10.1371/journal.pone.0078189	http://dx.doi.org/10.1371/journal.pone.0078189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167608	Green Published, gold, Green Submitted			2022-12-27	WOS:000326034500068
J	Wu, YY; Sarkissyan, M; Elshimali, Y; Vadgama, JV				Wu, Yanyuan; Sarkissyan, Marianna; Elshimali, Yahya; Vadgama, Jaydutt V.			Triple Negative Breast Tumors in African-American and Hispanic/Latina Women Are High in CD44+, Low in CD24+, and Have Loss of PTEN	PLOS ONE			English	Article							IGF-BINDING PROTEIN-3; GROWTH-FACTOR-I; CANCER CELLS; CD44(+)/CD24(-) PHENOTYPE; PROGNOSTIC-SIGNIFICANCE; SYSTEMIC THERAPY; INCIDENCE RATES; INSULIN; POPULATION; SUBTYPES	Background: African-American women have higher mortality from breast cancer than other ethnic groups. The association between poor survival and differences with tumor phenotypes is not well understood. The purpose of this study is to assess the clinical significance of (1) Stem cell-like markers CD44 and CD24; (2) PI3K/Akt pathway associated targets PTEN, activation of Akt, and FOXO1; and (3) the Insulin-like growth factor-1 (IGF-I) and IGF binding protein-3 (IGFBP3) in different breast cancer subtypes, and compare the differences between African-American and Hispanic/Latina women who have similar social-economic-status. Methods: A total of N=318 African-American and Hispanic/Latina women, with clinically-annotated information within the inclusion criteria were included. Formalin fixed paraffin embedded tissues from these patients were tested for the different markers using immunohistochemistry techniques. Kaplan-Meier survival-curves and Cox-regression analyses were used to assess Relative Risk and Disease-Free-Survival (DFS). Results: The triple-negative-breast-cancer (TNBC) receptor-subtype was more prevalent among premenopausal women, and the Hormonal Receptor (HR) positive subtype was most common overall. TNBC tumors were more likely to have loss of PTEN, express high Ki67, and have increased CD44+/CD24-expression. TNBC was also associated with higher plasma-IGF-I levels. HR-/HER2+ tumors showed high pAkt, decreased FOXO1, and high CD24+ expression. The loss of PTEN impacted DFS significantly in African Americans, but not in Hispanics/Latinas after adjusted for treatment and other tumor pathological factors. The CD44+/CD24- and CD24+/CD44-phenotypes decreased DFS, but were not independent predictors for DFS. HER2-positive and TNBC type of cancers continued to exhibit significant decrease in DFS after adjusting for the selected biomarkers and treatment. Conclusions: TNBC incidence is high among African-American and Hispanic/Latino women residing in South Los Angeles. Our study also shows for the first time that TNBC was significantly associated with PTEN loss, high Ki67 and the CD44+/CD24-phenotype. The loss of PTEN impacts DFS significantly in African Americans.	[Wu, Yanyuan; Sarkissyan, Marianna; Elshimali, Yahya; Vadgama, Jaydutt V.] David Geffen UCLA Sch Med, Div Canc Res & Training, Los Angeles, CA USA; [Wu, Yanyuan; Sarkissyan, Marianna; Elshimali, Yahya; Vadgama, Jaydutt V.] David Geffen UCLA Sch Med, Dept Internal Med, Los Angeles, CA USA; [Wu, Yanyuan; Sarkissyan, Marianna; Elshimali, Yahya; Vadgama, Jaydutt V.] Charles R Drew Univ Med & Sci, David Geffen UCLA Sch Med, Los Angeles, CA 90059 USA; [Wu, Yanyuan; Vadgama, Jaydutt V.] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA; [Wu, Yanyuan; Vadgama, Jaydutt V.] David Geffen UCLA Sch Med, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vadgama, JV (corresponding author), David Geffen UCLA Sch Med, Div Canc Res & Training, Los Angeles, CA USA.	jayvadgama@cdrewu.edu			National Institutes of Health (NIH)/National Cancer Institute [U54CA14393, U56 CA101599, CA15083-25S3, R25DK067015]; Department-of-Defense Breast Cancer Research Program [BC043180]; NIH/National Center for Advancing Translational Sciences CTSI [UL1TR000124]; NATIONAL CANCER INSTITUTE [P30CA015083, U54CA143931, U56CA101599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R25DK067015] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department-of-Defense Breast Cancer Research Program(United States Department of Defense); NIH/National Center for Advancing Translational Sciences CTSI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from National Institutes of Health (NIH)/National Cancer Institute U54CA14393; U56 CA101599; CA15083-25S3; R25DK067015; and Department-of-Defense Breast Cancer Research Program grant BC043180 to JVV and NIH/National Center for Advancing Translational Sciences CTSI (Grant Number UL1TR000124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Zahrani A, 2006, HUM MOL GENET, V15, P1, DOI 10.1093/hmg/ddi398; Amirikia KC, 2011, CANCER-AM CANCER SOC, V117, P2747, DOI 10.1002/cncr.25862; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; Depowski PL, 2001, MODERN PATHOL, V14, P672, DOI 10.1038/modpathol.3880371; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hines LM, 2011, J WOMENS HEALTH, V20, P1543, DOI 10.1089/jwh.2010.2558; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Kim HJ, 2011, BREAST, V20, P78, DOI 10.1016/j.breast.2010.08.001; Kirkegaard T, 2005, J PATHOL, V207, P139, DOI 10.1002/path.1829; Komenaka IK, 2010, J NATL CANCER I, V102, P1178, DOI 10.1093/jnci/djq215; Lara-Medina F, 2011, CANCER-AM CANCER SOC, V117, P3658, DOI 10.1002/cncr.25961; Lee HE, 2011, BRIT J CANCER, V104, P1730, DOI 10.1038/bjc.2011.159; Lin Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-59; Lund MJ, 2010, CANCER-AM CANCER SOC, V116, P2549, DOI 10.1002/cncr.25016; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Mylona E, 2008, HUM PATHOL, V39, P1096, DOI 10.1016/j.humpath.2007.12.003; Pal SK, 2010, EXPERT OPIN INV DRUG, V19, P1355, DOI 10.1517/13543784.2010.520701; Parise CA, 2010, CRIT REV ONCOL HEMAT, V76, P44, DOI 10.1016/j.critrevonc.2009.09.002; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Perrone G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043110; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Pollak Michael, 2007, V174, P49; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stark A, 2010, CANCER-AM CANCER SOC, V116, P4926, DOI 10.1002/cncr.25276; Stead LA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2242; Vadgama JV, 1999, ONCOLOGY-BASEL, V57, P330, DOI 10.1159/000012052; Wang LB, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-226; Wu YY, 2012, AM J CANCER RES, V2, P104; Wu YY, 2010, CANCER RES, V70, P5475, DOI 10.1158/0008-5472.CAN-10-0176; Wu Yu-Huan, 2008, P3; Xu DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046670; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	46	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78259	10.1371/journal.pone.0078259	http://dx.doi.org/10.1371/journal.pone.0078259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167614	Green Published, Green Submitted, gold			2022-12-27	WOS:000326034500075
J	Chandwani, S; Keilani, S; Ortiz-Virumbrales, M; Morant, A; Bezdecny, S; Ehrlich, ME				Chandwani, Samira; Keilani, Serene; Ortiz-Virumbrales, Maitane; Morant, Andrika; Bezdecny, Steve; Ehrlich, Michelle E.			Induction of DARPP-32 by Brain-Derived Neurotrophic Factor in Striatal Neurons In Vitro Is Modified by Histone Deacetylase Inhibitors and Nab2	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; HUNTINGTONS-DISEASE; EXPRESSION; DIFFERENTIATION; ACID; TRANSCRIPTION; BDNF; ACTIVATION; PHENOTYPE; REQUIREMENT	Neurotrophins and modifiers of chromatin acetylation and deacetylation participate in regulation of transcription during neuronal maturation and maintenance. The striatal medium spiny neuron is supported by cortically-derived brain derived neurotrophic factor and is the most vulnerable neuron in Huntington's disease, in which growth factor and histone deacetylase activity are both disrupted. We examined the ability of three histone deacetylase inhibitors, trichostatin A, valproic acid and Compound 4 b, alone and combined with brain derived neurotrophic factor (BDNF), to promote phenotypic maturation of striatal medium spiny neurons in vitro. Exposure of these neurons to each of the three compounds led to an increase in overall histone H3 and H4 acetylation, dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa (DARPP-32) mRNA and protein, and mRNA levels of other markers of medium spiny neuron maturation. We were, however, unable to prove that HDAC inhibitors directly lead to remodeling of Ppp1r1b chromatin. In addition, induction of DARPP-32 by brain-derived neurotrophic factor was inhibited by histone deacetylase inhibitors. Although BDNF-induced increases in pTrkB, pAkt, pERK and Egr-1 were unchanged by combined application with VPA, the increase in DARPP-32 was relatively diminished. Strikingly, the NGF1A-binding protein, Nab2, was induced by BDNF, but not in the presence of VPA or TSA. Gel shift analysis showed that alpha-Nab2 super-shifted a band that is more prominent with extract derived from BDNF-treated neurons than with extracts from cultures treated with VPA alone or VPA plus BDNF. In addition, overexpression of Nab2 induced DARPP-32. We conclude that histone deacetylase inhibitors inhibit the induction of Nab2 by BDNF, and thereby the relative induction of DARPP-32.	[Ehrlich, Michelle E.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ehrlich, ME (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	michelle.ehrlich@mssm.edu			National Institutes of Health [NS-059936, NS-045942]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059936, R01NS045942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health Grants NS-059936 and NS-045942 (M. E. E.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDELT AA, 1994, BRAIN RES, V647, P340, DOI 10.1016/0006-8993(94)91333-1; Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Baquet ZC, 2004, J NEUROSCI, V24, P4250, DOI 10.1523/JNEUROSCI.3920-03.2004; Bogush AI, 2005, GENESIS, V42, P37, DOI 10.1002/gene.20118; Bogush A, 2007, J BIOL CHEM, V282, P7352, DOI 10.1074/jbc.M606508200; Brown TB, 2008, HUM MOL GENET, V17, P3095, DOI 10.1093/hmg/ddn206; Carri AD, 2013, DEVELOPMENT, V140, P301, DOI 10.1242/dev.084608; Chen B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-78; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; EHRLICH ME, 1990, DEV BRAIN RES, V54, P257, DOI 10.1016/0165-3806(90)90148-R; Ehrlich ME, 2012, NEUROTHERAPEUTICS, V9, P270, DOI 10.1007/s13311-012-0112-2; Gavalda N, 2004, MOL CELL NEUROSCI, V25, P460, DOI 10.1016/j.mcn.2003.11.012; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Ivkovic S, 1999, J NEUROSCI, V19, P5409; Ivkovic S, 1997, NEUROSCIENCE, V79, P509, DOI 10.1016/S0306-4522(96)00684-7; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Keilani S, 2012, J NEUROSCI, V32, P6808, DOI 10.1523/JNEUROSCI.5448-11.2012; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; Leng Y, 2008, J NEUROSCI, V28, P2576, DOI 10.1523/JNEUROSCI.5467-07.2008; Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Mahan AL, 2012, J NEUROSCI, V32, P4651, DOI 10.1523/JNEUROSCI.3308-11.2012; McFarland KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041423; Morrison BE, 2007, CELL MOL LIFE SCI, V64, P2258, DOI 10.1007/s00018-007-7035-9; OUIMET CC, 1989, J NEUROSCI, V9, P865; Pedrini S, 2008, J NEUROCHEM, V106, P917, DOI 10.1111/j.1471-4159.2008.05475.x; Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Stroppolo A, 2001, J NEUROCHEM, V79, P1027, DOI 10.1046/j.1471-4159.2001.00651.x; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Swiss VA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018088; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; VENTIMIGLIA R, 1995, EUR J NEUROSCI, V7, P213, DOI 10.1111/j.1460-9568.1995.tb01057.x; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Wu XF, 2008, INT J NEUROPSYCHOPH, V11, P1123, DOI 10.1017/S1461145708009024; Xie YX, 2010, J NEUROSCI, V30, P14708, DOI 10.1523/JNEUROSCI.1637-10.2010; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	44	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76842	10.1371/journal.pone.0076842	http://dx.doi.org/10.1371/journal.pone.0076842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204683	gold, Green Published, Green Submitted			2022-12-27	WOS:000326032600013
J	Avasarala, S; Bikkavilli, RK; Van Scoyk, M; Zhang, W; Lapite, A; Hostetter, L; Byers, JT; Heasley, LE; Sohn, JW; Winn, RA				Avasarala, Sreedevi; Bikkavilli, Rama Kamesh; Van Scoyk, Michelle; Zhang, Wei; Lapite, Ajibike; Hostetter, Logan; Byers, Joshua T.; Heasley, Lynn E.; Sohn, Jang Won; Winn, Robert A.			Heterotrimeric G-Protein, G(alpha 16), Is a Critical Downstream Effector of Non-Canonical Wnt Signaling and a Potent Inhibitor of Transformed Cell Growth in Non Small Cell Lung Cancer	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; EPITHELIAL-MESENCHYMAL TRANSITIONS; COUPLED RECEPTORS; TERATOCARCINOMA CELLS; RAT FRIZZLED-1; TCF PATHWAY; CYCLIC-GMP; KINASE; EXPRESSION; TRANSDUCTION	G-protein-coupled receptors (GPCR) are the largest family of cell surface molecules that play important role/s in a number of biological and pathological processes including cancers. Earlier studies have highlighted the importance of Wnt7a signaling via its cognate receptor Frizzled9, a GPCR, in inhibition of cell proliferation, anchorage-independent growth, and reversal of transformed phenotype in non small cell lung cancer primarily through activation of the tumor suppressor, PPAR gamma. However, the G-protein effectors that couple to this important tumor suppressor pathway have not been identified, and are of potential therapeutic interest. In this study, by using two independent Wnt7a/Frizzled9-specific read-outs, we identify G(alpha 16) as a novel downstream effector of Wnt7a/Frizzled9 signaling. Interestingly, G(alpha 16) expression is severely down-regulated, both at the messenger RNA levels and protein levels, in many non small cell lung cancer cell lines. Additionally, through gene-specific knock-downs and expression of GTPase-deficient forms (Q212L) of G(alpha 16), we also establish G(alpha 16) as a novel regulator of non small cell lung cancer cell proliferation and anchorage-independent cell growth. Taken together, our data not only establish the importance of G(alpha 16) as a critical downstream effector of the non-canonical Wnt signaling pathway but also as a potential therapeutic target for the treatment of non small cell lung cancer.	[Avasarala, Sreedevi; Bikkavilli, Rama Kamesh; Van Scoyk, Michelle; Lapite, Ajibike; Hostetter, Logan; Byers, Joshua T.; Winn, Robert A.] Univ Illinois, Coll Med, Dept Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA; [Zhang, Wei] Univ Illinois, Coll Med, Dept Pediat, Chicago, IL USA; [Heasley, Lynn E.] Univ Colorado, Dept Craniofacial Biol, Denver, CO 80202 USA; [Sohn, Jang Won] Hanyang Univ, Sch Med, Dept Internal Med, Seoul 133791, South Korea; [Winn, Robert A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Colorado System; University of Colorado Denver; Hanyang University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Winn, RA (corresponding author), Univ Illinois, Coll Med, Dept Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA.	rwinn@uic.edu	Byers, Joshua/R-7690-2019		U.S. Department of Veterans Affairs, National Institutes of Health (NIH) [R01CA1385282522717, 5R21CA153268-02]; NATIONAL CANCER INSTITUTE [R21CA153268, R01CA138528] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL103286] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs, National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a Merit Award from the U.S. Department of Veterans Affairs, National Institutes of Health (NIH) grants R01CA1385282522717 and 5R21CA153268-02 to RAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Bikkavilli RK, 2008, J CELL SCI, V121, P234, DOI 10.1242/jcs.021964; Bikkavilli RK, 2012, J CELL SCI, V125, P2446, DOI 10.1242/jcs.100933; Bikkavilli Rama Kamesh, 2009, Commun Integr Biol, V2, P46; Blanquicett Carmelo, 2008, Cancer Ther, V6, P25; Bren-Mattison Y, 2005, ONCOGENE, V24, P1412, DOI 10.1038/sj.onc.1208333; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; CUTTITTA F, 1985, CANCER SURV, V4, P707; Diaz-Meco MT, 2001, MOL CELL BIOL, V21, P1218, DOI 10.1128/MCB.21.4.1218-1227.2001; Feigin ME, 2007, J CELL SCI, V120, P3404, DOI 10.1242/jcs.011254; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Gudermann T, 2006, ENDOCR-RELAT CANCER, V13, P1069, DOI 10.1677/erc.1.01302; Heasley LE, 1996, J BIOL CHEM, V271, P349, DOI 10.1074/jbc.271.1.349; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kirikoshi H, 2002, INT J ONCOL, V21, P895; Koval A, 2011, BIOCHEM J, V433, P435, DOI 10.1042/BJ20101878; Li GM, 2005, CELL IMMUNOL, V238, P10, DOI 10.1016/j.cellimm.2005.12.001; Li MY, 2010, AM J RESP CELL MOL, V43, P674, DOI 10.1165/rcmb.2009-0349OC; Liu T, 1999, J BIOL CHEM, V274, P33539, DOI 10.1074/jbc.274.47.33539; Liu T, 2002, J BIOL CHEM, V277, P30887, DOI 10.1074/jbc.M203852200; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Ma L, 2006, J BIOL CHEM, V281, P30990, DOI 10.1074/jbc.M603603200; Malbon CC, 2005, NAT REV MOL CELL BIO, V6, P689, DOI 10.1038/nrm1716; Malbon CC, 2004, FRONT BIOSCI-LANDMRK, V9, P1048, DOI 10.2741/1308; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Oliva JL, 2008, J BIOL CHEM, V283, P5466, DOI 10.1074/jbc.M707576200; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Tachibana K, 2008, PPAR RES, V2008, DOI 10.1155/2008/102737; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tennis MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032921; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wang H, 2004, BIOCHEM SOC T, V32, P792, DOI 10.1042/BST0320792; Wick M, 2002, MOL PHARMACOL, V62, P1207, DOI 10.1124/mol.62.5.1207; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Winn RA, 2006, J BIOL CHEM, V281, P26943, DOI 10.1074/jbc.M604145200; Zhang Wanguang, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P36	46	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76895	10.1371/journal.pone.0076895	http://dx.doi.org/10.1371/journal.pone.0076895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204697	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300062
J	Darvishi, E; Omidi, M; Bushehri, AAS; Golshani, A; Smith, ML				Darvishi, Emad; Omidi, Mansoor; Bushehri, Ali Akbar Shahnejat; Golshani, Ashkan; Smith, Myron L.			The Antifungal Eugenol Perturbs Dual Aromatic and Branched-Chain Amino Acid Permeases in the Cytoplasmic Membrane of Yeast	PLOS ONE			English	Article							GENETIC PROFILE ANALYSIS; CLOVE ESSENTIAL OIL; SACCHAROMYCES-CEREVISIAE; CHEMICAL-COMPOSITION; TYROSINE; PHENYLALANINE; MECHANISM; TRANSPORT; CANDIDA	Eugenol is an aromatic component of clove oil that has therapeutic potential as an antifungal drug, although its mode of action and precise cellular target(s) remain ambiguous. To address this knowledge gap, a chemical-genetic profile analysis of eugenol was done using similar to 4700 haploid Saccharomyces cerevisiae gene deletion mutants to reveal 21 deletion mutants with the greatest degree of susceptibility. Cellular roles of deleted genes in the most susceptible mutants indicate that the main targets for eugenol include pathways involved in biosynthesis and transport of aromatic and branched-chain amino acids. Follow-up analyses showed inhibitory effects of eugenol on amino acid permeases in the yeast cytoplasmic membrane. Furthermore, phenotypic suppression analysis revealed that eugenol interferes with two permeases, Tat1p and Gap1p, which are both involved in dual transport of aromatic and branched-chain amino acids through the yeast cytoplasmic membrane. Perturbation of cytoplasmic permeases represents a novel antifungal target and may explain previous observations that exposure to eugenol results in leakage of cell contents. Eugenol exposure may also contribute to amino acid starvation and thus holds promise as an anticancer therapeutic drug. Finally, this study provides further evidence of the usefulness of the yeast Gene Deletion Array approach in uncovering the mode of action of natural health products.	[Darvishi, Emad; Omidi, Mansoor; Bushehri, Ali Akbar Shahnejat] Univ Tehran, Dept Agron & Plant Breeding, Karaj, Iran; [Darvishi, Emad; Golshani, Ashkan; Smith, Myron L.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	University of Tehran; Carleton University	Golshani, A (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	ashkan_golshani@carleton.ca; myron_smith@carleton.ca	Darvishi, Emad/AAQ-2436-2020	Smith, Myron/0000-0001-6274-0053	Natural Sciences and Engineering Research Council of Canada; Ministry of Science, Research and Technology, Iran	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ministry of Science, Research and Technology, Iran	Funding was from Natural Sciences and Engineering Research Council of Canada to AG and MLS; Ministry of Science, Research and Technology, Iran to ED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgir Md, 2010, BMC Chemical Biology, V10, P6, DOI 10.1186/1472-6769-10-6; Alamgir M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-583; [Anonymous], 1983, MED PLANTS N AFRICA; Carrasco H, 2012, MOLECULES, V17, P1002, DOI 10.3390/molecules17011002; Chaieb K, 2007, PHYTOTHER RES, V21, P501, DOI 10.1002/ptr.2124; CLSI, 2008, M27A3 CLSI; Dixon SJ, 2009, CURR OPIN CHEM BIOL, V13, P549, DOI 10.1016/j.cbpa.2009.08.003; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Eloff JN, 1998, J ETHNOPHARMACOL, V60, P1, DOI 10.1016/S0378-8741(97)00123-2; Espinel-Ingroff A, 2008, REV IBEROAM MICOL, V25, P101, DOI 10.1016/S1130-1406(08)70027-5; Fu YM, 1999, CANCER RES, V59, P758; Galvan IJ, 2008, PHYTOCHEMISTRY, V69, P738, DOI 10.1016/j.phytochem.2007.09.007; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Gayoso CW, 2005, FITOTERAPIA, V76, P247, DOI 10.1016/j.fitote.2004.12.005; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GRAUSLUND M, 1995, BBA-MOL CELL RES, V1269, P275, DOI 10.1016/0167-4889(95)00138-8; Hagan P, 2002, TRENDS MICROBIOL, V10, pS1, DOI 10.1016/S0966-842X(02)02450-2; Hughes Timothy R, 2002, Funct Integr Genomics, V2, P199, DOI 10.1007/s10142-002-0059-1; Jirovetz L, 2006, J AGR FOOD CHEM, V54, P6303, DOI 10.1021/jf060608c; Kispal G, 1996, J BIOL CHEM, V271, P24458, DOI 10.1074/jbc.271.40.24458; Knijnenburg TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-53; Lauwers E, 2007, MOL BIOL CELL, V18, P3068, DOI 10.1091/mbc.E07-03-0196; Loeffler J, 2003, CLIN INFECT DIS, V36, pS31, DOI 10.1086/344658; Lopez P, 2005, J AGR FOOD CHEM, V53, P6939, DOI 10.1021/jf050709v; Louie GV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000993; Memarian N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-117; Miller JH., 1972, EXPT MOL GENETICS; Mir-Rashed N, 2010, MED MYCOL, V48, P949, DOI 10.3109/13693781003767584; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Pinto E, 2009, J MED MICROBIOL, V58, P1454, DOI 10.1099/jmm.0.010538-0; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Roberts SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043989; SCHMID R, 1972, AM J BOT, V59, P423, DOI 10.2307/2441553; SCHMIDT A, 1994, MOL CELL BIOL, V14, P6597, DOI 10.1128/MCB.14.10.6597; Schreve JL, 2004, BIOCHEM BIOPH RES CO, V313, P745, DOI 10.1016/j.bbrc.2003.11.172; Sherman F., 1986, METHODS YEAST GENETI; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Trombetta D, 2005, ANTIMICROB AGENTS CH, V49, P2474, DOI 10.1128/AAC.49.6.2474-2478.2005; Tsukahara K, 2001, MOL PHARMACOL, V60, P1254, DOI 10.1124/mol.60.6.1254; Urrestarazu A, 1998, MOL GEN GENET, V257, P230, DOI 10.1007/s004380050643; Zore GB, 2011, PHYTOMEDICINE, V18, P1181, DOI 10.1016/j.phymed.2011.03.008; [No title captured]	44	48	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76028	10.1371/journal.pone.0076028	http://dx.doi.org/10.1371/journal.pone.0076028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204588	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300008
J	Neymotin, SA; Hilscher, MM; Moulin, TC; Skolnick, Y; Lazarewicz, MT; Lytton, WW				Neymotin, Samuel A.; Hilscher, Markus M.; Moulin, Thiago C.; Skolnick, Yosef; Lazarewicz, Maciej T.; Lytton, William W.			I-h Tunes Theta/Gamma Oscillations and Cross-Frequency Coupling In an In Silico CA3 Model	PLOS ONE			English	Article							PYRAMIDAL NEURONS; GAMMA OSCILLATION; UP-REGULATION; HCN CHANNELS; THETA; INTERNEURONS; MODULATION; SYNCHRONIZATION; NETWORKS; CELLS	I-h channels are uniquely positioned to act as neuromodulatory control points for tuning hippocampal theta (4-12 Hz) and gamma (25 Hz) oscillations, oscillations which are thought to have importance for organization of information flow. contributes to neuronal membrane resonance and resting membrane potential, and is modulated by second messengers. We investigated oscillatory control using a multiscale computer model of hippocampal CA3, where each cell class (pyramidal, basket, and oriens-lacunosum moleculare cells), contained type-appropriate isoforms of. Our model demonstrated that modulation of pyramidal and basket allows tuning theta and gamma oscillation frequency and amplitude. Pyramidal also controlled cross-frequency coupling (CFC) and allowed shifting gamma generation towards particular phases of the theta cycle, effected via 's ability to set pyramidal excitability. Our model predicts that in vivo neuromodulatory control of allows flexibly controlling CFC and the timing of gamma discharges at particular theta phases.	[Neymotin, Samuel A.; Skolnick, Yosef; Lytton, William W.] State Univ New York Downstate, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Neymotin, Samuel A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Hilscher, Markus M.] Vienna Univ Technol, A-1040 Vienna, Austria; [Hilscher, Markus M.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Moulin, Thiago C.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil; [Skolnick, Yosef] CUNY Brooklyn Coll, Comp Sci Program, Brooklyn, NY 11210 USA; [Lazarewicz, Maciej T.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Lytton, William W.] State Univ New York Downstate, Dept Neurol, Brooklyn, NY USA; [Lytton, William W.] Kings Cty Hosp, Brooklyn, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Yale University; Technische Universitat Wien; Uppsala University; Universidade Federal do Rio de Janeiro; City University of New York (CUNY) System; Brooklyn College (CUNY); University of Pennsylvania; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Neymotin, SA (corresponding author), State Univ New York Downstate, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA.	samn@neurosim.downstate.edu	Moulin, Thiago/I-4070-2013; Hilscher, Markus M./I-5941-2013	Moulin, Thiago/0000-0001-7811-5383; Hilscher, Markus M./0000-0001-7782-0830; Neymotin, Samuel/0000-0003-3646-5195; Lytton, William/0000-0002-3727-2849; Skolnick, Yosef/0000-0002-8617-0347	National Institutes of Health [R01MH086638]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research supported by National Institutes of Health grant R01MH086638 (http://nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili EA, 2002, NEWS PHYSIOL SCI, V17, P32, DOI 10.1152/physiologyonline.2002.17.1.32; Aponte Y, 2006, J PHYSIOL-LONDON, V574, P229, DOI 10.1113/jphysiol.2005.104042; Arnsten AFT, 2010, TRENDS COGN SCI, V14, P365, DOI 10.1016/j.tics.2010.05.003; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Bender RA, 2001, NEUROSCIENCE, V106, P689, DOI 10.1016/S0306-4522(01)00314-1; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Caixeta FV, 2013, SCI REP-UK, V3, DOI 10.1038/srep02348; Canolty R, 2010, TRENDS COGN SCI, V14; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Carnevale NT, 2006, NEURON BOOK; Carr DB, 2007, J PHYSIOL-LONDON, V584, P437, DOI 10.1113/jphysiol.2007.141671; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; de Almeida L, 2009, J NEUROSCI, V29, P7497, DOI 10.1523/JNEUROSCI.6044-08.2009; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Dyhrfjeld-Johnsen J, 2009, FRONT NEUROSCI-SWITZ, V3, P25, DOI 10.3389/neuro.01.005.2009; Dyhrfjeld-Johnsen J, 2008, FRONT CELL NEUROSCI, V2, DOI 10.3389/neuro.03.002.2008; El Khoury N, 2013, CIRCULATION, V127, P2009, DOI 10.1161/CIRCULATIONAHA.113.001689; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; HAGIWARA N, 1989, J PHYSIOL-LONDON, V409, P121, DOI 10.1113/jphysiol.1989.sp017488; Heys JG, 2012, J NEUROSCI, V32, P9066, DOI 10.1523/JNEUROSCI.0868-12.2012; Hilscher MM, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00120; Hines Michael L, 2009, Front Neuroinform, V3, P1, DOI 10.3389/neuro.11.001.2009; JAHR CE, 1990, J NEUROSCI, V10, P3178; Kramer MA, 2008, J NEUROSCI METH, V170, P352, DOI 10.1016/j.jneumeth.2008.01.020; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lee H, 2012, NEURON, V75, P714, DOI 10.1016/j.neuron.2012.06.016; Lisman J., 1995, SCIENCE, V267, P10; Lytton WW, 2006, NEUROINFORMATICS, V4, P163, DOI 10.1385/NI:4:2:163; LYTTON WW, 1991, J NEUROPHYSIOL, V66, P1059, DOI 10.1152/jn.1991.66.3.1059; Marcelin B, 2009, NEUROBIOL DIS, V33, P436, DOI 10.1016/j.nbd.2008.11.019; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; Migliore M, 2004, J COMPUT NEUROSCI, V16, P5, DOI 10.1023/B:JCNS.0000004837.81595.b0; Migliore M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036867; Newman E, 2012, SOC NEUR ABSTR, V42; Neymotin Samuel, 2008, V151, P119; Neymotin SA, 2011, J NEUROSCI, V31, P11733, DOI 10.1523/JNEUROSCI.0501-11.2011; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Oppenheim Alan V., 1999, DISCRETE TIME SIGNAL; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Schroeder CE, 2009, BRAIN TOPOGR, V22, P24, DOI 10.1007/s10548-009-0080-y; Stacey WC, 2009, J NEUROPHYSIOL, V102, P2342, DOI 10.1152/jn.00397.2009; Tort ABL, 2007, P NATL ACAD SCI USA, V104, P13490, DOI 10.1073/pnas.0705708104; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Tsuno Y, 2013, J PHYSIOL-LONDON, V591, P2611, DOI 10.1113/jphysiol.2012.250431; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Wang XJ, 2002, J NEUROPHYSIOL, V87, P889, DOI 10.1152/jn.00135.2001; Wang XJ, 1996, J NEUROSCI, V16, P6402; White JA, 2000, P NATL ACAD SCI USA, V97, P8128, DOI 10.1073/pnas.100124097; Winograd M, 2008, P NATL ACAD SCI USA, V105, P7298, DOI 10.1073/pnas.0800360105; Zemankovics R, 2010, J PHYSIOL-LONDON, V588, P2109, DOI 10.1113/jphysiol.2009.185975; Zong XG, 2012, J BIOL CHEM, V287, P26506, DOI 10.1074/jbc.M112.357129	58	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76285	10.1371/journal.pone.0076285	http://dx.doi.org/10.1371/journal.pone.0076285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204609	Green Published, gold			2022-12-27	WOS:000326029300017
J	Dun, W; Lowe, JS; Wright, P; Hund, TJ; Mohler, PJ; Boyden, PA				Dun, Wen; Lowe, John S.; Wright, Patrick; Hund, Thomas J.; Mohler, Peter J.; Boyden, Penelope A.			Ankyrin-G Participates in I-Na Remodeling in Myocytes from the Border Zones of Infarcted Canine Heart	PLOS ONE			English	Article							SUBENDOCARDIAL PURKINJE MYOCYTES; EXTENSIVE MYOCARDIAL-INFARCTION; CHANNEL; CELLS; EXCITABILITY; CONNEXIN43; CURRENTS; PROTEIN; FIBERS	Cardiac Na channel remodeling provides a critical substrate for generation of reentrant arrhythmias in border zones of the infarcted canine heart. Recent studies show that Na(v)1.5 assembly and function are linked to ankyrin-G, gap, and mechanical junction proteins. In this study our objective is to expound the status of the cardiac Na channel, its interacting protein ankyrinG and the mechanical and gap junction proteins at two different times post infarction when arrhythmias are known to occur; that is, 48 hr and 5 day post coronary occlusion. Previous studies have shown the origins of arrhythmic events come from the subendocardial Purkinje and epicardial border zone. Our Purkinje cell (Pcell) voltage clamp study shows that I-Na and its kinetic parameters do not differ between Pcells from the subendocardium of the 48hr infarcted heart (IZPCs) and control non-infarcted Pcells (NZPCs). Immunostaining studies revealed that disturbances of Na(v)1.5 protein location with ankyrin-G are modest in 48 hr IZPCs. Therefore, Na current remodeling does not contribute to the abnormal conduction in the subendocardial border zone 48 hr post myocardial infarction as previously defined. In addition, immunohistochemical data show that Cx40/Cx43 co-localize at the intercalated disc (IDs) of control NZPCs but separate in IZPCs. At the same time, Purkinje cell desmoplakin and desmoglein2 immunostaining become diffuse while plakophilin2 and plakoglobin increase in abundance at IDs. In the epicardial border zone 5 days post myocardial infarction, immunoblot and immunocytochemical analyses showed that ankyrin-G protein expression is increased and re-localized to submembrane cell regions at a time when Nav1.5 function is decreased. Thus, Na(v)1.5 and ankyrin-G remodeling occur later after myocardial infarction compared to that of gap and mechanical junctional proteins. Gap and mechanical junctional proteins remodel in IZPCs early, perhaps to help maintain Na(v)1.5 subcellular location position and preserve its function soon after myocardial infarction.	[Dun, Wen; Boyden, Penelope A.] Columbia Univ, Dept Pharmacol, Ctr Mol Therapeut, New York, NY 10027 USA; [Lowe, John S.; Wright, Patrick; Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Dept Biomed Engn, Coll Engn, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA	Columbia University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Dun, W (corresponding author), Columbia Univ, Dept Pharmacol, Ctr Mol Therapeut, New York, NY 10027 USA.	pab4@columbia.edu	Hund, Thomas/C-9222-2012		National Institutes of Health [HL105983, HL066140, HL084583, HL083422, HL096805, HL114893]; Saving Tiny Hearts Society; American Heart Association; Gilead Sciences Research Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083422, R01HL066140, R00HL096805, R01HL114893, R01HL105983, R01HL084583, K99HL096805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saving Tiny Hearts Society; American Heart Association(American Heart Association); Gilead Sciences Research Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health [HL105983, HL066140 to PAB];[HL084583, HL083422 to PJM]; [HL096805, HL114893 to TJH]; Saving Tiny Hearts Society (PJM), American Heart Association (PJM), and Gilead Sciences Research Scholars Program (TJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Baba S, 2005, CIRCULATION, V112, P2386, DOI 10.1161/CIRCULATIONAHA.105.534784; BOYDEN PA, 1995, CARDIOVASC RES, V29, P312, DOI 10.1016/S0008-6363(96)88586-5; BOYDEN PA, 1989, CIRC RES, V65, P955, DOI 10.1161/01.RES.65.4.955; DeGrande S, 2012, HEART RHYTHM, V9, P2034, DOI 10.1016/j.hrthm.2012.08.026; FRIEDMAN PL, 1975, CIRC RES, V36, P127, DOI 10.1161/01.RES.36.1.127; FRIEDMAN PL, 1973, CIRC RES, V33, P597, DOI 10.1161/01.RES.33.5.597; Gudmundsson H, 2012, J MOL CELL CARDIOL, V52, P1183, DOI 10.1016/j.yjmcc.2012.02.008; HARRIS AS, 1950, CIRCULATION, V1, P1318, DOI 10.1161/01.CIR.1.6.1318; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; JECK C, 1995, CIRCULATION, V92, P465, DOI 10.1161/01.CIR.92.3.465; Kashef F, 2012, J BIOL CHEM, V287, P30268, DOI 10.1074/jbc.M112.368415; Koval OM, 2012, CIRCULATION, V126, P2084, DOI 10.1161/CIRCULATIONAHA.112.105320; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Noorman M, 2013, HEART RHYTHM, V10, P412, DOI 10.1016/j.hrthm.2012.11.018; Peters NS, 1997, CIRCULATION, V95, P988; Pieperhoff S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00022; Pieperhoff S, 2010, EUR J CELL BIOL, V89, P365, DOI 10.1016/j.ejcb.2009.11.025; Pinto JMB, 1998, J CARDIOVASC ELECTR, V9, P299, DOI 10.1111/j.1540-8167.1998.tb00915.x; Pu JL, 1997, CIRC RES, V81, P110, DOI 10.1161/01.RES.81.1.110; Sato PY, 2009, CIRC RES, V105, P523, DOI 10.1161/CIRCRESAHA.109.201418; Wit A. L., 1993, VENTRICULAR ARRHYTHM	24	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78087	10.1371/journal.pone.0078087	http://dx.doi.org/10.1371/journal.pone.0078087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155982	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300116
J	Wu, GS; Song, YL; Yin, ZQ; Guo, JJ; Wang, SP; Zhao, WW; Chen, XP; Zhang, QW; Lu, JJ; Wang, YT				Wu, Guo-Sheng; Song, Yue-Lin; Yin, Zhi-Qi; Guo, Jia-Jie; Wang, Sheng-Peng; Zhao, Wen-Wen; Chen, Xiu-Ping; Zhang, Qing-Wen; Lu, Jin-Jian; Wang, Yi-Tao			Ganoderiol A-Enriched Extract Suppresses Migration and Adhesion of MDA-MB-231 Cells by Inhibiting FAK-SRC-Paxillin Cascade Pathway	PLOS ONE			English	Article							BREAST-CANCER CELLS; RHO-GTPASES; TYROSINE PHOSPHORYLATION; MOLECULAR-MECHANISMS; ADENOCARCINOMA CELLS; POTENTIAL TARGET; TUMOR INVASION; CYCLE ARREST; IN-VITRO; N-WASP	Cell adhesion, migration and invasion are critical steps for carcinogenesis and cancer metastasis. Ganoderma lucidum, also called Lingzhi in China, is a traditional Chinese medicine, which exhibits anti-proliferation, anti-inflammation and anti-metastasis properties. Herein, GAEE, G. lucidum extract mainly contains ganoderiol A (GA), dihydrogenated GA and GA isomer, was shown to inhibit the abilities of adhesion and migration, while have a slight influence on that of invasion in highly metastatic breast cancer MDA-MB-231 cells at non-toxic doses. Further investigation revealed that GAEE decreased the active forms of focal adhesion kinase (FAK) and disrupted the interaction between FAK and SRC, which lead to deactivating of paxillin. Moreover, GAEE treatment downregulated the expressions of RhoA, Rac1, and Cdc42, and decreased the interaction between neural Wiskott-Aldrich Syndrome protein (N-WASP) and Cdc42, which impair cell migration and actin assembly. To our knowledge, this is the first report to show that G. lucidum triterpenoids could suppress cell migration and adhesion through FAK-SRC-paxillin signaling pathway. Our study also suggests that GAEE may be a potential agent for treatment of breast cancer.	[Wu, Guo-Sheng; Song, Yue-Lin; Guo, Jia-Jie; Wang, Sheng-Peng; Zhao, Wen-Wen; Chen, Xiu-Ping; Zhang, Qing-Wen; Lu, Jin-Jian; Wang, Yi-Tao] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China; [Yin, Zhi-Qi] China Pharmaceut Univ, Dept Nat Med Chem, Nanjing, Jiangsu, Peoples R China	University of Macau; China Pharmaceutical University	Lu, JJ (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China.	jinjianlu@umac.mo; ytwang@umac.mo	Wang, Yitao/O-5184-2016; Chen, Xiuping/O-8927-2017; Lu, Jinjian/R-6207-2019; Song, Yuelin/J-6508-2014; Zhang, Qingwen/F-9419-2011; Chen, Xiuping/AAG-3086-2020; Lu, Jinjian/X-2083-2019	Chen, Xiuping/0000-0003-2675-7645; Song, Yuelin/0000-0001-9431-6257; Lu, Jinjian/0000-0001-6703-3120	Macao Science and Technology Development Fund [074/2012/A3, 077/2011/A3]; University of Macau [UL016/09Y4/CMS/WYT01/ICMS, MYRG208(Y3-L4)-ICMS11-WYT, SRG026-ICMS13-LJ, MRG012/WYT/2013/ICMS, MRG013/WYT/2013/ICMS]	Macao Science and Technology Development Fund; University of Macau	This work was supported by Macao Science and Technology Development Fund (074/2012/A3 and 077/2011/A3) and Research Fund of University of Macau (UL016/09Y4/CMS/WYT01/ICMS, MYRG208(Y3-L4)-ICMS11-WYT, SRG026-ICMS13-LJ, MRG012/WYT/2013/ICMS and MRG013/WYT/2013/ICMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZNAVOORIAN S, 1993, CANCER-AM CANCER SOC, V71, P1368, DOI 10.1002/1097-0142(19930215)71:4<1368::AID-CNCR2820710432>3.0.CO;2-L; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Calvo F, 2011, CURR OPIN CELL BIOL, V23, P621, DOI 10.1016/j.ceb.2011.04.010; Chen NH, 2008, J PHARMACOL SCI, V108, P212, DOI 10.1254/jphs.SC0080019; Chen NH, 2010, PHARMACOL REP, V62, P150, DOI 10.1016/S1734-1140(10)70252-8; Chen TC, 2012, INVEST OPHTH VIS SCI, V53, P1539, DOI 10.1167/iovs.11-9203; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Galvao ERCGN, 2011, J CANCER RES CLIN, V137, P915, DOI 10.1007/s00432-011-0978-0; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Han EKH, 2007, ANTI-CANCER AGENT ME, V7, P681, DOI 10.2174/187152007784111296; Hsu YL, 2012, J AGR FOOD CHEM, V60, P852, DOI 10.1021/jf2052515; Hsu YL, 2011, MOL NUTR FOOD RES, V55, P318, DOI 10.1002/mnfr.201000148; Huang Z, 2008, CELL SIGNAL, V20, P2002, DOI 10.1016/j.cellsig.2008.07.014; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang JH, 2008, INT J MOL MED, V21, P577; Jiang JH, 2011, BIOCHEM BIOPH RES CO, V415, P325, DOI 10.1016/j.bbrc.2011.10.055; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lin KL, 2011, CHEM-BIOL INTERACT, V194, P148, DOI 10.1016/j.cbi.2011.10.002; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mego M, 2010, NAT REV CLIN ONCOL, V7, P693, DOI 10.1038/nrclinonc.2010.171; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Monteiro J, 2010, EUR J CANCER, V46, P1198, DOI 10.1016/j.ejca.2010.02.030; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nizamutdinova IT, 2008, CARCINOGENESIS, V29, P1885, DOI 10.1093/carcin/bgn151; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rathinam R, 2011, FRONT BIOSCI-LANDMRK, V16, P2561, DOI 10.2741/3872; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; SATO H, 1986, AGR BIOL CHEM TOKYO, V50, P2887, DOI 10.1080/00021369.1986.10867818; Schultze A, 2010, INVEST NEW DRUG, V28, P825, DOI 10.1007/s10637-009-9326-5; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sliva D, 2003, J ALTERN COMPLEM MED, V9, P491, DOI 10.1089/107555303322284776; Stopeck AT, 2012, CLIN EXP METASTAS, V29, P807, DOI 10.1007/s10585-012-9496-y; Tan W, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-27; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Turner CE, 2000, J CELL SCI, V113, P4139; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Vindis C, 2004, J BIOL CHEM, V279, P27965, DOI 10.1074/jbc.M401295200; Wang L, 2010, CANCER LETT, V297, P42, DOI 10.1016/j.canlet.2010.04.022; Weng CJ, 2007, MOL NUTR FOOD RES, V51, P1472, DOI 10.1002/mnfr.200700155; Weng CJ, 2010, CLIN EXP METASTAS, V27, P361, DOI 10.1007/s10585-010-9334-z; Wu GS, 2012, FITOTERAPIA, V83, P408, DOI 10.1016/j.fitote.2011.12.004; Wu GS, 2012, AM J CHINESE MED, V40, P631, DOI 10.1142/S0192415X12500474; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yu XZ, 2012, J CELL BIOL, V199, P527, DOI 10.1083/jcb.201203025; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001	53	37	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76620	10.1371/journal.pone.0076620	http://dx.doi.org/10.1371/journal.pone.0076620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204647	Green Published, gold			2022-12-27	WOS:000326270700008
J	Wang, H; Jessup, JA; Zhao, Z; Da Silva, J; Lin, M; MacNamara, LM; Ahmad, S; Chappell, MC; Ferrario, CM; Groban, L				Wang, Hao; Jessup, Jewell A.; Zhao, Zhuo; Da Silva, Jaqueline; Lin, Marina; MacNamara, Lindsay M.; Ahmad, Sarfaraz; Chappell, Mark C.; Ferrario, Carlos M.; Groban, Leanne			Characterization of the Cardiac Renin Angiotensin System in Oophorectomized and Estrogen-Replete mRen2.Lewis Rats	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITORS; ATTENUATES DIASTOLIC DYSFUNCTION; LEFT-VENTRICULAR HYPERTROPHY; REN-2 HYPERTENSIVE-RATS; POSTMENOPAUSAL WOMEN; HEART-FAILURE; OVARIECTOMIZED RATS; REPLACEMENT THERAPY; HORMONE REPLACEMENT; PRESSURE-OVERLOAD	The cardioprotective effects of estrogen are well recognized, but the mechanisms remain poorly understood. Accumulating evidence suggests that the local cardiac renin-angiotensin system (RAS) is involved in the development and progression of cardiac hypertrophy, remodeling, and heart failure. Estrogen attenuates the effects of an activated circulating RAS; however, its role in regulating the cardiac RAS is unclear. Bilateral oophorectomy (OVX; n = 17) or sham-operation (Sham; n = 13) was performed in 4-week-old, female mRen2.Lewis rats. At 11 weeks of age, the rats were randomized and received either 17 beta-estradiol (E2, 36 mu g/pellet, 60-day release, n = 8) or vehicle (OVX-V, n = 9) for 4 weeks. The rats were sacrificed, and blood and hearts were used to determine protein and/or gene expression of circulating and tissue RAS components. E2 treatment minimized the rise in circulating angiotensin (Ang) II and aldosterone produced by loss of ovarian estrogens. Chronic E2 also attenuated OVX-associated increases in cardiac Ang II, Ang-(1-7) content, chymase gene expression, and mast cell number. Neither OVX nor OVX+E2 altered cardiac expression or activity of renin, angiotensinogen, angiotensin-converting enzyme (ACE), and Ang II type 1 receptor (AT1R). E2 treatment in OVX rats significantly decreased gene expression of MMP-9, ACE2, and Ang-(1-7) mas receptor, in comparison to sham-operated and OVX littermates. E2 treatment appears to inhibit upsurges in cardiac Ang II expression in the OVX-mRen2 rat, possibly by reducing chymase-dependent Ang II formation. Further studies are warranted to determine whether an E2-mediated reduction in cardiac chymase directly contributes to this response in OVX rats.	[Wang, Hao; Jessup, Jewell A.; Zhao, Zhuo; Da Silva, Jaqueline; Lin, Marina; MacNamara, Lindsay M.; Groban, Leanne] Wake Forest Sch Med, Dept Anesthesiol, Winston Salem, NC 27106 USA; [Ahmad, Sarfaraz; Chappell, Mark C.; Groban, Leanne] Wake Forest Sch Med, Dept Hypertens, Winston Salem, NC USA; [Ahmad, Sarfaraz; Chappell, Mark C.; Groban, Leanne] Wake Forest Sch Med, Vasc Res Ctr, Winston Salem, NC USA; [Ferrario, Carlos M.] Wake Forest Sch Med, Dept Internal Med Nephrol, Winston Salem, NC USA; [Ferrario, Carlos M.] Wake Forest Sch Med, Dept Surg, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Groban, L (corresponding author), Wake Forest Sch Med, Dept Anesthesiol, Winston Salem, NC 27106 USA.	lgroban@wakehealth.edu	Ferrario, Carlos/ABB-4165-2021; Ferrario, Carlos/ABD-2791-2020; DA SILVA, JAQUELINE/Z-3311-2019; Chappell, Mark/AAX-9087-2021	Ferrario, Carlos/0000-0003-0792-6239; Wang, Hao/0000-0003-1537-661X; DA SILVA, JAQUELINE/0000-0003-3946-4753; Groban, Leanne/0000-0001-8934-7358	National Institutes of Health [R01-AG033727, 2P01 HL-051952]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work described here was supported in part by grants from the National Institutes of Health R01-AG033727 (Groban) and 2P01 HL-051952 (Ferrario). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Taha M, 2009, J IMMUNOL, V183, P1393, DOI 10.4049/jimmunol.0803157; Agabiti-Rosei E, 2002, J HYPERTENS, V20, pS34; Ahmad S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028501; AlJaroudi W, 2012, CIRCULATION, V125, P782, DOI 10.1161/CIRCULATIONAHA.111.066423; Brosnihan KB, 2008, EXP PHYSIOL, V93, P658, DOI 10.1113/expphysiol.2007.041806; Brosnihan KB, 2008, AM J PHYSIOL-HEART C, V294, pH1995, DOI 10.1152/ajpheart.01193.2007; Brosnihan KB, 1997, AM J PHYSIOL-REG I, V273, pR1908, DOI 10.1152/ajpregu.1997.273.6.R1908; Brosnihan KB, 1997, J HYPERTENS, V15, P719, DOI 10.1097/00004872-199715070-00003; Brosnihan KB, 1999, BRAZ J MED BIOL RES, V32, P373, DOI 10.1590/S0100-879X1999000400001; Catena C, 2012, HORM METAB RES, V44, P181, DOI 10.1055/s-0031-1291318; Catena C, 2012, AM J CARDIOVASC DIS, V2, P50; Chancey AL, 2005, AM J PHYSIOL-HEART C, V289, pH316, DOI 10.1152/ajpheart.00765.2004; Chappell MC, 2006, AM J PHYSIOL-REG I, V291, pR1557, DOI 10.1152/ajpregu.00051.2006; Chappell MC, 2003, HYPERTENSION, V42, P781, DOI 10.1161/01.HYP.0000085210.66399.A3; Cheng S, 2010, CIRCULATION, V122, P570, DOI 10.1161/CIRCULATIONAHA.110.937821; Chrysant SG, 2010, AM J CARDIOL, V105, P849, DOI 10.1016/j.amjcard.2009.11.044; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; de Sa DDC, 2010, HEART, V96, P528, DOI 10.1136/hrt.2009.177980; DellItalia LJ, 1995, AM J PHYSIOL-HEART C, V269, pH2065, DOI 10.1152/ajpheart.1995.269.6.H2065; Fak AS, 2000, FERTIL STERIL, V73, P66, DOI 10.1016/S0015-0282(99)00451-3; Ferrario CM, 2009, AM J PHYSIOL-HEART C, V296, pH1184, DOI 10.1152/ajpheart.01114.2008; Ferrario CM, 2005, AM J PHYSIOL-HEART C, V289, pH2281, DOI 10.1152/ajpheart.00618.2005; Gallagher PE, 1999, HYPERTENSION, V33, P323, DOI 10.1161/01.HYP.33.1.323; Garabelli PJ, 2008, EXP PHYSIOL, V93, P613, DOI 10.1113/expphysiol.2007.040246; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; Ghali Jalal K, 2008, Expert Rev Cardiovasc Ther, V6, P555, DOI 10.1586/14779072.6.4.555; Gonzalez A, 2004, MED CLIN N AM, V88, P83, DOI 10.1016/S0025-7125(03)00125-1; GORAYA TY, 1994, NUCLEIC ACIDS RES, V22, P1194, DOI 10.1093/nar/22.7.1194; Groban L, 2006, J GERONTOL A-BIOL, V61, P28, DOI 10.1093/gerona/61.1.28; Groban L, 2008, J GERONTOL A-BIOL, V63, P3, DOI 10.1093/gerona/63.1.3; Grobe JL, 2007, AM J PHYSIOL-HEART C, V292, pH736, DOI 10.1152/ajpheart.00937.2006; HOWARD T, 1993, MOL CELL BIOL, V13, P18, DOI 10.1128/MCB.13.1.18; Huentelman MJ, 2005, EXP PHYSIOL, V90, P783, DOI 10.1113/expphysiol.2005.031096; Iwata M, 2005, AM J PHYSIOL-HEART C, V289, pH2356, DOI 10.1152/ajpheart.00317.2005; Jessup JA, 2013, MENOPAUSE, V20, P860, DOI [10.1097/gme.0b013e318280589a, 10.1097/GME.0b013e318280589a]; Jessup JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015433; Jessup JA, 2011, ENDOCRINOLOGY, V152, P2428, DOI 10.1210/en.2011-0061; Jessup JA, 2011, MENOPAUSE, V18, P698, DOI 10.1097/gme.0b013e31820390a2; Ji H, 2008, EXP PHYSIOL, V93, P648, DOI 10.1113/expphysiol.2007.041392; Kane GC, 2011, JAMA-J AM MED ASSOC, V306, P856, DOI 10.1001/jama.2011.1201; Krishnamurthi K, 1999, ENDOCRINOLOGY, V140, P5435, DOI 10.1210/en.140.11.5435; Lam KK, 2006, MENOPAUSE, V13, P294, DOI 10.1097/01.gme.0000182806.99137.5e; Levick SP, 2011, CARDIOVASC RES, V89, P12, DOI 10.1093/cvr/cvq272; Li P, 2002, HYPERTENS RES, V25, P757; Lu H, 2012, AM J PHYSIOL-HEART C, V302, pH811, DOI 10.1152/ajpheart.00980.2011; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; Modena MG, 1999, HYPERTENSION, V34, P1041, DOI 10.1161/01.HYP.34.5.1041; Nappi JM, 2011, VASC HEALTH RISK MAN, V7, P353, DOI 10.2147/VHRM.S13779; Nickenig G, 1998, CIRCULATION, V97, P2197, DOI 10.1161/01.CIR.97.22.2197; Oberman A, 2006, AM J CARDIOL, V97, P512, DOI 10.1016/j.amjcard.2005.08.071; Okura H, 2009, CIRC-CARDIOVASC IMAG, V2, P41, DOI 10.1161/CIRCIMAGING.108.809087; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Oyamada S, 2011, J PHARMACOL EXP THER, V339, P143, DOI 10.1124/jpet.111.179697; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Prosser HCG, 2009, CARDIOVASC RES, V82, P40, DOI 10.1093/cvr/cvp003; PROUDLER AJ, 1995, LANCET, V346, P89, DOI 10.1016/S0140-6736(95)92114-1; Proudler AJ, 2003, CLIN ENDOCRINOL, V58, P30, DOI 10.1046/j.1365-2265.2003.01600.x; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; Ricchiuti V, 2009, J ENDOCRINOL, V200, P75, DOI 10.1677/JOE-08-0199; Roesch DM, 2000, ENDOCRINOLOGY, V141, P4629, DOI 10.1210/en.141.12.4629; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Sarkissian SD, 2008, HYPERTENSION, V51, P712, DOI 10.1161/HYPERTENSIONAHA.107.100693; Schunkert H, 1997, CIRCULATION, V95, P39, DOI 10.1161/01.CIR.95.1.39; Seely EW, 2004, CLIN ENDOCRINOL, V60, P315, DOI 10.1046/j.1365-2265.2004.01980.x; SHAI SY, 1990, BIOCHEM BIOPH RES CO, V167, P1128, DOI 10.1016/0006-291X(90)90640-9; Sharkey LC, 1999, J MOL CELL CARDIOL, V31, P1527, DOI 10.1006/jmcc.1999.0985; Shekelle PG, 2003, J AM COLL CARDIOL, V41, P1529, DOI 10.1016/S0735-1097(03)00262-6; SHEN V, 1993, J CLIN INVEST, V91, P2479, DOI 10.1172/JCI116483; Shenoy V, 2009, PEPTIDES, V30, P2309, DOI 10.1016/j.peptides.2009.09.005; Takai S, 2010, CURR MED CHEM, V17, P3223, DOI 10.2174/092986710792232003; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, pH1560, DOI 10.1152/ajpheart.00941.2004; Trask AJ, 2007, AM J PHYSIOL-HEART C, V292, pH3019, DOI 10.1152/ajpheart.01198.2006; Trask AJ, 2010, AM J HYPERTENS, V23, P687, DOI 10.1038/ajh.2010.51; URATA H, 1993, EUR HEART J, V14, P177; van Eickels M, 2001, CIRCULATION, V104, P1419, DOI 10.1161/hc3601.095577; van Kats JP, 1998, CIRCULATION, V98, P73, DOI 10.1161/01.CIR.98.1.73; Wang H, 2012, CARDIOVASC RES, V94, P96, DOI 10.1093/cvr/cvs090; Wassmann S, 2001, CIRCULATION, V103, P435; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Wu Z, 2003, ENDOCRINOLOGY, V144, P3251, DOI 10.1210/en.2003-0015; Zhou YD, 1996, P NATL ACAD SCI USA, V93, P12262, DOI 10.1073/pnas.93.22.12262; Zierau O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00169	82	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76992	10.1371/journal.pone.0076992	http://dx.doi.org/10.1371/journal.pone.0076992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204720	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400022
J	Araujo, VC; Demasi, APD; Soares, AB; Passador-Santos, F; Napimoga, MH; Martinez, EF; Freitas, NS; Araujo, NS				Araujo, Vera Cavalcanti; Dias Demasi, Ana Paula; Soares, Andresa Borges; Passador-Santos, Fabricio; Napimoga, Marcelo Henrique; Martinez, Elizabeth Ferreira; Freitas, Nadir Severina; Araujo, Ney Soares			Neutrophils in Oral Paracoccidioidomycosis and the Involvement of Nrf2	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; NF-KAPPA-B; ENHANCES SUSCEPTIBILITY; IMMUNE-RESPONSE; INNATE; MICE; ACTIVATION; PATHWAY; CELLS; RECRUITMENT	Neutrophils have been implicated in granuloma formation in several infectious diseases, in addition to their main phagocytic and pathogen destruction role. It has been demonstrated that Nrf2 regulates antioxidant protection in neutrophils, attenuating inflammation without compromising the hosts bacterial defense. In this study, we analyzed the presence of neutrophils in Paracoccidioides brasiliensis mycosis (PCM), as well as the immunoexpression of Nrf2. Thirty-nine cases of oral PCM were classified according to quantity of fungi and to the presence of loose or well-organized granulomas and microabscesses. An Nrf2 antibody was used for immunohistochemical analysis. The results showed that neutrophils are present in microabscesses and loose granulomas, but were absent in structured granulomas. A greater quantity of fungi was shown in cases with only loose granulomas when compared to loose and well organized granulomas. Nrf2 was observed in the nuclei of neutrophils of loose granulomas and abscesses, with its expression in loose granulomas maintained despite the additional presence of well organized granulomas in the same specimen. This study suggests that neutrophils participate in P. brasiliensis granuloma formation and that Nrf2 has a possible role in neutrophil survival, via modulation of the inflammatory response.	[Araujo, Vera Cavalcanti; Dias Demasi, Ana Paula; Soares, Andresa Borges; Passador-Santos, Fabricio; Napimoga, Marcelo Henrique; Martinez, Elizabeth Ferreira; Freitas, Nadir Severina; Araujo, Ney Soares] Sao Leopoldo Mand Inst & Res Ctr, Dept Pathol, Campinas, SP, Brazil	Faculdade Sao Leopoldo Mandic	Araujo, VC (corresponding author), Sao Leopoldo Mand Inst & Res Ctr, Dept Pathol, Campinas, SP, Brazil.	vcaraujo@usp.br	Napimoga, Marcelo/S-2434-2019; Passador-Santos, Fabricio/AAR-5899-2020; Martinez, Elizabeth Ferreira/F-8067-2012; Demasi, Ana/AAR-7854-2020; Passador-Santos, Fabricio/GRN-8160-2022; Araujo, Vera C/G-3586-2014; Soares, Ângela Maria/K-1765-2014	Napimoga, Marcelo/0000-0003-4472-365X; Passador-Santos, Fabricio/0000-0003-2777-8640; Demasi, Ana/0000-0003-4736-6694; Soares, Ângela Maria/0000-0003-1962-9901; Araujo, Vera/0000-0002-5860-3715	Brazilian Agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [473939/2011-8]	Brazilian Agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank the Brazilian Agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico for the financial support (473939/2011-8). URL: www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenbach C, 2006, J IMMUNOL, V176, P6656, DOI 10.4049/jimmunol.176.11.6656; Ameen M, 2010, CLIN EXP DERMATOL, V35, P576, DOI 10.1111/j.1365-2230.2009.03647.x; APPELBERG R, 1994, IMMUNOLOGY, V83, P302; Appelberg R, 2007, TRENDS MICROBIOL, V15, P87, DOI 10.1016/j.tim.2006.11.009; Bennouna S, 2003, J IMMUNOL, V171, P6052, DOI 10.4049/jimmunol.171.11.6052; Bliss SK, 1999, J IMMUNOL, V162, P7369; Charmoy M, 2007, J LEUKOCYTE BIOL, V82, P288, DOI 10.1189/jlb.0706440; Chen L, 2001, EUR J IMMUNOL, V31, P265, DOI 10.1002/1521-4141(200101)31:1<265::AID-IMMU265>3.3.CO;2-C; Copple IM, 2012, ADV PHARMACOL, V63, P43, DOI 10.1016/B978-0-12-398339-8.00002-1; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Franco M, 1993, Curr Top Med Mycol, V5, P115; Goven D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010886; Kaminagakura E, 2007, ORAL DIS, V13, P434, DOI 10.1111/j.1601-0825.2006.01319.x; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kaul N, 1996, FREE RADICAL BIO MED, V21, P401, DOI 10.1016/0891-5849(96)00178-5; Kennedy MA, 2010, VET CLIN N AM-SMALL, V40, P369, DOI 10.1016/j.cvsm.2010.01.003; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kinnula VL, 2002, ANTIOXID REDOX SIGN, V4, P27, DOI 10.1089/152308602753625825; Kong XN, 2011, AM J RESP CRIT CARE, V184, P928, DOI 10.1164/rccm.201102-0271OC; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marshall AJ, 1998, INFECT IMMUN, V66, P1325, DOI 10.1128/IAI.66.4.1325-1333.1998; McFarlane E, 2008, INFECT IMMUN, V76, P532, DOI 10.1128/IAI.01388-07; Pagliari C, 2011, MICROB PATHOGENESIS, V50, P263, DOI 10.1016/j.micpath.2010.12.008; Fortes MRP, 2011, AN BRAS DERMATOL, V86, P516, DOI 10.1590/S0365-05962011000300014; Pedrosa J, 2000, INFECT IMMUN, V68, P577, DOI 10.1128/IAI.68.2.577-583.2000; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Ribeiro-Gomes FL, 2004, J IMMUNOL, V172, P4454, DOI 10.4049/jimmunol.172.7.4454; Romani L, 1997, J IMMUNOL, V158, P2356; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Tateda K, 2001, J IMMUNOL, V166, P3355, DOI 10.4049/jimmunol.166.5.3355; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006	34	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76976	10.1371/journal.pone.0076976	http://dx.doi.org/10.1371/journal.pone.0076976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204715	Green Submitted, gold, Green Published			2022-12-27	WOS:000326152300011
J	Herbst, SK; Javadi, AH; van der Meer, E; Busch, NA				Herbst, Sophie K.; Javadi, Amir Homayoun; van der Meer, Elke; Busch, Niko A.			How Long Depends on How Fast-Perceived Flicker Dilates Subjective Duration	PLOS ONE			English	Article							TIME PERCEPTION; NEURAL MECHANISMS; VISUAL RESPONSES; INTERNAL CLOCK; SPEEDING-UP; ADAPTATION; MODELS; CORTEX; BRAIN	How do humans perceive the passage of time and the duration of events without a dedicated sensory system for timing? Previous studies have demonstrated that when a stimulus changes over time, its duration is subjectively dilated, indicating that duration judgments are based on the number of changes within an interval. In this study, we tested predictions derived from three different accounts describing the relation between a changing stimulus and its subjective duration as either based on (1) the objective rate of changes of the stimulus, (2) the perceived saliency of the changes, or (3) the neural energy expended in processing the stimulus. We used visual stimuli flickering at different frequencies (4-166 Hz) to study how the number of changes affects subjective duration. To this end, we assessed the subjective duration of these stimuli and measured participants' behavioral flicker fusion threshold (the highest frequency perceived as flicker), as well as their threshold for a frequency-specific neural response to the flicker using EEG. We found that only consciously perceived flicker dilated perceived duration, such that a 2 s long stimulus flickering at 4 Hz was perceived as lasting as long as a 2.7 s steady stimulus. This effect was most pronounced at the slowest flicker frequencies, at which participants reported the most consistent flicker perception. Flicker frequencies higher than the flicker fusion threshold did not affect perceived duration at all, even if they evoked a significant frequency-specific neural response. In sum, our findings indicate that time perception in the peri-second range is driven by the subjective saliency of the stimulus' temporal features rather than the objective rate of stimulus changes or the neural response to the changes.	[Herbst, Sophie K.; van der Meer, Elke; Busch, Niko A.] Berlin Sch Mind & Brain, Berlin, Germany; [Herbst, Sophie K.; van der Meer, Elke] Humboldt Univ, D-10099 Berlin, Germany; [Javadi, Amir Homayoun] UCL, Dept Cognit Perceptual & Brain Sci, Inst Behav Neurosci, London, England; [Busch, Niko A.] Charite, Inst Med Psychol, D-13353 Berlin, Germany	Humboldt University of Berlin; University of London; University College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Herbst, SK (corresponding author), Berlin Sch Mind & Brain, Berlin, Germany.	sophie.herbst@hu-berlin.de	Javadi, Amir-Homayoun/G-8547-2013	Javadi, Amir-Homayoun/0000-0003-0569-6441; Herbst, Sophie/0000-0001-6161-3167; Busch, Niko/0000-0003-4837-0345	German Research Foundation [BU2400/1-1]; Studienstiftung des deutschen Volkes	German Research Foundation(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	This work was supported by the German Research Foundation (Grant \# BU2400/1-1). Sophie Herbst is funded by the Studienstiftung des deutschen Volkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayhan I, 2009, J VISION, V9, DOI 10.1167/9.11.2; Bach M, 1999, DOC OPHTHALMOL, V99, P69, DOI 10.1023/A:1002648202420; Binetti N, 2012, J VISION, V12, DOI 10.1167/12.7.8; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown JF, 1931, PSYCHOL FORSCH, V14, P233, DOI 10.1007/BF00403874; Brown SA, 1996, AM J VET RES, V57, P105; Bruno A, 2012, FRONTIERS PSYCHOL, V3; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Burr DC, 2011, J VISION, V11, DOI 10.1167/11.2.21; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Droit-Volet S, 2002, Q J EXP PSYCHOL-B, V55, P193, DOI 10.1080/02724990143000252; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Eagleman DM, 2009, PHILOS T R SOC B, V364, P1841, DOI 10.1098/rstb.2009.0026; Fraisse P, 1963, PSYCHOL TIME; Fruend I, 2011, J VISION, V11, DOI 10.1167/11.6.16; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; GRONDIN S, 1993, PERCEPT PSYCHOPHYS, V54, P383, DOI 10.3758/BF03205274; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Gur M, 1997, VISION RES, V37, P377, DOI 10.1016/S0042-6989(96)00183-6; Guyau J-M, 1890, GENESE IDEE TEMPS; Herbst SK, 2012, PERCEPTION, V41, P883, DOI 10.1068/p7300; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; HOLM S, 1979, SCAND J STAT, V6, P65; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Javadi AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041496; Jeffries H., 1961, THEORY PROBABILITY; Jiang Y, 2007, NAT NEUROSCI, V10, P657, DOI 10.1038/nn1879; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Johnston A, 2008, VISION RES, V48, P1852, DOI 10.1016/j.visres.2008.04.029; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KELLY DH, 1961, J OPT SOC AM, V51, P422, DOI 10.1364/JOSA.51.000422; Kelly S, 2005, COGNITION BRAIN PHIL, P218; LANDIS C, 1954, PHYSIOL REV, V34, P259, DOI 10.1152/physrev.1954.34.2.259; Matthews WJ, 2011, J EXP PSYCHOL HUMAN, V37, P303, DOI 10.1037/a0019961; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Pastor MA, 2003, J NEUROSCI, V23, P11621; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PentonVoak IS, 1996, J EXP PSYCHOL ANIM B, V22, P307, DOI 10.1037/0097-7403.22.3.307; Plomp G, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00564; Poynter D., 1989, ADV PSYCHOL, VVol. 59, P305, DOI [10.1016/S0166-4115(08)61045-6, DOI 10.1016/S0166-4115(08)61045-6, 10.1016/s0166-4115(08)61045-6]; Ramos S, 2011, BIOS BIOR C BRC 2011, P1; REGAN D, 1968, ELECTROEN CLIN NEURO, V25, P231, DOI 10.1016/0013-4694(68)90020-5; Roeckelein J., 2000, CONCEPT TIME PSYCHOL; ROEHRIG WC, 1959, J PSYCHOL, V47, P317, DOI 10.1080/00223980.1959.9916333; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Shady S, 2004, P NATL ACAD SCI USA, V101, P5170, DOI 10.1073/pnas.0303452101; TREISMAN M, 1992, Q J EXP PSYCHOL-A, V45, P235, DOI 10.1080/14640749208401326; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; VANDERTWEEL LH, 1965, ELECTROEN CLIN NEURO, V18, P587, DOI 10.1016/0013-4694(65)90076-3; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wells EF, 2001, EXP BRAIN RES, V139, P106, DOI 10.1007/s002210100721	55	35	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76074	10.1371/journal.pone.0076074	http://dx.doi.org/10.1371/journal.pone.0076074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194829	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000008
J	Wagnild, J; Wall-Scheffler, CM				Wagnild, Janelle; Wall-Scheffler, Cara M.			Energetic Consequences of Human Sociality: Walking Speed Choices among Friendly Dyads	PLOS ONE			English	Article							PREFERRED SPEED; COSTS; FOOTPRINTS; OPTIMIZATION; LOCOMOTION; EVOLUTION; ILERET; TIME; SEX	Research has shown that individuals have an optimal walking speed-a speed which minimizes energy expenditure for a given distance. Because the optimal walking speed varies with mass and lower limb length, it also varies with sex, with males in any given population tending to have faster optimal walking speeds. This potentially creates an energetic dilemma for mixed-sex walking groups. Here we examine speed choices made by individuals of varying stature, mass, and sex walking together. Individuals (N = 22) walked around a track alone, with a significant other (with and without holding hands), and with friends of the same and opposite sex while their speeds were recorded every 100 m. Our findings show that males walk at a significantly slower pace to match the females' paces (p = 0.009), when the female is their romantic partner. The paces of friends of either same or mixed sex walking together did not significantly change (p > 0.05). Thus significant pace adjustment appears to be limited to romantic partners. These findings have implications for both mobility and reproductive strategies of groups. Because the male carries the energetic burden by adjusting his pace (slowing down 7%), the female is spared the potentially increased caloric cost required to walk together. In energetically demanding environments, we will expect to find gender segregation in group composition, particularly when travelling longer distances.	[Wagnild, Janelle; Wall-Scheffler, Cara M.] Seattle Pacific Univ, Dept Biol, Seattle, WA 98119 USA; [Wall-Scheffler, Cara M.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wall-Scheffler, CM (corresponding author), Seattle Pacific Univ, Dept Biol, Seattle, WA 98119 USA.	cwallsch@spu.edu		Wagnild, Janelle/0000-0003-3933-6380				Aiello LC, 2002, AM J HUM BIOL, V14, P551, DOI 10.1002/ajhb.10069; Alexander RM, 2002, AM J HUM BIOL, V14, P641, DOI 10.1002/ajhb.10067; [Anonymous], 1981, MAN ENV SYSTEMS; BELL RR, 1981, PSYCHOL WOMEN QUART, V5, P402, DOI 10.1111/j.1471-6402.1981.tb00582.x; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; BENTLEY GR, 1985, HUM ECOL, V13, P79, DOI 10.1007/BF01531090; Blurton Jones N. G., 1989, COMP SOCIOECOLOGY BE, P367; Brightman R, 1996, COMP STUD SOC HIST, V38, P687, DOI 10.1017/S0010417500020508; Browning RC, 2006, J APPL PHYSIOL, V100, P390, DOI 10.1152/japplphysiol.00767.2005; Browning RC, 2005, OBES RES, V13, P891, DOI 10.1038/oby.2005.103; Cashdan E, 2012, EVOL HUM BEHAV, V33, P274, DOI 10.1016/j.evolhumbehav.2011.10.005; Costa M, 2010, J NONVERBAL BEHAV, V34, P15, DOI 10.1007/s10919-009-0077-y; Dingwall HL, 2013, J HUM EVOL, V64, P556, DOI 10.1016/j.jhevol.2013.02.004; Dufour DL, 2002, AM J HUM BIOL, V14, P584, DOI 10.1002/ajhb.10071; DUNBAR RIM, 1992, BEHAV ECOL SOCIOBIOL, V31, P35, DOI 10.1007/BF00167814; ELKINS LE, 1993, SEX ROLES, V29, P497, DOI 10.1007/BF00289323; Ellison P.T., 2008, PALEOANTHROPOLOGY, V2008, P172; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; FRAYER DW, 1985, ANNU REV ANTHROPOL, V14, P429, DOI 10.1146/annurev.an.14.100185.002241; Gibbons A, 2011, SCIENCE, V332, P534, DOI 10.1126/science.332.6029.534-b; Gibson MA, 2006, PLOS MED, V3, P476, DOI 10.1371/journal.pmed.0030087; Hill RA, 2003, BEHAV ECOL SOCIOBIOL, V53, P278, DOI 10.1007/s00265-003-0590-7; JONES NB, 1986, ETHOL SOCIOBIOL, V7, P91, DOI 10.1016/0162-3095(86)90002-6; JONES NB, 1987, ETHOL SOCIOBIOL, V8, P183; Kramer PA, 1998, AM J PHYS ANTHROPOL, V107, P71; Marlowe FW, 2003, EVOL HUM BEHAV, V24, P217, DOI 10.1016/S1090-5138(03)00014-X; O'Connor SM, 2012, J NEUROPHYSIOL, V107, P2549, DOI 10.1152/jn.00866.2011; Peyrot N, 2012, MED SCI SPORT EXER, V44, P659, DOI 10.1249/MSS.0b013e318236edd8; Pollard KA, 2008, ANIM BEHAV, V76, P1683, DOI 10.1016/j.anbehav.2008.08.006; PRENTICE AM, 1988, ANNU REV NUTR, V8, P63, DOI 10.1146/annurev.nu.08.070188.000431; RALSTON H J, 1958, Int Z Angew Physiol, V17, P277; Richmond BG, 2011, PALEOANTHROPOLOGY AB, V2011, P29; Steudel-Numbers KL, 2009, J HUM EVOL, V56, P355, DOI 10.1016/j.jhevol.2008.11.002; Torrence Robin., 1983, HUNTER GATHERER EC P, P11, DOI DOI 10.1073/PNAS.0913047107; Wall-Scheffler CM, 2007, AM J PHYS ANTHROPOL, V133, P841, DOI 10.1002/ajpa.20603; Wall-Scheffler CM, 2013, J HUM EVOL, V64, P448, DOI 10.1016/j.jhevol.2013.01.014; Wall-Scheffler CM, 2012, ANNU REV ANTHROPOL, V41, P71, DOI 10.1146/annurev-anthro-092611-145739; Wall-Scheffler CM., 2012, J ANTHR, V2012, P1, DOI DOI 10.1155/2012/340493; Watson JC, 2008, J HUM EVOL, V54, P675, DOI 10.1016/j.jhevol.2007.10.004; Watson JC, 2011, PRIMATE LOCOMOTION L; WELLENS AR, 1978, J PSYCHOL, V99, P39, DOI 10.1080/00223980.1978.9921437; Wickler SJ, 2000, J EXP BIOL, V203, P2195; Ziomkiewicz A, 2008, HUM REPROD, V23, P2555, DOI 10.1093/humrep/den213	43	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76576	10.1371/journal.pone.0076576	http://dx.doi.org/10.1371/journal.pone.0076576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194840	Green Published, Green Submitted, gold			2022-12-27	WOS:000326037000019
J	Yashunsky, V; Kharilker, L; Zlotkin-Rivkin, E; Rund, D; Melamed-Book, N; Zahavi, EE; Perlson, E; Mercone, S; Golosovsky, M; Davidov, D; Aroeti, B				Yashunsky, Victor; Kharilker, Leorah; Zlotkin-Rivkin, Efrat; Rund, David; Melamed-Book, Naomi; Zahavi, Eitan Erez; Perlson, Eran; Mercone, Silvana; Golosovsky, Michael; Davidov, Dan; Aroeti, Benjamin			Real-Time Sensing of Enteropathogenic E. coli-Induced Effects on Epithelial Host Cell Height, Cell-Substrate Interactions, and Endocytic Processes by Infrared Surface Plasmon Spectroscopy	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; BARRIER FUNCTION; BACTERIAL PATHOGENS; LIVING CELLS; IN-VIVO; ESPF; DISRUPTION; INFECTION; RESONANCE; TRANSLOCATION	Enteropathogenic Escherichia coli (EPEC) is an important, generally non-invasive, bacterial pathogen that causes diarrhea in humans. The microbe infects mainly the enterocytes of the small intestine. Here we have applied our newly developed infrared surface plasmon resonance (IR-SPR) spectroscopy approach to study how EPEC infection affects epithelial host cells. The IR-SPR experiments showed that EPEC infection results in a robust reduction in the refractive index of the infected cells. Assisted by confocal and total internal reflection microscopy, we discovered that the microbe dilates the intercellular gaps and induces the appearance of fluid-phase-filled pinocytic vesicles in the lower basolateral regions of the host epithelial cells. Partial cell detachment from the underlying substratum was also observed. Finally, the waveguide mode observed by our IR-SPR analyses showed that EPEC infection decreases the host cell's height to some extent. Together, these observations reveal novel impacts of the pathogen on the host cell architecture and endocytic functions. We suggest that these changes may induce the infiltration of a watery environment into the host cell, and potentially lead to failure of the epithelium barrier functions. Our findings also indicate the great potential of the label-free IR-SPR approach to study the dynamics of host-pathogen interactions with high spatiotemporal sensitivity.	[Yashunsky, Victor; Golosovsky, Michael; Davidov, Dan] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Kharilker, Leorah; Zlotkin-Rivkin, Efrat; Rund, David; Aroeti, Benjamin] Hebrew Univ Jerusalem, Dept Cell & Dev Biol, Alexander Silberman Inst Life Sci, Jerusalem, Israel; [Kharilker, Leorah; Zlotkin-Rivkin, Efrat; Rund, David; Aroeti, Benjamin] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Bioimaging Unit, Jerusalem, Israel; [Yashunsky, Victor] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Zahavi, Eitan Erez; Perlson, Eran] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Mercone, Silvana] Univ Paris 13, Sorbonne Paris Cite, LSPM UPR CNRS 3407, F-93430 Villetaneuse, France; [Melamed-Book, Naomi] Hebrew Univ Jerusalem, Confocal Unit, Alexander Silberman Inst Life Sci, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Universite Paris 13; Hebrew University of Jerusalem	Yashunsky, V (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	victor.yashunsky@mail.huji.ac.il	Yashunsky, Victor/M-9523-2017; Yashunsky, Victor/P-1456-2019; Golosovsky, Michael/L-8303-2013; Mercone, Silvana/F-9799-2019	Yashunsky, Victor/0000-0003-3175-3390; Yashunsky, Victor/0000-0003-3175-3390; Mercone, Silvana/0000-0002-5790-1032; Perlson, Eran/0000-0001-6047-9613	NOFAR grant from the Israel Ministry of Industry and Trade; Start-Up grant Tack A from Yissum; Israel Science Foundation (ISF); Israel Academy of Sciences [1167/08]; Israel Cancer Association	NOFAR grant from the Israel Ministry of Industry and Trade; Start-Up grant Tack A from Yissum; Israel Science Foundation (ISF)(Israel Science Foundation); Israel Academy of Sciences; Israel Cancer Association	This work was supported by a NOFAR grant from the Israel Ministry of Industry and Trade. BA acknowledges support from the Start-Up grant Tack A from Yissum, the Israel Science Foundation (ISF), funded by the Israel Academy of Sciences (Grant 1167/08), and a grant from the Israel Cancer Association. The funders had no role in the study design, the data collection, and analysis, the decision to publish, or preparation of the manuscript.	Aroeti B, 2012, GUT MICROBES, V3, P267, DOI 10.4161/gmic.19814; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Chabot V, 2009, BIOSENS BIOELECTRON, V24, P1667, DOI 10.1016/j.bios.2008.08.025; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Elliott SJ, 2002, INFECT IMMUN, V70, P2271, DOI 10.1128/IAI.70.5.2271-2277.2002; Fang Y, 2006, BIOPHYS J, V91, P1925, DOI [10.1529/biophysj.105.077818, 10.1529/biophysj.105.007818]; Frankel G, 2008, CELL MICROBIOL, V10, P549, DOI 10.1111/j.1462-5822.2007.01103.x; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; Golosovsky M, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116143; Goosney DL, 2000, ANNU REV CELL DEV BI, V16, P173, DOI 10.1146/annurev.cellbio.16.1.173; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Guttman JA, 2006, CELL MICROBIOL, V8, P634, DOI 10.1111/j.1462-5822.2005.00656.x; Guttman JA, 2008, TRENDS MICROBIOL, V16, P535, DOI 10.1016/j.tim.2008.08.004; Guttman JA, 2007, ANAT REC, V290, P199, DOI 10.1002/ar.20414; Holmes A, 2010, INFECT IMMUN, V78, P4445, DOI 10.1128/IAI.00635-10; Howie HL, 2008, INFECT IMMUN, V76, P2715, DOI 10.1128/IAI.00153-08; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Johansen K, 2000, REV SCI INSTRUM, V71, P3530, DOI 10.1063/1.1287631; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Kroger C, 2013, J CELL BIOL, V201, P681, DOI 10.1083/jcb.201208162; Law RJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009977; Levayer R, 2012, TRENDS CELL BIOL, V22, P61, DOI 10.1016/j.tcb.2011.10.001; Lukyanenko V, 2011, AM J PHYSIOL-CELL PH, V301, pC1140, DOI 10.1152/ajpcell.00036.2011; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Moriez R, 2005, AM J PATHOL, V167, P1071, DOI 10.1016/S0002-9440(10)61196-0; Ochoa TJ, 2011, CURR OPIN INFECT DIS, V24, P478, DOI 10.1097/QCO.0b013e32834a8b8b; Opitz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017088; PALIK ED, 1984, J OPT SOC AM A, V1, P1297; Preston AM, 2006, J MORPHOL, V267, P103, DOI 10.1002/jmor.10390; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sason H, 2009, MOL BIOL CELL, V20, P544, DOI 10.1091/mbc.E08-05-0516; Schmitt M, 2004, PANCREAS, V28, P181, DOI 10.1097/00006676-200403000-00010; Shalabney A, 2011, LASER PHOTONICS REV, V5, P571, DOI 10.1002/lpor.201000009; Shames SR, 2010, CELL MICROBIOL, V12, P1322, DOI 10.1111/j.1462-5822.2010.01470.x; Shifflett DE, 2005, LAB INVEST, V85, P1308, DOI 10.1038/labinvest.3700330; Shifrin Y, 2002, CELL MICROBIOL, V4, P235, DOI 10.1046/j.1462-5822.2002.00188.x; Toomre D, 2000, J CELL BIOL, V149, P33, DOI 10.1083/jcb.149.1.33; Vallance BA, 2000, P NATL ACAD SCI USA, V97, P8799, DOI 10.1073/pnas.97.16.8799; VERTUTDOI A, 1994, ANTIMICROB AGENTS CH, V38, P2373, DOI 10.1128/AAC.38.10.2373; Vidal JE, 2006, INFECT IMMUN, V74, P2293, DOI 10.1128/IAI.74.4.2293-2303.2006; Viswanathan VK, 2004, CELL MICROBIOL, V6, P987, DOI 10.1111/j.1462-5822.2004.00416.x; Viswanathan VK, 2004, INFECT IMMUN, V72, P3218, DOI 10.1128/IAI.72.6.3218-3227.2004; Weflen AW, 2009, ANN NY ACAD SCI, V1165, P169, DOI 10.1111/j.1749-6632.2009.04060.x; Windt DL, 1998, COMPUT PHYS, V12, P360, DOI 10.1063/1.168689; Yashunsky V, 2010, AIP CONF PROC, V1281, P1617, DOI 10.1063/1.3498133; Yashunsky V, 2012, P SOC PHOTO-OPT INS, V8234, P823419; Yashunsky V, 2012, J BIOMED OPT, V17, DOI [10.1117/1.JBO.17.8.081409, DOI 10.1117/1.JB0.17.8.081409.PUBMED:23224170]; Yashunsky V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048454; Yashunsky V, 2010, BIOPHYS J, V99, P4028, DOI 10.1016/j.bpj.2010.10.017; Yashunsky V, 2009, BIOPHYS J, V97, P1003, DOI 10.1016/j.bpj.2009.05.052; Zahavi EE, 2011, MOL BIOL CELL, V22, P2436, DOI 10.1091/mbc.E11-01-0001; Zilbershtein A, 2012, VIB SPECTROSC, V61, P43, DOI 10.1016/j.vibspec.2012.01.019	57	6	6	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78431	10.1371/journal.pone.0078431	http://dx.doi.org/10.1371/journal.pone.0078431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194932	gold, Green Submitted, Green Published			2022-12-27	WOS:000326037000111
J	Danopoulos, S; Parsa, S; Al Alam, D; Tabatabai, R; Baptista, S; Tiozzo, C; Carraro, G; Wheeler, M; Barreto, G; Braun, T; Li, XK; Hajihosseini, MK; Bellusci, S				Danopoulos, Soula; Parsa, Sara; Al Alam, Denise; Tabatabai, Reza; Baptista, Sheryl; Tiozzo, Caterina; Carraro, Gianni; Wheeler, Matthew; Barreto, Guillermo; Braun, Thomas; Li, Xiaokun; Hajihosseini, Mohammad K.; Bellusci, Saverio			Transient Inhibition of FGFR2b-Ligands Signaling Leads to Irreversible Loss of Cellular beta-Catenin Organization and Signaling in AER during Mouse Limb Development	PLOS ONE			English	Article							APICAL ECTODERMAL RIDGE; MAMMARY-GLAND; MAINTENANCE; EXPRESSION; ORGANOGENESIS; MISEXPRESSION; INDUCTION; INTEGRINS; ROLES; FGF10	The vertebrate limbs develop through coordinated series of inductive, growth and patterning events. Fibroblast Growth Factor receptor 2b (FGFR2b) signaling controls the induction of the Apical Ectodermal Ridge (AER) but its putative roles in limb outgrowth and patterning, as well as in AER morphology and cell behavior have remained unclear. We have investigated these roles through graded and reversible expression of soluble dominant-negative FGFR2b molecules at various times during mouse limb development, using a doxycycline/transactivator/tet(O)-responsive system. Transient attenuation (<= 24 hours) of FGFR2b-ligands signaling at E8.5, prior to limb bud induction, leads mostly to the loss or truncation of proximal skeletal elements with less severe impact on distal elements. Attenuation from E9.5 onwards, however, has an irreversible effect on the stability of the AER, resulting in a progressive loss of distal limb skeletal elements. The primary consequences of FGFR2b-ligands attenuation is a transient loss of cell adhesion and down-regulation of P63, beta 1-integrin and E-cadherin, and a permanent loss of cellular beta-catenin organization and WNT signaling within the AER. Combined, these effects lead to the progressive transformation of the AER cells from pluristratified to squamous epithelial-like cells within 24 hours of doxycycline administration. These findings show that FGFR2b-ligands signaling has critical stage-specific roles in maintaining the AER during limb development.	[Danopoulos, Soula; Parsa, Sara; Baptista, Sheryl; Bellusci, Saverio] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Danopoulos, Soula; Parsa, Sara; Al Alam, Denise; Tabatabai, Reza; Tiozzo, Caterina; Bellusci, Saverio] Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA; [Parsa, Sara] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Tiozzo, Caterina] Nassau Univ, Med Ctr, Dept Pediat, New York, NY USA; [Carraro, Gianni; Bellusci, Saverio] Univ Giessen, Lung Ctr, Dept Internal Med 2, D-35390 Giessen, Germany; [Wheeler, Matthew; Braun, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, Bad Nauheim, Germany; [Barreto, Guillermo] Max Planck Inst Heart & Lung Res, LOEWE Res Grp Lung Canc Epigenet, Bad Nauheim, Germany; [Li, Xiaokun] Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China; [Hajihosseini, Mohammad K.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Southern California; Children's Hospital Los Angeles; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Justus Liebig University Giessen; Max Planck Society; Max Planck Society; Wenzhou Medical University; University of East Anglia	Bellusci, S (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA.	sbellusci@chla.usc.edu	Braun, Thomas/B-2310-2008; Barreto, Guillermo/U-5718-2017; Alam, Denise Al/AAG-9406-2019; tiozzo, caterina/AAD-1170-2022	Barreto, Guillermo/0000-0002-7777-4712; Tiozzo, Caterina/0000-0001-8317-7183; Carraro, Gianni/0000-0003-0824-7692; Baptista, Sheryl/0000-0002-0687-4089; Braun, Thomas/0000-0002-6165-4804	American Lung Association; NIH [HL086322, HD052609, HL074832]; DFG, LOEWE initiative; Excellence Cluster in Cardio-Pulmonary system, Giessen, Germany	American Lung Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG, LOEWE initiative; Excellence Cluster in Cardio-Pulmonary system, Giessen, Germany	D.A.A. acknowledges the support of the American Lung Association. S. B. acknowledges support from NIH (HL086322, HD052609 and HL074832) and DFG, LOEWE initiative as well as the Excellence Cluster in Cardio-Pulmonary system, Giessen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Altabef M, 1997, DEVELOPMENT, V124, P4547; Altabef M, 2000, DEV BIOL, V222, P307, DOI 10.1006/dbio.2000.9659; Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Bellusci S, 1996, DEVELOPMENT, V122, P1693; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Celli G, 1998, EMBO J, V17, P1642, DOI 10.1093/emboj/17.6.1642; DasGupta R, 1999, DEVELOPMENT, V126, P4557; De Arcangelis A, 1999, DEVELOPMENT, V126, P3957; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Fernandez-Teran M, 2008, INT J DEV BIOL, V52, P857, DOI 10.1387/ijdb.072416mf; Furniss D, 2009, J MED GENET, V46, P730, DOI 10.1136/jmg.2009.066027; Hajihosseini MK, 2004, DEVELOPMENT, V131, P325, DOI 10.1242/dev.00940; Hokuto I, 2003, J BIOL CHEM, V278, P415, DOI 10.1074/jbc.M208328200; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lu PF, 2008, DEVELOPMENT, V135, P1395, DOI 10.1242/dev.018945; Mailleux AA, 2002, DEVELOPMENT, V129, P53; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Parsa S, 2010, DEVELOPMENT, V137, P3743, DOI 10.1242/dev.051672; Rebustini IT, 2007, DEV BIOL, V308, P15, DOI 10.1016/j.ydbio.2007.04.031; Rohmann E, 2006, NAT GENET, V38, P414, DOI 10.1038/ng1757; Satoh A, 2010, DEV BIOL, V342, P157, DOI 10.1016/j.ydbio.2010.03.018; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106; Witte F, 2009, GENE EXPR PATTERNS, V9, P215, DOI 10.1016/j.gep.2008.12.009; Yu K, 2008, DEVELOPMENT, V135, P483, DOI 10.1242/dev.013268	33	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76248	10.1371/journal.pone.0076248	http://dx.doi.org/10.1371/journal.pone.0076248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167544	Green Submitted, Green Published, gold			2022-12-27	WOS:000326034500003
J	Giugno, R; Bonnici, V; Bombieri, N; Pulvirenti, A; Ferro, A; Shasha, D				Giugno, Rosalba; Bonnici, Vincenzo; Bombieri, Nicola; Pulvirenti, Alfredo; Ferro, Alfredo; Shasha, Dennis			GRAPES: A Software for Parallel Searching on Biological Graphs Targeting Multi-Core Architectures	PLOS ONE			English	Article							TOOL	Biological applications, from genomics to ecology, deal with graphs that represents the structure of interactions. Analyzing such data requires searching for subgraphs in collections of graphs. This task is computationally expensive. Even though multicore architectures, from commodity computers to more advanced symmetric multiprocessing (SMP), offer scalable computing power, currently published software implementations for indexing and graph matching are fundamentally sequential. As a consequence, such software implementations (i) do not fully exploit available parallel computing power and (ii) they do not scale with respect to the size of graphs in the database. We present GRAPES, software for parallel searching on databases of large biological graphs. GRAPES implements a parallel version of well-established graph searching algorithms, and introduces new strategies which naturally lead to a faster parallel searching system especially for large graphs. GRAPES decomposes graphs into subcomponents that can be efficiently searched in parallel. We show the performance of GRAPES on representative biological datasets containing antiviral chemical compounds, DNA, RNA, proteins, protein contact maps and protein interactions networks.	[Giugno, Rosalba; Pulvirenti, Alfredo; Ferro, Alfredo] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy; [Bonnici, Vincenzo; Bombieri, Nicola] Univ Verona, Dept Comp Sci, I-37100 Verona, Italy; [Shasha, Dennis] NYU, Courant Inst Math Sci, New York, NY USA	University of Catania; University of Verona; New York University	Giugno, R (corresponding author), Univ Catania, Dept Clin & Mol Biomed, Catania, Italy.	giugno@dmi.unict.it	Bombieri, Nicola/AAD-9726-2019; bonnici, vincenzo/AAY-7461-2020; Pulvirenti, Alfredo/I-7272-2018	bonnici, vincenzo/0000-0002-1637-7545; Pulvirenti, Alfredo/0000-0002-9764-0295; Bombieri, Nicola/0000-0003-3256-5885; Giugno, Rosalba/0000-0001-9843-7638	U.S. National Science Foundation [0922738, 0929338, 1158273]; National Institutes of Health [GM32877-21/22, 2R01GM032877-25A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032877] Funding Source: NIH RePORTER	U.S. National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DS's work was partly supported by U.S. National Science Foundation grants 0922738, 0929338, 1158273 and National Institutes of Health grants GM32877-21/22 and 2R01GM032877-25A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banks E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r138; Bonnici V, 2010, LECT N BIOINFORMAT, V6282, P195, DOI 10.1007/978-3-642-16001-1_17; Cheng J., 2007, SIGMOD, P857, DOI DOI 10.1145/1247480.1247574; Cohen E, 2001, IEEE T KNOWL DATA EN, V13, P64, DOI 10.1109/69.908981; Cordella LP, 2004, IEEE T PATTERN ANAL, V26, P1367, DOI 10.1109/TPAMI.2004.75; Di Natale R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-96; Dost B, 2008, J COMPUT BIOL, V15, P913, DOI 10.1089/cmb.2007.0172; Ferro A, 2007, BIOINFORMATICS, V23, P910, DOI 10.1093/bioinformatics/btm032; Ferro A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S4-S10; He H., 2006, ICDE, P38; He YN, 2002, P NATL ACAD SCI USA, V99, P10325, DOI 10.1073/pnas.152161599; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; Klein K, 2011, PROC INT CONF DATA, P1115, DOI 10.1109/ICDE.2011.5767909; Lacroix V, 2006, IEEE ACM T COMPUT BI, V3, P360, DOI 10.1109/TCBB.2006.55; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Messmer BT, 1995, LECT NOTES COMPUTER, V1035, P373; Rajapakse HA, 2007, CURR TOP MED CHEM, V7, P966, DOI 10.2174/156802607780906816; Shasha D., 2002, PODS, P39, DOI DOI 10.1145/543613.543620; Ullmann JR, 2011, J EXPT ALGORITHMICS, V15; Vehlow C, 2011, BIOINFORMATICS, V27, P1573, DOI 10.1093/bioinformatics/btr163; Williams DW, 2007, ICDE, P976; Yan X., 2004, SIGMOD, P335; Zhang C, 2012, BIOINFORMATICS, V28, P1943, DOI 10.1093/bioinformatics/bts278; Zhang S, 2007, P IEEE 23 INT C DAT, P181; Zhao P, 2007, VLDB, P938; Zou L., 2008, P 11 INT C EXTENDING, P181	28	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76911	10.1371/journal.pone.0076911	http://dx.doi.org/10.1371/journal.pone.0076911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167551	Green Submitted, gold, Green Published			2022-12-27	WOS:000326034500010
J	Naidoo, R; Nuttall, J; Whitelaw, A; Eley, B				Naidoo, Reene; Nuttall, James; Whitelaw, Andrew; Eley, Brian			Epidemiology of Staphylococcus aureus Bacteraemia at a Tertiary Children's Hospital in Cape Town, South Africa	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; ANTIMICROBIAL SUSCEPTIBILITY; INFECTED CHILDREN; COUNTRIES	Background: Staphylococcus aureus is an important pathogen in paediatric patients with bloodstream infections. The epidemiology of S. aureus bacteraemia, however, has not been well documented in children in South Africa. Methods: A retrospective study was conducted at a children's hospital in Cape Town, South Africa, to investigate the epidemiology of S. aureus bacteraemia from 2007-2011. The incidence, clinical presentation, risk factors, management and outcomes of methicillin sensitive S. aureus (MSSA) and methicillin resistant S. aureus (MRSA) bacteraemia were compared. Results: Over the five year study period, 365 episodes of S. aureus bacteraemia were identified. The annual incidence was 3.28 cases per 1000 hospital admissions. MRSA was responsible for 26% of S. aureus bacteraemia and 72% of nosocomial infections. Only six possible cases of community-acquired MRSA infections were described. MSSA bacteraemia was more likely to present as pulmonary and bone or joint infections, while bacteraemia without a source was the most common presentation with MRSA. Infants, children with malnutrition, and residents of long-term care facilities were at highest risk for MRSA bacteraemia. The overall case fatality rate for S. aureus bacteraemia was 8.8% over five years, with MRSA being the only significant risk factor for mortality. Conclusion: The incidence of S. aureus bacteraemia and MRSA bacteraemia in children has remained stable over the past five years. MRSA is a predominantly nosocomial pathogen in children with S. aureus bacteraemia in Cape Town, South Africa.	[Naidoo, Reene; Nuttall, James; Eley, Brian] Univ Cape Town, Paediat Infect Dis Unit, Red Cross War Mem Childrens Hosp, ZA-7925 Cape Town, South Africa; [Naidoo, Reene; Nuttall, James; Eley, Brian] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa; [Whitelaw, Andrew] Univ Cape Town, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Naidoo, R (corresponding author), Univ Cape Town, Paediat Infect Dis Unit, Red Cross War Mem Childrens Hosp, ZA-7925 Cape Town, South Africa.	reenenaidoo@gmail.com	Nuttall, James/CAF-4214-2022; Nuttall, James/CAE-8986-2022	Nuttall, James/0000-0002-9389-5880; Nuttall, James/0000-0002-9389-5880; Whitelaw, Andrew/0000-0001-9070-5247	PEPFAR/USAID through the ANOVA Health Institute; Institute of Child Health Research Award from the School of Child and Adolescent Health, University of Cape Town	PEPFAR/USAID through the ANOVA Health Institute(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Institute of Child Health Research Award from the School of Child and Adolescent Health, University of Cape Town	During the period of the research study, Reene Naidoo was an infectious diseases fellow supported by PEPFAR/USAID through the ANOVA Health Institute. The study was funded by an Institute of Child Health Research Award from the School of Child and Adolescent Health, University of Cape Town. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAMFORD C, 2010, S AFR J EPIDEMIOL 2, V26, P243; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bouchillon SK, 2004, INT J ANTIMICROB AG, V24, P119, DOI 10.1016/j.ijantimicag.2004.01.010; Burke RE, 2009, INFECT CONT HOSP EP, V30, P636, DOI 10.1086/597521; *CLIN LAB STAND I, 2006, M100S17 CLSI; Clinical and Laboratory Standards Institute, 2006, M2A9 CLSI; Cotton MF, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-40; COTTON MF, 1992, S AFR MED J, V81, P87; DAVIS WG, 1974, S AFR MED J, V48, P1341; de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5; *DEP HLTH REP S AF, 2012, INT MAN CHILD ILLN M; Frederiksen MS, 2007, PEDIATR INFECT DIS J, V26, P398, DOI 10.1097/01.inf.0000261112.53035.4c; FRIEDLAND IR, 1995, J PEDIATR-US, V127, P746, DOI 10.1016/S0022-3476(95)70166-4; Jaspan HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003260; Kaplan SL, 2005, INFECT DIS CLIN N AM, V19, P747, DOI 10.1016/j.idc.2005.05.011; Khairulddin N, 2004, ARCH DIS CHILD, V89, P378, DOI 10.1136/adc.2003.028712; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; le Roux DM, 2011, PEDIATR INFECT DIS J, V30, P904, DOI 10.1097/INF.0b013e318220a68b; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Marais E, 2009, SAMJ S AFR MED J, V99, P170; Nathoo KJ, 1996, PEDIATR INFECT DIS J, V15, P1092, DOI 10.1097/00006454-199612000-00007; Otter JA, 2012, J HOSP INFECT, V81, P143, DOI 10.1016/j.jhin.2012.04.009; Perovic O, 2006, SAMJ S AFR MED J, V96, P714; Shittu AO, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-125; Suryati BA, 2002, J PAEDIATR CHILD H, V38, P290, DOI 10.1046/j.1440-1754.2002.00787.x; Wisplinghoff H, 2003, PEDIATR INFECT DIS J, V22, P686, DOI 10.1097/01.inf.0000078159.53132.40; World Health Organization, 1999, MAN SEV MALN MAN PHY; Zinn CS, 2004, MICROB DRUG RESIST, V10, P160, DOI 10.1089/1076629041310055	28	31	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78396	10.1371/journal.pone.0078396	http://dx.doi.org/10.1371/journal.pone.0078396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167621	Green Published, gold, Green Submitted			2022-12-27	WOS:000326034500082
J	Redeker, C; Schuster-Gossler, K; Kremmer, E; Gossler, A				Redeker, Christian; Schuster-Gossler, Karin; Kremmer, Elisabeth; Gossler, Achim			Normal Development in Mice Over-Expressing the Intracellular Domain of DLL1 Argues against Reverse Signaling by DLL1 In Vivo	PLOS ONE			English	Article							NOTCH LIGAND DELTA1; NUCLEOTIDE-SEQUENCE; DROSOPHILA-MELANOGASTER; TRANSMEMBRANE PROTEIN; PROGENITOR CELLS; GENE-EXPRESSION; LEXA GENE; MOUSE; PROTEOLYSIS; ACTIVATION	The Notch signaling pathway mediates the direct communication between adjacent cells and regulates multiple developmental processes. Interaction of the Notch receptor with its ligands induces the liberation of the intracellular portion of Notch (NICD) referred to as regulated intramembraneous proteolysis (RIP). NICD translocates to the nucleus, and by complexing with the DNA binding protein RBPj kappa and other cofactors activates transcription of bHLH genes. RIP-like processing of various mammalian Notch ligands (DLL1, JAG1 and JAG2) and the translocation of their intracellular domains (ICDs) to the nucleus has also been observed. These observations together with effects of over-expressed ligand ICDs in cultured cells on cell proliferation, differentiation, and Notch activity and target gene expression have led to the idea that the intracellular domains of Notch ligands have signaling functions. To test this hypothesis in vivo we have generated ES cells and transgenic mice that constitutively express various versions of the intracellular domain of mouse DLL1. In contrast to other cell lines, expression of DICDs in ES cells did not block proliferation or stimulate neuronal differentiation. Embryos with ubiquitous DICD expression developed to term without any apparent phenotype and grew up to viable and fertile adults. Early Notch-dependent processes or expression of selected Notch target genes were unaltered in transgenic embryos. In addition, we show that mouse DICD enters the nucleus inefficiently. Collectively, our results argue against a signaling activity of the intracellular domain of DLL1 in mouse embryos in vivo.	[Redeker, Christian; Schuster-Gossler, Karin; Gossler, Achim] Hannover Med Sch, Inst Mol Biol OE5250, D-30623 Hannover, Germany; [Kremmer, Elisabeth] Forschungszentrum Umwelt & Gesundheit GmbH, Inst Mol Immunol, Helmholtz Zentrum Munchen, Munich, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Gossler, A (corresponding author), Hannover Med Sch, Inst Mol Biol OE5250, D-30623 Hannover, Germany.	gossler.achim@mh-hannover.de			DFG (Deutsche Forschungsgemeinschaft) [GO449/10]; Cluster of Excellence "From Regenerative Biology to Reconstructive Therapy"; DFG-Project "Open Access Publishing" by the German Research Foundation	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Cluster of Excellence "From Regenerative Biology to Reconstructive Therapy"; DFG-Project "Open Access Publishing" by the German Research Foundation(German Research Foundation (DFG))	This work was supported by DFG (Deutsche Forschungsgemeinschaft) grant GO449/10 to AG, and by funding of the Cluster of Excellence "From Regenerative Biology to Reconstructive Therapy". The article processing charge was funded by means of the DFG-Project "Open Access Publishing" by the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alten L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047785; Arnold HH, 2000, CURR TOP DEV BIOL, V48, P129; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; Bland CE, 2003, J BIOL CHEM, V278, P13607, DOI 10.1074/jbc.C300016200; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Cormier S, 2004, GENE EXPR PATTERNS, V4, P713, DOI 10.1016/j.modgep.2004.04.003; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; EBINA Y, 1983, J BIOL CHEM, V258, P3258; Feller J, 2008, GENE DEV, V22, P2166, DOI 10.1101/gad.480408; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Gravano DM, 2010, IMMUNOL CELL BIOL, V88, P746, DOI 10.1038/icb.2010.30; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; HORII T, 1981, CELL, V23, P689, DOI 10.1016/0092-8674(81)90432-3; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Jung J, 2011, MOL CELLS, V32, P161, DOI 10.1007/s10059-011-1046-y; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kiyota T, 2004, MECH DEVELOP, V121, P573, DOI 10.1016/j.mod.2004.03.034; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Kolev V, 2005, FEBS LETT, V579, P5798, DOI 10.1016/j.febslet.2005.09.042; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Liebler SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053074; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louvi A, 2012, SEMIN CELL DEV BIOL, V23, P473, DOI 10.1016/j.semcdb.2012.02.005; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; MIKI T, 1981, NUCLEIC ACIDS RES, V9, P529, DOI 10.1093/nar/9.3.529; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Neidhardt LM, 1997, DEV GENES EVOL, V207, P330, DOI 10.1007/s004270050120; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Ramos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015515; Rocha SF, 2009, DEV BIOL, V328, P54, DOI 10.1016/j.ydbio.2009.01.011; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; THOMAS U, 1991, DEVELOPMENT, V111, P749; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; VASSIN H, 1987, EMBO J, V6, P3431, DOI 10.1002/j.1460-2075.1987.tb02666.x; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; Wilkinson DG., 1992, SITU HYBRIDIZATION P, P75; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zender S, 2013, CANCER CELL, V23, P784, DOI 10.1016/j.ccr.2013.04.019	55	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e79050	10.1371/journal.pone.0079050	http://dx.doi.org/10.1371/journal.pone.0079050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167636	Green Submitted, gold, Green Published			2022-12-27	WOS:000326034500097
J	Jeon, C; Kim, M; Kwak, C; Kim, HH; Ku, JH				Jeon, Chanhoo; Kim, Myong; Kwak, Cheol; Kim, Hyeon Hoe; Ku, Ja Hyeon			Prognostic Role of Survivin in Bladder Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							TRANSITIONAL-CELL CARCINOMA; SUPERFICIAL UROTHELIAL CARCINOMA; MESSENGER-RNA EXPRESSION; INDIVIDUAL PATIENT DATA; TO-EVENT DATA; ELEVATED EXPRESSION; PROGRESSION; RECURRENCE; APOPTOSIS; MARKER	Purpose: The objective of the present study was to conduct a systematic review and meta-analysis of published literature investigating the survivin expression and its effects on bladder cancer prognosis. Materials and Methods: We carefully searched online Pubmed, Cochrane Library and SCOPUS database from August 1997 to May 2013. Results: A total of 14 articles met the eligibility criteria for this systematic review. The eligible studies included a total of 2,165 patients with a median number of 155 patients per study (range: 17-726). Of the 14 studies, nine evaluated immunohistochemistry in formalin-fixed paraffin-embedded tissue blocks. In non-muscle invasive bladder tumor, the pooled hazard ratio (HR) was statistically significant for recurrence-free survival (pooled HR, 1.81; 95% confidence interval [CI], 1.30-2.52), progression-free survival (pooled HR, 2.12; 95% CI, 1.60-2.82), cancer-specific survival (pooled HR, 2.01; 95% CI, 1.32-3.06), and overall survival (pooled HR, 1.53; 95% CI, 1.02-2.29). The overall HRs by survivin status were robust across advanced stages. When only adjusted survival data were included, statistically significant differences were identified for all survival subgroup analyses. There was no between-study heterogeneity in the effect of survivin status on the majority of meta-analyses. There was no clear evidence of publication bias in this meta-analysis. Conclusions: Survivin expression indicates worse prognosis in patients with bladder cancer but the results should be interpreted with caution. It is necessary that better-designed studies with standardized assays need to provide a better conclusion about the relationship between survivin expression and the outcome of patients with bladder cancer.	[Jeon, Chanhoo; Kim, Myong; Kwak, Cheol; Kim, Hyeon Hoe; Ku, Ja Hyeon] Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea	Seoul National University (SNU)	Ku, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea.	kuuro70@snu.ac.kr	Ku, Ja Hyeon/E-6682-2016	Kim, Myong/0000-0001-6995-6850				Als AB, 2007, CLIN CANCER RES, V13, P4407, DOI 10.1158/1078-0432.CCR-07-0109; ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Atlasi Y, 2009, CANCER DETECT PREV, V32, P308, DOI 10.1016/j.cdp.2008.12.001; Birkhahn M, 2010, EUR UROL, V57, P12, DOI 10.1016/j.eururo.2009.09.013; de Graeff P, 2009, BRIT J CANCER, V101, P149, DOI 10.1038/sj.bjc.6605112; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dong ZL, 2011, UROL INT, V87, P445, DOI 10.1159/000330911; Duchateau L, 2000, BIOMETRICS, V56, P886, DOI 10.1111/j.0006-341X.2000.00886.x; Duffy MJ, 2007, CANCER LETT, V249, P49, DOI 10.1016/j.canlet.2006.12.020; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Fortugno P, 2002, J CELL SCI, V115, P575; Fristrup N, 2012, AM J PATHOL, V180, P1824, DOI 10.1016/j.ajpath.2012.01.023; Gazzaniga P, 2003, ANN ONCOL, V14, P85, DOI 10.1093/annonc/mdg002; Gonzalez S, 2008, AM J CLIN PATHOL, V129, P232, DOI 10.1309/2TY6GTV1GQ6B5ARM; Gradilone A, 2010, BJU INT, V106, P710, DOI 10.1111/j.1464-410X.2009.09130.x; Hausladen DA, 2003, J UROLOGY, V170, P230, DOI 10.1097/01.ju.0000063685.29339.24; Hayes DF, 1996, JNCI-J NATL CANCER I, V88, P1456, DOI 10.1093/jnci/88.20.1456; Hayes DF, 2001, J MAMMARY GLAND BIOL, V6, P375, DOI 10.1023/A:1014778713034; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirooka T, 2009, METHOD INFORM MED, V48, P104, DOI 10.3414/ME0535; Jaiswal PK, 2012, MOL BIOL REP, V39, P5615, DOI 10.1007/s11033-011-1366-1; Jang TJ, 2009, KOREAN J PATHOL, V43, P206, DOI 10.4132/KoreanJPathol.2009.43.3.206; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kappler M, 2003, CLIN CANCER RES, V9, P1098; Karam JA, 2007, UROLOGY, V70, P482, DOI 10.1016/j.urology.2007.05.009; Karam JA, 2007, LANCET ONCOL, V8, P128, DOI 10.1016/S1470-2045(07)70002-5; Kitsukawa Shin-ichi, 2008, Hinyokika Kiyo, V54, P101; Koga F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027616; Ku JH, 2004, J UROLOGY, V171, P631, DOI 10.1097/01.ju.0000106082.44786.3b; Lehner R, 2002, APPL IMMUNOHISTO M M, V10, P134, DOI 10.1097/00022744-200206000-00007; Li FZ, 2006, J CELL PHYSIOL, V208, P476, DOI 10.1002/jcp.20634; Li FZ, 2005, INT J CANCER, V114, P509, DOI 10.1002/ijc.20768; Lopez-Knowles E, 2006, CLIN CANCER RES, V12, P6029, DOI 10.1158/1078-0432.CCR-06-0206; Margulis V, 2008, WORLD J UROL, V26, P59, DOI 10.1007/s00345-007-0219-y; Margulis V, 2007, J UROLOGY, V177, P1163, DOI 10.1016/j.juro.2006.10.033; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Michiels S, 2005, INT J TECHNOL ASSESS, V21, P119, DOI 10.1017/S0266462305050154; Mowla Seyed Javad, 2005, Urol J, V2, P141; Nouraee N, 2009, UROL J, V6, P101; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Patschan O, 2012, WORLD J UROL, V30, P785, DOI 10.1007/s00345-011-0727-7; Pennati M, 2008, EXPERT OPIN THER TAR, V12, P463, DOI 10.1517/14728222.12.4.463 ; Pina-Cabral L, 2007, CLIN TRANSL ONCOL, V9, P731, DOI 10.1007/s12094-007-0130-4; Pollard C, 2009, AM J PATHOL, V175, P1824, DOI 10.2353/ajpath.2009.090155; Rodel F, 2005, CANCER RES, V65, P4881, DOI 10.1158/0008-5472.CAN-04-3028; Schultz IJ, 2004, CLIN CHEM, V50, P1425, DOI 10.1373/clinchem.2004.032003; Schultz IJ, 2003, ANTICANCER RES, V23, P3327; Schultz IJ, 2007, ANTICANCER RES, V27, P1051; Schultz IJ, 2007, EUR UROL, V51, P416, DOI 10.1016/j.eururo.2006.07.023; Shariat SF, 2007, UROL ONCOL-SEMIN ORI, V25, P468, DOI 10.1016/j.urolonc.2006.09.011; Shariat SF, 2007, CANCER-AM CANCER SOC, V109, P1106, DOI 10.1002/cncr.22521; Shariat SF, 2010, J UROLOGY, V183, P1744, DOI 10.1016/j.juro.2010.01.018; Shariat SF, 2009, CLIN CANCER RES, V15, P7012, DOI 10.1158/1078-0432.CCR-08-2554; Shariat SF, 2009, J UROLOGY, V182, P78, DOI 10.1016/j.juro.2009.02.125; Skagias L, 2009, ANTICANCER RES, V29, P4163; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Sun YW, 2013, GENET MOL RES, V12, P1045, DOI 10.4238/2013.April.2.21; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Wang HD, 2004, J CANCER RES CLIN, V130, P487, DOI 10.1007/s00432-004-0561-z; Wang YB, 2007, J HUAZHONG U SCI-MED, V27, P444, DOI 10.1007/s11596-007-0424-3; Weikert S, 2005, INT J CANCER, V116, P100, DOI 10.1002/ijc.21000; Weiss C, 2009, INT J RADIAT ONCOL, V74, P1455, DOI 10.1016/j.ijrobp.2008.10.063; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; Wu Y, 2005, INT J PHARMACEUT, V295, P235, DOI 10.1016/j.ijpharm.2005.01.042; Xi RC, 2013, J SURG ONCOL, V107, P550, DOI 10.1002/jso.23272; Yildirim U, 2010, J INT MED RES, V38, P1689, DOI 10.1177/147323001003800514; Yin W, 2006, MODERN PATHOL, V19, P1487, DOI 10.1038/modpathol.3800675	69	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76719	10.1371/journal.pone.0076719	http://dx.doi.org/10.1371/journal.pone.0076719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204662	Green Submitted, gold, Green Published			2022-12-27	WOS:000326029300047
J	Kaneko, M; Shintani, Y; Narita, T; Ikebe, C; Tano, N; Yamahara, K; Fukushima, S; Coppen, SR; Suzuki, K				Kaneko, Masahiro; Shintani, Yasunori; Narita, Takuya; Ikebe, Chiho; Tano, Nobuko; Yamahara, Kenichi; Fukushima, Satsuki; Coppen, Steven R.; Suzuki, Ken			Extracellular High Mobility Group Box 1 Plays a Role in the Effect of Bone Marrow Mononuclear Cell Transplantation for Heart Failure	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL-INFARCTION; CARDIAC-FUNCTION; STEM-CELLS; INJECTION; RAT; INFLAMMATION; HMGB1; REGENERATION	Transplantation of unfractionated bone marrow mononuclear cells (BMCs) repairs and/or regenerates the damaged myocardium allegedly due to secretion from surviving BMCs (paracrine effect). However, donor cell survival after transplantation is known to be markedly poor. This discrepancy led us to hypothesize that dead donor BMCs might also contribute to the therapeutic benefits from BMC transplantation. High mobility group box 1 (HMGB1) is a nuclear protein that stabilizes nucleosomes, and also acts as a multi-functional cytokine when released from damaged cells. We thus studied the role of extracellular HMGB1 in the effect of BMC transplantation for heart failure. Four weeks after coronary artery ligation in female rats, syngeneic male BMCs (or PBS only as control) were intramyocardially injected with/without anti-HMGB1 antibody or control IgG. One hour after injection, ELISA showed that circulating extracellular HMGB1 levels were elevated after BMC transplantation compared to the PBS injection. Quantitative donor cell survival assessed by PCR for male-specific sry gene at days 3 and 28 was similarly poor. Echocardiography and catheterization showed enhanced cardiac function after BMC transplantation compared to PBS injection at day 28, while this effect was abolished by antibody-neutralization of HMGB1. BMC transplantation reduced post-infarction fibrosis, improved neovascularization, and increased proliferation, while all these effects in repairing the failing myocardium were eliminated by HMGB1-inhibition. Furthermore, BMC transplantation drove the macrophage polarization towards alternatively-activated, anti-inflammatory M2 macrophages in the heart at day 3, while this was abolished by HMGB1-inhibition. Quantitative RT-PCR showed that BMC transplantation upregulated expression of an anti-inflammatory cytokine IL-10 in the heart at day 3 compared to PBS injection. In contrast, neutralizing HMGB1 by antibody-treatment suppressed this anti-inflammatory expression. These data suggest that extracellular HMGB1 contributes to the effect of BMC transplantation to recover the damaged myocardium by favorably modulating innate immunity in heart failure.	[Kaneko, Masahiro; Shintani, Yasunori; Narita, Takuya; Ikebe, Chiho; Tano, Nobuko; Coppen, Steven R.; Suzuki, Ken] Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Yamahara, Kenichi] Natl Cerebral & Cardiovasc Ctr, Dept Regenerat Med & Tissue Engn, Suita, Osaka, Japan; [Fukushima, Satsuki] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan	University of London; Queen Mary University London; National Cerebral & Cardiovascular Center - Japan; Osaka University	Suzuki, K (corresponding author), Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.	ken.suzuki@qmul.ac.uk	Fukushima, Satsuki/ABE-6582-2020	Fukushima, Satsuki/0000-0002-9481-8860; Shintani, Yasunori/0000-0001-9579-0727	Barts and The London Charity [422/433]; NIHR; Medical Research Council, UK [G116/158]; Medical Research Council [G116/158] Funding Source: researchfish; MRC [G116/158] Funding Source: UKRI	Barts and The London Charity; NIHR(National Institute for Health Research (NIHR)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Barts and The London Charity Large Project Grant (422/433) and supported by NIHR-funded Barts Cardiovascular Biomedical Research Unit. This study was also funded by the Medical Research Council, UK (Senior Fellowship G116/158 to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Chavakis E, 2007, CIRC RES, V100, P204, DOI 10.1161/01.RES.0000257774.55970.f4; Donndorf P, 2011, J THORAC CARDIOV SUR, V142, P911, DOI 10.1016/j.jtcvs.2010.12.013; Francis J, 2001, AM J PHYSIOL-REG I, V281, pR1734, DOI 10.1152/ajpregu.2001.281.5.R1734; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Fukushima S, 2007, CIRCULATION, V115, P2254, DOI 10.1161/CIRCULATIONAHA.106.662577; George JC, 2008, J INTERV CARDIOL, V21, P424, DOI 10.1111/j.1540-8183.2008.00390.x; Hu YL, 2011, BASIC RES CARDIOL, V106, P1311, DOI 10.1007/s00395-011-0204-x; Kitahara T, 2008, CARDIOVASC RES, V80, P40, DOI 10.1093/cvr/cvn163; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Limana F, 2005, CIRC RES, V97, pE73, DOI 10.1161/01.RES.0000186276.06104.04; Limana F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019845; Narita T, 2013, INT J CARDIOL, V168, P261, DOI 10.1016/j.ijcard.2012.09.081; Ohnishi S, 2007, STEM CELLS, V25, P1166, DOI 10.1634/stemcells.2006-0347; Omura T, 2000, BASIC RES CARDIOL, V95, P316, DOI 10.1007/s003950070051; Oozawa S, 2008, CIRC J, V72, P1178, DOI 10.1253/circj.72.1178; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Popovic PJ, 2006, J IMMUNOL, V177, P8701, DOI 10.4049/jimmunol.177.12.8701; Rong LL, 2004, FASEB J, V18, P1818, DOI 10.1096/fj.04-1900com; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sekiguchi H, 2009, J CELL PHYSIOL, V219, P235, DOI 10.1002/jcp.21672; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Takahashi K, 2008, CIRCULATION, V118, pS106, DOI 10.1161/CIRCULATIONAHA.107.757443; Tang DL, 2005, SHOCK, V23, P434, DOI 10.1097/01.shk.0000159556.95285.df; van Ramshorst J, 2011, J CARDIOVASC TRANSL, V4, P182, DOI 10.1007/s12265-010-9249-8; Xu H, 2011, AM J PHYSIOL-HEART C, V300, pH913, DOI 10.1152/ajpheart.00703.2010; Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005; Yeghiazarians Y, 2009, MOL THER, V17, P1250, DOI 10.1038/mt.2009.85; Zhou XY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/743879; Ziebart T, 2008, CIRC RES, V103, P1327, DOI 10.1161/CIRCRESAHA.108.180463	32	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76908	10.1371/journal.pone.0076908	http://dx.doi.org/10.1371/journal.pone.0076908			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204700	gold, Green Submitted, Green Published			2022-12-27	WOS:000326029300064
J	Unger, SD; Rhodes, OE; Sutton, TM; Williams, RN				Unger, Shem D.; Rhodes, Olin E., Jr.; Sutton, Trent M.; Williams, Rod N.			Population Genetics of the Eastern Hellbender (Cryptobranchus alleganiensis alleganiensis) across Multiple Spatial Scales	PLOS ONE			English	Article							CONSERVATION GENETICS; LANDSCAPE GENETICS; AMPHIBIAN DECLINES; ATLANTIC SALMON; BROOK CHARR; DIVERSITY; SALAMANDER; SOFTWARE; BARRIERS; RANGE	Conservation genetics is a powerful tool to assess the population structure of species and provides a framework for informing management of freshwater ecosystems. As lotic habitats become fragmented, the need to assess gene flow for species of conservation management becomes a priority. The eastern hellbender (Cryptobranchus alleganiensis alleganiensis) is a large, fully aquatic paedamorphic salamander. Many populations are experiencing declines throughout their geographic range, yet the genetic ramifications of these declines are currently unknown. To this end, we examined levels of genetic variation and genetic structure at both range-wide and drainage (hierarchical) scales. We collected 1,203 individuals from 77 rivers throughout nine states from June 2007 to August 2011. Levels of genetic diversity were relatively high among all sampling locations. We detected significant genetic structure across populations (Fst values ranged from 0.001 between rivers within a single watershed to 0.218 between states). We identified two genetically differentiated groups at the range-wide scale: 1) the Ohio River drainage and 2) the Tennessee River drainage. An analysis of molecular variance (AMOVA) based on landscape-scale sampling of basins within the Tennessee River drainage revealed the majority of genetic variation (similar to 94-98%) occurs within rivers. Eastern hellbenders show a strong pattern of isolation by stream distance (IBSD) at the drainage level. Understanding levels of genetic variation and differentiation at multiple spatial and biological scales will enable natural resource managers to make more informed decisions and plan effective conservation strategies for cryptic, lotic species.	[Unger, Shem D.; Rhodes, Olin E., Jr.] Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA; [Sutton, Trent M.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Williams, Rod N.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; University of Alaska System; University of Alaska Fairbanks; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Unger, SD (corresponding author), Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA.	cryptobranchus11@gmail.com			Indiana Department of Natural Resources [E2-07-WD0007]; Department of Forestry and Natural Resources at Purdue University; Cryptobranchid Interest Group Ron Goellner Fund	Indiana Department of Natural Resources; Department of Forestry and Natural Resources at Purdue University; Cryptobranchid Interest Group Ron Goellner Fund	Funding was provided by the Indiana Department of Natural Resources (E2-07-WD0007; http://www.in.gov/dnr/), Department of Forestry and Natural Resources at Purdue University (https://ag.purdue.edu/fnr/Pages/default.aspx), and Cryptobranchid Interest Group Ron Goellner Fund (2010; http://www.caudata.org/cig/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrino J, 2000, MOL ECOL, V9, P771, DOI 10.1046/j.1365-294x.2000.00931.x; Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Allee W.C, 1931, ANIMAL AGGREGATION S; Angers B, 1999, MOL ECOL, V8, P1043, DOI 10.1046/j.1365-294x.1999.00669.x; [Anonymous], 2010, SALAMANDERS US CANAD; [Anonymous], 2015, PC ORD MULTIVARIATE; Avise J, 2004, MOL MARKERS NATURAL; Blair C, 2012, MOL ECOL RESOUR, V12, P822, DOI 10.1111/j.1755-0998.2012.03151.x; Burgmeier NG, 2011, J HERPETOL, V45, P195, DOI 10.1670/10-094.1; Burgmeier NG, 2011, HERPETOLOGICA, V67, P135, DOI 10.1655/HERPETOLOGICA-D-10-00027.1; Busch JD, 2007, MOL ECOL, V16, P2450, DOI 10.1111/j.1365-294X.2007.03283.x; Castric V, 2001, EVOLUTION, V55, P1016, DOI 10.1554/0014-3820(2001)055[1016:LSAHGD]2.0.CO;2; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Costello AB, 2003, EVOLUTION, V57, P328, DOI 10.1111/j.0014-3820.2003.tb00267.x; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Crowhurst RS, 2011, CONSERV GENET, V12, P637, DOI 10.1007/s10592-010-0170-0; Curtis JMR, 2004, BIOL CONSERV, V115, P45, DOI 10.1016/S0006-3207(03)00092-2; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Dionne M, 2008, MOL ECOL, V17, P2382, DOI 10.1111/j.1365-294X.2008.03771.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Echelle AA, 2010, CONSERV GENET, V11, P1375, DOI 10.1007/s10592-009-9966-1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Finn DS, 2007, FRESHWATER BIOL, V52, P1881, DOI 10.1111/j.1365-2427.2007.01813.x; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Gall BG, 2010, ETHOLOGY, V116, P47, DOI 10.1111/j.1439-0310.2009.01718.x; Garner TWJ, 2004, MOL ECOL, V13, P1047, DOI 10.1111/j.1365-294X.2004.02119.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grant EHC, 2007, ECOL LETT, V10, P165, DOI 10.1111/j.1461-0248.2006.01007.x; Grant EHC, 2010, P NATL ACAD SCI USA, V107, P6936, DOI 10.1073/pnas.1000266107; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P2222, DOI 10.1093/bioinformatics/btn419; Hailer F, 2006, BIOL LETTERS, V2, P316, DOI 10.1098/rsbl.2006.0453; Hughes JM, 2009, BIOSCIENCE, V59, P573, DOI 10.1525/bio.2009.59.7.8; Humphries WJ, 2005, J HERPETOL, V34, P604; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2008, CAN J FISH AQUAT SCI, V65, P2752, DOI 10.1139/F08-171; Kanno Y, 2011, MOL ECOL, V20, P3711, DOI 10.1111/j.1365-294X.2011.05210.x; Kelly MW, 2005, CONSERV GENET, V6, P789, DOI 10.1007/s10592-005-9037-1; King TL, 2001, MOL ECOL, V10, P807, DOI 10.1046/j.1365-294X.2001.01231.x; Krosch MN, 2011, FRESHWATER BIOL, V56, P1328, DOI 10.1111/j.1365-2427.2010.02571.x; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Latch EK, 2008, J HERED, V99, P265, DOI 10.1093/jhered/esn009; Leberg PL, 2010, MOLECULAR APPROACHES IN NATURAL RESOURCE CONSERVATION AND MANAGEMENT, P212; Lippe C, 2006, MOL ECOL, V15, P1769, DOI 10.1111/j.1365-294X.2006.02902.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2005, BIOTROPICA, V37, P222, DOI 10.1111/j.1744-7429.2005.00029.x; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; MEFFE G K, 1988, Conservation Biology, V2, P157, DOI 10.1111/j.1523-1739.1988.tb00167.x; Mullen LB, 2010, MOL ECOL, V19, P898, DOI 10.1111/j.1365-294X.2010.04541.x; Nickerson M.A., 1973, Publications Biol Geol Milwaukee publ Mus, VNo. 1,1973, P1; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pittman SE, 2011, CONSERV GENET, V12, P1589, DOI 10.1007/s10592-011-0257-2; Poissant J, 2005, MOL ECOL, V14, P1321, DOI 10.1111/j.1365-294X.2005.02500.x; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Quattro JM, 2002, CONSERV GENET, V3, P155, DOI 10.1023/A:1015275602748; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; Rhodes OE, 2010, MOLECULAR APPROACHES IN NATURAL RESOURCE CONSERVATION AND MANAGEMENT, P296; Rieux A, 2011, MOL ECOL, V20, P1661, DOI 10.1111/j.1365-294X.2011.05053.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sabatino SJ, 2009, CONSERV GENET, V10, P1235, DOI 10.1007/s10592-008-9655-5; Sambrook J., 2001, MOL CLONING LAB MANU; Samuiloviene A, 2009, FISH PHYSIOL BIOCHEM, V35, P649, DOI 10.1007/s10695-009-9310-1; Seymour AM, 2001, ANIM CONSERV, V4, P211, DOI 10.1017/S1367943001001251; Sterling KA, 2012, CONSERV GENET, V13, P859, DOI 10.1007/s10592-012-0335-0; STONEBURNER DL, 1978, FRESHWATER BIOL, V8, P291, DOI 10.1111/j.1365-2427.1978.tb01450.x; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tonione M, 2011, GENETICA, V139, P209, DOI 10.1007/s10709-010-9538-9; Unger SD, 2012, AMPHIBIA-REPTILIA, V33, P313, DOI 10.1163/156853812X641712; Unger SD, 2010, CONSERV GENET RESOUR, V2, P89, DOI 10.1007/s12686-009-9170-0; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wheeler BA, 2003, BIOL CONSERV, V109, P151, DOI 10.1016/S0006-3207(02)00136-2; Wooten JA, 2011, ACTA HERPETOL, V6, P175; Yang RC, 1998, EVOLUTION, V52, P950, DOI 10.1111/j.1558-5646.1998.tb01824.x	82	17	17	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e74180	10.1371/journal.pone.0074180	http://dx.doi.org/10.1371/journal.pone.0074180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204565	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300002
J	Yang, GK; Maahs, DM; Perkins, BA; Cherney, DZI				Yang, Gary K.; Maahs, David M.; Perkins, Bruce A.; Cherney, David Z. I.			Renal Hyperfiltration and Systemic Blood Pressure in Patients with Uncomplicated Type 1 Diabetes Mellitus	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; HEMODYNAMIC FUNCTION; ENDOTHELIAL FUNCTION; GLOMERULAR HYPERFILTRATION; ARTERIAL STIFFNESS; HYPERGLYCEMIA; INHIBITION; HUMANS; RESPONSES; HYPERTENSION	Background: Patients with type 1 diabetes mellitus (DM) and renal hyperfiltration also exhibit systemic microvascular abnormalities, including endothelial dysfunction. The effect of renal hyperfiltration on systemic blood pressure (BP) is less clear. We therefore measured BP, renal hemodynamic function and circulating renin angiotensin aldosterone system (RAAS) mediators in type 1 DM patients with hyperfiltration (n = 36, DM-H, GFR >= 135 ml/min/1.73 m(2)) or normofiltration (n = 40, DM-N), and 56 healthy controls (HC). Since renal hyperfiltration represents a state of intrarenal RAAS activation, we hypothesized that hyperfiltration would be associated with higher BP and elevated levels of circulating RAAS mediators. Methods: BP, glomerular filtration rate (GFR -inulin), effective renal plasma flow (paraaminohippurate) and circulating RAAS components were measured in DM-H, DM-N and HC during clamped euglycemia (4-6 mmol/L). Studies were repeated in DM-H and DM-N during clamped hyperglycemia (9-11 mmol/L). Results: Baseline GFR was elevated in DM-H vs. DM-N and HC (167 +/- 6 vs. 11562 and 115 +/- 2 ml/min/1.73 m(2), p<0.0001). Baseline systolic BP (SBP, 117 +/- 2 vs. 111 +/- 2 vs. 109 +/- 1, p = 0.004) and heart rate (76 +/- 1 vs. 67 +/- 1 vs. 61 +/- 1, p<0.0001) were higher in DM-H vs. DM-N and HC. Despite higher SBP in DM-H, plasma aldosterone was lower in DM-H vs. DM-N and HC (42 +/- 5 vs. 86 +/- 14 vs. 276 +/- 41 ng/dl, p = 0.01). GFR (p<0.0001) and SBP (p<0.0001) increased during hyperglycemia in DM-N but not in DM-H. Conclusions: DM-H was associated with higher heart rate and SBP values and an exaggerated suppression of systemic aldosterone. Future work should focus on the mechanisms that explain this paradox in diabetes of renal hyperfiltration coupled with systemic RAAS suppression.	[Yang, Gary K.] Univ Toronto, Fac Med, Toronto, ON M5G 1L7, Canada; [Maahs, David M.] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Perkins, Bruce A.] Univ Toronto, Toronto Gen Hosp, Div Endocrinol, Dept Med, Toronto, ON M5G 1L7, Canada; [Cherney, David Z. I.] Univ Toronto, Toronto Gen Hosp, Div Nephrol, Dept Med, Toronto, ON M5G 1L7, Canada	University of Toronto; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Cherney, DZI (corresponding author), Univ Toronto, Toronto Gen Hosp, Div Nephrol, Dept Med, Toronto, ON M5G 1L7, Canada.	david.cherney@uhn.on.ca	Perkins, Bruce A/L-3726-2017	Yang, Gary/0000-0002-3039-4392; Maahs, David/0000-0002-4602-7909	Kidney Foundation of Canada; Canadian Diabetes Association-KRESCENT Program; Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research	Kidney Foundation of Canada; Canadian Diabetes Association-KRESCENT Program; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	DC was also supported by a Kidney Foundation of Canada Scholarship and a Canadian Diabetes Association-KRESCENT Program Joint New Investigator Award. Operating funds were provided by the Heart and Stroke Foundation of Canada and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cherney DZI, 2010, DIABETIC MED, V27, P1358, DOI 10.1111/j.1464-5491.2010.03121.x; Cherney DZI, 2008, DIABETES, V57, P688, DOI 10.2337/db07-1230; Cherney DZI, 2012, DIABETES CARE, V35, P2324, DOI 10.2337/dc12-0773; Cherney DZI, 2012, AM J PHYSIOL-REG I, V303, pR710, DOI 10.1152/ajpregu.00286.2012; Cherney DZI, 2010, NEPHROL DIAL TRANSPL, V25, P4093, DOI 10.1093/ndt/gfq564; Cherney DZI, 2010, DIABETES CARE, V33, P2068, DOI 10.2337/dc10-0767; Cherney DZI, 2010, AM J PHYSIOL-REG I, V299, pR206, DOI 10.1152/ajpregu.00027.2010; Cherney DZI, 2010, DIABETES CARE, V33, P1344, DOI 10.2337/dc09-2340; Cherney DZI, 2010, DIABETES CARE, V33, P361, DOI 10.2337/dc09-1303; Cherney DZI, 2005, KIDNEY INT, V68, P1722, DOI 10.1111/j.1523-1755.2005.00588.x; Chillaron JJ, 2011, J DIABETES COMPLICAT, V25, P232, DOI 10.1016/j.jdiacomp.2011.03.006; Christiansen EH, 1998, EUR HEART J, V19, P1735, DOI 10.1053/euhj.1998.1090; DAVIDSON WD, 1963, J LAB CLIN MED, V62, P351; Ficociello LH, 2009, DIABETES CARE; FLORAS JS, 1993, J HYPERTENS, V11, P647, DOI 10.1097/00004872-199306000-00009; FLORIJN KW, 1994, KIDNEY INT, V46, P252, DOI 10.1038/ki.1994.267; Harrison-Bernard LM, 2009, ADV PHYSIOL EDUC, V33, P270, DOI 10.1152/advan.00049.2009; Hopkins PN, 1996, J HYPERTENS, V14, P199, DOI 10.1097/00004872-199602000-00008; Imano E, 2001, DIABETES RES CLIN PR, V52, P185, DOI 10.1016/S0168-8227(01)00219-4; Jacobsen P, 2003, J INTERN MED, V254, P464, DOI 10.1046/j.1365-2796.2003.01216.x; Jerums G, 2010, DIABETOLOGIA, V53, P2093, DOI 10.1007/s00125-010-1794-9; JUNG K, 1990, NEPHRON, V54, P360, DOI 10.1159/000185900; KALINYAK JE, 1993, J AM SOC NEPHROL, V4, P1337; KIKKAWA R, 1986, RENAL PHYSIOL BIOCH, V9, P187; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; Marcovecchio ML, 2009, DIABETOLOGIA, V52, P1173, DOI 10.1007/s00125-009-1327-6; Miller JA, 1999, J AM SOC NEPHROL, V10, P1778; Miller JA, 1996, CLIN SCI, V90, P189, DOI 10.1042/cs0900189; Miller JA, 2003, DIABETES, V52, P1806, DOI 10.2337/diabetes.52.7.1806; Pecis M, 1997, DIABETES CARE, V20, P1329, DOI 10.2337/diacare.20.8.1329; Price DA, 1999, J AM SOC NEPHROL, V10, P2382; Ritz E, 2007, CURR HYPERTENS REP, V9, P409, DOI 10.1007/s11906-007-0075-6; Rodrigues TD, 2006, DIABETES RES CLIN PR, V74, P135, DOI 10.1016/j.diabres.2006.03.016; ROSENBERG ME, 1994, KIDNEY INT, V45, P403, DOI 10.1038/ki.1994.52; Rosolowsky ET, 2008, DIABETES RES CLIN PR, V82, pS46, DOI 10.1016/j.diabres.2008.09.018; Ruggenenti P, 2012, DIABETES CARE, V35, P2061, DOI 10.2337/dc11-2189; Sasson AN, 2012, WORLD J DIABETES, V3, P1, DOI 10.4239/wjd.v3.i1.1; Sochett EB, 2006, J AM SOC NEPHROL, V17, P1703, DOI 10.1681/ASN.2005080872; SOWERS JR, 1995, HYPERTENSION, V26, P869, DOI 10.1161/01.HYP.26.6.869; Thulesen J, 1999, NEPHRON, V81, P172, DOI 10.1159/000045274; Torbjornsdotter TB, 2004, DIABETES CARE, V27, P510, DOI 10.2337/diacare.27.2.510; Vervoort G, 2005, EUR J CLIN INVEST, V35, P330, DOI 10.1111/j.1365-2362.2005.01497.x; ZATZ R, 1986, J CLIN INVEST, V77, P1925, DOI 10.1172/JCI112521	43	54	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68908	10.1371/journal.pone.0068908	http://dx.doi.org/10.1371/journal.pone.0068908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861950	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700107
J	Wang, RC; Kniazeva, M; Han, M				Wang, Rencheng; Kniazeva, Marina; Han, Min			Peroxisome Protein Transportation Affects Metabolism of Branched-Chain Fatty Acids That Critically Impact Growth and Development of C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; BIOSYNTHESIS; ROLES; DISORDERS; PATHWAY; GENES	The impact of specific lipid molecules, including fatty acid variants, on cellular and developmental regulation is an important research subject that remains under studied. Monomethyl branched-chain fatty acids (mmBCFAs) are commonly present in multiple organisms including mammals, however our understanding of mmBCFA functions is very limited. C. elegans has been the premier model system to study the functions of mmBCFAs and their derived lipids, as mmBCFAs have been shown to play essential roles in post-embryonic development in this organism. To understand more about the metabolism of mmBCFAs in C. elegans, we performed a genetic screen for suppressors of the L1 developmental arrest phenotype caused by mmBCFA depletion. Extensive characterization of one suppressor mutation identified prx-5, which encodes an ortholog of the human receptor for the type-1 peroxisomal targeting signal protein. Our study showed that inactivating prx-5 function compromised the peroxisome protein import, resulting in an increased level of branched-chain fatty acid C17ISO in animals lacking normal mmBCFA synthesis, thereby restoring wild-type growth and development. This work reveals a novel connection between peroxisomal functions and mmBCFA metabolism.	[Han, Min] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Han, M (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.	mhan@colorado.edu		You, Hai-Lu/0000-0003-2203-6461	Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the Howard Hughes Medical Institute Investigator fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Heird WC, 2005, ANNU REV NUTR, V25, P549, DOI 10.1146/annurev.nutr.24.012003.132254; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; HRADEC J, 1994, J CHROMATOGR B, V660, P386, DOI 10.1016/0378-4347(94)00292-4; Jones LN, 1997, MICRON, V28, P469, DOI 10.1016/S0968-4328(97)00039-5; Joo HJ, 2009, BIOCHEM J, V422, P61, DOI 10.1042/BJ20090513; Jordan SD, 2010, CELL MOL LIFE SCI, V67, P3255, DOI 10.1007/s00018-010-0414-7; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kniazeva M, 2008, GENE DEV, V22, P2102, DOI 10.1101/gad.1692008; Kniazeva M, 2012, GENE DEV, V26, P554, DOI 10.1101/gad.187054.112; Moser HW, 1999, MOL GENET METAB, V68, P316, DOI 10.1006/mgme.1999.2926; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Seamen E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000589; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Thieringer H, 2003, J CELL SCI, V116, P1797, DOI 10.1242/jcs.00380; Vrablik TL, 2013, MOL REPROD DEV, V80, P244, DOI 10.1002/mrd.22167; Vrablik TL, 2012, GENE DEV, V26, P631, DOI 10.1101/gad.190777.112; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Webster CM, 2013, DEV BIOL, V373, P14, DOI 10.1016/j.ydbio.2012.10.002; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; YEAGLE PL, 1989, FASEB J, V3, P1833, DOI 10.1096/fasebj.3.7.2469614; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107; Zhang YR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-164; Zhu H, 2013, ELIFE IN PRESS; Zhu HH, 2013, ELIFE, V2, DOI 10.7554/eLife.00429; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	35	14	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76270	10.1371/journal.pone.0076270	http://dx.doi.org/10.1371/journal.pone.0076270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24204734	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900092
J	Huang, HZ; Ding, Y; Sun, XZS; Nguyen, TA				Huang, Hongzhou; Ding, Ying; Sun, Xiuzhi S.; Nguyen, Thu A.			Peptide Hydrogelation and Cell Encapsulation for 3D Culture of MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							IN-VITRO; SCAFFOLDS; DESIGN; BETA; DIFFERENTIATION; NANOFIBERS; MEDICINE; BIOLOGY; TISSUES; GROWTH	Three-dimensional (3D) cell culture plays an invaluable role in tumor biology by providing in vivo like microenviroment and responses to therapeutic agents. Among many established 3D scaffolds, hydrogels demonstrate a distinct property as matrics for 3D cell culture. Most of the existing pre-gel solutions are limited under physiological conditions such as undesirable pH or temperature. Here, we report a peptide hydrogel that shows superior physiological properties as an in vitro matrix for 3D cell culture. The 3D matrix can be accomplished by mixing a self-assembling peptide directly with a cell culture medium without any pH or temperature adjustment. Results of dynamic rheological studies showed that this hydrogel can be delivered multiple times via pipetting without permanently destroying the hydrogel architecture, indicating the deformability and remodeling ability of the hydrogel. Human epithelial cancer cells, MCF-7, are encapsulated homogeneously in the hydrogel matrix during hydrogelation. Compared with two-dimensional (2D) monolayer culture, cells residing in the hydrogel matrix grow as tumor-like clusters in 3D formation. Relevant parameters related to cell morphology, survival, proliferation, and apoptosis were analyzed using MCF-7 cells in 3D hydrogels. Interestingly, treatment of cisplatin, an anti-cancer drug, can cause a significant decrease of cell viability of MCF-7 clusters in hydrogels. The responses to cisplatin were dose- and time-dependent, indicating the potential usage of hydrogels for drug testing. Results of confocal microscopy and Western blotting showed that cells isolated from hydrogels are suitable for downstream proteomic analysis. The results provided evidence that this peptide hydrogel is a promising 3D cell culture material for drug testing.	[Huang, Hongzhou; Sun, Xiuzhi S.] Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA; [Ding, Ying] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Nguyen, Thu A.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Kansas State University	Sun, XZS (corresponding author), Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA.	xss@k-state.edu; tnguyen@vet.k-state.edu	Ding, Ying/M-8060-2017	Ding, Ying/0000-0001-8600-9740	KSU Targeted Excellence Program; KSU Research Foundation Scholarship Program; Kansas Agricultural Experiment Station [12-181-J]; NATIONAL CANCER INSTITUTE [R15CA152922] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; Directorate For Engineering [1321261] Funding Source: National Science Foundation	KSU Targeted Excellence Program; KSU Research Foundation Scholarship Program; Kansas Agricultural Experiment Station; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This project was partially funded by KSU Targeted Excellence Program and KSU Research Foundation Scholarship Program as well as the contribution (no. 12-181-J) from the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azab AK, 2006, J CONTROL RELEASE, V111, P281, DOI 10.1016/j.jconrel.2005.12.014; Barralet JE, 2005, J MATER SCI-MATER M, V16, P515, DOI 10.1007/s10856-005-0526-z; Branco MC, 2010, BIOMATERIALS, V31, P9527, DOI 10.1016/j.biomaterials.2010.08.047; Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217; Cavalli S, 2010, CHEM SOC REV, V39, P241, DOI 10.1039/b906701a; Chawla K, 2011, BIOMACROMOLECULES, V12, P560, DOI 10.1021/bm100980w; Chignola R, 2000, CELL PROLIFERAT, V33, P219, DOI 10.1046/j.1365-2184.2000.00174.x; CHIRILA TV, 1993, BIOMATERIALS, V14, P26, DOI 10.1016/0142-9612(93)90072-A; Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171; Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI 10.1038/NNANO.2010.246; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027; Feder-Mengus C, 2008, TRENDS MOL MED, V14, P333, DOI 10.1016/j.molmed.2008.06.001; GORLACH A, 1994, INT J CANCER, V56, P249, DOI 10.1002/ijc.2910560218; Gurski LA, 2010, BIOMATERIALS, V31, P4248, DOI 10.1016/j.biomaterials.2010.01.141; Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h; Huang HZ, 2011, SOFT MATTER, V7, P8905, DOI 10.1039/c1sm05157a; Kelter G, 2005, ANTI-CANCER DRUG, V16, P1091, DOI 10.1097/00001813-200511000-00008; Kyle S, 2009, TRENDS BIOTECHNOL, V27, P423, DOI 10.1016/j.tibtech.2009.04.002; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100; Liu SQ, 2010, SOFT MATTER, V6, P67, DOI 10.1039/b916705f; Mather ML, 2010, REGEN MED, V5, P809, DOI 10.2217/RME.10.32; Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Perez-Castillejos R, 2010, MATER TODAY, V13, P32, DOI 10.1016/S1369-7021(10)70015-8; Rapaport H, 2008, ADV FUNCT MATER, V18, P2889, DOI 10.1002/adfm.200800117; Salick DA, 2009, ADV MATER, V21, P4120, DOI 10.1002/adma.200900189; SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005; Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g; Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107; Shea LD, 1999, NAT BIOTECHNOL, V17, P551, DOI 10.1038/9853; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k; ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508; Zhang S, 2008, ADV CANCER RES, V99, P335, DOI 10.1016/S0065-230X(07)99005-3	40	158	163	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59482	10.1371/journal.pone.0059482	http://dx.doi.org/10.1371/journal.pone.0059482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527204	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600075
J	Shen, LJ; Chen, FY; Zhang, Y; Cao, LF; Kuang, Y; Zhong, M; Wang, T; Zhong, H				Shen, Li-Jing; Chen, Fang-Yuan; Zhang, Yong; Cao, Lan-Fang; Kuang, Ying; Zhong, Min; Wang, Ting; Zhong, Hua			MYCN Transgenic Zebrafish Model with the Characterization of Acute Myeloid Leukemia and Altered Hematopoiesis	PLOS ONE			English	Article							GENE-EXPRESSION; DNA-DAMAGE; STEM-CELLS; TGF-BETA; C-MYC; DIFFERENTIATION; SCL; PROLIFERATION; ARREST; GROWTH	Background: Amplification of MYCN (N-Myc) oncogene has been reported as a frequent event and a poor prognostic marker in human acute myeloid leukemia (AML). The molecular mechanisms and transcriptional networks by which MYCN exerts its influence in AML are largely unknown. Methodology/Principal Findings: We introduced murine MYCN gene into embryonic zebrafish through a heat-shock promoter and established the stable germline Tg(MYCN: HSE:EGFP) zebrafish. N-Myc downstream regulated gene 1 (NDRG1), negatively controlled by MYCN in human and functionally involved in neutrophil maturation, was significantly under-expressed in this model. Using peripheral blood smear detection, histological section and flow cytometric analysis of single cell suspension from kidney and spleen, we found that MYCN overexpression promoted cell proliferation, enhanced the repopulating activity of myeloid cells and the accumulation of immature hematopoietic blast cells. MYCN enhanced primitive hematopoiesis by upregulating sc1 and Imo2 expression and promoted myelopoiesis by inhibiting gata1 expression and inducing pu.1, mpo expression. Microarray analysis identified that cell cycle, glycolysis/gluconeogenesis, MAPK/Ras, and p53-mediated apoptosis pathways were upregulated. In addition, mismatch repair, transforming and growth factor beta(TGF beta) were downregulated in MYCN-overexpressing blood cells (p<0.01). All of these signaling pathways are critical in the proliferation and malignant transformation of blood cells. Conclusion/Significance: The above results induced by overexpression of MYCN closely resemble the main aspects of human AML, suggesting that MYCN plays a role in the etiology of AML. MYCN reprograms hematopoietic cell fate by regulating NDRG1 and several lineage-specific hematopoietic transcription factors. Therefore, this MYCN transgenic zebrafish model facilitates dissection of MYCN-mediated signaling in vivo, and enables high-throughput scale screens to identify the potential therapeutic targets.	[Shen, Li-Jing; Chen, Fang-Yuan; Zhang, Yong; Zhong, Min; Wang, Ting; Zhong, Hua] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Hematol, Shanghai 200030, Peoples R China; [Cao, Lan-Fang] Shanghai Jiao Tong Univ, Sch Med, Dept Pediat, Renji Hosp, Shanghai 200030, Peoples R China; [Kuang, Ying] Shanghai Res Ctr Biomodel Organisms, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, FY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Hematol, Shanghai 200030, Peoples R China.	chenfangyuan62@163.com	; Rehman, Jalees/J-8258-2012	Marsboom, Glenn/0000-0001-6309-7557; Rehman, Jalees/0000-0002-2787-9292; Zhou, Yongqiang/0000-0003-1402-345X; Toth, Peter/0000-0003-2168-0124; Osburn, Christopher/0000-0002-9334-4202	National Natural Science Foundation of China [30900636]; Science and Technology Commission of Shanghai Municipality Grant [08JCI414900]; Science and Technology Fund Project of Shanghai Jiaotong University School of Medicine [09XJ21066]; Science and Technology Commission of Shanghai Fund Project of TCM guide project [12401906700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality Grant(Science & Technology Commission of Shanghai Municipality (STCSM)); Science and Technology Fund Project of Shanghai Jiaotong University School of Medicine; Science and Technology Commission of Shanghai Fund Project of TCM guide project	This work was supported in part by National Natural Science Foundation of China Grant (30900636), Science and Technology Commission of Shanghai Municipality Grant (08JCI414900), Science and Technology Fund Project of Shanghai Jiaotong University School of Medicine (09XJ21066), Science and Technology Commission of Shanghai Fund Project of TCM guide project (12401906700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Akers LJ, 2011, LEUKEMIA RES, V35, P814, DOI 10.1016/j.leukres.2010.12.028; Bajoghli B, 2004, DEV BIOL, V271, P416, DOI 10.1016/j.ydbio.2004.04.006; BECKMANN RP, 1992, J CELL BIOL, V117, P1137, DOI 10.1083/jcb.117.6.1137; Bell E, 2007, CELL CYCLE, V6, P1249, DOI 10.4161/cc.6.10.4222; Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Chen J, 2007, LEUKEMIA, V21, P462, DOI 10.1038/sj.leu.2404546; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; CUNNIFF NFA, 1993, J BIOL CHEM, V268, P8317; de Boer J, 2011, LEUKEMIA, V25, P321, DOI 10.1038/leu.2010.253; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; Dooley KA, 2005, DEV BIOL, V277, P522, DOI 10.1016/j.ydbio.2004.09.004; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Fujimori H, 2008, J HEPATOL, V48, P962, DOI 10.1016/j.jhep.2008.01.031; Gupta Tripti, 2010, J Vis Exp, DOI 10.3791/1717; Halloran MC, 2000, DEVELOPMENT, V127, P1953; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x; Kawagoe H, 2007, CANCER RES, V67, P10677, DOI 10.1158/0008-5472.CAN-07-1118; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Langenau DM, 2005, P NATL ACAD SCI USA, V102, P6068, DOI 10.1073/pnas.0408708102; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Le HY, 2008, J BIOL CHEM, V283, P17652, DOI 10.1074/jbc.M710517200; Levantini E, 2011, EMBO J, V30, P4059, DOI 10.1038/emboj.2011.285; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lin YW, 2010, BLOOD, V115, P824, DOI 10.1182/blood-2009-07-233445; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007768; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Ng KP, 2011, LEUKEMIA, V25, P1739, DOI 10.1038/leu.2011.159; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Patterson LJ, 2007, BLOOD, V109, P2389, DOI 10.1182/blood-2006-02-003087; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rinaldi A, 2011, BRIT J HAEMATOL, V154, P590, DOI 10.1111/j.1365-2141.2011.08789.x; Rowley AF, 1997, THROMB HAEMOSTASIS, V77, P227; Scandurra M, 2010, HEMATOL ONCOL, V28, P62, DOI 10.1002/hon.932; Shafizadeh E, 2004, CURR OPIN HEMATOL, V11, P255, DOI 10.1097/01.moh.0000138686.15806.71; Sheppard RD, 1998, ONCOGENE, V17, P2073, DOI 10.1038/sj.onc.1202125; Sugihara E, 2006, CANCER RES, V66, P4020, DOI 10.1158/0008-5472.CAN-05-3250; Sun W, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-22; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tschan MP, 2010, LEUKEMIA RES, V34, P393, DOI 10.1016/j.leukres.2009.08.037; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P11; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wu H, 2012, ONCOL LETT, V3, P1119, DOI 10.3892/ol.2012.614; Yeh JRJ, 2008, DEVELOPMENT, V135, P401, DOI 10.1242/dev.008904	47	209	220	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59070	10.1371/journal.pone.0059070	http://dx.doi.org/10.1371/journal.pone.0059070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	24204740	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800054
